Citrus Sinensis ID: 045553
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1082 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S7I6 | 1151 | LRR receptor-like serine/ | yes | no | 0.966 | 0.908 | 0.511 | 0.0 | |
| Q9ZRF9 | 540 | Probable LRR receptor-lik | no | no | 0.406 | 0.814 | 0.553 | 1e-134 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.912 | 0.889 | 0.318 | 1e-123 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.887 | 0.805 | 0.306 | 1e-123 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.828 | 0.813 | 0.310 | 1e-120 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.960 | 0.831 | 0.298 | 1e-119 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.913 | 0.897 | 0.312 | 1e-118 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.864 | 0.831 | 0.311 | 1e-115 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.864 | 0.746 | 0.303 | 1e-114 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.851 | 0.919 | 0.314 | 1e-114 |
| >sp|Q9S7I6|RPK2_ARATH LRR receptor-like serine/threonine-protein kinase RPK2 OS=Arabidopsis thaliana GN=RPK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 977 bits (2525), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 583/1139 (51%), Positives = 726/1139 (63%), Gaps = 93/1139 (8%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNL------S 54
K+ LL+ K ++ DP + ++W + D CSW GV+CD S RV +LN+S + +
Sbjct: 47 KSVLLRFKKTVS-DPGSILASWVEESEDYCSWFGVSCDS-SSRVMALNISGSGSSEISRN 104
Query: 55 RTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRV 114
R +C + P G F C H L+GNL I LT LRV
Sbjct: 105 RFTCGDIGKFPLYG----FGVRRDCTGNH------------GALAGNLPSVIMSLTGLRV 148
Query: 115 LLLAFNGFSGELPLEIGQLSLLEILDLS------------------------FNSFHGPI 150
L L FN FSGE+P+ I + LE+LDL FN G I
Sbjct: 149 LSLPFNSFSGEIPVGIWGMEKLEVLDLEGNLMTGSLPDQFTGLRNLRVMNLGFNRVSGEI 208
Query: 151 PPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLE 210
P +LQN + L ++NL GN+ NGT+P F G+ F+V+ L N L GS+P++ GD+C LE
Sbjct: 209 PNSLQNLTKLEILNLGGNKLNGTVPGFVGR---FRVLHLPLNWLQGSLPKDIGDSCGKLE 265
Query: 211 HILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI 270
H+ L+ N LTG IP SLG C LRSLLL N L+ IP FG L LEVLD+SRN LSG
Sbjct: 266 HLDLSGNFLTGRIPESLGKCAGLRSLLLYMNTLEETIPLEFGSLQKLEVLDVSRNTLSGP 325
Query: 271 VPSELGMCKQLKVLVLRNDYGPLYS-----REHGDLPIQPVVD---GGEDYNFFDGGLPD 322
+P ELG C L VLVL N Y +Y R DLP P D ED+NF+ GG+P+
Sbjct: 326 LPVELGNCSSLSVLVLSNLYN-VYEDINSVRGEADLP--PGADLTSMTEDFNFYQGGIPE 382
Query: 323 SITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLD 382
ITRLP L++ W P LEG FP +W C LEM+NL NFF G+IP L CK+L LD
Sbjct: 383 EITRLPKLKILWVPRATLEGRFPGDWGSCQNLEMVNLGQNFFKGEIPVGLSKCKNLRLLD 442
Query: 383 LSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRI---SHSEC------SKMSVNWSMS 433
LSSN LTG L +E+SVPCM+VF+V N LSG IP + S C + S+ S
Sbjct: 443 LSSNRLTGELLKEISVPCMSVFDVGGNSLSGVIPDFLNNTTSHCPPVVYFDRFSIE---S 499
Query: 434 QVDLIGFYTAFFYENALTSCAPFSSPSNG-LFILHDFSNNLFTGPVPPFLIDSDSLSSRP 492
D Y +FF E A + S+G + H+F++N FTG + + + L R
Sbjct: 500 YSDPSSVYLSFFTEKAQVGTSLIDLGSDGGPAVFHNFADNNFTGTLKSIPLAQERLGKRV 559
Query: 493 YYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAG 552
Y F GN L G FD C L + ++ NKL G +P + + C +K L +
Sbjct: 560 SYIFSAGGNRLYGQFPGNLFDNCDELKAVYVNVSFNKLSGRIPQGLNNMCTSLKILDASV 619
Query: 553 NEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWEL 611
N+ G IP S + SL LNLS N LQG +P + KM L +LS++ NN TG IP
Sbjct: 620 NQIFGPIPTSLGDLASLVALNLSWNQLQGQIPGSLGKKMAALTYLSIANNNLTGQIPQSF 679
Query: 612 TQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVS 671
QL SL+VL+LS+N LSG IP +F L++L VL L++NNL+G IP GF T ++F+VS
Sbjct: 680 GQLHSLDVLDLSSNHLSGGIPHDFVNLKNLTVLLLNNNNLSGPIPSGFAT---FAVFNVS 736
Query: 672 FNNLSGSAP-RNSLIKCENVQGNPNLQLCH----TDPSSSEWERQHSGN-VSQQEAYSPS 725
NNLSG P N L KC V GNP L+ CH T PSS R +G+ ++Q A SP
Sbjct: 737 SNNLSGPVPSTNGLTKCSTVSGNPYLRPCHVFSLTTPSSDS--RDSTGDSITQDYASSPV 794
Query: 726 ESIQGNS---SGLNPIEIASITSAAVILSVLIALVLLLICMKKFSCNSIADPGLVRKEVV 782
E+ S G N +EIASI SA+ I+SVLIALV+L +K+ S ++EV
Sbjct: 795 ENAPSQSPGKGGFNSLEIASIASASAIVSVLIALVILFFYTRKWHPKS-KIMATTKREVT 853
Query: 783 ICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQ 842
+ +IGV +T++NVVRAT FN N IG+GGFGATYKAEI VVVA+KRLS+GRFQGVQ
Sbjct: 854 MFMDIGVPITFDNVVRATGNFNASNLIGNGGFGATYKAEISQDVVVAIKRLSIGRFQGVQ 913
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
QF AEI+TLGR++HPNLVTLIGYH SE EMFL+YNYLPGGNLEKFIQ+R R +W +LH
Sbjct: 914 QFHAEIKTLGRLRHPNLVTLIGYHASETEMFLVYNYLPGGNLEKFIQERSTR--DWRVLH 971
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
KIALD+ARALAYLHD+CVPRVLHRD+KPSNILLD++ NAYLSDFGLARLLGTSETHATT
Sbjct: 972 KIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDCNAYLSDFGLARLLGTSETHATTG 1031
Query: 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022
VAGTFGYVAPEYAMTCRVSDKADVYS+GVVLLEL+SDKKALDPSF S+GNGFNIV WA M
Sbjct: 1032 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFVSYGNGFNIVQWACM 1091
Query: 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081
LL QGR EFFTAGLWD GPHDDL+E+L+LA++CT +SLS+RP+M+QV ++LKQ+QPP+
Sbjct: 1092 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPPS 1150
|
Key regulator of anther development (e.g. lignification pattern), including tapetum degradation during pollen maturation (e.g. germination capacity). Together with RPK1, required for pattern formation along the radial axis (e.g. the apical embryonic domain cell types that generate cotyledon primordia), and the apical-basal axis (e.g. differentiation of the basal pole during early embryogenesis). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZRF9|RPK1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RPK1 OS=Arabidopsis thaliana GN=RPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 479 bits (1232), Expect = e-134, Method: Compositional matrix adjust.
Identities = 271/490 (55%), Positives = 329/490 (67%), Gaps = 50/490 (10%)
Query: 592 DLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNL 651
DL S S G I + L+ + VL LS N L GEIP E LE L +L L NN
Sbjct: 96 DLSSCSSSKRRLGGVISPVVGDLSEIRVLSLSFNDLRGEIPKEIWGLEKLEILDLKGNNF 155
Query: 652 TG--RIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQLCHTDPSSSEWE 709
G R+ R +S D E+ G PSS++ +
Sbjct: 156 IGGIRVVDNVVLRKLMSFED------------------EDEIG----------PSSADDD 187
Query: 710 RQHSGNVSQQEAYSPSESIQGNSSGLNPIEIASITSAAVILSVLIALVLLLICMKKFSCN 769
SP + SGL PIEIASI SA+VI+ VL+ LV+L I +K+ N
Sbjct: 188 -------------SPGK------SGLYPIEIASIVSASVIVFVLLVLVILFIYTRKWKRN 228
Query: 770 SIADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVA 829
S + KE+ + +IG+ LTYE +VRAT F+ NCIG GGFG+TYKAE+ P V A
Sbjct: 229 SQVQVDEI-KEIKVFVDIGIPLTYEIIVRATGYFSNSNCIGHGGFGSTYKAEVSPTNVFA 287
Query: 830 VKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ 889
VKRLSVGRFQG QQF AEI L V+HPNLV LIGYH SE EMFLIYNYL GGNL+ FI+
Sbjct: 288 VKRLSVGRFQGDQQFHAEISALEMVRHPNLVMLIGYHASETEMFLIYNYLSGGNLQDFIK 347
Query: 890 DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949
+R + +EW +LHKIALDVARAL+YLH++C P+VLHRDIKPSNILLDNN NAYLSDFGL+
Sbjct: 348 ERSKAAIEWKVLHKIALDVARALSYLHEQCSPKVLHRDIKPSNILLDNNYNAYLSDFGLS 407
Query: 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS 1009
+LLGTS++H TT VAGTFGYVAPEYAMTCRVS+KADVYS+G+VLLELISDK+ALDPSF S
Sbjct: 408 KLLGTSQSHVTTGVAGTFGYVAPEYAMTCRVSEKADVYSYGIVLLELISDKRALDPSFSS 467
Query: 1010 FGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQ 1069
NGFNIV+WA M+L QG+ E FT GLW+ GP DDL+E+L+LA+ CT +SLS RP+M+Q
Sbjct: 468 HENGFNIVSWAHMMLSQGKAKEVFTTGLWETGPPDDLVEVLHLALKCTVDSLSIRPTMKQ 527
Query: 1070 VAQQLKQIQP 1079
+ LK+IQP
Sbjct: 528 AVRLLKRIQP 537
|
Involved in the main abscisic acid-mediated (ABA) signaling pathway and in early ABA perception. Together with RPK2, required for pattern formation along the radial axis (e.g. the apical embryonic domain cell types that generate cotyledon primordia), and the apical-basal axis (e.g. differentiation of the basal pole during early embryogenesis). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 444 bits (1141), Expect = e-123, Method: Compositional matrix adjust.
Identities = 367/1152 (31%), Positives = 519/1152 (45%), Gaps = 165/1152 (14%)
Query: 3 ALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSLLS 62
ALL L T P +T +WN D+ CSW GV CD V +LNLSS
Sbjct: 30 ALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVECDRRQ-FVDTLNLSSY---------- 78
Query: 63 LPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGF 122
+SG I L L+ ++L+ NGF
Sbjct: 79 ----------------------------------GISGEFGPEISHLKHLKKVVLSGNGF 104
Query: 123 SGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSP 182
G +P ++G SLLE +DLS NSF G IP TL +LR ++L N G P P
Sbjct: 105 FGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIP 164
Query: 183 GFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNM 242
+ V + N L+GS+P G N L + L N +G +P SLGN T L+ L L+ N
Sbjct: 165 HLETVYFTGNGLNGSIPSNIG-NMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNN 223
Query: 243 LQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLP 302
L G +P + L NL LD+ N L G +P + CKQ+ + L N
Sbjct: 224 LVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQIDTISLSN-------------- 269
Query: 303 IQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHN 362
N F GGLP + +LR F A + L G P + +KL+ L LA N
Sbjct: 270 -----------NQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGN 318
Query: 363 FFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSV-PCMAVFNVSQNLLSGEIP----R 417
F+G+IP LG CKS+ L L N L G +P E+ + + ++ N LSGE+P +
Sbjct: 319 HFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWK 378
Query: 418 ISHSECSKMSVN-----WSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNN 472
I + ++ N + +L + YEN T P +N + D + N
Sbjct: 379 IQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRN 438
Query: 473 LFTGPVPPFLIDSDSLSSRPYYGF-WLSG-------------------NSLKGNLSTYPF 512
+FTG +PP L L R G+ +L G N+L+G L
Sbjct: 439 MFTGHIPPNLCSQKKLK-RLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLP---- 493
Query: 513 DLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNL 572
D + L FD+ N G +P +G + K + + ++ N+ G IP + L +L
Sbjct: 494 DFVEKQNLLFFDLSGNNFTGPIPPSLG-NLKNVTAIYLSSNQLSGSIPPELGSLVKLEHL 552
Query: 573 NLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIP 632
NLS N L+G LPS ++ L L S N G+IP L L L L L NS SG IP
Sbjct: 553 NLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIP 612
Query: 633 SEF-----------------------SKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFD 669
+ L+ L L L N L G++P G L D
Sbjct: 613 TSLFQSNKLLNLQLGGNLLAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLKMLEELD 672
Query: 670 VSFNNLSGSAPRNSLIKCE---NVQGN-------PNL-QLCHTDPSSSEWERQHSGNVSQ 718
VS NNLSG+ S I+ N+ N P+L + ++ P+S N
Sbjct: 673 VSHNNLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINCPA 732
Query: 719 QEAYSPSESIQGNSSGLNPIEIASITSAAVILSVLIALVLL-----LICMKKFSCNSIAD 773
P SI L P + S T + ++ IA+++L +IC+ FS
Sbjct: 733 DGLACPESSI------LRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLH 786
Query: 774 PGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRL 833
+E+ I G V+ AT N + IG G G YKA + P V AVK+L
Sbjct: 787 CKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKL 846
Query: 834 S-VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQD-R 891
G G EI T+G+V+H NL+ L + + + ++Y Y+ G+L + +
Sbjct: 847 VFTGIKNGSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETN 906
Query: 892 PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951
P + ++WS H IA+ A LAYLH +C P ++HRDIKP NILLD++L ++SDFG+A+L
Sbjct: 907 PPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKL 966
Query: 952 LGTSETHATTD-VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSF 1010
L S T ++ V GT GY+APE A T S ++DVYS+GVVLLELI+ KKALDPSF
Sbjct: 967 LDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSF--- 1023
Query: 1011 GNG-FNIVAWASMLLLQGRPCEFFT-----AGLWDCGPHDDLIEMLNLAIMCTGESLSSR 1064
NG +IV W + Q + L D + + E L+LA+ C + + R
Sbjct: 1024 -NGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDKR 1082
Query: 1065 PSMRQVAQQLKQ 1076
P+MR V +QL +
Sbjct: 1083 PTMRDVVKQLTR 1094
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 347/1132 (30%), Positives = 525/1132 (46%), Gaps = 172/1132 (15%)
Query: 100 GNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSS 159
G + + I L LR L LA N FSG++P EI L L+ LDLS NS G +P L
Sbjct: 79 GQIPKEISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELPQ 138
Query: 160 LRLINLSGNQFNGTI-PAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANS 218
L ++LS N F+G++ P+FF P + +S N LSG +P E G +L ++ + NS
Sbjct: 139 LLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIG-KLSNLSNLYMGLNS 197
Query: 219 LTGSIPPSLGNCTELR------------------------SLLLSSNMLQGDIPSSFGQL 254
+G IP +GN + L+ L LS N L+ IP SFG+L
Sbjct: 198 FSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGEL 257
Query: 255 VNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQ----PVVDGG 310
NL +L+L L G++P ELG CK LK L+L ++ G LP++ P++
Sbjct: 258 HNLSILNLVSAELIGLIPPELGNCKSLKSLMLS------FNSLSGPLPLELSEIPLLTFS 311
Query: 311 EDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPA 370
+ N G LP + + L N G P E C L+ L+LA N +G IP
Sbjct: 312 AERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPR 371
Query: 371 SL------------GN------------CKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFN 405
L GN C SL L L++N + G +PE++ +P MA+ +
Sbjct: 372 ELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMAL-D 430
Query: 406 VSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTA-----------FFYENALTSCA 454
+ N +GEIP+ + M S ++++ G+ A +N LT
Sbjct: 431 LDSNNFTGEIPKSLWKSTNLMEFTASYNRLE--GYLPAEIGNAASLKRLVLSDNQLTGEI 488
Query: 455 PFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSS-------------------RPYYG 495
P + + + N+F G +P L D SL++
Sbjct: 489 PREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQC 548
Query: 496 FWLSGNSLKGNLSTYPF---------DLCLSLDGLIFDIGNNKLIGEVPSDMG------- 539
LS N+L G++ + P DL IFD+ N+L G +P ++G
Sbjct: 549 LVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVE 608
Query: 540 ----------------SHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
S + L ++GN G IP+ N L+ LNL+ N L G +
Sbjct: 609 ISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHI 668
Query: 584 PSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNV 643
P + L L+L+ N G +P L L L ++LS N+LSGE+ SE S +E L
Sbjct: 669 PESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVG 728
Query: 644 LRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQLCHTDP 703
L ++ N TG IP G + L DVS N LSG P + G PNL+ +
Sbjct: 729 LYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPT-------KICGLPNLEFLNLAK 781
Query: 704 SSSEWERQHSGNVSQ--QEAYSPSESIQGNSSGLN-PIEIASITSAAVILSVLIALVLLL 760
++ E G + S ++ + G G + IE + SA I +++ +++
Sbjct: 782 NNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAGLMLGFTIIV 841
Query: 761 IC----------------------MKKFSCNSIADPGLV-----RKEVVICNNIGV---- 789
M++ D L R + NI +
Sbjct: 842 FVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQP 901
Query: 790 --QLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAE 847
++ ++V AT F+ +N IG GGFG YKA + VAVK+LS + QG ++F AE
Sbjct: 902 LLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAE 961
Query: 848 IRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIA 905
+ TLG+V+HPNLV+L+GY E L+Y Y+ G+L+ +++++ ++WS KIA
Sbjct: 962 METLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIA 1021
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
+ AR LA+LH +P ++HRDIK SNILLD + ++DFGLARL+ E+H +T +AG
Sbjct: 1022 VGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAG 1081
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025
TFGY+ PEY + R + K DVYSFGV+LLEL++ K+ P F G N+V WA +
Sbjct: 1082 TFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKE-SEGGNLVGWAIQKIN 1140
Query: 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
QG+ + L + + +L +A++C E+ + RP+M V + LK+I
Sbjct: 1141 QGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1114), Expect = e-120, Method: Compositional matrix adjust.
Identities = 326/1051 (31%), Positives = 515/1051 (49%), Gaps = 155/1051 (14%)
Query: 122 FSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQS 181
SG+L IG L L+ LDLS+N G IP + NCSSL ++ L+ NQF+G IP G+
Sbjct: 85 LSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKL 144
Query: 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSN 241
+ + + N +SGS+P E G N +SL ++ +N+++G +P S+GN L S N
Sbjct: 145 VSLENLIIYNNRISGSLPVEIG-NLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQN 203
Query: 242 MLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQL-KVLVLRNDYGPLYSREHGD 300
M+ G +PS G +L +L L++N LSG +P E+GM K+L +V++ N++ RE +
Sbjct: 204 MISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISN 263
Query: 301 LPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLA 360
+ N G +P + L +L + L G P+ S ++ +
Sbjct: 264 CTSLETL--ALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFS 321
Query: 361 HNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS-VPCMAVFNVSQNLLSGEIPRIS 419
N TG+IP LGN + L L L N LTG +P E+S + ++ ++S N L+G IP
Sbjct: 322 ENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIP--- 378
Query: 420 HSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNG----LFILHDFSNNLFT 475
+ L G + ++N+L+ P P G L++L D S+N +
Sbjct: 379 ------------LGFQYLRGLFMLQLFQNSLSGTIP---PKLGWYSDLWVL-DMSDNHLS 422
Query: 476 GPVPPFL-------------------IDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCL 516
G +P +L I + + + L+ N+L G +P +LC
Sbjct: 423 GRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGR---FPSNLCK 479
Query: 517 SLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSR 576
++ ++G N+ G +P ++G +C ++ L +A N F G +P+ L LN+S
Sbjct: 480 QVNVTAIELGQNRFRGSIPREVG-NCSALQRLQLADNGFTGELPREIGMLSQLGTLNISS 538
Query: 577 NHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFS 636
N L G +PS I + L+ L + NNF+G +P E+ L LE+L+LS N+LSG IP
Sbjct: 539 NKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALG 598
Query: 637 KLEHLN-------------------------VLRLDHNNLTGRIPP-------------- 657
L L L L +N LTG IPP
Sbjct: 599 NLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLN 658
Query: 658 ----------GFGTRSSLSIFDVSFNNLSGSAP--RN----SLIKCENVQGNPNLQLCHT 701
F SSL ++ S+N+L+G P RN S I E + G P Q T
Sbjct: 659 NNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCGPPLNQCIQT 718
Query: 702 DPSSSEWERQHSGNVSQQEAYSPSESIQGNSSGLNPIEIASITSAAVILSVLIALVLLLI 761
P ++PS+S G G+ +I +IT AAVI V + L+ L++
Sbjct: 719 QP------------------FAPSQS-TGKPGGMRSSKIIAIT-AAVIGGVSLMLIALIV 758
Query: 762 CMKKFSCNSIA------DPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFG 815
+ + ++A P + ++ G T++++V AT F+ +G G G
Sbjct: 759 YLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG--FTFQDLVAATDNFDESFVVGRGACG 816
Query: 816 ATYKAEIIPGVVVAVKRLSVGRFQG-----VQQFAAEIRTLGRVQHPNLVTLIGYHVSEA 870
YKA + G +AVK+L+ G F AEI TLG ++H N+V L G+ +
Sbjct: 817 TVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQG 876
Query: 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKP 930
L+Y Y+P G+L + + D P ++WS KIAL A+ LAYLH +C PR+ HRDIK
Sbjct: 877 SNLLLYEYMPKGSLGEILHD-PSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKS 935
Query: 931 SNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFG 990
+NILLD+ A++ DFGLA+++ + + + +AG++GY+APEYA T +V++K+D+YS+G
Sbjct: 936 NNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYG 995
Query: 991 VVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDC--GPHDD--- 1045
VVLLEL++ K + P G ++V W + + + ++G+ D D+
Sbjct: 996 VVLLELLTGKAPVQP----IDQGGDVVNWVRSYIRR----DALSSGVLDARLTLEDERIV 1047
Query: 1046 --LIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074
++ +L +A++CT S +RPSMRQV L
Sbjct: 1048 SHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1101), Expect = e-119, Method: Compositional matrix adjust.
Identities = 372/1246 (29%), Positives = 569/1246 (45%), Gaps = 207/1246 (16%)
Query: 3 ALLQLKSAIT-----EDPLGLTSNWNPKDTDSCSWHGVTCDPLS-GRVTSLNLSS----- 51
LL++K ++ +DPL WN + + CSW GVTCD RV +LNL+
Sbjct: 29 TLLEVKKSLVTNPQEDDPL---RQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLGLTG 85
Query: 52 -------------NLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSN----- 93
+L +S +L+ P A N + G I S
Sbjct: 86 SISPWFGRFDNLIHLDLSSNNLVGPIPTAL--SNLTSLESLFLFSNQLTGEIPSQLGSLV 143
Query: 94 -------SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSF 146
++L G++ +G+L L++L LA +G +P ++G+L ++ L L N
Sbjct: 144 NIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNYL 203
Query: 147 HGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNC 206
GPIP L NCS L + + N NGTIPA G+ ++++L+ N L+G +P + G+
Sbjct: 204 EGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGE-M 262
Query: 207 VSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQL------------ 254
L+++ L AN L G IP SL + L++L LS+N L G+IP F +
Sbjct: 263 SQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNH 322
Query: 255 -------------VNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDL 301
NLE L LS LSG +P EL C+ LK L L N+ G +
Sbjct: 323 LSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNN------SLAGSI 376
Query: 302 P--IQPVVDGGEDY---NFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEM 356
P + +V+ + Y N +G L SI+ L NL+ + NLEG P+ KLE+
Sbjct: 377 PEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEV 436
Query: 357 LNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS-VPCMAVFNVSQNLLSGEI 415
L L N F+G+IP +GNC SL +D+ N+ G +P + + + + ++ QN L G +
Sbjct: 437 LFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGL 496
Query: 416 PRISHSECSKMSV-NWSMSQVD---------LIGFYTAFFYENALTSCAPFSSPS----- 460
P S C ++++ + + +Q+ L G Y N+L P S S
Sbjct: 497 P-ASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLT 555
Query: 461 ---------NGL---------FILHDFSNNLFTGPVPPFLIDSDSLSS------------ 490
NG ++ D +NN F +P L +S +L
Sbjct: 556 RINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKI 615
Query: 491 -------RPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGS--- 540
R +S N+L G T P L L D+ NN L G +P +G
Sbjct: 616 PWTLGKIRELSLLDMSSNALTG---TIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQ 672
Query: 541 --------------------HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ 580
+C + LS+ GN G IPQ N +L LNL +N
Sbjct: 673 LGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFS 732
Query: 581 GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLE-VLELSANSLSGEIPSEFSKLE 639
G LP + K+ L L LS N+ TG IP E+ QL L+ L+LS N+ +G+IPS L
Sbjct: 733 GSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLS 792
Query: 640 HLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN-SLIKCENVQGNPNLQL 698
L L L HN LTG +P G SL +VSFNNL G + S ++ GN L
Sbjct: 793 KLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTG--L 850
Query: 699 CHTDPSSSEWERQHSGNVSQQEAYSPSESIQGNSSGLNPIEIASITSAAVILSVLIALVL 758
C + S R + ++Q+ S + I S SA + ++I ++
Sbjct: 851 CGSPLSRCNRVRSN----NKQQGLSARSVV-----------IISAISALTAIGLMILVIA 895
Query: 759 LLIC-----MKKFSCNSIA------DPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQN 807
L KK S A K + + +E+++ AT + +
Sbjct: 896 LFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEF 955
Query: 808 CIGSGGFGATYKAEIIPGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
IGSGG G YKAE+ G VAVK+ L + F+ E++TLGR++H +LV L+GY
Sbjct: 956 MIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYC 1015
Query: 867 VSEAE--MFLIYNYLPGGNL------EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
S++E LIY Y+ G++ +K + ++ ++ ++W +IA+ +A+ + YLH +
Sbjct: 1016 SSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHD 1075
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT---SETHATTDVAGTFGYVAPEYA 975
CVP ++HRDIK SN+LLD+N+ A+L DFGLA++L + T + T A ++GY+APEYA
Sbjct: 1076 CVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYA 1135
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC--EFF 1033
+ + ++K+DVYS G+VL+E+++ K P+ FG ++V W L +
Sbjct: 1136 YSLKATEKSDVYSMGIVLMEIVTGKM---PTDSVFGAEMDMVRWVETHLEVAGSARDKLI 1192
Query: 1034 TAGLWDCGP--HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
L P D ++L +A+ CT S RPS RQ L +
Sbjct: 1193 DPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 427 bits (1098), Expect = e-118, Method: Compositional matrix adjust.
Identities = 355/1135 (31%), Positives = 530/1135 (46%), Gaps = 147/1135 (12%)
Query: 3 ALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSS-NLSRTSCSLL 61
LL+ K A D G ++WN D++ C+W G+ C L VTS++L+ NLS T L+
Sbjct: 30 VLLEFK-AFLNDSNGYLASWNQLDSNPCNWTGIACTHLR-TVTSVDLNGMNLSGTLSPLI 87
Query: 62 SLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNG 121
+LH + N+++N +SG + + + L VL L N
Sbjct: 88 C------------------KLHGLRKLNVSTNF---ISGPIPQDLSLCRSLEVLDLCTNR 126
Query: 122 FSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQS 181
F G +P+++ + L+ L L N G IP + N SSL+ + + N G IP +
Sbjct: 127 FHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKL 186
Query: 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSN 241
+++ N SG +P E C SL+ + LA N L GS+P L L L+L N
Sbjct: 187 RQLRIIRAGRNGFSGVIPSEI-SGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQN 245
Query: 242 MLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL-RNDYGPLYSREHGD 300
L G+IP S G + LEVL L N+ +G +P E+G ++K L L N RE G+
Sbjct: 246 RLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGN 305
Query: 301 LPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLA 360
L +D E+ L G P+ + L++L+L
Sbjct: 306 LIDAAEIDFSEN--------------------------QLTGFIPKEFGHILNLKLLHLF 339
Query: 361 HNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS-VPCMAVFNVSQNLLSGEIPRIS 419
N G IP LG L LDLS N L G +P+E+ +P + + N L G+IP
Sbjct: 340 ENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIP--- 396
Query: 420 HSECSKMSVNWSMSQVDLIGFYTAF----FYENALTSCAPFSSPSNGLFILHDFSNNLFT 475
LIGFY+ F N+L+ P IL +N +
Sbjct: 397 ----------------PLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLS 440
Query: 476 GPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVP 535
G +P L SL+ L N L G+L F+L +L L ++ N L G +
Sbjct: 441 GNIPRDLKTCKSLTK-----LMLGDNQLTGSLPIELFNL-QNLTAL--ELHQNWLSGNIS 492
Query: 536 SDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKF 595
+D+G K ++ L +A N F G IP N + N+S N L G +P + ++
Sbjct: 493 ADLGK-LKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQR 551
Query: 596 LSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRL--------- 646
L LS N F+G I EL QL LE+L LS N L+GEIP F L L L+L
Sbjct: 552 LDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENI 611
Query: 647 ----------------DHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN-----SLI 685
HNNL+G IP G L I ++ N LSG P + SL+
Sbjct: 612 PVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLL 671
Query: 686 KCENVQGNPNLQLCHTDPSSSEWERQHSGNVSQQEAYSPSES------IQGNSSGLNPI- 738
C N+ N L T P ++ ++R S N + S+ + + S LN +
Sbjct: 672 IC-NISNN---NLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLI 727
Query: 739 ------EIASITSAAVILSVLIALVLLLICMKKFSCNSIADPGLVRKEVVICNNIGVQ-L 791
+I +IT + LI + L +K+ +A + +V+ +
Sbjct: 728 NGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGF 787
Query: 792 TYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGV---QQFAAEI 848
TY+ +V AT F+ +G G G YKAE+ G V+AVK+L+ R +G F AEI
Sbjct: 788 TYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEI 846
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTV-EWSMLHKIALD 907
TLG+++H N+V L G+ + L+Y Y+ G+L + +Q + + +W+ ++IAL
Sbjct: 847 STLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALG 906
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
A L YLH +C P+++HRDIK +NILLD A++ DFGLA+L+ S + + + VAG++
Sbjct: 907 AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSY 966
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027
GY+APEYA T +V++K D+YSFGVVLLELI+ K + P G ++V W +
Sbjct: 967 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP----LEQGGDLVNWVRRSIRNM 1022
Query: 1028 RPC-EFFTAGLWDCGPHDDLIEM---LNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
P E F A L D + EM L +A+ CT S +SRP+MR+V + + +
Sbjct: 1023 IPTIEMFDARL-DTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1068), Expect = e-115, Method: Compositional matrix adjust.
Identities = 318/1021 (31%), Positives = 506/1021 (49%), Gaps = 86/1021 (8%)
Query: 122 FSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQS 181
SG + IG L L L+L++N+ G IP + NCS L ++ L+ NQF G+IP +
Sbjct: 97 LSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKL 156
Query: 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSN 241
+ ++ N LSG +PEE GD +LE ++ N+LTG +P SLGN +L + N
Sbjct: 157 SQLRSFNICNNKLSGPLPEEIGD-LYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQN 215
Query: 242 MLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL-RNDYGPLYSREHGD 300
G+IP+ G+ +NL++L L++NF+SG +P E+GM +L+ ++L +N + ++ G+
Sbjct: 216 DFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGN 275
Query: 301 LP-IQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNL 359
L ++ + G N G +P I + +L+ + L G P+ SK+ ++
Sbjct: 276 LTSLETLALYG---NSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDF 332
Query: 360 AHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS-VPCMAVFNVSQNLLSGEIPRI 418
+ N +G+IP L L L L N LTG++P E+S + +A ++S N L+G IP
Sbjct: 333 SENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPG 392
Query: 419 SHSECSKMSVNW---SMSQV--DLIGFYTAF----FYENALT-SCAPFSSPSNGLFILHD 468
+ S + S+S V +G Y+ F EN L+ PF + L +L+
Sbjct: 393 FQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNL 452
Query: 469 FSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNN 528
SN +F G +PP ++ SL + GN L G +P +LC ++ ++ N
Sbjct: 453 GSNRIF-GNIPPGVLRCKSL-----LQLRVVGNRLTGQ---FPTELCKLVNLSAIELDQN 503
Query: 529 KLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYIN 588
+ G +P ++G+ C+ ++ L +A N+F +P + +L N+S N L GP+PS I
Sbjct: 504 RFSGPLPPEIGT-CQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIA 562
Query: 589 KMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDH 648
+ L+ L LS N+F G++P EL L LE+L LS N SG IP L HL L++
Sbjct: 563 NCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGG 622
Query: 649 NNLTGRIPPGFGTRSSLSI-FDVSFNN------------------------LSGSAPR-- 681
N +G IPP G SSL I ++S+N+ LSG P
Sbjct: 623 NLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTF 682
Query: 682 ---NSLIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVS-----------QQEAYSPSES 727
+SL+ C N QL HT + GN ++ S
Sbjct: 683 ENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISS 742
Query: 728 IQGNSSGLNPIEIASITSAAVILSVLIALVL-LLICMKKFSCNSIADPGLVRKEVVICNN 786
++ S+ I I + I +LIA+V+ L + + + D +E I
Sbjct: 743 LKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFV 802
Query: 787 IGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQ--- 843
+ T ++++ AT GF+ +G G G YKA + G +AVK+L R
Sbjct: 803 PKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNN 862
Query: 844 ----FAAEIRTLGRVQHPNLVTLIG--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE 897
F AEI TLG+++H N+V L YH L+Y Y+ G+L + + +++
Sbjct: 863 TDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMD 922
Query: 898 WSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957
W IAL A LAYLH +C PR++HRDIK +NIL+D N A++ DFGLA+++ +
Sbjct: 923 WPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLS 982
Query: 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017
+ + VAG++GY+APEYA T +V++K D+YSFGVVLLEL++ K + P G ++
Sbjct: 983 KSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQP----LEQGGDLA 1038
Query: 1018 AWASMLL----LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073
W + L + + + D + +I + +A++CT S S RP+MR+V
Sbjct: 1039 TWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLM 1098
Query: 1074 L 1074
L
Sbjct: 1099 L 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 414 bits (1064), Expect = e-114, Method: Compositional matrix adjust.
Identities = 326/1075 (30%), Positives = 519/1075 (48%), Gaps = 140/1075 (13%)
Query: 96 DKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQ 155
++L G + IG+ T L + AFN +G LP E+ +L L+ L+L NSF G IP L
Sbjct: 202 NELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLG 261
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
+ S++ +NL GNQ G IP + Q + LS N L+G + EEF LE ++LA
Sbjct: 262 DLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFW-RMNQLEFLVLA 320
Query: 216 ANSLTGSIPPSL-GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSE 274
N L+GS+P ++ N T L+ L LS L G+IP+ +L++LDLS N L+G +P
Sbjct: 321 KNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDS 380
Query: 275 LGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW 334
L +L L L N N +G L SI+ L NL+ F
Sbjct: 381 LFQLVELTNLYLNN-------------------------NSLEGTLSSSISNLTNLQEFT 415
Query: 335 APNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPE 394
+ NLEG P+ KLE++ L N F+G++P +GNC L +D N L+G +P
Sbjct: 416 LYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPS 475
Query: 395 EVS-VPCMAVFNVSQNLLSGEIPRISHSECSKMSV------NWSMSQVDLIGFYTAF--- 444
+ + + ++ +N L G IP S C +M+V S S GF TA
Sbjct: 476 SIGRLKDLTRLHLRENELVGNIP-ASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELF 534
Query: 445 -FYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSL 503
Y N+L P S + +FS+N F G + P S Y F ++ N
Sbjct: 535 MIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPL------CGSSSYLSFDVTENGF 588
Query: 504 KGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSF 563
+G++ P +L S + +G N+ G +P G + + L ++ N G+IP
Sbjct: 589 EGDI---PLELGKSTNLDRLRLGKNQFTGRIPRTFGKISE-LSLLDISRNSLSGIIPVEL 644
Query: 564 TNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623
L +++L+ N+L G +P+++ K+ L L LS N F G++P E+ L ++ L L
Sbjct: 645 GLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLD 704
Query: 624 ANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSL------------------ 665
NSL+G IP E L+ LN L L+ N L+G +P G S L
Sbjct: 705 GNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEI 764
Query: 666 -------SIFDVSFNNLSGSAPR--NSLIKCENVQGNPNLQLCHTDP------------- 703
S D+S+NN +G P ++L K E++ + N QL P
Sbjct: 765 GQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHN-QLVGEVPGQIGDMKSLGYLN 823
Query: 704 ---SSSEWERQHSGNVSQQEAYSPSESIQG------------NSSGLNP---IEIASITS 745
++ E + + + Q +A+ + + G N L+P + I++I+S
Sbjct: 824 LSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISS 883
Query: 746 AAVILSVLIALVLLLICMKKFSCNSIADPG-------LVRKEVVICNNIGVQ--LTYENV 796
A I L+ LV++L + G + + +N G + + ++++
Sbjct: 884 LAAI--ALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDI 941
Query: 797 VRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQ 855
+ AT N + IGSGG G YKAE+ G +AVK+ L + F E++TLG ++
Sbjct: 942 MEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIR 1001
Query: 856 HPNLVTLIGYHVSEAE--MFLIYNYLPGGNLEKFIQ----DRPRRTVEWSMLHKIALDVA 909
H +LV L+GY S+A+ LIY Y+ G++ ++ + + + W KIAL +A
Sbjct: 1002 HRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLA 1061
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG---TSETHATTDVAGT 966
+ + YLH +CVP ++HRDIK SN+LLD+N+ A+L DFGLA++L + T + T AG+
Sbjct: 1062 QGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGS 1121
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL-- 1024
+GY+APEYA + + ++K+DVYS G+VL+E+++ K P+ F ++V W +L
Sbjct: 1122 YGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKM---PTEAMFDEETDMVRWVETVLDT 1178
Query: 1025 -----LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074
+ + + L C + ++L +A+ CT RPS RQ ++ L
Sbjct: 1179 PPGSEAREKLIDSELKSLLPC-EEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1063), Expect = e-114, Method: Compositional matrix adjust.
Identities = 343/1091 (31%), Positives = 510/1091 (46%), Gaps = 170/1091 (15%)
Query: 2 NALLQLKSAITEDPLG-LTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSS-NLSRTSCS 59
+ALL LKS+ T D L ++WN T CSW GVTCD VTSL+LS NLS T S
Sbjct: 29 HALLSLKSSFTIDEHSPLLTSWN-LSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSS 87
Query: 60 LLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAF 119
++ H P LQ N+ S +++++SG + I +L +LR L L+
Sbjct: 88 DVA-------------HLPLLQ-------NL-SLAANQISGPIPPQISNLYELRHLNLSN 126
Query: 120 NGFSGELPLEIGQ-LSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFF 178
N F+G P E+ L L +LDL N+ G +P +L N + LR ++L GN F+G IPA +
Sbjct: 127 NVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATY 186
Query: 179 GQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLL 238
G P + +++S N L+G +P E G+ E + N+ +PP +GN +EL
Sbjct: 187 GTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDA 246
Query: 239 SSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREH 298
++ L G+IP G+L L+ L L N +G + ELG+ LK + L N
Sbjct: 247 ANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSN---------- 296
Query: 299 GDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLN 358
N F G +P S ++L NL + L G P+ +LE+L
Sbjct: 297 ---------------NMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQ 341
Query: 359 LAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFNVSQNLLSGEIPR 417
L N FTG IP LG L LDLSSN LTG LP + S + N L G IP
Sbjct: 342 LWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPD 401
Query: 418 ISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAP---FSSPSNGLFILHDFSNNLF 474
S +C S++++ + EN L P F P L D N
Sbjct: 402 -SLGKCE------SLTRIRM--------GENFLNGSIPKELFGLPKLSQVELQD---NYL 443
Query: 475 TGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEV 534
TG +P +SG + G+L + NN+L G +
Sbjct: 444 TGELP------------------ISGGGVSGDLGQ-------------ISLSNNQLSGSL 472
Query: 535 PSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLK 594
P+ +G+ K L + GN+F G IP L L+ S N G + I++ + L
Sbjct: 473 PAAIGNLSGVQKLL-LDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLT 531
Query: 595 FLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGR 654
F+ LS N +G IP ELT + L L LS N L G IP + ++ L + +NNL+G
Sbjct: 532 FVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGL 591
Query: 655 IPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQLCHTDPSSSEWERQHSG 714
+P + S F+ + S + ++ G P L C + H
Sbjct: 592 VP----STGQFSYFNYT-----------SFVGNSHLCG-PYLGPC--------GKGTHQS 627
Query: 715 NVSQQEAYSPSESIQGNSSGLNPIEIASITSAAVILSVLIALVLLLICMKK--FSCNSIA 772
+V A + + G I +I A + + A L ++ F+C+ +
Sbjct: 628 HVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDDVL 687
Query: 773 DPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKR 832
D L +N++ G GG G YK + G +VAVKR
Sbjct: 688 D----------------SLKEDNII------------GKGGAGIVYKGTMPKGDLVAVKR 719
Query: 833 LSVGRFQGVQQ--FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQD 890
L+ F AEI+TLGR++H ++V L+G+ + L+Y Y+P G+L + +
Sbjct: 720 LATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHG 779
Query: 891 RPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950
+ + W+ +KIAL+ A+ L YLH +C P ++HRD+K +NILLD+N A+++DFGLA+
Sbjct: 780 KKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAK 839
Query: 951 LL---GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSF 1007
L GTSE + +AG++GY+APEYA T +V +K+DVYSFGVVLLELI+ KK +
Sbjct: 840 FLQDSGTSE--CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVG--- 894
Query: 1008 CSFGNGFNIVAWASMLLLQGRPCEFFTAGL-WDCGPHDDLIEMLNLAIMCTGESLSSRPS 1066
FG+G +IV W + + C L P ++ + +A++C E RP+
Sbjct: 895 -EFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPT 953
Query: 1067 MRQVAQQLKQI 1077
MR+V Q L +I
Sbjct: 954 MREVVQILTEI 964
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1082 | ||||||
| 225437806 | 1452 | PREDICTED: LRR receptor-like serine/thre | 0.980 | 0.730 | 0.706 | 0.0 | |
| 255548173 | 1099 | Leucine-rich repeat receptor protein kin | 0.990 | 0.975 | 0.695 | 0.0 | |
| 147818954 | 1050 | hypothetical protein VITISV_040167 [Viti | 0.944 | 0.973 | 0.710 | 0.0 | |
| 359488527 | 1139 | PREDICTED: LRR receptor-like serine/thre | 0.980 | 0.931 | 0.542 | 0.0 | |
| 449476612 | 1188 | PREDICTED: LOW QUALITY PROTEIN: LRR rece | 0.972 | 0.885 | 0.532 | 0.0 | |
| 449438807 | 1143 | PREDICTED: LRR receptor-like serine/thre | 0.972 | 0.920 | 0.532 | 0.0 | |
| 339790479 | 1125 | leucine rich repeat receptor protein kin | 0.974 | 0.936 | 0.535 | 0.0 | |
| 339790483 | 1125 | leucine rich repeat receptor protein kin | 0.974 | 0.936 | 0.535 | 0.0 | |
| 339790481 | 1125 | leucine rich repeat receptor protein kin | 0.974 | 0.936 | 0.532 | 0.0 | |
| 147803536 | 1136 | hypothetical protein VITISV_038106 [Viti | 0.904 | 0.861 | 0.560 | 0.0 |
| >gi|225437806|ref|XP_002274211.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1523 bits (3944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 764/1082 (70%), Positives = 886/1082 (81%), Gaps = 21/1082 (1%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSL 60
K LL+LKS +T+DPLG +NWNP D D CSW+GV CD LS RVT+L+LSSN +CS
Sbjct: 390 KLTLLELKSCVTQDPLGFLTNWNPNDPDPCSWNGVICDTLSRRVTALDLSSN---RNCSF 446
Query: 61 LSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFN 120
LSL A P + H CL ++ +S+S+ KL G L +G L+QLRVL L FN
Sbjct: 447 LSL--FATPASDV--HAACLLGGGFNK---SSSSASKLRGRLPPIVGRLSQLRVLSLGFN 499
Query: 121 GFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQ 180
GF GE+P EIG L+LLE+LD++ N+FHGPIPP L+NC++LR++NLSGN+FNGTIP
Sbjct: 500 GFFGEVPREIGHLALLEVLDVASNAFHGPIPPALRNCTALRVVNLSGNRFNGTIPELLAD 559
Query: 181 SPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSS 240
P Q++SLS+N+LSG +PEE G NC +LEH+ L NSL+GSIP SLGNC+ LRSL LSS
Sbjct: 560 LPSLQILSLSYNMLSGVIPEELGHNCGTLEHLYLTGNSLSGSIPASLGNCSMLRSLFLSS 619
Query: 241 NMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGD 300
N + +IPSSFG+L LE LDLSRNFLSGI+PS+LG C QLK+LVL+N++GPL + +
Sbjct: 620 NKFENEIPSSFGKLGMLEALDLSRNFLSGIIPSQLGNCTQLKLLVLKNNFGPLLLWRNEE 679
Query: 301 LPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLA 360
+ EDYN+F G LP+SI +LPNL VFWAP NLEGIFPQNW CS LEMLNLA
Sbjct: 680 V---------EDYNYFVGQLPNSIVKLPNLHVFWAPQANLEGIFPQNWGSCSNLEMLNLA 730
Query: 361 HNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISH 420
N+FTGQIP SLG CKSLYFLDL+SNNLTG LP+E+SVPCM VFN+S N LSG+IPR S
Sbjct: 731 QNYFTGQIPTSLGKCKSLYFLDLNSNNLTGFLPKEISVPCMVVFNISGNSLSGDIPRFSQ 790
Query: 421 SECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPP 480
SEC++ N MS +DL+G Y++FFY NA+TS A FSSPS GL +LHDFSNNLFTG VPP
Sbjct: 791 SECTEKVGNPWMSDIDLLGLYSSFFYWNAVTSIAYFSSPSYGLVMLHDFSNNLFTGLVPP 850
Query: 481 FLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGS 540
LI SD LS RP YGFW+ GN+LKGN ST FD C SL+ L+FDI +NK+ GE+P +GS
Sbjct: 851 LLITSDRLSVRPSYGFWVEGNNLKGNTSTLSFDSCQSLNSLVFDIASNKITGELPPKLGS 910
Query: 541 HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600
CK MK L++AGNE VG IP SF N SL NLNLS N LQGP+PSYI KM++LK+LSLS
Sbjct: 911 -CKYMKLLNVAGNELVGSIPLSFANLSSLVNLNLSGNRLQGPIPSYIGKMKNLKYLSLSG 969
Query: 601 NNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFG 660
NNF+G IP EL+QL SL VLELS+NSLSG+IPS+F+KLEHL+++ LDHN+L+G+IP FG
Sbjct: 970 NNFSGTIPLELSQLTSLVVLELSSNSLSGQIPSDFAKLEHLDIMLLDHNHLSGKIPSSFG 1029
Query: 661 TRSSLSIFDVSFNNLSGSAPRNS-LIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVSQQ 719
+SLS+ +VSFNNLSGS P NS +KCENVQGNPNLQ C+ D SS+EWER+HS +VSQQ
Sbjct: 1030 NLTSLSVLNVSFNNLSGSFPLNSNWVKCENVQGNPNLQPCYDDSSSTEWERRHSDDVSQQ 1089
Query: 720 EAYSPSESIQGNSSGLNPIEIASITSAAVILSVLIALVLLLICMKKFSCNSIADPGLVRK 779
EAY P+ S S +PIEIASITSA++I+ VLIALVLL + MKKF C+++ G +K
Sbjct: 1090 EAYPPTGSRSRKSDVFSPIEIASITSASIIVFVLIALVLLYVSMKKFVCHTVLGQGSGKK 1149
Query: 780 EVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ 839
EVV CNNIGVQLTYENVVRAT FNVQNCIGSGGFGATYKAEI+PGVVVAVKRLSVGRFQ
Sbjct: 1150 EVVTCNNIGVQLTYENVVRATGSFNVQNCIGSGGFGATYKAEIVPGVVVAVKRLSVGRFQ 1209
Query: 840 GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS 899
GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR RRTVEWS
Sbjct: 1210 GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRTRRTVEWS 1269
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
MLHKIALD+ARALAYLHDECVPRVLHRDIKPSNILLDNN NAYLSDFGLARLLGTSETHA
Sbjct: 1270 MLHKIALDIARALAYLHDECVPRVLHRDIKPSNILLDNNFNAYLSDFGLARLLGTSETHA 1329
Query: 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAW 1019
TTDVAGTFGYVAPEYAMTCRVSDKADVYS+GVVLLELISDKKALDPSF SFGNGFNIVAW
Sbjct: 1330 TTDVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELISDKKALDPSFSSFGNGFNIVAW 1389
Query: 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079
ASMLL QG+ C+FFTAGLW+ GPHDDLIE+L+LAIMCTGESLS+RPSM+QVAQ+LK+IQP
Sbjct: 1390 ASMLLRQGQACDFFTAGLWESGPHDDLIEILHLAIMCTGESLSTRPSMKQVAQRLKRIQP 1449
Query: 1080 PA 1081
P
Sbjct: 1450 PT 1451
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548173|ref|XP_002515143.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] gi|223545623|gb|EEF47127.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1511 bits (3913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 755/1085 (69%), Positives = 883/1085 (81%), Gaps = 13/1085 (1%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSL 60
K ALL+ KSAI+ DPLGLT+NWNP D D CSW+GVTC+P+S RVT LNLS+N + ++C L
Sbjct: 25 KQALLEFKSAISSDPLGLTANWNPNDPDPCSWYGVTCNPISHRVTVLNLSAN-NNSTCPL 83
Query: 61 LSLP--PAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLA 118
+SL P G NF+ FPC+ L N N++ S KL+GNLS +IG L++L VL L
Sbjct: 84 VSLSSNPINGVVSNFTVLFPCVGL------NSNNSVSPKLAGNLSPSIGQLSELTVLSLG 137
Query: 119 FNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFF 178
FN FSG+LPLEIGQL LE+LDL FN+FHG IP T+QNC+SLR+INLSGN+ NGTIP F
Sbjct: 138 FNLFSGDLPLEIGQLFFLEVLDLGFNAFHGTIPSTIQNCTSLRVINLSGNRLNGTIPEIF 197
Query: 179 GQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLL 238
Q G Q++ LSFNLLSG +P+ GD+C SLEH+ L NS++G IP +LGNCT LRSL+L
Sbjct: 198 SQFKGLQILMLSFNLLSGPIPDYLGDHCGSLEHLFLDGNSISGLIPSNLGNCTRLRSLIL 257
Query: 239 SSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREH 298
SSN+LQ DIPS+FG L NL+VLDLSRNFLSGI+P ELG CKQLK+LVL+N+YGPL+S +
Sbjct: 258 SSNLLQDDIPSTFGALENLQVLDLSRNFLSGIIPPELGYCKQLKLLVLKNNYGPLWSTDF 317
Query: 299 GDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLN 358
I+ G ++N+FDG LPDS+TRLPNLR+ WAPNLN +G FPQ W CS +EMLN
Sbjct: 318 SSSAIEEEERGEGEFNYFDGKLPDSVTRLPNLRMLWAPNLNFDGSFPQYWGSCSNMEMLN 377
Query: 359 LAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRI 418
LA N+FTG+IP SL +C++LYFLDLSSNNLTGLLP+ + VPCM VFNVSQN +G+IPR
Sbjct: 378 LAGNYFTGEIPESLADCENLYFLDLSSNNLTGLLPQALPVPCMVVFNVSQNSFTGDIPRF 437
Query: 419 SHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPV 478
S CSKMSVN S S D+ GF+++FFY++ + A FSS S GL +LHD S N FTG V
Sbjct: 438 SKDGCSKMSVNMSSSYGDVFGFFSSFFYKHTIMGIASFSSNSGGLAVLHDLSKNYFTGQV 497
Query: 479 PPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDM 538
P LI +S P YGFW+ GN+L GN S+Y F+LCLSLDGLIFD+GNN+++G++P +
Sbjct: 498 PSLLIAPESFPHMPLYGFWVDGNNLDGNFSSYSFNLCLSLDGLIFDVGNNRIVGQLPLAV 557
Query: 539 GSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSL 598
GS CKC+K+LS+ N +G IP +F DSL LNLSRN LQG +PSYI +M++L+ LSL
Sbjct: 558 GSSCKCIKYLSLERNNIIGSIPYTFAYLDSLVFLNLSRNRLQGSIPSYIVQMKELRHLSL 617
Query: 599 SLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG 658
S NNFTGAIP EL QL +LEVLELS+NSLSGEIP +F KL+HLNVLRLDHN+ +G+IP
Sbjct: 618 SSNNFTGAIPSELAQLPALEVLELSSNSLSGEIPPDFVKLQHLNVLRLDHNHFSGKIPSS 677
Query: 659 FGTRSSLSIFDVSFNNLSGSAPRN-SLIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVS 717
FG ++SLS+FDVSFNNLSGS P N SLI CE VQGNPNLQ C PS S+WE++HSG VS
Sbjct: 678 FGNKTSLSVFDVSFNNLSGSVPLNSSLITCEKVQGNPNLQPC---PSISQWEQEHSGYVS 734
Query: 718 QQEAYSPSESIQGNSSGLNPIEIASITSAAVILSVLIALVLLLICMKKFSCNSIADPGLV 777
QQ A PS S+Q N +PI IASITSA+VI SVL+ALVL L C KK+ CNS + G
Sbjct: 735 QQGANPPSASMQRNDGAFSPIVIASITSASVIFSVLVALVLFLGCTKKYVCNSTSGRGSG 794
Query: 778 RKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR 837
RKEVV CN+IG+QLTYENVVRAT GF++QNCIGSGGFGATYKAEI+PGVVVAVKRLSVGR
Sbjct: 795 RKEVVTCNDIGIQLTYENVVRATGGFSIQNCIGSGGFGATYKAEIVPGVVVAVKRLSVGR 854
Query: 838 FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE 897
FQGVQQF AEIRTLGRVQH NLV LIGYHVSE+EMFLIYNYLPGGNLE+FIQ+R RR VE
Sbjct: 855 FQGVQQFEAEIRTLGRVQHLNLVKLIGYHVSESEMFLIYNYLPGGNLERFIQERSRRAVE 914
Query: 898 WSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957
W+MLHKIALD+ARALAYLHDECVPRVLHRDIKPSNILLDNN NAYLSDFGLARLLGTSET
Sbjct: 915 WNMLHKIALDIARALAYLHDECVPRVLHRDIKPSNILLDNNFNAYLSDFGLARLLGTSET 974
Query: 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017
HATTDVAGTFGYVAPEYAMTCRVSDKADVYS+GVVLLELISDKKALDPSF SFGNGFNIV
Sbjct: 975 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELISDKKALDPSFSSFGNGFNIV 1034
Query: 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
AWASMLL QG+ EFFTAGLWD GPHDDL+E+L+L IMCTGESLSSRPSMRQVAQ+LK+I
Sbjct: 1035 AWASMLLRQGQASEFFTAGLWDSGPHDDLVEVLHLGIMCTGESLSSRPSMRQVAQRLKRI 1094
Query: 1078 QPPAS 1082
QP S
Sbjct: 1095 QPATS 1099
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147818954|emb|CAN67126.1| hypothetical protein VITISV_040167 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1470 bits (3806), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/1043 (71%), Positives = 856/1043 (82%), Gaps = 21/1043 (2%)
Query: 40 LSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLS 99
LS RVT+L+LSSN +CS LSL A P + H CL ++ +S+S+ KL
Sbjct: 27 LSRRVTALDLSSN---RNCSFLSL--FATPASDV--HAACLLGGGFNK---SSSSASKLR 76
Query: 100 GNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSS 159
G L +G L+QLRVL L FNGF GE+P EIG L+LLE+LDL+ N+FHGPIPP L+NC++
Sbjct: 77 GRLPPIVGRLSQLRVLSLGFNGFFGEVPREIGHLALLEVLDLASNAFHGPIPPALRNCTA 136
Query: 160 LRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSL 219
LR++NLSGN+FNGTIP P Q++SLS+N+LSG +PEE G NC +LEH+ L NSL
Sbjct: 137 LRVVNLSGNRFNGTIPELLADLPSLQILSLSYNMLSGVIPEELGHNCGTLEHLYLTGNSL 196
Query: 220 TGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCK 279
+GSIP SLGNC+ LRSL LSSN + +IPSSFG+L LE LDLSRNFLSGI+P +LG C
Sbjct: 197 SGSIPASLGNCSMLRSLFLSSNKFENEIPSSFGKLGMLEALDLSRNFLSGIIPPQLGNCT 256
Query: 280 QLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLN 339
QLK+LVL+N++GPL + ++ EDYN+F G LP+SI +LPNL VFWAP N
Sbjct: 257 QLKLLVLKNNFGPLLLWRNEEV---------EDYNYFIGQLPNSIVKLPNLHVFWAPQAN 307
Query: 340 LEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVP 399
LEGIFPQNW CS LEMLNLA N+FTGQIP SLG CKSLYFLDL+SNNLTG LP+E+SVP
Sbjct: 308 LEGIFPQNWGSCSNLEMLNLAQNYFTGQIPTSLGKCKSLYFLDLNSNNLTGFLPKEISVP 367
Query: 400 CMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSP 459
CM VFN+S N LSG+IPR S SEC++ N MS +DL+G Y++FFY NA+TS A FSSP
Sbjct: 368 CMVVFNISGNSLSGDIPRFSQSECTEKVGNPWMSDIDLLGLYSSFFYWNAVTSIAYFSSP 427
Query: 460 SNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLD 519
S GL +LHDFSNNLFTG VPP LI SD LS RP YGFW+ GN+LKGN ST FD C SL+
Sbjct: 428 SYGLVMLHDFSNNLFTGLVPPLLITSDRLSVRPSYGFWVEGNNLKGNTSTLSFDSCQSLN 487
Query: 520 GLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHL 579
L+FDI +NK+ GE+P +GS CK MK L++AGNE VG IP SF N SL NLNLS N L
Sbjct: 488 SLVFDIASNKITGELPPKLGS-CKYMKLLNVAGNELVGSIPLSFANLSSLVNLNLSGNRL 546
Query: 580 QGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLE 639
QGP+PSYI KM++LK+LSLS NNF+G IP EL+QL SL VLELS+NSLSG+IPS+F+KLE
Sbjct: 547 QGPIPSYIGKMKNLKYLSLSGNNFSGTIPLELSQLTSLVVLELSSNSLSGQIPSDFAKLE 606
Query: 640 HLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNS-LIKCENVQGNPNLQL 698
HL+++ LDHNNL+G+IP FG +SLS+ +VSFNNLSGS P NS +KCENVQGNPNLQ
Sbjct: 607 HLDIMLLDHNNLSGKIPSSFGNLTSLSVLNVSFNNLSGSFPLNSNWVKCENVQGNPNLQP 666
Query: 699 CHTDPSSSEWERQHSGNVSQQEAYSPSESIQGNSSGLNPIEIASITSAAVILSVLIALVL 758
C+ D SS+EWER+HS +VSQQEAY P+ S S +PIEIASITSA++I+ VLIALVL
Sbjct: 667 CYDDSSSTEWERRHSDDVSQQEAYPPTGSRSRKSDMFSPIEIASITSASIIVFVLIALVL 726
Query: 759 LLICMKKFSCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATY 818
L + MKKF C+++ G +KEVV CNNIGVQLTYENVVRAT FNVQNCIGSGGFGATY
Sbjct: 727 LYVSMKKFVCHTVLGQGSGKKEVVTCNNIGVQLTYENVVRATGSFNVQNCIGSGGFGATY 786
Query: 819 KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878
KAEI+PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY
Sbjct: 787 KAEIVPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 846
Query: 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN 938
LPGGNLEKFIQDR RRTVEWSMLHKIALD+ARALAYLHDECVPRVLHRDIKPSNILLDNN
Sbjct: 847 LPGGNLEKFIQDRTRRTVEWSMLHKIALDIARALAYLHDECVPRVLHRDIKPSNILLDNN 906
Query: 939 LNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS+GVVLLELIS
Sbjct: 907 FNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELIS 966
Query: 999 DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTG 1058
DKKALDPSF SFGNGFNIVAWASMLL QG+ C+FFTAGLW+ GPHDDLIE+L+LAIMCTG
Sbjct: 967 DKKALDPSFSSFGNGFNIVAWASMLLRQGQACDFFTAGLWESGPHDDLIEILHLAIMCTG 1026
Query: 1059 ESLSSRPSMRQVAQQLKQIQPPA 1081
ESLS+RPSM+QVAQ+LK+IQPP
Sbjct: 1027 ESLSTRPSMKQVAQRLKRIQPPT 1049
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488527|ref|XP_002279979.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1075 bits (2781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 605/1115 (54%), Positives = 748/1115 (67%), Gaps = 54/1115 (4%)
Query: 4 LLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSLLSL 63
LLQ K +++ DP GL S+W ++D CSW GVTCD S RV SLN+S + L +L
Sbjct: 41 LLQFKDSVS-DPSGLLSSWKSSNSDHCSWLGVTCDSGS-RVLSLNVSGGCGGGNSDLNAL 98
Query: 64 PPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFS 123
FP L L + + + KL G LS I LT+LR L L +N F
Sbjct: 99 ---------LGSQFPQLPLFGYGIMKNCTGGNVKLIGTLSPVIAKLTELRALSLPYNEFG 149
Query: 124 GELPLEIGQLSLLEILDLS------------------------FNSFHGPIPPTLQNCSS 159
G++P+EI + LE+LDL FN G IP +L N S
Sbjct: 150 GQIPIEIWGMEKLEVLDLEGNSMSGSLPIRFGGLRNSRVLNLGFNKIAGVIPSSLSNLMS 209
Query: 160 LRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSL 219
L ++NL+GN NGTIP F G + V LSFN L GS+P E G NC LE + L+ N L
Sbjct: 210 LEILNLAGNMVNGTIPGFIGSFKELRGVYLSFNRLGGSIPSEIGSNCQKLEDLDLSGNLL 269
Query: 220 TGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCK 279
G IP SLGNC++LRS+LL SN+L+ IP+ GQL NLEVLD+SRN LSG +P LG C
Sbjct: 270 VGGIPSSLGNCSQLRSILLFSNLLEEVIPAELGQLRNLEVLDVSRNSLSGSIPPALGNCS 329
Query: 280 QLKVLVLRNDYGPLYSREH--GDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPN 337
QL LVL N + PL + ++ GD +V G +DYN+F G +P IT LP LR+ WAP
Sbjct: 330 QLSALVLSNLFDPLLNIKNMKGDSNSGQLVSGNDDYNYFQGTIPVEITTLPKLRIIWAPR 389
Query: 338 LNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS 397
LEG FP NW C LE++NL+ NFFTG+IP CK L+FLDLSSN LTG L E++
Sbjct: 390 ATLEGRFPSNWGACDSLEVINLSQNFFTGEIPEGFSRCKKLHFLDLSSNKLTGELVEKLP 449
Query: 398 VPCMAVFNVSQNLLSGEIPRISHSECSKMSVN--WSMSQVDLIGFYTAFFYENALTSCAP 455
VPCM VF+VS NLLSG IPR + C+++ N + + L Y +FF + AP
Sbjct: 450 VPCMTVFDVSCNLLSGRIPRFYYGSCTRVPSNNRYVLESSSLSSAYVSFFANKGIVE-AP 508
Query: 456 --FSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFD 513
FS + L + H+F++N F G I SD L + Y F N+L G FD
Sbjct: 509 LLFSKGDDSLSVFHNFASNNFNGTFESMPIASDRLGKQTVYSFLAGENNLTGPFPRNLFD 568
Query: 514 LCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLN 573
C L+ ++ ++ NN++ G++P+++G+ CK + L +GN+ G IP S N SL LN
Sbjct: 569 KCYGLNRVVVNVSNNRISGQLPTEIGALCKTLTLLDASGNQINGSIPHSIGNLVSLVALN 628
Query: 574 LSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPS 633
LS NHLQG +PS + K+E LK+LSL+ N TG IP L L SLEVLELS+NSLSGEIP
Sbjct: 629 LSSNHLQGEIPSSLGKIEGLKYLSLAGNILTGPIPSSLGNLQSLEVLELSSNSLSGEIPR 688
Query: 634 EFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN-SLIKCENVQG 692
+ L L VL L+ N L+G+IP G ++LS F+VSFNNLSG P N +L+KC +V G
Sbjct: 689 DLVNLRSLTVLLLNDNKLSGQIPSGLANVTTLSAFNVSFNNLSGPLPLNDNLMKCSSVLG 748
Query: 693 NPNLQLCH----TDPSSSEWERQHSGNVSQQEAYSPSES-IQGNSSGLNPIEIASITSAA 747
NP L+ C T PSS ++Q SQ + SPS S + SS N IEIASITSA+
Sbjct: 749 NPLLRSCRLFSLTVPSS---DQQGGVGDSQDYSASPSGSPTRSRSSSFNSIEIASITSAS 805
Query: 748 VILSVLIALVLLLICMKKFSCNSIADP-GLVRKEVVICNNIGVQLTYENVVRATAGFNVQ 806
I+SVL+ALV+L I +K CN + RKEV + N+IGV LT+ENVVRAT FN
Sbjct: 806 AIVSVLLALVVLFIYTRK--CNPKSRILRSARKEVTVFNDIGVPLTFENVVRATGSFNAS 863
Query: 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
NCIG+GGFGATYKAEI PGV+VA+KRL+VGRFQGVQQF AE++TLGR+ HPNLVTLIGYH
Sbjct: 864 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEVKTLGRLDHPNLVTLIGYH 923
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
SE EMFLIYNYLPGGNLEKFIQ+R R V+W +LHKIALD+ARALAYLHD+CVPRVLHR
Sbjct: 924 ASETEMFLIYNYLPGGNLEKFIQERSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 983
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNILLD++ NAYLSDFGLARLLG SETHATT VAGTFGYVAPEYAMTCRVSDKADV
Sbjct: 984 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 1043
Query: 987 YSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDL 1046
YS+GVVLLEL+SDKKALDPSF S+GNGFNIVAW MLL QGR EFFTAGLWD GPHDDL
Sbjct: 1044 YSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDL 1103
Query: 1047 IEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081
+E+L+LA++CT +SLS+RP+MRQV ++LKQ+QPP+
Sbjct: 1104 VEVLHLAVVCTVDSLSTRPTMRQVVRRLKQLQPPS 1138
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476612|ref|XP_004154785.1| PREDICTED: LOW QUALITY PROTEIN: LRR receptor-like serine/threonine-protein kinase RPK2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1072 bits (2773), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 598/1123 (53%), Positives = 752/1123 (66%), Gaps = 71/1123 (6%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSL 60
K+ LLQ K+A++ DP L S+W P D++ C W GV+CD + RV SLN+S N
Sbjct: 94 KSVLLQFKNALS-DPSALLSSWIPTDSNYCLWFGVSCD-FNSRVVSLNISGN-------- 143
Query: 61 LSLPPAAGPGGNF-------SFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLR 113
G GNF S FP L RG + + S L G L IG+LT LR
Sbjct: 144 ------GGVSGNFNSFSCSESSKFPLYGLGIR-RGCVGNRGS--LIGKLPPVIGNLTHLR 194
Query: 114 VLLLAFNGFSGELPLEIGQLSLLEILDL------------------------SFNSFHGP 149
VL L F+GF GELP EI L LE+LDL +FN G
Sbjct: 195 VLSLPFHGFQGELPGEIFGLENLEVLDLEGNSVTGLLRNDFSRLSNLRVLNLAFNRVTGE 254
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209
IP +L C+SL ++NL+GNQ NGTIP F GQ G V LSFN L+GS+P E G+NC L
Sbjct: 255 IPSSLLGCASLEILNLAGNQLNGTIPEFVGQMRG---VYLSFNFLTGSIPSELGNNCGKL 311
Query: 210 EHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269
EH+ L+ N L IP +LGNCT+L++LLL SNML+ IP+ G+L LEVLDLSRN LSG
Sbjct: 312 EHLDLSGNFLVSGIPSNLGNCTQLQTLLLYSNMLEEAIPAGIGKLQKLEVLDLSRNSLSG 371
Query: 270 IVPSELGMCKQLKVLVLRNDYGPLYSREH--GDLPIQPVVDGGEDYNFFDGGLPDSITRL 327
+P ELG C QL VLVL N + P+ + D P + + D + +N+F GG+P++IT L
Sbjct: 372 PIPVELGNCSQLSVLVLSNLFDPIPKINYTGDDSPTEELSD--DSFNYFAGGIPETITTL 429
Query: 328 PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387
P LR+ WAP+ NL G FP W C LEM+NLA N+ G++P+ CK L LDLSSN
Sbjct: 430 PKLRILWAPSANLNGRFPSQWGQCESLEMINLAGNYLFGELPSGFTGCKKLQVLDLSSNR 489
Query: 388 LTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECS--KMSVNWSMSQVDLIGFYTAFF 445
L+G L + + VP M +F++S N GEIP +ECS K +N + D Y +FF
Sbjct: 490 LSGELNKNLPVPYMTLFDLSHNQFFGEIPSFCGNECSQVKFGLNGYVDFNDASSRYLSFF 549
Query: 446 YENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKG 505
+ +PF NG I+H+F +N FTG + + L S+ Y + + GN L G
Sbjct: 550 -ATIIRDASPFEFVGNGDLIIHNFGDNNFTGNLLSLPFPREKLGSKTVYAYLVGGNKLTG 608
Query: 506 NLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTN 565
F+ C +L GL+F+I +NK+ G +G C +KFL ++GN+ +G +P SF
Sbjct: 609 PFPDSLFEKCDNLGGLMFNISSNKISGPFSVTIGKKCGSLKFLDVSGNQMIGQVPASFGE 668
Query: 566 FDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSAN 625
SL +LNLSRN Q +P+ + +M +LK+L L+ NNF G+IP L +L SLE+L+LS N
Sbjct: 669 LLSLNHLNLSRNKFQYQIPTSLGQMANLKYLCLAGNNFNGSIPPALGKLQSLELLDLSYN 728
Query: 626 SLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP-RNSL 684
LSGEIP + L L VL L++N+L+G++P G ++LS F+VSFNNLSGS P N++
Sbjct: 729 DLSGEIPMDLVNLRGLKVLLLNNNSLSGQVPSGLANVTTLSAFNVSFNNLSGSLPSNNNM 788
Query: 685 IKCENVQGNPNLQLCH----TDPSSSEWERQHSGNVSQQEAYSPSESIQGNSSG--LNPI 738
IKC GNP L+ CH PSS E Q S A SPS S G N I
Sbjct: 789 IKCSGAIGNPYLRPCHMYSLAVPSS---EMQGSVGDPSGFAASPSGVAPQTSGGGSFNSI 845
Query: 739 EIASITSAAVILSVLIALVLLLICMKKFSCNSIADPGLVRKEVVICNNIGVQLTYENVVR 798
EIASITSA+ I+SVLIAL++L + +K++ S G +RKEV + +IGV LT+ENVVR
Sbjct: 846 EIASITSASAIVSVLIALIILFLYTRKWNSRSKV-LGSMRKEVTVFTDIGVSLTFENVVR 904
Query: 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
AT+ FN NCIGSGGFGATYKAEI GV+VA+KRL+VGRFQGVQQF AEI+TLGR++HPN
Sbjct: 905 ATSNFNASNCIGSGGFGATYKAEISSGVLVAIKRLAVGRFQGVQQFDAEIKTLGRLRHPN 964
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
LVTLIGYH SE EMFLIYNYLPGGNLEKFIQ+R R V+W +LHKIALD+ARALAYLHD+
Sbjct: 965 LVTLIGYHASETEMFLIYNYLPGGNLEKFIQERSTRAVDWRILHKIALDIARALAYLHDQ 1024
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
CVPRVLHRD+KPSNILLD++ NAYLSDFGLARLLGTSETHATT VAGTFGYVAPEYAMTC
Sbjct: 1025 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTC 1084
Query: 979 RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038
RVSDKADVYS+GVVLLEL+SDKKALDPSF S+GNGFNIVAWA MLL QGR EFFTAGLW
Sbjct: 1085 RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWACMLLRQGRAKEFFTAGLW 1144
Query: 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081
+ GPHDDL+E+L+LA++CT +SLS+RP+M+QV ++LKQ+QPP+
Sbjct: 1145 EVGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPPS 1187
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449438807|ref|XP_004137179.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1072 bits (2771), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 598/1123 (53%), Positives = 752/1123 (66%), Gaps = 71/1123 (6%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSL 60
K+ LLQ K+A++ DP L S+W P D++ C W GV+CD + RV SLN+S N
Sbjct: 49 KSVLLQFKNALS-DPSALLSSWIPTDSNYCLWFGVSCD-FNSRVVSLNISGN-------- 98
Query: 61 LSLPPAAGPGGNF-------SFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLR 113
G GNF S FP L RG + + S L G L IG+LT LR
Sbjct: 99 ------GGVSGNFNSFSCSESSKFPLYGLGIR-RGCVGNRGS--LIGKLPPVIGNLTHLR 149
Query: 114 VLLLAFNGFSGELPLEIGQLSLLEILDL------------------------SFNSFHGP 149
VL L F+GF GELP EI L LE+LDL +FN G
Sbjct: 150 VLSLPFHGFQGELPGEIFGLENLEVLDLEGNSVTGLLRNDFSRLSNLRVLNLAFNRVTGE 209
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209
IP +L C+SL ++NL+GNQ NGTIP F GQ G V LSFN L+GS+P E G+NC L
Sbjct: 210 IPSSLLGCASLEILNLAGNQLNGTIPEFVGQMRG---VYLSFNFLTGSIPSELGNNCGKL 266
Query: 210 EHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269
EH+ L+ N L IP +LGNCT+L++LLL SNML+ IP+ G+L LEVLDLSRN LSG
Sbjct: 267 EHLDLSGNFLVSGIPSNLGNCTQLQTLLLYSNMLEEAIPAGIGKLQKLEVLDLSRNSLSG 326
Query: 270 IVPSELGMCKQLKVLVLRNDYGPLYSREH--GDLPIQPVVDGGEDYNFFDGGLPDSITRL 327
+P ELG C QL VLVL N + P+ + D P + + D + +N+F GG+P++IT L
Sbjct: 327 PIPVELGNCSQLSVLVLSNLFDPIPKINYTGDDSPTEELSD--DSFNYFAGGIPETITTL 384
Query: 328 PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387
P LR+ WAP+ NL G FP W C LEM+NLA N+ G++P+ CK L LDLSSN
Sbjct: 385 PKLRILWAPSANLNGRFPSQWGQCESLEMINLAGNYLFGELPSGFTGCKKLQVLDLSSNR 444
Query: 388 LTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECS--KMSVNWSMSQVDLIGFYTAFF 445
L+G L + + VP M +F++S N GEIP +ECS K +N + D Y +FF
Sbjct: 445 LSGELNKNLPVPYMTLFDLSHNQFFGEIPSFCGNECSQVKFGLNGYVDFNDASSRYLSFF 504
Query: 446 YENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKG 505
+ +PF NG I+H+F +N FTG + + L S+ Y + + GN L G
Sbjct: 505 -ATIIRDASPFEFVGNGDLIIHNFGDNNFTGNLLSLPFPREKLGSKTVYAYLVGGNKLTG 563
Query: 506 NLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTN 565
F+ C +L GL+F+I +NK+ G +G C +KFL ++GN+ +G +P SF
Sbjct: 564 PFPDSLFEKCDNLGGLMFNISSNKISGPFSVTIGKKCGSLKFLDVSGNQMIGQVPASFGE 623
Query: 566 FDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSAN 625
SL +LNLSRN Q +P+ + +M +LK+L L+ NNF G+IP L +L SLE+L+LS N
Sbjct: 624 LLSLNHLNLSRNKFQYQIPTSLGQMANLKYLCLAGNNFNGSIPPALGKLQSLELLDLSYN 683
Query: 626 SLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP-RNSL 684
LSGEIP + L L VL L++N+L+G++P G ++LS F+VSFNNLSGS P N++
Sbjct: 684 DLSGEIPMDLVNLRGLKVLLLNNNSLSGQVPSGLANVTTLSAFNVSFNNLSGSLPSNNNM 743
Query: 685 IKCENVQGNPNLQLCH----TDPSSSEWERQHSGNVSQQEAYSPSESIQGNSSG--LNPI 738
IKC GNP L+ CH PSS E Q S A SPS S G N I
Sbjct: 744 IKCSGAIGNPYLRPCHMYSLAVPSS---EMQGSVGDPSGFAASPSGVAPQTSGGGSFNSI 800
Query: 739 EIASITSAAVILSVLIALVLLLICMKKFSCNSIADPGLVRKEVVICNNIGVQLTYENVVR 798
EIASITSA+ I+SVLIAL++L + +K++ S G +RKEV + +IGV LT+ENVVR
Sbjct: 801 EIASITSASAIVSVLIALIILFLYTRKWNSRSKV-LGSMRKEVTVFTDIGVSLTFENVVR 859
Query: 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
AT+ FN NCIGSGGFGATYKAEI GV+VA+KRL+VGRFQGVQQF AEI+TLGR++HPN
Sbjct: 860 ATSNFNASNCIGSGGFGATYKAEISSGVLVAIKRLAVGRFQGVQQFDAEIKTLGRLRHPN 919
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
LVTLIGYH SE EMFLIYNYLPGGNLEKFIQ+R R V+W +LHKIALD+ARALAYLHD+
Sbjct: 920 LVTLIGYHASETEMFLIYNYLPGGNLEKFIQERSTRAVDWRILHKIALDIARALAYLHDQ 979
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
CVPRVLHRD+KPSNILLD++ NAYLSDFGLARLLGTSETHATT VAGTFGYVAPEYAMTC
Sbjct: 980 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTC 1039
Query: 979 RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038
RVSDKADVYS+GVVLLEL+SDKKALDPSF S+GNGFNIVAWA MLL QGR EFFTAGLW
Sbjct: 1040 RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWACMLLRQGRAKEFFTAGLW 1099
Query: 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081
+ GPHDDL+E+L+LA++CT +SLS+RP+M+QV ++LKQ+QPP+
Sbjct: 1100 EVGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPPS 1142
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|339790479|dbj|BAK52396.1| leucine rich repeat receptor protein kinase 2 [Solanum lycopersicum] gi|339790485|dbj|BAK52399.1| leucine rich repeat receptor protein kinase 2 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 1065 bits (2754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 596/1112 (53%), Positives = 751/1112 (67%), Gaps = 58/1112 (5%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSS-NLSRTSCS 59
K+ALL+LK++ + D G+ S+W+ ++ D CSW GV+CD S RV +LN++ NL SC+
Sbjct: 40 KSALLELKASFS-DSSGVISSWSSRNNDHCSWFGVSCDSDS-RVVALNITGGNLGSLSCA 97
Query: 60 LLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAF 119
++ P G F C +N+S KL G + AI LT+LRVL L F
Sbjct: 98 KIAQFPLYG----FGITRVC------------ANNSVKLVGKVPLAISKLTELRVLSLPF 141
Query: 120 NGFSGELPLEIGQLSLLEILDLS------------------------FNSFHGPIPPTLQ 155
N G++PL I + LE+LDL FN G IP +L
Sbjct: 142 NELRGDIPLGIWDMDKLEVLDLQGNLITGSLPLEFKGLRKLRVLNLGFNQIVGAIPNSLS 201
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
NC +L++ NL+GN+ NGTIPAF G + + LSFN LSGS+P E G +C L+ + +A
Sbjct: 202 NCLALQIFNLAGNRVNGTIPAFIGGFEDLRGIYLSFNELSGSIPGEIGRSCEKLQSLEMA 261
Query: 216 ANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL 275
N L G IP SLGNCT L+SL+L SN+L+ IP+ FGQL LE+LDLSRN LSG +PSEL
Sbjct: 262 GNILGGVIPKSLGNCTRLQSLVLYSNLLEEAIPAEFGQLTELEILDLSRNSLSGRLPSEL 321
Query: 276 GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWA 335
G C +L +LVL + + PL + + +++NFF+G +P ITRLP+LR+ WA
Sbjct: 322 GNCSKLSILVLSSLWDPLPN-------VSDSAHTTDEFNFFEGTIPSEITRLPSLRMIWA 374
Query: 336 PNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEE 395
P L G FP +W C LE++NLA N++TG I LG+C+ L+FLDLSSN LTG L E+
Sbjct: 375 PRSTLSGKFPGSWGACDNLEIVNLAQNYYTGVISEELGSCQKLHFLDLSSNRLTGQLVEK 434
Query: 396 VSVPCMAVFNVSQNLLSGEIPRISHSECSKM--SVNWSMSQVDLIGFYTAFFYENALTSC 453
+ VPCM VF+VS N LSG IPR S+ C+ + S D Y A F ++
Sbjct: 435 LPVPCMFVFDVSGNYLSGSIPRFSNYSCAHVVSSGGDPFGPYDTSSAYLAHFTSRSVLDT 494
Query: 454 APFSSPSNGLFILHDFSNNLFTGPVPP-FLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPF 512
F+ N + H+F N FTG +PP LI + L + Y F N G + F
Sbjct: 495 TLFAGDGNHA-VFHNFGVNNFTGNLPPSMLIAPEMLGKQIVYAFLAGSNRFTGPFAGNLF 553
Query: 513 DLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNL 572
+ C L+G+I ++ NN L G++P D+G+ C ++ L + N+ VG +P S + SL L
Sbjct: 554 EKCHELNGMIVNVSNNALSGQIPEDIGAICGSLRLLDGSKNQIVGTVPPSLGSLVSLVAL 613
Query: 573 NLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIP 632
NLS NHL+G +PS + +++DL +LSL+ NN G IP QL SLE LELS+NSLSGEIP
Sbjct: 614 NLSWNHLRGQIPSRLGQIKDLSYLSLAGNNLVGPIPSSFGQLHSLETLELSSNSLSGEIP 673
Query: 633 SEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNS-LIKCENVQ 691
+ L +L L L++NNL+G+IP G ++L+ F+VSFNNLSG P N L+KC +VQ
Sbjct: 674 NNLVNLRNLTSLLLNNNNLSGKIPSGLANVTTLAAFNVSFNNLSGPLPLNKDLMKCNSVQ 733
Query: 692 GNPNLQLCHT-DPSSSEWERQHSGNVSQQEAYSPSESIQ-GNSSGLNPIEIASITSAAVI 749
GNP LQ CH S+ ++Q SQ A SPS S Q G SSG N IEIASITSAA I
Sbjct: 734 GNPFLQSCHVFSLSTPSTDQQGRIGDSQDSAASPSGSTQKGGSSGFNSIEIASITSAAAI 793
Query: 750 LSVLIALVLLLICMKKFSCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCI 809
+SVL+AL++L +K++ S G RKEV + + V LT+ENVVRAT FN NCI
Sbjct: 794 VSVLLALIVLFFYTRKWNPRSRV-AGSTRKEVTVFTEVPVPLTFENVVRATGSFNASNCI 852
Query: 810 GSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE 869
GSGGFGATYKAEI PG +VAVKRL+VGRFQG+QQF AEIRTLGR++HPNLVTLIGYH SE
Sbjct: 853 GSGGFGATYKAEIAPGFLVAVKRLAVGRFQGIQQFDAEIRTLGRLRHPNLVTLIGYHNSE 912
Query: 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIK 929
EMFLIYNYLPGGNLEKFIQ+R R V+W +LHKIALDVARALAYLHD+CVPRVLHRD+K
Sbjct: 913 TEMFLIYNYLPGGNLEKFIQERSTRAVDWRVLHKIALDVARALAYLHDQCVPRVLHRDVK 972
Query: 930 PSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSF 989
PSNILLD NAYLSDFGLARLLGTSETHATT VAGTFGYVAPEYAMTCRVSDKADVYS+
Sbjct: 973 PSNILLDEEYNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSY 1032
Query: 990 GVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEM 1049
GVVLLELISDKKALDPSF S+GNGFNIVAWA MLL QGR EFFTAGLWD GPHDDL+E+
Sbjct: 1033 GVVLLELISDKKALDPSFSSYGNGFNIVAWACMLLRQGRAKEFFTAGLWDSGPHDDLVEV 1092
Query: 1050 LNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081
L+LA++CT +SLS+RP+M+QV ++LKQ+QPP+
Sbjct: 1093 LHLAVVCTVDSLSTRPTMKQVVRRLKQLQPPS 1124
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|339790483|dbj|BAK52398.1| leucine rich repeat receptor protein kinase 2 [Solanum peruvianum] | Back alignment and taxonomy information |
|---|
Score = 1062 bits (2747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/1112 (53%), Positives = 750/1112 (67%), Gaps = 58/1112 (5%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSS-NLSRTSCS 59
K+ALL+LK++ + D G+ S+W+ ++ D CSW GV+CD S RV +LN++ NL SC+
Sbjct: 40 KSALLELKASFS-DSSGVISSWSSRNNDHCSWFGVSCDSDS-RVVALNITGGNLGSLSCA 97
Query: 60 LLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAF 119
++ P G F C +N+S KL G + AI LT+LRVL L F
Sbjct: 98 KIAQFPLYG----FGITRVC------------ANNSVKLVGKVPLAISKLTELRVLSLPF 141
Query: 120 NGFSGELPLEIGQLSLLEILDLS------------------------FNSFHGPIPPTLQ 155
N G++PL I + LE+LDL FN G IP +L
Sbjct: 142 NELRGDIPLGIWDMDKLEVLDLQGNLITGSLPLEFKGLRKLRVLNLGFNQIVGAIPNSLS 201
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
NC +L++ NL+GN+ NGTIPAF G + + LSFN LSGS+P E G +C L+ + +A
Sbjct: 202 NCLALQIFNLAGNRVNGTIPAFIGGFEDLRGIYLSFNELSGSIPGEIGRSCEKLQSLEMA 261
Query: 216 ANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL 275
N L G IP SLGNCT L+SL+L SN+L+ IP+ FGQL LE+LDLSRN LSG +PSEL
Sbjct: 262 GNILGGVIPKSLGNCTRLQSLVLYSNLLEEAIPAEFGQLTELEILDLSRNSLSGRLPSEL 321
Query: 276 GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWA 335
G C +L +LVL + + PL + + +++NFF+G +P ITRLP+LR+ WA
Sbjct: 322 GNCSKLSILVLSSLWDPLPN-------VSDSAHTTDEFNFFEGTIPSEITRLPSLRMIWA 374
Query: 336 PNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEE 395
P L G FP +W C LE++NLA N++TG I LG+C+ L+FLDLSSN LTG L E+
Sbjct: 375 PRSTLSGRFPGSWGACDNLEIVNLAQNYYTGVISEELGSCQKLHFLDLSSNRLTGQLVEK 434
Query: 396 VSVPCMAVFNVSQNLLSGEIPRISHSECSKM--SVNWSMSQVDLIGFYTAFFYENALTSC 453
+ VPCM VF+VS N LSG IPR S+ C+ + S D Y A F ++
Sbjct: 435 LPVPCMFVFDVSGNYLSGSIPRFSNYSCAHVVSSGGDPFGPYDTSSAYLAHFTSRSVLDT 494
Query: 454 APFSSPSNGLFILHDFSNNLFTGPVPP-FLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPF 512
F+ N + H+F N FTG +PP LI + L + Y F N G + F
Sbjct: 495 TLFAGDGNHA-VFHNFGGNNFTGNLPPSMLIAPEMLGKQIVYAFLAGSNRFTGPFAGNLF 553
Query: 513 DLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNL 572
+ C L+G+I ++ NN L G++P D+G+ C ++ L + N+ G +P S + SL L
Sbjct: 554 EKCHELNGMIVNVSNNALSGQIPEDIGAICGSLRLLDGSKNQIGGTVPPSLGSLVSLVAL 613
Query: 573 NLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIP 632
NLS NHL+G +PS + +++DL +LSL+ NN G IP QL SLE LELS+NSLSGEIP
Sbjct: 614 NLSWNHLRGQIPSSLGQIKDLSYLSLAGNNLVGPIPSSFGQLHSLETLELSSNSLSGEIP 673
Query: 633 SEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNS-LIKCENVQ 691
+ L +L L L++NNL+G+IP G ++L+ F+VSFNNLSG P N L+KC +VQ
Sbjct: 674 NNLVNLRNLTSLLLNNNNLSGKIPSGLANVTTLAAFNVSFNNLSGPLPLNKDLMKCNSVQ 733
Query: 692 GNPNLQLCHT-DPSSSEWERQHSGNVSQQEAYSPSESIQ-GNSSGLNPIEIASITSAAVI 749
GNP LQ CH S+ ++Q SQ A SPS S Q G SSG N IEIASITSAA I
Sbjct: 734 GNPFLQSCHVFSLSTPSTDQQGRIGDSQDSAASPSGSTQKGGSSGFNSIEIASITSAAAI 793
Query: 750 LSVLIALVLLLICMKKFSCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCI 809
+SVL+AL++L +K++ S G RKEV + + V LT+ENVVRAT FN NCI
Sbjct: 794 VSVLLALIVLFFYTRKWNPRSRV-AGSTRKEVTVFTEVPVPLTFENVVRATGSFNASNCI 852
Query: 810 GSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE 869
GSGGFGATYKAEI PG +VAVKRL+VGRFQG+QQF AEIRTLGR++HPNLVTLIGYH SE
Sbjct: 853 GSGGFGATYKAEIAPGFLVAVKRLAVGRFQGIQQFDAEIRTLGRLRHPNLVTLIGYHNSE 912
Query: 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIK 929
EMFLIYNYLPGGNLEKFIQ+R R V+W +LHKIALDVARALAYLHD+CVPRVLHRD+K
Sbjct: 913 TEMFLIYNYLPGGNLEKFIQERSTRAVDWRVLHKIALDVARALAYLHDQCVPRVLHRDVK 972
Query: 930 PSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSF 989
PSNILLD NAYLSDFGLARLLGTSETHATT VAGTFGYVAPEYAMTCRVSDKADVYS+
Sbjct: 973 PSNILLDEEYNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSY 1032
Query: 990 GVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEM 1049
GVVLLELISDKKALDPSF S+GNGFNIVAWA MLL QGR EFFTAGLWD GPHDDL+E+
Sbjct: 1033 GVVLLELISDKKALDPSFSSYGNGFNIVAWACMLLRQGRAKEFFTAGLWDSGPHDDLVEV 1092
Query: 1050 LNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081
L+LA++CT +SLS+RP+M+QV ++LKQ+QPP+
Sbjct: 1093 LHLAVVCTVDSLSTRPTMKQVVRRLKQLQPPS 1124
|
Source: Solanum peruvianum Species: Solanum peruvianum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|339790481|dbj|BAK52397.1| leucine rich repeat receptor protein kinase 2 [Solanum pennellii] | Back alignment and taxonomy information |
|---|
Score = 1059 bits (2739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 592/1112 (53%), Positives = 750/1112 (67%), Gaps = 58/1112 (5%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSS-NLSRTSCS 59
K+ALL+LK++++ D G+ S+W+ ++ D CSW GV+CD S RV +LN++ NL SC+
Sbjct: 40 KSALLELKASLS-DSSGVISSWSSRNNDHCSWFGVSCDSDS-RVVALNITGGNLGSLSCA 97
Query: 60 LLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAF 119
++ P G F C +N+S KL G + AI LT+LRVL L F
Sbjct: 98 KIAQFPLYG----FGITRVC------------ANNSVKLVGKVPLAISKLTELRVLSLPF 141
Query: 120 NGFSGELPLEIGQLSLLEILDLS------------------------FNSFHGPIPPTLQ 155
N G++PL I + LE+LDL FN G IP +L
Sbjct: 142 NELRGDIPLGIWDMDKLEVLDLQGNLITGSLPLEFKGLRKLRVLNLGFNQIVGAIPNSLS 201
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
NC +L++ NL+GN+ NGTIPAF G + + LSFN LSGS+P E G +C L+ + +A
Sbjct: 202 NCLALQIFNLAGNRVNGTIPAFIGGFGDLRGIYLSFNQLSGSIPGEIGRSCEKLQSLEMA 261
Query: 216 ANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL 275
N L G IP SLGNCT L+SL+L SN+L+ IP+ GQL L++LDLSRN LSG +PSEL
Sbjct: 262 GNILGGVIPKSLGNCTRLQSLVLYSNLLEEAIPAELGQLTELKILDLSRNSLSGRLPSEL 321
Query: 276 GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWA 335
G C +L +LVL + + PL + + +++NFF+G +P ITRLP+LR+ WA
Sbjct: 322 GNCSKLSILVLSSLWDPLPN-------VSDSAHTTDEFNFFEGTIPSEITRLPSLRMIWA 374
Query: 336 PNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEE 395
P L G FP +W C LE++NLA N++TG I LG+C+ L+FLDLSSN LTG L E+
Sbjct: 375 PRSTLSGKFPGSWGACDNLEIVNLAQNYYTGVISEELGSCQKLHFLDLSSNRLTGQLVEK 434
Query: 396 VSVPCMAVFNVSQNLLSGEIPRISHSECSKM--SVNWSMSQVDLIGFYTAFFYENALTSC 453
+ VPCM VF+VS N LSG IPR S+ C+ + S D Y A F ++
Sbjct: 435 LPVPCMFVFDVSGNYLSGSIPRFSNYSCAHVVSSGGDPFGPYDTSSAYLAHFTSRSVLDT 494
Query: 454 APFSSPSNGLFILHDFSNNLFTGPVPP-FLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPF 512
F+ N + H+F N FTG +PP LI + L + Y F N G + F
Sbjct: 495 TLFAGDGNHA-VFHNFGGNNFTGNLPPSMLIAPEMLVKQIVYAFLAGSNRFTGPFAGNLF 553
Query: 513 DLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNL 572
+ C + G+I ++ NN L G++P D+G+ C ++ L + N+ G +P S + SL L
Sbjct: 554 EKCHDMKGMIVNVSNNALSGQIPEDIGAICGSLRLLDGSKNQIGGTVPPSLGSLVSLVAL 613
Query: 573 NLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIP 632
NLS NHL+G +PS + +++DL +LSL+ NN G+IP QL SLE LELS+NSLSGEIP
Sbjct: 614 NLSWNHLRGQIPSSLGQIKDLSYLSLAGNNLVGSIPSSFGQLHSLETLELSSNSLSGEIP 673
Query: 633 SEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNS-LIKCENVQ 691
+ L +L L L++NNL+G+IP G ++L+ F+VSFNNLSG P N L+KC +VQ
Sbjct: 674 NNLVNLRNLTSLLLNNNNLSGKIPSGLANVTTLAAFNVSFNNLSGPLPLNKDLMKCNSVQ 733
Query: 692 GNPNLQLCHT-DPSSSEWERQHSGNVSQQEAYSPSESIQ-GNSSGLNPIEIASITSAAVI 749
GNP LQ CH S+ ++Q SQ A SPS S Q G SSG N IEIASITSAA I
Sbjct: 734 GNPFLQSCHVFSLSTPSTDQQGRIGDSQDSAASPSGSTQKGGSSGFNSIEIASITSAAAI 793
Query: 750 LSVLIALVLLLICMKKFSCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCI 809
+SVL+AL++L +K++ S G RKEV + + V LT+ENVVRAT FN NCI
Sbjct: 794 VSVLLALIVLFFYTRKWNPRSRV-AGSTRKEVTVFTEVPVPLTFENVVRATGSFNASNCI 852
Query: 810 GSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE 869
GSGGFGATYKAEI PG +VAVKRL+VGRFQG+QQF AEIRTLGR++HPNLVTLIGYH SE
Sbjct: 853 GSGGFGATYKAEIAPGFLVAVKRLAVGRFQGIQQFDAEIRTLGRLRHPNLVTLIGYHNSE 912
Query: 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIK 929
EMFLIYNYLPGGNLEKFIQ+R R V+W +LHKIALDVARALAYLHD+CVPRVLHRD+K
Sbjct: 913 TEMFLIYNYLPGGNLEKFIQERSTRAVDWRVLHKIALDVARALAYLHDQCVPRVLHRDVK 972
Query: 930 PSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSF 989
PSNILLD NAYLSDFGLARLLGTSETHATT VAGTFGYVAPEYAMTCRVSDKADVYS+
Sbjct: 973 PSNILLDEEYNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSY 1032
Query: 990 GVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEM 1049
GVVLLELISDKKALDPSF S+GNGFNIVAWA MLL QGR EFFTAGLWD GPHDDL+E+
Sbjct: 1033 GVVLLELISDKKALDPSFSSYGNGFNIVAWACMLLRQGRAKEFFTAGLWDSGPHDDLVEV 1092
Query: 1050 LNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081
L+LA++CT +SLS+RP+M+QV ++LKQ+QPP+
Sbjct: 1093 LHLAVVCTVDSLSTRPTMKQVVRRLKQLQPPS 1124
|
Source: Solanum pennellii Species: Solanum pennellii Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147803536|emb|CAN77668.1| hypothetical protein VITISV_038106 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1042 bits (2694), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 573/1022 (56%), Positives = 704/1022 (68%), Gaps = 43/1022 (4%)
Query: 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLS-------------- 142
KL G LS I LT+LR L L +N F G++P+EI + LE+LDL
Sbjct: 120 KLIGTLSPVIAKLTELRALSLPYNEFGGQIPIEIWGMEKLEVLDLEGNSMSGSLPIRFGG 179
Query: 143 ----------FNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192
FN G IP +L N SL ++NL+GN NGTIP F G + V LSFN
Sbjct: 180 LRNSRVLNLGFNKIAGVIPSSLSNLMSLEILNLAGNMVNGTIPGFIGSFKELRGVYLSFN 239
Query: 193 LLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFG 252
L GS+P E G NC LE + L+ N L G IP SLGNC++LRS+LL SN+L+ IP+ G
Sbjct: 240 RLGGSIPSEIGSNCQKLEDLDLSGNLLVGGIPSSLGNCSQLRSILLFSNLLEEVIPAELG 299
Query: 253 QLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREH--GDLPIQPVVDGG 310
QL NLEVLD+SRN LSG +P LG C QL LVL N + PL + ++ GD +V G
Sbjct: 300 QLRNLEVLDVSRNSLSGSIPPALGNCSQLSALVLSNLFDPLLNIKNMKGDSNSGQLVSGN 359
Query: 311 EDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPA 370
+DYN+F G +P IT LP LR+ WAP LEG FP NW C LE++NL+ NFFTG+IP
Sbjct: 360 DDYNYFQGTIPVEITTLPKLRIIWAPRATLEGRFPSNWGACDSLEVINLSQNFFTGEIPE 419
Query: 371 SLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVN- 429
CK L+FLDLSSN LTG L E++ VPCM VF+VS NLLSG IPR + C+++ N
Sbjct: 420 GFSRCKKLHFLDLSSNKLTGELVEKLPVPCMTVFDVSCNLLSGRIPRFYYGSCTRVPSNN 479
Query: 430 -WSMSQVDLIGFYTAFFYENALTSCAP--FSSPSNGLFILHDFSNNLFTGPVPPFLIDSD 486
+ + L Y +FF + AP FS + L + H+F++N F G I SD
Sbjct: 480 RYVLESSSLSSAYVSFFANKGIVE-APLLFSKGDDSLSVFHNFASNNFNGTFESMPIASD 538
Query: 487 SLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMK 546
L + Y F N+L G FD C L+ ++ ++ NN++ G++P+++G+ CK +
Sbjct: 539 RLGKQTVYSFLAGENNLTGPFPRNLFDKCYGLNRVVVNVSNNRISGQLPTEIGALCKTLT 598
Query: 547 FLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGA 606
L +GN+ G IP S N SL LNLS NHLQG +PS + K+E LK+LSL+ N TG
Sbjct: 599 LLDASGNQINGSIPHSIGNLVSLVALNLSSNHLQGEIPSSLGKIEGLKYLSLAGNILTGP 658
Query: 607 IPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLS 666
IP L L SLEVLELS+NSLSGEIP + L L VL L+ N L+G+IP G ++LS
Sbjct: 659 IPSSLGNLQSLEVLELSSNSLSGEIPRDLVNLRSLTVLLLNDNKLSGQIPSGLANVTTLS 718
Query: 667 IFDVSFNNLSGSAPRN-SLIKCENVQGNPNLQLCH----TDPSSSEWERQHSGNVSQQEA 721
F+VSFNNLSG P N +L+KC +V GNP L+ C T PSS ++Q SQ +
Sbjct: 719 AFNVSFNNLSGPLPLNDNLMKCSSVLGNPLLRSCRLFSLTVPSS---DQQGGVGDSQDYS 775
Query: 722 YSPSES-IQGNSSGLNPIEIASITSAAVILSVLIALVLLLICMKKFSCNSIADP-GLVRK 779
SPS S + SS N IEIASITSA+ I+SVL+ALV+L I +K CN + RK
Sbjct: 776 ASPSGSPTRSRSSSFNSIEIASITSASAIVSVLLALVVLFIYTRK--CNPKSRILRSARK 833
Query: 780 EVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ 839
EV + N+IGV LT+ENVVRAT FN NCIG+GGFGATYKAEI PGV+VA+KRL+VGRFQ
Sbjct: 834 EVTVFNDIGVPLTFENVVRATGSFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ 893
Query: 840 GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS 899
GVQQF AE++TLGR+ HPNLVTLIGYH SE EMFLIYNYLPGGNLEKFIQ+R R V+W
Sbjct: 894 GVQQFHAEVKTLGRLDHPNLVTLIGYHASETEMFLIYNYLPGGNLEKFIQERSTRAVDWR 953
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
+LHKIALD+ARALAYLHD+CVPRVLHRD+KPSNILLD++ NAYLSDFGLARLLG SETHA
Sbjct: 954 VLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 1013
Query: 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAW 1019
TT VAGTFGYVAPEYAMTCRVSDKADVYS+GVVLLEL+SDKKALDPSF S+GNGFNIVAW
Sbjct: 1014 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAW 1073
Query: 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079
MLL QGR EFFTAGLWD GPHDDL+E+L+LA++CT +SLS+RP+MRQV ++LKQ+QP
Sbjct: 1074 GCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMRQVVRRLKQLQP 1133
Query: 1080 PA 1081
P+
Sbjct: 1134 PS 1135
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1082 | ||||||
| TAIR|locus:2026408 | 540 | RPK1 "receptor-like protein ki | 0.394 | 0.790 | 0.561 | 4.7e-119 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.534 | 0.484 | 0.313 | 1.6e-118 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.891 | 0.772 | 0.321 | 4.7e-118 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.524 | 0.438 | 0.302 | 2.4e-115 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.872 | 0.856 | 0.315 | 5.2e-113 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.529 | 0.509 | 0.319 | 1.7e-112 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.874 | 0.853 | 0.313 | 6.2e-112 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.887 | 0.871 | 0.312 | 2.1e-111 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.883 | 0.763 | 0.314 | 5.1e-106 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.523 | 0.498 | 0.324 | 6.2e-106 |
| TAIR|locus:2026408 RPK1 "receptor-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1172 (417.6 bits), Expect = 4.7e-119, P = 4.7e-119
Identities = 243/433 (56%), Positives = 300/433 (69%)
Query: 651 LTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN--SLIKCE--NVQGNPNLQLCHTDPSSS 706
L G I P G S + + +SFN+L G P+ L K E +++GN + +
Sbjct: 107 LGGVISPVVGDLSEIRVLSLSFNDLRGEIPKEIWGLEKLEILDLKGNNFIGGIRV-VDNV 165
Query: 707 EWERQHSGNVSQQEAYSPSESIQGNSSGLNPIEIASITXXXXXXXXXXXXXXXXXCMKKF 766
+ S + S ++ SGL PIEIASI +K+
Sbjct: 166 VLRKLMSFEDEDEIGPSSADDDSPGKSGLYPIEIASIVSASVIVFVLLVLVILFIYTRKW 225
Query: 767 SCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGV 826
NS + KE+ + +IG+ LTYE +VRAT F+ NCIG GGFG+TYKAE+ P
Sbjct: 226 KRNSQVQVDEI-KEIKVFVDIGIPLTYEIIVRATGYFSNSNCIGHGGFGSTYKAEVSPTN 284
Query: 827 VVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEK 886
V AVKRLSVGRFQG QQF AEI L V+HPNLV LIGYH SE EMFLIYNYL GGNL+
Sbjct: 285 VFAVKRLSVGRFQGDQQFHAEISALEMVRHPNLVMLIGYHASETEMFLIYNYLSGGNLQD 344
Query: 887 FIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946
FI++R + +EW +LHKIALDVARAL+YLH++C P+VLHRDIKPSNILLDNN NAYLSDF
Sbjct: 345 FIKERSKAAIEWKVLHKIALDVARALSYLHEQCSPKVLHRDIKPSNILLDNNYNAYLSDF 404
Query: 947 GLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPS 1006
GL++LLGTS++H TT VAGTFGYVAPEYAMTCRVS+KADVYS+G+VLLELISDK+ALDPS
Sbjct: 405 GLSKLLGTSQSHVTTGVAGTFGYVAPEYAMTCRVSEKADVYSYGIVLLELISDKRALDPS 464
Query: 1007 FCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS 1066
F S NGFNIV+WA M+L QG+ E FT GLW+ GP DDL+E+L+LA+ CT +SLS RP+
Sbjct: 465 FSSHENGFNIVSWAHMMLSQGKAKEVFTTGLWETGPPDDLVEVLHLALKCTVDSLSIRPT 524
Query: 1067 MRQVAQQLKQIQP 1079
M+Q + LK+IQP
Sbjct: 525 MKQAVRLLKRIQP 537
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 1.6e-118, Sum P(2) = 1.6e-118
Identities = 191/610 (31%), Positives = 292/610 (47%)
Query: 99 SGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCS 158
+G L + I L L L L++N +P G+L L IL+L G IPP L NC
Sbjct: 223 NGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAELIGLIPPELGNCK 282
Query: 159 SLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANS 218
SL+ + LS N +G +P + P S N LSGS+P G V L+ +LLA N
Sbjct: 283 SLKSLMLSFNSLSGPLPLELSEIP-LLTFSAERNQLSGSLPSWMGKWKV-LDSLLLANNR 340
Query: 219 LTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMC 278
+G IP + +C L+ L L+SN+L G IP +LE +DLS N LSG + C
Sbjct: 341 FSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGC 400
Query: 279 KQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNL 338
L L+L N+ + DL P++ D N F G +P S+ + NL F A
Sbjct: 401 SSLGELLLTNNQ--INGSIPEDLWKLPLMALDLDSNNFTGEIPKSLWKSTNLMEFTASYN 458
Query: 339 NLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSV 398
LEG P + L+ L L+ N TG+IP +G SL L+L++N G +P E+
Sbjct: 459 RLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELG- 517
Query: 399 PC--MAVFNVSQNLLSGEIP----RISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTS 452
C + ++ N L G+IP ++ +C +S N ++S + +A+F++ +
Sbjct: 518 DCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYN-NLSG-SIPSKPSAYFHQIEMPD 575
Query: 453 CAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPF 512
+ F +G+F D S N +GP+P L + L LS N L G + P
Sbjct: 576 LS-FLQ-HHGIF---DLSYNRLSGPIPEELGECLVLVE-----ISLSNNHLSGEI---PA 622
Query: 513 DLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDXXXXX 572
L + I D+ N L G +P +MG+ K ++ L++A N+ G IP+SF
Sbjct: 623 SLSRLTNLTILDLSGNALTGSIPKEMGNSLK-LQGLNLANNQLNGHIPESFGLLGSLVKL 681
Query: 573 XXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIP 632
L GP+P+ + +++L + LS NN +G + EL+ + L L + N +GEIP
Sbjct: 682 NLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIP 741
Query: 633 SEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQG 692
SE L L L + N L+G IP +L +++ NNL G P + + C++
Sbjct: 742 SELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGV--CQDPSK 799
Query: 693 ---NPNLQLC 699
+ N +LC
Sbjct: 800 ALLSGNKELC 809
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 4.7e-118, Sum P(2) = 4.7e-118
Identities = 327/1018 (32%), Positives = 502/1018 (49%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
N+ +NS L+G + +G+++QL+ L L N G +P + L L+ LDLS N+ G
Sbjct: 245 NLANNS---LTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTG 301
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIP-AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCV 207
IP N S L + L+ N +G++P + + + + LS LSG +P E C
Sbjct: 302 EIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELS-KCQ 360
Query: 208 SLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267
SL+ + L+ NSL GSIP +L EL L L +N L+G + S L NL+ L L N L
Sbjct: 361 SLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNL 420
Query: 268 SGIVPSELGMCKQLKVLVL-RNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITR 326
G +P E+ ++L+VL L N + +E G+ ++D N F+G +P SI R
Sbjct: 421 EGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFG--NHFEGEIPPSIGR 478
Query: 327 LPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSN 386
L L + L G P + C +L +L+LA N +G IP+S G K L L L +N
Sbjct: 479 LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNN 538
Query: 387 NLTGLLPEE-VSVPCMAVFNVSQNLLSGEI-PRISHSECSKMSV--NWSMSQVDL-IGFY 441
+L G LP+ +S+ + N+S N L+G I P S V N ++ L +G
Sbjct: 539 SLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNS 598
Query: 442 TAF----FYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFW 497
+N LT P++ L D S+N TG +P L+ L+
Sbjct: 599 QNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHID----- 653
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG 557
L+ N L G + P+ LS G + + +N+ + +P+++ +C + LS+ GN G
Sbjct: 654 LNNNFLSGPIP--PWLGKLSQLGEL-KLSSNQFVESLPTEL-FNCTKLLVLSLDGNSLNG 709
Query: 558 LIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASL 617
IPQ N G LP + K+ L L LS N+ TG IP E+ QL L
Sbjct: 710 SIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDL 769
Query: 618 E-VLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
+ L+LS N+ +G+IPS L L L L HN LTG +P G SL +VSFNNL
Sbjct: 770 QSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLG 829
Query: 677 GSAPRN-SLIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVSQQEAYSPSESIQGNSSGL 735
G + S ++ GN L C + P S R S N QQ + S I S L
Sbjct: 830 GKLKKQFSRWPADSFLGNTGL--CGS-PLS-RCNRVRSNN-KQQGLSARSVVIISAISAL 884
Query: 736 NPIEIASITXXXXXXXXXXXXXXXXXCMKKFSCNSIADPGLVRKEVVICNNIGVQLTYEN 795
I + + ++ +S + K + + +E+
Sbjct: 885 TAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQA-THKPLFRNGASKSDIRWED 943
Query: 796 VVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRV 854
++ AT + + IGSGG G YKAE+ G VAVK+ L + F+ E++TLGR+
Sbjct: 944 IMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRI 1003
Query: 855 QHPNLVTLIGYHVSEAE--MFLIYNYLPGGNLEKFI-QDRP-----RRTVEWSMLHKIAL 906
+H +LV L+GY S++E LIY Y+ G++ ++ +D+P ++ ++W +IA+
Sbjct: 1004 RHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAV 1063
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS---ETHATTDV 963
+A+ + YLH +CVP ++HRDIK SN+LLD+N+ A+L DFGLA++L + T + T
Sbjct: 1064 GLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWF 1123
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML 1023
A ++GY+APEYA + + ++K+DVYS G+VL+E+++ K P+ FG ++V W
Sbjct: 1124 ACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKM---PTDSVFGAEMDMVRWVETH 1180
Query: 1024 L-LQGRPCE-FFTAGLWDCGP--HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
L + G + L P D ++L +A+ CT S RPS RQ L +
Sbjct: 1181 LEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 2.4e-115, Sum P(3) = 2.4e-115
Identities = 183/605 (30%), Positives = 282/605 (46%)
Query: 99 SGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCS 158
SG L A+G+L L+ L L+ N +G +P+ + L +L+ + L +NS G + P +
Sbjct: 102 SGELPEALGNLQNLQYLDLSNNELTGPIPISLYNLKMLKEMVLDYNSLSGQLSPAIAQLQ 161
Query: 159 SLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANS 218
L +++S N +G++P G +++ + N +GS+P FG N L H + N+
Sbjct: 162 HLTKLSISMNSISGSLPPDLGSLKNLELLDIKMNTFNGSIPATFG-NLSCLLHFDASQNN 220
Query: 219 LTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMC 278
LTGSI P + + T L +L LSSN +G IP GQL NLE+L L +N L+G +P E+G
Sbjct: 221 LTGSIFPGITSLTNLLTLDLSSNSFEGTIPREIGQLENLELLILGKNDLTGRIPQEIGSL 280
Query: 279 KQLKVLVLRN-DYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPN 337
KQLK+L L + L +D + N FD LP S+ L NL A N
Sbjct: 281 KQLKLLHLEECQFTGKIPWSISGLSSLTELDISD--NNFDAELPSSMGELGNLTQLIAKN 338
Query: 338 LNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS 397
L G P+ C KL ++NL+ N G IP + +++ + N L+G +P+ +
Sbjct: 339 AGLSGNMPKELGNCKKLTVINLSFNALIGPIPEEFADLEAIVSFFVEGNKLSGRVPDWIQ 398
Query: 398 VPCMA-VFNVSQNLLSGEIP--RISH-----SECSKMSVNWSMSQVDLIGFYTAFFYENA 449
A + QN SG +P + H +E + +S + ++ + N
Sbjct: 399 KWKNARSIRLGQNKFSGPLPVLPLQHLLSFAAESNLLSGSIPSHICQANSLHSLLLHHNN 458
Query: 450 LTSCAP--FSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNL 507
LT F +N L L+ N++ G VP +L + P LS N G L
Sbjct: 459 LTGTIDEAFKGCTN-LTELNLLDNHIH-GEVPGYLAEL------PLVTLELSQNKFAGML 510
Query: 508 STYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFD 567
P +L S L + NN++ G +P +G ++ L + N G IPQS +
Sbjct: 511 ---PAELWESKTLLEISLSNNEITGPIPESIGK-LSVLQRLHIDNNLLEGPIPQSVGDLR 566
Query: 568 XXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSL 627
L G +P + L L LS NN TG IP ++ L L+ L LS+N L
Sbjct: 567 NLTNLSLRGNRLSGIIPLALFNCRKLATLDLSYNNLTGNIPSAISHLTLLDSLILSSNQL 626
Query: 628 SGEIPSE----FSK--------LEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
SG IP+E F L+H +L L +N LTG+IP + + + ++ N L
Sbjct: 627 SGSIPAEICVGFENEAHPDSEFLQHHGLLDLSYNQLTGQIPTSIKNCAMVMVLNLQGNLL 686
Query: 676 SGSAP 680
+G+ P
Sbjct: 687 NGTIP 691
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1115 (397.6 bits), Expect = 5.2e-113, P = 5.2e-113
Identities = 319/1011 (31%), Positives = 490/1011 (48%)
Query: 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
S + LSG + + IG+ + L +L L N F GE+P+EIG+L LE L + N G +P
Sbjct: 105 SYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVE 164
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
+ N SL + N +G +P G N++SGS+P E G C SL +
Sbjct: 165 IGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIG-GCESLVMLG 223
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPS 273
LA N L+G +P +G +L ++L N G IP +LE L L +N L G +P
Sbjct: 224 LAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPK 283
Query: 274 ELGMCKQLKVLVL-RNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRV 332
ELG + L+ L L RN RE G+L +D E N G +P + + L +
Sbjct: 284 ELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSE--NALTGEIPLELGNIEGLEL 341
Query: 333 FWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLL 392
+ L G P L L+L+ N TG IP + L+ L L N+L+G +
Sbjct: 342 LYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTI 401
Query: 393 PEEVS-VPCMAVFNVSQNLLSGEIPRIS--HSECSKMSVNWSMSQVDL-IGFYTAF---- 444
P ++ + V ++S N LSG IP HS +++ + ++ G T
Sbjct: 402 PPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQ 461
Query: 445 --FYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNS 502
N L P + + N F G +P + + +L L+ N
Sbjct: 462 LRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQR-----LQLADNG 516
Query: 503 LKGNLSTYPFDL-CLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQ 561
G L P ++ LS G + +I +NKL GEVPS++ +CK ++ L M N F G +P
Sbjct: 517 FTGEL---PREIGMLSQLGTL-NISSNKLTGEVPSEI-FNCKMLQRLDMCCNNFSGTLPS 571
Query: 562 SFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEV-L 620
+ +L G +P + + L L + N F G+IP EL L L++ L
Sbjct: 572 EVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIAL 631
Query: 621 ELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680
LS N L+GEIP E S L L L L++NNL+G IP F SSL ++ S+N+L+G P
Sbjct: 632 NLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP 691
Query: 681 RNSLIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVSQQEAYSPSESIQGNSSGLNPIEI 740
I + GN L C P ++ Q + ++PS+S G G+ +I
Sbjct: 692 LLRNISMSSFIGNEGL--C--GPPLNQ--------CIQTQPFAPSQST-GKPGGMRSSKI 738
Query: 741 ASITXXXXXXXXXXXXXXXXXCMKK---FSCNSIAD--PGLVRKEVVICNNIGVQLTYEN 795
+IT M++ +S D P + ++ G T+++
Sbjct: 739 IAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG--FTFQD 796
Query: 796 VVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSV----GRFQGVQQ-FAAEIRT 850
+V AT F+ +G G G YKA + G +AVK+L+ G V F AEI T
Sbjct: 797 LVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILT 856
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR 910
LG ++H N+V L G+ + L+Y Y+P G+L + + D P ++WS KIAL A+
Sbjct: 857 LGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD-PSCNLDWSKRFKIALGAAQ 915
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
LAYLH +C PR+ HRDIK +NILLD+ A++ DFGLA+++ + + + +AG++GY+
Sbjct: 916 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYI 975
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030
APEYA T +V++K+D+YS+GVVLLEL++ K + P G ++V W + +
Sbjct: 976 APEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP----IDQGGDVVNWVRSYIRR---- 1027
Query: 1031 EFFTAGLWDCGP--HDD-----LIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074
+ ++G+ D D+ ++ +L +A++CT S +RPSMRQV L
Sbjct: 1028 DALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 697 (250.4 bits), Expect = 1.7e-112, Sum P(2) = 1.7e-112
Identities = 193/605 (31%), Positives = 310/605 (51%)
Query: 90 INSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGP 149
I N S + S + S ++ +T L L + N SG + IG L L L+L++N+ G
Sbjct: 69 IGVNCSSQGSSSSSNSLV-VTSLD--LSSMN-LSGIVSPSIGGLVNLVYLNLAYNALTGD 124
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209
IP + NCS L ++ L+ NQF G+IP + + ++ N LSG +PEE GD +L
Sbjct: 125 IPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGD-LYNL 183
Query: 210 EHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269
E ++ N+LTG +P SLGN +L + N G+IP+ G+ +NL++L L++NF+SG
Sbjct: 184 EELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISG 243
Query: 270 IVPSELGMCKQLKVLVL-RNDYGPLYSREHGDLP-IQPVVDGGEDYNFFDGGLPDSITRL 327
+P E+GM +L+ ++L +N + ++ G+L ++ + G N G +P I +
Sbjct: 244 ELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYG---NSLVGPIPSEIGNM 300
Query: 328 PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387
+L+ + L G P+ SK+ ++ + N +G+IP L L L L N
Sbjct: 301 KSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNK 360
Query: 388 LTGLLPEEVS-VPCMAVFNVSQNLLSGEIPRISHSECSKMSVNW---SMSQV--DLIGFY 441
LTG++P E+S + +A ++S N L+G IP + S + S+S V +G Y
Sbjct: 361 LTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLY 420
Query: 442 TAF----FYENALTS-CAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGF 496
+ F EN L+ PF + L +L+ SN +F G +PP ++ SL
Sbjct: 421 SPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIF-GNIPPGVLRCKSLLQ-----L 474
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
+ GN L G +P +LC ++ ++ N+ G +P ++G+ C+ ++ L +A N+F
Sbjct: 475 RVVGNRLTGQ---FPTELCKLVNLSAIELDQNRFSGPLPPEIGT-CQKLQRLHLAANQFS 530
Query: 557 GLIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLAS 616
+P + L GP+PS I + L+ L LS N+F G++P EL L
Sbjct: 531 SNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQ 590
Query: 617 LEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSI-FDVSFNNL 675
LE+L LS N SG IP L HL L++ N +G IPP G SSL I ++S+N+
Sbjct: 591 LEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDF 650
Query: 676 SGSAP 680
SG P
Sbjct: 651 SGEIP 655
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 6.2e-112, Sum P(2) = 6.2e-112
Identities = 315/1004 (31%), Positives = 484/1004 (48%)
Query: 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
SS+ +GN+ +G L LR L L FN G P + + LE + + N +G IP
Sbjct: 124 SSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSN 183
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
+ N S L + L NQF+G +P+ G Q + L+ N L G++P +N +L ++
Sbjct: 184 IGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTL-NNLENLVYLD 242
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPS 273
+ NSL G+IP +C ++ ++ LS+N G +P G +L LSG +PS
Sbjct: 243 VRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPS 302
Query: 274 ELGMCKQLKVLVLR-NDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRV 332
G +L L L N + E G + ++D N +G +P + L L+
Sbjct: 303 CFGQLTKLDTLYLAGNHFSGRIPPELGKC--KSMIDLQLQQNQLEGEIPGELGMLSQLQY 360
Query: 333 FWAPNLNLEGIFPQN-WELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
NL G P + W++ S L+ L L N +G++P + K L L L N+ TG+
Sbjct: 361 LHLYTNNLSGEVPLSIWKIQS-LQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGV 419
Query: 392 LPEEVSV-PCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENAL 450
+P+++ + V ++++N+ +G IP + CS+ + ++ L+G+ + E ++
Sbjct: 420 IPQDLGANSSLEVLDLTRNMFTGHIPP---NLCSQKK----LKRL-LLGYN---YLEGSV 468
Query: 451 TSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTY 510
S S L IL + NNL G +P F ++ +L F LSGN+ G +
Sbjct: 469 PSDLGGCSTLERL-ILEE--NNL-RGGLPDF-VEKQNLLF-----FDLSGNNFTGPI--- 515
Query: 511 PFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDXXX 570
P L + + +N+L G +P ++GS K ++ L+++ N G++P +N
Sbjct: 516 PPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVK-LEHLNLSHNILKGILPSELSNCHKLS 574
Query: 571 XXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGE 630
L G +PS + + +L LSL N+F+G IP L Q L L+L N L+G+
Sbjct: 575 ELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGD 634
Query: 631 IPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCEN- 689
IP L+ L L L N L G++P G L DVS NNLSG+ S I+
Sbjct: 635 IPP-VGALQALRSLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTLRVLSTIQSLTF 693
Query: 690 VQGNPNLQLCHTDPSSSEW----ERQHSGNVSQQEAYSPSESIQ-GNSSGLNPIEIASIT 744
+ + NL PS +++ SGN S P++ + SS L P + S T
Sbjct: 694 INISHNLFSGPVPPSLTKFLNSSPTSFSGN-SDLCINCPADGLACPESSILRPCNMQSNT 752
Query: 745 XXXXXXXXXXXXXXXXX-----CMKKFSCNSIADPGLVRKEVVICNNIGVQLTYENVVRA 799
C+ FS +E+ I G V+ A
Sbjct: 753 GKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAISAQEGDGSLLNKVLEA 812
Query: 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPN 858
T N + IG G G YKA + P V AVK+L G G EI T+G+V+H N
Sbjct: 813 TENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSVSMVREIETIGKVRHRN 872
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSMLHKIALDVARALAYLHD 917
L+ L + + + ++Y Y+ G+L + + P + ++WS H IA+ A LAYLH
Sbjct: 873 LIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHF 932
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAM 976
+C P ++HRDIKP NILLD++L ++SDFG+A+LL S T ++ V GT GY+APE A
Sbjct: 933 DCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAF 992
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNG-FNIVAWASMLLLQ-GRPCEFFT 1034
T S ++DVYS+GVVLLELI+ KKALDPSF NG +IV W + Q G +
Sbjct: 993 TTVKSRESDVYSYGVVLLELITRKKALDPSF----NGETDIVGWVRSVWTQTGEIQKIVD 1048
Query: 1035 AGLWD----CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074
L D + + E L+LA+ C + + RP+MR V +QL
Sbjct: 1049 PSLLDELIDSSVMEQVTEALSLALRCAEKEVDKRPTMRDVVKQL 1092
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1044 (372.6 bits), Expect = 2.1e-111, Sum P(2) = 2.1e-111
Identities = 323/1034 (31%), Positives = 495/1034 (47%)
Query: 81 QLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILD 140
+LH + N+++N +SG + + + L VL L N F G +P+++ + L+ L
Sbjct: 89 KLHGLRKLNVSTNF---ISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLY 145
Query: 141 LSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPE 200
L N G IP + N SSL+ + + N G IP + +++ N SG +P
Sbjct: 146 LCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPS 205
Query: 201 EFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVL 260
E C SL+ + LA N L GS+P L L L+L N L G+IP S G + LEVL
Sbjct: 206 EIS-GCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVL 264
Query: 261 DLSRNFLSGIVPSELGMCKQLKVLVL-RNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGG 319
L N+ +G +P E+G ++K L L N RE G+L +D E N G
Sbjct: 265 ALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSE--NQLTGF 322
Query: 320 LPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLY 379
+P + NL++ L G P+ + LE L+L+ N G IP L L
Sbjct: 323 IPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLV 382
Query: 380 FLDLSSNNLTGLLPEEVSVPC-MAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLI 438
L L N L G +P + +V ++S N LSG IP +H + + S+ L
Sbjct: 383 DLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIP--AHFCRFQTLILLSLGSNKLS 440
Query: 439 GFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWL 498
G L +C + +L D N TG +P L + +L++ + WL
Sbjct: 441 GNIP-----RDLKTCKSLTK-----LMLGD---NQLTGSLPIELFNLQNLTALELHQNWL 487
Query: 499 SGN------SLKG----NLSTYPF--DLCLSLDGLI----FDIGNNKLIGEVPSDMGSHC 542
SGN LK L+ F ++ + L F+I +N+L G +P ++GS C
Sbjct: 488 SGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGS-C 546
Query: 543 KCMKFLSMAGNEFVGLIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNN 602
++ L ++GN+F G I Q L G +P + L L L N
Sbjct: 547 VTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL 606
Query: 603 FTGAIPWELTQLASLEV-LELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGT 661
+ IP EL +L SL++ L +S N+LSG IP L+ L +L L+ N L+G IP G
Sbjct: 607 LSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGN 666
Query: 662 RSSLSIFDVSFNNLSGSAPRNSLIK---CENVQGNPNLQLCHTDPSSSEWERQHSGNVSQ 718
SL I ++S NNL G+ P ++ + N GN L C++ +R H
Sbjct: 667 LMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGL--CNS-------QRSHC----- 712
Query: 719 QEAYSPSES-IQGNSSGLNPIEIASITXXXXXXXXXXXXXXXXXCMKKFSCNSIADPGLV 777
Q S+S + +G +I +IT +K+ +A
Sbjct: 713 QPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQT 772
Query: 778 RKEVVICNNIGVQ-LTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVG 836
+ +V+ + TY+ +V AT F+ +G G G YKAE+ G V+AVK+L+
Sbjct: 773 KPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-S 831
Query: 837 RFQGVQQ---FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR 893
R +G F AEI TLG+++H N+V L G+ + L+Y Y+ G+L + +Q +
Sbjct: 832 RGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEK 891
Query: 894 RTV-EWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+ +W+ ++IAL A L YLH +C P+++HRDIK +NILLD A++ DFGLA+L+
Sbjct: 892 NCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI 951
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012
S + + + VAG++GY+APEYA T +V++K D+YSFGVVLLELI+ K + P
Sbjct: 952 DLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP----LEQ 1007
Query: 1013 GFNIVAWASMLLLQGRPC-EFFTAGLWDCGPHDDLIEM---LNLAIMCTGESLSSRPSMR 1068
G ++V W + P E F A L D + EM L +A+ CT S +SRP+MR
Sbjct: 1008 GGDLVNWVRRSIRNMIPTIEMFDARL-DTNDKRTVHEMSLVLKIALFCTSNSPASRPTMR 1066
Query: 1069 QVAQQLKQIQPPAS 1082
+V + + + +S
Sbjct: 1067 EVVAMITEARGSSS 1080
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1049 (374.3 bits), Expect = 5.1e-106, P = 5.1e-106
Identities = 322/1023 (31%), Positives = 500/1023 (48%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
N+ NS SG + +GDL ++ L L N G +P + +L+ L+ LDLS N+ G
Sbjct: 246 NLGDNS---FSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTG 302
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIP-AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCV 207
I + L + L+ N+ +G++P + + + LS LSG +P E NC
Sbjct: 303 VIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEIS-NCQ 361
Query: 208 SLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267
SL+ + L+ N+LTG IP SL EL +L L++N L+G + SS L NL+ L N L
Sbjct: 362 SLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNL 421
Query: 268 SGIVPSELGMCKQLKVLVL-RNDYGPLYSREHGDLPIQPVVDGGEDY-NFFDGGLPDSIT 325
G VP E+G +L+++ L N + E G+ +D Y N G +P SI
Sbjct: 422 EGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDW---YGNRLSGEIPSSIG 478
Query: 326 RLPNL-RVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLS 384
RL +L R+ N L G P + C ++ +++LA N +G IP+S G +L +
Sbjct: 479 RLKDLTRLHLREN-ELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIY 537
Query: 385 SNNLTGLLPEE-VSVPCMAVFNVSQNLLSGEI-PRISHSECSKMSVNWSMSQVDL---IG 439
+N+L G LP+ +++ + N S N +G I P S V + + D+ +G
Sbjct: 538 NNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELG 597
Query: 440 FYTAF----FYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYG 495
T +N T P + L D S N +G +P L L + +
Sbjct: 598 KSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVEL----GLCKKLTH- 652
Query: 496 FWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEF 555
L+ N L G + T+ L L L L + +NK +G +P+++ S + L + GN
Sbjct: 653 IDLNNNYLSGVIPTWLGKLPL-LGEL--KLSSNKFVGSLPTEIFSLTNILT-LFLDGNSL 708
Query: 556 VGLIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
G IPQ N L GPLPS I K+ L L LS N TG IP E+ QL
Sbjct: 709 NGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQ 768
Query: 616 SLE-VLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNN 674
L+ L+LS N+ +G IPS S L L L L HN L G +P G SL ++S+NN
Sbjct: 769 DLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNN 828
Query: 675 LSGSAPRN-SLIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVSQQEAYSPSESIQGNS- 732
L G + S + + GN L C + P S R S N Q + SP + ++
Sbjct: 829 LEGKLKKQFSRWQADAFVGNAGL--CGS-PLS-HCNRAGSKN---QRSLSPKTVVIISAI 881
Query: 733 SGLNPIEIASITXXXXXXXXXXXXXXXXXCMKKFSCNSIADPGLVRKEVVICNNIGVQ-- 790
S L I + + FS NS + + + +N G +
Sbjct: 882 SSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSS------QAPLFSNGGAKSD 935
Query: 791 LTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKR-LSVGRFQGVQQFAAEIR 849
+ +++++ AT N + IGSGG G YKAE+ G +AVK+ L + F E++
Sbjct: 936 IKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVK 995
Query: 850 TLGRVQHPNLVTLIGYHVSEAE--MFLIYNYLPGGNLEKFIQ----DRPRRTVEWSMLHK 903
TLG ++H +LV L+GY S+A+ LIY Y+ G++ ++ + + + W K
Sbjct: 996 TLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLK 1055
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL-GTSETH--AT 960
IAL +A+ + YLH +CVP ++HRDIK SN+LLD+N+ A+L DFGLA++L G +T+ +
Sbjct: 1056 IALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESN 1115
Query: 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWA 1020
T AG++GY+APEYA + + ++K+DVYS G+VL+E+++ K P+ F ++V W
Sbjct: 1116 TMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKM---PTEAMFDEETDMVRWV 1172
Query: 1021 SMLL--LQGRPC--EFFTAGLWDCGPHDD--LIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074
+L G + + L P ++ ++L +A+ CT RPS RQ ++ L
Sbjct: 1173 ETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
Query: 1075 KQI 1077
+
Sbjct: 1233 LNV 1235
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 661 (237.7 bits), Expect = 6.2e-106, Sum P(3) = 6.2e-106
Identities = 195/601 (32%), Positives = 299/601 (49%)
Query: 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQN 156
+LSG +S I L LR L L N F+G +P + + L + L +NS G +PP ++N
Sbjct: 79 QLSGRISDRISGLRMLRKLSLRSNSFNGTIPTSLAYCTRLLSVFLQYNSLSGKLPPAMRN 138
Query: 157 CSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA 216
+SL + N++GN+ +G IP G Q + +S N SG +P N L+ + L+
Sbjct: 139 LTSLEVFNVAGNRLSGEIPV--GLPSSLQFLDISSNTFSGQIPSGLA-NLTQLQLLNLSY 195
Query: 217 NSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELG 276
N LTG IP SLGN L+ L L N+LQG +PS+ +L L S N + G++P+ G
Sbjct: 196 NQLTGEIPASLGNLQSLQYLWLDFNLLQGTLPSAISNCSSLVHLSASENEIGGVIPAAYG 255
Query: 277 MCKQLKVLVLRNDY--GPLYSREHGDLPIQPVVDGGEDYNFF-DGGLPDSITRL-PNLRV 332
+L+VL L N+ G + + + +V G +N F D P++ L+V
Sbjct: 256 ALPKLEVLSLSNNNFSGTVPFSLFCNTSLT-IVQLG--FNAFSDIVRPETTANCRTGLQV 312
Query: 333 FWAPNLNLEGIFPQNWELCSKLEMLNL--AHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390
+ G FP W L + L + NL + N F+G+IP +GN K L L L++N+LTG
Sbjct: 313 LDLQENRISGRFPL-W-LTNILSLKNLDVSGNLFSGEIPPDIGNLKRLEELKLANNSLTG 370
Query: 391 LLPEEVSVPC--MAVFNVSQNLLSGEIPR-ISHSECSK-MSV---NWS----MSQVDLIG 439
+P E+ C + V + N L G+IP + + + K +S+ ++S S V+L
Sbjct: 371 EIPVEIK-QCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLGRNSFSGYVPSSMVNLQQ 429
Query: 440 FYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLS 499
EN L P + D S N F+G VP + +LS+ + LS
Sbjct: 430 LERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVP---VSISNLSNLSFLN--LS 484
Query: 500 GNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLI 559
GN G + +L L L D+ + GEVP ++ S ++ +++ GN F G++
Sbjct: 485 GNGFSGEIPASVGNL-FKLTAL--DLSKQNMSGEVPVEL-SGLPNVQVIALQGNNFSGVV 540
Query: 560 PQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEV 619
P+ F++ G +P + L LSLS N+ +G+IP E+ ++LEV
Sbjct: 541 PEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVSLSLSDNHISGSIPPEIGNCSALEV 600
Query: 620 LELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSA 679
LEL +N L G IP++ S+L L VL L NNL+G IPP SSL+ + N+LSG
Sbjct: 601 LELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEIPPEISQSSSLNSLSLDHNHLSGVI 660
Query: 680 P 680
P
Sbjct: 661 P 661
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9S7I6 | RPK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5118 | 0.9667 | 0.9087 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00028256001 | SubName- Full=Chromosome chr7 scaffold_42, whole genome shotgun sequence; (1079 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1082 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-107 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-11 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.004 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 356 bits (915), Expect = e-107
Identities = 340/1116 (30%), Positives = 488/1116 (43%), Gaps = 230/1116 (20%)
Query: 4 LLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLS-SNLS-RTSCSLL 61
LL KS+I DPL SNWN D C W G+TC+ S RV S++LS N+S + S ++
Sbjct: 34 LLSFKSSI-NDPLKYLSNWNSS-ADVCLWQGITCNNSS-RVVSIDLSGKNISGKISSAIF 90
Query: 62 SLPPAAG---PGGNFSFHFPCLQLHQHDRGNINSN------SSDKLSGNLSRAIGDLTQL 112
LP S P D +S+ S++ +G++ R G + L
Sbjct: 91 RLPYIQTINLSNNQLSGPIP------DDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNL 142
Query: 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNG 172
L L+ N SGE+P +IG S L++LDL N G IP +L N +SL + L+ NQ G
Sbjct: 143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVG 202
Query: 173 TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTE 232
IP GQ + + L +N LSG +P E G SL H+ L N+LTG IP SLGN
Sbjct: 203 QIPRELGQMKSLKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKN 261
Query: 233 LRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGP 292
L+ L L N L G IP S L L LDLS N LSG +P + + L++L
Sbjct: 262 LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL-------H 314
Query: 293 LYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCS 352
L+S N F G +P ++T LP L+V
Sbjct: 315 LFS------------------NNFTGKIPVALTSLPRLQV-------------------- 336
Query: 353 KLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLS 412
L L N F+G+IP +LG +L LDLS+NNLT
Sbjct: 337 ----LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT----------------------- 369
Query: 413 GEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNN 472
GEIP CS S LF L FSN+
Sbjct: 370 GEIP---EGLCS-----------------------------------SGNLFKLILFSNS 391
Query: 473 LFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIG 532
L G +P L SL L NS G L + L L DI NN L G
Sbjct: 392 L-EGEIPKSLGACRSLRR-----VRLQDNSFSGELPSEFTKLPLVY---FLDISNNNLQG 442
Query: 533 EVPS---DMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINK 589
+ S DM S ++ LS+A N+F G +P SF + L NL+LSRN G +P +
Sbjct: 443 RINSRKWDMPS----LQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGS 497
Query: 590 MEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHN 649
+ +L L LS N +G IP EL+ L L+LS N LSG+IP+ FS++ L+ L L N
Sbjct: 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557
Query: 650 NLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNS---LIKCENVQGNPNLQLCHTDPSSS 706
L+G IP G SL ++S N+L GS P I V G N+ LC D
Sbjct: 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAG--NIDLCGGD---- 611
Query: 707 EWERQHSGNVSQQEAYSPSESIQGNSSGLNPIEIASITSA--AVILSVLIALVLLLICMK 764
+SGL P + T + I L A ++L +
Sbjct: 612 ------------------------TTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAF 647
Query: 765 KFSCNSIADPGLVRK--------EVVICNN-IGVQLTYENVVRATAGFNVQNCIGSGGFG 815
F + +++ E+ ++ + +T +++ + +N I G G
Sbjct: 648 GFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL---KEENVISRGKKG 704
Query: 816 ATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874
A+YK + I G+ VK + + +EI +G++QHPN+V LIG SE +L
Sbjct: 705 ASYKGKSIKNGMQFVVKE--INDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYL 760
Query: 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNIL 934
I+ Y+ G NL + + R + W KIA+ +A+AL +LH C P V+ ++ P I+
Sbjct: 761 IHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815
Query: 935 LDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLL 994
+D +L L LL T + YVAPE T +++K+D+Y FG++L+
Sbjct: 816 IDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILI 869
Query: 995 ELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW-------DCGPH-DDL 1046
EL++ K D FG +IV WA C +W D + +++
Sbjct: 870 ELLTGKSPADA---EFGVHGSIVEWARYCY---SDCHL---DMWIDPSIRGDVSVNQNEI 920
Query: 1047 IEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPAS 1082
+E++NLA+ CT ++RP V + L+ +S
Sbjct: 921 VEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 7e-51
Identities = 67/192 (34%), Positives = 106/192 (55%), Gaps = 9/192 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G GGFG Y A G VA+K + +++ EI L ++ HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
E ++L+ Y GG+L+ +++ + + + +I L + L YLH ++HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 927 DIKPSNILLDN-NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
D+KP NILLD+ N L+DFGL++LL + ++ T V GT Y+APE + S+K+
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 985 DVYSFGVVLLEL 996
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-49
Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV 860
+ + +G G FG Y A + G +VA+K + + + ++ EI+ L +++HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L E +++L+ Y GG+L ++ R R + + + AL YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLHSK-- 116
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
++HRD+KP NILLD + + L+DFGLAR L T GT Y+APE +
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 981 SDKADVYSFGVVLLELIS 998
D++S GV+L EL++
Sbjct: 174 GKAVDIWSLGVILYELLT 191
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 76/202 (37%), Positives = 105/202 (51%), Gaps = 10/202 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNL 859
+ + +GSG FG YKA G +VAVK L + Q EIR L R+ HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V LI + ++L+ Y GG+L ++ + KIAL + R L YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSN- 117
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
++HRD+KP NILLD N ++DFGLA+ L S + TT GT Y+APE +
Sbjct: 118 --GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGN 174
Query: 980 VSD-KADVYSFGVVLLELISDK 1000
K DV+S GV+L EL++ K
Sbjct: 175 GYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 7e-44
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 45/281 (16%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG YK ++ V VAVK L Q +++F E R + ++ HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G E ++++ Y+ GG+L +++ R + S L AL +AR + YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+HRD+ N L+ NL +SDFGL+R L + + ++APE + +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 983 KADVYSFGVVLLELISDKKALDPSFCSFG-------NGFNIVAWASMLLLQG--RPCEFF 1033
K+DV+SFGV+L E+ + G + ++ + L G P
Sbjct: 183 KSDVWSFGVLLWEI-----------FTLGEQPYPGMSNEEVLEY----LKNGYRLPQ--- 224
Query: 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074
P + E+ +L + C E RP+ ++ + L
Sbjct: 225 --------PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 44/281 (15%)
Query: 809 IGSGGFGATYKAEIIPG-----VVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG YK + V VAVK L Q +++F E R + ++ HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G E + ++ Y+PGG+L +++ + + S L AL +AR + YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+HRD+ N L+ NL +SDFGL+R L + + ++APE + +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 983 KADVYSFGVVLLELISDKKALDPSFCSFG-------NGFNIVAWASMLLLQG--RPCEFF 1033
K+DV+SFGV+L E+ + G + ++ + L +G P
Sbjct: 184 KSDVWSFGVLLWEI-----------FTLGEEPYPGMSNAEVLEY----LKKGYRLPK--- 225
Query: 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074
P + E+ L + C E RP+ ++ + L
Sbjct: 226 --------PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 9e-38
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG YK + VAVK L G + ++F E + ++ HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++++ Y+PGG+L F++ + + L ++AL +A+ + YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESK---N 122
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV-----APEYAMT 977
+HRD+ N L+ NL +SDFGL+R + + + G + APE
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGGKLPIKWMAPESLKD 178
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+ + K+DV+SFGV+L E+ +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 807 NCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ Y A G ++AVK + + + ++ EIR L +QHPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 864 GYHVSEAEMFL-IY-NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G E + L I+ Y+ GG+L ++ + + ++ K + LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAYLHSN--- 120
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRV 980
++HRDIK +NIL+D++ L+DFG A+ LG ET T V GT ++APE
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 981 SDKADVYSFGVVLLELISDK 1000
AD++S G ++E+ + K
Sbjct: 181 GRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 807 NCIGSGGFGATYKAEIIPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG YK ++ VAVK L + + F E R + ++ HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDR-------PRRTVEWSMLHKIALDVARALAY 914
L+G E ++L+ Y+ GG+L +++ + T+ L A+ +A+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAP 972
L + + +HRD+ N L+ +L +SDFGL+R + + + G ++AP
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKKTGGKLPIRWMAP 176
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E + K+DV+SFGV+L E+ +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 805 VQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVT 861
+ IG G FG Y G + +K + + ++ A E++ L ++ HPN++
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE------WSMLHKIALDVARALAYL 915
+ ++ ++ Y GG+L + I+ + + ++ L AL YL
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYL 119
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE-- 973
H ++LHRDIKP NI L +N L DFG++++L ++ A T V GT Y++PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELC 175
Query: 974 ----YAMTCRVSDKADVYSFGVVLLELISDKKA 1002
Y + K+D++S G VL EL + K
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 62/196 (31%), Positives = 105/196 (53%), Gaps = 7/196 (3%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
F + IG GGFG YKA G VA+K + + + ++ EI+ L + +HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G ++ + E++++ + GG+L+ ++ + E S + + ++ + L YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTE-SQIAYVCKELLKGLEYLHSN--- 117
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRDIK +NILL ++ L DFGL+ L S+T A + GT ++APE
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 982 DKADVYSFGVVLLELI 997
KAD++S G+ +EL
Sbjct: 176 YKADIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGV--QQFAAEIRTLGRVQHPNL 859
+ V IG G FG K G ++ K + G QQ +E+ L ++HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 860 VTLIGYHVSEAE--MFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYL 915
V + + ++++ Y GG+L + IQ + R+ +E + +I + AL
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 916 HDECVP--RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
H+ P VLHRD+KP+NI LD N N L DFGLA++LG + A T V GT Y++PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPE 180
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSF 1007
+K+D++S G ++ EL AL P F
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELC----ALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSV-GRFQGVQQFAAEIRTLGRVQHPNLV 860
+G G G YK P G + A+K++ V G + +Q E++TL + P +V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G E E+ ++ Y+ GG+L ++ + +L IA + + L YLH +
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTK-- 118
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
++HRDIKPSN+L+++ ++DFG++++L + T V GT Y++PE R+
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE-----RI 172
Query: 981 -----SDKADVYSFGVVLLEL 996
S AD++S G+ LLE
Sbjct: 173 QGESYSYAADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (302), Expect = 2e-29
Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 25/292 (8%)
Query: 802 GFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHP- 857
+ + +G G FG Y A +VA+K L+ + V++F EI+ L + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTV-EWSMLHKIALDVARALAYLH 916
N+V L + E ++L+ Y+ GG+LE ++ R+ S I + AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 917 DECVPRVLHRDIKPSNILLDNNLN-AYLSDFGLARLLGTSETHA-----TTDVAGTFGYV 970
+ ++HRDIKP NILLD + L DFGLA+LL + + + GT GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 971 APEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027
APE + S +D++S G+ L EL++ P F N ++L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL----PPFEGEKNSSATSQTLKIILELP 231
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079
P + L P +L + +R S
Sbjct: 232 TPS--LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/191 (31%), Positives = 94/191 (49%), Gaps = 9/191 (4%)
Query: 808 CIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G FG G VAVK L Q F AE + ++HPNLV L+G +
Sbjct: 13 TIGKGEFGDVMLG-DYRGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
++++ Y+ G+L +++ R R + + ALDV + YL ++ +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N+L+ +L A +SDFGLA+ + V T APE + S K+DV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 988 SFGVVLLELIS 998
SFG++L E+ S
Sbjct: 184 SFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSV-GRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG P G VAVK L+ G Q F EI L + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 863 IG--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G + LI YLP G+L ++Q R R + L + + + + YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ-- 128
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMT 977
R +HRD+ NIL+++ +SDFGLA++L + + G F Y APE T
Sbjct: 129 -RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+ S +DV+SFGV L EL +
Sbjct: 187 SKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVK--RLSVGRFQGVQQFAA-EIRTLGRVQHPN 858
+ +G G +G YKA + G +VA+K RL +G+ A EI L ++HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPN 59
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V L+ +E +++L++ Y +L+K++ D+ + +++ I + R LAY H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R+LHRD+KP NIL++ + L+DFGLAR G T +V T Y APE +
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGS 173
Query: 979 RVSDKA-DVYSFGVVLLELISDKKAL 1003
+ A D++S G + E+I+ K L
Sbjct: 174 KHYSTAVDIWSVGCIFAEMIT-GKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL 859
+ + + IG G FG YK + G VA+K++S+ + + ++ EI L ++HPN+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V IG + +++I Y G+L + I+ + E S++ V + LAYLH++
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPE-SLVAVYVYQVLQGLAYLHEQ- 118
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
V+HRDIK +NIL + L+DFG+A L + V GT ++APE
Sbjct: 119 --GVIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 980 VSDKADVYSFGVVLLELI 997
S +D++S G ++EL+
Sbjct: 176 ASTASDIWSLGCTVIELL 193
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/198 (33%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 809 IGSGGFGAT----YKAEIIPGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ Y + V VAVK L G ++F E + ++ HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 864 GYHVSEAEMF-LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G V + E L+ P G L K+++ R V S L ++A VA +AYL +
Sbjct: 63 G--VCKGEPLMLVMELAPLGPLLKYLKKRREIPV--SDLKELAHQVAMGMAYL-ESK--H 115
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRV 980
+HRD+ N+LL N A +SDFG++R LG + AG + + APE +
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 981 SDKADVYSFGVVLLELIS 998
S K+DV+S+GV L E S
Sbjct: 176 SSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G YKA + G VA+K++ + + Q + EI + +HPN+V ++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ Y+ GG+L I R E + + +V + L YLH + V+HRD
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNE-PQIAYVCREVLQGLEYLHSQ---NVIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK NILL + + L+DFG A L ++ + V GT ++APE K D++
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIW 200
Query: 988 SFGVVLLELI 997
S G++ +E+
Sbjct: 201 SLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 64/190 (33%), Positives = 104/190 (54%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G K P G ++AVK + + + +Q Q E+ L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ ++ + Y+ GG+L+K +++ R E +L KIA+ V + L YLH+ +++HR
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPE-RILGKIAVAVLKGLTYLHE--KHKIIHR 125
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S A T V GT Y+APE S K+D+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFV-GTSSYMAPERIQGNDYSVKSDI 182
Query: 987 YSFGVVLLEL 996
+S G+ L+EL
Sbjct: 183 WSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRV-QHPNLVTLI 863
IG G F A E A+K L + + + V+ E L R+ HP ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
E ++ + Y P G L ++I+ + + A ++ AL YLH + +
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YAAEILLALEYLHSK---GI 123
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA------------------- 964
+HRD+KP NILLD +++ ++DFG A++L + + +
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDK 1000
GT YV+PE +D+++ G ++ ++++ K
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 4/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG ++ VAVK L G + F AE + + +++HP L+ L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ + G+L +++Q R ++ L +A VA +AYL + +HRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDL 129
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L+ N ++DFGLAR++ A + APE A+ R S K+DV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 190 FGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 80/277 (28%), Positives = 122/277 (44%), Gaps = 33/277 (11%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVK--RLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGY 865
IG G FG Y A + G ++AVK R+ + +++ A E++ L ++HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
V ++++ Y GG LE+ + R ++ ++ L + LAYLH ++H
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVH 122
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG---YVAPEYAMTCRVSD 982
RDIKP+NI LD+N L DFG A L + T +V G Y+APE +
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 983 K---ADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039
AD++S G V+LE+ + K + N F I+ F G
Sbjct: 183 HGRAADIWSLGCVVLEMATGK----RPWSELDNEFQIM---------------FHVGAGH 223
Query: 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076
P D +++ L S P R A +L Q
Sbjct: 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G G FG G + A+K L + + + V+ E L R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+E +++L+ Y PGG L + R + E + A ++ AL YLH ++
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLHSL---GII 115
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA 984
+RD+KP NILLD + + L+DFGLA+ L SE T GT Y+APE +
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELS-SEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 985 DVYSFGVVLLELISDK 1000
D +S GV+L E+++ K
Sbjct: 175 DWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 8/192 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV- 867
+G+G FG + VAVK L G + F E + + +++H LV L Y V
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQL--YAVC 70
Query: 868 SEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
SE E ++++ Y+ G+L F++ + + L +A +A +AYL +HR
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHR 127
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+ NIL+ NL ++DFGLARL+ E A + APE A R + K+DV
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 987 YSFGVVLLELIS 998
+SFG++L E+++
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + + G +VA+K++ + A EI+ L + HPN++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ +++L++ ++ +L K I+DR +R + S++ + + LA+ H +LH
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH---GILH 121
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA- 984
RD+KP N+L++ L+DFGLAR G+ T V T Y APE + +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTPV 180
Query: 985 DVYSFGVVLLELIS 998
D++S G + EL+S
Sbjct: 181 DIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 7/205 (3%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNL 859
F + N IG G FG +K V A+K++ + + ++ A E R L ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ + + ++ ++ Y G+L K ++ + R + + + + + LA+LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
++LHRDIK N+ LD N + D G+A+LL + A T V GT Y++PE
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKP 177
Query: 980 VSDKADVYSFGVVLLELISDKKALD 1004
++K+DV++ GVVL E + K D
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 9/193 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGR-FQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G G +KA+ G VA+K++++ R G+ A EI+ L QHP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ L+ Y+P L + ++D R E + + + + +AY+H ++H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEERPLPE-AQVKSYMRMLLKGVAYMHAN---GIMH 122
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA- 984
RD+KP+N+L+ + ++DFGLARL E + T Y APE R D
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182
Query: 985 DVYSFGVVLLELI 997
D+++ G + EL+
Sbjct: 183 DLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHP 857
F + IG G FG + + A+K ++ V+ E R L + HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
LV L E M+L+ + L GG+L + + + + E ++ AL YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--WICEIVLALEYLHS 118
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ ++HRDIKP NILLD + +++DF +A + TT +GT GY+APE
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCR 173
Query: 978 CRVSDKADVYSFGVVLLELISDKK 1001
S D +S GV E + K+
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ P + ++ + + LA+ H RVLH
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 123
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + C+ S
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 182
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 183 DIWSLGCIFAEMVT-RRALFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 4/196 (2%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
F ++ +GSG FG ++ V VA+K L Q F E++ L R++H +L++L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+++I + G+L F++ + + + L +A VA +AYL ++
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+HRD+ NIL+ +L ++DFGLARL+ + + ++D + + APE A S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 983 KADVYSFGVVLLELIS 998
K+DV+SFG++L E+ +
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 800 TAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFA-----AEIRTLGR 853
F ++ IG G F YKA + G VVA+K++ + F+ + A EI L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQI--FEMMDAKARQDCLKEIDLLKQ 58
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFI-----QDR--PRRTVEWSMLHKIAL 906
+ HPN++ + + E+ ++ G+L + I Q R P RT+ W K +
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-W----KYFV 113
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
+ AL ++H + R++HRDIKP+N+ + L D GL R +S+T A + GT
Sbjct: 114 QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGT 169
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
Y++PE + K+D++S G +L E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSV-GRFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + + G +VA+K++ + +GV A EI L + HPN+V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
SE +++L++ +L +L+K++ P ++ ++ + + +AY H RVLH
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLH 122
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L+D L+DFGLAR G T +V T Y APE + R S
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPV 181
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++ L P
Sbjct: 182 DIWSIGCIFAEMVN-RRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 17/198 (8%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQ---FAA--EIRTLGRVQHPNLVTL 862
+G G + YKA G +VA+K++ +G + + F A EI+ L ++HPN++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLHDECV 920
+ ++ + L++ ++ +LEK I+D+ ++ + L R L YLH
Sbjct: 68 LDVFGHKSNINLVFEFMET-DLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN-- 121
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+LHRD+KP+N+L+ ++ L+DFGLAR G+ T V T Y APE R
Sbjct: 122 -WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARH 179
Query: 981 -SDKADVYSFGVVLLELI 997
D++S G + EL+
Sbjct: 180 YGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G + F E + + +++H LV L VS
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAV-VS 71
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++D R ++ L +A VA +AY+ +HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 128
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL++ + P
Sbjct: 189 FGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 802 GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPN 858
F V +G G +G+ YK + + A+K + +G ++ A EIR L V HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 859 LVTLIGYHVSEAEMFLIYN-------YLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVA 909
+ I Y E FL N Y P G+L K I R R+ + + +I + +
Sbjct: 61 I---ISYK----EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
R L LH++ ++LHRD+K +NILL N + D G++++L + A T + GT Y
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHY 167
Query: 970 VAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+APE S K+D++S G +L E+ +
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
F++ +G G +G+ YKA G VVA+K + V + +Q+ EI L + P +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G + +++++ Y G++ ++ +T+ + I + L YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN--- 118
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+ +HRDIK NILL+ A L+DFG++ L + T V GT ++APE +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 177
Query: 982 DKADVYSFGVVLLEL 996
+KAD++S G+ +E+
Sbjct: 178 NKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSV--GRFQGVQQFAAEIRTLGRVQHPNL 859
+ IG G +G YKA G +VA+K++ + + EI+ L +++HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 860 VTLIGYHVSEA--EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
V L S+ +++++ Y+ +L + D P S + + L YLH
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+LHRDIK SNIL++N+ L+DFGLAR + T+ T Y PE +
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 978 CRVSDKA-DVYSFGVVLLELISDK 1000
D++S G +L EL K
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IG G FGA + E G VAVK + Q F E + ++ H NLV L+G +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
++++ + GNL F++ R R V L + +LDVA + YL + +++HRD+
Sbjct: 71 NG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDL 126
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
NIL+ + A +SDFGLAR+ + + + APE + S K+DV+S
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182
Query: 989 FGVVLLELISDKKALDP 1005
+GV+L E+ S +A P
Sbjct: 183 YGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLV 860
+ + IG G Y A +P VA+KR+ + + Q V + E++ + + HPN+V
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR-PRRTVEWSMLHKIALDVARALAYLHDEC 919
V E++L+ YL GG+L ++ PR ++ +++ + +V + L YLH
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN- 121
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL---GTSETHATTDVAGTFGYVAPEYAM 976
+HRDIK NILL + + ++DFG++ L G GT ++APE
Sbjct: 122 --GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 977 TCRVSD-KADVYSFGVVLLELI 997
D KAD++SFG+ +EL
Sbjct: 180 QVHGYDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSV---GRFQGVQQFAAEIRTLGRVQHPN 858
+ + IGSG +G YKA I G +VA+K + + F+ +QQ EI L +HPN
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ---EISMLKECRHPN 61
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V G ++ +++++ Y GG+L+ I R + + + + + LAYLH+
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA--- 975
+HRDIK +NILL + + L+DFG++ L + + + GT ++APE A
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVE 176
Query: 976 MTCRVSDKADVYSFGVVLLEL 996
K D+++ G+ +EL
Sbjct: 177 RKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 805 VQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ--FAAEIRTLGRVQHPN 858
++ IG G FG + + +PG + VA+K L G Q+ F E +G+ HPN
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPN 66
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ L G + +I Y+ G+L+KF+++ L + +A + YL +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYA 975
+HRD+ NIL+++NL +SDFGL+R L SE AT G + APE A
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKGGKIPIRWTAPE-A 179
Query: 976 MTCRV-SDKADVYSFGVVLLELIS 998
+ R + +DV+SFG+V+ E++S
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 809 IGSGGFGATY----KAEIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTL 862
+G G FG + KA+ +V +K++ V + ++ AA E + L + HPN++
Sbjct: 8 VGRGAFGIVHLCRRKAD---QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ + + ++ Y PGG L ++IQ R ++ + + + AL ++H +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---L 121
Query: 923 VLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+LHRD+K NILLD + + DFG++++L + T V GT Y++PE +
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYN 179
Query: 982 DKADVYSFGVVLLELISDKKALD 1004
K+D+++ G VL EL S K+A +
Sbjct: 180 QKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+ IG G FG + G VAVK + Q F AE + +++H NLV L+G
Sbjct: 10 LLQTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 865 YHVSE-AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
V E ++++ Y+ G+L +++ R R + L K +LDV A+ YL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAPEYAMTCRVSD 982
+HRD+ N+L+ + A +SDFGL T E +T D + APE + S
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGL-----TKEASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 983 KADVYSFGVVLLELIS 998
K+DV+SFG++L E+ S
Sbjct: 179 KSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 809 IGSGGFGATYKAE-------IIPGVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLV 860
+G G FG + E +IP VAVK L + + F E + + H NL+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIP---VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L G V + ++ P G+L ++ S L A+ +A + YL +
Sbjct: 60 RLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK-- 116
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAMTC 978
R +HRD+ NILL ++ + DFGL R L +E H + F + APE T
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 979 RVSDKADVYSFGVVLLELIS 998
S +DV+ FGV L E+ +
Sbjct: 176 TFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRF-----QGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG+ Y+ + G AVK +S+ + V+Q EI L ++QHPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+G E +++ +PGG+L K ++ + + L L YLHD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLHDR--- 121
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+HRDIK +NIL+D N L+DFG+A+ + E G+ ++APE
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 982 D-KADVYSFGVVLLELISDK 1000
AD++S G +LE+ + K
Sbjct: 180 GLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 5/193 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IGSG FG + + VA+K + G + F E + + ++ HP LV L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ + L++ ++ G L +++ + R L + LDV +AYL V +HRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNV---IHRDL 126
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+ N +SDFG+ R + + ++T + +PE + S K+DV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 989 FGVVLLELISDKK 1001
FGV++ E+ S+ K
Sbjct: 187 FGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 71
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV--LHR 926
E ++++ Y+ G+L F++ + + L +A +A +AY V R+ +HR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-----VERMNYVHR 126
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D++ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 987 YSFGVVLLELISDKKALDP 1005
+SFG++L EL + + P
Sbjct: 187 WSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 59/195 (30%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 805 VQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+++ +G G +G Y+ + VAVK L + V++F E + ++HPNLV L+
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
G E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRVS 981
+HRD+ N L+ N ++DFGL+RL+ T +T+ T F + APE + S
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTY-TAHAGAKFPIKWTAPESLAYNKFS 183
Query: 982 DKADVYSFGVVLLEL 996
K+DV++FGV+L E+
Sbjct: 184 IKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSV-GRFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YK G +VA+K++ + +GV A EI L +QHPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL-DVARALAYLHDECVPRVL 924
+ E+ ++LI+ +L +L+K++ P+ + L K L + + + + H RVL
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVL 123
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDK 983
HRD+KP N+L+DN L+DFGLAR G T +V T Y APE + + R S
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTP 182
Query: 984 ADVYSFGVVLLELISDK 1000
D++S G + E+ + K
Sbjct: 183 VDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 17/224 (7%)
Query: 803 FNVQNCIGSGGFG-ATYKAEIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLV 860
+NV +G G FG A + A+K + + + V+ E L +++HPN+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
++ ++++ Y GG+L + I+ + + + + + + + ++H++
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-- 119
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
RVLHRDIK NI L N L DFG ARLL + +A T V GT YV PE
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPY 177
Query: 981 SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024
++K+D++S G +L EL C+ + F +W +++L
Sbjct: 178 NNKSDIWSLGCILYEL-----------CTLKHPFQANSWKNLIL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-21
Identities = 66/197 (33%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRF-QGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + + +A+K++ + + +GV A EI L +QH N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
SE ++L++ YL +L+K + P ++ + R +AY H RVLH
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLH 125
Query: 926 RDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDK 983
RD+KP N+L+D NA L+DFGLAR G T +V T Y APE + + S
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYSTP 184
Query: 984 ADVYSFGVVLLELISDK 1000
D++S G + E+++ K
Sbjct: 185 VDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 808 CIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF-----QGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y ++ G +AVK++ + V EI+ L +QH +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G + + + Y+PGG+++ + + + ++ K + + YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSN--- 123
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT--TDVAGTFGYVAPEYAMTCR 979
++HRDIK +NIL D+ N L DFG ++ L T + T V GT +++PE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 980 VSDKADVYSFGVVLLELISDK 1000
KADV+S G ++E++++K
Sbjct: 184 YGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 809 IGSGGFG-ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTLIGY 865
+G G FG AT +V K +++ R ++ A EI L +QHPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDR-----PRRTVEWSMLHKIALDVARALAYLHDECV 920
+ + + + Y GG L I + V W + + A++Y+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-----IVSAVSYIHKA-- 120
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+LHRDIK NI L L DFG++++LG+ + A T V GT Y++PE +
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKY 178
Query: 981 SDKADVYSFGVVLLELISDKKALDPS 1006
+ K+D+++ G VL EL++ K+ D +
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-21
Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG YKA+ G+ A K + + + ++ F EI L +HPN+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E +++++ + GG L+ + + R E + + + AL +LH +V+HRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTE-PQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 928 IKPSNILLDNNLNAYLSDFGL-ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD---- 982
+K NILL + + L+DFG+ A+ T + T GT ++APE D
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186
Query: 983 -KADVYSFGVVLLEL 996
KAD++S G+ L+EL
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 5/193 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+GSG FG + + + VA+K + G F E + + ++ HPNLV L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +F++ Y+ G L ++++R + + L + DV A+ YL +HRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+ + +SDFGLAR + + ++ + PE R S K+DV+S
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 989 FGVVLLELISDKK 1001
FGV++ E+ S+ K
Sbjct: 187 FGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 806 QNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLV 860
Q IG+G FG ++ + +PG V VA+K L G + +Q F +E +G+ H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLHDE 918
L G +I Y+ G L+K+++D E+S + + +A + YL D
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL--GTSETHATTDVAGTFGYVAPEYAM 976
+HRD+ NIL+++NL +SDFGL+R+L T+ T+ + APE
Sbjct: 127 ---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ + +DV+SFG+V+ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 58/197 (29%), Positives = 104/197 (52%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAV-VS 71
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ ++ G+L F+++ + ++ L +A +A +AY+ +HRD+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDL 128
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ +NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL++ + P
Sbjct: 189 FGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G FG YK + VAVK + ++F E L + HPN+V LIG V
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ ++++ +PGG+L F++ + + + L +++LD A + YL + +HRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG-----YVAPEYAMTCRVSD 982
+ N L+ N +SDFG++R E V+ + APE R +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 983 KADVYSFGVVLLELIS 998
++DV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRL----SVGRFQGVQQFAAEIRTLGRVQHP 857
F + CIG G FG YKA + VVA+K + + + +QQ EI+ L + + P
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ---EIQFLSQCRSP 59
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ G + +++++I Y GG+ ++ + I +V L YLH+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---ILREVLLGLEYLHE 116
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
E +HRDIK +NILL + L+DFG++ L ++ + T V GT ++APE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQ 172
Query: 978 CRVSDKADVYSFGVVLLELI 997
+KAD++S G+ +EL
Sbjct: 173 SGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 86/289 (29%), Positives = 127/289 (43%), Gaps = 35/289 (12%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + L+ YLP G+L ++Q + R ++ L A + + + YL +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK--- 127
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL+++ + DFGL ++L + + G F Y APE
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTES 186
Query: 979 RVSDKADVYSFGVVLLELI--SDKKALDPS-FCS-FGN---GFNIVAWASMLLLQGR--P 1029
+ S +DV+SFGVVL EL SDK P+ F GN G IV LL P
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP 246
Query: 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
P E+ + C S RPS ++A Q++ I+
Sbjct: 247 -----------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 80/290 (27%), Positives = 126/290 (43%), Gaps = 44/290 (15%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVT 861
+G G FG YK E+ VA+K L VQQ F E + +QHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKF-IQDRPRRTVEWS--------------MLHKIAL 906
L+G E +++ YL G+L +F +++ P V LH IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH-IAI 131
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG- 965
+A + YL +HRD+ N L+ L +SDFGL+R + +++ + +
Sbjct: 132 QIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025
++ PE + + + ++D++SFGVVL E+ S L P + F N I S LL
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS--YGLQP-YYGFSNQEVIEMIRSRQLL 245
Query: 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
PC P D + L I C E + RP + + +L+
Sbjct: 246 ---PC-----------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQ 855
F +G+G FG +K G A+K LS + + + V+ E R L ++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
HP LV L G ++ ++L+ Y+PGG L ++ R + + A V AL YL
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--AAQVVLALEYL 117
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H +++RD+KP N+LLD++ ++DFG A+ + + T + GT Y+APE
Sbjct: 118 HSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYLAPE-I 169
Query: 976 MTCRVSDKA-DVYSFGVVLLELI 997
+ + KA D ++ G+++ E++
Sbjct: 170 ILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G G G+ K + G++ A+K ++ +Q Q E+ + P +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 867 VSEAE--MFLIYNYLPGGNLE---KFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+ E+ + + Y GG+L+ K ++ R R E +L KIA V + L+YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE-KVLGKIAESVLKGLSYLHSR--- 124
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG----YVAPEYAMT 977
+++HRDIKPSNILL L DFG++ L S +AGTF Y+APE
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-------LAGTFTGTSFYMAPERIQG 177
Query: 978 CRVSDKADVYSFGVVLLEL 996
S +DV+S G+ LLE+
Sbjct: 178 KPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 73/285 (25%), Positives = 128/285 (44%), Gaps = 27/285 (9%)
Query: 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQH 856
A F ++ IG G F Y+A ++ GV VA+K++ + + EI L ++ H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ--DRPRRTVEWSMLHKIALDVARALAY 914
PN++ + + E+ ++ G+L + I+ + +R + + K + + AL +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
+H RV+HRDIKP+N+ + L D GL R +S+T A + GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 177
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034
+ K+D++S G +L E+ AL F +G+ N+ + + C++
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM----AALQSPF--YGDKMNLYSLCKKI----EQCDYPP 227
Query: 1035 AGLWDCGPHDDLIEML-NLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
P D E L L MC RP + V K++
Sbjct: 228 L------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG----------VQQFAAEIRTLGRVQHP 857
IG G +G Y A + G ++AVK++ + V+ +EI TL + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N+V +G+ +E + + Y+PGG++ ++ R E ++ V LAYLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEGLAYLHS 126
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE----THATTDVAGTFGYVAPE 973
+ +LHRD+K N+L+D + +SDFG+++ S+ + G+ ++APE
Sbjct: 127 K---GILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 974 YAMTCR--VSDKADVYSFGVVLLELISDKK 1001
+ S K D++S G V+LE+ + ++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNL 859
+ + IG G FG Y A+ +K + + + ++ A+ E+ L +++HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
VT +F++ Y GG+L K I + + + ++ L ++HD
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR- 120
Query: 920 VPRVLHRDIKPSNILLDNN-LNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
++LHRDIK NI L N + A L DFG+AR L S A T GT Y++PE
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQNR 177
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
++K D++S G VL EL + K
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-20
Identities = 68/205 (33%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLIG 864
IG G FGA Y A ++ VVA+K++S Q Q E+R L +++HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 865 YHVSEAEMFLIYNYLPGGN---LEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
++ E +L+ Y G LE + +P + VE + I + LAYLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVE---IAAICHGALQGLAYLHSHER- 136
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE--YAM-TC 978
+HRDIK NILL L+DFG A L+ + + GT ++APE AM
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAMDEG 189
Query: 979 RVSDKADVYSFGVVLLELISDKKAL 1003
+ K DV+S G+ +EL K L
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+GSG FG YK IP + VA+K L + ++ E + V HP++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-KANKEILDEAYVMASVDHPHVVR 73
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L+G +S ++ LI +P G L ++++ + + L + +A+ ++YL ++
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEK--- 128
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRV 980
R++HRD+ N+L+ + ++DFGLA+LL E + ++A E +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 981 SDKADVYSFGVVLLELIS 998
+ K+DV+S+GV + EL++
Sbjct: 189 THKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQH-PNLVTLI 863
IG G FG K P G ++AVKR+ + Q ++ ++ + R P +V
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ--KRLLMDLDVVMRSSDCPYIVKFY 69
Query: 864 GYHVSEAE----MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
G E + M L+ L K++ + + + +L KIA+ +AL YL +E
Sbjct: 70 GALFREGDCWICMELMDISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
+++HRD+KPSNILLD N N L DFG++ L S A T AG Y+APE
Sbjct: 128 --KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPSA 183
Query: 980 VSD---KADVYSFGVVLLEL 996
++DV+S G+ L E+
Sbjct: 184 RDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 54/209 (25%), Positives = 106/209 (50%), Gaps = 28/209 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG------VQQFAAEIRTLGRVQHPNLVT 861
+G+G F + Y+A ++ G ++AVK+++ R V+ EIR + R+ HP+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
++G ++ L ++ GG++ + + +++ + R L+YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN--- 122
Query: 922 RVLHRDIKPSNILLDNN-LNAYLSDFGLARLLGTSETHA---TTDVAGTFGYVAPE---- 973
+++HRD+K +N+L+D+ ++DFG A L T A + GT ++APE
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 974 --YAMTCRVSDKADVYSFGVVLLELISDK 1000
Y +C DV+S G V++E+ + K
Sbjct: 183 EQYGRSC------DVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 796 VVRATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLG 852
R+ F N IG G +G Y+A + G +VA+K++ + + ++ EI L
Sbjct: 2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLL 61
Query: 853 RVQHPNLVTL----IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
++HPN+V L +G H+ +FL+ Y +L + + P E S + + L +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDS--IFLVMEYCEQ-DLASLLDNMPTPFSE-SQVKCLMLQL 117
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
R L YLH+ + +HRD+K SN+LL + ++DFGLAR G T V T
Sbjct: 118 LRGLQYLHENFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLW 173
Query: 969 YVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
Y APE + C A D+++ G +L EL++ K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 28/225 (12%)
Query: 802 GFNVQNCIGSGGFGATYKA---EIIPGVVVAVKRL--SVGRFQGVQQFAA-EIRTLGRVQ 855
+ ++ CIG G +G YKA G A+K+ ++ G+ Q A EI L ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 856 HPNLVTLIGYHVSEAEM--FLIYNY----LPGGNLEKFIQDRPRRTVEWSMLHKIALDVA 909
H N+V+L+ + A+ +L+++Y L + KF + R ++ SM+ + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDL--WQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAY----LSDFGLARLLGT-SETHATTD-V 963
+ YLH V LHRD+KP+NIL+ + D GLARL + A D V
Sbjct: 119 NGVHYLHSNWV---LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 964 AGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDKKALDPSF 1007
T Y APE + R KA D+++ G + EL++ L+P F
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT----LEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 53/192 (27%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K + G +F E + + ++ H LV L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ ++++ Y+ G L ++++ +R + S L ++ DV +AYL + + +HRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLESK---QFIHRDL 126
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRVSDKADV 986
N L+D+ +SDFGL+R + E T+ V F + PE + + S K+DV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 987 YSFGVVLLELIS 998
++FGV++ E+ S
Sbjct: 185 WAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG +K + VAVK Q ++ +F +E R L + HPN+V LIG
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
++++ +PGG+ F++ + + ++ L K ALD A +AYL + +HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRD 118
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG----TFGYVAPEYAMTCRVSDK 983
+ N L+ N +SDFG++R E +G + APE R S +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 984 ADVYSFGVVLLELIS 998
+DV+S+G++L E S
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG------VQQFAA-EIRTLGRV 854
+ V +G G +G K G +VA+K+ F+ V++ A E++ L ++
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKK-----FKESEDDEDVKKTALREVKVLRQL 57
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+H N+V L + ++L++ Y+ LE + + + + +A+AY
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELL--EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
H ++HRDIKP NIL+ + L DFG AR L TD T Y APE
Sbjct: 116 CHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172
Query: 975 AMTCRVSDKA-DVYSFGVVLLELIS 998
+ K DV++ G ++ EL+
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 10/196 (5%)
Query: 808 CIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVTL 862
CIG G FG Y + + VAVK V ++F E + + HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
IG ++E ++++ P G L ++Q + +++ + L + ++ ALAYL + R
Sbjct: 73 IGV-ITENPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---R 127
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+HRDI N+L+ + L DFGL+R L + + ++APE R +
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 983 KADVYSFGVVLLELIS 998
+DV+ FGV + E++
Sbjct: 188 ASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 73/285 (25%), Positives = 130/285 (45%), Gaps = 27/285 (9%)
Query: 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQH 856
A F ++ IG G F Y+A ++ VA+K++ + + Q EI L ++ H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ--DRPRRTVEWSMLHKIALDVARALAY 914
PN++ + + + E+ ++ G+L + I+ + +R + + K + + A+ +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
+H RV+HRDIKP+N+ + L D GL R +S+T A + GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 177
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034
+ K+D++S G +L E+ AL F +G+ N+ + L + C++
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM----AALQSPF--YGDKMNLFS----LCQKIEQCDYPP 227
Query: 1035 AGLWDCGPHDDLIEML-NLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
P + E L L MC RP + V Q KQ+
Sbjct: 228 L------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 55/190 (28%), Positives = 93/190 (48%), Gaps = 4/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G VQ F E + +QH LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E +++I Y+ G+L F++ V L + +A +AY+ + +HRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 129
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +N+L+ +L ++DFGLAR++ +E A + APE + K+DV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 190 FGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 74/290 (25%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 802 GFNVQNCIGSGGFGATYKAEI--IPGVVVAVKRLSV----------GRFQGVQQFAAEIR 849
+ V +GSG FG YK ++A+K ++V R + + +E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 850 TLG-RVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL-EKFI--QDRPRRTVE---WSMLH 902
+ +++HPN+V + ++++ + + G L E F +++ +R E W++
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
++ L AL YLH E R++HRD+ P+NI+L + ++DFGLA+ T
Sbjct: 121 QMVL----ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTS 172
Query: 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022
V GT Y PE +KADV++FG +L ++ L P F S +M
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC----TLQPPFYS----------TNM 218
Query: 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIM-CTGESLSSRPSMRQVA 1071
L L + E +++ P E + I C +RP + QV+
Sbjct: 219 LSLATKIVE----AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKR--LSVGRFQG-------VQQFAAEIRTLGRVQHPN 858
IGSG FG+ Y G ++AVK+ L + A EI L +QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V +G + + + Y+PGG++ + + E +++ + + L YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR 125
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGL-----ARLLGTSETHATTDVAGTFGYVAPE 973
++HRDIK +NIL+DN +SDFG+ A L T A + G+ ++APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDK 1000
+ KAD++S G +++E+++ K
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G GGFG ++ G + A K+L R +G Q E + L +V +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
++ ++ L+ + GG+L+ I + + A + L +LH R++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLA-RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
+RD+KP N+LLD++ N +SD GLA L G + AGT GY+APE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYDFS 174
Query: 984 ADVYSFGVVLLELIS 998
D ++ G L E+I+
Sbjct: 175 VDWFALGCTLYEMIA 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 56/203 (27%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 805 VQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNL 859
++ IG+G FG + +PG + VA+K L G + ++ F +E +G+ HPN+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLHD 917
+ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL D
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYLSD 124
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG--YVAPEYA 975
+HRD+ NIL+++NL +SDFGL+R+L A T G + APE
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+V+ E++S
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K L G + F AE + ++QHP LV L V+
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV-VT 71
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ +HRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ L ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 189 FGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAA--------EIRTLGR 853
+ V +G G FG+ Y A G +VA+K++ ++F + E+++L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 854 VQ-HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
+ HPN+V L E++ ++ Y+ G NL + ++DR + S++ I + + L
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT---TDVAGTFGY 969
A++H HRD+KP N+L+ ++DFGLAR E + TD T Y
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWY 164
Query: 970 VAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFC 1008
APE + S D+++ G ++ EL + L P F
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT----LRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG YKA+ G + A K + + ++ + EI L HP +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ +++++ + PGG ++ + + R E + I + AL YLH +++HRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVICRQMLEALQYLHSM---KIIHRD 135
Query: 928 IKPSNILLDNNLNAYLSDFGL-ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD---- 982
+K N+LL + + L+DFG+ A+ + T + + GT ++APE M + D
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYD 193
Query: 983 -KADVYSFGVVLLEL 996
KAD++S G+ L+E+
Sbjct: 194 YKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 57/190 (30%), Positives = 95/190 (50%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYH 866
IG G FG YK + VVA+K + + + ++ EI L + P + G +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ ++++I YL GG+ ++ P +E + + I ++ + L YLH E R +HR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE---RKIHR 125
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIK +N+LL + L+DFG+A L ++ T V F ++APE KAD+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDFKADI 184
Query: 987 YSFGVVLLEL 996
+S G+ +EL
Sbjct: 185 WSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 52/190 (27%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G Y A ++ G VA+K++++ + + EI + +HPN+V + ++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ YL GG+L + + ++ + + + +AL +LH +V+HRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 140
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK NILL + + L+DFG + T E + + GT ++APE K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 988 SFGVVLLELI 997
S G++ +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 35/216 (16%)
Query: 809 IGSGGFGATYKAE---IIPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVT 861
+G G FG + E + P +VAVK L ++ F E L QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFI------------QDRPRRTVEWSMLHKIALDVA 909
G +++ Y+ G+L KF+ D P + S L +IA+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD---VAGT 966
+ YL + +HRD+ N L+ +L + DFG++R + TTD V G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVGGH 183
Query: 967 ----FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++ PE M + + ++DV+SFGVVL E+ +
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLS-------VGRFQGVQQFAAEIRTLGRVQHPNLV 860
IG G +GA Y+ + +P G VVA+K ++ V Q +++R + Q PN+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLR---QSQPPNIT 65
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G ++ +++I Y GG++ ++ P + + I +V AL Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALKYIHKV-- 120
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
V+HRDIK +NIL+ N N L DFG+A LL + + +T GT ++APE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKY 178
Query: 981 SD-KADVYSFGVVLLELIS 998
D KAD++S G+ + E+ +
Sbjct: 179 YDTKADIWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 71/232 (30%), Positives = 112/232 (48%), Gaps = 23/232 (9%)
Query: 807 NCIGSGGFGATYKAEIIPG----VVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
IG G FG Y +I + AVK L+ + + V+QF E + HPN+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 862 LIGYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRR-TVEWSMLHKIALDVARALAYLHDEC 919
L+G + SE ++ Y+ G+L FI+ TV+ L L VA+ + YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK--DLIGFGLQVAKGMEYLASK- 117
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE---THATTDVAGTFGYVAPEYAM 976
+ +HRD+ N +LD + ++DFGLAR + E H T ++A E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
T + + K+DV+SFGV+L EL++ P + F+I + LLQGR
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----DSFDITVY----LLQGR 219
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 38/212 (17%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
I G +G + A+ G + A+K + V Q E L + Q P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKI-ALD--VAR--------ALA 913
+ ++L+ YLPGG+L S+L + +LD VAR AL
Sbjct: 61 SFQGKKNLYLVMEYLPGGDL-------------ASLLENVGSLDEDVARIYIAEIVLALE 107
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-------LLGTSETHATTDVAGT 966
YLH ++HRD+KP NIL+D+N + L+DFGL++ + + + GT
Sbjct: 108 YLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
Y+APE + S D +S G +L E +
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 9e-18
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 35/220 (15%)
Query: 809 IGSGGFGATYKAEIIPGVV-------VAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLV 860
IG G FG ++A PG++ VAVK L +Q F E + HPN+V
Sbjct: 13 IGQGAFGRVFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK----------------- 903
L+G M L++ Y+ G+L +F++ R R S+ H
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQC-SLSHSTSSARKCGLNPLPLSCT 130
Query: 904 ----IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETH 958
IA VA +AYL + + +HRD+ N L+ N+ ++DFGL+R +
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
A+ + A ++ PE R + ++DV+++GVVL E+ S
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 68/198 (34%), Positives = 106/198 (53%), Gaps = 19/198 (9%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ--H--PNLVTLI 863
IGSG G YK G V+AVK++ R ++ + L V H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
GY ++++++F I L L+K ++ R + + +L K+ + + +AL YL ++ V
Sbjct: 81 GYFITDSDVF-ICMELMSTCLDKLLK-RIQGPIPEDILGKMTVAIVKALHYLKEK--HGV 136
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLA-RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+HRD+KPSNILLD + N L DFG++ RL+ ++ A T AG Y+APE +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPPDPNP 193
Query: 983 K----ADVYSFGVVLLEL 996
K ADV+S G+ L+EL
Sbjct: 194 KYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-18
Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 42/289 (14%)
Query: 809 IGSGGFGATYKAEI-IPGV----VVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G FG YK + +PG+ +VA+K L + Q +F E + + HPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR-----------TVEWSMLH----KIALD 907
+G E + +++ YL G+L +F+ R TV+ S+ H IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGT 966
+A + YL +H+D+ NIL+ L+ +SD GL+R + +++ +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026
++ PE M + S +D++SFGVVL E+ S L P + F N I LL
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--FGLQPYY-GFSNQEVIEMVRKRQLL- 245
Query: 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
PC DC P M +L C E S RP + + +L+
Sbjct: 246 --PCS------EDCPP-----RMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 63/190 (33%), Positives = 107/190 (56%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G+ K + IP G V+A K + +G V+ Q E++ + + P +V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
++E + + ++ G+L++ + VE +L KIA+ V L YL++ V R++HR
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVE--ILGKIAVAVVEGLTYLYN--VHRIMHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIKPSNIL+++ L DFG++ L S A T V GT Y++PE + + K+DV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFV-GTSTYMSPERIQGGKYTVKSDV 185
Query: 987 YSFGVVLLEL 996
+S G+ ++EL
Sbjct: 186 WSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 53/198 (26%), Positives = 98/198 (49%), Gaps = 5/198 (2%)
Query: 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLV 860
++ +G+G FG + A VAVK + G V+ F AE + +QH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 64
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L V++ +++I ++ G+L F++ L + +A +A++
Sbjct: 65 KLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-- 121
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+HRD++ +NIL+ +L ++DFGLAR++ +E A + APE
Sbjct: 122 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 981 SDKADVYSFGVVLLELIS 998
+ K+DV+SFG++L+E+++
Sbjct: 181 TIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG YKA+ GV+ A K + + ++ + EI L HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++++ + GG ++ + + R E + + AL YLH+ +++HRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTE-PQIRVVCKQTLEALNYLHEN---KIIHRD 128
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD----- 982
+K NIL + + L+DFG++ T GT ++APE M C S
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVM-CETSKDRPYD 186
Query: 983 -KADVYSFGVVLLEL 996
KADV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 60/204 (29%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 805 VQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNL 859
++ IG+G FG + + +PG + VA+K L G + + F +E +G+ HPN+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFI-QDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ L G + +I ++ G L+ F+ Q+ + TV L + +A + YL +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLSEM 125
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL--GTSETHATTDVAGTFG--YVAPEY 974
+HRD+ NIL+++NL +SDFGL+R L TS+ T+ + G + APE
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 975 AMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+V+ E++S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 15/195 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G+G FG + + I A+K ++ V R + Q E R L V HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+ ++++ Y+PGG L F R S A ++ AL YLH + ++
Sbjct: 69 TEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIV 123
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA 984
+RD+KP NILLD + L+DFG A+ L T + GT Y+APE + + +KA
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAPE-VIQSKGHNKA 178
Query: 985 -DVYSFGVVLLELIS 998
D ++ G+++ E++
Sbjct: 179 VDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 73/283 (25%), Positives = 113/283 (39%), Gaps = 21/283 (7%)
Query: 806 QNCIGSGGFGATYKAEIIP-----GVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNL 859
+G G FG P G +VAVK L Q + EI L + H N+
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 860 VTLIGYHVSEAE--MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
V G + + LI Y+P G+L ++ P+ + + L A + +AYLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEY 974
+ +HRD+ N+LLDN+ + DFGLA+ + + G F Y A E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034
+ S +DV+SFGV L EL++ D ++ + R E
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTH---CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
Query: 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
G+ P + E+ L C RP+ R + LK++
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 2e-17
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLIG 864
IG G FGA Y A ++ VVA+K++S Q Q E++ L R++HPN + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 865 YHVSEAEMFLIYNYLPGGNLEKF-IQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
++ E +L+ Y G + + +P + VE + + AL + LAYLH +
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSH---NM 146
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC---RV 980
+HRDIK NILL L+DFG A + + + GT ++APE + +
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMDEGQY 201
Query: 981 SDKADVYSFGVVLLELISDKKAL 1003
K DV+S G+ +EL K L
Sbjct: 202 DGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 66/224 (29%), Positives = 114/224 (50%), Gaps = 36/224 (16%)
Query: 809 IGSGGFGATYKAEIIP----GVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTL 862
IG G FG KA ++ G +K +++ + ++ + E+ L ++HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 863 IGYHVSEAE---MFLIYNYLPGGNLEKFIQDR------PRRTVEWSMLHKIALDVARALA 913
Y S E ++++ +Y GG+L K I + + ++W + +I L AL
Sbjct: 64 --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV--QICL----ALK 115
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++HD ++LHRDIK NI L + L DFG+AR+L ++ A T + GT Y++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017
++K+D+++ G VL E+ + K A + GN N+V
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-----GNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 20/200 (10%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRL-----SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G +G K +P G ++AVKR+ S + + + +R+ V P VT
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS---VDCPYTVTF 65
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYLHDECV 920
G E +++ I + +L+KF + T+ +L KIA+ + +AL YLH +
Sbjct: 66 YGALFREGDVW-ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY---AMT 977
V+HRD+KPSN+L++ N L DFG++ L S A T AG Y+APE +
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTIDAGCKPYMAPERINPELN 180
Query: 978 CRVSD-KADVYSFGVVLLEL 996
+ D K+DV+S G+ ++EL
Sbjct: 181 QKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 3e-17
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
+ + IGSG +G A G VA+K+ + A EI+ L ++H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKK--ISNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 858 NLVTL--IGYHVSEAEM---FLIYNYLPGGNLEKFIQDRPRRTVE------WSMLHKIAL 906
N++ L I S + +++ + +L K I+ T + + +L
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL----- 113
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT--TDVA 964
R L YLH V+HRD+KPSNIL+++N + + DFGLAR + E T+
Sbjct: 114 ---RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 965 GTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELI 997
T Y APE ++ KA D++S G + EL+
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
+G G FG A + + G VA+K++ + F ++ E++ L ++H N+++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+S E L G +L + + RP +E + + R L Y+H V+
Sbjct: 77 IFISPLEDIYFVTELLGTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHS---AGVV 130
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD-K 983
HRD+KPSNIL++ N + + DFGLAR+ + T T Y APE +T + D +
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVE 186
Query: 984 ADVYSFGVVLLELISDK 1000
D++S G + E++ K
Sbjct: 187 VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLI 863
+GSG FG YK + VA+K L + V+ + E + ++ +P +V +I
Sbjct: 3 LGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 864 GYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G V EAE + L+ GG L KF+ + + + S + ++ V+ + YL +
Sbjct: 62 G--VCEAEALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---N 115
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRV 980
+HRD+ N+LL N A +SDFGL++ LG +++ AG + + APE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 981 SDKADVYSFGVVLLELIS 998
S ++DV+S+G+ + E S
Sbjct: 176 SSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 14/193 (7%)
Query: 806 QNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLI 863
Q +G G G YKA + ++AVK + + +Q Q +E+ L + P ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
G E + + ++ GG+L+ + R + +L +IA+ V + L YL ++
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSL---KI 116
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
LHRD+KPSN+L++ L DFG++ L S A T V GT Y+APE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYV-GTNAYMAPERISGEQYGIH 173
Query: 984 ADVYSFGVVLLEL 996
+DV+S G+ +EL
Sbjct: 174 SDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-17
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 19/197 (9%)
Query: 807 NCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIG 864
N IGSG G YK P G + A+K + V+ Q EI L V HPN+V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
E+ ++ ++ GG+LE + L +A + +AYLH ++
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEG------THIADEQFLADVARQILSGIAYLHRR---HIV 190
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA 984
HRDIKPSN+L+++ N ++DFG++R+L + + V GT Y++PE T ++ A
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINT-DLNHGA 248
Query: 985 ------DVYSFGVVLLE 995
D++S GV +LE
Sbjct: 249 YDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-17
Identities = 57/199 (28%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G K + P G+++A K + + ++ Q E++ L P +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ +++ R E +L K+++ V R LAYL ++ +++HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEE--ILGKVSIAVLRGLAYLREK--HQIMHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 185
Query: 987 YSFGVVLLELISDKKALDP 1005
+S G+ L+EL + + P
Sbjct: 186 WSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-17
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPNLVTLIG 864
IG G FGA Y A VVAVK++S Q Q E++ L +++HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 865 YHVSEAEMFLIYNYLPGGNLEKF-IQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
++ E +L+ Y G + + +P + VE + + AL + LAYLH +
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSHNM--- 142
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC---RV 980
+HRDIK NILL L+DFG A S++ GT ++APE + +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 981 SDKADVYSFGVVLLELISDKKAL 1003
K DV+S G+ +EL K L
Sbjct: 198 DGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSV-GRFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G +KA +VA+KR+ + +GV A EI L ++H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
S+ ++ L++ Y +L+K+ D ++ ++ + + LA+ H VLH
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYF-DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLH 122
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA- 984
RD+KP N+L++ N L+DFGLAR G + +V T Y P+ ++ +
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 181
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + EL + + L P
Sbjct: 182 DMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 807 NCIGSGGFGATYKA-EIIPGVVVAVKRLSV-GRFQGVQQFA----AEIRTLGRVQHPNLV 860
IG G +G YKA ++ G VA+K++ V +G+ A ++ L +HPN+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 861 TLI----GYHVS-EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
L+ G E ++ L++ ++ +L ++ P+ + + + + R + +L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE-- 973
H R++HRD+KP NIL+ ++ ++DFGLAR+ S A T V T Y APE
Sbjct: 124 HSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRAPEVL 178
Query: 974 ----YAMTCRVSDKADVYSFGVVLLEL 996
YA D++S G + EL
Sbjct: 179 LQSSYATPV------DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 809 IGSGGFGATYKAEIIP--GVVVAVKRLSV-----GRFQGVQQFAAEIRTLGRVQHPNLVT 861
IG G +G +KA + G VA+KR+ V G + A +R L +HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 862 L-----IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
L + E ++ L++ ++ +L ++ P V + + + R L +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
RV+HRD+KP NIL+ ++ L+DFGLAR+ S A T V T Y APE +
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLL 182
Query: 977 TCRVSDKADVYSFGVVLLELISDK 1000
+ D++S G + E+ K
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 75/295 (25%), Positives = 132/295 (44%), Gaps = 49/295 (16%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLV 860
+G G FG KAE + VAVK L + + +E+ + + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKIAL 906
L+G E ++++ Y GNL F++ R P T+ L A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAG 965
VAR + +L + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 966 TFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM-- 1022
++APE A+ RV + ++DV+SFGV+L E+ F G+ + + +
Sbjct: 197 PVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEI----------FTLGGSPYPGIPVEELFK 245
Query: 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
LL +G E P + E+ +L C E S RP+ +Q+ + L ++
Sbjct: 246 LLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 33/220 (15%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTLIGY 865
+G G FG YKA +I G VVA+K++ + + A EI+ L +++HPN+V LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 866 HVSEAE--------MFLIYNYLP---GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
V + ++++ Y+ G LE P + S + L + + Y
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-----PSVKLTESQIKCYMLQLLEGINY 130
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL----------GTSETHATTDVA 964
LH+ +LHRDIK +NIL+DN ++DFGLAR G T T++
Sbjct: 131 LHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 965 GTFGYVAPEYAM-TCRVSDKADVYSFGVVLLELISDKKAL 1003
T Y PE + R + D++ G V E+ + + L
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPNLVTLIG 864
+G GGFG ++ G + A K+L R + G + E L +V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
S+ + L+ + + GG+L+ I + R +E + + + + +LH ++
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIV 117
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA 984
+RD+KP N+LLD+ N LSD GLA + + T AGT GY+APE S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 985 DVYSFGVVLLELISDK 1000
D ++ G + E+++ +
Sbjct: 176 DWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G GGFG ++ A+K + + + +E L HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL---DVAR--------ALA 913
+ ++++ Y GG L W++L L AR A
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL-------------WTILRDRGLFDEYTARFYIACVVLAFE 107
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
YLH+ +++RD+KP N+LLD+N L DFG A+ L + + T GT YVAPE
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPE 162
Query: 974 YAMTCRVSDK-----ADVYSFGVVLLELI 997
+ +K D +S G++L EL+
Sbjct: 163 I-----ILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
+G G + YK G +VA+K + + +G A EI + ++H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDR-PRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E ++ L++ Y+ +L+K++ R ++ + + + + +A+ H+ RVLH
Sbjct: 68 HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLH 123
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
RD+KP N+L++ L+DFGLAR G + +V T Y AP+ + R S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSI 182
Query: 985 DVYSFGVVLLELISDK 1000
D++S G ++ E+I+ +
Sbjct: 183 DIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYH 866
IG G FG +K + VVA+K + + + ++ EI L + P + G +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ + ++++I YL GG+ ++ P ++ + + I ++ + L YLH E + +HR
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE---KKIHR 125
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIK +N+LL + L+DFG+A L ++ T V F ++APE KAD+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKADI 184
Query: 987 YSFGVVLLEL 996
+S G+ +EL
Sbjct: 185 WSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 50/190 (26%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G + A ++ G VA+K++++ + + EI + +++PN+V + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E+F++ YL GG+L + + ++ + + + + +AL +LH +V+HRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK N+LL + + L+DFG + T E + + GT ++APE K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 988 SFGVVLLELI 997
S G++ +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 807 NCIGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNL 859
+G G FG Y+ G + VAVK L Q F E + + H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFI-QDRPR--RTVEWSM--LHKIALDVARALAY 914
V LIG F++ + GG+L+ F+ ++RPR R +M L A DVA+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 915 LHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAG-TFGYV 970
L + +HRDI N LL A ++DFG+AR + + + A ++
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
PE + + K DV+SFGV+L E+ S
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 3e-16
Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 34/217 (15%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRV-QHP 857
+ + +G G +G +KA + VVA+K++ F+ Q+ EI L + HP
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 858 NLVTLIGYHVSEAE----MFLIYNYLPGGNLEKFI-----QDRPRRTVEWSMLHKIALDV 908
N+V L+ +V +AE ++L++ Y+ +L I +D +R + + +L
Sbjct: 68 NIVKLL--NVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLL------- 117
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT----TDVA 964
+AL Y+H V+HRD+KPSNILL+++ L+DFGLAR L E + TD
Sbjct: 118 -KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 965 GTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
T Y APE + K D++S G +L E++ K
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 54/190 (28%), Positives = 94/190 (49%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYH 866
IG G FG +K + VVA+K + + + ++ EI L + P + G +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ ++++I YL GG+ ++ P + + + K ++ + L YLH E + +HR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE---KKIHR 125
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIK +N+LL + L+DFG+A L ++ T V F ++APE KAD+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSAYDSKADI 184
Query: 987 YSFGVVLLEL 996
+S G+ +EL
Sbjct: 185 WSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTLIGY 865
IG G +G +K G +VA+K+ V + A EIR L +++HPNLV LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ ++ L++ Y L + ++ R V ++ KI +A+ + H +H
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIH 123
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA- 984
RD+KP NIL+ L DFG AR+L T VA T Y APE V D
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELL----VGDTQY 178
Query: 985 ----DVYSFGVVLLELIS 998
DV++ G V EL++
Sbjct: 179 GPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A + G VAVK++ + + Q + E+ + QHPN+V + ++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + R E + + L V +AL++LH + V+HRD
Sbjct: 87 VGDELWVVMEFLEGGALTDIVT-HTRMNEE--QIATVCLAVLKALSFLHAQ---GVIHRD 140
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL ++ LSDFG + + E + GT ++APE + D++
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIW 199
Query: 988 SFGVVLLELI 997
S G++++E++
Sbjct: 200 SLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIG-- 864
IG G +G YKA G +VA+K + + ++ E L + HPN+ T G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 865 ----YHVSEAEMFLIYNYLPGG---NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
++ +++L+ GG +L K ++ + +R E + I + R LAYLH+
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EWIAYILRETLRGLAYLHE 131
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE---- 973
+V+HRDIK NILL N L DFG++ L S GT ++APE
Sbjct: 132 N---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFIGTPYWMAPEVIAC 187
Query: 974 -YAMTCRVSDKADVYSFGVVLLEL 996
++DV+S G+ +EL
Sbjct: 188 DEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 4e-16
Identities = 51/190 (26%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G Y A ++ G VA++++++ + + EI + ++PN+V + ++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ YL GG+L + + ++ + + + +AL +LH +V+HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK NILL + + L+DFG + T E + + GT ++APE K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 988 SFGVVLLELI 997
S G++ +E+I
Sbjct: 201 SLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 74/290 (25%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 809 IGSGGFGATYKAEII---PG---VVVAVKRLSVGRFQGV--QQFAAEIRTLGRVQHPNLV 860
+G FG YK + PG VA+K L + +G ++F E R+QHPN+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIAL 906
L+G E + +I++Y +L +F+ R + T+E + I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DVAG 965
+A + +L V+H+D+ N+L+ + LN +SD GL R + ++ + +
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025
+++PE M + S +D++S+GVVL E+ S L P +C + N I + +L
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQP-YCGYSNQDVIEMIRNRQVL 245
Query: 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
PC P D + L + C E S RP + + +L+
Sbjct: 246 ---PC-----------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 80/310 (25%), Positives = 128/310 (41%), Gaps = 77/310 (24%)
Query: 806 QNCIGSGGFGATYKAEIIPG---VVVAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
++ IG G FG +A I + A+K L + FA E+ L ++ HPN++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS----------------MLHKI 904
L+G + +++ Y P GNL F+ R R +E L +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964
A DVA + YL ++ + +HRD+ N+L+ NL + ++DFGL+R E + V
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY----VK 174
Query: 965 GTFG-----YVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAW 1019
T G ++A E + K+DV+SFGV+L E++S
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS--------------------- 213
Query: 1020 ASMLLLQGRP-CEFFTAGLWDCGPH----------DDLIEMLNLAIMCTGESLSSRPSMR 1068
L G P C A L++ P DD E+ L C + RP
Sbjct: 214 -----LGGTPYCGMTCAELYEKLPQGYRMEKPRNCDD--EVYELMRQCWRDRPYERPPFA 266
Query: 1069 QVAQQLKQIQ 1078
Q++ QL ++
Sbjct: 267 QISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 8e-16
Identities = 52/190 (27%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G Y A +I G VA+K++++ + + EI + ++PN+V + ++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ YL GG+L + + ++ + + + +AL +LH +V+HRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK NILL + + L+DFG + T E + + GT ++APE K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 988 SFGVVLLELI 997
S G++ +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-16
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
IG G FGA Y A ++ VVA+K++S Q Q E+R L +++HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 865 YHVSEAEMFLIYNYLPGGNLEKF-IQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
++ E +L+ Y G + + +P + VE + + AL + LAYLH +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSH---NM 136
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC---RV 980
+HRD+K NILL L DFG A ++ + GT ++APE + +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQY 191
Query: 981 SDKADVYSFGVVLLELISDKKAL 1003
K DV+S G+ +EL K L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G GGFG ++ G + A K+L+ R +G + E R L +V +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFI----QDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
++ ++ L+ + GG+L I ++ P + + + L +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY--TAQIISGLEHLHQR-- 116
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
R+++RD+KP N+LLDN+ N +SD GLA L ++ T AGT G++APE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174
Query: 981 SDKADVYSFGVVLLELISDK 1000
D ++ GV L E+I+ +
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 34/217 (15%)
Query: 806 QNCIGSGGFGATYKAEIIPGVV---VAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNLV 860
Q+ IG G FG KA I + A+KR+ + + FA E+ L ++ HPN++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKF--------------IQDRPRRTVEWSMLHKIAL 906
L+G ++L Y P GNL F I + T+ L A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
DVAR + YL + + +HRD+ NIL+ N A ++DFGL+R E + V T
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY----VKKT 181
Query: 967 FG-----YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G ++A E + +DV+S+GV+L E++S
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y A ++ V +A+K + + VQ EI ++H N+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG-SD 74
Query: 868 SEAEMFLIY-NYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
SE F I+ +PGG+L ++ + P + E +++ + L YLHD +++
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-YTKQILEGLKYLHDN---QIV 130
Query: 925 HRDIKPSNILLDNNLNAY-----LSDFGLA-RLLGTSETHATTDVAGTFGYVAPEYAMTC 978
HRDIK N+L +N Y +SDFG + RL G + T GT Y+APE
Sbjct: 131 HRDIKGDNVL----VNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPE----- 179
Query: 979 RVSDK--------ADVYSFGVVLLELISDKKALDPSFCSFGN 1012
V DK AD++S G ++E+ + K P F G
Sbjct: 180 -VIDKGPRGYGAPADIWSLGCTIVEMATGK----PPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 56/190 (29%), Positives = 104/190 (54%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G K P G+++A K + + + Q E++ L P +V G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ + R E ++L KI++ V R L YL ++ +++HR
Sbjct: 69 YSDGEISICMEHMDGGSLDQVLK-KAGRIPE-NILGKISIAVLRGLTYLREK--HKIMHR 124
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S A + V GT Y++PE + ++D+
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFV-GTRSYMSPERLQGTHYTVQSDI 181
Query: 987 YSFGVVLLEL 996
+S G+ L+E+
Sbjct: 182 WSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 809 IGSGGFGATYKAE---IIP---GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE + P ++VAVK L + F E L +QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQ------------DRPRRTVEWSMLHKIALDVAR 910
G V + +++ Y+ G+L KF++ +RP + MLH IA +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH-IAQQIAA 131
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG----T 966
+ YL + +HRD+ N L+ NL + DFG++R + +++ + V G
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR---VGGHTMLP 185
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++ PE M + + ++DV+S GVVL E+ +
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-15
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 20/190 (10%)
Query: 828 VAVKRLSVGRFQGVQQFA---AEIRTLGRVQHPNLVTLIGYHVSEAE-MFLIYNYLPGGN 883
VA+K L + Q A E R+ HPN+V L+ + +F ++ Y+PG
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 884 LEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL---DNNL 939
L + + D E L LD ALA H++ ++HRD+KP NI++
Sbjct: 66 LREVLAADGALPAGETGRLMLQVLD---ALACAHNQ---GIVHRDLKPQNIMVSQTGVRP 119
Query: 940 NAYLSDFGLARLL-GTSETHA-----TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVL 993
+A + DFG+ LL G + TT+V GT Y APE V+ +D+Y++G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 994 LELISDKKAL 1003
LE ++ ++ +
Sbjct: 180 LECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 809 IGSGGFGATYKAE---IIP---GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE + P ++VAVK L + F E L +QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQ-----------DRPRRT---VEWSMLHKIALDV 908
G + +++ Y+ G+L KF++ +PR+ + S + IA +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG--- 965
A + YL + +HRD+ N L+ NL + DFG++R + +++ + V G
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---VGGHTM 186
Query: 966 -TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++ PE M + + ++DV+SFGV+L E+ +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-15
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQ 855
FN +G+G FG ATYK E P V A+KR + + + V +E + L +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPV--AIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
HP V L G E+ ++L+ ++ GG F++ R + + A + YL
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY--AAQIVLIFEYL 147
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
+++RD+KP N+LLD + ++DFG A+++ T T + GT Y+APE
Sbjct: 148 QSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEIL 200
Query: 976 MTCRVSDKADVYSFGVVLLELI 997
+ AD ++ G+ + E++
Sbjct: 201 LNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG------VQQFAAEIRTLGRVQHPNLVT 861
IG G +G YKA + G VA+K + V + V++ A ++ L HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIVR 66
Query: 862 LIGYHVS-----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
L+ + E ++ L++ ++ +L ++ P + + + R L +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
C+ +HRD+KP NIL+ + L+DFGLAR+ S A T V T Y APE +
Sbjct: 126 ANCI---VHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVLL 180
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFC 1008
+ D++S G + E+ K P FC
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK----PLFC 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVG---------RFQGVQQFAAEIRTLGRVQHP 857
+G G +G Y G ++AVK++ + ++ +Q+ E+ L ++H
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQE---EVDLLKSLKHV 62
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N+V +G + + + + ++PGG++ + +R E + K + +AYLH+
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPE-PVFCKYTKQILDGVAYLHN 120
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL---GTSETHATT--DVAGTFGYVAP 972
CV +HRDIK +N++L N L DFG AR L G TH+ + GT ++AP
Sbjct: 121 NCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 973 EYAMTCRVSDKADVYSFGVVLLELISDKKAL 1003
E K+D++S G + E+ + K L
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPG----VVVAVKRLSVGRFQGVQQFAAEIRTLGRV---- 854
F + +G+G +G + + G + A+K L + RT +V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 855 -QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
Q P LVTL ++ ++ LI +Y+ GG L + R R + ++ + ++ AL
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY--SGEIVLALE 119
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH +++RDIK NILLD+N + L+DFGL++ E GT Y+AP+
Sbjct: 120 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 974 YAMTCRVS-DKA-DVYSFGVVLLELIS 998
DKA D +S GV++ EL++
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG P G VAVK L + EI L + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 863 IGYHVSEAE--MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G + + LI +LP G+L++++ R + + K A+ + + + YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT--DVAGTFGYVAPEYAMTC 978
+ +HRD+ N+L+++ + DFGL + + T + + T D+ + APE +
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 979 RVSDKADVYSFGVVLLELIS 998
+ +DV+SFGV L EL++
Sbjct: 188 KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 5/193 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+GSG FG + + + VA+K ++ G + F E + + ++ HP LV L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ ++++ ++ G L +++ R + + ML + DV + YL +HRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDL 126
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+ + +SDFG+ R + E +++ + PE + S K+DV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 989 FGVVLLELISDKK 1001
FGV++ E+ ++ K
Sbjct: 187 FGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+GSG FG YK +P + VA+K L + G V+ F E + + HP+LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 73
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L+G +S + L+ +P G L ++ + + + +L + +A+ + YL +
Sbjct: 74 LLGVCLSPT-IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRV 980
R++HRD+ N+L+ + + ++DFGLARLL E D ++A E +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 981 SDKADVYSFGVVLLELIS 998
+ ++DV+S+GV + EL++
Sbjct: 189 THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 17/195 (8%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFAAEIRTLGRVQ--HPNLVTL 862
I G FG+ Y A+ G A+K L + V AE R + +Q P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE-RAIMMIQGESPYVAKL 62
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
S+ ++L+ YL GG+ I+ +W+ + +V + LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA--KQYIAEVVLGVEDLHQR---G 117
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
++HRDIKP N+L+D + L+DFGL+R ++ GT Y+APE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDK 172
Query: 983 KADVYSFGVVLLELI 997
+D +S G V+ E +
Sbjct: 173 MSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV 860
+ + IG G +G A P GV VA+K++S Q Q+ EI+ L R +H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKF-----IQD-------RPRRTVEWSMLH--KIAL 906
I + + + E F +Q+ + +T S H
Sbjct: 67 G-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY 113
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA---TTDV 963
+ R L Y+H VLHRD+KPSN+LL+ N + + DFGLAR+ H T V
Sbjct: 114 QILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 964 AGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
A T Y APE + + KA D++S G +L E++S++
Sbjct: 171 A-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLS--VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+GSG FG +K IP + VA+K + GR Q Q+ + +G + H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR-QTFQEITDHMLAMGSLDHAYIVR 73
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDR-----PRRTVEWSMLHKIALDVARALAYLH 916
L+G A + L+ P G+L ++ P+R + W + +A+ + YL
Sbjct: 74 LLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYA 975
+ + +HR++ NILL ++ ++DFG+A LL + + ++ ++A E
Sbjct: 127 EHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
+ R + ++DV+S+GV + E++S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLS---VGRFQGVQQFAAEIRTL-GRVQHPNLVTLI 863
IG G FG A+ G AVK L + + + + AE L V+HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ +++ + +Y+ GG L +Q R R E A ++A AL YLH +
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPE-PRARFYAAEIASALGYLHSL---NI 117
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
++RD+KP NILLD+ + L+DFGL + G + T+ GT Y+APE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 984 ADVYSFGVVLLELISDKKALDPSFC 1008
D + G VL E++ L P +
Sbjct: 177 VDWWCLGAVLYEMLY---GLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-14
Identities = 38/91 (41%), Positives = 56/91 (61%)
Query: 572 LNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEI 631
L L L+G +P+ I+K+ L+ ++LS N+ G IP L + SLEVL+LS NS +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 632 PSEFSKLEHLNVLRLDHNNLTGRIPPGFGTR 662
P +L L +L L+ N+L+GR+P G R
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 807 NCIGSGGFGATY----KAEIIPG---VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPN 858
N +GSG FG Y + PG + VAVK L G Q ++F E + HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRT----VEWSMLHKIALDVARALA 913
+V L+G + ++I + GG+L +++D R R + L I LDVA+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 914 YLHDECVPRVLHRDIKPSNILL-----DNNLNAYLSDFGLARLLGTSETHATTDVAG--- 965
YL +HRD+ N L+ D + + DFGLAR + S+ + G
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174
Query: 966 -TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + + + ++DV+SFGV++ E+++
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-14
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 809 IGSGGFGATYKAE-----IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG A+ V V K++ + R + A L V+HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ +++ + +++ GG L F + R+ A ++A AL YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHS---INI 117
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
++RD+KP NILLD+ + L+DFGL + G +++ TT GT Y+APE +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 984 ADVYSFGVVLLELISDKKALDPSFC 1008
D + G VL E++ L P +C
Sbjct: 177 VDWWCLGAVLYEMLY---GLPPFYC 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-14
Identities = 53/199 (26%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+++A K + + ++ Q E++ L P +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK--HKIMHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 185
Query: 987 YSFGVVLLELISDKKALDP 1005
+S G+ L+E+ + + P
Sbjct: 186 WSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 51/163 (31%), Positives = 77/163 (47%), Gaps = 22/163 (13%)
Query: 846 AEIRTLGRVQH-PNLVTLIGYHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVE 897
E + L V+ P LVTL ++ ++ LI +Y+ GG L E F + R +
Sbjct: 53 TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA 112
Query: 898 WSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957
++ AL +LH +++RDIK NILLD+ + L+DFGL++ E
Sbjct: 113 ---------EIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 958 HATTDVAGTFGYVAPEYAMT-CRVSDKA-DVYSFGVVLLELIS 998
GT Y+APE DKA D +S GV+ EL++
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 56/190 (29%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A E G VAVK++ + + Q + E+ + H N+V + ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + R E + + L V RAL+YLH++ V+HRD
Sbjct: 90 VGDELWVVMEFLEGGALTDIVT-HTRMNEE--QIATVCLSVLRALSYLHNQ---GVIHRD 143
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL ++ LSDFG + + E + GT ++APE + D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 988 SFGVVLLELI 997
S G++++E+I
Sbjct: 203 SLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSV-GRFQGVQQFAA-EIRTLGRVQHPNL 859
F++ IG G +G YKA + G +VA+K++ + +G A EI+ L ++ H N+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 860 VTL----------IGYHVSEAEMFLIYNYLPG---GNLEKFIQDRPRRTVEWSMLHKIAL 906
V L + + + +L++ Y+ G LE + ++ M K L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM--KQLL 126
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
+ L Y H + LHRDIK SNILL+N L+DFGLARL + E+ T+ T
Sbjct: 127 E---GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 967 FGYVAPEYAM-TCRVSDKADVYSFGVVLLELISDK 1000
Y PE + R DV+S G +L EL + K
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A + G +VAVK++ + + Q + E+ + QH N+V + ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + R E + + L V +AL+ LH + V+HRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIVT-HTRMNEE--QIAAVCLAVLKALSVLHAQ---GVIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL ++ LSDFG + + E + GT ++APE + D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 988 SFGVVLLELI 997
S G++++E++
Sbjct: 201 SLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 35/187 (18%)
Query: 841 VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY--NYLPGGNLEKFIQDRPRRTVEW 898
V++ E L + HP L TL Y + E +L +Y PGG L + +Q +P + +
Sbjct: 45 VKRVLTEQEILATLDHPFLPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSE 102
Query: 899 SMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG----- 953
+ A +V AL YLH +++RD+KP NILL + + LSDF L++
Sbjct: 103 EVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159
Query: 954 -----------------TSETHATTDVA------GTFGYVAPEYAMTCRVSDKADVYSFG 990
SET + GT Y+APE D ++ G
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219
Query: 991 VVLLELI 997
++L E++
Sbjct: 220 ILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 15/185 (8%)
Query: 826 VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884
V+VAVK L + + F EI+ + R+++PN++ L+G VS+ + +I Y+ G+L
Sbjct: 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 885 EKFIQDRPRRT----------VEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNIL 934
+F+ R + V + L +A+ +A + YL +HRD+ N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161
Query: 935 LDNNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAPEYAMTCRVSDKADVYSFGVVL 993
+ N+ ++DFG++R L + + + A ++A E + + + +DV++FGV L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 994 LELIS 998
E+ +
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 36/218 (16%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRL---SVGRFQ-GVQQFAAEIRTLGRVQHPNLV 860
+G GG+G ++ + G + A+K L ++ R Q AE L V+HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 861 TLIGYHVSEAEMFLIYNYLPGG----NLEK---FIQDRPRRTVEWSMLHKIALDVARALA 913
LI + +++LI YL GG +LE+ F++D L +I+L AL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMED-----TACFYLSEISL----ALE 114
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR--LLGTSETHATTDVAGTFGYVA 971
+LH + +++RD+KP NILLD + L+DFGL + + + TH GT Y+A
Sbjct: 115 HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMA 168
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS 1009
PE M D +S G ++ ++++ P F +
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGA----PPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 31/208 (14%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F + +G+G FG A +K + +K+ + + + VQ A E L + HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR-------- 910
+V ++ E ++ + ++ GG E F R + DVA+
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGG--ELFTHLRKA--------GRFPNDVAKFYHAELVL 129
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
A YLH + +++RD+KP N+LLDN + ++DFG A+ + T + GT Y+
Sbjct: 130 AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYL 182
Query: 971 APEYAMTCRVSDKA-DVYSFGVVLLELI 997
APE + + KA D ++ GV+L E I
Sbjct: 183 APE-VIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
IG G FG + + VAVK ++ +F E R L + HPN+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDR-PRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ ++++ + GG+ F++ PR V+ L ++ + A + YL + +H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK--ELIQMVENAAAGMEYLESKH---CIH 117
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF-----GYVAPEYAMTCRV 980
RD+ N L+ +SDFG++R E G + APE R
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 981 SDKADVYSFGVVLLELIS 998
S ++DV+SFG++L E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 36/68 (52%), Positives = 46/68 (67%)
Query: 209 LEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
L+ I L+ NS+ G+IPPSLG+ T L L LS N G IP S GQL +L +L+L+ N LS
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503
Query: 269 GIVPSELG 276
G VP+ LG
Sbjct: 504 GRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQF--AAEIRTLGRVQ-HPNLVTLIG 864
IG G F KA+ G A+K + F+ ++Q EI+ L R+ HPN++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 865 YHVSE--AEMFLIYNYLPGGNLEKFIQDR----PRRTVEWSMLHKIALDVARALAYLHDE 918
+ L++ L NL + I+ R P + V+ M + ++L ++H
Sbjct: 66 VLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLL-----KSLDHMHRN 119
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
+ HRDIKP NIL+ +++ L+DFG R G T+ T Y APE +T
Sbjct: 120 ---GIFHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 979 -RVSDKADVYSFGVVLLELISDKKALDPSF 1007
K D+++ G V E++S L P F
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS----LFPLF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQH 856
F +GSG FG YK IP + VA+K L ++ E + V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P++ L+G ++ + LI +P G L ++++ +L+ + +A+ + YL
Sbjct: 69 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGMNYLE 126
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYA 975
+ R++HRD+ N+L+ + ++DFGLA+LLG E + ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
+ + ++DV+S+GV + EL++
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ L+ +Y G+L + I+ R + + H+ L + L +H ++HRDIK +
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFRE-HEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 932 NILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG----YVAPEYAMTCRVSDKADVY 987
NILL +N L DFG +++ + + DV TF YVAPE S KAD++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMF 229
Query: 988 SFGVVLLELISDKKALD 1004
S GV+L EL++ K+ D
Sbjct: 230 SLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 20/197 (10%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVK--RLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+GSG +G YKA + G + AVK +L G F +QQ EI + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECVPR 922
++S ++++ Y GG+L QD T S L + + + LAYLH +
Sbjct: 74 SYLSREKLWICMEYCGGGSL----QDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR--- 979
+HRDIK +NILL +N + L+DFG+A + T+ GT ++APE A +
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKI-TATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 980 VSDKADVYSFGVVLLEL 996
+ D+++ G+ +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAA----EIRTLGRVQHPNLVTL 862
+GSG +G A G VA+K+LS R FQ A E+R L + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS--RPFQSAI-HAKRTYRELRLLKHMDHENVIGL 79
Query: 863 I-----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + + + + +L G +L + + ++ + + + + R L Y+H
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLMGADLNNIV--KCQKLSD-DHIQFLVYQILRGLKYIHS 136
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
++HRD+KPSNI ++ + + DFGLAR + T VA T Y APE M
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVA-TRWYRAPE-IML 188
Query: 978 CRV--SDKADVYSFGVVLLELISDK 1000
+ + D++S G ++ EL++ K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRL-----SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG Y ++ G +A K++ S + V EI+ L +QH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 863 IGYHVSEAE--MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G AE + + Y+PGG+++ Q + + S+ K + ++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKD--QLKAYGALTESVTRKYTRQILEGMSYLHSN-- 125
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT--TDVAGTFGYVAPEYAMTC 978
++HRDIK +NIL D+ N L DFG ++ L T T V GT +++PE
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
KADV+S G ++E++++K
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTLI-- 863
IG G FG +KA +VA+K++ + + A EI+ L ++H N+V LI
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 864 ------GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
Y+ + +L++ + +L + + S + K+ + L Y+H
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHR 137
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA----TTDVAGTFGYVAPE 973
++LHRD+K +NIL+ + L+DFGLAR S+ T V T Y PE
Sbjct: 138 N---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
Query: 974 YAMTCRVSDKA-DVYSFGVVLLEL 996
+ R D++ G ++ E+
Sbjct: 194 LLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPN 858
F +G GGFG ++ G + A K+L R + G E + L +V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V+L + ++ + L+ + GG+L+ I E A ++ L LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R+++RD+KP NILLD++ + +SD GLA + E GT GY+APE
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNE 176
Query: 979 RVSDKADVYSFGVVLLELIS 998
R + D ++ G +L E+I+
Sbjct: 177 RYTFSPDWWALGCLLYEMIA 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIPG-----VVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V P + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + L+ +P G L ++++ R +L+ + +A+ ++YL + R
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCVQIAKGMSYLEE---VR 129
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + + ++DFGLARLL ET D ++A E + R +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 190 HQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKR-LSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
+G G +G K + G +VA+K+ L + V++ A EIR L +++H NLV LI
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 866 HVSEAEMFLIYNYLPG---GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ ++L++ ++ +LEK+ ++ S + K + R + + H
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH---N 120
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
++HRDIKP NIL+ + L DFG AR L + TD T Y APE +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 983 KA-DVYSFGVVLLELIS 998
+A D+++ G ++ E+++
Sbjct: 180 RAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 809 IGSGGFGATYKAEIIPG---VVVAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLVTLI 863
IG G FG KA I + A+KR+ + FA E+ L ++ HPN++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS----------------MLHKIALD 907
G ++L Y P GNL F+ R R +E L A D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
VAR + YL + + +HRD+ NIL+ N A ++DFGL+R E + V T
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY----VKKTM 170
Query: 968 G-----YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G ++A E + +DV+S+GV+L E++S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVK--RLSVGR-FQGVQQFAAEIRTLGRVQHPN 858
F + IGSG +G YKA + G + A+K +L G F VQQ EI + +H N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSN 67
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT--VEWSMLHKIALDVARALAYLH 916
+V G ++ ++++ + GG+L QD T + S + ++ + + L YLH
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSL----QDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRDIK +NILL +N + L+DFG++ + T+ GT ++APE A
Sbjct: 124 SK---GKMHRDIKGANILLTDNGHVKLADFGVSAQI-TATIAKRKSFIGTPYWMAPEVAA 179
Query: 977 TCR---VSDKADVYSFGVVLLEL 996
R + D+++ G+ +EL
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 25/201 (12%)
Query: 809 IGSGGFGATYKAEIIPG----VVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLI 863
+G G FG + AE+ + A+K+ V V+ E R L +HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQ-----DRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ +F + YL GG+L IQ D PR T A ++ L +LH +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-------YAAEIICGLQFLHSK 115
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR--LLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+K NILLD + + ++DFG+ + +LG ++T GT Y+APE +
Sbjct: 116 ---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILL 169
Query: 977 TCRVSDKADVYSFGVVLLELI 997
+ + D +SFGV+L E++
Sbjct: 170 GQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 54/206 (26%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 809 IGSGGFGATYKAEI-----IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ + ++ I V V ++++ ++ F +E + HPN++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 864 G--YHVSEAEMF----LIYNYLPGGNLEKFI-----QDRPRRTVEWSMLHKIALDVARAL 912
G E+E + +I ++ G+L F+ D P+ + ML K D+A +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ-YLPTQMLVKFMTDIASGM 125
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVA 971
YL + +HRD+ N +L+ N+N ++DFGL++ + + + +A ++A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 972 PEYAMTCRV-SDKADVYSFGVVLLEL 996
E ++ RV + K+DV+SFGV + E+
Sbjct: 183 IE-SLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 47/208 (22%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 809 IGSGGFGATYKAEI----IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG+ + ++ + VAVK + + +++F +E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 863 IG--YHVSEAEMF----LIYNYLPGGNLEKF-----IQDRPRRTVEWSMLHKIALDVARA 911
IG + S + +I ++ G+L F + P + + L K +D+A
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTLLKFMVDIALG 125
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYV 970
+ YL + +HRD+ N +L ++ ++DFGL++ + + + + +A ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
A E + K+DV++FGV + E+ +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-13
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRL---SVGRFQGVQQFAAEIRTLGR-VQHPNLV 860
IG G FG A K++ G AVK L ++ + + AE L + ++HP LV
Sbjct: 3 IGKGSFGKVLLAKRKSD---GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L + +++ + +Y+ GG L +Q R R +E A +VA A+ YLH
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLE-PRARFYAAEVASAIGYLHSL-- 115
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+++RD+KP NILLD+ + L+DFGL + G T+ GT Y+APE
Sbjct: 116 -NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 981 SDKADVYSFGVVLLELI 997
D + G VL E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 35/83 (42%), Positives = 53/83 (63%)
Query: 121 GFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQ 180
G G +P +I +L L+ ++LS NS G IPP+L + +SL +++LS N FNG+IP GQ
Sbjct: 429 GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 181 SPGFQVVSLSFNLLSGSVPEEFG 203
++++L+ N LSG VP G
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 809 IGSGGFGATYKAE---IIP---GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE ++P ++VAVK L Q F E L +QH ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFI-------------QDRPRRTVEWSMLHKIALDVA 909
G + +++ Y+ G+L +F+ +D + + IA +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---- 965
+ YL +HRD+ N L+ L + DFG++R + +++ + V G
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGRTML 186
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++ PE + + + ++D++SFGVVL E+ +
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 16/198 (8%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVK--RLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGY 865
+G G +G+ YK P GV +A+K RL + + Q E+ L + P +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYGA 67
Query: 866 HVSEAEMFLIYNYLPGGNLEK-FIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
E +++ Y+ G+L+K + + +L +I V + L +L +E ++
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD-- 982
HRD+KP+N+L++ N L DFG++ L S A T++ G Y+APE + +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNI-GCQSYMAPERIKSGGPNQNP 182
Query: 983 ----KADVYSFGVVLLEL 996
++DV+S G+ +LE+
Sbjct: 183 TYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-13
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 809 IGSGGFGATYKAEIIP--GVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI 863
IG G FG + + P G VA+K++ FQ + ++ E++ L +H N+++ +
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 864 GY----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH-KIAL-DVARALAYLHD 917
H+ E + L +L K I + + H K+ L + R L YLH
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD----HVKVFLYQILRGLKYLHS 121
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAM 976
+LHRDIKP N+L+++N + DFGLAR+ E+ H T +V + Y APE M
Sbjct: 122 ---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILM 177
Query: 977 TCR-VSDKADVYSFGVVLLELISDK 1000
R + D++S G + EL+ +
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 9/202 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G GGFG ++ G + A K+L + + +G E + L +V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V+L + ++ + L+ + GG+L+ I + + A ++ L LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R+++RD+KP NILLD+ + +SD GLA + ET GT GY+APE
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNE 176
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
R + D + G ++ E+I K
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 797 VRATAG-FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV 854
+R AG F + +G+G +G YK + G + A+K + V + ++ EI L +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKY 69
Query: 855 -QHPNLVTLIGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
H N+ T G + ++ +++L+ + G++ +++ ++ + I +
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
+ R LA+LH +V+HRDIK N+LL N L DFG++ L + T + GT
Sbjct: 130 ILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 185
Query: 968 GYVAPEYAMTCRVSD-----KADVYSFGVVLLEL 996
++APE D ++D++S G+ +E+
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 9e-13
Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 797 VRATAG-FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV 854
+R AG F + +G+G +G YK + G + A+K + V + ++ EI L +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKY 59
Query: 855 -QHPNLVTLIGYHVS------EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
H N+ T G + + +++L+ + G++ I++ T++ + I +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
+ R L++LH +V+HRDIK N+LL N L DFG++ L + T + GT
Sbjct: 120 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 175
Query: 968 GYVAPEYAMTCRVSD-----KADVYSFGVVLLEL 996
++APE D K+D++S G+ +E+
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 32/77 (41%), Positives = 48/77 (62%)
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLAS 616
G IP + L+++NLS N ++G +P + + L+ L LS N+F G+IP L QL S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 617 LEVLELSANSLSGEIPS 633
L +L L+ NSLSG +P+
Sbjct: 492 LRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 805 VQNCIGSGGFGATY-----KAEIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHP 857
+Q +G G FG Y KA + V +K + VG + A E + L ++ HP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR--------RTVEWSMLHKIALDVA 909
+V + +I Y G +L+ +++ + EW ++ L V
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW--FIQLLLGVH 120
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
Y+H R+LHRD+K NI L NNL + DFG++RLL S ATT GT Y
Sbjct: 121 ----YMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYY 171
Query: 970 VAPEYAMTCRVSDKADVYSFGVVLLEL 996
++PE K+D++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 63/208 (30%), Positives = 110/208 (52%), Gaps = 23/208 (11%)
Query: 807 NCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQ-FAA----EIRTLGRVQHPNLV 860
N I G +G Y+A + G +VA+K+L + + ++ F EI L ++QHPN+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 861 TL----IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
T+ +G ++ + ++++ Y+ +L+ ++ + ++ S + + L + +A+LH
Sbjct: 68 TVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQ-SEVKCLMLQLLSGVAHLH 123
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
D +LHRD+K SN+LL+N + DFGLAR G+ T V T Y APE +
Sbjct: 124 DN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLL 179
Query: 977 -TCRVSDKADVYSFGVVLLELISDKKAL 1003
S D++S G + EL++ KK L
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 48/184 (26%), Positives = 94/184 (51%), Gaps = 19/184 (10%)
Query: 830 VKRLSVGRFQGVQQFAAE--IRTLGRVQHPNLVTLI-GYHVSEAEMFLIYNYLPGGNLEK 886
+K+L++ ++ AAE + L +++HPN+V + + ++++ + GG+L
Sbjct: 30 IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYH 89
Query: 887 FIQDRP------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN 940
++++ + VEW + +A AL YLH++ +LHRD+K N+ L
Sbjct: 90 KLKEQKGKLLPENQVVEW------FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNI 140
Query: 941 AYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDK 1000
+ D G+AR+L A+T + GT Y++PE + K+DV++ G + E+ + K
Sbjct: 141 IKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
Query: 1001 KALD 1004
A +
Sbjct: 200 HAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLV 860
+G G FG + A+ G+ +V VK L + + +Q F E+ ++ H N+V
Sbjct: 13 LGRGEFGEVFLAKA-KGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 861 TLIGYHVSEAEMF-LIYNYLPGGNLEKFIQ-----DRPRRTVEWSMLHKIAL--DVARAL 912
L+G EAE +I Y G+L++F++ D + S K+AL +A +
Sbjct: 72 RLLGL-CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
+L + R +HRD+ N L+ + +S L++ + SE + + ++AP
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E S K+DV+SFGV++ E+ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 43/143 (30%), Positives = 75/143 (52%), Gaps = 6/143 (4%)
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HP L L ++ +F + YL GG+L IQ R + + A ++ L +
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY--AAEIICGLQF 111
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
LH + +++RD+K N+LLD + + ++DFG+ + E A+T GT Y+APE
Sbjct: 112 LHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEI 167
Query: 975 AMTCRVSDKADVYSFGVVLLELI 997
+ ++ D +SFGV+L E++
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 809 IGSGGFGATYKA--EIIPGV-VVAVKRLSVGRFQGV--QQFAAEIRTLGRVQHPNLVTLI 863
+GSG FG K ++ VAVK L + E + ++ +P +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 864 GYHVSEAEMFLIYNYLPG-GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + EAE +++ L G L KF+Q + V + ++ V+ + YL +
Sbjct: 63 G--ICEAESWMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---N 115
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRV 980
+HRD+ N+LL A +SDFGL++ LG E + G + + APE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 981 SDKADVYSFGVVLLELIS 998
S K+DV+SFGV++ E S
Sbjct: 176 SSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPG----VVVAVKRLS----VGRFQGVQQFAAEIRTLGRV 854
F + +G+G +G + + G + A+K L V + + V+ E L V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 855 -QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
Q P LVTL +EA++ LI +Y+ GG E F R + + ++ AL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGG--EMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH +++RDIK NILLD+ + L+DFGL++ + E T GT Y+APE
Sbjct: 120 HLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 974 YAMTCRVSDKA-DVYSFGVVLLELIS 998
KA D +S G+++ EL++
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM--------------LHKI 904
++ L+G + +++I Y GNL ++++ R +E+S L
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
VAR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 964 AGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELIS 998
++APE A+ RV + ++DV+SFGV++ E+ +
Sbjct: 200 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I V VAVK L + + +E+ + + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + ++++ Y GNL ++++ R P + + L
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 35/90 (38%), Positives = 46/90 (51%), Gaps = 1/90 (1%)
Query: 139 LDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSV 198
L L G IP + L+ INLSGN G IP G +V+ LS+N +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 199 PEEFGDNCVSLEHILLAANSLTGSIPPSLG 228
PE G SL + L NSL+G +P +LG
Sbjct: 483 PESLGQ-LTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 808 CIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA---------EIRTLGRVQHP 857
IGSG +G A + G VA+K++ F E++ L +H
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIP-------HAFDVPTLAKRTLRELKILRHFKHD 64
Query: 858 NLVTLIGYHVSEAEMF----LIYNYLPGGNLEKFIQDRPRRTVEW--SMLHKIALDVARA 911
N++ + F ++ + L +L I T E L+++ R
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL----RG 119
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET----HATTDVAGTF 967
L Y+H V +HRD+KPSN+L++ + + DFG+AR L +S T T VA T
Sbjct: 120 LKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TR 175
Query: 968 GYVAPEYAMTC-RVSDKADVYSFGVVLLELI 997
Y APE ++ + D++S G + E++
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A E G VAVK + + + Q + E+ + QH N+V + ++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + + R E + + V +AL YLH + V+HRD
Sbjct: 89 VGEELWVLMEFLQGGALTDIVS-QTRLNEE--QIATVCESVLQALCYLHSQ---GVIHRD 142
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL + LSDFG + + + + GT ++APE + D++
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 988 SFGVVLLELI 997
S G++++E++
Sbjct: 202 SLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 805 VQNCIGSGGFGATYKAE-IIPGVVVAVKRLSV--------GRFQGVQQ----FAA--EIR 849
+G G +G KA + G +VA+K++ + Q V F E++
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 850 TLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVA 909
+ ++H N++ L+ +V + L+ + + +L+K + + R T S + I L +
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTE--SQVKCILLQIL 129
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG-------------TSE 956
L LH +HRD+ P+NI +++ ++DFGLAR G
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 957 THATTDVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVLLELISDKKALDP 1005
T T Y APE M + D++S G + EL++ K L P
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKPLFP 235
|
Length = 335 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPN 858
F +G GGFG ++ G + A KRL R + G E + L +V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V L + ++ + L+ + GG+L+ I + E A ++ L LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
++RD+KP NILLD+ + +SD GLA + E + GT GY+APE
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 979 RVSDKADVYSFGVVLLELI 997
R + D + G ++ E+I
Sbjct: 177 RYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 809 IGSGGFGATYKAEIIPGVVVA---VKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG E G+ A VK L Q F E++ + HPN++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFI---QDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+ L+ + P G+L+ ++ + + + +L ++A +VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYA----- 975
+H D+ N L +L+ + D+GLA + + T D A ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 976 --MTCRVSDKADVYSFGVVLLEL 996
+ + K++++S GV + EL
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-12
Identities = 34/85 (40%), Positives = 52/85 (61%)
Query: 98 LSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNC 157
L G + I L L+ + L+ N G +P +G ++ LE+LDLS+NSF+G IP +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 158 SSLRLINLSGNQFNGTIPAFFGQSP 182
+SLR++NL+GN +G +PA G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 70/299 (23%), Positives = 121/299 (40%), Gaps = 50/299 (16%)
Query: 809 IGSGGFGATYKAEI-----IPGVV-VAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVT 861
+G G FG KA G VAVK L ++ +E L +V HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQ---------------------DRP-RRTVEWS 899
L G + + LI Y G+L F++ D P R +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
L A ++R + YL + +++HRD+ N+L+ +SDFGL+R + +++
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 960 TTDVAGT-FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVA 1018
++A E + ++DV+SFGV+L E+++ P FN
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERLFN--- 240
Query: 1019 WASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
LL G E P + EM NL + C + RP+ ++++L+++
Sbjct: 241 ----LLKTGYRME---------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 11/194 (5%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRV-QHPNLVTLI 863
+G G FG AE+ G AVK L V V+ E R L ++P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
++ +F + +L GG+L IQD+ R + + + A ++ L +LH + +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSK---GI 117
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
++RD+K N++LD + + ++DFG+ + + A+T GT Y+APE + +
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYTFS 176
Query: 984 ADVYSFGVVLLELI 997
D +SFGV+L E++
Sbjct: 177 VDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F+V++ +G G FG E G + A+K + + + V F E L P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ L + ++L+ Y PGG+L + +R + M ++ A+ +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
+HRDIKP N+L+D + L+DFG A L ++ + GT Y+APE T
Sbjct: 122 ---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 979 RVSDKA------DVYSFGVVLLELI 997
K D +S GV+ E+I
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-11
Identities = 21/38 (55%), Positives = 27/38 (71%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCD 38
++ALL KS++ DP G S+WNP +D CSW GVTCD
Sbjct: 5 RDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L + +E++ + + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE-C 919
L+G + +I Y G+L F++ + + L + VA+ +A+L + C
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTFGYVAPEYAMTC 978
+ HRD+ N+LL + + DFGLAR ++ S + ++APE C
Sbjct: 163 I----HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218
Query: 979 RVSDKADVYSFGVVLLELIS 998
+ ++DV+S+G++L E+ S
Sbjct: 219 VYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 11/194 (5%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR-VQHPNLVTLI 863
IG G FG A +KAE V +++ ++ + + + +E L + V+HP LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ +++ + +Y+ GG L +Q R R +E A ++A AL YLH +
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQ-RERCFLE-PRARFYAAEIASALGYLHSL---NI 117
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
++RD+KP NILLD+ + L+DFGL + T+ GT Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 984 ADVYSFGVVLLELI 997
D + G VL E++
Sbjct: 177 VDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 41/149 (27%), Positives = 78/149 (52%), Gaps = 6/149 (4%)
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
HP LV L +E+ +F + Y+ GG+L +Q + + E + + + +++ AL YL
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYL 112
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H+ +++RD+K N+LLD+ + L+D+G+ + G T+ GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALD 1004
D ++ GV++ E+++ + D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 6/148 (4%)
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR 910
L V HP +V L +E +++LI ++L GG+L + T E + L A
Sbjct: 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--AL 109
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL +LH +++RD+KP NILLD + L+DFGL++ E A + GT Y+
Sbjct: 110 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYM 165
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + AD +SFGV++ E+++
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPNLVTLIG 864
+G GGFG ++ G + A K+L R + G E R L +V +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV---- 920
+ ++ + L+ + GG+L+ I + + D RA+ Y + C
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYN----------MGNPGFDEQRAIFYAAELCCGLED 117
Query: 921 ---PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
R+++RD+KP NILLD+ + +SD GLA + ET GT GY+APE
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINN 175
Query: 978 CRVSDKADVYSFGVVLLELI 997
+ + D + G ++ E+I
Sbjct: 176 EKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 854 VQHPNLVTLIGYHVSEAEM-FLIYNYLPGGNLEKFIQD------RPRRTVEWSMLHKIAL 906
+ H N++ ++ + + E F++Y Y+ GNL+ F+Q + + L +A+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG- 965
+A ++YLH V+H+DI N ++D L ++D L+R L + H D
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++A E + S +DV+SFGV+L EL++
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIA 905
AE L +V P +V L S +++L+ ++ GG L +Q R + + +
Sbjct: 42 AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAE 101
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
L A L LH V++RD+KP NILLD + L DFGL + L + T G
Sbjct: 102 LLCA--LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCG 155
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
T Y+APE + + D ++ GV+L E+++
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-11
Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 41/191 (21%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEA--EMFLIYNYLPGGNLEKFIQDRPRRTVEWSM 900
Q E+ + ++H N+V I +++A +++++ + G+L + IQ + M
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC------YKM 111
Query: 901 LHKIA----LDVAR----ALAYLHD----ECVPRVLHRDIKPSNILLD------------ 936
KI +D+ R ALAY H+ RVLHRD+KP NI L
Sbjct: 112 FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 937 -NNLN----AYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM--TCRVSDKADVYSF 989
NNLN A + DFGL++ +G E+ A + V GT Y +PE + T DK+D+++
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGI-ESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 990 GVVLLELISDK 1000
G ++ EL S K
Sbjct: 230 GCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-11
Identities = 53/163 (32%), Positives = 80/163 (49%), Gaps = 20/163 (12%)
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR-----PRRTVEWSM 900
+E+ L H +V S+ ++ LI Y GG+L K I+ R P + E +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 901 L-HKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
L ++I L AL +H + +HRD+K +NI L L DFG ++ S
Sbjct: 174 LFYQIVL----ALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS---V 223
Query: 960 TTDVAGTFG----YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ DVA +F Y+APE R S KAD++S GV+L EL++
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRL-----SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG Y + G +AVK++ S + V EI+ L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 863 IGY--HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G E + + ++PGG+++ Q + + ++ K + ++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKD--QLKSYGALTENVTRKYTRQILEGVSYLHSN-- 125
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT--TDVAGTFGYVAPEYAMTC 978
++HRDIK +NIL D+ N L DFG ++ L T T V GT +++PE
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
KAD++S G ++E++++K
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 40/97 (41%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
R L Y+H VLHRD+KPSN+LL+ N + + DFGLAR T V T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 970 VAPEYAMTCRVSDKA-DVYSFGVVLLELISDKKALDP 1005
APE + C A DV+S G + EL+ +K L P
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-11
Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 793 YENVVRATAG-------FNVQNCIGSGGFGAT----YKAEIIPGVVVAVKRLSVGRFQGV 841
YE +VR ++V IG G FG +K+ V A+K LS +F+ +
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSS---QKVYAMKLLS--KFEMI 82
Query: 842 QQ-----FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ--DRPRR 894
++ F E + P +V L + ++++ Y+PGG+L + D P +
Sbjct: 83 KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK 142
Query: 895 TVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA-RLLG 953
W+ + +V AL +H ++HRD+KP N+LLD + + L+DFG ++
Sbjct: 143 ---WAKFY--TAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194
Query: 954 TSETHATTDVAGTFGYVAPE----------YAMTCRVSDKADVYSFGVVLLELI 997
T T V GT Y++PE Y C D +S GV L E++
Sbjct: 195 TGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC------DWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 61/196 (31%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 809 IGSGGFGATYKAEIIPGV--VVAVKRL---SVGRFQGVQQFAAEIRTLG-RVQHPNLVTL 862
+G G FG AE+ G V A+K L + + V E R L +HP L L
Sbjct: 3 LGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
++ +F + Y+ GG+L IQ R R+ E A +V AL +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDE-PRSRFYAAEVTLALMFLHRH---G 116
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
V++RD+K NILLD + L+DFG+ + G TT GT Y+APE
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 983 KADVYSFGVVLLELIS 998
D ++ GV++ E+++
Sbjct: 176 SVDWWALGVLMYEMMA 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 826 VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884
++VAVK L + + F E++ L R++ PN++ L+G V E + +I Y+ G+L
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 885 EKFI-----------------QDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+F+ + +S L +AL +A + YL +HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAPEYAMTCRVSDKADV 986
+ N L+ NL ++DFG++R L + + A ++A E + + + +DV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 987 YSFGVVLLELIS 998
++FGV L E++
Sbjct: 224 WAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-11
Identities = 30/81 (37%), Positives = 44/81 (54%), Gaps = 1/81 (1%)
Query: 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV 396
N L G P + L+ +NL+ N G IP SLG+ SL LDLS N+ G +PE +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 397 S-VPCMAVFNVSQNLLSGEIP 416
+ + + N++ N LSG +P
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 6e-11
Identities = 64/240 (26%), Positives = 92/240 (38%), Gaps = 43/240 (17%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHP 857
F V IG G FG + + G V A+K L + R Q + AE L P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSP 61
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+V L E ++L+ Y+PGG+L + + E + + IA V AL +H
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-IAELVL-ALDSVHK 119
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA-------------------------RLL 952
+HRDIKP NIL+D + + L+DFGL +
Sbjct: 120 L---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 953 GTSETHATTD---VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS 1009
GT Y+APE + D +S GV+L E++ P F S
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG----FPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRL-----SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG Y + G +AVK++ S + V EI+ L ++H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 863 IG--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G E ++ + Y+PGG+++ Q + + ++ + + + ++YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKD--QLKAYGALTENVTRRYTRQILQGVSYLHSN-- 125
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT--TDVAGTFGYVAPEYAMTC 978
++HRDIK +NIL D+ N L DFG ++ + T T V GT +++PE
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
KADV+S ++E++++K
Sbjct: 185 GYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG +AE V VAVK L + + +E+ + + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G E +++I Y GNL +F++ R P + + L
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL R +HRD+ N+L+ + ++DFGLAR + + + T++
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 964 AGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELIS 998
++APE A+ RV + ++DV+SFG+++ E+ +
Sbjct: 197 RLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 50/187 (26%), Positives = 92/187 (49%), Gaps = 20/187 (10%)
Query: 826 VVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884
V+VAVK L + F E++ L R+ PN+ L+G + + +I Y+ G+L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 885 EKFIQDR---------PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935
+F+Q +++ +S L +A +A + YL +HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163
Query: 936 DNNLNAYLSDFGLARLLGTSETHATTDVAGT----FGYVAPEYAMTCRVSDKADVYSFGV 991
N ++DFG++R L +S+ + V G ++A E + + + K+DV++FGV
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 992 VLLELIS 998
L E+++
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 791 LTYENVVRATAGFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGVQQFAAEIR 849
L E++ T + + IG G +G YK G + AVK L ++ AE
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYN 70
Query: 850 TLGRV-QHPNLVTLIGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRR--TVEWSML 901
L + HPN+V G + +++L+ GG++ + ++ ++ +M+
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 902 HKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961
I L +LH+ R++HRD+K +NILL L DFG++ L ++ T
Sbjct: 131 SYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 962 DVAGTFGYVAPEYAMTCRVSD-----KADVYSFGVVLLEL 996
V GT ++APE + D + DV+S G+ +EL
Sbjct: 188 SV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 40/149 (26%), Positives = 77/149 (51%), Gaps = 6/149 (4%)
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
+P LV L + + +FL+ Y+ GG+L +Q + + E + + A ++ AL +L
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY--AAEICIALNFL 112
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H+ +++RD+K N+LLD + + L+D+G+ + G T+ GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALD 1004
D ++ GV++ E+++ + D
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRV-QHPNLVTLI 863
+G G FG A + G + AVK L + + V+ E R L HP L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ +F + ++ GG+L IQ + RR E + A ++ AL +LHD+ +
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDE-ARARFYAAEITSALMFLHDK---GI 117
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
++RD+K N+LLD+ + L+DFG+ + G T+ GT Y+APE
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 984 ADVYSFGVVLLELIS 998
D ++ GV+L E++
Sbjct: 177 VDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
+G G + YK + +VA+K + + +G A E+ L ++H N+VTL
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL---DVARALAYLHDECVPRV 923
+E + L++ YL +L++++ D +H + L + R L Y H +V
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSI----NMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSD 982
LHRD+KP N+L++ L+DFGLAR + +V T Y P+ + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 983 KADVYSFGVVLLELISDK 1000
+ D++ G + E+ + +
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 28/203 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRV---QHPNLVT 861
IG G FG Y+ + + A+K LS + + V E L R + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 862 LIGYHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVARALAY 914
L ++++++L+ +Y+ GG L +F +DR + + +L AL +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL---------ALEH 111
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
LH +++RD+KP NILLD + L DFGL++ ++ T GT Y+APE
Sbjct: 112 LHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 975 AMTCRVSDK-ADVYSFGVVLLEL 996
+ + K D +S GV++ E+
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 31/235 (13%)
Query: 776 LVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS 834
L R E +++ E+ F+V IG G FG V A+K LS
Sbjct: 25 LSRYEKAAEKITKLRMKAED-------FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS 77
Query: 835 VGRFQGVQQ-----FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ 889
+F+ +++ F E + +V L + ++++ Y+PGG+L +
Sbjct: 78 --KFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS 135
Query: 890 --DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFG 947
D P +W+ + +V AL +H +HRD+KP N+LLD + + L+DFG
Sbjct: 136 NYDIPE---KWARFY--TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 948 LA-RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD----KADVYSFGVVLLELI 997
++ T V GT Y++PE + + D +S GV L E++
Sbjct: 188 TCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQH 856
F + +G G FG A K+E VAVK L F +++F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 857 PNLVTLIGYHV-SEAEMFL-----IYNYLPGGNLEKF-----IQDRPRRTVEWSMLHKIA 905
PN++ LIG + S A+ L I ++ G+L F I + P T+ L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF-TLPLQTLVRFM 119
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
+D+A + YL + +HRD+ N +L+ N+ ++DFGL++ + + + + +
Sbjct: 120 IDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 966 -TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++A E + +DV++FGV + E+++
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 803 FNVQNC-IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLV 860
F + C +G G +G YKA+ G L G+ A EI L ++HPN++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 861 TLIGYHVSEAE--MFLIYNYLP-----------GGNLEKFIQDRPRRTVEWSMLHKIALD 907
+L +S A+ ++L+++Y K PR V+ S+L++I LD
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK-SLLYQI-LD 119
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLARLLGTS-ETHATTD 962
+ YLH V LHRD+KP+NIL+ ++D G ARL + + A D
Sbjct: 120 ---GIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 963 -VAGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
V TF Y APE + R KA D+++ G + EL++ +
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
+G G + +K + +VA+K + + +G A E+ L ++H N+VTL
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL---DVARALAYLHDECVPRV 923
++ + L++ YL +L++++ D +H + + + R LAY H +V
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHRR---KV 125
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSD 982
LHRD+KP N+L++ L+DFGLAR + +V T Y P+ + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 983 KADVYSFGVVLLELISDK 1000
+ D++ G + E+ S +
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 803 FNVQNC-IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLV 860
F + C +G G +G YKA+ G L G+ A EI L ++HPN++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 861 TLIGYHVSEAE--MFLIYNYLP-----------GGNLEKFIQDRPRRTVEWSMLHKIALD 907
L +S ++ ++L+++Y K PR V+ S+L++I LD
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK-SLLYQI-LD 119
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLARLLGTS-ETHATTD 962
+ YLH V LHRD+KP+NIL+ ++D G ARL + + A D
Sbjct: 120 ---GIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 963 -VAGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
V TF Y APE + R KA D+++ G + EL++ +
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVK--RLSVGRFQGVQQFA-AEIRTLGRVQH-PNLVTLI 863
IG G +G YKA + G +VA+K RL + +G+ A EI L + +V L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLL 67
Query: 864 GY-HVSE----AEMFLIYNYLPGGNLEKFIQD---RPRRTVEWSMLHKIALDVARALAYL 915
HV E ++L++ YL +L+KF+ P R + + + + +A+
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
H V+HRD+KP N+L+D ++D GL R T ++ T Y APE
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEV 182
Query: 975 AMTCR-VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
+ S D++S G + E+ K+ L P +I
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQLLHI 224
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQG---VQQFAAEIR---TLGRVQ 855
F +G G FG AE G + A+K L G V+ E R T +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR---PRRTVEWSMLHKIALDVARAL 912
HP LV L +E + + Y GG+L I R V + A V L
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY------AACVVLGL 114
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL-LGTSETHATTDVAGTFGYVA 971
YLH+ ++++RD+K N+LLD ++DFGL + +G + +T GT ++A
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFLA 169
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELI 997
PE + D + GV++ E++
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-10
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 43/213 (20%)
Query: 809 IGSGGFGAT-YKAEIIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHPNLVTLI 863
+GSG +G + G VA+K+L FQ + FA E+R L ++H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQS-ELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 864 GYHVSEAEM------FLIYNYLPGGNL------EKFIQDRPRRTVEWSMLHKIALDVARA 911
+ + +L+ ++ G +L EK +DR + V + ML +
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLV-YQML--------KG 130
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFG 968
L Y+H ++HRD+KP N+ ++ + + DFGLAR +++ G T
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRW 180
Query: 969 YVAPEYAMT-CRVSDKADVYSFGVVLLELISDK 1000
Y APE + + D++S G ++ E+++ K
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HP L L ++ +F + Y+ GG+L IQ R + + A ++ L +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY--AAEIVLGLQF 111
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
LH+ +++RD+K N+LLD+ + ++DFG+ + G T+ GT Y+APE
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEI 167
Query: 975 AMTCRVSDKADVYSFGVVLLELI 997
D ++ GV+L E++
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-10
Identities = 29/72 (40%), Positives = 42/72 (58%)
Query: 219 LTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMC 278
L G IP + L+S+ LS N ++G+IP S G + +LEVLDLS N +G +P LG
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 279 KQLKVLVLRNDY 290
L++L L +
Sbjct: 490 TSLRILNLNGNS 501
|
Length = 623 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 809 IGSGGFGATY---KAEIIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQH---PNL 859
IG GGFG Y KA+ G + A+K L R QG E L V P +
Sbjct: 2 IGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 860 VTLI-GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V + +H + F I + + GG+L + + A ++ L ++H+
Sbjct: 60 VCMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR 116
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
V ++RD+KP+NILLD + + +SD GLA + HA+ GT GY+APE
Sbjct: 117 FV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170
Query: 979 RVSD-KADVYSFGVVLLELI 997
D AD +S G +L +L+
Sbjct: 171 TAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLP--GGNLEKFIQDRPRRTVEWSMLHKIALDV 908
L V HP+++ + VS A ++ LP +L ++ R R L I +
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQAL-IIEKQI 166
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD--VAGT 966
L YLH + R++HRD+K NI +++ + D G A+ A +AGT
Sbjct: 167 LEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF----PVVAPAFLGLAGT 219
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKAL 1003
APE + + KAD++S G+VL E+++ +
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQ---QFAAEIRTLGRVQHPN 858
+ +Q IG G +G A + G VA+K+++ F+ V + EI+ L ++HP+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 60
Query: 859 LVTL--IGYHVSEAEMFLIYNY--LPGGNLEKFIQDRPRRTVEWSMLHKIAL-DVARALA 913
+V + I S E IY L +L + I+ T E H+ L + RAL
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH---HQFFLYQLLRALK 117
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR--LLGTSETHATTDVAGTFGYVA 971
Y+H V HRD+KP NIL + + + DFGLAR T TD T Y A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 972 PEY--AMTCRVSDKADVYSFGVVLLELISDK 1000
PE + + + D++S G + E+++ K
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 9/217 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNL 859
F V +G G +G K +VA+K+ S + + E++ L ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L +++L++ Y+ LE +++ P + I + +A+ + H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN- 119
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
++HRDIKP N+L+ +N L DFG AR L T+ T Y +PE +
Sbjct: 120 --DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
D++S G +L EL SD + L P F I
Sbjct: 178 YGKAVDMWSVGCILGEL-SDGQPLFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 39/149 (26%), Positives = 77/149 (51%), Gaps = 6/149 (4%)
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
HP LV L +E+ +F + ++ GG+L +Q + + E + + + +++ AL +L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFY--SAEISLALNFL 112
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H+ +++RD+K N+LLD + L+D+G+ + G T+ GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALD 1004
D ++ GV++ E+++ + D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 32/85 (37%), Positives = 48/85 (56%), Gaps = 2/85 (2%)
Query: 598 LSLNN--FTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRI 655
L L+N G IP ++++L L+ + LS NS+ G IP + L VL L +N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 656 PPGFGTRSSLSIFDVSFNNLSGSAP 680
P G +SL I +++ N+LSG P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 29/78 (37%), Positives = 46/78 (58%), Gaps = 4/78 (5%)
Query: 620 LELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSA 679
L L L G IP++ SKL HL + L N++ G IPP G+ +SL + D+S+N+ +GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 680 PRN----SLIKCENVQGN 693
P + + ++ N+ GN
Sbjct: 483 PESLGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 28/194 (14%)
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNL----EKFIQDRPRRTVEWSMLHKIALDVARAL 912
PN+V L Y VSE +FL+ + GG L KF+ W+ +ALD
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS-ETHATTDVAGTFGYVA 971
LH E ++ RD+ P+NILLD+ + L+ F + S + A ++ Y A
Sbjct: 101 --LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCA 150
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELISDKKALD--PSFCSFGNGFNIVAW-----ASML- 1023
PE ++ D +S G +L EL++ K ++ PS + NI W S+L
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQ 210
Query: 1024 -LLQGRPCEFFTAG 1036
LLQ P E AG
Sbjct: 211 QLLQFNPTERLGAG 224
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ + N IG+G FG Y+A I VA+K++ Q Q E+ + + H N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIF 123
Query: 862 LIGYHVSEA------EMFL--IYNYLPGGNLEKFIQDRPRRTVEWSML--HKIALDVARA 911
L Y+ +E +FL + ++P + K+++ R + + + RA
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLAR-LLGTSETHATTDVAGTFGY 969
LAY+H + + HRD+KP N+L+D N + L DFG A+ LL + + + F Y
Sbjct: 183 LAYIHSKFI---CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRF-Y 236
Query: 970 VAPEYAM-TCRVSDKADVYSFGVVLLELI 997
APE + + D++S G ++ E+I
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 33/208 (15%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLIG 864
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 865 YHVSEAEMFLIYN------YLPGGNLEKFI--QDRPRRTVEWSMLHKIALDVARALAYLH 916
+ A +N +L G +L + Q V++ + + R L Y+H
Sbjct: 84 V-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIH 137
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPE 973
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 187
Query: 974 YAMT-CRVSDKADVYSFGVVLLELISDK 1000
+ + D++S G ++ EL++ +
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 20/199 (10%)
Query: 809 IGSGGFGATY---KAEIIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQH---PNL 859
IG GGFG Y KA+ G + A+K L R QG E L V P +
Sbjct: 2 IGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V + + ++ I + + GG+L + + E M A ++ L ++H+
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EAEMRF-YAAEIILGLEHMHNRF 117
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
V ++RD+KP+NILLD + + +SD GLA + HA+ GT GY+APE
Sbjct: 118 V---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171
Query: 980 VSD-KADVYSFGVVLLELI 997
D AD +S G +L +L+
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 68/257 (26%), Positives = 97/257 (37%), Gaps = 80/257 (31%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA---AEIRTLGRVQHPNLVTLIG 864
IG G FG + G + A+K+L +Q A AE L +P +V L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 865 YHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
E ++LI YLPGG++ + F ++ R + ++L A+D L Y+H
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL---AIDSIHKLGYIH- 124
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD--------------- 962
RDIKP N+LLD + LSDFGL G ++H T
Sbjct: 125 --------RDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSNFLDF 174
Query: 963 ------------------------VAGTFGYVAPE------YAMTCRVSDKADVYSFGVV 992
GT Y+APE Y C D +S GV+
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC------DWWSLGVI 228
Query: 993 LLELISDKKALDPSFCS 1009
+ E++ P FCS
Sbjct: 229 MYEMLVGY----PPFCS 241
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 47/189 (24%), Positives = 90/189 (47%), Gaps = 24/189 (12%)
Query: 826 VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884
V+VAVK L + + F EI+ + R++ PN++ L+ ++ + +I Y+ G+L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 885 EKFI---------QDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935
+F+ + T+ +S L +A +A + YL +HRD+ N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163
Query: 936 DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP------EYAMTCRVSDKADVYSF 989
N ++DFG++R L + + + A V P E + + + +DV++F
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRA-----VLPIRWMSWESILLGKFTTASDVWAF 218
Query: 990 GVVLLELIS 998
GV L E+++
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 809 IGSGGFGATYKAEIIPGVVVA---VKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG +EI VA VK L Q +F + +QHPN++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFI--QDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
V L++ Y G+L+ ++ + RR + +L ++A ++A + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD--VAGTFGYVAPEYA----- 975
LH D+ N L ++L + D+G+ E + T+ ++APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 976 --MTCRVSDKADVYSFGVVLLELISDKK 1001
+T + ++V++ GV L EL +
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFENAA 206
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLIG 864
+GSG +G+ A + VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 865 YHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
E++L+ N L G +L ++ + + + E + + + R L Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTN-LMGADLNNIVKCQ-KLSDE--HVQFLIYQLLRGLKYIHS- 136
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT- 977
++HRD+KPSN+ ++ + + DFGLAR ++ T VA T Y APE +
Sbjct: 137 --AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVA-TRWYRAPEIMLNW 190
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDP 1005
+ D++S G ++ EL+ KAL P
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKG-KALFP 217
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 809 IGSGGFGATYKAEIIPGVV---VAVKRLSV-GRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG E+ G V VK L V Q +F E + +QH NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRR---TVEWSMLHKIALDVARALAYLHDECVP 921
L+ + P G+L+ +++ + T + + L ++A ++A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYA----- 975
+H D+ N LL +L + D+GL+ + + T D ++APE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 976 --MTCRVSDKADVYSFGVVLLEL 996
+ + +++V+S GV + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 34/194 (17%)
Query: 825 GVVVAVKRLSVGRFQGVQQFAAEI--------------RTLGRVQHPNLVTLIGYHVSEA 870
G V+ V+ + GR+ ++ E+ R L +HP L L +
Sbjct: 9 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 68
Query: 871 EMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ + Y GG L F ++R R ++ AL YLH V
Sbjct: 69 RLCFVMEYANGGELFFHLSRERVFTEERARF---------YGAEIVSALEYLHSR---DV 116
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
++RDIK N++LD + + ++DFGL + G S+ GT Y+APE
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 984 ADVYSFGVVLLELI 997
D + GVV+ E++
Sbjct: 176 VDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 45/210 (21%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 809 IGSGGFGATYK---AEIIPGVV---VAVKRLSV-GRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ G VA+K ++ + +F E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFI--------QDRPRRTVEWSMLHKIALDVARALA 913
L+G + ++ + G+L+ ++ + ++A ++A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG----- 968
YL + + +HRD+ N ++ +L + DFG+ R + ++ + G G
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 186
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + K+DV+SFGVVL E+ +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQ 855
AT+ N++ +G G + YK I G +VA+K +S+ +GV F A E L ++
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-----IALDVAR 910
H N+V L ++ + ++ Y+ +L +++ P LH + R
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHP------GGLHPYNVRLFMFQLLR 114
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGY 969
LAY+H + +LHRD+KP N+L+ L+DFGLAR S+T+++ V T Y
Sbjct: 115 GLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWY 169
Query: 970 VAPEYAM-TCRVSDKADVYSFGVVLLELI 997
P+ + S D++ G + +E++
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-09
Identities = 35/107 (32%), Positives = 58/107 (54%), Gaps = 3/107 (2%)
Query: 306 VVDG-GEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFF 364
+DG G D G +P+ I++L +L+ ++ G P + + LE+L+L++N F
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 365 TGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCM--AVFNVSQN 409
G IP SLG SL L+L+ N+L+G +P + + A FN + N
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
+G G + +K + +VA+K + + +G A E+ L ++H N+VTL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+E + L++ YL +L++++ D + + + R L+Y H ++LHR
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHR 127
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
D+KP N+L++ L+DFGLAR + +V T Y P+ + + S D
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPID 186
Query: 986 VYSFGVVLLELISDK 1000
++ G +L E+ + +
Sbjct: 187 MWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 6e-09
Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
+PN + L + LI +Y+ G+L ++ + + + + KI + AL L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDL 125
Query: 916 HDECVPRVLHRDIKPSNILLDNNLN-AYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
H ++H DIK N+L D + YL D+GL +++GT + D GT Y +PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY---D--GTLDYFSPE- 176
Query: 975 AMTCRVSDKA-DVYSFGVVLLELISDK 1000
+ D + D ++ GV+ EL++ K
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 27/192 (14%)
Query: 828 VAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV---------------SEAEM 872
VAVK++ + Q V+ EI+ + R+ H N+V + Y V +E
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--YEVLGPSGSDLTEDVGSLTELNS 90
Query: 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSN 932
I +L ++ P E + L + R L Y+H VLHRD+KP+N
Sbjct: 91 VYIVQEYMETDLANVLEQGPLSE-EHARL--FMYQLLRGLKYIHS---ANVLHRDLKPAN 144
Query: 933 ILLD-NNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTCRVSDKA-DVYS 988
+ ++ +L + DFGLAR++ +H ++ T Y +P ++ KA D+++
Sbjct: 145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204
Query: 989 FGVVLLELISDK 1000
G + E+++ K
Sbjct: 205 AGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 44/187 (23%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 825 GVVVAVKRLSVGRFQGVQQFAAEI--------------RTLGRVQHPNLVTLIGYHVSEA 870
G V+ V+ + G++ ++ E+ R L +HP L +L ++
Sbjct: 9 GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD 68
Query: 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKP 930
+ + Y+ GG L F R ++ AL YLH ++++RD+K
Sbjct: 69 RLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKL 123
Query: 931 SNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFG 990
N++LD + + ++DFGL + G ++ GT Y+APE D + G
Sbjct: 124 ENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 991 VVLLELI 997
VV+ E++
Sbjct: 183 VVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-09
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 39/207 (18%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G GG+G + A+ G +VA+KR+ + + V+ E L + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 865 YHVSEAE-MFLIYNYLPGGNLEKFI------QDRPRRTVEWSMLHKIALDVARALAYLHD 917
Y + E ++L Y+PGG+ + + R M A+D L Y+H
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMF--EAVDALHELGYIH- 124
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE---- 973
RD+KP N L+D + + L+DFGL++ + ++ V G+ Y+APE
Sbjct: 125 --------RDLKPENFLIDASGHIKLTDFGLSK-GIVTYANS---VVGSPDYMAPEVLRG 172
Query: 974 --YAMTCRVSDKADVYSFGVVLLELIS 998
Y T D +S G +L E +
Sbjct: 173 KGYDFTV------DYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 9e-09
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 38/244 (15%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALA 913
+ + +++L+ L NL + IQ D R + +L+++ +
Sbjct: 82 LNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQMELDHERMSY---LLYQMLC----GIK 133
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH ++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 134 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 188
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
+ + D++S G ++ E++ K L P G + I W ++ G PC F
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVR-HKILFP-----GRDY-IDQWNKVIEQLGTPCPEF 241
Query: 1034 TAGL 1037
L
Sbjct: 242 MKKL 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
IGSG G A + + G+ VAVK+LS FQ ++ E+ L V H N+++L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 87
Query: 865 YHVSEA------EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALAYL 915
+ +++L+ L NL + I D R + +L+++ + +L
Sbjct: 88 VFTPQKSLEEFQDVYLVME-LMDANLCQVIHMELDHERMSY---LLYQMLC----GIKHL 139
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H ++HRD+KPSNI++ ++ + DFGLAR T+ T T Y APE
Sbjct: 140 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVI 194
Query: 976 MTCRVSDKADVYSFGVVLLELI 997
+ + D++S G ++ EL+
Sbjct: 195 LGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 19/150 (12%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTLIGY 865
+G G + YK + G +VA+K + + +G F A E L ++H N+VTL
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHDI 71
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH----KIAL-DVARALAYLHDECV 920
++ + L++ YL +L++++ D L ++ L + R LAY H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQR-- 122
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950
RVLHRD+KP N+L+ L+DFGLAR
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 19/187 (10%)
Query: 825 GVVVAVKRLSVGRFQGVQQFAAEI--------------RTLGRVQHPNLVTLIGYHVSEA 870
G V+ VK + GR+ ++ E+ R L +HP L L +
Sbjct: 9 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 68
Query: 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKP 930
+ + Y GG L F R ++ AL YLH E V++RD+K
Sbjct: 69 RLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKL 124
Query: 931 SNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFG 990
N++LD + + ++DFGL + G + GT Y+APE D + G
Sbjct: 125 ENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 991 VVLLELI 997
VV+ E++
Sbjct: 184 VVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTLIGY 865
+G G + YK + + G +VA+K + + +G F A E L ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
++ + L++ Y+ +L +++ P + + + R L+Y+H +LH
Sbjct: 72 IHTKETLTLVFEYV-HTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQR---YILH 126
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKA 984
RD+KP N+L+ + L+DFGLAR + +H ++ T Y P+ + + S
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCL 185
Query: 985 DVYSFGVVLLELI 997
D++ G + +E+I
Sbjct: 186 DMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 40/211 (18%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHPNLVTLI 863
+GSG +G+ A + G VA+K+LS FQ + FA E+ L +QH N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQS-EIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 864 GYHVSEA---EMFLIYNYLP--GGNLEK-----FIQDRPRRTVEWSMLHKIALDVARALA 913
S E Y +P +L+K +D+ + V + ML L
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV-YQML--------CGLK 131
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYV 970
Y+H ++HRD+KP N+ ++ + + DFGLAR HA ++ G T Y
Sbjct: 132 YIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYR 181
Query: 971 APEYAMT-CRVSDKADVYSFGVVLLELISDK 1000
APE + + D++S G ++ E+++ K
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 9/203 (4%)
Query: 801 AGFNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQ 855
++ +G+G FG + + +P + VA+ L G ++ F AE TLG+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
H N+V L G M ++ Y+ G L+ F++ + V L + +A + YL
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA-GQLMGMLPGLASGMKYL 123
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
+ +H+ + +L++++L +S F + + + T + APE
Sbjct: 124 SEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
S +DV+SFG+V+ E++S
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 46/178 (25%), Positives = 70/178 (39%), Gaps = 55/178 (30%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH----KIALDVARALAYLHDECVPRVLHRD 927
++LI +LPGG++ + + T E + + +A+D L ++H RD
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH---------RD 126
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-------------------------- 961
IKP N+LLD+ + LSDFGL G + H T
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 962 ----------DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS 1009
GT Y+APE M + D +S GV++ E++ P FCS
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY----PPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-08
Identities = 45/178 (25%), Positives = 69/178 (38%), Gaps = 55/178 (30%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH----KIALDVARALAYLHDECVPRVLHRD 927
++LI +LPGG++ + + + E + + +A+D L ++H RD
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH---------RD 126
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-------------------------- 961
IKP N+LLD + LSDFGL G + H T
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 962 ----------DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS 1009
GT Y+APE M + D +S GV++ E++ P FCS
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY----PPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 802 GFNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-- 855
+ + +G G +G A AE VA+K+++ F +R L ++
Sbjct: 1 RYELIKELGQGAYGIVCSARN-AETSEEETVAIKKIT-NVFSKKILAKRALRELKLLRHF 58
Query: 856 --HPNLVTLIGYHVSEAEMF---LIYNYLPGGNLEKFIQ-DRPRRTVEW-SMLHKIALDV 908
H N+ L + F +Y L +L + I+ +P + S +++I
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL--- 115
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT-----TDV 963
L Y+H VLHRD+KP N+L++ + + DFGLAR G SE T+
Sbjct: 116 -CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR--GFSENPGENAGFMTEY 169
Query: 964 AGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
T Y APE ++ + KA DV+S G +L EL+ K
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 32/241 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
IGSG G A + I VA+K+LS FQ ++ E+ + V H N++ L+
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 865 Y-----HVSEAEMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALAYLH 916
+ E + I L NL + IQ D R + +L+++ + +LH
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY---LLYQMLC----GIKHLH 143
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E+I F +I W ++ G PC F
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG-------VLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251
Query: 1037 L 1037
L
Sbjct: 252 L 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 17/206 (8%)
Query: 801 AGFNVQNCIGSGGFGATY---KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
AGF++ G G + + VV+ G+ G A E L + HP
Sbjct: 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVI-----KAGQRGGT---ATEAHILRAINHP 143
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+++ L G LI LP + + +R + + I V RA+ YLH+
Sbjct: 144 SIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
R++HRDIK NI +++ + L DFG A + AGT APE
Sbjct: 201 N---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR 257
Query: 978 CRVSDKADVYSFGVVLLELISDKKAL 1003
D++S G+VL E+ + +L
Sbjct: 258 DPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-08
Identities = 35/94 (37%), Positives = 45/94 (47%), Gaps = 4/94 (4%)
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS-ETHATTDVAGTFGY 969
ALAYLH ++HRD+K NI LD NA L DFG A L +T +GT
Sbjct: 197 ALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 970 VAPEYAMTCRVSDKADVYSFGVVLLELISDKKAL 1003
+PE K D++S G+VL E+ L
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-08
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 31/204 (15%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGV---QQFAAEIRTLGRVQHPNLVTLI 863
IGSG G A + + G VA+K+LS R FQ V ++ E+ + V H N++ L+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLS--RPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 864 GYHVSE------AEMFLIYNYLPGGNLEKFIQ---DRPRRT-VEWSMLHKIALDVARALA 913
+ +++L+ L NL + IQ D R + + + ML I
Sbjct: 82 NVFTPQKSLEEFQDVYLVME-LMDANLCQVIQMDLDHERMSYLLYQMLCGIK-------- 132
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH ++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 133 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELI 997
+ + D++S G ++ E+I
Sbjct: 188 VILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 42/217 (19%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQ-----FAAEIRTLGRVQH 856
+ V IG G FG V A+K LS +F+ +++ F E +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFANS 102
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ--DRPRRTVEWSMLHK----IALDVAR 910
P +V L + ++++ Y+PGG+L + D P + W+ + +ALD
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLALDAIH 159
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
++ ++H RD+KP N+LLD + + L+DFG + GT Y+
Sbjct: 160 SMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 971 APE----------YAMTCRVSDKADVYSFGVVLLELI 997
+PE Y C D +S GV L E++
Sbjct: 211 SPEVLKSQGGDGYYGREC------DWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-08
Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 872 MFLIYNYLPGGNL----EKFIQDRPRRTVEWSMLHK-IALDVARALAYLHDECVPRVLHR 926
++L+ +Y GG+L KF P + + IA+D L Y+H R
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH---------R 126
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC-----RVS 981
DIKP NIL+D N + L+DFG L T ++ GT Y++PE +
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYG 186
Query: 982 DKADVYSFGVVLLELI 997
+ D +S GV + E++
Sbjct: 187 PECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 42/151 (27%), Positives = 64/151 (42%), Gaps = 6/151 (3%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL 906
E R L +HP L L + + + Y GG L F R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
++ AL YLH V++RD+K N++LD + + ++DFGL + G S+ GT
Sbjct: 103 EIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGT 158
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-07
Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 35/185 (18%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI--------YNYLPGGNLEKFIQDRPRR 894
Q EI LGR+ H N++ + SEA ++I Y+++ + +DRP
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD--WKDRP-- 264
Query: 895 TVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954
+ I + A+ Y+HD+ +++HRDIK NI L+ + L DF GT
Sbjct: 265 -LLKQT-RAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDF------GT 313
Query: 955 SETHATTDVAGTFGYV------APEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFC 1008
+ A +G+V +PE + D++S G++LL+++S FC
Sbjct: 314 AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD------FC 367
Query: 1009 SFGNG 1013
G+G
Sbjct: 368 PIGDG 372
|
Length = 501 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
FN +G G FG AE + A+K L V + V+ E R L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 859 LVTLIGYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+T + + ++ + Y+ GG+L IQ + ++ + A +++ L +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISVGLFFLHR 119
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+++RD+K N++LD+ + ++DFG+ + + T GT Y+APE
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 978 CRVSDKADVYSFGVVLLELISDKKALD 1004
D +++GV+L E+++ + D
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 49/167 (29%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFA---AEIRTLGRVQHPN 858
F+ IG G FG + G + A+K L Q A AE L P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVARA 911
+V+L ++LI +LPGG+L + F +D R + +L A++
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL---AIEAVHK 119
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958
L ++H RDIKP NIL+D + LSDFGL+ G + H
Sbjct: 120 LGFIH---------RDIKPDNILIDRGGHIKLSDFGLS--TGFHKQH 155
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 23/226 (10%)
Query: 787 IGVQLTYENVVRATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQF 844
G + +++ + + + IG G +G +K G AVK L + ++
Sbjct: 4 SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEI 61
Query: 845 AAEIRTLGRVQ-HPNLVTLIGYH-----VSEAEMFLIYNYLPGGNLEKFIQDRPRR--TV 896
AE L + HPN+V G + + +++L+ GG++ ++ +R +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 897 EWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956
E ++ I + L +LH + +HRD+K +NILL L DFG++ L ++
Sbjct: 122 EEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178
Query: 957 THATTDVAGTFGYVAPEYAMTCR------VSDKADVYSFGVVLLEL 996
T V GT ++APE + C + DV+S G+ +EL
Sbjct: 179 LRRNTSV-GTPFWMAPE-VIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 869 EAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKI-ALDVARALAYLHDECVPRV 923
E ++L+ +Y GG+ L KF P + + + A+D L Y+H
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH------- 125
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY--AM---TC 978
RDIKP N+LLD N + L+DFG L T + GT Y++PE AM
Sbjct: 126 --RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 979 RVSDKADVYSFGVVLLELI 997
R + D +S GV + E++
Sbjct: 184 RYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++L+ +Y GG+L + R E M ++ A+ +H +HRDI
Sbjct: 73 ENYLYLVMDYYVGGDLLTLLSKFEDRLPE-DMARFYIAEMVLAIHSIHQL---HYVHRDI 128
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY--AM---TCRVSDK 983
KP N+LLD N + L+DFG + T ++ GT Y++PE AM + +
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188
Query: 984 ADVYSFGVVLLELI 997
D +S GV + E++
Sbjct: 189 CDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-07
Identities = 50/163 (30%), Positives = 71/163 (43%), Gaps = 39/163 (23%)
Query: 3 ALLQLKSAITEDPLGLTS--NWNPKDTDSCS-----WHGVTC--DPLSGR--VTSLNLSS 51
AL LKS+ LGL WN D C W G C D G+ + L L +
Sbjct: 376 ALQTLKSS-----LGLPLRFGWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDN 427
Query: 52 NLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQ 111
G G L+ Q +IN S + + GN+ ++G +T
Sbjct: 428 Q---------------GLRGFIPNDISKLRHLQ----SINL-SGNSIRGNIPPSLGSITS 467
Query: 112 LRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTL 154
L VL L++N F+G +P +GQL+ L IL+L+ NS G +P L
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-07
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG--GNLEKFIQDRPRRTVEWSMLHKI 904
E R L R+ HP ++ L+ V L+ LP +L ++ R R + + + +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLR-PLGLAQVTAV 265
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL-GTSETHATTDV 963
A + A+ Y+H E ++HRDIK N+L++ + L DFG A G+ T +
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLE 995
AGT APE + D++S G+V+ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 45/171 (26%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 841 VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM 900
+QQ E L ++P +V++ ++ + ++ Y+ GG+ +++ V+ +
Sbjct: 45 IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMAR 104
Query: 901 LHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL----LGTS- 955
++ A V AL YLH+ ++HRD+KP N+L+ + + L+DFGL+++ L T+
Sbjct: 105 MY-FAETVL-ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 956 -ETHATTD--------VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
E H D V GT Y+APE + D ++ G++L E +
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV--VVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHP 857
FN +G G FG AE G + A+K L V + V+ E R L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAER-KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 858 NLVT-LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+T L + ++ + Y+ GG+L IQ R ++ + A ++A L +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--AAEIAIGLFFLH 118
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +++RD+K N++LD+ + ++DFG+ + + T GT Y+APE
Sbjct: 119 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALD 1004
D ++FGV+L E+++ + +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-07
Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 9/180 (5%)
Query: 90 INSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSL-LEILDLSFNSFHG 148
+ ++L N+S + +LT L L L N + ++P IG L L+ LDLS N
Sbjct: 97 SLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-E 153
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVS 208
+P L+N +L+ ++LS N + +P + LS N +S +P E +
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE-LLSA 210
Query: 209 LEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
LE + L+ NS+ + SL N L L LS+N D+P S G L NLE LDLS N +S
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-06
Identities = 37/116 (31%), Positives = 57/116 (49%), Gaps = 15/116 (12%)
Query: 841 VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ-----DRPRRT 895
V Q AE L + P +V L S ++L+ YL GG+++ + D
Sbjct: 48 VHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE--- 104
Query: 896 VEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951
M K +VA AL YLH ++HRD+KP N+L+ N + L+DFGL+++
Sbjct: 105 ----MAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV--VVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHP 857
FN +G G FG AE G + A+K L + + V+ E R L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAER-KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 858 N-LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
L L + ++ + Y+ GG+L IQ + ++ + A ++A L +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--AAEIAIGLFFLH 118
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +++RD+K N++LD + ++DFG+ + T GT Y+APE
Sbjct: 119 SK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPEIIA 174
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALD 1004
D ++FGV+L E+++ + D
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 37/138 (26%), Positives = 59/138 (42%), Gaps = 49/138 (35%)
Query: 236 LLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYS 295
L L + L+G IP+ +L +L+ ++LS N + G +P LG L+VL L
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL--------- 473
Query: 296 REHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLE 355
YN F+G +P+S+ +L +LR+
Sbjct: 474 ----------------SYNSFNGSIPESLGQLTSLRI----------------------- 494
Query: 356 MLNLAHNFFTGQIPASLG 373
LNL N +G++PA+LG
Sbjct: 495 -LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DV 963
+ VAR + +L + +HRD+ NILL N + DFGLAR + + D
Sbjct: 179 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ S
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-06
Identities = 34/117 (29%), Positives = 53/117 (45%), Gaps = 24/117 (20%)
Query: 899 SMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET- 957
S+ HKI + Y+H + VLHRD+KP NILL + D+G A E
Sbjct: 117 SIFHKICATIE----YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 958 -------------HATT---DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ T + GT Y+APE + S+ D+Y+ GV+L ++++
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 44/209 (21%), Positives = 88/209 (42%), Gaps = 34/209 (16%)
Query: 808 CIGSGGFGATYKAEIIPGVVVAVKRLSV-----GRFQGVQQFAAEIRTLGRVQHPNLVTL 862
C K + +VAVK++++ + +QQ EI T ++QHPN++
Sbjct: 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQ---EIITSRQLQHPNILPY 64
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE-CVP 921
+ + ++E++++ + G+ E ++ + + I DV AL Y+H + +
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI- 123
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTFG-----YVAPE-- 973
HR +K S+ILL + LS + ++ + +++PE
Sbjct: 124 ---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 974 ------YAMTCRVSDKADVYSFGVVLLEL 996
Y ++K+D+YS G+ EL
Sbjct: 181 QQNLQGY------NEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-06
Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 6/120 (5%)
Query: 889 QDRPRRTVEWSMLHKIALDVARALAYLHDE-CVPRVLHRDIKPSNILLDNNLNAYLSDFG 947
++ L + + VA+ + +L + C+ HRD+ N+LL + A + DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFG 257
Query: 948 LAR-LLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPS 1006
LAR ++ S + ++APE C + ++DV+S+G++L E+ S K+ P
Sbjct: 258 LARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 27/146 (18%), Positives = 52/146 (35%), Gaps = 16/146 (10%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV--QHPNLV-TLIGY 865
+ G Y V +K E+ L ++ + V ++
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKINPSREKG--ADREREVAIL-QLLARKGLPVPKVLAS 61
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
S+ +L+ ++ G L++ ++ IA +A LA LH + + H
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKE---------DIAEQLAELLAKLHQLPLLVLCH 112
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARL 951
D+ P NIL+D+ + D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 908 VARALAYLHDE-CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG- 965
VA+ +++L + C+ HRD+ NILL + + DFGLAR + + A
Sbjct: 223 VAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE C + ++DV+S+G++L E+ S
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 10/111 (9%)
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DV 963
+ VA+ + +L + +HRD+ NILL N + DFGLAR + + D
Sbjct: 185 SFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964
+ VAR + +L + +HRD+ NILL N + DFGLAR + + A
Sbjct: 180 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 965 G-TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ S
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 25/158 (15%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRL---SVGRFQGVQQFAAEIRTLGRVQHPN 858
F IG G FG ++ + A+K L V AE L +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL---DVAR---AL 912
+V L + ++ + +Y+PGG++ S+L ++ + D+AR A
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDM-------------MSLLIRLGIFEEDLARFYIAE 109
Query: 913 AYLHDECVPRV--LHRDIKPSNILLDNNLNAYLSDFGL 948
E V ++ +HRDIKP NIL+D + + L+DFGL
Sbjct: 110 LTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 66/234 (28%), Positives = 104/234 (44%), Gaps = 5/234 (2%)
Query: 457 SSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCL 516
S + L + S L + P I S S L L N L
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL 113
Query: 517 SLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSR 576
L L +N I ++P +G +K L ++ N+ + +P N +L+NL+LS
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNLDLSF 172
Query: 577 NHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFS 636
N L LP ++ + +L L LS N + +P E+ L++LE L+LS NS+ E+ S S
Sbjct: 173 NDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLS 229
Query: 637 KLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENV 690
L++L+ L L +N L +P G S+L D+S N +S + SL +
Sbjct: 230 NLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLREL 282
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 6e-05
Identities = 23/56 (41%), Positives = 29/56 (51%)
Query: 233 LRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
L+SL LS+N L +F L NL+VLDLS N L+ I P L+ L L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57
|
Length = 60 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 809 IGSGGFGATYKAEIIPGVV-------VAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLV 860
+G G FG Y+ I GVV VA+K ++ + +F E + ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM-------LHKIALDVARAL 912
L+G +I + G+L+ +++ RP + ++A ++A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG---- 968
AYL+ + +HRD+ N ++ + + DFG+ R + ++ + G G
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPV 185
Query: 969 -YVAPEYAMTCRVSDKADVYSFGVVLLEL 996
+++PE + +DV+SFGVVL E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 23/60 (38%), Positives = 32/60 (53%)
Query: 568 SLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSL 627
+L++L+LS N L + +LK L LS NN T P + L SL L+LS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 22/59 (37%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 208 SLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265
+L+ + L+ N LT IP + L+ L LS N L P +F L +L LDLS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 61/288 (21%), Positives = 103/288 (35%), Gaps = 74/288 (25%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQF----AAEIRTLGRVQH-- 856
F + +G G FG YKA + K+ +++ A EI RV+
Sbjct: 134 FVLGKKLGEGAFGVVYKASL------VNKQSKKEGKYVLKKATEYGAVEIWMNERVRRAC 187
Query: 857 PNLVT--LIGYHVS-----EAEMFLIYNYLPGGNLEKFIQDR------------------ 891
PN + G+ E E +L++ Y L +Q +
Sbjct: 188 PNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 892 --PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY-LSDFGL 948
R E ++ I + AL LH ++HRD+KP NI+ ++ + D G
Sbjct: 248 KGLER--ENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGA 302
Query: 949 ARLLGTSETHATTDVAGTFGYVAPE-YAMTCR---------------------VSDKADV 986
A L + + Y APE Y M+ + + D+ D+
Sbjct: 303 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362
Query: 987 YSFGVVLLELISDKKALDPSFCSFG-----NGFNIVAWASMLLLQGRP 1029
YS G++ L++ D + F N +++VAW L++ R
Sbjct: 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRK--LVEPRA 408
|
Length = 566 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 8/179 (4%)
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG 557
L+ N L P L L + + + + + L + N
Sbjct: 50 LALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSEN--LLNLLPLPSLDLNLNRLRS 107
Query: 558 LIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMED-LKFLSLSLNNFTGAIPWELTQLAS 616
I + +L +L+L N++ +P I ++ LK L LS N ++P L L +
Sbjct: 108 NISELL-ELTNLTSLDLDNNNI-TDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPN 164
Query: 617 LEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
L+ L+LS N LS ++P S L +LN L L N ++ +PP S+L D+S N++
Sbjct: 165 LKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 33/213 (15%)
Query: 809 IGSGGFGATYKA---EIIPG---VVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ +II G VAVK ++ + +F E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 862 LIGYHVSEAE-MFLIYNYLPGGNLEKFI----------QDRPRRTVEWSMLHKIALDVAR 910
L+G VS+ + ++ + G+L+ ++ RP T++ M+ ++A ++A
Sbjct: 74 LLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EMI-QMAAEIAD 130
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG-- 968
+AYL+ + + +HRD+ N ++ ++ + DFG+ R + ++ + G G
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----GGKGLL 183
Query: 969 ---YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + +D++SFGVVL E+ S
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 3e-04
Identities = 27/60 (45%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 593 LKFLSLSLNNFTGAIPWE-LTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNL 651
LK L LS NN IP L +L+VL+LS N+L+ P FS L L L L NNL
Sbjct: 2 LKSLDLS-NNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 25/171 (14%)
Query: 844 FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK 903
F + ++ H +LV L G V + E ++ Y+ G L+ F+ R + V
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLH-REKNNVSLHWKLD 105
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILL-------DNNLNAYLSDFGLARLLGTSE 956
+A +A AL YL D+ +++H ++ NIL+ LSD G+ + + E
Sbjct: 106 VAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE 162
Query: 957 THATTDVAGTFGYVAPEYAMTCRVSDK-----ADVYSFGVVLLELISDKKA 1002
++APE R AD +SFG LLE+ S+ +
Sbjct: 163 ERVER-----IPWIAPEC---IRNGQASLTIAADKWSFGTTLLEICSNGEE 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 24/99 (24%), Positives = 40/99 (40%), Gaps = 11/99 (11%)
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
Y V ++ Y+ G L+ I +++ ++ R + LH ++
Sbjct: 67 YFVDPENFIIVMEYIEGEPLKDLINSNGME------ELELSREIGRLVGKLHSA---GII 117
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
H D+ SN++L YL DFGLA E A D+
Sbjct: 118 HGDLTTSNMILSGG-KIYLIDFGLAEFSKDLEDRA-VDL 154
|
Length = 211 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 33/127 (25%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE-CVPRVLHRDIKPSNIL 934
Y ++ + D + L VAR + +L + CV HRD+ N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV----HRDLAARNVL 269
Query: 935 LDNNLNAYLSDFGLARLLGTSETHATTDVAGTF---GYVAPEYAMTCRVSDKADVYSFGV 991
L + DFGLAR + + + TF ++APE + +DV+S+G+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSK--GSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 992 VLLELIS 998
+L E+ S
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-04
Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
++ N + G +P +GS ++ L ++ N F G IP+S SLR LNL+ N L G +
Sbjct: 448 NLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 584 PS 585
P+
Sbjct: 507 PA 508
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-04
Identities = 83/293 (28%), Positives = 120/293 (40%), Gaps = 36/293 (12%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSF--HGPIPPTLQNCSSLRLINLS 166
L + V LA N S L L LS L LDL S L N L ++L+
Sbjct: 42 LESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLN 101
Query: 167 GNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPS 226
N+ I + + L N ++ +P G +L+ + L+ N + S+P
Sbjct: 102 LNRLRSNISELLELT-NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158
Query: 227 LGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL 286
L N L++L LS N L D+P L NL LDLS N +S +P E+ + L+ L L
Sbjct: 159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216
Query: 287 RNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQ 346
N I L S++ L NL N LE P+
Sbjct: 217 SN------------NSIIE--------------LLSSLSNLKNLSGLELSNNKLED-LPE 249
Query: 347 NWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVP 399
+ S LE L+L++N +SLG+ +L LDLS N+L+ LP +
Sbjct: 250 SIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLL 300
|
Length = 394 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 9/102 (8%)
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
++ I D+ L Y+H+ + H DIKP NI++D N Y+ D+G+A H
Sbjct: 127 LIKNIMKDMLTTLEYIHEHGIS---HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 960 -----TTDV-AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLE 995
D+ GT Y + V+ + D+ S G +L+
Sbjct: 184 EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 29/166 (17%)
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFI-QDRPRRTVEWSMLHKIALDVA 909
+ +V H +L + G V +E ++ ++ G L+ + +++ R V W + +A +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT--VAQQLA 127
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG- 968
AL+YL D+ ++H ++ NILL + GLA GTS +D +F
Sbjct: 128 SALSYLEDK---NLVHGNVCAKNILL--------ARLGLAE--GTSPFIKLSDPGVSFTA 174
Query: 969 -----------YVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKA 1002
++APE +S AD +SFG LLE+ D +
Sbjct: 175 LSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 853 RVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR-RTVEWSMLHKIALDVARA 911
+V H ++V L G V + E ++ ++ G L+ F+ + T W K+A +A A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASA 117
Query: 912 LAYLHDECVPRVLHRDIKPSNILL-----DNNLNAY--LSDFGLARLLGTSETHATTDVA 964
L+YL D+ ++H ++ NILL D + LSD G+ + + + +
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ-----ECV 169
Query: 965 GTFGYVAPEYAMTCRV-SDKADVYSFGVVLLEL 996
++APE + S AD +SFG L E+
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 13/96 (13%)
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
Y V ++ Y+ G L+ +++ + +V R + LH ++
Sbjct: 67 YDVDPDNGLIVMEYIEGELLKDALEEARPDLLR---------EVGRLVGKLHKA---GIV 114
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960
H D+ SNI+L Y DFGL E A
Sbjct: 115 HGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDKAV 149
|
Length = 204 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.003
Identities = 54/244 (22%), Positives = 92/244 (37%), Gaps = 65/244 (26%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG A ++ + A+K L + R Q V AE L + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-VAHVKAERDILAEADNEWVVKLY 67
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFI---QDRPRRTVEWSMLH-KIALDVARALAYLHDEC 919
+ ++ + +Y+PGG++ + + P + + +A++ + ++H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH--- 124
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGL------------------------------- 948
RDIKP NIL+D + + L+DFGL
Sbjct: 125 ------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 949 -------ARLLGTSETHATT--------DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVL 993
L T E AT + GT Y+APE + + D +S GV+L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 994 LELI 997
E++
Sbjct: 239 FEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.003
Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 23/130 (17%)
Query: 896 VEWSMLH---------KIALDVARALAYLHDECVPRVLHRDIKPSNILL-------DNNL 939
++W M H +I AL Y H E ++H D+KP NIL+ D
Sbjct: 219 LDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVT 276
Query: 940 NAYL-SDFGLARL--LG--TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLL 994
N L D R+ LG E H+ T + T Y +PE + D++S G ++
Sbjct: 277 NRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336
Query: 995 ELISDKKALD 1004
EL + K D
Sbjct: 337 ELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 20/60 (33%), Positives = 28/60 (46%)
Query: 329 NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNL 388
NL+ N L I ++ L++L+L+ N T P + SL LDLS NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 52/240 (21%), Positives = 90/240 (37%), Gaps = 57/240 (23%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRL---SVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G G FG A ++ + A+K L V V AE L + +V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTV-EWSMLHKIALDVARALAYLHDECVPRV 923
+ ++ + +Y+PGG++ + R + + ++ A+ +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCAVESVHKM---GF 122
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLA---RLLGTSETHATTD------------------ 962
+HRDIKP NIL+D + + L+DFGL R S+ + + D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 963 -------------------------VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
+ GT Y+APE + + D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.004
Identities = 23/96 (23%), Positives = 41/96 (42%), Gaps = 14/96 (14%)
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
Y V E ++ Y+ G +L+ ++ P ++ V +A LH ++
Sbjct: 404 YDVDPEEKTIVMEYIGGKDLKDVLEGNP----------ELVRKVGEIVAKLHKA---GIV 450
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960
H D+ SN ++ ++ YL DFGL + E A
Sbjct: 451 HGDLTTSNFIVRDD-RLYLIDFGLGKYSDLIEDKAV 485
|
Length = 535 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.004
Identities = 19/74 (25%), Positives = 36/74 (48%), Gaps = 4/74 (5%)
Query: 887 FIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946
+I+ +P + V ++ ++ R + LH ++H D+ SNI++ ++ YL DF
Sbjct: 78 YIEGKPLKDVIEEGNDELLREIGRLVGKLHKA---GIVHGDLTTSNIIVRDD-KLYLIDF 133
Query: 947 GLARLLGTSETHAT 960
GL + E A
Sbjct: 134 GLGKYSDEIEDKAV 147
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1082 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.38 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.27 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.13 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.02 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.96 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.91 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.87 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.87 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.86 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.82 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.53 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.44 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.43 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.33 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.3 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-106 Score=1045.78 Aligned_cols=914 Identities=33% Similarity=0.527 Sum_probs=742.8
Q ss_pred CHHHHHHHHhcccCCCCCCCCCCCCCCCCceeeeeEeeCCCCCeeeeecCCCccccccccCCCCCCCCCCCCcccCcCcc
Q 045553 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCL 80 (1082)
Q Consensus 1 ~~~l~~~k~~~~~~~~~~~~~W~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (1082)
++||++||+++. +|.+.+++|+. +.|||.|.||+|++ .++|++|||++
T Consensus 31 ~~~l~~~~~~~~-~~~~~~~~w~~-~~~~c~w~gv~c~~-~~~v~~L~L~~----------------------------- 78 (968)
T PLN00113 31 LELLLSFKSSIN-DPLKYLSNWNS-SADVCLWQGITCNN-SSRVVSIDLSG----------------------------- 78 (968)
T ss_pred HHHHHHHHHhCC-CCcccCCCCCC-CCCCCcCcceecCC-CCcEEEEEecC-----------------------------
Confidence 479999999995 78888999974 57899999999985 57999999976
Q ss_pred cccccccCcccCCCCCCccccccccccCCCCCCEEEcccCCCcccCChhhc-CCCCCCEEeCcCCCCCCCCCccccCCCC
Q 045553 81 QLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIG-QLSLLEILDLSFNSFHGPIPPTLQNCSS 159 (1082)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~ 159 (1082)
++++|.++++|..+++|++|+|++|++++.+|..+. .+++|++|+|++|.+++.+|. +.+++
T Consensus 79 ---------------~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~ 141 (968)
T PLN00113 79 ---------------KNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPN 141 (968)
T ss_pred ---------------CCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCC
Confidence 456777888899999999999999999988887755 899999999999999988885 56899
Q ss_pred CCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEcc
Q 045553 160 LRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLS 239 (1082)
Q Consensus 160 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 239 (1082)
|++|+|++|.+.+.+|..++.+++|++|+|++|.+.+.+|..+. .+++|++|+|++|++++.+|..++++++|+.|+|+
T Consensus 142 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 220 (968)
T PLN00113 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT-NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220 (968)
T ss_pred CCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh-hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECc
Confidence 99999999999999999999999999999999999988888876 68999999999999999999999999999999999
Q ss_pred CCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCC
Q 045553 240 SNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGG 319 (1082)
Q Consensus 240 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~ 319 (1082)
+|++++.+|..|+.+++|++|++++|++++.+|..++++++|++|++++ |.+.+.
T Consensus 221 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-------------------------n~l~~~ 275 (968)
T PLN00113 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ-------------------------NKLSGP 275 (968)
T ss_pred CCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcC-------------------------Ceeecc
Confidence 9999999999999999999999999999999999999999999999977 556677
Q ss_pred CCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-cc
Q 045553 320 LPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SV 398 (1082)
Q Consensus 320 ~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l 398 (1082)
+|.++.++++|+.|++++|.+.+..|..+..+++|++|++++|.+++.+|..+..+++|+.|+|++|++++.+|..+ .+
T Consensus 276 ~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~ 355 (968)
T PLN00113 276 IPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355 (968)
T ss_pred CchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCC
Confidence 88899999999999999999999999999999999999999999999999999999999999999999998888766 67
Q ss_pred CcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCC
Q 045553 399 PCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPV 478 (1082)
Q Consensus 399 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~ 478 (1082)
++|+.|++++|.+++.+|... |. ..-+..+++++|.+.|.+
T Consensus 356 ~~L~~L~Ls~n~l~~~~p~~~---~~------------------------------------~~~L~~L~l~~n~l~~~~ 396 (968)
T PLN00113 356 NNLTVLDLSTNNLTGEIPEGL---CS------------------------------------SGNLFKLILFSNSLEGEI 396 (968)
T ss_pred CCCcEEECCCCeeEeeCChhH---hC------------------------------------cCCCCEEECcCCEecccC
Confidence 899999999999988777421 00 001234578889999999
Q ss_pred CCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCccccc
Q 045553 479 PPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGL 558 (1082)
Q Consensus 479 p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~ 558 (1082)
|..+..+..+ ..+++.+|.+++. .|..+.....++.|++++|++.+.+|.... .+++|+.|+|++|++.+.
T Consensus 397 p~~~~~~~~L-----~~L~L~~n~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~n~~~~~ 467 (968)
T PLN00113 397 PKSLGACRSL-----RRVRLQDNSFSGE---LPSEFTKLPLVYFLDISNNNLQGRINSRKW-DMPSLQMLSLARNKFFGG 467 (968)
T ss_pred CHHHhCCCCC-----CEEECcCCEeeeE---CChhHhcCCCCCEEECcCCcccCccChhhc-cCCCCcEEECcCceeeee
Confidence 9887766554 4567788887764 566778888999999999999988887655 467899999999999999
Q ss_pred CccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCC
Q 045553 559 IPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKL 638 (1082)
Q Consensus 559 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 638 (1082)
+|..+ ..++|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|..+.++++|++|+|++|++++.+|..|..+
T Consensus 468 ~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 546 (968)
T PLN00113 468 LPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546 (968)
T ss_pred cCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCc
Confidence 88866 46899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCCccc---ccccCCCCCCCCCCCCCCCCCcccccCCCC
Q 045553 639 EHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLI---KCENVQGNPNLQLCHTDPSSSEWERQHSGN 715 (1082)
Q Consensus 639 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~---~~~~~~~Np~~c~c~~~~~~~~~~~~~~~~ 715 (1082)
++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|....+ ....+.|||.. |+..+...
T Consensus 547 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l--c~~~~~~~--------- 615 (968)
T PLN00113 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDL--CGGDTTSG--------- 615 (968)
T ss_pred ccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccc--cCCccccC---------
Confidence 99999999999999999999999999999999999999999987543 45678999998 55311100
Q ss_pred CCCcccCCCCccccCCCCCCCCchhhhHHHHHHHHHHHHHHHHHhhhhcccCCC--CCCCCCCccceeEEeccccccccH
Q 045553 716 VSQQEAYSPSESIQGNSSGLNPIEIASITSAAVILSVLIALVLLLICMKKFSCN--SIADPGLVRKEVVICNNIGVQLTY 793 (1082)
Q Consensus 716 ~~~~~~~~~~~s~~~~~~~~~~~~i~~i~~~~~~~~~l~~l~~~~~~~rk~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 793 (1082)
.+++........+ ...+. ++++++++++++++++++++++.... .........+...........+++
T Consensus 616 -------~~~c~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (968)
T PLN00113 616 -------LPPCKRVRKTPSW-WFYIT--CTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI 685 (968)
T ss_pred -------CCCCcccccccee-eeehh--HHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhH
Confidence 0001000001111 11111 11111112222222222222221111 111100000000000111123445
Q ss_pred HHHHHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 794 ENVVRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 794 ~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
+++. ..|+..+.||+|+||.||+|+. .++..||||++...... ..+|++.+++++|||||++++++.+.+..
T Consensus 686 ~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 686 NDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred HHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 5543 4577788999999999999976 57899999998644322 23568889999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++|+|.++++. ++|.++.+++.|+|+|++|||+.+.++|+||||||+||+++.++.+++. ||.+...
T Consensus 759 ~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999999999999999963 7899999999999999999997777799999999999999999988875 6655433
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... ....|++.|+|||++.+..++.++|||||||++|||++|+.||+... +......+|++..........+
T Consensus 833 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 833 CTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred ccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhhe
Confidence 211 22368899999999999999999999999999999999999997543 2356778888776666656667
Q ss_pred cccccCCC--CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1033 FTAGLWDC--GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1033 ~d~~l~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
+|+.+... .+.++..++.+++.+||+.+|++||+|.||+++|+++...
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 77766443 3456677889999999999999999999999999998653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-56 Score=572.85 Aligned_cols=513 Identities=36% Similarity=0.528 Sum_probs=465.4
Q ss_pred CCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCcccc-CCCCCCeEEccCcccccccCccccCCCCCcEE
Q 045553 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQ-NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187 (1082)
Q Consensus 109 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 187 (1082)
..+++.|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+. ++++|++|+|++|.+++.+|. +.+++|++|
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 35799999999999999999999999999999999999988998765 999999999999999988886 468999999
Q ss_pred EcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcC
Q 045553 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267 (1082)
Q Consensus 188 ~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 267 (1082)
+|++|.+.+.+|..+. .+++|++|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..++.+++|++|+|++|++
T Consensus 146 ~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 146 DLSNNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred ECcCCcccccCChHHh-cCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence 9999999999998886 699999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcc
Q 045553 268 SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN 347 (1082)
Q Consensus 268 ~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~ 347 (1082)
++.+|..++.+++|++|++++ |.+.+.+|..++++++|++|++++|.+.+..|..
T Consensus 225 ~~~~p~~l~~l~~L~~L~L~~-------------------------n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 279 (968)
T PLN00113 225 SGEIPYEIGGLTSLNHLDLVY-------------------------NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279 (968)
T ss_pred CCcCChhHhcCCCCCEEECcC-------------------------ceeccccChhHhCCCCCCEEECcCCeeeccCchh
Confidence 999999999999999999987 5566788999999999999999999999999999
Q ss_pred cccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-ccCcccEEEecCCcceecCCCCCCcccccc
Q 045553 348 WELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFNVSQNLLSGEIPRISHSECSKM 426 (1082)
Q Consensus 348 l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~ 426 (1082)
+..+++|++|+|++|.+.+.+|..+.++++|+.|++++|.+++.+|..+ .+++|+.|++++|.+.+.+|..-. .
T Consensus 280 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~---- 354 (968)
T PLN00113 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG-K---- 354 (968)
T ss_pred HhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHh-C----
Confidence 9999999999999999999999999999999999999999999988876 689999999999999987774210 0
Q ss_pred cccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccc
Q 045553 427 SVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGN 506 (1082)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~ 506 (1082)
..-+..+++++|.++|.+|..+.....+ ..+++++|.+.+.
T Consensus 355 ----------------------------------~~~L~~L~Ls~n~l~~~~p~~~~~~~~L-----~~L~l~~n~l~~~ 395 (968)
T PLN00113 355 ----------------------------------HNNLTVLDLSTNNLTGEIPEGLCSSGNL-----FKLILFSNSLEGE 395 (968)
T ss_pred ----------------------------------CCCCcEEECCCCeeEeeCChhHhCcCCC-----CEEECcCCEeccc
Confidence 0112356899999999999988766554 4567788887653
Q ss_pred cCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCccc
Q 045553 507 LSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSY 586 (1082)
Q Consensus 507 l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 586 (1082)
+|..+....+++.|++++|++.+.+|..+ ..+++|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..
T Consensus 396 ---~p~~~~~~~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~ 471 (968)
T PLN00113 396 ---IPKSLGACRSLRRVRLQDNSFSGELPSEF-TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471 (968)
T ss_pred ---CCHHHhCCCCCCEEECcCCEeeeECChhH-hcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcc
Confidence 56677778899999999999999888765 56788999999999999999999999999999999999999888876
Q ss_pred ccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCccc
Q 045553 587 INKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLS 666 (1082)
Q Consensus 587 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 666 (1082)
+ ..++|+.|++++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|++++.+|..|..+++|+
T Consensus 472 ~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 550 (968)
T PLN00113 472 F-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550 (968)
T ss_pred c-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCC
Confidence 6 468999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEeccCCccccCCCCC----cccccccCCCCCCCCC
Q 045553 667 IFDVSFNNLSGSAPRN----SLIKCENVQGNPNLQL 698 (1082)
Q Consensus 667 ~l~ls~N~l~~~~p~~----~~~~~~~~~~Np~~c~ 698 (1082)
.|+|++|+++|.+|.. ..+...++.+|+..+.
T Consensus 551 ~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~ 586 (968)
T PLN00113 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586 (968)
T ss_pred EEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence 9999999999999974 3456778899998743
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=457.97 Aligned_cols=291 Identities=44% Similarity=0.747 Sum_probs=257.2
Q ss_pred ccccccHHHHHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeee
Q 045553 787 IGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866 (1082)
Q Consensus 787 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 866 (1082)
....|+++++..||++|...++||+|+||.||+|.+.+|+.||||++........++|..|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34579999999999999999999999999999999999999999988765433156699999999999999999999999
Q ss_pred ccCC-eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEee
Q 045553 867 VSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSD 945 (1082)
Q Consensus 867 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 945 (1082)
.+.+ +.+||||||++|+|+++++......++|.+|.+||.++|+||+|||+.+.|+||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999986433889999999999999999999999999999999999999999999999999
Q ss_pred cccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 946 FGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 946 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
||+|+..............||.+|+|||++..+..+.|+|||||||+++|++||+++.+..... ....+..|++..+.
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~--~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR--GELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc--ccccHHHHHHHHHH
Confidence 9999665431222111117999999999999999999999999999999999999998865422 34559999999999
Q ss_pred cCCCccccccccC-CCCCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1026 QGRPCEFFTAGLW-DCGPH-DDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
++...+++|+.+. ..++. ++..++.+++.+|++.+|.+||+|.||+++|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 9999999999987 55664 688889999999999999999999999999987654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=397.06 Aligned_cols=256 Identities=34% Similarity=0.548 Sum_probs=218.5
Q ss_pred ccccceecccCceEEEEEEEcCCeEEEEEEeecCcccc--HHHHHHHHHHHhccCCCceeeEeeeeccCC-eEEEEEeec
Q 045553 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLIGYHVSEA-EMFLIYNYL 879 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~ 879 (1082)
..+.+.||+|+||+||+|.+.....||||++....... .++|.+|+.++++++|||||+++|+|.+.. ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999844449999997654332 568999999999999999999999999887 799999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEeccCCCCCEEEcCCC-cEEEeecccceecCCCCC
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR-VLHRDIKPSNILLDNNL-NAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~~~ 957 (1082)
++|+|.++++......+++..+.++|.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999985567899999999999999999999999 7 99999999999999997 99999999998765432
Q ss_pred ccccCcccCCCcccchhcc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 958 HATTDVAGTFGYVAPEYAM--TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||... ...+.+..+...+....
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~--------~~~~~~~~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL--------APVQVASAVVVGGLRPP---- 266 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhcCCCCC----
Confidence 2334468999999999999 569999999999999999999999999743 23555555555554333
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.|..+...+..++.+||+.||++||++.|++..|+.+..
T Consensus 267 -----~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 267 -----IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -----CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 344466789999999999999999999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=366.16 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=212.0
Q ss_pred cccceecccCceEEEEEEEc-CCeEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCC-eEEEEEeecC
Q 045553 804 NVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA-EMFLIYNYLP 880 (1082)
Q Consensus 804 ~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~ 880 (1082)
+..+.||+|..|+|||+.++ +++.+|+|.+... +....+++.+|++++++.+||+||+++|+|.... +..++||||.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34567999999999999654 6899999999543 3455688999999999999999999999999988 5999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
+|||++++... .++++....+|+.++++||.|||+ . +||||||||+|||++..|++||||||.++.+... .
T Consensus 162 gGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 162 GGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred CCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 99999999874 569999999999999999999996 5 9999999999999999999999999999877544 4
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
..+++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.+... ......+.+..+..+. .++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~Ll~~Iv~~p-pP~-------- 301 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFELLCAIVDEP-PPR-------- 301 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHHHHHHhcCC-CCC--------
Confidence 4567899999999999999999999999999999999999999986522 2334444444444332 222
Q ss_pred CCCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPH-DDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.|. ..+.++..++..|+++||.+||+++|++++
T Consensus 302 -lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 -LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 233 367899999999999999999999999865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=383.99 Aligned_cols=256 Identities=28% Similarity=0.463 Sum_probs=223.3
Q ss_pred ccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
++..+.||+|-||.||.|.+.....||+|.++... ...+.|.+|+++|++++|++||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 44567899999999999999977899999998763 34578999999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccC
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 962 (1082)
+|.+||+...+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+....+.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999999987778899999999999999999999999 99999999999999999999999999999666555555555
Q ss_pred cccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 963 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
..-...|.|||.+..++++.|+|||||||+||||+| |+.|+. +....+.+.... ...+-..
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~--------~msn~ev~~~le----------~GyRlp~ 425 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP--------GMSNEEVLELLE----------RGYRLPR 425 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC--------CCCHHHHHHHHh----------ccCcCCC
Confidence 566789999999999999999999999999999998 555554 334445444433 3334456
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
|..++.++.++|..||+.+|++||||..+...++++...
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 788899999999999999999999999999999887543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=379.68 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=216.1
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.+|...+.||+|||+.||.++. .+|..||+|++... .....+.+.+|+++.++++|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688999999999999999976 78999999999764 2344667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
|+|+.++|..+++. +..+++.+++.++.||+.|+.|||+. +|+|||||..|++++++.++||+|||+|..+..+.
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999985 57899999999999999999999999 99999999999999999999999999999886553
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
. ...+.+||+.|.|||++.....+..+||||+|||+|-|+.|++||+.. .+.+....+...+ +
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~~~-Y------- 235 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKLNE-Y------- 235 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHhcC-c-------
Confidence 3 445689999999999999999999999999999999999999999732 2333333332221 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..|...+.++.+||..+++.+|.+|||+.+|+.+
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2345667789999999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=362.15 Aligned_cols=200 Identities=31% Similarity=0.558 Sum_probs=181.0
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
...+|.+.+.||+|+||+||+|+.. ++..||||.+... .....+-...|+.+++.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467889999999999999999654 5899999999766 445566778999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC------CcEEEeecccc
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN------LNAYLSDFGLA 949 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~DfGla 949 (1082)
||||.||+|.+|++.+ ..+++.+++.++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+|
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999985 4799999999999999999999999 99999999999999864 46899999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDP 1005 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~ 1005 (1082)
+.+.+. ....+.+|++.|||||+++.++|+.|+|+||+|+++|||++|+.||+.
T Consensus 163 R~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 988633 344567999999999999999999999999999999999999999984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=352.19 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=213.0
Q ss_pred cCccccceecccCceEEEEE-EEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEee-eeccCCe-EEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIG-YHVSEAE-MFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 875 (1082)
..|++.++||+|.||+|||+ ...+|..||.|.+.... ....+....|+.++++++|||||++++ .+.++.+ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 45899999999999999999 57789999999997543 345667889999999999999999998 4444444 8999
Q ss_pred EeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCC-CeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVP-RVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
|||+..|+|.++++..+ .+.+++.++|+++.|+++||.++|+..++ -|+||||||.||+++.+|.+|++|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999997543 67899999999999999999999995332 2889999999999999999999999999988
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
..... .....+|||.||+||.+.+..|+.|+||||+||++|||+.-..||.+ .++.+..+. +.++++..+
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g--------~n~~~L~~K-I~qgd~~~~ 248 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG--------DNLLSLCKK-IEQGDYPPL 248 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc--------ccHHHHHHH-HHcCCCCCC
Confidence 65443 34567899999999999999999999999999999999999999973 355554444 344444322
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
..+..+.++.+||..|+..||+.||+...+++.+
T Consensus 249 --------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 249 --------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred --------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1156788999999999999999999854444443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=365.59 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=209.5
Q ss_pred hcCccccceecccCceEEEEE-EEcCCeEEEEEEeecCccc-------cHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ-------GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
...|.+.+.||+|+||.|-+| +.++|+.||||++...... ......+|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356788899999999999999 5678999999999654221 12335799999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC---CcEEEeeccc
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN---LNAYLSDFGL 948 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGl 948 (1082)
.|+|||||+||+|.+.+-.+ ..+.+.....++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999875 4577778889999999999999999 99999999999999765 7899999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCRV---SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
|+..+ +...+.+.+||+.|.|||++.++.+ ..+.|+||+||++|-+++|.+||.....+ ..+...+.
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--------~sl~eQI~ 395 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--------PSLKEQIL 395 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--------ccHHHHHh
Confidence 99876 4456778899999999999976543 34789999999999999999999865433 11233344
Q ss_pred cCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.|.+... + ....+..++...+|.+|+..||++||++.|++++
T Consensus 396 ~G~y~f~--p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 KGRYAFG--P----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCccccc--C----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 4433311 1 1224667899999999999999999999998763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=383.63 Aligned_cols=269 Identities=26% Similarity=0.438 Sum_probs=227.5
Q ss_pred ccccHHHHHHHhcC---------ccccceecccCceEEEEEEEcC----CeEEEEEEeecCcc-ccHHHHHHHHHHHhcc
Q 045553 789 VQLTYENVVRATAG---------FNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV 854 (1082)
Q Consensus 789 ~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l 854 (1082)
..++|+|-.++... ..|.++||.|.||.||+|+++. ...||||.++.... ....+|..|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 45677776655544 4578999999999999997653 46799999987754 4457899999999999
Q ss_pred CCCceeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEE
Q 045553 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNIL 934 (1082)
Q Consensus 855 ~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nil 934 (1082)
.||||+++.|+.......++|.|||++|+|+.||+.+. ..+++.+...++++||.||.||-++ ++|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence 99999999999999999999999999999999999985 4599999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeecccceecCCCCCccccCccc--CCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCC
Q 045553 935 LDNNLNAYLSDFGLARLLGTSETHATTDVAG--TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFG 1011 (1082)
Q Consensus 935 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~ 1011 (1082)
++.+..+||+|||+++.+.++.....+..-| ..+|.|||.+...++|.++||||||+||||.++ |.+||.....
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--- 840 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--- 840 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---
Confidence 9999999999999999886554333333333 469999999999999999999999999999775 8888874422
Q ss_pred CCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1012 NGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.+.+ ..++...+-+.|++++..+.+||++||++|-.+||++.+|+.+|.++..
T Consensus 841 -----QdVI----------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 841 -----QDVI----------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -----HHHH----------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1222 2334445556789999999999999999999999999999999987543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.60 Aligned_cols=242 Identities=27% Similarity=0.383 Sum_probs=208.3
Q ss_pred hcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.+.|++.++||+|+||+||.++ ..+++.+|+|++++... .+.+...+|..++.+++||.||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4579999999999999999995 45689999999976532 4467788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
+||+.||.|..+|+. ...+++..+.-++.+|+.||.|||+. +|||||+||+|||+|.+|+++|+|||+++..-..
T Consensus 104 ld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999987 45799999999999999999999999 9999999999999999999999999999864333
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.....+++||+.|||||++.+..|+..+|+||+|+++|||++|.+||.. .+...+.+.+..+. ..
T Consensus 179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~--------~~~~~~~~~I~~~k-~~----- 243 (357)
T KOG0598|consen 179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA--------EDVKKMYDKILKGK-LP----- 243 (357)
T ss_pred -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC--------ccHHHHHHHHhcCc-CC-----
Confidence 2344558999999999999999999999999999999999999999973 34455655555443 11
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRP 1065 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RP 1065 (1082)
..|.-...+...++.+.++.+|++|-
T Consensus 244 ----~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 ----LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 12223456889999999999999995
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=376.33 Aligned_cols=494 Identities=23% Similarity=0.329 Sum_probs=330.7
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
..|+.|.|++|.+. .+-+.+.++.-|++|++.+|++. ..|.+++.+..++.|+.++|+++ .+|..++.+.+|..|+.
T Consensus 45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC 121 (565)
T ss_pred cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence 44566666666665 44445666666666666666666 56666666666666666666666 56666666666666666
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
++|++. .+|+.++ .+..|+.|+..+|+++ ..|..++.+.+|..|++.+|+++...|+.+. ++.|++||..+|-++
T Consensus 122 s~n~~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~- 196 (565)
T KOG0472|consen 122 SSNELK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE- 196 (565)
T ss_pred ccccee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-
Confidence 666666 5555555 3556666666666666 5566666666666666666666644444443 666666666666665
Q ss_pred cCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccc
Q 045553 270 IVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWE 349 (1082)
Q Consensus 270 ~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~ 349 (1082)
.+|..++.+.+|..|+++.|.+. .+| +|.++..|++|++..|.|.....+...
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~--------------------------~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~ 249 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIR--------------------------FLP-EFPGCSLLKELHVGENQIEMLPAEHLK 249 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccc--------------------------cCC-CCCccHHHHHHHhcccHHHhhHHHHhc
Confidence 55666666666666666665443 233 456666677777777777666656666
Q ss_pred cccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceecCCCCCCccccccccc
Q 045553 350 LCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVN 429 (1082)
Q Consensus 350 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 429 (1082)
.+++|..|||++|+++ ..|+.++-+.+|++||+|+|.|++.+++...+ .|+.|-+.||++...--++- .|....+
T Consensus 250 ~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii--~~gT~~v- 324 (565)
T KOG0472|consen 250 HLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRTIRREII--SKGTQEV- 324 (565)
T ss_pred ccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchHHHHHHHH--cccHHHH-
Confidence 7788888888888888 77888888888888888888888777776666 78888888888752111000 0000000
Q ss_pred ccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCC
Q 045553 430 WSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLST 509 (1082)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~ 509 (1082)
+...+. ... |...+.+..+-..-.+ ...+.+|+. -..+....+.+++ .+++.
T Consensus 325 -------LKyLrs------~~~-~dglS~se~~~e~~~t----~~~~~~~~~------~~~i~tkiL~~s~----~qlt~ 376 (565)
T KOG0472|consen 325 -------LKYLRS------KIK-DDGLSQSEGGTETAMT----LPSESFPDI------YAIITTKILDVSD----KQLTL 376 (565)
T ss_pred -------HHHHHH------hhc-cCCCCCCcccccccCC----CCCCcccch------hhhhhhhhhcccc----ccccc
Confidence 000000 000 0000100000000000 001111110 0001111111221 24678
Q ss_pred cccccccCCc---eeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCccc
Q 045553 510 YPFDLCLSLD---GLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSY 586 (1082)
Q Consensus 510 ~p~~~~~~~~---l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 586 (1082)
+|.+++.... ...++++.|++. ++|..+...-.-++.+.+++|.+. .+|..++.+++|..|+|++|-+. .+|..
T Consensus 377 VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e 453 (565)
T KOG0472|consen 377 VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEE 453 (565)
T ss_pred CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchh
Confidence 8888877766 789999999999 899888755444566777777776 77889999999999999999998 78999
Q ss_pred ccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCccc
Q 045553 587 INKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLS 666 (1082)
Q Consensus 587 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 666 (1082)
++.+..|+.|++|.|+|. .+|...-.+..|+.+-.++|++....|..+.++.+|.+|||.+|.|. .+|+.++++++|+
T Consensus 454 ~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~ 531 (565)
T KOG0472|consen 454 MGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLR 531 (565)
T ss_pred hhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhcccccee
Confidence 999999999999999999 89999888888999989999999777777999999999999999999 8999999999999
Q ss_pred EEeccCCccc
Q 045553 667 IFDVSFNNLS 676 (1082)
Q Consensus 667 ~l~ls~N~l~ 676 (1082)
.|++.+|++.
T Consensus 532 hLeL~gNpfr 541 (565)
T KOG0472|consen 532 HLELDGNPFR 541 (565)
T ss_pred EEEecCCccC
Confidence 9999999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=379.36 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=217.2
Q ss_pred CccccceecccCceEEEEEEEc------CCeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
+....+.||+|+||+||+|+.. +...||||.++..... ..++|++|++.++.++|||||+++|.|.+++.+++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 4456678999999999999643 3478999999876554 67899999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC--------CCC----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEE
Q 045553 875 IYNYLPGGNLEKFIQDRP--------RRT----VEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY 942 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 942 (1082)
|+|||..|+|.+||+.+. +.. ++..+.+.||.|||.||+||-++ .+|||||..+|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEE
Confidence 999999999999998643 223 88899999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCcccc-CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHH
Q 045553 943 LSDFGLARLLGTSETHATT-DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 943 l~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1020 (1082)
|+|||+++..-..+.+... ...-..+|||||.++.++++.++|||||||++||+++ |+-|+... .-.+ +
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl--------Sn~E-V 714 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL--------SNQE-V 714 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc--------chHH-H
Confidence 9999999976554444332 3445679999999999999999999999999999998 67776532 1122 3
Q ss_pred HHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1021 SMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1021 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...+++|.+. +.|+.++.++..||..||+..|++||+++||-..|+...
T Consensus 715 Ie~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 715 IECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 3344555443 467889999999999999999999999999999998754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.43 Aligned_cols=396 Identities=25% Similarity=0.251 Sum_probs=289.6
Q ss_pred CCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccc
Q 045553 93 NSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNG 172 (1082)
Q Consensus 93 ~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 172 (1082)
.++..+.|-+|+ +-+.|++++|.+...-+..|.++++|++++|..|.++ .+|.......+|+.|+|.+|.|+.
T Consensus 67 ~~~~~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~s 139 (873)
T KOG4194|consen 67 IDKSRLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISS 139 (873)
T ss_pred ccccccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeecccccc
Confidence 344556666664 4567888888888777777888888888888888888 788766666778888888888887
Q ss_pred ccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCcccc
Q 045553 173 TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFG 252 (1082)
Q Consensus 173 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 252 (1082)
.-...+..++.|+.|||+.|.|+ .+|..-+..-.++++|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.
T Consensus 140 v~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk 218 (873)
T KOG4194|consen 140 VTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFK 218 (873)
T ss_pred ccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhh
Confidence 66777888888888888888887 66655544456677777777777766666777777777777777777755566677
Q ss_pred CCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcE
Q 045553 253 QLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRV 332 (1082)
Q Consensus 253 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~ 332 (1082)
+|++|+.|+|..|+|.-.--.. |.+|++|+.
T Consensus 219 ~L~~L~~LdLnrN~irive~lt-------------------------------------------------FqgL~Sl~n 249 (873)
T KOG4194|consen 219 RLPKLESLDLNRNRIRIVEGLT-------------------------------------------------FQGLPSLQN 249 (873)
T ss_pred hcchhhhhhccccceeeehhhh-------------------------------------------------hcCchhhhh
Confidence 7777777777777775221223 445555556
Q ss_pred EEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcce
Q 045553 333 FWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLS 412 (1082)
Q Consensus 333 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~ 412 (1082)
|.+..|+|......+|..|.+++.|+|+.|+++..--.++.++++|+.|+||+|.|....++.+
T Consensus 250 lklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~W---------------- 313 (873)
T KOG4194|consen 250 LKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSW---------------- 313 (873)
T ss_pred hhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchh----------------
Confidence 6666666666667778888888888888888886667778888888888888888763322221
Q ss_pred ecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccc
Q 045553 413 GEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRP 492 (1082)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~ 492 (1082)
T Consensus 314 -------------------------------------------------------------------------------- 313 (873)
T KOG4194|consen 314 -------------------------------------------------------------------------------- 313 (873)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEE
Q 045553 493 YYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNL 572 (1082)
Q Consensus 493 ~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 572 (1082)
..+++|++|+|+.|+|+...++.|..+..|++|
T Consensus 314 -----------------------------------------------sftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~L 346 (873)
T KOG4194|consen 314 -----------------------------------------------SFTQKLKELDLSSNRITRLDEGSFRVLSQLEEL 346 (873)
T ss_pred -----------------------------------------------hhcccceeEeccccccccCChhHHHHHHHhhhh
Confidence 112446777777777777777777777777777
Q ss_pred EccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCc---hhhhcCcccchhhccCcccCCCCCccccCCcccceecccCc
Q 045553 573 NLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIP---WELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHN 649 (1082)
Q Consensus 573 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 649 (1082)
+|++|.|+.+....|..+.+|+.|||++|.|+..+. ..|.+|++|+.|+|.+|+|+.+...+|.+++.|+.|||.+|
T Consensus 347 nLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~N 426 (873)
T KOG4194|consen 347 NLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDN 426 (873)
T ss_pred cccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCC
Confidence 777777776666677777777777777777765443 34788999999999999998666788999999999999999
Q ss_pred ccCCCCCCCCCCCCcccEEeccCCccccCCCCCcccccccCCCCCCCCCCCCCCCCCcccc
Q 045553 650 NLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQLCHTDPSSSEWER 710 (1082)
Q Consensus 650 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~Np~~c~c~~~~~~~~~~~ 710 (1082)
.|..+-|+.|..+ .|+.|-+..-. .+|||. ..|...|..
T Consensus 427 aiaSIq~nAFe~m-~Lk~Lv~nSss--------------------flCDCq-l~Wl~qWl~ 465 (873)
T KOG4194|consen 427 AIASIQPNAFEPM-ELKELVMNSSS--------------------FLCDCQ-LKWLAQWLY 465 (873)
T ss_pred cceeecccccccc-hhhhhhhcccc--------------------eEEecc-HHHHHHHHH
Confidence 9998889999888 88888764332 358888 666666643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=351.10 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=208.8
Q ss_pred HhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccccHH-HHHHHHHHHhccC-CCceeeEeeeeccCC-eEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQ-HPNLVTLIGYHVSEA-EMFL 874 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 874 (1082)
..++|.+.++||.|+||.||+|+ ..+|..||||+++..-....+ -=.||+..+++++ ||||+++.+++.+.+ ..|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34679999999999999999995 557999999999765433222 2368999999999 999999999999888 9999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||| ..+|+++++++ ++.+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||....
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 99999 67999999998 88999999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCccccCcccCCCcccchhcc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC-c-c
Q 045553 955 SETHATTDVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP-C-E 1031 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~ 1031 (1082)
.. ..+.++.|..|+|||++. .+.|+.+.||||+|||++|+.+-++-|.+.. ++.+..+..-.-|.+ . +
T Consensus 163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-------E~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-------EIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-------HHHHHHHHHHHhCCCcccc
Confidence 43 345678999999999875 5789999999999999999999988776421 111211111111111 1 1
Q ss_pred ccc-----------------cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 FFT-----------------AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d-----------------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.. ..+..-. ..+..++.+++.+|+++||++|||++|++++
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 0000001 2367889999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=347.64 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=210.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCC--eEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA--EMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E 877 (1082)
.+|...+.||+|+||+||++... +|...|||..........+.+.+|+.++++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35777899999999999999654 48999999987664333677899999999999999999999855544 6999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-CCcEEEeecccceecCC--
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYLSDFGLARLLGT-- 954 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~-- 954 (1082)
|+++|+|.+++...++ .+++..+..+..||++||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998766 899999999999999999999999 9999999999999999 79999999999987653
Q ss_pred CCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
........+.||+.|||||++..+ ....++||||+||++.||+||+.||... ....+++-........+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~P--- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSLP--- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCCC---
Confidence 222334457899999999999963 3345999999999999999999998732 22233333333333222
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
..|...+.+..+++.+|++.+|++|||+.|++++-.-
T Consensus 243 ------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 ------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2345567789999999999999999999999987543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=324.50 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=203.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
+.|+...++|+|+||+|||++.+ +|+.||||++.... ....+-..+|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777788999999999999654 69999999996543 2334556899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|++. ++.+-+..+ ...++.+.+.+++.|++.|+.|+|++ ++|||||||+|||++.++.+|+||||+|+.+.. ..
T Consensus 82 ~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 9955 665666655 45789999999999999999999999 999999999999999999999999999998864 33
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC-------
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP------- 1029 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 1029 (1082)
...+.++.|..|+|||.+.+ ..|....||||.||++.||++|.+-|.... ++.+.......-|+.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-------DiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-------DIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-------hHHHHHHHHHHHcccCHHHHHH
Confidence 45567889999999999987 789999999999999999999988775321 122222111111111
Q ss_pred -------ccccccccCCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1030 -------CEFFTAGLWDC-----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1030 -------~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+.-+..... .-+.....+..++..|++.||++|++-+|++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00100111110 11233457899999999999999999988864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=356.24 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=214.5
Q ss_pred HHHHHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCC
Q 045553 793 YENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 793 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 870 (1082)
.++.....+.+.+.+.||+|.||+||+|+|. ..||||++.... .+..+.|+.|+.++++-+|.||+-+.|||....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3444445556678899999999999999996 479999997654 356788999999999999999999999999887
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
. .+|..+++|.+|+.++|.. +..++..+.+.||.|||+||.|||.+ +|||||||..||++.+++.|||+|||++.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred e-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 7 9999999999999999987 46799999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCC-CCccccCcccCCCcccchhccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 951 LLGTS-ETHATTDVAGTFGYVAPEYAMT---CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 951 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
....- .........|...|||||+++. .+|++.+||||||+|+|||++|..||.... . .+.+. ++..
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~-------dqIif-mVGr 607 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-R-------DQIIF-MVGR 607 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-h-------hheEE-Eecc
Confidence 54321 1122334568889999999975 368899999999999999999999997211 1 11111 1111
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
|-. +.|.. .....+++++.+|+..||..++++||.+.+|+.+|+++.+
T Consensus 608 G~l--~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 GYL--MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccc--Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 110 11110 1123567899999999999999999999999999988766
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=352.33 Aligned_cols=250 Identities=23% Similarity=0.418 Sum_probs=217.1
Q ss_pred cCccccceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
..|+..++||+|+.|.||.| +..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 35777789999999999999 56678999999998877777778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
+||+|.+.+... .+++.++..|+.++++||+|||.. +|+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 999999999864 599999999999999999999999 999999999999999999999999999998765544 4
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....+||+.|||||+.....|+.|.||||||+|++||+-|.+||-. +...+-+..+...|.+ +.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln--------E~PlrAlyLIa~ng~P-~l------- 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN--------ENPLRALYLIATNGTP-KL------- 489 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--------CChHHHHHHHhhcCCC-Cc-------
Confidence 5668899999999999999999999999999999999999999862 2233333444334322 11
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..++..+..+.+++.+|++.|+++||++.|++++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2345567789999999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=335.75 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=216.5
Q ss_pred cCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..|++.+.||.|..++||+|. ...+..||||++..++. ...+.+.+|+..++.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 468999999999999999994 66789999999987654 3468899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
|.+||+.+.+.......+++..+..|.+++++||.|||++ |.||||||+.|||++.+|.|||+|||.+..+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999988778899999999999999999999999 9999999999999999999999999998766443322
Q ss_pred c---ccCcccCCCcccchhcc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 959 A---TTDVAGTFGYVAPEYAM--TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 959 ~---~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
. ....+||+.|||||+++ -..|+.|+||||||+...|+.+|..||... ...+..-..+ ++.++...
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~--------pPmkvLl~tL-qn~pp~~~ 253 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY--------PPMKVLLLTL-QNDPPTLL 253 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC--------ChHHHHHHHh-cCCCCCcc
Confidence 1 14568999999999954 357999999999999999999999999732 2233333333 33343332
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...+..+........+.+++..|+..||++|||++++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 2222222223445689999999999999999999998753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.51 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=210.6
Q ss_pred HHhcCccccceecccCceEEEEE-EEcCCeEEEEEEeecC---ccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeE
Q 045553 798 RATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 872 (1082)
+...+|.+.+.||+|+|++|++| +..+++.+|||++.+. +....+-+.+|-++|.++ .||.|++++..|+++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34567999999999999999999 4567999999998643 223344567888899999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
|+|+||+++|+|.++++.. ..+++...+.++.+|+.|++|||+. |||||||||+|||+|+|++++|+|||.|+.+
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999985 5799999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCc------------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHH
Q 045553 953 GTSETH------------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 953 ~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 1020 (1082)
...... ....++||..|.+||++.....+..+|+|+|||++|+|+.|++||..... + ...
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------y-liF 296 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-------Y-LIF 296 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-------H-HHH
Confidence 532111 12458999999999999999999999999999999999999999974321 1 111
Q ss_pred HHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1021 SMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1021 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.++. +.-..|+..++.+.+|+.+.+..||.+|++..||.++
T Consensus 297 qkI~~-----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QKIQA-----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHH-----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11111 0112344555788999999999999999999988765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.75 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=216.5
Q ss_pred cCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|.+.+.||+|+||.||||+ ..+.+.||+|.+.+..+ ++.+.+.+|++++++++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 468888999999999999995 55689999999965543 446678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+.| +|..++.. ...++++.+..|+.+++.||.|||+. +|.|||+||.||+++..+.+|+||||+|+.+.. ..
T Consensus 82 ~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9965 99999988 56799999999999999999999999 999999999999999999999999999998865 34
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
...+...||+.|||||+..++.|+..+|+||+||++|||++|++||. ...+.+.++.+..+.-
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~--------a~si~~Lv~~I~~d~v--------- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY--------ARSITQLVKSILKDPV--------- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch--------HHHHHHHHHHHhcCCC---------
Confidence 45667889999999999999999999999999999999999999997 3356666666655431
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+|......+..++...+..||..|-+-.+++.+
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1345677889999999999999999998877643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.14 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=208.4
Q ss_pred cCccccceecccCceEEEEE-EEcCCeEEEEEEeecCcccc--HHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.+|...+++|+|.||.||+| ...+|+.||||+++.....+ .....+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35777889999999999999 46679999999998764432 3456899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
||+ .+|+..+++. ...++...+..++.++++|++|+|++ .|+||||||.|+|++++|.+||+|||+|+.++....
T Consensus 82 fm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 995 6999999886 56799999999999999999999999 999999999999999999999999999999976655
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC--ccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP--CEFFT 1034 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~d 1034 (1082)
..... +-|..|+|||.+.| +.|+...||||.||++.||+-|.+-|.+. -++.|.....-.-|.+ ..+-+
T Consensus 157 ~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-------sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 157 IQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-------SDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred ccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-------chHHHHHHHHHHcCCCCcccCcc
Confidence 44333 67999999999887 56999999999999999999998666432 2233333322222211 11111
Q ss_pred ccc-------C-------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGL-------W-------DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l-------~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
-.- + ...=..+...+.+++..++..+|.+|.++.|++++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 100 0 00012345667999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.31 Aligned_cols=268 Identities=28% Similarity=0.458 Sum_probs=208.5
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHh--ccCCCceeeEeeeeccCC----eEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLG--RVQHPNLVTLIGYHVSEA----EMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~l 874 (1082)
...+..++||+|.||.||||.+. ++.||||++.. +..+.|+.|-++.+ .++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34566788999999999999887 69999999874 44566777777665 458999999999876555 8999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC------VPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
|+||.+.|+|.+||..+ .++|....+|+..+++||+|||+.. +|+|+|||||++|||+..|+++.|+|||+
T Consensus 286 Vt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999965 7999999999999999999999764 47899999999999999999999999999
Q ss_pred ceecCCCCCc-cccCcccCCCcccchhcccCC-CC-----chhhHHHHHHHHHHHHhCCCCCCCC--------cc-CCCC
Q 045553 949 ARLLGTSETH-ATTDVAGTFGYVAPEYAMTCR-VS-----DKADVYSFGVVLLELISDKKALDPS--------FC-SFGN 1012 (1082)
Q Consensus 949 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~slGvll~elltg~~p~~~~--------~~-~~~~ 1012 (1082)
|..+...... .....+||.+|||||++.+.. .. .+.||||+|.|+|||+++..-+++. |. ..+.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9988654432 223368999999999998643 22 3689999999999999987655421 11 1122
Q ss_pred CccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1013 GFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...+.+.-..++++...+.+-|.-.. ...+..+.+.+..||+.||+.|-|+.=|.+.+.++..
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 33444444444444444433332221 2446779999999999999999999888888777654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=352.30 Aligned_cols=261 Identities=24% Similarity=0.379 Sum_probs=207.6
Q ss_pred hcCccccceecccCceEEEEEEE------cCCeEEEEEEeecCcc-ccHHHHHHHHHHHhcc-CCCceeeEeeeeccC-C
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI------IPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE-A 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 870 (1082)
.++|++.++||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45799999999999999999963 2356899999875432 3346788999999999 899999999988764 4
Q ss_pred eEEEEEeecCCCCHHHHHhhCC----------------------------------------------------------
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP---------------------------------------------------------- 892 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 892 (1082)
..++||||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999997532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc-cccCcccCCCc
Q 045553 893 --RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGY 969 (1082)
Q Consensus 893 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y 969 (1082)
...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 13478889999999999999999999 9999999999999999999999999999865432221 22234567889
Q ss_pred ccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHH
Q 045553 970 VAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIE 1048 (1082)
Q Consensus 970 ~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 1048 (1082)
+|||++.+..++.++|||||||++|||++ |..||...... .........+... ..+...+..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~~~~---------~~~~~~~~~ 305 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--------EEFCQRLKDGTRM---------RAPENATPE 305 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--------HHHHHHHhcCCCC---------CCCCCCCHH
Confidence 99999999999999999999999999997 99998642111 1111222222211 112334567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1049 MLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1049 l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
+.+++.+||+.+|++||++.||++.|+++...
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 89999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.68 Aligned_cols=260 Identities=27% Similarity=0.372 Sum_probs=208.4
Q ss_pred cCccccceecccCceEEEEE-EEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 875 (1082)
..|+..++||+|+||.||+| +..+|+.||+|++.... ........+|+.+++++.||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 34677789999999999999 56789999999997664 34456678999999999999999999988876 689999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
+|||+ -+|.-++... .-.+++.++..++.|++.||.|+|+. +|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 197 FeYMd-hDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eeccc-chhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99995 5898888754 56799999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc-
Q 045553 956 ETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF- 1033 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1033 (1082)
.....+..+-|..|+|||.+.+ ..|+.+.|+||.|||+.||++|++.|.... .+.|.-.....-|.+.+..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t-------EveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT-------EVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc-------HHHHHHHHHHHhCCCChhcc
Confidence 7666788889999999999987 579999999999999999999999886432 1122111111111111100
Q ss_pred ---ccc----cC--CCCC-------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1034 ---TAG----LW--DCGP-------HDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1034 ---d~~----l~--~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
+-. +. ..+. ...+....+|+..++..||++|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000 00 0111 122456788999999999999999998875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.33 Aligned_cols=240 Identities=28% Similarity=0.411 Sum_probs=206.3
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCHH
Q 045553 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLE 885 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 885 (1082)
.+-||.|+.|.||+|++. ++.||||+++.- -..+++.+++++||||+.+.|+|....-+||||||+..|-|+
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 456999999999999987 789999986532 245788999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCccc
Q 045553 886 KFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965 (1082)
Q Consensus 886 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 965 (1082)
.+|+. ++.++......|..+||.||.|||.+ .|||||||+-||||..+..+||+|||.++..... ..+..++|
T Consensus 201 ~VLka--~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 201 EVLKA--GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred HHHhc--cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 99998 56788899999999999999999999 9999999999999999999999999999876543 34566899
Q ss_pred CCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHH
Q 045553 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDD 1045 (1082)
Q Consensus 966 t~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1045 (1082)
|..|||||++.+...++|.||||||||+|||+||..||...... ..++ | +=...+.-..|..+
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--------AIIw-----G----VGsNsL~LpvPstc 336 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--------AIIW-----G----VGSNSLHLPVPSTC 336 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--------eeEE-----e----ccCCcccccCcccC
Confidence 99999999999999999999999999999999999998743211 0000 0 01112233457788
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1046 LIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1046 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
++.++-|++.||+..|..||+|.+++.+|+-.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 89999999999999999999999999999744
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.64 Aligned_cols=248 Identities=28% Similarity=0.416 Sum_probs=209.0
Q ss_pred HhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecC----cc-ccHHHHHHHHHHHhccC-CCceeeEeeeeccCCe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG----RF-QGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 871 (1082)
..++|.+.+.||+|+||+|+.|. ..++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45689999999999999999994 556899999977553 11 23456778999999999 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-CcEEEeecccce
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-LNAYLSDFGLAR 950 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~ 950 (1082)
.++||||+.+|+|.+++.. ..++.+..+.+++.|++.|++|+|+. +|+||||||+||+++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999998 45788899999999999999999999 99999999999999999 999999999999
Q ss_pred ecCCCCCccccCcccCCCcccchhcccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTCR-VS-DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
... .......+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.. +....... +..+.
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--------~~~~l~~k-i~~~~ 239 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--------NVPNLYRK-IRKGE 239 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--------cHHHHHHH-HhcCC
Confidence 874 2334556679999999999999977 75 7899999999999999999999842 22222222 22222
Q ss_pred CccccccccCCCCChHH-HHHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDD-LIEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
. ..|... +.++..++.+|+..+|.+|+++.||.
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1 122333 67899999999999999999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.83 Aligned_cols=236 Identities=26% Similarity=0.394 Sum_probs=202.5
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccc---cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.+|+..+.||.|+||+|.+++. .+|..+|+|++...... ..+....|..+++.+.||.++++++.+.+....|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4688889999999999999964 46899999999876543 3455678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||++||.|.++++. .+++++..++.+|.||+.|++|||+. +|++||+||+|||+|++|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 99999999999998 45799999999999999999999999 999999999999999999999999999998643
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
...+.+||+.|+|||+++++.+..++|.|||||++|||+.|..||....+ .+.. ..+.++++
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY-~KI~~~~v------- 258 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIY-EKILEGKV------- 258 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHH-HHHHhCcc-------
Confidence 24567999999999999999999999999999999999999999974321 2222 22223322
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCC
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSR 1064 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~R 1064 (1082)
.+|..-..++..|+...++.|-.+|
T Consensus 259 ---~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ---KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2455556688899999999999888
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.80 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=211.7
Q ss_pred CccccceecccCceEEEEEEEcC--C--eE-EEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIP--G--VV-VAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
+....++||+|+||.||+|++.. + .. ||||..+.. ......+|..|++++++++|||||+++|++..+..++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34455899999999999996553 2 23 899998852 3466788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+|||++.||+|.++|+..+. .++..++..++.+.|+||+|||++ +++||||.++|+|++.++.+||+|||+++.-.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999998743 799999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
..........-...|+|||.+....++.++|||||||++||+++ |..||.+. ...+....+...+...
T Consensus 314 -~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--------~~~~v~~kI~~~~~r~-- 382 (474)
T KOG0194|consen 314 -QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--------KNYEVKAKIVKNGYRM-- 382 (474)
T ss_pred -ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--------CHHHHHHHHHhcCccC--
Confidence 11111111134579999999999999999999999999999998 78888643 3334333333433222
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
..+...+.++..++.+||..+|++||+|.++.+.++.+...
T Consensus 383 -------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 383 -------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred -------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 23446677899999999999999999999999999987654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=342.86 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=212.8
Q ss_pred cCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
+-|+..+.||.|+.|.|-.|+ ..+|+.+|||++..... .....+.+|+-+|+-+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 458899999999999999995 56799999999976521 22456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|-|.+++-.+ ..+++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|.... .
T Consensus 92 Eyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--P 164 (786)
T ss_pred EecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--C
Confidence 999999999999874 5789999999999999999999999 99999999999999999999999999998643 3
Q ss_pred CccccCcccCCCcccchhcccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVS-DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.....+.+|+++|.|||++.+..|. .++||||+|||+|.|++|+.||+ ++++...... ++.|.+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--------DdNir~LLlK-V~~G~f------ 229 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--------DDNIRVLLLK-VQRGVF------ 229 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--------CccHHHHHHH-HHcCcc------
Confidence 3345567999999999999998875 68999999999999999999998 2344443333 333322
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.|...+.+++.|+.+|+..||++|-|+.||.++
T Consensus 230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2466777899999999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.40 Aligned_cols=246 Identities=17% Similarity=0.285 Sum_probs=203.4
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEeecCcccc---HHHHHHHHHHHhccCCCceeeEeeeecc----CCeEEEEEeec
Q 045553 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIGYHVS----EAEMFLIYNYL 879 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~ 879 (1082)
..||+|++|.||+|.. +|+.||||++....... .+.|.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999987 58999999997654333 4678899999999999999999999876 35789999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++|+|.++++.. ..+++....+++.|++.|++|||+.. +++||||||+||++++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 999999999874 46889999999999999999999842 78899999999999999999999999998654322
Q ss_pred ccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 960 TTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||... ...++.......+...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~--------~~~~~~~~i~~~~~~~------- 241 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--------TTKEIYDLIINKNNSL------- 241 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhcCCCC-------
Confidence 22457899999999976 68999999999999999999999999732 2233333333222111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+...+..+.+++.+||+.||++|||+.||++.|+.++
T Consensus 242 --~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 --KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 122244568999999999999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=334.88 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=204.4
Q ss_pred HhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
..++|++.+.||+|+||.||+|+ ..+|..+|+|++++... ...+.+..|-++|....+|.||+++..|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 55679999999999999999995 55799999999987643 445667889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||++||++..+|.. ...++++.+..++.+++-|+..+|+. |+|||||||+|+|||..|++|++|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999987 45799999999999999999999999 999999999999999999999999999853211
Q ss_pred ----------------------CC-C-----c------------------cccCcccCCCcccchhcccCCCCchhhHHH
Q 045553 955 ----------------------SE-T-----H------------------ATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988 (1082)
Q Consensus 955 ----------------------~~-~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 988 (1082)
.+ . . .....+|||.|+|||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00 0 0 011356999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCC--
Q 045553 989 FGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS-- 1066 (1082)
Q Consensus 989 lGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-- 1066 (1082)
+|||+|||+.|.+||....+. +....+..|..... . ........++.++|.+|+. ||++|--
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~l~-------f-------P~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQ-ETYRKIVNWRETLK-------F-------PEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhhhcc-------C-------CCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999754332 11112222221111 1 1112334689999999999 9999974
Q ss_pred -HHHHHH
Q 045553 1067 -MRQVAQ 1072 (1082)
Q Consensus 1067 -~~ev~~ 1072 (1082)
+.||.+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 555543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=368.26 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=213.8
Q ss_pred CccccceecccCceEEEEEEEcC--C----eEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIP--G----VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~--~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
..+..+.||+|.||.||.|...+ | ..||||.+... +.++..+|.+|..+|+.++|||||+++|++.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34566789999999999996543 3 34899988654 45667889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 875 IYNYLPGGNLEKFIQDRP-----RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
++|||++|+|..|+++.+ ...++....+.++.|||+|+.||+++ ++|||||..+|+|+++...|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999999753 45688999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCc-ccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 950 RLLGTSETHATTDV-AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
+.+...+.+..... .-...|||||.+..+.++.|+|||||||++||++| |..||.. .+-.+.+..+..++
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~--------~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS--------RSNFEVLLDVLEGG 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC--------cchHHHHHHHHhCC
Confidence 95544443333222 33468999999999999999999999999999998 5555542 12233444444444
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
+-+.|..++..+.++|..||+.+|++||++..|++.+..+.+
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 224577889999999999999999999999999998887653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=303.56 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=213.3
Q ss_pred hcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|-||.||.|+ .+++..||+|++.+.. ....+++.+|+++-+.++||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3568999999999999999995 5568899999986543 24457889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
+||..+|++...+++.+...+++.....+..|+|.|+.|+|.. +|+||||||+|+|++.++..||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999999999988788899999999999999999999999 99999999999999999999999999997643
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.....+.+||..|.+||+..+..++...|+|++|++.||++.|.+||..... .+..+.+.. .+.
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~k----~~~--- 239 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIRK----VDL--- 239 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHHH----ccc---
Confidence 3345668999999999999999999999999999999999999999974221 111111111 011
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..|...+..+.++|.+|+..+|.+|.+..||+++
T Consensus 240 ----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ----KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2344556789999999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=304.44 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=214.5
Q ss_pred hcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccC-----CeEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-----AEMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 873 (1082)
.++|++.+.+|+|||+-||.++ ..+++.+|+|++.....++.+...+|++..++++|||+++++++...+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4579999999999999999995 677899999999988888889999999999999999999999987643 3589
Q ss_pred EEEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 874 LIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
++++|...|+|.+.+.... +..+++.+++.|+.++++||++||+. .|+++||||||.||++.+++.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999998643 55799999999999999999999998 34699999999999999999999999999976
Q ss_pred cCCCCCc--------cccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHH
Q 045553 952 LGTSETH--------ATTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 952 ~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 1020 (1082)
..-.-.. ....-..|..|+|||.+. +...++++|||||||++|+|+.|..||+.....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------- 247 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------- 247 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence 5321111 111234788999999885 567899999999999999999999999854432
Q ss_pred HHHHhcCCCc--cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1021 SMLLLQGRPC--EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1021 ~~~~~~~~~~--~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
|... .+....+.-+-....++.+.+++.+|++.||.+||++.+++..+..+.
T Consensus 248 ------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 2111 111112211122346789999999999999999999999999988764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=321.32 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=212.9
Q ss_pred hcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..+|++.+.||+|.||.|-+|. ...|+.||||.++.... ++.-.+.+|+++|+.++||||+.++.+|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3468899999999999999994 57799999999976544 4455688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||..+|.|++|+..+ +.+++.+++.+++||.+|+.|+|.+ +++|||+|.+|||+|.++++||+|||++-.+...
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999984 5799999999999999999999999 9999999999999999999999999999887533
Q ss_pred CCccccCcccCCCcccchhcccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVS-DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
...++++|++-|.+||...+..|. +..|-||+||++|-++.|..||+. .+....++++. .|.+.+
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG--------~Dhk~lvrQIs-~GaYrE--- 272 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG--------RDHKRLVRQIS-RGAYRE--- 272 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC--------chHHHHHHHhh-cccccC---
Confidence 345678999999999999998874 689999999999999999999983 34444444432 222211
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
+..+....-+|++|+..+|++|.|+.+|..+.
T Consensus 273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 --------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 23345677899999999999999999998764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.29 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=214.1
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
....+.++||+|-||+|..++...+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345678999999999999999887899999999876544 4588999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc-
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH- 958 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 958 (1082)
++|+|.+|+..+......-....+|+.|||.||+||.+. .+||||+.++|+|+|.++++||+|||+++-+-..+.+
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999987444445566778999999999999999 9999999999999999999999999999966544444
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI--SDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ell--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....+-..+|||||.+..++++.++|||+||+.+||++ +...||.... -.+.++. ..++++..
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--------~e~vven------~~~~~~~~ 760 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--------DEQVVEN------AGEFFRDQ 760 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--------HHHHHHh------hhhhcCCC
Confidence 333455678999999999999999999999999999975 4667775321 1122221 12222222
Q ss_pred cC---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1037 LW---DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1037 l~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
-. ...|.-++.++.+++.+||..+.++||+++++...|.+.
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 124567788999999999999999999999999988764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.11 Aligned_cols=255 Identities=21% Similarity=0.334 Sum_probs=207.2
Q ss_pred cCccccceecccCceEEEEEEEc----CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.+|++.+.||+|+||.||+|.+. .+..||+|.++.... .....|.+|+..+++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999653 357899999876532 3345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999865 34689999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.........++..|+|||++.+..++.++|||||||++||+++ |+.||.... ..+..... .++...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--------~~~~~~~~-~~~~~~---- 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--------GQDVIKAV-EDGFRL---- 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHH-HCCCCC----
Confidence 2222222345678999999999999999999999999999775 999986321 12222222 222111
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+.+++.+||+.+|++||++.||.+.|+++
T Consensus 228 -----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 12334566899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.28 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=211.8
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35688999999999999999988888899999986543 33578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.++++......+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999876566789999999999999999999999 99999999999999999999999999998765433222
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||+..+..++.++|||||||++|||++ |+.||.... ..+.... ...+...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~-~~~~~~~-------- 223 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--------NSDVMSA-LQRGYRM-------- 223 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--------HHHHHHH-HHcCCCC--------
Confidence 233446778999999998889999999999999999998 888885321 1111122 1222111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
......+.++.+++.+|++.+|++||++.++.+.|+++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11123346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=355.82 Aligned_cols=473 Identities=27% Similarity=0.377 Sum_probs=360.1
Q ss_pred ccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCC
Q 045553 102 LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQS 181 (1082)
Q Consensus 102 l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 181 (1082)
+.+.+.+|..|.+|++.+|++. .+|.+++.+..++.|+.++|+++ ++|++++.+.+|+.|+.++|.+. .+|+.++.+
T Consensus 60 l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~ 136 (565)
T KOG0472|consen 60 LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRL 136 (565)
T ss_pred ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHH
Confidence 4566899999999999999999 89999999999999999999999 99999999999999999999999 788899999
Q ss_pred CCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEe
Q 045553 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLD 261 (1082)
Q Consensus 182 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 261 (1082)
-.|+.|+..+|+++ ++|+.++ ++.+|..|++.+|+++.. |+..-+++.|++||+.+|.++ .+|..++.+.+|+.|+
T Consensus 137 ~~l~dl~~~~N~i~-slp~~~~-~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~Ly 212 (565)
T KOG0472|consen 137 LDLEDLDATNNQIS-SLPEDMV-NLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLY 212 (565)
T ss_pred hhhhhhhccccccc-cCchHHH-HHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHH
Confidence 99999999999999 8898887 589999999999999954 444445999999999999998 7999999999999999
Q ss_pred CCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCcccc-CCCCCcEEEcCCCcc
Q 045553 262 LSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSIT-RLPNLRVFWAPNLNL 340 (1082)
Q Consensus 262 Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~-~l~~L~~L~l~~n~l 340 (1082)
|.+|+|. .+| .|..+..|++|+++.|++.. +|.+.. ++++|..|++.+|++
T Consensus 213 L~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~--------------------------lpae~~~~L~~l~vLDLRdNkl 264 (565)
T KOG0472|consen 213 LRRNKIR-FLP-EFPGCSLLKELHVGENQIEM--------------------------LPAEHLKHLNSLLVLDLRDNKL 264 (565)
T ss_pred hhhcccc-cCC-CCCccHHHHHHHhcccHHHh--------------------------hHHHHhcccccceeeecccccc
Confidence 9999998 677 89999999999999877653 445544 899999999999999
Q ss_pred cCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcc------cCcccEEEecCCcceec
Q 045553 341 EGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS------VPCMAVFNVSQNLLSGE 414 (1082)
Q Consensus 341 ~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------l~~L~~L~l~~N~l~~~ 414 (1082)
.. .|+.+..+.+|++||+|+|.|+ .+|.+++++ .|+.|-+.||++...-.+.+. +..|+. .+..-.++..
T Consensus 265 ke-~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs-~~~~dglS~s 340 (565)
T KOG0472|consen 265 KE-VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS-KIKDDGLSQS 340 (565)
T ss_pred cc-CchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH-hhccCCCCCC
Confidence 87 4788888999999999999999 789999999 899999999999754333322 222222 0001111100
Q ss_pred CCCCCCccccccc-ccccccce-eeeeecccccccccccCcCC--CCCCCCCceeEeeccCCcccCCCCCccccCCCccc
Q 045553 415 IPRISHSECSKMS-VNWSMSQV-DLIGFYTAFFYENALTSCAP--FSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSS 490 (1082)
Q Consensus 415 ~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~ 490 (1082)
+- ..-+.++ .+|+..+. ..+.-.++...+.+++.++. +..-...++...+++.|++
T Consensus 341 --e~--~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL---------------- 400 (565)
T KOG0472|consen 341 --EG--GTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQL---------------- 400 (565)
T ss_pred --cc--cccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchH----------------
Confidence 00 0000000 01110000 00000111111111111111 1111222333344444443
Q ss_pred cccceeeeccCCCccccCCcccccccCCceeEE-EccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCC
Q 045553 491 RPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIF-DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSL 569 (1082)
Q Consensus 491 ~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l-~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L 569 (1082)
.++|..+..+.++++. ++++|.+ +-+|..+. .+++|..|+|++|-+. .+|..++.+..|
T Consensus 401 -----------------~elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~-~l~kLt~L~L~NN~Ln-~LP~e~~~lv~L 460 (565)
T KOG0472|consen 401 -----------------CELPKRLVELKELVTDLVLSNNKI-SFVPLELS-QLQKLTFLDLSNNLLN-DLPEEMGSLVRL 460 (565)
T ss_pred -----------------hhhhhhhHHHHHHHHHHHhhcCcc-ccchHHHH-hhhcceeeecccchhh-hcchhhhhhhhh
Confidence 3555555555554444 4455544 35555554 5577999999999888 557888889899
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCc
Q 045553 570 RNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHN 649 (1082)
Q Consensus 570 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 649 (1082)
++||++.|++. .+|..+..+..|+.+-.++|++..+.|..+.+|.+|.+|||.+|.|. .+|+.++++++|++|+|++|
T Consensus 461 q~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gN 538 (565)
T KOG0472|consen 461 QTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGN 538 (565)
T ss_pred heecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCC
Confidence 99999999999 88999888888998888999999777777999999999999999999 88999999999999999999
Q ss_pred ccCCCCC
Q 045553 650 NLTGRIP 656 (1082)
Q Consensus 650 ~l~~~~p 656 (1082)
+|+ .++
T Consensus 539 pfr-~Pr 544 (565)
T KOG0472|consen 539 PFR-QPR 544 (565)
T ss_pred ccC-CCH
Confidence 999 444
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=351.70 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=216.5
Q ss_pred cCccccceecccCceEEEEEEEcCC-eEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeec-c------CCe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPG-VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHV-S------EAE 871 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-~------~~~ 871 (1082)
.+++|.++|.+|||+.||.|....+ ..||+|++...+..+.+.+.+|+++|+.++ |+|||.+++... . ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4577889999999999999977666 999999998888888899999999999997 999999999322 1 257
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
++|.||||++|+|-+++..+....+++.++++|+.|+++|+++||.. .|+|||||||-+|||++.++..||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 89999999999999999987777799999999999999999999996 67899999999999999999999999999874
Q ss_pred cCCCC-Cc-------cccCcccCCCcccchhc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHH
Q 045553 952 LGTSE-TH-------ATTDVAGTFGYVAPEYA---MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 952 ~~~~~-~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 1020 (1082)
.-... .. ..-....|+-|+|||++ .+..+++|+|||||||+||-|+.+..||+..-
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------- 262 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------- 262 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------
Confidence 32211 11 01123478999999987 46789999999999999999999999997431
Q ss_pred HHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1021 SMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1021 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
...++.....-.....+...+..||+.|++++|++||++-+|...+.+++..
T Consensus 263 --------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 --------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1233333333333357889999999999999999999999999999887654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.31 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=209.5
Q ss_pred cCccccceecccCceEEEEE-EEcCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..|...+.||+|.||.||+| ...+++.||+|++..... .+.+.+++|+.++.+.+++||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999 455789999999987643 4567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+.||++.+.++.. ..+.+..+.-|++++..|+.|+|.+ +.+|||||+.||++..+|.+|++|||.+..+......
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999874 3458888889999999999999999 9999999999999999999999999999887655444
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
. .+++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+- .++-. +.+. .-|.+.
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------rvlfl-Ipk~-----~PP~L~ 232 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------RVLFL-IPKS-----APPRLD 232 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------eEEEe-ccCC-----CCCccc
Confidence 4 6789999999999999889999999999999999999999998754321 00000 0001 011111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+++++..|++.+|+.||++.+++++
T Consensus 233 ----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 ----GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2456679999999999999999999999864
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=326.14 Aligned_cols=252 Identities=22% Similarity=0.406 Sum_probs=207.1
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.+|++.+.||+|+||.||+|++.++..+|+|.+.... ...+++.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3578889999999999999998888899999886443 335678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+|+|.++++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999998643 3589999999999999999999999 999999999999999999999999999986543333222
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+...........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--------~~~~~~~~i~~~~~~---------- 220 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--------SNYEVVEMISRGFRL---------- 220 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHCCCCC----------
Confidence 33345678999999998889999999999999999999 88888632 122222332222111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
..+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 012223457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.55 Aligned_cols=265 Identities=25% Similarity=0.342 Sum_probs=202.1
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhc--cCCCceeeEeeeeccC----CeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR--VQHPNLVTLIGYHVSE----AEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~l 874 (1082)
.+..+.+.||+|.||.||+|+|. |+.||||++...+ .+.+.+|.++.+. ++|+||+.+++.-..+ .+.||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34678899999999999999998 9999999997543 3456666666654 5999999999976543 46899
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE-----CVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
|.+|.+.|||++||.. ..++-+...+++..+|.||+|||.. .+|.|.|||||++|||+.+++.+.|+|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999999986 4789999999999999999999954 4689999999999999999999999999999
Q ss_pred eecCCCCCc---cccCcccCCCcccchhcccCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCCccCC
Q 045553 950 RLLGTSETH---ATTDVAGTFGYVAPEYAMTCR------VSDKADVYSFGVVLLELISD----------KKALDPSFCSF 1010 (1082)
Q Consensus 950 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGvll~elltg----------~~p~~~~~~~~ 1010 (1082)
......... .....+||.+|||||++...- .-..+||||||.|+||+.-+ +.||++.-+.
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~- 442 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS- 442 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC-
Confidence 877544321 334578999999999986421 12368999999999998642 3555533222
Q ss_pred CCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1011 GNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
+.++.+ ++.++--.+....+.++. ...+....+.++|+.||..+|..|-|+--|.+.|.++.+
T Consensus 443 --DPs~ee-MrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 --DPSFEE-MRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred --CCCHHH-HhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 122222 111111111111111111 234677889999999999999999999999999988763
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=329.33 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=210.8
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.+|.+.+.||+|+||.||+|... .++.||+|++... ....+++.+|++.+++++|||++++++++..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35788899999999999999654 5889999998754 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.......+++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999876566789999999999999999999999 99999999999999999999999999998765433322
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||++.+..++.++|||||||++|||++ |..||... ...++.... ..+. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--------~~~~~~~~~-~~~~---------~ 223 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVYELL-EKGY---------R 223 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHH-HCCC---------C
Confidence 223345678999999999999999999999999999998 88887532 122222222 1111 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
...+...+.++.+++.+|++.+|++||++.++.++|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112334456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=328.58 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=211.6
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++|||++++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688999999999999999987778899999987543 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.......+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999999876556789999999999999999999999 99999999999999999999999999998775332222
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
......+..|+|||+..+..++.++||||||+++|||++ |+.||.... ..+..... .....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~-~~~~~--------- 222 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--------NAEVLQQV-DQGYR--------- 222 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHH-HcCCC---------
Confidence 222334568999999999999999999999999999999 888886321 11111111 11111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
...+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 012234456899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=328.99 Aligned_cols=249 Identities=32% Similarity=0.552 Sum_probs=200.0
Q ss_pred ccceecccCceEEEEEEEc-----CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 805 VQNCIGSGGFGATYKAEII-----PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 805 ~~~~lg~G~~g~Vy~a~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+.+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999877 368899999965432 3478899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC-
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET- 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 957 (1082)
+++|+|.++++......+++..+..|+.|+++||+|||+. +++||||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987567899999999999999999999999 999999999999999999999999999987732222
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.......+...|+|||.+.+..++.++||||||+++||+++ |+.||... ...++.... .++...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~-~~~~~~------ 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKL-KQGQRL------ 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHH-HTTEET------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccc-cccccc------
Confidence 22333457789999999999999999999999999999999 67777522 333444443 332221
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
..+...+..+.+++.+||+.+|++||+|.+|++.|
T Consensus 225 ---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12234456899999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=331.41 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=204.6
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.|++.+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|++++++++|++++++.+++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999964 5789999999865422 233457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888765455789999999999999999999999 99999999999999999999999999998754322
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ....-+.......
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~---------- 220 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKED---------- 220 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhcc----------
Confidence 223457899999999999999999999999999999999999999743211 1111111111111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 1073 (1082)
....+...+..+.+++.+|++.+|++||+ +.|+.++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 01123344568899999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=333.10 Aligned_cols=262 Identities=23% Similarity=0.411 Sum_probs=205.5
Q ss_pred cCccccceecccCceEEEEEEEcC-----------------CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP-----------------GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTL 862 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 862 (1082)
++|++.++||+|+||.||+|.+.+ +..||+|.+.... .....+|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999996532 3479999987543 2345678999999999999999999
Q ss_pred eeeeccCCeEEEEEeecCCCCHHHHHhhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 045553 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRP-----------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925 (1082)
Q Consensus 863 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 925 (1082)
++++.+.+..++||||+++|+|.+++.... ...+++..+.+++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999986532 13478889999999999999999999 9999
Q ss_pred ccCCCCCEEEcCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh--CCCC
Q 045553 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS--DKKA 1002 (1082)
Q Consensus 926 ~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt--g~~p 1002 (1082)
|||||+||+++.++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999866433322 2223456789999999998899999999999999999987 4456
Q ss_pred CCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1003 LDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1003 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
|.... .......+............ ...+...+..+.+++.+||+.+|++||++.||.+.|++
T Consensus 242 ~~~~~-----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT-----DEQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC-----HHHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 64321 12222322222222111110 01123445689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=343.37 Aligned_cols=258 Identities=23% Similarity=0.397 Sum_probs=206.0
Q ss_pred hcCccccceecccCceEEEEEEE------cCCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI------IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 871 (1082)
.++|++.+.||+|+||.||+|.+ .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34689999999999999999963 235689999986443 23456788999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------------------------------------------
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP----------------------------------------------------------- 892 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 892 (1082)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999997532
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 893 --------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 893 --------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
...+++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478899999999999999999999 9999999999999999999999999999876433222
Q ss_pred c-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 959 A-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 959 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .....+ .+..+...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~----~~~~~~----~~~~~~~~------ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV----DSKFYK----MIKEGYRM------ 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc----hHHHHH----HHHhCccC------
Confidence 1 122345678999999999999999999999999999998 8888863211 111111 22222111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+.++.+++.+|++.+|++||+|.||+++|++.
T Consensus 337 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11222345799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=330.48 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=215.6
Q ss_pred HhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
...+|++.++||.|+||.||+|...++..+|+|.+.........++.+|+++++.++|+|++++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568899999999999999998888999999999876665677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.++++......+++..+.+++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999876667789999999999999999999999 9999999999999999999999999999876432222
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
.....++..|+|||+..+..++.++||||||+++|+|++ |+.||.... ..+.........
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~---------- 221 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITAGY---------- 221 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHHhCC----------
Confidence 223446778999999998899999999999999999998 888886321 122222222111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
....+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1112234456889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=339.62 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=204.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 874 (1082)
..+|.+.++||+|.||+|++|+.+ +++.+|||++++.. .++.+..+.|.+++... +||.++.++.++.+.++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 457999999999999999999654 58899999998764 35567777888887766 59999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+.||++..+.+ ...+++..+.-+|..++.||+|||++ +|||||||.+|||+|.+|.+||+|||+++.--
T Consensus 447 vmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred EEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC-
Confidence 999999999555444 45799999999999999999999999 99999999999999999999999999998642
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.....+.+++||+.|+|||++.+..|+.+.|.|||||++|||+.|..||.++.. .+....++.++
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------ee~FdsI~~d~------- 584 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------EEVFDSIVNDE------- 584 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCC-------
Confidence 223356779999999999999999999999999999999999999999974321 12222222111
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
-.||...+.+...|+++++..+|++|--+
T Consensus 585 ----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 13677888999999999999999999865
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=345.52 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=206.2
Q ss_pred hcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 871 (1082)
.++|++.+.||+|+||.||+|... ++..||||++.... ....+.+.+|+++++.+ +|+||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457899999999999999998632 23579999997543 23356688999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------------------------------------------
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP----------------------------------------------------------- 892 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 892 (1082)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986421
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc-cccC
Q 045553 893 ---------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTD 962 (1082)
Q Consensus 893 ---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~ 962 (1082)
...+++.++.+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 12478899999999999999999999 9999999999999999999999999999865433221 1122
Q ss_pred cccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 963 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
..++..|+|||++.+..++.++|||||||++|||++ |+.||...... . .. ......+. ....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----~---~~-~~~~~~~~---------~~~~ 336 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----S---KF-YKMVKRGY---------QMSR 336 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----H---HH-HHHHHccc---------CccC
Confidence 345678999999999999999999999999999997 99998643211 1 11 11111111 0011
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
+...+.++.+++.+||+.+|++||++.+|+++|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2223468999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=339.46 Aligned_cols=295 Identities=22% Similarity=0.187 Sum_probs=237.0
Q ss_pred cCCCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccc
Q 045553 91 NSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQF 170 (1082)
Q Consensus 91 ~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 170 (1082)
.+.+.|+++..-+..|.++++|+.++|..|.++ .+|...+...+|+.|+|.+|.|+..-.+++..++.|+.||||.|.|
T Consensus 83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~i 161 (873)
T KOG4194|consen 83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLI 161 (873)
T ss_pred eeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchh
Confidence 456778999988999999999999999999999 8998777888999999999999988888999999999999999999
Q ss_pred ccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCcc
Q 045553 171 NGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSS 250 (1082)
Q Consensus 171 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 250 (1082)
+...-..|..-.++++|+|++|+|+ .+...-+.++.+|..|.|+.|+|+...+..|.++++|+.|+|..|+|.-..--.
T Consensus 162 s~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt 240 (873)
T KOG4194|consen 162 SEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT 240 (873)
T ss_pred hcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence 9655578888899999999999999 676666678999999999999999666678888999999999999998544678
Q ss_pred ccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCC
Q 045553 251 FGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNL 330 (1082)
Q Consensus 251 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L 330 (1082)
|.+|++|+.|.|..|.|...-..+|..+.++++|+|..|.+. ..--.++.+|+.|
T Consensus 241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~-------------------------~vn~g~lfgLt~L 295 (873)
T KOG4194|consen 241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ-------------------------AVNEGWLFGLTSL 295 (873)
T ss_pred hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh-------------------------hhhcccccccchh
Confidence 999999999999999999887888888888888888765433 2233566677777
Q ss_pred cEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-ccCcccEEEecCC
Q 045553 331 RVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFNVSQN 409 (1082)
Q Consensus 331 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~~L~l~~N 409 (1082)
+.|++++|.|..+.++.|+.+++|++|+|++|+|+...+.+|..+.+|++|+|++|.|+......+ .+.+|+.|||++|
T Consensus 296 ~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N 375 (873)
T KOG4194|consen 296 EQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSN 375 (873)
T ss_pred hhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCC
Confidence 777777777777777777777777777777777776666666667777777777777665444333 3445555555555
Q ss_pred cce
Q 045553 410 LLS 412 (1082)
Q Consensus 410 ~l~ 412 (1082)
.|+
T Consensus 376 ~ls 378 (873)
T KOG4194|consen 376 ELS 378 (873)
T ss_pred eEE
Confidence 444
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=332.17 Aligned_cols=245 Identities=23% Similarity=0.330 Sum_probs=203.5
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999654 689999999865422 33456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999999864 4689999999999999999999999 9999999999999999999999999999865322
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||... ............ ..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~-~~------- 215 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD--------NPFGIYEKILAG-KL------- 215 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhC-Cc-------
Confidence 22346899999999999999999999999999999999999999632 122222222221 11
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 1073 (1082)
..+......+.+++.+|++.||.+||+ +.|++++
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 122233457899999999999999995 7887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.27 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=206.8
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.+|++.+.||+|+||.||+|+..++..||+|.+.... ...+++.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3578889999999999999988777789999987543 335678999999999999999999999999889999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.+++.... ..+++..++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.++..........
T Consensus 83 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999998753 3689999999999999999999999 999999999999999999999999999986644332222
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....++..|+|||+..+..++.++||||||+++|||++ |+.||.... ......... .+...
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~~--------- 220 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--------NSETVEKVS-QGLRL--------- 220 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHh-cCCCC---------
Confidence 23345678999999998889999999999999999998 998886321 112222222 22111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112223568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.77 Aligned_cols=253 Identities=27% Similarity=0.455 Sum_probs=208.5
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46889999999999999999888888999999875443 3567899999999999999999999875 456899999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.++++......+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||.+..+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999876556789999999999999999999999 999999999999999999999999999987654333222
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....++..|+|||+..+..++.++||||||+++|||++ |+.||... ...+...... .+.. .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~~---------~ 222 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--------NNREVLEQVE-RGYR---------M 222 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHH-cCCC---------C
Confidence 33345678999999998899999999999999999999 88888632 1122222221 1111 1
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
..+...+..+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223445689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.50 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=224.0
Q ss_pred HHhcCccccceecccCceEEEEEEEcC-CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
....+....++||-|.||.||.|.|+. .-.||||.++.+ ....++|..|..+|+.++|||+|+++|+|..+...|||.
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 333456677999999999999999875 567999998755 355789999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
|||..|+|.+|++...+..++.--.+.+|.||+.||.||..+ .+|||||..+|+|+.++..+||+|||+++++..+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 999999999999998888888888999999999999999999 99999999999999999999999999999987655
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
........-...|.|||-+....++.|+|||+|||++||+.| |..||. +.++.++... ++.
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP--------GidlSqVY~L----------LEk 481 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP--------GIDLSQVYGL----------LEK 481 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC--------CccHHHHHHH----------Hhc
Confidence 555555556778999999999999999999999999999988 556664 3444443322 233
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
..+-+.|+.++..+.+||+.||+++|.+||+++|+-+.++.+-..
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 334456778889999999999999999999999999999876543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.43 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=208.9
Q ss_pred cCccccceecccCceEEEEEEEcC------CeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP------GVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
.+|++.+.||+|+||.||+|.... ...||+|.+..... .....|.+|++.+++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999996542 26799999865432 33567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC
Q 045553 874 LIYNYLPGGNLEKFIQDRPR--------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL 939 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 939 (1082)
++|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999976421 4688999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHH
Q 045553 940 NAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 940 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~ 1017 (1082)
.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.... ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--------~~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--------NQ 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence 999999999986543322 22233456789999999998899999999999999999998 999986421 11
Q ss_pred HHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
+.... +..+... ..+...+.++.+++.+||+.+|++||+++||+++|+.+
T Consensus 234 ~~~~~-i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 EVIEM-IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHH-HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 22222 2222111 12345567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=337.40 Aligned_cols=260 Identities=22% Similarity=0.371 Sum_probs=208.9
Q ss_pred hcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccC-CCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 871 (1082)
..+|.+.++||+|+||.||+|+.. .+..||||++..... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457889999999999999999642 235799999965433 33467899999999996 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------------------------------------------
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP----------------------------------------------------------- 892 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 892 (1082)
.++||||+++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999987531
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC
Q 045553 893 -----------------------------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN 937 (1082)
Q Consensus 893 -----------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 937 (1082)
...+++..+..++.|+++|++|||+. +|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12478888999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCcc
Q 045553 938 NLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFN 1015 (1082)
Q Consensus 938 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~ 1015 (1082)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------ 346 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------ 346 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------
Confidence 999999999999876433221 2223456788999999999899999999999999999997 88888642111
Q ss_pred HHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1016 IVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.........+... ..+...+..+.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 347 --~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 --STFYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111222222111 1223445689999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=339.92 Aligned_cols=262 Identities=23% Similarity=0.257 Sum_probs=200.2
Q ss_pred hcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..+|++.+.||+|+||.||+|. ..+++.||+|+.. .+.+.+|++++++++||||+++++++......++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3579999999999999999995 4568999999753 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+ +++|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 165 ~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 Y-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9 57898888763 4688999999999999999999999 9999999999999999999999999999754333323
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc------
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF------ 1032 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 1032 (1082)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.......+......+........+.....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 33456799999999999999999999999999999999999988754321111111111111110000100000
Q ss_pred --c-------------ccccCCC--CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 --F-------------TAGLWDC--GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 --~-------------d~~l~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+ .+..+.. .....+.++.+++.+|++.||++|||+.|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 0000000 001235678999999999999999999999853
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.27 Aligned_cols=262 Identities=25% Similarity=0.337 Sum_probs=205.9
Q ss_pred HhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcccc--HHHHHHHHHHHhccCCCceeeEeeeecc--CCeEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEMF 873 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 873 (1082)
..+.|+..+.|++|+||.||+|+ ..+++.||+|+++...... .-...+|+.++.+.+|||||.+..+... -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 34568889999999999999995 5578999999997654211 1235799999999999999999987764 46799
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||++ .+|..+++.. .+++...++..++.|+++|++|||.. .|+|||||++|+|+...|.+||+|||+|+.++
T Consensus 154 ~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999995 5999999987 47899999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.+. ...+..+-|..|+|||.+.+ ..|+.+.||||+|||+.||+++++-|.... .+.+.-+....-|.+.+.
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-------E~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-------EIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-------hHHHHHHHHHHhCCCccc
Confidence 653 34556678999999999987 569999999999999999999998886432 222222222222322222
Q ss_pred cccccC-------------------CCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLW-------------------DCGPHD-DLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~-------------------~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+-+.+. ...+.. ..+.-.+++...+.+||.+|-|+.|.+++
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 222211 111111 23667889999999999999999998754
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=322.35 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=207.9
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.++||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 356999999999999999999877777899999875432 34678999999999999999999998754 5679999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++|+|.++++......+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.++|+|||.++.+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999875556689999999999999999999999 99999999999999999999999999998765443322
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||+..+..++.++||||||+++|||++ |..||.... ..+.... ...+...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--------~~~~~~~-~~~~~~~-------- 222 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQ-VERGYRM-------- 222 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------hHHHHHH-HhcCCCC--------
Confidence 233456778999999998899999999999999999999 777775321 1111111 1111100
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11234556789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=326.99 Aligned_cols=264 Identities=20% Similarity=0.251 Sum_probs=203.4
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999765 57899999987542 2334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|++++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9988777655433 34689999999999999999999999 999999999999999999999999999987654333
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHH-----------HHHHHHhc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVA-----------WASMLLLQ 1026 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~ 1026 (1082)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ..... +.......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI----DQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhhCCCCHHHHHhhhcc
Confidence 3334467899999999999989999999999999999999999999642110 00000 00000000
Q ss_pred CCCccccccccCC------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1027 GRPCEFFTAGLWD------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
........+.... ......+..+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000 0111235679999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=327.90 Aligned_cols=260 Identities=23% Similarity=0.407 Sum_probs=212.4
Q ss_pred cCccccceecccCceEEEEEEEc------CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++.+++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999642 356799999876665566789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc
Q 045553 875 IYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN 940 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 940 (1082)
||||+++++|.+++.... ...+++..+++++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999997642 23489999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHH
Q 045553 941 AYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVA 1018 (1082)
Q Consensus 941 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 1018 (1082)
++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------~~~ 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--------NTE 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHH
Confidence 99999999976543322 12233456788999999999999999999999999999999 999986321 111
Q ss_pred HHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1019 WASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1019 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
... ....+...+ .+...+..+.+++.+|++.+|++||++.+|+++|+++.++.
T Consensus 234 ~~~-~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 234 VIE-CITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HHH-HHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 111 122222211 12234567999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=323.20 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=208.2
Q ss_pred cCccccceecccCceEEEEEEEcC----CeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|++.+.||+|+||.||+|.+.. ...||||.+..... .....|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999997642 46899999875433 3456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++.+...
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999998753 3789999999999999999999999 9999999999999999999999999999877522
Q ss_pred CC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 956 ET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 956 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+..... ..+...
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~~~--- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVIKAV-EDGYRL--- 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHHHHH-HcCCCC---
Confidence 22 12222345678999999999899999999999999999998 988885321 11222221 121111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+.+++.+|++.+|++||++.||+++|+++
T Consensus 228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11234456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=329.98 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=204.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57999999999999999999654 68899999987643 23356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++... ..+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 85 MDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 9999999999864 46899999999999999999999862 6999999999999999999999999999765332
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC--cc-----
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP--CE----- 1031 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----- 1031 (1082)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+..........+.. ..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-----KELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhcccccccccCCccccCcc
Confidence 22345689999999999999999999999999999999999999963211 1111110000000000 00
Q ss_pred -----------------------ccc---cccCCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1032 -----------------------FFT---AGLWDC-GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1032 -----------------------~~d---~~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
..+ ...... .......++.+++.+||+.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000 000000 0112356799999999999999999999998763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.87 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=204.3
Q ss_pred CccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 478889999999999999988777889999986433 2345788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
++|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++...........
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999998653 3689999999999999999999999 9999999999999999999999999999866433222222
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDC 1040 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 1040 (1082)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||+... ..+..... ..+. ...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~---------~~~ 221 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--------NSEVVESV-SAGY---------RLY 221 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC--------HHHHHHHH-HcCC---------cCC
Confidence 2234568999999999899999999999999999999 788886321 11111111 1111 111
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1041 GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1041 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
.+...+.++.+++.+|++.+|++||+|.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2233466899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=334.40 Aligned_cols=242 Identities=22% Similarity=0.287 Sum_probs=199.0
Q ss_pred ceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 807 NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 468999999987542 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccC
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 962 (1082)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence 999999863 4689999999999999999999999 9999999999999999999999999998753221 122334
Q ss_pred cccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCC
Q 045553 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042 (1082)
Q Consensus 963 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 1042 (1082)
..|++.|+|||++.+..++.++||||+||++|||++|+.||... +.......... +.. ..+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--------~~~~~~~~~~~-~~~----------~~p 215 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILM-EEI----------RFP 215 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC--------CHHHHHHHHHc-CCC----------CCC
Confidence 57999999999999999999999999999999999999999632 11222222211 111 123
Q ss_pred hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1043 HDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1043 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
.....++.+++.+|++.||++|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 34456789999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.48 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=205.7
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999765 58999999997542 234566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999763 4688999999999999999999999 999999999999999999999999999976543
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......|++.|+|||++.+..++.++||||+||++|||++|+.||.... ..+........... +...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~---~~~~ 220 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST--------PNETWENLKYWKET---LQRP 220 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC--------HHHHHHHHHhcccc---ccCC
Confidence 2234579999999999999999999999999999999999999997421 11221221111110 1100
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.........+.++.+++.+|++.+|++||++.|++++
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000012345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=335.06 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=203.4
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56899999999999999999764 58999999987532 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999999874 4688999999999999999999999 99999999999999999999999999998764322
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
....|++.|+|||++.+..++.++|||||||++|||++|+.||... ...+..... ..+..
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~i-~~~~~------- 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--------TPFRIYEKI-LAGRL------- 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC--------CHHHHHHHH-hcCCc-------
Confidence 2357899999999999999999999999999999999999999632 112222222 22211
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 1073 (1082)
..+.....++.+++.+|++.||++||+ +.+++.+
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112233457889999999999999996 6777644
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=321.35 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=209.6
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.+.|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 356889999999999999999888899999999875443 3567899999999999999999999874 45789999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.......+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999999876666789999999999999999999999 99999999999999999999999999998765333322
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||++.+..++.++||||||+++||+++ |+.||.... ..+..... ..+...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~-~~~~~~-------- 222 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--------NPEVIQNL-ERGYRM-------- 222 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--------hHHHHHHH-HcCCCC--------
Confidence 333456778999999998889999999999999999998 999986321 11222221 111111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
..+...+.++.+++.+|++.+|++||++.++...|+.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=311.58 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=205.8
Q ss_pred HhcCccccceecccCceEEEEEE-EcCCeEEEEEEee--cCccccHHHHHHHHHHHhccCCCceeeEeeeecc-----CC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLS--VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-----EA 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 870 (1082)
....|...+.||+|+||.|+.|. ..+|+.||||++. .......++..+|+++++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566667899999999999994 5579999999997 4455567788999999999999999999998865 35
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..|+|+|+| +.+|...++.. +.++.+.+..++.|+++||.|+|+. +|+|||+||+|++++.+...||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 689999999 67999999873 4599999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCC-CCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH-hcC
Q 045553 951 LLGTS-ETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL-LQG 1027 (1082)
Q Consensus 951 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 1027 (1082)
..... ....++.++.|..|+|||.+.. ..|+.+.||||.||++.||++|+.-|.+... .+-+..+. .-|
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--------v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--------VHQLQLILELLG 245 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--------HHHHHHHHHhcC
Confidence 87543 2234567888999999998864 6899999999999999999999998865321 11111111 111
Q ss_pred CCccccccccCC-----------CC---C-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1028 RPCEFFTAGLWD-----------CG---P-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1028 ~~~~~~d~~l~~-----------~~---~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+.+..-..+.+ .. + +.......+++.+|+..||.+|+|+.|.+++
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111110001100 00 0 2345678899999999999999999999865
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.00 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=217.3
Q ss_pred cCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccc--cHHHHHHHHHHHhccCCCceeeEeeeeccCCe-EEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE-MFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 876 (1082)
++|...+++|+|+||.++.++ ..+++.+++|++...... ..+....|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578899999999999999985 445789999999765432 33457889999999999999999999999888 99999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
+|++||++.+.+...++..++++++.+++.|++.|+.|||+. +|+|||||+.||+++.+..|||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999988778899999999999999999999998 99999999999999999999999999999987665
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
. ...+++||+.|+.||.+.+.+|..|+||||+||++|||++-+++|... +....+..+....
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~--------~m~~Li~ki~~~~--------- 222 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS--------NMSELILKINRGL--------- 222 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc--------chHHHHHHHhhcc---------
Confidence 3 345578999999999999999999999999999999999999999743 2333333332221
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....|..+..++..++..|++.+|+.||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123456777899999999999999999999999876
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=344.97 Aligned_cols=250 Identities=23% Similarity=0.280 Sum_probs=205.9
Q ss_pred CccccceecccCceEEEEEEEc-C-CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-P-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.|.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+++++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999543 4 6788999876555555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 880 PGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 880 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
++|+|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988653 234688999999999999999999999 999999999999999999999999999987653322
Q ss_pred -ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 958 -HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 958 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.+...... ...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~--------~~~~~~~~~~~~-~~~------ 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP--------SQREIMQQVLYG-KYD------ 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhC-CCC------
Confidence 2234457999999999999999999999999999999999999999632 222333332221 111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+...+.++.+++.+|++.+|++||++.+++.
T Consensus 290 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 ---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112234567999999999999999999999865
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=318.21 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=206.6
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
++|.+.+.||+|+||.||+|....+..||+|++.... ...+.+.+|++++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4588899999999999999988777789999876543 33467889999999999999999999875 456889999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.++++......+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999876556689999999999999999999999 999999999999999999999999999987644332222
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....++..|+|||+..+..++.++||||||+++|||++ |+.||.... ..+..... ..+...
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~-~~~~~~--------- 222 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--------NREVLEQV-ERGYRM--------- 222 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-HcCCCC---------
Confidence 23446778999999998899999999999999999999 888886321 11111111 111111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
..+...+..+.+++.+|++.+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223445689999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=325.42 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=210.7
Q ss_pred hcCccccceecccCceEEEEEEE------cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI------IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
..+|.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|||++++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35688899999999999999964 234679999987665556678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEE
Q 045553 874 LIYNYLPGGNLEKFIQDRP-----------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY 942 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 942 (1082)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999997542 23589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHH
Q 045553 943 LSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 943 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1020 (1082)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.... .....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--------~~~~~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVI 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH
Confidence 9999999865432221 1222345778999999999899999999999999999998 888886322 11222
Q ss_pred HHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1021 SMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1021 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.. +..+.... .+...+.++.+++.+|++.+|.+||++.||.+.|+++..
T Consensus 233 ~~-i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 233 EC-ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HH-HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 22 22222111 112234579999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=334.02 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=206.6
Q ss_pred cCccccceecccCceEEEEEEEc------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhcc-CCCceeeEeeeecc-CCe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVS-EAE 871 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~~ 871 (1082)
.+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|+++++++ +|+||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 47999999999999999999532 347899999875432 3345678899999999 89999999998764 457
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------------------------------------------
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP----------------------------------------------------------- 892 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 892 (1082)
.+++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999986432
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc-cccCcccCCCccc
Q 045553 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVA 971 (1082)
Q Consensus 893 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~a 971 (1082)
...+++..+.+++.||+.|++|||+. +|+||||||+||+++.++.++|+|||+++.+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 12689999999999999999999999 9999999999999999999999999999876433222 2223456778999
Q ss_pred chhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHH
Q 045553 972 PEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEML 1050 (1082)
Q Consensus 972 PE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 1050 (1082)
||++.+..++.++|||||||++|||++ |..||...... +........+... ..+.....++.
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~---------~~~~~~~~~~~ 306 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTRM---------RAPEYATPEIY 306 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCCC---------CCCccCCHHHH
Confidence 999999999999999999999999998 99998642111 1111222222111 11223456799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1051 NLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1051 ~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
+++.+|++.+|++||++.||+++|+++...
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=324.78 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=208.1
Q ss_pred cCccccceecccCceEEEEEEEc------CCeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
.+|.+.+.||+|+||.||+|... ++..||||.+...... ..+.+.+|++++++++|+|++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46888999999999999999653 3478999998765443 4578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcE
Q 045553 874 LIYNYLPGGNLEKFIQDRP------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 941 (1082)
+||||+++++|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997642 24578999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHH
Q 045553 942 YLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--------~~~~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--------NEEV 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHH
Confidence 99999999865332221 1223346788999999999999999999999999999998 999986321 1122
Q ss_pred HHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1020 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
.... ..+... ..+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 234 ~~~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECI-TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHH-HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 2222 122111 1122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=322.72 Aligned_cols=265 Identities=29% Similarity=0.415 Sum_probs=206.4
Q ss_pred cCccccceecccCceEEEEEEEc-----CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeecc--CCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-----PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 873 (1082)
.+|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++|||++++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999642 578999999887666667789999999999999999999997653 35689
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999999764 34589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcc--ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCC----CCC---ccHHHHHHHHH
Q 045553 954 TSETHA--TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSF----GNG---FNIVAWASMLL 1024 (1082)
Q Consensus 954 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~----~~~---~~~~~~~~~~~ 1024 (1082)
...... .....++..|+|||+..+..++.++||||||+++|||++|..++......+ +.. ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 332211 111234456999999998899999999999999999999887654221000 000 00000111111
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+ .....+...+.++.+++.+||+.+|++|||+.||++.|+.++
T Consensus 240 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 240 KNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 111 111122344568999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=332.92 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=203.0
Q ss_pred hcCccccceecccCceEEEEEEEcC--CeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP--GVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+++++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3469999999999999999996543 3689999986432 2345668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999874 4689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....... +..+..
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--------~~~~~~~-i~~~~~----- 245 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--------PLLIYQK-ILEGII----- 245 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC--------HHHHHHH-HhcCCC-----
Confidence 2 234579999999999999889999999999999999999999996321 1111112 222211
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
..|......+.+++.+|++.+|++|+ +++|+.++
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 12233445788999999999999995 88888764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=314.00 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=202.1
Q ss_pred HHhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc--------------ccHHHHHHHHHHHhccCCCceeeE
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF--------------QGVQQFAAEIRTLGRVQHPNLVTL 862 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l 862 (1082)
...++|++.+.||+|.||.|-+|+ ..+++.||||++..... ...+...+|+.+++++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 356789999999999999999995 55789999999964321 123578899999999999999999
Q ss_pred eeeeccC--CeEEEEEeecCCCCHHHHHhhCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC
Q 045553 863 IGYHVSE--AEMFLIYNYLPGGNLEKFIQDRPRRT-VEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL 939 (1082)
Q Consensus 863 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 939 (1082)
+++..+. +..|+|+||+..|.+...=. ... +++.+++++++++..||+|||.+ +||||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 9998764 67899999998887744322 233 89999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCC----ccccCcccCCCcccchhcccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCccCCC
Q 045553 940 NAYLSDFGLARLLGTSET----HATTDVAGTFGYVAPEYAMTCR----VSDKADVYSFGVVLLELISDKKALDPSFCSFG 1011 (1082)
Q Consensus 940 ~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGvll~elltg~~p~~~~~~~~~ 1011 (1082)
++||+|||.+..+..... ......+||+.|+|||...++. .+.+.||||+||.+|.|+.|+.||...+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---- 323 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---- 323 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----
Confidence 999999999987733221 1223368999999999987632 3568999999999999999999997432
Q ss_pred CCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1012 NGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
.......++.+ .+.-....+..+.+..|+.+++++||+.|.+..+|..+..
T Consensus 324 ----~~~l~~KIvn~---------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 324 ----ELELFDKIVND---------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ----HHHHHHHHhcC---------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 22222222211 1111122345678999999999999999999999987653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=330.12 Aligned_cols=239 Identities=25% Similarity=0.339 Sum_probs=196.3
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999654 57899999986432 23456678899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcc
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 964 (1082)
.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 9999763 4689999999999999999999999 99999999999999999999999999997543222 2233457
Q ss_pred cCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChH
Q 045553 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHD 1044 (1082)
Q Consensus 965 gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1044 (1082)
||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+......... . ..+..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~--------~~~~~~~~~~~~~-~----------~~~~~ 215 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE--------NVNEMYRKILQEP-L----------RFPDG 215 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC--------CHHHHHHHHHcCC-C----------CCCCc
Confidence 999999999999999999999999999999999999999632 2233333332211 0 12233
Q ss_pred HHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 045553 1045 DLIEMLNLAIMCTGESLSSRPS---MRQVAQ 1072 (1082)
Q Consensus 1045 ~~~~l~~li~~cl~~~p~~RPt---~~ev~~ 1072 (1082)
...++.+++.+|++.+|++||+ +.|++.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 4567899999999999999985 455544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=318.84 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=211.4
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|.+.+.||+|+||.||+|...++..||||.+.... ...+++.+|+.++++++|+|++++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 45789999999999999999988778899999987543 34577899999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.......+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.+.......
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999886666799999999999999999999999 99999999999999999999999999998765432222
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||.+.+..++.++||||+|+++||+++ |+.||.... .............
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~~~~~~~---------- 222 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREVLEQVERGYR---------- 222 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCC----------
Confidence 223345678999999999899999999999999999998 898885321 1122222211110
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
...+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01122335689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=323.63 Aligned_cols=267 Identities=26% Similarity=0.363 Sum_probs=205.5
Q ss_pred ccccceecccCceEEEEEEE-----cCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEEE
Q 045553 803 FNVQNCIGSGGFGATYKAEI-----IPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMFL 874 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 874 (1082)
|++.+.||+|+||+||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988642 3578899999875432 3456788999999999999999999987653 45899
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999763 589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 955 SETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 955 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.... ......++..|+|||...+..++.++||||||+++|||++|+.|+........ ....+...........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE---EMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh---hhhcccccccchhhhhhh
Confidence 3221 11223456679999999988999999999999999999999999864321110 000000000000011111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.+.......+...+.++.+++.+|++.+|++||++++|++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1222222233445678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.45 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=197.6
Q ss_pred cCccccceecccCceEEEEEEEc--CCeEEEEEEeecCcc--ccHHHHHHHHHHHhcc---CCCceeeEeeeec-----c
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII--PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRV---QHPNLVTLIGYHV-----S 868 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~ 868 (1082)
.+|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999652 468899999865432 2234556677776665 6999999999875 2
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 869 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
....++||||++ ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 6999999876666789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
++..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.... .......+........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~-----~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVIGLPG 229 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC-----HHHHHHHHHHHhCCCC
Confidence 9876433 22334568999999999998899999999999999999999999997431 1111111111110000
Q ss_pred Ccc----------ccccccCC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1029 PCE----------FFTAGLWD---CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1029 ~~~----------~~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+ .+...... .........+.+++.+|++.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 000123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=316.49 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=211.3
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+++++.++|||++++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4789999999999999999965 468999999876432 233456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 877 NYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 34578999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
... ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||... ......+..... ......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~------~~~~~~~~~~~~-~~~~~~--- 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLFSLCQKIE-QCDYPP--- 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc------cccHHHHHHHHh-cCCCCC---
Confidence 322 222346888999999999888999999999999999999999998632 122233333221 111111
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+...+..+.+++.+||+.+|++||++.||++.+++++
T Consensus 228 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 -----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 112234567999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=329.43 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=205.6
Q ss_pred cCccccceecccCceEEEEEEEc-CCe----EEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGV----VVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|++.+.||+|+||.||+|.+. ++. .||+|++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999754 333 48999986543 34456788999999999999999999998764 5789
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
|+||+++|+|.++++.. ...+++..+.+++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999999875 34688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 955 SETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 955 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||+.. ...++ ......+...
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~--------~~~~~-~~~~~~~~~~-- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEI-SSILEKGERL-- 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------CHHHH-HHHHhCCCCC--
Confidence 33221 122334678999999999999999999999999999998 99998632 11222 1222222111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+......+.+++.+||+.+|++||++.+++..+..+..
T Consensus 231 -------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1122344678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.88 Aligned_cols=258 Identities=25% Similarity=0.340 Sum_probs=197.6
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCC-----eEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA-----EMFLI 875 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lV 875 (1082)
.|...+++|.|+||.||+|... ++..||||+.-..... -.+|+++|+.+.|||||+++.+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667799999999999999654 4799999998654332 257999999999999999999886432 24679
Q ss_pred EeecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-CcEEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-LNAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~~ 952 (1082)
||||+ .+|.++++.. ....++.-.+.-+..||++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99995 5999999853 245678888889999999999999998 99999999999999976 89999999999988
Q ss_pred CCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH-------
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL------- 1024 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 1024 (1082)
...+.. ..+..|..|+|||.+.+ ..|+.+.||||.|||+.||+.|+.-|.+.. ....++..++..-
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s----~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS----SVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC----HHHHHHHHHHHhCCCCHHHH
Confidence 665544 45678999999999987 579999999999999999999998886432 1122222222110
Q ss_pred --hcCCCccccccccCCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 --LQGRPCEFFTAGLWDC-----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 --~~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+.-.+.+... .......+..+++.+++.++|.+|.++.|++++
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0011111111222211 123456789999999999999999999998753
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=323.33 Aligned_cols=255 Identities=25% Similarity=0.418 Sum_probs=205.5
Q ss_pred cCccccceecccCceEEEEEEE-----cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-----IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
..|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999964 246789999987533 2334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC
Q 045553 875 IYNYLPGGNLEKFIQDRP---------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL 939 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 939 (1082)
||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999986432 23578899999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHH
Q 045553 940 NAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 940 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~ 1017 (1082)
.+||+|||+++....... .......++..|+|||+..+..++.++||||||+++|||++ |..||... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~--------~~~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF--------SNQ 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------CHH
Confidence 999999999986543322 22233446778999999998889999999999999999998 88888532 111
Q ss_pred HHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
.... ........ ..+...+.++.+++.+|++.+|++||++.+|.++|+.
T Consensus 234 ~~~~-~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIE-MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH-HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2222 22222111 1223345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=329.63 Aligned_cols=242 Identities=23% Similarity=0.285 Sum_probs=198.0
Q ss_pred ceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 807 NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
+.||+|+||.||+|+. .+|..||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999964 468999999997542 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccC
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 962 (1082)
+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 999988763 4689999999999999999999999 99999999999999999999999999987532221 22234
Q ss_pred cccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCC
Q 045553 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042 (1082)
Q Consensus 963 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 1042 (1082)
..|++.|+|||++.+..++.++|||||||++|||++|+.||.... ............ . ..+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~~~~~~-~----------~~p 215 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE-I----------RFP 215 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCC-C----------CCC
Confidence 579999999999999999999999999999999999999996321 112222221111 0 122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1043 HDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1043 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
.....++.+++.+|++.+|++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 34456889999999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.29 Aligned_cols=262 Identities=20% Similarity=0.293 Sum_probs=200.6
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.++||+|+||.||+|... ++..||+|+++.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46899999999999999999654 689999999865432 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 96 5999998765 34578999999999999999999999 999999999999999999999999999976543222
Q ss_pred cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC----------
Q 045553 959 ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG---------- 1027 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 1027 (1082)
......|++.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+.......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-----EELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhcccc
Confidence 2233468999999999865 56899999999999999999999999643211 1111111111000
Q ss_pred --CCccccccccCCC----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1028 --RPCEFFTAGLWDC----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1028 --~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......+..... .......++.+++.+|++.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000 011234578899999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.09 Aligned_cols=257 Identities=20% Similarity=0.359 Sum_probs=205.6
Q ss_pred HhcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
..++|++.+.||+|+||.||+|... ++..||+|++.... .....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998643 25679999986432 2345678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEE
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP--------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL 943 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 943 (1082)
.++||||+++++|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999997632 12467889999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHH
Q 045553 944 SDFGLARLLGTSETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||... .......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--------~~~~~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--------SNEQVLR 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHH
Confidence 9999997654332211 122345778999999999899999999999999999999 67787532 1122222
Q ss_pred HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1022 MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
... .+.... .+...+..+.+++.+|++.+|++||++.|++++|++
T Consensus 233 ~~~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVM-EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHH-cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 222 221111 122345679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=330.92 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=202.1
Q ss_pred CccccceecccCceEEEEEEE----cCCeEEEEEEeecCc----cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI----IPGVVVAVKRLSVGR----FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 872 (1082)
+|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++.+ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999864 357899999986432 22345678899999999 489999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999999763 4689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
............||..|+|||++.+. .++.++|||||||++|||++|+.||...... .......... ....
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~-~~~~--- 227 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRRI-LKCD--- 227 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHHH-hcCC---
Confidence 44433334456799999999999865 4788999999999999999999999643211 1112222221 1111
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
+ ..+......+.+++.+|++.||++|| ++.+++++
T Consensus 228 ---~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 ---P----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---C----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1 12233456789999999999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=334.02 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=205.6
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+. .+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688999999999999999965 4689999999975422 34566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999875 34689999999999999999999999 99999999999999999999999999998775444
Q ss_pred CccccCcccCCCcccchhcc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 957 THATTDVAGTFGYVAPEYAM------TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
........||+.|+|||++. ...++.++|||||||++|||++|+.||... ................
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--------~~~~~~~~i~~~~~~~ 228 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG--------TSAKTYNNIMNFQRFL 228 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC--------CHHHHHHHHHcCCCcc
Confidence 33333457899999999986 456788999999999999999999999632 1222333322221111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ......+..+.+++..|++ +|++||++.+++++
T Consensus 229 ~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11 1112345678899999998 99999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=295.98 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=208.4
Q ss_pred HhcCccccceecccCceEEEEE-EEcCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++.|++.+.||+|.|+.||+. ...+|+.+|+|++... ...+.+++.+|+++-+.++||||+++...+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567889999999999999998 5667999999988543 234678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc---CCCcEEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~~ 952 (1082)
+|+|.|++|..-+-.+ ..+++..+-..+.||++++.|.|.. +|||||+||+|+++. ....+|++|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999997666543 4578888999999999999999999 999999999999995 3457999999999988
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
+ .......++||++|||||+....+|+..+|||+.||++|-++.|..||.... -....+.+ ..+.+.
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye~I-~~g~yd-- 230 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYEQI-KAGAYD-- 230 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHHHH-hccccC--
Confidence 7 4456677899999999999999999999999999999999999999997421 11222222 222211
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
++++.+ ....++...++++|+..||.+|.|+.|.+.+
T Consensus 231 ~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 YPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 222222 2445688999999999999999999887653
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=327.15 Aligned_cols=199 Identities=26% Similarity=0.470 Sum_probs=174.8
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.++||+|+||.||+|... ++..+|+|.+..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999765 588899998875432 334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++... ..+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999999864 45889999999999999999999752 7999999999999999999999999998765322
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDP 1005 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~ 1005 (1082)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234689999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.71 Aligned_cols=251 Identities=20% Similarity=0.315 Sum_probs=200.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999654 57899999997542 23345677888888776 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|..++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 9999988763 4689999999999999999999999 99999999999999999999999999987532221 1223
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+..............++...+..... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CC
Confidence 45799999999999999999999999999999999999999964322211222333444443333221 12
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPS------MRQVAQQ 1073 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt------~~ev~~~ 1073 (1082)
|......+.+++.+|++.||++||+ +.+++++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 3344567889999999999999998 5666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=329.39 Aligned_cols=242 Identities=21% Similarity=0.301 Sum_probs=199.0
Q ss_pred ceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 807 NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999964 468999999997542 234567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccC
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 962 (1082)
+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccc
Confidence 999998763 4689999999999999999999999 9999999999999999999999999998754222 122334
Q ss_pred cccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCC
Q 045553 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042 (1082)
Q Consensus 963 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 1042 (1082)
..|++.|+|||++.+..++.++|||||||++|||++|+.||... ...+......... . ..+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~--------~~~~~~~~~~~~~-~----------~~p 215 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILMED-I----------KFP 215 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC--------CHHHHHHHhccCC-c----------cCC
Confidence 57999999999999999999999999999999999999999632 1122222221111 0 122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1043 HDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1043 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
.....++.+++.+|++.+|++|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 33456789999999999999997 88988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=335.85 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=204.7
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457999999999999999999654 68899999986432 2334557889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999999753 478889999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccCcccCCCcccchhcccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTC----RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||... ................
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~~~~~ 266 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSKIMDHKNSL 266 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC--------CHHHHHHHHHcCCCcC
Confidence 333233456799999999998653 4788999999999999999999999732 2222222222211111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS--RPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 1073 (1082)
.. ......+.++.+++.+|++.+|++ ||++.|++++
T Consensus 267 ~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11 111234568899999999999998 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.34 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=201.6
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCHH
Q 045553 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLE 885 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 885 (1082)
++||+|+||.||+|...++..||+|.+..... .....+.+|++++++++|||++++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999888889999999875432 23456889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCccc
Q 045553 886 KFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965 (1082)
Q Consensus 886 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 965 (1082)
+++... ...+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++...............+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 998765 34678999999999999999999999 99999999999999999999999999997654322222222345
Q ss_pred CCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChH
Q 045553 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHD 1044 (1082)
Q Consensus 966 t~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1044 (1082)
+..|+|||+..+..++.++||||||+++||+++ |..||.... .... ......+... ..+..
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--------~~~~-~~~~~~~~~~---------~~~~~ 218 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT--------NQQA-REQVEKGYRM---------SCPQK 218 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--------HHHH-HHHHHcCCCC---------CCCCC
Confidence 678999999998899999999999999999998 888986321 1111 1122222111 12233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1045 DLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1045 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
.+..+.+++.+|++.+|++||++.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=342.75 Aligned_cols=255 Identities=26% Similarity=0.316 Sum_probs=207.4
Q ss_pred HHhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCC----
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA---- 870 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 870 (1082)
....+|++.+.||+|+||+||+|+ ..+|+.||||++.... ......+.+|+..+..++|+|++++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345789999999999999999996 4568999999986543 234566889999999999999999988665332
Q ss_pred ----eEEEEEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEe
Q 045553 871 ----EMFLIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS 944 (1082)
Q Consensus 871 ----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 944 (1082)
..++||||+++|+|.++++.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999997542 35689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH
Q 045553 945 DFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML 1023 (1082)
Q Consensus 945 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1023 (1082)
|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... .....+...
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------~~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEEVMHKT 257 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHH
Confidence 9999987643222 2233467999999999999999999999999999999999999999632 233333333
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... ... ..+...+.++.+++.+|++.+|++||++.+++++
T Consensus 258 ~~~-~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAG-RYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcC-CCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 221 111 1233445689999999999999999999999764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.66 Aligned_cols=254 Identities=24% Similarity=0.425 Sum_probs=208.9
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++.+++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45789999999999999999987778889999887542 345678899999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.......+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999876566789999999999999999999998 99999999999999999999999999998764433322
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||++.+..++.++|||||||++|++++ |+.||.... ...... ....+...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~----~~~~~~~~-------- 222 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIR----ALERGYRM-------- 222 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHH----HHhCCCCC--------
Confidence 233446678999999998889999999999999999998 888886321 111111 11222111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
..+...+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.25 Aligned_cols=251 Identities=20% Similarity=0.314 Sum_probs=201.4
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999654 68899999997542 23345678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 9999988763 4689999999999999999999999 99999999999999999999999999987432211 2233
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+..............+....+...... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------I 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------C
Confidence 457999999999999999999999999999999999999999743222111223334444443333211 2
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPS------MRQVAQQ 1073 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt------~~ev~~~ 1073 (1082)
|...+.++.+++.+|++.+|.+||+ +.+++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 2334567899999999999999997 6677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.67 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=202.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCe----EEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGV----VVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|++.+.||+|+||+||+|.+. +++ .|++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46888899999999999999764 343 47888875432 2334667888889999999999999998754 55788
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
|+||+++|+|.++++.. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++....
T Consensus 86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999999865 34689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 955 SET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 955 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... .......++..|+|||++.+..++.++||||||+++||+++ |+.||..... .. ....+..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~-~~~~~~~~~~~~- 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HE-VPDLLEKGERLA- 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHHHHCCCcCC-
Confidence 322 22233457789999999999899999999999999999998 9988864321 11 112222222111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.+......+.+++.+||..+|++||++.|+++.|..+..
T Consensus 232 --------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 --------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 112234567889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=320.46 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=218.6
Q ss_pred ccccceecccCceEEEEEEEc---CC--eEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 803 FNVQNCIGSGGFGATYKAEII---PG--VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~---~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
....++||.|-||.||+|... .| -.||||..+.. ..+..+.|..|.-+|+.++||||++++|+|.+ ...|+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 445678999999999999532 23 45888888764 34567889999999999999999999999975 4689999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
|.++-|.|..|++.+ ...++..+...++.||+.||+|||+. ++|||||..+|||+....-+|++|||+++.+..+.
T Consensus 470 EL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999999987 56789999999999999999999999 99999999999999999999999999999998777
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.+..+...-...|||||.+.-.+++.++|||.|||.+||++. |..||.... ..++.-.++.
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------------NsDVI~~iEn 607 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------------NSDVIGHIEN 607 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc------------------ccceEEEecC
Confidence 666555566779999999999999999999999999999865 999996432 2234445555
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.-+-+.|+.++..+..++.+||+++|.+||++.|+...|+++..
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 66667889999999999999999999999999999999987643
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=321.93 Aligned_cols=260 Identities=22% Similarity=0.339 Sum_probs=200.0
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357999999999999999999754 689999999875432 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+ .++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 99 46888888764 35688999999999999999999999 99999999999999999999999999997643222
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc-CCCc-c---
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ-GRPC-E--- 1031 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~--- 1031 (1082)
.......|++.|+|||++.+ ..++.++||||+||++|||++|+.||.... +........... +... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK-------DIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc-------cHHHHHHHHHHHhCCCChhhcc
Confidence 22234568999999999865 457889999999999999999999997421 111111111110 0000 0
Q ss_pred ------cccc-ccCCCCCh---------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1032 ------FFTA-GLWDCGPH---------DDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1032 ------~~d~-~l~~~~~~---------~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.+++ ......+. .....+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00000000 12346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.05 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=209.3
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+|++++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888999999999999999765 88999999976644 5678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.++++......+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999999876555799999999999999999999999 999999999999999999999999999987632221
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
...++..|+|||++.+..++.++||||||+++|||++ |..||.... ... +......+...
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~-~~~~~~~~~~~-------- 218 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKD-VVPHVEKGYRM-------- 218 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHH-HHHHHhcCCCC--------
Confidence 2335678999999998889999999999999999997 988886321 111 11222222111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+.+++.+|++.+|++||++.|++++|+.+
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 -EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11223456889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.72 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=206.8
Q ss_pred CccccceecccCceEEEEEEEc------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
+|++.+.||+|+||.||+|... ....+|+|.+..... ...+++.+|+++++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999643 235789988865432 335678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCC
Q 045553 875 IYNYLPGGNLEKFIQDRP----------------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSN 932 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 932 (1082)
||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986531 23578999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCC
Q 045553 933 ILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSF 1010 (1082)
Q Consensus 933 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~ 1010 (1082)
|++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 99999999999999999865433221 1222345678999999998899999999999999999998 988886321
Q ss_pred CCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1011 GNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
...+.. ....+. ....+...+.++.+++.+|++.+|++||++.|+++.|+++..+
T Consensus 235 -----~~~~~~-~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 -----PERLFN-LLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -----HHHHHH-HHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 122222 122111 1112234456899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.64 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=204.3
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
+|++.++||+|+||+||+|.. .+++.||+|++..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999965 4689999999865322 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999998765455789999999999999999999999 999999999999999999999999999987643222
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||.... .......+...+....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~--------- 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK-----EKVKREEVERRVKEDQ--------- 221 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc-----hhhHHHHHHHHhhhcc---------
Confidence 223468999999999999899999999999999999999999997421 1111111122111111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
...+...+..+.+++.+|++.||++|| ++.++.++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112334556789999999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.67 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=198.5
Q ss_pred ceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 807 NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999965 468999999876443 23456789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc-cCc
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT-TDV 963 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 963 (1082)
.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++........... ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999764 34689999999999999999999999 999999999999999999999999999876532211111 111
Q ss_pred ccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCC
Q 045553 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042 (1082)
Q Consensus 964 ~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 1042 (1082)
.++..|+|||.+.++.++.++||||||+++|||++ |..||.... .... ........ ....+
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--------~~~~-~~~~~~~~---------~~~~~ 218 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS--------NQQT-REAIEQGV---------RLPCP 218 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC--------HHHH-HHHHHcCC---------CCCCc
Confidence 23457999999999899999999999999999998 888875321 1111 11111111 11122
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1043 HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1043 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
...+..+.+++.+|++.+|++||++.||.++|+.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 3445689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=314.35 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=212.7
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999765 78999999886432 233567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 877 NYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||+++++|.+++... ....+++..+..++.+++.|++|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998753 245689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.... .....++..|+|||+..+..++.++|||||||++|+|++|+.||... .....++...... +...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~-~~~~---- 226 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEK-CDYP---- 226 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC------CccHHHHHhhhhc-CCCC----
Confidence 3221 22346888999999999888999999999999999999999998632 1222333222211 1111
Q ss_pred cccCCCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1035 AGLWDCGP-HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1035 ~~l~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+ ......+.+++.+|++.+|++||++.+|+++|+++.+
T Consensus 227 -----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 227 -----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred -----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 111 2445688999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=328.12 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=196.9
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccC-----CeEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-----AEMF 873 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 873 (1082)
+|++.++||+|+||.||+|.. .++..||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 488899999999999999964 46899999998643 223345688999999999999999999987543 3579
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+ +++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 57999998764 4689999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCC--ccccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH-----
Q 045553 954 TSET--HATTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL----- 1024 (1082)
Q Consensus 954 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 1024 (1082)
.... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGTPSP 229 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCCH
Confidence 2221 12234579999999999876 6789999999999999999999999964211 01111111100
Q ss_pred ------hcCCCccccccccCCCC-------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 ------LQGRPCEFFTAGLWDCG-------PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ------~~~~~~~~~d~~l~~~~-------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+.++. +.... -......+.+++.+|++.+|++||++.|++++
T Consensus 230 ~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 00000 01224567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.64 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=208.0
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|.+.+.||+|++|.||+|... +++.|++|.+... .....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999654 6899999998653 234567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.++++......+++..++.++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999886567899999999999999999999999 9999999999999999999999999999876543322
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....|++.|+|||+..+..++.++||||||+++|||++|+.||.... ....... ...+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~~-------- 219 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILK-IIRGVFP-------- 219 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HHcCCCC--------
Confidence 233468899999999999999999999999999999999999996321 1111122 1222111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|++.+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122345679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=334.17 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=206.2
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36899999999999999999655 68999999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999874 5789999999999999999999998 99999999999999999999999999998765433
Q ss_pred ----------------------------CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCcc
Q 045553 957 ----------------------------THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFC 1008 (1082)
Q Consensus 957 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~ 1008 (1082)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~- 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence 112234569999999999999999999999999999999999999997432
Q ss_pred CCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 045553 1009 SFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS-MRQVAQQ 1073 (1082)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~~ 1073 (1082)
............... .-......+.++.+++.+|+. +|++||+ +.|++++
T Consensus 235 -------~~~~~~~i~~~~~~~-------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 -------LQETYNKIINWKESL-------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -------HHHHHHHHhccCCcc-------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 112222222110000 000111235688999999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=319.50 Aligned_cols=258 Identities=22% Similarity=0.382 Sum_probs=208.2
Q ss_pred hcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 871 (1082)
.++|.+.+.||+|+||.||+|... ++..||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 346899999999999999999632 35689999987543 23346788999999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||+++|+|.++++......+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++++|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999999875445589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 952 LGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 952 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
....... ......++..|+|||++.+..++.++||||+||++|||++ |+.||..... ..-.......+..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~ 262 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--------DSKFYKLIKEGYR 262 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--------hHHHHHHHHcCCc
Confidence 6433221 1222346778999999999999999999999999999998 8998863211 1111122222211
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
. ..+...+.++.+++.+|++.+|++||++.||++.|+++
T Consensus 263 ~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 M---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1 11223346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=312.92 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=207.0
Q ss_pred cCccccceecccCceEEEEEEEc-CC---eEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PG---VVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.+|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+..|++++++++|||++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999754 23 379999986542 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999765 35689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCcccc--CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 956 ETHATT--DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 956 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||.... ..++..........
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~~~~~i~~~~~~--- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHEVMKAINDGFRL--- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhcCCCC---
Confidence 222111 1223457999999998899999999999999999997 999986321 12333333221111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 230 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 -------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=332.50 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=203.2
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4567999999999999999999765 57899999986422 2234567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999753 578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccCcccCCCcccchhcccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTC----RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
..........||+.|+|||++.+. .++.++||||+||++|||++|+.||... +...............
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~--------~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD--------SLVGTYSKIMDHKNSL 266 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCccc
Confidence 333333456799999999998754 3788999999999999999999999632 2222223332221111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS--RPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 1073 (1082)
.. ......+..+.+++.+|+..++.+ ||++.|++++
T Consensus 267 ~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11 011133567888999999866554 8999999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.73 Aligned_cols=265 Identities=23% Similarity=0.365 Sum_probs=205.6
Q ss_pred CccccceecccCceEEEEEE-EcCCeEEEEEEeecCccc--cHHHHHHHHHHHhccCCCc-eeeEeeeeccCC------e
Q 045553 802 GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPN-LVTLIGYHVSEA------E 871 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~ 871 (1082)
.|+..++||+|+||+||+|+ ..+|+.||+|++...... ......+|+.++++++|+| |+++.+++.... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 46666789999999999995 557899999999766442 2345689999999999999 999999998877 7
Q ss_pred EEEEEeecCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPR--RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
.++||||+ ..+|..++...+. ..++...+..++.||++|++|+|++ +|+||||||+||+++++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999 6799999998753 4677789999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC-
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG- 1027 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 1027 (1082)
+.+..+.. ..+.-++|..|+|||++.+. .|+...||||+||++.||++++.-|..... ..+..+....-|
T Consensus 168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-------~~ql~~If~~lGt 239 (323)
T KOG0594|consen 168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-------IDQLFRIFRLLGT 239 (323)
T ss_pred HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-------HHHHHHHHHHcCC
Confidence 97653332 24445789999999999886 789999999999999999999988864321 222222211111
Q ss_pred -----CCccccccc----cCCCC-Ch-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhC
Q 045553 1028 -----RPCEFFTAG----LWDCG-PH-------DDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQ 1078 (1082)
Q Consensus 1028 -----~~~~~~d~~----l~~~~-~~-------~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~ 1078 (1082)
|.....-+. ..... +. .-.....+++.+|++++|.+|.++++++++ +..+.
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 111110011 11111 11 111468899999999999999999999987 55543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.52 Aligned_cols=255 Identities=22% Similarity=0.377 Sum_probs=206.8
Q ss_pred cCccccceecccCceEEEEEEEc------CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|.+.++||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35778899999999999999532 367899999876666667789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcE
Q 045553 875 IYNYLPGGNLEKFIQDRPR-------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 941 (1082)
||||+++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999986432 3588999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHH
Q 045553 942 YLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
||+|||++......... ......+++.|+|||+..+..++.++|||||||++|||++ |+.||..... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~ 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TEA 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HHH
Confidence 99999999765433221 1222345678999999999999999999999999999998 8888853211 111
Q ss_pred HHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1020 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
.... ..+... ..+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 234 ~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 IECI-TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHH-HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 2221 111111 1122344678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=322.00 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=208.2
Q ss_pred cCccccceecccCceEEEEEEEc--------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII--------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 870 (1082)
++|.+.+.||+|+||.||+|... ++..||+|.+.... .....++.+|+++++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999642 23579999987542 23456788899999999 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD 936 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 936 (1082)
..++||||+++|+|.+++.... ...+++.++.+++.|++.|++|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 9999999999999999998642 23588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCc
Q 045553 937 NNLNAYLSDFGLARLLGTSETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGF 1014 (1082)
Q Consensus 937 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~ 1014 (1082)
.++.+||+|||.++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-------- 246 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-------- 246 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--------
Confidence 99999999999997654322111 112234568999999999899999999999999999998 77887532
Q ss_pred cHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1015 NIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
...+.... ...+... ..+.....++.+++.+|++.+|++||+|.||++.|+++.+.
T Consensus 247 ~~~~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 247 PVEELFKL-LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CHHHHHHH-HHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 22222222 2222111 12234456889999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.48 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=205.1
Q ss_pred HhcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
.+++|++.+.||+|+||.||+|... .+..||+|.+..... .....|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467899999999999999999764 357899998865432 334568999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC---cEEE
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPR-----RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL---NAYL 943 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl 943 (1082)
.++||||+++++|.++++.... ..+++..+.+++.||+.|++|||+. +++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976531 3589999999999999999999999 999999999999998654 5999
Q ss_pred eecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHH
Q 045553 944 SDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||.... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~--------~~~~~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--------NQEVME 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH
Confidence 999999876322211 1112234568999999999999999999999999999997 888886321 122222
Q ss_pred HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1022 MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
....... ...+...+..+.+++.+|++.+|++||++.+|+++|..
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 233 FVTGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 2221111 11233445688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=325.46 Aligned_cols=242 Identities=26% Similarity=0.370 Sum_probs=197.4
Q ss_pred ceecccCceEEEEEEE----cCCeEEEEEEeecCc----cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 807 NCIGSGGFGATYKAEI----IPGVVVAVKRLSVGR----FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999964 357899999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 9999999999764 4678889999999999999999999 999999999999999999999999999875432222
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
......|++.|+|||++.+..++.++|||||||++|||++|+.||... .....+..... +..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~--------~~~~~~~~~~~-~~~--------- 217 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE--------NRKKTIDKILK-GKL--------- 217 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC--------CHHHHHHHHHc-CCC---------
Confidence 223457999999999999988999999999999999999999999642 12222222222 111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
..+......+.+++.+|++.+|++|| ++.++.++
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 12233456789999999999999999 78877653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=313.83 Aligned_cols=254 Identities=22% Similarity=0.409 Sum_probs=203.9
Q ss_pred ccccceecccCceEEEEEEEcC----CeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCe-----
Q 045553 803 FNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE----- 871 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 871 (1082)
|++.+.||+|+||.||+|.... +..||+|+++... ......+.+|++.++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999997542 3789999987543 2345678999999999999999999998876554
Q ss_pred -EEEEEeecCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 872 -MFLIYNYLPGGNLEKFIQDRP----RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 872 -~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
.++||||+++++|..++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999986532 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 947 GLARLLGTSETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 947 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
|+++.+....... .....++..|+|||++.+..++.++||||||+++|||++ |..||.... ..+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--------~~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--------NHEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHH
Confidence 9998765433221 112335678999999988899999999999999999999 888875321 122222222
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
.+... ..+...+.++.+++.+|++.+|++||++.||++.|+++
T Consensus 230 -~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 -HGNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -cCCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22111 12334556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.32 Aligned_cols=259 Identities=26% Similarity=0.450 Sum_probs=208.9
Q ss_pred HhcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 870 (1082)
..++|++.+.||+|+||.||+|... ....+|+|.+.... .....++.+|+++++++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456889999999999999999654 23689999987542 23345688999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD 936 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 936 (1082)
..++||||+++|+|.++++.. ....+++..+.+++.|++.|++|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999999753 245689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCc
Q 045553 937 NNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGF 1014 (1082)
Q Consensus 937 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~ 1014 (1082)
.++.+|++|||.++.+...... ......++..|+|||+..+..++.++|||||||++||+++ |..||...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------- 238 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-------- 238 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC--------
Confidence 9999999999999876543321 1222345678999999999899999999999999999997 88887532
Q ss_pred cHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1015 NIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...+.... ...+... ..+......+.+++.+|++.+|++|||+.|+++.|+.+.
T Consensus 239 ~~~~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVEELFKL-LKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHH-HHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11222222 1121111 123344568999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=310.51 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=204.8
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeec-cCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV-SEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~ 879 (1082)
.+|++.+.||+|+||.||+|... |..||+|.+.... ..+.+.+|+.++++++|+|++++++++. .....++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999765 8889999986442 3467899999999999999999999754 556789999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.++++......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999999876556689999999999999999999999 99999999999999999999999999987653322
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.. ....+..... ..+...
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~--------~~~~~~~~~~-~~~~~~-------- 218 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------IPLKDVVPRV-EKGYKM-------- 218 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHH-hcCCCC--------
Confidence 22345678999999999899999999999999999997 8888752 1223332222 112111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11234456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.74 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=201.5
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36889999999999999999654 68999999997532 233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999864 4689999999999999999999999 99999999999999999999999999987653211
Q ss_pred Cc-------------------------------------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhC
Q 045553 957 TH-------------------------------------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISD 999 (1082)
Q Consensus 957 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg 999 (1082)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 045553 1000 KKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS---MRQVAQQ 1073 (1082)
Q Consensus 1000 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~~ 1073 (1082)
..||.... ..+.............. ......+..+.+++.+|+. +|.+|++ +.|++++
T Consensus 236 ~~Pf~~~~--------~~~~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDN--------PQETYRKIINWKETLQF-------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCC--------HHHHHHHHHcCCCccCC-------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99996321 22222222211111100 0111234578889999996 8999997 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=329.95 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=197.0
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.++++++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688999999999999999964 458999999997532 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999864 4689999999999999999999999 99999999999999999999999999987543211
Q ss_pred C----------------------------------ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCC
Q 045553 957 T----------------------------------HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA 1002 (1082)
Q Consensus 957 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p 1002 (1082)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 011235799999999999999999999999999999999999999
Q ss_pred CCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 045553 1003 LDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTG--ESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1003 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~ev~~~ 1073 (1082)
|.... ................ +.+ ......++.+++.+++. .++..||++.||+++
T Consensus 236 f~~~~--------~~~~~~~i~~~~~~~~-~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSET--------PQETYKKVMNWKETLI-FPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCC--------HHHHHHHHHcCcCccc-CCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 96321 1222222221111110 000 01123456667766443 334457999999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=321.77 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=203.7
Q ss_pred cCccccceecccCceEEEEEEEcC-C--eEEEEEEeecC-ccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP-G--VVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~-~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+++++++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999997643 3 35788887643 233456788999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcE
Q 045553 876 YNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 941 (1082)
|||+++++|.++++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999997642 13588999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHH
Q 045553 942 YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1020 (1082)
||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||... ...+..
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~--------~~~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM--------TCAELY 228 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CHHHHH
Confidence 999999986432111 1111223567999999998899999999999999999997 99998632 122222
Q ss_pred HHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1021 SMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1021 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.... .+. ....+...+..+.+++.+|++.+|.+||++.++++.|+++..
T Consensus 229 ~~~~-~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 229 EKLP-QGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHh-cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2221 111 111223345678999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.78 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=198.6
Q ss_pred eecccCceEEEEEEE---cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 808 CIGSGGFGATYKAEI---IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
.||+|+||.||+|.+ .++..||+|+++.... ...+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 3578999999865432 34567899999999999999999999875 45678999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc--c
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--T 960 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--~ 960 (1082)
+|.+++... ..+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999999763 4689999999999999999999999 99999999999999999999999999998765433221 1
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....++..|+|||.+....++.++|||||||++|||++ |+.||.... ...+... +..+...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~-i~~~~~~--------- 217 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--------GNEVTQM-IESGERM--------- 217 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH-HHCCCCC---------
Confidence 22334678999999988889999999999999999998 999986321 1222222 2222211
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
..+...+.++.+++.+|++.+|++||++.+|++.|++
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1223455688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=315.18 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=210.8
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|.. .+++.||||.+.... .....++.+|+++++.++|||++++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999964 578999999886532 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 877 NYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||+++++|.+++... ....+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998742 234689999999999999999999999 999999999999999999999999999886643
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||... ......+.+...... .
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~-~----- 225 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEQCD-Y----- 225 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc------cchHHHHhhhhhcCC-C-----
Confidence 322 123346889999999999888999999999999999999999998632 112222222221111 0
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
+. ..+......+.+++.+|++.+|++||||.+|+++++++.
T Consensus 226 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00 112235568999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=328.36 Aligned_cols=259 Identities=21% Similarity=0.349 Sum_probs=207.4
Q ss_pred hcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccC-CCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 871 (1082)
..+|.+.+.||+|+||.||+|.+. .+..||||++..... ...+.+.+|++++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345778899999999999999753 246899999975533 23457889999999997 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCC----------------------------------------------------------
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPR---------------------------------------------------------- 893 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 893 (1082)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 894 --------------------------------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 894 --------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
..+++..+.+++.|++.|++|||+. +|+||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 2467788899999999999999998 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCC
Q 045553 936 DNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNG 1013 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 1013 (1082)
++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~------ 346 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP------ 346 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC------
Confidence 9999999999999986533221 12223457889999999998889999999999999999998 888885321
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+.....+..+... ..+.....++.+++.+||+.+|++||+++||++.|+++.
T Consensus 347 --~~~~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 --MNEQFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --chHHHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111122222222111 123344568999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=332.51 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=197.8
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.|++.+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999954 468899999997542 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999764 4688999999999999999999999 999999999999999999999999999764311000
Q ss_pred ----------------------------------------------ccccCcccCCCcccchhcccCCCCchhhHHHHHH
Q 045553 958 ----------------------------------------------HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGV 991 (1082)
Q Consensus 958 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv 991 (1082)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012357999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHH--cccCCCCCCCCHHH
Q 045553 992 VLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIM--CTGESLSSRPSMRQ 1069 (1082)
Q Consensus 992 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~e 1069 (1082)
++|||++|+.||..... ................ ........++.+++.+ |...+|..||++.|
T Consensus 237 il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~-------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 237 ILFEMLVGQPPFLAPTP--------TETQLKVINWENTLHI-------PPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHHhCCCCCcCCCH--------HHHHHHHHccccccCC-------CCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999974211 1111111111111100 0111234567778877 55666667999999
Q ss_pred HHHH
Q 045553 1070 VAQQ 1073 (1082)
Q Consensus 1070 v~~~ 1073 (1082)
++++
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=309.88 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=205.8
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3678889999999999999988778899999886543 335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.++++.. ...++++.+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++..........
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999865 24578999999999999999999999 999999999999999999999999999986643322222
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....++.+|+|||+..++.++.++||||+|+++|||++ |+.||.... ........ ..+. ....
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~-~~~~--~~~~----- 222 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETI-NAGF--RLYK----- 222 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHH-hCCC--CCCC-----
Confidence 23345678999999998899999999999999999998 888886321 12222222 1111 1111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
+...+..+.+++.+|++.+|++||++.||+++|.
T Consensus 223 --~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 --PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1223467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=324.85 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=196.3
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHH---hccCCCceeeEeeeeccCCeEEEE
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTL---GRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|.+++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999654 68999999997542 22344566666554 567899999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|..+++. ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988864 3689999999999999999999999 9999999999999999999999999998753222
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||... ...+..........
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~--------~~~~~~~~i~~~~~------- 218 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD--------DEEEVFDSIVNDEV------- 218 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCC-------
Confidence 1 2234467999999999999999999999999999999999999999632 12222222222111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQ 1072 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 1072 (1082)
..+...+..+.+++.+|++.||++|| ++.++++
T Consensus 219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 12233456788999999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.99 Aligned_cols=246 Identities=25% Similarity=0.402 Sum_probs=198.3
Q ss_pred ecccCceEEEEEEEc---CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 809 IGSGGFGATYKAEII---PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999653 356799999875532 33467899999999999999999999875 4578999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc--ccC
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTD 962 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--~~~ 962 (1082)
.+++... ...+++..+.+++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.......... ...
T Consensus 82 ~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 82 NKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999754 35689999999999999999999999 99999999999999999999999999998654333221 112
Q ss_pred cccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 963 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
..++..|+|||.+.+..++.++||||||+++||+++ |+.||... ....+.. .+..+... ..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~-~~~~~~~~---------~~ 219 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM--------KGPEVMS-FIEQGKRL---------DC 219 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC--------CHHHHHH-HHHCCCCC---------CC
Confidence 233578999999998889999999999999999996 99998632 1122222 22222111 12
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
+...+.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 334457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=319.03 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=209.5
Q ss_pred hcCccccceecccCceEEEEEEEc--------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII--------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE 869 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 869 (1082)
..+|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456888999999999999999631 24579999986442 34456789999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
...++||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999998642 23578899999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCC
Q 045553 936 DNNLNAYLSDFGLARLLGTSETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNG 1013 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 1013 (1082)
+.++.+||+|||.++.+....... .....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------- 243 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------- 243 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-------
Confidence 999999999999998765433221 222345678999999999899999999999999999998 77777522
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...++.... ..+... ..+...+..+.+++.+||+.+|++||+|.||++.|+++..
T Consensus 244 -~~~~~~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 244 -PVEELFKLL-KEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -CHHHHHHHH-HcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 233333332 222111 1123445689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=322.46 Aligned_cols=240 Identities=24% Similarity=0.334 Sum_probs=192.8
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhc-cCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGR-VQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999754 57899999987542 2233445566666664 4899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 9999999764 4689999999999999999999999 99999999999999999999999999998653322 2233
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+......... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~-----------~~~ 215 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE--------DEDELFDSILNDR-----------PHF 215 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCC-----------CCC
Confidence 457999999999999989999999999999999999999999632 1122222221111 112
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMR-QVA 1071 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 1071 (1082)
+.....++.+++.+|++.+|++||++. ++.
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 333456788999999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.97 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=208.5
Q ss_pred CccccceecccCceEEEEEEEcC-CeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.|+..+.||+|.-|+||+++..+ +..+|+|++..... ....+.+.|-++|+.+.||.++.+++.++.++..|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 47778899999999999998764 58999999976533 344567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC---
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT--- 954 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~--- 954 (1082)
||+||+|....+.++.+.+++..++.++.+++-||+|||.. |||+|||||+||||.++|++-++||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999754311
Q ss_pred ------------------------------CCC----------------------ccccCcccCCCcccchhcccCCCCc
Q 045553 955 ------------------------------SET----------------------HATTDVAGTFGYVAPEYAMTCRVSD 982 (1082)
Q Consensus 955 ------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 982 (1082)
... .....++||..|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 0122467999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCC
Q 045553 983 KADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLS 1062 (1082)
Q Consensus 983 ~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~ 1062 (1082)
+.|+|+|||++|||+.|+.||.... -.+....++.+. +.=......+..+.+||++.+.+||.
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~--------~~~Tl~NIv~~~---------l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSN--------NKETLRNIVGQP---------LKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCC--------chhhHHHHhcCC---------CcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999997532 223333333322 11111224567899999999999999
Q ss_pred CCCC----HHHHHH
Q 045553 1063 SRPS----MRQVAQ 1072 (1082)
Q Consensus 1063 ~RPt----~~ev~~ 1072 (1082)
+|-. +.||.+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9997 667654
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.02 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=200.3
Q ss_pred ccccceecccCceEEEEEEEcCC---eEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccC------Ce
Q 045553 803 FNVQNCIGSGGFGATYKAEIIPG---VVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------AE 871 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 871 (1082)
|.+.+.||+|+||.||+|..... ..||+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678899999999999976543 36899988654 234456788999999999999999999977432 25
Q ss_pred EEEEEeecCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecc
Q 045553 872 MFLIYNYLPGGNLEKFIQDR----PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFG 947 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 947 (1082)
.++||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999988532 134589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 948 LARLLGTSETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 948 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
+++.+....... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||.... ..+... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~-~~~ 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSEIYD-YLR 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH-HHH
Confidence 998765433211 122346778999999999999999999999999999999 788875321 112222 222
Q ss_pred cCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
.+.... .+...+..+.+++.+||+.+|++||++.||++.|+++
T Consensus 229 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222111 1223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.26 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=204.6
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc-----ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF-----QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
++|++.+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999964 4689999999864421 224568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999999864 4588899999999999999999999 999999999999999999999999999986643
Q ss_pred CCCccc--cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 955 SETHAT--TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 955 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
...... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||.... .... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~-~~~~~~~~~~--- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-------AMAA-IFKIATQPTN--- 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-------hHHH-HHHHhccCCC---
Confidence 222111 33467889999999999889999999999999999999999986321 1111 1111111111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...+......+.+++.+|++.+|++||++.|++++
T Consensus 226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11233445678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=328.61 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=195.5
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
+|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566789999999999999654 689999999865432 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+. ...++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..... .
T Consensus 155 ~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 155 DGGSLEGT------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 99998653 2356778889999999999999999 999999999999999999999999999987643221 2
Q ss_pred ccCcccCCCcccchhccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 960 TTDVAGTFGYVAPEYAMT-----CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.....|+..|+|||++.. ...+.++|||||||++|||++|+.||.... ............... ..
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~-~~---- 294 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-----QGDWASLMCAICMSQ-PP---- 294 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhccC-CC----
Confidence 234578999999998743 234568999999999999999999997321 111112111111111 00
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.....++.+++.+||+.+|++||++.|++++
T Consensus 295 -----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 -----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123445689999999999999999999999876
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=330.02 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=206.5
Q ss_pred HHHHHHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccC
Q 045553 794 ENVVRATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE 869 (1082)
Q Consensus 794 ~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 869 (1082)
.++....++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344445678999999999999999999654 57899999986422 22345578899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
...++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999999753 478889999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTC----RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
+..............||+.|+|||++.+. .++.++||||+||++|||++|+.||... +..........
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~ 261 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSKIMN 261 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC--------CHHHHHHHHHc
Confidence 87654333333456799999999998754 3788999999999999999999999732 22233333332
Q ss_pred cCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 045553 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS--RPSMRQVAQQL 1074 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~L 1074 (1082)
........ .....+..+..++..|+..++.+ ||++.|+.++.
T Consensus 262 ~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 22111111 11234567889999999854443 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=314.35 Aligned_cols=255 Identities=24% Similarity=0.426 Sum_probs=205.9
Q ss_pred cCccccceecccCceEEEEEEEc----CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.+|++.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999653 23479999986543 23356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++..+...
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999865 34689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccc--cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 956 ETHAT--TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 956 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
..... ....++..|+|||++.+..++.++||||||+++||+++ |+.||..... .+..... .++...
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~-~~~~~~-- 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAI-EEGYRL-- 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHH-hCCCcC--
Confidence 32221 12223568999999999899999999999999999886 9999863211 1111111 111110
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=316.03 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=205.1
Q ss_pred CccccceecccCceEEEEEEEc------CCeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.|++.+.||+|+||.||+|... ++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4777889999999999999653 2578999999755332 24568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc
Q 045553 875 IYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN 940 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 940 (1082)
++||+++++|.+++.... ...+++..+..++.|++.|++|+|+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999986321 23588899999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHH
Q 045553 941 AYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVA 1018 (1082)
Q Consensus 941 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 1018 (1082)
+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||... ...+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------CHHH
Confidence 99999999886543322 12233446789999999988889999999999999999998 77777532 2233
Q ss_pred HHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1019 WASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1019 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
+...... +... ..+...+..+.+++.+|++.+|++||+++||++.|+.
T Consensus 235 ~~~~i~~-~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRN-RQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHc-CCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3333322 2111 1233456679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.25 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=204.0
Q ss_pred ceecccCceEEEEEEEcC--C--eEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEIIP--G--VVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++.+++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 2 3699999987665 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc--c
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH--A 959 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~ 959 (1082)
++|.+++.......+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999876435789999999999999999999999 9999999999999999999999999999877543222 1
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+............
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~~-------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--------SGSQILKKIDKEGERL-------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHhcCCcC--------
Confidence 123457789999999999999999999999999999998 99998632 1222222222211111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
..+...+..+.+++.+|++.+|++||++.||++.|.+
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 1122345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=326.95 Aligned_cols=242 Identities=22% Similarity=0.291 Sum_probs=197.7
Q ss_pred ceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 807 NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999964 568999999997542 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
+|..++... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMK 154 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccc
Confidence 999988763 468999999999999999999997 6 99999999999999999999999999987543222 1223
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++|||||||++|||++|+.||... ............. . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~--------~~~~~~~~i~~~~-~----------~~ 215 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILMEE-I----------RF 215 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC--------CHHHHHHHHhcCC-C----------CC
Confidence 456999999999999999999999999999999999999999632 1122222221111 0 12
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
+.....++.+++.+|++.||++|+ ++.+++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 233456789999999999999996 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=309.70 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=206.8
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
+|++.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+.+++.++|+|++++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999654 68999999986532 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.......+++..+..++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999998875566789999999999999999999999 999999999999999999999999999987643322 2
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||... +........ ..+....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~--------~~~~~~~~~-~~~~~~~-------- 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN--------SWKNLILKV-CQGSYKP-------- 219 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC--------CHHHHHHHH-hcCCCCC--------
Confidence 23356889999999999989999999999999999999999999632 122222222 2222111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+......+.+++.+||+.+|++||++.|++..
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=313.85 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=209.4
Q ss_pred hcCccccceecccCceEEEEEEEcC-----CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeecc-CCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP-----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-EAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 872 (1082)
.++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++|+|++++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678999999999999999997665 6889999886442 3345678899999999999999999998766 5678
Q ss_pred EEEEeecCCCCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPR------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
++++||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999976432 4689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 947 GLARLLGTSETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 947 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.... ..++....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~- 232 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--------PFEMAAYL- 232 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--------HHHHHHHH-
Confidence 9998664333221 122345778999999998899999999999999999999 999986421 12222222
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+... ..+...+.++.+++.+||+.+|++||++.||++.|+.+..
T Consensus 233 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111 0112234578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.86 Aligned_cols=195 Identities=26% Similarity=0.443 Sum_probs=173.8
Q ss_pred CccccceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC-C-----CceeeEeeeeccCCeEEE
Q 045553 802 GFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-H-----PNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 874 (1082)
+|.+.+.||+|+||.|-+| +..+++.||||+++... .-..+...|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999 56679999999998664 33456678999999997 4 389999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC--CcEEEeecccceec
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN--LNAYLSDFGLARLL 952 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfGla~~~ 952 (1082)
|+|.+ ..+|+++++.+....++...++.|+.||+.||.+||+. +|||+||||+|||+..- ..+||+|||.|...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 67999999999888999999999999999999999999 99999999999999744 37999999999875
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDP 1005 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~ 1005 (1082)
... ...++.+..|+|||++.+.+|+.+.||||||||+.||++|.+-|..
T Consensus 342 ~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 322 2256789999999999999999999999999999999999776654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=313.47 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=203.7
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.+|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++|||++++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4689999999999999999975 568899999997665555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.++++.. ..+++..+..++.|++.|++|||+. +|+|||++|+||+++.++.++|+|||++........ .
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 999999998763 4689999999999999999999999 999999999999999999999999999987643221 2
Q ss_pred ccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 960 TTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....|+..|+|||.+. ...++.++||||+||++|||++|+.||...... ... ... .... ...+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~----~~~----~~~-~~~~---~~~~~ 230 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RAL----FLM-SKSN---FQPPK 230 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh----hhh----eee-ecCC---CCCCC
Confidence 23346889999999884 345788999999999999999999998532211 000 000 0000 00011
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
.. .....+..+.+++.+|++.+|++||++.++++++
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 1123456899999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.63 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=207.9
Q ss_pred cCccccceecccCceEEEEEEEcC----CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.+|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++|||++++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999996543 3578999887654 3455678999999999999999999998875 457899
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999999765 34689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.........++..|+|||.+.+..++.++||||||+++||+++ |..||..... . +..... ..+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~---~~~~~~-~~~~~~---- 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----N---DVIGRI-ENGERL---- 227 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----H---HHHHHH-HcCCcC----
Confidence 3332333345678999999988889999999999999999986 9999864321 1 111111 111111
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
..+...+..+.+++.+|+..+|++||++.++++.|+++....
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 112344568999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.45 Aligned_cols=259 Identities=20% Similarity=0.337 Sum_probs=206.0
Q ss_pred HhcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999543 24689999876443 2334567889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEE
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP--------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL 943 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 943 (1082)
.++||||+++|+|.++++... ....++..+.+++.|++.|++|||+. +|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 23456778899999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHH
Q 045553 944 SDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||... ...++..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~--------~~~~~~~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--------SNEQVLK 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHH
Confidence 999999865432221 1122345678999999999899999999999999999998 67787532 1223322
Q ss_pred HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1022 MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.....+ ... .+...+..+.+++.+|++.+|++||++.++++.|+...
T Consensus 233 ~~~~~~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDGG-YLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcCC-CCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 222221 111 12233468999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=322.99 Aligned_cols=236 Identities=25% Similarity=0.355 Sum_probs=193.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999654 58899999987532 23445677888888776 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 9999998764 4689999999999999999999999 99999999999999999999999999987543221 2233
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++||||+||++|||++|+.||... ...+...... .+.. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--------~~~~~~~~i~-~~~~----------~~ 215 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE--------NEDDLFEAIL-NDEV----------VY 215 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC--------CHHHHHHHHh-cCCC----------CC
Confidence 457999999999999999999999999999999999999999632 2223333322 1111 11
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
+.....++.+++.+|++.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 22345678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=318.77 Aligned_cols=263 Identities=22% Similarity=0.391 Sum_probs=203.2
Q ss_pred hcCccccceecccCceEEEEEEEcC---------------CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP---------------GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLI 863 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~ 863 (1082)
..+|++.+.||+|+||.||+|.... ...||+|.+.... ......|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3579999999999999999985432 2358999987542 23346789999999999999999999
Q ss_pred eeeccCCeEEEEEeecCCCCHHHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCE
Q 045553 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRP----------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNI 933 (1082)
Q Consensus 864 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 933 (1082)
+++......++||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999996532 12478899999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCccCC
Q 045553 934 LLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS--DKKALDPSFCSF 1010 (1082)
Q Consensus 934 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt--g~~p~~~~~~~~ 1010 (1082)
+++.++.+||+|||++......... ......++..|+|||+..++.++.++|||||||++|||++ |..||....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--- 237 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--- 237 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---
Confidence 9999999999999999765433221 1222345678999999998899999999999999999998 555665321
Q ss_pred CCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1011 GNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
.....+............ .....+...+..+.+++.+|++.+|++||+|.+|++.|++
T Consensus 238 --~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 --DEQVIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --hHHHHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111111111100 0011122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=323.54 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=212.7
Q ss_pred ccccceecccCceEEEEEEEcC--C--eEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 803 FNVQNCIGSGGFGATYKAEIIP--G--VVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~--~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.+..++||+|.||.|++|.|.. | ..||||.+...... ....|.+|+.+|-+++|||+++++|+..+ ....+|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 4456789999999999998763 3 56899999876543 67899999999999999999999999987 67889999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
.++.|||.+.|++.....+-......++.|||.||+||.++ +.||||+..+|+++-....+||+|||+.+-++..+.
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999996677888899999999999999999999 999999999999999999999999999998876554
Q ss_pred cc--ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 958 HA--TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 958 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
+. .....-.+.|+|||.+...+++.++|||+|||.+|||++ |..||... .-.+..+ .+|
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--------~g~qIL~----------~iD 329 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--------RGIQILK----------NID 329 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--------CHHHHHH----------hcc
Confidence 32 222345678999999999999999999999999999998 56777533 2223322 334
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
...+-.-|..+++++.+++..||...|++||+|..|.+.+-.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 444445678899999999999999999999999999855533
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=322.80 Aligned_cols=241 Identities=23% Similarity=0.299 Sum_probs=195.6
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCC-ceeeEeeeeccCCeEEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHP-NLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 876 (1082)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.++++.++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999654 57899999987532 23456678899999999765 5888999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999999764 4688999999999999999999999 99999999999999999999999999987532221
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||.... ..+...... ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~-~~~-------- 217 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSIM-EHN-------- 217 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-cCC--------
Confidence 12234568999999999999999999999999999999999999996321 112222221 111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
...+.....++.+++.+|++.+|.+|++.
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 --VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01223345678999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.48 Aligned_cols=255 Identities=24% Similarity=0.444 Sum_probs=204.8
Q ss_pred cCccccceecccCceEEEEEEEcC-C---eEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP-G---VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|++.+.||+|+||.||+|.... + ..||||.+... .....++|..|++++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999997543 3 36999998754 233456899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999865 34689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCc-ccc-Ccc--cCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 956 ETH-ATT-DVA--GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 956 ~~~-~~~-~~~--gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
... ... ... .+..|+|||++.+..++.++||||+||++|||++ |..||.... ......++ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i----~~~~~- 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAI----EQDYR- 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHH----HcCCc-
Confidence 221 111 111 2457999999999999999999999999999886 999986321 11222221 11110
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
...+.+.+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 --------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=320.51 Aligned_cols=257 Identities=29% Similarity=0.407 Sum_probs=202.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCe--EEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGV--VVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 874 (1082)
.++|++.+.||+|+||.||+|... ++. .+|+|.+.... ......+.+|++++.++ +||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457899999999999999999754 343 46777765432 23456788999999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc
Q 045553 875 IYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN 940 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 940 (1082)
||||+++++|.++++... ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999997542 23578999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHH
Q 045553 941 AYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 941 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+.
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~ 232 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL 232 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--------hHHH
Confidence 9999999986432111 1111234668999999988889999999999999999998 999986321 1122
Q ss_pred HHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1020 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.... ..+. ....+...+..+.+++.+|++.+|++||++.+++++|+++..
T Consensus 233 ~~~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 233 YEKL-PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHH-hcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2221 1110 001122334578999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=323.10 Aligned_cols=242 Identities=26% Similarity=0.325 Sum_probs=196.5
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.++++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999754 57899999987542 23345677888888765 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
++|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 9999998764 4689999999999999999999999 99999999999999999999999999987543222 2233
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++||||+||++|||++|+.||.... ............ . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~-~----------~~ 215 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDD-V----------LY 215 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC-C----------CC
Confidence 4578999999999999999999999999999999999999997421 222223222211 1 11
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRP-------SMRQVAQQ 1073 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RP-------t~~ev~~~ 1073 (1082)
+.....++.+++.+|++.+|++|| ++.++.++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 223346789999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=314.19 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=197.0
Q ss_pred ecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
||+|+||+||+|.. .+++.||+|++..... ...+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999964 4689999999865432 2335677899999999999999999999999999999999999999
Q ss_pred HHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccC
Q 045553 885 EKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962 (1082)
Q Consensus 885 ~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 962 (1082)
..++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887542 235689999999999999999999999 999999999999999999999999999987643322 2234
Q ss_pred cccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCC
Q 045553 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042 (1082)
Q Consensus 963 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 1042 (1082)
..|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......... ..+ .. ..+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~-~~~--------~~--~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRI-LND--------SV--TYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhh-ccc--------CC--CCc
Confidence 57899999999999999999999999999999999999999743211 1111111111 111 00 123
Q ss_pred hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1043 HDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1043 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
...+..+.+++.+|++.+|++|| ++.|++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 34556889999999999999999 67777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.90 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=196.7
Q ss_pred ecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
||+|+||.||+++. .+|+.||+|++..... ...+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999965 4589999999864321 2234556799999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcc
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 964 (1082)
.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9998776566789999999999999999999999 99999999999999999999999999998764332 223346
Q ss_pred cCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChH
Q 045553 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHD 1044 (1082)
Q Consensus 965 gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1044 (1082)
|+..|+|||++.+..++.++||||+||++|||++|+.||..... ......+....... ... . ....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~-~~~----~-----~~~~ 221 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKRRTLED-EVK----F-----EHQN 221 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHHHhhcc-ccc----c-----cccc
Confidence 89999999999998899999999999999999999999864221 11112222221111 110 0 0112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1045 DLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1045 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...++.+++.+|++.+|++||+++|+++.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 34578999999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=310.30 Aligned_cols=248 Identities=29% Similarity=0.456 Sum_probs=200.2
Q ss_pred ceecccCceEEEEEEEcC----CeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEIIP----GVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
++||+|+||.||+|.... +..||+|.+..... ...+++.+|+++++++.|+|++++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999995432 26899999875543 34567899999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc-
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT- 960 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~- 960 (1082)
++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998753 689999999999999999999999 999999999999999999999999999987654333221
Q ss_pred -cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 961 -TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 961 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
....++..|+|||...+..++.++||||||+++|||++ |+.||.... . .+..... ..+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~---~~~~~~~-~~~~~~-------- 217 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----G---AEVIAML-ESGERL-------- 217 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----H---HHHHHHH-HcCCcC--------
Confidence 11223568999999999999999999999999999998 999986421 1 2222222 222111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+...+..+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 122344568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=331.74 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=198.7
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999964 468999999986432 233466888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999764 4688999999999999999999999 99999999999999999999999999996432110
Q ss_pred Cc----------------------------------------------cccCcccCCCcccchhcccCCCCchhhHHHHH
Q 045553 957 TH----------------------------------------------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFG 990 (1082)
Q Consensus 957 ~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 990 (1082)
.. ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCC---CCCH
Q 045553 991 VVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS---RPSM 1067 (1082)
Q Consensus 991 vll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~---RPt~ 1067 (1082)
|++|||++|+.||.... ................. ........++.+++.+|+. +|.+ |+++
T Consensus 236 vil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~-------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 236 AIMFECLIGWPPFCSEN--------SHETYRKIINWRETLYF-------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhhcCCCCCCCCC--------HHHHHHHHHccCCccCC-------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999996321 11222222211111111 0111234678899999997 6665 4699
Q ss_pred HHHHHH
Q 045553 1068 RQVAQQ 1073 (1082)
Q Consensus 1068 ~ev~~~ 1073 (1082)
.|++++
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=314.37 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=205.6
Q ss_pred hcCccccceecccCceEEEEEEEc-CCe----EEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGV----VVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
..+|++.++||+|+||+||+|++. ++. .||+|++.... ....+.+.+|+.+++.++|||++++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356888999999999999999753 444 48999986543 2345678899999999999999999999875 4578
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
++|||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999999865 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 954 TSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 954 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
..... ......++..|+|||...+..++.++|||||||++|||++ |..||+... ...... .+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~----~~~~~~~~- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPD----LLEKGERL- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH----HHHCCCcC-
Confidence 33221 1122345678999999999999999999999999999998 888886321 111222 12222111
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
..+...+..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 --------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11223456789999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=313.83 Aligned_cols=262 Identities=23% Similarity=0.386 Sum_probs=206.4
Q ss_pred CccccceecccCceEEEEEEE-----cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-----IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMF 873 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 873 (1082)
.|++.+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|++++++++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478889999999999999964 357899999986543 33456789999999999999999999988765 5689
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 999999999999999764 34689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCC-------CCCccHHHHHHHHH
Q 045553 954 TSETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSF-------GNGFNIVAWASMLL 1024 (1082)
Q Consensus 954 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~-------~~~~~~~~~~~~~~ 1024 (1082)
..... ......++..|+|||+..+..++.++||||||+++|||++++.|........ ........++. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HH
Confidence 33221 1223456778999999998889999999999999999999887653221100 01111112211 11
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+... ..+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 222111 11233456899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=327.81 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=200.2
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccCC-----eEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA-----EMF 873 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 873 (1082)
+|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999964 56899999998643 2234567889999999999999999999998766 789
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 688888765 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCC--------CCccHHHH-----
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFG--------NGFNIVAW----- 1019 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~--------~~~~~~~~----- 1019 (1082)
...........++..|+|||++.+. .++.++||||+||++|||++|+.||........ .......+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 4443334445689999999998874 578999999999999999999999974321100 00000000
Q ss_pred -HHHHHhc-CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1020 -ASMLLLQ-GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1020 -~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+.. ......... .. ........++.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPV-LY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHH-hc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 000000000 00 0111235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.33 Aligned_cols=263 Identities=24% Similarity=0.411 Sum_probs=206.8
Q ss_pred hcCccccceecccCceEEEEEEEcC-----------------CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP-----------------GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVT 861 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 861 (1082)
..+|++.+.||+|+||.||+|+... +..||+|.+.... ....+++.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999986542 2568999987543 234677899999999999999999
Q ss_pred EeeeeccCCeEEEEEeecCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCC
Q 045553 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP---------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSN 932 (1082)
Q Consensus 862 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 932 (1082)
+++++..++..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999997643 13689999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCccC
Q 045553 933 ILLDNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS--DKKALDPSFCS 1009 (1082)
Q Consensus 933 ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt--g~~p~~~~~~~ 1009 (1082)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986543322 12233456788999999998889999999999999999998 666664221
Q ss_pred CCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1010 FGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
.................... ...+...+.++.+++.+|++.+|++||++.||++.|++
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 ---DQQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---hHHHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11122222111111111111 11223345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=316.51 Aligned_cols=263 Identities=21% Similarity=0.372 Sum_probs=204.1
Q ss_pred hcCccccceecccCceEEEEEEEc-----------------CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-----------------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVT 861 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 861 (1082)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... ....+++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998532 23578999987543 234567899999999999999999
Q ss_pred EeeeeccCCeEEEEEeecCCCCHHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCC
Q 045553 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR---------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSN 932 (1082)
Q Consensus 862 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 932 (1082)
+++++...+..++||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999999986431 3477889999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeecccceecCCCCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCccC
Q 045553 933 ILLDNNLNAYLSDFGLARLLGTSETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS--DKKALDPSFCS 1009 (1082)
Q Consensus 933 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt--g~~p~~~~~~~ 1009 (1082)
|+++.++.++++|||+++.+....... .....++..|+|||+..++.++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-- 238 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC--
Confidence 999999999999999998654332211 222344678999999988889999999999999999998 667775321
Q ss_pred CCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1010 FGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
.................... ...+..++..+.+++.+|++.+|++||++.||++.|++
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 ---DEQVIENTGEFFRDQGRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---hHHHHHHHHHHHhhcccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111111110000 01123345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=342.90 Aligned_cols=258 Identities=21% Similarity=0.277 Sum_probs=203.7
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.++||+|+||.||+|... +|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999654 58999999986532 223467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecc
Q 045553 877 NYLPGGNLEKFIQDRP---------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFG 947 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 947 (1082)
||+++++|.+++.... ....++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999987421 23456778899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCC-----------------ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCC
Q 045553 948 LARLLGTSET-----------------HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSF 1010 (1082)
Q Consensus 948 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~ 1010 (1082)
+++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 9987621110 011235699999999999999999999999999999999999999964211
Q ss_pred CCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhh
Q 045553 1011 GNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-SMRQVAQQLKQI 1077 (1082)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~i 1077 (1082)
. ..... .... ++... ....+.+..+.+++.+|++.+|++|| ++.++.+.|+..
T Consensus 237 ---~---ki~~~----~~i~---~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 237 ---R---KISYR----DVIL---SPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---h---hhhhh----hhcc---Chhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 00000 0000 00000 00123446788999999999999996 677788877765
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.56 Aligned_cols=255 Identities=21% Similarity=0.372 Sum_probs=206.3
Q ss_pred cCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|||++++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 46888999999999999999654 24789999986543 234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEee
Q 045553 874 LIYNYLPGGNLEKFIQDRP--------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSD 945 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 945 (1082)
+||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 9999999999999997532 23478899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHH
Q 045553 946 FGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASML 1023 (1082)
Q Consensus 946 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1023 (1082)
||+++....... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||... ...+.....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--------~~~~~~~~~ 234 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--------SNEEVLKFV 234 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--------CHHHHHHHH
Confidence 999986543322 12233456789999999998889999999999999999998 88888532 112222222
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
. .+... ..+...+.++.+++.+|++.+|++|||+.|+++.|++
T Consensus 235 ~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 I-DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred h-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2 22111 1223346789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=333.32 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=193.7
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccC--------C
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--------A 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~ 870 (1082)
..+|++.++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999965 468999999885432 2345799999999999999998876432 2
Q ss_pred eEEEEEeecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFG 947 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG 947 (1082)
..++||||++ +++.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999996 5787777542 245789999999999999999999999 999999999999999665 79999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
+++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+...+ .....
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~-~~~~~ 289 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRII-QVLGT 289 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHH-HHhCC
Confidence 998664322 2234578999999999876 46899999999999999999999999642111 1111111 11000
Q ss_pred C----------CCcc-----ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1027 G----------RPCE-----FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1027 ~----------~~~~-----~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. ...+ .....+....|...+.++.+++.+|++.+|++|||+.|++++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000 000011111223345689999999999999999999999854
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=318.88 Aligned_cols=241 Identities=25% Similarity=0.388 Sum_probs=193.6
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhc-cCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGR-VQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..+++. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999754 57899999987542 2234556677777775 4899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 9999999763 4688999999999999999999999 999999999999999999999999999875422221 223
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...||..|+|||++.+..++.++||||+||++|||++|+.||... ...+......... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--------~~~~~~~~i~~~~-~----------~~ 215 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH--------DEEELFQSIRMDN-P----------CY 215 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC-C----------CC
Confidence 456899999999999999999999999999999999999999632 1122222221111 0 11
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMR-QVAQ 1072 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~~ 1072 (1082)
+.....++.+++.+|++.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 223445788999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.95 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=200.7
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36889999999999999999754 5899999998642 2233456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999764 34689999999999999999999999 99999999999999999999999999998765433
Q ss_pred CccccCcccCCCcccchhccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 957 THATTDVAGTFGYVAPEYAMT-----CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
........||+.|+|||++.. ..++.++||||+||++|||++|+.||... ...+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~--------~~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHKEHFQ 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC--------CHHHHHHHHHcCCCccc
Confidence 333333569999999999863 45788999999999999999999999632 22233333322211111
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS--RPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 1073 (1082)
. . ......+..+.+++.+|+..++++ ||++.+++++
T Consensus 229 ~-~-----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 F-P-----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C-C-----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1 0 011124557788888877654443 8899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=316.78 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=206.3
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788999999999999999964 468999999998766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+........ .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999999998753 578999999999999999999999 999999999999999999999999999876543222 1
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ..+.......+. .. +
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--------~~~~~~~~~~~~-~~-----~-- 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGT-PE-----L-- 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--------HHhHHHHhcCCC-CC-----C--
Confidence 2334688999999999988899999999999999999999999964221 111111111111 00 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|+..+|++||++.||+++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1123345678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=313.12 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=206.7
Q ss_pred hcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
.++|++.+.||+|+||.||+|... ++..||+|++..... ...+++.+|+.++++++|||++++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356889999999999999999753 468899999875432 3456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCC
Q 045553 873 FLIYNYLPGGNLEKFIQDRP--------------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSN 932 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 932 (1082)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999997532 13478889999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCC
Q 045553 933 ILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSF 1010 (1082)
Q Consensus 933 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~ 1010 (1082)
|+++.++.++|+|||.+......... ......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~---- 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM---- 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----
Confidence 99999999999999998765433221 1222345678999999999999999999999999999997 77787532
Q ss_pred CCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1011 GNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
...++.... ..+.... .+...+.++.+++.+|++.+|++||++.|+++.|++
T Consensus 237 ----~~~~~~~~~-~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 ----AHEEVIYYV-RDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----CHHHHHHHH-hcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 222333322 2222211 122345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.53 Aligned_cols=250 Identities=22% Similarity=0.384 Sum_probs=205.3
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc-CCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-EAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E 877 (1082)
+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999644 57899999986543 2345678899999999999999999988764 446899999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++.......+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999876566789999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......|++.|+|||+..+..++.++||||+|++++||++|+.||+.. +...+..... .+...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--------~~~~~~~~~~-~~~~~------- 220 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--------DMNSLVYRII-EGKLP------- 220 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHH-hcCCC-------
Confidence 223456889999999999999999999999999999999999998632 2222222222 22211
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|++.+|++||++.|++++
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1223455689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=320.30 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=195.7
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
+|++.+.||+|+||.||+|... +++.||||++..... ...+.+..|..++... +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999654 578999999875422 2334566777887777 5889999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999998764 4689999999999999999999999 99999999999999999999999999997543222
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~i~~~~-~------- 218 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN-V------- 218 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C-------
Confidence 12334579999999999999999999999999999999999999997421 122222222111 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
..|.....++.+++.+|++.+|++|++.
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1233455688999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=331.89 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=198.0
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688999999999999999964 458999999986432 2234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC-
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE- 956 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~- 956 (1082)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999864 4688899999999999999999999 99999999999999999999999999975331000
Q ss_pred -----------------------------------------CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHH
Q 045553 957 -----------------------------------------THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLE 995 (1082)
Q Consensus 957 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~e 995 (1082)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 001123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCC---CHHHHHH
Q 045553 996 LISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP---SMRQVAQ 1072 (1082)
Q Consensus 996 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~ev~~ 1072 (1082)
|++|+.||.... ...+............. ........++.+++.+|+ .+|++|+ ++.|+++
T Consensus 237 ll~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADT--------PAETQLKVINWETTLHI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCC--------HHHHHHHHhccCccccC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999997432 11222222111100000 111123456777888866 5999999 8888876
Q ss_pred H
Q 045553 1073 Q 1073 (1082)
Q Consensus 1073 ~ 1073 (1082)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=319.99 Aligned_cols=242 Identities=23% Similarity=0.321 Sum_probs=196.9
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||+||+|+.. ++..||||++.... ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999655 57899999997542 23345677888888877 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 9999998764 4689999999999999999999999 99999999999999999999999999987532222 1223
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++||||+||++|||++|+.||... +......... .... ..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~--------~~~~~~~~i~-~~~~----------~~ 215 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD--------DEDELFQSIL-EDEV----------RY 215 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC--------CHHHHHHHHH-cCCC----------CC
Confidence 456899999999999999999999999999999999999999632 1222222222 1111 12
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSM-----RQVAQQ 1073 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~~ 1073 (1082)
+...+..+.+++.+|++.||++||++ .+++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 23345678999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=322.07 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=204.1
Q ss_pred hcCccccceecccCceEEEEEEE------cCCeEEEEEEeecCcc-ccHHHHHHHHHHHhcc-CCCceeeEeeeeccC-C
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI------IPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE-A 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 870 (1082)
.++|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999953 3478999999975432 3346688999999999 689999999987654 5
Q ss_pred eEEEEEeecCCCCHHHHHhhCC----------------------------------------------------------
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP---------------------------------------------------------- 892 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 892 (1082)
..++||||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6799999999999999987532
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc-cccCcc
Q 045553 893 -------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDVA 964 (1082)
Q Consensus 893 -------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~ 964 (1082)
...+++..+.+++.|+++|++|||+. +|+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12468888999999999999999999 9999999999999999999999999999865332221 122234
Q ss_pred cCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCCh
Q 045553 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPH 1043 (1082)
Q Consensus 965 gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 1043 (1082)
++..|+|||++.+..++.++||||||+++|||++ |..||...... .........+.... .+.
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~---------~~~ 305 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGTRMR---------APD 305 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------HHHHHHHhccCCCC---------CCC
Confidence 5678999999999899999999999999999997 88888532111 11112222221111 111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1044 DDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1044 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
....++.+++.+||+.+|++||++.||+++|+.+..
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 233578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.77 Aligned_cols=254 Identities=23% Similarity=0.397 Sum_probs=203.0
Q ss_pred HHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccC------
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE------ 869 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 869 (1082)
.+++.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|||++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999654 58899999987543 3456788999999998 699999999988652
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
...++||||+++++|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999999876566789999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||+.... ..... ..
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~-~~- 228 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF-LI- 228 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHH-HH-
Confidence 8654322 2233456899999999986 34578899999999999999999999863211 11111 11
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
........ .+...+..+.+++.+|++.+|.+||++.|++++
T Consensus 229 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 PRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred hcCCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11111111 112334578999999999999999999999763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=319.60 Aligned_cols=240 Identities=23% Similarity=0.324 Sum_probs=193.3
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhc-cCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGR-VQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|+.. +|+.||+|+++... ....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999654 58899999997542 2234556677777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 9999998763 4688999999999999999999999 99999999999999999999999999987532221 2233
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++||||+||++|||++|+.||... +..+...... .+. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~--------~~~~~~~~~~-~~~----------~~~ 215 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--------DEDELFESIR-VDT----------PHY 215 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHH-hCC----------CCC
Confidence 467999999999999999999999999999999999999999632 1122222221 111 012
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMR-QVA 1071 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 1071 (1082)
+.....++.+++.+|++.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223456788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=316.70 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=206.6
Q ss_pred hcCccccceecccCceEEEEEEEc--------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII--------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE 869 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 869 (1082)
..+|.+.+.||+|+||.||+|+.. ....||+|.+.... ......+..|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999642 24579999987543 23456788999999999 699999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
...++||||+++|+|.+++.... ...+++.++.+++.|++.|++|||+. +|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999997642 24588999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCC
Q 045553 936 DNNLNAYLSDFGLARLLGTSETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNG 1013 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 1013 (1082)
+.++.+||+|||.++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~------- 240 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI------- 240 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-------
Confidence 999999999999998664322211 111234567999999999899999999999999999999 88887532
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...+.... ...+... ..+...+.++.+++.+|++.+|++||++.|+++.|+++..
T Consensus 241 -~~~~~~~~-~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 241 -PVEELFKL-LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -CHHHHHHH-HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 12222222 2222111 1123345678899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=286.84 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=209.5
Q ss_pred HhcCccccceecccCceEEEEE-EEcCCeEEEEEEeecCcc----c----cHHHHHHHHHHHhcc-CCCceeeEeeeecc
Q 045553 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF----Q----GVQQFAAEIRTLGRV-QHPNLVTLIGYHVS 868 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~----~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 868 (1082)
.-+.|...+.+|+|..++|.+. ...+|..+|+|++..... + -.+.-..|+++++++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788899999999999888 455789999999864322 1 123446799999988 69999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 869 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
+...++|+|.|+.|.|.+++.. .-.+++.+..+|++|+.+|+.|||.. .|||||+||+|||+|++.++||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999987 46799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAM------TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
|..+.+++ .....+||++|+|||.+. ...|+...|+||+||++|-++.|.+||... -.-.+-.
T Consensus 170 a~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---------kQmlMLR 238 (411)
T KOG0599|consen 170 ACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---------KQMLMLR 238 (411)
T ss_pred eeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---------HHHHHHH
Confidence 99876543 445679999999999884 346888999999999999999999999621 1123334
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+.+|++. +.++...+.+...+++|.+|++.||++|-|.+|++++
T Consensus 239 ~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 55566543 1222234567789999999999999999999999864
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.95 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=206.3
Q ss_pred hcCccccceecccCceEEEEEEEcC-CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||.||+|...+ +..||+|.+..... .+++.+|++++++++|||++++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578999999999999999997764 78999999875533 67899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 80 CGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999999764 45789999999999999999999999 999999999999999999999999999987644322
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... +-... ...... ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~~~-~~~~~~-----~~~- 219 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIFM-IPNKPP-----PTL- 219 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhhhh-hccCCC-----CCC-
Confidence 223345788999999999999999999999999999999999998642111 00000 000000 000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|++.+|++||++.||+++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 -SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1123345678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=315.69 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=201.8
Q ss_pred ccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+..|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67788999999999999964 4689999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++.......+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999999766556799999999999999999999998 999999999999999999999999999976543222
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ... .......... .
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~~-~~~~~~~~~~----------~ 221 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKR-EEVERLVKEV----------Q 221 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----chH-HHHHhhhhhh----------h
Confidence 22346899999999999999999999999999999999999999743211 000 1111111100 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQ 1072 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 1072 (1082)
...+.....++.+++.+|++.+|++||+ +.|+.+
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0122234457899999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=319.98 Aligned_cols=243 Identities=20% Similarity=0.299 Sum_probs=195.6
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +||+|+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999654 57899999997542 23345678899998888 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|..++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 9999988763 4689999999999999999999999 99999999999999999999999999987532221 1223
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++|||||||++|||++|+.||+..... .......+.......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~----------~~ 222 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN--PDMNTEDYLFQVILEKPI----------RI 222 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC--cccccHHHHHHHHHhCCC----------CC
Confidence 457999999999999999999999999999999999999999643221 112223333333332211 12
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
|...+..+.+++.+|++.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 23345678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=330.10 Aligned_cols=251 Identities=21% Similarity=0.282 Sum_probs=195.8
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.|++.++||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999964 468899999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC-
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE- 956 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~- 956 (1082)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999764 4688999999999999999999999 99999999999999999999999999975331100
Q ss_pred ---------------------------------------------CccccCcccCCCcccchhcccCCCCchhhHHHHHH
Q 045553 957 ---------------------------------------------THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGV 991 (1082)
Q Consensus 957 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv 991 (1082)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00112346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCC---HH
Q 045553 992 VLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS---MR 1068 (1082)
Q Consensus 992 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ 1068 (1082)
++|||++|+.||.... ..+.............. ........++.+++.+++ .+|++|++ +.
T Consensus 237 il~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~-------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 237 ILYEMLVGQPPFLAQT--------PLETQMKVINWQTSLHI-------PPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHHhCCCCCCCCC--------HHHHHHHHHccCCCcCC-------CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 9999999999997421 11222222111110000 111123446667777765 59999987 77
Q ss_pred HHHHH
Q 045553 1069 QVAQQ 1073 (1082)
Q Consensus 1069 ev~~~ 1073 (1082)
|++++
T Consensus 301 ei~~h 305 (382)
T cd05625 301 EIKAH 305 (382)
T ss_pred HHhcC
Confidence 77653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=310.19 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=200.5
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
+|++.++||+|+||.||+|.. .++..||+|++.... ....+++.+|++++++++|||++++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999964 568999999986542 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++...... .
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 999997652 467889999999999999999999 9999999999999999999999999999865432 2
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ......+........ ... +
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~-~~~-----~-- 220 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG-SLMPLQLLQCIVDED-PPV-----L-- 220 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc-ccchHHHHHHHhccC-CCC-----C--
Confidence 2335789999999999998999999999999999999999999975332211 111112222211111 000 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......++.+++.+|++.+|++||++.|++++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011234578999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=315.31 Aligned_cols=252 Identities=25% Similarity=0.311 Sum_probs=213.0
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc---cHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 873 (1082)
....|++.+.||+|.||.||++... +|+.+|+|.+...... +...+.+|+++|+++. |||||.+.+++++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457888999999999999999654 5999999999766443 3468899999999998 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC----CcEEEeecccc
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN----LNAYLSDFGLA 949 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfGla 949 (1082)
+|||++.||.|.+.+... .+++..+..++.|++.|++|||+. +|+|||+||+|+|+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999876 399999999999999999999999 99999999999999633 57999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...... .... .+..++.
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--------~~~~-~i~~~~~ 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--------EIFL-AILRGDF 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--------HHHH-HHHcCCC
Confidence 98766 44566789999999999999999999999999999999999999999743211 1111 2333332
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+..+.-......+..++.+|+..||.+|+++.+++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122234557789999999999999999999999986
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=310.26 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=202.3
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|||++++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999655 4788999998766556667889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
++|..++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9999988753 34689999999999999999999999 99999999999999999999999999987653222 2223
Q ss_pred CcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 962 DVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.+....... ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~-~~~~---- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSE-PPTL---- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhcC-CCCC----
Confidence 456899999999984 4557789999999999999999999986321 112222221111 1111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+.++.+++.+||+.+|++||++.+++++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122345689999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=323.30 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=195.1
Q ss_pred ceecccCceEEEEEEE----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 807 NCIGSGGFGATYKAEI----IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999854 3579999999975432 234557789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 99999999763 4689999999999999999999999 999999999999999999999999999986543322 23
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDC 1040 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 1040 (1082)
....|++.|+|||++.+..++.++|||||||++|||++|+.||... ...+....... ... .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~--------~~~~~~~~i~~-~~~----------~ 216 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK--------DRKETMTMILK-AKL----------G 216 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC--------CHHHHHHHHHc-CCC----------C
Confidence 3457899999999999888999999999999999999999999632 11222222221 111 1
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 045553 1041 GPHDDLIEMLNLAIMCTGESLSSRPSMRQ 1069 (1082)
Q Consensus 1041 ~~~~~~~~l~~li~~cl~~~p~~RPt~~e 1069 (1082)
.+......+.+++.+|++.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22334567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=304.46 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=209.0
Q ss_pred CccccceecccCceEEEEEE-EcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|+||.||.++ ..++..+++|++.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58889999999999999995 4458899999986543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++.......+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999876556789999999999999999999999 999999999999999999999999999987644332
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
......|+..|+|||+..+..++.++||||||+++|||++|+.||... ...+.+..... +....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~-~~~~~------- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--------NPLNLVVKIVQ-GNYTP------- 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHc-CCCCC-------
Confidence 223456899999999999888899999999999999999999998642 22233333322 21111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
.+...+.++.+++.+|++.+|++||++.|+++++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1123456789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=305.45 Aligned_cols=252 Identities=29% Similarity=0.471 Sum_probs=196.3
Q ss_pred ceecccCceEEEEEEEc----CCeEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeec-cCCeEEEEEeecC
Q 045553 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV-SEAEMFLIYNYLP 880 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~~ 880 (1082)
+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++|||++++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999653 2467999998543 2344567889999999999999999999775 4556899999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC---
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET--- 957 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~--- 957 (1082)
+++|.+++... ....++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999999865 33467888899999999999999999 999999999999999999999999999976533211
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
.......++..|+|||++.+..++.++||||||+++|||++|+.|+... ........... .+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-------~~~~~~~~~~~-~~~~~------- 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------VDSFDITVYLL-QGRRL------- 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-------CCHHHHHHHHh-cCCCC-------
Confidence 1112334677899999999889999999999999999999965543211 11222222222 21111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 222 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 --LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0112234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.98 Aligned_cols=249 Identities=30% Similarity=0.428 Sum_probs=197.1
Q ss_pred ceecccCceEEEEEEEcC-Ce--EEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEIIP-GV--VVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|...+ +. .+|+|.++... ....+.+.+|+++++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999997653 33 57888876432 34456788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecc
Q 045553 882 GNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFG 947 (1082)
Q Consensus 882 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 947 (1082)
++|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999997642 13578999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||... +......... .
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~--------~~~~~~~~~~-~ 226 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELYEKLP-Q 226 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc--------CHHHHHHHHh-C
Confidence 98632211 11111234567999999988889999999999999999997 99998532 1122222221 1
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
+... ..+......+.+++.+|++.+|.+||++.|+++.|+++.
T Consensus 227 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111 112234457899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=306.63 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=190.9
Q ss_pred ceecccCceEEEEEEEcC-------------CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 807 NCIGSGGFGATYKAEIIP-------------GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
+.||+|+||.||+|.+.+ ...||+|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2368999887655555667889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc-------EEEeec
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN-------AYLSDF 946 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-------~kl~Df 946 (1082)
+||||+++++|..+++.. ...+++..+.+++.|+++|++|||+. +|+||||||+||+++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998754 34689999999999999999999999 9999999999999987654 899999
Q ss_pred ccceecCCCCCccccCcccCCCcccchhcc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 947 GLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVLLELI-SDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 947 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+.... ..+... .
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~-~- 221 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--------LAEKER-F- 221 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc--------hhHHHH-H-
Confidence 998755322 2245788999999887 467899999999999999998 5777765321 111111 1
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
..+.. . . ......++.+++.+||+.||++||++.+|++.+.
T Consensus 222 ~~~~~-~-----~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YEGQC-M-----L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HhcCc-c-----C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11110 0 0 1122357889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.00 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=205.5
Q ss_pred eecccCceEEEEEE-EcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCHHH
Q 045553 808 CIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEK 886 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 886 (1082)
+||+|.||+||-|+ ..+...+|||.+........+...+|+...++++|.|||+++|.+.+++..-+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999995 45578899999987777777889999999999999999999999999999999999999999999
Q ss_pred HHhhC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc-CCCcEEEeecccceecCCCCCccccCcc
Q 045553 887 FIQDR-PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVA 964 (1082)
Q Consensus 887 ~l~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~ 964 (1082)
+++.. +.-.-.+.++-.+..||++||.|||+. .|||||||-.|||++ -.|.+||+|||.++.+..-. ..+.++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccccc
Confidence 99874 222337888889999999999999999 999999999999996 67999999999998775333 2345678
Q ss_pred cCCCcccchhcccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCC
Q 045553 965 GTFGYVAPEYAMTC--RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042 (1082)
Q Consensus 965 gt~~y~aPE~~~~~--~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 1042 (1082)
||..|||||++..+ .|..++|||||||.+.||.||++||.+.-.+ .. .+..-|.+ ....+.|
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-------qA---AMFkVGmy------KvHP~iP 801 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-------QA---AMFKVGMY------KVHPPIP 801 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-------hH---hhhhhcce------ecCCCCc
Confidence 99999999999754 5889999999999999999999999754322 11 00111111 1233567
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1043 HDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1043 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
++...+.+.+|.+|+.+||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 888999999999999999999999999875
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=326.50 Aligned_cols=262 Identities=21% Similarity=0.248 Sum_probs=198.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999655 478899996432 3457899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC-
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET- 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 957 (1082)
+ .++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 Y-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9 57999988764 34699999999999999999999999 999999999999999999999999999987643222
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc--cc---
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC--EF--- 1032 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--- 1032 (1082)
.......||..|+|||++.+..++.++|||||||++|||++|..|+..............+ +...+...... +.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~-l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ-ILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHH-HHHHHHhhccccccCCCC
Confidence 1223457999999999999999999999999999999999988765432111111111111 11122211110 00
Q ss_pred cccc------------cCCCCC-------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAG------------LWDCGP-------HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~------------l~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... .+.... ......+.+|+.+|++.||.+|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 000000 0122468899999999999999999999875
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=305.77 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=201.0
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCHH
Q 045553 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLE 885 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 885 (1082)
++||+|+||.||+|...+++.||+|++...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999998777999999998765443 4567899999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc-cCcc
Q 045553 886 KFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT-TDVA 964 (1082)
Q Consensus 886 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~~~ 964 (1082)
+++... ...+++..+..++.+++.|++|||+. +++||||+|+||+++.++.+||+|||.+........... ....
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999764 34678999999999999999999999 999999999999999999999999999976542221111 1123
Q ss_pred cCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCCh
Q 045553 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPH 1043 (1082)
Q Consensus 965 gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 1043 (1082)
++..|+|||.+.++.++.++||||||+++|||++ |..||.... ....... ...+. ....+.
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--------~~~~~~~-~~~~~---------~~~~~~ 218 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--------NQQTRER-IESGY---------RMPAPQ 218 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--------HHHHHHH-HhcCC---------CCCCCc
Confidence 4567999999998899999999999999999999 777775321 1111111 11111 111233
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1044 DDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1044 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
..+.++.+++.+|++.+|++||++.||++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 445689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=296.99 Aligned_cols=248 Identities=23% Similarity=0.393 Sum_probs=211.2
Q ss_pred ccccceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
|++.++||+|+||.||+| ....|..||+|++... .+.+++..|+.++++.+.|++|+++|.|......|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 778899999999999999 4556999999998754 4578899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|++.+.++.+ ..++++.++..++...+.||+|||.. .-+|||||..|||++.+|.+|++|||.|..+.... ....
T Consensus 113 GSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRN 187 (502)
T KOG0574|consen 113 GSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRN 187 (502)
T ss_pred CcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhC
Confidence 9999999987 67899999999999999999999999 89999999999999999999999999998764322 2345
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
++.||+.|||||+++.-.|+.++||||+|+...||..|++||....+- +.+.. .+.---+.+ ..
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----------RAIFM---IPT~PPPTF--~K 251 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----------RAIFM---IPTKPPPTF--KK 251 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----------ceeEe---ccCCCCCCC--CC
Confidence 578999999999999999999999999999999999999998743221 00000 000001111 24
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
|+..+.++.++++.|+-..|++|-|+.++.++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 67888999999999999999999999888775
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=310.54 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=201.9
Q ss_pred ccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
|+..+.||+|+||+||+|.. .+++.||+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67778999999999999965 4689999999865432 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++.......+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999998765555799999999999999999999999 999999999999999999999999999976543222
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....|+..|+|||++.+..++.++||||+|+++|||++|+.||...... .....+ ........ .
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~----~~~~~~-~~~~~~~~--~------- 222 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK----VKREEV-DRRVLETE--E------- 222 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-HHhhhccc--c-------
Confidence 23457899999999999989999999999999999999999999742111 111111 11111111 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 1073 (1082)
..+......+.+++.+|++.+|++||+ +.+++++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 112234457889999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.08 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=203.0
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
++|++.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++|||++++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999964 468999999987665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 999999998764 4689999999999999999999999 99999999999999999999999999997664322 22
Q ss_pred ccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 960 TTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....|+..|+|||++. ...++.++||||+||++|||++|+.||...... ...............
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~---- 230 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMTKSNFQPPK---- 230 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--------hhHHhhhccCCCCCc----
Confidence 23456899999999874 456888999999999999999999998532211 111111111111110
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... ....+..+.+++.+|++.+|++||++.+|+++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 11234568899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.81 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=206.0
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35799999999999999999964 57899999999876555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+........
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 999999999875 3578999999999999999999999 999999999999999999999999999986543322
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
......+++.|+|||...+..++.++|||||||++|+|++|+.||...... .. .......+ ...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-------~~-~~~~~~~~-~~~------- 234 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RA-LYLIATNG-TPE------- 234 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-------hh-eeeeccCC-CCC-------
Confidence 223346888999999999988999999999999999999999999643211 00 00000001 000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
...+......+.+++.+|++.+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112334567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=315.22 Aligned_cols=265 Identities=27% Similarity=0.390 Sum_probs=208.6
Q ss_pred cCccccceecccCceEEEEEEEc-----CCeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeecc--CCeE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-----PGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEM 872 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 872 (1082)
..|++.+.||+|+||.||+|.+. ++..||||++...... ..+.|.+|++.++.++|||++++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777899999999999999754 3689999999765443 46789999999999999999999999877 5678
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999998753 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC------CccHHHHHHHHH
Q 045553 953 GTSETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN------GFNIVAWASMLL 1024 (1082)
Q Consensus 953 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~------~~~~~~~~~~~~ 1024 (1082)
...... ......++..|+|||...+..++.++||||||+++|||++|+.|+......... .......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532221 111234556799999999889999999999999999999999998643211100 000011111111
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+. ....+...+.++.+++.+|++.+|++||+|.||+++|+.+.
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 240 KEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1111 11122334468999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=308.43 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=202.6
Q ss_pred HHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++..+.....||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++|+||+++++++..++..++||
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3455566667899999999999964 457889999987766666778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-CCcEEEeecccceecC
Q 045553 877 NYLPGGNLEKFIQDRPRRTV--EWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYLSDFGLARLLG 953 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~ 953 (1082)
||+++++|.++++... ..+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||.+....
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999998642 234 7888999999999999999999 9999999999999986 6799999999997654
Q ss_pred CCCCccccCcccCCCcccchhcccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTC--RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
.... ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||...... ....+..... .
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~--~---- 228 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMF--K---- 228 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhh--c----
Confidence 3222 22234588999999998664 3788999999999999999999998642111 1111111000 0
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.....+.....++..++.+|++.+|++||++.|++++
T Consensus 229 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0011233445678999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=304.50 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=205.3
Q ss_pred ceecccCceEEEEEEEcC----CeEEEEEEeecCcccc-HHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEIIP----GVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997653 7899999997654433 67889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 882 GNLEKFIQDRP-------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 882 gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998752 36789999999999999999999999 999999999999999999999999999987754
Q ss_pred CCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 955 SET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 955 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||... ...+...... .+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~~~-- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--------SNEEVLEYLR-KGYRL-- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHH-cCCCC--
Confidence 331 22233457889999999998899999999999999999999 58888643 1222222222 11111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
..+...+.++.+++.+|++.+|++||++.|++++|+
T Consensus 227 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 123344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=316.70 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=207.0
Q ss_pred cCccccceecccCceEEEEEEEc--------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII--------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 870 (1082)
.+|++.+.||+|+||.||+|... ++..||+|.+.... ....+++.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999642 12478999887543 23456789999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD 936 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 936 (1082)
..++||||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999997532 24588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCc
Q 045553 937 NNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGF 1014 (1082)
Q Consensus 937 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~ 1014 (1082)
.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------- 240 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-------- 240 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--------
Confidence 9999999999999876432221 1222334568999999999999999999999999999998 77887532
Q ss_pred cHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1015 NIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...++..... .+... ..+.....++.+++.+|++.+|++||++.|+++.|+++.
T Consensus 241 ~~~~~~~~~~-~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 241 PVEELFKLLK-EGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CHHHHHHHHH-cCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 2233333322 22111 112234568999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=304.76 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=207.4
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488899999999999999954 468999999987542 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++.......+++..+.+++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999999876555789999999999999999999999 9999999999999999999999999999866433221
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....|+..|+|||+..+..++.++||||||+++++|++|+.||... .....+....... ..
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~~~-~~-------- 219 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--------NMKNLVLKIIRGS-YP-------- 219 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--------CHHHHHHHHhcCC-CC--------
Confidence 22345888999999999989999999999999999999999998632 2223333332221 11
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.....++.+++.+|++.+|++||+|.||+++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1123345679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=314.16 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=202.3
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.+.||+|+||.||+|... ++..+|+|.+..... ....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999654 578899998875432 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.++++.. ..+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999864 46889999999999999999999732 8999999999999999999999999998765322
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc--------
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC-------- 1030 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 1030 (1082)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..... .....+...........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-----hhHHHhhcCccccccccCCcccccC
Confidence 12335689999999999888899999999999999999999999863211 11111111000000000
Q ss_pred ------------cccccccC---CCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 ------------EFFTAGLW---DCGP-HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ------------~~~d~~l~---~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+..+.... ...+ .....++.+++.+|++.+|++||++.||+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0000 1134578999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=309.94 Aligned_cols=253 Identities=23% Similarity=0.408 Sum_probs=204.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.+.|++.+.||+|+||.||+|+.. ++..||+|.+........+.+.+|+++++.++|||++++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 356889999999999999999765 4899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|..++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+....... .
T Consensus 91 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 91 CPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 9999999888654 34689999999999999999999999 99999999999999999999999999987543221 1
Q ss_pred cccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 959 ATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
......++..|+|||++. ...++.++|||||||++|||++|+.||.... ......... .......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~- 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIA-KSEPPTL- 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--------HHHHHHHHh-cCCCccC-
Confidence 223346888999999985 3456789999999999999999999986321 112222221 1111111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.....++.+++.+|++.+|++||++.|++++
T Consensus 236 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 ------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1122344578999999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.57 Aligned_cols=245 Identities=27% Similarity=0.403 Sum_probs=204.0
Q ss_pred ccccceecccCceEEEEEE-EcCCeEEEEEEeecCccc---cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
|.-.+-||.|+||.||.|+ ..+...||||++.....+ ..+++..|++++++++|||++.+.|+|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4455679999999999995 556899999999765443 356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
| -||-.+++.-+ ..++.+.++..|+.+.+.||+|||+. +.||||||..|||+++.|.||++|||.|..+.+..
T Consensus 108 C-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-- 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-- 180 (948)
T ss_pred H-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence 9 56888887765 45788999999999999999999999 99999999999999999999999999998775443
Q ss_pred cccCcccCCCcccchhccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMT---CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.++||+.|||||++.. +.|+-|+||||+|+...|+..+++|... ++-..-... +.+++.+..
T Consensus 181 ---sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn--------MNAMSALYH-IAQNesPtL--- 245 (948)
T KOG0577|consen 181 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYH-IAQNESPTL--- 245 (948)
T ss_pred ---cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC--------chHHHHHHH-HHhcCCCCC---
Confidence 4689999999999864 6799999999999999999999999752 222222222 223322211
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
. ..+++..+..++..|++.-|.+|||..+++++-
T Consensus 246 --q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 246 --Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred --C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1 246788999999999999999999999988753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=320.22 Aligned_cols=237 Identities=26% Similarity=0.332 Sum_probs=190.8
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHH-HHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIR-TLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||+||+|... +|+.||+|++.... .....++.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999654 68999999986532 122344455544 56889999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence 9999999763 4689999999999999999999999 9999999999999999999999999998753222 12233
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++|||||||++|||++|+.||... +..+......... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~-~----------~~ 215 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------DTAEMYDNILNKP-L----------RL 215 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC--------CHHHHHHHHHcCC-C----------CC
Confidence 457999999999999999999999999999999999999999632 2223333322211 0 01
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMR 1068 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ 1068 (1082)
+...+..+.+++.+|++.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 123356789999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=305.29 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=193.3
Q ss_pred ceecccCceEEEEEEEcC---CeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 807 NCIGSGGFGATYKAEIIP---GVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
+.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999997643 46799998865432 33457889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc-
Q 045553 883 NLEKFIQDRP---RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH- 958 (1082)
Q Consensus 883 sL~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 958 (1082)
+|.++++... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997642 23567788889999999999999999 9999999999999999999999999999754332221
Q ss_pred cccCcccCCCcccchhcccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 959 ATTDVAGTFGYVAPEYAMTC-------RVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||..... ..... ... .+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~~~~~---~~~-~~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQVLT---YTV-REQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----HHHHH---HHh-hcccC
Confidence 12234578889999998642 35789999999999999996 9999863211 11111 111 11112
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
...++.+. ......+.+++.+|+ .+|++||++.||++.|+
T Consensus 229 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222221 123346888999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=305.16 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=202.8
Q ss_pred CccccceecccCceEEEEEEEcCCeEEEEEEeecCcc------ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
+|++.+.||+|+||+||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999888899999999865421 2235688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999764 4678999999999999999999999 9999999999999999999999999998765321
Q ss_pred C-----CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 956 E-----THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 956 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
. ........|+..|+|||++.+..++.++||||+|+++|||++|+.||.... ............+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-------RLAAMFYIGAHRGLM- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-------hHHHHHHhhhccCCC-
Confidence 1 111223568899999999999889999999999999999999999996321 111111111111111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
+ ..+.....++..++.+|++.+|++||++.|+++
T Consensus 228 ----~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ----P----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----C----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 112234567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=322.12 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=197.8
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccCC-----
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA----- 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 870 (1082)
..++|++.+.||+|+||.||+|.. .+|..||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999964 46899999998643 2234567789999999999999999999886443
Q ss_pred -eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 871 -EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 871 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
..++||||++ +++.+.++. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 5799999995 567776643 478899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH------
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML------ 1023 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 1023 (1082)
+..... .......||..|+|||++.+..++.++||||+||++|||++|+.||.... ....|....
T Consensus 171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~-------~~~~~~~~~~~~~~~ 241 (359)
T cd07876 171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD-------HIDQWNKVIEQLGTP 241 (359)
T ss_pred cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHhcCCC
Confidence 764322 22334578999999999999999999999999999999999999997431 111111111
Q ss_pred ---------------HhcCC-Cc-----cccccccC---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 ---------------LLQGR-PC-----EFFTAGLW---DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 ---------------~~~~~-~~-----~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..... .. +....... ...+......+.+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00 00000000 00011224578999999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=316.66 Aligned_cols=241 Identities=22% Similarity=0.296 Sum_probs=195.3
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.|++.+.||+|+||+||+|.. .+|+.||+|++.... ....+.+..|.++++... |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367889999999999999965 468999999987532 233456778888888886 567888999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999998763 4689999999999999999999999 99999999999999999999999999987543222
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............ .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~~-~------- 218 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--------EDELFQSIMEHN-V------- 218 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C-------
Confidence 12234568999999999999999999999999999999999999997421 122222222211 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
..+...+.++.+++.+|++.+|++|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1233345678999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.07 Aligned_cols=247 Identities=28% Similarity=0.466 Sum_probs=202.1
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.+|++.+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588999999999999999975 57889999986542 346788999999999999999999988654 4799999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.+++.......+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999876556789999999999999999999998 99999999999999999999999999997643221
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||... ....+.... ..+...
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~-~~~~~~--------- 216 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM--------SLKEVKECV-EKGYRM--------- 216 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC--------CHHHHHHHH-hCCCCC---------
Confidence 12234568999999998899999999999999999997 88888632 122222222 222111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
..+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=303.81 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=207.7
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||.|+||.||+|... +++.+|+|.+........+.+.+|++++++++|||++++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357899999999999999999654 5788999999877666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+........
T Consensus 82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 9999999998764 35689999999999999999999999 999999999999999999999999999976543221
Q ss_pred cccCcccCCCcccchhcccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTC---RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ..-.... ...... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~~-~~~~~~---~~ 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFLI-SKSNFP---PP 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HhccCC---Cc
Confidence 22335688899999999876 889999999999999999999999864221 1111111 111000 00
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.+ ..+...+.++.+++.+|++.+|.+||++.+|+.
T Consensus 225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 112345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=313.03 Aligned_cols=261 Identities=24% Similarity=0.306 Sum_probs=195.9
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhcc---CCCceeeEeeeecc-----CC
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRV---QHPNLVTLIGYHVS-----EA 870 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 870 (1082)
+|++.+.||+|+||+||+|... +++.||+|.+..... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999654 689999999875422 2233456677766655 79999999998764 34
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5899999996 5899999876556689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC---
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG--- 1027 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 1027 (1082)
...... ......|+..|+|||++.+..++.++||||+||++|||++|+.||..... ........ ......
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~~~~~~~~-~~~~~~~~~ 229 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIF-DLIGLPPED 229 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----HHHHHHHH-HHhCCCChh
Confidence 764322 22335689999999999998999999999999999999999999863211 11111111 111000
Q ss_pred -CCc------cccccccC---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1028 -RPC------EFFTAGLW---DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1028 -~~~------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.. ..+.+... .........++.+++.+|++.||++||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00000000 00112335678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=306.93 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=205.9
Q ss_pred cCccccceecccCceEEEEEEEc------CCeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
.+|++.+.||+|+||.||+|+.. +.+.||+|.+...... ..+.+.+|++++++++|+|++++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999754 2467999988654433 4577999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 874 LIYNYLPGGNLEKFIQDRPR-------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
+||||+++++|.++++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999986542 2689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 947 GLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 947 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ........ .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--------~~~~~~~~-~ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------DEEVLNRL-Q 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--------hHHHHHHH-H
Confidence 9987554333333334456788999999988889999999999999999998 777875221 11222221 1
Q ss_pred cCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
.+... . ..+...+..+.+++.+|++.+|++||++.|++++|+
T Consensus 233 ~~~~~-~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLE-L-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcC-C-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111 0 112234468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=319.35 Aligned_cols=240 Identities=25% Similarity=0.298 Sum_probs=190.8
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHH-HHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEI-RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999654 578899999875321 2223344444 456888999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
++|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 9999999863 4678889999999999999999999 99999999999999999999999999997543222 2233
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++||||+||++|||++|+.||... ...+......... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~-~----------~~ 215 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------NTAEMYDNILNKP-L----------QL 215 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC--------CHHHHHHHHHhCC-c----------CC
Confidence 457999999999999999999999999999999999999999632 1222222222211 0 11
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
+......+.+++.+|++.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 223456789999999999999999876443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=309.46 Aligned_cols=250 Identities=22% Similarity=0.408 Sum_probs=206.3
Q ss_pred cCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.+|++.+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+..++.++|||++++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 468999999999999999995 4568999999997665556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999998753 589999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||.... ...........+ ....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~--------~~~~~~~~~~~~-~~~~------- 235 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN--------PLRALYLIATNG-TPEL------- 235 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcC-Cccc-------
Confidence 223468889999999998889999999999999999999999996421 111111111111 1110
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+||+.+|++||++.+|+.+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1123345578899999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=304.03 Aligned_cols=254 Identities=23% Similarity=0.436 Sum_probs=203.9
Q ss_pred CccccceecccCceEEEEEEEcC--CeEEEEEEeecCc----------cccHHHHHHHHHHHhc-cCCCceeeEeeeecc
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIP--GVVVAVKRLSVGR----------FQGVQQFAAEIRTLGR-VQHPNLVTLIGYHVS 868 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 868 (1082)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++|||++++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999997654 6889999885431 2234556778887764 799999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 869 EAEMFLIYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 869 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
.+..++||||+++++|.+++... ....+++..+++++.|++.|+.|||+.. +++||||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988542 2456899999999999999999999632 8999999999999999999999999
Q ss_pred ccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 947 GLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 947 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
|.+....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||... .......... .
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~--------~~~~~~~~~~-~ 227 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--------NMLSLATKIV-E 227 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc--------CHHHHHHHHh-h
Confidence 9998765433 334456899999999999988999999999999999999999998632 1222222222 1
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
+..... ........+.+++.+|++.+|++||++.||.+++++
T Consensus 228 ~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111111 111234678999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=302.47 Aligned_cols=251 Identities=28% Similarity=0.486 Sum_probs=205.1
Q ss_pred ccccceecccCceEEEEEEEcC-----CeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 803 FNVQNCIGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
+++.+.||+|+||.||+|...+ +..||+|++...... ..+.+..|++.+++++|+|++++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999997653 388999999765433 5678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.+++.......+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999875443389999999999999999999999 99999999999999999999999999998775543
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
........++..|+|||.+.+..++.++||||+|+++|||++ |..||... .......... .+...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~~~----- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------SNEEVLEYLK-KGYRL----- 223 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHh-cCCCC-----
Confidence 332222347789999999988889999999999999999998 77777531 2222222222 11111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
..+...+.++.+++.+|++.+|++|||+.|+++.|
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11223456899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=313.52 Aligned_cols=261 Identities=21% Similarity=0.311 Sum_probs=199.2
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56899999999999999999654 578999999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 96 5898888765 34588999999999999999999999 999999999999999999999999999976543222
Q ss_pred cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC--------
Q 045553 959 ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP-------- 1029 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 1029 (1082)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+.........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhhcc
Confidence 2223467899999998865 56889999999999999999999999643211 111111111000000
Q ss_pred -ccccccccCCC-------CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1030 -CEFFTAGLWDC-------GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1030 -~~~~d~~l~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.+..+...... .....+.++.+++.+|++.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 01123457889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=321.26 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=198.5
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC------
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------ 869 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 869 (1082)
...+|++.+.||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999954 468999999986542 23346678899999999999999999987643
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
...++||||++ +++.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 35799999995 577777653 478899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH-------
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM------- 1022 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 1022 (1082)
+..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ....+...
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~ 237 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-------YIDQWNKVIEQLGTP 237 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHHhCCC
Confidence 865332 22334578999999999999999999999999999999999999996421 11111111
Q ss_pred --------------HHhcC-CCccccccc-----cC---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1023 --------------LLLQG-RPCEFFTAG-----LW---DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1023 --------------~~~~~-~~~~~~d~~-----l~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..... .......+. .. ...+......+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 000000000 00 00112234578999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.37 Aligned_cols=238 Identities=26% Similarity=0.345 Sum_probs=190.8
Q ss_pred ceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHH-HHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIR-TLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||+||+|+. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999964 468999999986532 223344555554 46789999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 999998876 34689999999999999999999999 9999999999999999999999999998753221 12233
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++|||||||++|||++|+.||... +..+......... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--------~~~~~~~~~~~~~-~----------~~ 215 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--------DVAEMYDNILHKP-L----------VL 215 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC--------CHHHHHHHHHcCC-c----------cC
Confidence 457999999999999999999999999999999999999999632 2222222222211 1 01
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQ 1069 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~e 1069 (1082)
+......+.+++.+|++.+|.+||++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1234457889999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.61 Aligned_cols=253 Identities=30% Similarity=0.496 Sum_probs=202.8
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHH--HHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQ--QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
|++.+.||+|+||+||+|+.. +++.||+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999765 4678999999877543322 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.. ...+++..+..++.|+++||++||+. +|+||||||+||++++++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred ccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 99999999983 35689999999999999999999999 99999999999999999999999999998652 22233
Q ss_pred ccCcccCCCcccchhcc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||++. +..++.++||||+|+++|+|++|+.||.... ..+............ ... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~-~~~----~~~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRP-LPS----SSQ 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTH-HHH----HTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhccccc-ccc----ccc
Confidence 44567899999999998 8889999999999999999999999987431 111112221111111 000 000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
........+.+++.+|++.+|++||++.+++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001123789999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=315.07 Aligned_cols=257 Identities=19% Similarity=0.259 Sum_probs=196.0
Q ss_pred ccceeccc--CceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 805 VQNCIGSG--GFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 805 ~~~~lg~G--~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
+.++||+| +|++||++.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999954 568999999987543 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc-
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH- 958 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 958 (1082)
++|+|.+++..+....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999765455689999999999999999999999 9999999999999999999999999875433211110
Q ss_pred -----cccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 959 -----ATTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 959 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +...... .+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~-~~~~~~ 229 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--------QMLLEKL-NGTVPC 229 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--------HHHHHHh-cCCccc
Confidence 1112346778999999976 46889999999999999999999999642110 1111110 111111
Q ss_pred cccc-------------------cc-----------------CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 FFTA-------------------GL-----------------WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~-------------------~l-----------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.++. .. ...........+.+++.+|++.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 1000 00 000112334678999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=317.77 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=201.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.++||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++..++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36889999999999999999765 47889999986421 223345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.++++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999864 34689999999999999999999999 99999999999999999999999999997654333
Q ss_pred CccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 957 THATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
........||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~--------~~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHKERFQ 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC--------CHHHHHHHHhCCCcccc
Confidence 33333457999999999986 346788999999999999999999999632 23333333322211111
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS--RPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 1073 (1082)
. . ......+.++.+++.+|+..++++ ||++.|++++
T Consensus 229 ~-p-----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 F-P-----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C-C-----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 011234567888899988665554 7899999776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=318.20 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=201.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|..++...+|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36899999999999999999754 57899999986421 233455788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999864 34689999999999999999999999 99999999999999999999999999998765443
Q ss_pred CccccCcccCCCcccchhccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 957 THATTDVAGTFGYVAPEYAMT-----CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
........|++.|+|||++.+ +.++.++|||||||++|||++|+.||... +..+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--------~~~~~~~~i~~~~~~~~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHEERFQ 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC--------CHHHHHHHHHcCCCccc
Confidence 333334579999999999875 46788999999999999999999999632 12222222222111110
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS--RPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 1073 (1082)
+.. .....+.++.+++.+|+...+++ |+++.++.++
T Consensus 229 -~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 -FPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -CCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 01123467888999998876554 5688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=323.61 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=197.6
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||+|+++++++.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6888999999999999999654 68999999986432 2345667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 82 FLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999763 4689999999999999999999999 999999999999999999999999999875422100
Q ss_pred ----------------------------------ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 045553 958 ----------------------------------HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKAL 1003 (1082)
Q Consensus 958 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~ 1003 (1082)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0112357999999999999999999999999999999999999999
Q ss_pred CCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 045553 1004 DPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS---MRQVAQQ 1073 (1082)
Q Consensus 1004 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~~ 1073 (1082)
.... ................ +.+ ......++.+++.+++ .+|++|++ +.|+.++
T Consensus 237 ~~~~--------~~~~~~~i~~~~~~~~-~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSET--------PQETYRKVMNWKETLV-FPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCC--------HHHHHHHHHcCCCcee-cCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 6421 1222222221111000 000 1123456778888866 49999985 6666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=305.83 Aligned_cols=255 Identities=25% Similarity=0.466 Sum_probs=206.1
Q ss_pred cCccccceecccCceEEEEEEEcC-C----eEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP-G----VVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~-~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|++.+.||+|+||.||+|...+ | ..||+|....... ....++.+|+..+++++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568889999999999999997542 3 3689998865543 345678899999999999999999999887 78999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++|+|.++++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999875 34589999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCcc-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 955 SETHA-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 955 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
..... .....++..|+|||.+....++.++||||||+++||+++ |+.||+.. ...++..... .+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~-~~~~~-- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--------PAVEIPDLLE-KGERL-- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC--------CHHHHHHHHh-CCCCC--
Confidence 33221 112234568999999988899999999999999999998 99998632 2223322222 22111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+......+.+++.+||..+|.+||++.++++.|+++.
T Consensus 231 -------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 231 -------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 112234457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=337.75 Aligned_cols=261 Identities=26% Similarity=0.369 Sum_probs=202.9
Q ss_pred HHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc--CCeE
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEM 872 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 872 (1082)
....+|.+.+.||+|+||+||+|... ++..||+|.+.... ......|..|+.++++++||||+++++++.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999654 57889999987542 2345678899999999999999999998754 4578
Q ss_pred EEEEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEeccCCCCCEEEcCC--------
Q 045553 873 FLIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECV----PRVLHRDIKPSNILLDNN-------- 938 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlk~~Nill~~~-------- 938 (1082)
|+||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997632 3469999999999999999999998521 259999999999999642
Q ss_pred ---------CcEEEeecccceecCCCCCccccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 045553 939 ---------LNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALDPSF 1007 (1082)
Q Consensus 939 ---------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~~~~ 1007 (1082)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~- 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA- 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC-
Confidence 348999999998764322 2234579999999999854 45889999999999999999999999632
Q ss_pred cCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHHhhhC
Q 045553 1008 CSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVA--QQLKQIQ 1078 (1082)
Q Consensus 1008 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~--~~L~~i~ 1078 (1082)
....+++... ..+... . ....+.++.+|+..||+.+|++||++.|++ ..+..+.
T Consensus 247 ------~~~~qli~~l-k~~p~l-----p-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 247 ------NNFSQLISEL-KRGPDL-----P-----IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred ------CcHHHHHHHH-hcCCCC-----C-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 1223333222 221100 0 012346789999999999999999999998 3454443
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=306.84 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=189.0
Q ss_pred eecccCceEEEEEEEcC-------------------------CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeE
Q 045553 808 CIGSGGFGATYKAEIIP-------------------------GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 862 (1082)
.||+|+||.||+|.+.. ...||+|++..........|.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999996421 24589998865544445678899999999999999999
Q ss_pred eeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC---
Q 045553 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL--- 939 (1082)
Q Consensus 863 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~--- 939 (1082)
++++......++||||+++|+|..++... ...+++..+.+++.|+++||+|||+. +|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998754 34688999999999999999999999 999999999999997643
Q ss_pred ----cEEEeecccceecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCccCCCCC
Q 045553 940 ----NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELI-SDKKALDPSFCSFGNG 1013 (1082)
Q Consensus 940 ----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~ell-tg~~p~~~~~~~~~~~ 1013 (1082)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---- 228 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS---- 228 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH----
Confidence 4899999988643221 12357788999998865 56899999999999999984 788888643211
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
....+ ..... ..+......+.+++.+||+.+|++||+|.+|++.|+
T Consensus 229 -~~~~~----~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 -EKERF----YEKKH-----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHH----HHhcc-----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 11110 011112346899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=323.43 Aligned_cols=260 Identities=22% Similarity=0.276 Sum_probs=199.7
Q ss_pred hcCccccceecccCceEEEEEEEc---CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII---PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
..+|.+.+.||+|+||.||+|... .+..||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999643 3578999987643 23568999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
|++ +++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 166 e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999 4789888854 45789999999999999999999999 99999999999999999999999999997664432
Q ss_pred Cc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc---
Q 045553 957 TH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF--- 1032 (1082)
Q Consensus 957 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1032 (1082)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...++. .... ..+.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~-~~~~-~~~~~~~ 316 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRC-MQVH-PLEFPQN 316 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHH-hccC-ccccCCc
Confidence 22 2234679999999999999999999999999999999999999996543210 01111111110 0000 0000
Q ss_pred -----------cccccCCCC--C-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 -----------FTAGLWDCG--P-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 -----------~d~~l~~~~--~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+....+..+ + .....++..++.+|+..+|++||++.|++.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0 1224568889999999999999999999865
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=317.53 Aligned_cols=237 Identities=27% Similarity=0.361 Sum_probs=190.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHH-HHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIR-TLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|+.. +++.||+|++..... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999754 588999999865321 22334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
++|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 999988876 34688899999999999999999999 99999999999999999999999999987532222 2233
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|++.|+|||++.+..++.++|||||||++|||++|+.||... +..+......... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~-~----------~~ 215 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------DVSQMYDNILHKP-L----------QL 215 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC--------CHHHHHHHHhcCC-C----------CC
Confidence 457899999999999989999999999999999999999999632 2223333322211 0 12
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMR 1068 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ 1068 (1082)
+......+.+++.+|++.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 233456789999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=309.33 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=202.1
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466778899999999999964 457899999987443 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.. ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++++|||++........ .
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 99999999864 4688999999999999999999999 999999999999999999999999999976643222 2
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
.....|+..|+|||++.+..++.++||||||+++|||++|+.|+...... .+... ...+.. +
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~-~~~~~~-----~---- 219 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLFL-IPKNSP-----P---- 219 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHhh-hhcCCC-----C----
Confidence 22346788999999999989999999999999999999999998632211 11111 111111 1
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+..+.+++.+|++.+|++||+|.||+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122345678999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=307.95 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=206.3
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|||++++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356899999999999999999764 6899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999998764 34689999999999999999999999 999999999999999999999999999876533222
Q ss_pred cccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 959 ATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
......|+..|+|||++. +..++.++||||||+++|||++|+.||.... ..+.+... ..+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~~~~- 228 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--------PMRVLLKI-LKSEPPTL- 228 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--------HHHHHHHH-hcCCCCCc-
Confidence 223346889999999975 3456789999999999999999999986421 11222222 11111111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+.++.+++.+|++.+|++||++.+|+++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 ------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1122345678899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.86 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=203.8
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-----cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-----FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
+|+..+.||+|+||.||+|... ++..||+|.+.... .+..+.+.+|+++++.++|+|++++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999765 78999999986543 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999864 3588999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCccccCcccCCCcccchhcccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCR-VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ...............
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~---- 221 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELP---- 221 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCC----
Confidence 2 223456889999999988766 8999999999999999999999987432 112222211111111
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|++.+|++||++.+++.+
T Consensus 222 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 -----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1122345678899999999999999999999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=313.19 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=203.2
Q ss_pred hcCccccceecccCceEEEEEEEc-CCe----EEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGV----VVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
..+|+..+.||+|+||.||+|.+. +|. .||+|.+..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 346788899999999999999653 343 578888865432 3344688999999999999999999998754 567
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999999865 34688999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 954 TSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 954 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..++. .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--------~~~~~-~~~~~~~~~- 230 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--------TREIP-DLLEKGERL- 230 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHCCCCC-
Confidence 33221 2223345778999999999999999999999999999997 888886321 11111 122222111
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+..+...+.+++.+||..+|++||++.++++.|+++..
T Consensus 231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1112334578999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.40 Aligned_cols=248 Identities=24% Similarity=0.421 Sum_probs=201.4
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCccc---------cHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---------GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
+|.+.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999964 45889999988654321 12567889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999764 4688899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-----ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 952 LGTSET-----HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 952 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
...... .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||.... . ..-+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~-~~~~~~~-~~ 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-------Q-LQAIFKI-GE 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-------H-HHHHHHH-hc
Confidence 642211 11123458889999999998889999999999999999999999996421 1 1111111 11
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
. .....+...+..+.+++.+|++.+|++||++.||++
T Consensus 227 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 N---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1 011122344568899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=328.44 Aligned_cols=385 Identities=23% Similarity=0.323 Sum_probs=250.6
Q ss_pred CCCCCEEEcccCCCc-ccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEE
Q 045553 109 LTQLRVLLLAFNGFS-GELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187 (1082)
Q Consensus 109 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 187 (1082)
|+-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-..++.|+.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 444555666666666 356666666666666666666666 66666666666666666666666 455566666666666
Q ss_pred EcccCccc-ccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCc
Q 045553 188 SLSFNLLS-GSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF 266 (1082)
Q Consensus 188 ~L~~N~l~-~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 266 (1082)
++..|++. .-+|..++ .+..|+.|+|++|+++ ..|..+...+++-.|+||+|+|..+....|.+|+.|-.||||+|+
T Consensus 84 ~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence 66666655 23455555 3666666666666666 666666666777777777777764333455667777777777777
Q ss_pred CcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcc-cCCCC
Q 045553 267 LSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNL-EGIFP 345 (1082)
Q Consensus 267 l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l-~~~~~ 345 (1082)
+. .+|..+.++..|++|.|++|++..++. ..+..|+.|+.|.+++.+- ..-+|
T Consensus 162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~hfQL-------------------------rQLPsmtsL~vLhms~TqRTl~N~P 215 (1255)
T KOG0444|consen 162 LE-MLPPQIRRLSMLQTLKLSNNPLNHFQL-------------------------RQLPSMTSLSVLHMSNTQRTLDNIP 215 (1255)
T ss_pred hh-hcCHHHHHHhhhhhhhcCCChhhHHHH-------------------------hcCccchhhhhhhcccccchhhcCC
Confidence 76 566666677777777776665543321 1122233344444444321 12234
Q ss_pred cccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceecCCCCCCccccc
Q 045553 346 QNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSK 425 (1082)
Q Consensus 346 ~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~ 425 (1082)
..+..+.+|..+|||.|.+. .+|+.+.++++|+.|+||+|+|+..-.
T Consensus 216 tsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~-------------------------------- 262 (1255)
T KOG0444|consen 216 TSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNM-------------------------------- 262 (1255)
T ss_pred CchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeec--------------------------------
Confidence 44555555555555555555 555555555555555555555541100
Q ss_pred ccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCcc
Q 045553 426 MSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKG 505 (1082)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~ 505 (1082)
T Consensus 263 -------------------------------------------------------------------------------- 262 (1255)
T KOG0444|consen 263 -------------------------------------------------------------------------------- 262 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCC-CCCc
Q 045553 506 NLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ-GPLP 584 (1082)
Q Consensus 506 ~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p 584 (1082)
.+.. -.+|+.|+||.|+++ ..|.+++++++|+.|++.+|++. .-+|
T Consensus 263 ---------------------------~~~~-----W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiP 309 (1255)
T KOG0444|consen 263 ---------------------------TEGE-----WENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIP 309 (1255)
T ss_pred ---------------------------cHHH-----Hhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCc
Confidence 0000 023777888888887 66888999999999999999886 3478
Q ss_pred ccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCc
Q 045553 585 SYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSS 664 (1082)
Q Consensus 585 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 664 (1082)
..++.|.+|+.+..++|++. .+|+.+..|..|+.|.|++|++. .+|+.+.-|+.|+.|||.+|.---.+|.--..-++
T Consensus 310 SGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~ 387 (1255)
T KOG0444|consen 310 SGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKK 387 (1255)
T ss_pred cchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhc
Confidence 88999999999999999998 88999999999999999999988 78888988999999999998766455554333455
Q ss_pred ccEEecc
Q 045553 665 LSIFDVS 671 (1082)
Q Consensus 665 L~~l~ls 671 (1082)
|..-++.
T Consensus 388 lefYNID 394 (1255)
T KOG0444|consen 388 LEFYNID 394 (1255)
T ss_pred ceeeecc
Confidence 5554443
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=307.57 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=205.4
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999654 68999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.++++.. .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999999864 689999999999999999999999 999999999999999999999999999987754322
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
......|+..|+|||+..+..++.++||||||+++|||++|+.||..... ..... .+..+......+
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~-~~~~~~~~~~~~---- 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLF-LIPKNNPPSLEG---- 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHH-HhhhcCCCCCcc----
Confidence 22334688899999999998899999999999999999999999964321 11111 111221111111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...+..+.+++.+|+..+|++||++.+++++
T Consensus 221 ----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 ----NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0144578899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.52 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=205.0
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999964 468899999987543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-CcEEEeecccceecCCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-LNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~~~~~~~ 957 (1082)
+++++|.+++.......+++..+.+++.|++.|++|||+. +++||||+|+||+++++ +.+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999876556789999999999999999999999 99999999999999865 4689999999987643322
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||... +....+....... ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~--------~~~~~~~~~~~~~-~~------- 219 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA--------NLPALVLKIMSGT-FA------- 219 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC--------chHHHHHHHHhcC-CC-------
Confidence 22346889999999999888999999999999999999999998632 1222222222211 11
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+.++.+++.+||+.+|++|||+.|++++
T Consensus 220 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 --PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1122345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=307.92 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=198.9
Q ss_pred ceecccCceEEEEEEEcC-------CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 807 NCIGSGGFGATYKAEIIP-------GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+.||+|+||.||+|+..+ +..||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997542 2579999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-----cEEEeeccc
Q 045553 879 LPGGNLEKFIQDRP-----RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-----NAYLSDFGL 948 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~DfGl 948 (1082)
+++++|.++++... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 23478999999999999999999998 999999999999999877 899999999
Q ss_pred ceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 949 ARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 949 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--------~~~~~~~~-~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--------NQEVLQHV-TA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--------HHHHHHHH-hc
Confidence 9765433221 1222345678999999999999999999999999999998 999886321 11221211 11
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
+... ..+...+..+.+++.+|++.+|++||++.+|.+.|++
T Consensus 229 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111 1223445688999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=307.98 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=207.6
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.+|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.....+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888899999999999999654 58899999886543 33457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++... ..+++..+..++.+++.|+.|||+.. +++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 9999999998763 46899999999999999999999732 89999999999999999999999999987543221
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCC---CCccHHHHHHHHHhcCCCcccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFG---NGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||+......+ .......+......+.. .
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----- 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-P----- 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-C-----
Confidence 2235689999999999888999999999999999999999999975432111 11122233333222211 1
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
.+ .....+.++.+++.+|++.+|++||++.||+++..
T Consensus 232 ~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 RL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00 11124567899999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=309.62 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=204.6
Q ss_pred cHHHHHHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeec--
Q 045553 792 TYENVVRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHV-- 867 (1082)
Q Consensus 792 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-- 867 (1082)
.++.+..++++|++.+.||+|+||.||+|.. .+++.+|+|++.... ....++.+|+.+++++ +|||++++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3455666888999999999999999999965 457899999876432 2345678899999999 6999999999874
Q ss_pred ---cCCeEEEEEeecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEE
Q 045553 868 ---SEAEMFLIYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY 942 (1082)
Q Consensus 868 ---~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 942 (1082)
.+...++||||+++++|.++++.. ....+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 345789999999999999988642 245688999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHH
Q 045553 943 LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 943 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 1017 (1082)
|+|||+++....... ......|+..|+|||++. +..++.++||||+||++|||++|+.||..... ..
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-------~~ 236 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------MR 236 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-------hH
Confidence 999999987643222 223346899999999875 34578899999999999999999999864311 11
Q ss_pred HHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
.... .......... .+.....++..++.+|++.+|++||++.||+++.
T Consensus 237 ~~~~--~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ALFK--IPRNPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHhh--ccccCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111 0111111111 1122345799999999999999999999998763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.14 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=204.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..|+..+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|||++++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35778889999999999999754 58999999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++.. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999999875 3588899999999999999999999 999999999999999999999999999987643322
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
......++..|+|||++.+..++.++|||||||++|||++|+.||...... ...... ..+. .
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~-~~~~---------~ 218 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFLI-PKNN---------P 218 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhhh-hcCC---------C
Confidence 222346788999999999888999999999999999999999998643211 111111 1111 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...+...+..+.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12234566789999999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=312.33 Aligned_cols=195 Identities=26% Similarity=0.435 Sum_probs=161.9
Q ss_pred cceecccCceEEEEEEEc---CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeecc--CCeEEEEEeecC
Q 045553 806 QNCIGSGGFGATYKAEII---PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEMFLIYNYLP 880 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 880 (1082)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 367999999999999754 46889999986543 23457889999999999999999998854 45689999999
Q ss_pred CCCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE----cCCCcEEEeecccc
Q 045553 881 GGNLEKFIQDRP-------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLA 949 (1082)
Q Consensus 881 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGla 949 (1082)
+++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 468888876421 23589999999999999999999999 99999999999999 45678999999999
Q ss_pred eecCCCCC--ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 045553 950 RLLGTSET--HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPS 1006 (1082)
Q Consensus 950 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~ 1006 (1082)
+.+..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87653322 12334678999999999977 45889999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=308.42 Aligned_cols=262 Identities=25% Similarity=0.373 Sum_probs=199.1
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|++|.||+|+.. ++..||+|++.... ....+.+.+|+.++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999754 68999999986542 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 879 LPGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 96 68999887643 35789999999999999999999999 999999999999999999999999999986543321
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-----------
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL----------- 1025 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 1025 (1082)
......+++.|+|||++.+ ..++.++||||||+++|||++|+.||...... ............
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhcchh
Confidence 2223357889999998865 45788999999999999999999998643110 000000000000
Q ss_pred ----cCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 ----QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ----~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
............ .......+.++.+++.+|++.||++|||+.+|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 00111235678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=318.48 Aligned_cols=258 Identities=22% Similarity=0.288 Sum_probs=197.8
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC------
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------ 869 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 869 (1082)
..++|++.+.||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 456899999999999999999964 458899999986532 23456678999999999999999999987543
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
...|+||||++ +++.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999995 578777753 478899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH-----
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL----- 1024 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 1024 (1082)
+..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+.....
T Consensus 174 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~~~ 244 (364)
T cd07875 174 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-------IDQWNKVIEQLGTP 244 (364)
T ss_pred cccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhcCCC
Confidence 865432 222345789999999999999999999999999999999999999964311 111111100
Q ss_pred ----------------hcCC-Cccc----cccccC----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 ----------------LQGR-PCEF----FTAGLW----DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ----------------~~~~-~~~~----~d~~l~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... .... +.+... ..........+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000 000000 00011224578899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=301.36 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=191.4
Q ss_pred eecccCceEEEEEEEcC---CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCC
Q 045553 808 CIGSGGFGATYKAEIIP---GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGN 883 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 883 (1082)
.||+|+||.||+|+..+ ...+|+|.+.... ......+.+|++.++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996543 3578888875443 2334578899999999999999999999999999999999999999
Q ss_pred HHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc-c
Q 045553 884 LEKFIQDRPR---RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-A 959 (1082)
Q Consensus 884 L~~~l~~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~ 959 (1082)
|.+++..... ...++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999987532 3356788899999999999999999 9999999999999999999999999998754322211 1
Q ss_pred ccCcccCCCcccchhccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 960 TTDVAGTFGYVAPEYAMT-------CRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
.....++..|+|||+... ..++.++|||||||++|||++ |..||.... ..+......... ..+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~-~~~ 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--------DEQVLKQVVREQ-DIK 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhhcc-Ccc
Confidence 223346778999998743 456789999999999999999 677775321 112222222222 112
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
..++.+ +......+.+++..|+ .||++||+++||++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222221 2234467788899998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=301.45 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=196.8
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-----cccHHHHHHHHHHHhccCCCceeeEeeeecc--CCeE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-----FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEM 872 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 872 (1082)
.+|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999965 468999999886432 1234568889999999999999999998765 3578
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
+++|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999999999864 3588999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCC--ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 953 GTSET--HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 953 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
..... .......++..|+|||++.+..++.++||||+||++|||++|+.||.... . ...+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-------~-~~~~~~~~~~~~-- 226 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-------A-MAAIFKIATQPT-- 226 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-------h-HHHHHHHhcCCC--
Confidence 32211 11223458889999999999889999999999999999999999986321 1 111111111111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.+ ..+......+..++ +|+..+|++||+|+||++
T Consensus 227 ---~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ---NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01 12233345566676 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.89 Aligned_cols=240 Identities=23% Similarity=0.307 Sum_probs=191.4
Q ss_pred ceecccCceEEEEEEEcC--------CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 807 NCIGSGGFGATYKAEIIP--------GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999996532 234888888655555567789999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc--------EEEeecccce
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN--------AYLSDFGLAR 950 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~DfGla~ 950 (1082)
+++|+|.++++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++. ++++|||.+.
T Consensus 81 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999875 33689999999999999999999999 9999999999999987765 6999999987
Q ss_pred ecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDK-KALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
..... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.... ....... ....
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~--------~~~~~~~-~~~~- 221 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD--------SQKKLQF-YEDR- 221 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc--------HHHHHHH-HHcc-
Confidence 54322 22457889999999986 45789999999999999999995 4443211 1111111 1110
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
. ..+.....++.+++.+|++.+|++||+++++++.|+
T Consensus 222 -~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -H---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -c---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 122233457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.89 Aligned_cols=238 Identities=26% Similarity=0.357 Sum_probs=190.6
Q ss_pred ceecccCceEEEEEEEcCC-----------eEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 807 NCIGSGGFGATYKAEIIPG-----------VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~-----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
+.||+|+||.||+|...+. ..|++|.+...... ...+.+|+.++++++|||++++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4689999999999976543 25788877654433 6788999999999999999999999888 788999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-------cEEEeeccc
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-------NAYLSDFGL 948 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl~DfGl 948 (1082)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999998753 3689999999999999999999999 999999999999999888 799999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccC--CCCchhhHHHHHHHHHHHHhC-CCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTC--RVSDKADVYSFGVVLLELISD-KKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
+..... .....++..|+|||++.+. .++.++||||||+++|||++| ..||..... ..+......
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--------~~~~~~~~~ 221 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--------SEKERFYQD 221 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--------hhHHHHHhc
Confidence 986543 1223567789999999876 789999999999999999994 666653211 111111111
Q ss_pred cCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
.. . .+......+.+++.+|++.+|++||++.||++.|+
T Consensus 222 ~~-~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH-R-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC-C-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11 0 01111268899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=307.66 Aligned_cols=260 Identities=22% Similarity=0.391 Sum_probs=205.8
Q ss_pred ccHHHHHHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeecc
Q 045553 791 LTYENVVRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVS 868 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 868 (1082)
.++.++..+.+.|++.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.+++++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34555556778899999999999999999965 458899999986543 2345688899999998 69999999998853
Q ss_pred ------CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEE
Q 045553 869 ------EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY 942 (1082)
Q Consensus 869 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 942 (1082)
....++||||+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999999876666788999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHH
Q 045553 943 LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 943 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 1017 (1082)
|+|||++........ ......|+..|+|||.+. +..++.++|||||||++|||++|+.||...... .
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~ 233 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------R 233 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------h
Confidence 999999876532221 223356899999999875 356788999999999999999999999643211 0
Q ss_pred HHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
. ... ........ ......+..+.+++.+||+.+|++||++.|+++
T Consensus 234 ~-~~~-~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 A-LFL-IPRNPPPK--------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h-hhh-HhhCCCCC--------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 11110000 011234568999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=316.87 Aligned_cols=193 Identities=26% Similarity=0.377 Sum_probs=166.6
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999765 4688999975432 23568999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+ .++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 138 HY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred cc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 99 56899988764 45789999999999999999999999 9999999999999999999999999999753222
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~ 1004 (1082)
.......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12234568999999999999999999999999999999998766653
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=327.68 Aligned_cols=264 Identities=21% Similarity=0.239 Sum_probs=193.3
Q ss_pred HHHHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCC------CceeeEeeeec
Q 045553 795 NVVRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH------PNLVTLIGYHV 867 (1082)
Q Consensus 795 ~~~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~ 867 (1082)
++....++|++.++||+|+||+||+|.. .+++.||||+++... .....+..|+++++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3344568899999999999999999964 458899999986432 223445667777776654 45888988887
Q ss_pred cC-CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-------
Q 045553 868 SE-AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL------- 939 (1082)
Q Consensus 868 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~------- 939 (1082)
.. ..+++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+.+ +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccc
Confidence 54 5789999988 78999988764 46899999999999999999999732 999999999999998765
Q ss_pred ---------cEEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCC
Q 045553 940 ---------NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSF 1010 (1082)
Q Consensus 940 ---------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~ 1010 (1082)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-- 350 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN-- 350 (467)
T ss_pred ccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--
Confidence 49999999876432 223446799999999999999999999999999999999999999974321
Q ss_pred CCCccHHHHHHHHHh---------------------cCCCccccccc----c-CCCC--ChHHHHHHHHHHHHcccCCCC
Q 045553 1011 GNGFNIVAWASMLLL---------------------QGRPCEFFTAG----L-WDCG--PHDDLIEMLNLAIMCTGESLS 1062 (1082)
Q Consensus 1011 ~~~~~~~~~~~~~~~---------------------~~~~~~~~d~~----l-~~~~--~~~~~~~l~~li~~cl~~~p~ 1062 (1082)
......+..... .+......++. + .... .......+.+|+.+|++.||+
T Consensus 351 ---~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 351 ---LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred ---HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 111111111000 00000000000 0 0000 001134578999999999999
Q ss_pred CCCCHHHHHHH
Q 045553 1063 SRPSMRQVAQQ 1073 (1082)
Q Consensus 1063 ~RPt~~ev~~~ 1073 (1082)
+|||+.|++++
T Consensus 428 ~R~ta~e~L~H 438 (467)
T PTZ00284 428 KRLNARQMTTH 438 (467)
T ss_pred hCCCHHHHhcC
Confidence 99999999873
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=303.09 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=207.1
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5788899999999999999765 58999999987653 244567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999999998753 578999999999999999999999 7 9999999999999999999999999998765322211
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
...++..|+|||+..+..++.++||||+|+++|+|++|+.||...... .....+.+....... ....
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~------ 224 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEP-PPRL------ 224 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCC-CCCC------
Confidence 156888999999999999999999999999999999999999754221 122333333332221 1111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......++.+++.+|+..+|++||++.|++.+
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 --PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011145679999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=300.02 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=191.4
Q ss_pred eecccCceEEEEEEEcCC---eEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCC
Q 045553 808 CIGSGGFGATYKAEIIPG---VVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGN 883 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 883 (1082)
.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+..++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999965443 345667665433 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC-Cccc
Q 045553 884 LEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE-THAT 960 (1082)
Q Consensus 884 L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~ 960 (1082)
|.++++... ....++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999998642 23467778889999999999999999 99999999999999999999999999986432211 1122
Q ss_pred cCcccCCCcccchhccc-------CCCCchhhHHHHHHHHHHHHhC-CCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 961 TDVAGTFGYVAPEYAMT-------CRVSDKADVYSFGVVLLELISD-KKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
....++..|+|||+... ..++.++||||||+++|||+++ ..||... ...........++ ....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--------~~~~~~~~~~~~~-~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--------SDREVLNHVIKDQ-QVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHhhc-cccc
Confidence 34567889999998753 3457899999999999999975 5566421 1223333333222 2233
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
.++.+.. .....+.+++..|| .+|++||++.||++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333322 23457888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=307.10 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=201.2
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.++||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999765 589999998864322 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|++++++..+.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998877653 3589999999999999999999999 99999999999999999999999999998764433
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc-----
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE----- 1031 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1031 (1082)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||.... ....+.......+...+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS-------DIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc-------hHHHHHHHHHHhCCCchhhHHH
Confidence 22334568899999999875 457889999999999999999998886321 11111111110000000
Q ss_pred ---------ccccccCC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 ---------FFTAGLWD-----CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ---------~~d~~l~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+..+.... ......+..+.+++.+|++.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000 0012345679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=298.82 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=211.2
Q ss_pred hcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccc--cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.+-|+..+.||+|.|+.|-+|+ .-+|..||||++...... ....+..|++.|+-++|||||+++++...+...|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3458889999999999999994 457999999999776443 3457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE-cCCCcEEEeecccceecCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL-DNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~DfGla~~~~~~ 955 (1082)
|.=.+|+|++|+.++ ...+.+....+++.||+.|+.|.|+. .+||||+||+||.+ .+-|-+|++|||++-.+.+.
T Consensus 97 ELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999999887 56799999999999999999999999 99999999999866 56789999999999877554
Q ss_pred CCccccCcccCCCcccchhcccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVS-DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. ...+.+|+..|.|||++.+..|+ ++.||||+||++|-+++|+.||.+.... + .+..++|
T Consensus 173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--------E---------TLTmImD 233 (864)
T KOG4717|consen 173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--------E---------TLTMIMD 233 (864)
T ss_pred c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------h---------hhhhhhc
Confidence 3 34567899999999999998887 4789999999999999999999753222 1 1122333
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
... ..|.....+..++|..|+..||.+|.+..||+.
T Consensus 234 CKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 CKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 332 246677889999999999999999999999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=301.00 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=200.2
Q ss_pred ccccceecccCceEEEEEEEc----CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCC------
Q 045553 803 FNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA------ 870 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 870 (1082)
|.+.+.||+|+||.||+|.+. ++..||||++.... ....+++.+|++++++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999653 36889999986542 234567889999999999999999999876532
Q ss_pred eEEEEEeecCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP----RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
..++++||+++|+|.+++.... ...+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875421 23578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 947 GLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 947 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
|.++........ ......++..|++||...+..++.++||||||+++|||++ |+.||.... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--------NSEIYNYLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--------HHHHHHHHH
Confidence 999866433221 1222345678999999998889999999999999999999 788875321 112222221
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...... .+......+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 230 ~~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 230 KGNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred cCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 111110 11234568999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=314.97 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=196.9
Q ss_pred HHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccC-----
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE----- 869 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 869 (1082)
+..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999964 5688999999865322 2345677899999999999999999887543
Q ss_pred -CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 870 -AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 870 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 4579999998 8899988864 3689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-c
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-Q 1026 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 1026 (1082)
++..... .....|+..|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+.+..... .
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~ 232 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND--------YIDQLKRIMEVV 232 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHHh
Confidence 9865432 234568999999999877 568899999999999999999999986321 1111111100 0
Q ss_pred CCC-ccccc-----------cccCCCCC--------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1027 GRP-CEFFT-----------AGLWDCGP--------HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1027 ~~~-~~~~d-----------~~l~~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.. .+... ..+. ..+ ......+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000 0000 000 0122357899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=307.01 Aligned_cols=261 Identities=20% Similarity=0.285 Sum_probs=199.7
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46889999999999999999654 58899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 96 6999998765 34688999999999999999999999 999999999999999999999999999976533222
Q ss_pred cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC---CCccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG---RPCEFFT 1034 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d 1034 (1082)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+....... .....++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCChhhchhhhc
Confidence 2223457889999999865 4578899999999999999999999964321 11111111110000 0000000
Q ss_pred ---------cccCCC----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1035 ---------AGLWDC----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1035 ---------~~l~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
+..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 01123457889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=318.72 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=210.1
Q ss_pred cccceecccCceEEEEEEEc-CC----eEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 804 NVQNCIGSGGFGATYKAEII-PG----VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 804 ~~~~~lg~G~~g~Vy~a~~~-~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
+-.++||+|+||+||+|.|- +| -+||+|++... ..+...++.+|+-.|.+++|||+++++|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 44578999999999999653 33 56899988644 3456788999999999999999999999998766 889999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
||+.|+|.+|++.+ +..+.....+.|..|||+||.|||.+ +++||||..+|||+.+-..+||.|||+++....++.
T Consensus 778 ~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999987 56788899999999999999999999 999999999999999999999999999998865544
Q ss_pred c-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 958 H-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 958 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. ......-.+.|||-|.+....++.++|||||||.+||++| |..|++... ..+ +.+.+..
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--------~~e----------I~dlle~ 915 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--------AEE----------IPDLLEK 915 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--------HHH----------hhHHHhc
Confidence 3 2333345678999999999999999999999999999987 888876432 111 1222223
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+-..|+.+..++..++.+||..|++.||+++++...+.+..
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 3333567788899999999999999999999999999887653
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=307.73 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=203.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc---cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++.++.++|+||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999655 4899999999765332 4567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+.+++|.+++.......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999876567799999999999999999999999 99999999999999999999999999987553221
Q ss_pred Cc----------------------------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCcc
Q 045553 957 TH----------------------------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFC 1008 (1082)
Q Consensus 957 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~ 1008 (1082)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11134688899999999998999999999999999999999999863211
Q ss_pred CCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 045553 1009 SFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS----MRQVAQ 1072 (1082)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~ev~~ 1072 (1082)
...+ ....... . .-......+..+.+++.+|++.+|++||+ +.|+++
T Consensus 238 -------~~~~-~~~~~~~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 -------DETF-SNILKKE-V--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -------HHHH-HHHhcCC-c--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111 1111111 0 00011124678999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=301.68 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=201.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888999999999999999765 58999999986442 2234567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|++++++..+... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999888887764 34689999999999999999999999 999999999999999999999999999987654332
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-----------
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL----------- 1025 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 1025 (1082)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ..... ......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV----DQLYL-IRKTLGDLIPRHQQIFS 229 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH----HHHHH-HHHHhCCCChHHhhhcc
Confidence 2223457889999999876 55789999999999999999999999643211 01111 111000
Q ss_pred cCCC-ccccccccCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 QGRP-CEFFTAGLWDCGP-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~-~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... .....+......+ ...+..+.+++.+|++.+|++||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 0000000000001 1234678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=342.75 Aligned_cols=449 Identities=26% Similarity=0.307 Sum_probs=307.4
Q ss_pred cccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCC
Q 045553 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGF 184 (1082)
Q Consensus 105 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 184 (1082)
.+..--+|+.|+|++|++. ..|..+..+.+|+.|.++.|.|. .+|.+..++.+|++|+|.+|++. ..|..+..+.+|
T Consensus 40 ~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl 116 (1081)
T KOG0618|consen 40 FVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNL 116 (1081)
T ss_pred HhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcc
Confidence 3444555999999999998 89999999999999999999999 88999999999999999999998 899999999999
Q ss_pred cEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCC
Q 045553 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSR 264 (1082)
Q Consensus 185 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 264 (1082)
+.|++++|++. .+|..+. .+..++.+..++|..... ++... ++.+++..|.+.+.++..+..++. .|+|.+
T Consensus 117 ~~LdlS~N~f~-~~Pl~i~-~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~ 187 (1081)
T KOG0618|consen 117 QYLDLSFNHFG-PIPLVIE-VLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRY 187 (1081)
T ss_pred cccccchhccC-CCchhHH-hhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeeccc
Confidence 99999999998 8888876 478888889999832222 33322 788899999998888888887777 799999
Q ss_pred CcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCC
Q 045553 265 NFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF 344 (1082)
Q Consensus 265 N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 344 (1082)
|.+. -..+..+.+|+.|....|.+..+......+. ....++|.+....+. ..-.+|++++++.|+++...
T Consensus 188 N~~~---~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~-----~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp 257 (1081)
T KOG0618|consen 188 NEME---VLDLSNLANLEVLHCERNQLSELEISGPSLT-----ALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLP 257 (1081)
T ss_pred chhh---hhhhhhccchhhhhhhhcccceEEecCcchh-----eeeeccCcceeeccc--cccccceeeecchhhhhcch
Confidence 9986 3456777888888887776544332111110 011112222211110 11124445555555554433
Q ss_pred CcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceecCCCCCCcccc
Q 045553 345 PQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECS 424 (1082)
Q Consensus 345 ~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~ 424 (1082)
+++..+.+|+.|+..+|+++ .+|..+..+++|+.|++.+|.+...+|...++..|+.|+|..|+|.
T Consensus 258 -~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~------------ 323 (1081)
T KOG0618|consen 258 -EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLP------------ 323 (1081)
T ss_pred -HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhcccc------------
Confidence 44555555555555555553 4444444455555555555555444444444455555555555443
Q ss_pred cccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCc
Q 045553 425 KMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLK 504 (1082)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~ 504 (1082)
.+|+.+.....
T Consensus 324 ----------------------------------------------------~lp~~~l~v~~----------------- 334 (1081)
T KOG0618|consen 324 ----------------------------------------------------SLPDNFLAVLN----------------- 334 (1081)
T ss_pred ----------------------------------------------------ccchHHHhhhh-----------------
Confidence 11211000000
Q ss_pred cccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCc
Q 045553 505 GNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLP 584 (1082)
Q Consensus 505 ~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 584 (1082)
..+..|..+-|++. ..|..-...+..|+.|++.+|.++...-..+.++.+|++|+|++|+|.....
T Consensus 335 -------------~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpa 400 (1081)
T KOG0618|consen 335 -------------ASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPA 400 (1081)
T ss_pred -------------HHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCH
Confidence 00112333333333 3333333344558889999999987777778889999999999999985555
Q ss_pred ccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCc
Q 045553 585 SYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSS 664 (1082)
Q Consensus 585 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 664 (1082)
..+.++..|++|+||+|+++ .+|..+..++.|++|...+|+|. ..| .+..+++|+.+|||.|+|+...-.....-++
T Consensus 401 s~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~ 477 (1081)
T KOG0618|consen 401 SKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPN 477 (1081)
T ss_pred HHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcc
Confidence 67788999999999999999 78899999999999999999998 677 7888999999999999998443333333388
Q ss_pred ccEEeccCCcc
Q 045553 665 LSIFDVSFNNL 675 (1082)
Q Consensus 665 L~~l~ls~N~l 675 (1082)
|++||+++|..
T Consensus 478 LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 478 LKYLDLSGNTR 488 (1081)
T ss_pred cceeeccCCcc
Confidence 99999999974
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=303.72 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=203.3
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999754 68999999997654 23356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999987653 5689999999999999999999999 9999999999999999999999999999877544332
Q ss_pred cccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC------cc
Q 045553 959 ATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP------CE 1031 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 1031 (1082)
......|+..|+|||++.+. .++.++||||+|+++|||++|..||.... ......++......... .+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-----DIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-----HHHHHHHHHHHcCCCChHHHhhccC
Confidence 33345689999999998754 46889999999999999999977775321 11111111111100000 00
Q ss_pred cc--ccc-cC-------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 FF--TAG-LW-------DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~--d~~-l~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. +.. .. .....+....+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000 00 00011334789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=306.69 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=198.3
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|||++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999654 689999999865422 2235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++ ++|.+++... ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 96 6888888754 34689999999999999999999999 999999999999999999999999999986543322
Q ss_pred cccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC------Ccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR------PCE 1031 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 1031 (1082)
......++..|+|||++.+. .++.++|||||||++|||++|+.|+...... ............... ...
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH----HHHHHHHHHHhCCCChHHhHHhhh
Confidence 22334578899999998764 4689999999999999999999997532211 000111100000000 000
Q ss_pred ccccc----cC-----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 FFTAG----LW-----DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~~----l~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.. .. .........++.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 00 01112235678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=300.01 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=206.3
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+......++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36889999999999999999754 57899999986543 23567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 879 LPGGNLEKFIQDRPR-RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
+++++|.++++.... ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999986432 5689999999999999999999999 999999999999999999999999999976654332
Q ss_pred c---cccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 958 H---ATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 958 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
. ......|+..|+|||++... .++.++|||||||++|||++|+.||..... ........... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~~--- 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--------MKVLMLTLQND-PP--- 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--------hhhHHHHhcCC-CC---
Confidence 2 22334688999999998876 788999999999999999999999964321 11111111111 11
Q ss_pred ccccCCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1034 TAGLWDC-GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1034 d~~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..... .....+..+.+++.+|++.+|++||++.|++++
T Consensus 226 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 --SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11100 012345678999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=304.55 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=201.8
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
+|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5888999999999999999765 6899999988754 2233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 880 PGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 880 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++++|.++++... ...+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||.+..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 9999999987632 236899999999999999999999632 89999999999999999999999999997653222
Q ss_pred cccCcccCCCcccchhcccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTCR------VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.....++..|+|||.+.+.. ++.++||||+||++|||++|+.||.... .......... ...+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~-~~~~~~~-- 228 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-----YANIFAQLSA-IVDGDPP-- 228 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-----hhhHHHHHHH-HhhcCCC--
Confidence 22345788999999986543 4789999999999999999999996321 1111111111 1111111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.....++..++.+|++.+|++||++.+++++
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 -------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1223456788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=305.24 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=206.1
Q ss_pred ccHHHHHHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeecc
Q 045553 791 LTYENVVRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVS 868 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 868 (1082)
++++++..++++|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566677889999999999999999999965 468899999986432 2345678899999998 89999999998864
Q ss_pred C-----CeEEEEEeecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcE
Q 045553 869 E-----AEMFLIYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941 (1082)
Q Consensus 869 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 941 (1082)
. ...++||||+++++|.++++.. ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 3689999999999999988642 245689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccCcccCCCcccchhcccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccH
Q 045553 942 YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC-----RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~ 1016 (1082)
||+|||.+......... .....|+..|+|||++... .++.++|||||||++|||++|+.||..... .
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------~ 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------V 239 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------H
Confidence 99999998865432221 2234688999999997543 367899999999999999999999864311 1
Q ss_pred HHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1017 VAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. +.. ...+...... .+......+.+++.+|++.+|++||++.|++++
T Consensus 240 ~~-~~~-~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 KT-LFK-IPRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH-HHH-HhcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 111 1111111111 122344579999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=308.25 Aligned_cols=194 Identities=26% Similarity=0.442 Sum_probs=160.9
Q ss_pred ceecccCceEEEEEEEc---CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeec--cCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII---PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV--SEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lV~E~~~~ 881 (1082)
.+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++. .+...++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999764 35789999886543 2346788999999999999999999885 3567899999995
Q ss_pred CCHHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE----cCCCcEEEeecccce
Q 045553 882 GNLEKFIQDR-------PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLAR 950 (1082)
Q Consensus 882 gsL~~~l~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGla~ 950 (1082)
++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5888877532 123588999999999999999999999 99999999999999 566799999999998
Q ss_pred ecCCCCC--ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 045553 951 LLGTSET--HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPS 1006 (1082)
Q Consensus 951 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~ 1006 (1082)
....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7654322 12334578999999999876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=302.57 Aligned_cols=260 Identities=25% Similarity=0.335 Sum_probs=204.0
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 876 (1082)
++|.+.+.||.|++|.||+|.. .+++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3688889999999999999976 4589999999875432 3456789999999999999999999988653 4689999
Q ss_pred eecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 877 NYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||+++++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987642 245688999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+..... .....+........ ..... .
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~-~~~~~-~ 229 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP---PLGPIELLSYIVNM-PNPEL-K 229 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC---CCChHHHHHHHhcC-Cchhh-c
Confidence 221 2345788999999999999999999999999999999999999754321 11222222222211 11111 1
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... .....+..+.+++.+|++.+|++|||+.||+++
T Consensus 230 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1100 012345678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.91 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=203.2
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecC--ccccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 877 (1082)
..|++.++||+||.+.||++...+.+.+|+|++... +.+....|..|+..|.+++ |.+||++++|-..++..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 458899999999999999999888899999987543 4455678999999999995 8999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|= ..+|..+|+........| .++.+..||+.|+.+.|++ ||||.||||.|+++-. |.+||+|||.|..+..+.+
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 86 679999999875555555 7888999999999999999 9999999999999854 6899999999998876655
Q ss_pred c-cccCcccCCCcccchhcccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 958 H-ATTDVAGTFGYVAPEYAMTC-----------RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 958 ~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
. .....+||+.||+||.+... +++.++||||+||++|+|+.|+.||.. ..-.|.+..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---------~~n~~aKl~-- 583 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---------IINQIAKLH-- 583 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---------HHHHHHHHH--
Confidence 4 34456899999999998532 256799999999999999999999962 111333332
Q ss_pred cCCCccccccccCCCCChHH-HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 QGRPCEFFTAGLWDCGPHDD-LIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+.|+....++|.-. ..++.++|+.|++.||++||+..|++++
T Consensus 584 -----aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 -----AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 233333322333211 2239999999999999999999999874
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=298.39 Aligned_cols=251 Identities=29% Similarity=0.462 Sum_probs=203.7
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc--cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999654 6899999998766443 567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.++++.. ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999864 3578999999999999999999999 9999999999999999999999999999876543332
Q ss_pred cc---cCcccCCCcccchhcccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 959 AT---TDVAGTFGYVAPEYAMTCR---VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 959 ~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.. ....++..|+|||++.+.. ++.++||||||+++||+++|+.||.... .-........ .+.....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-------~~~~~~~~~~-~~~~~~~ 227 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------NEFQIMFHVG-AGHKPPI 227 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-------chHHHHHHHh-cCCCCCC
Confidence 21 2356788999999998766 8899999999999999999999996421 1111111111 1111111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.........+.+++.+|++.+|++||++.|++.
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 -------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001122567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=305.27 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=201.2
Q ss_pred ccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
|+....||+|+||.||+|.. .+++.||+|++........+.+.+|+..++.++|||++++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44455799999999999965 46899999998765555567788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++........ ...
T Consensus 103 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 103 GALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 999998764 3589999999999999999999999 999999999999999999999999999876543222 223
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|+..|+|||++.+..++.++|||||||++|||++|+.||.... ........ ........ ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~-~~~~~~~~-------~~ 239 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--------PVQAMKRL-RDSPPPKL-------KN 239 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-hccCCCCc-------cc
Confidence 3568999999999998899999999999999999999999986321 11111111 11111100 01
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......+.+++.+|++.+|++||++.|++++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12234578899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=300.01 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=200.5
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc----------ccHHHHHHHHHHHhccCCCceeeEeeeeccCC
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF----------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 870 (1082)
+|.+.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999954 4689999998864211 11346788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..++||||+++++|.++++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999875 4689999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCc-cccCcccCCCcccchhcccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 951 LLGTSETH-ATTDVAGTFGYVAPEYAMTCR--VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 951 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
........ ......|+..|+|||++.... ++.++||||+|+++||+++|+.||... .....+. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-------~~~~~~~-~~~~~~ 228 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-------EAIAAMF-KLGNKR 228 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc-------chHHHHH-Hhhccc
Confidence 65432211 223346889999999987654 789999999999999999999998532 1111111 111111
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+.... ....+..+.+++.+|++.+|++||++.+|+++
T Consensus 229 -~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 -SAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -cCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111111 12345689999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=298.66 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=205.6
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|.+.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+++++.++|+|++++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999654 58899999986542 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecccceecCCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~~~ 957 (1082)
+++++|.+++.......+++..+..++.|++.|++|||+. +++|+||||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999876555789999999999999999999999 999999999999999885 569999999987643322
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......|++.|+|||+..+..++.++||||||+++|||++|+.||... ...+++....... ...
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~~~------ 221 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--------NLHQLVLKICQGY-FAP------ 221 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHhccc-CCC------
Confidence 222345889999999998888999999999999999999999998632 2334444332221 111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+......+.+++.+|++.+|++||++.||+++
T Consensus 222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 112334579999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=299.04 Aligned_cols=252 Identities=23% Similarity=0.417 Sum_probs=203.3
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc------ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
+|+..+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|++.+++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999964 5689999999865431 234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecccceecC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFGLARLLG 953 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~ 953 (1082)
||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++ .+||+|||.+..+.
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999764 4688999999999999999999999 999999999999998776 59999999998765
Q ss_pred CCCCc---cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 954 TSETH---ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 954 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
..... ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||..... ...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIASATT-- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhccCC--
Confidence 43211 12234688999999999888899999999999999999999999863211 111122211111111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
....+.....++.+++.+|++.+|++||++.|+++
T Consensus 229 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 -------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11223345578999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=297.02 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=198.7
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-----cccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-----FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEM 872 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 872 (1082)
.+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688999999999999999965 458999999886432 12345788899999999999999999988764 467
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++++|.+++... ..+++..+.+++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999999764 3578889999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC--ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 953 GTSET--HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 953 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.... .... +........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~-~~~~~~~~~-- 226 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAA-IFKIATQPT-- 226 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHH-HHHHhcCCC--
Confidence 32211 12233468899999999998889999999999999999999999986321 1111 111111110
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+......+..++.+|+. +|++||++.||+++
T Consensus 227 -------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 -------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111234455678889999984 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=304.45 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=201.7
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999654 578999999875432 33457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999764 4689999999999999999999999 99999999999999999999999999986421110
Q ss_pred C--------------ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH
Q 045553 957 T--------------HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 957 ~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||... ...++...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--------~~~~~~~~ 227 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--------TPEELFGQ 227 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHH
Confidence 0 0112245788999999998888999999999999999999999998632 12233333
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
...... . .+. .+...+..+.+++.+|++.+|++||++.++.+.|+
T Consensus 228 ~~~~~~-~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 228 VISDDI-E---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHhccc-C---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 222210 0 010 01123457899999999999999999766655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=296.48 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=209.6
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.+.||+|++|.||+|... +++.||||++..... ...+.+.+|++.+++++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999765 589999999876644 4467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999864 568999999999999999999999 8 999999999999999999999999999987654332
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.......... .
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~-~------- 221 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPP-P------- 221 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCC-C-------
Confidence 2 1234678899999999999999999999999999999999999864321 122333333221111 1
Q ss_pred CCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 WDCGPHD-DLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.. .+..+.+++.+|++.+|++||++.|++++
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 --SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11222 55789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=304.24 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=205.2
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5789999999999999999964 468899999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999999753 578999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
.....|++.|+|||.+.+..++.++||||||+++|++++|+.||...... ..+......+. .. .
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--------~~~~~~~~~~~-~~-------~ 235 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGT-PE-------L 235 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------hheeehhcCCC-CC-------C
Confidence 23346888999999998888999999999999999999999999643211 00000101110 00 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122345678899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=305.35 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=201.0
Q ss_pred ccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
|.....||+|+||.||+|.. .++..||||++........+.+.+|+..++.++|+|++++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 44446799999999999965 46889999998766555667789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++........ ...
T Consensus 104 ~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 104 GALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 999998864 3588999999999999999999999 999999999999999999999999999876533222 223
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|+..|+|||+..+..++.++||||||+++|||++|+.||.... ..+.+... ... +...+..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~-~~~-----~~~~~~~-- 240 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--------PLQAMRRI-RDN-----LPPRVKD-- 240 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-Hhc-----CCCcccc--
Confidence 3568899999999988889999999999999999999999986321 11111111 111 1111111
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......+..++.+|+..+|.+|||+.|++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234578899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=303.64 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=203.5
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999765 57899999986532 2335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|++++.+..+... ...+++..+..++.|++.|++|||+. +++|||++|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9988777665544 34589999999999999999999999 999999999999999999999999999987755443
Q ss_pred ccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-----------
Q 045553 958 HATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL----------- 1025 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 1025 (1082)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||..... .+..........
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhhcc
Confidence 333445688999999999887 889999999999999999999999863211 110000000000
Q ss_pred -cCC-----Cccccccc-cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 -QGR-----PCEFFTAG-LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 -~~~-----~~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... .....++. ....++...+.++.+++.+|++.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 00000000 0001122336789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=300.04 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=203.4
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc--CCeEEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEMFLIY 876 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 876 (1082)
+|++.+.||.|+||.||+|.. .++..||+|++.... ....+++..|++++++++|||++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999954 468899999986543 2345678899999999999999999997754 45689999
Q ss_pred eecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 877 NYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLH-----DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
||+++++|.+++... ....+++..++.++.|++.|++||| +. +++||||+|+||+++.++.+||+|||.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999763 2457899999999999999999999 66 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ...+... ...+..
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~ 227 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASK-IKEGKF 227 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHH-HhcCCC
Confidence 876543321 233468999999999999889999999999999999999999987421 1222222 222211
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...+...+..+.+++.+|++.+|++||++.+|+++
T Consensus 228 ---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11233456789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=285.79 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=206.2
Q ss_pred hcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccc---cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.++||+|.||+|.+++ ..+++.+|+|+++....- +...-..|-++++..+||.+..+.-.|+..++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4568999999999999999994 567999999999876443 334456788999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||..||.|.-++.. .+.+++...+.+..+|+.||.|||+. +||+||+|.+|.|+|+||++||+|||+++.- -.
T Consensus 247 MeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IK 320 (516)
T ss_pred EEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-cc
Confidence 999999999888776 56799999999999999999999999 9999999999999999999999999999753 23
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
....+.+++||+.|+|||++....|..+.|.|.+|||+|||++|+.||..... ......+..++
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------~kLFeLIl~ed-------- 384 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------EKLFELILMED-------- 384 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------hHHHHHHHhhh--------
Confidence 34456779999999999999999999999999999999999999999974221 12222222211
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQ 1072 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 1072 (1082)
+ ..|.....+...++...+..||.+|- .++||.+
T Consensus 385 -~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 385 -L--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -c--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1 24555567888999999999999996 4555543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=301.97 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=199.7
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||.|++|.||+|+.. ++..||||++..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999654 689999999865432 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+. ++|.+++.......+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6899999876667799999999999999999999999 999999999999999999999999999876543222
Q ss_pred cccCcccCCCcccchhcccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc-
Q 045553 959 ATTDVAGTFGYVAPEYAMTCR-VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG- 1036 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~- 1036 (1082)
......++..|+|||+..+.. ++.++||||||+++|||++|+.||..... .....+... ..+...+...+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~ 228 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFR---TLGTPDEVVWPGV 228 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHH---HhCCCChhhhhhh
Confidence 122335688999999887644 58899999999999999999999863211 011111111 011000000000
Q ss_pred -------------cCC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 -------------LWD---CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 -------------l~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... ........++.+++.+|++.||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 0011223567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=299.59 Aligned_cols=247 Identities=22% Similarity=0.337 Sum_probs=202.8
Q ss_pred ccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
|...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.+++.++|||++++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 45567999999999999964 46899999998765555566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++++|||.+........ ...
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 999999876 3589999999999999999999999 999999999999999999999999998875543222 223
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|+..|+|||...+..++.++||||||+++|||++|+.||... +.......... ...... . .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~--------~~~~~~~~~~~-~~~~~~-----~--~ 237 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--------PPLQAMKRIRD-NLPPKL-----K--N 237 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC--------CHHHHHHHHHh-cCCCCC-----c--c
Confidence 356899999999998888999999999999999999999998632 12233332222 111111 0 1
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
+......+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1123468999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=314.16 Aligned_cols=240 Identities=24% Similarity=0.312 Sum_probs=187.8
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhcc---CCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRV---QHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
||+|+||+||+|+.. +++.||||++..... .....+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999654 589999999864322 2233445566666655 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|.+++.. ...+++..+..++.||++|++|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 999999876 34689999999999999999999999 99999999999999999999999999987543222 2233
Q ss_pred CcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCC
Q 045553 962 DVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDC 1040 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 1040 (1082)
...||..|+|||++.+. .++.++||||+||++|||++|+.||... ...+..... ..+... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~--------~~~~~~~~i-~~~~~~-~-----~-- 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE--------DTQQMYRNI-AFGKVR-F-----P-- 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC--------CHHHHHHHH-HcCCCC-C-----C--
Confidence 45799999999998764 4789999999999999999999999632 222222222 222110 0 0
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 045553 1041 GPHDDLIEMLNLAIMCTGESLSSRP----SMRQVAQ 1072 (1082)
Q Consensus 1041 ~~~~~~~~l~~li~~cl~~~p~~RP----t~~ev~~ 1072 (1082)
.......+.+++.+|++.+|++|| ++.|+++
T Consensus 218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 012345788999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=300.54 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=202.9
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCC------
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEA------ 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------ 870 (1082)
++++|++.+.||+|++|.||+|... +++.+|+|++..... ..+++.+|+++++++ +|+|++++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999764 578999999876543 346789999999999 6999999999986544
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
..++||||+++++|.++++... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987643 46789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMT-----CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML 1023 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1023 (1082)
+........ ......|+..|+|||++.. ..++.++||||||+++|+|++|+.||..... . .. ....
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~---~~-~~~~ 230 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP----M---RA-LFKI 230 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch----H---HH-HHHh
Confidence 986543222 2234568999999998753 3467899999999999999999999963211 1 11 1111
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. .+.... + ..+.....++.+++.+|++.||++|||+.|++++
T Consensus 231 ~-~~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 P-RNPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred h-ccCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 111111 1 1123355689999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=300.05 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=201.0
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccC---CCceeeEeeeeccCCeEEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQ---HPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477888999999999999975 568999999986542 344567889999999997 999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.++++.. .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+..+....
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998753 689999999999999999999999 99999999999999999999999999998775443
Q ss_pred CccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..+... .......
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~-~~~~~~~----- 220 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMML-IPKSKPP----- 220 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhc-cccCCCC-----
Confidence 2 2233468899999998875 4568899999999999999999999974321 111111 1111111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+. ....+.++.+++.+|++.+|++||++.|++.+
T Consensus 221 ~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111 11245678999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=301.17 Aligned_cols=244 Identities=25% Similarity=0.403 Sum_probs=201.8
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999654 58999999986532 233566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999874 5689999999999999999999999 9999999999999999999999999999876443
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.... ......... .+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~------- 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKIL-EGKV------- 215 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHh-cCCc-------
Confidence 233468899999999988888999999999999999999999986321 111111211 2111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQ 1072 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 1072 (1082)
..+......+.+++.+|++.+|++|| +++|+++
T Consensus 216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11223356889999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=301.88 Aligned_cols=261 Identities=24% Similarity=0.323 Sum_probs=200.3
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc-----cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ-----GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
+|++.+.||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999754 6899999999765432 234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+ +++|.++++... ..+++..+..++.|+++||+|||+. +|+||||+|+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999998653 4689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC-------
Q 045553 956 ETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG------- 1027 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 1027 (1082)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|..||..... ...+..... .....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~ 229 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----IDQLGKIFE-ALGTPTEENWPG 229 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----HHHHHHHHH-HcCCCchhhhhh
Confidence 22 2223356788999998865 4678999999999999999999777653211 011111110 00000
Q ss_pred --CCccccccccCCCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1028 --RPCEFFTAGLWDCG-----PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1028 --~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.............. .......+.+++.+|++.+|++||++.||+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000001 12335678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=299.27 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=207.8
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++.|++.+.||+|++|.||+|... ++..||+|++..... ..+.+.+|++.++.++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888999999999999999765 688999999976544 46778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999998753 4799999999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......++..|+|||++.+..++.++||||||+++|+|++|+.||... ............+ ....
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~~~~----- 236 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE--------PPLRALFLITTKG-IPPL----- 236 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcC-CCCC-----
Confidence 223345788999999999888999999999999999999999998632 1112222221111 1111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+..+.+++.+|++.+|.+||++.+|+++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112245679999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=290.46 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=207.4
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.|++.+.||+|++|.||+|... ++..+++|++........+.+.+|++.+++++|++++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999765 689999999977655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999998752 5789999999999999999999998 999999999999999999999999999987654432 3
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDC 1040 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 1040 (1082)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......... .......
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~~~------- 218 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--------PMKALFKIAT-NGPPGLR------- 218 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHh-cCCCCcC-------
Confidence 34568899999999998889999999999999999999999986321 1122222111 1111111
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1041 GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1041 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+......+.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111225679999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=298.82 Aligned_cols=247 Identities=23% Similarity=0.401 Sum_probs=202.4
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
-|++.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++.+++++|||++++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 477888999999999999965 468899999986443 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 99999999874 3589999999999999999999999 999999999999999999999999999876643221 2
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
.....++..|+|||...+...+.++|||||||++|+|++|..||.... ...+.... ..+...
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~~--------- 219 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--------PMKVLFLI-PKNNPP--------- 219 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--------hHHHHHHH-hcCCCC---------
Confidence 223467889999999998889999999999999999999999986321 11222221 111111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+.++.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122345678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=307.96 Aligned_cols=245 Identities=24% Similarity=0.416 Sum_probs=198.7
Q ss_pred cccceecccCceEEEEE-EEcCCeEEEEEEeec---C-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCe--EEEEE
Q 045553 804 NVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSV---G-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE--MFLIY 876 (1082)
Q Consensus 804 ~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~---~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lV~ 876 (1082)
++..+||+|+|-+||+| .-.+|..||=-.++. . .....+.|..|+++++.++||||++++.++.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44578999999999999 444576766333221 1 23445789999999999999999999999887654 78899
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-CCcEEEeecccceecCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~~ 955 (1082)
|.+..|+|..|.+++ +..+...+..|++||++||.|||++ .|+|+|||||..||+|+. .|.|||+|.|+|..+...
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999999985 4688889999999999999999997 779999999999999975 589999999999987543
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.. ..+.|||.|||||++. ..|++..||||||+.++||+|+.-||.++ .+..+..+.+..+-.+. .+..
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-------~n~AQIYKKV~SGiKP~-sl~k 267 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-------TNPAQIYKKVTSGIKPA-ALSK 267 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-------CCHHHHHHHHHcCCCHH-Hhhc
Confidence 22 2378999999999988 78999999999999999999999998754 34456555555443332 2221
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
- ...++.++|.+|+.. .++||++.|++.
T Consensus 268 V--------~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 V--------KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred c--------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1 124789999999999 999999999976
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=301.55 Aligned_cols=262 Identities=22% Similarity=0.317 Sum_probs=197.3
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999654 689999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++ ++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.++.......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 96 59999987653 4789999999999999999999999 999999999999999999999999999875432211
Q ss_pred cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc------
Q 045553 959 ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE------ 1031 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 1031 (1082)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... ......+...........
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV----EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHhcCCCChhhhhhhhh
Confidence 1122346889999999875 45789999999999999999999998643210 000000000000000000
Q ss_pred ---ccc--------cccCCCC-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1032 ---FFT--------AGLWDCG-PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1032 ---~~d--------~~l~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
... ..+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000 0111267789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=300.41 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=199.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc--cHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 875 (1082)
++|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999765 5889999999754322 234567899999999999999999998776 889999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+..+...
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 59999987653 3689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHH------------HHHH
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVA------------WASM 1022 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~------------~~~~ 1022 (1082)
.. ......++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... ..... |...
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI----DQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCchHHHHHh
Confidence 22 22234578899999998764 4688999999999999999999998642110 00000 1000
Q ss_pred HHhc----CCCccccccccCCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1023 LLLQ----GRPCEFFTAGLWDCGPHD-DLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1023 ~~~~----~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... ..........+....+.. ....+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000000011111111222 35678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=301.05 Aligned_cols=247 Identities=28% Similarity=0.388 Sum_probs=199.1
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
...|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++|||++++.+++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999654 689999999864432 2345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||++ |++.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99996 6787777654 34689999999999999999999999 9999999999999999999999999999765322
Q ss_pred CCccccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
....++..|+|||++. ...++.++||||||+++|||++|+.||.... ......... ......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~--------~~~~~~~~~-~~~~~~- 233 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIA-QNDSPT- 233 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc--------HHHHHHHHh-cCCCCC-
Confidence 2346788999999874 4568889999999999999999999986321 111111111 111111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+..+.+++.+||+.+|++||++.+|+.+
T Consensus 234 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 -------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1123355689999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=305.00 Aligned_cols=251 Identities=23% Similarity=0.397 Sum_probs=209.9
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
-|.|..-||.|+||.||+|..+ ++-..|.|++........+.|.-|++++....||+||++++.|..++..|+..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 4667777999999999999544 455668888887777888999999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
||-++..+-.- ++.+++.++..++.|++.||.|||+. .|||||||+.|||++-+|.++++|||.+.... ......
T Consensus 113 GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKR 187 (1187)
T ss_pred CchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHhhh
Confidence 99999888765 56899999999999999999999999 99999999999999999999999999986432 222345
Q ss_pred cCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 961 TDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
..+.||+.|||||+.. ..+|+.++||||||+.+.||..+.+|-.. .+...++.. +....++..+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe--------lnpMRVllK-iaKSePPTLl-- 256 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE--------LNPMRVLLK-IAKSEPPTLL-- 256 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc--------cchHHHHHH-HhhcCCCccc--
Confidence 6789999999999874 57899999999999999999999988652 222333222 2223333332
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.|..+...+.+++.+|+..+|..||++++++++
T Consensus 257 -----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 -----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 355778899999999999999999999998864
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=297.81 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=199.7
Q ss_pred ccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
|++.+.||.|++|.||+|.. .+|..||+|++..... ...+.+.+|++.+++++|||++++++++.+....++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67788999999999999965 4699999999875432 23456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
+++|.+++.......+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+..+......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 57999999876555789999999999999999999999 9999999999999999999999999999765432221
Q ss_pred ccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc-------
Q 045553 960 TTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE------- 1031 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 1031 (1082)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||..... ........+. .+...+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~ 228 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIFRT---LGTPDEDVWPGVT 228 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHH---hCCCChHHhhhhh
Confidence 2223568899999988664 578899999999999999999999864211 0111111110 000000
Q ss_pred -----------ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 -----------FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 -----------~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...... ..........+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00112334678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=298.11 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=198.0
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++++|.+.+.||+|+||.||+|.. .++..||+|++..... .....+.+|+++++.++|+||+++.+++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999964 4689999999865432 22346788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+. +++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 7887777654 34578888999999999999999999 99999999999999999999999999997643322
Q ss_pred CccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC-------
Q 045553 957 THATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR------- 1028 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 1028 (1082)
. ......++..|+|||++.+. .++.++|||||||++|||++|+.||+..... ...........+.
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~------~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV------FEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH------HHHHHHHHHHcCCCChhhhh
Confidence 1 12334578899999998764 5788999999999999999999999743211 1111111000000
Q ss_pred ----CccccccccCCCCC---------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1029 ----PCEFFTAGLWDCGP---------HDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1029 ----~~~~~d~~l~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+..........+ ......+.+++.+|++.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000 112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=319.74 Aligned_cols=371 Identities=27% Similarity=0.378 Sum_probs=258.2
Q ss_pred CCCCEEeCcCCCCC-CCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEE
Q 045553 134 SLLEILDLSFNSFH-GPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212 (1082)
Q Consensus 134 ~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L 212 (1082)
+-.+-.|+++|.++ +..|..+..+++++.|-|...++. .+|+.++.+ .+|++|
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~l-------------------------qkLEHL 60 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRL-------------------------QKLEHL 60 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHH-------------------------hhhhhh
Confidence 33444555555555 335555555555555555555554 444444444 444444
Q ss_pred EcccCccCCCCCccccCCCCccEEEccCCcCCC-CcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccC
Q 045553 213 LLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG-DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYG 291 (1082)
Q Consensus 213 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~ 291 (1082)
.+++|++. .+-..++.++.|+.+.+.+|++.. -+|..+-.+..|+.||||+|+++ ..|..+...+++-+|
T Consensus 61 s~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVL------- 131 (1255)
T KOG0444|consen 61 SMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVL------- 131 (1255)
T ss_pred hhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEE-------
Confidence 44444444 444456667777777777777752 25666667777777777777776 455554444333333
Q ss_pred CcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCcc
Q 045553 292 PLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPAS 371 (1082)
Q Consensus 292 ~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~ 371 (1082)
++++|+|..++..-|.++..|-+||||+|++. .+|..
T Consensus 132 ------------------------------------------NLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ 168 (1255)
T KOG0444|consen 132 ------------------------------------------NLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQ 168 (1255)
T ss_pred ------------------------------------------EcccCccccCCchHHHhhHhHhhhccccchhh-hcCHH
Confidence 33334444444444556666777777777777 67777
Q ss_pred ccCCCCCCEEecCCCcCcccC-CCCcccCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccc
Q 045553 372 LGNCKSLYFLDLSSNNLTGLL-PEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENAL 450 (1082)
Q Consensus 372 ~~~l~~L~~L~Ls~N~l~~~~-p~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (1082)
+..+..|+.|+|++|++...- -..-++++|++|.+++-+=
T Consensus 169 ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqR--------------------------------------- 209 (1255)
T KOG0444|consen 169 IRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQR--------------------------------------- 209 (1255)
T ss_pred HHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccc---------------------------------------
Confidence 777777777777777765321 1111223333333332211
Q ss_pred cCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcc
Q 045553 451 TSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKL 530 (1082)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l 530 (1082)
.+..+|..+..+.+|..+|+|.|.+
T Consensus 210 -------------------------------------------------------Tl~N~Ptsld~l~NL~dvDlS~N~L 234 (1255)
T KOG0444|consen 210 -------------------------------------------------------TLDNIPTSLDDLHNLRDVDLSENNL 234 (1255)
T ss_pred -------------------------------------------------------hhhcCCCchhhhhhhhhccccccCC
Confidence 1234455555666777899999999
Q ss_pred cccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCc-cCch
Q 045553 531 IGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG-AIPW 609 (1082)
Q Consensus 531 ~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~ 609 (1082)
. .+|+.++. +.+|+.|+||+|+|+.. ........+|++|+||.|+++ .+|+++..|++|+.|++.+|+++- -+|.
T Consensus 235 p-~vPecly~-l~~LrrLNLS~N~iteL-~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 235 P-IVPECLYK-LRNLRRLNLSGNKITEL-NMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred C-cchHHHhh-hhhhheeccCcCceeee-eccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCcc
Confidence 8 89999886 46799999999999954 344556678999999999999 899999999999999999999873 4899
Q ss_pred hhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC
Q 045553 610 ELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN 682 (1082)
Q Consensus 610 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 682 (1082)
.++.|..|+.+..++|++. ..|+.++.+..|+.|.|++|++- ++|+.+.-++.|+.||+..|+=-.-.|..
T Consensus 311 GIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP 381 (1255)
T KOG0444|consen 311 GIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP 381 (1255)
T ss_pred chhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence 9999999999999999999 89999999999999999999999 89999999999999999999765555543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=298.42 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=195.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHH-HhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRT-LGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|+||.||+|... +|+.||+|++..... ....++..|+.. ++..+|||++++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36889999999999999999654 689999999875432 233455556664 667789999999999999999999999
Q ss_pred ecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 878 YLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|++ |+|.++++.. ....+++..+..++.|++.|++|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 995 7898888653 2356899999999999999999999854 8999999999999999999999999999865332
Q ss_pred CCccccCcccCCCcccchhccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMT----CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
. ......|+..|+|||++.+ ..++.++||||+|+++|||++|+.||...... . +......... ...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~-~~~ 227 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------F-QQLKQVVEEP-SPQ 227 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------H-HHHHHHHhcC-CCC
Confidence 1 1223468889999998865 45688999999999999999999998632111 1 1111221111 111
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
. .....+.++.+++.+|++.+|++||++.++++
T Consensus 228 ~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 L--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred C--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 01123467899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=297.85 Aligned_cols=261 Identities=26% Similarity=0.347 Sum_probs=198.6
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++|||++++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999754 688999999865432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-CCcEEEeecccceecCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~~~ 956 (1082)
|++ +++.+++.......+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 6888888765555578899999999999999999999 9999999999999985 5679999999997654322
Q ss_pred CccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC-Cccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR-PCEFFT 1034 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d 1034 (1082)
. ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||..... .....+.....+. .....+
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~ 229 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-------IDELFKIFRILGTPNEETWP 229 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhCCCChhhcc
Confidence 1 2223457889999998876 4578999999999999999999999863211 1111111110000 000000
Q ss_pred ------------cccCC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 ------------AGLWD----CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ------------~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.... ........++.+++.+|++.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0012234568999999999999999999999863
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=305.43 Aligned_cols=258 Identities=23% Similarity=0.312 Sum_probs=199.4
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccC------
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------ 869 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 869 (1082)
...+|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999964 46899999998643 223445677899999999999999999987643
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
...++||||+. ++|.+++... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 6888888642 88999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH------
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML------ 1023 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 1023 (1082)
+...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||.... ....|....
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~ 236 (353)
T cd07850 166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD-------HIDQWNKIIEQLGTP 236 (353)
T ss_pred eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHHhcCCC
Confidence 8764322 2233467899999999999999999999999999999999999986431 111111111
Q ss_pred ---------------HhcCCC------ccccccc----cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 ---------------LLQGRP------CEFFTAG----LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 ---------------~~~~~~------~~~~d~~----l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...... .+.+... .....+......+.+++.+|++.||++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0000000 0001122345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=297.65 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=204.0
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
+|++.+.||.|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999765 589999999975432 346788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++... ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999864 4789999999999999999999999 99999999999999999999999999998764332
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......|+..|+|||++.+..++.++||||+|+++|+|++|+.||..... . ...+........
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~~~~~~---------- 217 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR-----T-IRDQIRAKQETA---------- 217 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc-----c-HHHHHHHHhccc----------
Confidence 22335688899999999988899999999999999999999999874321 1 122222211110
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSM--RQVA 1071 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~ev~ 1071 (1082)
....+...+..+.+++.+|++.+|++||++ +|+.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 112233445789999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=298.03 Aligned_cols=259 Identities=19% Similarity=0.265 Sum_probs=187.3
Q ss_pred hcCccccceecccCceEEEEEEEcC----CeEEEEEEeecCccccH-----------HHHHHHHHHHhccCCCceeeEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGRFQGV-----------QQFAAEIRTLGRVQHPNLVTLIG 864 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~ 864 (1082)
..+|++.++||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3579999999999999999997654 34666665433321110 11223445566778999999998
Q ss_pred eeccCC----eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc
Q 045553 865 YHVSEA----EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN 940 (1082)
Q Consensus 865 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 940 (1082)
++.... ..++++|++ ..++.+.+... ...++..+..++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 765443 347788877 34777776543 3457888999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCc
Q 045553 941 AYLSDFGLARLLGTSETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGF 1014 (1082)
Q Consensus 941 ~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~ 1014 (1082)
++|+|||+|+.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~----~~ 240 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH----NG 240 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc----ch
Confidence 999999999876432211 12234699999999999999999999999999999999999999974311 11
Q ss_pred cHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1015 NIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
............. ...... .....+..+.+++..|++.+|++||++.++++.+.
T Consensus 241 ~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAKCDFIKR----LHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhHHHHHHH----hhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111111100000 000000 01233567999999999999999999999998763
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=291.91 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=207.9
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMFLIY 876 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 876 (1082)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.+++++|||++++++.+... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999765 689999999876543 4567889999999999999999999999888 8999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998753 789999999999999999999998 99999999999999999999999999998775443
Q ss_pred Cc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 TH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.. ......++..|+|||...+...+.++||||||+++|+|++|+.||.... ..............
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~------- 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGE------- 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCC-------
Confidence 21 1233568899999999998889999999999999999999999997432 11111111111111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+......+.+++.+|++.+|++||++.|++++
T Consensus 222 --~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 --PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 112233446789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=300.54 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=196.8
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|...+.||+|+||.||++.. .+++.||+|++.... ......+.+|+..+.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455667899999999999965 458999999986543 234567889999999996 99999999999999999999999
Q ss_pred cCCCCHHHHH---hhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 879 LPGGNLEKFI---QDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 879 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
+. +++.++. .......+++..+.+++.|++.|++|||+.. +|+||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 5665543 3333467899999999999999999999743 8999999999999999999999999999765432
Q ss_pred CCccccCcccCCCcccchhcccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTC---RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... ....|+..|+|||++.+. .++.++||||+||++|||++|+.||.... ...+.+..... +..
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~-~~~--- 228 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVK-GDP--- 228 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcC-CCC---
Confidence 221 223578899999998776 68899999999999999999999986321 11122222111 111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.+....+...+.++.+++.+|++.+|++||++.||+++
T Consensus 229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111223456689999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=297.51 Aligned_cols=261 Identities=26% Similarity=0.325 Sum_probs=200.3
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEEEEEe
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMFLIYN 877 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 877 (1082)
|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999765 48999999997653 33456788999999999999999999999887 89999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|++ ++|.+++... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 5899888764 25789999999999999999999999 999999999999999999999999999987755443
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc---c-
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE---F- 1032 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~- 1032 (1082)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+........... .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-----LEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchhhccccc
Confidence 23334457889999998765 4578999999999999999999999864321 111111111100000000 0
Q ss_pred -------------cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 -------------FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 -------------~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+........+..+.+++.+|++.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000011125678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=290.42 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=208.4
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+++++.++|||++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999654 589999999976543 4567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 879 LPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
+++++|.+++.... ...+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998753 46799999999999999999999999 99999999999999999999999999998765443
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
. ......|++.|+|||...+..++.++||||+|+++++|++|+.||+.. ...+........ ...
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~~~~-~~~------ 221 (258)
T cd08215 158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE--------NLLELALKILKG-QYP------ 221 (258)
T ss_pred c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC--------cHHHHHHHHhcC-CCC------
Confidence 1 223346889999999999888999999999999999999999998632 122332332221 111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|++.+|++||++.|++++
T Consensus 222 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 ---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1222445688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=301.10 Aligned_cols=268 Identities=22% Similarity=0.331 Sum_probs=198.8
Q ss_pred CccccceecccCceEEEEEEEc---CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII---PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMF 873 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 873 (1082)
+|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999754 47999999997633 33346678899999999999999999999988 7899
Q ss_pred EEEeecCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC----CCcEEEeec
Q 045553 874 LIYNYLPGGNLEKFIQDRP---RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN----NLNAYLSDF 946 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Df 946 (1082)
+||||++ +++.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 57777765432 23689999999999999999999999 9999999999999999 999999999
Q ss_pred ccceecCCCCC--ccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCc-----cHHH
Q 045553 947 GLARLLGTSET--HATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGF-----NIVA 1018 (1082)
Q Consensus 947 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~-----~~~~ 1018 (1082)
|++........ .......++..|+|||++.+. .++.++||||||+++|||++|+.||........... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 122345678999999988764 578999999999999999999999975432210000 0011
Q ss_pred HHHHH-----------HhcCCCccccccccCCCCC---------h--HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1019 WASML-----------LLQGRPCEFFTAGLWDCGP---------H--DDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1019 ~~~~~-----------~~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
++... ..........+.......+ . ....++.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 10000 0000000000000000011 0 234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-31 Score=297.56 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=198.9
Q ss_pred ccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
|+..+.||+|+||.||+|.. .++..||+|++..... .....+.+|++++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 67788999999999999975 4689999999865422 2345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++ |++.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 96 5888877654 45689999999999999999999999 9999999999999999999999999998754322
Q ss_pred cccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 959 ATTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
....|+..|+|||++. ++.++.++|||||||++|||++|+.||... ............+...
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~~~~----- 243 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNESPT----- 243 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHhccCCC-----
Confidence 2346888999999974 456889999999999999999999998632 1111122222221111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
.........+.+++.+|++.+|.+||++.+|+++...+
T Consensus 244 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 244 ----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 11123456789999999999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=293.60 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=204.9
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|+||.||+|+. .++..+|+|.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999954 468899999987543 23455778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 879 LPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
+++++|.+++.... ...+++..++.++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987632 35689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......++..|+|||...+..++.++|+||+|+++|||++|+.||.... ....... ...+...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~~------ 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--------MQDLRYK-VQRGKYP------ 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HhcCCCC------
Confidence 2223457889999999999999999999999999999999999986321 1121111 1222111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.....++.+++.+|++.+|++||++.|++++
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1223456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-31 Score=290.09 Aligned_cols=250 Identities=19% Similarity=0.279 Sum_probs=196.2
Q ss_pred HHHHHHHhcCcccccee--cccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeecc
Q 045553 793 YENVVRATAGFNVQNCI--GSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVS 868 (1082)
Q Consensus 793 ~~~~~~~~~~~~~~~~l--g~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 868 (1082)
..+.....++|++.+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +|||++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556778888877 9999999999964 4688899999865432211 22222222 79999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecc
Q 045553 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFG 947 (1082)
Q Consensus 869 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG 947 (1082)
.+..++||||+++++|.+++... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999999874 3789999999999999999999999 999999999999999998 99999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
.++...... ...|+..|+|||++.+..++.++||||+|+++|||++|+.||..... .......+.... ..
T Consensus 156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~--~~ 225 (267)
T PHA03390 156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLESLLKRQ--QK 225 (267)
T ss_pred cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHHHHHhh--cc
Confidence 998654322 23588999999999998999999999999999999999999973321 122223332222 11
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS-MRQVAQ 1072 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~ 1072 (1082)
.. ..+...+..+.+++.+|++.+|++||+ +.|+++
T Consensus 226 -~~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 -KL---------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -cC---------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 112245568999999999999999995 688875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=331.44 Aligned_cols=252 Identities=29% Similarity=0.438 Sum_probs=207.0
Q ss_pred HhcCccccceecccCceEEEEE-EEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.+-+|+-...||.|.||.||.| ...+|...|||.++... ....+.+.+|+.++..++|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 4456778889999999999999 56679999999987543 33456688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
||||++|+|.+.++. ++..++.....+..|++.|++|||+. |||||||||.||+++.+|.+|.+|||.|..+...
T Consensus 1313 MEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999986 34566666677889999999999999 9999999999999999999999999999987544
Q ss_pred CC---ccccCcccCCCcccchhcccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH-HhcCC
Q 045553 956 ET---HATTDVAGTFGYVAPEYAMTC---RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML-LLQGR 1028 (1082)
Q Consensus 956 ~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1028 (1082)
.. .......||+.|||||++.+. ....++||||+|||+.||+||++||..... .|.... +..|.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHVAAGH 1458 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHHhccC
Confidence 31 233467899999999999763 345689999999999999999999974321 233322 12222
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+ ..|...+.+-.+++.+|+..||++|.++.|++++
T Consensus 1459 ~P---------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KP---------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CC---------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22 3456677788999999999999999888877654
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=295.37 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=195.1
Q ss_pred ecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
||+|+||+||+|.. .+|+.||+|.+.... ......+.+|++++++++|||++++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999954 468999999986432 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcc
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 964 (1082)
.+++.......+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 9999876556799999999999999999999999 9999999999999999999999999998765432 1223346
Q ss_pred cCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChH
Q 045553 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHD 1044 (1082)
Q Consensus 965 gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1044 (1082)
++..|+|||++.+..++.++||||+|+++|+|++|+.||...... ...... ...... . ....+..
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~----~------~~~~~~~ 220 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEEL-KRRTLE----M------AVEYPDK 220 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHH-Hhcccc----c------cccCCcc
Confidence 788999999998888999999999999999999999999643211 011111 110000 0 0112233
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045553 1045 DLIEMLNLAIMCTGESLSSRP-----SMRQVAQ 1072 (1082)
Q Consensus 1045 ~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 1072 (1082)
....+.+++.+|++.+|++|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 456889999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=320.40 Aligned_cols=266 Identities=22% Similarity=0.255 Sum_probs=190.6
Q ss_pred HhcCccccceecccCceEEEEEEEcC--CeEEEEE------------------EeecCccccHHHHHHHHHHHhccCCCc
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIP--GVVVAVK------------------RLSVGRFQGVQQFAAEIRTLGRVQHPN 858 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~n 858 (1082)
...+|++.+.||+|+||+||++.... +..+++| .+. ........+.+|++++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45689999999999999999985432 2222222 111 11123456789999999999999
Q ss_pred eeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP---RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 859 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
|+++++++...+..|+|+|++ ++++.+++.... ........+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 999999999999999999999 567887775432 12234566788999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCcc
Q 045553 936 DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFN 1015 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~ 1015 (1082)
+.++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||++|||++|+.++..... ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~----~~~ 376 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG----GKP 376 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC----CCH
Confidence 9999999999999987765444444456799999999999999999999999999999999998754332111 111
Q ss_pred HHHHHHHHHhcCCCc-cccc----------cccCCCC----C-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1016 IVAWASMLLLQGRPC-EFFT----------AGLWDCG----P-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1016 ~~~~~~~~~~~~~~~-~~~d----------~~l~~~~----~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+..+....-+... ++.+ ....... + ......+.+++.+|++.||++||++.|++++
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111111111000000 0000 0000000 0 0123457788999999999999999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-34 Score=332.58 Aligned_cols=471 Identities=27% Similarity=0.295 Sum_probs=336.7
Q ss_pred ccccccCCCCCCEEEcccCCCcccCC-hhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccC
Q 045553 102 LSRAIGDLTQLRVLLLAFNGFSGELP-LEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQ 180 (1082)
Q Consensus 102 l~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 180 (1082)
||..+..-..|+.|+++.|.+. ..| +.+.+--+|+.|||++|++. ..|..+..+.+|+.|+++.|-|. .+|....+
T Consensus 13 ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~ 89 (1081)
T KOG0618|consen 13 IPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSN 89 (1081)
T ss_pred cchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhh
Confidence 5555666666899999999877 334 33444556999999999998 89999999999999999999999 78899999
Q ss_pred CCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEE
Q 045553 181 SPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVL 260 (1082)
Q Consensus 181 l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 260 (1082)
+.+|++|.|.+|++. .+|..+. .+.+|++|+++.|++. .+|..+..++.+..+..++|..... ++... ++.+
T Consensus 90 ~~~l~~lnL~~n~l~-~lP~~~~-~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~ 161 (1081)
T KOG0618|consen 90 MRNLQYLNLKNNRLQ-SLPASIS-ELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKL 161 (1081)
T ss_pred hhcchhheeccchhh-cCchhHH-hhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhh
Confidence 999999999999998 8998886 6899999999999999 8899999999999999999932212 33333 8899
Q ss_pred eCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcc
Q 045553 261 DLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNL 340 (1082)
Q Consensus 261 ~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l 340 (1082)
++..|.+.+.++..+..++. .|+|+.|.+.. -.+..+.+|+.+....|++
T Consensus 162 ~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~----------------------------~dls~~~~l~~l~c~rn~l 211 (1081)
T KOG0618|consen 162 DLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV----------------------------LDLSNLANLEVLHCERNQL 211 (1081)
T ss_pred hhhhhhcccchhcchhhhhe--eeecccchhhh----------------------------hhhhhccchhhhhhhhccc
Confidence 99999999888888887776 68998875441 1233444555555555544
Q ss_pred cCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceecCCCCCC
Q 045553 341 EGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISH 420 (1082)
Q Consensus 341 ~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~~~~~~~ 420 (1082)
....- ..++|+.|+.++|.++...+ .+ .-.+|+++|+++|++++.+.....+.+|+.+++.+|.|+..+-++..
T Consensus 212 s~l~~----~g~~l~~L~a~~n~l~~~~~-~p-~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~ 285 (1081)
T KOG0618|consen 212 SELEI----SGPSLTALYADHNPLTTLDV-HP-VPLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRLVALPLRISR 285 (1081)
T ss_pred ceEEe----cCcchheeeeccCcceeecc-cc-ccccceeeecchhhhhcchHHHHhcccceEecccchhHHhhHHHHhh
Confidence 43211 12445555555555542111 11 12345555555555554442222445555555555555311111100
Q ss_pred cccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeecc
Q 045553 421 SECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSG 500 (1082)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~ 500 (1082)
+ +++ ..+....
T Consensus 286 -----~---~~L-------------------------------------------------------------~~l~~~~ 296 (1081)
T KOG0618|consen 286 -----I---TSL-------------------------------------------------------------VSLSAAY 296 (1081)
T ss_pred -----h---hhH-------------------------------------------------------------HHHHhhh
Confidence 0 000 0000111
Q ss_pred CCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCc-ccEEEccCCcccccCccccCCCCCCCEEEccCCCC
Q 045553 501 NSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKC-MKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHL 579 (1082)
Q Consensus 501 n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 579 (1082)
|. +..+|........+++|||..|++. .+|+..+.-... |+.|..+.|.+....--.=..+..|+.|+|.+|.+
T Consensus 297 ne----l~yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~L 371 (1081)
T KOG0618|consen 297 NE----LEYIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHL 371 (1081)
T ss_pred hh----hhhCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcc
Confidence 11 1122233333445679999999988 888877765543 88888899998855422233467899999999999
Q ss_pred CCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCC
Q 045553 580 QGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGF 659 (1082)
Q Consensus 580 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 659 (1082)
+...-..+.+...|+.|+|++|++.......+.++..|+.|+||+|+++ .+|.....++.|++|...+|+|. ..| .+
T Consensus 372 td~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~ 448 (1081)
T KOG0618|consen 372 TDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-EL 448 (1081)
T ss_pred cccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hh
Confidence 9877778999999999999999999555555799999999999999999 88999999999999999999999 777 88
Q ss_pred CCCCcccEEeccCCcccc-CCCCC---cccccccCCCCCCC
Q 045553 660 GTRSSLSIFDVSFNNLSG-SAPRN---SLIKCENVQGNPNL 696 (1082)
Q Consensus 660 ~~l~~L~~l~ls~N~l~~-~~p~~---~~~~~~~~~~Np~~ 696 (1082)
..+++|+.+|+|.|+|+- .+|.. ..++..++.||+|+
T Consensus 449 ~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 449 AQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999999999999999984 33432 45678899999986
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=304.82 Aligned_cols=268 Identities=23% Similarity=0.306 Sum_probs=208.1
Q ss_pred CccccceecccCceEEEEEE-EcCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccC------CeEE
Q 045553 802 GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------AEMF 873 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 873 (1082)
.|...+.||+|+||.||+|+ ..+|+.||||.+.... ....+...+|++++++++|+|||+++++-++. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35566889999999999997 6679999999997643 34456778999999999999999999976654 4679
Q ss_pred EEEeecCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc--CCC--cEEEeeccc
Q 045553 874 LIYNYLPGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD--NNL--NAYLSDFGL 948 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~DfGl 948 (1082)
+|||||.+|||+.+++... ...+++.+.+.++.+++.||.|||++ +|+||||||.||++- ++| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999998743 56799999999999999999999999 999999999999983 334 479999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
|+....+. ....++||..|.+||++.. +.|+..+|.|||||++||+.||..||-+...+ ....+.++..+.+.
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p----k~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP----KNNKEIMWHIITKK 244 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc----cccchhhhhhhccC
Confidence 99876544 5567899999999999994 88999999999999999999999999865433 12222222222222
Q ss_pred C--CccccccccCCC--------C----ChHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHhhhC
Q 045553 1028 R--PCEFFTAGLWDC--------G----PHDDLIEMLNLAIMCTGESLSSRP--SMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1028 ~--~~~~~d~~l~~~--------~----~~~~~~~l~~li~~cl~~~p~~RP--t~~ev~~~L~~i~ 1078 (1082)
. .....++...++ . .......+.+....++..+|.+|- .+.+....+..|.
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 1 111122222111 1 134456677888888999999998 7777666666553
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=299.91 Aligned_cols=260 Identities=19% Similarity=0.272 Sum_probs=194.8
Q ss_pred ceeccc--CceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSG--GFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G--~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
..||+| +||+||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999965 478999999987543 23356788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc--
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA-- 959 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-- 959 (1082)
+++.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999876556789999999999999999999999 99999999999999999999999998654332111110
Q ss_pred ----ccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHH------------
Q 045553 960 ----TTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWAS------------ 1021 (1082)
Q Consensus 960 ----~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~------------ 1021 (1082)
.....++..|+|||++.+ ..++.++||||+||++|||++|+.||...... ........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHhcCCCCCCcccccc
Confidence 111234567999999976 34789999999999999999999999643211 00000000
Q ss_pred --------------------HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1022 --------------------MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1022 --------------------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.....+......+..+....+......+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000000001111112222233456789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=295.11 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=195.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccC-CCceeeEeeeeccCCe-----
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAE----- 871 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 871 (1082)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++ |||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36889999999999999999754 689999998865432 23456888999999995 6999999998877655
Q ss_pred EEEEEeecCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-CCcEEEeecc
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP---RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYLSDFG 947 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG 947 (1082)
.++||||+++ +|.+++.... ...+++..+..++.||+.||+|||+. +|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8988887543 24689999999999999999999999 9999999999999998 8899999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
.+..+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||.... ............
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~-------~~~~~~~~~~~~ 228 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS-------ELQQLLHIFKLL 228 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHHHh
Confidence 9986543222 1122356888999998865 457899999999999999999999986321 111111111100
Q ss_pred CCCcc-cc----ccc-------cCC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1027 GRPCE-FF----TAG-------LWD----CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1027 ~~~~~-~~----d~~-------l~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.... .. +.. ... ........++.+++.+|++++|++||++.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 00 000 000 0001245678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=287.03 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=204.9
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999654 578999999976644 4567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999864 5789999999999999999999999 9999999999999999999999999999877544332
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||...+..++.++|||++|+++|+|++|+.||.... ..... .... .....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~-~~~~-~~~~~-------- 217 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAAL-FRIV-QDDHP-------- 217 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHH-HHHh-ccCCC--------
Confidence 233568899999999988888999999999999999999999986321 11111 1111 11111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+...+..+..++.+|++.+|++||++.+++.
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 -PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112234568899999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=289.56 Aligned_cols=243 Identities=25% Similarity=0.324 Sum_probs=204.0
Q ss_pred cCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
+.|+.-++||+||||.||-.. ..+|+.+|.|++...+. ....-...|-.++.+++.+.||.+--+|++.+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 457788999999999999884 45699999998855432 33445678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
..|.||+|.-++.......+++..+..++.+|+.||++||.. +||+||+||+|||+|+.|+++|+|.|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999999887778899999999999999999999999 99999999999999999999999999999886554
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.. ...+||.+|||||++.+..|+...|.||+||++|||+.|+.||...... +.| +-+|.+
T Consensus 342 ~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-------vk~-----------eEvdrr 401 (591)
T KOG0986|consen 342 PI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-------VKR-----------EEVDRR 401 (591)
T ss_pred cc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------hhH-----------HHHHHH
Confidence 43 3458999999999999999999999999999999999999999632111 111 011211
Q ss_pred cC---CCCChHHHHHHHHHHHHcccCCCCCCCC
Q 045553 1037 LW---DCGPHDDLIEMLNLAIMCTGESLSSRPS 1066 (1082)
Q Consensus 1037 l~---~~~~~~~~~~l~~li~~cl~~~p~~RPt 1066 (1082)
+. ..+++..++++..+....++.||++|--
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 11 1355666788999999999999999863
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=295.08 Aligned_cols=261 Identities=21% Similarity=0.333 Sum_probs=199.0
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
+|++.+.||+|++|.||+|+.. +|..||||++..... ...+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4888999999999999999764 589999999876533 23466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 880 PGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 880 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+ ++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 58988887643 34689999999999999999999999 999999999999999999999999999976543221
Q ss_pred cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH-----------HHhc
Q 045553 959 ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM-----------LLLQ 1026 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~ 1026 (1082)
......++..|++||++.+ ..++.++||||+|+++|||++|+.||...... ......... ....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhHHHHhcC
Confidence 1223457889999998865 45788999999999999999999998643211 111111000 0000
Q ss_pred CCC----ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1027 GRP----CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1027 ~~~----~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
... ....+... .......+..+.+++.+|++.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00000000 0011123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=297.52 Aligned_cols=256 Identities=19% Similarity=0.265 Sum_probs=194.8
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 805 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
+.+.+|.|+++.||+++. +++.||||++... .....+.+.+|++.+++++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 444455566666666544 6899999998754 3345678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC-----
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET----- 957 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~----- 957 (1082)
+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999876556789999999999999999999999 999999999999999999999999999875532211
Q ss_pred -ccccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 958 -HATTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 958 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||...... ...... .. +.....++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-------~~~~~~-~~-~~~~~~~~ 232 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEK-VR-GTVPCLLD 232 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH-Hh-ccCccccc
Confidence 11223457788999999876 35788999999999999999999999742111 111111 10 00000000
Q ss_pred --------------------ccc----CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 --------------------AGL----WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 --------------------~~l----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... ..........++.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 001122345678999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=292.81 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=200.7
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc--cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
|++.+.||+|++|.||+|... +++.+|+|++...... ....+.+|++++++++|+|++++++++.++...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999654 6899999998754332 4567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
+ +++.+++... ...+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~-~~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 D-TDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred C-CCHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 6 5888888765 25789999999999999999999999 99999999999999999999999999998775443 12
Q ss_pred ccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC---ccccc-
Q 045553 960 TTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP---CEFFT- 1034 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d- 1034 (1082)
.....++..|+|||...+. .++.++||||+|+++|+|++|+.||..... ................ .+..+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-----IDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCchHhcccchhh
Confidence 2334578899999998876 789999999999999999999999863211 1111111111000000 00000
Q ss_pred ----------cccC--CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 ----------AGLW--DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ----------~~l~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... .........++.+++.+|++.+|.+||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00112346789999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=297.01 Aligned_cols=261 Identities=26% Similarity=0.342 Sum_probs=198.5
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc--cHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMF 873 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 873 (1082)
...+|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+|++++++++|+|++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3467999999999999999999654 5899999998754322 233466899999999999999999998754 5689
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+. ++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 85 lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 85 LVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999995 5898888764 35689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc-CCCcc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ-GRPCE 1031 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1031 (1082)
.... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.... ..+........ +....
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--------~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--------EIEQLDLIIQLLGTPNE 230 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhcCCCCh
Confidence 4322 2222345788999999875 557899999999999999999999986321 11222211110 00000
Q ss_pred cccc-----------ccCCC-C------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 FFTA-----------GLWDC-G------PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~-----------~l~~~-~------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..-+ .+... . .......+.+++.+|++.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 00000 0 01125667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=289.20 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=198.3
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
||.|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999765 489999999865432 3456789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcc
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 964 (1082)
.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999864 3589999999999999999999998 99999999999999999999999999998765432 223346
Q ss_pred cCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChH
Q 045553 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHD 1044 (1082)
Q Consensus 965 gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1044 (1082)
|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... +............. ....+..
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~ 218 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNG---------KLEFPNY 218 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCC---------CCCCCcc
Confidence 88999999999888899999999999999999999999974321 12233333221111 1122333
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045553 1045 DLIEMLNLAIMCTGESLSSRPS-----MRQVAQ 1072 (1082)
Q Consensus 1045 ~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 1072 (1082)
...++.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3568999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=299.56 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=207.0
Q ss_pred hcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
...|.+.+.||+|.|+.|.+|+ ..++..||+|.+....- ...+.+.+|+++|..++|||||+++.+...+...|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4679999999999999999995 45699999999976543 33455889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+.+|.+.+|+..+. ...+..+..++.|+.+|++|+|++ .|||||||++|++++.+.++||+|||++..+. .
T Consensus 135 eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred EeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--c
Confidence 9999999999999863 455588889999999999999999 99999999999999999999999999999886 3
Q ss_pred CccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.....+.+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||+... +...-. +++--
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------lk~Lr~---------rvl~g 270 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------LKELRP---------RVLRG 270 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------cccccc---------hheee
Confidence 345567899999999999998775 578999999999999999999998422 111111 11111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.++ .|.-...+..+++++++-.+|.+|++++++...
T Consensus 271 k~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eec--ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111 122335578899999999999999999998754
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=294.37 Aligned_cols=242 Identities=25% Similarity=0.333 Sum_probs=188.6
Q ss_pred eecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHH---hccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 808 CIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTL---GRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.||+|+||.||+|.. .+++.||+|.+..... .....+.+|..++ ...+||+++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 4589999998865422 1122334444333 34479999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++........
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 99999998764 4689999999999999999999999 999999999999999999999999999976543222
Q ss_pred cCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....|+..|+|||...+ ..++.++||||+||++|||++|..||...... .... ....... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~-~~~~~~~----------~~~ 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHE-IDRMTLT----------VNV 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CHHH-HHHHhhc----------CCc
Confidence 23468999999999864 56889999999999999999999999743211 1111 1111100 001
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
..+...+.++.+++.+|++.+|++|| +++|++++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12334456889999999999999999 69999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=294.06 Aligned_cols=255 Identities=23% Similarity=0.298 Sum_probs=202.8
Q ss_pred CccccceecccCceEEEEEEE----cCCeEEEEEEeecCc----cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI----IPGVVVAVKRLSVGR----FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 872 (1082)
+|++.+.||+|+||.||+|.. .+++.||||.++... ....+.+.+|+++++++ +|||++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999864 357889999986432 22345688999999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998763 4688999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCccccCcccCCCcccchhcccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCR--VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
............|+..|+|||...+.. .+.++||||||+++|||++|+.||..... ........+......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~--- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE----QNSQSEISRRILKSK--- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc----cchHHHHHHHHHccC---
Confidence 544333333456899999999987755 78899999999999999999999863211 111122222221111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
...+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 229 --------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 --------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01122334578899999999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=291.64 Aligned_cols=257 Identities=24% Similarity=0.322 Sum_probs=196.7
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc--cHHHHHHHHHHHhcc---CCCceeeEeeeeccCCe-----
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRV---QHPNLVTLIGYHVSEAE----- 871 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 871 (1082)
|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+++++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999876 4899999999754322 234466677766655 69999999999987776
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.+++|||+. ++|.+++.......+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 5899998876555799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC--
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP-- 1029 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1029 (1082)
+..... .....++..|+|||++.+..++.++||||||+++|||++|+.||.... ..+........-..
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 226 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS--------EADQLDKIFDVIGLPS 226 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC--------hHHHHHHHHHHcCCCC
Confidence 643322 123357889999999999899999999999999999999998886321 11222222111000
Q ss_pred -cc----------ccccccCC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 -CE----------FFTAGLWD---CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 -~~----------~~d~~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. .+...... .........+.+++.+|++.||++||++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 00000000 0012335678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=290.89 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=198.1
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
||+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|++++++++|||++++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999776 489999999865433 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC-------
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET------- 957 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~------- 957 (1082)
.++++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999874 3689999999999999999999999 999999999999999999999999999876543321
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
.......++..|+|||.......+.++||||||+++||+++|+.||.... .......... +... .
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~-~----- 220 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILN-GKIE-W----- 220 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-CCcC-C-----
Confidence 12233567889999999988889999999999999999999999986321 2222222221 1111 0
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
......+..+..++.+|++.+|++||++.++.+.|+
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 --PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000112568899999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=291.59 Aligned_cols=258 Identities=24% Similarity=0.300 Sum_probs=194.5
Q ss_pred ccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccC-CCceeeEeeeeccC--CeEEEEEe
Q 045553 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSE--AEMFLIYN 877 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 877 (1082)
|++.+.||+|+||.||+|.. .+++.||+|+++.... .......+|+..++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 66788999999999999964 4689999999875422 22234457888888885 99999999999887 88999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|++ +++.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++.......
T Consensus 81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 6888888764 34689999999999999999999999 9999999999999999 9999999999987643322
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-----------
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL----------- 1025 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 1025 (1082)
. ....++..|+|||++.+ ..++.++||||+||++|||++|+.||.... ......+......
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-----ELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-----HHHHHHHHHHHcCCCCHHHHHhhc
Confidence 1 23457889999997654 567889999999999999999999996422 1111222211110
Q ss_pred cCCCccccccccCC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 QGRPCEFFTAGLWD----CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.........+.... ......+..+.+++.+|++.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0012346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=293.17 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=198.5
Q ss_pred cceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 806 QNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
..+||+|+||.||+|.. .++..||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36799999999999965 46899999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcc
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 964 (1082)
.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........ ......
T Consensus 105 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 105 TDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 998864 3579999999999999999999999 999999999999999999999999999876543221 223356
Q ss_pred cCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChH
Q 045553 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHD 1044 (1082)
Q Consensus 965 gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1044 (1082)
|+..|+|||+..+..++.++||||+|+++|||++|+.||.... ........ ...... .+. ....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--------~~~~~~~~-~~~~~~-----~~~--~~~~ 241 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMI-RDNLPP-----KLK--NLHK 241 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-HhhCCc-----ccC--Cccc
Confidence 8899999999988889999999999999999999999986321 11111111 111110 000 0112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1045 DLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1045 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+.+++.+|++.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 34568899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=295.13 Aligned_cols=265 Identities=26% Similarity=0.344 Sum_probs=200.5
Q ss_pred HHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCC----
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA---- 870 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 870 (1082)
...++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999765 588999999875432 33456788999999999999999999887654
Q ss_pred ------eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEe
Q 045553 871 ------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS 944 (1082)
Q Consensus 871 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 944 (1082)
..++|+||+++ ++..++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999965 777777654 44689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH
Q 045553 945 DFGLARLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML 1023 (1082)
Q Consensus 945 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1023 (1082)
|||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|+.||.... .......+...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-----~~~~~~~~~~~ 233 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-----ELAQLELISRL 233 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHH
Confidence 999998765433322233356788999998865 457889999999999999999999986321 11111111111
Q ss_pred HhcCCCc---ccc--------cc------ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 LLQGRPC---EFF--------TA------GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 ~~~~~~~---~~~--------d~------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....... ++. +. ..+. .....+..+.+++.+|++.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111000 000 00 0000 011235678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=300.62 Aligned_cols=267 Identities=24% Similarity=0.328 Sum_probs=199.5
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccC-----CeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-----AEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 872 (1082)
+++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999964 468999999986432 23456678899999999999999999876543 357
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||++ +++.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999995 588888764 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 953 GTSETH--ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 953 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
...... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.... .......+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~-----~~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD-----YLHQLNLILGVLGTPSQ 231 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHcCCCCH
Confidence 432221 2233568999999998754 568899999999999999999999986321 01111111111111000
Q ss_pred c---cccccc-------cC--CCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhC
Q 045553 1030 C---EFFTAG-------LW--DCG-----PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQ 1078 (1082)
Q Consensus 1030 ~---~~~d~~-------l~--~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~ 1078 (1082)
. ...+.. .. ... ......++.+++.+|++.+|++||++.|++++ ++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000000 00 000 01224568899999999999999999999886 54443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=292.55 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=200.4
Q ss_pred CccccceecccCceEEEEEEE----cCCeEEEEEEeecCcc----ccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeE
Q 045553 802 GFNVQNCIGSGGFGATYKAEI----IPGVVVAVKRLSVGRF----QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 872 (1082)
+|++.+.||+|+||.||+|+. .+|..||+|++..... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999965 3689999999875322 2346678899999999 589999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999864 4688999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCccccCcccCCCcccchhcccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTC--RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
............|+..|+|||...+. .++.++||||||+++|+|++|+.||.... .......+.........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~-- 229 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEP-- 229 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC----ccccHHHHHHHhhccCC--
Confidence 54333333345688999999998753 46789999999999999999999986321 11222333322222111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQ 1072 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 1072 (1082)
..+......+.+++.+|++.+|++|| +..++..
T Consensus 230 ---------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 ---------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 12233456789999999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.58 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=199.4
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecC-----ccccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG-----RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEM 872 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 872 (1082)
.+|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999964 46899999987532 123446788999999999999999999988654 468
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999999764 3578999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC--ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 953 GTSET--HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 953 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.... . ..-+......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~-~~~~~~~~~~~~~- 227 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------A-MAAIFKIATQPTK- 227 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------H-HHHHHHHHcCCCC-
Confidence 32111 11223568899999999998889999999999999999999999986321 1 1111122111111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...+......+.+++.+|++ +|.+||+..++..+
T Consensus 228 --------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 --------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11234455789999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=316.22 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=194.0
Q ss_pred HHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeecc-------
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS------- 868 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 868 (1082)
+-..+|+..+.||+||||.||+++.+ ||+.||||++.... ......+.+|+..+++++|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888899999999999999644 79999999997653 3345668899999999999999998742110
Q ss_pred --------------------------------------------------------------------------------
Q 045553 869 -------------------------------------------------------------------------------- 868 (1082)
Q Consensus 869 -------------------------------------------------------------------------------- 868 (1082)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 045553 869 ------------------------E--------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916 (1082)
Q Consensus 869 ------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH 916 (1082)
+ ...||=||||+..++.++++.+.... .....++++++|++|++|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 0 01578899999888888887653211 46788999999999999999
Q ss_pred hCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC------C-----------CCCccccCcccCCCcccchhcccC-
Q 045553 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG------T-----------SETHATTDVAGTFGYVAPEYAMTC- 978 (1082)
Q Consensus 917 ~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~- 978 (1082)
+. +||||||||.||++|++..|||+|||+|.... . ......+..+||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998721 0 011134567899999999999764
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHc
Q 045553 979 --RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMC 1056 (1082)
Q Consensus 979 --~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~c 1056 (1082)
.|+.|+||||+|+|++||+. ||.. .+.-...+.. ++.+..+.- +. ........-.++|+++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~T-------sMERa~iL~~-LR~g~iP~~--~~----f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGT-------SMERASILTN-LRKGSIPEP--AD----FFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCc-------hHHHHHHHHh-cccCCCCCC--cc----cccccchHHHHHHHHH
Confidence 49999999999999999985 4542 3333333332 334444332 11 1223445667899999
Q ss_pred ccCCCCCCCCHHHHHH
Q 045553 1057 TGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1057 l~~~p~~RPt~~ev~~ 1072 (1082)
++.||.+|||+.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=292.54 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=197.5
Q ss_pred hcCccccceecccCceEEEEEEEcC-CeEEEEEEeecCcc-ccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++|++.+.||+|+||.||+|...+ ++.||||.+..... ....++.+|+..+.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3568889999999999999998764 89999999975432 33455677777666665 999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+ ++++.++.... ...+++..+..++.|++.|++|||+.. +|+||||+|+||++++++.+||+|||++..+....
T Consensus 94 e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 94 ELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 998 45787777654 347899999999999999999999732 89999999999999999999999999997654322
Q ss_pred CccccCcccCCCcccchhcccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCR----VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
. .....++..|+|||++.+.. ++.++||||||+++|||++|+.||.... ...+......... ....
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~-~~~~ 239 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK-------TEFEVLTKILQEE-PPSL 239 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch-------hHHHHHHHHhcCC-CCCC
Confidence 2 22335788999999987654 7889999999999999999999986321 1122222222221 1111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
- .......++.+++.+|++.+|++||++.+++++-
T Consensus 240 ~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 P-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 1112356789999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=300.92 Aligned_cols=267 Identities=22% Similarity=0.315 Sum_probs=202.1
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccC-----Ce
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-----AE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 871 (1082)
..+|++.+.||+|+||+||+|.. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999964 46899999998643 233455677899999999999999999987654 35
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7899988763 4689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc----
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ---- 1026 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 1026 (1082)
..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .............
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLGSPSEE 231 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCChH
Confidence 64332 22233467889999998865 4688999999999999999999999864211 0000000000000
Q ss_pred -------CCCcccc-------ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhCC
Q 045553 1027 -------GRPCEFF-------TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQP 1079 (1082)
Q Consensus 1027 -------~~~~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~~ 1079 (1082)
+...+.+ +.... ......+.++.+++.+|++.+|++||++.|++++ ++.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0000000 00000 0112345678999999999999999999999987 665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=293.62 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=195.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCC------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA------ 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 870 (1082)
.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999654 689999999865432 22345678999999999999999999886543
Q ss_pred --eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 871 --EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 871 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
..++||||+. +++.+++... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999995 5888888754 34689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc---cccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 949 ARLLGTSETH---ATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 949 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
+..+...... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~~~~ 240 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLISQLC 240 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHh
Confidence 9866433221 12234578899999988664 468899999999999999999999864321 11111111111
Q ss_pred hcCCCccc---------ccc-ccCCCC---------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 LQGRPCEF---------FTA-GLWDCG---------PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ~~~~~~~~---------~d~-~l~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.....+. .+. ...... +......+.+++.+|++.+|++||++.|++++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 -GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred -CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 000 000000 01123467799999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=285.73 Aligned_cols=243 Identities=23% Similarity=0.278 Sum_probs=189.2
Q ss_pred ceecccCceEEEEEEE-cCCeEEEEEEeecCccc---cHHHHHHHHHH-HhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEIRT-LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|.. .+++.||+|.+...... ....+..|... ....+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999965 45899999998654321 12234445444 4455899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
++|.++++.. ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 9999999764 4688999999999999999999999 999999999999999999999999999876432 22
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...|+..|+|||...+..++.++||||+|+++|||++|..||.... .......... +... ... ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~--~~~----~~ 216 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--------PDAVFDNILS-RRIN--WPE----EV 216 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHh-cccC--CCC----cc
Confidence 3458889999999988889999999999999999999999996321 1222222211 1110 000 11
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
....+..+.+++.+|++.+|++||++.++.+.|
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 123456899999999999999999775554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=299.69 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=199.1
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc----CCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS----EAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 872 (1082)
..+|++.+.||+|+||.||+|.. .+|..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46799999999999999999964 468999999987542 2345677889999999999999999988753 3468
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6999998763 4589999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCCc---cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 953 GTSETH---ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 953 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
...... ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+.... +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~-g~~ 231 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVL-GSP 231 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHh-CCC
Confidence 432221 1234568899999999865 56889999999999999999999999643110 0111111100 000
Q ss_pred Cccc------------cccc-cCCCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEF------------FTAG-LWDCG-----PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~------------~d~~-l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+. .+.. ..... ....+.++.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000 0000 00000 12235789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=270.48 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=207.9
Q ss_pred HHHHHHHhcCccccceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeeccCC
Q 045553 793 YENVVRATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEA 870 (1082)
Q Consensus 793 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 870 (1082)
++++.+.+. +.||+|+|+.|-.+ .+.+|..+|||++.+.......++.+|++++.+.+ |+||+.++++|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 456655554 68999999999988 57789999999998776667788899999998885 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC---cEEEeecc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL---NAYLSDFG 947 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfG 947 (1082)
..|+|||.|.||+|..+++.+ ..+++.++.++..+|+.||.|||.+ +|.|||+||+|||-.... .+|||||.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred eEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999999984 5799999999999999999999999 999999999999996543 58999999
Q ss_pred cceecCCCC------CccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC---ccCCCCC
Q 045553 948 LARLLGTSE------THATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPS---FCSFGNG 1013 (1082)
Q Consensus 948 la~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~---~~~~~~~ 1013 (1082)
+..-+.... +....+.+|+..|||||+.. ...|+.++|.||+|||+|-|++|..||... .+.++.+
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 876442211 12233567999999999873 346889999999999999999999999764 2333333
Q ss_pred ccH---HHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1014 FNI---VAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1014 ~~~---~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
+.= .+..-..+++|.+. +-|.. ....+.+..+++...+..++..|-++.+++.
T Consensus 305 e~Cr~CQ~~LFesIQEGkYe-FPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKYE-FPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccCCc-CChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 221 11222233444322 21111 1345678889999999999999999888876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=290.74 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=203.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV 875 (1082)
++|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36889999999999999999654 68999999986532 233467889999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999874 3699999999999999999999999 9999999999999999999999999999866433
Q ss_pred CC-------------------ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccH
Q 045553 956 ET-------------------HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016 (1082)
Q Consensus 956 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~ 1016 (1082)
.. .......++..|+|||...+..++.++||||+|++++++++|+.||.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~ 227 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--------E 227 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--------H
Confidence 21 12233467889999999998889999999999999999999999987431 1
Q ss_pred HHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 045553 1017 VAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSM----RQVAQ 1072 (1082)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~ev~~ 1072 (1082)
........... ...+...+..+.+++.+|++.+|++||++ .++++
T Consensus 228 ~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLTFQKILKLE-----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHHhcC-----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11112211111 11233345689999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=297.44 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=206.2
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCC-----eEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA-----EMF 873 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 873 (1082)
+|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999765 48999999987543 344567899999999999999999999988765 789
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||++ ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 5899998764 3799999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCC--ccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC--
Q 045553 954 TSET--HATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR-- 1028 (1082)
Q Consensus 954 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1028 (1082)
.... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||.... ..+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~~ 226 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD--------YIDQLNLIVEVLGTP 226 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC--------HHHHHHHHHHhcCCC
Confidence 4431 123345678899999999887 78999999999999999999999996432 1111111111000
Q ss_pred C------------cccccc-ccC-----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhCCC
Q 045553 1029 P------------CEFFTA-GLW-----DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQPP 1080 (1082)
Q Consensus 1029 ~------------~~~~d~-~l~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~~~ 1080 (1082)
. .+.+.. ... .......+..+.+++.+|++.+|++||++.+++++ +++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0 000000 000 00011235678999999999999999999999985 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=297.74 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=198.3
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecC--ccccHHHHHHHHHHHhcc-CCCceeeEeeeeccC--CeE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE--AEM 872 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 872 (1082)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567999999999999999999754 5889999988542 223345677899999999 999999999988653 468
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||++ ++|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 6999988753 688999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC----ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH---
Q 045553 953 GTSET----HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL--- 1024 (1082)
Q Consensus 953 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 1024 (1082)
..... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~ 232 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-----NQLEKIIEVIGPP 232 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCC
Confidence 43322 12334568999999998765 55788999999999999999999998632110 0000000000
Q ss_pred --------hcCCCccccccccCC------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 --------LQGRPCEFFTAGLWD------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 --------~~~~~~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
........++..... ......+.++.+++.+|++.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000011100000 0001245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=291.92 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=197.7
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
..|+..+.||+|+||.||+|... ++..||+|.+.... ....+++.+|+++++.++|+|++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999754 57889999986432 233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+. |++.+++... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9995 6888877654 34589999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 957 THATTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
....|+..|+|||.+. ...++.++|||||||++|||++|+.||.... -........ .+.....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~- 234 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIA-QNESPAL- 234 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHHh-hcCCCCc-
Confidence 2345788999999975 3567889999999999999999999985321 111111111 1111111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
.+......+.+++.+||+.+|++||++.+++++-.
T Consensus 235 -------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11234567899999999999999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=289.68 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=199.0
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEEeec
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
|++.+.||+|++|+||+|... +++.||+|++..... .......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999765 478999999865432 22334567899999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
+|+|.+++.......+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 88999999876545789999999999999999999999 999999999999999999999999999986643322
Q ss_pred ccCcccCCCcccchhcc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCC--------CCccHHHHHHHHHhcCCCc
Q 045553 960 TTDVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFG--------NGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 1030 (1082)
.....++..|+|||++. +..++.++||||||++++||++|+.||........ ....-..|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 22346788999999875 45678999999999999999999999864321000 0000001111111111111
Q ss_pred cccccccC---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 EFFTAGLW---DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+..... .........++.+++.+|++.+|++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00011224679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=297.32 Aligned_cols=260 Identities=21% Similarity=0.320 Sum_probs=196.6
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC------C
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------A 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 870 (1082)
..+|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999965 468999999986532 22345678999999999999999999988654 3
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
.+++|+||+. .++.++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 5799999995 47777653 3589999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc-C-
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ-G- 1027 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~- 1027 (1082)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...-+...... +
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~--------~~~~~~~~~~~~~~ 233 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQLTQILKVTGV 233 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhcCC
Confidence 64321 223467889999999876 468899999999999999999999997421 11111111110 0
Q ss_pred CCccc------------cc--ccc-CCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhCC
Q 045553 1028 RPCEF------------FT--AGL-WDCG---PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQP 1079 (1082)
Q Consensus 1028 ~~~~~------------~d--~~l-~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~~ 1079 (1082)
...+. ++ +.. .... .......+.+++.+|++.+|++||++.|++.+ +++.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 00 000 0000 01234568899999999999999999999865 655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=290.07 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=195.0
Q ss_pred ccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
|...+.||+|+||+||+|+. .+++.||+|++..... ...+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55667899999999999965 4689999999865432 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+. +++.+++... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 6888887654 34689999999999999999999999 999999999999999999999999999864321
Q ss_pred cccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 959 ATTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.....|+..|+|||++. ...++.++|||||||++|||++|..||.... ............ .....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~-~~~~~-- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQND-SPTLQ-- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcC-CCCCC--
Confidence 22346889999999984 4568889999999999999999999986321 112222222211 11111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......+.+++.+|++.+|.+||++.+++.+
T Consensus 242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11233568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=284.12 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=197.2
Q ss_pred CccccceecccCceEEEEEEEcC-CeEEEEEEeecC-----ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVG-----RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
+|.+.+.||+|+||.||+|+... +..+++|..+.. ......++..|+.++++++|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999996543 444555555421 122344577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 876 YNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
|||+++++|.++++.. ....+++..+..++.|++.|+.|||+. +++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998752 245789999999999999999999999 9999999999999975 569999999998764
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
.... ......|+..|+|||...+..++.++||||||+++|+|++|..||... .......... .+....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--------~~~~~~~~~~-~~~~~~-- 224 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--------NFLSVVLRIV-EGPTPS-- 224 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHH-cCCCCC--
Confidence 3222 223346788999999998888899999999999999999999998632 1222222222 121111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+...+.++.+++.+|++.+|++||++.|++++
T Consensus 225 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 -------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 123455688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=314.31 Aligned_cols=258 Identities=22% Similarity=0.284 Sum_probs=211.5
Q ss_pred HHHHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCC
Q 045553 795 NVVRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 795 ~~~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 870 (1082)
++....++|.+.++||+|+||.|..++. .+++.||+|++... .......|.+|-++|..-+.+=|+.++-+|.+..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3334456799999999999999999965 46899999999762 3345667899999999989999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
+.|+|||||+||+|-.++.... .+++..++.++..|+-||.-+|+. |+|||||||+|||+|..|++|++|||.+.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999999999874 799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCccccCcccCCCcccchhccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMT-----CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
.+..+........+|||.|.+||+++. +.|+..+|.||+||++|||+.|..||+. ..++.....++.
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa--------dslveTY~KIm~ 295 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA--------DSLVETYGKIMN 295 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH--------HHHHHHHHHHhc
Confidence 887766666677899999999999862 5789999999999999999999999984 344444444443
Q ss_pred cCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 045553 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS---MRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~~ 1073 (1082)
..+...+.| ....++++..||++.+. +|+.|-. +.++..+
T Consensus 296 hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 296 HKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 322222211 12345678888888774 5566655 7766543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=287.35 Aligned_cols=242 Identities=24% Similarity=0.325 Sum_probs=188.3
Q ss_pred eecccCceEEEEEEE-cCCeEEEEEEeecCccc---cHHHHHHHH---HHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 808 CIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEI---RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.||+|+||.||+|.. .+++.||+|.+...... ....+..|. +.++...||+++++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999964 45899999998654221 112233343 34455679999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.+++... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||++..+.... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999998753 4689999999999999999999999 99999999999999999999999999987653322 2
Q ss_pred cCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....|+..|+|||++.++ .++.++||||+|+++|||++|+.||...... ..... ....... ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~------~~---- 216 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEI-DRMTLTM------AV---- 216 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHHH-HHHhhcc------CC----
Confidence 234689999999998754 6889999999999999999999999743211 11111 1111100 01
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
..+...+.++.+++.+|+..+|.+|| ++.|++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 12223356899999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=270.92 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=202.7
Q ss_pred HhcCcccc-ceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeecc----CCe
Q 045553 799 ATAGFNVQ-NCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVS----EAE 871 (1082)
Q Consensus 799 ~~~~~~~~-~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 871 (1082)
.+++|.+. ++||-|-.|.|-.. ...+++++|+|++... ....+|++..-.. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566664 57999999999988 4557999999998643 3346777765444 69999999998864 356
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc---CCCcEEEeeccc
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD---NNLNAYLSDFGL 948 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGl 948 (1082)
..+|||.|+||.|.+.+++++...+++.++..|+.||+.|+.|||+. .|.||||||+|+|.. .+..+|++|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 78999999999999999999888999999999999999999999999 999999999999996 456799999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
|+.... .....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||+... +..+..-++..++.+.
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h-----g~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKRRIRTGQ 283 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC-----CccCChhHHhHhhccC
Confidence 987543 334556678999999999999999999999999999999999999997432 2223333444444443
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+. +-+ +.....++..+++|+..+..+|++|-|+.|++.+
T Consensus 284 y~-FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 YE-FPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cc-CCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 22 100 0112446778999999999999999999998754
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=270.68 Aligned_cols=271 Identities=23% Similarity=0.325 Sum_probs=200.4
Q ss_pred HhcCccccceecccCceEEEEEEEcC-----CeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeecc-CC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIP-----GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-EA 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~-----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 870 (1082)
-...|+....||+|+||.||+|.-.+ .+.+|+|+++.... .-.....+|+..++.++|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34568899999999999999994322 23789999976532 223556899999999999999999998877 78
Q ss_pred eEEEEEeecCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC----CcEEE
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP---RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN----LNAYL 943 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl 943 (1082)
..++++||.+ -+|.+.++.++ .+.++...+..|+.||+.|+.|||++ -|+|||+||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 8999999996 48999887643 45789999999999999999999999 79999999999999877 89999
Q ss_pred eecccceecCCCCCc--cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCC--ccHHH
Q 045553 944 SDFGLARLLGTSETH--ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNG--FNIVA 1018 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~--~~~~~ 1018 (1082)
+|||+++.+...-.. ....++-|..|+|||.+.+ ..||.+.||||.||++.||+|-++-|.....+.... ....+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999988654322 3345678999999999987 568999999999999999999888776543222221 11112
Q ss_pred HHHHHHhcCCCc--cccccc-----------cCCCC--C---hH-------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1019 WASMLLLQGRPC--EFFTAG-----------LWDCG--P---HD-------DLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1019 ~~~~~~~~~~~~--~~~d~~-----------l~~~~--~---~~-------~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.-+....-|.+. ++-|-. ++..+ + .. .......++.+++++||.+|-|..+.+++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111111111110 111000 00000 0 00 11237789999999999999999998765
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=292.86 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=194.4
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc--cHHHHHHHHHHHhccCCCceeeEeeeeccC-------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------- 869 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 869 (1082)
.++|++.++||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999754 5899999998654322 234567899999999999999999977543
Q ss_pred -CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 870 -AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 870 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
...++||||+. +++...+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999995 5787777654 45799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCc----------cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHH
Q 045553 949 ARLLGTSETH----------ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 949 a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 1017 (1082)
++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~--------~ 233 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD--------I 233 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence 9865432211 1123457888999998765 4578999999999999999999999863211 1
Q ss_pred HHHHHHHhc-CC-----------CccccccccCCCCC-------hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1018 AWASMLLLQ-GR-----------PCEFFTAGLWDCGP-------HDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1018 ~~~~~~~~~-~~-----------~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
......... +. .....+.......+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111100 00 00000000000011 112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=264.83 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=198.4
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecC-ccccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEEeec
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++...||.|+-|.||+++.. +|..+|||.+... ..++.+++...++++..-. .|.||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344566999999999999654 5899999999654 4566778888888876654 899999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
..-++.+++.. ..++++.-+-++...+..||.||.+++ +|+|||+||+|||+|+.|++|+||||.+.++-....+
T Consensus 174 -s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 174 -STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred -HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 44566666554 557888888899999999999999886 9999999999999999999999999999877544433
Q ss_pred ccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 960 TTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
+..+|-+.|||||.+. ...|+-++||||||+.++|+.||+-||...... .+.+..+.. ..++ .
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~ltkvln-~ePP-~---- 314 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEVLTKVLN-EEPP-L---- 314 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHHHHHHHh-cCCC-C----
Confidence 3447889999999985 346889999999999999999999999754322 122223322 2221 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+. +....+..+.+++..|+..|+.+||...+++++
T Consensus 315 L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 112246689999999999999999999988764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=313.43 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=208.9
Q ss_pred cCccccceecccCceEEEEEEEc--------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhcc-CCCceeeEeeeeccCC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII--------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 870 (1082)
++..+.+.+|+|.||.||+|... ....||||..+.... .+.+.+..|+++++.+ +|+|++.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34456679999999999999533 146799999875433 4567899999999999 5999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC------------C--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP------------R--RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD 936 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 936 (1082)
..++|+||++.|+|.++++..+ . ..++......++.|||.|++||++. +++|||+..+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence 9999999999999999999764 0 2388899999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCccccCcc--cCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCC
Q 045553 937 NNLNAYLSDFGLARLLGTSETHATTDVA--GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNG 1013 (1082)
Q Consensus 937 ~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 1013 (1082)
++..+||+|||+|+............-. -...|||||.+....++.++|||||||++||+++ |..|+....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~------ 526 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP------ 526 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC------
Confidence 9999999999999976554444322222 2456999999999999999999999999999998 555654211
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
...... ..+.+|... ..|..+..++.++|+.||+.+|++||++.|+++.++..
T Consensus 527 -~~~~l~-~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 -PTEELL-EFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -cHHHHH-HHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 012222 244444322 34667788999999999999999999999999999874
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=294.11 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=200.1
Q ss_pred cHHHHHHHhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc
Q 045553 792 TYENVVRATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868 (1082)
Q Consensus 792 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 868 (1082)
...++..+.++|.+.+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 455667788999999999999999999995 4568999999986532 2234567889999999999999999998754
Q ss_pred C------CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEE
Q 045553 869 E------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY 942 (1082)
Q Consensus 869 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 942 (1082)
. ...++++|++ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3 3468888887 7899988864 3589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHH
Q 045553 943 LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 943 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
|+|||+++.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... .....
T Consensus 161 l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~--------~~~~~ 228 (345)
T cd07877 161 ILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--------IDQLK 228 (345)
T ss_pred Eecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 999999876432 2233467889999999876 5688899999999999999999999853211 01111
Q ss_pred HHHh-cCCC-cccc---------------ccccC---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1022 MLLL-QGRP-CEFF---------------TAGLW---DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1022 ~~~~-~~~~-~~~~---------------d~~l~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... .+.. .+.. +.... .........++.+++.+|++.+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1000 0000 0000 00000 00001234578899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=291.78 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=199.5
Q ss_pred HHHHhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeecc-CCe
Q 045553 796 VVRATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-EAE 871 (1082)
Q Consensus 796 ~~~~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 871 (1082)
+..++++|++.+.||+|+||.||+|. ..+++.||+|++... .....+.+.+|++++++++|||++++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 34567899999999999999999996 447899999988543 22335678899999999999999999998865 567
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||+|+||++++++.++|+|||.+..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 89999999 6799988874 3578888999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCC-------CCccHHHHHHHH
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFG-------NGFNIVAWASML 1023 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~ 1023 (1082)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||........ .+....+|....
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4322 223457889999998766 5689999999999999999999999863211000 000001111111
Q ss_pred HhcCCCccccc-cccCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 LLQGRPCEFFT-AGLWDCGP-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 ~~~~~~~~~~d-~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... ..+.+. .......+ ......+.+++.+|++.+|++||++.|++.+
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000 00001111 1234689999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=292.09 Aligned_cols=255 Identities=20% Similarity=0.329 Sum_probs=196.1
Q ss_pred HhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCC-----
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA----- 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 870 (1082)
..++|++.+.||+|+||.||+|. ..++..||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 56789999999999999999995 4568999999986432 223456789999999999999999999887543
Q ss_pred -eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 871 -EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 871 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
.+++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 469999999 7899988864 3689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-cC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-QG 1027 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 1027 (1082)
...... .....++..|+|||++.+ ..++.++||||+|+++|++++|+.||..... ......... .+
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--------~~~~~~~~~~~~ 233 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--------LDQLMEIMKVTG 233 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcC
Confidence 865332 223467889999999876 4588999999999999999999999863211 111111110 00
Q ss_pred CCccccccc---------------cCC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1028 RPCEFFTAG---------------LWD----CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1028 ~~~~~~d~~---------------l~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.....+... ... .........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000 001123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=294.10 Aligned_cols=258 Identities=19% Similarity=0.273 Sum_probs=195.1
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccC---------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--------- 869 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 869 (1082)
..+|.+.+.||+|+||.||+|.. .+|..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46799999999999999999965 46899999999776666677889999999999999999999876543
Q ss_pred -----CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-CCcEEE
Q 045553 870 -----AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYL 943 (1082)
Q Consensus 870 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl 943 (1082)
...++||||++ ++|.+++.. ..+++..+..++.|++.|+.|||+. +|+||||||+||+++. ++.+|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35799999996 689888864 3588999999999999999999999 9999999999999984 567899
Q ss_pred eecccceecCCCCCc--cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHH
Q 045553 944 SDFGLARLLGTSETH--ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 1020 (1082)
+|||.++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..... ..-.
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--------~~~~ 228 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE--------LEQM 228 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 999999866432221 1122357889999998754 5678899999999999999999999964321 0101
Q ss_pred HHHHhcCCC--------------ccccccccCCCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1021 SMLLLQGRP--------------CEFFTAGLWDCG-----PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1021 ~~~~~~~~~--------------~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
......... ............ ......++.+++.+|++.+|++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 111000000 000000000000 0123467889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=292.68 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=196.5
Q ss_pred hcCcc-ccceecccCceEEEEEEE-cCCeEEEEEEeecCcccc--------------HHHHHHHHHHHhccCCCceeeEe
Q 045553 800 TAGFN-VQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQG--------------VQQFAAEIRTLGRVQHPNLVTLI 863 (1082)
Q Consensus 800 ~~~~~-~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~ 863 (1082)
.++|. +.+.||+|+||+||+|.. .+++.||||++....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 457799999999999964 468999999986542211 12467899999999999999999
Q ss_pred eeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEE
Q 045553 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL 943 (1082)
Q Consensus 864 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 943 (1082)
+++..++..++||||+. ++|.+++.. ...+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.+++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 99999999999999995 699999875 34689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCC-------------CccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccC
Q 045553 944 SDFGLARLLGTSE-------------THATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCS 1009 (1082)
Q Consensus 944 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~ 1009 (1082)
+|||.+....... ........++..|+|||++.+. .++.++||||+|+++|||++|+.||.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~- 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE- 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 9999998765211 1112223467889999998764 468999999999999999999999864321
Q ss_pred CCCCccHHHHHHHHHhcCCCc---cccccc----cCC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1010 FGNGFNIVAWASMLLLQGRPC---EFFTAG----LWD-------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~---~~~d~~----l~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+.......... ...+.. ... ........++.+++.+|++.+|++||++.|++.+
T Consensus 240 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ----IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ----HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111111111111000 000000 000 0011234678899999999999999999999864
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=285.54 Aligned_cols=260 Identities=26% Similarity=0.378 Sum_probs=199.3
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+..|++++++++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999755 48999999997653 333467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
+ ++|.+++.... ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 6 69999998752 4689999999999999999999999 999999999999999999999999999987643322 2
Q ss_pred ccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc------c-
Q 045553 960 TTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC------E- 1031 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~- 1031 (1082)
.....++..|+|||.+.+. .++.++||||||+++||+++|+.||..... ......+.......... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-----IDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHHHhCCCcHHHHHhhccc
Confidence 2233467789999998776 789999999999999999999998863211 11111111110000000 0
Q ss_pred -ccccccCC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 -FFTAGLWD-------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 -~~d~~l~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+..... .........+.+++.+|++.+|++||++.+|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 0001225679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=281.78 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=201.5
Q ss_pred hcCccccceecccCceEEEEE-EEcCCeEEEEEEeecCcc--c-----cHHHHHHHHHHHhccCCCceeeEeeeecc-CC
Q 045553 800 TAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF--Q-----GVQQFAAEIRTLGRVQHPNLVTLIGYHVS-EA 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~--~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 870 (1082)
.++|-..++||+|||+.||+| .+...+.||||+-..... + -.+...+|+++.+.+.||.||++++|+.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 456888899999999999999 666789999998754321 1 12446789999999999999999999974 56
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc---CCCcEEEeecc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD---NNLNAYLSDFG 947 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfG 947 (1082)
.+|-|+||++|.+|+-|++.+ +.+++.+++.|+.||+.||.||... .++|||-||||.|||+- ..|.+||+|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999999884 5789999999999999999999986 67999999999999994 45789999999
Q ss_pred cceecCCCCCc------cccCcccCCCcccchhcccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHH
Q 045553 948 LARLLGTSETH------ATTDVAGTFGYVAPEYAMTC----RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 948 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 1017 (1082)
+++++..+... .+....||+.|++||.+.-+ +++.|.||||.||++|+++.|+.||...... .
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ----Q--- 691 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ----Q--- 691 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----H---
Confidence 99998654332 34457899999999988533 5788999999999999999999999743211 1
Q ss_pred HHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.++.+..+...-+..+ +.-+....+...+|++|+++--++|....++..
T Consensus 692 ----dILqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 ----DILQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ----HHHhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1222222222111111 011233467889999999999999998887753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=294.63 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=197.8
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCe----
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE---- 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 871 (1082)
..++|++.+.||+|++|.||+|... ++..||||++.... ....+.+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999764 57899999986532 2334567789999999999999999998776554
Q ss_pred --EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 872 --MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 872 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||+|+||+++.++.++|+|||.+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 6799999875 3689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc-C
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ-G 1027 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 1027 (1082)
...... .....++..|+|||...+ ..++.++||||+|+++|||++|+.||..... .......... +
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--------~~~~~~i~~~~~ 233 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--------IDQLKRIMNLVG 233 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHhcC
Confidence 865432 233467889999999865 4678899999999999999999999863211 1111111110 0
Q ss_pred CCc-cc------------cccc-cC--CC---CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1028 RPC-EF------------FTAG-LW--DC---GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1028 ~~~-~~------------~d~~-l~--~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... +. +... .. .. .....+.++.+++.+|++.+|++|||+.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 00 0000 00 00 001235679999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=310.42 Aligned_cols=145 Identities=31% Similarity=0.469 Sum_probs=131.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|.+.++||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999765 689999999875432 23467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
||+++++|.++++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999764 4588999999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=276.02 Aligned_cols=236 Identities=27% Similarity=0.360 Sum_probs=194.7
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
||+|+||.||+|... +++.||+|.+..... .....+..|++++++++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999765 589999999875433 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcc
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 964 (1082)
.+++... ..+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 9999864 3689999999999999999999998 99999999999999999999999999998764332 1223456
Q ss_pred cCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChH
Q 045553 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHD 1044 (1082)
Q Consensus 965 gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1044 (1082)
++..|+|||...+...+.++|+||||+++||+++|+.||.... ..+....... +.. ..+..
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~----------~~~~~ 215 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--------RKEIYEKILK-DPL----------RFPEF 215 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHhc-CCC----------CCCCC
Confidence 8889999999998889999999999999999999999986321 1222222222 110 12223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHH
Q 045553 1045 DLIEMLNLAIMCTGESLSSRPSMRQ 1069 (1082)
Q Consensus 1045 ~~~~l~~li~~cl~~~p~~RPt~~e 1069 (1082)
.+..+.+++.+|+..+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3568899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=287.48 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=192.1
Q ss_pred CccccceecccCceEEEEEEEc-C--CeEEEEEEeecC--ccccHHHHHHHHHHHhcc-CCCceeeEeeeecc----CCe
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-P--GVVVAVKRLSVG--RFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVS----EAE 871 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 871 (1082)
+|++.+.||+|+||.||+|... . +..||+|++... .....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999754 3 678999998643 222346678899999999 59999999986542 245
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++++||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899984 799999875 35689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc---cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh--
Q 045553 952 LGTSETH---ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-- 1025 (1082)
Q Consensus 952 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 1025 (1082)
....... ......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||..... ......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 229 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLNQILQVLGTP 229 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHHHHHHHhCCC
Confidence 6432221 1233568999999998765 5688999999999999999999999864210 000000000000
Q ss_pred ---------cCCCccc---cccc--c-CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1026 ---------QGRPCEF---FTAG--L-WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1026 ---------~~~~~~~---~d~~--l-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
....... +... . ...........+.+++.+|++.+|++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0000 0 00001123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.04 Aligned_cols=240 Identities=23% Similarity=0.322 Sum_probs=195.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 875 (1082)
.+|.+..+||+|+||.|-+|+.+ +.+.+|||+++.... .+.+--..|-+++.-. +-|.++.+..+++.-++.|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46899999999999999999544 568899999876532 2233334566666655 467899999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+.||+|-..++.. ..+.+..+..+|.+||-||-+||++ +|++||||..|||+|.+|.+||+|||+++.-- -
T Consensus 429 MEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-F 502 (683)
T ss_pred EEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc-c
Confidence 9999999999888874 4678888999999999999999999 99999999999999999999999999997532 2
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
....+.+++||+.|+|||.+..++|+...|.|||||++|||+.|+.||+... -.+....+...
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD--------E~elF~aI~eh--------- 565 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQAIMEH--------- 565 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHHc---------
Confidence 2234556899999999999999999999999999999999999999998532 12222222221
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRP 1065 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RP 1065 (1082)
.+ .+|...+.+...+....+...|.+|-
T Consensus 566 nv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 36667778889999999999999985
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=281.46 Aligned_cols=243 Identities=25% Similarity=0.394 Sum_probs=195.9
Q ss_pred cceecccCceEEEEEE-EcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 806 QNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
.++||.|.||+||-|+ .++|+.||||++.+.+. ....++.+|+.+++++.||.||.+-..|+..+..++|||.+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 4789999999999995 45799999999976543 44577899999999999999999999999999999999999 45
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC---CcEEEeecccceecCCCCCcc
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN---LNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~~~~~~~~~~ 959 (1082)
+..+++-.....++++.....+..||+.||.|||.+ +|+|+|+||+|||+... -++||||||+|+++++...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 665655555567899888889999999999999999 99999999999999644 2699999999999875443
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
...++||+.|+|||+++++.|...-||||.||++|--++|..||.++ +++.+-+..+ .-++-+.-+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-------EdIndQIQNA------aFMyPp~PW- 788 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-------EDINDQIQNA------AFMYPPNPW- 788 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-------cchhHHhhcc------ccccCCCch-
Confidence 34578999999999999999999999999999999999999999743 2222222211 112222222
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
.+......++|...++..=.+|-+....+
T Consensus 789 ---~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 ---SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 34556777888888888777887776543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=272.07 Aligned_cols=259 Identities=20% Similarity=0.323 Sum_probs=203.0
Q ss_pred hcCccccceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCC--C----ceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH--P----NLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~~~ 872 (1082)
+++|.+...+|+|+||.|-.. ....+..||||+++.-.. -.+...-|+++++++.+ | -+|.+.+++...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 789999999999999999998 344589999999875432 23445679999999943 2 377888899999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---------------
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN--------------- 937 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--------------- 937 (1082)
|+|+|.+ |-|+.+++..+...+++...+..|+.|++++++|||+. +++|.||||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999 77999999998888999999999999999999999999 9999999999999941
Q ss_pred -----CCcEEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC
Q 045553 938 -----NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012 (1082)
Q Consensus 938 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 1012 (1082)
+..++|+|||.|+.-.... ...+.|..|+|||++.+-.++.++||||+|||++|+++|..-|.... +
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe----n 314 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE----N 314 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC----c
Confidence 3458999999998743322 45678999999999999999999999999999999999998886422 1
Q ss_pred CccHHHHHHHHHhcCCCccccccc------------------------cC-CCC--------ChHHHHHHHHHHHHcccC
Q 045553 1013 GFNIVAWASMLLLQGRPCEFFTAG------------------------LW-DCG--------PHDDLIEMLNLAIMCTGE 1059 (1082)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~d~~------------------------l~-~~~--------~~~~~~~l~~li~~cl~~ 1059 (1082)
.+.+ ..++.++. .-+..++... +. .+. ...+..++.+|+.+|+..
T Consensus 315 ~EHL-aMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 315 LEHL-AMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred HHHH-HHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 1211 22222222 1111111111 00 011 134567799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 045553 1060 SLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1060 ~p~~RPt~~ev~~~ 1073 (1082)
||.+|+|+.|++.+
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-31 Score=263.27 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=195.9
Q ss_pred cceecccCceEEEEEE-EcCCeEEEEEEeecCcc-ccHHHHHHHHHHH-hccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 806 QNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF-QGVQQFAAEIRTL-GRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
...||.|+||+|+|-. .+.|+..|||++..... .+.+++..|.+.. +.-+.||||+++|++..++..|+-||.| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 3459999999999984 45699999999987654 5667888888764 4457899999999999999999999999 56
Q ss_pred CHHHHHh---hCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 883 NLEKFIQ---DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 883 sL~~~l~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
|++.+-. .-....+++.-.-+|....+.||.||-... .|||||+||+|||++..|.+|+||||.+..+... ..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--HH
Confidence 7765543 333567899999999999999999999875 8999999999999999999999999999766332 22
Q ss_pred ccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 960 TTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
.+.-+|-..|||||.+.. ..|+-++||||+|+.+||+.||+.|+.... +..+-+..++.+. .+...-+
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gd-pp~l~~~-- 293 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGD-PPILLFD-- 293 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCC-CCeecCc--
Confidence 333467889999999853 458999999999999999999999987432 2333344443333 2222111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
....+....+..++..|+-.|-.+||.+.++.+
T Consensus 294 --~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 --KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111345678999999999999999999988765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=270.94 Aligned_cols=220 Identities=24% Similarity=0.225 Sum_probs=177.5
Q ss_pred cCceEEEEEE-EcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCHHHHHhh
Q 045553 812 GGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQD 890 (1082)
Q Consensus 812 G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 890 (1082)
|.+|.||+|. ..+++.||+|++.... .+.+|...+....|||++++++++......++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999995 4568999999987543 234455555566799999999999999999999999999999999876
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcc
Q 045553 891 RPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970 (1082)
Q Consensus 891 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 970 (1082)
. ..+++..+..++.|+++|++|+|+. +|+||||||+||+++.++.++++|||.+...... .....++..|+
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 4 3589999999999999999999999 9999999999999999999999999988665432 12234577899
Q ss_pred cchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHH
Q 045553 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEML 1050 (1082)
Q Consensus 971 aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 1050 (1082)
|||...+..++.++||||+|+++|||++|+.|++..... .... .....+......+.
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------------~~~~---------~~~~~~~~~~~~~~ 206 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------------INTH---------TTLNIPEWVSEEAR 206 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------------cccc---------cccCCcccCCHHHH
Confidence 999998888999999999999999999999887532110 0000 00012233456789
Q ss_pred HHHHHcccCCCCCCCCHH
Q 045553 1051 NLAIMCTGESLSSRPSMR 1068 (1082)
Q Consensus 1051 ~li~~cl~~~p~~RPt~~ 1068 (1082)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=288.22 Aligned_cols=262 Identities=22% Similarity=0.403 Sum_probs=213.4
Q ss_pred ccHHHHHHHhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeecc
Q 045553 791 LTYENVVRATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVS 868 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 868 (1082)
..++.+...+.-|++.+.||.|.+|.||+++ .++|+.+|+|+..... ...+++..|+++++.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445555567789999999999999999995 5678999999886543 3456788899999888 59999999998863
Q ss_pred -----CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEE
Q 045553 869 -----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL 943 (1082)
Q Consensus 869 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 943 (1082)
+++.|||||||.+||.-++++...+..+.|+.+..|++++++|+++||.. .++|||||-.|||++.++.+|+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 57899999999999999999988788999999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHH
Q 045553 944 SDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVA 1018 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~ 1018 (1082)
+|||.+....... ....+..||+.|||||++. ...|+.++|+||+|++..||-.|.+|+-...+- .
T Consensus 165 vDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------r 235 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------R 235 (953)
T ss_pred eeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------h
Confidence 9999998774332 3445578999999999984 345778999999999999999999998643221 1
Q ss_pred HHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1019 WASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1019 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+-.+.+. .+ +.+ .-|....+++.++|..|+..|.++||++.+++++
T Consensus 236 aLF~IpRN-PP-----PkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ALFLIPRN-PP-----PKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhccCCCC-CC-----ccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111111 01 111 2356788999999999999999999999988753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=284.31 Aligned_cols=241 Identities=26% Similarity=0.322 Sum_probs=192.9
Q ss_pred HhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++.|.+...+|.|+|+.|-.+. ..+++..+||++.... .+-.+|+.++... +|||++++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 35668888889999999999884 5568899999997652 2234566555444 7999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE-cCCCcEEEeecccceecCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL-DNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~DfGla~~~~~~ 955 (1082)
|++.++-+.+.+...+ .+. ..+..|+.+|+.|+.|||++ +|||||+||+|||+ +..++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988877776542 222 67778999999999999999 99999999999999 68899999999999876544
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
....+-|..|.|||+.....|++++|+||||+++|+|++|+.||..... + .-+...+..+..
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~----~----~ei~~~i~~~~~------ 531 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA----G----IEIHTRIQMPKF------ 531 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc----h----HHHHHhhcCCcc------
Confidence 2233568899999999999999999999999999999999999973211 1 112222222211
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+..+++|+.+|++.||.+||+|.++..+
T Consensus 532 ------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 ------SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 13446789999999999999999999998654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=236.15 Aligned_cols=260 Identities=24% Similarity=0.326 Sum_probs=197.1
Q ss_pred CccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+|+-.++||+|.||+||+|+ +.+++.||+|+...... .......+|+-+++.++|+|||++++..+.+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556789999999999995 55689999999876533 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+ ..+|..|.... ...++.+.+..++.|+++|+.|.|++ .+.|||+||.|.+++.+|+.|++|||+++-++.+-..
T Consensus 83 c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred h-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9 66899988876 45688999999999999999999999 9999999999999999999999999999988755432
Q ss_pred cccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc------
Q 045553 959 ATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE------ 1031 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 1031 (1082)
...-+-|..|++|.++.+. -|+...|+||-||++.|+.....|.-+.. ....+..+....-|.+.+
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~------dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN------DVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC------cHHHHHHHHHHHhCCCccccCCcc
Confidence 2233468899999999875 47889999999999999998666654321 112222222222222211
Q ss_pred --ccccccCCCCC---------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 --FFTAGLWDCGP---------HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 --~~d~~l~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.-|-..-..+| +.....=.++.+..+.-+|..|.++.+.+++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111111111 1122334567777888899999999887763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=295.80 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=173.3
Q ss_pred HhcCccccceecccCceEEEEEEEc-C----CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeee------ec
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-P----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGY------HV 867 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 867 (1082)
..++|++.+.||+|+||.||+|... + +..||||++..... .+.+..| .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999764 4 68999998764321 1111111 1122222222222221 24
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhCCC------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 045553 868 SEAEMFLIYNYLPGGNLEKFIQDRPR------------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIK 929 (1082)
Q Consensus 868 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 929 (1082)
...+.++||||+++++|.++++.... .......+..++.|++.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 56789999999999999999875421 0112344668999999999999999 99999999
Q ss_pred CCCEEEcC-CCcEEEeecccceecCCCCCccccCcccCCCcccchhcccC----------------------CCCchhhH
Q 045553 930 PSNILLDN-NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC----------------------RVSDKADV 986 (1082)
Q Consensus 930 ~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 986 (1082)
|+|||++. ++.+||+|||+|+.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987654444445567889999999965322 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCccC-----CCCCccHHHHHHHHHhcCCCccccccccCCC--CChHHHHHHHHHHHHcccC
Q 045553 987 YSFGVVLLELISDKKALDPSFCS-----FGNGFNIVAWASMLLLQGRPCEFFTAGLWDC--GPHDDLIEMLNLAIMCTGE 1059 (1082)
Q Consensus 987 ~slGvll~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~ 1059 (1082)
||+||++|||+++..+++..... ...+.+...|....... ..+.+... ..........+|+.+|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999987665421100 00011222332211100 00000000 0001122455899999999
Q ss_pred CCCCCCCHHHHHHH
Q 045553 1060 SLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1060 ~p~~RPt~~ev~~~ 1073 (1082)
||++|||+.|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=263.17 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=209.2
Q ss_pred HHHHHHHhcCccccceecccCceEEEEEEEcC------CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeee
Q 045553 793 YENVVRATAGFNVQNCIGSGGFGATYKAEIIP------GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGY 865 (1082)
Q Consensus 793 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~ 865 (1082)
.+++.....+++...++-+|.||.||.|.|.+ .+.|.||.++... .-....+..|.-.+....|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 33444455667778889999999999996553 3556777665432 2334567788888888999999999998
Q ss_pred ecc-CCeEEEEEeecCCCCHHHHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC
Q 045553 866 HVS-EAEMFLIYNYLPGGNLEKFIQDR------PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN 938 (1082)
Q Consensus 866 ~~~-~~~~~lV~E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 938 (1082)
+.+ ....+++|.++.-|+|..++... ..+.++-.+...++.|++.|++|||.+ +|||.||..+|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 765 45789999999999999999832 245677778889999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCCcccc-CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccH
Q 045553 939 LNAYLSDFGLARLLGTSETHATT-DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNI 1016 (1082)
Q Consensus 939 ~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 1016 (1082)
.++||+|=.+++.+-+.+.+... .--....||+||.+....|+.++|||||||++|||+| |+.|+.+. +.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI--------DP 504 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI--------DP 504 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc--------CH
Confidence 99999999999987666554322 2234568999999999999999999999999999987 88887633 22
Q ss_pred HHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1017 VAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
.+. ...+.+| .+-..|-+++.++..+|.-||...|++||++++++.-|+++
T Consensus 505 fEm-~~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 505 FEM-EHYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHH-HHHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 222 2222333 22234668889999999999999999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=254.92 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=201.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 874 (1082)
.+.|+...+||+|+|++|-.+++. +.+.+|+|++++.- .++....+.|-.+..+. +||.+|-+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457999999999999999999654 57889999987642 23444555666555444 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
|.||++||+|--+++. .+.++++.++.+..+|+-||.|||+. ||++||+|..|+++|..|.+|++|||+++.- -
T Consensus 329 vieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~-l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-L 402 (593)
T ss_pred EEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC-C
Confidence 9999999999766665 56899999999999999999999999 9999999999999999999999999999753 2
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.....+.+++||+.|.|||.+.+..|....|.|++||+++||+.|+.||+-.-.+ ...++-.++.-+++.+..+
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~-n~d~ntedylfqvilekqi----- 476 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD-NPDMNTEDYLFQVILEKQI----- 476 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC-CcccchhHHHHHHHhhhcc-----
Confidence 2334566789999999999999999999999999999999999999999854321 1233444454444443321
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCC
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRP 1065 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP 1065 (1082)
+ .|...+.+...+++.-++.||.+|-
T Consensus 477 ---r--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ---R--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---c--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 2444456777888999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=261.72 Aligned_cols=238 Identities=29% Similarity=0.412 Sum_probs=195.5
Q ss_pred CceEEEEEEEc-CCeEEEEEEeecCcccc-HHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCHHHHHhh
Q 045553 813 GFGATYKAEII-PGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQD 890 (1082)
Q Consensus 813 ~~g~Vy~a~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 890 (1082)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999776 48999999997765544 68899999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcc
Q 045553 891 RPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970 (1082)
Q Consensus 891 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 970 (1082)
.. .+++..+..++.+++++++|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..|+
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 43 389999999999999999999999 99999999999999999999999999998775432 233456888999
Q ss_pred cchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHH
Q 045553 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEML 1050 (1082)
Q Consensus 971 aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 1050 (1082)
+||...+..++.++|||++|++++++++|..||+.. .......... ..+..... ........++.
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-------~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~~ 218 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-------DQLLELFKKI-GKPKPPFP-------PPEWKISPEAK 218 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHH-hccCCCCc-------cccccCCHHHH
Confidence 999999888999999999999999999999998632 1112222221 11111100 00001446899
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 045553 1051 NLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1051 ~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=255.89 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=194.6
Q ss_pred cCccccceecccCceEEEEEE-EcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc--------C
Q 045553 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--------E 869 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 869 (1082)
..|.-..+||+|.||.||+|+ .++|+.||+|++-... ..-.....+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345556789999999999995 4457889998764422 1223445789999999999999999998764 2
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
...|+||++++ -+|..++... ..+++..++.+++.++..||.|+|.. .|+|||+|+.|+|++.++.+||+|||++
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 35899999995 4888888765 46799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc---cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 950 RLLGTSETH---ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 950 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
+.+...+.. ..+..+-|..|++||.+.+ ..|+++.|||+-||++.||++|.+-+..... ..-.+.+ +.+.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-----qqql~~I-s~Lc 245 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-----QQQLHLI-SQLC 245 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-----HHHHHHH-HHHh
Confidence 877543332 3445667999999999887 5699999999999999999999887764321 1111111 1111
Q ss_pred cCCCcccc---cc-ccCC----C-CC-------hHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 QGRPCEFF---TA-GLWD----C-GP-------HDD------LIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~~~~~---d~-~l~~----~-~~-------~~~------~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+....++. |. .+.. + .+ ++. ..+..+++..++..||++|++..+++.+
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111110 00 0000 0 00 111 2367789999999999999999988765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=283.73 Aligned_cols=262 Identities=19% Similarity=0.279 Sum_probs=183.3
Q ss_pred HhcCccccceecccCceEEEEEEE-----------------cCCeEEEEEEeecCccccHHHH--------------HHH
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-----------------IPGVVVAVKRLSVGRFQGVQQF--------------AAE 847 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e 847 (1082)
..++|++.++||+|+||.||+|.. .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999953 2356899999875443322333 346
Q ss_pred HHHHhccCCCce-----eeEeeeecc--------CCeEEEEEeecCCCCHHHHHhhCC----------------------
Q 045553 848 IRTLGRVQHPNL-----VTLIGYHVS--------EAEMFLIYNYLPGGNLEKFIQDRP---------------------- 892 (1082)
Q Consensus 848 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------- 892 (1082)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766654 667777653 356899999999999999987531
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcccc
Q 045553 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972 (1082)
Q Consensus 893 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 972 (1082)
...+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||++..+............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788999999999999999999 999999999999999999999999999976543322222223457899999
Q ss_pred hhcccCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCccC----CCCCccHHHHHHHHHh
Q 045553 973 EYAMTCRV----------------------SDKADVYSFGVVLLELISDKK-ALDPSFCS----FGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 973 E~~~~~~~----------------------~~~~Dv~slGvll~elltg~~-p~~~~~~~----~~~~~~~~~~~~~~~~ 1025 (1082)
|.+..... ..+.||||+||++|||++|.. |+.....- .....+...|... .
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence 98754221 134799999999999999875 55421100 0001122222211 1
Q ss_pred cCCCccccccccCCCCChHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 045553 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESL---SSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~ev~~~ 1073 (1082)
... ++-.. .........+++.+++..+| .+|+|+.|++++
T Consensus 458 ~~~----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQK----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccC----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 11111 12234578889999999766 689999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=271.16 Aligned_cols=247 Identities=21% Similarity=0.289 Sum_probs=203.9
Q ss_pred ccccceecccCceEEEEEEEcCCe-EEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 803 FNVQNCIGSGGFGATYKAEIIPGV-VVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++....||-|+||.|-++...... .+|+|++++. +....+.+..|-++|...+.|.||+++..|.+.+..|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 445567999999999999766433 3788877543 344556778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
|-||.++..++++ ..++..+...++..+.+|++|||++ +||+|||||+|.++|.+|-+|+.|||+|+.++.. .
T Consensus 502 ClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~ 574 (732)
T KOG0614|consen 502 CLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--R 574 (732)
T ss_pred hcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--C
Confidence 9999999999984 5788889999999999999999999 9999999999999999999999999999987644 3
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.+.+++||+.|.|||++.++..+.++|.||+|+++||+++|.+||.... .......++.+-+..
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d--------pmktYn~ILkGid~i-------- 638 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD--------PMKTYNLILKGIDKI-------- 638 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc--------hHHHHHHHHhhhhhh--------
Confidence 4567899999999999999999999999999999999999999997432 222222332222111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 1073 (1082)
..|.........++++....+|.+|-- +.+|.++
T Consensus 639 -~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 -EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 345667778899999999999999974 5555443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=281.69 Aligned_cols=244 Identities=25% Similarity=0.337 Sum_probs=187.2
Q ss_pred ccccceecccCce-EEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEeecC
Q 045553 803 FNVQNCIGSGGFG-ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 803 ~~~~~~lg~G~~g-~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
|...+++|.|+.| .||+|... |+.||||++-.. ...-..+|+..++.- .|||||++++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3445678999887 47888775 899999998643 234567899998877 6999999999999999999999999
Q ss_pred CCCHHHHHhhC-CC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---C--CcEEEeecccceecC
Q 045553 881 GGNLEKFIQDR-PR-RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---N--LNAYLSDFGLARLLG 953 (1082)
Q Consensus 881 ~gsL~~~l~~~-~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~DfGla~~~~ 953 (1082)
..+|.+++... .. ....-...+.+..|++.|+++||+. +||||||||+||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 67999999873 11 1111134567899999999999998 9999999999999975 3 479999999999886
Q ss_pred CCCC--ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 954 TSET--HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISD-KKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 954 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
.+.. ....+..||.+|+|||++....-+.++||||+|||+|+.++| .+||...... - ..++......
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---------~-~NIl~~~~~L 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---------Q-ANILTGNYTL 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---------h-hhhhcCccce
Confidence 5443 235567899999999999998888899999999999998886 8999743211 0 0111111111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+. ...++ +..+||.+|++++|..||++.+|+.
T Consensus 733 ~~L~------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VHLE------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeec------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1110 11122 8899999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=229.72 Aligned_cols=198 Identities=29% Similarity=0.441 Sum_probs=164.7
Q ss_pred ccceecccCceEEEEEE-EcCCeEEEEEEeecCc-cccHHHHHHHHHHHh-ccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 805 VQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLG-RVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 805 ~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
....||+|+||.|-+.+ ..+|...|+|++.... .+..++..+|+++.. ...+|.+|.++|........|+.||.| .
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~ 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-D 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-h
Confidence 34569999999998875 4579999999997653 345567788888754 447999999999999999999999999 6
Q ss_pred CCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 882 GNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 882 gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
.||+.+-.. ..+...++.-+-+||..+.+||.|||++. .|+|||+||+|||++.+|++||||||.+..+.+.-.
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-- 204 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-- 204 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH--
Confidence 788877654 23668899999999999999999999986 899999999999999999999999999987743322
Q ss_pred ccCcccCCCcccchhccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 045553 960 TTDVAGTFGYVAPEYAMT----CRVSDKADVYSFGVVLLELISDKKALDPSF 1007 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGvll~elltg~~p~~~~~ 1007 (1082)
.+.-.|-..|+|||.+.. ..|+-|+||||+|+.+.||.+++.||+...
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 222356678999998853 478899999999999999999999998543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=250.23 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=196.2
Q ss_pred cccceecccCceEEEEEE-EcCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccC-----CeEEEE
Q 045553 804 NVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-----AEMFLI 875 (1082)
Q Consensus 804 ~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV 875 (1082)
+-.+.||.|+||.||.++ -.+|+.||.|++..- .-...+.+.+|++++..++|.|++..+++.... .+.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 345789999999999984 457999999998643 234567888999999999999999888866543 357889
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
.|.| ..+|+..+-. .+.++.+.+.-+..||++||.|||+. +|.||||||.|.+++.+...||||||+++....+
T Consensus 136 TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 9999 5688888765 56788889999999999999999999 9999999999999999999999999999987776
Q ss_pred CCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCC-------CCccHHHHHHHHHhcC
Q 045553 956 ETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFG-------NGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~ 1027 (1082)
+...++.-+-|..|+|||.+++ ..|+.+.||||.||++.|++.++.-|..-.+... -+..-.+-++..- +|
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC-EG 288 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC-EG 288 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh-hh
Confidence 6666666677899999999987 5689999999999999999999887764221100 0000000011100 11
Q ss_pred CCccccccccCC---------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1028 RPCEFFTAGLWD---------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1028 ~~~~~~d~~l~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
--..++-...+. ..+.....+...+.+.++..||++|.+..+....+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000011000000 11223345567788899999999999998887654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=260.81 Aligned_cols=203 Identities=25% Similarity=0.399 Sum_probs=173.7
Q ss_pred CccccceecccCceEEEEEE-EcCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
-|...+.||-|+||+|.++. ..+...+|+|.+.+.+. ......+.|-++|..-..+=||+++-.|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47777899999999999994 55577899999876543 334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec-----
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL----- 952 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~----- 952 (1082)
|++||++-.+|-.. ..+++..++.++.+++.|+++.|.. |+|||||||+|||||.+|.+|++|||++.-+
T Consensus 710 YIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999998774 4788899999999999999999999 9999999999999999999999999998533
Q ss_pred ----CCCCCc--------------------------------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHH
Q 045553 953 ----GTSETH--------------------------------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996 (1082)
Q Consensus 953 ----~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~el 996 (1082)
...+.. .....+||+.|+|||++....|+..+|.||.|||+|||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 111100 01135699999999999999999999999999999999
Q ss_pred HhCCCCCCCCccC
Q 045553 997 ISDKKALDPSFCS 1009 (1082)
Q Consensus 997 ltg~~p~~~~~~~ 1009 (1082)
+.|+.||-...+.
T Consensus 865 ~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 865 LVGQPPFLADTPG 877 (1034)
T ss_pred hhCCCCccCCCCC
Confidence 9999999765443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=250.26 Aligned_cols=133 Identities=29% Similarity=0.459 Sum_probs=116.6
Q ss_pred hcCccccceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC-----C---CceeeEeeeecc--
Q 045553 800 TAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-----H---PNLVTLIGYHVS-- 868 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~-- 868 (1082)
.++|.+.++||-|.|++||+| .....+.||+|+.+..... .+....|++++++++ | ..||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 478999999999999999999 5667899999998765322 345678999999984 3 369999998874
Q ss_pred --CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc
Q 045553 869 --EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD 936 (1082)
Q Consensus 869 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 936 (1082)
+.+.|+|+|++ |.+|..++.....+.++...+.+|+.||+.||.|||.+| +|||.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 46899999999 889999999888889999999999999999999999999 999999999999994
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=230.70 Aligned_cols=257 Identities=19% Similarity=0.269 Sum_probs=197.0
Q ss_pred cCccccceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeeccC--CeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSE--AEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 876 (1082)
++|++.+++|+|-|+.||.| ...+.++++||+++. ...+.+.+|+.+++.++ ||||+++++...+. ....+|+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 46899999999999999999 456788999999874 34577899999999997 99999999998865 5679999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-CcEEEeecccceecCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-LNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~~~~~ 955 (1082)
||+.+.+...+.. .++...+..++.+++.||.|+|+. ||+|||+||+|+|+|.. -..+++|+|+|.++.+.
T Consensus 115 E~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999988877654 477788999999999999999999 99999999999999965 46999999999988765
Q ss_pred CCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh------cCC
Q 045553 956 ETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL------QGR 1028 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~ 1028 (1082)
.... ..+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-.. .++...++..++-.-. -..
T Consensus 187 ~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG---~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 187 KEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG---HDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred ceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC---CCCHHHHHHHHHHhChHHHHHHHHH
Confidence 5443 2356788999999875 45788899999999999999999998532 2223333332221000 000
Q ss_pred CccccccccCC----------------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAGLWD----------------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~l~~----------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..-.+|+...+ +...-...++.+++.+.+..|-.+|||++|...+
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11112222111 0011123678899999999999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-25 Score=234.91 Aligned_cols=210 Identities=33% Similarity=0.597 Sum_probs=185.0
Q ss_pred ecccCceEEEEEEEcC-CeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCHHH
Q 045553 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEK 886 (1082)
Q Consensus 809 lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 886 (1082)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999997654 899999999765432 35678999999999999999999999999999999999999899999
Q ss_pred HHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-CCcEEEeecccceecCCCCCccccCccc
Q 045553 887 FIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYLSDFGLARLLGTSETHATTDVAG 965 (1082)
Q Consensus 887 ~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~g 965 (1082)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 998642 4689999999999999999999999 9999999999999999 89999999999987654321 2233457
Q ss_pred CCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChH
Q 045553 966 TFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHD 1044 (1082)
Q Consensus 966 t~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 1044 (1082)
...|++||..... .++.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999887 888999999999999998
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1045 DLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1045 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 368899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=238.53 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=201.8
Q ss_pred cCccccceecccCceEEEEE-EEcCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccC------Ce
Q 045553 801 AGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------AE 871 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 871 (1082)
.+|.-.+.+|.|.- .|..| ..-.++.||+|+.... .....+...+|...+..++|+|+++++.++... .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888887 55555 4445899999998554 234456778999999999999999999998754 35
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.|+||||| ..+|...++. .++=.++.++..|++.|++|||+. +|+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 79999999 6799999884 466788999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
-... ...+.++.+..|.|||++.+..+.+.+||||.||++.||++|+--|.+ +..+.+|.+..-.-|.+.+
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-------~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-------KDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-------chHHHHHHHHHHHhcCCCH
Confidence 5433 467778899999999999998899999999999999999999987763 4455666665544443322
Q ss_pred ccccccC----------------------------C--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 FFTAGLW----------------------------D--CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~~l~----------------------------~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+-..+. . +.+.-....+..++.+|+-.+|++|-++++++++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 2111110 0 0112234557889999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=251.38 Aligned_cols=197 Identities=23% Similarity=0.361 Sum_probs=168.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--------ccHHHHHHHHHHHhccC---CCceeeEeeeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--------QGVQQFAAEIRTLGRVQ---HPNLVTLIGYHV 867 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 867 (1082)
...|...+.+|.|+||.|+.|..+ +...|+||.+.+.+. .....+-.|+++|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999544 467899998876532 11223557999999997 999999999999
Q ss_pred cCCeEEEEEeec-CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 868 SEAEMFLIYNYL-PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 868 ~~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
+++.+|++||.. ++-+|.+++..+ ..+++.++..|+.|++.|+++||+. +|||||||-+||.++.+|-+|++||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 999999999986 445899999874 4689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 045553 947 GLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALD 1004 (1082)
Q Consensus 947 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~ 1004 (1082)
|.|.+...+ ....++||.+|.|||++.+.+| ...-|||++|+++|-++....||+
T Consensus 715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999875433 3445789999999999998876 456899999999999998888875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-25 Score=233.04 Aligned_cols=198 Identities=32% Similarity=0.517 Sum_probs=174.0
Q ss_pred ccccceecccCceEEEEEEEcC-CeEEEEEEeecCccc-cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
|++.+.||.|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999997765 899999999866544 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.+++..... .+++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999987532 278999999999999999999999 999999999999999999999999999987754431122
Q ss_pred cCcccCCCcccchhc-ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 045553 961 TDVAGTFGYVAPEYA-MTCRVSDKADVYSFGVVLLELISDKKALD 1004 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGvll~elltg~~p~~ 1004 (1082)
....++..|++||.. ....++.++|||+||++++||++|+.||+
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 345678899999998 66778889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-28 Score=251.60 Aligned_cols=410 Identities=21% Similarity=0.201 Sum_probs=236.6
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccC-cccccccCccccCCCCCcEEEccc
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSG-NQFNGTIPAFFGQSPGFQVVSLSF 191 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~ 191 (1082)
..++|..|+|+...|.+|+.+++|++||||+|.|+.+-|++|.++++|..|-+.+ |+|+....+.|++|..|+.|.+.-
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNa 149 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNA 149 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcCh
Confidence 4455566666644445566666666666666666655555666665555554444 555544345555555555555555
Q ss_pred CcccccCCcccccccccccEEEcccCccCCCCCc-cccCCCCccEEEccCCcCC------------CCcCccccCCCCCC
Q 045553 192 NLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQ------------GDIPSSFGQLVNLE 258 (1082)
Q Consensus 192 N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~------------~~~p~~~~~l~~L~ 258 (1082)
|++. -++...+..+++|..|.+.+|.+. .++. +|..+.+++.+++..|.+- ...|..++...-..
T Consensus 150 n~i~-Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 150 NHIN-CIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred hhhc-chhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 5555 444444444555555555555555 3332 5555555555555555521 11222222222233
Q ss_pred EEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCC-ccccCCCCCcEEEcCC
Q 045553 259 VLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLP-DSITRLPNLRVFWAPN 337 (1082)
Q Consensus 259 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p-~~l~~l~~L~~L~l~~ 337 (1082)
-..+.++++..+-+..|... ++.+ ...-.+.....+..| ..|..|++|+.|++++
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~--~esl----------------------~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsn 283 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCS--LESL----------------------PSRLSSEDFPDSICPAKCFKKLPNLRKLNLSN 283 (498)
T ss_pred hHHHHHHHhcccchhhhhhh--HHhH----------------------HHhhccccCcCCcChHHHHhhcccceEeccCC
Confidence 33333333332222222110 1111 000001112222333 4589999999999999
Q ss_pred CcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-ccCcccEEEecCCcceecCC
Q 045553 338 LNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFNVSQNLLSGEIP 416 (1082)
Q Consensus 338 n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~~L~l~~N~l~~~~~ 416 (1082)
|+|+.+.+.+|.++..+++|+|..|+|...-...|.++..|+.|+|.+|+|+...|..| .+..|..|+|-.|++.
T Consensus 284 N~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~---- 359 (498)
T KOG4237|consen 284 NKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN---- 359 (498)
T ss_pred CccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc----
Confidence 99999999999999999999999999997777789999999999999999999999888 6889999999999985
Q ss_pred CCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCcee---EeeccCCcccCCCCCccccCCCcccccc
Q 045553 417 RISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFI---LHDFSNNLFTGPVPPFLIDSDSLSSRPY 493 (1082)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~n~~~g~~p~~~~~~~~l~~~~~ 493 (1082)
.+|...+..-++.....+ +.++. .+++.+. +.|+..-.|+..-|+...-.
T Consensus 360 ----CnC~l~wl~~Wlr~~~~~-------------~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~-------- 412 (498)
T KOG4237|consen 360 ----CNCRLAWLGEWLRKKSVV-------------GNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCL-------- 412 (498)
T ss_pred ----CccchHHHHHHHhhCCCC-------------CCCCC--CCCchhccccchhccccccccCCccccCCC--------
Confidence 456555432222221111 11111 1111111 12222223333333221100
Q ss_pred ceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEE
Q 045553 494 YGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLN 573 (1082)
Q Consensus 494 ~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 573 (1082)
....=..-|.+.+ +++.+|++.+. .+|..+... .++|++.+|.++.+..+ .+.+| .+|
T Consensus 413 -------------~s~~cP~~c~c~~-tVvRcSnk~lk-~lp~~iP~d---~telyl~gn~~~~vp~~---~~~~l-~~d 470 (498)
T KOG4237|consen 413 -------------TSSPCPPPCTCLD-TVVRCSNKLLK-LLPRGIPVD---VTELYLDGNAITSVPDE---LLRSL-LLD 470 (498)
T ss_pred -------------CCCCCCCCcchhh-hhHhhcccchh-hcCCCCCch---hHHHhcccchhcccCHH---HHhhh-hcc
Confidence 0000012233333 45666666665 788877644 67888888888855433 55667 788
Q ss_pred ccCCCCCCCCcccccCCCCCCEEEcCCC
Q 045553 574 LSRNHLQGPLPSYINKMEDLKFLSLSLN 601 (1082)
Q Consensus 574 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 601 (1082)
|++|+|+......|.++++|..|-||+|
T Consensus 471 ls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 471 LSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred cccCceehhhcccccchhhhheeEEecC
Confidence 8888888666667778888888877765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-26 Score=254.91 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=205.7
Q ss_pred hcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..+|.....+|.|+||.||||+ ..+++..|+|+++........-.+.|+-+++..+||||+.+++.+...+..|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4568888999999999999994 567999999999987777777888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+.+|+|++.-+. ...+++.++..++++..+|++|||+. +-+|||||-.||++++.+.+|++|||.+..+... ..
T Consensus 94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IA 167 (829)
T ss_pred cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hh
Confidence 999999998876 45789999999999999999999999 9999999999999999999999999998776432 22
Q ss_pred cccCcccCCCcccchhc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 959 ATTDVAGTFGYVAPEYA---MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
+...+.||+.|||||+. ..+.|..++|||+.|+...|+-.-..|..... ..+..... ....+++
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--------pmr~l~Lm-----TkS~~qp 234 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--------PMRALFLM-----TKSGFQP 234 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------hHHHHHHh-----hccCCCC
Confidence 44567899999999987 35678999999999999999877666643211 11111111 1122222
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.-.. .+......+.++++.|+..+|++||++..+++
T Consensus 235 p~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2221 23456778999999999999999999866543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=238.95 Aligned_cols=199 Identities=25% Similarity=0.299 Sum_probs=170.0
Q ss_pred HhcCccccceecccCceEEEEEE-EcCCeEEEEEEeecCccccHHHHHHHHHHHhccC------CCceeeEeeeeccCCe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ------HPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~ 871 (1082)
.-.+|.+....|+|-|++|..|. ...|..||||+|...... .+.=.+|+++|++++ --|.++++..|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 34679999999999999999995 445889999999865432 233468999999995 3478999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecccc
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFGLA 949 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla 949 (1082)
+|+|+|-+ .-+|.+++...+ .-.+....+..++.|+.-||..|-.. +|+|.||||.|||+++.. .+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccc
Confidence 99999988 679999999865 34678889999999999999999998 999999999999998765 6899999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDP 1005 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~ 1005 (1082)
...+..+. +.+.-+..|.|||++.|..|+...|+||.||.+||+.||+..|.+
T Consensus 585 ~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 585 SFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 87654432 345567899999999999999999999999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=217.85 Aligned_cols=253 Identities=19% Similarity=0.299 Sum_probs=191.3
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEee-eeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIG-YHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lV~E 877 (1082)
+.|.+.+.+|+|.||.+-+++.+ +.+.+++|.+.... ...++|.+|+..--.+ .|.||+.-++ .|+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 46889999999999999999765 46889999887553 3467899998765555 4889998776 5677789999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE-cCC-CcEEEeecccceecCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL-DNN-LNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~-~~~kl~DfGla~~~~~~ 955 (1082)
|++.|+|.+-+.. ..+.+....+++.|+++|+.|||++ .+||||||.+|||+ +.| .++|+||||+++..+..
T Consensus 103 ~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred cCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999998875 4588889999999999999999999 99999999999999 344 48999999999865432
Q ss_pred CCccccCcccCCCcccchhcccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTC-----RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
-.. ..-+-.|.+||..... ...+.+|||.||+++|.++||+.||..... ....++.|.+..- +...
T Consensus 177 V~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~~Y~~~~~w~~--rk~~ 247 (378)
T KOG1345|consen 177 VKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDKPYWEWEQWLK--RKNP 247 (378)
T ss_pred ehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCchHHHHHHHhc--ccCc
Confidence 111 2235579999987532 346789999999999999999999985433 3455666655432 2222
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
..- +... ...+.+.++.++-+.++|++|-...++.++..
T Consensus 248 ~~P--~~F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 ALP--KKFN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cCc--hhhc----ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 211 1111 22356778888889999999966666655543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=230.25 Aligned_cols=269 Identities=25% Similarity=0.369 Sum_probs=199.1
Q ss_pred HHHHHhcCccccceecccCceEEEEEEEc----CCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeeccC
Q 045553 795 NVVRATAGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSE 869 (1082)
Q Consensus 795 ~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 869 (1082)
.+....+.|...++||+|.|++||+|... ..+.||+|.+.... ....+..|++.+..+. +.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34445677999999999999999999432 47899999987653 3456889999999994 89999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-CCcEEEeeccc
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYLSDFGL 948 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGl 948 (1082)
+...+|+||++.....++... ++...+..+++.+..||+++|.. |||||||||+|++.+. .+.-.|+|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 999999999999999998875 67889999999999999999999 9999999999999984 46789999999
Q ss_pred ceecCCCC------C-------------------------------------ccccCcccCCCcccchhcccC-CCCchh
Q 045553 949 ARLLGTSE------T-------------------------------------HATTDVAGTFGYVAPEYAMTC-RVSDKA 984 (1082)
Q Consensus 949 a~~~~~~~------~-------------------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 984 (1082)
|....... . .......||++|+|||++... ..+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221000 0 011135699999999999764 578899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHH------HHHHHhcCC--Ccc---------------ccc-cccCC-
Q 045553 985 DVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAW------ASMLLLQGR--PCE---------------FFT-AGLWD- 1039 (1082)
Q Consensus 985 Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~--~~~---------------~~d-~~l~~- 1039 (1082)
||||.||++.-+++++.||-....+.+.-..+... .+.+...|. +.+ -++ ..+..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999997543322211111110 011111121 000 000 00000
Q ss_pred --------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 --------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 --------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...+..+..+..+..+|++.+|.+|-+++|.+++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011223478899999999999999999998764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-23 Score=264.40 Aligned_cols=199 Identities=19% Similarity=0.203 Sum_probs=103.7
Q ss_pred ccccCCCCCcEEEcccCc------ccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCc
Q 045553 176 AFFGQSPGFQVVSLSFNL------LSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPS 249 (1082)
Q Consensus 176 ~~~~~l~~L~~L~L~~N~------l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 249 (1082)
.+|.++++|+.|.+..+. +...+|..+..-..+|+.|.+.++.++ .+|..+ ...+|+.|+|++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 455666666666665442 222344444322234666666666655 455544 3456666666666665 4555
Q ss_pred cccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCC
Q 045553 250 SFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPN 329 (1082)
Q Consensus 250 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~ 329 (1082)
.+..+++|+.|+|++|...+.+|. ++.+++|+.|++++|. ....+|..+..+++
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~-------------------------~L~~lp~si~~L~~ 682 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCS-------------------------SLVELPSSIQYLNK 682 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCC-------------------------CccccchhhhccCC
Confidence 555666666666665543334443 5555666666665431 11244555555666
Q ss_pred CcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecC
Q 045553 330 LRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQ 408 (1082)
Q Consensus 330 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~ 408 (1082)
|+.|++++|...+.+|..+ .+++|+.|+|++|...+.+|.. .++|+.|+|++|.+.. +|..+.+++|+.|++.+
T Consensus 683 L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~ 756 (1153)
T PLN03210 683 LEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNLRLENLDELILCE 756 (1153)
T ss_pred CCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccccccccccccccc
Confidence 6666666554444444433 4556666666665544344432 2455666666666542 33333445555554443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-22 Score=260.92 Aligned_cols=270 Identities=19% Similarity=0.205 Sum_probs=166.1
Q ss_pred ccccCCCCCCEEEcccCC------CcccCChhhcCCC-CCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCc
Q 045553 104 RAIGDLTQLRVLLLAFNG------FSGELPLEIGQLS-LLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPA 176 (1082)
Q Consensus 104 ~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 176 (1082)
.+|.++.+|+.|.+..+. +...+|+.|..++ +|+.|++.++.++ .+|..| ...+|++|+|++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 457777777777776543 2234666666664 5777777777776 667666 4677777788777776 5666
Q ss_pred cccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCC
Q 045553 177 FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256 (1082)
Q Consensus 177 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 256 (1082)
.+..+++|+.|+|++|.....+|. + ..+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|..+ ++++
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-l-s~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-L-SMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-c-ccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 667777777777777654446664 2 246777777777776555777777777777777777765444566554 6777
Q ss_pred CCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcC
Q 045553 257 LEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAP 336 (1082)
Q Consensus 257 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~ 336 (1082)
|+.|++++|.....+|.. .++|+.|++++|.+. .+|..+ .+++|+.|.+.
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~--------------------------~lP~~~-~l~~L~~L~l~ 755 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE--------------------------EFPSNL-RLENLDELILC 755 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc--------------------------cccccc-ccccccccccc
Confidence 777777777655455533 356677777665332 233333 35566666665
Q ss_pred CCcccC-------CCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCC
Q 045553 337 NLNLEG-------IFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQN 409 (1082)
Q Consensus 337 ~n~l~~-------~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N 409 (1082)
++.... ..+..+...++|+.|+|++|...+.+|.+++++++|+.|+|++|...+.+|....+++|+.|++++|
T Consensus 756 ~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c 835 (1153)
T PLN03210 756 EMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGC 835 (1153)
T ss_pred ccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCC
Confidence 533211 1111222345667777777665556666677777777777766644334444444444444444443
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=213.02 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=194.7
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 805 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
..-+|.+...|..|+|+|. |..+++|++..... ...+.|.+|+-.++.+.||||.++++.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456888999999999998 66777788765432 33467999999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccC
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 962 (1082)
||+..+|+...-..+-.++.+++.++|+|++|||+.- |-|.---+.++.+++|++.+++|+= +-+++- .....
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs-----fqe~g 345 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----FQEVG 345 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee-----eeccc
Confidence 9999999987777788899999999999999999973 2233346899999999999888741 112111 11112
Q ss_pred cccCCCcccchhcccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 963 VAGTFGYVAPEYAMTCRVS---DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 963 ~~gt~~y~aPE~~~~~~~~---~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
..-.+.|++||.++.++.+ .++|+|||++++||+.|+..||....+- +.-.. +.-..++-
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm--------ecgmk---------ialeglrv 408 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM--------ECGMK---------IALEGLRV 408 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch--------hhhhh---------hhhccccc
Confidence 2346889999999876543 4799999999999999999999743221 11011 11123444
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..|+..+..+.+++.-|++.||.+||.+..|+-.|++++
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 567788889999999999999999999999999999865
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-25 Score=232.39 Aligned_cols=391 Identities=22% Similarity=0.213 Sum_probs=278.9
Q ss_pred CCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcC-CCCCCCCCccccCCCCCCeEEccCcccccc
Q 045553 95 SDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSF-NSFHGPIPPTLQNCSSLRLINLSGNQFNGT 173 (1082)
Q Consensus 95 ~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 173 (1082)
.|.|+..-|.+|+.+.+|+.|||++|+|+.+-|++|..+..|..|-+-+ |+|+......|.+|.+|+.|.+.-|++.-.
T Consensus 76 qN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Ci 155 (498)
T KOG4237|consen 76 QNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCI 155 (498)
T ss_pred cCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcch
Confidence 4778777788999999999999999999999999999999998887776 999965567899999999999999999988
Q ss_pred cCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccC------------CCCCccccCCCCccEEEccCC
Q 045553 174 IPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLT------------GSIPPSLGNCTELRSLLLSSN 241 (1082)
Q Consensus 174 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~------------~~~~~~~~~l~~L~~L~L~~N 241 (1082)
..+.|..|++|..|.+..|.+. .++...+..+.+++.+.++.|.+. ...|..++.+.-..-..+.++
T Consensus 156 r~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~ 234 (498)
T KOG4237|consen 156 RQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYK 234 (498)
T ss_pred hHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHH
Confidence 8899999999999999999999 888877778999999999999833 344445555555555566666
Q ss_pred cCCCCcCccccCC-CCCCEEeCCCCcCcccCC-ccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCC
Q 045553 242 MLQGDIPSSFGQL-VNLEVLDLSRNFLSGIVP-SELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGG 319 (1082)
Q Consensus 242 ~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~ 319 (1082)
++....+..|... ..+..=-.+.+...++.| ..|.++++|+.|++++ |.+++.
T Consensus 235 Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsn-------------------------N~i~~i 289 (498)
T KOG4237|consen 235 RINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSN-------------------------NKITRI 289 (498)
T ss_pred HhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCC-------------------------Cccchh
Confidence 6664444444432 222222223333333444 4688999999999988 455666
Q ss_pred CCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccC-------
Q 045553 320 LPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLL------- 392 (1082)
Q Consensus 320 ~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~------- 392 (1082)
-+.+|.++..+++|++..|+|..+....|.++..|+.|+|.+|+|+..-|..|..+.+|.+|+|-.|++.-.-
T Consensus 290 ~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~ 369 (498)
T KOG4237|consen 290 EDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE 369 (498)
T ss_pred hhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH
Confidence 7788999999999999999999988889999999999999999999888999999999999999999875321
Q ss_pred ----------CCCcccCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCC
Q 045553 393 ----------PEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNG 462 (1082)
Q Consensus 393 ----------p~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (1082)
|..-+-..++.+.++++.+.. ..|. .+++. +|-
T Consensus 370 Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~-------~~c~---------------------~~ee~-~~~-------- 412 (498)
T KOG4237|consen 370 WLRKKSVVGNPRCQSPGFVRQIPISDVAFGD-------FRCG---------------------GPEEL-GCL-------- 412 (498)
T ss_pred HHhhCCCCCCCCCCCCchhccccchhccccc-------cccC---------------------Ccccc-CCC--------
Confidence 111111122333333332210 0000 01110 000
Q ss_pred ceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccC
Q 045553 463 LFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHC 542 (1082)
Q Consensus 463 ~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~ 542 (1082)
-+++=|+ .+..+... -..+...++--...+|.+. .++.+.+|.+. .+|... +
T Consensus 413 -----------~s~~cP~---~c~c~~tV----vRcSnk~lk~lp~~iP~d~------telyl~gn~~~-~vp~~~---~ 464 (498)
T KOG4237|consen 413 -----------TSSPCPP---PCTCLDTV----VRCSNKLLKLLPRGIPVDV------TELYLDGNAIT-SVPDEL---L 464 (498)
T ss_pred -----------CCCCCCC---Ccchhhhh----HhhcccchhhcCCCCCchh------HHHhcccchhc-ccCHHH---H
Confidence 0111111 11111100 0112222222233444433 57889999988 899884 4
Q ss_pred CcccEEEccCCcccccCccccCCCCCCCEEEccCC
Q 045553 543 KCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRN 577 (1082)
Q Consensus 543 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 577 (1082)
++| .+|+++|+|.......|.++++|.+|-|++|
T Consensus 465 ~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 465 RSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 557 8999999999888889999999999999987
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-24 Score=267.12 Aligned_cols=196 Identities=16% Similarity=0.209 Sum_probs=140.5
Q ss_pred ccCC-CceeeEeeeec-------cCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 045553 853 RVQH-PNLVTLIGYHV-------SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924 (1082)
Q Consensus 853 ~l~h-~niv~l~~~~~-------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 924 (1082)
..+| +||+++++++. ..+..+.++||+ +++|.++++.. ...+++.++..++.||++||+|||+. +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 3455 57777888762 234577888988 67999999754 45699999999999999999999999 999
Q ss_pred eccCCCCCEEEcC-------------------CCcEEEeecccceecCCCC---------------CccccCcccCCCcc
Q 045553 925 HRDIKPSNILLDN-------------------NLNAYLSDFGLARLLGTSE---------------THATTDVAGTFGYV 970 (1082)
Q Consensus 925 H~Dlk~~Nill~~-------------------~~~~kl~DfGla~~~~~~~---------------~~~~~~~~gt~~y~ 970 (1082)
||||||+|||++. ++.+|++|||+++...... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 4456666777665421100 00011245788999
Q ss_pred cchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHH
Q 045553 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEML 1050 (1082)
Q Consensus 971 aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 1050 (1082)
|||++.+..++.++|||||||++|||++|..|+.... ..+.... ... +.+. .........
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~-~~~----~~~~-----~~~~~~~~~ 242 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLR-HRV----LPPQ-----ILLNWPKEA 242 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHH-Hhh----cChh-----hhhcCHHHH
Confidence 9999999999999999999999999999888764210 1111111 110 0110 011123456
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 045553 1051 NLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1051 ~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.++.+|++++|.+||+|.||+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 78899999999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=206.46 Aligned_cols=168 Identities=19% Similarity=0.192 Sum_probs=128.9
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|+|.++++.+ ...+++..++.++.|++.||+|||+. + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6899999865 45699999999999999999999998 5 999999999999999 99998764322
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ............... ++... ..
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~---~~~~~-~~ 131 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLNGMPAD---DPRDR-SN 131 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHHHhccC---Ccccc-cc
Confidence 2588999999999999999999999999999999999999864321 112222211111100 00000 11
Q ss_pred ChHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1042 PHDDLI--EMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1042 ~~~~~~--~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
+..... ++.+++.+|++.+|++||++.|+++++..+.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 222333 6999999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-21 Score=218.26 Aligned_cols=259 Identities=22% Similarity=0.245 Sum_probs=197.3
Q ss_pred CccccceecccCceEEEEEEEcC--CeEEEEEEeecCccccHHHHHHHHHHHhccCC----CceeeEeeee-ccCCeEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIP--GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH----PNLVTLIGYH-VSEAEMFL 874 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 874 (1082)
+|.+.++||+|+||.||.|.... ...+|+|............+..|..++..+.. +++..+++.+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999996554 35789998776533322267788888888873 6899999988 57788999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-----CcEEEeecccc
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-----LNAYLSDFGLA 949 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~DfGla 949 (1082)
||+.+ |.+|.++....+.+.++..++.+|+.|++.+|.++|+. |++||||||.|+++... ..+++.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 88999998777668899999999999999999999999 99999999999999865 46999999999
Q ss_pred e--ecCCCCC-----c-c-ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHH
Q 045553 950 R--LLGTSET-----H-A-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 950 ~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 1020 (1082)
+ .+..... . . .....||..|+++..+.+.+.+.+.|+||+++++.|+..|..||...... .. ..-+
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~----~~-~~~~ 249 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT----DL-KSKF 249 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc----ch-HHHH
Confidence 8 3321111 1 1 23456999999999999999999999999999999999999998543211 11 1111
Q ss_pred HHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1021 SMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1021 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
........... .....+.++.++...+-..+..++|....+...+++..
T Consensus 250 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 250 EKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 11111111110 11122345666666666689999999999998887653
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=237.54 Aligned_cols=74 Identities=22% Similarity=0.370 Sum_probs=37.6
Q ss_pred CCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEc
Q 045553 135 LLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILL 214 (1082)
Q Consensus 135 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L 214 (1082)
.-..|+|++|.++ .+|..+. ++|+.|++++|+++ .+|.. .++|++|+|++|+|+ .+|.. .++|+.|++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~L 269 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL----PPGLLELSI 269 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc----ccccceeec
Confidence 3556666666666 5565553 25666666666666 23321 345555555555555 33321 124444444
Q ss_pred ccCccC
Q 045553 215 AANSLT 220 (1082)
Q Consensus 215 ~~N~l~ 220 (1082)
++|.++
T Consensus 270 s~N~L~ 275 (788)
T PRK15387 270 FSNPLT 275 (788)
T ss_pred cCCchh
Confidence 444444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=199.33 Aligned_cols=259 Identities=17% Similarity=0.226 Sum_probs=198.4
Q ss_pred hcCccccceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.-.|++.++||+|.||+++.| .+-++..||||.-... .+..++..|++..+.+. .++|..++-|..++.+-.+|+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 457999999999999999999 4667999999986543 33466788888888885 6899999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-----CcEEEeecccceec
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-----LNAYLSDFGLARLL 952 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~DfGla~~~ 952 (1082)
.+ |-||+++..-. ++.++..++..||.|++.-++|+|++ ..|.|||||+|+||..- ..+.|+|||+|+.+
T Consensus 105 LL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 99 88999998877 67899999999999999999999999 99999999999999743 35899999999998
Q ss_pred CCCCCcc------ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 953 GTSETHA------TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 953 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
..+.+.. .....||.+||+-....+.+.+.+.|+-|+|.|+++++-|..||.....+ ...+-.+ .+.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-----tnK~kYe-KIGe 253 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-----TNKEKYE-KIGE 253 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-----chHHHHH-Hhcc
Confidence 7666542 34567999999999999999999999999999999999999999764322 1111111 1111
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
.+...-++. +. +..++++..-+.-.-..+-++-|+..-+...+..
T Consensus 254 ~Kr~T~i~~-Lc----~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 254 TKRSTPIEV-LC----EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred ccccCCHHH-HH----hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111111111 11 1223455555555555577777877666555543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=235.48 Aligned_cols=119 Identities=26% Similarity=0.333 Sum_probs=57.7
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 600 (1082)
++|++++|+|. .+|.. ..+|+.|++++|+|+.+ |.. ..+|+.|+|++|+|++ +|.. .++|+.|++++
T Consensus 345 q~LdLS~N~Ls-~LP~l----p~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~ 411 (788)
T PRK15387 345 QELSVSDNQLA-SLPTL----PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSG 411 (788)
T ss_pred ceEecCCCccC-CCCCC----CcccceehhhccccccC-ccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccC
Confidence 34555555554 34432 12355555666665532 322 2345566666666553 3322 23455555555
Q ss_pred CcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCC
Q 045553 601 NNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPP 657 (1082)
Q Consensus 601 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 657 (1082)
|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++.
T Consensus 412 N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 412 NRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 5555 234322 23455555555555 4455555555555555555555544443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=218.97 Aligned_cols=166 Identities=22% Similarity=0.221 Sum_probs=130.9
Q ss_pred HHHHhcCccccceecccCceEEEEEEEc--CCeEEEEEEeecC-----ccccHHHHHHHHHHHhccCCCceee-Eeeeec
Q 045553 796 VVRATAGFNVQNCIGSGGFGATYKAEII--PGVVVAVKRLSVG-----RFQGVQQFAAEIRTLGRVQHPNLVT-LIGYHV 867 (1082)
Q Consensus 796 ~~~~~~~~~~~~~lg~G~~g~Vy~a~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~ 867 (1082)
......+|.+.+.||+|+||+||+|... +++.||||++... .....+.|.+|++++++++|+|+++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3445678999999999999999999654 5788899987532 1223456899999999999999985 4432
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC-CCCCEEEcCCCcEEEeec
Q 045553 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI-KPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 868 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Df 946 (1082)
+..++||||+++++|... ... . ...++.++++|++|||+. +|+|||| ||+||+++.++.+||+||
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 468999999999999632 111 1 146788999999999999 9999999 999999999999999999
Q ss_pred ccceecCCCCCcc-------ccCcccCCCcccchhccc
Q 045553 947 GLARLLGTSETHA-------TTDVAGTFGYVAPEYAMT 977 (1082)
Q Consensus 947 Gla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 977 (1082)
|+|+.+....... .....+++.|+|||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999775433211 134668889999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=191.51 Aligned_cols=259 Identities=22% Similarity=0.270 Sum_probs=199.4
Q ss_pred hcCccccceecccCceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCC-CceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH-PNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 877 (1082)
.+.|++.++||.|+||.+|.| ...+|..||||.-+.... ..+...|.++.+.++| ..|..+..|..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 467999999999999999999 567799999999765432 3457788888888876 678888888888999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---CCcEEEeecccceecCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla~~~~~ 954 (1082)
.+ |.||+++.... .+.++..+++-.+-|++.-++|+|.+ +++||||||+|+|+.- ...+.++|||+|+.+..
T Consensus 92 LL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 99 88999999877 56799999999999999999999999 9999999999999974 35789999999998754
Q ss_pred CCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 955 SETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 955 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
..+. ......||.+|.+-....+.+.+.+.|+-|+|.++..+--|..||...... .-.+..+. +.+.+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-----tk~QKyEk-I~EkK 240 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-----TKKQKYEK-ISEKK 240 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-----hHHHHHHH-HHHhh
Confidence 4332 223467999999999988888899999999999999999999999754322 11111111 11111
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 1076 (1082)
....+. .+.. ..+.++.-.+.-|-..--++-|+..-+-+.++-
T Consensus 241 ~s~~ie-~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 241 MSTPIE-VLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred cCCCHH-HHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 111111 1111 224567777788888888888887766665543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-18 Score=196.41 Aligned_cols=260 Identities=29% Similarity=0.419 Sum_probs=199.5
Q ss_pred ccccceecccCceEEEEEEEcCCeEEEEEEeecCccc---cHHHHHHHHHHHhccCCC-ceeeEeeeeccCCeEEEEEee
Q 045553 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHP-NLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~ 878 (1082)
|.+.+.||.|+||.||++... ..+|+|.+...... ....+.+|+..++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999766 78899998765432 367899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecccceecCCCC
Q 045553 879 LPGGNLEKFIQDRPR-RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 956 (1082)
+.++++.+++..... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765422 2688999999999999999999999 999999999999999988 79999999998665443
Q ss_pred Cc-----cccCcccCCCcccchhccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 957 TH-----ATTDVAGTFGYVAPEYAMT---CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 957 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
.. ......|+..|+|||...+ ..+....|+|++|++++++++|..||...... ....+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~- 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP- 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC-
Confidence 32 2356789999999999987 57889999999999999999999996533210 01111111111111
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. .................+.+++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 000000000001223578899999999999999998887653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-20 Score=221.20 Aligned_cols=252 Identities=18% Similarity=0.192 Sum_probs=188.0
Q ss_pred ccceecccCceEEEEEEE-cCCeEEEEEEeecC--cccc----HHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 805 VQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG--RFQG----VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 805 ~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
..+++|.|++|.|+.+.. ......+.|.+... .... ...+..|+-+-..+.|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998887743 33444444443311 1111 1225668888888999999998888887777777799
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++ +|..++... ..++..++..++.|+..|++|+|+. +|.|||+|++|++++.++.+||+|||.+..+..+..
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9998 999998863 3578888999999999999999999 999999999999999999999999999988765444
Q ss_pred ---ccccCcccCCCcccchhcccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 958 ---HATTDVAGTFGYVAPEYAMTCRVSD-KADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 958 ---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
......+|+..|+|||++.+.+|.+ ..||||.|+++..|.+|+.||....... ..+ ......++....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~---~~~----~~~~~~~~~~~~- 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD---NSF----KTNNYSDQRNIF- 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc---cch----hhhccccccccc-
Confidence 4567788999999999999999876 5899999999999999999997432221 110 000000000000
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
... .......+.+...++.++++.+|.+|-|+.+|++
T Consensus 548 -~~~-~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 -EGP-NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -cCh-HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 0011344667889999999999999999999975
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=219.21 Aligned_cols=117 Identities=21% Similarity=0.354 Sum_probs=53.3
Q ss_pred CCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcc
Q 045553 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215 (1082)
Q Consensus 136 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~ 215 (1082)
.+.|+++++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|+|+
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls 249 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMELS 249 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEECc
Confidence 344555555444 3443332 24555555555554 2333222 24555555555544 3443332 244555555
Q ss_pred cCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCc
Q 045553 216 ANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268 (1082)
Q Consensus 216 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 268 (1082)
+|+++ .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+++
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR 296 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc
Confidence 55554 3443332 24555555555555 3444332 34555555555554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-19 Score=186.50 Aligned_cols=171 Identities=12% Similarity=0.133 Sum_probs=133.5
Q ss_pred HhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHH---------HHHHHHHHHhccCCCceeeEeeeeccC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQ---------QFAAEIRTLGRVQHPNLVTLIGYHVSE 869 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~---------~~~~e~~~l~~l~h~niv~l~~~~~~~ 869 (1082)
..++|++.+++|.|+||.||.++. ++..+|||.+......... .+.+|++.+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999866 5778999999754332222 268999999999999999998876533
Q ss_pred --------CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcE
Q 045553 870 --------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941 (1082)
Q Consensus 870 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 941 (1082)
...++||||++|.+|.++.. .+. ....+++.++..+|+. +++|||++|+||+++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 35899999999999988732 222 2456999999999999 999999999999999988 9
Q ss_pred EEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHH
Q 045553 942 YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ell 997 (1082)
+++|||........... ..+.....+..++|+|+||+.+..+.
T Consensus 174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988755322111 11333445667899999999876553
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=215.34 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=196.2
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
.+...|+|++++++ .+|..+. ++|+.|+|++|.|+ .+|..+. ++|++|++++|+++ .+|..+. ++|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 46789999999998 6787664 58999999999999 6787664 58999999999998 5676553 47999999
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
++|++. .+|..+. .+|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+++.
T Consensus 249 s~N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 249 SINRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred cCCccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc
Confidence 999998 8888765 47999999999999 6777665 58999999999998 4665543 579999999999984
Q ss_pred cCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccc
Q 045553 270 IVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWE 349 (1082)
Q Consensus 270 ~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~ 349 (1082)
+|..+. ++|+.|++++|.+. .+|..+. ++|+.|++++|++.. +|..+.
T Consensus 319 -LP~~l~--~sL~~L~Ls~N~Lt--------------------------~LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp 366 (754)
T PRK15370 319 -LPETLP--PGLKTLEAGENALT--------------------------SLPASLP--PELQVLDVSKNQITV-LPETLP 366 (754)
T ss_pred -CCcccc--ccceeccccCCccc--------------------------cCChhhc--CcccEEECCCCCCCc-CChhhc
Confidence 565443 68999999886443 2444443 689999999999985 454443
Q ss_pred cccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-----ccCcccEEEecCCcce
Q 045553 350 LCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-----SVPCMAVFNVSQNLLS 412 (1082)
Q Consensus 350 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~l~~L~~L~l~~N~l~ 412 (1082)
++|++|+|++|+++ .+|..+. ..|+.|++++|+|++. |..+ .++.+..|++.+|+++
T Consensus 367 --~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~L-P~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 --PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVRL-PESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred --CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcccC-chhHHHHhhcCCCccEEEeeCCCcc
Confidence 68999999999999 6677654 3699999999999854 4322 2478899999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=182.20 Aligned_cols=140 Identities=18% Similarity=0.227 Sum_probs=109.0
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEeecCccc--c-------H-----------------HHHHHHHHHHhccCCCce
Q 045553 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ--G-------V-----------------QQFAAEIRTLGRVQHPNL 859 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni 859 (1082)
...||+|+||.||+|...+|+.||||+++..... . . .....|++.++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998778999999999754221 1 0 122359999999988776
Q ss_pred eeEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEeccCCCCCEEEcCC
Q 045553 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL-HDECVPRVLHRDIKPSNILLDNN 938 (1082)
Q Consensus 860 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~Nill~~~ 938 (1082)
.....+.. ...++||||++++++...... ...+++.++..++.|++.++.|+ |+. +|+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 43333222 234899999988777654322 24688999999999999999999 688 999999999999998 4
Q ss_pred CcEEEeecccceecC
Q 045553 939 LNAYLSDFGLARLLG 953 (1082)
Q Consensus 939 ~~~kl~DfGla~~~~ 953 (1082)
+.++++|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-18 Score=175.31 Aligned_cols=139 Identities=19% Similarity=0.248 Sum_probs=110.8
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEeecCccc--c------------------------HHHHHHHHHHHhccCCCce
Q 045553 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ--G------------------------VQQFAAEIRTLGRVQHPNL 859 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni 859 (1082)
...||+|+||.||+|...+|+.||||++...... . ...+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998778999999998754211 0 1223578999999999987
Q ss_pred eeEeeeeccCCeEEEEEeecCCCCHHHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcC
Q 045553 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKF-IQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDN 937 (1082)
Q Consensus 860 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~ 937 (1082)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 544443322 24899999988755433 332 357788999999999999999999 8 999999999999999
Q ss_pred CCcEEEeecccceecC
Q 045553 938 NLNAYLSDFGLARLLG 953 (1082)
Q Consensus 938 ~~~~kl~DfGla~~~~ 953 (1082)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.5e-18 Score=169.32 Aligned_cols=185 Identities=18% Similarity=0.113 Sum_probs=140.7
Q ss_pred cccceecccCceEEEEEEEcCCeEEEEEEeecCccc----cHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEEee
Q 045553 804 NVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ----GVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 804 ~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.+...|++|+||+||.+.- .+.+++.+.+...... ....+.+|++++++++ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998865 5788887777654321 1225789999999995 4789999886 457999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC-CCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI-KPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
++|.+|.+.... ....++.|+++++.++|+. +|+|||| ||+||+++.++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754321 1135778999999999999 9999999 79999999999999999999986554331
Q ss_pred c----c--------ccCcccCCCcccchhcccC-CCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 045553 958 H----A--------TTDVAGTFGYVAPEYAMTC-RVS-DKADVYSFGVVLLELISDKKALDP 1005 (1082)
Q Consensus 958 ~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slGvll~elltg~~p~~~ 1005 (1082)
. . ..-...++.|++|+...-- ..+ ...+.++-|+.+|.++||+.+...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 0112357788888865432 233 567888999999999999998754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.3e-18 Score=193.54 Aligned_cols=217 Identities=27% Similarity=0.435 Sum_probs=166.9
Q ss_pred HhccCCCceeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-EeccCC
Q 045553 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV-LHRDIK 929 (1082)
Q Consensus 851 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dlk 929 (1082)
++.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.....+.++++.||+|+|.. +| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 35689999999999999999999999999999999999874 56789999999999999999999998 55 899999
Q ss_pred CCCEEEcCCCcEEEeecccceecCC-CCCccccCcccCCCcccchhcccCC-------CCchhhHHHHHHHHHHHHhCCC
Q 045553 930 PSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCR-------VSDKADVYSFGVVLLELISDKK 1001 (1082)
Q Consensus 930 ~~Nill~~~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slGvll~elltg~~ 1001 (1082)
+.|+++|..+.+|++|||+...... ..........-...|.|||.+.+.. .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999999887642 1111122223456799999987631 4677999999999999999999
Q ss_pred CCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1002 ALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1002 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
||+........ ..+...++. .+ ...+-+.+.... +....+..++.+||..+|++||++.+|-..++.+..
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~---~~--~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKK---GG--SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCCh-HHHHHHHHh---cC--CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99865444222 222222222 11 111222222111 333479999999999999999999999988877654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=176.35 Aligned_cols=231 Identities=19% Similarity=0.247 Sum_probs=150.3
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCC----------CceeeEeee---
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQH----------PNLVTLIGY--- 865 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~niv~l~~~--- 865 (1082)
+...+.||.|+++.||.++.. +++.+|||++..... ...+++.+|.-....+.+ -.++-.++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999765 489999999865432 345667777655555432 111111111
Q ss_pred ------ec---cCC-----eEEEEEeecCCCCHHHHHhh---CCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 045553 866 ------HV---SEA-----EMFLIYNYLPGGNLEKFIQD---RPR--RTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926 (1082)
Q Consensus 866 ------~~---~~~-----~~~lV~E~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 926 (1082)
+. +.. ..+++|+-+ .++|.+++.. ... ..+....+..+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 111 247788888 5788888652 211 2234445667778999999999999 99999
Q ss_pred cCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcccchhccc--------CCCCchhhHHHHHHHHHHHHh
Q 045553 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT--------CRVSDKADVYSFGVVLLELIS 998 (1082)
Q Consensus 927 Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slGvll~ellt 998 (1082)
||+|+|++++++|.++++||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988775432221 234578999997743 257889999999999999999
Q ss_pred CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCC
Q 045553 999 DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSR 1064 (1082)
Q Consensus 999 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R 1064 (1082)
|..||+......... ..+. .+. +.++.+..||..+++.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~---------------------~~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE---------------------WDFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG---------------------GGGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc---------------------ccch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999998543221110 0222 233 778899999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-18 Score=203.76 Aligned_cols=253 Identities=22% Similarity=0.270 Sum_probs=185.6
Q ss_pred CccccceecccCceEEEEEEEcCCeEEEEEEeecCc-cccHHHHH---HHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR-FQGVQQFA---AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~-~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
+|...+.||.+.|=+|.+|+...|. |+||++-... ....+.|. +|++ ...++|||.+++...-..++..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677789999999999999888776 8999986654 33344444 4444 556699999999998888888899999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee--cCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL--LGTS 955 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~--~~~~ 955 (1082)
|+ .-+|++.+..++ -+...+.+-|+.|++.|+.-.|.. +|+|||||.+|||++.=.=+.|+||..-+- +..+
T Consensus 102 yv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 99 459999998754 466677778999999999999999 999999999999999887889999976542 2222
Q ss_pred CCccc----cCcccCCCcccchhcccC-----------CCCchhhHHHHHHHHHHHHhC-CCCCCCCccCCCCCccHHHH
Q 045553 956 ETHAT----TDVAGTFGYVAPEYAMTC-----------RVSDKADVYSFGVVLLELISD-KKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 956 ~~~~~----~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slGvll~elltg-~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
+.... .+...-.+|.|||.+... ..+++.||||+||++.|+++. +++|. +.+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----------LSQL 244 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----------LSQL 244 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----------HHHH
Confidence 22211 112233479999987531 156789999999999999885 66664 2333
Q ss_pred HHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1020 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
.+..-.+....+.+-..+. ...+.+++..|++.||++|-++.+.++.-+++..|
T Consensus 245 ~aYr~~~~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP 298 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP 298 (1431)
T ss_pred HhHhccCccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence 3322221111111111121 13688999999999999999999999998876654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.3e-20 Score=171.48 Aligned_cols=166 Identities=31% Similarity=0.553 Sum_probs=151.2
Q ss_pred ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 185 (1082)
+.++++.+.|.|++|+++ .+|..+..+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.+|.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 667888999999999999 88889999999999999999999 89999999999999999999998 8999999999999
Q ss_pred EEEcccCcccc-cCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCC
Q 045553 186 VVSLSFNLLSG-SVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSR 264 (1082)
Q Consensus 186 ~L~L~~N~l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 264 (1082)
.|||.+|.+.. .+|..|+ .+..|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|.+++.++.|++|.+.+
T Consensus 106 vldltynnl~e~~lpgnff-~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFF-YMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhccccccccccCCcchh-HHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 99999999874 5677777 5889999999999999 88999999999999999999998 7999999999999999999
Q ss_pred CcCcccCCccccCC
Q 045553 265 NFLSGIVPSELGMC 278 (1082)
Q Consensus 265 N~l~~~~p~~l~~l 278 (1082)
|+++ .+|..++.+
T Consensus 183 nrl~-vlppel~~l 195 (264)
T KOG0617|consen 183 NRLT-VLPPELANL 195 (264)
T ss_pred ceee-ecChhhhhh
Confidence 9998 677766554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=175.97 Aligned_cols=196 Identities=21% Similarity=0.262 Sum_probs=141.0
Q ss_pred CCCceeeEeeeecc---------------------------CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHH
Q 045553 855 QHPNLVTLIGYHVS---------------------------EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907 (1082)
Q Consensus 855 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 907 (1082)
+|||||++.++|.+ ....|+||..+ ..+|.+|+..+ ..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999887653 23479999988 56999999864 3555667778999
Q ss_pred HHHHHHHHhhCCCCCeEeccCCCCCEEEc--CCC--cEEEeecccceecCC-----CCCccccCcccCCCcccchhcccC
Q 045553 908 VARALAYLHDECVPRVLHRDIKPSNILLD--NNL--NAYLSDFGLARLLGT-----SETHATTDVAGTFGYVAPEYAMTC 978 (1082)
Q Consensus 908 i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~DfGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~ 978 (1082)
+++|+.|||.+ +|.|||+|++|||+. +|+ ...|+|||.+---.. +.........|...-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 999999999999994 443 578999998753221 111122345678889999998753
Q ss_pred C------CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHH
Q 045553 979 R------VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNL 1052 (1082)
Q Consensus 979 ~------~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 1052 (1082)
. --.|+|.|+.|.+.||+++...||+..- +..+ +. ...++.+++ ..|+..+..+.++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-----em~L-~~--r~Yqe~qLP---------alp~~vpp~~rql 489 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-----EMLL-DT--RTYQESQLP---------ALPSRVPPVARQL 489 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccc-----hhee-ch--hhhhhhhCC---------CCcccCChHHHHH
Confidence 3 2358999999999999999999997410 0000 00 001222222 1344556789999
Q ss_pred HHHcccCCCCCCCCHHHHHHHH
Q 045553 1053 AIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1053 i~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
+...++.||.+||+..-....|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 9999999999999875544443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-19 Score=201.78 Aligned_cols=267 Identities=22% Similarity=0.192 Sum_probs=138.1
Q ss_pred cccccCCCCCCEEEcccCCCcc----cCChhhcCCCCCCEEeCcCCCCCC------CCCccccCCCCCCeEEccCccccc
Q 045553 103 SRAIGDLTQLRVLLLAFNGFSG----ELPLEIGQLSLLEILDLSFNSFHG------PIPPTLQNCSSLRLINLSGNQFNG 172 (1082)
Q Consensus 103 ~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~------~~p~~l~~l~~L~~L~Ls~N~l~~ 172 (1082)
...+..+.+|+.|+++++.++. .++..+...++|++|+++++.+.+ .++..+.++++|++|++++|.+.+
T Consensus 16 ~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~ 95 (319)
T cd00116 16 TELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGP 95 (319)
T ss_pred HHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCCh
Confidence 3444445555555555555532 133344445555555555555441 122334445555555555555543
Q ss_pred ccCccccCCCC---CcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCC-CCccEEEccCCcCCCC--
Q 045553 173 TIPAFFGQSPG---FQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNC-TELRSLLLSSNMLQGD-- 246 (1082)
Q Consensus 173 ~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~-- 246 (1082)
..+..+..+.+ |++|++++|++.+... ..+...+..+ ++|+.|++++|.+++.
T Consensus 96 ~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~---------------------~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 154 (319)
T cd00116 96 DGCGVLESLLRSSSLQELKLNNNGLGDRGL---------------------RLLAKGLKDLPPALEKLVLGRNRLEGASC 154 (319)
T ss_pred hHHHHHHHHhccCcccEEEeeCCccchHHH---------------------HHHHHHHHhCCCCceEEEcCCCcCCchHH
Confidence 33333333332 5555555554441110 1112223334 5555566665555521
Q ss_pred --cCccccCCCCCCEEeCCCCcCccc----CCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCC
Q 045553 247 --IPSSFGQLVNLEVLDLSRNFLSGI----VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGL 320 (1082)
Q Consensus 247 --~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~ 320 (1082)
++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+... -...+
T Consensus 155 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~---------------------~~~~l 213 (319)
T cd00116 155 EALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE---------------------GASAL 213 (319)
T ss_pred HHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH---------------------HHHHH
Confidence 223344455566666666665531 223344445666666655432100 00112
Q ss_pred CccccCCCCCcEEEcCCCcccCCCCccccc-----ccCCCeEEcCCccccC----CCCccccCCCCCCEEecCCCcCccc
Q 045553 321 PDSITRLPNLRVFWAPNLNLEGIFPQNWEL-----CSKLEMLNLAHNFFTG----QIPASLGNCKSLYFLDLSSNNLTGL 391 (1082)
Q Consensus 321 p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~-----l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~ 391 (1082)
+..+..+++|++|++++|.+.+.....+.. .+.|++|++++|.++. .+...+..+++|+++++++|+++..
T Consensus 214 ~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 214 AETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 334556677777777777776533333322 3688888888888862 2344556668888899999888855
Q ss_pred ----CCCCcc-c-CcccEEEecCCcc
Q 045553 392 ----LPEEVS-V-PCMAVFNVSQNLL 411 (1082)
Q Consensus 392 ----~p~~~~-l-~~L~~L~l~~N~l 411 (1082)
....+. . +.|+.+++.+|++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 294 GAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHHHHhhcCCchhhcccCCCCC
Confidence 333332 2 5788888887764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.9e-17 Score=195.13 Aligned_cols=246 Identities=18% Similarity=0.251 Sum_probs=182.9
Q ss_pred HhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC---CCceeeEeeeeccCCeEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ---HPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV 875 (1082)
....|.|.+.||+|+||+||+|...+|+.||+|+-+..... +|.--.+++.+++ -+-|..+..++...+.-++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 34568899999999999999998888999999997665433 2333334455555 23455556666677888999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc-------CCCcEEEeeccc
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-------NNLNAYLSDFGL 948 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-------~~~~~kl~DfGl 948 (1082)
+||.+.|+|.+++.. .+.++|.-+..+..|+++.+++||.. +||||||||+|+||. ....++|+|||-
T Consensus 773 ~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 999999999999984 56799999999999999999999999 999999999999994 234689999999
Q ss_pred ceecCC-CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 949 ARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 949 a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
+-.+.- .+.......++|..+--+|+..|+.++..+|.|.++.+++-|+.|+.. + ..+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~------------------q---~~~ 906 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM------------------E---VKN 906 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH------------------H---hcC
Confidence 976642 222345567899999999999999999999999999999999999642 1 111
Q ss_pred CCccccccccCCCCChHHH-HHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1028 RPCEFFTAGLWDCGPHDDL-IEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~-~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
.....++..+. +... .-..++..++++.|-..=|...++...|++.
T Consensus 907 g~~~~~~~~~~----Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 907 GSSWMVKTNFP----RYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred Ccceeccccch----hhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 11112222211 1111 1234556666665555567777777777654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.3e-18 Score=190.34 Aligned_cols=224 Identities=25% Similarity=0.284 Sum_probs=178.4
Q ss_pred ecccCceEEEEEE----EcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEEeecCC
Q 045553 809 IGSGGFGATYKAE----IIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 809 lg~G~~g~Vy~a~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+|+|+||.|+.++ ...|..+|+|+.+.... ........|-.++...+ ||.++++...+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999873 23467788888765422 11124456777888887 99999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
|.+...+.. ...+++.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-..+..
T Consensus 82 g~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 82 GDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred chhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 999887766 44677777888889999999999999 9999999999999999999999999999876433322
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
+||..|||||++. ......|.||||++++||++|..||.. +.+..+.... -..
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~-----------~~~ 206 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAE-----------LEM 206 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhc-----------cCC
Confidence 8999999999998 567789999999999999999999863 2223322211 124
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
|.+....+..++..+...+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 56667778888888888888888633
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=163.60 Aligned_cols=135 Identities=18% Similarity=0.224 Sum_probs=106.3
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhcc-----CCCceeeEeeeeccCC---e-EEEE
Q 045553 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-----QHPNLVTLIGYHVSEA---E-MFLI 875 (1082)
Q Consensus 805 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lV 875 (1082)
-.+.||+|+||.||. ...++.. +||++........+.+.+|+++++.+ .||||+++++++.++. . +.+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 357899999999996 3233444 79988765445567899999999999 5799999999998763 3 3478
Q ss_pred Eee--cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEeccCCCCCEEEcC----CCcEEEeeccc
Q 045553 876 YNY--LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL-AYLHDECVPRVLHRDIKPSNILLDN----NLNAYLSDFGL 948 (1082)
Q Consensus 876 ~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~DfGl 948 (1082)
+|| +++++|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+||+++. +..++|+||+-
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 999 5579999999753 35555 35677888777 999999 9999999999999974 34799999543
Q ss_pred c
Q 045553 949 A 949 (1082)
Q Consensus 949 a 949 (1082)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-18 Score=194.43 Aligned_cols=244 Identities=22% Similarity=0.218 Sum_probs=162.2
Q ss_pred cccccccCCCCCCEEEcccCCCcc------cCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCC---CCeEEccCcccc
Q 045553 101 NLSRAIGDLTQLRVLLLAFNGFSG------ELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSS---LRLINLSGNQFN 171 (1082)
Q Consensus 101 ~l~~~l~~l~~L~~L~L~~n~l~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~---L~~L~Ls~N~l~ 171 (1082)
.+++.+...+.|++|+++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|++++|+++
T Consensus 42 ~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~ 121 (319)
T cd00116 42 ALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG 121 (319)
T ss_pred HHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence 467778899999999999998872 34567888999999999999998777777766666 999999999998
Q ss_pred c----ccCccccCC-CCCcEEEcccCcccccCCcccc---cccccccEEEcccCccCCC----CCccccCCCCccEEEcc
Q 045553 172 G----TIPAFFGQS-PGFQVVSLSFNLLSGSVPEEFG---DNCVSLEHILLAANSLTGS----IPPSLGNCTELRSLLLS 239 (1082)
Q Consensus 172 ~----~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~---~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~ 239 (1082)
+ .+...+..+ ++|+.|+|++|.+++.....+. ..+.+|++|++++|.+++. ++..+..+++|++|+++
T Consensus 122 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~ 201 (319)
T cd00116 122 DRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201 (319)
T ss_pred hHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEecc
Confidence 4 233456667 8999999999998843332221 2345677777777777742 22334455677777777
Q ss_pred CCcCCCC----cCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccc
Q 045553 240 SNMLQGD----IPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNF 315 (1082)
Q Consensus 240 ~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~ 315 (1082)
+|.+++. +...+..+++|++|++++|.+++.....+...
T Consensus 202 ~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~------------------------------------- 244 (319)
T cd00116 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA------------------------------------- 244 (319)
T ss_pred CCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHH-------------------------------------
Confidence 7777633 23345556677777777777664222221110
Q ss_pred cCCCCCccccCCCCCcEEEcCCCcccC----CCCcccccccCCCeEEcCCccccCC----CCccccCC-CCCCEEecCCC
Q 045553 316 FDGGLPDSITRLPNLRVFWAPNLNLEG----IFPQNWELCSKLEMLNLAHNFFTGQ----IPASLGNC-KSLYFLDLSSN 386 (1082)
Q Consensus 316 ~~~~~p~~l~~l~~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~Ls~N~i~~~----~p~~~~~l-~~L~~L~Ls~N 386 (1082)
+ ....++|+.|++++|.++. .....+..+++|++|++++|.++.. ....+... +.|++|++.+|
T Consensus 245 ----~---~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (319)
T cd00116 245 ----L---LSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDD 317 (319)
T ss_pred ----H---hccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCC
Confidence 0 0023456666666666652 1223455567788888888888744 33344444 67888888887
Q ss_pred cC
Q 045553 387 NL 388 (1082)
Q Consensus 387 ~l 388 (1082)
++
T Consensus 318 ~~ 319 (319)
T cd00116 318 SF 319 (319)
T ss_pred CC
Confidence 64
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-16 Score=166.42 Aligned_cols=142 Identities=20% Similarity=0.210 Sum_probs=112.4
Q ss_pred CccccceecccCceEEEEEE--EcCCeEEEEEEeecCccc------------------------cHHHHHHHHHHHhccC
Q 045553 802 GFNVQNCIGSGGFGATYKAE--IIPGVVVAVKRLSVGRFQ------------------------GVQQFAAEIRTLGRVQ 855 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 855 (1082)
.|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999997 568999999998754210 0123568999999997
Q ss_pred CC--ceeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEeccCCCCC
Q 045553 856 HP--NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR-VLHRDIKPSN 932 (1082)
Q Consensus 856 h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~N 932 (1082)
+. .+.+++++ ...++||||+++.++..+.... ......+...++.|++.++++||+. + |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 63 34445543 2358999999998887665332 2455666789999999999999999 9 9999999999
Q ss_pred EEEcCCCcEEEeecccceecC
Q 045553 933 ILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 933 ill~~~~~~kl~DfGla~~~~ 953 (1082)
|+++ ++.++++|||.+...+
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-18 Score=160.72 Aligned_cols=173 Identities=25% Similarity=0.429 Sum_probs=152.1
Q ss_pred CceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEE
Q 045553 518 LDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLS 597 (1082)
Q Consensus 518 ~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 597 (1082)
..+..|-||+|+++ .+|..+.. +.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ++|..|+.++.|+.||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~-l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAE-LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHH-hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 34457889999998 88888864 577999999999999 55778999999999999999998 8999999999999999
Q ss_pred cCCCcCCc-cCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccc
Q 045553 598 LSLNNFTG-AIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676 (1082)
Q Consensus 598 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 676 (1082)
|++|++.. ..|+.|..+..|+.|+|+.|.+. .+|.+.+.+++|+.|.+..|.+- .+|.+++.++.|+.|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 99999963 68999999999999999999999 88999999999999999999999 88999999999999999999999
Q ss_pred cCCCCCccc------ccccCCCCCCC
Q 045553 677 GSAPRNSLI------KCENVQGNPNL 696 (1082)
Q Consensus 677 ~~~p~~~~~------~~~~~~~Np~~ 696 (1082)
...|+-+.+ .....+.|||.
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 777765433 33456788886
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=158.33 Aligned_cols=144 Identities=19% Similarity=0.211 Sum_probs=113.1
Q ss_pred HHHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccc----------------------cHHHHHHHHHHHh
Q 045553 795 NVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ----------------------GVQQFAAEIRTLG 852 (1082)
Q Consensus 795 ~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~ 852 (1082)
++.+....|.+.+.||+|+||.||+|...+|+.||||++...... ....+..|+..+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444458888999999999999998888999999987643210 1123567888898
Q ss_pred ccCCCc--eeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCC
Q 045553 853 RVQHPN--LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKP 930 (1082)
Q Consensus 853 ~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 930 (1082)
.+.|++ +++.++. ...++||||+++++|...... .....++.+++.++.++|+. +|+||||+|
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 888774 4444442 356899999999998765431 24567889999999999998 999999999
Q ss_pred CCEEEcCCCcEEEeecccceecC
Q 045553 931 SNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 931 ~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||++++++.++|+|||.+....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=160.13 Aligned_cols=134 Identities=22% Similarity=0.418 Sum_probs=113.9
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEeecCccc--------cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ--------GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+.||+|++|.||+|.. .|..|++|+....... ....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5788999986543221 124577899999999999988777777777788999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
++|++|.+++.... + .+..++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999987531 2 7889999999999999999 999999999999999 78999999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=157.15 Aligned_cols=131 Identities=23% Similarity=0.417 Sum_probs=107.6
Q ss_pred eecccCceEEEEEEEcCCeEEEEEEeecCcc--------ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 808 CIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.||+|+||.||+|.+ +|..|++|+...... ....++.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 478899998654321 11355778999999999887665555555666779999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
+|++|.+++..... .++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998765310 7899999999999999 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.5e-16 Score=173.14 Aligned_cols=174 Identities=27% Similarity=0.407 Sum_probs=134.0
Q ss_pred eEEEEEeecCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDR-PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
..|+.|+++...+|.+|+..+ .....++.....++.|++.|+.| + +.+|||+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999743 35678889999999999999999 5 8999999999999999999999999999
Q ss_pred eecCCCC-----CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHH
Q 045553 950 RLLGTSE-----THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASML 1023 (1082)
Q Consensus 950 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1023 (1082)
..+.... ...++...||..||+||.+.+..|+.|+||||+|++++|++. -..+++. .. ....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------~~-t~~d 471 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------IA-TLTD 471 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------HH-hhhh
Confidence 8776554 234556789999999999999999999999999999999987 2222221 01 1112
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
++.+.++ +.....+| .-..+..+++.+.|.+||++.++.
T Consensus 472 ~r~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 472 IRDGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhcCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence 2222222 12222233 234788999999999999665554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.1e-15 Score=178.06 Aligned_cols=139 Identities=22% Similarity=0.324 Sum_probs=113.3
Q ss_pred HhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCc--c------ccHHHHHHHHHHHhccCCCceeeEeeeeccCC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR--F------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 870 (1082)
....|...+.||+|+||+||+|.+... .+++|+..... . ...+.+.+|+++++.++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556789999999999999987644 44444432111 1 12356789999999999999998888877777
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ .++.++|+|||+++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 8899999999999999885 3467899999999999999 99999999999999 67799999999997
Q ss_pred ec
Q 045553 951 LL 952 (1082)
Q Consensus 951 ~~ 952 (1082)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.8e-15 Score=176.89 Aligned_cols=208 Identities=22% Similarity=0.290 Sum_probs=143.2
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..+|...+.|..|+||.||.++.+ +.+.+|+|+ .... -+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee------------------
Confidence 457888999999999999999654 467788843 2211 01110 22222233322
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC-
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET- 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 957 (1082)
|+-...++..+ .++. +++.+++|+|+. +|+|||+||+|.+++.-|.+|++|||+++.......
T Consensus 136 ---gDc~tllk~~g--~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG--PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCC--CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 44444444322 2221 227889999999 999999999999999999999999999865422111
Q ss_pred -------------ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 958 -------------HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 958 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
.....++||+.|+|||++..+.|....|+|++|+++||++-|+.||..+. ..+.+...+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt--------peelfg~vi 271 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFGQVI 271 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC--------HHHHHhhhh
Confidence 12335789999999999999999999999999999999999999997542 222333322
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCC
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP 1065 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP 1065 (1082)
.+. ..+.+..+....+++.++.+.++.+|.+|-
T Consensus 272 sd~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 SDD--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhh--------ccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 221 111112233456788999999999999985
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.5e-14 Score=175.58 Aligned_cols=143 Identities=35% Similarity=0.614 Sum_probs=99.4
Q ss_pred HHHHHHHHhcccCCCCCCCCCCCCCCCCc----eeeeeEeeCC--CC--CeeeeecCCCccccccccCCCCCCCCCCCCc
Q 045553 2 NALLQLKSAITEDPLGLTSNWNPKDTDSC----SWHGVTCDPL--SG--RVTSLNLSSNLSRTSCSLLSLPPAAGPGGNF 73 (1082)
Q Consensus 2 ~~l~~~k~~~~~~~~~~~~~W~~~~~~~c----~w~gv~C~~~--~~--~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~ 73 (1082)
+||++||+++. +|.. .+|.. ..|| .|.||.|+.. .+ +|+.|+|++
T Consensus 375 ~aL~~~k~~~~-~~~~--~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~---------------------- 427 (623)
T PLN03150 375 SALQTLKSSLG-LPLR--FGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDN---------------------- 427 (623)
T ss_pred HHHHHHHHhcC-Cccc--CCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCC----------------------
Confidence 69999999996 4432 48963 2232 7999999532 22 466666654
Q ss_pred ccCcCcccccccccCcccCCCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCcc
Q 045553 74 SFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153 (1082)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~ 153 (1082)
+.+.|.+|++|+.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..
T Consensus 428 ----------------------n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~ 485 (623)
T PLN03150 428 ----------------------QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485 (623)
T ss_pred ----------------------CCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchH
Confidence 4566777777777777777777777777777777777777777777777777777777
Q ss_pred ccCCCCCCeEEccCcccccccCccccCC-CCCcEEEcccCc
Q 045553 154 LQNCSSLRLINLSGNQFNGTIPAFFGQS-PGFQVVSLSFNL 193 (1082)
Q Consensus 154 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~ 193 (1082)
++++++|++|+|++|++++.+|..+..+ .++..+++.+|.
T Consensus 486 l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 486 LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred HhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence 7777777777777777777777666543 344555555554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.9e-14 Score=144.66 Aligned_cols=136 Identities=22% Similarity=0.283 Sum_probs=97.8
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEeecCccc--cHHHH----------------------HHHHHHHhccCCCc--e
Q 045553 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ--GVQQF----------------------AAEIRTLGRVQHPN--L 859 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~e~~~l~~l~h~n--i 859 (1082)
.+.||+|+||+||+|...+++.||||++...... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998778999999998754221 11111 24555555554432 3
Q ss_pred eeEeeeeccCCeEEEEEeecCCCCHHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcC
Q 045553 860 VTLIGYHVSEAEMFLIYNYLPGGNLEK-FIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDN 937 (1082)
Q Consensus 860 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~ 937 (1082)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 444443 24689999999854321 111110 11 5678899999999999999 7 999999999999999
Q ss_pred CCcEEEeecccceecC
Q 045553 938 NLNAYLSDFGLARLLG 953 (1082)
Q Consensus 938 ~~~~kl~DfGla~~~~ 953 (1082)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-13 Score=136.77 Aligned_cols=135 Identities=19% Similarity=0.174 Sum_probs=114.7
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCC--CceeeEeeeeccCCeEEEEEeecCCC
Q 045553 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH--PNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 805 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| ..+++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999998754 7899999865433 4678899999999977 58999999888888999999999887
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.+..+ +......++.+++++++++|.....+++|||++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77554 4566778899999999999997445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.2e-13 Score=143.18 Aligned_cols=134 Identities=24% Similarity=0.328 Sum_probs=105.3
Q ss_pred ceec-ccCceEEEEEEEcCCeEEEEEEeecCc-------------cccHHHHHHHHHHHhccCCCce--eeEeeeeccC-
Q 045553 807 NCIG-SGGFGATYKAEIIPGVVVAVKRLSVGR-------------FQGVQQFAAEIRTLGRVQHPNL--VTLIGYHVSE- 869 (1082)
Q Consensus 807 ~~lg-~G~~g~Vy~a~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~- 869 (1082)
..|| .||.|+||+++.. +..++||.+.... ......+.+|++++.+++|+++ ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999775 7789999885321 1223567889999999998875 6677764432
Q ss_pred C---eEEEEEeecCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEee
Q 045553 870 A---EMFLIYNYLPG-GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSD 945 (1082)
Q Consensus 870 ~---~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 945 (1082)
. ..++||||+++ .+|.+++... .++.. .+.+++.++.+||+. +|+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23699999997 6999988653 34433 357899999999999 999999999999999999999999
Q ss_pred ccccee
Q 045553 946 FGLARL 951 (1082)
Q Consensus 946 fGla~~ 951 (1082)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.1e-14 Score=173.92 Aligned_cols=253 Identities=26% Similarity=0.307 Sum_probs=190.5
Q ss_pred cCccccceecccCceEEEEEEEc--CCeEEEEEEeecCc--cccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII--PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV 875 (1082)
..|.+.+.||+|+|+.|-.+... ....+|+|.+.... .........|..+-+... |+|++.+++........+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45777788999999999887543 34567777775543 233344555777777776 99999999999999999999
Q ss_pred EeecCCCCHHHHH-hhCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEeccCCCCCEEEcCCC-cEEEeecccceec
Q 045553 876 YNYLPGGNLEKFI-QDRPRRTVEWSMLHKIALDVARALAYLH-DECVPRVLHRDIKPSNILLDNNL-NAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l-~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~ 952 (1082)
.||..++++.+-+ +.. ....+......+..|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998888 432 225566677789999999999999 76 999999999999999999 9999999999987
Q ss_pred CC--CCCccccCccc-CCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 953 GT--SETHATTDVAG-TFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 953 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
.. .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++..... ......|+.....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~---~~~~~~~~~~~~~--- 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK---DGRYSSWKSNKGR--- 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc---cccceeecccccc---
Confidence 65 33344455678 9999999999884 4567899999999999999999998754322 2222333222100
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
... ............+..+++..+|..|.+..++.
T Consensus 250 ----~~~----~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 ----FTQ----LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ----ccc----CccccCChhhhhcccccccCCchhcccccccc
Confidence 000 11123344677788888889999999887764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.5e-15 Score=161.64 Aligned_cols=179 Identities=35% Similarity=0.460 Sum_probs=157.0
Q ss_pred cCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcE
Q 045553 107 GDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQV 186 (1082)
Q Consensus 107 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 186 (1082)
-.|+.-...||+.|++. ++|..+..+-.|+.|.|..|.+. .+|..+.++..|++|||+.|+++ .+|..++.++ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 45666677889999998 89999988899999999999998 88999999999999999999998 7888888877 899
Q ss_pred EEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCc
Q 045553 187 VSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF 266 (1082)
Q Consensus 187 L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 266 (1082)
|.+++|+++ .+|..++ .+..|..|+.+.|++. .+|..++++.+|+.|.+..|++. .+|..++.|+ |..||+|.|+
T Consensus 148 li~sNNkl~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNk 222 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNK 222 (722)
T ss_pred EEEecCccc-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCc
Confidence 999999998 8999988 7889999999999999 78888999999999999999998 6888888654 8899999999
Q ss_pred CcccCCccccCCCCCcEEEeccccCCccc
Q 045553 267 LSGIVPSELGMCKQLKVLVLRNDYGPLYS 295 (1082)
Q Consensus 267 l~~~~p~~l~~l~~L~~L~l~~n~~~~~~ 295 (1082)
+. .+|-.|.+|+.|++|.|.+|++...+
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence 98 78999999999999999998776544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.4e-13 Score=160.85 Aligned_cols=105 Identities=38% Similarity=0.632 Sum_probs=71.3
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccC
Q 045553 569 LRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDH 648 (1082)
Q Consensus 569 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 648 (1082)
++.|+|++|.++|.+|..+..+++|+.|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|..++.+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56677777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cccCCCCCCCCCCC-CcccEEeccCC
Q 045553 649 NNLTGRIPPGFGTR-SSLSIFDVSFN 673 (1082)
Q Consensus 649 N~l~~~~p~~~~~l-~~L~~l~ls~N 673 (1082)
|+++|.+|..+..+ .++..+++++|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N 525 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDN 525 (623)
T ss_pred CcccccCChHHhhccccCceEEecCC
Confidence 77777777665442 23344444433
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.4e-14 Score=156.98 Aligned_cols=205 Identities=29% Similarity=0.375 Sum_probs=148.5
Q ss_pred cccCCCCCCEEEcccCCCcccCChh--hcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCC
Q 045553 105 AIGDLTQLRVLLLAFNGFSGELPLE--IGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSP 182 (1082)
Q Consensus 105 ~l~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 182 (1082)
++..-..=-.|.|++-++. ..|.. =..+..-...||+.|++. ++|..++.+..|+.|.|.+|.|. .+|..++++.
T Consensus 45 ~leeA~~sg~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~ 121 (722)
T KOG0532|consen 45 ALEEAEYSGRLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLE 121 (722)
T ss_pred HHHHHhhhcccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhh
Confidence 3333333445666666665 44422 244566678999999999 89999999999999999999998 8899999999
Q ss_pred CCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeC
Q 045553 183 GFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDL 262 (1082)
Q Consensus 183 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 262 (1082)
.|+.|+|+.|+++ .+|..++ .--|+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.+
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC--~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLC--DLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred HHHHhhhccchhh-cCChhhh--cCcceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 9999999999998 7777765 234777777777777 66666776667777777777776 56666666777777777
Q ss_pred CCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccC
Q 045553 263 SRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEG 342 (1082)
Q Consensus 263 s~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~ 342 (1082)
..|++. .+|..+.. |
T Consensus 197 rRn~l~-~lp~El~~-------------------------------------------------L--------------- 211 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCS-------------------------------------------------L--------------- 211 (722)
T ss_pred hhhhhh-hCCHHHhC-------------------------------------------------C---------------
Confidence 766665 33332221 1
Q ss_pred CCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCC
Q 045553 343 IFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLP 393 (1082)
Q Consensus 343 ~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 393 (1082)
.|..||+|.|++. .+|-.|.+|+.|++|-|.+|+|+..+.
T Consensus 212 ----------pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 212 ----------PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred ----------ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChH
Confidence 3677888888888 788888888888888888888875433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.7e-12 Score=146.97 Aligned_cols=142 Identities=19% Similarity=0.231 Sum_probs=101.4
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEeecCccccH----------------------------------------HHHH
Q 045553 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGV----------------------------------------QQFA 845 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 845 (1082)
.+.||.|++|.||+|++.+|+.||||+.+....... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999864321100 0234
Q ss_pred HHHHHHhccC----CCceeeEeeee-ccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH-HHHHHhhCC
Q 045553 846 AEIRTLGRVQ----HPNLVTLIGYH-VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR-ALAYLHDEC 919 (1082)
Q Consensus 846 ~e~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~ 919 (1082)
+|.+.+.+++ |.+-+.+-..+ ......++||||++|++|.++..... ... .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHHHHHHHhC-
Confidence 4555555552 33333333333 23456799999999999988875421 112 23456666666 46788988
Q ss_pred CCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 920 ~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
+++|+|++|.||+++.+++++++|||++..+..
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.3e-12 Score=132.48 Aligned_cols=205 Identities=20% Similarity=0.293 Sum_probs=142.1
Q ss_pred HHHHHhccCCCceeeEeeeeccC-----CeEEEEEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 045553 847 EIRTLGRVQHPNLVTLIGYHVSE-----AEMFLIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDEC 919 (1082)
Q Consensus 847 e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~ 919 (1082)
-++.+-++-|.|||+++.|+.+. .+..++.|||..|++.++|+... ...+......+|+.||..||.|||+ |
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 34556666799999999988754 35789999999999999998643 4567778888999999999999999 5
Q ss_pred CCCeEeccCCCCCEEEcCCCcEEEeecccceecCC----CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHH
Q 045553 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT----SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLE 995 (1082)
Q Consensus 920 ~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~e 995 (1082)
.|+|+|+++..+-|++..++-+||.--.-. .... ........-.+-++|.|||+-.....+-++|||+||+-..|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 889999999999999999998887421111 1100 00011112246789999998888788889999999999999
Q ss_pred HHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 996 LISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 996 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
|--+..--...... ...+..... ..-.....+ =..++..|++..|..||+|++++.+.
T Consensus 275 mailEiq~tnseS~-----~~~ee~ia~-----~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 275 MAILEIQSTNSESK-----VEVEENIAN-----VIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHheeccCCCcce-----eehhhhhhh-----heeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 98776432211111 111100000 000011111 12467889999999999999887553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-10 Score=132.39 Aligned_cols=168 Identities=15% Similarity=0.241 Sum_probs=131.9
Q ss_pred EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHH
Q 045553 821 EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM 900 (1082)
Q Consensus 821 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~ 900 (1082)
+..++.+|.|+.++...........+-++.++.++||||++++.....++..|+|+|-+ ..|..++... ....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----GKEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----HHHH
Confidence 45568899999987765544566778899999999999999999999999999999998 4688888763 3556
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcccchhcccCCC
Q 045553 901 LHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980 (1082)
Q Consensus 901 ~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 980 (1082)
+...+.||+.||.|||+.| +++|+++.-..|++++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 6677899999999999887 999999999999999999999999998865432211 111122233566777553322
Q ss_pred CchhhHHHHHHHHHHHHhCC
Q 045553 981 SDKADVYSFGVVLLELISDK 1000 (1082)
Q Consensus 981 ~~~~Dv~slGvll~elltg~ 1000 (1082)
-..|.|.||++++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.1e-12 Score=147.95 Aligned_cols=168 Identities=32% Similarity=0.460 Sum_probs=80.0
Q ss_pred EEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCC-CCCeEEccCcccccccCccccCCCCCcEEEcccC
Q 045553 114 VLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCS-SLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 114 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (1082)
.|++..|.+. .....+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 3444444443 12223333445555555555555 4444444442 5555555555555 33344445555555555555
Q ss_pred cccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCC
Q 045553 193 LLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVP 272 (1082)
Q Consensus 193 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 272 (1082)
+++ .+|...+ .++.|+.|++++|+++ .+|..+.....|++|.+++|.+. ..+..+..+.++..|.+.+|++. ..+
T Consensus 174 ~l~-~l~~~~~-~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 DLS-DLPKLLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred hhh-hhhhhhh-hhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 555 4443322 2445555555555555 44444333444555555555332 24444555555555555555554 224
Q ss_pred ccccCCCCCcEEEeccc
Q 045553 273 SELGMCKQLKVLVLRND 289 (1082)
Q Consensus 273 ~~l~~l~~L~~L~l~~n 289 (1082)
..++.+++|+.|++++|
T Consensus 249 ~~~~~l~~l~~L~~s~n 265 (394)
T COG4886 249 ESIGNLSNLETLDLSNN 265 (394)
T ss_pred chhccccccceeccccc
Confidence 44555555555555554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.7e-12 Score=145.63 Aligned_cols=144 Identities=32% Similarity=0.430 Sum_probs=63.8
Q ss_pred EEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCC-CCcEEEcccCcccccCCcccccccccccEEEccc
Q 045553 138 ILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSP-GFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA 216 (1082)
Q Consensus 138 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~ 216 (1082)
.|+++.|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+. .+++|+.|++++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~-~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLR-NLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhh-ccccccccccCC
Confidence 3444444443 12223334444555555555544 3344434442 4555555555544 3332222 344555555555
Q ss_pred CccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEecc
Q 045553 217 NSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288 (1082)
Q Consensus 217 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 288 (1082)
|+++ .+|...+.+++|+.|++++|++. .+|.....+..|++|.+++|.+. ..+..+.+++++..|.+.+
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~ 241 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSN 241 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCC
Confidence 5555 33333334444555555555554 34443333344555555555322 2344444444444444443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.6e-10 Score=132.39 Aligned_cols=143 Identities=15% Similarity=0.200 Sum_probs=94.0
Q ss_pred hcCccccceecccCceEEEEEEEcC-CeEEEEEEeecCccc------------------------------c----HH--
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQ------------------------------G----VQ-- 842 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~------------------------------~----~~-- 842 (1082)
...|+. +.||.|++|.||+|++.+ |+.||||+.+..... . .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999887 999999998644110 0 01
Q ss_pred ----HHHHHHHHHhccC----CCceeeEeeeecc-CCeEEEEEeecCCCCHHHHH--hhCCC--CCCCHHHHHHHHHHHH
Q 045553 843 ----QFAAEIRTLGRVQ----HPNLVTLIGYHVS-EAEMFLIYNYLPGGNLEKFI--QDRPR--RTVEWSMLHKIALDVA 909 (1082)
Q Consensus 843 ----~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~~i~ 909 (1082)
+|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++- ...+. ..+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 1334444444442 3333443333332 45678999999999998753 22110 012222233333333
Q ss_pred HHHHHHhhCCCCCeEeccCCCCCEEEcCCC----cEEEeecccceecC
Q 045553 910 RALAYLHDECVPRVLHRDIKPSNILLDNNL----NAYLSDFGLARLLG 953 (1082)
Q Consensus 910 ~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGla~~~~ 953 (1082)
+.. +++|+|++|.||+++.++ +++++|||++..+.
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 345 999999999999999988 99999999998653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.1e-11 Score=137.14 Aligned_cols=247 Identities=20% Similarity=0.238 Sum_probs=182.0
Q ss_pred Cccccceecc--cCceEEEEEEE---cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEE
Q 045553 802 GFNVQNCIGS--GGFGATYKAEI---IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 802 ~~~~~~~lg~--G~~g~Vy~a~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 873 (1082)
.|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+.....+ .|++.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999954 4688999998543322 2222234566665555 4999999888888899999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEeccCCCCCEEEcCC-CcEEEeeccc
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDECVPRVLHRDIKPSNILLDNN-LNAYLSDFGL 948 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGl 948 (1082)
+-.|++ +.++.++.+.. ...++....+.+..+..+ |+.++|+. .++|-|+||.||++..+ ...+++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 999988 68998888864 344777888888888888 99999999 99999999999999999 8899999999
Q ss_pred ceecCCCCCc----cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 949 ARLLGTSETH----ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 949 a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
...++...-. ......|...|++||...+ .++.+.|+|++|.++.+-.++.+....... ..|...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~~-- 338 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQL-- 338 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC--------CCcccc--
Confidence 9988765432 1223367889999998765 678899999999999999998876542210 112111
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
+++- +..++-.....++...+..+++.+|-.|++.+++..
T Consensus 339 r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1110 000111122345566899999999999999887754
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-12 Score=138.13 Aligned_cols=161 Identities=25% Similarity=0.157 Sum_probs=91.6
Q ss_pred cCCCCCCEEEcccCCCcccCC--hhhcCCCCCCEEeCcCCCCCCC--CCccccCCCCCCeEEccCcccccccCc-cccCC
Q 045553 107 GDLTQLRVLLLAFNGFSGELP--LEIGQLSLLEILDLSFNSFHGP--IPPTLQNCSSLRLINLSGNQFNGTIPA-FFGQS 181 (1082)
Q Consensus 107 ~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~Ls~n~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l 181 (1082)
+++.+|+...|.++... ..+ .....+++++.||||+|-+..- +-.....|++|+.|+|+.|++..-... .-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45666777777766655 333 2455667777777777766532 223345667777777777766532221 11245
Q ss_pred CCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcC--ccccCCCCCCE
Q 045553 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP--SSFGQLVNLEV 259 (1082)
Q Consensus 182 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~ 259 (1082)
++|+.|.|+.|.++..--..+...+|+|+.|+|..|.....-.....-+..|+.|+|++|++.. .+ ...+.++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhh
Confidence 6666777777766643333344456666666666664332333344445566666666666652 22 34556666666
Q ss_pred EeCCCCcCcc
Q 045553 260 LDLSRNFLSG 269 (1082)
Q Consensus 260 L~Ls~N~l~~ 269 (1082)
|+++.+.+..
T Consensus 276 Lnls~tgi~s 285 (505)
T KOG3207|consen 276 LNLSSTGIAS 285 (505)
T ss_pred hhccccCcch
Confidence 6666666653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-10 Score=118.13 Aligned_cols=130 Identities=20% Similarity=0.193 Sum_probs=96.7
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCcee-eEeeeeccCCeEEEEEeecCCCCHH
Q 045553 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLV-TLIGYHVSEAEMFLIYNYLPGGNLE 885 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~gsL~ 885 (1082)
+.++.|.++.||+++.. +..|++|....... ....+..|++.++.+.+.+++ +++.+.. ...++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 56889999999999865 78899999764432 223467889999888665544 4554432 3458999999998875
Q ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 886 KFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC--VPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 886 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.. . .....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~~--~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE--D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc--c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 43 0 112345679999999999983 22369999999999999 66899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.2e-12 Score=134.37 Aligned_cols=255 Identities=24% Similarity=0.283 Sum_probs=155.2
Q ss_pred cccccccCCCCCCEEEcccCCCccc----CChhhcCCCCCCEEeCcCC---CCCCCCCc-------cccCCCCCCeEEcc
Q 045553 101 NLSRAIGDLTQLRVLLLAFNGFSGE----LPLEIGQLSLLEILDLSFN---SFHGPIPP-------TLQNCSSLRLINLS 166 (1082)
Q Consensus 101 ~l~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n---~l~~~~p~-------~l~~l~~L~~L~Ls 166 (1082)
.+-+.+..+..++.++|++|.|... +...+.+.++|+.-++|+- ++..++|+ .+...++|++||||
T Consensus 21 ~v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLS 100 (382)
T KOG1909|consen 21 DVEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLS 100 (382)
T ss_pred hHHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecc
Confidence 3456677788888888888888743 4455677778888887753 22233443 34455677888888
Q ss_pred CcccccccCcc----ccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCc
Q 045553 167 GNQFNGTIPAF----FGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNM 242 (1082)
Q Consensus 167 ~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 242 (1082)
+|-|....+.. +.....|++|.|.+|.+.-.-...++. .|.+|. .| ...+.-++|+++..++|+
T Consensus 101 DNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~---al~~l~--~~-------kk~~~~~~Lrv~i~~rNr 168 (382)
T KOG1909|consen 101 DNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR---ALFELA--VN-------KKAASKPKLRVFICGRNR 168 (382)
T ss_pred ccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH---HHHHHH--HH-------hccCCCcceEEEEeeccc
Confidence 88776444433 334566666666666654111112221 122111 11 123344689999999999
Q ss_pred CCCC----cCccccCCCCCCEEeCCCCcCccc----CCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCccc
Q 045553 243 LQGD----IPSSFGQLVNLEVLDLSRNFLSGI----VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYN 314 (1082)
Q Consensus 243 l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n 314 (1082)
+... +...|...+.|+.+.++.|.|... +...|..++.|++|+|++|.+..-
T Consensus 169 len~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~e-------------------- 228 (382)
T KOG1909|consen 169 LENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLE-------------------- 228 (382)
T ss_pred cccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhH--------------------
Confidence 8732 234567778899999999988532 234577888888888888543210
Q ss_pred ccCCCCCccccCCCCCcEEEcCCCcccCCCCccc-----ccccCCCeEEcCCccccCC----CCccccCCCCCCEEecCC
Q 045553 315 FFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNW-----ELCSKLEMLNLAHNFFTGQ----IPASLGNCKSLYFLDLSS 385 (1082)
Q Consensus 315 ~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l-----~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~Ls~ 385 (1082)
-+..+...+..+++|+.|++++|.+......+| ...++|+.|.|.+|.|+.. +...+...+.|..|+|++
T Consensus 229 -gs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLng 307 (382)
T KOG1909|consen 229 -GSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNG 307 (382)
T ss_pred -HHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCc
Confidence 001234555666777777777777776554443 2356777777777776521 233344566677777777
Q ss_pred CcC
Q 045553 386 NNL 388 (1082)
Q Consensus 386 N~l 388 (1082)
|.+
T Consensus 308 N~l 310 (382)
T KOG1909|consen 308 NRL 310 (382)
T ss_pred ccc
Confidence 766
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-09 Score=110.63 Aligned_cols=136 Identities=14% Similarity=0.185 Sum_probs=99.0
Q ss_pred ceecccCceEEEEEEEcC-------CeEEEEEEeecCcc----------------------ccHHHH----HHHHHHHhc
Q 045553 807 NCIGSGGFGATYKAEIIP-------GVVVAVKRLSVGRF----------------------QGVQQF----AAEIRTLGR 853 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~-------~~~vavK~~~~~~~----------------------~~~~~~----~~e~~~l~~ 853 (1082)
..||.|--+.||.|.-.+ +..+|||+++.... ...+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996442 47999998853210 011223 379999988
Q ss_pred cCC--CceeeEeeeeccCCeEEEEEeecCCCCHHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEeccCC
Q 045553 854 VQH--PNLVTLIGYHVSEAEMFLIYNYLPGGNLEK-FIQDRPRRTVEWSMLHKIALDVARALAYL-HDECVPRVLHRDIK 929 (1082)
Q Consensus 854 l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk 929 (1082)
+.. -++.+++++ ...++||||+.+..+.. .+++ ..++.++...+..+++.++..| |.. ++||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 864 356666654 56789999997654322 2222 2345556778889999999999 787 99999999
Q ss_pred CCCEEEcCCCcEEEeecccceecC
Q 045553 930 PSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 930 ~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+.||+++ ++.++|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.1e-11 Score=118.53 Aligned_cols=121 Identities=28% Similarity=0.342 Sum_probs=50.6
Q ss_pred cccEEEccCCcccccCccccC-CCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhh-hcCcccchhh
Q 045553 544 CMKFLSMAGNEFVGLIPQSFT-NFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWEL-TQLASLEVLE 621 (1082)
Q Consensus 544 ~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ 621 (1082)
.+++|+|++|+|+.+ +.+. .+++|+.|+|++|.|+.+ + .+..+++|+.|++++|+|+. +++.+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 488899999999865 2455 578899999999999854 3 58889999999999999994 44444 5689999999
Q ss_pred ccCcccCCCC-CccccCCcccceecccCcccCCCCCC----CCCCCCcccEEec
Q 045553 622 LSANSLSGEI-PSEFSKLEHLNVLRLDHNNLTGRIPP----GFGTRSSLSIFDV 670 (1082)
Q Consensus 622 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~l~l 670 (1082)
|++|+|...- -..+..+++|+.|+|.+|+++.. +. .+..+++|+.||-
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 9999997532 24567888999999999999843 33 2566788888874
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.2e-11 Score=131.31 Aligned_cols=138 Identities=24% Similarity=0.172 Sum_probs=88.9
Q ss_pred hcCCCCCCEEeCcCCCCCCCCC--ccccCCCCCCeEEccCcccccccC--ccccCCCCCcEEEcccCcccccCCcccccc
Q 045553 130 IGQLSLLEILDLSFNSFHGPIP--PTLQNCSSLRLINLSGNQFNGTIP--AFFGQSPGFQVVSLSFNLLSGSVPEEFGDN 205 (1082)
Q Consensus 130 ~~~l~~L~~L~Ls~n~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 205 (1082)
=.++++|+...|.+..+. ..+ .....+++++.||||.|-+....+ .....||+|+.|+|+.|++...........
T Consensus 117 Qsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 356788999999998887 334 367789999999999998875544 456678999999999998874444333334
Q ss_pred cccccEEEcccCccCCCC-CccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCc
Q 045553 206 CVSLEHILLAANSLTGSI-PPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268 (1082)
Q Consensus 206 l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 268 (1082)
++.|+.|.|+.|.++-.- ......+|+|..|+|..|...+.......-+..|++|||++|++-
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li 259 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI 259 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence 556666666666666211 112334566666666666422233333344555666666666654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2e-09 Score=104.82 Aligned_cols=131 Identities=24% Similarity=0.438 Sum_probs=102.1
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEeecCccc--------cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ--------GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..+++|+-+.+|.+.+. |..+++|.-...... ....-.+|++++.+.+--.|.-.+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999875 555666654332221 123456799999988766666666666778888999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
++|..|.+++... ...++..+-+-+.-||.. +|+|||+.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888764 245667777778889999 999999999999998875 99999999975
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.7e-09 Score=103.01 Aligned_cols=144 Identities=20% Similarity=0.284 Sum_probs=108.9
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEeecCccc--------cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ--------GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 805 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
....+-+|+-+.|+++.+. |+...||.-...... ..++...|++.+.+.+--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5578999999999999886 777777764332221 2345678999998887555554445566667778999
Q ss_pred eecCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC---cEEEeecccceec
Q 045553 877 NYLPG-GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL---NAYLSDFGLARLL 952 (1082)
Q Consensus 877 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~~ 952 (1082)
||+++ .++.+++...-......+....++..|-+.+.-||.. +|+||||..+||++..++ .+.++|||++..-
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99966 4888888775444444444478899999999999999 999999999999997654 4589999998754
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.1e-11 Score=121.89 Aligned_cols=127 Identities=25% Similarity=0.286 Sum_probs=57.7
Q ss_pred ccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccC
Q 045553 545 MKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSA 624 (1082)
Q Consensus 545 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 624 (1082)
|++|||++|.|+. +.++..-++.++.|++|+|.|..+ +.+..+++|+.||||+|.++ .+.++-..|.+.++|.|++
T Consensus 286 LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 286 LTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 4444444444442 223344444455555555554422 22444455555555555554 3333334444555555555
Q ss_pred cccCCCCCccccCCcccceecccCcccCCCC-CCCCCCCCcccEEeccCCcccc
Q 045553 625 NSLSGEIPSEFSKLEHLNVLRLDHNNLTGRI-PPGFGTRSSLSIFDVSFNNLSG 677 (1082)
Q Consensus 625 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~~ 677 (1082)
|.|... ..+..|-+|..||+++|+|.... -..+++++-|+.+.|.+|++.+
T Consensus 362 N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 362 NKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 554411 23344444555555555554211 1234555555555555555553
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.1e-11 Score=120.41 Aligned_cols=131 Identities=25% Similarity=0.242 Sum_probs=65.2
Q ss_pred CCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccC
Q 045553 230 CTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDG 309 (1082)
Q Consensus 230 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~ 309 (1082)
.+.|++||||+|.|+ .+.++..-++.++.|++|+|.|+.+ . .+..+++|+.|+|++|.+....
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls~~~-------------- 345 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLAECV-------------- 345 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee-h-hhhhcccceEeecccchhHhhh--------------
Confidence 345555555555555 4445555555555555555555422 1 2555555555555554332111
Q ss_pred CCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCC-CCccccCCCCCCEEecCCCcC
Q 045553 310 GEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQ-IPASLGNCKSLYFLDLSSNNL 388 (1082)
Q Consensus 310 ~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~Ls~N~l 388 (1082)
.+-..|-+.+.|.++.|.|... ..+.++-+|..||+++|+|... -...++++|-|+.|.|.+|+|
T Consensus 346 ------------Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 346 ------------GWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred ------------hhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 1112233444444444444332 2345555666666666666521 123456666666666666666
Q ss_pred ccc
Q 045553 389 TGL 391 (1082)
Q Consensus 389 ~~~ 391 (1082)
.+.
T Consensus 412 ~~~ 414 (490)
T KOG1259|consen 412 AGS 414 (490)
T ss_pred ccc
Confidence 543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.5e-10 Score=113.67 Aligned_cols=126 Identities=30% Similarity=0.324 Sum_probs=36.8
Q ss_pred CCCCCCEEEcccCCCcccCChhhc-CCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccc-cCCCCCc
Q 045553 108 DLTQLRVLLLAFNGFSGELPLEIG-QLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFF-GQSPGFQ 185 (1082)
Q Consensus 108 ~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~ 185 (1082)
+..++++|+|++|.|+ .+. .++ .+.+|+.|||++|.|+ .+. .+..+++|++|++++|+|+. +...+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 3344556666666555 222 233 3555555666665555 222 34555555555555555552 22222 2345555
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCccCCCC-CccccCCCCccEEEccCCcCCCCc---CccccCCCCCCEEe
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSI-PPSLGNCTELRSLLLSSNMLQGDI---PSSFGQLVNLEVLD 261 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~ 261 (1082)
+|+|++|+|. ..- -..+..+++|+.|+|.+|.++... ...+..+++|+.||
T Consensus 92 ~L~L~~N~I~-------------------------~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 92 ELYLSNNKIS-------------------------DLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EEE-TTS----------------------------SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred EEECcCCcCC-------------------------ChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 5555555544 211 124566777777777777776321 13456678888877
Q ss_pred CC
Q 045553 262 LS 263 (1082)
Q Consensus 262 Ls 263 (1082)
-.
T Consensus 147 ~~ 148 (175)
T PF14580_consen 147 GQ 148 (175)
T ss_dssp TE
T ss_pred CE
Confidence 53
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.3e-09 Score=112.05 Aligned_cols=142 Identities=20% Similarity=0.238 Sum_probs=110.0
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCC--ceeeEeeeeccC---CeEEEEEeecC
Q 045553 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHP--NLVTLIGYHVSE---AEMFLIYNYLP 880 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~E~~~ 880 (1082)
+.|+.|.++.||+++..+|..+++|....... .....+..|+++++.+++. .+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887678999999765432 2345688999999999764 456677776654 36789999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC----------------------------------------- 919 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 919 (1082)
|.++.+.+.. ..++......++.++++++++||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888776531 24677777788888888888888531
Q ss_pred ------------CCCeEeccCCCCCEEEcC--CCcEEEeeccccee
Q 045553 920 ------------VPRVLHRDIKPSNILLDN--NLNAYLSDFGLARL 951 (1082)
Q Consensus 920 ------------~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~ 951 (1082)
...++|||+.+.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-10 Score=121.39 Aligned_cols=218 Identities=21% Similarity=0.215 Sum_probs=131.8
Q ss_pred ccccccCCCCCCEEEcccC---CCcccCChh-------hcCCCCCCEEeCcCCCCCCCCCcc----ccCCCCCCeEEccC
Q 045553 102 LSRAIGDLTQLRVLLLAFN---GFSGELPLE-------IGQLSLLEILDLSFNSFHGPIPPT----LQNCSSLRLINLSG 167 (1082)
Q Consensus 102 l~~~l~~l~~L~~L~L~~n---~l~~~~p~~-------~~~l~~L~~L~Ls~n~l~~~~p~~----l~~l~~L~~L~Ls~ 167 (1082)
+.+.+.+.++|+..++++- +....+|+. +...++|++||||.|.|....+.. +.++..|++|.|.+
T Consensus 50 i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N 129 (382)
T KOG1909|consen 50 IAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNN 129 (382)
T ss_pred HHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhc
Confidence 4556777788888888863 333355554 345579999999999988555443 46788999999999
Q ss_pred cccccccCc-------------cccCCCCCcEEEcccCcccccCCc----ccccccccccEEEcccCccCCCC----Ccc
Q 045553 168 NQFNGTIPA-------------FFGQSPGFQVVSLSFNLLSGSVPE----EFGDNCVSLEHILLAANSLTGSI----PPS 226 (1082)
Q Consensus 168 N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~~~~p~----~~~~~l~~L~~L~L~~N~l~~~~----~~~ 226 (1082)
|.+.-.--. ....-++|+++..++|++. ..+. ..+...+.|+.+.+..|.|.... ...
T Consensus 130 ~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle-n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~ea 208 (382)
T KOG1909|consen 130 CGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE-NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEA 208 (382)
T ss_pred CCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc-cccHHHHHHHHHhccccceEEEecccccCchhHHHHHH
Confidence 988732111 2334467777777777766 2221 12223456666666666655221 224
Q ss_pred ccCCCCccEEEccCCcCCCC----cCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCC
Q 045553 227 LGNCTELRSLLLSSNMLQGD----IPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLP 302 (1082)
Q Consensus 227 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~ 302 (1082)
+..+++|+.|||..|.++.. +...+..+++|++|++++|.+......+|.
T Consensus 209 l~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~-------------------------- 262 (382)
T KOG1909|consen 209 LEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFV-------------------------- 262 (382)
T ss_pred HHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHH--------------------------
Confidence 45566666666666666521 234455566666666666666543332221
Q ss_pred CcccccCCCcccccCCCCCccc-cCCCCCcEEEcCCCcccCCC----CcccccccCCCeEEcCCcccc
Q 045553 303 IQPVVDGGEDYNFFDGGLPDSI-TRLPNLRVFWAPNLNLEGIF----PQNWELCSKLEMLNLAHNFFT 365 (1082)
Q Consensus 303 ~~~~~~~~~~~n~~~~~~p~~l-~~l~~L~~L~l~~n~l~~~~----~~~l~~l~~L~~L~Ls~N~i~ 365 (1082)
+.+ ...|+|+.|.+.+|.|+..- .......+.|+.|+|++|++.
T Consensus 263 -------------------~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 263 -------------------DALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred -------------------HHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 111 12456667777777665422 223455788999999999983
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.1e-10 Score=133.61 Aligned_cols=244 Identities=23% Similarity=0.249 Sum_probs=135.9
Q ss_pred CCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccE
Q 045553 132 QLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEH 211 (1082)
Q Consensus 132 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~ 211 (1082)
.+..++.+++..|.+. .+-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|+|+...+-. .++.|+.
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~l~---~l~~L~~ 144 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEGLS---TLTLLKE 144 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccchh---hccchhh
Confidence 3444555555555555 233335555566666666666552 2222445556666666666555222211 2344666
Q ss_pred EEcccCccCCCCCccccCCCCccEEEccCCcCCCCcC-ccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEecccc
Q 045553 212 ILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP-SSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDY 290 (1082)
Q Consensus 212 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~ 290 (1082)
|++.+|.|+.. ..+..+++|+.+++++|.+....+ . ...+.+++.+++..|.+.. ...+..+..+..+++.+|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 66666666522 234446666666677776663333 1 3556666667777776652 2333444444444555443
Q ss_pred CCcccccCCCCCCcccccCCCcccccCCCCCccccCCC--CCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCC
Q 045553 291 GPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP--NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQI 368 (1082)
Q Consensus 291 ~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~--~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~ 368 (1082)
+.... .+..+. +|+.+++++|.+.... ..+..+..+..|++++|++...
T Consensus 220 i~~~~---------------------------~l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~- 270 (414)
T KOG0531|consen 220 ISKLE---------------------------GLNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNL- 270 (414)
T ss_pred ceecc---------------------------CcccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccccc-
Confidence 32111 011112 3677778887776643 4566677888888888888732
Q ss_pred CccccCCCCCCEEecCCCcCccc---CCC--CcccCcccEEEecCCcceecC
Q 045553 369 PASLGNCKSLYFLDLSSNNLTGL---LPE--EVSVPCMAVFNVSQNLLSGEI 415 (1082)
Q Consensus 369 p~~~~~l~~L~~L~Ls~N~l~~~---~p~--~~~l~~L~~L~l~~N~l~~~~ 415 (1082)
..+...+.+..+.+..|++... ... ....+.++.+.+..|++....
T Consensus 271 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
T KOG0531|consen 271 -EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS 321 (414)
T ss_pred -ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence 3355567778888888877632 222 335677888888888876543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.87 E-value=9.6e-10 Score=82.23 Aligned_cols=38 Identities=53% Similarity=1.172 Sum_probs=28.7
Q ss_pred CHHHHHHHHhcccCCCCCCCCCCCCC-CCCceeeeeEee
Q 045553 1 KNALLQLKSAITEDPLGLTSNWNPKD-TDSCSWHGVTCD 38 (1082)
Q Consensus 1 ~~~l~~~k~~~~~~~~~~~~~W~~~~-~~~c~w~gv~C~ 38 (1082)
++||++||+++..+|.+.+++|+..+ ++||+|.||+|+
T Consensus 5 ~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 5 RQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred HHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 48999999999878889999998753 899999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.6e-10 Score=132.92 Aligned_cols=248 Identities=23% Similarity=0.195 Sum_probs=156.6
Q ss_pred cCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcE
Q 045553 107 GDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQV 186 (1082)
Q Consensus 107 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 186 (1082)
..+..++.+.++.|.+. .+-..+..+++|+.|++.+|.|. .+...+..+++|++|+|++|+|+... .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhh
Confidence 34566666667777776 34445667777777777777777 44444667777778888887777432 3345566777
Q ss_pred EEcccCcccccCCcccccccccccEEEcccCccCCCCC-ccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCC
Q 045553 187 VSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP-PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265 (1082)
Q Consensus 187 L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 265 (1082)
|++++|.|+ .+...- .++.|+.+++++|.+...-+ . ...+.+++.+++.+|.+. ....+..+..+..+++..|
T Consensus 145 L~l~~N~i~-~~~~~~--~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 145 LNLSGNLIS-DISGLE--SLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDN 218 (414)
T ss_pred heeccCcch-hccCCc--cchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccc
Confidence 778887776 443322 26777777888887774433 1 466677777888888776 2334445555666677777
Q ss_pred cCcccCCccccCCC--CCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCC
Q 045553 266 FLSGIVPSELGMCK--QLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGI 343 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~--~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~ 343 (1082)
.++..-+ +..+. .|+.++++.|.+.. .+..+..+.++..|++.+|.+...
T Consensus 219 ~i~~~~~--l~~~~~~~L~~l~l~~n~i~~--------------------------~~~~~~~~~~l~~l~~~~n~~~~~ 270 (414)
T KOG0531|consen 219 KISKLEG--LNELVMLHLRELYLSGNRISR--------------------------SPEGLENLKNLPVLDLSSNRISNL 270 (414)
T ss_pred cceeccC--cccchhHHHHHHhcccCcccc--------------------------ccccccccccccccchhhcccccc
Confidence 7763322 12222 26667776654332 113455666777777777777654
Q ss_pred CCcccccccCCCeEEcCCccccCC---CCcc-ccCCCCCCEEecCCCcCcccCCC
Q 045553 344 FPQNWELCSKLEMLNLAHNFFTGQ---IPAS-LGNCKSLYFLDLSSNNLTGLLPE 394 (1082)
Q Consensus 344 ~~~~l~~l~~L~~L~Ls~N~i~~~---~p~~-~~~l~~L~~L~Ls~N~l~~~~p~ 394 (1082)
. .+.....+..+.+..|.+... .... ....+.+..+.+.+|++....+.
T Consensus 271 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 271 E--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred c--cccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence 2 345556777788888876522 2222 55678899999999988865543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.8e-08 Score=107.25 Aligned_cols=168 Identities=21% Similarity=0.321 Sum_probs=130.8
Q ss_pred ceEEEEE-EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeecc----CCeEEEEEeecCC-CCHHHH
Q 045553 814 FGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS----EAEMFLIYNYLPG-GNLEKF 887 (1082)
Q Consensus 814 ~g~Vy~a-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~ 887 (1082)
-.+.||+ ...+|..|++|+++..+.........-++.++++.|+|+|++..++.. +...++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4678998 455799999999965544443334566889999999999999998873 4568999999986 477765
Q ss_pred HhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 888 IQDRP-------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 888 l~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
--... ....+++.+|.++.|++.||.++|+. |..-+-+.+.+|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43221 34578899999999999999999999 999999999999999999999998888776543
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCC
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA 1002 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p 1002 (1082)
+.. |-+. -..+-|.-.||.+++.|.||..-
T Consensus 446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 331 1111 12467999999999999999653
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.3e-09 Score=130.60 Aligned_cols=272 Identities=22% Similarity=0.167 Sum_probs=127.7
Q ss_pred CCCEEEcccCC--CcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEE
Q 045553 111 QLRVLLLAFNG--FSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVS 188 (1082)
Q Consensus 111 ~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 188 (1082)
.|++|-+..|. +....++.|..++.|+.|||++|.=-+.+|+.+++|-+|++|+|++..++ .+|..+.+|..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 45555555554 33222233555566666666655444455666666666666666666555 5555556666666666
Q ss_pred cccCcccccCCcccccccccccEEEcccCccC--CCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCC----EEeC
Q 045553 189 LSFNLLSGSVPEEFGDNCVSLEHILLAANSLT--GSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLE----VLDL 262 (1082)
Q Consensus 189 L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L 262 (1082)
+.++.-...+|. +...+.+|++|.+..-... ...-..+.++.+|+.+....... .+-..+..++.|. .+.+
T Consensus 625 l~~~~~l~~~~~-i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~ 701 (889)
T KOG4658|consen 625 LEVTGRLESIPG-ILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSI 701 (889)
T ss_pred cccccccccccc-hhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhh
Confidence 655544433322 2223555666555443311 11112233333333333322222 0111122222222 2222
Q ss_pred CCCcCcccCCccccCCCCCcEEEeccccCCcccccC-CCCCCcc---cccCCCcccccCCCCCccccCCCCCcEEEcCCC
Q 045553 263 SRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREH-GDLPIQP---VVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNL 338 (1082)
Q Consensus 263 s~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~-~~l~~~~---~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n 338 (1082)
..+... ..+..+..+.+|+.|.+.++.+....... ....... ....-...+.-....+.+..-.++|+.|++..+
T Consensus 702 ~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~ 780 (889)
T KOG4658|consen 702 EGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSC 780 (889)
T ss_pred cccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEecc
Confidence 222222 33445555566666666554432111000 0000000 000000001111233444456678888888888
Q ss_pred cccCCCCcccccccCCCeEEcCCccccCC-CCccccCCCCCCEEecCCCc
Q 045553 339 NLEGIFPQNWELCSKLEMLNLAHNFFTGQ-IPASLGNCKSLYFLDLSSNN 387 (1082)
Q Consensus 339 ~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~Ls~N~ 387 (1082)
.....+......+..+..+-+..+.+.+. .......++++..+.+++=.
T Consensus 781 ~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~~~ 830 (889)
T KOG4658|consen 781 RLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSFLK 830 (889)
T ss_pred cccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCccc
Confidence 87777777777777777777777777655 34555556666655555443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.8e-09 Score=120.44 Aligned_cols=251 Identities=20% Similarity=0.198 Sum_probs=175.7
Q ss_pred HHhcCccccceecccCceEEEEEEEc--CCeEEEEEEeecCccccHHHH--HHHHHHHhcc-CCCceeeEeeeeccCCeE
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEII--PGVVVAVKRLSVGRFQGVQQF--AAEIRTLGRV-QHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~--~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 872 (1082)
....+|.....||.|.|+.|++.... ++..+++|...........++ ..|+.+...+ .|.++++....+..-+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888899999999999998543 578899998865543322221 2344444444 588888877777777777
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-CcEEEeeccccee
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-LNAYLSDFGLARL 951 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~ 951 (1082)
|+=-||+++++......- ...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..
T Consensus 342 ~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 899999999987766532 34577788999999999999999999 99999999999999886 7889999999864
Q ss_pred cCCCCCccccCcccCCCc-ccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 952 LGTSETHATTDVAGTFGY-VAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
+... ......++..| .+++......+..+.|+||||.-+.|..+|..- .... .+|.. ++.+.+.
T Consensus 417 ~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l-s~~~---------~~~~~--i~~~~~p 481 (524)
T KOG0601|consen 417 LAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL-SESG---------VQSLT--IRSGDTP 481 (524)
T ss_pred ccee---cccccccccccccchhhccccccccccccccccccccccccCccc-Cccc---------cccee--eeccccc
Confidence 3211 11111223334 355566677888999999999999999888642 2111 11111 1111111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
. .+ .....+..+...++.+++..||.+.++..+.+-..
T Consensus 482 ~---------~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 482 N---------LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred C---------CC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 1 11 22267788888899999999999998877665443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.4e-09 Score=129.57 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=171.6
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.-..+.+.+-+-+|.++.++-++-. .|...+.|...... ....+....+-.+.-..++|-+++....+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3445667778889999999987432 34444444432221 1111222222233323345666665555556778899
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
|++|..+++|..-++..+ ..+.+........+..+.+|||.. .+.|||++|.|.+...++..+++|||.....+.
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999998754 345455556677788899999998 799999999999999999999999984432211
Q ss_pred C---------------------C---------CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 045553 955 S---------------------E---------THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004 (1082)
Q Consensus 955 ~---------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~ 1004 (1082)
. . ........||+.|.+||...+......+|+|+.|+.++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 011334679999999999999999999999999999999999999998
Q ss_pred CCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHH
Q 045553 1005 PSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMR 1068 (1082)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 1068 (1082)
...+. +.++.+.... .-+...+.....++..++.+.+..+|.+|-.|.
T Consensus 1037 a~tpq--------~~f~ni~~~~--------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQ--------QIFENILNRD--------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchh--------hhhhccccCC--------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 55433 2221111110 011223455667888889999999999997665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.6e-07 Score=101.50 Aligned_cols=262 Identities=15% Similarity=0.139 Sum_probs=162.6
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeee------eccC-CeEEEEEe
Q 045553 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGY------HVSE-AEMFLIYN 877 (1082)
Q Consensus 805 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~~~-~~~~lV~E 877 (1082)
....||+|+.+.+|-..- -..-+.|++.........+..+|+ ...-.||-+-.-+.+ ...+ ....+.|.
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 456799999999996521 122345777655444333322222 222356544331221 1122 23677888
Q ss_pred ecCCC-CHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 878 YLPGG-NLEKFIQDR----PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 878 ~~~~g-sL~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
.+++. -+..+.... .-....|....++++.+|.+.+-||.. |.+-||+.++|+|+++++.+.+.|=+.-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 87664 233333221 123478999999999999999999999 9999999999999999999999986655443
Q ss_pred CCCCCccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISD-KKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
.+ ....-..+|...|.+||.-. +..-+...|-|.+||++++++.| ++||............+.. .+..
T Consensus 168 ~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~----~Ia~ 241 (637)
T COG4248 168 AN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET----DIAH 241 (637)
T ss_pred cC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----hhhc
Confidence 22 22333457899999999764 34456789999999999999887 8999865433222211111 1111
Q ss_pred CCCccccccc-cCCCCC-----hHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHHhhhCC
Q 045553 1027 GRPCEFFTAG-LWDCGP-----HDDLIEMLNLAIMCTGES--LSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1027 ~~~~~~~d~~-l~~~~~-----~~~~~~l~~li~~cl~~~--p~~RPt~~ev~~~L~~i~~ 1079 (1082)
+.....-|.. -....| .-.+..+.-+..+|+... +.-||+.+..+..|..++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1111111110 000111 222456778888888764 5679999998888876543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.4e-08 Score=104.40 Aligned_cols=140 Identities=19% Similarity=0.187 Sum_probs=101.5
Q ss_pred eecccCceEEEEEEEcCCeEEEEEEeecCccc-----------cHHHHHHHHHHHhccCCCce--eeEeeeecc-----C
Q 045553 808 CIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ-----------GVQQFAAEIRTLGRVQHPNL--VTLIGYHVS-----E 869 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~-----~ 869 (1082)
.+-......|+++++ +|+.|.||+....... ....+.+|++.+.++...+| +++++++.. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333345667766 4788999987543311 11137789999888854433 344556543 2
Q ss_pred CeEEEEEeecCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-------CCcE
Q 045553 870 AEMFLIYNYLPGG-NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-------NLNA 941 (1082)
Q Consensus 870 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-------~~~~ 941 (1082)
...++|+|++++. +|.+++........+......++.+++..+.-||.. +|+|||++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999876 899998643233456677889999999999999999 9999999999999975 4689
Q ss_pred EEeeccccee
Q 045553 942 YLSDFGLARL 951 (1082)
Q Consensus 942 kl~DfGla~~ 951 (1082)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.1e-08 Score=98.94 Aligned_cols=126 Identities=23% Similarity=0.321 Sum_probs=83.9
Q ss_pred EEEEEEEcCCeEEEEEEeecCcc-------------c-------------cHHHHHHHHHHHhccCCC--ceeeEeeeec
Q 045553 816 ATYKAEIIPGVVVAVKRLSVGRF-------------Q-------------GVQQFAAEIRTLGRVQHP--NLVTLIGYHV 867 (1082)
Q Consensus 816 ~Vy~a~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 867 (1082)
.||.|...+|..+|||..+.... . ......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999888899999999854211 0 023456899999999866 456666543
Q ss_pred cCCeEEEEEeecC--CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEeccCCCCCEEEcCCCcEEEe
Q 045553 868 SEAEMFLIYNYLP--GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL-HDECVPRVLHRDIKPSNILLDNNLNAYLS 944 (1082)
Q Consensus 868 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 944 (1082)
..++||||++ |..+..+.... ++.+....++.+++..+..+ |.. +|+|||+.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 4589999998 54554433321 11344566778888866664 677 99999999999999988 99999
Q ss_pred ecccceecC
Q 045553 945 DFGLARLLG 953 (1082)
Q Consensus 945 DfGla~~~~ 953 (1082)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.2e-09 Score=85.20 Aligned_cols=60 Identities=32% Similarity=0.579 Sum_probs=36.0
Q ss_pred cccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcC
Q 045553 544 CMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNF 603 (1082)
Q Consensus 544 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 603 (1082)
+|++|++++|+|+.+.+.+|.++++|++|++++|.|+.+.|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 355666666666655555666666666666666666655555566666666666666553
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.2e-09 Score=84.82 Aligned_cols=59 Identities=42% Similarity=0.582 Sum_probs=29.7
Q ss_pred ccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCc
Q 045553 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNN 674 (1082)
Q Consensus 616 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~ 674 (1082)
+|++|+|++|+|+...+..|.++++|++|++++|+++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34445555555554434445555555555555555554444455555555555555554
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.7e-08 Score=125.40 Aligned_cols=126 Identities=29% Similarity=0.339 Sum_probs=71.1
Q ss_pred CCCCeEEccCcccccccCccccCCCCCcEEEcccCc--ccccCCcccccccccccEEEcccCccCCCCCccccCCCCccE
Q 045553 158 SSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNL--LSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRS 235 (1082)
Q Consensus 158 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 235 (1082)
...+...+-+|++. .++.... .+.|++|-+..|. +. .++..++..++.|..|+|++|.=.+.+|..++++-+|++
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 44555555555554 2222221 2245555555554 33 555555555666666666655544466666666666666
Q ss_pred EEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEec
Q 045553 236 LLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287 (1082)
Q Consensus 236 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 287 (1082)
|+|++..+. .+|..+.+|..|.+|++..+.-...+|.....+.+|++|.+.
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~ 650 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLP 650 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEee
Confidence 666666666 566666666666666666665444445555556666666663
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2e-07 Score=96.56 Aligned_cols=135 Identities=20% Similarity=0.191 Sum_probs=98.0
Q ss_pred ccccceecccCceEEEEEEEcCCeEEEEEEeecCccc----------------------cHHHHHHHHHHHhccCCC--c
Q 045553 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ----------------------GVQQFAAEIRTLGRVQHP--N 858 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~--n 858 (1082)
+.+.+.||-|--+.||.|..++|.++|||.-+..... .....++|+++|+++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999889999999976433211 122356899999988755 5
Q ss_pred eeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC
Q 045553 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN 938 (1082)
Q Consensus 859 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 938 (1082)
+.+.++ .+...+||||++|--|...- ++.+....++..|++-+.-.-.. ||||||+++-||+++++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 666655 35778999999886665432 12233334455555555544455 99999999999999999
Q ss_pred CcEEEeeccccee
Q 045553 939 LNAYLSDFGLARL 951 (1082)
Q Consensus 939 ~~~kl~DfGla~~ 951 (1082)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999965543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.2e-09 Score=95.55 Aligned_cols=108 Identities=22% Similarity=0.326 Sum_probs=70.0
Q ss_pred ccEEEccCCcccccCcc---ccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhh
Q 045553 545 MKFLSMAGNEFVGLIPQ---SFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLE 621 (1082)
Q Consensus 545 L~~L~L~~N~i~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 621 (1082)
+..++|++|++-.+ ++ .+.....|+..+|++|.+....+..-...+.++.|+|++|+|+ .+|.++..++.|+.|+
T Consensus 29 ~h~ldLssc~lm~i-~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYI-ADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhhHH-HHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 55666777766522 22 3344555666777777777433333344557777777777777 6677777777777777
Q ss_pred ccCcccCCCCCccccCCcccceecccCcccCCCCC
Q 045553 622 LSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIP 656 (1082)
Q Consensus 622 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 656 (1082)
++.|.|. ..|..+..|.+|..|+..+|.+. .+|
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid 139 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EID 139 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCc
Confidence 7777777 56666666777777777777776 344
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=9.4e-07 Score=89.96 Aligned_cols=138 Identities=14% Similarity=0.123 Sum_probs=105.6
Q ss_pred cccCceEEEEEEEcCCeEEEEEEeecCc------cccHHHHHHHHHHHhccCCCc--eeeEeeeecc----CCeEEEEEe
Q 045553 810 GSGGFGATYKAEIIPGVVVAVKRLSVGR------FQGVQQFAAEIRTLGRVQHPN--LVTLIGYHVS----EAEMFLIYN 877 (1082)
Q Consensus 810 g~G~~g~Vy~a~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~----~~~~~lV~E 877 (1082)
|+||.+.|+..... |..+-+|+-.... +.....|.+|+..+.++..-+ +.+++.+... ....+||+|
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 67899999998765 5578888764221 235678999999999986433 4444422211 234689999
Q ss_pred ecCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc--EEEeeccccee
Q 045553 878 YLPG-GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN--AYLSDFGLARL 951 (1082)
Q Consensus 878 ~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfGla~~ 951 (1082)
-+.+ .+|.+++......+.+......+..+++.+++-||+. ++.|+|+.++||+++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 8854 5999998775555677888889999999999999999 9999999999999986666 99999987764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.7e-08 Score=92.34 Aligned_cols=137 Identities=19% Similarity=0.287 Sum_probs=105.9
Q ss_pred ceeEEEccCCcccccCCccccc--cCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEE
Q 045553 519 DGLIFDIGNNKLIGEVPSDMGS--HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFL 596 (1082)
Q Consensus 519 ~l~~l~l~~n~l~~~ip~~~~~--~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 596 (1082)
++..+||+.+.+- .|++.... ....|+..+|++|.+....+..-..++.++.|+|++|.|+ .+|..+..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 4457788888765 56654432 2345778999999999776665567789999999999999 678889999999999
Q ss_pred EcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCC
Q 045553 597 SLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGF 659 (1082)
Q Consensus 597 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 659 (1082)
+++.|.+. ..|..+..|.+|-+|+..+|.+. .+|.++..-...-..++.++.+.+.-+..+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccc
Confidence 99999999 78888888999999999999998 666554433444455667777776655443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.4e-08 Score=100.93 Aligned_cols=124 Identities=21% Similarity=0.185 Sum_probs=85.1
Q ss_pred CccccccccccCCCCCCEEEcccCCCcccCC-hhh-cCCCCCCEEeCcCCCCCC--CCCccccCCCCCCeEEccCccccc
Q 045553 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSGELP-LEI-GQLSLLEILDLSFNSFHG--PIPPTLQNCSSLRLINLSGNQFNG 172 (1082)
Q Consensus 97 ~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p-~~~-~~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~ 172 (1082)
...|..+-.+..+..++.|.+.++.|...-. ..| ...+.++.|||.+|.|+. ++..-+.+|+.|++|+|+.|++..
T Consensus 32 ~~~g~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s 111 (418)
T KOG2982|consen 32 TSAGLSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSS 111 (418)
T ss_pred cccccceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCC
Confidence 3445555556666677778888877763221 223 345788999999999883 345556788999999999998885
Q ss_pred ccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccC
Q 045553 173 TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLT 220 (1082)
Q Consensus 173 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~ 220 (1082)
.+...-..+.+|++|.|.+..+...--..+...+|.+++|.++.|++.
T Consensus 112 ~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r 159 (418)
T KOG2982|consen 112 DIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR 159 (418)
T ss_pred ccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh
Confidence 443332466788888888888776656666666777777777777443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.2e-06 Score=88.37 Aligned_cols=107 Identities=29% Similarity=0.435 Sum_probs=85.0
Q ss_pred HHHHHHHHHHHhccCCC--ceeeEeeeeccC----CeEEEEEeecCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH
Q 045553 841 VQQFAAEIRTLGRVQHP--NLVTLIGYHVSE----AEMFLIYNYLPGG-NLEKFIQDRPRRTVEWSMLHKIALDVARALA 913 (1082)
Q Consensus 841 ~~~~~~e~~~l~~l~h~--niv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~ 913 (1082)
.....+|...+..+... .+++.+++.... ...++|+|++++. +|.+++..... .+......++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 34577888888877543 345566666542 3458999999874 89999986322 566678899999999999
Q ss_pred HHhhCCCCCeEeccCCCCCEEEcCCC---cEEEeecccceec
Q 045553 914 YLHDECVPRVLHRDIKPSNILLDNNL---NAYLSDFGLARLL 952 (1082)
Q Consensus 914 ~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~~ 952 (1082)
-||.. +|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.6e-07 Score=108.65 Aligned_cols=152 Identities=19% Similarity=0.212 Sum_probs=104.2
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc--------cccCcccCCCcccchhcc
Q 045553 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH--------ATTDVAGTFGYVAPEYAM 976 (1082)
Q Consensus 905 ~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~ 976 (1082)
+.+++.|+.|+|... ++||++|.|++|.+++.+.+||+.|+.+......... ...-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345559999999874 9999999999999999999999999988654331111 001122355799999999
Q ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHc
Q 045553 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMC 1056 (1082)
Q Consensus 977 ~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~c 1056 (1082)
....+.++|+||+||++|.+..|+.+.-... +..+..... ... +..-.-.+..+.+.++.+=+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-----~~~~~~~~~--~~~-------~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN-----GGLLSYSFS--RNL-------LNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc-----CCcchhhhh--hcc-------cccccccccccCcHHHHHHHHHH
Confidence 9888999999999999999995554432111 101000000 000 11111123455677888999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 045553 1057 TGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1057 l~~~p~~RPt~~ev~~ 1072 (1082)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998877653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.1e-08 Score=116.62 Aligned_cols=159 Identities=29% Similarity=0.280 Sum_probs=110.7
Q ss_pred cccccCCCCCCEEEcccCCCcc---cCC----------------------hhhcCC------CCCCEEeCcCCCCCCCCC
Q 045553 103 SRAIGDLTQLRVLLLAFNGFSG---ELP----------------------LEIGQL------SLLEILDLSFNSFHGPIP 151 (1082)
Q Consensus 103 ~~~l~~l~~L~~L~L~~n~l~~---~~p----------------------~~~~~l------~~L~~L~Ls~n~l~~~~p 151 (1082)
|-.|..+..|++|.|+++.+.. ..+ ...+.. -.|...+.+.|.+. .+-
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD 180 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMD 180 (1096)
T ss_pred CceeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHH
Confidence 4567888999999999988762 110 001111 23666777777777 566
Q ss_pred ccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCC
Q 045553 152 PTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCT 231 (1082)
Q Consensus 152 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 231 (1082)
.++.=++.|+.|||++|++... +.+..+++|++|||++|.+. .+|.--...+. |+.|.+++|.++.. ..+.++.
T Consensus 181 ~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~Lk 254 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLK 254 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHhhh
Confidence 6777788888888888888743 27778888888888888887 77755443444 88888888888732 2467778
Q ss_pred CccEEEccCCcCCCCc-CccccCCCCCCEEeCCCCcCc
Q 045553 232 ELRSLLLSSNMLQGDI-PSSFGQLVNLEVLDLSRNFLS 268 (1082)
Q Consensus 232 ~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 268 (1082)
+|+.||+++|-|.+.- -..++.|..|+.|+|.+|.+-
T Consensus 255 sL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 255 SLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8888888888876432 233556677888888888874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1082 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-37 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-37 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-29 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-37 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-18 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 418 bits (1077), Expect = e-132
Identities = 174/689 (25%), Positives = 276/689 (40%), Gaps = 154/689 (22%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSL 60
+ L+ K + D L +W+ + + C++ GVTC +VTS++LSS
Sbjct: 14 IHQLISFKDVLP-DK-NLLPDWSS-NKNPCTFDGVTCR--DDKVTSIDLSSK-------- 60
Query: 61 LSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFN 120
+ F +S ++ LT L L L+ +
Sbjct: 61 -----------PLNVGF----------------------SAVSSSLLSLTGLESLFLSNS 87
Query: 121 GFSGELPLEIGQLSLLEILDLSFNSFHGPIPP--TLQNCSSLRLINLSGNQFNGTIPA-F 177
+G + + L LDLS NS GP+ +L +CS L+ +N+S N +
Sbjct: 88 HINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG 146
Query: 178 FGQSPGFQVVSLSFNLLSGSVPEEFG--DNCVSLEHILLAANSLTGSIPPSLGNCTELRS 235
+ +V+ LS N +SG+ + D C L+H+ ++ N ++G + + C L
Sbjct: 147 GLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEF 204
Query: 236 LLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYS 295
L +SSN IP G L+ LD+S N LSG + C +LK+L + +
Sbjct: 205 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS------- 256
Query: 296 REHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN-WELCSKL 354
N F G +P L +L+ G P C L
Sbjct: 257 ------------------NQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTL 296
Query: 355 EMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV--SVPCMAVFNVSQNLLS 412
L+L+ N F G +P G+C L L LSSNN +G LP + + + V ++S N S
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 413 GEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNN 472
GE+P ++ S L L D S+N
Sbjct: 357 GELP-------------------------------------ESLTNLSASLLTL-DLSSN 378
Query: 473 LFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIG 532
F+GP+ P L + K L + NN G
Sbjct: 379 NFSGPILPNL-----------------CQNPKNTLQE-------------LYLQNNGFTG 408
Query: 533 EVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMED 592
++P + + C + L ++ N G IP S + LR+L L N L+G +P + ++
Sbjct: 409 KIPPTLSN-CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467
Query: 593 LKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
L+ L L N+ TG IP L+ +L + LS N L+GEIP +LE+L +L+L +N+ +
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
Query: 653 GRIPPGFGTRSSLSIFDVSFNNLSGSAPR 681
G IP G SL D++ N +G+ P
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 405 bits (1042), Expect = e-127
Identities = 175/635 (27%), Positives = 248/635 (39%), Gaps = 118/635 (18%)
Query: 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
S +KLSG+ SRAI T+L++L ++ N F G +P L L+ L L+ N F G IP
Sbjct: 231 SGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDF 288
Query: 154 LQ-NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212
L C +L ++LSGN F G +P FFG + ++LS N SG +P + L+ +
Sbjct: 289 LSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL 348
Query: 213 LLAANSLTGSIPPSLGNCT-ELRSLLLSSNMLQGDIPSSFGQ--LVNLEVLDLSRNFLSG 269
L+ N +G +P SL N + L +L LSSN G I + Q L+ L L N +G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 270 IVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPN 329
+P L C +L L L N+ G +P S+ L
Sbjct: 409 KIPPTLSNCSELVSLHLSF-------------------------NYLSGTIPSSLGSLSK 443
Query: 330 LRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLT 389
LR LEG PQ LE L L N TG+IP+ L NC +L ++ LS+N LT
Sbjct: 444 LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503
Query: 390 GLLPEEVSV-PCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYEN 448
G +P+ + +A+ +S N SG IP +C
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPA-ELGDCRS----------------------- 539
Query: 449 ALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLS 508
L L D + NLF G +P
Sbjct: 540 --------------LIWL-DLNTNLFNGTIPA---------------------------- 556
Query: 509 TYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGN--EFVGLIPQSFTNF 566
++ I N + G+ + + K AGN EF G+ +
Sbjct: 557 --------AMFKQSGKIAANFIAGKRYVYIKN-DGMKKECHGAGNLLEFQGIRSEQLNRL 607
Query: 567 DSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANS 626
+ N++ G + + FL +S N +G IP E+ + L +L L N
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 627 LSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN---S 683
+SG IP E L LN+L L N L GRIP + L+ D+S NNLSG P
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 684 LIKCENVQGNPNL-----QLCHTDPSSSEWERQHS 713
NP L C + Q S
Sbjct: 728 TFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 9e-68
Identities = 121/472 (25%), Positives = 175/472 (37%), Gaps = 91/472 (19%)
Query: 233 LRSLLLSSNMLQ---GDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRND 289
+ S+ LSS L + SS L LE L LS + ++G V L L L
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSR- 109
Query: 290 YGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPD--SITRLPNLRVFWAPNLNLEGIFPQN 347
N G + S+ L+ + L+ +
Sbjct: 110 ------------------------NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 145
Query: 348 WEL-CSKLEMLNLAHNFFTGQIPASL---GNCKSLYFLDLSSNNLTGLLPEEVSVPCMAV 403
L + LE+L+L+ N +G C L L +S N ++G + +
Sbjct: 146 GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEF 204
Query: 404 FNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGL 463
+VS N S IP + ++ L
Sbjct: 205 LDVSSNNFSTGIPFLGD-----------------------------CSA----------L 225
Query: 464 FILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIF 523
L D S N +G + L +S N G + P SL L
Sbjct: 226 QHL-DISGNKLSGDFSRAISTCTELKL-----LNISSNQFVGPI---PPLPLKSLQYL-- 274
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
+ NK GE+P + C + L ++GN F G +P F + L +L LS N+ G L
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 584 P-SYINKMEDLKFLSLSLNNFTGAIPWELTQL-ASLEVLELSANSLSGEIPSEF--SKLE 639
P + KM LK L LS N F+G +P LT L ASL L+LS+N+ SG I +
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394
Query: 640 HLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQ 691
L L L +N TG+IPP S L +SFN LSG+ P +SL ++
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP-SSLGSLSKLR 445
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 365 bits (939), Expect = e-118
Identities = 104/287 (36%), Positives = 168/287 (58%), Gaps = 3/287 (1%)
Query: 792 TYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQ-QFAAEIRT 850
+ + A+ F+ +N +G GGFG YK + G +VAVKRL R QG + QF E+
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDV 908
+ H NL+ L G+ ++ E L+Y Y+ G++ +++RP + ++W +IAL
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AR LAYLHD C P+++HRD+K +NILLD A + DFGLA+L+ +TH TT V GT G
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
++APEY T + S+K DV+ +GV+LLELI+ ++A D + + + ++ W LL + +
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
L +++ +++ +A++CT S RP M +V + L+
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-106
Identities = 102/293 (34%), Positives = 155/293 (52%), Gaps = 8/293 (2%)
Query: 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAE 847
++ ++ AT F+ + IG G FG YK + G VA+KR + QG+++F E
Sbjct: 26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 848 IRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEK--FIQDRPRRTVEWSMLHKIA 905
I TL +HP+LV+LIG+ EM LIY Y+ GNL++ + D P ++ W +I
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL-LGTSETHATTDVA 964
+ AR L YLH ++HRD+K NILLD N ++DFG+++ +TH +T V
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024
GT GY+ PEY + R+++K+DVYSFGVVL E++ + A+ S N+ WA
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESH 260
Query: 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
G+ + L D + L + + A+ C S RPSM V +L+
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-100
Identities = 91/299 (30%), Positives = 147/299 (49%), Gaps = 21/299 (7%)
Query: 792 TYENVVRATAGFN------VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR----FQGV 841
++ + T F+ N +G GGFG YK + VAVK+L+ +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELK 74
Query: 842 QQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTV-EWSM 900
QQF EI+ + + QH NLV L+G+ ++ L+Y Y+P G+L + W M
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 901 LHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHA 959
KIA A + +LH+ +HRDIK +NILLD A +SDFGLAR ++T
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAW 1019
T+ + GT Y+APE + ++ K+D+YSFGVVLLE+I+ A+D ++
Sbjct: 192 TSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH----REPQLLLDI 246
Query: 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
+ + + E + + + M ++A C E + RP +++V Q L+++
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 2e-78
Identities = 133/712 (18%), Positives = 223/712 (31%), Gaps = 121/712 (16%)
Query: 38 DPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQ-LHQHDRGNINSNSSD 96
D L +T LNL+ N L LP A F+ + L L ++ N
Sbjct: 21 DDLPTNITVLNLTHN------QLRRLPAAN-----FT-RYSQLTSL------DVGFN--- 59
Query: 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQN 156
+S L L+VL L N S + L L L NS
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 157 CSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGD-NCVSLEHILLA 215
+L ++LS N + T Q Q + LS N + EE SL+ + L+
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 216 ANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFG---QLVNLEVLDLSRNFLSGIVP 272
+N + P L L L++ L + ++ L LS + LS
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 273 SELGMCK--QLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNL 330
+ K L +L L YN + DS LP L
Sbjct: 240 TTFLGLKWTNLTMLDLS-------------------------YNNLNVVGNDSFAWLPQL 274
Query: 331 RVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQI---------PASLGNCKSLYFL 381
F+ N++ +F + + LNL +F I S K L L
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL 334
Query: 382 DLSSNNLTGLLPEE-VSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGF 440
++ N++ G+ + + ++S + S
Sbjct: 335 NMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL--------------------------- 367
Query: 441 YTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSG 500
LT+ S + L IL + + N + L L
Sbjct: 368 -------RTLTNETFVSLAHSPLHIL-NLTKNKISKIESDAFSWLGHLEV-----LDLGL 414
Query: 501 NSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEF--VGL 558
N + L+ + ++ + + NK + + + + ++ L + V
Sbjct: 415 NEIGQELTGQEWRGLENIFEI--YLSYNKYLQ-LTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 559 IPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFT--------GAIPWE 610
P F +L L+LS N++ + +E L+ L L NN G +
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
Query: 611 LTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDV 670
L L+ L +L L +N F L L ++ L NNL F + SL ++
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNL 591
Query: 671 SFNNLSGS-----APRNSLIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVS 717
N ++ P + +++ NP C + W + N+
Sbjct: 592 QKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIP 643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 1e-64
Identities = 108/565 (19%), Positives = 187/565 (33%), Gaps = 91/565 (16%)
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195
E+ D S +P L +++ ++NL+ NQ A F + + + FN +S
Sbjct: 6 HEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255
PE L+ + L N L+ + CT L L L SN +Q + F +
Sbjct: 63 KLEPELCQ-KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 256 NLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNF 315
NL LDLS N LS + L+ L+L N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLL-------------------------SNNK 156
Query: 316 FDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNC 375
+ + N S L+ L L+ N P
Sbjct: 157 IQALKSEELDIFAN----------------------SSLKKLELSSNQIKEFSPGCFHAI 194
Query: 376 KSLYFLDLSSNNLTGLLPEEVSVPC----MAVFNVSQNLLSGEIPRISHSECSKMSVNWS 431
L+ L L++ L L E++ + + ++S + LS +
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK-----WTN 249
Query: 432 MSQVDLIGFYTAFFYENALTSCAP--FSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLS 489
++ +DL N L F+ L N L ++
Sbjct: 250 LTMLDL--------SYNNLNVVGNDSFAWLPQ-LEYF-FLEYNNIQHLFSHSLHGLFNVR 299
Query: 490 SRPYYGFWLSGNSLKGNLS-----TYPFDLCLSLDGL-IFDIGNNKLIGEVPSDMGSHCK 543
L + K ++S L L ++ +N + G + S+M +
Sbjct: 300 Y-----LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLI 353
Query: 544 CMKFLSMAGN--EFVGLIPQSFTNFD--SLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS 599
+K+LS++ + L ++F + L LNL++N + + + L+ L L
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413
Query: 600 LNNFTGAIP-WELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTG--RIP 656
LN + E L ++ + LS N + F+ + L L L L P
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473
Query: 657 PGFGTRSSLSIFDVSFNNLSGSAPR 681
F +L+I D+S NN++
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-60
Identities = 110/583 (18%), Positives = 171/583 (29%), Gaps = 89/583 (15%)
Query: 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSG--ELPLEIGQLSLLEILDLSFNSFHGPIPPTL 154
LS L L+ LLL+ N L+I S L+ L+LS N P
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 155 QNCSSLRLINLSGNQFNGTIPAFFGQSPG---FQVVSLSFNLLSGSVPEEFGD-NCVSLE 210
L + L+ Q ++ + +SLS + LS + F +L
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT 251
Query: 211 HILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF---- 266
+ L+ N+L S +L L N +Q S L N+ L+L R+F
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 267 -----LSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLP 321
L I K L+ L + + N G
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNM-------------------------EDNDIPGIKS 346
Query: 322 DSITRLPNLRVFWAPNLNLEGIFPQNWELC----SKLEMLNLAHNFFTGQIPASLGNCKS 377
+ T L NL+ N N S L +LNL N + +
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406
Query: 378 LYFLDLSSNNLTGLLPEEVSVPCMA--VFNVSQNLLSGEIPRISHSECSKMSVNWSMSQV 435
L LDL N + L + +S N ++ S+ ++
Sbjct: 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS-------FALVPSLQRL 459
Query: 436 DLIGFYTAFFYENALTSCAPFSSPSNGLFILH--DFSNNLFTGPVPPFLIDSDSLSSRPY 493
L AL + SP L L D SNN L + L
Sbjct: 460 ML--------RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI--- 508
Query: 494 YGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGN 553
L N+L L G + + + L++ N
Sbjct: 509 --LDLQHNNLA------------RLWKHANPGGPIYFLKGLSH--------LHILNLESN 546
Query: 554 EFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWEL-T 612
F + + F + L+ ++L N+L S N LK L+L N T
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 613 QLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRI 655
+L L++ N S + +N + L+
Sbjct: 607 AFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-39
Identities = 76/443 (17%), Positives = 144/443 (32%), Gaps = 71/443 (16%)
Query: 255 VNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYN 314
V+ EV D S L+ + P +L + VL L + N
Sbjct: 4 VSHEVADCSHLKLTQV-PDDLP--TNITVLNLTH-------------------------N 35
Query: 315 FFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGN 374
+ TR L + + P+ + L++LNL HN + +
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 375 CKSLYFLDLSSNNLTGLLPEEVS-VPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMS 433
C +L L L SN++ + + ++S N LS ++ ++
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL----GTQVQLE---NLQ 148
Query: 434 QVDLIGFYTAFFYENALTSCAPFSSPSNGLFILH--DFSNNLFTGPVPPFLIDSDSLSSR 491
++ L N + + L + S+N P L
Sbjct: 149 ELLL--------SNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFG- 199
Query: 492 PYYGFWLSGNSLKGNLSTYPFDLC--LSLDGLIFDIGNNKLIGEVPSDMGSHCKCM--KF 547
+L+ L +L+ S+ L + N++L + K
Sbjct: 200 ----LFLNNVQLGPSLTEKLCLELANTSIRNL--SLSNSQLST-TSNTTFLGLKWTNLTM 252
Query: 548 LSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSL--------- 598
L ++ N + SF L L N++Q ++ + ++++L+L
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312
Query: 599 SLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG 658
SL + + L LE L + N + G + F+ L +L L L ++ + R
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372
Query: 659 ----FGTRSSLSIFDVSFNNLSG 677
S L I +++ N +S
Sbjct: 373 ETFVSLAHSPLHILNLTKNKISK 395
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-24
Identities = 41/196 (20%), Positives = 69/196 (35%), Gaps = 10/196 (5%)
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG 557
S L+ P DL ++ L ++ +N+L ++ + + L + N
Sbjct: 11 CSHL----KLTQVPDDLPTNITVL--NLTHNQLRRLPAANF-TRYSQLTSLDVGFNTISK 63
Query: 558 LIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASL 617
L P+ L+ LNL N L +L L L N+ + +L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 618 EVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTR--SSLSIFDVSFNNL 675
L+LS N LS +LE+L L L +N + SSL ++S N +
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 676 SGSAPRNSLIKCENVQ 691
+P +
Sbjct: 184 KEFSP-GCFHAIGRLF 198
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-19
Identities = 29/171 (16%), Positives = 64/171 (37%), Gaps = 15/171 (8%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFN--------GFSGELPLEIGQLSLLEILD 140
++++N ++ + L +L +L L N G + LS L IL+
Sbjct: 486 DLSNN---NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 141 LSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPE 200
L N F ++ L++I+L N N + F + ++L NL++ +
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 201 EFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSF 251
FG +L + + N + + + + ++ ++ S +
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCE----SIAWFVNWINETHTNIPELSSHY 649
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 3e-76
Identities = 115/620 (18%), Positives = 190/620 (30%), Gaps = 82/620 (13%)
Query: 78 PCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLE 137
PC+++ + + K+ NL + L L+FN L+
Sbjct: 2 PCVEVVPNITYQCMELNFYKIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQ 55
Query: 138 ILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGS 197
+LDLS Q+ S L + L+GN F Q + L+
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 198 VPEEFGDNCVSLEHILLAANSLTG-SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256
G + +L+ + +A N + +P N T L L LSSN +Q + L
Sbjct: 116 ENFPIG-HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 257 LEV----LDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGED 312
+ + LDLS N ++ I P + L L LRN
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRN------------------------ 209
Query: 313 YNFFDGGLP-DSITRLPNLRVFW------APNLNLEGIFPQNWELCSKLEMLNLAHN--- 362
NF + I L L V NLE E L +
Sbjct: 210 -NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 363 FFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSE 422
++ I ++ L S + + + + + +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKD-------------FSYNFGWQHLELVNCK 315
Query: 423 CSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNN--LFTGPVPP 480
+ S L F N + + L L D S N F G
Sbjct: 316 FGQFPTLKLKSLKRLT------FTSNKGGNAFSEVDLPS-LEFL-DLSRNGLSFKGCCSQ 367
Query: 481 FLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGS 540
+ SL LS N + + F L+ L D ++ L +
Sbjct: 368 SDFGTTSLKY-----LDLSFNGVIT--MSSNFLGLEQLEHL--DFQHSNLKQMSEFSVFL 418
Query: 541 HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLS 599
+ + +L ++ F SL L ++ N Q I ++ +L FL LS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGF 659
P L+SL+VL +S N+ + L L VL N++
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
Query: 660 G-TRSSLSIFDVSFNNLSGS 678
SSL+ +++ N+ + +
Sbjct: 539 QHFPSSLAFLNLTQNDFACT 558
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-67
Identities = 108/592 (18%), Positives = 199/592 (33%), Gaps = 47/592 (7%)
Query: 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQN 156
L S + +L+VL L+ LS L L L+ N
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 157 CSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA 216
SSL+ + G + ++++ NL+ E+ N +LEH+ L++
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 217 NSLTGSIPPSLGNCTELR----SLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVP 272
N + L ++ SL LS N + P +F ++ L L L NF S V
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVM 217
Query: 273 SE-LGMCKQLKVLVLR----NDYGPLYSREHGDLPIQPVVDGGE----DYNFFDGGLPDS 323
+ L+V L + G L + L + E +++ + D
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 324 ITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDL 383
L N+ F ++ +E + ++ + L L + F L + K L F
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN 335
Query: 384 SSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTA 443
N + +P + ++S+N +S C S + S L
Sbjct: 336 KGGNAFSEV----DLPSLEFLDLSRN-------GLSFKGCCSQSDFGTTSLKYL------ 378
Query: 444 FFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPP-FLIDSDSLSSRPYYGFWLSGNS 502
N + + + L L DF ++ + +L +S
Sbjct: 379 DLSFNGVITMSSNFLGLEQLEHL-DFQHSNLKQMSEFSVFLSLRNLIY-----LDISHTH 432
Query: 503 LKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQS 562
+ F+ SL+ L + N D+ + + + FL ++ + L P +
Sbjct: 433 TRV-AFNGIFNGLSSLEVL--KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 563 FTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA-SLEVLE 621
F + SL+ LN+S N+ + L+ L SLN+ + EL SL L
Sbjct: 490 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 549
Query: 622 LSANSLSGEIPSE--FSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVS 671
L+ N + + ++ L ++ + P LS +++
Sbjct: 550 LTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS-LNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 42/178 (23%), Positives = 66/178 (37%), Gaps = 9/178 (5%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFH 147
+I+ + L+ L VL +A N F +I +L L LDLS
Sbjct: 427 DISHT---HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 148 GPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCV 207
P + SSL+++N+S N F + QV+ S N + S +E
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 543
Query: 208 SLEHILLAANSLTGSIPPS--LGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
SL + L N + L + R LL+ ++ PS + VL L+
Sbjct: 544 SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD---KQGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-24
Identities = 34/165 (20%), Positives = 63/165 (38%), Gaps = 5/165 (3%)
Query: 517 SLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSR 576
+ + + ++P ++ K L ++ N L SF +F L+ L+LSR
Sbjct: 6 VVPNITYQCMELNFY-KIPDNLPFS---TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 577 NHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFS 636
+Q + L L L+ N + L+SL+ L +L+
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 637 KLEHLNVLRLDHNNLTG-RIPPGFGTRSSLSIFDVSFNNLSGSAP 680
L+ L L + HN + ++P F ++L D+S N +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-20
Identities = 28/124 (22%), Positives = 42/124 (33%)
Query: 568 SLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSL 627
S +NL+LS N L+ +L+ L LS L+ L L L+ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 628 SGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKC 687
FS L L L NL G +L +V+ N +
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 688 ENVQ 691
N++
Sbjct: 149 TNLE 152
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 1e-75
Identities = 89/606 (14%), Positives = 182/606 (30%), Gaps = 115/606 (18%)
Query: 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGP----IPPTLQNCSSLR 161
+ ++ L L G SG +P IGQL+ LE+L L + P + S
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 162 LINLSGNQFNGTIPAFFG--QSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSL 219
+ T + ++ + S+ + + I +N++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR-ITLKDTQIGQLSNNI 195
Query: 220 TGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCK 279
T + ++ T+LR + ++ + + N E + K
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ-----QYKTEDLKWDNLK 249
Query: 280 QLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW----- 334
L + + N LP + LP +++
Sbjct: 250 DLTDVEVYN-------------------------CPNLTKLPTFLKALPEMQLINVACNR 284
Query: 335 ---APNLNLEGIFPQNWELCSKLEMLNLAHN-FFTGQIPASLGNCKSLYFLDLSSNNLTG 390
L + + + K++++ + +N T + SL K L L+ N L G
Sbjct: 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG 344
Query: 391 LLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENAL 450
LP S +A N++ N ++
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITEIPANF-------------------------------- 372
Query: 451 TSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDS-DSLSSRPYYGFWLSGNSLKGNLST 509
+ L F++N F S +S+ S N +
Sbjct: 373 -----CGFTEQ-VENL-SFAHNKLKYIPNIFDAKSVSVMSA-----IDFSYNEIGSVDGK 420
Query: 510 YPFDLCLSLDGLI----FDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGL------- 558
L + I ++ NN++ P ++ S + +++ GN +
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQISK-FPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 559 IPQSFTNFDSLRNLNLSRNHLQG-PLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASL 617
++F N L +++L N L + L + LS N+F+ P + ++L
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 618 EVLEL------SANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVS 671
+ + N E P + L L++ N++ + ++S+ D+
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKIT--PNISVLDIK 595
Query: 672 FNNLSG 677
N
Sbjct: 596 DNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 1e-70
Identities = 95/663 (14%), Positives = 173/663 (26%), Gaps = 122/663 (18%)
Query: 18 LTSNWNPKDTDSCSWH---GVTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFS 74
+NWN + + W GV+ + GRVT L+L
Sbjct: 56 PGANWNF-NKELDMWGAQPGVSLNSN-GRVTGLSLEGF---------------------- 91
Query: 75 FHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSG----ELPLEI 130
SG + AIG LT+L VL L +G P I
Sbjct: 92 ----------------------GASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 131 GQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN--LSGNQFNGTIPAFFGQSPGFQVVS 188
E + LI ++ + +I + +
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 189 LSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP 248
N ++ V + L + +
Sbjct: 190 QLSNNIT-FVSKAVM-RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----ED 242
Query: 249 SSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVD 308
+ L +L +++ +P+ L +++++ + + G
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG----------------- 285
Query: 309 GGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWEL--CSKLEMLNLAHNFFTG 366
+ D +++ + NL+ P L KL ML +N G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTF-PVETSLQKMKKLGMLECLYNQLEG 344
Query: 367 QIPASLGNCKSLYFLDLSSNNLTGLLPEEVSV-PCMAVFNVSQNLLSGEIPRISHSECSK 425
++P + G+ L L+L+ N +T + + + + N L S
Sbjct: 345 KLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV 403
Query: 426 MSVNWSMSQVDLIGFYTAFFYENALTSCAP--FSSPSNGLFILH-----DFSNNLFTGPV 478
MS +D N + S F F + SNN +
Sbjct: 404 MSA------IDF--------SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFP 449
Query: 479 PPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGL----IFDIGNNKLIGEV 534
LSS L GN L D + D+ NKL
Sbjct: 450 KELFSTGSPLSS-----INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLS 504
Query: 535 PSDMGSHCKCMKFLSMAGNEFVGLIP-----QSFTNFDSLRNLNLSRNHLQGPLPSYINK 589
+ + + ++ N F + F + N P I
Sbjct: 505 DDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL 564
Query: 590 MEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHN 649
L L + N+ + ++ ++ VL++ N S + L ++
Sbjct: 565 CPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
Query: 650 NLT 652
Sbjct: 622 KTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-26
Identities = 38/244 (15%), Positives = 72/244 (29%), Gaps = 40/244 (16%)
Query: 45 TSLNLSSNL--SRTSCSLLSLPPAAGPGGNFSFHFPCLQ-LHQHDRGNINSNSSDKLSGN 101
++++ S N S + L P G N + + N+++N ++S
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGIN-------VSSI------NLSNN---QISKF 448
Query: 102 LSRAIGDLTQLRVLLLAFNGFSG-------ELPLEIGQLSLLEILDLSFNSFHGPIPPTL 154
+ L + L N + + LL +DL FN +
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDF 507
Query: 155 Q--NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNL------LSGSVPEEFGDNC 206
+ L I+LS N F+ P S + + PE C
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT-LC 565
Query: 207 VSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF 266
SL + + +N + + + + L + N S + + L +
Sbjct: 566 PSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
Query: 267 LSGI 270
I
Sbjct: 623 TQDI 626
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 15/90 (16%), Positives = 24/90 (26%), Gaps = 4/90 (4%)
Query: 597 SLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTG--- 653
+ L+ + L + L L SG +P +L L VL L +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 654 -RIPPGFGTRSSLSIFDVSFNNLSGSAPRN 682
P G S + +
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDY 152
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 6e-74
Identities = 85/317 (26%), Positives = 129/317 (40%), Gaps = 36/317 (11%)
Query: 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAE 847
GV L EN+ + + G FG +KA++ VAVK + Q Q E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYE 68
Query: 848 IRTLGRVQHPNLVTLIGY----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK 903
+ +L ++H N++ IG + +++LI + G+L F++ V W+ L
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCH 125
Query: 904 IALDVARALAYLHDECV-------PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956
IA +AR LAYLH++ P + HRDIK N+LL NNL A ++DFGLA +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 957 THA-TTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSF 1010
+ T GT Y+APE + D+Y+ G+VL EL S A D +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 1011 GNGFNIVAWASMLLLQ---------GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESL 1061
F L RP H + + C
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVL-----RDYWQKHAGMAMLCETIEECWDHDA 300
Query: 1062 SSRPSMRQVAQQLKQIQ 1078
+R S V +++ Q+Q
Sbjct: 301 EARLSAGCVGERITQMQ 317
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-70
Identities = 89/291 (30%), Positives = 135/291 (46%), Gaps = 28/291 (9%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPK-DTDSCSWHGVTCDPL--SGRVTSLNLSSN-LSRT 56
K ALLQ+K + +P L S+W P D + +W GV CD + RV +L+LS L +
Sbjct: 8 KQALLQIKKDLG-NPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 57 SCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLL 116
+P + N + L+ G IN+ L G + AI LTQL L
Sbjct: 66 ----YPIPSSL---ANLPY------LNFLYIGGINN-----LVGPIPPAIAKLTQLHYLY 107
Query: 117 LAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPA 176
+ SG +P + Q+ L LD S+N+ G +PP++ + +L I GN+ +G IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 177 FFGQSPG-FQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRS 235
+G F +++S N L+G +P F N +L + L+ N L G G+ +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFA-NL-NLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 236 LLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL 286
+ L+ N L D+ G NL LDL N + G +P L K L L +
Sbjct: 226 IHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-61
Identities = 68/304 (22%), Positives = 114/304 (37%), Gaps = 57/304 (18%)
Query: 120 NGFSGELPLEIGQLSLLEILDLSFNSFHG--PIPPTLQNCSSLRLINLSG-NQFNGTIPA 176
+ G L Q + LDLS + PIP +L N L + + G N G IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 177 FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSL 236
+ + ++ +SG++P+ +L + + N+L+G++PPS+ + L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLS-QIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 237 LLSSNMLQGDIPSSFGQLVNL-EVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYS 295
N + G IP S+G L + +SRN L+G +P L + L
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDL--------- 204
Query: 296 REHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLE 355
N +G +
Sbjct: 205 ----------------SRNMLEGDASVLFGS------------------------DKNTQ 224
Query: 356 MLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS-VPCMAVFNVSQNLLSGE 414
++LA N + +G K+L LDL +N + G LP+ ++ + + NVS N L GE
Sbjct: 225 KIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 415 IPRI 418
IP+
Sbjct: 284 IPQG 287
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-56
Identities = 52/282 (18%), Positives = 93/282 (32%), Gaps = 55/282 (19%)
Query: 139 LDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGT--IPAFFGQSPGFQVVSLS-FNLLS 195
D ++ G + T + ++LSG IP+ P + + N L
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255
G +P L ++ + +++G+IP L L +L S N L G +P S L
Sbjct: 91 GPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149
Query: 256 NLEVLDLSRNFLSGIVPSELGMCKQL-KVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYN 314
NL + N +SG +P G +L + + N
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTI-------------------------SRN 184
Query: 315 FFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGN 374
G +P + L L ++L+ N G G+
Sbjct: 185 RLTGKIPPTFANL-------------------------NLAFVDLSRNMLEGDASVLFGS 219
Query: 375 CKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIP 416
K+ + L+ N+L L + + ++ N + G +P
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-47
Identities = 74/348 (21%), Positives = 130/348 (37%), Gaps = 78/348 (22%)
Query: 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQ--IPASLGNCKSLYFLDLSS-NNLTGLLP 393
N G+ ++ L+L+ IP+SL N L FL + NNL G +P
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 394 EEVS-VPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTS 452
++ + + ++ +SG IP S++
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIP----DFLSQIK------------------------- 125
Query: 453 CAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPF 512
L L DFS N +G +PP + +L
Sbjct: 126 ---------TLVTL-DFSYNALSGTLPPSI----------------------SSLP---- 149
Query: 513 DLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNL 572
+L G+ N++ G +P GS K ++++ N G IP +F N +L +
Sbjct: 150 ----NLVGI--TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFV 202
Query: 573 NLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIP 632
+LSRN L+G ++ + + L+ N+ + ++ +L L+L N + G +P
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLP 261
Query: 633 SEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680
++L+ L+ L + NNL G IP G G + + N +P
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 52/269 (19%), Positives = 95/269 (35%), Gaps = 38/269 (14%)
Query: 448 NALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNL 507
L + SS D N + G + + +++ LSG +L
Sbjct: 16 KDLGNPTTLSSWLPTT----DCCNRTWLGVLCDTDTQTYRVNN-----LDLSGLNLPKPY 66
Query: 508 STYPF--------DLCLS----LDGLI------------FDIGNNKLIGEVPSDMGSHCK 543
L + L G I I + + G +P + K
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ-IK 125
Query: 544 CMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDL-KFLSLSLNN 602
+ L + N G +P S ++ +L + N + G +P L +++S N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 603 FTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTR 662
TG IP L +L ++LS N L G+ F ++ + L N+L + G
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLS 243
Query: 663 SSLSIFDVSFNNLSGSAPRNSLIKCENVQ 691
+L+ D+ N + G+ P+ L + + +
Sbjct: 244 KNLNGLDLRNNRIYGTLPQ-GLTQLKFLH 271
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-63
Identities = 104/691 (15%), Positives = 190/691 (27%), Gaps = 140/691 (20%)
Query: 10 AITEDPLGLTSNWNPKDTDSCSWHGVTCDPLS--GRVTSLNLSSNLSRTSCSLLSLPPAA 67
+ T + + NWN + + W L GRVT L+L+
Sbjct: 290 SGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGF--------------- 333
Query: 68 GPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELP 127
G + AIG LT+L+VL + +
Sbjct: 334 -----------------------------GAKGRVPDAIGQLTELKVLSFGTHSETVSGR 364
Query: 128 LEIGQLSLLEILDLSFNSFHGPIPP-TLQNCSSLRLINLSGNQFN-----GTIPAFFGQS 181
L + ++ + + L L L +L + N I S
Sbjct: 365 LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424
Query: 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSN 241
+ N ++ + + L+ I A + T +
Sbjct: 425 LKDTQIGNLTNRIT-FISKAIQ-RLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYA 477
Query: 242 MLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDL 301
+ S+ L +L ++L +P L +L+ L + + G ++ D
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 302 PIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWEL--CSKLEMLNL 359
L D P +++F+ NLE P + L KL +L+
Sbjct: 538 ----------------TRLADDEDTGPKIQIFYMGYNNLEEF-PASASLQKMVKLGLLDC 580
Query: 360 AHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV--SVPCMAVFNVSQNLLSGEIPR 417
HN + + G L L L N + + PE+ + S N L
Sbjct: 581 VHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEI-PEDFCAFTDQVEGLGFSHNKLKYIPNI 637
Query: 418 ISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILH-----DFSNN 472
+ M VD N + S S S + S N
Sbjct: 638 FNAKSVYVMGS------VDF--------SYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683
Query: 473 LFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIG 532
+S+ LS N +++ P + DG
Sbjct: 684 EIQKFPTELFATGSPIST-----IILSNN----LMTSIPENSLKPKDGNY---------- 724
Query: 533 EVPSDMGSHCKCMKFLSMAGNEFVGLIPQ-SFTNFDSLRNLNLSRNHLQGPLPSYINKME 591
+ + + + N+ L T L N+++S N P+
Sbjct: 725 -------KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSS 776
Query: 592 DLKFLSLSL------NNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLR 645
LK + N P +T SL L++ +N + ++ + L +L
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILD 833
Query: 646 LDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
+ N ++ + ++
Sbjct: 834 IADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-59
Identities = 80/616 (12%), Positives = 172/616 (27%), Gaps = 117/616 (18%)
Query: 119 FNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFF 178
+ + + +++ + L L+ G +P + + L++++ + + F
Sbjct: 308 LDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367
Query: 179 GQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLT-----GSIPPSLGNCTEL 233
+ + + + + F D L L +++ I +
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427
Query: 234 RSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPL 293
+ +N + I + +L L+++ + + + +
Sbjct: 428 TQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS------------ 474
Query: 294 YSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSK 353
DY S + L +L
Sbjct: 475 ------------------DYAKQYENEELSWSNLKDLTD--------------------- 495
Query: 354 LEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL---------LPEEVS-VPCMAV 403
+ L + Q+P L + L L+++ N L ++ P + +
Sbjct: 496 ---VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552
Query: 404 FNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGL 463
F + N L S + + +D N + F + L
Sbjct: 553 FYMGYNNLEEFPASASLQKMV------KLGLLDC--------VHNKVRHLEAFGTNVK-L 597
Query: 464 FILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIF 523
L N F +D + S N LK + + + +
Sbjct: 598 TDL-KLDYNQIEEIPEDFCAFTDQVEG-----LGFSHNKLKYIPNIFNAKSVYVMGSV-- 649
Query: 524 DIGNNKLIGEVPSDMGS----HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHL 579
D NK+ E + S ++++ NE + F + + LS N +
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709
Query: 580 Q-------GPLPSYINKMEDLKFLSLSLNNFTGAIP--WELTQLASLEVLELSANSLSGE 630
P L + L N T + + T L L +++S N S
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-S 767
Query: 631 IPSEFSKLEHLNVLRLDH------NNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSL 684
P++ L + H N + + P G T SL + N++
Sbjct: 768 FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLT 826
Query: 685 IKCE--NVQGNPNLQL 698
+ ++ NPN+ +
Sbjct: 827 PQLYILDIADNPNISI 842
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 41/374 (10%), Positives = 89/374 (23%), Gaps = 66/374 (17%)
Query: 317 DGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCK 376
+ D N N N + + Q L N
Sbjct: 265 AEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNG 323
Query: 377 SLYFLDLSSNNLTGLLPEEVS-VPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQV 435
+ L L+ G +P+ + + + V + + +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR------------------- 364
Query: 436 DLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYG 495
F + + + + FL L+
Sbjct: 365 -------------------LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD--- 402
Query: 496 FWLSGNSLKGN--LSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGN 553
L +++ N + D +SL N++ + + ++ + A +
Sbjct: 403 --LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI-TFISKAIQ-RLTKLQIIYFANS 458
Query: 554 EFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQ 613
F + N + ++DL + L +P L
Sbjct: 459 PFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
Query: 614 LASLEVLELSANSLSG---------EIPSEFSKLEHLNVLRLDHNNLTGRIPP--GFGTR 662
L L+ L ++ N + + + + + +NNL P
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKM 572
Query: 663 SSLSIFDVSFNNLS 676
L + D N +
Sbjct: 573 VKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-25
Identities = 45/271 (16%), Positives = 83/271 (30%), Gaps = 39/271 (14%)
Query: 40 LSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLS 99
+ +V L S N L +P ++ + + N
Sbjct: 617 FTDQVEGLGFSHN------KLKYIPNIFNAK----------SVYVMGSVDFSYNKIGSEG 660
Query: 100 GNLSRAIGD--LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSF-------HGPI 150
N+S ++ D + L++N S + + LS N P
Sbjct: 661 RNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPK 720
Query: 151 PPTLQNCSSLRLINLSGNQFNGTIPA--FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVS 208
+N L I+L N+ ++ P + +S+N S S P + N
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPL-NSSQ 777
Query: 209 LEHI------LLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDL 262
L+ N + P + C L L + SN ++ + L +LD+
Sbjct: 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDI 834
Query: 263 SRNFLSGIVPSELGMCKQLKVLVLRNDYGPL 293
+ N I + + + + VL D
Sbjct: 835 ADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-22
Identities = 31/241 (12%), Positives = 69/241 (28%), Gaps = 36/241 (14%)
Query: 45 TSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSR 104
S++ S N + S + ++ N ++ +
Sbjct: 647 GSVDFSYN------KIGSEGRNISCS------MDDYKGINASTVTLSYN---EIQKFPTE 691
Query: 105 AIGDLTQLRVLLLAFNGFS-------GELPLEIGQLSLLEILDLSFNSFHGPIPPTLQ-- 155
+ + ++L+ N + LL +DL FN + +
Sbjct: 692 LFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRAT 750
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNL------LSGSVPEEFGDNCVSL 209
L +++S N F+ + P S + + + P C SL
Sbjct: 751 TLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT-TCPSL 808
Query: 210 EHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269
+ + +N + + L +L L ++ N +S + + L +
Sbjct: 809 IQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
Query: 270 I 270
I
Sbjct: 866 I 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 6e-11
Identities = 14/122 (11%), Positives = 35/122 (28%), Gaps = 1/122 (0%)
Query: 570 RNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSG 629
L+ + + F + L+ + +L + L L+ G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 630 EIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCEN 689
+P +L L VL ++ T + + + + + + L +
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
Query: 690 VQ 691
+
Sbjct: 398 LN 399
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 6e-60
Identities = 99/590 (16%), Positives = 178/590 (30%), Gaps = 62/590 (10%)
Query: 101 NLSRAIGDL-TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSS 159
L+ G L L +FN +L L LDL+ + T Q+
Sbjct: 23 GLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82
Query: 160 LRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSL 219
L + L+ N + + +S N +LE + L +N +
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH-NQKTLESLYLGSNHI 141
Query: 220 TGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEV--LDLSRNFLSGIVPSELGM 277
+ P +L+ L +N + L L+L+ N ++GI
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI-EPGAFD 200
Query: 278 CKQLKVLVLRNDYGPLYSREHGD-LPIQPVVDGGEDYNFFDGGLPDSITRLP--NLRVFW 334
+ L L + IQ + G + + P L ++
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 335 APNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPE 394
I + S L+ L+L + ++P+ L +L L LS+N L
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 395 EVS-VPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSC 453
S P + ++ N E+ + +DL + + +
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE------LDL--------SHDDIETS 365
Query: 454 APFSSPSNGLFILH--DFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYP 511
+ L L + S N + L L+ LK + P
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL-----LDLAFTRLKVKDAQSP 420
Query: 512 FDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRN 571
F L K L+++ + Q F +L++
Sbjct: 421 FQNLHLL---------------------------KVLNLSHSLLDISSEQLFDGLPALQH 453
Query: 572 LNLSRNHLQGPLPSYINKMED---LKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLS 628
LNL NH N ++ L+ L LS + + T L + ++LS N L+
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 629 GEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGS 678
S L+ + L L N+++ +P S ++ N L +
Sbjct: 514 SSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-45
Identities = 84/520 (16%), Positives = 159/520 (30%), Gaps = 89/520 (17%)
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ 244
+ + L+ +P ++ E + + N L + L L L+ +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNS---TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 245 GDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQ 304
+F L+ L L+ N L + + L K LK L
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF------------------ 112
Query: 305 PVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFF 364
+ L + + ++ I KL++L+ +N
Sbjct: 113 -------IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
Query: 365 TGQIPASLGNCKSL--YFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPR-ISHS 421
+ + + L+L+ N++ G+ P N I + + +S
Sbjct: 166 HYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225
Query: 422 ECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPF 481
+ + F + P
Sbjct: 226 TIQSLWLG--------------------------------------TFEDMDDEDISPAV 247
Query: 482 LIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSH 541
+S L + +S+ F L L D+ + E+PS +
Sbjct: 248 FEGLCEMSVE---SINLQKHYFFN-ISSNTFHCFSGLQEL--DLTATH-LSELPSGL-VG 299
Query: 542 CKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSY-INKMEDLKFLSLSL 600
+K L ++ N+F L S +NF SL +L++ N + L + + +E+L+ L LS
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359
Query: 601 NNFT--GAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG 658
++ +L L+ L+ L LS N F + L +L L L +
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
Query: 659 -FGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQ 697
F L + ++S + L S+ + G P LQ
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSE-------QLFDGLPALQ 452
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-27
Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 4/195 (2%)
Query: 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT-LQ 155
+ S + + +L+ L+ L L++N + LE+LDL+F + Q
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFG--DNCVSLEHIL 213
N L+++NLS + + + F P Q ++L N ++ LE ++
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPS 273
L+ L+ + + + + LS N L + L + L+L+ N +S I+PS
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS 541
Query: 274 ELGMCKQLKVLVLRN 288
L + Q + + LR
Sbjct: 542 LLPILSQQRTINLRQ 556
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-20
Identities = 27/164 (16%), Positives = 53/164 (32%), Gaps = 4/164 (2%)
Query: 517 SLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSR 576
++ N L E+P + + + L + N + +F+ +L L+L+R
Sbjct: 11 KEVNKTYNCENLGL-NEIPGTLPNS---TECLEFSFNVLPTIQNTTFSRLINLTFLDLTR 66
Query: 577 NHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFS 636
+ L L L+ N L+ +L+ L +S
Sbjct: 67 CQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH 126
Query: 637 KLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680
+ L L L N+++ P L + D N + +
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-19
Identities = 37/207 (17%), Positives = 74/207 (35%), Gaps = 12/207 (5%)
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG 557
L+ P L S + L + N + + + S + FL + +
Sbjct: 19 CENL----GLNEIPGTLPNSTECL--EFSFNV-LPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 558 LIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASL 617
+ +F + L L L+ N L + ++ + LK L + L +L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 618 EVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSI--FDVSFNNL 675
E L L +N +S + E L VL +N + + + +++ N++
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 676 SG---SAPRNSLIKCENVQGNPNLQLC 699
+G A +++ + N G NL +
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVI 218
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-10
Identities = 23/109 (21%), Positives = 45/109 (41%), Gaps = 1/109 (0%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
N+ N K + + ++ L +L +L+L+F S L ++ +DLS N
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGS 197
L + + L NL+ N + +P+ + ++L N L +
Sbjct: 515 SSIEALSHLKGIYL-NLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 9e-58
Identities = 65/325 (20%), Positives = 116/325 (35%), Gaps = 43/325 (13%)
Query: 789 VQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI 848
++ + IG G +GA YK + VAVK S Q I
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKG-SLDERPVAVKVFSFANRQNFINEK-NI 58
Query: 849 RTLGRVQHPNLVTLIGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK 903
+ ++H N+ I E L+ Y P G+L K++ T +W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 904 IALDVARALAYLHDE------CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS-- 955
+A V R LAYLH E P + HRD+ N+L+ N+ +SDFGL+ L +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 956 -----ETHATTDVAGTFGYVAPEYAMTC-------RVSDKADVYSFGVVLLELISDKKAL 1003
E +A GT Y+APE + D+Y+ G++ E+ L
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 1004 DPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD---------CGPHDD-LIEMLNLA 1053
P + +A+ + + + + + + +
Sbjct: 236 FPG--ESVPEYQ-MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 1054 IMCTGESLSSRPSMRQVAQQLKQIQ 1078
C + +R + + +++ ++
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELM 317
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-57
Identities = 93/590 (15%), Positives = 178/590 (30%), Gaps = 81/590 (13%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP 152
LS N S + + ++L+ L L+ L L L L+ N P
Sbjct: 39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98
Query: 153 TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212
+ +SL + + GQ + ++++ N + + N +L H+
Sbjct: 99 SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV 158
Query: 213 LLAANSLTGSIPPSLGNCTELRSLL----LSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
L+ N + L E + +S N + I Q + L L L NF S
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNS 217
Query: 269 G-IVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRL 327
I+ + L L V L +D + P + L
Sbjct: 218 SNIMKTCLQNLAGLHVHRLIL-------------------GEFKDERNLEIFEPSIMEGL 258
Query: 328 PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387
++ ++ L + ++ + L+ +
Sbjct: 259 CDVT----------------------IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 388 LTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYE 447
+ L + ++ + L + P + + + L
Sbjct: 297 IKY-LEDVPKHFKWQSLSIIRCQLK-QFPTLDLP---------FLKSLTL--------TM 337
Query: 448 NALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNL 507
N + + + L L D S N + D + S R LS N +
Sbjct: 338 NKGSISFKKVALPS-LSYL-DLSRNALSFSGCCSYSDLGTNSLR---HLDLSFNGA--II 390
Query: 508 STYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFD 567
+ F L L D ++ L + + +L ++ F
Sbjct: 391 MSANFMGLEELQHL--DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
Query: 568 SLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANS 626
SL L ++ N + S + +L FL LS L L++L +S N+
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508
Query: 627 LSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
L S +++L L+ L N + SL+ F+++ N+++
Sbjct: 509 LLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-45
Identities = 93/566 (16%), Positives = 171/566 (30%), Gaps = 91/566 (16%)
Query: 139 LDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSV 198
+P + SS + I+LS N F Q + LS +
Sbjct: 16 YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 199 PEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLE 258
+ + L +++L N + P S T L +L+ L GQL+ L+
Sbjct: 73 DKAWH-GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 259 VLDLSRNFLSGI-VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFD 317
L+++ NF+ +P+ L + L YN+
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDL-------------------------SYNYIQ 166
Query: 318 GGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKS 377
+ + L L+++ N I
Sbjct: 167 TITVNDLQFLRENP--------------------QVNLSLDMSLNPID-FIQDQAFQGIK 205
Query: 378 LYFLDLSSNNLTGLLPEEV--SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQV 435
L+ L L N + + + ++ + V + + E S M ++
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD-ERNLEIFEPSIMEGLCDVTID 264
Query: 436 DLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYG 495
+ YT F ++ + F +N + + ++ P SLS
Sbjct: 265 EFRLTYTNDFSDDIVK----FHCLAN-VSAMSLAGVSIKYLEDVPKHFKWQSLS------ 313
Query: 496 FWLSGNSLKG------------NLSTYPFDLCLSLDGL----IFDIGNNKLIGEVPSDMG 539
+ LK L+ + L D+ N +
Sbjct: 314 --IIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNA-LSFSGCCSY 370
Query: 540 SHCKCM--KFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQG-PLPSYINKMEDLKFL 596
S + L ++ N + ++ +F + L++L+ + L+ S +E L +L
Sbjct: 371 SDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429
Query: 597 SLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRI 655
+S N L SL L+++ NS S F+ +L L L L I
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-I 488
Query: 656 PPG-FGTRSSLSIFDVSFNNLSGSAP 680
G F T L + ++S NNL
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-36
Identities = 82/484 (16%), Positives = 145/484 (29%), Gaps = 74/484 (15%)
Query: 211 HILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI 270
L+ +P + + +++ LS N L+ SF L+ LDLSR + I
Sbjct: 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 271 VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNL 330
L L+L N P S + L +L
Sbjct: 72 EDKAWHGLHHLSNLILTG-------------------------NPIQSFSPGSFSGLTSL 106
Query: 331 RVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTG-QIPASLGNCKSLYFLDLSSNNLT 389
A L + L+ LN+AHNF ++PA N +L +DLS N +
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 390 GLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENA 449
+ + + +S++ S+ N
Sbjct: 167 TITVND--------LQFLRENPQ-----------VNLSLDMSL---------------NP 192
Query: 450 LTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLST 509
+ + L L N + + L + L
Sbjct: 193 IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252
Query: 510 YPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSL 569
+ + F + + + +S+AG L +
Sbjct: 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVKF-HCLANVSAMSLAGVSIKYL--EDVPKHFKW 309
Query: 570 RNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSG 629
++L++ R L+ P+ + LK L+L++N + I ++ L SL L+LS N+LS
Sbjct: 310 QSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF 364
Query: 630 EIPSEFS--KLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKC 687
+S L L L N + F L D + L ++ +
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 688 ENVQ 691
E +
Sbjct: 424 EKLL 427
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-21
Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 5/162 (3%)
Query: 517 SLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSR 576
+ + + + KL +VP D+ S K + ++ N L SF+NF L+ L+LSR
Sbjct: 10 VVPNITYQCMDQKL-SKVPDDIPSS---TKNIDLSFNPLKILKSYSFSNFSELQWLDLSR 65
Query: 577 NHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFS 636
++ + + L L L+ N P + L SLE L L+
Sbjct: 66 CEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIG 125
Query: 637 KLEHLNVLRLDHNNLTG-RIPPGFGTRSSLSIFDVSFNNLSG 677
+L L L + HN + ++P F ++L D+S+N +
Sbjct: 126 QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 19/78 (24%), Positives = 26/78 (33%)
Query: 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
S +L L +L++L ++ N QL L LD SFN
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
Query: 154 LQNCSSLRLINLSGNQFN 171
SL NL+ N
Sbjct: 541 QHFPKSLAFFNLTNNSVA 558
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLIGYH 866
IG+G FG ++A G VAVK L F V +F E+ + R++HPN+V +G
Sbjct: 45 IGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDR-PRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ ++ YL G+L + + R ++ +A DVA+ + YLH P ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKAD 985
R++K N+L+D + DFGL+RL S ++ AGT ++APE ++K+D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 986 VYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG-RPCEFFTAGLWDCGPHD 1044
VYSFGV+L EL + ++ P N + + + R E P +
Sbjct: 222 VYSFGVILWELATLQQ---PW-----GNLNPAQVVAAVGFKCKRL-EI---------PRN 263
Query: 1045 DLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
++ + C RPS + L+ +
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 7e-55
Identities = 72/292 (24%), Positives = 137/292 (46%), Gaps = 42/292 (14%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG-------VQQFAAEIRTLGRV 854
+ IG GGFG +K + VVA+K L +G +G Q+F E+ + +
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
HPN+V L G + ++ ++P G+L + D+ ++WS+ ++ LD+A + Y
Sbjct: 81 NHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 915 LHDECVPRVLHRDIKPSNILLDN-----NLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
+ + P ++HRD++ NI L + + A ++DFGL++ H+ + + G F +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 970 VAPE--YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN-GFNIVAWASMLLLQ 1026
+APE A ++KAD YSF ++L +++ + P F + + + +M+ +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEG---P----FDEYSYGKIKFINMIREE 245
Query: 1027 G-RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
G RP P D + N+ +C RP + ++L ++
Sbjct: 246 GLRP-TI---------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-53
Identities = 76/279 (27%), Positives = 122/279 (43%), Gaps = 29/279 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V+ +G G FG KA VA+K++ + + F E+R L RV HPN+V L
Sbjct: 10 IEVEEVVGRGAFGVVCKA-KWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKL 66
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G + L+ Y GG+L + P + L ++ +AYLH
Sbjct: 67 YG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 922 RVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
++HRD+KP N+LL + DFG A + T T+ G+ ++APE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNY 180
Query: 981 SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG-RPCEFFTAGLWD 1039
S+K DV+S+G++L E+I+ +K P F G + WA + G RP
Sbjct: 181 SEKCDVFSWGIILWEVITRRK---P-FDEIGGPAFRIMWA---VHNGTRP-PL------- 225
Query: 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
+ + +L C + S RPSM ++ + + +
Sbjct: 226 --IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 36/285 (12%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ----GVQQFAAEIRTLGRVQHPNLV 860
++ IG GGFG Y+A G VAVK + ++ E + ++HPN++
Sbjct: 11 LEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L G + E + L+ + GG L + + + + +L A+ +AR + YLHDE +
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 921 PRVLHRDIKPSNILLDNNLNAY--------LSDFGLARLLGTSETHATTDVAGTFGYVAP 972
++HRD+K SNIL+ + ++DFGLAR + AG + ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAP 183
Query: 973 EYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032
E S +DV+S+GV+L EL++ + P G + +A A + +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE---VPF-----RGIDGLAVAYGVAMNKLALPI 235
Query: 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
P L C SRPS + QL I
Sbjct: 236 ---------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-52
Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 34/283 (12%)
Query: 804 NVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVT 861
N + G +K G + VK L V + + F E L HPN++
Sbjct: 13 NFLTKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 862 LIGYHVS--EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
++G S LI +++P G+L + + V+ S K ALD+AR +A+LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE---YAM 976
P + + ++++D ++ A +S + + +VAPE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKP 184
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG-RPCEFFTA 1035
AD++SF V+L EL++ + P F + + + L+G RP
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE---VP-F----ADLSNMEIGMKVALEGLRP-TIPP- 234
Query: 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
PH + L +C E + RP + L+++Q
Sbjct: 235 ---GISPH-----VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-50
Identities = 64/299 (21%), Positives = 111/299 (37%), Gaps = 36/299 (12%)
Query: 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGY 865
IG G +G + G VAVK EI ++H N++ I
Sbjct: 42 VKQIGKGRYGEVWMG-KWRGEKVAVKVFFTTEEAS-WFRETEIYQTVLMRHENILGFIAA 99
Query: 866 ----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE--- 918
S +++LI +Y G+L +++ T++ + K+A L +LH E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 919 --CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH---ATTDVAGTFGYVAPE 973
P + HRD+K NIL+ N ++D GLA + GT Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 974 ------YAMTCRVSDKADVYSFGVVLLELISDKKALD-------PSFCSFGNGFNIVAWA 1020
+ AD+YSFG++L E+ + P + +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 1021 SMLLLQG-RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
++ ++ RP +C +M L C + +SR + +V + L ++
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLR-----QMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-50
Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTL 862
IGSG FG + + VAVK L+V +Q F E+ L + +H N++
Sbjct: 32 IGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY + ++ ++ + G +L + E L IA AR + YLH
Sbjct: 86 MGY-STAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPE---YAMTC 978
++HRD+K +NI L + + DFGLA S +H ++G+ ++APE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 979 RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038
S ++DVY+FG+VL EL++ + P + N N M+ +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQL---P----YSNINNRDQIIEMVGRGSLSPDLSKVRS- 252
Query: 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
+C M L C + RPS ++ +++++
Sbjct: 253 NCPK-----RMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-49
Identities = 72/289 (24%), Positives = 112/289 (38%), Gaps = 44/289 (15%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG K G V+ +K L + + F E++ + ++HPN++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ + I Y+ GG L I+ WS A D+A +AYLH ++HRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRD 133
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHAT-------------TDVAGTFGYVAPEY 974
+ N L+ N N ++DFGLARL+ +T V G ++APE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKA---LDPSFCSFGNGFNIVAWASMLLLQGR--P 1029
+K DV+SFG+VL E+I A P FG
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR----------GFLDRY 243
Query: 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
C P + + + C RPS ++ L+ ++
Sbjct: 244 C-----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 9e-49
Identities = 70/308 (22%), Positives = 118/308 (38%), Gaps = 56/308 (18%)
Query: 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAE--IRTLGRVQHPNLVTLI 863
C+G G +G ++ G VAVK S + + + E + ++H N++ I
Sbjct: 13 LECVGKGRYGEVWRG-SWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 864 GY----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
S +++LI +Y G+L ++Q T++ +I L +A LA+LH E
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 920 V-----PRVLHRDIKPSNILLDNNLNAYLSDFGLARLL---GTSETHATTDVAGTFGYVA 971
P + HRD+K NIL+ N ++D GLA + GT Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 972 PE------YAMTCRVSDKADVYSFGVVLLELIS----------------DKKALDPSFCS 1009
PE + D+++FG+VL E+ D DPSF
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 1010 FGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQ 1069
+ + Q RP D + L C ++ S+R + +
Sbjct: 246 M--------RKVVCVDQQRP-NIPNRWFSDPTLT----SLAKLMKECWYQNPSARLTALR 292
Query: 1070 VAQQLKQI 1077
+ + L +I
Sbjct: 293 IKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 1e-47
Identities = 72/310 (23%), Positives = 120/310 (38%), Gaps = 56/310 (18%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAE--IRTLGRVQHPNLVTL 862
+Q IG G FG ++ G VAVK + + + E I ++H N++
Sbjct: 46 LQESIGKGRFGEVWRG-KWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 863 IG----YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
I + + +++L+ +Y G+L ++ R TV + K+AL A LA+LH E
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 919 CV-----PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH---ATTDVAGTFGYV 970
V P + HRD+K NIL+ N ++D GLA ++ A GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 971 APE------YAMTCRVSDKADVYSFGVVLLELIS----------------DKKALDPSFC 1008
APE +AD+Y+ G+V E+ D DPS
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 1009 SFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMR 1068
+ + RP W + L M + C + ++R +
Sbjct: 279 EM--------RKVVCEQKLRPN---IPNRWQS--CEALRVMAKIMRECWYANGAARLTAL 325
Query: 1069 QVAQQLKQIQ 1078
++ + L Q+
Sbjct: 326 RIKKTLSQLS 335
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 56/292 (19%), Positives = 110/292 (37%), Gaps = 53/292 (18%)
Query: 809 IGSGGFGATYKA----EIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTL 862
IG G FG Y E VA++ + + R ++ F E+ + +H N+V
Sbjct: 41 IGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G +S + +I + G L ++D + ++ + +IA ++ + + YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARL----LGTSETHATTDVAGTFGYVAPE----- 973
+LH+D+K N+ DN ++DFGL + G ++APE
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 974 ----YAMTCRVSDKADVYSFGVVLLELISDK---KALDPSFCSFGNGFNIVAWASMLLLQ 1026
S +DV++ G + EL + + K + G +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM---------- 259
Query: 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
+P G E+ ++ + C RP+ ++ L+++
Sbjct: 260 -KP----NLSQIGMGK-----EISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-42
Identities = 112/578 (19%), Positives = 193/578 (33%), Gaps = 81/578 (14%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
+ L L+FN L++LDLS Q+ S L + L+GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 170 FNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGN 229
S+ SL+ ++ +L +G+
Sbjct: 88 IQ-------------------------SLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 230 CTELRSLLLSSNMLQ-GDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
L+ L ++ N++Q +P F L NLE LDLS N + I ++L + Q+ +L L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 289 DYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW-APNLNLEGIFPQN 347
D N + + + L N + +
Sbjct: 183 DL---------------------SLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 348 WELCSKLEMLNLAHNFFTGQ---IPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVF 404
+ + LE+ L F + + L L + L L + + +F
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL--DYYLDDIIDLF 278
Query: 405 NVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLF 464
N N+ S + ++ S N+ ++L+ F L S
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS-----------L 327
Query: 465 ILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSL-KGNLSTYPFDLCLSLDGLIF 523
F++N +D SL LS N L + SL L
Sbjct: 328 KRLTFTSNKGGN--AFSEVDLPSLEF-----LDLSRNGLSFKGCCSQSDFGTTSLKYL-- 378
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQS-FTNFDSLRNLNLSRNHLQGP 582
D+ N +I + S+ + ++ L + + S F + +L L++S H +
Sbjct: 379 DLSFNGVI-TMSSNF-LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 583 LPSYINKMEDLKFLSLSLNNFTGAIPWE-LTQLASLEVLELSANSLSGEIPSEFSKLEHL 641
N + L+ L ++ N+F + T+L +L L+LS L P+ F+ L L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 642 NVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLSGS 678
VL + N L +P G F +SL + N S
Sbjct: 497 QVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-34
Identities = 108/555 (19%), Positives = 187/555 (33%), Gaps = 69/555 (12%)
Query: 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
S + L S + +L+VL L+ LS L L L+ N
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA 95
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLL-SGSVPEEFGDNCVSLEHI 212
SSL+ + G + ++++ NL+ S +PE F N +LEH+
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-SNLTNLEHL 154
Query: 213 LLAANSLTGSIPPSLGNCTELR----SLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
L++N + L ++ SL LS N + I + + L L L NF S
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDS 213
Query: 269 GIVPSE-LGMCKQLKVLVLR----NDYGPLYSREHGDLPIQPVVDGGE----DYNFFDGG 319
V + L+V L + G L + L + E +++
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 320 LPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLY 379
+ D L N+ F ++ +E + +++ + L L + F L + K L
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL- 330
Query: 380 FLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIG 439
+SN EV +P + ++S+N +S C S
Sbjct: 331 --TFTSNKGGNA-FSEVDLPSLEFLDLSRN-------GLSFKGCCSQS------------ 368
Query: 440 FYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLS 499
++ L L D S N + + + L
Sbjct: 369 ----------------DFGTTS-LKYL-DLSFNGVIT-MSSNFLGLEQLEH-----LDFQ 404
Query: 500 GNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLI 559
++LK F +L L DI + + + + ++ L MAGN F
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYL--DISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 560 PQ-SFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLE 618
FT +L L+LS+ L+ P+ N + L+ L+++ N +L SL+
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQ 521
Query: 619 VLELSANSLSGEIPS 633
+ L N P
Sbjct: 522 KIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-32
Identities = 88/539 (16%), Positives = 164/539 (30%), Gaps = 98/539 (18%)
Query: 158 SSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAAN 217
S + ++LS N F P QV+ LS + + + L ++L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY-QSLSHLSTLILTGN 86
Query: 218 SLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI-VPSELG 276
+ + + L+ L+ L G L L+ L+++ N + +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 277 MCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAP 336
L+ L L + N + L + +
Sbjct: 147 NLTNLEHLDLSS-------------------------NKIQSIYCTDLRVLHQMPL---- 177
Query: 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV 396
L+L+ N I L+ L L +N
Sbjct: 178 ----------------LNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFD-------- 212
Query: 397 SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPF 456
S N++ I ++ E ++ + ++ +L F ++AL
Sbjct: 213 ----------SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL-----EKFDKSALEGLCNL 257
Query: 457 SSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCL 516
+ L L + +++ + S SL +++ F
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV----------SVTIE---RVKDFSYNF 304
Query: 517 SLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSR 576
L ++ N K + S +K L+ N+ S + SL L+LSR
Sbjct: 305 GWQHL--ELVNCKFGQFPTLKLKS----LKRLTFTSNKGGNAF--SEVDLPSLEFLDLSR 356
Query: 577 NHLQ--GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE 634
N L G LK+L LS N + L LE L+ ++L ++
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 414
Query: 635 --FSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQ 691
F L +L L + H + F SSL + ++ N+ + + + N+
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-31
Identities = 82/499 (16%), Positives = 142/499 (28%), Gaps = 83/499 (16%)
Query: 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG 245
+P+ S +++ L+ N L S + EL+ L LS +Q
Sbjct: 11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 246 DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQP 305
++ L +L L L+ N + + L+ LV
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA------------------- 107
Query: 306 VVDGGEDYNFFDGGLPDSITRLPNLRVFW-APNLNLEGIFPQNWELCSKLEMLNLAHNFF 364
I L L+ A NL P+ + + LE L+L+ N
Sbjct: 108 ------VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 365 TGQIPASLGNCKSLYF----LDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISH 420
L + LDLS N + + P + + N S + +
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 421 SECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPP 480
+ + V+ +
Sbjct: 222 QGLAGLEVHR--------------LVLGEFRNEGNLEKFDKSAL---------------- 251
Query: 481 FLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGS 540
+ L + F L+ + F+ ++ F + + I V S
Sbjct: 252 -----EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS--SFSLVSVT-IERVKD--FS 301
Query: 541 HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600
+ + L + +F SL+ L + N + L+FL LS
Sbjct: 302 YNFGWQHLELVNCKFGQF---PTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSR 356
Query: 601 NNFT--GAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG 658
N + G SL+ L+LS N + + S F LE L L H+NL
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS 415
Query: 659 -FGTRSSLSIFDVSFNNLS 676
F + +L D+S +
Sbjct: 416 VFLSLRNLIYLDISHTHTR 434
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 46/239 (19%), Positives = 77/239 (32%), Gaps = 9/239 (3%)
Query: 57 SCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIG---DLTQLR 113
S ++ + + G + Q + S + N DL L
Sbjct: 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLE 350
Query: 114 VLLLAFNG--FSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFN 171
L L+ NG F G + L+ LDLSFN + L ++ +
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
Query: 172 GTIPA-FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGN 229
F + +S + SLE + +A NS + P
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 230 CTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
L L LS L+ P++F L +L+VL+++ N L + L+ + L
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHT 527
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-18
Identities = 37/180 (20%), Positives = 69/180 (38%), Gaps = 12/180 (6%)
Query: 520 GLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHL 579
+ + ++P ++ K L ++ N L SF +F L+ L+LSR +
Sbjct: 9 NITYQCMELNFY-KIPDNLPFS---TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 64
Query: 580 QGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLE 639
Q + L L L+ N + L+SL+ L +L+ L+
Sbjct: 65 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 640 HLNVLRLDHNNLT-GRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQL 698
L L + HN + ++P F ++L D+S N + I C +++ + L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-------IYCTDLRVLHQMPL 177
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-41
Identities = 137/686 (19%), Positives = 232/686 (33%), Gaps = 88/686 (12%)
Query: 101 NLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP-TLQNCSS 159
NL++ L LLL+FN L L++L+L I +N +
Sbjct: 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 160 LRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS-GSVPEEFGDNCVSLEHILLAANS 218
LR+++L ++ P F + L F LS + + + N +L + L+ N
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 219 LTG-SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQL--VNLEVLDLSRNFLSGIVPSEL 275
+ + PS G L+S+ SSN + L L L+ N L V +
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 276 GMCKQ-LKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW 334
G C + +VL L +G G N S+ ++
Sbjct: 195 GKCMNPFRNMVLEI----LDVSGNGWTVDIT----GNFSNAISKSQAFSLILAHHIMGAG 246
Query: 335 APNLNLEGIFPQNWE-LC-SKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLL 392
N++ + L S + L+L+H F K L L+L+ N + +
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA 306
Query: 393 PEE-VSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALT 451
E + + V N+S NLL E+ + K++ +DL +N +
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAY------IDL--------QKNHIA 351
Query: 452 --SCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLST 509
F L L D +N T + S+ +LSGN L L
Sbjct: 352 IIQDQTFKFLEK-LQTL-DLRDNALT-----TIHFIPSIPD-----IFLSGNKLV-TLPK 398
Query: 510 YPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQS-FTNFDS 568
++L + + N+L ++ L + N F + S
Sbjct: 399 ------INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452
Query: 569 LRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLS 628
L L L N LQ + + L+ L+VL L+ N L+
Sbjct: 453 LEQLFLGENMLQLAWETELC-------------------WDVFEGLSHLQVLYLNHNYLN 493
Query: 629 GEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCE 688
P FS L L L L+ N LT + ++L I D+S N L + + +
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLS 550
Query: 689 NVQGNPNLQLCHTDPSS-SEWERQH----SGNVSQQEAYSPSESIQGNS------SGLNP 737
+ N +C + S+ W +G + P +S G S G +
Sbjct: 551 VLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYP-DSFSGVSLFSLSTEGCDE 609
Query: 738 IEIASITSAAVILSVLIALVLLLICM 763
E+ ++ + + L L L+ +
Sbjct: 610 EEVLKSLKFSLFIVCTVTLTLFLMTI 635
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-22
Identities = 75/465 (16%), Positives = 134/465 (28%), Gaps = 108/465 (23%)
Query: 217 NSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSE-L 275
+LT +P L LLLS N ++ SSF L L++L+L + + E
Sbjct: 14 CNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAF 69
Query: 276 GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWA 335
L++L L + + I L
Sbjct: 70 RNLPNLRILDLGS-------------------------S--------KIYFLH------- 89
Query: 336 PNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQI--PASLGNCKSLYFLDLSSNNLTGLLP 393
F + L L L + + N K+L LDLS N +
Sbjct: 90 -----PDAF----QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR---- 136
Query: 394 EEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSC 453
S+ F ++ + I F + +
Sbjct: 137 ---SLYLHPSFG-------------------------KLNSLKSIDFSSNQIFLVCEHEL 168
Query: 454 APFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFD 513
P + L +N+L++ + + + +SGN +++ +
Sbjct: 169 EPLQGKT--LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
Query: 514 LCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFD--SLRN 571
+ ++ + + +F S+R+
Sbjct: 227 AISKSQAFSLILAHH----------------IMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 572 LNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEI 631
L+LS + ++DLK L+L+ N L +L+VL LS N L
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330
Query: 632 PSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
S F L + + L N++ F L D+ N L+
Sbjct: 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-21
Identities = 75/386 (19%), Positives = 131/386 (33%), Gaps = 42/386 (10%)
Query: 98 LSGN-----LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP 152
LS SR L L+VL LA+N + L L++L+LS+N
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332
Query: 153 TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212
+ I+L N F Q + L N L+ S+ I
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT------TIHFIPSIPDI 386
Query: 213 LLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG-DIPSSFGQLVNLEVLDLSRNFLSGIV 271
L+ N L ++P + LS N L+ DI ++ +L++L L++N S
Sbjct: 387 FLSGNKLV-TLPK---INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCS 442
Query: 272 PSEL-GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNL 330
+ L+ L L +Q + ++ F+G L +L
Sbjct: 443 GDQTPSENPSLEQLFLGE------------NMLQLAWETELCWDVFEG--------LSHL 482
Query: 331 RVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390
+V + + L + P + + L L+L N T + + +L LD+S N L
Sbjct: 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLA 540
Query: 391 LLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMS-VNWSMSQVDLIGFYTAFFYENA 449
++V +++ N E + + V + D+ Y F +
Sbjct: 541 P--NPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVS 598
Query: 450 LTSCAPFSSPSNGLFILHDFSNNLFT 475
L S + + FS +
Sbjct: 599 LFSLSTEGCDEEEVLKSLKFSLFIVC 624
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-15
Identities = 56/365 (15%), Positives = 110/365 (30%), Gaps = 51/365 (13%)
Query: 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV 396
NL + + E L L+ N+ +S + L L+L S + +E
Sbjct: 13 FCNLTQVPQVL----NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68
Query: 397 --SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCA 454
++P + + ++ + + + + + + L Y L+
Sbjct: 69 FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFE------LRL--------YFCGLSDAV 113
Query: 455 PFSSPSNGLFILH--DFSNNLFTG-PVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYP 511
L L D S N + P +SL S S N + + +
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKS-----IDFSSNQIF-LVCEHE 167
Query: 512 FDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLS-----------------MAGNE 554
+ F + N L V D G + + N
Sbjct: 168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA 227
Query: 555 FVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMED--LKFLSLSLNNFTGAIPWELT 612
S + ++++ P + + ++ L LS
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE 287
Query: 613 QLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVS 671
L L+VL L+ N ++ F L++L VL L +N L + F ++ D+
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQ 346
Query: 672 FNNLS 676
N+++
Sbjct: 347 KNHIA 351
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-39
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 11/208 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL 859
+ IG G FG + G +K +++ R + ++ E+ L ++HPN+
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V ++++ +Y GG+L K I + + + + + AL ++HD
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR- 144
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
++LHRDIK NI L + L DFG+AR+L ++ A GT Y++PE
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKP 201
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSF 1007
++K+D+++ G VL EL L +F
Sbjct: 202 YNNKSDIWALGCVLYELC----TLKHAF 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG----VQQFAAEIRTLGRVQHPNLVTLI 863
+G GG G Y+AE + +VA+K +S + E RT GR+Q P++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDR----PRRTVEWSMLHKIALDVARALAYLHDEC 919
+ + ++++ + G +L ++ + P R V I + AL H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA------IVRQIGSALDAAHAA- 153
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
HRD+KP NIL+ + AYL DFG+A + + GT Y+APE
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 980 VSDKADVYSFGVVLLELI 997
+ +AD+Y+ VL E +
Sbjct: 212 ATYRADIYALTCVLYECL 229
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
F IGSGGFG +KA+ I G +KR+ ++ E++ L ++ H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 862 LIGYHVSEAEM----------------FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIA 905
G F+ + G LE++I+ R ++ + ++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
+ + + Y+H + ++++RD+KPSNI L + + DFGL L + G
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--KG 183
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
T Y++PE + + D+Y+ G++L EL+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 7e-37
Identities = 88/504 (17%), Positives = 160/504 (31%), Gaps = 73/504 (14%)
Query: 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSN 241
V + S+P +++ + L+ N +T L C L+ L+L S+
Sbjct: 5 DASGVCDGRSRSFT-SIPS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 242 MLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDL 301
+ +F L +LE LDLS N LS + S G LK L L
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL--------------- 105
Query: 302 PIQPVVDGGEDYNFFDG-GLPDSITRLPNLRVFW-APNLNLEGIFPQNWELCSKLEMLNL 359
N + G+ L NL+ I ++ + L L +
Sbjct: 106 ----------MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155
Query: 360 AHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNL--LSGEIPR 417
SL + + ++ L L + LL ++ ++ L
Sbjct: 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI--------FADILSSVRYLELRDTN 207
Query: 418 ISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGP 477
++ + S + V+ S + + F + + + N L L + L
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF----------NELLKLLRYILELSEV- 256
Query: 478 VPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSD 537
G S +S +++ L I + S
Sbjct: 257 ---------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL--HIPQFY-LFYDLST 304
Query: 538 MGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ---GPLPSYINKMEDLK 594
+ S + +K +++ ++ + + SL L+LS N + + L+
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 595 FLSLSLNNFT--GAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
L LS N+ L L +L L++S N+ +P E + L L +
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
Query: 653 GRIPPGFGTRSSLSIFDVSFNNLS 676
+ +L + DVS NNL
Sbjct: 424 -VVKTCIPQ--TLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-36
Identities = 97/576 (16%), Positives = 187/576 (32%), Gaps = 63/576 (10%)
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
+C + + + F +IP+ G + + + LSFN ++ + C +L+ ++L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDL-RACANLQVLILK 58
Query: 216 ANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI-VPSE 274
++ + + + L L LS N L S FG L +L+ L+L N + V S
Sbjct: 59 SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 275 LGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW 334
L+ L + N F L +L
Sbjct: 119 FPNLTNLQTLRIGN------------------------VETFSEIRRIDFAGLTSLNELE 154
Query: 335 APNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPE 394
L+L Q+ + + L L + + S+ +L+L NL
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214
Query: 395 EVSVPCMAVFNVSQNLLSGEIPRISHSECSKM-SVNWSMSQVDLIGFYTAFFYENALTSC 453
+ V ++ + S +E K+ +S+V+ + +
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274
Query: 454 APFSSPSN-GLFILH--DFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTY 510
S + + + + + + +
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR-----ITVENS----KVFLV 325
Query: 511 PFDLCLSLDGLIF-DIGNNKLIGEVPSDMG--SHCKCMKFLSMAGNEFVGL--IPQSFTN 565
P L L F D+ N ++ E + ++ L ++ N + +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 566 FDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSAN 625
+L +L++SRN P+P E ++FL+LS + + +LEVL++S N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNN 441
Query: 626 SLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLI 685
+L +L+ L + N L +P L + +S N L S P
Sbjct: 442 NLD-SFSLFLPRLQELY---ISRNKLK-TLPDASLF-PVLLVMKISRNQLK-SVPDGIFD 494
Query: 686 KCENVQ-----GNPNLQLCHTDPSSSEWERQHSGNV 716
+ ++Q NP C S W ++S
Sbjct: 495 RLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKE 530
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-32
Identities = 88/547 (16%), Positives = 178/547 (32%), Gaps = 66/547 (12%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168
++ L L+FN + ++ + L++L L + + + SL ++LS N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 169 QFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SL 227
+ ++FG + ++L N N +L+ + + I
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 228 GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287
T L L + + L+ S + ++ L L + + ++ + ++ L LR
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204
Query: 288 NDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPD-SITRLPNLRVFWAPNLNLEGIFPQ 346
+ L + LP+ V + F L D S L L + +E
Sbjct: 205 DTN--LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE----- 257
Query: 347 NWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSV-PCMAVFN 405
++ C+ + + + ++ L + L L S+ +
Sbjct: 258 -FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 406 VSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFI 465
V + ++ + S + L
Sbjct: 317 VENS----KVFLVPCSFSQHLK----------------------------------SLEF 338
Query: 466 LHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGL-IFD 524
L D S NL + S LS N L+ ++ ++ L+L L D
Sbjct: 339 L-DLSENLMVEEYLKNSACKGAWPS--LQTLVLSQNHLR-SMQKTG-EILLTLKNLTSLD 393
Query: 525 IGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLP 584
I N +P + M+FL+++ + +L L++S N+L
Sbjct: 394 ISRNT-FHPMPDSCQWP-EKMRFLNLSSTGIRVV---KTCIPQTLEVLDVSNNNLDS-FS 447
Query: 585 SYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVL 644
++ + L+ L +S N +P + + L V+++S N L F +L L +
Sbjct: 448 LFLPR---LQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKI 502
Query: 645 RLDHNNL 651
L N
Sbjct: 503 WLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 84/518 (16%), Positives = 155/518 (29%), Gaps = 77/518 (14%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG-PIP 151
L + A L L L L+ N S G LS L+ L+L N + +
Sbjct: 57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 152 PTLQNCSSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLE 210
N ++L+ + + + I F + + L + + +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL-KSIRDIH 175
Query: 211 HILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI 270
H+ L + + + +R L L L S + S +
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 271 VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNL 330
+L +L D + + D + + D +
Sbjct: 236 TDESFNELLKLLRYILELSEVEFD-----DCTLNGLGDF--NPSESDVVSELGKVETVTI 288
Query: 331 RVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLG-NCKSLYFLDLSSNNLT 389
R P L + L K++ + + ++ +P S + KSL FLDLS N +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347
Query: 390 GLLPEEVSV----PCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFF 445
+ + P + +SQN L + +
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEI------------------------ 382
Query: 446 YENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKG 505
+ N L L D S N F P+P + + LS
Sbjct: 383 ----------LLTLKN-LTSL-DISRNTFH-PMPDSCQWPEKMRF-----LNLSST---- 420
Query: 506 NLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTN 565
+ + +L+ L D+ NN L + ++ L ++ N+ L S
Sbjct: 421 GIRVVKTCIPQTLEVL--DVSNNNL-DSFSLFLPR----LQELYISRNKLKTLPDASL-- 471
Query: 566 FDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNF 603
F L + +SRN L+ +++ L+ + L N +
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-20
Identities = 52/354 (14%), Positives = 98/354 (27%), Gaps = 49/354 (13%)
Query: 43 RVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNL 102
V L L +L + P S L + + N KL +
Sbjct: 197 SVRYLELRDT------NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI 250
Query: 103 SR----AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCS 158
D T + + L + + L + +
Sbjct: 251 LELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLE 310
Query: 159 SLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFG--DNCVSLEHILLAA 216
++ I + ++ +F + + LS NL+ + SL+ ++L+
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 217 NSLT--GSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSE 274
N L L L SL +S N +P S + L+LS + +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCI 429
Query: 275 LGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW 334
+ L+VL + N+ L LP L+ +
Sbjct: 430 P---QTLEVLDVSNNN-----------------------------LDSFSLFLPRLQELY 457
Query: 335 APNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNL 388
L+ + + L L ++ ++ N SL + L +N
Sbjct: 458 ISRNKLKTL--PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-18
Identities = 49/369 (13%), Positives = 97/369 (26%), Gaps = 66/369 (17%)
Query: 45 TSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSR 104
LNL N +L + + L++ N + ++
Sbjct: 101 KYLNLMGN------PYQTLGVTSLFPNLTNLQT--LRIG-------NVETFSEIR---RI 142
Query: 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN 164
LT L L + + + + L L + + SS+R +
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL----------- 213
L + + S E F + L +IL
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
Query: 214 ------LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267
+ +R L + L D+ + + L ++ + + + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 268 SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFF---DGGLPDSI 324
+ S K L+ L L N
Sbjct: 323 FLVPCSFSQHLKSLEFLDL-------------------------SENLMVEEYLKNSACK 357
Query: 325 TRLPNLRVFWAPNLNLEGIFPQNWELCS--KLEMLNLAHNFFTGQIPASLGNCKSLYFLD 382
P+L+ +L + L + L L+++ N F +P S + + FL+
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 383 LSSNNLTGL 391
LSS + +
Sbjct: 417 LSSTGIRVV 425
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-10
Identities = 39/179 (21%), Positives = 67/179 (37%), Gaps = 27/179 (15%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIG---QLSLLEILDLSFNS 145
+++ N + S G L+ L+L+ N + L L LD+S N+
Sbjct: 340 DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNT 398
Query: 146 FHGPIPPTLQNCSSLRLINLSGNQF-----------------NGTIPAFFGQSPGFQVVS 188
FH P+P + Q +R +NLS N + +F P Q +
Sbjct: 399 FH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELY 457
Query: 189 LSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPS-LGNCTELRSLLLSSNMLQGD 246
+S N L ++P+ L + ++ N L S+P T L+ + L +N
Sbjct: 458 ISRNKLK-TLPD--ASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 512
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-37
Identities = 67/305 (21%), Positives = 114/305 (37%), Gaps = 53/305 (17%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ +G GGF E + G A+KR+ Q ++ E HPN++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 862 LIGYHVSEA----EMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYL 915
L+ Y + E E +L+ + G L I+ + + + + L + R L +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL-----GTSETHATTDVA---GTF 967
H HRD+KP+NILL + L D G G+ + D A T
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 968 GYVAPE------YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWAS 1021
Y APE + C + ++ DV+S G VL ++ + + + +
Sbjct: 208 SYRAPELFSVQSH---CVIDERTDVWSLGCVLYAMM----FGEGPY----DMVFQKGDSV 256
Query: 1022 MLLLQGR----PCEFFTAGLWDCGPHDDLIE-MLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076
L +Q + ++ LW L+ M+ RP + + QL+
Sbjct: 257 ALAVQNQLSIPQSPRHSSALW------QLLNSMMT-------VDPHQRPHIPLLLSQLEA 303
Query: 1077 IQPPA 1081
+QPPA
Sbjct: 304 LQPPA 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL 859
+ V IG+G +G K G ++ K L G Q +E+ L ++HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 860 VTLIGYHVSEA--EMFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYL 915
V + ++++ Y GG+L I + R+ ++ + ++ + AL
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 916 HDECVP--RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
H VLHRD+KP+N+ LD N L DFGLAR+L + A T V GT Y++PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPE 186
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSF 1007
++K+D++S G +L EL AL P F
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELC----ALMPPF 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-36
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 26/206 (12%)
Query: 805 VQNCIGSGGFGATYKAE--IIPGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
V+ CI GG G Y A + G V +K L G + AE + L V HP++V
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 862 LIGY-----HVSEAEMFLIYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAY 914
+ + + +++ Y+ G +L++ + + L++ AL+Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA------YLLEILPALSY 197
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
LH +++ D+KP NI+L L D G + + + GT G+ APE
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPEI 248
Query: 975 AMTCRVSDKADVYSFGVVLLELISDK 1000
T + D+Y+ G L L D
Sbjct: 249 VRT-GPTVATDIYTVGRTLAALTLDL 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 67/292 (22%), Positives = 123/292 (42%), Gaps = 43/292 (14%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPN 858
F ++ IG G F Y+A ++ GV VA+K++ + + EI L ++ HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE------WSMLHKIALDVARAL 912
++ + + E+ ++ G+L + I+ ++ W ++ AL
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----AL 149
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
++H RV+HRDIKP+N+ + L D GL R + T A + + GT Y++P
Sbjct: 150 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSP 205
Query: 973 EYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR---- 1028
E + K+D++S G +L E+ AL F +G+ N+ + + Q
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMA----ALQSPF--YGDKMNLYS-LCKKIEQCDYPPL 258
Query: 1029 PCEFFTAGLWDCGPHDDLIE-MLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079
P + ++ L L+ +N RP + V K++
Sbjct: 259 PSDHYSEELR------QLVNMCINP-------DPEKRPDVTYVYDVAKRMHA 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 43/306 (14%), Positives = 92/306 (30%), Gaps = 44/306 (14%)
Query: 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSL--LEILDLSFNSFHGPIPPTLQNCSSLRLI 163
+ ++ + + L+L P S L+ +
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHM 109
Query: 164 NLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSI 223
+ +P Q G + ++L+ N L ++P + L + + A +
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIA-SLNRLRELSIRACPELTEL 166
Query: 224 PPSLGNC---------TELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSE 274
P L + L+SL L ++ +P+S L NL+ L + + LS +
Sbjct: 167 PEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPA 224
Query: 275 LGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW 334
+ +L+ L LR P L+
Sbjct: 225 IHHLPKLEELDLRG------------------------CTAL-RNYPPIFGGRAPLKRLI 259
Query: 335 APNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPE 394
+ + P + ++LE L+L ++P+ + + + + + L
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
Query: 395 E-VSVP 399
V+ P
Sbjct: 320 RPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 51/311 (16%), Positives = 92/311 (29%), Gaps = 30/311 (9%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168
+ L + + Q D + N ++ ++ +G
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66
Query: 169 QFNGTIPAFFGQ--SPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPS 226
PG + L L P++ L+H+ + A L +P +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAF-RLSHLQHMTIDAAGLM-ELPDT 122
Query: 227 LGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL 286
+ L +L L+ N L+ +P+S L L L + +P L
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH-- 179
Query: 287 RNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQ 346
L + + L ++ LP SI L NL+ N L +
Sbjct: 180 ----QGLVNLQSLRL----------EWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GP 223
Query: 347 NWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFN 405
KLE L+L P G L L L + LP ++ + + +
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283
Query: 406 VSQNLLSGEIP 416
+ + +P
Sbjct: 284 LRGCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 39/205 (19%), Positives = 71/205 (34%), Gaps = 19/205 (9%)
Query: 98 LSGN----LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
+ L + L L LA N LP I L+ L L + +P
Sbjct: 111 IDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169
Query: 154 LQNCS---------SLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGD 204
L + +L+ + L ++PA + + + + LS ++
Sbjct: 170 LASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH- 226
Query: 205 NCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSS-NMLQGDIPSSFGQLVNLEVLDLS 263
+ LE + L + + PP G L+ L+L + L +P +L LE LDL
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLR 285
Query: 264 RNFLSGIVPSELGMCKQLKVLVLRN 288
+PS + ++++
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPP 310
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 41/269 (15%), Positives = 81/269 (30%), Gaps = 27/269 (10%)
Query: 129 EIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVS 188
S E L ++ P L + + S Q+ +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIET 62
Query: 189 LSFNLLSGSVPEEFGD-NCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDI 247
+ L + + D + L + L P + L+ + + + L ++
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 248 PSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVV 307
P + Q LE L L+RN L + P+ + +L+ L +R E +LP
Sbjct: 120 PDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRA------CPELTELP----- 167
Query: 308 DGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQ 367
L NL+ + + P + L+ L + ++ +
Sbjct: 168 -----EPLASTDASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLS-A 220
Query: 368 IPASLGNCKSLYFLDLSSNNLTGLLPEEV 396
+ ++ + L LDL P
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 34/185 (18%), Positives = 70/185 (37%), Gaps = 18/185 (9%)
Query: 98 LSGN----LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSL---------LEILDLSFN 144
L+ N L +I L +LR L + ELP + L+ L L +
Sbjct: 134 LARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 145 SFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGD 204
+P ++ N +L+ + + + + + P + + L + P FG
Sbjct: 194 GIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFG- 250
Query: 205 NCVSLEHILLA-ANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
L+ ++L ++L ++P + T+L L L + +PS QL ++ +
Sbjct: 251 GRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309
Query: 264 RNFLS 268
+ +
Sbjct: 310 PHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 39/201 (19%), Positives = 66/201 (32%), Gaps = 27/201 (13%)
Query: 496 FWLSGNSLK------GNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGS--------H 541
L+ N L+ +L+ L L I + E+P + S
Sbjct: 132 LTLARNPLRALPASIASLN--------RLREL--SIRACPELTELPEPLASTDASGEHQG 181
Query: 542 CKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLN 601
++ L + L P S N +L++L + + L L I+ + L+ L L
Sbjct: 182 LVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGC 239
Query: 602 NFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGT 661
P A L+ L L S +P + +L L L L R+P
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
Query: 662 RSSLSIFDVSFNNLSGSAPRN 682
+ I V +L ++
Sbjct: 300 LPANCIILVP-PHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 48/418 (11%), Positives = 98/418 (23%), Gaps = 105/418 (25%)
Query: 205 NCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSR 264
+ E++ ++ L + + N ++ +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTG 65
Query: 265 NFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSI 324
L L Q + L PL PD
Sbjct: 66 RALKAT-ADLLEDATQPGRVALELRSVPLPQ------------------------FPDQA 100
Query: 325 TRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLS 384
RL +L+ + + ++P ++ L L L+
Sbjct: 101 FRLSHLQH------------------------MTIDAAGLM-ELPDTMQQFAGLETLTLA 135
Query: 385 SNNLTGLLPEEV-SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTA 443
N L L P + S+ + ++ E+P + + A
Sbjct: 136 RNPLRAL-PASIASLNRLRELSIRACPELTELP-------------------EPLASTDA 175
Query: 444 FFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSL 503
L + L L +P + + +L S + + L
Sbjct: 176 SGEHQGLVN----------LQSL-RLEWTGIRS-LPASIANLQNLKS-----LKIRNSPL 218
Query: 504 KGNLSTYPFDLCLSLDGL----IFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLI 559
L ++ L D+ + P G +K L + + +
Sbjct: 219 SA--------LGPAIHHLPKLEELDLRGCTALRNYPPIFG-GRAPLKRLILKDCSNLLTL 269
Query: 560 PQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASL 617
P L L+L LPS I ++ + + + +
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 22/138 (15%), Positives = 43/138 (31%), Gaps = 9/138 (6%)
Query: 541 HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600
H + L G+ + + + N + +R H + + + +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTG 65
Query: 601 NNFTGAIPWELTQLAS--LEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG 658
A L LEL + L + P + +L HL + +D L +P
Sbjct: 66 RALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122
Query: 659 FGTRSSLSIFDVSFNNLS 676
+ L ++ N L
Sbjct: 123 MQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 32/182 (17%), Positives = 53/182 (29%), Gaps = 19/182 (10%)
Query: 221 GSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPS------E 274
GS + + +L + Q D +R + + E
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 275 LGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW 334
+ LK + R +L PD RL +L+
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALEL----------RSVPLP-QFPDQAFRLSHLQHMT 110
Query: 335 APNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPE 394
L + P + + LE L LA N +PAS+ + L L + + LPE
Sbjct: 111 IDAAGLMEL-PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168
Query: 395 EV 396
+
Sbjct: 169 PL 170
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 76/288 (26%), Positives = 119/288 (41%), Gaps = 33/288 (11%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q + ++ L + + + + YL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCR 979
R +HRD+ NIL++N + DFGL ++L + G + APE +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM-------LLLQGR--PC 1030
S +DV+SFGVVL EL + + F M LL P
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR 253
Query: 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
P E+ + C +++ RPS R +A ++ QI+
Sbjct: 254 -----------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 8e-36
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 5/196 (2%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
++ +G G FG + VA+K L G + F E + + +++H LV L
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
VSE ++++ Y+ G+L F++ + + L +A +A +AY+
Sbjct: 245 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+HRD++ +NIL+ NL ++DFGLARL+ +E A + APE A+ R +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 983 KADVYSFGVVLLELIS 998
K+DV+SFG++L EL +
Sbjct: 361 KSDVWSFGILLTELTT 376
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLV 860
F C+G GGFG ++A+ + A+KR+ + + ++ E++ L +++HP +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 861 TLIGYHVSEAEM------------FLIYNYLPGGNLEKFIQDRPRRT-VEWSMLHKIALD 907
+ + ++ NL+ ++ R E S+ I L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA--- 964
+A A+ +LH + ++HRD+KPSNI + + DFGL + E T
Sbjct: 127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 965 --------GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
GT Y++PE S K D++S G++L EL+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 805 VQNCIGSGGFGATYKAE-IIPGVVVAVKRLS---------VGRFQGVQQFAAEIRTLGRV 854
+ + +G GG Y AE I + VA+K + + RF+ E+ ++
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE------REVHNSSQL 68
Query: 855 QHPNLVTLIGYHVSEAE--MFLIYNYLPGGNLEKFIQDR----PRRTVEWSMLHKIALDV 908
H N+V++ V E + +L+ Y+ G L ++I+ + +
Sbjct: 69 SHQNIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN------FTNQI 120
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
+ + HD R++HRDIKP NIL+D+N + DFG+A+ L + T V GT
Sbjct: 121 LDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y +PE A + D+YS G+VL E++
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 76/287 (26%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q + ++ L + + + + YL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCR 979
R +HRD+ NIL++N + DFGL ++L + + G + APE +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM-------LLLQGR--PC 1030
S +DV+SFGVVL EL + + F M LL P
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR 284
Query: 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
P E+ + C +++ RPS R +A ++ QI
Sbjct: 285 -----------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 53/232 (22%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
F +G G FG KA + A+K++ + + +E+ L + H +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 862 LIGYHV-------------SEAEMFLIYNYLPGGNLEKFIQDRPRRTVE---WSMLHKIA 905
+ ++ +F+ Y G L I W + +I
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL------------- 952
AL+Y+H + ++HRD+KP NI +D + N + DFGLA+ +
Sbjct: 127 E----ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 953 -GTSETHATTDVAGTFGYVAPE-------YAMTCRVSDKADVYSFGVVLLEL 996
S + T+ + GT YVA E Y ++K D+YS G++ E+
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHY------NEKIDMYSLGIIFFEM 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-35
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+++ +G G +G Y+ + VAVK L + V++F E + ++HPNLV
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 280
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L+G E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL +
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--- 337
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+HR++ N L+ N ++DFGL+RL+ A + APE + S
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 982 DKADVYSFGVVLLELIS 998
K+DV++FGV+L E+ +
Sbjct: 398 IKSDVWAFGVLLWEIAT 414
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F + +G G FG Y A E ++A+K L + + Q E+ ++HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ L GY ++LI Y P G + + +Q + + + ++A AL+Y H +
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--ATYITELANALSYCHSK 128
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
RV+HRDIKP N+LL + ++DFG + S GT Y+ PE
Sbjct: 129 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDL--CGTLDYLPPEMIEGR 182
Query: 979 RVSDKADVYSFGVVLLELI 997
+K D++S GV+ E +
Sbjct: 183 MHDEKVDLWSLGVLCYEFL 201
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 5/194 (2%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
++ +G G FG + VA+K L G + F E + + +++H LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
VSE ++++ Y+ G+L F++ + + L +A +A +AY+ +
Sbjct: 330 V-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA 984
HRD++ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 985 DVYSFGVVLLELIS 998
DV+SFG++L EL +
Sbjct: 446 DVWSFGILLTELTT 459
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 65/285 (22%), Positives = 109/285 (38%), Gaps = 46/285 (16%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVT 861
F ++ +G G G + VAVKR+ F + E++ L +HPN++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIR 82
Query: 862 LIGYHVSEAEMFLIYNYLP----GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + F Y+ L+++++ + + + + LA+LH
Sbjct: 83 Y--FCTEKDRQFQ---YIAIELCAATLQEYVEQKDFAHLGLEPIT-LLQQTTSGLAHLHS 136
Query: 918 ECVPRVLHRDIKPSNILLDN-----NLNAYLSDFGLARLL--GTSETHATTDVAGTFGYV 970
++HRD+KP NIL+ + A +SDFGL + L G + V GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 971 APEY---AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027
APE + D++S G V +IS+ P FG A +L G
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--P----FGKSLQRQA----NILLG 243
Query: 1028 RPCEFFTAGLWDCGPH-DDLIE-MLNLAIMCTGESLSSRPSMRQV 1070
+LIE M+ + RPS + V
Sbjct: 244 ACSLDCLHPEKHEDVIARELIEKMIAM-------DPQKRPSAKHV 281
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-34
Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 9/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLV 860
+ IG G FG + + +VAVK +F E R L + HPN+V
Sbjct: 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
LIG + ++++ + GG+ F++ + L ++ D A + YL +
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK-- 232
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTC 978
+HRD+ N L+ +SDFG++R +A + APE
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 979 RVSDKADVYSFGVVLLELISD 999
R S ++DV+SFG++L E S
Sbjct: 291 RYSSESDVWSFGILLWETFSL 311
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-34
Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 5/194 (2%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
++ +G+G FG + A VAVK + G V+ F AE + +QH LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
V++ +++I ++ G+L F++ L + +A +A++ +
Sbjct: 251 V-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA 984
HRD++ +NIL+ +L ++DFGLAR++ +E A + APE + K+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 985 DVYSFGVVLLELIS 998
DV+SFG++L+E+++
Sbjct: 367 DVWSFGILLMEIVT 380
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 15/198 (7%)
Query: 808 CIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG G F YK + V VA L + Q+F E L +QHPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 865 YHV----SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
+ + L+ + G L+ +++ + ++ +L + + L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH-TRT 149
Query: 921 PRVLHRDIKPSNILLDNNL-NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
P ++HRD+K NI + + + D GLA L S V GT ++APE +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM-YEEK 205
Query: 980 VSDKADVYSFGVVLLELI 997
+ DVY+FG+ +LE+
Sbjct: 206 YDESVDVYAFGMCMLEMA 223
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 42/211 (19%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL- 859
+++ IGSGG ++ + A+K +++ Q + + EI L ++Q +
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 860 -VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ L Y +++ ++++ +L +++ + ++ A+ +H
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK--SYWKNMLEAVHTIHQH 146
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPE---- 973
++H D+KP+N L+ + L DFG+A + T D GT Y+ PE
Sbjct: 147 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 974 -------YAMTCRVSDKADVYSFGVVLLELI 997
++S K+DV+S G +L +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G +VAVK+L + F EI+ L + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + L+ YLP G L F+Q R ++ S L + + + + YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCR 979
R +HRD+ NIL+++ + ++DFGLA+LL + + G + APE
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 980 VSDKADVYSFGVVLLELIS 998
S ++DV+SFGVVL EL +
Sbjct: 207 FSRQSDVWSFGVVLYELFT 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F++ +G G FG Y A E ++A+K L + + Q EI ++HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ + Y ++L+ + P G L K +Q + R E + ++A AL Y H+
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFME-ELADALHYCHER 133
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
+V+HRDIKP N+L+ ++DFG + + T GT Y+ PE
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPEMIEGK 187
Query: 979 RVSDKADVYSFGVVLLELI 997
+K D++ GV+ E +
Sbjct: 188 THDEKVDLWCAGVLCYEFL 206
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 809 IGSGGFGATYKAEIIPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTLIG 864
+G G FG+ + + VA+K L G + + E + + ++ +P +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 865 YHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
V +AE + L+ GG L KF+ + R + S + ++ V+ + YL ++
Sbjct: 78 --VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NF 131
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRVS 981
+HRD+ N+LL N A +SDFGL++ LG +++ T AG + + APE + S
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + E +S
Sbjct: 192 SRSDVWSYGVTMWEALS 208
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQ---FAAEIRTLGRVQHPNLVT 861
+G G FG + A V VAVK L + F E+ + + H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L G V M ++ P G+L ++ + L + A+ VA + YL +
Sbjct: 86 LYGV-VLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCR 979
R +HRD+ N+LL + DFGL R L ++ H + APE T
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 980 VSDKADVYSFGVVLLELIS 998
S +D + FGV L E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIPG-----VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + E + V +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 83 LGI-CLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+ +G+G FG + VAVK L G F AE + ++QH LV L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
V++ +++I Y+ G+L F++ + + L +A +A +A++ +
Sbjct: 74 YAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCRV 980
+HRD++ +NIL+ + L+ ++DFGLARL+ + T F APE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 981 SDKADVYSFGVVLLELIS 998
+ K+DV+SFG++L E+++
Sbjct: 188 TIKSDVWSFGILLTEIVT 205
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRV-QHPN 858
F + +G G +G +K G + AVKR + + AE+ + +V QHP
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L ++L G +L++ + E + + D ALA+LH +
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE-AQVWGYLRDTLLALAHLHSQ 176
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE----- 973
++H D+KP+NI L L DFGL LGT+ G Y+APE
Sbjct: 177 ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQGS 231
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKK 1001
Y ADV+S G+ +LE+ + +
Sbjct: 232 Y------GTAADVFSLGLTILEVACNME 253
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG P G VAVK L + EI L + H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 863 IG--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G + LI +LP G+L++++ + + K A+ + + + YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTC 978
+ +HRD+ N+L+++ + DFGL + + T + + T + APE M
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 979 RVSDKADVYSFGVVLLELIS 998
+ +DV+SFGV L EL++
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 805 VQNCIGSGGFGATYKAE-IIPGVVVAVKRL---------SVGRFQGVQQFAAEIRTLGRV 854
+ +G GG + A + VAVK L RF+ E + +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR------REAQNAAAL 69
Query: 855 QHPNLVTLIGYHVSEAEM------FLIYNYLPGGNLEKFIQDR----PRRTVEWSMLHKI 904
HP +V + Y EAE +++ Y+ G L + P+R +E +
Sbjct: 70 NHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------V 121
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-- 962
D +AL + H ++HRD+KP+NI++ + DFG+AR + S T
Sbjct: 122 IADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
V GT Y++PE A V ++DVYS G VL E++
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 809 IGSGGFGATYKAEIIPG---VVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLI 863
+GSG FG K VAVK L + AE + ++ +P +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 864 GYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + EAE L+ G L K++Q R V+ + ++ V+ + YL +
Sbjct: 85 G--ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---N 137
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRV 980
+HRD+ N+LL A +SDFGL++ L E + G + + APE +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 981 SDKADVYSFGVVLLELIS 998
S K+DV+SFGV++ E S
Sbjct: 198 SSKSDVWSFGVLMWEAFS 215
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-33
Identities = 42/211 (19%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL- 859
+++ IGSGG ++ + A+K +++ Q + + EI L ++Q +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 860 -VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ L Y +++ ++++ +L +++ + ++ A+ +H
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK--SYWKNMLEAVHTIHQH 127
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPE---- 973
++H D+KP+N L+ + L DFG+A + T D GT Y+ PE
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 974 -------YAMTCRVSDKADVYSFGVVLLELI 997
++S K+DV+S G +L +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMT 214
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVK---RLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F V N +G G F Y+A I G+ VA+K + ++ + VQ+ E++ +++HP+
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ L Y ++L+ G + +++++R + E H + + + YLH
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSH 131
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMT 977
+LHRD+ SN+LL N+N ++DFGLA L E H T GT Y++PE A
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATR 186
Query: 978 CRVSDKADVYSFGVVLLELI 997
++DV+S G + L+
Sbjct: 187 SAHGLESDVWSLGCMFYTLL 206
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 105/570 (18%), Positives = 180/570 (31%), Gaps = 128/570 (22%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168
T L+ L + + E+P+E + +++ + PP + + L
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 169 QFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG 228
+ L+ LS S+PE LE ++ + NSLT +P
Sbjct: 69 LDRQA-----------HELELNNLGLS-SLPELPP----HLESLVASCNSLT-ELPELPQ 111
Query: 229 NCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
+ L + L P LE L +S N L + EL LK++ + N
Sbjct: 112 SLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDN 162
Query: 289 DYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNW 348
N LPD L + N LE +
Sbjct: 163 -------------------------NSLKK-LPDLPPSLEFIAAG---NNQLEEL--PEL 191
Query: 349 ELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQ 408
+ L + +N ++P + +S+ +N L LPE ++P +
Sbjct: 192 QNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE-ELPELQNLPFLTTIYADN 246
Query: 409 NLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFF-YENALTSCAPFSSPSNGLFILH 467
NLL +P DL A +N LT L +
Sbjct: 247 NLLK-TLP-------------------DLPPSLEALNVRDNYLTDLPELPQSLTFLDVSE 286
Query: 468 DFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGL-IFDIG 526
+ + L P +L S N ++ LC L ++
Sbjct: 287 NIFSGLSELP--------PNLYY-----LNASSNEIR--------SLCDLPPSLEELNVS 325
Query: 527 NNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSY 586
NNKLI E+P+ ++ L + N + P+ N L+ L++ N L+ P
Sbjct: 326 NNKLI-ELPALPPR----LERLIASFNHLAEV-PELPQN---LKQLHVEYNPLRE-FPDI 375
Query: 587 INKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRL 646
+EDL+ +N+ +P +L+ L + N L E P +E L R+
Sbjct: 376 PESVEDLR-----MNSHLAEVPELPQ---NLKQLHVETNPLR-EFPDIPESVEDL---RM 423
Query: 647 DHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
+ + T L ++
Sbjct: 424 NSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-26
Identities = 92/468 (19%), Positives = 149/468 (31%), Gaps = 114/468 (24%)
Query: 223 IPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLK 282
I P + T L+ L S+ L ++P + + + + P G +++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 283 VLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEG 342
V LR+ NL L
Sbjct: 62 VSRLRDC------------------------------------LDRQAHELELNNLGLSS 85
Query: 343 IFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMA 402
+ EL LE L + N T ++P + KSL + + L+ L P +
Sbjct: 86 LP----ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYL---- 136
Query: 403 VFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNG 462
VS N L ++P + +S + +D+ N+L P +
Sbjct: 137 --GVSNNQLE-KLPELQNSS--------FLKIIDV--------DNNSLKKL--PDLPPS- 174
Query: 463 LFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLI 522
L + NN P L + L++ + NSL DL LSL+ +
Sbjct: 175 LEFI-AAGNNQLE--ELPELQNLPFLTA-----IYADNNSL-----KKLPDLPLSLESI- 220
Query: 523 FDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGP 582
GNN L E ++ + + + N L P + L LN+ N+L
Sbjct: 221 -VAGNNIL--EELPELQ-NLPFLTTIYADNNLLKTL-PDLPPS---LEALNVRDNYLTD- 271
Query: 583 LPSYINKMEDLKFLSLSLNNFTGAIPWELTQL--------------ASLEVLELSANSLS 628
LP + L + + P L L SLE L +S N L
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPP-NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330
Query: 629 GEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
E+P+ +LE L N+L +P +L V +N L
Sbjct: 331 -ELPALPPRLERLI---ASFNHLA-EVPELPQ---NLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 66/322 (20%), Positives = 108/322 (33%), Gaps = 62/322 (19%)
Query: 97 KLSGN-LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIP---- 151
+L+ LS L L+ + N + ELP L L + + + + P
Sbjct: 77 ELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEY 135
Query: 152 -----------PTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPE 200
P LQN S L++I++ N +P + ++ N L +PE
Sbjct: 136 LGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPE 190
Query: 201 EFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVL 260
N L I NSL +P + L S++ +N+L+ L L +
Sbjct: 191 -LQ-NLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTI 242
Query: 261 DLSRNFLSGIVPSELGMCKQLKVL-----VLRNDYGPLYSREHGDLPIQPVVDGGEDYNF 315
N L + P + L V L L + +
Sbjct: 243 YADNNLLKTL-PDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS----------- 290
Query: 316 FDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNC 375
GL + PNL A + + + +L LE LN+++N ++PA
Sbjct: 291 ---GLSELP---PNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLI-ELPALPPR- 338
Query: 376 KSLYFLDLSSNNLTGLLPEEVS 397
L L S N+L +PE
Sbjct: 339 --LERLIASFNHLAE-VPELPQ 357
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-12
Identities = 63/341 (18%), Positives = 108/341 (31%), Gaps = 49/341 (14%)
Query: 343 IFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMA 402
I P+N E + T ++P N KS + + P
Sbjct: 3 INPRNVSNTFLQE-PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 403 VFNVSQNLLSGEIPRISHSECSKMSVNWSMSQV---DLIGFYTAFFYENALTSCAPFSSP 459
+ ++ L + + + S+ + N+LT P
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVA--------SCNSLTE-LPELPQ 111
Query: 460 SNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLD 519
S ++ + + + +PP L L +S N L+ L L
Sbjct: 112 SLKSLLVDNNNLKALSD-LPPLLE---YL--------GVSNNQLE-KLP--ELQNSSFLK 156
Query: 520 GLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHL 579
+ D+ NN L ++P S ++F++ N+ L N L + N L
Sbjct: 157 II--DVDNNSLK-KLPDLPPS----LEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSL 207
Query: 580 QGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLE 639
+ LP L+ + N EL L L + N L +P LE
Sbjct: 208 KK-LPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE 260
Query: 640 HLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680
LN + N LT +P + + L + + F+ LS P
Sbjct: 261 ALN---VRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-11
Identities = 41/222 (18%), Positives = 79/222 (35%), Gaps = 47/222 (21%)
Query: 98 LSGNLSRAIGD-LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQ- 155
NL + + D L L + N + +LP L+ L++ + F+ +PP L
Sbjct: 244 ADNNLLKTLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLYY 301
Query: 156 -------------NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEF 202
SL +N+S N+ +PA + + + SFN L+ VPE
Sbjct: 302 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELP 356
Query: 203 GDNCVSLEHILLAANSLTGSIPPSLGNCTE----------------LRSLLLSSNMLQGD 246
+L+ + + N L P + + L+ L + +N L+ +
Sbjct: 357 Q----NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-E 410
Query: 247 IPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
P ++E L ++ + +L+ V +
Sbjct: 411 FPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEH 449
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 35/172 (20%), Positives = 53/172 (30%), Gaps = 23/172 (13%)
Query: 98 LSGN-LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQN 156
S N + L L ++ N ELP +L E L SFN +P QN
Sbjct: 304 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLAE-VPELPQN 358
Query: 157 CSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA 216
L ++ N P V L N VPE +L+ + +
Sbjct: 359 LKQL---HVEYNPLR-EFPDIPES-----VEDLRMNSHLAEVPELPQ----NLKQLHVET 405
Query: 217 NSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
N L P + +LR ++S + + LE +
Sbjct: 406 NPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 88/554 (15%), Positives = 159/554 (28%), Gaps = 113/554 (20%)
Query: 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN 164
L + +L + + L + L ++ ++L IN
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQIN 74
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP 224
S NQ P + ++ N ++ N +L + L N +T P
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLA-NLTNLTGLTLFNNQITDIDP 129
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
L N T L L LSSN + S+ L +L+ L L L+ L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERL 182
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF 344
+ + N + +L NL A N + I
Sbjct: 183 DISS-------------------------NKVSD--ISVLAKLTNLESLIATNNQISDIT 215
Query: 345 PQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVF 404
P + + L+ L+L N +L + +L LDL++N ++ L P + +
Sbjct: 216 PL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS-GLTKLTEL 270
Query: 405 NVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLF 464
+ N +S I ++ L EN L +P S+ N L
Sbjct: 271 KLGANQISN-ISPLAG----------------LTALTNLELNENQLEDISPISNLKN-LT 312
Query: 465 ILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFD 524
L N + P + L + N + + L
Sbjct: 313 YL-TLYFNNISDISP--VSSLTKLQR-----LFFYNNKVS------------DVSSL--- 349
Query: 525 IGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLP 584
++ + +LS N+ L P N + L L+
Sbjct: 350 ---------------ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV 392
Query: 585 SYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLS--GEIPSEFSKLEHLN 642
+Y + + P ++ S +++ N S E+ FS+ +
Sbjct: 393 NYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIG 450
Query: 643 VLRLDHNNLTGRIP 656
+G +
Sbjct: 451 ---KGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 89/533 (16%), Positives = 169/533 (31%), Gaps = 90/533 (16%)
Query: 77 FPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLL 136
F L + + + + + DL Q+ L G + L+ L
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTV-----SQTDLDQVTTLQADRLGIKS--IDGVEYLNNL 70
Query: 137 EILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSG 196
++ S N P L+N + L I ++ NQ P ++L N ++
Sbjct: 71 TQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 126
Query: 197 SVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256
+ N +L + L++N+++ +L T L+ L + + L
Sbjct: 127 --IDPLK-NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTT 178
Query: 257 LEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFF 316
LE LD+S N +S I S L L+ L+ N N
Sbjct: 179 LERLDISSNKVSDI--SVLAKLTNLESLIATN-------------------------NQI 211
Query: 317 DGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCK 376
+ L NL L+ I + L L+LA+N + P L
Sbjct: 212 SD--ITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLT 265
Query: 377 SLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVD 436
L L L +N ++ + P + + +++N L I IS+ +++ +
Sbjct: 266 KLTELKLGANQISNISPLA-GLTALTNLELNENQLED-ISPISN--------LKNLTYLT 315
Query: 437 LIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGF 496
L Y N ++ +P SS + L L F NN + L + +++
Sbjct: 316 L--------YFNNISDISPVSSLTK-LQRL-FFYNNKVSDV--SSLANLTNINW-----L 358
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
N + P + L + + + + + + N
Sbjct: 359 SAGHNQIS---DLTPLANLTRITQL--GLNDQAWTNAPVN----YKANVSIPNTVKNVTG 409
Query: 557 GLI-PQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIP 608
LI P + ++ S +++ N + F+G +
Sbjct: 410 ALIAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-28
Identities = 89/496 (17%), Positives = 168/496 (33%), Gaps = 106/496 (21%)
Query: 204 DNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
+L ++T ++ + ++ +L ++ L NL ++ S
Sbjct: 21 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFS 76
Query: 264 RNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDS 323
N L+ I + L +L +++ N N
Sbjct: 77 NNQLTDI--TPLKNLTKLVDILMNN-------------------------NQIAD--ITP 107
Query: 324 ITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDL 383
+ L NL N + I P + + L L L+ N + ++L SL L
Sbjct: 108 LANLTNLTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF 163
Query: 384 SSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTA 443
N +T L P NL + E IS ++ S +SV ++ ++ +
Sbjct: 164 -GNQVTDLKPLA-------------NLTTLERLDISSNKVSDISVLAKLTNLESL----- 204
Query: 444 FFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSL 503
N ++ P +N L L L+GN L
Sbjct: 205 IATNNQISDITPLGILTN-LDELS------------------------------LNGNQL 233
Query: 504 KGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSF 563
K ++ +L L D+ NN++ P S + L + N+ + P
Sbjct: 234 K-DIG--TLASLTNLTDL--DLANNQISNLAPL---SGLTKLTELKLGANQISNISP--L 283
Query: 564 TNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623
+L NL L+ N L+ P I+ +++L +L+L NN + P ++ L L+ L
Sbjct: 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339
Query: 624 ANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP-RN 682
N +S S + L ++N L HN ++ P + ++ ++ + +
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYK 395
Query: 683 SLIKCENVQGNPNLQL 698
+ + N N L
Sbjct: 396 ANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-19
Identities = 70/365 (19%), Positives = 134/365 (36%), Gaps = 52/365 (14%)
Query: 323 SITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLD 382
+ T L N+ Q ++ L + +L ++
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVSQTD--LDQVTTLQADRLGIK--SIDGVEYLNNLTQIN 74
Query: 383 LSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYT 442
S+N LT + ++ + ++ N ++ P +++ +++ + L
Sbjct: 75 FSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP-LANLT--------NLTGLTL----- 119
Query: 443 AFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNS 502
+ N +T P + +N L L + S+N + + L+S L S
Sbjct: 120 ---FNNQITDIDPLKNLTN-LNRL-ELSSNTISD-ISAL----SGLTS-------LQQLS 162
Query: 503 LKGNLSTY-PFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQ 561
++ P +L+ L DI +NK+ S + ++ L N+ + P
Sbjct: 163 FGNQVTDLKPLANLTTLERL--DISSNKVSD--ISVLA-KLTNLESLIATNNQISDITP- 216
Query: 562 SFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLE 621
+L L+L+ N L+ + + +L L L+ N + P L+ L L L+
Sbjct: 217 -LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 622 LSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPR 681
L AN +S P + L L L L+ N L +L+ + FNN+S +P
Sbjct: 272 LGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPV 327
Query: 682 NSLIK 686
+SL K
Sbjct: 328 SSLTK 332
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 18/119 (15%), Positives = 40/119 (33%), Gaps = 7/119 (5%)
Query: 568 SLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSL 627
L + ++++ + + + + L N T + T L + L+ +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 628 SGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIK 686
L +L + +N LT I P + L ++ N ++ P +L
Sbjct: 59 K--SIDGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITPLANLTN 113
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 9/192 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IGSG FG + + VA+K + G + F E + ++ HP LV L G +
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+A + L+ ++ G L +++ + R L + LDV +AYL + V+HRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDL 130
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCRVSDKADV 986
N L+ N +SDFG+ R + + T+ F +PE R S K+DV
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 987 YSFGVVLLELIS 998
+SFGV++ E+ S
Sbjct: 189 WSFGVLMWEVFS 200
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-32
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+ IG G FG + G VAVK + Q F AE + +++H NLV L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 865 YHV---SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
V + ++++ Y+ G+L +++ R R + L K +LDV A+ YL
Sbjct: 254 --VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+HRD+ N+L+ + A +SDFGL + +++ V T APE + S
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 982 DKADVYSFGVVLLELIS 998
K+DV+SFG++L E+ S
Sbjct: 365 TKSDVWSFGILLWEIYS 381
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 55/196 (28%), Positives = 106/196 (54%), Gaps = 9/196 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSV-GRFQGVQQFAAEIRTLGRVQHPNLV 860
F + +G+G G +K P G+V+A K + + + Q E++ L P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G S+ E+ + ++ GG+L++ ++ + R E +L K+++ V + L YL ++
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE-QILGKVSIAVIKGLTYLREKH- 151
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+++HRD+KPSNIL+++ L DFG++ L ++ A + GT Y++PE
Sbjct: 152 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTHY 207
Query: 981 SDKADVYSFGVVLLEL 996
S ++D++S G+ L+E+
Sbjct: 208 SVQSDIWSMGLSLVEM 223
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-32
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 809 IGSGGFGATYKAEIIPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTLIG 864
+G G FG+ + + VA+K L G + + E + + ++ +P +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+ L+ GG L KF+ + R + S + ++ V+ + YL ++ +
Sbjct: 404 V-CQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCRVSD 982
HR++ N+LL N A +SDFGL++ LG +++ T AG + APE + S
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 983 KADVYSFGVVLLELIS 998
++DV+S+GV + E +S
Sbjct: 519 RSDVWSYGVTMWEALS 534
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG P G +VAVK L Q + EI L + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 863 IG--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G A + L+ Y+P G+L ++ R ++ + L A + +AYLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTC 978
+HRD+ N+LLDN+ + DFGLA+ + + G + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 979 RVSDKADVYSFGVVLLELIS 998
+ +DV+SFGV L EL++
Sbjct: 213 KFYYASDVWSFGVTLYELLT 232
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 41/211 (19%), Positives = 88/211 (41%), Gaps = 23/211 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL- 859
+++ IGSGG ++ + A+K +++ Q + + EI L ++Q +
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 860 -VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ L Y +++ ++++ +L +++ + ++ A+ +H
Sbjct: 118 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK--SYWKNMLEAVHTIHQH 174
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPE---- 973
++H D+KP+N L+ + L DFG+A + T D G Y+ PE
Sbjct: 175 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 974 -------YAMTCRVSDKADVYSFGVVLLELI 997
++S K+DV+S G +L +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMT 261
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 54/192 (28%), Positives = 94/192 (48%), Gaps = 9/192 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+GSG FG + VAVK + G +F E +T+ ++ HP LV G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G L +++ + +E S L ++ DV +A+L + +HRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCRVSDKADV 986
N L+D +L +SDFG+ R + + + V F APE + S K+DV
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 987 YSFGVVLLELIS 998
++FG+++ E+ S
Sbjct: 189 WAFGILMWEVFS 200
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 9/193 (4%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCRVSDKAD 985
+ N L+ N ++DFGL+RL+ A F APE + S K+D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKWTAPESLAYNKFSIKSD 194
Query: 986 VYSFGVVLLELIS 998
V++FGV+L E+ +
Sbjct: 195 VWAFGVLLWEIAT 207
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 54/230 (23%), Positives = 89/230 (38%), Gaps = 44/230 (19%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVT 861
+ +G G G G VAVKR+ + EI+ L HPN++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIR 73
Query: 862 LIGYHVSEAEMFLIYNYLP----GGNLEKFIQDRPRRTVEWSMLH-----KIALDVARAL 912
Y + FL Y+ NL+ ++ + + + +A +
Sbjct: 74 Y--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 913 AYLHDECVPRVLHRDIKPSNILLDN-------------NLNAYLSDFGLARLLG---TSE 956
A+LH +++HRD+KP NIL+ NL +SDFGL + L +S
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 957 THATTDVAGTFGYVAPE-------YAMTCRVSDKADVYSFGVVLLELISD 999
+ +GT G+ APE R++ D++S G V ++S
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIPG-----VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + E + V +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 83 LGI-CLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-31
Identities = 26/225 (11%), Positives = 59/225 (26%), Gaps = 43/225 (19%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
+ G + ++ A+K ++G +++ R+ +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 865 YH--------------------VSEAEMFLIYNY-----LPGGNLEKFIQ-----DRPRR 894
+ + + NY +LE R
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 895 TVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954
LH + + R A L + ++H P N+ + + L D +GT
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 955 SETHATTDVAGTFGYVAPEYAM--TCRVSDKADVYSFGVVLLELI 997
+ Y E+ T + + + G+ + +
Sbjct: 247 R----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-31
Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIPG-----VVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG +K IP + V +K + Q Q + +G + H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G + + L+ YLP G+L ++ R + +L + +A+ + YL +
Sbjct: 81 LGL-CPGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---G 135
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HR++ N+LL + ++DFG+A LL + A T ++A E + +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 196 HQSDVWSYGVTVWELMT 212
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-31
Identities = 50/192 (26%), Positives = 78/192 (40%), Gaps = 17/192 (8%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+GSG FG ++ E G V K ++ EI + ++ HP L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDECVPRV 923
+ EM LI +L GG L I + E ++ R L ++H+ +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSE-----AEVINYMRQACEGLKHMHEH---SI 170
Query: 924 LHRDIKPSNILLDNNLNAYL--SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+H DIKP NI+ + + + DFGLA L E T + APE V
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVG 228
Query: 982 DKADVYSFGVVL 993
D+++ GV+
Sbjct: 229 FYTDMWAIGVLG 240
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 11/195 (5%)
Query: 808 CIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G Y ++ V +A+K + + Q EI ++H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+ + +PGG+L ++ + P + E + + L YLHD +++
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIGFYTKQILEGLKYLHDN---QIV 144
Query: 925 HRDIKPSNILLDN-NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV--S 981
HRDIK N+L++ + +SDFG ++ L T GT Y+APE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203
Query: 982 DKADVYSFGVVLLEL 996
AD++S G ++E+
Sbjct: 204 KAADIWSLGCTIIEM 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-31
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+ IG G FG + G VAVK + Q F AE + +++H NLV L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 865 YHV---SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
V + ++++ Y+ G+L +++ R R + L K +LDV A+ YL
Sbjct: 82 --VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCR 979
+HRD+ N+L+ + A +SDFGL + ++T G APE +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKK 190
Query: 980 VSDKADVYSFGVVLLELIS 998
S K+DV+SFG++L E+ S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-31
Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 9/192 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K + G +F E + + + H LV L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +F+I Y+ G L ++++ R + L ++ DV A+ YL + + LHRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 146
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCRVSDKADV 986
N L+++ +SDFGL+R + + T+ V F PE M + S K+D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 987 YSFGVVLLELIS 998
++FGV++ E+ S
Sbjct: 205 WAFGVLMWEIYS 216
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 48/216 (22%), Positives = 84/216 (38%), Gaps = 28/216 (12%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV 860
+ + + +G G ++ G + A+K + F V E L ++ H N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 861 TLIGYHVSEAE----MFLIYNYLPGGNLEKFIQDRPRRTV--EWSMLHKIALDVARALAY 914
L + + E LI + P G+L +++ E S + DV + +
Sbjct: 71 KL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLRDVVGGMNH 127
Query: 915 LHDECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
L + ++HR+IKP NI+ D L+DFG AR L E + + GT Y+
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYL 182
Query: 971 APE--------YAMTCRVSDKADVYSFGVVLLELIS 998
P+ + D++S GV +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 12/189 (6%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+GSG F + + + G + A+K + EI L +++H N+VTL +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
S +L+ + GG L I +R T E + V A+ YLH+ ++HRD
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYT-E-KDASLVIQQVLSAVKYLHEN---GIVHRD 131
Query: 928 IKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA 984
+KP N+L + N ++DFGL+++ + + GT GYVAPE S
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVAPEVLAQKPYSKAV 188
Query: 985 DVYSFGVVL 993
D +S GV+
Sbjct: 189 DCWSIGVIT 197
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 16/198 (8%)
Query: 806 QNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
Q +G G FG ++ + G AVK++ + F+ + E+ + P +V L G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--VE---ELVACAGLSSPRIVPLYG 117
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+ + L GG+L + I + + L YLH R+L
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTR---RIL 172
Query: 925 HRDIKPSNILLDNN-LNAYLSDFGLARLLGTSETHATT----DVAGTFGYVAPEYAMTCR 979
H D+K N+LL ++ A L DFG A L + + GT ++APE M
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 980 VSDKADVYSFGVVLLELI 997
K D++S ++L ++
Sbjct: 233 CDAKVDIWSSCCMMLHML 250
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 805 VQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNL 859
++ IGSG G + V VA+K L G + ++ F +E +G+ HPN+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ L G ++ Y+ G+L+ F++ + L + V + YL D
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMT 977
+HRD+ N+L+D+NL +SDFGL+R+L A T G APE
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 978 CRVSDKADVYSFGVVLLELIS 998
S +DV+SFGVV+ E+++
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG Y + VAVK ++F +E + + HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
G + E ++I P G L +++ + +++ L +L + +A+AYL
Sbjct: 80 GI-IEEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NC 134
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMTCRV 980
+HRDI NIL+ + L DFGL+R + + + + T +++PE R
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS---VTRLPIKWMSPESINFRRF 191
Query: 981 SDKADVYSFGVVLLELIS 998
+ +DV+ F V + E++S
Sbjct: 192 TTASDVWMFAVCMWEILS 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 25/218 (11%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLV 860
V+ + GGF Y+A+ + G A+KRL + + E+ + ++ HPN+V
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 861 TLIGYHVSE--------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
AE L+ G +E + R + + KI RA+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA-------- 964
++H P ++HRD+K N+LL N L DFG A + ++ +
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 965 ---GTFGYVAPE---YAMTCRVSDKADVYSFGVVLLEL 996
T Y PE + +K D+++ G +L L
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 28/208 (13%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVK---RLSVGRFQGVQQFAAEIRTLGRVQHPN 858
+ +G GGF ++ + V A K + + + ++ + EI + H +
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR-------- 910
+V G+ +F++ +L + + R + AR
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR----------KALTEPEARYYLRQIVL 126
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGY 969
YLH RV+HRD+K N+ L+ +L + DFGLA + E GT Y
Sbjct: 127 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNY 181
Query: 970 VAPEYAMTCRVSDKADVYSFGVVLLELI 997
+APE S + DV+S G ++ L+
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLL 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 46/200 (23%), Positives = 82/200 (41%), Gaps = 12/200 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVK---RLSVGRFQGVQQFAAEIRTLGRVQHPN 858
+ +G GGF ++ + V A K + + + ++ + EI + H +
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V G+ +F++ +L + + R T + + YLH
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA--RYYLRQIVLGCQYLHRN 160
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMT 977
RV+HRD+K N+ L+ +L + DFGLA + E GT Y+APE
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSK 215
Query: 978 CRVSDKADVYSFGVVLLELI 997
S + DV+S G ++ L+
Sbjct: 216 KGHSFEVDVWSIGCIMYTLL 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 1e-29
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVK----RLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G+GGFG + G VA+K LS + EI+ + ++ HPN+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL---EIQIMKKLNHPNVVSA- 77
Query: 864 GYHVSEAE--------MFLIYNYLPGGNLEKFIQDRPRRTV--EWSMLHKIALDVARALA 913
V + L Y GG+L K++ E + ++ D++ AL
Sbjct: 78 -REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALR 135
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAY---LSDFGLARLLGTSETHATTDVAGTFGYV 970
YLH+ R++HRD+KP NI+L + D G A+ L T V GT Y+
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFV-GTLQYL 190
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + + D +SFG + E I+
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-29
Identities = 55/285 (19%), Positives = 96/285 (33%), Gaps = 43/285 (15%)
Query: 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN 164
A+ +LT LR L L + S PL L+ + L+L N L N + L +
Sbjct: 105 ALQNLTNLRELYLNEDNISDISPL--ANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLT 161
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP 224
++ ++ P +SL++N + + SL + N +T P
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDI--SPLA-SLTSLHYFTAYVNQITDITP 216
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
+ N T L SL + +N + S L L L++ N +S I + + +LK+L
Sbjct: 217 --VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKML 270
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF 344
+ N + L L + N L
Sbjct: 271 NV-------------------------GSNQISD--ISVLNNLSQLNSLFLNNNQLGNED 303
Query: 345 PQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLT 389
+ + L L L+ N T P L + + D ++ +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 50/289 (17%), Positives = 97/289 (33%), Gaps = 43/289 (14%)
Query: 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN 164
+ +L +L L + N + + L+ L L L+ ++ P L N + + +N
Sbjct: 83 PLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN 138
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP 224
L N N + + G ++++ + + N L + L N + P
Sbjct: 139 LGANH-NLSDLSPLSNMTGLNYLTVTESKVKDV--TPIA-NLTDLYSLSLNYNQIEDISP 194
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
L + T L N + + + L L + N ++ + S L QL L
Sbjct: 195 --LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDL--SPLANLSQLTWL 248
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF 344
+ N +++ L L++ + + I
Sbjct: 249 EI-------------------------GTNQISD--INAVKDLTKLKMLNVGSNQISDI- 280
Query: 345 PQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLP 393
S+L L L +N + +G +L L LS N++T + P
Sbjct: 281 -SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 58/293 (19%), Positives = 96/293 (32%), Gaps = 45/293 (15%)
Query: 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN 164
I LT L L L N + PL L L L + N LQN ++LR +
Sbjct: 61 GIEYLTNLEYLNLNGNQITDISPL--SNLVKLTNLYIGTNKIT--DISALQNLTNLRELY 116
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP 224
L+ + + P ++L N S N L ++ + + + P
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLS-NMTGLNYLTVTESKVKDVTP 172
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
+ N T+L SL L+ N ++ S L +L N ++ I + + +L L
Sbjct: 173 --IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDI--TPVANMTRLNSL 226
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF 344
+ N + L L + I
Sbjct: 227 KI-------------------------GNNKITD--LSPLANLSQLTWLEIGTNQISDI- 258
Query: 345 PQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS 397
+ +KL+MLN+ N + + L N L L L++N L E +
Sbjct: 259 -NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIG 308
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 51/286 (17%), Positives = 103/286 (36%), Gaps = 45/286 (15%)
Query: 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINL 165
DL + +L + + E +L + L ++ I ++ ++L +NL
Sbjct: 18 DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS-IQG-IEYLTNLEYLNL 73
Query: 166 SGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP 225
+GNQ P + + N ++ N +L + L ++++ P
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQ-NLTNLRELYLNEDNISDISP- 127
Query: 226 SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLV 285
L N T++ SL L +N D+ S + L L ++ + + + + + L L
Sbjct: 128 -LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDV--TPIANLTDLYSLS 183
Query: 286 LRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFP 345
L +YN + + L +L F A + I P
Sbjct: 184 L-------------------------NYNQIED--ISPLASLTSLHYFTAYVNQITDITP 216
Query: 346 QNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
++L L + +N T P L N L +L++ +N ++ +
Sbjct: 217 VAN--MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 69/451 (15%), Positives = 136/451 (30%), Gaps = 121/451 (26%)
Query: 226 SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLV 285
+ E +L + + +L ++ L ++ ++ I + L+ L
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTNLEYLN 72
Query: 286 LRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFP 345
L + IT + L
Sbjct: 73 LNGN---------------------------------QITDISPL--------------- 84
Query: 346 QNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFN 405
KL L + N T ++L N +L L L+ +N++ + P ++ M N
Sbjct: 85 ---SNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISPLA-NLTKMYSLN 138
Query: 406 VSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFI 465
+ N ++ +S+ + G E+ + P ++ ++ L+
Sbjct: 139 LGANHNLSDLSPLSN----------------MTGLNYLTVTESKVKDVTPIANLTD-LYS 181
Query: 466 LHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDI 525
L + N + P +L+ SL
Sbjct: 182 L-SLNYNQIED-ISPL-----------------------ASLT--------SLHYF--TA 206
Query: 526 GNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPS 585
N++ P ++ + L + N+ L P N L L + N + +
Sbjct: 207 YVNQITDITPV---ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--N 259
Query: 586 YINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLR 645
+ + LK L++ N + L L+ L L L+ N L E L +L L
Sbjct: 260 AVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317
Query: 646 LDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
L N++T I P + S + D + +
Sbjct: 318 LSQNHITD-IRP-LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 59/354 (16%), Positives = 116/354 (32%), Gaps = 51/354 (14%)
Query: 354 LEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSG 413
L P + L ++T ++ +E + + V+ ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE-ELESITKLVVAGEKVA- 57
Query: 414 EIPRISHSECSKM-SVNWSMSQVDLIGFYTAF-------FYENALTSCAPFSSPSNGLFI 465
I I + + + +N + +Q+ I + N +T + + +N L
Sbjct: 58 SIQGIEY--LTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISALQNLTN-LRE 114
Query: 466 LHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDI 525
L + + + L + + S L N +LS P L+ L +
Sbjct: 115 L-YLNEDNISD--ISPLANLTKMYS-----LNLGANHNLSDLS--PLSNMTGLNYL--TV 162
Query: 526 GNNKL--IGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
+K+ + + ++ + LS+ N+ + P + SL N +
Sbjct: 163 TESKVKDVTPI-----ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215
Query: 584 PSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNV 643
P + M L L + N T P L L+ L LE+ N +S + L L +
Sbjct: 216 P--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKM 269
Query: 644 LRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQ 697
L + N ++ S L+ ++ N L E + G NL
Sbjct: 270 LNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDM-------EVIGGLTNLT 314
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV 860
F IG G FG +K VVA+K + + + ++ EI L + P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G ++ + ++++I YL GG+ ++ P + + I ++ + L YLH E
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGLDYLHSE-- 138
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+ +HRDIK +N+LL + L+DFG+A L ++ T GT ++APE
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 196
Query: 981 SDKADVYSFGVVLLELI 997
KAD++S G+ +EL
Sbjct: 197 DSKADIWSLGITAIELA 213
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 29/228 (12%), Positives = 64/228 (28%), Gaps = 43/228 (18%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGR------FQGVQQFAAEIRTLGRVQHPNLVT 861
+G A +A G V + +++ +R L +++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 862 LIGYHVSEAE-----------------------MFLIYNYLPGGNLEKFIQD-----RPR 893
+ + + NL+ F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 894 RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953
+++ ++ L V R LA LH ++H ++P +I+LD +L+ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 954 TSETHATTDVAGTFGYVAPE-----YAMTCRVSDKADVYSFGVVLLEL 996
S A ++ D ++ G+ + +
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSV-GRFQGVQQFAAEIRTLGR-VQHPNL 859
IG G +G+ K P G ++AVKR+ + +Q ++ + R P +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 860 VTLIGYHVSEAEMFLIYNYLPGG--NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
V G E + ++ + K++ + +L KI L +AL +L +
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+++HRDIKPSNILLD + N L DFG++ L ++ A T AG Y+APE
Sbjct: 144 NL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDP 199
Query: 978 CRVSD----KADVYSFGVVLLEL 996
++DV+S G+ L EL
Sbjct: 200 SASRQGYDVRSDVWSLGITLYEL 222
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 774 PGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKR 832
PG + + + VQ + + + Q +G G FG + I G AVK
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKV 58
Query: 833 LSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ 889
+S + + + E++ L ++ HPN++ L + + +L+ GG L I
Sbjct: 59 ISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 890 DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDF 946
R R + E +I V + Y+H +++HRD+KP N+LL++ + N + DF
Sbjct: 119 SRKRFS-E-VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 947 GLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
GL+ S+ D GT Y+APE + +K DV+S GV+L L+S
Sbjct: 174 GLSTHFEASKKM--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS 222
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
F+V +G G +G+ YKA G +VA+K++ V +Q+ EI + + P++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL---DVARALAYLHDE 918
G + +++++ Y G++ I+ R + E +IA + L YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE----DEIATILQSTLKGLEYLHFM 144
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R +HRDIK NILL+ +A L+DFG+A L + T + GT ++APE
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 200
Query: 979 RVSDKADVYSFGVVLLELI 997
+ AD++S G+ +E+
Sbjct: 201 GYNCVADIWSLGITAIEMA 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ + +G G FG YKA G + A K + + ++ + EI L HP +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL---DVARALAYLHDE 918
L+G + + +++++ + PGG ++ + + R E +I + + AL +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE----PQIQVVCRQMLEALNFLHSK 136
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R++HRD+K N+L+ + L+DFG++ + + GT ++APE M
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCE 192
Query: 979 RVSD-----KADVYSFGVVLLELI 997
+ D KAD++S G+ L+E+
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMA 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSV-GRFQGVQQFAAEIRTLGR-VQHPNL 859
+G G +G K +P G ++AVKR+ Q ++ ++ R V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 860 VTLIGYHVSEAEMFLIYNYLPGG--NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
VT G E ++++ + K + D+ + E +L KIA+ + +AL +LH
Sbjct: 69 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPE-DILGKIAVSIVKALEHLHS 127
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ V+HRD+KPSN+L++ + DFG++ L + A AG Y+APE
Sbjct: 128 KL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINP 183
Query: 978 CRVSD----KADVYSFGVVLLEL 996
K+D++S G+ ++EL
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIEL 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 30/198 (15%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G +G A + + A K++ + V +F EI + + HPN++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDECVPRV 923
+++L+ GG L + + + E A + + A+AY H V
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFR-E-----SDAARIMKDVLSAVAYCHKL---NV 127
Query: 924 LHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE-----YA 975
HRD+KP N L + L DFGLA + GT YV+P+ Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEGLY- 184
Query: 976 MTCRVSDKADVYSFGVVL 993
+ D +S GV++
Sbjct: 185 -----GPECDEWSAGVMM 197
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 50/196 (25%), Positives = 99/196 (50%), Gaps = 8/196 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ IG G G Y A ++ G VA++++++ + + EI + ++PN+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+ ++ E++++ YL GG+L + + + + + + +AL +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSN--- 135
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+V+HRDIK NILL + + L+DFG + ++ +T + GT ++APE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 194
Query: 982 DKADVYSFGVVLLELI 997
K D++S G++ +E+I
Sbjct: 195 PKVDIWSLGIMAIEMI 210
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 27/230 (11%)
Query: 772 ADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAV 830
A P +V V Y + +G G FG +K E G+ +A
Sbjct: 68 APPAPFDHRIVTAKQGAVNSFYT--------VSKTEILGGGRFGQVHKCEETATGLKLAA 119
Query: 831 KRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL-EKFIQ 889
K + + ++ EI + ++ H NL+ L S+ ++ L+ Y+ GG L ++ I
Sbjct: 120 KIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179
Query: 890 DRPRRTVEWSMLHKIALDVAR----ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL-- 943
+ T E + + + ++H +LH D+KP NIL N +
Sbjct: 180 ESYNLT-E-----LDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKI 230
Query: 944 SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVL 993
DFGLAR E GT ++APE VS D++S GV+
Sbjct: 231 IDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-29
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 17/198 (8%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+++ +G+G FG ++ E G A K + + EI+T+ ++HP LV
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHD 917
L + EM +IY ++ GG L + + D + E A++ R L ++H+
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-----DEAVEYMRQVCKGLCHMHE 273
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYL--SDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
+H D+KP NI+ + L DFGL L ++ GT + APE A
Sbjct: 274 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVA 328
Query: 976 MTCRVSDKADVYSFGVVL 993
V D++S GV+
Sbjct: 329 EGKPVGYYTDMWSVGVLS 346
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTLI 863
IG G FG Y + P + VA+K V++ F E T+ + HP++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
G ++E +++I G L F+Q R + +++ + L A ++ ALAYL + R
Sbjct: 83 GV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRVS 981
+HRDI N+L+ +N L DFGL+R + S + + G ++APE R +
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFT 195
Query: 982 DKADVYSFGVVLLELIS 998
+DV+ FGV + E++
Sbjct: 196 SASDVWMFGVCMWEILM 212
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-29
Identities = 48/216 (22%), Positives = 84/216 (38%), Gaps = 28/216 (12%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV 860
+ + + +G G ++ G + A+K + F V E L ++ H N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 861 TLIGYHVSEAE----MFLIYNYLPGGNLEKFIQDRPRRTV--EWSMLHKIALDVARALAY 914
L + + E LI + P G+L +++ E S + DV + +
Sbjct: 71 KL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-SEFLIVLRDVVGGMNH 127
Query: 915 LHDECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
L + ++HR+IKP NI+ D L+DFG AR L E + + GT Y+
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYL 182
Query: 971 APE--------YAMTCRVSDKADVYSFGVVLLELIS 998
P+ + D++S GV +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLIGY 865
+G G F + G+ A K ++ + Q+ E R ++QHPN+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
E+ +L+++ + GG L + I R + E + + ++AY H ++H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYS-E-ADASHCIQQILESIAYCHSN---GIVH 128
Query: 926 RDIKPSNILLDNNLNAY---LSDFGLARLLGTSETHATTDVAGTFGYVAPE------YAM 976
R++KP N+LL + L+DFGLA + ++ A AGT GY++PE Y
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLSPEVLKKDPY-- 184
Query: 977 TCRVSDKADVYSFGVVL 993
S D+++ GV+L
Sbjct: 185 ----SKPVDIWACGVIL 197
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 7e-29
Identities = 66/543 (12%), Positives = 154/543 (28%), Gaps = 88/543 (16%)
Query: 102 LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLR 161
+ + + ++ + + L ++ LDLS N L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 162 LINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTG 221
L+NLS N T+ + + L+ N + + S+E + A N+++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS- 112
Query: 222 SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL-GMCKQ 280
+ S G +++ L++N + G ++ LDL N + + +EL
Sbjct: 113 RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 281 LKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNL 340
L+ L L+ N I +
Sbjct: 171 LEHLNLQY-------------------------N--------FIYDVK------------ 185
Query: 341 EGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPC 400
+ +KL+ L+L+ N + + + ++ L +N L +
Sbjct: 186 GQVV------FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN 238
Query: 401 MAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPS 460
+ F++ N R S+ ++ + + +
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQT----------------VAKQTVKKLTGQNEEE 282
Query: 461 NGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDG 520
+ L + PF +L + + G+ + L +
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQ-ARQRE 340
Query: 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ 580
+ D + V + + L + L
Sbjct: 341 I--DALKEQ-YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI 397
Query: 581 GPLPSYINKMEDLKFLSLSLNNFT-GAIPWELTQLASLEVLELSANSLSGEIPSEFSKLE 639
L + L+ L + + + + Q ++ ++ + + ++ E ++L+
Sbjct: 398 E-LQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QLAEENARLK 455
Query: 640 HLN 642
LN
Sbjct: 456 KLN 458
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 52/327 (15%), Positives = 99/327 (30%), Gaps = 45/327 (13%)
Query: 98 LSGNL---SRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTL 154
LS N+ + + L+ LR L L N E+ +E L + N+ + +
Sbjct: 65 LSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCS- 117
Query: 155 QNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILL 214
+ I L+ N+ G Q + L N + E + +LEH+ L
Sbjct: 118 -RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 215 AANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSE 274
N + + + +L++L LSSN L + F + + L N L I
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI-EKA 232
Query: 275 LGMCKQLKVLVL------------------------RNDYGPLYSREHGDLPIQPVVDGG 310
L + L+ L + L + + + + G
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 311 EDYNFFDGGLPDSITRLPNLRVFWAPNLNLEG----IFPQNWELCSKLEMLNLAHNFFTG 366
+ RL L+ L+ +G E ++ ++ +
Sbjct: 293 --AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 367 QIPASLGNCKSLYFLDLSSNNLTGLLP 393
I ++ L+ L +
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 66/533 (12%), Positives = 142/533 (26%), Gaps = 77/533 (14%)
Query: 197 SVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256
++ E N + + +SL ++ + ++ L LS N L +
Sbjct: 1 AIHEIKQ-NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 257 LEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFF 316
LE+L+LS N L +L L+ L L + N+
Sbjct: 60 LELLNLSSNVLYET--LDLESLSTLRTLDL-------------------------NNNYV 92
Query: 317 DGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCK 376
+ P++ A N N+ + + + + LA+N T G
Sbjct: 93 -----QELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKITMLRDLDEGCRS 144
Query: 377 SLYFLDLSSNNLTGLLPEEVSVPC--MAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQ 434
+ +LDL N + + E++ + N+ N + ++ +
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFA--------KLKT 195
Query: 435 VDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYY 494
+DL N L P + G+ + NN + L S +L
Sbjct: 196 LDL--------SSNKLAFMGPEFQSAAGVTWI-SLRNNKLVL-IEKALRFSQNLEH---- 241
Query: 495 GFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNE 554
F L GN F + + + + ++ C
Sbjct: 242 -FDLRGNGFHCGTLRDFFSKNQRVQTV-----AKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 555 FVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINK----MEDLKFLSLSLNNFTGAIPWE 610
L +L+ + QG + + + + I
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQV 355
Query: 611 LTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDV 670
+ + LE +L ++ + L+ + +S L +
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSPLQLLRA 414
Query: 671 SFNNLSGSAPRNSLIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVSQQEAYS 723
++ ++ Q ++ +++
Sbjct: 415 IVKRYEEMYVEQQSVQNNAIRDWDMYQ-----HKETQLAEENARLKKLNGEAD 462
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-24
Identities = 44/321 (13%), Positives = 84/321 (26%), Gaps = 35/321 (10%)
Query: 98 LSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNC 157
L+ N + + + L A N S + + + + L+ N
Sbjct: 87 LNNNYVQELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCR 143
Query: 158 SSLRLINLSGNQFNG-TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA 216
S ++ ++L N+ + S + ++L +N + V + L+ + L++
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLSS 200
Query: 217 NSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELG 276
N L + P + + + L +N L I + NLE DL N +
Sbjct: 201 NKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 277 MCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGE------DYNFFDG------------ 318
Q V + L + + + + G F D
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 319 --------GLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPA 370
L R A + Q L Q+
Sbjct: 319 SGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN 378
Query: 371 SLGNCKSLYFLDLSSNNLTGL 391
L + L
Sbjct: 379 GRRAHAELDGTLQQAVGQIEL 399
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 38/290 (13%), Positives = 78/290 (26%), Gaps = 14/290 (4%)
Query: 98 LSGN----LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
LS N + + + L N + + LE DL N FH
Sbjct: 198 LSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
+ + R+ ++ + + +P F D ++L+
Sbjct: 257 FFS-KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKE 314
Query: 214 LAANSLTGS----IPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269
A S GS + N R + + I + L+ + L
Sbjct: 315 HALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDE 374
Query: 270 IVPSELGMCKQLKVLVLR-NDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP 328
V + +L + + L P+Q + + Y + +
Sbjct: 375 QVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMY--VEQQSVQNN 432
Query: 329 NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSL 378
+R + + +N L +LA + + ++L
Sbjct: 433 AIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNL 482
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSV-GRFQGVQQFAAEIRTLGR-VQHPNL 859
+GSG G +K G V+AVK++ G + ++ ++ + + P +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V G ++ ++F+ + G EK + E +L K+ + + +AL YL ++
Sbjct: 87 VQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPE-RILGKMTVAIVKALYYLKEK- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
V+HRD+KPSNILLD L DFG++ L + A AG Y+APE
Sbjct: 144 -HGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 980 VSD-----KADVYSFGVVLLEL 996
+ +ADV+S G+ L+EL
Sbjct: 201 PTKPDYDIRADVWSLGISLVEL 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTLI 863
+G+G FG K + VA+K L VG + ++ F E +G+ HPN++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
G + ++ Y+ G+L+ F++ + ++ + +A + YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG-MLRGIASGMKYLSDM---GY 168
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCRVS 981
+HRD+ NIL+++NL +SDFGL R+L A T G +PE + +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 982 DKADVYSFGVVLLELIS 998
+DV+S+G+VL E++S
Sbjct: 229 SASDVWSYGIVLWEVMS 245
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYH 866
+GSG FG + E G+ +K ++ R Q ++Q AEI L + HPN++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDECVPR 922
M+++ GG L + I R S ++ + ALAY H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALS--EGYVAELMKQMMNALAYFHSQ---H 144
Query: 923 VLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE-----Y 974
V+H+D+KP NIL + + + DFGLA L + E T+ AGT Y+APE
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFKRDV 202
Query: 975 AMTCRVSDKADVYSFGVVL 993
+ K D++S GVV+
Sbjct: 203 ------TFKCDIWSAGVVM 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 42/192 (21%), Positives = 76/192 (39%), Gaps = 18/192 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG ++ E K + V + EI L +H N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDECVPRV 923
S E+ +I+ ++ G ++ + I + + + + AL +LH +
Sbjct: 72 SMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 924 LHRDIKPSNILLDNNLNAYL--SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
H DI+P NI+ ++ + +FG AR L + + Y APE VS
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVS 181
Query: 982 DKADVYSFGVVL 993
D++S G ++
Sbjct: 182 TATDMWSLGTLV 193
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 804 NVQNCIGSGGFGATYKAEIIPG----VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPN 858
+ IG G FG Y ++ + AVK L+ V QF E + HPN
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 859 LVTLIGYHV---SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
+++L+G + SE ++ Y+ G+L FI++ L L VA+ + YL
Sbjct: 88 VLSLLG--ICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYL 144
Query: 916 HDE-CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV---A 971
+ V HRD+ N +LD ++DFGLAR + E ++ + G V A
Sbjct: 145 ASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELIS 998
E T + + K+DV+SFGV+L EL++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLV 860
+ +Q IGSG A P VA+KR+++ + Q + + EI+ + + HPN+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSML---HKIAL---DVARALAY 914
+ V + E++L+ L GG++ I+ + S + IA +V L Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF-G---YV 970
LH +HRD+K NILL + + ++DFG++ L T V TF G ++
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 971 APEYAMTCRVSD-KADVYSFGVVLLELI 997
APE R D KAD++SFG+ +EL
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELA 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 24/196 (12%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLIGY 865
+G G FG K + I AVK ++ + E+ L ++ HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ +++ GG L I R R + E +I V + Y+H ++H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFS-E-HDAARIIKQVFSGITYMHKH---NIVH 144
Query: 926 RDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE-----YAMT 977
RD+KP NILL + + + + DFGL+ + D GT Y+APE Y
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEVLRGTY--- 199
Query: 978 CRVSDKADVYSFGVVL 993
+K DV+S GV+L
Sbjct: 200 ---DEKCDVWSAGVIL 212
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 95/548 (17%), Positives = 177/548 (32%), Gaps = 65/548 (11%)
Query: 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG 245
+V S N L VP++ L ++ N ++ + + ++LR L++S N +Q
Sbjct: 4 LVDRSKNGLI-HVPKDLSQKTTILN---ISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 246 DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL-RNDYGPLYSREHGDLPIQ 304
S F LE LDLS N L I LK L L N + LPI
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAF--------DALPIC 108
Query: 305 PVVDG-------GEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEML 357
G + I L +V ++ E
Sbjct: 109 KEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTE 166
Query: 358 NLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPR 417
+L F T + + + +L +N+ +L N S +
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVL--------------EDNKCSYFLSI 212
Query: 418 ISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGP 477
++ + + N +++ ++ N+ + + SN G
Sbjct: 213 LAKLQTNPKLSNLTLNNIET--------TWNSFIRILQLVWHTTVWYF--SISNVKLQGQ 262
Query: 478 VPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSD 537
F S +S + + G +Y +++ +++ F + +++ +
Sbjct: 263 -LDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPS 321
Query: 538 MGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ--GPLPSYINKMEDLKF 595
L + N + ++ + L L L N L+ + +M+ L+
Sbjct: 322 ---KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378
Query: 596 LSLSLNNFTGAIPWEL-TQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGR 654
L +S N+ + + SL L +S+N L+ I + VL L N +
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-S 435
Query: 655 IPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQ-----GNPNLQLCHTDPSSSEWE 709
IP +L +V+ N L S P + ++Q NP C S W
Sbjct: 436 IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 494
Query: 710 RQHSGNVS 717
++S
Sbjct: 495 NKNSQKEQ 502
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-18
Identities = 89/520 (17%), Positives = 154/520 (29%), Gaps = 62/520 (11%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
+ +L ++ N S +I LS L IL +S N + L ++LS N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 170 FNGTIPAFFGQSPGFQVVSLSFNLL-SGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG 228
I + + + LSFN + + +EF N L+ + L+ L S +
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFNAFDALPICKEF-GNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 229 NCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
+ + LL+ L + L F + + V L
Sbjct: 137 HLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE- 193
Query: 289 DYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNW 348
S L S L N+ W + + +
Sbjct: 194 -----LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 349 ELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQ 408
+ + L S + K+L + S+ + +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ-----------SYIYE 297
Query: 409 NLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHD 468
+ I + S + S S L + D
Sbjct: 298 IFSNMNIKNFTVS-------------------------GTRMVHMLCPSKISPFLHL--D 330
Query: 469 FSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKG-NLSTYPFDLCLSLDGLIFDIGN 527
FSNNL T V L+ L N LK + SL L DI
Sbjct: 331 FSNNLLTDTVFEN---CGHLTELET--LILQMNQLKELSKIAEMTTQMKSLQQL--DISQ 383
Query: 528 NKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI 587
N + + S K + L+M+ N I + ++ L+L N ++ +P +
Sbjct: 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIKS-IPKQV 440
Query: 588 NKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSL 627
K+E L+ L+++ N +L SL+ + L N
Sbjct: 441 VKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 46/277 (16%), Positives = 85/277 (30%), Gaps = 18/277 (6%)
Query: 16 LGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSF 75
L + N + T L L N S+L+ N +
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTL 227
Query: 76 HFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSL 135
+ NS ++ + + + L + L
Sbjct: 228 N----------NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195
L I + + F P + S++ + N + + + F + S NLL+
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG---NCTELRSLLLSSNMLQGDIPS-SF 251
+V E + LE ++L N L + L+ L +S N + D
Sbjct: 338 DTVFENC-GHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395
Query: 252 GQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
+L L++S N L+ + L ++KVL L +
Sbjct: 396 SWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHS 430
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 48/298 (16%), Positives = 90/298 (30%), Gaps = 38/298 (12%)
Query: 109 LTQLRVLLLAFNGFSGELPL--EIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLS 166
L+ L L+FN F LP+ E G +S L+ L LS + + + +++ +
Sbjct: 89 TVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVL 147
Query: 167 GNQFNGTIPAFFGQSPGFQVVSLSF--NLLSGSVPEEFGDNCVSLEHILLAANSLTG--- 221
G + Q + + + F N + + +LE +
Sbjct: 148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 222 ---SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV---NLEVLDLSRNFLSGIVPSEL 275
SI L +L +L L++ + QLV + +S L G +
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267
Query: 276 --GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVF 333
LK L + + + F + + + +
Sbjct: 268 FDYSGTSLKALSIHQVV-------------------SDVFGFPQSYIYEIFSNMNIKNF- 307
Query: 334 WAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
+ S L+ ++N T + + G+ L L L N L L
Sbjct: 308 --TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL 363
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLIGY 865
+G G F + G+ A K ++ + Q+ E R ++QHPN+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDECVP 921
E+ +L+++ + GG L + I R + E A + ++AY H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYS-E-----ADASHCIQQILESIAYCHSN--- 147
Query: 922 RVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
++HR++KP N+LL L+DFGLA + ++ A AGT GY++PE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLSPEVLKKD 205
Query: 979 RVSDKADVYSFGVVL 993
S D+++ GV+L
Sbjct: 206 PYSKPVDIWACGVIL 220
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 45/312 (14%), Positives = 98/312 (31%), Gaps = 41/312 (13%)
Query: 102 LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLR 161
+ + + ++ + + L ++ LDLS N L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 162 LINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTG 221
L+NLS N + + L+ N + + S+E + A N+++
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS- 112
Query: 222 SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI-VPSELGMCKQ 280
+ S G +++ L++N + G ++ LDL N + +
Sbjct: 113 RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 281 LKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNL 340
L+ L L+ NF + + L+ + L
Sbjct: 171 LEHLNLQY-------------------------NFIY-DVKGQVV-FAKLKTLDLSSNKL 203
Query: 341 EGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPC 400
+ ++ + + ++L +N I +L ++L DL N +
Sbjct: 204 AFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
Query: 401 MAVFNVSQNLLS 412
V V++ +
Sbjct: 262 QRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 43/194 (22%), Positives = 70/194 (36%), Gaps = 15/194 (7%)
Query: 98 LSGNL---SRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTL 154
LS N+ + + L+ LR L L N E+ +E L + N+
Sbjct: 65 LSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRG 119
Query: 155 QNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILL 214
Q + I L+ N+ G Q + L N + E + +LEH+ L
Sbjct: 120 QG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 215 AANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSE 274
N + + + +L++L LSSN L + F + + L N L I
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI-EKA 232
Query: 275 LGMCKQLKVLVLRN 288
L + L+ LR
Sbjct: 233 LRFSQNLEHFDLRG 246
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 32/193 (16%), Positives = 69/193 (35%), Gaps = 10/193 (5%)
Query: 98 LSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNC 157
L+ N + + + L A N S + GQ + + L+ N
Sbjct: 87 LNNNYVQELLVGPSIETLHAANNNIS-RVSCSRGQG--KKNIYLANNKITMLRDLDEGCR 143
Query: 158 SSLRLINLSGNQFNG-TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA 216
S ++ ++L N+ + S + ++L +N + V + L+ + L++
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLSS 200
Query: 217 NSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL- 275
N L + P + + + L +N L I + NLE DL N +
Sbjct: 201 NKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 276 GMCKQLKVLVLRN 288
++++ + +
Sbjct: 259 SKNQRVQTVAKQT 271
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 37/169 (21%), Positives = 60/169 (35%), Gaps = 9/169 (5%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQG-P 582
NN I V G K + +A N+ L ++ L+L N +
Sbjct: 105 HAANNN-ISRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160
Query: 583 LPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLN 642
+ L+ L+L N + A L+ L+LS+N L+ + EF +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 643 VLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQ 691
+ L +N L I +L FD+ N R+ K + VQ
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 38/221 (17%), Positives = 74/221 (33%), Gaps = 22/221 (9%)
Query: 197 SVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256
++ E N + + +SL ++ + ++ L LS N L +
Sbjct: 1 AIHEIKQ-NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 257 LEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN----DYGPLYSREHGDLPIQPVVDGGED 312
LE+L+LS N L +L L+ L L N + S E
Sbjct: 60 LELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQELLVGPSIETLHA----------A 107
Query: 313 YNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTG-QIPAS 371
N + S + + N + + + S+++ L+L N
Sbjct: 108 NNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 372 LGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLS 412
+ +L L+L N + + +V + ++S N L+
Sbjct: 165 AASSDTLEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 26/183 (14%), Positives = 69/183 (37%), Gaps = 21/183 (11%)
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG 557
++ +SLK ++ L D+ N + ++ + + ++ L+++ N
Sbjct: 17 VTDSSLK-QALASLRQSAWNVKEL--DLSGNP-LSQISAADLAPFTKLELLNLSSNVLYE 72
Query: 558 LIPQSFTNFDSLRNLNLSRNHLQ--GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
+ + +LR L+L+ N++Q PS ++ L + NN + +
Sbjct: 73 TLD--LESLSTLRTLDLNNNYVQELLVGPS-------IETLHAANNNIS-RVSCSR--GQ 120
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG--FGTRSSLSIFDVSFN 673
+ + L+ N ++ + + L L N + + + +L ++ +N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYN 179
Query: 674 NLS 676
+
Sbjct: 180 FIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 43/341 (12%), Positives = 102/341 (29%), Gaps = 43/341 (12%)
Query: 319 GLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSL 378
+ + ++ + +L+ + ++ L+L+ N + A L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 379 YFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLI 438
L+LSSN L + S+ + +++ N + E+ S+ +
Sbjct: 61 ELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-ELLVGP-----------SIETLHA- 106
Query: 439 GFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDS-DSLSSRPYYGFW 497
N ++ S + +NN T + +
Sbjct: 107 -------ANNNISR-VSCSRGQG-KKNI-YLANNKITM-LRDLDEGCRSRVQY-----LD 150
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG 557
L N + +L+ L ++ N + +V +K L ++ N+
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHL--NLQYNFIY-DVKG--QVVFAKLKTLDLSSNKLAF 205
Query: 558 LIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFT-GAIPWELTQLAS 616
+ F + + ++L N L + + ++L+ L N F G + ++
Sbjct: 206 -MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 617 LEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPP 657
++ + E + L + P
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTL----GHYGAYCCEDLP 300
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 28/118 (23%), Positives = 49/118 (41%), Gaps = 7/118 (5%)
Query: 559 IPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLE 618
I + N + + ++ + L+ L S ++K L LS N + +L LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 619 VLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
+L LS+N L + L L L L++N + + G S+ + NN+S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 25/163 (15%), Positives = 50/163 (30%), Gaps = 11/163 (6%)
Query: 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINL 165
L L L +N ++ ++ + L+ LDLS N + P Q+ + + I+L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221
Query: 166 SGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP 225
N+ I S + L N +F ++ +
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280
Query: 226 SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
+ +L D+P+ F ++ L +
Sbjct: 281 EECT---VPTLGHYGAYCCEDLPAPFA----DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 13/73 (17%), Positives = 28/73 (38%)
Query: 614 LASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFN 673
++ +++ +SL + S ++ L L N L+ + L + ++S N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 674 NLSGSAPRNSLIK 686
L + SL
Sbjct: 69 VLYETLDLESLST 81
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-28
Identities = 43/212 (20%), Positives = 81/212 (38%), Gaps = 24/212 (11%)
Query: 803 FNVQNCIGSG--GFGATYKAEIIP-GVVVAVKRLSVGR-----FQGVQQFAAEIRTLGRV 854
+ + IG G A P G V V+R+++ +Q E+
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG---ELHVSKLF 83
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
HPN+V +++ E++++ +++ G+ + I + + I V +AL Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV---- 970
+H +HR +K S+IL+ + YLS + + V
Sbjct: 144 IHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 971 --APEYAMTCRVS---DKADVYSFGVVLLELI 997
+PE + + K+D+YS G+ EL
Sbjct: 201 WLSPE-VLQQNLQGYDAKSDIYSVGITACELA 231
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 48/224 (21%), Positives = 83/224 (37%), Gaps = 34/224 (15%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRV-QHPN 858
F+ IGSG FG+ +K + + G + A+KR V + A E+ + QH +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYLH 916
+V + M + Y GG+L I + R + L + L V R L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAY-------------------LSDFGLARLLGTSET 957
++H DIKPSNI + + D G + + +
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 958 HATTDVAGTFGYVAPE-YAMTCRVSDKADVYSFGVVLLELISDK 1000
G ++A E KAD+++ + ++ +
Sbjct: 190 -----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 19/198 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-----VQQFAAEIRTLGRVQHPNLVTL 862
IG G F + G AVK + V +F + E ++HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDE 918
+ + S+ +++++ ++ G +L I R +S +A R AL Y HD
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS--EAVASHYMRQILEALRYCHDN 149
Query: 919 CVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
++HRD+KP +LL +N+ L FG+A LG GT ++APE
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVV 205
Query: 976 MTCRVSDKADVYSFGVVL 993
DV+ GV+L
Sbjct: 206 KREPYGKPVDVWGCGVIL 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 35/220 (15%), Positives = 63/220 (28%), Gaps = 26/220 (11%)
Query: 803 FNVQNCIGSGGFGATYKAE------IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH 856
V + +G G F Y+A +K + L
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH----KIALDVARAL 912
+ H+ + L+ G L I + T E M A+ + +
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY-KNTPEKVMPQGLVISFAMRMLYMI 185
Query: 913 AYLHDECVPRVLHRDIKPSNILL-----------DNNLNAYLSDFGLARLLGT-SETHAT 960
+HD ++H DIKP N +L D + L D G + + +
Sbjct: 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDK 1000
T T G+ E + + D + + ++
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 34/237 (14%), Positives = 73/237 (30%), Gaps = 56/237 (23%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLS-------------------VGRFQGVQ------ 842
+G A +A + G V + +G++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 843 ---QFAAEIRTLGRVQHPNLVTLIGY--HVSEAEMFLIYNYLPGGNLEKFIQD-----RP 892
+F + Q ++ + + F +Y NL+ F +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY-PRMQSNLQTFGEVLLSHSST 199
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+++ ++ L V R LA LH ++H ++P +I+LD +L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 953 GTSETHATTDVAGTFGYVAPEYAMT-----------CRVSDKADVYSFGVVLLELIS 998
G + + G+ PE ++ D ++ G+V+ +
Sbjct: 257 GA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 45/220 (20%), Positives = 88/220 (40%), Gaps = 31/220 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLS-----------------VGRFQGVQQFA 845
+ + + G F E A+K+ + F
Sbjct: 33 YRIIRTLNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--- 902
E++ + +++ +T G + E+++IY Y+ ++ KF + ++
Sbjct: 92 NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 903 ---KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
I V + +Y+H+E + HRD+KPSNIL+D N LSDFG + + +
Sbjct: 152 VIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK- 208
Query: 960 TTDVAGTFGYVAPEYAMTCRVSD--KADVYSFGVVLLELI 997
+ GT+ ++ PE+ + K D++S G+ L +
Sbjct: 209 GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 806 QNCIGSGGFGATYKAEIIPG----VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLV 860
IG G FG Y E I + A+K LS Q V+ F E + + HPN++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 861 TLIGYHVSEAE--MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
LIG + E ++ Y+ G+L +FI+ P+R L L VAR + YL ++
Sbjct: 86 ALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 919 -CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV---APEY 974
V HRD+ N +LD + ++DFGLAR + E ++ V A E
Sbjct: 144 KFV----HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 975 AMTCRVSDKADVYSFGVVLLELIS 998
T R + K+DV+SFGV+L EL++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 32/206 (15%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---------QQFAAEIRTLGRV-QHP 857
+G G + AVK + V + E+ L +V HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALA 913
N++ L + + FL+++ + G L ++ ++ + E K + R +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS-E-----KETRKIMRALLEVIC 138
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
LH ++HRD+KP NILLD+++N L+DFG + L +V GT Y+APE
Sbjct: 139 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAPE 193
Query: 974 ------YAMTCRVSDKADVYSFGVVL 993
+ D++S GV++
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 8/196 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ IG G G A E G VAVK + + + Q + E+ + QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+ ++ E++++ +L GG L + + + + V +ALAYLH +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT---VCEAVLQALAYLHAQ--- 160
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
V+HRDIK +ILL + LSDFG + + + GT ++APE +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLYA 219
Query: 982 DKADVYSFGVVLLELI 997
+ D++S G++++E++
Sbjct: 220 TEVDIWSLGIMVIEMV 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 26/198 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVK-----RLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G F + +++ G A +LS Q +++ E R ++HPN+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLKHPNIVRL 75
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDE 918
E +LI++ + GG L + I R + E A + A+ + H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-E-----ADASHCIQQILEAVLHCHQM 129
Query: 919 CVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
V+HR++KP N+LL L+DFGLA + E A AGT GY++PE
Sbjct: 130 ---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTPGYLSPEVL 185
Query: 976 MTCRVSDKADVYSFGVVL 993
D+++ GV+L
Sbjct: 186 RKDPYGKPVDLWACGVIL 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 21/193 (10%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G Y+ + A+K L + + EI L R+ HPN++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDECVPRV 923
+ E+ L+ + GG L I ++ + E + A D + A+AYLH+ +
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYS-E-----RDAADAVKQILEAVAYLHEN---GI 169
Query: 924 LHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+HRD+KP N+L + ++DFGL++++ V GT GY APE C
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRGCAY 227
Query: 981 SDKADVYSFGVVL 993
+ D++S G++
Sbjct: 228 GPEVDMWSVGIIT 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 809 IGSGGFGATYKA-----EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTL 862
IG+G FG YK V VA+K L G + F E +G+ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 863 IGYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G +S+ + M +I Y+ G L+KF++++ ++ + +A + YL +
Sbjct: 112 EGV-ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG-MLRGIAAGMKYLANM--- 166
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY--VAPEYAMTCR 979
+HRD+ NIL+++NL +SDFGL+R+L T G APE +
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 980 VSDKADVYSFGVVLLELIS 998
+ +DV+SFG+V+ E+++
Sbjct: 227 FTSASDVWSFGIVMWEVMT 245
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 26/200 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG------VQQFAAEIRTLGRVQHPNLVT 861
+GSG F K E G+ A K + + + ++ E+ L +V H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHD 917
L + + ++ LI + GG L F+ + + E + A + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS-E-----EEATSFIKQILDGVNYLHT 133
Query: 918 ECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+ ++ H D+KP NI+L + L DFGLA + ++ GT +VAPE
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPE 188
Query: 974 YAMTCRVSDKADVYSFGVVL 993
+ +AD++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-28
Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 14/196 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLIGY 865
+GSG +G + + V A+K + + E+ L + HPN++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ +L+ GG L I R + E I V + YLH ++H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFN-E-VDAAVIIKQVLSGVTYLHKH---NIVH 159
Query: 926 RDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
RD+KP N+LL++ + + DFGL+ + + + GT Y+APE + + +
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VLRKKYDE 216
Query: 983 KADVYSFGVVLLELIS 998
K DV+S GV+L L++
Sbjct: 217 KCDVWSIGVILFILLA 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-28
Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y + P + VA+K ++F E T+ + HP++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
G ++E +++I G L F+Q R + +++ + L A ++ ALAYL + R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RF 512
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
+HRDI N+L+ +N L DFGL+R + S + + ++APE R +
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 984 ADVYSFGVVLLELIS 998
+DV+ FGV + E++
Sbjct: 573 SDVWMFGVCMWEILM 587
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 26/200 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG------VQQFAAEIRTLGRVQHPNLVT 861
+GSG F K + G A K + R ++ E+ L ++HPN++T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHD 917
L ++ ++ LI + GG L F+ ++ T E A + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLT-E-----DEATQFLKQILDGVHYLHS 126
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY----LSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+ R+ H D+KP NI+L + L DFG+A + ++ GT +VAPE
Sbjct: 127 K---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPE 181
Query: 974 YAMTCRVSDKADVYSFGVVL 993
+ +AD++S GV+
Sbjct: 182 IVNYEPLGLEADMWSIGVIT 201
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 806 QNCIGSGGFGATYKAEIIPG----VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLV 860
IG G FG Y ++ + AVK L+ V QF E + HPN++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 861 TLIGYHV---SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+L+G + SE ++ Y+ G+L FI++ L L VA+ + +L
Sbjct: 154 SLLG--ICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 918 E-CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV---APE 973
+ V HRD+ N +LD ++DFGLAR + E + + G V A E
Sbjct: 211 KKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
T + + K+DV+SFGV+L EL++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 31/205 (15%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA--------EIRTLGRV-QHPN 858
IG G + G AVK + V + + E L +V HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAY 914
++TLI + S + MFL+++ + G L ++ ++ + E K + R A+++
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS-E-----KETRSIMRSLLEAVSF 215
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE- 973
LH ++HRD+KP NILLD+N+ LSDFG + L ++ GT GY+APE
Sbjct: 216 LHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRELCGTPGYLAPEI 270
Query: 974 -----YAMTCRVSDKADVYSFGVVL 993
+ D+++ GV+L
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVIL 295
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 40/213 (18%), Positives = 78/213 (36%), Gaps = 38/213 (17%)
Query: 809 IGSGGFGATYKAE--------IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLV 860
+G G F +K + V +K L + F + ++ H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G V E L+ ++ G+L+ +++ + + ++A +A A+ +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN-- 132
Query: 921 PRVLHRDIKPSNILLDNNLNAY--------LSDFGLARLLGTSETHATTDVAGTFGY--- 969
++H ++ NILL + LSD G++ + +
Sbjct: 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQER 180
Query: 970 ---VAPEYAMTCRV-SDKADVYSFGVVLLELIS 998
V PE + + D +SFG L E+ S
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 54/241 (22%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVK-----RLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
IG G +G A E + A+K ++ + V++ E+R + ++ HPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH-------------------- 902
+ E + L+ GG+L + + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 903 ------------------KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL- 943
I + AL YLH++ + HRDIKP N L N + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 944 -SDFGLARLLG---TSETHATTDVAGTFGYVAPE--YAMTCRVSDKADVYSFGVVLLELI 997
DFGL++ E + T AGT +VAPE K D +S GV+L L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 998 S 998
Sbjct: 271 M 271
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG------VQQFAAEIRTLGRVQHPNLVT 861
+GSG F K E G+ A K + + + ++ E+ L +V HPN++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHD 917
L + + ++ LI + GG L F+ + + E + A + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS-E-----EEATSFIKQILDGVNYLHT 133
Query: 918 ECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+ ++ H D+KP NI+L + L DFGLA + ++ GT +VAPE
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPE 188
Query: 974 YAMTCRVSDKADVYSFGVVL 993
+ +AD++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG------VQQFAAEIRTLGRVQHPNLVT 861
+GSG F K E G+ A K + R + + E+ L +QHPN++T
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHD 917
L + ++ ++ LI + GG L F+ ++ T E + A + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLT-E-----EEATEFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY----LSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI+L + + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVL 993
+ +AD++S GV+
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG--------VQQFAAEIRTLGRVQHPNL 859
+GSG G A E VA+K +S +F EI L ++ HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----ALAYL 915
+ + + +E + +++ + GG L + R E A+ YL
Sbjct: 78 IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLK-E-----ATCKLYFYQMLLAVQYL 130
Query: 916 HDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
H+ ++HRD+KP N+LL + + ++DFG +++LG ET + GT Y+AP
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 185
Query: 973 E---YAMTCRVSDKADVYSFGVVL 993
E T + D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-27
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLS-------------VGRFQGVQQFAAEIRTLGRV 854
+GSG +G E A+K + + ++ EI L +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR---- 910
HPN++ L + +L+ + GG L + I +R + E A ++ +
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD-E-----CDAANIMKQILS 157
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTF 967
+ YLH ++HRDIKP NILL+N LN + DFGL+ D GT
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTA 212
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
Y+APE + + ++K DV+S GV++ L+
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLC 242
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-27
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 14/196 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLIGY 865
+G G FG K + I AVK ++ + E+ L ++ HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ +++ GG L I R R + E +I V + Y+H ++H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFS-E-HDAARIIKQVFSGITYMHKH---NIVH 144
Query: 926 RDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
RD+KP NILL++ + + + DFGL+ + D GT Y+APE + +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGTYDE 201
Query: 983 KADVYSFGVVLLELIS 998
K DV+S GV+L L+S
Sbjct: 202 KCDVWSAGVILYILLS 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-27
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLS--------VGRFQGVQQFAAEIRTLGRVQHPNL 859
+GSG G A E VA++ +S EI L ++ HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ + + +E + +++ + GG L + R E + + A+ YLH+
Sbjct: 203 IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLK-E-ATCKLYFYQMLLAVQYLHEN- 258
Query: 920 VPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE--- 973
++HRD+KP N+LL + + ++DFG +++LG ET + GT Y+APE
Sbjct: 259 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLV 314
Query: 974 YAMTCRVSDKADVYSFGVVL 993
T + D +S GV+L
Sbjct: 315 SVGTAGYNRAVDCWSLGVIL 334
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 45/215 (20%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 805 VQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPN 858
+ +G G FG+ +A++ V VAVK L +++F E + HP+
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 859 LVTLIG------YHVSEAEMFLIYNYLPGGNLEKFIQDR----PRRTVEWSMLHKIALDV 908
+ L+G +I ++ G+L F+ + L + +D+
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
A + YL +HRD+ N +L ++ ++DFGL+R + + + + G
Sbjct: 147 ACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199
Query: 969 YV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
+ A E + +DV++FGV + E+++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 22/197 (11%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQH-PNLVTLIG 864
+G G F + G A K L R + EI L + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 865 YHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSMLHKIALDVAR----ALAYLHDEC 919
+ + +E+ LI Y GG + + + E + + + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSE-----NDVIRLIKQILEGVYYLHQN- 150
Query: 920 VPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
++H D+KP NILL + + + DFG++R +G + ++ GT Y+APE
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILN 206
Query: 977 TCRVSDKADVYSFGVVL 993
++ D+++ G++
Sbjct: 207 YDPITTATDMWNIGIIA 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 44/210 (20%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG+ + + + VAVK + + + +++F +E + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 863 IG-----YHVSEAEMFLIYNYLPGGNLEKFIQDR----PRRTVEWSMLHKIALDVARALA 913
+G + +I ++ G+L ++ + + L K +D+A +
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV--- 970
YL + LHRD+ N +L +++ ++DFGL++ + + + + G +
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVK 214
Query: 971 --APEYAMTCRVSDKADVYSFGVVLLELIS 998
A E + K+DV++FGV + E+ +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 10/199 (5%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ-GVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G +KA +VA+KR+ + GV A EI L ++H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
S+ ++ L++ + +L+K+ ++ + + L + H VLH
Sbjct: 70 LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
RD+KP N+L++ N L++FGLAR G + +V T Y P+ ++ S
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 985 DVYSFGVVLLELISDKKAL 1003
D++S G + EL + + L
Sbjct: 184 DMWSAGCIFAELANAGRPL 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 16/191 (8%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR-VQHPNLVTLIGYH 866
IG G + + + AVK + + + EI L R QHPN++TL +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
++++ + GG L I + + E + + + + YLH + V+HR
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFS-E-REASAVLFTITKTVEYLHAQ---GVVHR 140
Query: 927 DIKPSNILL----DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
D+KPSNIL N + + DFG A+ L +E T +VAPE
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYTANFVAPEVLERQGYDA 199
Query: 983 KADVYSFGVVL 993
D++S GV+L
Sbjct: 200 ACDIWSLGVLL 210
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 809 IGSGGFGATYKAE---IIPG---VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE + P ++VAVK L + F E L +QH ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 863 IGYHVSEAE-MFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKIALD 907
G + + + +++ Y+ G+L KF++ + + S + IA
Sbjct: 83 YGV-CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 908 VARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
+A + YL V HRD+ N L+ NL + DFG++R + +++ + G
Sbjct: 142 IASGMVYLASQHFV----HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----VGG 193
Query: 967 FGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
+ PE M + + ++DV+SFGV+L E+ +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPN 858
F+ IG G FGA Y A ++ VVA+K++S Q Q E+R L +++HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL---DVARALAYL 915
+ G ++ E +L+ Y G + ++ + E +IA + LAYL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD-LLEVHKKPLQE----VEIAAVTHGALQGLAYL 170
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H ++HRD+K NILL L DFG A ++ + + GT ++APE
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVI 222
Query: 976 MTCRVSD---KADVYSFGVVLLELI 997
+ K DV+S G+ +EL
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELA 247
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 36/211 (17%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ----GVQQFAAEIRTLGRVQHPNLVTLI 863
+G G +G + AVK L + + G EI+ L R++H N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71
Query: 864 GYHV----SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR--------A 911
V + +M+++ Y G E D + + A
Sbjct: 72 -VDVLYNEEKQKMYMVMEYCVCGMQEML--DSVPE-------KRFPVCQAHGYFCQLIDG 121
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL--GTSETHATTDVAGTFGY 969
L YLH + ++H+DIKP N+LL +S G+A L ++ T G+ +
Sbjct: 122 LEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAF 177
Query: 970 VAPEYAMTCRVSD--KADVYSFGVVLLELIS 998
PE A K D++S GV L + +
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ-GVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G +K G +VA+K+ +++ A EIR L +++HPNLV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ + L++ Y + + R V ++ I +A+ + H +H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCHKH---NCIH 125
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA- 984
RD+KP NIL+ + L DFG ARLL + +VA T Y +PE +
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYGPPV 184
Query: 985 DVYSFGVVLLELISDKKALDP 1005
DV++ G V EL+S L P
Sbjct: 185 DVWAIGCVFAELLS-GVPLWP 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
F + +G+G +G YK + G + A+K + V ++ EI L + H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 861 TLIG------YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
T G + +++L+ + G++ I++ T++ + I ++ R L++
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
LH +V+HRDIK N+LL N L DFG++ L + T GT ++APE
Sbjct: 145 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 200
Query: 975 AMTCRVSD-----KADVYSFGVVLLELI 997
D K+D++S G+ +E+
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 57/196 (29%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYH 866
+G G F K AVK +S Q+ EI L + HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ FL+ L GG L + I+ + + E + I + A++++HD V+HR
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFS-E-TEASYIMRKLVSAVSHMHDV---GVVHR 130
Query: 927 DIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE------YAMT 977
D+KP N+L ++NL + DFG ARL + T Y APE Y +
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTLHYAAPELLNQNGYDES 189
Query: 978 CRVSDKADVYSFGVVL 993
C D++S GV+L
Sbjct: 190 C------DLWSLGVIL 199
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 809 IGSGGFGATYKAE---IIPG---VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE ++P ++VAVK L Q F E L +QH ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 863 IGYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWS-------------MLHKIALDV 908
G +E + +++ Y+ G+L +F++ + L +A V
Sbjct: 109 FGV-CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 909 ARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
A + YL V HRD+ N L+ L + DFG++R + +++ + G
Sbjct: 168 AAGMVYLAGLHFV----HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VGGR 219
Query: 968 GYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
+ PE + + + ++DV+SFGVVL E+ +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ P VA+K ++ + +F E + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 862 LIGYHVSEAE-MFLIYNYLPGGNLEKFIQDR--------PRRTVEWSMLHKIALDVARAL 912
L+G VS+ + +I + G+L+ +++ S + ++A ++A +
Sbjct: 93 LLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 913 AYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV- 970
AYL+ + V HRD+ N ++ + + DFG+ R + ++ + G G +
Sbjct: 152 AYLNANKFV----HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 203
Query: 971 ----APEYAMTCRVSDKADVYSFGVVLLELIS 998
+PE + +DV+SFGVVL E+ +
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 23/167 (13%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR-----PRRTVEWSML 901
+IR + N V + + +++ NL+ ++ R V +
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 902 HKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT- 960
+IA A+ +LH + ++HRD+KPSNI + + DFGL + E T
Sbjct: 171 IQIAE----AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 961 ----------TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
T GT Y++PE S K D++S G++L EL+
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ-GVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
+G G +G YKA+ G +VA+KR+ + G+ A EI L + HPN+V+LI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
SE + L++ ++ +L+K + + + S + + R +A+ H R+LHR
Sbjct: 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQD-SQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKAD 985
D+KP N+L++++ L+DFGLAR G T +V T Y AP+ M + S D
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 986 VYSFGVVLLELISDKKALDP 1005
++S G + E+I+ K L P
Sbjct: 203 IWSIGCIFAEMIT-GKPLFP 221
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 52/202 (25%), Positives = 84/202 (41%), Gaps = 23/202 (11%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYH 866
+G G +I AVK + + E+ L + Q H N++ LI +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRT-VEWSMLHKIALDVARALAYLHDECVPRVLH 925
E +L++ + GG++ I R +E S + DVA AL +LH+ + H
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHN---KGIAH 134
Query: 926 RDIKPSNILL---DNNLNAYLSDFGLARLL------GTSETHATTDVAGTFGYVAPE--- 973
RD+KP NIL + + DF L + T G+ Y+APE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 974 -YAMTCRVSDKA-DVYSFGVVL 993
++ + DK D++S GV+L
Sbjct: 195 AFSEEASIYDKRCDLWSLGVIL 216
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 809 IGSGGFGATYKAEIIPG---VVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLVTLI 863
IG G FG KA I + A+KR+ + FA E+ L ++ HPN++ L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKIALDVA 909
G ++L Y P GNL F++ T+ L A DVA
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 910 RALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD--VAGT 966
R + YL + + HRD+ NIL+ N A ++DFGL+R + V T
Sbjct: 153 RGMDYLSQKQFI----HRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKT 199
Query: 967 FGYV-----APEYAMTCRV-SDKADVYSFGVVLLELIS 998
G + A E ++ V + +DV+S+GV+L E++S
Sbjct: 200 MGRLPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 47/207 (22%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVK-----RLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
IG G F A I+ G VA+K +L+ Q + + E+R + + HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---EVRIMKILNHPNIVKL 79
Query: 863 IGYHV--SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR--------AL 912
+ V +E ++LI Y GG + ++ ++ AR A+
Sbjct: 80 --FEVIETEKTLYLIMEYASGGEVFDYLVAH----------GRMKEKEARSKFRQIVSAV 127
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
Y H + + +HRD+K N+LLD ++N ++DFG + G Y AP
Sbjct: 128 QYCHQKRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAP 182
Query: 973 E------YAMTCRVSDKADVYSFGVVL 993
E Y + DV+S GV+L
Sbjct: 183 ELFQGKKYD-----GPEVDVWSLGVIL 204
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 37/218 (16%)
Query: 809 IGSGGFGATYKAE---IIPG---VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVT 861
+G FG YK PG VA+K L ++F E R+QHPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 862 LIGYHVSEAE-MFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKIAL 906
L+G V++ + + +I++Y G+L +F+ R + +E +
Sbjct: 77 LLGV-VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 907 DVARALAYLHDE-CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
+A + YL V H+D+ N+L+ + LN +SD GL R + ++ +
Sbjct: 136 QIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----KLL 187
Query: 966 TFGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
+ APE M + S +D++S+GVVL E+ S
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-24
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ-GVQQFAA-EIRTLGRVQHPNLVTLIGY 865
+G G +G K G +VA+K+ V++ A EI+ L +++H NLV L+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ +L++ ++ + ++ P +++ ++ K + + + H ++H
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSH---NIIH 147
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA- 984
RDIKP NIL+ + L DFG AR L +VA T Y APE + KA
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKAV 206
Query: 985 DVYSFGVVLLELISDKKALDP 1005
DV++ G ++ E+ + L P
Sbjct: 207 DVWAIGCLVTEMFM-GEPLFP 226
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 64/311 (20%), Positives = 104/311 (33%), Gaps = 64/311 (20%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168
+LR L ++ N + LP+ L L I +P L + GN
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKL---WIFGN 131
Query: 169 QFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG 228
Q ++P Q +S+S N L+ S+P L + N LT S+P
Sbjct: 132 QLT-SLPVLPPG---LQELSVSDNQLA-SLPALPS----ELCKLWAYNNQLT-SLPMLPS 181
Query: 229 NCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
L+ L +S N L +P+ +L L + L P+ LK L++
Sbjct: 182 G---LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSL----PALPS---GLKELIVSG 230
Query: 289 DYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNW 348
N LP + L L V L + P
Sbjct: 231 -------------------------NRL-TSLPVLPSELKELMVS---GNRLTSL-P--- 257
Query: 349 ELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQ 408
L S L L++ N T ++P SL + S ++L N L+ + + S
Sbjct: 258 MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE-RTLQALREITSAPGYSG 315
Query: 409 NLLSGEIPRIS 419
++ ++ S
Sbjct: 316 PIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-18
Identities = 59/376 (15%), Positives = 107/376 (28%), Gaps = 85/376 (22%)
Query: 128 LEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187
+ + +L++ + +P L + + + + N ++PA + + +
Sbjct: 34 MRACLNNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALPPE---LRTL 86
Query: 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDI 247
+S N L+ S+P + L L + L L + N L +
Sbjct: 87 EVSGNQLT-SLPVLPP-GLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SL 136
Query: 248 PSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL-----VLRNDYGPLYSREHGDLP 302
P L+ L +S N L+ + P+ +L L L + +
Sbjct: 137 PVLPP---GLQELSVSDNQLASL-PALPSELCKLWAYNNQLTSLPMLPSGL---QELSV- 188
Query: 303 IQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHN 362
N LP + L L + N L + P L S L+ L ++ N
Sbjct: 189 ---------SDNQL-ASLPTLPSELYKLWAY---NNRLTSL-P---ALPSGLKELIVSGN 231
Query: 363 FFTGQIPASLGNCKSLY-----------------FLDLSSNNLTGLLPEEV-SVPCMAVF 404
T +P K L L + N LT LPE + +
Sbjct: 232 RLT-SLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETTV 289
Query: 405 NVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLF 464
N+ N LS + S A Y + + +
Sbjct: 290 NLEGNPLSERTLQALREITS------------------APGYSGPIIRFDMAGASAPRET 331
Query: 465 ILHDFSNNLFTGPVPP 480
+ + P
Sbjct: 332 RALHLAAADWLVPARE 347
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 1e-17
Identities = 59/323 (18%), Positives = 99/323 (30%), Gaps = 77/323 (23%)
Query: 98 LSGN----LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSL--------------LEIL 139
+SGN L L +L + LP + +L + L+ L
Sbjct: 88 VSGNQLTSLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQEL 146
Query: 140 DLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVP 199
+S N +P L NQ ++P Q +S+S N L+ S+P
Sbjct: 147 SVSDNQLAS-LPALPSELCKL---WAYNNQLT-SLPMLPSG---LQELSVSDNQLA-SLP 197
Query: 200 EEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEV 259
L + N LT S+P L+ L++S N L +P L+
Sbjct: 198 TLPS----ELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPVLPS---ELKE 245
Query: 260 LDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGG 319
L +S N L+ + P L L + + L
Sbjct: 246 LMVSGNRLTSL-PMLPS---GLLSLSVYRN--QLTR------------------------ 275
Query: 320 LPDSITRLPNLRVFWAPNLNLEG--IFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKS 377
LP+S+ L + +NLEG + + + ++ A +
Sbjct: 276 LPESLIHLSSETT-----VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 378 LYFLDLSSNNLTGLLPEEVSVPC 400
L L++ + E P
Sbjct: 331 TRALHLAAADWLVPAREGEPAPA 353
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-16
Identities = 78/466 (16%), Positives = 141/466 (30%), Gaps = 143/466 (30%)
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ 244
V+++ + L+ ++P+ + + +++ N+LT S+P LR+L +S N L
Sbjct: 43 AVLNVGESGLT-TLPDCLPAH---ITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLT 94
Query: 245 GDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQ 304
+P L+ L + L + L L + +
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGN--------------- 131
Query: 305 PVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFF 364
+T LP L L+ L+++ N
Sbjct: 132 ------------------QLTSLP--------------------VLPPGLQELSVSDNQL 153
Query: 365 TGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECS 424
+PA L+ +N LT L P S + +VS N L+ +P
Sbjct: 154 A-SLPALPSELCKLW---AYNNQLTSL-PMLPS--GLQELSVSDNQLA-SLP-------- 197
Query: 425 KMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLID 484
L L+ L ++N L + +P
Sbjct: 198 -----------TLPS----------------------ELYKLWAYNNRLTS--LPALP-- 220
Query: 485 SDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKC 544
L +SGN L T L L L + N+L +P
Sbjct: 221 -SGLKE-----LIVSGNRL-----TSLPVLPSELKEL--MVSGNRLT-SLPMLPSG---- 262
Query: 545 MKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFT 604
+ LS+ N+ L P+S + S +NL N L + ++ S + F
Sbjct: 263 LLSLSVYRNQLTRL-PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
Query: 605 GAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNN 650
A + +L +A+ L E + + ++ + N
Sbjct: 322 MAGASAPRETRALH--LAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-16
Identities = 61/305 (20%), Positives = 100/305 (32%), Gaps = 66/305 (21%)
Query: 349 ELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQ 408
L + + L + N T +PA ++L ++S N LT L + +++F+
Sbjct: 58 CLPAHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLTSLPVLPPGLLELSIFSNPL 113
Query: 409 NLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHD 468
L + N LTS GL L
Sbjct: 114 THLPALPSGLCKLWIF----------------------GNQLTS---LPVLPPGLQEL-S 147
Query: 469 FSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIF-DIGN 527
S+N +P + L W N L L + GL + +
Sbjct: 148 VSDNQLAS-LPALPSELCKL--------WAYNNQLT--------SLPMLPSGLQELSVSD 190
Query: 528 NKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI 587
N+L +P+ + L N L P + L+ L +S N L LP
Sbjct: 191 NQLA-SLPTLPSE----LYKLWAYNNRLTSL-PALPSG---LKELIVSGNRLTS-LPVLP 240
Query: 588 NKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLD 647
++ LK L +S N T ++P + L L + N L+ +P L + L+
Sbjct: 241 SE---LKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 648 HNNLT 652
N L+
Sbjct: 293 GNPLS 297
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L + +E++ L + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM---------------LHKI 904
L+G +I Y G+L F++ R + L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964
+ VA+ +A+L + +HRD+ NILL + + DFGLAR + + V
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY----VV 203
Query: 965 GTFGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
+ APE C + ++DV+S+G+ L EL S
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ-GVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G +G YKA+ G A+K++ + + G+ EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
++ + L++ +L +L+K + L + +AY HD RVLHR
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLES-VTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKAD 985
D+KP N+L++ ++DFGLAR G T ++ T Y AP+ M + S D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTID 183
Query: 986 VYSFGVVLLELISDKKAL 1003
++S G + E+++ L
Sbjct: 184 IWSVGCIFAEMVN-GTPL 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
+G+G + YK GV VA+K + + +G A EI + ++H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH----KIALDVARALAYLHDECVPR 922
+E ++ L++ ++ +L+K++ R + + + LA+ H+ +
Sbjct: 73 HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---K 128
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-S 981
+LHRD+KP N+L++ L DFGLAR G +++V T Y AP+ M R S
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYS 187
Query: 982 DKADVYSFGVVLLELISDKKALDP 1005
D++S G +L E+I+ K L P
Sbjct: 188 TSIDIWSCGCILAEMIT-GKPLFP 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 49/222 (22%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAA--------------------- 846
IG G +G A A+K LS + F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 847 -----EIRTLGRVQHPNLVTLIGYHV----SEAEMFLIYNYLPGGNLEKFIQDRPRRTVE 897
EI L ++ HPN+V L V +E +++++ + G + + +P +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 898 WSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957
D+ + + YLH + +++HRDIKPSN+L+ + + ++DFG++ S+
Sbjct: 139 ---ARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 958 HATTDVAGTFGYVAPEYAMTCRVSDK------ADVYSFGVVL 993
+ GT ++APE + + K DV++ GV L
Sbjct: 193 LLSN-TVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTL 230
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 69/432 (15%), Positives = 131/432 (30%), Gaps = 92/432 (21%)
Query: 222 SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQL 281
I +L + + L N +++ + + + + L +Q+
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 282 KVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLE 341
++L L + + + ++ + +
Sbjct: 72 ELLNLND-------------------------LQIEEIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 342 GIFPQNWELCSKLEMLNLAHNFFTGQIPASL-GNCKSLYFLDLSSNNLTGLLPEEVSVPC 400
+ P ++ L +L L N + +P + N L L +S+NNL + +
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDD------ 159
Query: 401 MAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPS 460
F + +L + L N LT S
Sbjct: 160 --TFQATTSL----------------------QNLQL--------SSNRLTHV-DLSLIP 186
Query: 461 NGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDG 520
+ LF + N L T +P + + S N +++ + + L
Sbjct: 187 S-LFHANVSYNLLSTLAIPIAVEE-----------LDASHN----SINVVRGPVNVELTI 230
Query: 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ 580
L + +N L + + + + ++ NE ++ F L L +S N L
Sbjct: 231 L--KLQHNNLT-DTAW--LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
Query: 581 GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEH 640
L Y + LK L LS N+ + Q LE L L NS+ + S
Sbjct: 286 A-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHT 340
Query: 641 LNVLRLDHNNLT 652
L L L HN+
Sbjct: 341 LKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 53/288 (18%), Positives = 100/288 (34%), Gaps = 43/288 (14%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP-TLQNCSSLRLINLSG 167
+ + E L+ +I+ ++ +P L + + L+NL+
Sbjct: 20 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLND 78
Query: 168 NQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL 227
Q F + Q + + FN + +P N L ++L N L+ S+P +
Sbjct: 79 LQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGI 136
Query: 228 -GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL 286
N +L +L +S+N L+ +F +L+ L LS N L+ + S + L +
Sbjct: 137 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI---PSLFHANV 193
Query: 287 RNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQ 346
YN ++ + A + ++ +
Sbjct: 194 -------------------------SYNLL-----STLAIPIAVEELDASHNSINVVRG- 222
Query: 347 NWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPE 394
+ +L +L L HN T L N L +DLS N L ++
Sbjct: 223 --PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYH 266
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 55/304 (18%), Positives = 94/304 (30%), Gaps = 56/304 (18%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEIGQ-LSLLEILDLSFNSFHGPIP 151
L+ + A ++ L + FN LP + Q + LL +L L N
Sbjct: 76 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPR 134
Query: 152 PTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEH 211
N L +++S N F + Q + LS N L+ SL H
Sbjct: 135 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP----SLFH 190
Query: 212 ILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIV 271
++ N L+ +L + L S N + + V L +L L N L+
Sbjct: 191 ANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTDT- 241
Query: 272 PSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLR 331
+ L L + L YN + + ++ L
Sbjct: 242 -AWLLNYPGLVEVDL-------------------------SYNELEKIMYHPFVKMQRLE 275
Query: 332 VFWAPNLNLEG----IFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387
L + + L++L+L+HN + + L L L N+
Sbjct: 276 R-----LYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329
Query: 388 LTGL 391
+ L
Sbjct: 330 IVTL 333
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 18/193 (9%)
Query: 98 LSGN-LSR-AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQ 155
LS N L+ + + L +++N S + +E LD S NS + + +
Sbjct: 172 LSSNRLTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV- 224
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
L ++ L N PG V LS+N L + LE + ++
Sbjct: 225 -NVELTILKLQHNNLT-DTAWLLNY-PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYIS 280
Query: 216 ANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL 275
N L ++ L+ L LS N L + + Q LE L L N + + S
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTH 338
Query: 276 GMCKQLKVLVLRN 288
LK L L +
Sbjct: 339 ---HTLKNLTLSH 348
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 67/315 (21%), Positives = 99/315 (31%), Gaps = 85/315 (26%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIP 151
+ N ++ L VL+L N S LP I L L +S N+ I
Sbjct: 100 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IE 157
Query: 152 P-TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEF-------- 202
T Q +SL+ + LS N+ + P ++S+NLLS ++
Sbjct: 158 DDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPIAVEELDAS 213
Query: 203 --------GDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQL 254
G V L + L N+LT L N L + LS N L+ + F ++
Sbjct: 214 HNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 271
Query: 255 VNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYN 314
LE L +S N L + LKVL L +N
Sbjct: 272 QRLERLYISNNRLVAL-NLYGQPIPTLKVLDL-------------------------SHN 305
Query: 315 FFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGN 374
+ + +LE L L HN + L
Sbjct: 306 --------HLLHVE------------RNQPQ-----FDRLENLYLDHNSIV-TLK--LST 337
Query: 375 CKSLYFLDLSSNNLT 389
+L L LS N+
Sbjct: 338 HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 73/433 (16%), Positives = 134/433 (30%), Gaps = 95/433 (21%)
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209
I LQ +++ + ++V+ + + +P D+ +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 210 EHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
E + L + I + ++ L + N ++ P F + L VL L RN LS
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 269 GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP 328
+ +L L + N N ++ R+
Sbjct: 131 SLPRGIFHNTPKLTTLSMSN-------------------------N--------NLERIE 157
Query: 329 NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNL 388
+ F + L+ L L+ N T + L SL+ ++S N L
Sbjct: 158 ------------DDTFQA----TTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 198
Query: 389 TGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYEN 448
+ L + + S N ++ + VN ++ + L N
Sbjct: 199 STLAIP----IAVEELDASHNSIN-VVRG---------PVNVELTILKL--------QHN 236
Query: 449 ALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPY-YGFWLSGNSLKGNL 507
LT A + L + D S N I ++S N L L
Sbjct: 237 NLTDTAWLLNYPG-LVEV-DLSYNELE------KIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 508 STYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFD 567
+ Y + +L L D+ +N + V + ++ L + N V L +
Sbjct: 288 NLYGQPI-PTLKVL--DLSHNH-LLHVERNQP-QFDRLENLYLDHNSIVTL---KLSTHH 339
Query: 568 SLRNLNLSRNHLQ 580
+L+NL LS N
Sbjct: 340 TLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-14
Identities = 45/198 (22%), Positives = 70/198 (35%), Gaps = 30/198 (15%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
L N L +L F L L + NN + + D ++ L ++ N
Sbjct: 123 VLERNDLS-SLPRGIFHNTPKLTTL--SMSNNN-LERIEDDTFQATTSLQNLQLSSNRLT 178
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYIN-----------------KMEDLKFLSLS 599
+ + SL + N+S N L L I +L L L
Sbjct: 179 HV---DLSLIPSLFHANVSYNLLST-LAIPIAVEELDASHNSINVVRGPVNVELTILKLQ 234
Query: 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG 658
NN T W L L ++LS N L +I F K++ L L + +N L +
Sbjct: 235 HNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLY 290
Query: 659 FGTRSSLSIFDVSFNNLS 676
+L + D+S N+L
Sbjct: 291 GQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 35/183 (19%), Positives = 72/183 (39%), Gaps = 10/183 (5%)
Query: 498 LSGNSLKGNLSTYPFDL-CLSLDGL-IFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEF 555
+ F ++L+ I N+ + ++P+ + + ++ L++ +
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQI 81
Query: 556 VGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWEL-TQL 614
+ +F +++ L + N ++ P + L L L N+ + ++P +
Sbjct: 82 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 140
Query: 615 ASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFN 673
L L +S N+L I + F L L+L N LT + SL +VS+N
Sbjct: 141 PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 196
Query: 674 NLS 676
LS
Sbjct: 197 LLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 34/171 (19%), Positives = 63/171 (36%), Gaps = 11/171 (6%)
Query: 98 LSGNLSRAI--GDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQ 155
S N + +L +L L N + + + L +DLS+N +
Sbjct: 212 ASHNSINVVRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFV 269
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
L + +S N+ + + P +V+ LS N L V LE++ L
Sbjct: 270 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQP-QFDRLENLYLD 326
Query: 216 ANSLTGSIPPSLGNCTELRSLLLSSNMLQGD-IPSSFGQLVNLEVLDLSRN 265
NS+ ++ L++L LS N + + + F + V D ++
Sbjct: 327 HNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 18/120 (15%), Positives = 42/120 (35%), Gaps = 4/120 (3%)
Query: 559 IPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLE 618
I + ++++ + + K ++ + L +E
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 619 VLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLS 676
+L L+ + EI + F+ + L + N + +PP F L++ + N+LS
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 48/223 (21%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L + +E++ + + QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 861 TLIGYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSM------------LHKIALD 907
L+G + + +I Y G+L F++ + R L +
Sbjct: 114 NLLG-ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
VA+ +A+L + +HRD+ N+LL N A + DFGLAR D+
Sbjct: 173 VAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR-----------DIMNDS 218
Query: 968 GYV------------APEYAMTCRVSDKADVYSFGVVLLELIS 998
Y+ APE C + ++DV+S+G++L E+ S
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 40/245 (16%)
Query: 769 NSIADPGLVRKEVVICNNIG--VQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGV 826
N + DP V K + G ++ Y N IG+G FG ++A+++
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIAYTNC----------KVIGNGSFGVVFQAKLVESD 65
Query: 827 VVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHPNLVTLIGYHVS------EAEMFLIY 876
VA+K+ V Q E++ + V+HPN+V L + S E + L+
Sbjct: 66 EVAIKK--------VLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 877 NYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECVPRVLHRDIKPSNIL 934
Y+P + + + + ML + R+LAY+H + HRDIKP N+L
Sbjct: 118 EYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLL 173
Query: 935 LDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA-DVYSFGVV 992
LD L DFG A++L E + + + + Y APE D++S G V
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEPN-VSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCV 231
Query: 993 LLELI 997
+ EL+
Sbjct: 232 MAELM 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 42/210 (20%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVK---RLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G G FG E + G VAVK R + V + EI+ L +HP+++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 865 YHV--SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR--------ALAY 914
Y V + + F++ Y+ GG L +I R + AR A+ Y
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGR----------VEEMEARRLFQQILSAVDY 126
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE- 973
H V+HRD+KP N+LLD ++NA ++DFGL+ ++ E T+ G+ Y APE
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEV 181
Query: 974 -----YAMTCRVSDKADVYSFGVVLLELIS 998
YA + D++S GV+L L+
Sbjct: 182 ISGRLYA-----GPEVDIWSCGVILYALLC 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 809 IGSGGFGATYKA---EIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIG 864
+G G +G YKA + A+K++ G+ A EI L ++HPN+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACREIALLRELKHPNVISLQK 85
Query: 865 YHVSEAEM--FLIYNYLPGGNLEKFI-------QDRPRRTVEWSMLHKIALDVARALAYL 915
+S A+ +L+++Y +L I ++ + M+ + + + YL
Sbjct: 86 VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAY----LSDFGLARLLGT---SETHATTDVAGTFG 968
H VLHRD+KP+NIL+ ++D G ARL + V TF
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 969 YVAPEYAMTCRVSDKA-DVYSFGVVLLELISDKKAL 1003
Y APE + R KA D+++ G + EL++ + +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-24
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 793 YENVVRATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFA----AE 847
E + F V+ G G FG + G+ VA+K++ Q +F
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQ-DPRFRNRELQI 69
Query: 848 IRTLGRVQHPNLVTLIGYHVSEAE-------MFLIYNYLPGGNLEKFIQDRPRRTVEWSM 900
++ L + HPN+V L Y + E + ++ Y+P L + ++ RR V
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPP 128
Query: 901 LHK--IALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSET 957
+ + R++ LH V V HRDIKP N+L++ + L DFG A+ L SE
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 958 HATTDVAGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
+ + + Y APE + A D++S G + E++ +
Sbjct: 188 N-VAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 21/220 (9%)
Query: 798 RATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ-GVQQFAA----EI--- 848
AT+ + IG G +G YKA + G VA+K + V G E+
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 849 RTLGRVQHPNLVTLI-----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK 903
R L +HPN+V L+ E ++ L++ ++ +L ++ P + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+ R L +LH ++HRD+KP NIL+ + L+DFGLAR+ T V
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVV 180
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKAL 1003
T Y APE + + D++S G + E+ +K L
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
+G G + YK + +VA+K + + +G A E+ L ++H N+VTL
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+E + L++ YL +L++++ D + + R LAY H +VLHR
Sbjct: 70 HTEKSLTLVFEYLDK-DLKQYLDDCGNIINM-HNVKLFLFQLLRGLAYCHR---QKVLHR 124
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKAD 985
D+KP N+L++ L+DFGLAR +V T Y P+ + S + D
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQID 183
Query: 986 VYSFGVVLLELISDKKALDP 1005
++ G + E+ + + L P
Sbjct: 184 MWGVGCIFYEMAT-GRPLFP 202
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 37/219 (16%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLV 860
+G G FG +A+ VAVK L G + +E++ L + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 861 TLIGYHVSEAE--MFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
L+G ++ + +I + GNL +++ + + + L
Sbjct: 95 NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964
+ VA+ + +L + +HRD+ NILL + DFGLAR + + V
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VR 206
Query: 965 GTFGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
+ APE + ++DV+SFGV+L E+ S
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + +
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 215
Query: 965 GTFGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
T G + APE + ++DV+SFGV++ E+ +
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 54/223 (24%), Positives = 84/223 (37%), Gaps = 50/223 (22%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVK--------RLSVGRFQGVQQFAAEIRTLGR 853
++ + +GSG FG + A V VK + + EI L R
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 854 VQHPNLVTLIGYHVSEAEMFLIY----NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVA 909
V+H N++ + + E + F + G +L FI PR + +A
Sbjct: 86 VEHANIIKV--LDIFENQGF-FQLVMEKHGSGLDLFAFIDRHPR----------LDEPLA 132
Query: 910 R--------ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961
A+ YL + ++HRDIK NI++ + L DFG A L + T
Sbjct: 133 SYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189
Query: 962 DVAGTFGYVAPE------YAMTCRVSDKADVYSFGVVLLELIS 998
GT Y APE Y + +++S GV L L+
Sbjct: 190 --CGTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVF 225
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 26/198 (13%), Positives = 52/198 (26%), Gaps = 47/198 (23%)
Query: 808 CIGSGGFGATYKAE-IIPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLI 863
G ++A VA+ + +Q+ + L R+ P + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV- 96
Query: 864 GYHVSEAE--MFLIYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDEC 919
V ++ ++ GG+L++ P + +A A H
Sbjct: 97 -LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAHRA- 148
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
V PS + +S G L +
Sbjct: 149 --GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPD------- 178
Query: 980 VSDKADVYSFGVVLLELI 997
+ + D+ G L L+
Sbjct: 179 ANPQDDIRGIGASLYALL 196
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 14/204 (6%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQ---FAA--EIRTLGRVQHPNLVTL 862
+G G F YKA + +VA+K++ +G + A EI+ L + HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ ++ + L+++++ +LE I+D S + L + L YLH
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEYLHQH---W 132
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+LHRD+KP+N+LLD N L+DFGLA+ G+ T V T Y APE R+
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGARMYG 191
Query: 983 KA-DVYSFGVVLLELISDKKALDP 1005
D+++ G +L EL+ + P
Sbjct: 192 VGVDMWAVGCILAELLL-RVPFLP 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 809 IGSGGFGATYKAE---IIPG-----VVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I V VAVK L + + +E+ + + +H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 859 LVTLIGYHVSEAE-MFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHK 903
++ L+G ++ +++I Y GNL ++++ R P + + L
Sbjct: 149 IINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + +
Sbjct: 208 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----K 260
Query: 964 AGTFGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
T G + APE + ++DV+SFGV++ E+ +
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG KA VAVK L ++ +E L +V HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM-------------------- 900
L G + + LI Y G+L F+++ R
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 901 -LHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
L A +++ + YL + +++HRD+ NIL+ +SDFGL+R + +++
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 960 TTDVAGTFGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
V + G + A E + ++DV+SFGV+L E+++
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ + VAVK L Q F E + + H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 862 LIGYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH-----KIALDVARALAYL 915
IG ++ F++ + GG+L+ F+++ R + S L +A D+A YL
Sbjct: 98 CIGV-SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 916 HD-ECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYV- 970
+ + HRDI N LL A + DFG+AR + + + G +
Sbjct: 157 EENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR----KGGCAMLP 208
Query: 971 ----APEYAMTCRVSDKADVYSFGVVLLELIS 998
PE M + K D +SFGV+L E+ S
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHPNLVTLI 863
IG+G FG Y+A++ G +VA+K+ V Q E++ + ++ H N+V L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 864 GYHVSEAEMF------LIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYL 915
+ S E L+ +Y+P + + + R +++ + R+LAY+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
H + HRDIKP N+LLD + L DFG A+ L E + + + + Y APE
Sbjct: 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYIC-SRYYRAPEL 227
Query: 975 AMTCRVSDKA-DVYSFGVVLLELIS 998
+ DV+S G VL EL+
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLL 252
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLV 860
+GSG FG A + VAVK L + +E++ + ++ H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM------------------- 900
L+G ++LI+ Y G+L +++ R + + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 901 -LHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
L A VA+ + +L + +HRD+ N+L+ + + DFGLAR + + +
Sbjct: 173 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY- 228
Query: 960 TTDVAGTFGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
V + APE + K+DV+S+G++L E+ S
Sbjct: 229 ---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 41/210 (19%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V Y
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF--YG 72
Query: 867 V--SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR--------ALAYLH 916
+L Y GG L I+ + A+ + YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLMAGVVYLH 122
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL--LGTSETHATTDVAGTFGYVAPE- 973
+ HRDIKP N+LLD N +SDFGLA + E GT YVAPE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 974 -----YAMTCRVSDKADVYSFGVVLLELIS 998
+ ++ DV+S G+VL +++
Sbjct: 179 LKRREFH-----AEPVDVWSCGIVLTAMLA 203
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 69/432 (15%), Positives = 131/432 (30%), Gaps = 92/432 (21%)
Query: 222 SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQL 281
I +L + + L N +++ + + + + L +Q+
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 282 KVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLE 341
++L L + + + ++ + +
Sbjct: 78 ELLNLND-------------------------LQIEEIDTYAFAYAHTIQKLYMGFNAIR 112
Query: 342 GIFPQNWELCSKLEMLNLAHNFFTGQIPASL-GNCKSLYFLDLSSNNLTGLLPEEVSVPC 400
+ P ++ L +L L N + +P + N L L +S+NNL + +
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDD------ 165
Query: 401 MAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPS 460
F + +L + L N LT S
Sbjct: 166 --TFQATTSL----------------------QNLQL--------SSNRLTHV-DLSLIP 192
Query: 461 NGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDG 520
+ LF + N L T +P + + S N +++ + + L
Sbjct: 193 S-LFHANVSYNLLSTLAIPIAVEE-----------LDASHN----SINVVRGPVNVELTI 236
Query: 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ 580
L + +N L + + + + ++ NE ++ F L L +S N L
Sbjct: 237 L--KLQHNNLT---DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
Query: 581 GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEH 640
L Y + LK L LS N+ + Q LE L L NS+ + S
Sbjct: 292 A-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHT 346
Query: 641 LNVLRLDHNNLT 652
L L L HN+
Sbjct: 347 LKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 1e-21
Identities = 53/285 (18%), Positives = 99/285 (34%), Gaps = 43/285 (15%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168
+ + E L+ +I+ ++ L + + L+NL+
Sbjct: 26 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85
Query: 169 QFNGTIPAF-FGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL 227
Q I + F + Q + + FN + +P N L ++L N L+ S+P +
Sbjct: 86 QIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGI 142
Query: 228 -GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL 286
N +L +L +S+N L+ +F +L+ L LS N L+ + S + L +
Sbjct: 143 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI---PSLFHANV 199
Query: 287 RNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQ 346
YN ++ + A + ++ +
Sbjct: 200 -------------------------SYNLL-----STLAIPIAVEELDASHNSINVVRG- 228
Query: 347 NWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
+ +L +L L HN T L N L +DLS N L +
Sbjct: 229 --PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKI 269
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 3e-19
Identities = 57/305 (18%), Positives = 97/305 (31%), Gaps = 58/305 (19%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEIGQ-LSLLEILDLSFNSFHGPIP 151
L+ + A ++ L + FN LP + Q + LL +L L N +P
Sbjct: 82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LP 139
Query: 152 P-TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLE 210
N L +++S N F + Q + LS N L+ V SL
Sbjct: 140 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL---SLIPSLF 195
Query: 211 HILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI 270
H ++ N L+ +L + L S N + + V L +L L N L+
Sbjct: 196 HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTDT 247
Query: 271 VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNL 330
+ L L + L YN + + ++ L
Sbjct: 248 --AWLLNYPGLVEVDL-------------------------SYNELEKIMYHPFVKMQRL 280
Query: 331 RVFWAPNLNLEG----IFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSN 386
L + + L++L+L+HN + + L L L N
Sbjct: 281 ER-----LYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 334
Query: 387 NLTGL 391
++ L
Sbjct: 335 SIVTL 339
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 7e-17
Identities = 67/315 (21%), Positives = 99/315 (31%), Gaps = 85/315 (26%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIP 151
+ N ++ L VL+L N S LP I L L +S N+ I
Sbjct: 106 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IE 163
Query: 152 P-TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEF-------- 202
T Q +SL+ + LS N+ + P ++S+NLLS ++
Sbjct: 164 DDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPIAVEELDAS 219
Query: 203 --------GDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQL 254
G V L + L N+LT L N L + LS N L+ + F ++
Sbjct: 220 HNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 277
Query: 255 VNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYN 314
LE L +S N L + LKVL L + N
Sbjct: 278 QRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSH-------------------------N 311
Query: 315 FFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGN 374
+ + +LE L L HN + L
Sbjct: 312 --------HLLHVE------------RNQPQ-----FDRLENLYLDHNSIV-TLK--LST 343
Query: 375 CKSLYFLDLSSNNLT 389
+L L LS N+
Sbjct: 344 HHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 7e-15
Identities = 93/602 (15%), Positives = 178/602 (29%), Gaps = 82/602 (13%)
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209
I LQ +++ + ++V+ + + +P D+ +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 210 EHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
E + L + I + ++ L + N ++ P F + L VL L RN LS
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 269 GIVPSELGMCKQLKVLVLRN---------DYGPLYSREHGDLPIQPVVDGGEDYNFFDGG 319
+ +L L + N + S ++ L N
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL----------SSNRLT-H 185
Query: 320 LPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLY 379
+ S+ +P+L + N+ + +E L+ +HN + + L
Sbjct: 186 VDLSL--IPSLF-----HANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELT 235
Query: 380 FLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIG 439
L L NNLT ++ P + ++S N L +I + KM + ++ +
Sbjct: 236 ILKLQHNNLTD-TAWLLNYPGLVEVDLSYNELE----KIMYHPFVKMQ---RLERLYISN 287
Query: 440 FYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLS 499
N L + + P L +L D S+N V D L + +L
Sbjct: 288 --------NRLVALNLYGQPIPTLKVL-DLSHNHLLH-VERNQPQFDRLEN-----LYLD 332
Query: 500 GNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKC-MKFLSMAGNEFVGL 558
N ++ T +L L + +N C V
Sbjct: 333 HN----SIVTLKLSTHHTLKNL--TLSHNDW----------DCNSLRALFRNVARPAVDD 376
Query: 559 IPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLE 618
Q L + + + P + + L + + G + S++
Sbjct: 377 ADQHCKIDYQLEHGLCCKESDK-PYLDRLLQYIALTSVVEKVQRAQGRCS-ATDTINSVQ 434
Query: 619 VLELSANSLSGEIPSEFSKLE-HLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSG 677
L G +LE +N LR + LT L +
Sbjct: 435 SLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHA------EIDT 488
Query: 678 SAPRNSLIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVSQQEAYSPSESIQGNSSGLNP 737
+ R L K + + NL T + + + EA + + +
Sbjct: 489 NLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIA 548
Query: 738 IE 739
+E
Sbjct: 549 LE 550
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 38/209 (18%), Positives = 71/209 (33%), Gaps = 22/209 (10%)
Query: 98 LSGN----LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
+S N L+ + L+VL L+ N + Q LE L L NS +
Sbjct: 285 ISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL- 341
Query: 154 LQNCSSLRLINLSGNQFNGT-IPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212
+L+ + LS N ++ + A F V + E S +
Sbjct: 342 -STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPY 400
Query: 213 L------LAANSLTGSIPPSLGNCTELRSLLLSSNML-----QGDIPSSFGQLVNLEVLD 261
L +A S+ + + G C+ ++ ++ QG +P + + EV +
Sbjct: 401 LDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNE 460
Query: 262 LSRNF--LSGIVPSELGMCKQLKVLVLRN 288
L L+ + + + L + N
Sbjct: 461 LRAEVQQLTNEQIQQEQLLQGLHAEIDTN 489
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ-GVQQFAA-EIRTLGRVQHPNLVTLIGY 865
+G G +G YKA + + VA+KR+ + + GV A E+ L +QH N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ LI+ Y +L+K++ P ++ ++ + + + H R LH
Sbjct: 102 IHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM--RVIKSFLYQLINGVNFCHS---RRCLH 155
Query: 926 RDIKPSNILLDNNLNAY-----LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
RD+KP N+LL + + + DFGLAR G T ++ T Y PE + R
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRH 214
Query: 981 -SDKADVYSFGVVLLELISDKKAL 1003
S D++S + E++ K L
Sbjct: 215 YSTSVDIWSIACIWAEMLM-KTPL 237
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 28/198 (14%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQ-HPNLVTL 862
+G G G + G A+K L + E+ + P++V +
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---------EVDHHWQASGGPHIVCI 87
Query: 863 IGY----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ H + + +I + GG L IQ+R + +I D+ A+ +LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 919 CVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
+ HRD+KP N+L + + L+DFG A+ + T YVAPE
Sbjct: 148 ---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVL 201
Query: 976 MTCRVSDKADVYSFGVVL 993
+ D++S GV++
Sbjct: 202 GPEKYDKSCDMWSLGVIM 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 38/220 (17%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I VAVK L + + +E+ + + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 859 LVTLIGYHVSEAE-MFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHK 903
++ L+G ++ +++I Y GNL +++Q R P + L
Sbjct: 137 IINLLG-ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + +
Sbjct: 196 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----K 248
Query: 964 AGTFGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
T G + APE + ++DV+SFGV+L E+ +
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 809 IGSGGFGATYKAE---IIPG---VVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVT 861
IG G FG ++A ++P +VAVK L F E + +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWS--------------------- 899
L+G M L++ Y+ G+L +F++ P S
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 900 MLHKIALDVARALAYLHDE-CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958
IA VA +AYL + V HRD+ N L+ N+ ++DFGL+R + +++ +
Sbjct: 175 EQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 959 ATTDVAGTFGYV-----APEYAMTCRVSDKADVYSFGVVLLELIS 998
A + PE R + ++DV+++GVVL E+ S
Sbjct: 231 ----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ + VAVK L Q F E + + H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 917 D-ECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYV-- 970
+ + HRDI N LL A + DFG+AR + + + G +
Sbjct: 199 ENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGCAMLPV 250
Query: 971 ---APEYAMTCRVSDKADVYSFGVVLLELIS 998
PE M + K D +SFGV+L E+ S
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 798 RATAGFNVQNCIGSGGFGATYKA--EIIPGVVVAVKRLSVGRFQ-GVQQFAA-EI---RT 850
RA + IG G +G +KA G VA+KR+ V + G+ E+ R
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 851 LGRVQHPNLVTLI-----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIA 905
L +HPN+V L E ++ L++ ++ +L ++ P V + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
+ R L +LH RV+HRD+KP NIL+ ++ L+DFGLAR+ T+ V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV- 181
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKAL 1003
T Y APE + + D++S G + E+ +K L
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 51/204 (25%), Positives = 80/204 (39%), Gaps = 32/204 (15%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRL------SVGRFQGVQQFAAEIRTLGRV----QHP 857
+G GGFG + + + VA+K + E+ L +V HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 858 NLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
++ L+ + ++ L+ LP +L +I ++ + V A+ + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCH 156
Query: 917 DECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
V+HRDIK NIL+D A L DFG LL D GT Y PE+
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-DFD--GTRVYSPPEW- 209
Query: 976 MTCRVSDK------ADVYSFGVVL 993
+S A V+S G++L
Sbjct: 210 ----ISRHQYHALPATVWSLGILL 229
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 41/210 (19%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V Y
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF--YG 72
Query: 867 V--SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR--------ALAYLH 916
+L Y GG L I+ + A+ + YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLMAGVVYLH 122
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL--LGTSETHATTDVAGTFGYVAPE- 973
+ HRDIKP N+LLD N +SDFGLA + E GT YVAPE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 974 -----YAMTCRVSDKADVYSFGVVLLELIS 998
+ ++ DV+S G+VL +++
Sbjct: 179 LKRREFH-----AEPVDVWSCGIVLTAMLA 203
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR-------- 910
V L + +++ +Y G L K+I+ + E R
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDE---------TCTRFYTAEIVS 141
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGY 969
AL YLH + ++HRD+KP NILL+ +++ ++DFG A++L A + GT Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 970 VAPEYAMTCRVSDKADVYSFGVVLLELIS 998
V+PE +D+++ G ++ +L++
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 49/342 (14%), Positives = 96/342 (28%), Gaps = 73/342 (21%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
N N+ + A + + N L ++ L L+ +
Sbjct: 16 NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFSELQLNRLNLSS 73
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVS 208
+P L + ++ ++ N ++P + + N LS ++PE S
Sbjct: 74 -LPDNL--PPQITVLEITQNAL-ISLPELPAS---LEYLDACDNRLS-TLPELPA----S 121
Query: 209 LEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
L+H+ + N LT +P L + +N L +P +LEVL + N L+
Sbjct: 122 LKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPEL---PTSLEVLSVRNNQLT 173
Query: 269 GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP 328
+ P L+ L + N + LP R
Sbjct: 174 FL-PELPE---SLEALDVST-------------------------NLLE-SLPAVPVRNH 203
Query: 329 NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNL 388
+ N T IP ++ + + L N L
Sbjct: 204 HSE--------------------ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242
Query: 389 TGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNW 430
+ + E +S + ++ ++
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAV 284
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 1e-13
Identities = 60/296 (20%), Positives = 93/296 (31%), Gaps = 89/296 (30%)
Query: 133 LSLLEILDLSFNSFHGPIPPT-------LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185
L + LS NSF+ I T L + N+ + F
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFS 62
Query: 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG 245
+ L+ LS S+P+ LE + N+L S+P + L L N L
Sbjct: 63 ELQLNRLNLS-SLPDNLPPQITVLE---ITQNALI-SLPELPAS---LEYLDACDNRLS- 113
Query: 246 DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQP 305
+P L +L D+ N L+ + P L+ + N
Sbjct: 114 TLPELPASLKHL---DVDNNQLTML-PELPA---LLEYINADN----------------- 149
Query: 306 VVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFT 365
N +T LP EL + LE+L++ +N T
Sbjct: 150 --------N--------QLTMLP--------------------ELPTSLEVLSVRNNQLT 173
Query: 366 GQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-----SVPCMAVFNVSQNLLSGEIP 416
+P + L LD+S+N L LP S F +N ++ IP
Sbjct: 174 -FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIP 223
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 41/183 (22%), Positives = 70/183 (38%), Gaps = 26/183 (14%)
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG 557
N LST P +L SL L D+ NN+L +P +++++ N+
Sbjct: 107 ACDN----RLSTLP-ELPASLKHL--DVDNNQLT-MLPELPAL----LEYINADNNQLTM 154
Query: 558 LIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASL 617
L P+ T+ L L++ N L LP E L+ L +S N ++P +
Sbjct: 155 L-PELPTS---LEVLSVRNNQLTF-LPE---LPESLEALDVS-TNLLESLPAVPVRNHHS 205
Query: 618 E----VLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFN 673
E N ++ IP L+ + L+ N L+ RI +++ +
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
Query: 674 NLS 676
S
Sbjct: 265 YFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 69/468 (14%), Positives = 129/468 (27%), Gaps = 110/468 (23%)
Query: 213 LLAANSLTGSIPPSLGNC-TELRSLLLSS---NMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
N+++ + + L N + + L L+R LS
Sbjct: 16 NSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKEC--LINQFSELQLNRLNLS 72
Query: 269 GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP 328
+ P L Q+ VL + N LP+ L
Sbjct: 73 SL-PDNLP--PQITVLEITQ-------------------------NALI-SLPELPASLE 103
Query: 329 NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNL 388
L + L + P EL + L+ L++ +N T +P L +++ +N L
Sbjct: 104 YLDAC---DNRLSTL-P---ELPASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQL 152
Query: 389 TGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYEN 448
T +LPE + + V +V N L+ +P + S+ +D+ N
Sbjct: 153 T-MLPELPT--SLEVLSVRNNQLT-FLPELPE----------SLEALDV--------STN 190
Query: 449 ALTS-----CAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSL 503
L S S +F N T +P ++ D + L N
Sbjct: 191 LLESLPAVPVRNHHSEETEIFF--RCRENRITH-IPENILSLDPTCT-----IILEDN-- 240
Query: 504 KGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCK-----CMKFLSMAGNEFVGL 558
LS+ + G + + + V
Sbjct: 241 --PLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQ 298
Query: 559 IPQSFTN-------FDSLRNLNLSRNHLQGP-----LPSYINKMEDLKFLSLSLNNFTGA 606
I +F + L L+ + + + +++ K+ L
Sbjct: 299 IWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAAD 358
Query: 607 IPWELTQLAS-----LEVLELSANSLSGEIPSEFSKLEHL--NVLRLD 647
+ L L + G ++ L L + RL+
Sbjct: 359 ATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGREMFRLE 406
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 49/309 (15%), Positives = 94/309 (30%), Gaps = 52/309 (16%)
Query: 350 LCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQN 409
L ++ L L + +P +L + L+++ N L L PE + + + N
Sbjct: 57 LINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALISL-PELPA--SLEYLDACDN 110
Query: 410 LLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDF 469
LS +P + + V N LT L + +
Sbjct: 111 RLS-TLPE-LPASLKHLDV-----------------DNNQLTM---LPELPALLEYI-NA 147
Query: 470 SNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNK 529
NN T +P SL + N L T+ +L SL+ L D+ N
Sbjct: 148 DNNQLTM-LPELP---TSLEV-----LSVRNNQL-----TFLPELPESLEAL--DVSTNL 191
Query: 530 LIGEVPSDMGSHCKCMK---FLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSY 586
L +P+ + + F N + P++ + D + L N L +
Sbjct: 192 LE-SLPAVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRES 249
Query: 587 INKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRL 646
+++ F+ + + + S+ S++ H
Sbjct: 250 LSQQTAQPDYHGPRIYFS--MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEE 307
Query: 647 DHNNLTGRI 655
N + +
Sbjct: 308 HANTFSAFL 316
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 71/435 (16%), Positives = 125/435 (28%), Gaps = 104/435 (23%)
Query: 222 SIPPSLGNCTELRSLLLSSNMLQ---GDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMC 278
SI + N L S N + D S++ + + +RN ++ L
Sbjct: 2 SIMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 279 KQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNL 338
Q L L LPD++ P + V
Sbjct: 59 NQFSELQLNR-------------------------LNLS-SLPDNL--PPQITVLEITQN 90
Query: 339 NLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSV 398
L + P EL + LE L+ N + +P + K LD+ +N LT +LPE ++
Sbjct: 91 ALISL-P---ELPASLEYLDACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPAL 141
Query: 399 PCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSS 458
+ N N L+ +P
Sbjct: 142 --LEYINADNNQLT-MLP----------------------------------------EL 158
Query: 459 PSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLC-LS 517
P++ L +L NN T +P +SL + +S N L+ +L P
Sbjct: 159 PTS-LEVL-SVRNNQLTF-LPELP---ESLEA-----LDVSTNLLE-SLPAVPVRNHHSE 206
Query: 518 LDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRN 577
+ F N+ I +P ++ + + N I +S + + + + R
Sbjct: 207 ETEIFFRCRENR-ITHIPENIL-SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
Query: 578 HLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSK 637
+ L F +++Q+ E AN+ S S
Sbjct: 265 YFSMSDGQQNTLHRPLA--DAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSD 321
Query: 638 LEHLNVLRLDHNNLT 652
+
Sbjct: 322 TVSARNTSGFREQVA 336
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 5e-22
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 42/209 (20%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVK---RLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G G FG + + G VAVK R + V + EI+ L +HP+++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 865 YHV--SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR--------ALAY 914
Y V + +++F++ Y+ GG L +I R + +R + Y
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGR----------LDEKESRRLFQQILSGVDY 131
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE- 973
H V+HRD+KP N+LLD ++NA ++DFGL+ ++ E T+ G+ Y APE
Sbjct: 132 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEV 186
Query: 974 -----YAMTCRVSDKADVYSFGVVLLELI 997
YA + D++S GV+L L+
Sbjct: 187 ISGRLYA-----GPEVDIWSSGVILYALL 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-22
Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ----GVQQFAA-EIRTLGRVQH 856
+ IG G FG +KA G VA+K++ + G A EI+ L ++H
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKH 75
Query: 857 PNLVTLIGYHVSEAE--------MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
N+V LI ++A ++L++++ +L + S + ++ +
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLSEIKRVMQML 133
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA----TTDVA 964
L Y+H ++LHRD+K +N+L+ + L+DFGLAR ++ T V
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 965 GTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDKKAL 1003
T Y PE + R D++ G ++ E+ + + +
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 8e-22
Identities = 48/194 (24%), Positives = 78/194 (40%), Gaps = 19/194 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYH 866
+G G G + A+K L ++ E+ R P++V ++ +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARR---EVELHWRASQCPHIVRIVDVY 124
Query: 867 ----VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ ++ L GG L IQDR + +I + A+ YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---N 181
Query: 923 VLHRDIKPSNILL-DNNLNAYL--SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
+ HRD+KP N+L NA L +DFG A+ + + T T YVAPE +
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPEK 239
Query: 980 VSDKADVYSFGVVL 993
D++S GV++
Sbjct: 240 YDKSCDMWSLGVIM 253
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 55/210 (26%), Positives = 78/210 (37%), Gaps = 46/210 (21%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRL------SVGRFQGVQQFAAEIRTLGRVQH--PNL 859
+GSGGFG+ Y + + VA+K + G + E+ L +V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 860 VTLIGYHV--SEAEMFLIYNY-LPGGNLEKFIQDRPR------RTVEWSMLHKIALDVAR 910
+ L LI P +L FI +R R V
Sbjct: 111 IRL--LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--------SFFWQVLE 160
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
A+ + H+ VLHRDIK NIL+D N L DFG LL + D GT Y
Sbjct: 161 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVY 214
Query: 970 VAPEYAMTCRVSDK------ADVYSFGVVL 993
PE+ + A V+S G++L
Sbjct: 215 SPPEW-----IRYHRYHGRSAAVWSLGILL 239
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 51/284 (17%), Positives = 87/284 (30%), Gaps = 30/284 (10%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP-TLQNCSSLRLINLSGN 168
T+ R+L L N E LE L+L+ N + P N +LR + L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSN 90
Query: 169 QFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SL 227
+ F + +S N + + + + +L+ + + N L I +
Sbjct: 91 RLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 228 GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287
L L L L + L L VL L ++ I +LKVL +
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEI- 207
Query: 288 NDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN 347
+ + + + NL + NL +
Sbjct: 208 ------------------------SHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA 243
Query: 348 WELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
L LNL++N + + L L + L L +
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVV 287
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-18
Identities = 47/243 (19%), Positives = 93/243 (38%), Gaps = 30/243 (12%)
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209
+P + + RL++L N+ F P + + L+ N++S +V +N +L
Sbjct: 26 VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82
Query: 210 EHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
+ L +N L IP + L L +S N + + F L NL+ L++ N L
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 269 GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP 328
I L+ L L + ++++ L
Sbjct: 142 YISHRAFSGLNSLEQLTL-------------------------EKCNLTSIPTEALSHLH 176
Query: 329 NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNL 388
L V +LN+ I +++ +L++L ++H + + + +L L ++ NL
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236
Query: 389 TGL 391
T +
Sbjct: 237 TAV 239
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-17
Identities = 41/181 (22%), Positives = 80/181 (44%), Gaps = 8/181 (4%)
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG 557
L+ N + + F+ +L L + +N+ + +P + + + L ++ N+ V
Sbjct: 63 LNENIVS-AVEPGAFNNLFNLRTL--GLRSNR-LKLIPLGVFTGLSNLTKLDISENKIVI 118
Query: 558 LIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWE-LTQLAS 616
L+ F + +L++L + N L + + L+ L+L N T +IP E L+ L
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHG 177
Query: 617 LEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
L VL L +++ I F +L L VL + H + P +L+ ++ NL
Sbjct: 178 LIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236
Query: 676 S 676
+
Sbjct: 237 T 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 40/197 (20%), Positives = 75/197 (38%), Gaps = 8/197 (4%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP 152
+ N RA L L L L + + L L +L L + +
Sbjct: 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 153 TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212
+ + L+++ +S + T+ +S++ L+ +VP + V L +
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253
Query: 213 LLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIV 271
L+ N ++ +I L L+ + L L P +F L L VL++S N L+ +
Sbjct: 254 NLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLE 312
Query: 272 PSELGMCKQLKVLVLRN 288
S L+ L+L +
Sbjct: 313 ESVFHSVGNLETLILDS 329
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-17
Identities = 40/199 (20%), Positives = 73/199 (36%), Gaps = 12/199 (6%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIP 151
+S N DL L+ L + N + L+ LE L L + IP
Sbjct: 111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-IP 168
Query: 152 P-TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLE 210
L + L ++ L N F + +V+ +S ++ +L
Sbjct: 169 TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL-NLT 227
Query: 211 HILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269
+ + +LT ++P ++ + LR L LS N + S +L+ L+ + L L+
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV 286
Query: 270 IVPSELGMCKQLKVLVLRN 288
+ P L+VL +
Sbjct: 287 VEPYAFRGLNYLRVLNVSG 305
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-17
Identities = 57/296 (19%), Positives = 98/296 (33%), Gaps = 58/296 (19%)
Query: 29 SCSWHGVTCD-----------PLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHF 77
CS + L+L N + +L F+ F
Sbjct: 8 ECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKN------RIKTLNQDE-----FA-SF 55
Query: 78 PCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLL 136
P L+ +N N + A +L LR L L N +PL + LS L
Sbjct: 56 PHLE-----ELELNENIVSAVE---PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNL 106
Query: 137 EILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ--------FNG---------------T 173
LD+S N + Q+ +L+ + + N F+G +
Sbjct: 107 TKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS 166
Query: 174 IPAF-FGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTE 232
IP G V+ L ++ ++ + L+ + ++ ++ P+
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225
Query: 233 LRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
L SL ++ L + LV L L+LS N +S I S L +L+ + L
Sbjct: 226 LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 42/183 (22%), Positives = 71/183 (38%), Gaps = 10/183 (5%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
+ N L +S F SL+ L + + +P++ SH + L +
Sbjct: 134 EVGDNDLV-YISHRAFSGLNSLEQL--TLEKCN-LTSIPTEALSHLHGLIVLRLRHLNIN 189
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWE-LTQLA 615
+ SF L+ L +S + +L LS++ N T A+P+ + L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLV 248
Query: 616 SLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFN 673
L L LS N +S I +L L ++L L + P F + L + +VS N
Sbjct: 249 YLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306
Query: 674 NLS 676
L+
Sbjct: 307 QLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-15
Identities = 38/178 (21%), Positives = 68/178 (38%), Gaps = 10/178 (5%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP 152
L + A+ L L VL L + +L L++L++S + + P
Sbjct: 159 LEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218
Query: 153 TLQNCSSLRLINLSGNQFNGTIPAF-FGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEH 211
+L ++++ +P + ++LS+N +S ++ + L+
Sbjct: 219 NCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQE 276
Query: 212 ILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
I L L + P + LR L +S N L S F + NLE L L N L+
Sbjct: 277 IQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 43/189 (22%), Positives = 72/189 (38%), Gaps = 10/189 (5%)
Query: 506 NLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTN 565
P + L D+G N+ I + D + ++ L + N + P +F N
Sbjct: 22 RFVAVPEGIPTETRLL--DLGKNR-IKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN 78
Query: 566 FDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWEL-TQLASLEVLELSA 624
+LR L L N L+ + +L L +S N + + L +L+ LE+
Sbjct: 79 LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGD 137
Query: 625 NSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLSGSAPRN 682
N L I FS L L L L+ NLT IP L + + N++ +
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDY 194
Query: 683 SLIKCENVQ 691
S + ++
Sbjct: 195 SFKRLYRLK 203
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 60/349 (17%), Positives = 123/349 (35%), Gaps = 44/349 (12%)
Query: 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV 396
+ P+ + ++ +L+L N + L L+L+ N ++ + P
Sbjct: 20 RKRFVAV-PEG--IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG-- 74
Query: 397 SVPCMAVFNVSQNL----LSG-EIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALT 451
FN NL L + I + +S +++++D+ EN +
Sbjct: 75 ------AFNNLFNLRTLGLRSNRLKLIPLGVFTGLS---NLTKLDI--------SENKIV 117
Query: 452 SCAP--FSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLST 509
F N L L + +N +SL L +L ++ T
Sbjct: 118 ILLDYMFQDLYN-LKSL-EVGDNDLVYISHRAFSGLNSLEQ-----LTLEKCNLT-SIPT 169
Query: 510 YPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSL 569
L L + + I + +K L ++ ++ + + +L
Sbjct: 170 EALSHLHGLIVL--RLRHLN-INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226
Query: 570 RNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSG 629
+L+++ +L + + L+FL+LS N + L +L L+ ++L L+
Sbjct: 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA- 285
Query: 630 EIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLS 676
+ F L +L VL + N LT + F + +L + N L+
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-14
Identities = 75/432 (17%), Positives = 119/432 (27%), Gaps = 108/432 (25%)
Query: 225 PSLGNCT-ELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKV 283
P C+ + R++L +P +LDL +N + + E L+
Sbjct: 4 PPRCECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEE 60
Query: 284 LVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGI 343
L L N ++ + G
Sbjct: 61 LELNE-------------------------N--------IVSAVE------------PGA 75
Query: 344 FPQNWELCSKLEMLNLAHNFFTGQIPA-SLGNCKSLYFLDLSSNNLTGLLPEE-VSVPCM 401
F L L L N IP +L LD+S N + LL + +
Sbjct: 76 FNN----LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130
Query: 402 AVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAP--FSSP 459
V N L I + S + S+ Q+ L + LTS S
Sbjct: 131 KSLEVGDNDLV-YISHRAFSGLN------SLEQLTL--------EKCNLTSIPTEALSHL 175
Query: 460 SNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLD 519
L +L + L +S ++ L+L
Sbjct: 176 HG-LIVLR-LRHLNINAIRDYSFKRLYRLKV-----LEISHWPYLDTMTPNCLYG-LNLT 227
Query: 520 GLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHL 579
L I + + VP H ++FL+++ N + L+ + L L
Sbjct: 228 SL--SITHCN-LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL 284
Query: 580 QGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLE 639
+ F G L L VL +S N L+ S F +
Sbjct: 285 A----------------VVEPYAFRG--------LNYLRVLNVSGNQLTTLEESVFHSVG 320
Query: 640 HLNVLRLDHNNL 651
+L L LD N L
Sbjct: 321 NLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-12
Identities = 60/372 (16%), Positives = 113/372 (30%), Gaps = 55/372 (14%)
Query: 211 HILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI 270
+L ++P + TE R L L N ++ F +LE L+L+ N +S +
Sbjct: 15 AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 271 VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNL 330
P L+ L LR+ N T L NL
Sbjct: 72 EPGAFNNLFNLRTLGLRS-------------------------NRLKLIPLGVFTGLSNL 106
Query: 331 RVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390
+ + ++ L+ L + N + SL L L NLT
Sbjct: 107 TKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS 166
Query: 391 LLPEE-VSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENA 449
+ E + + V + ++ I ++ + +++ +
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNIN----AIRDYSFKRLY---RLKVLEISHW-------PY 212
Query: 450 LTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPY-YGFWLSGNSLKGNLS 508
L + P L L ++ T + ++ Y LS N + +
Sbjct: 213 LDTMTPNCLYGLNLTSL-SITHCNLTA------VPYLAVRHLVYLRFLNLSYNPIS-TIE 264
Query: 509 TYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDS 568
L L + + + + V ++ L+++GN+ L F + +
Sbjct: 265 GSMLHELLRLQEI--QLVGGQ-LAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN 321
Query: 569 LRNLNLSRNHLQ 580
L L L N L
Sbjct: 322 LETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 19/82 (23%), Positives = 32/82 (39%), Gaps = 5/82 (6%)
Query: 596 LSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRI 655
+ F A+P + +L+L N + EF+ HL L L+ N ++ +
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AV 71
Query: 656 PPG-FGTRSSLSIFDVSFNNLS 676
PG F +L + N L
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLK 93
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-21
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F + IG G FG + + A+K ++ V+ E++ + ++HP
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
LV L E +MF++ + L GG+L +Q + E ++ I ++ AL YL ++
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFIC-ELVMALDYLQNQ 134
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R++HRD+KP NILLD + + +++DF +A +L T +AGT Y+APE +
Sbjct: 135 ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSR 189
Query: 979 RVS--DKA-DVYSFGVVLLELI 997
+ + A D +S GV EL+
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELL 211
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 43/210 (20%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVK---RLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+G G FG A VA+K R + + + EI L ++HP+++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 865 YHV--SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR--------ALAY 914
Y V + ++ ++ Y GG L +I ++ R + D R A+ Y
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKR----------MTEDEGRRFFQQIICAIEY 123
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE- 973
H +++HRD+KP N+LLD+NLN ++DFGL+ ++ T+ G+ Y APE
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 178
Query: 974 -----YAMTCRVSDKADVYSFGVVLLELIS 998
YA + DV+S G+VL ++
Sbjct: 179 INGKLYA-----GPEVDVWSCGIVLYVMLV 203
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-21
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
+ IGSG G A + I VA+K+LS FQ Q A E+ + V H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQN-QTHAKRAYRELVLMKCVNHK 84
Query: 858 NLVTLIGYHVSEA------EMFLIYNYLPGGNLEKFIQ----DRPRRTVEWSMLHKIALD 907
N++ L+ + +++++ + NL + IQ + + ML
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQML------ 137
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
+ +LH ++HRD+KPSNI++ ++ + DFGLAR + T T
Sbjct: 138 --CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 190
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELISDK 1000
Y APE + + D++S G ++ E+I
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-20
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPN 858
F +G GGFG + ++ G + A K+L+ R +G Q E + L +V
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKI--ALDVARALAYLH 916
+V+L ++ ++ L+ + GG++ I + + I + L +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+LLD++ N +SD GLA L +T AGT G++APE +
Sbjct: 307 QR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLL 362
Query: 977 TCRVSDKADVYSFGVVLLELI 997
D ++ GV L E+I
Sbjct: 363 GEEYDFSVDYFALGVTLYEMI 383
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-20
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPN 858
F +G GGFG ++ G + A K+L R +G E + L +V
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V+L + ++ + L+ + GG+L+ I + + A ++ L LH E
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R+++RD+KP NILLD++ + +SD GLA + +T GT GY+APE
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNE 360
Query: 979 RVSDKADVYSFGVVLLELI 997
R + D ++ G +L E+I
Sbjct: 361 RYTFSPDWWALGCLLYEMI 379
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 6e-20
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRV---Q 855
F+V IG GGFG Y G + A+K L + QG E L V
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
P +V + + ++ I + + GG+L + + + A ++ L ++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILGLEHM 308
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H+ V++RD+KP+NILLD + + +SD GLA + HA GT GY+APE
Sbjct: 309 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVL 362
Query: 976 MTCRVSDKA-DVYSFGVVLLELI 997
D + D +S G +L +L+
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLL 385
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 6e-20
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
+ IGSG G A + + VA+K+LS FQ Q A E+ + V H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQN-QTHAKRAYRELVLMKCVNHK 121
Query: 858 NLVTLIGYHVSEA------EMFLIYNYLPGGNLEKFIQ----DRPRRTVEWSMLHKIALD 907
N+++L+ + +++L+ + NL + IQ + + ML
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQML------ 174
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
+ +LH + +HRD+KPSNI++ ++ + DFGLAR + T T
Sbjct: 175 --CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 227
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELISDK 1000
Y APE + + D++S G ++ E++ K
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 57/204 (27%), Positives = 81/204 (39%), Gaps = 42/204 (20%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IGSG FG + +VAVK + G + EI ++HPN+V V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRF--KEV 84
Query: 868 --SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR--------ALAYLHD 917
+ + +I Y GG L + I + R E D AR ++Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNA-GRFSE---------DEARFFFQQLLSGVSYCHS 134
Query: 918 ECVPRVLHRDIKPSNILLDNN--LNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE-- 973
++ HRD+K N LLD + + DFG ++ +T GT Y+APE
Sbjct: 135 M---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVL 189
Query: 974 ----YAMTCRVSDKADVYSFGVVL 993
Y ADV+S GV L
Sbjct: 190 LRQEYD-----GKIADVWSCGVTL 208
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 94/533 (17%), Positives = 165/533 (30%), Gaps = 52/533 (9%)
Query: 206 CVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265
+ + +LT +P ++L LS N + L L VL LS N
Sbjct: 30 NELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHN 86
Query: 266 FLSGIVPSELGMCKQLKVLVLRN------DYGPLYSREHGDLPIQPVVDGGEDYNFFDG- 318
+ + + L+ L + + P+ S H DL +N FD
Sbjct: 87 RIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDL----------SFNDFDVL 136
Query: 319 GLPDSITRLPNLRVFWAPNLNLEGI-FPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKS 377
+ L L + L +L+L G SL +
Sbjct: 137 PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196
Query: 378 LYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDL 437
L L + + + + V L ++ I ++ + + +S++
Sbjct: 197 TV-LHLVFHPNS--------LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTR 247
Query: 438 IGFYTAFFYENALTSCAPFSSPSNGLFILH----DFSNNLFTGPVPPFLIDSDSLSSRPY 493
++ T+ + + N T + + +
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307
Query: 494 YGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGN 553
+ + + ++ + I + I V FL+ N
Sbjct: 308 MIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTPFIHMVCPP---SPSSFTFLNFTQN 363
Query: 554 EFVGLIPQSFTNFDSLRNLNLSRNHLQ--GPLPSYINKMEDLKFLSLSLNNFTGAIPWEL 611
F + Q + L+ L L RN L+ + M L+ L +SLN+
Sbjct: 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423
Query: 612 TQL-ASLEVLELSANSLSGEIPSEFSKL-EHLNVLRLDHNNLTGRIPPGFGTRSSLSIFD 669
S+ VL LS+N L+G + F L + VL L +N + IP +L +
Sbjct: 424 CAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479
Query: 670 VSFNNLSGSAPRNSLIKCENVQ-----GNPNLQLCHTDPSSSEWERQHSGNVS 717
V+ N L S P + ++Q NP C SEW +HSG V
Sbjct: 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINKHSGVVR 531
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 5e-14
Identities = 31/221 (14%), Positives = 67/221 (30%), Gaps = 7/221 (3%)
Query: 71 GNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEI 130
I + + ++ + +L+ + +
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 131 GQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLS 190
S L+ + N F + L+ + L N + +
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408
Query: 191 FNLLSGSVPEEFGDNCV---SLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDI 247
L+ + C S+ + L++N LTGS+ L +++ L L +N + I
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SI 465
Query: 248 PSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
P L L+ L+++ N L + L+ + L +
Sbjct: 466 PKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 94/522 (18%), Positives = 166/522 (31%), Gaps = 94/522 (18%)
Query: 109 LTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSG 167
L++LRVL L+ N L + LE LD+S N I +SLR ++LS
Sbjct: 75 LSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSF 130
Query: 168 NQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL 227
N F+ +P V +EF N L + L+A +
Sbjct: 131 NDFD-VLP----------------------VCKEF-GNLTKLTFLGLSAAKFR-QLDLLP 165
Query: 228 GNCTELRSLLLS--SNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLV 285
L +LL S ++G S N VL L + S L L
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224
Query: 286 LRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFP 345
L N + + + + G N L ++ W ++ L F
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNV----------TLQHIETTWKCSVKLFQFF- 273
Query: 346 QNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFN 405
+E LN+ + T +I L ++
Sbjct: 274 ----WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK--------------NQ 315
Query: 406 VSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFI 465
V + +S++ + SPS+ F+
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSIS-----------------DTPFIHMVCPPSPSSFTFL 358
Query: 466 LHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGL-IFD 524
+F+ N+FT V +L L N LK N + ++ L D
Sbjct: 359 --NFTQNVFTDSVFQ---GCSTLKRLQTL--ILQRNGLK-NFFK-VALMTKNMSSLETLD 409
Query: 525 IGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLP 584
+ N L + + + L+++ N G + + ++ L+L N + +P
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IP 466
Query: 585 SYINKMEDLKFLSLSLNNFTGAIPWE-LTQLASLEVLELSAN 625
+ ++ L+ L+++ N ++P +L SL+ + L N
Sbjct: 467 KDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 35/185 (18%), Positives = 65/185 (35%), Gaps = 25/185 (13%)
Query: 35 VTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCL-QLHQHDRGNINSN 93
+ C P T LN + N+ L +L + N
Sbjct: 346 MVCPPSPSSFTFLNFTQNV------FTDSVFQG---------CSTLKRLQTL---ILQRN 387
Query: 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGF-SGELPLEIGQLSLLEILDLSFNSFHGPIPP 152
++ +++ L L ++ N S + +L+LS N G +
Sbjct: 388 GLKNFFK-VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446
Query: 153 TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212
L +++++L N+ +IP Q ++++ N L SVP+ D SL++I
Sbjct: 447 CLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYI 502
Query: 213 LLAAN 217
L N
Sbjct: 503 WLHDN 507
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-19
Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQ 855
F+ +G+G FG +K G A+K L V + + ++ E R L V
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
P LV L + ++++ Y+ GG + ++ R + + + A + YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLTFEYL 157
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H +++RD+KP N+L+D ++DFG A+ + T + GT +APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEII 210
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
++ + D ++ GV++ E+ +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAA 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHP 857
F + IG G FG ++ V A+K L+ + R + F E L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-TACFREERDVLVNGDSK 134
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR------- 910
+ TL + ++L+ +Y GG+L + R E ++AR
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE---------EMARFYLAEMV 185
Query: 911 -ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
A+ +H +HRDIKP NIL+D N + L+DFG L T ++ GT Y
Sbjct: 186 IAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 970 VAPEYAMTCRVSDK-----ADVYSFGVVLLELI 997
++PE D +S GV + E++
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 53/218 (24%), Positives = 80/218 (36%), Gaps = 39/218 (17%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHP 857
F + IG G F ++ G V A+K ++ + R + V F E L
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE-VSCFREERDVLVNGDRR 121
Query: 858 NLVTLIGYHVS---EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR---- 910
+ L H + E ++L+ Y GG+L + R ++AR
Sbjct: 122 WITQL---HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA---------EMARFYLA 169
Query: 911 ----ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
A+ +H +HRDIKP NILLD + L+DFG L T + GT
Sbjct: 170 EIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 967 FGYVAPEYAMTCRVSDKADVY-------SFGVVLLELI 997
Y++PE Y + GV E+
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 54/218 (24%), Positives = 79/218 (36%), Gaps = 44/218 (20%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHP 857
+ V IG G FG V A+K LS + R F E + P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-SAFFWEERDIMAFANSP 129
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR------- 910
+V L + ++++ Y+PGG+L E AR
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPE---------KWARFYTAEVV 178
Query: 911 -ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
AL +H +HRD+KP N+LLD + + L+DFG + GT Y
Sbjct: 179 LALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 970 VAPE----------YAMTCRVSDKADVYSFGVVLLELI 997
++PE Y C D +S GV L E++
Sbjct: 236 ISPEVLKSQGGDGYYGREC------DWWSVGVFLYEML 267
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLS--VGRFQGVQQFAA---------EIRTL 851
+ VQ I SG +GA G+ VA+KR+ V + V + EIR L
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 852 GRVQHPNLVTLIGYHVSEA-----EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--I 904
HPN++ L V +++L+ + +L + I D+ + S H
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR---IVISPQHIQYF 139
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA 964
+ L LH+ V+HRD+ P NILL +N + + DF LAR + T
Sbjct: 140 MYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYV 194
Query: 965 GTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
Y APE M + K D++S G V+ E+ + K
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
+ + IG G +G A + + V VA+K++S F+ Q + EI+ L R +H
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEH-QTYCQRTLREIKILLRFRHE 85
Query: 858 NLVTLIGYHVSEA-----EMFLIYNYLPGGNLEKFIQDRP-----RRTVEWSMLHKIALD 907
N++ + + +++++ + + +L K ++ + + +L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQIL------ 138
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT--TDVAG 965
R L Y+H VLHRD+KPSN+LL+ + + DFGLAR+ H T+
Sbjct: 139 --RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 966 TFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
T Y APE + + K+ D++S G +L E++S++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 53/238 (22%), Positives = 86/238 (36%), Gaps = 59/238 (24%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHPNLVTLI 863
+G+G FG + I G A+K+ V Q E+ + + H N++ L+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM--------------------LHK 903
Y + + P + + ++ S+ LHK
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 904 IALDVA-------------------RALAYLHDECVPRVLHRDIKPSNILLDNNLNAY-L 943
+ RA+ ++H + HRDIKP N+L+++ N L
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKL 183
Query: 944 SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
DFG A+ L SE + F Y APE + + D++S G V ELI K
Sbjct: 184 CDFGSAKKLIPSEPS-VAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 50/222 (22%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA 846
G Q Y+ V + +G G + ++A I V VK L + + +++
Sbjct: 33 GNQDDYQLVRK----------LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR--- 79
Query: 847 EIRTLGRVQ-HPNLVTLIGYHVSEAEM--FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK 903
EI+ L ++ PN++TL L++ ++ + ++ Q + +++
Sbjct: 80 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR-FYMYE 138
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTD 962
I L +AL Y H ++HRD+KP N+++D + L D+GLA + +
Sbjct: 139 I-L---KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVR 190
Query: 963 VAGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDKKAL 1003
VA + + PE + ++ D + D++S G +L +I K+
Sbjct: 191 VA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-18
Identities = 67/460 (14%), Positives = 132/460 (28%), Gaps = 84/460 (18%)
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVS 208
+P + ++LS N F + Q + + + S
Sbjct: 27 ELPAHVNY------VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 209 LEHILLAANSLTGSIPPS-LGNCTELRSLLLSSNMLQGDI--PSSFGQLVNLEVLDLSRN 265
L + L N + L L L+ L G + + F L +LE+L L N
Sbjct: 81 LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 266 FLSGIVPSEL--GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDS 323
+ I P+ M ++ VL L N
Sbjct: 140 NIKKIQPASFFLNM-RRFHVLDLTF-------------------------N--------K 165
Query: 324 ITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDL 383
+ + + + + + L + + + + S+ LDL
Sbjct: 166 VKSICEEDLLNFQGKHFTLLRLSSITLQD------MNEYWLGWEKCGNPFKNTSITTLDL 219
Query: 384 SSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTA 443
S N + + F + + +S+S S + +
Sbjct: 220 SGNGFKESMAK--------RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK--------- 262
Query: 444 FFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSL 503
+ ++G+ + +F F + L+ N +
Sbjct: 263 -----DPDNFTFKGLEASGVKTCDLSKSKIFALLKSVF----SHFTDLEQ--LTLAQNEI 311
Query: 504 KGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSF 563
+ F L L ++ N L G + S M + ++ L ++ N L QSF
Sbjct: 312 N-KIDDNAFWGLTHLLKL--NLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSF 367
Query: 564 TNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNF 603
+L+ L L N L+ +++ L+ + L N +
Sbjct: 368 LGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 80/455 (17%), Positives = 138/455 (30%), Gaps = 87/455 (19%)
Query: 207 VSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPS-SFGQLVNLEVLDLSR 264
+ ++ L+ NS+ + S +L+ L + I + +F L +L +L L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 265 NFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSI 324
N + L+VL L N L +
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQ------------------------CNLDGAVLSGNF 124
Query: 325 -TRLPNLRVFWAPNLNLEGIFPQN-WELCSKLEMLNLAHNFFTGQIPASL---GNCKSLY 379
L +L + + N++ I P + + + +L+L N I K
Sbjct: 125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFT 183
Query: 380 FLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIG 439
L LSS L + +
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPF------------------------------KNTS 213
Query: 440 FYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLS 499
T N F + I S LS+ G
Sbjct: 214 ITTLDLSGNGFKESMAKR----------------FFDAIAGTKIQSLILSNSYNMGSSFG 257
Query: 500 GNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLI 559
+ K + + F + D+ +K I + + SH ++ L++A NE +
Sbjct: 258 HTNFK-DPDNFTFKGLEASGVKTCDLSKSK-IFALLKSVFSHFTDLEQLTLAQNEINKID 315
Query: 560 PQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWEL-TQLASL 617
+F L LNLS+N L + S + ++ L+ L LS N+ A+ + L +L
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNL 373
Query: 618 EVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNL 651
+ L L N L +P F +L L + L N
Sbjct: 374 KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 90/509 (17%), Positives = 150/509 (29%), Gaps = 119/509 (23%)
Query: 222 SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL-GMCKQ 280
+P + + LS N + +SF +L +L+ L + + ++ +
Sbjct: 27 ELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 281 LKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNL 340
L +L L DYN +L
Sbjct: 81 LIILKL-------------------------DYN--------QFLQLE------------ 95
Query: 341 EGIFPQNWELCSKLEMLNLAHNFFTGQI--PASLGNCKSLYFLDLSSNNLTGLLPEEV-- 396
G F + LE+L L G + SL L L NN+ + P
Sbjct: 96 TGAFNG----LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 397 SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPF 456
++ V +++ N + S C +
Sbjct: 152 NMRRFHVLDLTFNKVK--------SICEED------------------LLNFQGKHFTLL 185
Query: 457 SSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCL 516
S L ++++ P +L LSGN K +++ FD
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTL--------DLSGNGFKESMAKRFFDAIA 237
Query: 517 SLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSR 576
+ N+ +MGS F F GL ++ +LS+
Sbjct: 238 GTKIQSLILSNS-------YNMGSSFGHTNFKDPDNFTFKGLEASG------VKTCDLSK 284
Query: 577 NHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE- 634
+ + L + + DL+ L+L+ N L L L LS N L I S
Sbjct: 285 SKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRM 342
Query: 635 FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLSGSAPRN---SLIKCENV 690
F L+ L VL L +N++ + F +L + N L S P L + +
Sbjct: 343 FENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKI 400
Query: 691 --QGNPNLQLCHTDPSSSEWERQHSGNVS 717
NP C S W ++S
Sbjct: 401 WLHTNPWDCSCPRIDYLSRWLNKNSQKEQ 429
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 61/325 (18%), Positives = 100/325 (30%), Gaps = 45/325 (13%)
Query: 103 SRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIPP-TLQNCSSL 160
+ L L+ L + + LS L IL L +N F + ++L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANL 105
Query: 161 RLINLSGNQFNGTI--PAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANS 218
++ L+ +G + FF +++ L N + P F N + L N
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165
Query: 219 LTGSIPPSL---GNCTELRSLLLSSNMLQ--------GDIPSSFGQLVNLEVLDLSRNFL 267
+ SI L LSS LQ + + + ++ LDLS N
Sbjct: 166 VK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF 224
Query: 268 SGIVPS---ELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSI 324
+ + +++ L+L N Y S H + D F G +
Sbjct: 225 KESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK-------DPDNFTFKGLEASGV 277
Query: 325 TRL------------------PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTG 366
+L + I + + L LNL+ NF
Sbjct: 278 KTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS 337
Query: 367 QIPASLGNCKSLYFLDLSSNNLTGL 391
N L LDLS N++ L
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHIRAL 362
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-12
Identities = 41/202 (20%), Positives = 67/202 (33%), Gaps = 14/202 (6%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFH 147
+ + L T + L L+ NGF + ++ +I L ++ +
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 148 GPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCV 207
+ F G ++ G + LS + + ++ + +
Sbjct: 251 NMGSSFGHTN----FKDPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKSVFSHFT 299
Query: 208 SLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF 266
LE + LA N + I + T L L LS N L F L LEVLDLS N
Sbjct: 300 DLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358
Query: 267 LSGIVPSELGMCKQLKVLVLRN 288
+ + LK L L
Sbjct: 359 IRALGDQSFLGLPNLKELALDT 380
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 31/137 (22%), Positives = 59/137 (43%), Gaps = 7/137 (5%)
Query: 132 QLSLLEILDLSFNSFHGPIPPTL-QNCSSLRLINLSGNQFNGTIPAF-FGQSPGFQVVSL 189
+ S ++ DLS + + ++ + + L + L+ N+ N I F ++L
Sbjct: 273 EASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNL 330
Query: 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIP 248
S N L S+ +N LE + L+ N + ++ S L+ L L +N L+
Sbjct: 331 SQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPD 388
Query: 249 SSFGQLVNLEVLDLSRN 265
F +L +L+ + L N
Sbjct: 389 GIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 45/294 (15%), Positives = 88/294 (29%), Gaps = 75/294 (25%)
Query: 109 LTQLRVLLLAFN--------GFSGELPLEIGQLSL--LEILDLSFNSFHGPIPPTLQNCS 158
+ + VL L FN L L + + D++ +
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
Query: 159 SLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANS 218
S+ ++LSGN F ++ F F+ ++G+ + + +
Sbjct: 213 SITTLDLSGNGFKESMAKRF------------FDAIAGTKIQSLILSNSYNMGSSFGHTN 260
Query: 219 LTGSIPPSLGN--CTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELG 276
+ + +++ LS + + + S F +LE L L++N ++ I +
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFW 320
Query: 277 MCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAP 336
L L L NF + +
Sbjct: 321 GLTHLLKLNL-------------------------SQNF--------LGSID-------- 339
Query: 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPA-SLGNCKSLYFLDLSSNNLT 389
+F KLE+L+L++N + S +L L L +N L
Sbjct: 340 ----SRMFEN----LDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 5/113 (4%)
Query: 109 LTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSG 167
T L L LA N + ++ L+ L L+LS N +N L +++LS
Sbjct: 298 FTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356
Query: 168 NQFNGTIPA-FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSL 219
N + F P + ++L N L SVP+ D SL+ I L N
Sbjct: 357 NHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 44/202 (21%), Positives = 67/202 (33%), Gaps = 15/202 (7%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEIGQ---LSLLEILDLSFNSFHGP 149
L N LTQL L L+ NG S + L+ LDLSFN
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGTTSLKYLDLSFNGVIT- 92
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPA--FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCV 207
+ L ++ + + F + +S +
Sbjct: 93 MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 150
Query: 208 SLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF 266
SLE + +A NS + P L L LS L+ P++F L +L+VL++S N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210
Query: 267 LSGIVPSELGMCKQLKVLVLRN 288
+ L+VL
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSL 232
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 37/183 (20%), Positives = 66/183 (36%), Gaps = 5/183 (2%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG-PIPPTLQNCSSLRLINLSG 167
T L+ L L+FNG + L LE LD ++ + +L +++S
Sbjct: 77 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135
Query: 168 NQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-S 226
F +V+ ++ N + + +L + L+ L + P +
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194
Query: 227 LGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL-GMCKQLKVLV 285
+ + L+ L +S N + L +L+VLD S N + EL L L
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 254
Query: 286 LRN 288
L
Sbjct: 255 LTQ 257
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 49/258 (18%), Positives = 87/258 (33%), Gaps = 32/258 (12%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFN--SFHGPIPPTLQNCSSLRLINLSG 167
+ L L N +L+ L L LS N SF G + +SL+ ++LS
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 168 NQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-S 226
N T+ + F + + + L + +L ++ ++
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145
Query: 227 LGNCTELRSLLLSSNMLQGDIPS-SFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLV 285
+ L L ++ N Q + F +L NL LDLS+ L + P+ L+VL
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205
Query: 286 LRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFP 345
+ ++ + D + L +L+V ++
Sbjct: 206 MSHN------------NFFSL-----DTFPYKC--------LNSLQVLDYSLNHIMTSKK 240
Query: 346 QNWE-LCSKLEMLNLAHN 362
Q + S L LNL N
Sbjct: 241 QELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 50/260 (19%), Positives = 81/260 (31%), Gaps = 55/260 (21%)
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ--FNGTIPAFFGQSPGFQVVSLSFNL 193
L+L N + L ++LS N F G + + + LSFN
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 194 LSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL-GNCTELRSLLLSSNMLQGDIPSSFG 252
+ ++ F LEH+ ++L S+ + L L +S + F
Sbjct: 90 VI-TMSSNF-LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
Query: 253 QLVNLEVLDLSRN-FLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGE 311
L +LEVL ++ N F +P + L L L
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL------------------------- 182
Query: 312 DYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPAS 371
+ +L F +L S L++LN++HN F
Sbjct: 183 SQC--------QLEQLSP-TAFN----SL-----------SSLQVLNMSHNNFFSLDTFP 218
Query: 372 LGNCKSLYFLDLSSNNLTGL 391
SL LD S N++
Sbjct: 219 YKCLNSLQVLDYSLNHIMTS 238
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 39/168 (23%), Positives = 64/168 (38%), Gaps = 11/168 (6%)
Query: 527 NNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHL--QGPLP 584
N+K + VP+ + S L + N+ L F L L+LS N L +G
Sbjct: 15 NSKGLTSVPTGIPSS---ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 585 SYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE--FSKLEHLN 642
LK+L LS N + L LE L+ ++L ++ F L +L
Sbjct: 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129
Query: 643 VLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLSGSAPRNSLIKCEN 689
L + H + G F SSL + ++ N+ + + + N
Sbjct: 130 YLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 38/186 (20%), Positives = 67/186 (36%), Gaps = 14/186 (7%)
Query: 497 WLSGNSLKGNLSTYP--FDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNE 554
LS N + T F L+ L D ++ L + + + +L ++
Sbjct: 84 DLSFN----GVITMSSNFLGLEQLEHL--DFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 555 FVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWE-LT 612
F SL L ++ N Q I ++ +L FL LS +
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN 196
Query: 613 QLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG--FGTRSSLSIFDV 670
L+SL+VL +S N+ + L L VL N++ SSL+ ++
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNL 255
Query: 671 SFNNLS 676
+ N+ +
Sbjct: 256 TQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 50/198 (25%), Positives = 68/198 (34%), Gaps = 29/198 (14%)
Query: 208 SLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267
S I + LT S+P + + L L SN LQ F +L L L LS N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 268 S--GIVPSELGMCKQLKVLVLRN--------DYGPLYSREHGDL---PIQPVVDGGEDYN 314
S G LK L L ++ L EH D ++ + +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFS---- 120
Query: 315 FFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPA-SLG 373
F L NL + + F + S LE+L +A N F
Sbjct: 121 VFLS--------LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172
Query: 374 NCKSLYFLDLSSNNLTGL 391
++L FLDLS L L
Sbjct: 173 ELRNLTFLDLSQCQLEQL 190
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 51/299 (17%), Positives = 84/299 (28%), Gaps = 69/299 (23%)
Query: 354 LEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSG 413
L L N L L LSSN L+ + F +
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-----FKGCCSQSDFGTTS----- 79
Query: 414 EIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNL 473
+ +DL N + + + L L +NL
Sbjct: 80 ------------------LKYLDL--------SFNGVITMSSNFLGLEQLEHLDFQHSNL 113
Query: 474 FTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGE 533
+ +L +S + F+ SL+ L + N
Sbjct: 114 KQMSEFSVFLSLRNLIY-----LDISHTHTR-VAFNGIFNGLSSLEVL--KMAGNSFQEN 165
Query: 534 VPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDL 593
D+ + + + FL ++ + L P +F + SL+ LN+S N+
Sbjct: 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF------------- 212
Query: 594 KFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKL-EHLNVLRLDHNNL 651
SL + L SL+VL+ S N + E L L L N+
Sbjct: 213 ---SLDTFPYKC--------LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 9e-08
Identities = 32/113 (28%), Positives = 46/113 (40%), Gaps = 1/113 (0%)
Query: 108 DLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLS 166
L+ L VL +A N F +I +L L LDLS P + SSL+++N+S
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207
Query: 167 GNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSL 219
N F + QV+ S N + S +E SL + L N
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 22/87 (25%), Positives = 34/87 (39%), Gaps = 5/87 (5%)
Query: 592 DLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNL 651
+ + T ++P + +S LEL +N L F KL L L L N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 652 TGR-IPPG-FGTRSSLSIFDVSFNNLS 676
+ + +SL D+SFN +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI 91
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 7e-18
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQ 855
F + +G+G FG + G A+K L V R + V+ E L V
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR----- 910
HP ++ + G ++F+I +Y+ GG L ++ + +R VA+
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPN---------PVAKFYAAE 114
Query: 911 ---ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
AL YLH + +++RD+KP NILLD N + ++DFG A+ + T + GT
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTP 167
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
Y+APE T + D +SFG+++ E+++
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 38/222 (17%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
F +++ +G G +G A P G +VA+K++ F FA EI+ L +H
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FDK-PLFALRTLREIKILKHFKHE 69
Query: 858 NLVTLIGYHVSEA-------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDV 908
N++T+ +++ E+++I + +L + I T S H
Sbjct: 70 NIITI--FNIQRPDSFENFNEVYIIQELM-QTDLHRVI-----STQMLSDDHIQYFIYQT 121
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF- 967
RA+ LH V+HRD+KPSN+L+++N + + DFGLAR++ S +
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 968 --GYV------APEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
+V APE +T +A DV+S G +L EL +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
+ +GSG +G+ A G VA+K+LS FQ + FA E+ L +QH
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQS-EIFAKRAYRELLLLKHMQHE 83
Query: 858 NLVTL--IGYHVSEAEMF----LIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVA 909
N++ L + S F L+ ++ +L+K + + S + +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKF------SEEKIQYLVYQML 136
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
+ L Y+H V+HRD+KP N+ ++ + + DFGLAR ++ T V T Y
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWY 189
Query: 970 VAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
APE ++ ++ D++S G ++ E+++ K
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 75/459 (16%), Positives = 134/459 (29%), Gaps = 90/459 (19%)
Query: 209 LEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
+ AA + + S L SL ++ + D+ +L L L + N ++
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77
Query: 269 GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP 328
+ +L L L + N L +T L
Sbjct: 78 TL---DLSQNTNLTYLACDS-------------------------NKL-TNLD--VTPLT 106
Query: 329 NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNL 388
L L + L LN A N T +I + + L LD N
Sbjct: 107 KLTYLNCDTNKLTKLDVSQ---NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK 160
Query: 389 TGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYEN 448
L + + S N ++ + S+ +++++ N
Sbjct: 161 ITKLDVT-PQTQLTTLDCSFNKITE----LDVSQNKL------LNRLNC--------DTN 201
Query: 449 ALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLS 508
+T + L L D S+N T ID L+ Y F S N L+
Sbjct: 202 NITK-LDLNQNIQ-LTFL-DCSSNKLTE------IDVTPLTQLTY--FDCSVN----PLT 246
Query: 509 TYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDS 568
L L L+ E+ +H + + G + T+
Sbjct: 247 ELDVSTLSKLTTL--HCIQTDLL-EIDL---THNTQLIYFQAEGCRK--IKELDVTHNTQ 298
Query: 569 LRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLS 628
L L+ + L +++ L +L L+ T + ++ L+ L +
Sbjct: 299 LYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
Query: 629 GEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSI 667
+ K+ LN +P T +SL+I
Sbjct: 353 -DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTI 388
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 67/444 (15%), Positives = 122/444 (27%), Gaps = 89/444 (20%)
Query: 233 LRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGP 292
S + ++ +Q S QL L LD + ++ + + + L L+ +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS---- 73
Query: 293 LYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCS 352
N L +++ NL + L + +
Sbjct: 74 ---------------------NNIT-TLD--LSQNTNLTYLACDSNKLTNLDVTP---LT 106
Query: 353 KLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLS 412
KL LN N T + L +L+ + N LT + +VS N
Sbjct: 107 KLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLTEI-------------DVSHN--- 147
Query: 413 GEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNN 472
+++ +C + T N +T S L L+ +NN
Sbjct: 148 ---TQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL-DVSQNKL-LNRLNCDTNN 202
Query: 473 LFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIG 532
+ + + L+ S N L+ L D N L
Sbjct: 203 ITKLDLNQNI----QLTF-----LDCSSN----KLTEIDVTPLTQLTYF--DCSVNPLT- 246
Query: 533 EVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMED 592
E+ S + L + + + T+ L L +
Sbjct: 247 ELDV---STLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKELD--VTHNTQ 298
Query: 593 LKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
L L T +L+Q L L L+ L+ E+ S L L + ++
Sbjct: 299 LYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
Query: 653 GRIPPGFGTRSSLSIFDVSFNNLS 676
G +L+ +
Sbjct: 353 D-FSS-VGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-15
Identities = 51/293 (17%), Positives = 94/293 (32%), Gaps = 45/293 (15%)
Query: 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN 164
I LT L L+ N + L++ Q + L L N + + + L +N
Sbjct: 59 GIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLN 112
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP 224
N+ + Q+P ++ + N L+ + + L + N +
Sbjct: 113 CDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLD 165
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
+ T+L +L S N + ++ Q L L+ N ++ + +L QL L
Sbjct: 166 --VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFL 217
Query: 285 VLRN------DYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNL 338
+ D PL + D N L S L L
Sbjct: 218 DCSSNKLTEIDVTPLTQLTYFDC----------SVNPLT-ELDVST--LSKLTTLHCIQT 264
Query: 339 NLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
+L I + ++L ++ + + LY LD + +T L
Sbjct: 265 DLLEI---DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL 312
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-15
Identities = 75/545 (13%), Positives = 147/545 (26%), Gaps = 135/545 (24%)
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195
+ + + ++L ++ + +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI------------------ 60
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255
+ L ++ +N++T ++ L T L L SN L ++ L
Sbjct: 61 --------EKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLT 106
Query: 256 NLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNF 315
L L+ N L+ + S+ L L + + +
Sbjct: 107 KLTYLNCDTNKLTKLDVSQN---PLLTYLNCARN------------TLTEI--------- 142
Query: 316 FDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNC 375
++ L ++L L+ + N T +
Sbjct: 143 -------DVSHNTQLTELDCHLNKKITKLDVTP--QTQLTTLDCSFNKITE---LDVSQN 190
Query: 376 KSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQV 435
K L L+ +NN+T L + + + S N L+ ++ +
Sbjct: 191 KLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLT--------------EIDVT---- 230
Query: 436 DLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYG 495
L N LT S+ S L LH +L + L
Sbjct: 231 PLTQLTYFDCSVNPLTEL-DVSTLSK-LTTLHCIQTDLLEIDLTHNT----QLIY----- 279
Query: 496 FWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEF 555
F G + L L D + S + +L + E
Sbjct: 280 FQAEGCR---KIKELDVTHNTQLYLL--DCQAAGIT----ELDLSQNPKLVYLYLNNTEL 330
Query: 556 VGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
L ++ L++L+ H+Q S + K+ L +
Sbjct: 331 TEL---DVSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTI----------- 374
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
++ L+ NSL+ + ++L N + I PG G + +++ NL
Sbjct: 375 TMPKETLTNNSLTIAVS--------PDLLDQFGNPMN--IEPGDGGVYDQATNTITWENL 424
Query: 676 SGSAP 680
S P
Sbjct: 425 STDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-15
Identities = 45/293 (15%), Positives = 95/293 (32%), Gaps = 34/293 (11%)
Query: 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINL 165
+ L L A N + +++ + L LD N + + L ++
Sbjct: 123 VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITK--LDVTPQTQLTTLDC 177
Query: 166 SGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP 225
S N+ + Q+ ++ N ++ + + L + ++N LT I
Sbjct: 178 SFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLN---QNIQLTFLDCSSNKLT-EID- 228
Query: 226 SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLV 285
+ T+L S N L ++ S L L L + L I +L QL
Sbjct: 229 -VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQ 281
Query: 286 LRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPD-SITRLPNLRVFWAPNLNLEGIF 344
+ D+ + + G+ + +++ P L + N L +
Sbjct: 282 AEG----CRKIKELDVTHNTQL---YLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL- 333
Query: 345 PQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS 397
+ +KL+ L+ + S+G +L + + E ++
Sbjct: 334 --DVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLT 382
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-13
Identities = 74/531 (13%), Positives = 141/531 (26%), Gaps = 125/531 (23%)
Query: 112 LRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFN 171
+ A + QL+ L LD +S + ++ + L + + N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTSNNIT 77
Query: 172 GTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCT 231
+L + +L ++ +N LT ++ + T
Sbjct: 78 ----------------TLDLS------------QNTNLTYLACDSNKLT-NLD--VTPLT 106
Query: 232 ELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYG 291
+L L +N L Q L L+ +RN L+ I ++ QL L
Sbjct: 107 KLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHL--- 157
Query: 292 PLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELC 351
+T L + +
Sbjct: 158 ------------------------NKKITKLDVTPQTQLTTLDCSFNKITELDVSQ---N 190
Query: 352 SKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLL 411
L LN N T ++ L L FLD SSN LT + + + + F+ S N L
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFDCSVNPL 245
Query: 412 SGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSN 471
+ E+ +S ++ + + L + + L
Sbjct: 246 T-ELD---------VSTLSKLTTLHC--------IQTDLLEI-DLTHNTQ-LIYFQAEGC 285
Query: 472 NLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLI 531
+ + L ++ L L + N +L
Sbjct: 286 RKIK---ELDVTHNTQLYL-----LDCQAA----GITELDLSQNPKLVYL--YLNNTELT 331
Query: 532 GEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKME 591
E+ SH +K LS +L N +
Sbjct: 332 -ELDV---SHNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTI----------- 374
Query: 592 DLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLN 642
+ +L+ N+ T A+ +L + + + + E+L+
Sbjct: 375 TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLS 425
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-12
Identities = 52/323 (16%), Positives = 92/323 (28%), Gaps = 59/323 (18%)
Query: 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN 164
+ TQL L +FN + L++ Q LL L+ N+ L L ++
Sbjct: 165 DVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLD 218
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP 224
S N+ I S N L+ + L + L I
Sbjct: 219 CSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS---TLSKLTTLHCIQTDLL-EID 270
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
L + T+L + L +LD ++ + +L +L L
Sbjct: 271 --LTHNTQLIYFQAEGC--RKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYL 323
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF 344
L N E +L ++ L+ N +++
Sbjct: 324 YLNNT-------ELTELD---------------------VSHNTKLKSLSCVNAHIQDFS 355
Query: 345 PQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYF------LDLSSNNLTGLLPEEVSV 398
L A +P SL LD N + + P + V
Sbjct: 356 S--VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGV 411
Query: 399 PCMAVFNVSQNLLSGEIPRISHS 421
A ++ LS + P ++++
Sbjct: 412 YDQATNTITWENLSTDNPAVTYT 434
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 51/356 (14%), Positives = 101/356 (28%), Gaps = 49/356 (13%)
Query: 328 PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387
N A ++ + E + L L+ ++ T + + L L +SNN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75
Query: 388 LTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSK-----MSVNW--SMSQVDLIGF 440
+T L + + N L+ + + +K N +
Sbjct: 76 ITTL--DLSQNTNLTYLACDSNKLT----NLDVTPLTKLTYLNCDTNKLTKLDVSQNPLL 129
Query: 441 YTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSG 500
N LT S + L L N T + L++ S
Sbjct: 130 TYLNCARNTLTEI-DVSHNTQ-LTELDCHLNKKIT---KLDVTPQTQLTT-----LDCSF 179
Query: 501 NSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIP 560
N ++ L+ L + N + ++ + + FL + N+ +
Sbjct: 180 N----KITELDVSQNKLLNRL--NCDTNNIT-KLDL---NQNIQLTFLDCSSNKLTEI-- 227
Query: 561 QSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVL 620
T L + S N L L ++ + L L + +LT L
Sbjct: 228 -DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYF 280
Query: 621 ELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
+ E+ + + L +L +T + L ++ L+
Sbjct: 281 QAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 63/363 (17%), Positives = 104/363 (28%), Gaps = 68/363 (18%)
Query: 335 APNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPE 394
+ FP A S +L LD ++++T +
Sbjct: 6 GQTQSFNDWFPD-----DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTG 59
Query: 395 EVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCA 454
+ + + N ++ + S+ + + N LT+
Sbjct: 60 IEKLTGLTKLICTSNNITT----LDLSQNTNL--------------TYLACDSNKLTN-L 100
Query: 455 PFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDL 514
+ + L L + N T +D Y + N L+
Sbjct: 101 DVTPLTK-LTYL-NCDTNKLTK------LDVSQNPLLTY--LNCARN----TLTEIDVSH 146
Query: 515 CLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNL 574
L L D NK I ++ + + L + N+ L + L LN
Sbjct: 147 NTQLTEL--DCHLNKKITKLDV---TPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNC 198
Query: 575 SRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE 634
N++ L +N+ L FL S N T ++T L L + S N L+ S
Sbjct: 199 DTNNITK-LD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTELDVST 252
Query: 635 FSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNP 694
SKL L+ +L I T L F IK +V N
Sbjct: 253 LSKLTTLH---CIQTDLL-EIDLTHNT--QLIYFQAEGCR---------KIKELDVTHNT 297
Query: 695 NLQ 697
L
Sbjct: 298 QLY 300
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
+ + +GSG +G+ A G+ VAVK+LS FQ A E+R L ++H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQS-IIHAKRTYRELRLLKHMKHE 88
Query: 858 NLVTLIGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVA 909
N++ L+ +++L+ + + G +L + + + + H + +
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-----KCQKLTDDHVQFLIYQIL 142
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
R L Y+H ++HRD+KPSN+ ++ + + DFGLAR + T VA T Y
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVA-TRWY 195
Query: 970 VAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
APE + ++ D++S G ++ EL++ +
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 49/228 (21%), Positives = 91/228 (39%), Gaps = 48/228 (21%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
+ +G GG G + A + VA+K++ Q EI+ + R+ H
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTD-PQSVKHALREIKIIRRLDHD 68
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEK---FIQDRPRRTVEWSM---LHKI----ALD 907
N+V + + + + + + +Q+ M L + L
Sbjct: 69 NIVKV--FEILGPSGSQLTDDVGSLTELNSVYIVQE--------YMETDLANVLEQGPLL 118
Query: 908 ----------VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS--DFGLARLLGTS 955
+ R L Y+H VLHRD+KP+N+ + N + L DFGLAR++
Sbjct: 119 EEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFI-NTEDLVLKIGDFGLARIMDPH 174
Query: 956 ETHAT--TDVAGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
+H ++ T Y +P ++ KA D+++ G + E+++ K
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 5e-17
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLS----VGRFQGVQQFAAEIRTLGRV 854
F + +G GG+G ++ + G + A+K L V + AE L V
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 855 QHPNLVTLIGYHVS---EAEMFLIYNYLPGGNL-------EKFIQDRPR-RTVEWSMLHK 903
+HP +V L + +++LI YL GG L F++D E
Sbjct: 79 KHPFIVDL---IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE------ 129
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
I++ AL +LH + +++RD+KP NI+L++ + L+DFGL + + T
Sbjct: 130 ISM----ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTF 181
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
GT Y+APE M + D +S G ++ +++
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 29/206 (14%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHPNLVTLI 863
+GSG +GA A G VA+K+L FQ + FA E+R L ++H N++ L+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQS-ELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 864 GYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYL 915
+ + +L+ ++ G +L K ++ + + + L Y+
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYI 144
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H ++HRD+KP N+ ++ + + DFGLAR +++ T V T Y APE
Sbjct: 145 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVV-TRWYRAPEVI 197
Query: 976 MTCRVSDKA-DVYSFGVVLLELISDK 1000
+ + D++S G ++ E+I+ K
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 53/244 (21%), Positives = 98/244 (40%), Gaps = 49/244 (20%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
+ +++ IG+G +G +A + + VVA+K+ + R EI L R+ H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK--ILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 858 NLVTLIG-YHVSEAEMF----LIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVAR 910
++V ++ + E F ++ + +K R V + LH + ++
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLF----RTPVYLTELHIKTLLYNLLV 167
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--- 967
+ Y+H +LHRD+KP+N L++ + + + DFGLAR + E +
Sbjct: 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 968 -----------------GYV------APEYAMTCRVSDKA-DVYSFGVVLLELISDKKAL 1003
G+V APE + +A DV+S G + EL++ K
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 1004 DPSF 1007
Sbjct: 285 VAYH 288
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-16
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 17/203 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRV 854
F +G G FG KA G A+K L V + + V E R L
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDE-VAHTLTENRVLQNS 205
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HP L L + + + Y GG L + + + + + ++ AL Y
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--GAEIVSALDY 263
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
LH E V++RD+K N++LD + + ++DFGL + G + GT Y+APE
Sbjct: 264 LHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEV 320
Query: 975 AMTCRVSDKADVYSFGVVLLELI 997
D + GVV+ E++
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMM 343
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 50/199 (25%), Positives = 78/199 (39%), Gaps = 11/199 (5%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP 152
L GN + + L +L L N + L+LLE LDLS N+ + P
Sbjct: 39 LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
Query: 153 -TLQNCSSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLE 210
T L ++L + F Q + L N L ++P++ + +L
Sbjct: 99 ATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLT 156
Query: 211 HILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269
H+ L N ++ S+P + L LLL N + P +F L L L L N LS
Sbjct: 157 HLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
Query: 270 IVPSELGMCKQLKVLVLRN 288
+ L + L+ L L +
Sbjct: 216 LPTEALAPLRALQYLRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 43/182 (23%), Positives = 64/182 (35%), Gaps = 9/182 (4%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
WL N L + F L+ L D+ +N + V + L +
Sbjct: 62 WLHSNVLA-RIDAAAFTGLALLEQL--DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWELTQLA 615
L P F +L+ L L N LQ LP + +L L L N + L
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 616 SLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFN 673
SL+ L L N ++ + F L L L L NNL+ +P +L ++ N
Sbjct: 178 SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
Query: 674 NL 675
Sbjct: 236 PW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 35/155 (22%), Positives = 52/155 (33%), Gaps = 4/155 (2%)
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195
+ + L N + + C +L ++ L N A F + + LS N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPS-SFGQ 253
SV L + L L + P L+ L L N LQ +P +F
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 254 LVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
L NL L L N +S + L L+L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 52/249 (20%), Positives = 84/249 (33%), Gaps = 30/249 (12%)
Query: 23 NPKDTDSCSWHGVTCDP--LSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCL 80
PK T SC G+ P + + L N + +P A+ F L
Sbjct: 11 EPKVTTSCPQQGLQAVPVGIPAASQRIFLHGN------RISHVPAAS-----FR-ACRNL 58
Query: 81 QLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEIL 139
+ + + +G L L L L+ N + L L L
Sbjct: 59 TILWLHSNVLARIDAAAFTG--------LALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110
Query: 140 DLSFNSFHGPIPP-TLQNCSSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFNLLSGS 197
L + P + ++L+ + L N +P F + L N +S S
Sbjct: 111 HLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-S 167
Query: 198 VPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256
VPE SL+ +LL N + + P + + L +L L +N L + L
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 257 LEVLDLSRN 265
L+ L L+ N
Sbjct: 227 LQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 44/241 (18%), Positives = 78/241 (32%), Gaps = 31/241 (12%)
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209
+P + ++ + I L GN+ + A F ++ L N+L+ + L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82
Query: 210 EHILLAANSLTGSIPPS-LGNCTELRSLLLSSNMLQGDIPS-SFGQLVNLEVLDLSRNFL 267
E + L+ N+ S+ P+ L +L L LQ ++ F L L+ L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 268 SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRL 327
+ L L L N + L
Sbjct: 142 QALPDDTFRDLGNLTHLFL-------------------------HGNRISSVPERAFRGL 176
Query: 328 PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387
+L + + P + +L L L N + +L ++L +L L+ N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 388 L 388
Sbjct: 237 W 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 8/157 (5%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
+ N+ I VP+ C+ + L + N + +FT L L+LS N +
Sbjct: 38 FLHGNR-ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 584 PSYI-NKMEDLKFLSLSLNNFTGAIPWE-LTQLASLEVLELSANSLSGEIPSE-FSKLEH 640
+ + L L L + LA+L+ L L N+L +P + F L +
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGN 154
Query: 641 LNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLS 676
L L L N ++ +P F SL + N ++
Sbjct: 155 LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 42/187 (22%), Positives = 64/187 (34%), Gaps = 28/187 (14%)
Query: 207 VSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265
+ + I L N ++ +P S C L L L SN+L ++F L LE LDLS N
Sbjct: 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 266 F-LSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSI 324
L + P+ +L L L L + P F G
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRC--GLQE-------LGP--------GLFRG------ 127
Query: 325 TRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLS 384
L L+ + + L+ + + L L L N + + SL L L
Sbjct: 128 --LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 385 SNNLTGL 391
N + +
Sbjct: 186 QNRVAHV 192
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 28/176 (15%), Positives = 48/176 (27%), Gaps = 53/176 (30%)
Query: 217 NSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELG 276
L ++P + + + L N + +SF NL +L L N L+ I +
Sbjct: 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 277 MCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAP 336
L+ L L +
Sbjct: 78 GLALLEQLDLSD------------------------------------------------ 89
Query: 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPA-SLGNCKSLYFLDLSSNNLTGL 391
N L + P + +L L+L ++ +L +L L N L L
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQAL 144
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 28/195 (14%), Positives = 60/195 (30%), Gaps = 14/195 (7%)
Query: 76 HFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSL 135
+ P + G + +S+ ++ + L + LA + +E
Sbjct: 16 NIPDSTFKAYLNGLLGQSSTANIT------EAQMNSLTYITLANINVTDLTGIE--YAHN 67
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195
++ L ++ P + S+L + + G ++ +S +
Sbjct: 68 IKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255
S+ + + I L+ N I P L EL+SL + + + D
Sbjct: 126 DSILTKIN-TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DY-RGIEDFP 181
Query: 256 NLEVLDLSRNFLSGI 270
L L + G
Sbjct: 182 KLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 22/179 (12%), Positives = 61/179 (34%), Gaps = 8/179 (4%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
+ + L G S + Q++ L + L+ + + ++ +++ + ++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIH 77
Query: 170 FNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGN 229
P + + + ++ SL + ++ ++ SI +
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKINT 134
Query: 230 CTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
++ S+ LS N DI L L+ L++ + + + +L L +
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 24/131 (18%), Positives = 57/131 (43%), Gaps = 5/131 (3%)
Query: 546 KFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG 605
++++A L ++++L ++ H + I+ + +L+ L + + T
Sbjct: 47 TYITLANINVTDLTG--IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTS 102
Query: 606 AIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSL 665
L+ L SL +L++S ++ I ++ + L +N + L +N I P T L
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPEL 161
Query: 666 SIFDVSFNNLS 676
++ F+ +
Sbjct: 162 KSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 20/108 (18%), Positives = 38/108 (35%), Gaps = 3/108 (2%)
Query: 546 KFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG 605
+ L + G + + + SL L++S + + + IN + + + LS N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 606 AIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTG 653
I L L L+ L + + + LN L + G
Sbjct: 151 DIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 17/186 (9%), Positives = 53/186 (28%), Gaps = 30/186 (16%)
Query: 208 SLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267
+ + L + + + L + L++ + D+ + N++ L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA 78
Query: 268 SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRL 327
+ + + L+ L + +++ L
Sbjct: 79 TNY--NPISGLSNLERLRIMG-------------------------KDVTSDKIPNLSGL 111
Query: 328 PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387
+L + + + K+ ++L++N I L L L++ +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDG 170
Query: 388 LTGLLP 393
+
Sbjct: 171 VHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 24/188 (12%), Positives = 57/188 (30%), Gaps = 54/188 (28%)
Query: 204 DNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
+ +++ + + T + P + + L L + + D + L +L +LD+S
Sbjct: 63 EYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 264 RNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDS 323
+ + +++ ++ + L YN +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDL-------------------------SYN-------GA 148
Query: 324 ITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDL 383
IT + L+ L +L+ LN+ + + + L L
Sbjct: 149 ITDIMPLK-------TL-----------PELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188
Query: 384 SSNNLTGL 391
S + G
Sbjct: 189 FSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 21/162 (12%), Positives = 49/162 (30%), Gaps = 37/162 (22%)
Query: 231 TELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN-- 288
+ ++ L + Q+ +L + L+ ++ + + + +K L + N
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77
Query: 289 --DYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQ 346
+Y P+ L NL ++
Sbjct: 78 ATNYNPISG-------------------------------LSNLERLRIMGKDVTSDKIP 106
Query: 347 NWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNL 388
N + L +L+++H+ I + + +DLS N
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-16
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 32/214 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLS----VGRFQGVQQFAAEIRTLGRV 854
F + +G+G +G + I G + A+K L V + + + E + L +
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 855 QH-PNLVTLIGYHVSEAEMFLIYNYLPGGNL-------EKFIQDRPR-RTVEWSMLHKIA 905
+ P LVTL +E ++ LI +Y+ GG L E+F + + E I
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE------IV 169
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
L AL +LH +++RDIK NILLD+N + L+DFGL++ ET D G
Sbjct: 170 L----ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 966 TFGYVAPEYAMTCRVS-DKA-DVYSFGVVLLELI 997
T Y+AP+ DKA D +S GV++ EL+
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 43/259 (16%), Positives = 87/259 (33%), Gaps = 37/259 (14%)
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195
+LDL N +N +L + L N+ + P F + + LS N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDI--PSSFG 252
+ +L+ + + N +T + ++ + L +N L+ +F
Sbjct: 114 ELPEKMPK----TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 253 QLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGED 312
+ L + ++ ++ I G+ L L L I V
Sbjct: 169 GMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDG------------NKITKVDAA--- 210
Query: 313 YNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASL 372
S+ L NL ++ + + L L+L +N ++P L
Sbjct: 211 ----------SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 373 GNCKSLYFLDLSSNNLTGL 391
+ K + + L +NN++ +
Sbjct: 260 ADHKYIQVVYLHNNNISAI 278
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 62/347 (17%), Positives = 106/347 (30%), Gaps = 60/347 (17%)
Query: 29 SCSWHGVTCD---------PLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPC 79
C V C L L+L +N + + F +
Sbjct: 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNN------KITEIKDGD-----FK-NLKN 77
Query: 80 LQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEIL 139
L + +N K+S A L +L L L+ N ELP L+ L
Sbjct: 78 LH-----TLILINN---KISKISPGAFAPLVKLERLYLSKNQLK-ELP--EKMPKTLQEL 126
Query: 140 DLSFNSFHGPIPP-TLQNCSSLRLINLSGNQF-NGTIPA-FFGQSPGFQVVSLSFNLLSG 196
+ N + + + ++ L N + I F + ++ ++
Sbjct: 127 RVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 184
Query: 197 SVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255
++P+ SL + L N +T + SL L L LS N + S
Sbjct: 185 TIPQ---GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240
Query: 256 NLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNF 315
+L L L+ N L VP L K ++V+ L N+ I + +F
Sbjct: 241 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN------------NISAI----GSNDF 283
Query: 316 FDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHN 362
G + +F P + I P + + L +
Sbjct: 284 CPPGYNTKKASYSGVSLFSNP-VQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 42/204 (20%), Positives = 75/204 (36%), Gaps = 16/204 (7%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEF- 555
+LS N L P + +L L + N+ I +V + + M + + N
Sbjct: 106 YLSKN----QLKELPEKMPKTLQEL--RVHENE-ITKVRKSVFNGLNQMIVVELGTNPLK 158
Query: 556 -VGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWE-LTQ 613
G+ +F L + ++ ++ +P + L L L N T + L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKG 214
Query: 614 LASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFN 673
L +L L LS NS+S + HL L L++N L ++P G + + + N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 674 NLSGSAPRNSLIKCENVQGNPNLQ 697
N+S + N +
Sbjct: 274 NIS-AIGSNDFCPPGYNTKKASYS 296
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 49/288 (17%), Positives = 85/288 (29%), Gaps = 41/288 (14%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
+L L N + + L L L L N P L + LS NQ
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 170 FNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLT-GSIPP-SL 227
+P Q + + N ++ V + + + + L N L I +
Sbjct: 112 LK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 228 GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287
+L + ++ + IP G +L L L N ++ + + L L L L
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL- 223
Query: 288 NDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN 347
+N S+ P+LR N L + P
Sbjct: 224 ------------------------SFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGG 258
Query: 348 WELCSKLEMLNLAHNFFTG------QIPASLGNCKSLYFLDLSSNNLT 389
++++ L +N + P S + L SN +
Sbjct: 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 59/308 (19%), Positives = 116/308 (37%), Gaps = 44/308 (14%)
Query: 354 LEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEE-VSVPCMAVFNVSQNLLS 412
+L+L +N T N K+L+ L L +N ++ + P + + +S+N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 413 GEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAP--FSSPSNGLFILHDFS 470
E+P ++ ++ + +EN +T F+ + + ++ +
Sbjct: 114 -ELPEKMPK---------TLQELRV--------HENEITKVRKSVFNGLNQ-MIVVELGT 154
Query: 471 NNLFTGPVPP-FLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNK 529
N L + + LS ++ N++T P L SL L + NK
Sbjct: 155 NPLKSSGIENGAFQGMKKLSY-----IRIADT----NITTIPQGLPPSLTEL--HLDGNK 203
Query: 530 LIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINK 589
I +V + + L ++ N + S N LR L+L+ N L +P +
Sbjct: 204 -ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLAD 261
Query: 590 MEDLKFLSLSLNNFTG------AIPWELTQLASLEVLELSANSLS-GEIPSE-FSKLEHL 641
+ ++ + L NN + P T+ AS + L +N + EI F +
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 642 NVLRLDHN 649
++L +
Sbjct: 322 AAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 33/153 (21%), Positives = 62/153 (40%), Gaps = 10/153 (6%)
Query: 527 NNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSY 586
++ + +VP D+ L + N+ + F N +L L L N + P
Sbjct: 39 SDLGLEKVPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95
Query: 587 INKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLR 645
+ L+ L LS N +P ++ +L+ L + N ++ ++ F+ L + V+
Sbjct: 96 FAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVE 151
Query: 646 LDHNNLT-GRIPPG-FGTRSSLSIFDVSFNNLS 676
L N L I G F LS ++ N++
Sbjct: 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 41/158 (25%), Positives = 67/158 (42%), Gaps = 15/158 (9%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ--- 580
D+ NNK I E+ + K + L + N+ + P +F L L LS+N L+
Sbjct: 58 DLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELP 116
Query: 581 GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSL-SGEIPSE-FSKL 638
+P L+ L + N T L + V+EL N L S I + F +
Sbjct: 117 EKMPK------TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 639 EHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
+ L+ +R+ N+T IP G SL+ + N ++
Sbjct: 171 KKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT 205
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 36/187 (19%), Positives = 63/187 (33%), Gaps = 18/187 (9%)
Query: 497 WLSGNSLK-GNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEF 555
L N LK + F L + I + I +P + + L + GN+
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYI--RIADTN-ITTIPQGLPPS---LTELHLDGNKI 204
Query: 556 VGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
+ S ++L L LS N + + L+ L L+ N +P L
Sbjct: 205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263
Query: 616 SLEVLELSANSLSGEIPSE-------FSKLEHLNVLRLDHNNLT-GRIPPG-FGTRSSLS 666
++V+ L N++S I S +K + + L N + I P F +
Sbjct: 264 YIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 322
Query: 667 IFDVSFN 673
+
Sbjct: 323 AVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 28/109 (25%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 568 SLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSL 627
LR + S L+ +P + D L L N T + L +L L L N +
Sbjct: 32 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 628 SGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
S P F+ L L L L N L +P +L V N ++
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT 134
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 31/191 (16%), Positives = 57/191 (29%), Gaps = 43/191 (22%)
Query: 208 SLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267
L + + L +P L + L L +N + F L NL L L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 268 SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRL 327
S I P +L+ L L N + L
Sbjct: 89 SKISPGAFAPLVKLERLYLSK-------------------------N--------QLKEL 115
Query: 328 P-----NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFT-GQIPA-SLGNCKSLYF 380
P L+ + + + +++ ++ L N I + K L +
Sbjct: 116 PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 175
Query: 381 LDLSSNNLTGL 391
+ ++ N+T +
Sbjct: 176 IRIADTNITTI 186
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 50/210 (23%), Positives = 72/210 (34%), Gaps = 39/210 (18%)
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNML 243
+VV S L VP++ + L+ L N +T I N L +L+L +N +
Sbjct: 34 RVVQCSDLGLE-KVPKDLPPDTALLD---LQNNKIT-EIKDGDFKNLKNLHTLILINNKI 88
Query: 244 QGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPI 303
P +F LV LE L LS+N L + M K L+ L +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKELPE---KMPKTLQELRVHE--------------- 130
Query: 304 QPVVDGGEDYNFFDGGLPDSITRLPNLRVFW--APNLNLEGIFPQNWELCSKLEMLNLAH 361
N L + V L GI ++ KL + +A
Sbjct: 131 ----------NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180
Query: 362 NFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
T IP L SL L L N +T +
Sbjct: 181 TNIT-TIPQGL--PPSLTELHLDGNKITKV 207
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 42/188 (22%), Positives = 63/188 (33%), Gaps = 14/188 (7%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
N++ + D L + + L+VL +A ++ L LDLS N G
Sbjct: 130 NVSWATRDAWLAELQQWL--KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 149 PIPPTLQNC----SSLRLINLSGNQFN---GTIPAFFGQSPGFQVVSLSFNLLSGSVPEE 201
C +L+++ L G A Q + LS N L +
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
Query: 202 FGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLD 261
D L + L+ L +P L +L L LS N L P S +L + L
Sbjct: 248 SCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NP-SPDELPQVGNLS 302
Query: 262 LSRNFLSG 269
L N
Sbjct: 303 LKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 39/220 (17%), Positives = 62/220 (28%), Gaps = 18/220 (8%)
Query: 468 DFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGL-IFDIG 526
N TG PP L+++ L S + GL + I
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLN---ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 527 NNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFT----NFDSLRNLNLSRNHLQ-- 580
+ + L ++ N +G F +L+ L L ++
Sbjct: 158 QAHS-LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 581 -GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQ-LASLEVLELSANSLSGEIPSEFSKL 638
G + L+ L LS N+ A + L L LS L +KL
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKL 276
Query: 639 EHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGS 678
L+ L +N L P + + N S
Sbjct: 277 SVLD---LSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 44/276 (15%), Positives = 79/276 (28%), Gaps = 43/276 (15%)
Query: 128 LEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187
++ L L + S + S L+ + L + GT P ++ G +
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 188 SLSFNLLSGSVPEEFGDNCV-----SLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNM 242
L+ +S + + + L+ + +A + L +L LS N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 243 LQGDIPSS----FGQLVNLEVLDLSRNF---LSGIVPSELGMCKQLKVLVLRNDYGPLYS 295
G+ + L+VL L SG+ + QL+ L L
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS-------- 236
Query: 296 REHGDLPIQPVVDGGEDYNFFDGGLPDSI-TRLPNLRVFWAPNLNLEGIFPQNWELCSKL 354
+N L L+ + L +KL
Sbjct: 237 -----------------HNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK---GLPAKL 276
Query: 355 EMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390
+L+L++N P S + L L N
Sbjct: 277 SVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 32/160 (20%), Positives = 51/160 (31%), Gaps = 13/160 (8%)
Query: 545 MKFLSMAGNEFVGLIPQSFTNFD--SLRNLNLSRNHLQGPLPS----YINKMEDLKFLSL 598
++ L++ E G P L LNL LK LS+
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 599 SLNNFTGAIPWELTQLASLEVLELSANSLSGEI-------PSEFSKLEHLNVLRLDHNNL 651
+ + ++ +L L+LS N GE P +F L+ L +
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 652 TGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQ 691
+G R L D+S N+L +A S +
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 39/236 (16%), Positives = 71/236 (30%), Gaps = 18/236 (7%)
Query: 195 SGSVPEEFGDNCVSLEHILLAANSLTGSIPPS-LGNCTELRSLLLSSNMLQGDIPSSFGQ 253
G+ E SLE++L ++ + + L+ L + + + I +
Sbjct: 31 LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 254 LVN---LEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGG 310
++ L+ L L ++G P L + +L +R+ +Q + G
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 311 -----EDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELC----SKLEMLNLAH 361
+ + P L + G LC L++L L +
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 362 NFFT---GQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSV--PCMAVFNVSQNLLS 412
G A L LDLS N+L + N+S L
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 47/240 (19%), Positives = 99/240 (41%), Gaps = 46/240 (19%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQHP 857
+ +++ IG G +G Y A + VA+K+++ F+ EI L R++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFED-LIDCKRILREITILNRLKSD 85
Query: 858 NLVTLIGYHVSEAEMFLIYN--Y----LPGGNLEKFIQDRPRRTVEWSMLHK--IALDVA 909
++ L Y + + L ++ Y + +L+K + + + H I ++
Sbjct: 86 YIIRL--YDLIIPDDLLKFDELYIVLEIADSDLKKLF----KTPIFLTEEHIKTILYNLL 139
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF-- 967
++H+ ++HRD+KP+N LL+ + + + DFGLAR + + + +
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 968 -------------GYV------APEYAMTCRVSDKA-DVYSFGVVLLELISDKKALDPSF 1007
+V APE + K+ D++S G + EL++ ++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 46/284 (16%), Positives = 94/284 (33%), Gaps = 25/284 (8%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP-TLQNCSSLRLINLSGN 168
++ L L+ N + ++ + L+ L L+ N + I + + SL ++LS N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYN 110
Query: 169 QFNGTIPA-FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-S 226
+ + +F ++L N + L+ + + I
Sbjct: 111 YL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 227 LGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL 286
T L L + ++ LQ P S + N+ L L ++ + + ++ L L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 287 RNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQ 346
R+ L + +L G +S+ + R + +L + +
Sbjct: 230 RDT--DLDTFHFSELS---------------TGETNSLIKKFTFRNVKITDESLFQV-MK 271
Query: 347 NWELCSKLEMLNLAHNFFTGQIPAS-LGNCKSLYFLDLSSNNLT 389
S L L + N +P SL + L +N
Sbjct: 272 LLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 48/238 (20%), Positives = 81/238 (34%), Gaps = 21/238 (8%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
LS N L NLS+ F SL L ++ N + + SH ++ L + +
Sbjct: 106 DLSYNYLS-NLSSSWFKPLSSLTFL--NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 557 GLIP-QSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
I + F L L + + LQ P + ++++ L L + + + +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 616 SLEVLELSANSLSGEIPSE--------FSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSI 667
S+E LEL L SE K +++ +L ++ S L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 668 FDVSFNNLSGSAPRN---SLIKCENVQ--GNPNLQ-LCHTDPSSSEWERQHSGNVSQQ 719
+ S N L S P L + + NP C S W ++S
Sbjct: 282 LEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNP-WDCSCPRIDYLSRWLNKNSQKEQGS 337
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 66/377 (17%), Positives = 120/377 (31%), Gaps = 75/377 (19%)
Query: 133 LSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192
+ + + S +C + S N +IP+ G + + + LS N
Sbjct: 6 WMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNN 62
Query: 193 LLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSS- 250
++ + CV+L+ ++L +N + +I S + L L LS N L ++ SS
Sbjct: 63 RIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW 119
Query: 251 FGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGG 310
F L +L L+L N + +
Sbjct: 120 FKPLSSLTFLNLLGNPYKTLGET------------------------------------- 142
Query: 311 EDYNFFDGGLPDSITRLPNLR-VFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIP 369
+ F L L+ + I +++ + LE L + + P
Sbjct: 143 ---SLFSH--------LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 370 ASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNL--LSGEIPRISHSECSKMS 427
SL + +++ L L LL +V+ ++ L + S++S
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLE--------IFVDVTSSVECLELRDTDLDTFHFSELS 243
Query: 428 VNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDS-D 486
+ S + F + +L + +GL L FS N VP + D
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELE-FSRNQLKS-VPDGIFDRLT 301
Query: 487 SLSSRPYYGFWLSGNSL 503
SL WL N
Sbjct: 302 SLQK-----IWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 40/175 (22%), Positives = 75/175 (42%), Gaps = 9/175 (5%)
Query: 506 NLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTN 565
+L++ P L ++ L D+ NN+ I + + C ++ L + N + SF++
Sbjct: 42 SLNSIPSGLTEAVKSL--DLSNNR-ITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSS 98
Query: 566 FDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWEL-TQLASLEVLELS 623
SL +L+LS N+L L S + L FL+L N + L + L L++L +
Sbjct: 99 LGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVG 157
Query: 624 ANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLS 676
+I + F+ L L L +D ++L P + ++S +
Sbjct: 158 NMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 21/120 (17%), Positives = 38/120 (31%), Gaps = 10/120 (8%)
Query: 109 LTQLRVLLLAFNG--------FSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSL 160
+ + L+L +E +L ++ F+ +L +
Sbjct: 197 IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256
Query: 161 RLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLT 220
R + ++ + Q G + S N L SVP+ D SL+ I L N
Sbjct: 257 RNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 38/214 (17%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRV 854
F + +G G FG + + A+K L R + + E L V
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVEV 83
Query: 855 QHPNLVTLIGYHVS---EAEMFLIYNYLPGGNL-------EKFIQDRPR-RTVEWSMLHK 903
HP +V L H + E +++LI ++L GG+L F ++ + E
Sbjct: 84 NHPFIVKL---HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE------ 134
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+AL AL +LH +++RD+KP NILLD + L+DFGL++
Sbjct: 135 LAL----ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSF 186
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
GT Y+APE + AD +SFGV++ E++
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 43/195 (22%), Positives = 70/195 (35%), Gaps = 42/195 (21%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYH 866
+G G G + A+K L ++ E+ R Q P++V ++ +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARR---EVELHWRASQCPHIVRIVDVY 80
Query: 867 ----VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ ++ L GG L IQDR + +I + A+ YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---N 137
Query: 923 VLHRDIKPSNILL---DNNLNAYLSDFGLAR-LLGTSETHATTDVAGTFGYVAPEYAMTC 978
+ HRD+KP N+L N L+DFG A+ G Y
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE-------------KY--------- 175
Query: 979 RVSDKADVYSFGVVL 993
D++S GV++
Sbjct: 176 --DKSCDMWSLGVIM 188
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 7e-15
Identities = 52/256 (20%), Positives = 81/256 (31%), Gaps = 33/256 (12%)
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAF-FGQSPGFQVVSLSFNLL 194
L+L N+ T ++ L ++ L N I F + L N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL 135
Query: 195 SGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSS-NMLQGDIPSSFG 252
+ +P + L + L N + SIP + L L L L+ +F
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 253 QLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGED 312
L NL+ L+L + + L L+ L +
Sbjct: 194 GLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEM-------------------------S 226
Query: 313 YNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASL 372
N F P S L +L+ W N + I ++ + L LNLAHN +
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLF 286
Query: 373 GNCKSLYFLDLSSNNL 388
+ L L L N
Sbjct: 287 TPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 11/183 (6%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
L NS++ + F+ SL+ L ++ +N + +PS + ++ L + N
Sbjct: 105 QLGRNSIR-QIEVGAFNGLASLNTL--ELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIE 160
Query: 557 GLIPQSFTNFDSLRNLNLSR-NHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
+ +F SL L+L L+ + +LK+L+L + N +P LT L
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLV 218
Query: 616 SLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFN 673
LE LE+S N EI F L L L + ++ ++ I F +SL +++ N
Sbjct: 219 GLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHN 276
Query: 674 NLS 676
NLS
Sbjct: 277 NLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-13
Identities = 57/267 (21%), Positives = 95/267 (35%), Gaps = 34/267 (12%)
Query: 29 SCSWHGVTCDP--LSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHD 86
C+ G++ P + LNL N ++ + F H L++ Q
Sbjct: 60 VCTRRGLSEVPQGIPSNTRYLNLMEN------NIQMIQADT-----FR-HLHHLEVLQLG 107
Query: 87 RGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNS 145
R +I +G L L L L N + +P LS L L L N
Sbjct: 108 RNSIRQIEVGAFNG--------LASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNP 158
Query: 146 FHGPIPP-TLQNCSSLRLINLSGNQFNGTIP--AFFGQSPGFQVVSLSFNLLSGSVPEEF 202
IP SL ++L + I AF G + ++L + +P
Sbjct: 159 IES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL-FNLKYLNLGMCNIK-DMPN-- 213
Query: 203 GDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLD 261
V LE + ++ N I P S + L+ L + ++ + ++F L +L L+
Sbjct: 214 LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272
Query: 262 LSRNFLSGIVPSELGMCKQLKVLVLRN 288
L+ N LS + + L L L +
Sbjct: 273 LAHNNLSSLPHDLFTPLRYLVELHLHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-13
Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 7/156 (4%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
WL N ++ ++ +Y F+ SL L D+G K + + +K+L++
Sbjct: 153 WLRNNPIE-SIPSYAFNRVPSLMRL--DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLAS 616
+ + T L L +S NH P + + LK L + + + LAS
Sbjct: 210 DM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS 267
Query: 617 LEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNL 651
L L L+ N+LS +P + F+ L +L L L HN
Sbjct: 268 LVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 44/238 (18%), Positives = 76/238 (31%), Gaps = 32/238 (13%)
Query: 158 SSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAAN 217
+ + + + +P G + ++L N + + + + LE + L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109
Query: 218 SLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELG 276
S+ I + L +L L N L +F L L L L N + I
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 277 MCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAP 336
L L L + L I F+G L NL+
Sbjct: 169 RVPSLMRLDL-GELKKLEY-------ISE--------GAFEG--------LFNLKYLNLG 204
Query: 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPE 394
N++ + N LE L ++ N F P S SL L + ++ ++ +
Sbjct: 205 MCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 33/155 (21%), Positives = 54/155 (34%), Gaps = 6/155 (3%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
++ N I + +D H ++ L + N + +F SL L L N L
Sbjct: 81 NLMENN-IQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIP 139
Query: 584 PSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS-ANSLSGEIPSE-FSKLEHL 641
+ L+ L L N + ++ SL L+L L I F L +L
Sbjct: 140 SGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNL 198
Query: 642 NVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
L L N+ +P L ++S N+
Sbjct: 199 KYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 19/86 (22%), Positives = 37/86 (43%), Gaps = 5/86 (5%)
Query: 592 DLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNL 651
+ + + +P + ++ L L N++ F L HL VL+L N++
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 652 TGRIPPG-FGTRSSLSIFDVSFNNLS 676
+I G F +SL+ ++ N L+
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT 136
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-15
Identities = 38/182 (20%), Positives = 67/182 (36%), Gaps = 9/182 (4%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
L N ++ + F L+ L + N I + + + L + N
Sbjct: 70 NLHENQIQ-IIKVNSFKHLRHLEIL--QLSRNH-IRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWE-LTQLA 615
+ +F L+ L L N ++ N++ L+ L L I L+
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNN 674
+L L L+ +L EIP+ + L L+ L L N+L+ I PG F L + +
Sbjct: 186 NLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQ 242
Query: 675 LS 676
+
Sbjct: 243 IQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 52/255 (20%), Positives = 78/255 (30%), Gaps = 31/255 (12%)
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195
+L+L N + ++ L ++ LS N F + L N L+
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPPSL-GNCTELRSLLLSS-NMLQGDIPSSFGQ 253
++P L+ + L N + SIP LR L L L +F
Sbjct: 126 -TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 254 LVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDY 313
L NL L+L+ L I L +L L L
Sbjct: 184 LSNLRYLNLAMCNLREI--PNLTPLIKLDELDL-------------------------SG 216
Query: 314 NFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLG 373
N P S L +L+ W ++ I ++ L +NLAHN T
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276
Query: 374 NCKSLYFLDLSSNNL 388
L + L N
Sbjct: 277 PLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 44/183 (24%), Positives = 71/183 (38%), Gaps = 13/183 (7%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAG-NEF 555
L N L + F L L + NN I +PS + ++ L +
Sbjct: 118 ELFDNRLT-TIPNGAFVYLSKLKEL--WLRNNP-IESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 556 VGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWE-LTQL 614
+ +F +LR LNL+ +L+ +P+ + + L L LS N+ + AI L
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGL 230
Query: 615 ASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSF 672
L+ L + + + I F L+ L + L HNNLT +P F L +
Sbjct: 231 MHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHH 288
Query: 673 NNL 675
N
Sbjct: 289 NPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 6e-13
Identities = 53/253 (20%), Positives = 94/253 (37%), Gaps = 30/253 (11%)
Query: 40 LSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLS 99
+S LNL N + + + F H L++ Q R +I + +
Sbjct: 62 ISTNTRLLNLHEN------QIQIIKVNS-----FK-HLRHLEILQLSRNHIRTIEIGAFN 109
Query: 100 GNLSRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIPP-TLQNC 157
G L L L L N + +P LS L+ L L N IP
Sbjct: 110 G--------LANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRI 159
Query: 158 SSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA 216
SLR ++L + I F + ++L+ L +P + L+ + L+
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN--LTPLIKLDELDLSG 216
Query: 217 NSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL 275
N L+ +I P S L+ L + + +Q ++F L +L ++L+ N L+ +
Sbjct: 217 NHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLF 275
Query: 276 GMCKQLKVLVLRN 288
L+ + L +
Sbjct: 276 TPLHHLERIHLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 8/153 (5%)
Query: 527 NNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSY 586
K + EVP + ++ + L++ N+ + SF + L L LSRNH++
Sbjct: 51 VRKNLREVPDGISTN---TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGA 107
Query: 587 INKMEDLKFLSLSLNNFTGAIPWE-LTQLASLEVLELSANSLSGEIPSE-FSKLEHLNVL 644
N + +L L L N T IP L+ L+ L L N + IPS F+++ L L
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165
Query: 645 RLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLS 676
L I G F S+L +++ NL
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 53/266 (19%), Positives = 86/266 (32%), Gaps = 35/266 (13%)
Query: 133 LSLLEILDLSFNSFHGPIPPTLQNCS---SLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189
+SLL +L + + G CS + +P G S ++++L
Sbjct: 15 VSLLSVLLMGCVAETGSAQTCPSVCSCSNQFSKVICVRKNLR-EVPD--GISTNTRLLNL 71
Query: 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIP 248
N + + + LE + L+ N + +I + L +L L N L
Sbjct: 72 HENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPN 129
Query: 249 SSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVD 308
+F L L+ L L N + I L+ L L + L I
Sbjct: 130 GAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL-GELKRLSY-------ISE--- 178
Query: 309 GGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQI 368
F+G L NLR NL I N KL+ L+L+ N +
Sbjct: 179 -----GAFEG--------LSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIR 223
Query: 369 PASLGNCKSLYFLDLSSNNLTGLLPE 394
P S L L + + + +
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERN 249
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 37/156 (23%), Positives = 54/156 (34%), Gaps = 11/156 (7%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIP 151
L N S A + LR L L + LS L L+L+ +
Sbjct: 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-- 200
Query: 152 PTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEH 211
P L L ++LSGN + P F Q + + + + + DN SL
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVE 259
Query: 212 ILLAANSLTGSIPPS-LGNCTELRSLLLSSNMLQGD 246
I LA N+LT +P L + L N +
Sbjct: 260 INLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNCN 294
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 592 DLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNL 651
+ N +P + + +L L N + + F L HL +L+L N++
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 652 TGRIPPG-FGTRSSLSIFDVSFNNLS 676
I G F ++L+ ++ N L+
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLT 125
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 8e-15
Identities = 46/310 (14%), Positives = 105/310 (33%), Gaps = 39/310 (12%)
Query: 108 DLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSG 167
+ L + + +L+ ++ + + + + +Q ++ + L+G
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNG 74
Query: 168 NQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL 227
N+ P + L N + + + L+ + L N ++ I L
Sbjct: 75 NKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLK---DLKKLKSLSLEHNGIS-DING-L 127
Query: 228 GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287
+ +L SL L +N + DI + +L L+ L L N +S I L +L+ L L
Sbjct: 128 VHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLS 183
Query: 288 N----DYGPLYSREHG---DLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNL 340
D L ++ +L Q ++ ++ + ++ N +
Sbjct: 184 KNHISDLRALAGLKNLDVLELFSQECLNKPINHQSN-------LVVPNTVK-----NTDG 231
Query: 341 EGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPC 400
+ P+ E N+ + P +++ ++ V+ P
Sbjct: 232 SLVTPEIISDDGDYEKPNVKWHL-----PEFTNEVSFIFYQPVTIGKAKARFHGRVTQPL 286
Query: 401 MAVFNVSQNL 410
V+ VS ++
Sbjct: 287 KEVYTVSYDV 296
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 7e-13
Identities = 41/200 (20%), Positives = 72/200 (36%), Gaps = 18/200 (9%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
N++ + G I L + L L N + PL L L L L N
Sbjct: 49 IANNSDIKSVQG-----IQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIKD 101
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVS 208
+ L++ L+ ++L N + I P + + L N ++
Sbjct: 102 -LSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI---TVLSRLTK 154
Query: 209 LEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
L+ + L N ++ I P L T+L++L LS N + D+ + L NL+VL+L
Sbjct: 155 LDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECL 210
Query: 269 GIVPSELGMCKQLKVLVLRN 288
+ + +
Sbjct: 211 NKPINHQSNLVVPNTVKNTD 230
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 5e-09
Identities = 41/181 (22%), Positives = 72/181 (39%), Gaps = 22/181 (12%)
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMG--SHCKCMKFLSMAGNEF 555
L S+ + S+D + N+ + + + + L + GN+
Sbjct: 28 LKKKSVT---DAVTQNELNSIDQI--IANNSDI-----KSVQGIQYLPNVTKLFLNGNKL 77
Query: 556 VGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
+ P TN +L L L N ++ S + ++ LK LSL N + L L
Sbjct: 78 TDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDING--LVHLP 131
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
LE L L N ++ + S+L L+ L L+ N ++ I P + L +S N++
Sbjct: 132 QLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI 187
Query: 676 S 676
S
Sbjct: 188 S 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 9e-07
Identities = 21/133 (15%), Positives = 48/133 (36%), Gaps = 17/133 (12%)
Query: 565 NFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSA 624
F NL + + + N++ + + + ++ ++ + L ++ L L+
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74
Query: 625 NSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSL 684
N L+ +I + L++L L LD N + + L + N +S
Sbjct: 75 NKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-------- 122
Query: 685 IKCENVQGNPNLQ 697
+ P L+
Sbjct: 123 -DINGLVHLPQLE 134
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-14
Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 12/200 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHP 857
F+ +G G FG G A+K L + + + V E R L +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHP 65
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
L L + + + Y GG L + T E + + ++ AL YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHS 123
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
V++RDIK N++LD + + ++DFGL + G S+ GT Y+APE
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 978 CRVSDKADVYSFGVVLLELI 997
D + GVV+ E++
Sbjct: 180 NDYGRAVDWWGLGVVMYEMM 199
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 54/284 (19%), Positives = 84/284 (29%), Gaps = 60/284 (21%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP-TLQNCSSLRLINLSGN 168
+L L N S + L L L L N I L+ + +S N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKN 112
Query: 169 QFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLT-GSIPPSL 227
IP + + N + VP+ ++ I + N L P
Sbjct: 113 HLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 228 GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287
+ +L L +S L IP L L L N + I +L +L L L
Sbjct: 169 FDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLG 225
Query: 288 NDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN 347
+ N I + N L
Sbjct: 226 H-------------------------N--------QIRMIEN-GSLS----FL------- 240
Query: 348 WELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
L L+L +N + ++PA L + K L + L +NN+T +
Sbjct: 241 ----PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 50/274 (18%), Positives = 83/274 (30%), Gaps = 58/274 (21%)
Query: 29 SCSWHGVTCD---------PLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPC 79
C V C +S T L+L +N + L F
Sbjct: 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNN------DISELRKDD-----FK----- 75
Query: 80 LQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEIL 139
L + +N K+S +A L +L+ L ++ N + S L L
Sbjct: 76 -GLQHLYALVLVNN---KISKIHEKAFSPLRKLQKLYISKNHLVE---IPPNLPSSLVEL 128
Query: 140 DLSFNSFHGPIPP-TLQNCSSLRLINLSGNQF-NGTIPAFFGQSPGFQVVSLSFNLLSG- 196
+ N +P ++ I + GN N + +S L+G
Sbjct: 129 RIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI 187
Query: 197 -------------------SVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSL 236
++ E L + L N + I SL LR L
Sbjct: 188 PKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLREL 246
Query: 237 LLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI 270
L +N L +P+ L L+V+ L N ++ +
Sbjct: 247 HLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 34/160 (21%), Positives = 58/160 (36%), Gaps = 10/160 (6%)
Query: 519 DGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNH 578
+ + L VP ++ L + N+ L F L L L N
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPD---TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK 89
Query: 579 LQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE-FSK 637
+ + + L+ L +S N+ IP L +SL L + N + ++P FS
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSG 145
Query: 638 LEHLNVLRLDHNNLT-GRIPPGFGTRSSLSIFDVSFNNLS 676
L ++N + + N L PG L+ +S L+
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 57/303 (18%), Positives = 90/303 (29%), Gaps = 47/303 (15%)
Query: 98 LSGNL-----SRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP 152
L N L L L+L N S L L+ L +S N IPP
Sbjct: 61 LQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPP 119
Query: 153 TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212
L SSL + + N+ F + + N L S E + + L ++
Sbjct: 120 NL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL 177
Query: 213 LLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPS-SFGQLVNLEVLDLSRNFLSGIV 271
++ LT IP L L L L N +Q I + L L L N + I
Sbjct: 178 RISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIE 233
Query: 272 PSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLR 331
L L+ L L D L +P + L L+
Sbjct: 234 NGSLSFLPTLRELHL--DNNKLSR------------------------VPAGLPDLKLLQ 267
Query: 332 VFWAPNLNLEGIFP------QNWELCSKLEMLNLAHNFFT-GQIPASLGNC-KSLYFLDL 383
V + N+ + + ++L +N ++ + C +
Sbjct: 268 VVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQF 327
Query: 384 SSN 386
+
Sbjct: 328 GNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 55/308 (17%), Positives = 110/308 (35%), Gaps = 45/308 (14%)
Query: 354 LEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEE-VSVPCMAVFNVSQNLLS 412
+L+L +N + + LY L L +N ++ + + + + +S+N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 413 GEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAP--FSSPSNGLFILHDFS 470
EIP S S+ ++ + ++N + FS N + +
Sbjct: 116 -EIPPNLPS---------SLVELRI--------HDNRIRKVPKGVFSGLRN-MNCIEMGG 156
Query: 471 NNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKL 530
N L P D L+ +S L+ P DL +L+ L + +NK
Sbjct: 157 NPLENSGFEPGAFDGLKLNY-----LRISEA----KLTGIPKDLPETLNEL--HLDHNK- 204
Query: 531 IGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKM 590
I + + + L + N+ + S + +LR L+L N L +P+ + +
Sbjct: 205 IQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDL 263
Query: 591 EDLKFLSLSLNNFTGAIP-------WELTQLASLEVLELSANSLS-GEIPSE-FSKLEHL 641
+ L+ + L NN T + + A + L N + E+ F +
Sbjct: 264 KLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR 322
Query: 642 NVLRLDHN 649
++ +
Sbjct: 323 LAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 35/188 (18%), Positives = 68/188 (36%), Gaps = 17/188 (9%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKL-IGEVPSDMGSHCKCMKFLSMAGNEF 555
+ N ++ + F +++ + ++G N L K + +L ++ +
Sbjct: 129 RIHDNRIR-KVPKGVFSGLRNMNCI--EMGGNPLENSGFEPGAFDGLK-LNYLRISEAKL 184
Query: 556 VGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
G+ L L+L N +Q + + L L L N L+ L
Sbjct: 185 TGIPKDLPET---LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP 241
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG-------FGTRSSLSIF 668
+L L L N LS +P+ L+ L V+ L NN+T ++ R+ +
Sbjct: 242 TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGI 299
Query: 669 DVSFNNLS 676
+ N +
Sbjct: 300 SLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 46/219 (21%), Positives = 75/219 (34%), Gaps = 34/219 (15%)
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNML 243
+VV S L +VP+E + L+ L N ++ + L +L+L +N +
Sbjct: 36 RVVQCSDLGLK-AVPKEISPDTTLLD---LQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 244 QGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN---------DYGPLY 294
+F L L+ L +S+N L I P + L L + + + L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPP---NLPSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 295 SREHGDLPIQPVVDGGEDYN-FFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSK 353
+ ++ N + G L L GI P++ L
Sbjct: 148 NMNCIEM----------GGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI-PKD--LPET 194
Query: 354 LEMLNLAHNFFTGQIPA-SLGNCKSLYFLDLSSNNLTGL 391
L L+L HN I L LY L L N + +
Sbjct: 195 LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMI 232
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 33/191 (17%), Positives = 56/191 (29%), Gaps = 23/191 (12%)
Query: 208 SLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267
L + + L ++P + + L L +N + F L +L L L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 268 SGIVPSELGMCKQLKVLVLRN------DYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLP 321
S I ++L+ L + S + N
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRI----------HDNRIRKVPK 140
Query: 322 DSITRLPNLRVFW-APNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYF 380
+ L N+ N F KL L ++ T IP L ++L
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNE 197
Query: 381 LDLSSNNLTGL 391
L L N + +
Sbjct: 198 LHLDHNKIQAI 208
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 46/231 (19%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA----EIRTLGRVQ-H 856
+ + +G G +G +K+ + G VVAVK++ FQ A EI L + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQN-STDAQRTFREIMILTELSGH 68
Query: 857 PNLVTLIGYHVSEAEMF----LIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVAR 910
N+V L +V A+ L+++Y+ +L I R +HK + + +
Sbjct: 69 ENIVNL--LNVLRADNDRDVYLVFDYM-ETDLHAVI-----RANILEPVHKQYVVYQLIK 120
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--- 967
+ YLH +LHRD+KPSNILL+ + ++DFGL+R
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 968 -----------GYV------APEYAMTCRVSDKA-DVYSFGVVLLELISDK 1000
YV APE + K D++S G +L E++ K
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 42/184 (22%), Positives = 74/184 (40%), Gaps = 15/184 (8%)
Query: 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN 164
+ L L L L N + PL+ L+ + L+LS N + S++ ++
Sbjct: 58 GVQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGNPLKNVSA--IAGLQSIKTLD 113
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP 224
L+ Q P QV+ L N ++ P +L+++ + ++ +
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA---GLTNLQYLSIGNAQVS-DLT 167
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
P L N ++L +L N + DI S L NL + L N +S + S L L ++
Sbjct: 168 P-LANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIV 222
Query: 285 VLRN 288
L N
Sbjct: 223 TLTN 226
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 41/200 (20%), Positives = 74/200 (37%), Gaps = 20/200 (10%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
++ DL + L G + + + L+ L L+L N
Sbjct: 25 AAGKSNVTDTVT-----QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD 77
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVS 208
+ P L+N + + + LSGN + A + + L+ ++ P +
Sbjct: 78 -LAP-LKNLTKITELELSGNPLK-NVSAI-AGLQSIKTLDLTSTQITDVTPLA---GLSN 130
Query: 209 LEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
L+ + L N +T +I P L T L+ L + + + D+ + L L L N +S
Sbjct: 131 LQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS 186
Query: 269 GIVPSELGMCKQLKVLVLRN 288
I S L L + L+N
Sbjct: 187 DI--SPLASLPNLIEVHLKN 204
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 13/170 (7%)
Query: 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINL 165
+ +LT++ L L+ N + L ++ LDL+ P L S+L+++ L
Sbjct: 81 LKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYL 136
Query: 166 SGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP 225
NQ P Q +S+ +S P N L + N ++ I P
Sbjct: 137 DLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLA---NLSKLTTLKADDNKIS-DISP 190
Query: 226 SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL 275
L + L + L +N + D+ S NL ++ L+ ++
Sbjct: 191 -LASLPNLIEVHLKNNQIS-DV-SPLANTSNLFIVTLTNQTITNQPVFYN 237
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 44/240 (18%), Positives = 84/240 (35%), Gaps = 42/240 (17%)
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
++ I + T+ G +S ++ E +L +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI---EGVQYLNNLIGLE 69
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPS 273
L N +T + P L N T++ L LS N L+ ++ S+ L +++ LDL+ ++ + +
Sbjct: 70 LKDNQIT-DLAP-LKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDV--T 123
Query: 274 ELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVF 333
L L+VL L + I + + L NL+
Sbjct: 124 PLAGLSNLQVLYLDLN------------QITNI---------------SPLAGLTNLQYL 156
Query: 334 WAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLP 393
N + + SKL L N + I L + +L + L +N ++ + P
Sbjct: 157 SIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP 212
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 34/181 (18%), Positives = 74/181 (40%), Gaps = 22/181 (12%)
Query: 498 LSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMG--SHCKCMKFLSMAGNEF 555
G + + +L GL ++ +N++ +D+ + + L ++GN
Sbjct: 48 AFGTGVT-TIE--GVQYLNNLIGL--ELKDNQI-----TDLAPLKNLTKITELELSGNPL 97
Query: 556 VGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
+ S++ L+L+ + + + + +L+ L L LN T P L L
Sbjct: 98 KNVSA--IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP--LAGLT 151
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
+L+ L + +S ++ + + L L L+ D N ++ I P + +L + N +
Sbjct: 152 NLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQI 207
Query: 676 S 676
S
Sbjct: 208 S 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 41/281 (14%), Positives = 88/281 (31%), Gaps = 65/281 (23%)
Query: 372 LGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWS 431
+ + +N+T + + + + + ++ I + +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA-DLDGITTLSAFGTGVT-TIEGVQY----------- 61
Query: 432 MSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSR 491
L +N +T AP + + + L
Sbjct: 62 -----LNNLIGLELKDNQITDLAPLKNLTK-ITEL------------------------- 90
Query: 492 PYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMA 551
LSGN LK N+S S+ L D+ + ++ P + ++ L +
Sbjct: 91 -----ELSGNPLK-NVS--AIAGLQSIKTL--DLTSTQITDVTPL---AGLSNLQVLYLD 137
Query: 552 GNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWEL 611
N+ + P +L+ L++ + P + + L L N + P L
Sbjct: 138 LNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--L 191
Query: 612 TQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
L +L + L N +S S + +L ++ L + +T
Sbjct: 192 ASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 46/217 (21%), Positives = 88/217 (40%), Gaps = 32/217 (14%)
Query: 805 VQNCIGSGGFGATYKAE-IIPGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQ------- 855
+ +G G F + A+ ++ VA+K + + + EI+ L RV
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADNTKE 80
Query: 856 ----HPNLVTLIG--YHVSEAE--MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
+++ L+ H + +++ L G NL I+ R + + +I+
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY------LSDFGLARLLGTSETHATT 961
+ L Y+H C ++H DIKP N+L++ + ++D G A T
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYT 193
Query: 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ T Y +PE + AD++S ++ ELI+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 48/201 (23%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRV-QHP 857
F++ IG G + + + A+K + V + + E + HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
LV L +E+ +F + Y+ GG+L +Q + + E + + + +++ AL YLH+
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLHE 128
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+++RD+K N+LLD+ + L+D+G+ + G T+ GT Y+APE
Sbjct: 129 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG 184
Query: 978 CRVSDKADVYSFGVVLLELIS 998
D ++ GV++ E+++
Sbjct: 185 EDYGFSVDWWALGVLMFEMMA 205
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 3e-13
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRV-QHP 857
FN +G G FG +E + AVK L V + V+ E R L + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVAR 910
L L + ++ + Y+ GG+L +F + A ++A
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF---------YAAEIAI 453
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
L +L + +++RD+K N++LD+ + ++DFG+ + + T GT Y+
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 509
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELI 997
APE D ++FGV+L E++
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRV-QHP 857
FN +G G FG +E + AVK L V + V+ E R L + P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVAR 910
L L + ++ + Y+ GG+L +F + A ++A
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF---------YAAEIAI 132
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
L +L + +++RD+K N++LD+ + ++DFG+ + + T GT Y+
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 188
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELI 997
APE D ++FGV+L E++
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 5e-13
Identities = 48/310 (15%), Positives = 87/310 (28%), Gaps = 31/310 (10%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSL 60
+ L + + E L + + + D V + L
Sbjct: 242 HDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWL 301
Query: 61 LSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFN 120
LP A+ F + + R QL L+
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC--WCRDSATDEQLFRCELSVE 359
Query: 121 GFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNG-------- 172
S L E+ L+ L+ I ++ L + F+
Sbjct: 360 -KSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418
Query: 173 -------------TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSL 219
+ +V+ L+ L+ + + + + H+ L+ N L
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRL 475
Query: 220 TGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI-VPSELGMC 278
++PP+L L L S N L+ ++ L L+ L L N L L C
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSC 532
Query: 279 KQLKVLVLRN 288
+L +L L+
Sbjct: 533 PRLVLLNLQG 542
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 1e-10
Identities = 51/299 (17%), Positives = 92/299 (30%), Gaps = 31/299 (10%)
Query: 421 SECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPP 480
E + +SV +S T + + +P H + +L +
Sbjct: 252 REEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLND 311
Query: 481 FLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGS 540
L LK + D ++ K + S++ S
Sbjct: 312 QLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELES 370
Query: 541 HCKCMKF------------LSMAGNEFVGLIPQSFTNFDSLRNLN--------LSRNHLQ 580
+ + L M + + ++ F +L+ ++ R+
Sbjct: 371 CKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFL 430
Query: 581 GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEH 640
+ D++ L L+ + T + L QL + L+LS N L +P + L
Sbjct: 431 LENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRC 487
Query: 641 LNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCE-----NVQGNP 694
L VL+ N L + G L + N L SA L+ C N+QGN
Sbjct: 488 LEVLQASDNALE-NV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 2e-09
Identities = 43/269 (15%), Positives = 71/269 (26%), Gaps = 68/269 (25%)
Query: 126 LPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFF---GQSP 182
+ L +LS + L++C L+ + TI
Sbjct: 341 WCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 183 GFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNM 242
+ F+ L P L ++R L L+
Sbjct: 400 YEKETLQYFSTLKAVDPMRAAYLDDLRSKFL-------LENSVLKMEYADVRVLHLAHKD 452
Query: 243 LQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLP 302
L + QL+ + LDLS N L + P L + L+VL +
Sbjct: 453 LT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASD-------------- 495
Query: 303 IQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHN 362
N + + + +L+ L L +N
Sbjct: 496 -----------NA--------LENVDGV------------------ANLPRLQELLLCNN 518
Query: 363 FFTGQIPA--SLGNCKSLYFLDLSSNNLT 389
Q A L +C L L+L N+L
Sbjct: 519 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 5e-09
Identities = 37/218 (16%), Positives = 72/218 (33%), Gaps = 19/218 (8%)
Query: 80 LQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEIL 139
L + + S +L L + +L+ A + + S L+ +
Sbjct: 356 LSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALD-PLLYEKETLQYFSTLKAV 414
Query: 140 D--------LSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSF 191
D + F + +R+++L+ T+ Q + LS
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSH 472
Query: 192 NLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG-DIPSS 250
N L ++P LE + + N+L ++ + N L+ LLL +N LQ
Sbjct: 473 NRLR-ALPPALA-ALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQP 528
Query: 251 FGQLVNLEVLDLSRNFLSGIVPSE---LGMCKQLKVLV 285
L +L+L N L + M + ++
Sbjct: 529 LVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 1e-06
Identities = 30/175 (17%), Positives = 53/175 (30%), Gaps = 24/175 (13%)
Query: 237 LLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPL--- 293
+ L +LS + ++ SEL CK+L+ L N + L
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII 389
Query: 294 -YSREHGDLP----------------IQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAP 336
R L + + F ++RV
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
+ +L + + E + L+L+HN +P +L + L L S N L +
Sbjct: 450 HKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV 501
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 7e-05
Identities = 24/137 (17%), Positives = 42/137 (30%), Gaps = 8/137 (5%)
Query: 506 NLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTN 565
L D + + + L + + L ++ N +P +
Sbjct: 429 FLLENSVLKMEYADVRVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLRA-LPPALAA 484
Query: 566 FDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG-AIPWELTQLASLEVLELSA 624
L L S N L+ + + + L+ L L N A L L +L L
Sbjct: 485 LRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542
Query: 625 NSLSGEIPSEFSKLEHL 641
NSL + +L +
Sbjct: 543 NSLC-QEEGIQERLAEM 558
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 47/201 (23%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRV-QHP 857
F++ IG G + + + A++ + V + + E + HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
LV L +E+ +F + Y+ GG+L +Q + + E + + + +++ AL YLH+
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLHE 171
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+++RD+K N+LLD+ + L+D+G+ + G T+ GT Y+APE
Sbjct: 172 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 978 CRVSDKADVYSFGVVLLELIS 998
D ++ GV++ E+++
Sbjct: 228 EDYGFSVDWWALGVLMFEMMA 248
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-13
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRV 854
F + +G G FG A +K A+K L + V+ E R L
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDD-VECTMVEKRVLSLA 74
Query: 855 -QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
+HP L + ++ +F + YL GG+L IQ + + + + A ++ L
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQ 132
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH + +++RD+K NILLD + + ++DFG+ + T GT Y+APE
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPE 188
Query: 974 YAMTCRVSDKADVYSFGVVLLELI 997
+ + + D +SFGV+L E++
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEML 212
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 36/149 (24%), Positives = 61/149 (40%), Gaps = 12/149 (8%)
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
L ++ S + F+ L E+ +D + + L + VA+ + +
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV---- 970
L + +HRD+ NILL + DFGLAR + + V +
Sbjct: 209 LASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKW 261
Query: 971 -APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + ++DV+SFGV+L E+ S
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 23/97 (23%), Positives = 40/97 (41%), Gaps = 9/97 (9%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLV 860
+G G FG +A+ VAVK L G + +E++ L + H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 861 TLIGYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTV 896
L+G + +I + GNL +++ + V
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 126
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS----VGRFQGVQQFAAEIRTLGRV-QH 856
F +G G FG A + G + AVK L + V+ E R L H
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD-VECTMTEKRILSLARNH 83
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P L L + +F + ++ GG+L IQ R + + A ++ AL +LH
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEIISALMFLH 141
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
D+ +++RD+K N+LLD+ + L+DFG+ + G T GT Y+APE
Sbjct: 142 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQ 197
Query: 977 TCRVSDKADVYSFGVVLLELI 997
D ++ GV+L E++
Sbjct: 198 EMLYGPAVDWWAMGVLLYEML 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 39/212 (18%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGR-V 854
F+ IG G FG A +KAE V AVK L + + + + +E L + V
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 855 QHPNLVTLIGYHVS---EAEMFLIYNYLPGGNL-------EKFIQDRPR-RTVEWSMLHK 903
+HP LV L H S +++ + +Y+ GG L F++ R R E
Sbjct: 97 KHPFLVGL---HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE------ 147
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
IA AL YLH +++RD+KP NILLD+ + L+DFGL + T+
Sbjct: 148 IAS----ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTF 199
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLE 995
GT Y+APE D + G VL E
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 32/180 (17%), Positives = 67/180 (37%), Gaps = 15/180 (8%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168
+ L + + +L+ ++ + + + + +Q ++ + L+GN
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGN 78
Query: 169 QFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG 228
+ P + L N + + + L+ + L N ++ I L
Sbjct: 79 KLTDIKP--LANLKNLGWLFLDENKVKDLSSLK---DLKKLKSLSLEHNGIS-DING-LV 131
Query: 229 NCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
+ +L SL L +N + DI + +L L+ L L N +S I L +L+ L L
Sbjct: 132 HLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSK 187
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 45/200 (22%), Positives = 73/200 (36%), Gaps = 20/200 (10%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
N+ S +L + ++ + ++ L + L L+ N
Sbjct: 30 NLKKKSVTDAVT-----QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKLTD 82
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVS 208
I P L N +L + L N+ + +SL N +S + +
Sbjct: 83 -IKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DI--NGLVHLPQ 135
Query: 209 LEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
LE + L N +T I L T+L +L L N + DI L L+ L LS+N +S
Sbjct: 136 LESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS 191
Query: 269 GIVPSELGMCKQLKVLVLRN 288
+ L K L VL L +
Sbjct: 192 DL--RALAGLKNLDVLELFS 209
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 41/200 (20%), Positives = 72/200 (36%), Gaps = 18/200 (9%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
N++ + G I L + L L N + PL L L L L N
Sbjct: 52 IANNSDIKSVQG-----IQYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVKD 104
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVS 208
+ L++ L+ ++L N + I P + + L N ++
Sbjct: 105 -LSS-LKDLKKLKSLSLEHNGIS-DINGL-VHLPQLESLYLGNNKITDI---TVLSRLTK 157
Query: 209 LEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
L+ + L N ++ I P L T+L++L LS N + D+ + L NL+VL+L
Sbjct: 158 LDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECL 213
Query: 269 GIVPSELGMCKQLKVLVLRN 288
+ + +
Sbjct: 214 NKPINHQSNLVVPNTVKNTD 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 42/209 (20%), Positives = 73/209 (34%), Gaps = 40/209 (19%)
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ 244
+L ++ +V + S++ I+ + + S+ + + L L+ N L
Sbjct: 27 IKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT 81
Query: 245 GDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQ 304
DI L NL L L N + + L K+LK L L ++ I
Sbjct: 82 -DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNG------------IS 125
Query: 305 PVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFF 364
+ + + LP L + N + I +KL+ L+L N
Sbjct: 126 DI---------------NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 168
Query: 365 TGQIPASLGNCKSLYFLDLSSNNLTGLLP 393
+ I L L L LS N+++ L
Sbjct: 169 S-DIV-PLAGLTKLQNLYLSKNHISDLRA 195
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 33/176 (18%), Positives = 56/176 (31%), Gaps = 26/176 (14%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ--G 581
++ + V + + + ++ + Q ++ L L+ N L
Sbjct: 30 NLKKKSVTDAVTQ---NELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIK 84
Query: 582 PLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHL 641
PL + N L +L L N L L L+ L L N +S +I L L
Sbjct: 85 PLANLKN----LGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQL 136
Query: 642 NVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQ 697
L L +N +T + L + N +S + G LQ
Sbjct: 137 ESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS---------DIVPLAGLTKLQ 181
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 19/112 (16%), Positives = 42/112 (37%), Gaps = 8/112 (7%)
Query: 565 NFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSA 624
F NL + + + N++ + + + ++ + L ++ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 625 NSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676
N L+ +I + L++L L LD N + + L + N +S
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 32/158 (20%), Positives = 60/158 (37%), Gaps = 18/158 (11%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMG--SHCKCMKFLSMAGNE 554
+L N +K L L + +N + SD+ H ++ L + N+
Sbjct: 96 FLDENKVK---DLSSLKDLKKLKSL--SLEHNGI-----SDINGLVHLPQLESLYLGNNK 145
Query: 555 FVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQL 614
+ + L L+L N + +P + + L+ L LS N+ + L L
Sbjct: 146 ITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRA--LAGL 199
Query: 615 ASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
+L+VLEL + + + S L N ++ +L
Sbjct: 200 KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 43/168 (25%), Positives = 66/168 (39%), Gaps = 26/168 (15%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ + IGSG FG Y I G VA+K Q E + +Q +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 862 LIGYHVSEAEMFLIYNYLP----GGNLEKFIQDRPRR----TVEWSMLHKIALDVARALA 913
I + +E + YN + G +LE R+ TV +A + +
Sbjct: 69 TIRWCGAEGD----YNVMVMELLGPSLEDLFNFCSRKFSLKTVLL-----LADQMISRIE 119
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNA---YLSDFGLARLLGTSETH 958
Y+H + +HRD+KP N L+ Y+ DFGLA+ + TH
Sbjct: 120 YIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 39/195 (20%), Positives = 78/195 (40%), Gaps = 12/195 (6%)
Query: 103 SRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIPP-TLQNCSSL 160
S A +L + + ++ + +L LS + +++ I P L+ L
Sbjct: 48 SHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLL 107
Query: 161 RLINLSGNQFNGTIPA--FFGQSPGFQVVSLSFNLLSGSVPEE-FGDNCVSLEHILLAAN 217
+ + + P + F ++ ++ N S+P F C + L N
Sbjct: 108 KFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166
Query: 218 SLTGSIPPSLGNCTELRSLLLSSNMLQGDIPS-SFGQLVN-LEVLDLSRNFLSGIVPSEL 275
T S+ N T+L ++ L+ N I +FG + + +LD+S+ ++ + PS
Sbjct: 167 GFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PS-- 222
Query: 276 GMCKQLKVLVLRNDY 290
+ LK L+ RN +
Sbjct: 223 KGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 27/188 (14%), Positives = 64/188 (34%), Gaps = 14/188 (7%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
L L+ + ++ F ++ + + + + ++ S + + + + +
Sbjct: 37 KLIETHLR-TIPSHAFSNLPNISRI--YVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNL 93
Query: 557 GLIPQS-FTNFDSLRNLNLSRNHLQG-PLPSYINKMEDLKFLSLSLNNFTGAIP----WE 610
I L+ L + L+ P + + + L ++ N + +IP
Sbjct: 94 TYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
Query: 611 LTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG--FGTRSSLSIF 668
L L+L N + + L+ + L+ N I G S S+
Sbjct: 154 LCNE--TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 669 DVSFNNLS 676
DVS +++
Sbjct: 211 DVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 40/242 (16%), Positives = 70/242 (28%), Gaps = 60/242 (24%)
Query: 158 SSLRLINLSGNQFNGTIPAF-FGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA 216
S + + L TIP+ F P + +S ++ + N + HI +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 217 NSLTGSIPPS-LGNCTELRSLLLSSNMLQGDIP--SSFGQLVNLEVLDLSRNFLSGIVPS 273
I P L L+ L + + L+ P + +L+++ N +P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 274 EL--GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLR 331
G+C + L L N N T +
Sbjct: 149 NAFQGLCNETLTLKLYN-------------------------N--------GFTSVQ--- 172
Query: 332 VFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASL--GNCKSLYFLDLSSNNLT 389
F +KL+ + L N + I G LD+S ++T
Sbjct: 173 ---------GYAFNG-----TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
Query: 390 GL 391
L
Sbjct: 219 AL 220
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 19/138 (13%), Positives = 43/138 (31%), Gaps = 7/138 (5%)
Query: 545 MKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRN-HLQGPLPSYINKMEDLKFLSLSLNNF 603
+ L + + +F+N ++ + +S + LQ + + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 604 TGAIPWE-LTQLASLEVLELSANSLSGEIPSE--FSKLEHLNVLRLDHNNLTGRIPPG-- 658
I + L +L L+ L + L P + +L + N IP
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 659 FGTRSSLSIFDVSFNNLS 676
G + + N +
Sbjct: 152 QGLCNETLTLKLYNNGFT 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 26/167 (15%), Positives = 60/167 (35%), Gaps = 9/167 (5%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
++S + L ++ F + + +I N + + + D +KFL +
Sbjct: 61 YVSIDVTLQQLESHSFYNLSKVTHI--EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
Query: 557 GLIPQSF-TNFDSLRNLNLSRNHLQGPLP--SYINKMEDLKFLSLSLNNFTGAIPWELTQ 613
+ + D L ++ N +P ++ + L L N FT ++
Sbjct: 119 MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFN 177
Query: 614 LASLEVLELSANSLSGEIPSE-FSKL-EHLNVLRLDHNNLTGRIPPG 658
L+ + L+ N I + F + ++L + ++T +P
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK 223
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 11/87 (12%), Positives = 26/87 (29%), Gaps = 2/87 (2%)
Query: 592 DLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNN 650
+ L L + + L ++ + +S + ++ S F L + + + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 651 LTGRIPPG-FGTRSSLSIFDVSFNNLS 676
I P L + L
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 33/203 (16%), Positives = 65/203 (32%), Gaps = 49/203 (24%)
Query: 208 SLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPS-SFGQLVNLEVLDLSRN 265
S + + L L +IP + N + + +S ++ + S SF L + +++
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 266 -FLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSI 324
L+ I P L LK L + N +
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFN-------------------------T--------GL 117
Query: 325 TRLPNLRVFWAPNLNLEGIFPQNWE-----------LCSKLEMLNLAHNFFTGQIPASLG 373
P+L ++ ++ N LC++ L L +N FT +
Sbjct: 118 KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAF 176
Query: 374 NCKSLYFLDLSSNNLTGLLPEEV 396
N L + L+ N ++ ++
Sbjct: 177 NGTKLDAVYLNKNKYLTVIDKDA 199
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 41/175 (23%), Positives = 67/175 (38%), Gaps = 35/175 (20%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLV------- 860
IGSGGFG Y A A + V Q +E++ RV + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 861 --------TLIGYHVSEAEM----FLIYNYLPGGNLEKFIQDRPR---RTVEWSMLHKIA 905
G ++E + F++ L G +L+K TV ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV-----LQLG 157
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLD--NNLNAYLSDFGLARLLGTSETH 958
+ + L Y+H+ +H DIK +N+LL N YL+D+GL+ + H
Sbjct: 158 IRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 43/177 (24%), Positives = 66/177 (37%), Gaps = 36/177 (20%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLI--- 863
IG GGFG Y A++ V V + E++ R P +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 864 --------------GYHVSEAEM--FLIYNYLPGGNLEKFIQDRPRR----TVEWSMLHK 903
G H + F+I + G +L+K + +R TV +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTV-----LQ 156
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLD--NNLNAYLSDFGLARLLGTSETH 958
++L + L Y+H+ +H DIK SN+LL+ N YL D+GLA H
Sbjct: 157 LSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 6/157 (3%)
Query: 136 LEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFNLL 194
+ LDLSFN + + L++++LS + TI + + L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 195 SGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL-GNCTELRSLLLSSNMLQG-DIPSSFG 252
S+ SL+ ++ +L S+ G+ L+ L ++ N++Q +P F
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 253 QLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRND 289
L NLE LDLS N + I ++L + Q+ +L L D
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 13/168 (7%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
LS ++ + + L L + N + + S ++ L
Sbjct: 58 DLSRCEIQ-TIEDGAYQSLSHLSTL--ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQG-PLPSYINKMEDLKFLSLSLNNFTGAIP----WEL 611
L + +L+ LN++ N +Q LP Y + + +L+ L LS N +I L
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172
Query: 612 TQLASLEV-LELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG 658
Q+ L + L+LS N ++ P F ++ L L LD N L +P G
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLK-SVPDG 218
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 51/242 (21%), Positives = 83/242 (34%), Gaps = 34/242 (14%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
LS N L+ +L +Y F L L D+ + I + + L + GN
Sbjct: 34 DLSFNPLR-HLGSYSFFSFPELQVL--DLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWE--LTQ 613
L +F+ SL+ L +L L ++ ++ LK L+++ N + +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN 147
Query: 614 LASLEVLELSANSLSGEIPSE-FSKLEHLNV----LRLDHNNLTGRIPPGFGTRSSLSIF 668
L +LE L+LS+N + I L + + L L N + I PG L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 669 DVSFNNLSGSAPRNSLIKCENVQGNPNLQL-----------CHTDPSSSEWERQHSGNVS 717
+ N L S P +LQ C S W ++S
Sbjct: 206 ALDTNQLK-SVPDGIF------DRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQ 258
Query: 718 QQ 719
Sbjct: 259 GS 260
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 33/135 (24%), Positives = 58/135 (42%), Gaps = 7/135 (5%)
Query: 546 KFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFT 604
K L ++ N L SF +F L+ L+LSR +Q + + L L L+ N
Sbjct: 31 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ 89
Query: 605 GAIPWEL-TQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGT 661
++ + L+SL+ L +L+ + + L+ L L + HN + P F
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 662 RSSLSIFDVSFNNLS 676
++L D+S N +
Sbjct: 148 LTNLEHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 44/192 (22%), Positives = 72/192 (37%), Gaps = 21/192 (10%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIG---QLSLLEILDLSFNSFHGPIPP-TLQNCSSLRLIN 164
+L+VL L+ +E G LS L L L+ N + SSL+ +
Sbjct: 51 FPELQVLDLSRCEIQT---IEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLV 106
Query: 165 LSGNQFNGTIPAF-FGQSPGFQVVSLSFNLLSGSVPEE--FGDNCVSLEHILLAANSLTG 221
++ F G + ++++ NL+ S F N +LEH+ L++N +
Sbjct: 107 AVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYF-SNLTNLEHLDLSSNKIQ- 162
Query: 222 SIPP----SLGNCTELR-SLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELG 276
SI L L SL LS N + I + + L+ L L N L +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFD 221
Query: 277 MCKQLKVLVLRN 288
L+ + L
Sbjct: 222 RLTSLQKIWLHT 233
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 9e-08
Identities = 34/165 (20%), Positives = 64/165 (38%), Gaps = 11/165 (6%)
Query: 108 DLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIPP-TLQNCSSLRLINL 165
L+ L L+L N L L LS L+ L + + + + +L+ +N+
Sbjct: 74 SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNV 131
Query: 166 SGNQF-NGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLE----HILLAANSLT 220
+ N + +P +F + + LS N + S+ + + L+ N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 221 GSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265
I P L+ L L +N L+ F +L +L+ + L N
Sbjct: 191 -FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 45/246 (18%), Positives = 74/246 (30%), Gaps = 53/246 (21%)
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
C L IP + + LSFN L F + L+ + L+
Sbjct: 13 QCMELNFY---------KIPD--NLPFSTKNLDLSFNPLRHLGSYSF-FSFPELQVLDLS 60
Query: 216 ANSLTGSIPPSL-GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSE 274
+ +I + + L +L+L+ N +Q +F L +L+ L L+ +
Sbjct: 61 RCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 275 LGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW 334
+G K LK L + IQ +F L NL
Sbjct: 120 IGHLKTLKELNV------------AHNLIQSFKLPE----YFSN--------LTNLEH-- 153
Query: 335 APNLNL---------EGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSS 385
L+L ++ L+L+ N I L L L +
Sbjct: 154 ---LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDT 209
Query: 386 NNLTGL 391
N L +
Sbjct: 210 NQLKSV 215
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 43/180 (23%), Positives = 64/180 (35%), Gaps = 7/180 (3%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
+L L+ N + + L L+L L ++LS NQ
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQ 88
Query: 170 FNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL-G 228
++P P V+ +SFN L+ S+P L+ + L N L ++PP L
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLT 145
Query: 229 NCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
+L L L++N L L NL+ L L N L I G L L
Sbjct: 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGS-HLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 50/214 (23%), Positives = 78/214 (36%), Gaps = 14/214 (6%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
+ N + + L++ E L Q L L+LS N LQ L
Sbjct: 37 HLSENL-LYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQS-L 92
Query: 584 PSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHLN 642
P + L L +S N T L L L+ L L N L +P + L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLE 151
Query: 643 VLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLSGSAPR----NSLIKCENVQGNPNLQ 697
L L +NNLT +P G +L + N+L + P+ + L+ + GNP L
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209
Query: 698 LCHTDPSSSEWERQHSGNVSQQEAYSPSESIQGN 731
C W + ++ NV + +++ N
Sbjct: 210 NCEILYFR-RWLQDNAENVYVWKQGVDVKAMTSN 242
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 12/179 (6%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
LS N L S L L ++ +L ++ D + L ++ N+
Sbjct: 37 HLSENLLY-TFSLATLMPYTRLTQL--NLDRAEL-TKLQVD--GTLPVLGTLDLSHNQLQ 90
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWELTQLA 615
L P +L L++S N L LP + +L+ L L N P LT
Sbjct: 91 SL-PLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 616 SLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFN 673
LE L L+ N+L+ E+P+ + LE+L+ L L N+L IP GF L + N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 30/139 (21%), Positives = 46/139 (33%), Gaps = 10/139 (7%)
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209
+P ++LS N A ++L L+ + L
Sbjct: 29 LPKDTTI------LHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--DGTLPVL 79
Query: 210 EHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269
+ L+ N L S+P L L +S N L + L L+ L L N L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 270 IVPSELGMCKQLKVLVLRN 288
+ P L +L+ L L N
Sbjct: 139 LPPGLLTPTPKLEKLSLAN 157
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 29/112 (25%), Positives = 39/112 (34%), Gaps = 5/112 (4%)
Query: 566 FDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSAN 625
L+LS N L + + L L+L T + L L L+LS N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHN 87
Query: 626 SLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLS 676
L +P L L VL + N LT +P G L + N L
Sbjct: 88 QLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 33/136 (24%), Positives = 49/136 (36%), Gaps = 7/136 (5%)
Query: 153 TLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212
+ +S +N +P ++ LS NLL L +
Sbjct: 5 EVSKVASHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATL-MPYTRLTQL 60
Query: 213 LLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVP 272
L LT + G L +L LS N LQ +P L L VLD+S N L+ +
Sbjct: 61 NLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 273 SELGMCKQLKVLVLRN 288
L +L+ L L+
Sbjct: 118 GALRGLGELQELYLKG 133
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 28/172 (16%), Positives = 61/172 (35%), Gaps = 26/172 (15%)
Query: 809 IGSGGFGATYKAE---------IIPGVVVAVK-------RLSVGRFQGVQQFAAEIRTLG 852
G Y+A ++K + F ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 853 RVQHPNLV---TLIGYHVSEAEM-FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
++ L+ T +G+ V + + FL+ L G +L+ + P+ + + ++A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL 168
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILL--DNNLNAYLSDFGLARLLGTSETH 958
AL +LH+ +H ++ NI + ++ L+ +G A S H
Sbjct: 169 LDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHP--- 857
+ + + IG G FG KA + VA+K + + F Q E+R L +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL--NQAQIEVRLLELMNKHDTE 113
Query: 858 ---NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+V L + + + L++ L NL +++ R V ++ K A + AL +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAY--LSDFGLARLLGTSETHATTDVAGTFGYVAP 972
L + ++H D+KP NILL N + + DFG + + + F Y +P
Sbjct: 173 LATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRI-YQYIQSRF-YRSP 227
Query: 973 EYAMTCRVSDKADVYSFGVVLLEL 996
E + D++S G +L+E+
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEM 251
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 38/170 (22%), Positives = 63/170 (37%), Gaps = 28/170 (16%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
F V IG G FG + + VA+K Q E R ++ + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP--MKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 862 LIGYHVSEAEMFLIYNYLP----GGNLEKFIQDRPRR----TVEWSMLHKIALDVARALA 913
+ Y + YN + G +LE R TV IA+ + +
Sbjct: 69 QVYYFGPCGK----YNAMVLELLGPSLEDLFDLCDRTFSLKTVL-----MIAIQLISRME 119
Query: 914 YLHDECVPRVLHRDIKPSNILL----DNNLN-AYLSDFGLARLLGTSETH 958
Y+H + + ++RD+KP N L+ + ++ DF LA+ ET
Sbjct: 120 YVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 20/202 (9%)
Query: 805 VQNCIGSGGFGATYKAE-IIPGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQH------ 856
V IG G FG KA VA+K + + RF +Q A EIR L ++
Sbjct: 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH--RQAAEEIRILEHLRKQDKDNT 158
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
N++ ++ + + + L NL + I+ + ++ K A + + L LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAY--LSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
R++H D+KP NILL + + DFG + + T + F Y APE
Sbjct: 218 KN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRV-YTYIQSRF-YRAPEV 270
Query: 975 AMTCRVSDKADVYSFGVVLLEL 996
+ R D++S G +L EL
Sbjct: 271 ILGARYGMPIDMWSLGCILAEL 292
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 36/183 (19%), Positives = 68/183 (37%), Gaps = 16/183 (8%)
Query: 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINL 165
L L + + + +LS ++ + ++ + +Q ++L+ ++L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQS-LAG-MQFFTNLKELHL 70
Query: 166 SGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP 225
S NQ + + + +S++ N L G L + L N L
Sbjct: 71 SHNQIS-DLSPL-KDLTKLEELSVNRNRLK----NLNGIPSACLSRLFLDNNELR-DTDS 123
Query: 226 SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLV 285
L + L L + +N L+ I G L LEVLDL N ++ L K++ +
Sbjct: 124 -LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWID 178
Query: 286 LRN 288
L
Sbjct: 179 LTG 181
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 32/180 (17%), Positives = 66/180 (36%), Gaps = 19/180 (10%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHG 148
N+ S L +L+ ++ + ++ + L+ L LS N
Sbjct: 25 NLGKQSVTDLVS-----QKELSGVQNFNGDNSNIQSLAGMQ--FFTNLKELHLSHNQISD 77
Query: 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVS 208
+ P L++ + L ++++ N+ + S + L N L + + +
Sbjct: 78 -LSP-LKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRDTDSLI---HLKN 129
Query: 209 LEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
LE + + N L SI LG ++L L L N + + +L + +DL+
Sbjct: 130 LEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 39/262 (14%), Positives = 76/262 (29%), Gaps = 93/262 (35%)
Query: 130 IGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189
L+ +L S + + S ++ N + ++
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGM------------ 59
Query: 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPS 249
+L+ + L+ N ++ + P L + T+L L ++ N L+ ++
Sbjct: 60 --------------QFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NL-- 100
Query: 250 SFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDG 309
+ L L L N L L K L++L +RN+
Sbjct: 101 NGIPSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNK------------------- 139
Query: 310 GEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIP 369
+ + L SKLE+L+L N +I
Sbjct: 140 --------------LKSIVML------------------GFLSKLEVLDLHGN----EIT 163
Query: 370 --ASLGNCKSLYFLDLSSNNLT 389
L K + ++DL+
Sbjct: 164 NTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 32/200 (16%), Positives = 62/200 (31%), Gaps = 58/200 (29%)
Query: 204 DNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
+ L S+T + + +++ ++ +Q + + NL+ L LS
Sbjct: 16 PGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLS 71
Query: 264 RNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDS 323
N +S + P L +L+ L + N
Sbjct: 72 HNQISDLSP--LKDLTKLEELSVNR-------------------------N--------R 96
Query: 324 ITRLPNLRVFWAPNLNLEGIF--------PQNWELCSKLEMLNLAHNFFTGQIP--ASLG 373
+ L + P+ L +F + LE+L++ +N ++ LG
Sbjct: 97 LKNLNGI-----PSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNN----KLKSIVMLG 147
Query: 374 NCKSLYFLDLSSNNLTGLLP 393
L LDL N +T
Sbjct: 148 FLSKLEVLDLHGNEITNTGG 167
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 29/131 (22%), Positives = 47/131 (35%), Gaps = 11/131 (8%)
Query: 546 KFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG 605
++ L+ Q ++N N +++Q + + +LK L LS N +
Sbjct: 22 VKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHNQISD 77
Query: 606 AIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSL 665
P L L LE L ++ N L + L L LD+N L +L
Sbjct: 78 LSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD--TDSLIHLKNL 130
Query: 666 SIFDVSFNNLS 676
I + N L
Sbjct: 131 EILSIRNNKLK 141
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 36/157 (22%), Positives = 63/157 (40%), Gaps = 9/157 (5%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
D+ +N L + + L ++ N + ++F +LR L+LS NHL L
Sbjct: 45 DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT-L 103
Query: 584 PSYI-NKMEDLKFLSLSLNNFTGAIPWE-LTQLASLEVLELSANSLSGEIPSE----FSK 637
++ + ++ L+ L L N+ + +A L+ L LS N +S P E +K
Sbjct: 104 DEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK 161
Query: 638 LEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNN 674
L L +L L N L + + +N
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 13/160 (8%)
Query: 136 LEILDLSFNSFHGPIPP--TLQNCSSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFN 192
+LDLS N+ + T ++L + LS N N I + F P + + LS N
Sbjct: 41 TALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 193 LLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIP--- 248
L ++ E + +LE +LL N + + + + +L+ L LS N + P
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 249 -SSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287
+L L +LDLS N L + ++L L
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 12/163 (7%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
LS N+L + + +L L + +N + + S+ +++L ++ N
Sbjct: 45 DLSHNNLSRLRAEWTPTRLTNLHSL--LLSHNH-LNFISSEAFVPVPNLRYLDLSSNHLH 101
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWE----L 611
L F++ +L L L NH+ + M L+ L LS N + P E
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDG 159
Query: 612 TQLASLEVLELSANSLSGEIPSEFSKLEHL--NVLRLDHNNLT 652
+L L +L+LS+N L ++ KL N L L +N L
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 50/238 (21%), Positives = 73/238 (30%), Gaps = 63/238 (26%)
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
+CS +L +P ++ LS N LS E +L +LL+
Sbjct: 24 SCSKQQLP---------NVPQ--SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLS 72
Query: 216 ANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPS-SFGQLVNLEVLDLSRNFLSGIVPS 273
N L I + LR L LSSN L + F L LEVL L N + + +
Sbjct: 73 HNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRN 130
Query: 274 ELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVF 333
QL+ L L N I+R P
Sbjct: 131 AFEDMAQLQKLYL-------------------------SQN--------QISRFP----- 152
Query: 334 WAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLY--FLDLSSNNLT 389
+ ++ KL +L+L+ N L + L L +N L
Sbjct: 153 -------VELI-KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 29/145 (20%), Positives = 57/145 (39%), Gaps = 15/145 (10%)
Query: 150 IPPTLQNCSSLRLINLSGNQFNGTIPA--FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCV 207
+P ++LS N + A + + LS N L+ + E
Sbjct: 37 LPSYTAL------LDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 208 SLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF 266
+L ++ L++N L ++ + L LLL +N + ++F + L+ L LS+N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 267 LSGIVP---SELGMCKQLKVLVLRN 288
+S + +L +L L +
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSS 172
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 49/220 (22%), Positives = 74/220 (33%), Gaps = 63/220 (28%)
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP--SLGNCTELRSLLLSSNM 242
++S S L +VP+ + L+ N+L+ + + T L SLLLS N
Sbjct: 21 NILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNH 75
Query: 243 LQGDIPS-SFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDL 301
L I S +F + NL LDLS N L + + L+VL+L
Sbjct: 76 LN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL--------------- 119
Query: 302 PIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAH 361
N I + F ++L+ L L+
Sbjct: 120 ----------YNN--------HIVVVD------------RNAFED----MAQLQKLYLSQ 145
Query: 362 NFFTGQIPA----SLGNCKSLYFLDLSSNNLTGLLPEEVS 397
N + + P L LDLSSN L L ++
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQ 184
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 22/86 (25%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 615 ASLEVLELSANSLSGEIPSE--FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVS 671
+ +L+LS N+LS + +E ++L +L+ L L HN+L I F +L D+S
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 672 FNNLSGSAPRNSLIKCENVQGNPNLQ 697
N+L + L+
Sbjct: 97 SNHLH-TLDEFLF------SDLQALE 115
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 41/170 (24%), Positives = 67/170 (39%), Gaps = 28/170 (16%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ V IG G FG ++ ++ VA+K R Q E RT + +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 862 LIGYHVSEAEMFLIYNYLP----GGNLEKFIQDRPRR----TVEWSMLHKIALDVARALA 913
+ Y E +N L G +LE + R+ TV +M A + +
Sbjct: 70 NVYYFGQEGL----HNVLVIDLLGPSLEDLLDLCGRKFSVKTV--AM---AAKQMLARVQ 120
Query: 914 YLHDECVPRVLHRDIKPSNILL----DNNLN-AYLSDFGLARLLGTSETH 958
+H++ + ++RDIKP N L+ N N Y+ DFG+ + T
Sbjct: 121 SIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 61/280 (21%), Positives = 95/280 (33%), Gaps = 88/280 (31%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQ---- 855
++V +G G F + + I VA+K V + A EIR L V+
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNSDP 95
Query: 856 -HPN---LVTLI---------GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
PN +V L+ G H+ +++ L G +L K+I + + +
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPCVK 149
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILL--------------------------- 935
KI V + L YLH +C R++H DIKP NILL
Sbjct: 150 KIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 936 ----------------------DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
L ++D G A + H T D+ T Y + E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDI-QTRQYRSLE 263
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNG 1013
+ + AD++S + EL + D F
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATG----DYLFEPHSGE 299
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 45/168 (26%), Positives = 66/168 (39%), Gaps = 26/168 (15%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
F + IGSG FG Y I VA+K + Q E + +Q +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--VKTKHPQLLYESKIYRILQGGTGIP 66
Query: 862 LIGYHVSEAEMFLIYNYLP----GGNLEKFIQDRPRR----TVEWSMLHKIALDVARALA 913
+ + E + YN L G +LE R+ TV +A + +
Sbjct: 67 NVRWFGVEGD----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVL-----MLADQMINRVE 117
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNA---YLSDFGLARLLGTSETH 958
++H + LHRDIKP N L+ A Y+ DFGLA+ + TH
Sbjct: 118 FVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 7/114 (6%)
Query: 548 LSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGA 606
+ + N + P +F+ + LR ++LS N + L + L L L N T
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 607 IPWEL-TQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG 658
+P L L SL++L L+AN ++ + + F L +LN+L L N L I G
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKG 146
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 32/132 (24%), Positives = 55/132 (41%), Gaps = 7/132 (5%)
Query: 137 EILDLSFNSFHGPIPPT-LQNCSSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFNLL 194
+ L N+ IPP LR I+LS NQ + + F + L N +
Sbjct: 35 TEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 195 SGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQ 253
+ +P+ + SL+ +LL AN + + + + L L L N LQ +F
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 254 LVNLEVLDLSRN 265
L ++ + L++N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 31/127 (24%), Positives = 50/127 (39%), Gaps = 3/127 (2%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
+ N I +P S K ++ + ++ N+ L P +F SL +L L N + L
Sbjct: 38 RLEQNT-IKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE-L 95
Query: 584 PSYI-NKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLN 642
P + + L+ L L+ N L +L +L L N L FS L +
Sbjct: 96 PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155
Query: 643 VLRLDHN 649
+ L N
Sbjct: 156 TMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 4/88 (4%)
Query: 591 EDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHN 649
E + + L N P + L ++LS N +S E+ + F L LN L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 650 NLTGRIPPG-FGTRSSLSIFDVSFNNLS 676
+T +P F SL + ++ N ++
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 22/83 (26%), Positives = 39/83 (46%), Gaps = 2/83 (2%)
Query: 207 VSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265
++ I L N++ IPP + +LR + LS+N + P +F L +L L L N
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90
Query: 266 FLSGIVPSELGMCKQLKVLVLRN 288
++ + S L++L+L
Sbjct: 91 KITELPKSLFEGLFSLQLLLLNA 113
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 2e-09
Identities = 82/553 (14%), Positives = 153/553 (27%), Gaps = 190/553 (34%)
Query: 258 EVLDLSRNFLSG-------IVPSELGMCKQLKVL------------------VLRNDYGP 292
+V D+ ++ LS + + L VLR +Y
Sbjct: 37 DVQDMPKSILSKEEIDHIIMSKDAV---SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF 93
Query: 293 LYSREHGDLPIQPVVDGGEDYNFFDGGL--------PDSITR----------LPNLRVFW 334
L S + QP + Y L +++R L LR
Sbjct: 94 LMSPIKTE-QRQPSMM-TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP-- 149
Query: 335 APNLNLEGI--FPQNW---ELCSKLEMLNLAHNFFTGQIP-ASLGNCKSLYFLDLSSNNL 388
A N+ ++G+ + W ++C ++ +I +L NC S
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKV----QCKMDFKIFWLNLKNCNS----------- 194
Query: 389 TGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKM--SVNWSMSQVDLIGFYTAFFY 446
PE V + Q LL +I + S+ S N + +
Sbjct: 195 ----PET-------VLEMLQKLLY----QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 447 ENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGN 506
+C L +L + N ++
Sbjct: 240 SKPYENC---------LLVLLNVQN--------AKAWNA--------------------- 261
Query: 507 LSTYPFDL-CLSL----DGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQ 561
F+L C L + D + + D S +++ +E L
Sbjct: 262 -----FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS-------MTLTPDEVKSL--- 306
Query: 562 SFTNFDSLRNLNLSRNHLQG-PLPSYINKMEDLKFLSLSLNNFTGAI-PWELTQLASL-E 618
+ R +L R L P L ++ S+ + W+ L
Sbjct: 307 -LLKYLDCRPQDLPREVLTTNPRR--------LSIIAESIRDGLATWDNWKHVNCDKLTT 357
Query: 619 VLELSANSLSGEIPSEFSKL-EHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSG 677
++E S N L P+E+ K+ + L+V + IP LS+ + ++
Sbjct: 358 IIESSLNVLE---PAEYRKMFDRLSVFPPSAH-----IPT-----ILLSLI---WFDVIK 401
Query: 678 SAPRNSLIKCEN---VQGNPN--------LQLCHTDPSSSEWERQHSGNVSQQEAYSPSE 726
S + K V+ P + L H V + Y+ +
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIPSIYL-ELKVKLENEYALHRSIV---DHYNIPK 457
Query: 727 SIQGNSSGLNPIE 739
+ + ++
Sbjct: 458 TFDSDDLIPPYLD 470
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 4e-08
Identities = 98/677 (14%), Positives = 177/677 (26%), Gaps = 217/677 (32%)
Query: 319 GLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSL 378
D+++ LR+FW L SK E + F
Sbjct: 56 MSKDAVSGT--LRLFWT--------------LLSKQE--EMVQKFVEE------------ 85
Query: 379 YFLDLSSNNLTGLLPEEVSVPCM--AVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVD 436
L ++ L + E P M ++ ++ L + + K +V +
Sbjct: 86 -VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA-----KYNV-SRLQPYL 138
Query: 437 LIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGP--------VPPFLIDSDSL 488
+ AL P+ + ++ G +
Sbjct: 139 KL--------RQALLEL----RPAKNV-LID--------GVLGSGKTWVALDVCLSYKVQ 177
Query: 489 SSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFL 548
+ FWL+ N ++ P + L L++ I N SD S+
Sbjct: 178 CKMDFKIFWLN----LKNCNS-PETVLEMLQKLLYQIDPN---WTSRSDHSSN------- 222
Query: 549 SMAGNEFVGLIPQSFTNF-DSLRNLNLSRNHLQGPL-------PSYINKMEDL--KFLSL 598
I + LR L S+ + L N +L K L
Sbjct: 223 ----------IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF-NLSCKIL-- 269
Query: 599 SLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG 658
T T+ + + LS + S L+H +
Sbjct: 270 ----LT-------TRFKQV------TDFLSAATTTHIS-LDHHS--------------MT 297
Query: 659 FGTRSSLSIF----DVSFNNLSGSAPRNSLIKCENVQGNPNL-----QLCHTDPSSSEWE 709
S+ D +L PR E + NP + ++ W+
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDL----PR------EVLTTNPRRLSIIAESIRDGLAT--WD 345
Query: 710 RQHSGNVSQQEAYSPSESIQGNSSGLNPIEIASITSAAVIL--SVLI---ALVLLLICMK 764
N + I+ + + L P E + + S I L L+ +
Sbjct: 346 -----NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 765 KFSCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIP 824
K + + L + +V + T I S K E
Sbjct: 401 KSDVMVVVN-KLHKYSLVEKQP--KESTIS--------------IPSIYLELKVKLENEY 443
Query: 825 GVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-----QHPNLVTLIGYHVSEAEMFLIYN-- 877
A+ R V + + F ++ + H IG+H+ E
Sbjct: 444 ----ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH------IGHHLKNIEHPERMTLF 493
Query: 878 ---YLPGGNLEKFIQDRPRRT-VEWSMLHKIA---LDVARALAYLHDEC-VPRVLHRDIK 929
+L + +F++ + R W+ I + Y+ D L I
Sbjct: 494 RMVFL---DF-RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL 549
Query: 930 PSNILLDNNLNAYLSDF 946
+ L N S +
Sbjct: 550 --DFLPKIEENLICSKY 564
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 66/471 (14%), Positives = 124/471 (26%), Gaps = 168/471 (35%)
Query: 226 SLGNCTELRSLLLSSNMLQGDIPSSFGQL--------VNLEVLD--LSRNFLSGIVPSEL 275
+L NC ++L L I ++ + + + L R S + L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 276 ----------------GMCKQLKVLVL-RN----DYGPLYSREHGDLPIQPVVDG---GE 311
C K+L+ R D+ + H + + E
Sbjct: 248 LVLLNVQNAKAWNAFNLSC---KILLTTRFKQVTDFLSAATTTH--ISLDHHSMTLTPDE 302
Query: 312 DYNFFDGGLPDSITRLPNLRVFWAPNLNLEGI------FP---QNWE--LCSKLEMLNLA 360
+ L LP + P L I NW+ C KL +
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNP-RRLSIIAESIRDGLATWDNWKHVNCDKLTTI--- 358
Query: 361 HNFFTGQIPASLGNCKSL----YFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIP 416
I +SL + F LS + P +P + ++ +
Sbjct: 359 -------IESSLNVLEPAEYRKMFDRLS------VFPPSAHIP-TILLSLIWFDVIKSDV 404
Query: 417 RISHSECSKMSV---NWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNL 473
+ ++ K S+ S + + Y + LH
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLE------------LKVKLENEYALHR----- 447
Query: 474 FTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFD--LCLSLDGLIFDIGNNKLI 531
++D Y T+ D + LD +
Sbjct: 448 -------SIVDH--------YNI----------PKTFDSDDLIPPYLDQYFY-------- 474
Query: 532 GEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNF---------------------DSLR 570
S +G H +K + E + L F +F ++L+
Sbjct: 475 ----SHIGHH---LKNIEHP--ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ 525
Query: 571 NLNLSRNHLQGPLPSYINKMEDL-KFL-----SLSLNNFTGAIPWELTQLA 615
L + ++ P Y + + FL +L + +T +L ++A
Sbjct: 526 QLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYT-----DLLRIA 571
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-06
Identities = 78/546 (14%), Positives = 154/546 (28%), Gaps = 190/546 (34%)
Query: 632 PSEFSKL-EHLNVLRLDHNNLT--GRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCE 688
+ KL + L LR N+ G G G ++ +++ + ++C+
Sbjct: 134 LQPYLKLRQALLELR-PAKNVLIDG--VLGSG-KTWVAL----------DVCLSYKVQCK 179
Query: 689 NVQGNP----NLQLCHTDPSSSEWERQHSGNVSQQEAY---SPSESIQGNSSGLNPIEIA 741
NL+ C++ + E Q+ P+ + + + S + I
Sbjct: 180 M--DFKIFWLNLKNCNSPETVLE---------MLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 742 SITSAAVILSVLIA--------LVLLLICMKK------FSC--------NSIAD--PGLV 777
SI + L L+ LVLL + K SC + D
Sbjct: 229 SIQAE---LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285
Query: 778 RKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR 837
+ + ++ + LT + V + + + +P V+ +
Sbjct: 286 TTHISL-DHHSMTLTPDEVKSLLL-----KYLDC-------RPQDLPREVLTTNPRRLS- 331
Query: 838 FQGVQQFAAEIR----TLGRVQHPN---LVTLIGY---HVSEAEMFLIYNYL-------- 879
A IR T +H N L T+I + AE +++ L
Sbjct: 332 -----IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH 386
Query: 880 -PGGNLEKFIQDRPRRTVEWSM-------------------LHKIALDV---ARALAYLH 916
P L D + V + + I L++ LH
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
V S+ L+ L+ Y G+ +
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYFYSH--------------------IGH----HLK 482
Query: 977 TCRVSDKADVYSFGVVLLEL--ISDK-KALDPSFCSFGNGFNIVAWASMLLLQGRP---- 1029
++ + F +V L+ + K + ++ + G+ N L Q +
Sbjct: 483 NIEHPERMTL--FRMVFLDFRFLEQKIRHDSTAWNASGSILN-------TLQQLKFYKPY 533
Query: 1030 ----CEFFTAGLWD-------------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072
+ + C + DL+ +A+M E++ +
Sbjct: 534 ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR---IALMAEDEAI--------FEE 582
Query: 1073 QLKQIQ 1078
KQ+Q
Sbjct: 583 AHKQVQ 588
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 42/139 (30%), Positives = 63/139 (45%), Gaps = 9/139 (6%)
Query: 548 LSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGA 606
L + N+ L ++F LR L L+ N LQ LP+ I ++++L+ L ++ N A
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ-A 99
Query: 607 IPWEL-TQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRS 663
+P + QL +L L L N L +P F L L L L +N L +P G F +
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT 157
Query: 664 SLSIFDVSFNNLSGSAPRN 682
SL + N L P
Sbjct: 158 SLKELRLYNNQLK-RVPEG 175
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
L N L +L + F L L + +NKL +P+ + K ++ L + N+
Sbjct: 43 DLQSNKLS-SLPSKAFHRLTKLRLL--YLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWEL-TQL 614
L F +L L L RN L+ LP + + + L +LSL N ++P + +L
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 615 ASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFN 673
SL+ L L N L F KL L L+LD+N L R+P G F + L + + N
Sbjct: 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 7/182 (3%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTL-QNCSSLRLINLSGN 168
+ L L N S +L+ L +L L+ N +P + + +L + ++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95
Query: 169 QFNGTIPA-FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL 227
+ +P F Q + L N L S+P D+ L ++ L N L S+P +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 228 -GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVL 286
T L+ L L +N L+ +F +L L+ L L N L + ++LK+L L
Sbjct: 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 287 RN 288
+
Sbjct: 213 QE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 6/114 (5%)
Query: 566 FDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWEL-TQLASLEVLELSA 624
+ L+L N L +++ L+ L L+ N +P + +L +LE L ++
Sbjct: 36 PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94
Query: 625 NSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLS 676
N L +P F +L +L LRLD N L +PP F + + L+ + +N L
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 12/181 (6%)
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFH 147
++ SN L A LT+LR+L L N LP I +L LE L ++ N
Sbjct: 43 DLQSNKLSSLPSK---AFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ 98
Query: 148 GPIPP-TLQNCSSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFNLLSGSVPEEFGDN 205
+P +L + L NQ ++P F +SL +N L S+P+ D
Sbjct: 99 A-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 206 CVSLEHILLAANSLTGSIPPSL-GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSR 264
SL+ + L N L +P TEL++L L +N L+ +F L L++L L
Sbjct: 156 LTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214
Query: 265 N 265
N
Sbjct: 215 N 215
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 27/90 (30%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 200 EEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEV 259
E D LE + LT SI +L +L+ L LS N + G + + NL
Sbjct: 35 EGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92
Query: 260 LDLSRNFLSGI-VPSELGMCKQLKVLVLRN 288
L+LS N + + L + LK L L N
Sbjct: 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 20/90 (22%), Positives = 34/90 (37%), Gaps = 3/90 (3%)
Query: 200 EEFGDNCVSLEHILLAANSLT-GSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLE 258
E ++ ++L + G + EL L + L I ++ +L L+
Sbjct: 10 ELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLK 67
Query: 259 VLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
L+LS N +SG + C L L L
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 26/135 (19%), Positives = 53/135 (39%), Gaps = 8/135 (5%)
Query: 155 QNCSSLRLINLSGNQFN-GTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
+ S ++ + L ++ N G + + + +S L+ S+ L+ +
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANL-PKLNKLKKLE 70
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQG-DIPSSFGQLVNLEVLDLSRNFLSGIV- 271
L+ N ++G + C L L LS N ++ +L NL+ LDL ++ +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130
Query: 272 --PSELGMCKQLKVL 284
+ + QL L
Sbjct: 131 YRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 10/112 (8%)
Query: 515 CLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNL 574
L LD + G + + + ++FLS + + + L+ L L
Sbjct: 21 ELVLDNSRSNEGKLE-------GLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLEL 71
Query: 575 SRNHLQGPLPSYINKMEDLKFLSLSLNNFTG-AIPWELTQLASLEVLELSAN 625
S N + G L K +L L+LS N + L +L +L+ L+L
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 3/89 (3%)
Query: 565 NFDSLRNLNLSRNHLQ-GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623
++ L L + G L ++ E+L+FLS T +I L +L L+ LELS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 624 ANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
N +SG + K +L L L N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 24/108 (22%), Positives = 41/108 (37%), Gaps = 9/108 (8%)
Query: 591 EDLKFLSLSLNNFT-GAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHN 649
D+K L L + G + + LE L L+ I + KL L L L N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDN 74
Query: 650 NLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQ 697
++G + +L+ ++S N + L E ++ NL+
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIK------DLSTIEPLKKLENLK 116
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 29/190 (15%), Positives = 54/190 (28%), Gaps = 55/190 (28%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVG--------RFQGVQQFAAEIRTL--------- 851
IG G FG ++ I VA+K +++ + ++ EI
Sbjct: 28 IGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 852 GRVQHPNLVTLIGYHV------------------------------SEAEMFLIYNYLPG 881
+ + L H + ++F++ + G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 882 GN-LEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN 940
G LE+ + + I + +LA R HRD+ N+LL
Sbjct: 147 GIDLEQM----RTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSL 200
Query: 941 AYLSDFGLAR 950
L +
Sbjct: 201 KKLHYTLNGK 210
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 52/197 (26%), Positives = 73/197 (37%), Gaps = 24/197 (12%)
Query: 548 LSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGA 606
L + L +F L LNL N LQ L + + + + +L L L+ N
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASL 98
Query: 607 IPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSL 665
L L+ L L N L F +L L LRL+ N L IP G F ++L
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 666 SIFDVSFNNLSGSAPR---NSLIKCENVQGNPN---------LQLCHTDPSSSEWERQHS 713
+S N L S P + L K + + N L L S+W R++S
Sbjct: 158 QTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFDCSRCEILYL-------SQWIRENS 209
Query: 714 GNVSQQEAYSPSESIQG 730
V + ES G
Sbjct: 210 NKVKDGTGQNLHESPDG 226
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 137 EILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFNLLS 195
E LDL T + + L +NL NQ T+ A F + L+ N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPP----SLGNCTELRSLLLSSNMLQGDIPSS- 250
S+P D+ L+ + L N L S+P L T+L+ L L++N LQ IP+
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRL---TKLKELRLNTNQLQ-SIPAGA 150
Query: 251 FGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
F +L NL+ L LS N L + +L+ + L
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 33/147 (22%), Positives = 52/147 (35%), Gaps = 16/147 (10%)
Query: 156 NCSSLRL-------------INLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEF 202
+C L ++L A F ++L +N L ++
Sbjct: 20 DCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGV 78
Query: 203 GDNCVSLEHILLAANSLTGSIPPSL-GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLD 261
D+ L + LA N L S+P + + T+L L L N L+ F +L L+ L
Sbjct: 79 FDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137
Query: 262 LSRNFLSGIVPSELGMCKQLKVLVLRN 288
L+ N L I L+ L L
Sbjct: 138 LNTNQLQSIPAGAFDKLTNLQTLSLST 164
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 36/146 (24%), Positives = 56/146 (38%), Gaps = 7/146 (4%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
D+ + + + + +L++ N+ L F + L L L+ N L L
Sbjct: 41 DLQSTG-LATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-L 98
Query: 584 PSYI-NKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHL 641
P + + + L L L N +L L+ L L+ N L IP+ F KL +L
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 642 NVLRLDHNNLTGRIPPG-FGTRSSLS 666
L L N L +P G F L
Sbjct: 158 QTLSLSTNQLQ-SVPHGAFDRLGKLQ 182
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 41/156 (26%), Positives = 63/156 (40%), Gaps = 9/156 (5%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
L L LS F L L ++ N+L + + + + L +A N+
Sbjct: 41 DLQSTGLA-TLSDATFRGLTKLTWL--NLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWEL-TQL 614
L F + L L L N L+ LPS + +++ LK L L+ N +IP +L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 615 ASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNN 650
+L+ L LS N L F +L L + L N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL-FGN 189
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 53/228 (23%), Positives = 82/228 (35%), Gaps = 46/228 (20%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQH---- 856
F V +G G FG + I AVK + ++ ++ + E L ++Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT--RSAKIEADILKKIQNDDIN 94
Query: 857 -PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
N+V G + M LI+ L G +L + I + +++ +AL YL
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL 153
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT----FG--- 968
+ H D+KP NILLD+ G T G FG
Sbjct: 154 RKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 969 --------------YVAPE------YAMTCRVSDKADVYSFGVVLLEL 996
Y APE + ++ D++SFG VL EL
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGWDVSS------DMWSFGCVLAEL 252
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 19/103 (18%), Positives = 36/103 (34%), Gaps = 6/103 (5%)
Query: 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG 245
+V L+ L+ + N V + L + I + ++ S N ++
Sbjct: 1 MVKLTAELIEQA---AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR- 55
Query: 246 DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
+ F L L+ L ++ N + I L L+L N
Sbjct: 56 KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 24/136 (17%), Positives = 41/136 (30%), Gaps = 29/136 (21%)
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
N R ++L G + IP E G + I
Sbjct: 15 YTNAVRDRELDLRGYK----IPVI----------------------ENLGATLDQFDAID 48
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVP- 272
+ N + + L++LL+++N + L +L L L+ N L +
Sbjct: 49 FSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL 106
Query: 273 SELGMCKQLKVLVLRN 288
L K L L +
Sbjct: 107 DPLASLKSLTYLCILR 122
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 20/99 (20%), Positives = 32/99 (32%), Gaps = 17/99 (17%)
Query: 561 QSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDL-------KFLSLSLNNFTGAIPWELTQ 613
+TN R L+L I +E+L + S N +
Sbjct: 13 AQYTNAVRDRELDLRGY--------KIPVIENLGATLDQFDAIDFSDNEIRKLDGFP--L 62
Query: 614 LASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
L L+ L ++ N + L L L L +N+L
Sbjct: 63 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 27/167 (16%), Positives = 42/167 (25%), Gaps = 55/167 (32%)
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
N R L L + I + L + +D S N + +
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-------------- 57
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF 344
G P L L+ N + I
Sbjct: 58 ---------------------------------DGFP----LLRRLKTLLVNNNRICRIG 80
Query: 345 PQNWELCSKLEMLNLAHNFFT--GQIPASLGNCKSLYFLDLSSNNLT 389
+ L L L +N G + L + KSL +L + N +T
Sbjct: 81 EGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 11/65 (16%), Positives = 22/65 (33%), Gaps = 2/65 (3%)
Query: 327 LPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSN 386
L + + + + L +L+ L + +N L L L++N
Sbjct: 41 LDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
Query: 387 NLTGL 391
+L L
Sbjct: 99 SLVEL 103
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 40/256 (15%), Positives = 66/256 (25%), Gaps = 34/256 (13%)
Query: 112 LRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPP-TLQNCSSLRLINLS-GNQ 169
L LE +++S N I N L I + N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 170 FNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL-- 227
P F P Q + +S + +P+ + + + + N +I +
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 228 GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287
G E L L+ N +Q S+F E+ N L + +L +
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210
Query: 288 NDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN 347
I + G + L LR NL
Sbjct: 211 RT------------RIHSLPSYG-----LEN--------LKKLRARSTYNLKKLPTL--- 242
Query: 348 WELCSKLEMLNLAHNF 363
E L +L +
Sbjct: 243 -EKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 25/155 (16%), Positives = 54/155 (34%), Gaps = 9/155 (5%)
Query: 527 NNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSY 586
+ E+PSD+ + L + + +F+ F L + +S+N + + +
Sbjct: 17 QESKVTEIPSDLPRN---AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 587 I-NKMEDLKFLSLSLNNFTGAIPWE-LTQLASLEVLELSANSLSGEIPSE-FSKLEHLNV 643
+ + + L + + N I E L +L+ L +S + +P +
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVL 132
Query: 644 LRLDHNNLTGRIPPG--FGTRSSLSIFDVSFNNLS 676
L + N I G I ++ N +
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 34/187 (18%), Positives = 71/187 (37%), Gaps = 14/187 (7%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMA-GNEF 555
L+ + F L+ + +I N ++ + +D+ S+ + + + N
Sbjct: 36 RFVLTKLR-VIQKGAFSGFGDLEKI--EISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 92
Query: 556 VGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIP----WEL 611
+ + P++F N +L+ L +S ++ + L + N I L
Sbjct: 93 LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152
Query: 612 TQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFD 669
+ +L L+ N + EI + F+ + + D+NNL +P F S I D
Sbjct: 153 SFE--SVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 208
Query: 670 VSFNNLS 676
+S +
Sbjct: 209 ISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 39/240 (16%), Positives = 73/240 (30%), Gaps = 32/240 (13%)
Query: 158 SSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI-LLAA 216
+ + + F + + +S N + + + N L I + A
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 217 NSLTGSIPPS-LGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL 275
N+L I P N L+ LL+S+ ++ + +LD+ N +
Sbjct: 90 NNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 276 --GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVF 333
G+ + +L L IQ + + F+G +
Sbjct: 149 FVGLSFESVILWLNK------------NGIQEIHNS-----AFNG--------TQLDELN 183
Query: 334 WAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLP 393
+ N NLE + + S +L+++ L N K L NL L
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPT 241
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 39/266 (14%), Positives = 76/266 (28%), Gaps = 57/266 (21%)
Query: 151 PPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLE 210
+ +CS+ R+ ++ IP+ + L F LE
Sbjct: 3 HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAF-SGFGDLE 57
Query: 211 HILLAANSLTGSIPPS-LGNCTELRSLLLS-SNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268
I ++ N + I N +L + + +N L P +F L NL+ L +S +
Sbjct: 58 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 117
Query: 269 GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP 328
+ Q +L ++ N +I +
Sbjct: 118 HLPDVHKIHSLQKVLLDIQ-------------------------DN-------INIHTIE 145
Query: 329 NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNL 388
F L + +L L N ++ + +NNL
Sbjct: 146 ------------RNSFVG---LSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNL 190
Query: 389 TGLLPEEV--SVPCMAVFNVSQNLLS 412
LP +V + ++S+ +
Sbjct: 191 EE-LPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 37/220 (16%), Positives = 70/220 (31%), Gaps = 27/220 (12%)
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNML 243
+V + ++ +P + N + L L I + +L + +S N +
Sbjct: 12 RVFLCQESKVT-EIPSDLPRNAIELR---FVLTKLR-VIQKGAFSGFGDLEKIEISQNDV 66
Query: 244 QGDIPSS-FGQLVNLEVLDLSR-NFLSGIVPSELGMCKQLKVLVLRN-------DYGPLY 294
I + F L L + + + N L I P L+ L++ N D ++
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126
Query: 295 SREHGDLPIQPVVDGGEDYNFFDGGLPD-SITRLP-NLRVFWAPNLNLEGIFPQNWELCS 352
S + L IQ N + S L + W ++ I +
Sbjct: 127 SLQKVLLDIQ--------DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQ 178
Query: 353 KLEMLNLAHNFFTGQIPA-SLGNCKSLYFLDLSSNNLTGL 391
E+ +N ++P LD+S + L
Sbjct: 179 LDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL 217
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 8e-08
Identities = 60/364 (16%), Positives = 108/364 (29%), Gaps = 63/364 (17%)
Query: 43 RVTSLNLSSNLSRTSCSLLSLPPAAGPG---GNFSFHFPCLQLHQHDRGNINSNSSDKLS 99
+ SL L +L+ S + L+ R ++ D+L
Sbjct: 74 NLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRL- 132
Query: 100 GNLSRAIGDLTQLRVLLLAF-NGFSGELPLEIGQ-LSLLEILDLSFNSFHGPIPPTL--- 154
A L L L +GF+ + L I ++ L + +SF L
Sbjct: 133 -----AKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHEL 187
Query: 155 -QNCSSLRLINLSGNQFNG----TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209
Q+ +SL ++N +F + +VS+ F +L
Sbjct: 188 AQHNTSLEVLNFYMTEFAKISPKDLETIARNCR--SLVSVKVGDFEILELVGFFKAAANL 245
Query: 210 EHILLAANSLTGSIPPSLGNCTELRSLLLS--SNMLQGDIPSSFGQLVNLEVLDLSRNFL 267
E + + +P N R L S M ++P F + LDL L
Sbjct: 246 EEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALL 305
Query: 268 SG-IVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITR 326
+ + C L+VL RN G D GL
Sbjct: 306 ETEDHCTLIQKCPNLEVLETRNVIG-------------------------DRGLEVLAQY 340
Query: 327 LPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLG-NCKSLYFLDLSS 385
L+ L +E + + + + + +L C+ L ++ +
Sbjct: 341 CKQLK-----RLRIER--------GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYV 387
Query: 386 NNLT 389
+++T
Sbjct: 388 SDIT 391
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 37/277 (13%), Positives = 76/277 (27%), Gaps = 38/277 (13%)
Query: 132 QLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSF 191
L L+ + L L + LS N +P F + + + L +
Sbjct: 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLY 302
Query: 192 NLLSGSVPEEFGDNCVSLEHILLAANSLT-GSIPPSLGNCTELRSLLLSSNMLQGDIPSS 250
LL C +LE + N + + C +L+ L + + +
Sbjct: 303 ALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDE 361
Query: 251 FGQL------------VNLEVLDLSRNFLSGIVPSELGM-CKQLKVLVLRNDYGPLYSRE 297
G + LE + + + ++ +G K L L +
Sbjct: 362 EGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD 421
Query: 298 HGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWA----PNLNLEGIFPQNWELCSK 353
D G+ + LR F L G+ +
Sbjct: 422 LP----------------LDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS-YIGQYSPN 464
Query: 354 LEMLNLAHNFFTGQ-IPASLGNCKSLYFLDLSSNNLT 389
+ + L + + + + C +L L++ +
Sbjct: 465 VRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 34/132 (25%), Positives = 55/132 (41%), Gaps = 6/132 (4%)
Query: 137 EILDLSFNSFHGPIPPT--LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLL 194
L L+ N F + T + LR IN S N+ F + G + L+ N L
Sbjct: 35 AELRLNNNEFTV-LEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93
Query: 195 SGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQ 253
+V + SL+ ++L +N +T + S + +R L L N + P +F
Sbjct: 94 E-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151
Query: 254 LVNLEVLDLSRN 265
L +L L+L N
Sbjct: 152 LHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 26/128 (20%), Positives = 53/128 (41%), Gaps = 4/128 (3%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
+ NN+ + + ++ ++ + N+ + +F + + L+ N L+ +
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-V 96
Query: 584 PSYI-NKMEDLKFLSLSLNNFTGAIPWEL-TQLASLEVLELSANSLSGEIPSEFSKLEHL 641
+ +E LK L L N T + + L+S+ +L L N ++ P F L L
Sbjct: 97 QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSL 155
Query: 642 NVLRLDHN 649
+ L L N
Sbjct: 156 STLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 33/170 (19%), Positives = 59/170 (34%), Gaps = 18/170 (10%)
Query: 568 SLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANS 626
L L+ N + I K+ L+ ++ S N T + + + L++N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 627 LSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLSGSAPR--- 681
L + + F LE L L L N +T + F SS+ + + N ++ +
Sbjct: 93 LE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAF 149
Query: 682 NSLIKCENVQ--GNP---NLQLCHTDPSSSEWERQHSGNVSQQEAYSPSE 726
++L + NP N C+ EW R+ P
Sbjct: 150 DTLHSLSTLNLLANPFNCN---CYLA-WLGEWLRKKRIVTGNPRCQKPYF 195
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 25/135 (18%), Positives = 50/135 (37%), Gaps = 15/135 (11%)
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
+CS+ +L IP + L+ N + L I +
Sbjct: 17 DCSNQKLN---------KIPE--HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFS 65
Query: 216 ANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSS-FGQLVNLEVLDLSRNFLSGIVPS 273
N +T I + + + +LL+SN L+ ++ F L +L+ L L N ++ +
Sbjct: 66 NNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGND 123
Query: 274 ELGMCKQLKVLVLRN 288
+++L L +
Sbjct: 124 SFIGLSSVRLLSLYD 138
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 19/94 (20%), Positives = 31/94 (32%), Gaps = 4/94 (4%)
Query: 584 PSYINKMEDLKFLSLSLNNFTGAIPWE-LTQLASLEVLELSANSLSGEIPSE-FSKLEHL 641
++ E+L L + + L L L L + + L + + F L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 642 NVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
+ L L N L + SL +S N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 15/73 (20%), Positives = 23/73 (31%), Gaps = 3/73 (4%)
Query: 606 AIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTRS 663
L +L L + + L L L + + L + P F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 664 SLSIFDVSFNNLS 676
LS ++SFN L
Sbjct: 81 RLSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 19/93 (20%), Positives = 32/93 (34%), Gaps = 3/93 (3%)
Query: 197 SVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255
+L + + + L ELR+L + + L+ P +F
Sbjct: 22 DSLHHL-PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80
Query: 256 NLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
L L+LS N L + + L+ LVL
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLS-LQELVLSG 112
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 29/90 (32%), Positives = 39/90 (43%), Gaps = 3/90 (3%)
Query: 200 EEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEV 259
E V+LE + L L S+ L +L+ L LS N + G + +L NL
Sbjct: 42 EGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99
Query: 260 LDLSRNFLSGIVP-SELGMCKQLKVLVLRN 288
L+LS N L I L + LK L L N
Sbjct: 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFN 129
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 19/77 (24%), Positives = 28/77 (36%), Gaps = 2/77 (2%)
Query: 212 ILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIV 271
+L S G I L L L + L + S+ +L L+ L+LS N + G +
Sbjct: 30 VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGL 87
Query: 272 PSELGMCKQLKVLVLRN 288
L L L
Sbjct: 88 DMLAEKLPNLTHLNLSG 104
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 25/89 (28%), Positives = 36/89 (40%), Gaps = 3/89 (3%)
Query: 565 NFDSLRNLNLSRNHLQ-GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623
++R L L G + + +L+FLSL L +L L+ LELS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELS 79
Query: 624 ANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
N + G + KL +L L L N L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 3/106 (2%)
Query: 524 DIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL 583
+ N K + + ++FLS+ + + + L+ L LS N + G L
Sbjct: 30 VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGL 87
Query: 584 PSYINKMEDLKFLSLSLNNFTG-AIPWELTQLASLEVLELSANSLS 628
K+ +L L+LS N + L +L L+ L+L ++
Sbjct: 88 DMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 47/222 (21%), Positives = 87/222 (39%), Gaps = 38/222 (17%)
Query: 803 FNVQNCIGSGGFGATYKA--EIIPGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHP-- 857
+ + +G G FG + VA+K + +VG+++ + EI L +++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR--EAARLEINVLKKIKEKDK 78
Query: 858 ----NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
V + + M + + L G N +F+++ + + +A + AL
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAY-------------------LSDFGLARLLGT 954
+LH+ ++ H D+KP NIL N+ ++DFG A T
Sbjct: 138 FLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----T 190
Query: 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
+ T + T Y PE + + DV+S G +L E
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 38/222 (17%)
Query: 803 FNVQNCIGSGGFGATYKA--EIIPGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHP-- 857
+ + + +G G FG + G VAVK + +V R+ + +EI+ L +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC--EAARSEIQVLEHLNTTDP 73
Query: 858 ----NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
V ++ + + +++ L G + FI++ + K+A + +++
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLS-------------------DFGLARLLGT 954
+LH ++ H D+KP NIL + DFG A
Sbjct: 133 FLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--D 187
Query: 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
E H+T T Y APE + S DV+S G +L+E
Sbjct: 188 DEHHSTLVS--TRHYRAPEVILALGWSQPCDVWSIGCILIEY 227
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 56/335 (16%), Positives = 93/335 (27%), Gaps = 100/335 (29%)
Query: 98 LSGN---------LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQ-----------LSLLE 137
LSGN LS I L + + F+G + EI + L
Sbjct: 39 LSGNTIGTEAARWLSENIASKKDLEIAEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLH 97
Query: 138 ILDLSFNSFHGP-----IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192
+ LS N+F GP + L + L + L N ++
Sbjct: 98 TVRLSDNAF-GPTAQEPLIDFLSKHTPLEHLYLHNNGL---------GPQAGAKIA---R 144
Query: 193 LLSGSVPEEFGDNCVSLEHILLAANSLTG----SIPPSLGNCTELRSLLLSSNML----- 243
L + N L I+ N L + + L ++ + N +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 244 QGDIPSSFGQLVNLEVLDLSRNFLS--GIVP--SELGMCKQLKVLVLRNDYGPLYSREHG 299
+ + L+VLDL N + G L L+ L L
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL------------N 252
Query: 300 DLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNL 359
D + G + D+ ++L N L+ L L
Sbjct: 253 DCLLSA--RGAAA-------VVDAFSKLEN----------------------IGLQTLRL 281
Query: 360 AHNFFTGQ----IPASLG-NCKSLYFLDLSSNNLT 389
+N + + L FL+L+ N +
Sbjct: 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 46/300 (15%), Positives = 83/300 (27%), Gaps = 83/300 (27%)
Query: 130 IGQLSLLEILDLSFNSFHG----PIPPTLQNCSSLRLINLSGNQFNGT----IPAFFGQS 181
+ + S+ L ++ + L S++ I LSGN +
Sbjct: 1 MARFSIEG-KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSN 241
++ S G V +E + L +L C +L ++ LS N
Sbjct: 60 KDLEIAEFSDIFT-GRVKDEIPEALRLL--------------LQALLKCPKLHTVRLSDN 104
Query: 242 MLQGDIPSSFGQL----VNLEVLDLSRNFLS-------------GIVPSELGMCKQLKVL 284
LE L L N L V + L+ +
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164
Query: 285 VL-RNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNL--- 340
+ RN ++ + L + +
Sbjct: 165 ICGRNRLEN---------------GSMKE-------WAKTFQSHRLLH-----TVKMVQN 197
Query: 341 ----EGIFP---QNWELCSKLEMLNLAHNFFTGQ----IPASLGNCKSLYFLDLSSNNLT 389
EGI + C +L++L+L N FT + +L + +L L L+ L+
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 48/330 (14%), Positives = 94/330 (28%), Gaps = 53/330 (16%)
Query: 74 SFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQL 133
+ QL + G + + LS A+ +LR L ++ LP
Sbjct: 229 TLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288
Query: 134 SLLEILDLSFNSFHGP-IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLS-- 190
S L L+LS+ + + L C L+ + + + + + + +
Sbjct: 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPS 348
Query: 191 -------FNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG-NCTELRSLLLSSNM 242
L+ C LE +L +T + ++ N + L
Sbjct: 349 EPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCI-- 406
Query: 243 LQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLP 302
I + LE LD+ + + CK L+ L L
Sbjct: 407 ----IEPKAPDYLTLEPLDIG-------FGAIVEHCKDLRRLSLS--------------- 440
Query: 303 IQPVVDGGEDYNFFDGGLPDSITRLPNLRV--FWAPNLNLEGIFPQNWELCSKLEMLNLA 360
D T + + + G+ C L L +
Sbjct: 441 ----------GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH-HVLSGCDSLRKLEIR 489
Query: 361 H-NFFTGQIPASLGNCKSLYFLDLSSNNLT 389
F + A+ +++ L +SS +++
Sbjct: 490 DCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 45/304 (14%), Positives = 87/304 (28%), Gaps = 42/304 (13%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSF------NSFHGPIPPTLQNCSSLRL 162
L+ L L +L + + LE L + + L C LR
Sbjct: 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRC 269
Query: 163 INLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGS 222
++ + +PA + ++LS+ + + C L+ + +
Sbjct: 270 LSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAG 329
Query: 223 IPPSLGNCTELRSL-LLSSNMLQGDIPSSFGQ---------LVNLEVLDLSRNFLSGIVP 272
+ C +LR L + S + + + LE + ++
Sbjct: 330 LEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAAL 389
Query: 273 SELGM-CKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLR 331
+ + L I+P D G + +LR
Sbjct: 390 ITIARNRPNMTRFRLCI--------------IEPKAPDYLTLEPLDIGFGAIVEHCKDLR 435
Query: 332 VFWAPNLNLEG-----IFPQNWELCSKLEMLNLAHNFFTGQ-IPASLGNCKSLYFLDLSS 385
L+L G +F K+EML++A + + L C SL L++
Sbjct: 436 -----RLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD 490
Query: 386 NNLT 389
Sbjct: 491 CPFG 494
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 41/278 (14%), Positives = 78/278 (28%), Gaps = 36/278 (12%)
Query: 133 LSLLEILDLSFNSFHGPIPPTL-QNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSF 191
+ + + + P T+ + +R + L G F +V +
Sbjct: 40 IERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFAD----------FNLVPDGW 89
Query: 192 NLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG-NCTELRSLLLSSNMLQGD--IP 248
E + LE I L +T + + + L+LSS +
Sbjct: 90 GGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLA 149
Query: 249 SSFGQLVNLEVLDLSRNFLSGIVPSELGM----CKQLKVLVLRNDYGPLYSREHGDLPIQ 304
+ NL+ LDL + + + L L L + + E ++
Sbjct: 150 AIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC-----LASEVSFSALE 204
Query: 305 PVVDGGED-------YNFFDGGLPDSITRLPNLRVF------WAPNLNLEGIFPQNWELC 351
+V + L + R P L ++ C
Sbjct: 205 RLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGC 264
Query: 352 SKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLT 389
+L L+ + +PA C L L+LS +
Sbjct: 265 KELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 59/347 (17%), Positives = 106/347 (30%), Gaps = 72/347 (20%)
Query: 89 NINSNS-SDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSL-----LEILDLS 142
++ + + G LS + L L+ L L+ N + + L LE L L
Sbjct: 91 SLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLE 150
Query: 143 FNSFH----GPIPPTLQNCSSLRLINLSGNQFNGT-----IPAFFGQSPGFQVVSLSFNL 193
+ S P+ L+ + + +S N N + + L
Sbjct: 151 YCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG 210
Query: 194 LSGSVPEEFGD---NCVSLEHILLAANSLTGS-----IPPSLGNCTELRSLLLSSNMLQG 245
++ + + SL + L +N L P L + LR+L + +
Sbjct: 211 VTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITA 270
Query: 246 D----IPSSFGQLVNLEVLDLSRNFLS-----GIVPSELGMCKQLKVLVLRNDYGPLYSR 296
+ +L+ L L+ N L + + L QL+ L +++
Sbjct: 271 KGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCS------ 324
Query: 297 EHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN---WELC-- 351
+ + L L + ++ ELC
Sbjct: 325 ------FTA--ACCSH-------FSSVLAQNRFLL-----ELQISNNRLEDAGVRELCQG 364
Query: 352 -----SKLEMLNLAHNFFTGQ----IPASLGNCKSLYFLDLSSNNLT 389
S L +L LA + + A+L SL LDLS+N L
Sbjct: 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 55/334 (16%), Positives = 97/334 (29%), Gaps = 73/334 (21%)
Query: 102 LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQL-----SLLEILDLSFNSFH----GPIPP 152
+S A+ L L L N + Q ++ L L G +
Sbjct: 48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107
Query: 153 TLQNCSSLRLINLSGNQFNGT-----IPAFFGQSPGFQVVSLSFNLLSGSVPEEFGD--- 204
TL+ +L+ ++LS N + + L + LS + E
Sbjct: 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLR 167
Query: 205 NCVSLEHILLAANSLTGS----IPPSLGNCTE-LRSLLLSSNMLQGD----IPSSFGQLV 255
+ + ++ N + + + L + L +L L S + D +
Sbjct: 168 AKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKA 227
Query: 256 NLEVLDLSRNFLSG-----IVPSELGMCKQLKVLVLR-NDYGPLYSREHGDLPIQPVVDG 309
+L L L N L + P L +L+ L + G
Sbjct: 228 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITA---------------KG 272
Query: 310 GEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN----------WELCSKLEMLNL 359
D L + +L+ L+L G + E +LE L +
Sbjct: 273 CGD-------LCRVLRAKESLK-----ELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320
Query: 360 AHNFFTGQ----IPASLGNCKSLYFLDLSSNNLT 389
FT + L + L L +S+N L
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 7e-05
Identities = 49/280 (17%), Positives = 79/280 (28%), Gaps = 81/280 (28%)
Query: 45 TSLNLSSN-------------LSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNIN 91
L +S+N L + C L +L +
Sbjct: 173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEAL-------------------------KLE 207
Query: 92 SNS-SDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSL-----LEILDLSFNS 145
S + +L + LR L L N E+ L L L +
Sbjct: 208 SCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267
Query: 146 FHGP----IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEE 201
+ L+ SL+ ++L+GN+ G L LL
Sbjct: 268 ITAKGCGDLCRVLRAKESLKELSLAGNEL---------GDEG--ARLLCETLL------- 309
Query: 202 FGDNCVSLEHILLAANSLTG----SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV-- 255
+ LE + + + S T L L L +S+N L+ Q +
Sbjct: 310 --EPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ 367
Query: 256 ---NLEVLDLSRNFLSGI----VPSELGMCKQLKVLVLRN 288
L VL L+ +S + + L L+ L L N
Sbjct: 368 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 407
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-04
Identities = 35/197 (17%), Positives = 58/197 (29%), Gaps = 38/197 (19%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQ-LSLLEILDLSFNSFH----GPIPPTLQNCSSLRLIN 164
++ L + S E+ L +++ L I L+ +L +N
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLT---- 220
L N+ G V + ++ + L LT
Sbjct: 63 LRSNEL---------GDVGVHCVL-----------QGLQTPSCKIQKLSLQNCCLTGAGC 102
Query: 221 GSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV-----NLEVLDLSRNFLSGI----V 271
G + +L L+ L LS N+L + + LE L L LS +
Sbjct: 103 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162
Query: 272 PSELGMCKQLKVLVLRN 288
S L K L + N
Sbjct: 163 ASVLRAKPDFKELTVSN 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 30/160 (18%), Positives = 54/160 (33%), Gaps = 33/160 (20%)
Query: 128 LEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187
+ + +E L + TL + + + LS N + +
Sbjct: 20 VVATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNN--------------IEKI 63
Query: 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDI 247
S +L +L + L N + I L L +S N + +
Sbjct: 64 S---SL----------SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL 108
Query: 248 PSSFGQLVNLEVLDLSRNFLSGIVP-SELGMCKQLKVLVL 286
S +LVNL VL +S N ++ +L +L+ L+L
Sbjct: 109 -SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLL 147
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 34/179 (18%), Positives = 55/179 (30%), Gaps = 57/179 (31%)
Query: 223 IPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLK 282
+ +L + L LS+N ++ I SS + NL +L L RN + I + + L+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIENLD-AVADTLE 96
Query: 283 VLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEG 342
L + N I L +
Sbjct: 97 ELWISY-------------------------NQ--------IASLSGI------------ 111
Query: 343 IFPQNWELCSKLEMLNLAHNFFT--GQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVP 399
E L +L +++N T G+I L L L L+ N L E +
Sbjct: 112 ------EKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 26/160 (16%), Positives = 49/160 (30%), Gaps = 55/160 (34%)
Query: 232 ELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYG 291
E L ++ + ++ L + L LS N + I S L + L++L L
Sbjct: 26 EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSL----- 77
Query: 292 PLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELC 351
N I ++ NL +
Sbjct: 78 --------------------GRN--------LIKKIENLD-----------------AVA 92
Query: 352 SKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391
LE L +++N + + + +L L +S+N +T
Sbjct: 93 DTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNW 130
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 24/97 (24%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 559 IPQSFTNFDSLRNLNLSRNHLQ---GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
+ + + + ++L LS N+++ ++ ME+L+ LSL N +
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIKKIENLD-AVAD 93
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
+LE L +S N ++ + S KL +L VL + +N +T
Sbjct: 94 TLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 22/112 (19%), Positives = 46/112 (41%), Gaps = 14/112 (12%)
Query: 586 YINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLR 645
+ E ++ L + + L+ L + + L LS N++ +I S S +E+L +L
Sbjct: 21 VATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILS 76
Query: 646 LDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQ 697
L N + +I +L +S+N ++ ++ NL+
Sbjct: 77 LGRNLIK-KIENLDAVADTLEELWISYNQIA---------SLSGIEKLVNLR 118
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/120 (26%), Positives = 55/120 (45%), Gaps = 8/120 (6%)
Query: 540 SHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS 599
S K K L+++ N + S + ++LR L+L RN ++ + + + L+ L +S
Sbjct: 45 STLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWIS 101
Query: 600 LNNFTGAIPWELTQLASLEVLELSANSLS--GEIPSEFSKLEHLNVLRLDHNNLTGRIPP 657
N E +L +L VL +S N ++ GEI + + L+ L L L N L
Sbjct: 102 YNQIASLSGIE--KLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKE 158
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 34/130 (26%), Positives = 52/130 (40%), Gaps = 4/130 (3%)
Query: 137 EILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPA-FFGQSPGFQVVSLSFNLLS 195
+IL L N P + +L+ + L NQ +P F V+ L N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255
+P D V L+ + + N LT +P + T L L L N L+ +F +L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 256 NLEVLDLSRN 265
+L L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 38/163 (23%), Positives = 58/163 (35%), Gaps = 21/163 (12%)
Query: 570 RNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSG 629
+ L L N + P + + +LK L L N L L VL+L N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 630 EIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPR---NSLIK 686
+ F +L HL L + N LT +P G + L+ + N L S P + L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSS 160
Query: 687 CENVQ--GNP-------NLQLCHTDPSSSEWERQHSGNVSQQE 720
+ GNP + L W H+ + +
Sbjct: 161 LTHAYLFGNPWDCECRDIMYL-------RNWVADHTSIAMRWD 196
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 32/132 (24%), Positives = 47/132 (35%), Gaps = 23/132 (17%)
Query: 156 NCSSLRL-------------INLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEF 202
+C S R + L NQ P F + + L N L ++P
Sbjct: 25 DCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGV 83
Query: 203 GDNCVSLEHILLAANSLTGSIPP----SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLE 258
D+ L + L N LT +P L + EL + N L +P +L +L
Sbjct: 84 FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELF---MCCNKLTE-LPRGIERLTHLT 138
Query: 259 VLDLSRNFLSGI 270
L L +N L I
Sbjct: 139 HLALDQNQLKSI 150
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 49/179 (27%), Positives = 68/179 (37%), Gaps = 27/179 (15%)
Query: 566 FDSLRN---LNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLE 621
L N L L+ N LQ LP+ + +K+ +LK L L N +L +L L
Sbjct: 81 LKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139
Query: 622 LSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLSGSAP 680
L+ N L F KL +L L L +N L +P G F + L + N L S P
Sbjct: 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVP 197
Query: 681 R---NSLIKCENVQ--GNP-------NLQLCHTDPSSSEWERQHSGNVSQQEAYSPSES 727
+ L + + NP L SEW +HSG V +S
Sbjct: 198 DGVFDRLTSLQYIWLHDNPWDCTCPGIRYL-------SEWINKHSGVVRNSAGSVAPDS 249
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 51/231 (22%), Positives = 78/231 (33%), Gaps = 61/231 (26%)
Query: 45 TSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSR 104
NL S+ L+ D+ N++ + G
Sbjct: 22 IKANLKKK------SVTDAVTQNE-------------LNSIDQIIANNSDIKSVQG---- 58
Query: 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLIN 164
I L +R L L N +L + L ++L +
Sbjct: 59 -IQYLPNVRYLALGGN-----------KLHDISALK---------------ELTNLTYLI 91
Query: 165 LSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP 224
L+GNQ F + + + L N L S+P+ D +L ++ LA N L S+P
Sbjct: 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLP 149
Query: 225 P----SLGNCTELRSLLLSSNMLQGDIPSS-FGQLVNLEVLDLSRNFLSGI 270
L T L L LS N LQ +P F +L L+ L L +N L +
Sbjct: 150 KGVFDKL---TNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKSV 196
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 15/183 (8%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
+ L + + + L+ ++ + + + +Q ++R + L GN+
Sbjct: 19 AETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNK 74
Query: 170 FNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGN 229
+ I A + + L+ N L S+P D +L+ ++L N L S+P + +
Sbjct: 75 LH-DISALKELTN-LTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD 130
Query: 230 C-TELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI---VPSELGMCKQLKVLV 285
T L L L+ N LQ F +L NL LDLS N L + V +L QLK L
Sbjct: 131 KLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLT---QLKDLR 187
Query: 286 LRN 288
L
Sbjct: 188 LYQ 190
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 37/115 (32%), Positives = 54/115 (46%), Gaps = 5/115 (4%)
Query: 546 KFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFT 604
+L + GN+ L F +L+ L L N LQ LP + +K+ +L +L+L+ N
Sbjct: 88 TYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 605 GAIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG 658
+L +L L+LS N L +P F KL L LRL N L +P G
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDG 199
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 50/264 (18%), Positives = 86/264 (32%), Gaps = 41/264 (15%)
Query: 134 SLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSP-GFQVVSLSFN 192
SL + LDL+ + H P S +I + P SP Q + LS +
Sbjct: 47 SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNS 103
Query: 193 LLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLS--SNMLQGDIPSS 250
++ S C L+++ L L+ I +L + L L LS S + + +
Sbjct: 104 VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 163
Query: 251 FGQLVNLEVLDLSRNFL---SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVV 307
L+ L+LS F + + + + + L L
Sbjct: 164 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS-------------------- 203
Query: 308 DGGEDYNFFDGGLPDSITRLPNLR---VFWAPNLNLEGIFPQNWEL--CSKLEMLNLAH- 361
G N L + R PNL + + L + E + L+ L+L+
Sbjct: 204 --GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF----QEFFQLNYLQHLSLSRC 257
Query: 362 NFFTGQIPASLGNCKSLYFLDLSS 385
+ LG +L L +
Sbjct: 258 YDIIPETLLELGEIPTLKTLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 53/270 (19%), Positives = 83/270 (30%), Gaps = 34/270 (12%)
Query: 29 SCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRG 88
W+ + D + L + + LLS +G
Sbjct: 36 CKRWYRLASDESLWQTLDLTGKNLHPDVTGRLLS------------------------QG 71
Query: 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQ-LSLLEILDLSFNSFH 147
I +++ + L+ + I S L+ L L
Sbjct: 72 VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLS 131
Query: 148 GPIPPTLQNCSSLRLINLSGNQF--NGTIPAFFGQSPGFQVVSLSF--NLLSGSVPEEFG 203
PI TL S+L +NLSG + ++LS+ + V
Sbjct: 132 DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA 191
Query: 204 DNCVSLEHILLA--ANSLTGSIPPSLG-NCTELRSLLLSS-NMLQGDIPSSFGQLVNLEV 259
++ + L+ +L S +L C L L LS ML+ D F QL L+
Sbjct: 192 HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 251
Query: 260 LDLSR-NFLSGIVPSELGMCKQLKVLVLRN 288
L LSR + ELG LK L +
Sbjct: 252 LSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 43/171 (25%), Positives = 59/171 (34%), Gaps = 22/171 (12%)
Query: 570 RNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSG 629
L+L N L+ +++ L L L N +L SL L LS N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 630 EIPSEFSKLEHLNVLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLSGSAPR---NSLI 685
F KL L L L+ N L +P G F + L + N L S P + L
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148
Query: 686 KCENVQGNPN---------LQLCHTDPSSSEWERQHSGNVSQQEAYSPSES 727
+ + + N L SEW +HSG V +S
Sbjct: 149 SLQYIWLHDNPWDCTCPGIRYL-------SEWINKHSGVVRNSAGSVAPDS 192
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 41/124 (33%), Positives = 54/124 (43%), Gaps = 6/124 (4%)
Query: 546 KFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI-NKMEDLKFLSLSLNNFT 604
+L + N L F SL L L N LQ LP+ + NK+ L +L+LS N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 605 GAIPWELTQLASLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGRIPPG-FGTR 662
+L L+ L L+ N L +P F KL L LRL N L +P G F
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL 147
Query: 663 SSLS 666
+SL
Sbjct: 148 TSLQ 151
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 36/135 (26%), Positives = 52/135 (38%), Gaps = 22/135 (16%)
Query: 596 LSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRI 655
L L N FT +P EL+ L +++LS N +S FS + L L L +N L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 656 PPG-FGTRSSLSIFDVSFNNLSGSAPR---NSLIKCENVQ--GNP------NLQLCHTDP 703
PP F SL + + N++S P N L ++ NP L
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDCNMQWL----- 147
Query: 704 SSSEWERQHSGNVSQ 718
S+W +
Sbjct: 148 --SDWVKSEYKEPGI 160
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 24/75 (32%), Positives = 31/75 (41%), Gaps = 1/75 (1%)
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPS 273
L N T +P L N L + LS+N + SF + L L LS N L I P
Sbjct: 38 LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPR 96
Query: 274 ELGMCKQLKVLVLRN 288
K L++L L
Sbjct: 97 TFDGLKSLRLLSLHG 111
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 4e-05
Identities = 18/178 (10%), Positives = 54/178 (30%), Gaps = 28/178 (15%)
Query: 100 GNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQ--NC 157
+LS + + L L + L + L+ L++ + + +
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 158 SSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAAN 217
+L + L + + P +L+ + +
Sbjct: 219 PNLEKLVLYVGVED--------YGFDGDMNVFRPLFSKDRFP--------NLKWLGIVDA 262
Query: 218 SLTGSIPPSLGNC---TELRSLLLSSNMLQGD----IPSSFGQLVNLEVLDLSRNFLS 268
+ +L ++ +S+ +L + + ++ +L+ +++ N+LS
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 3e-04
Identities = 38/289 (13%), Positives = 81/289 (28%), Gaps = 34/289 (11%)
Query: 144 NSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFG 203
+ + + + + + + G E
Sbjct: 63 KGYVETLEEVAKEMKVEAKKYALSYDEAEEGVNLMDKILKDKKLPSLKQITIGXWGYEGE 122
Query: 204 DNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
D + I+ G+ + S + Q D+ + L L +
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEI--SWIEQVDLSPVLDAMPLLNNLKIK 180
Query: 264 RNFLSGIVPSELGMCKQLKVLVLRNDYGP-----------LYSREHGDLPIQPVVDGGED 312
I LK L + + P L + E L G +
Sbjct: 181 GTNNLSIGKKPR---PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVL------YVGVE 231
Query: 313 YNFFDGGLPD-----SITRLPNLRVFWAPNLNLEGIFPQ---NWELCSKLEMLNLAHNFF 364
FDG + S R PNL+ + + + + ++ +LE ++++
Sbjct: 232 DYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291
Query: 365 TG----QIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQN 409
T + + K L F+++ N L+ + +E+ +VS +
Sbjct: 292 TDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDS 340
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 5e-04
Identities = 14/81 (17%), Positives = 31/81 (38%), Gaps = 7/81 (8%)
Query: 564 TNFDSLRNLNLSRNHLQGPLPSYI---NKMEDLKFLSLSLNNFTG----AIPWELTQLAS 616
F +L+ L + Q + + + L+ + +S T + + ++
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 617 LEVLELSANSLSGEIPSEFSK 637
L+ + + N LS E+ E K
Sbjct: 309 LKFINMKYNYLSDEMKKELQK 329
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 15/114 (13%)
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIA 905
E R L V+ + + V ++ +Y+ G + I+D A
Sbjct: 388 REARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDI----------A 437
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
+ + LH V+H D+ SN + D +L Y+ DFGL ++ E A
Sbjct: 438 YKIGEIVGKLHKN---DVIHNDLTTSNFIFDKDL--YIIDFGLGKISNLDEDKA 486
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 Length = 264 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 29/203 (14%), Positives = 52/203 (25%), Gaps = 46/203 (22%)
Query: 794 ENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR 853
V G++ A ++ V+ VK G +Q AA + L
Sbjct: 13 AAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLAT 72
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM----LHKIALD-- 907
P ++ +L+ +PG +L + + LH +
Sbjct: 73 TGVP-CAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATC 131
Query: 908 ---------VARALAYLHDECV------------------------------PRVLHRDI 928
+ RA + V V H D
Sbjct: 132 PFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDA 191
Query: 929 KPSNILLDNNLNAYLSDFGLARL 951
NI+++N + D G +
Sbjct: 192 CLPNIMVENGRFSGFIDCGRLGV 214
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 21/91 (23%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP----SLGNCTELRSLLLSS 240
+ L+ N L + L + L N LT I P + ++ L L
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA---SHIQELQLGE 87
Query: 241 NMLQGDIPS-SFGQLVNLEVLDLSRNFLSGI 270
N ++ +I + F L L+ L+L N +S +
Sbjct: 88 NKIK-EISNKMFLGLHQLKTLNLYDNQISCV 117
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1082 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.98 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.85 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.85 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.84 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.74 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.74 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.74 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.53 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.44 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.23 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.17 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.95 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.88 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.84 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.79 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.69 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.67 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.32 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.3 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.22 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.14 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.01 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.99 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.97 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.76 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.59 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.56 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.46 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.43 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.35 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.92 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.88 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.79 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.73 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.65 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.61 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.61 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.95 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.49 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.0 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 84.06 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.77 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-73 Score=715.76 Aligned_cols=643 Identities=28% Similarity=0.406 Sum_probs=508.4
Q ss_pred CHHHHHHHHhcccCCCCCCCCCCCCCCCCceeeeeEeeCCCCCeeeeecCCCccccccccCCCCCCCCCCCCcccCcCcc
Q 045553 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCL 80 (1082)
Q Consensus 1 ~~~l~~~k~~~~~~~~~~~~~W~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (1082)
|+||++||+++. ||. .+++|. .++|||.|.||+|+ ++||++|||+++....... .+++ .
T Consensus 14 ~~all~~k~~~~-~~~-~l~~W~-~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~--~l~~----------~---- 72 (768)
T 3rgz_A 14 IHQLISFKDVLP-DKN-LLPDWS-SNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFS--AVSS----------S---- 72 (768)
T ss_dssp HHHHHHHHTTCS-CTT-SSTTCC-TTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHH--HHHH----------H----
T ss_pred HHHHHHHHhhCC-Ccc-cccCCC-CCCCCcCCcceEEC--CCcEEEEECCCCCcCCccC--ccCh----------h----
Confidence 579999999997 887 899998 46899999999999 7999999998752211000 0000 0
Q ss_pred cccccccCcccCCCCCCccccccccccCCCCCCEEEcccCCCcccCCh--hhcCCCCCCEEeCcCCCCCCCCCccc-cCC
Q 045553 81 QLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPL--EIGQLSLLEILDLSFNSFHGPIPPTL-QNC 157 (1082)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~l-~~l 157 (1082)
+..+......+++.+++. .+|+.|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++
T Consensus 73 -l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l 150 (768)
T 3rgz_A 73 -LLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKL 150 (768)
T ss_dssp -TTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCC
T ss_pred -HhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccC
Confidence 111122233334444442 2458899999999999999999998998 89999999999999999998888776 899
Q ss_pred CCCCeEEccCcccccccCcc---ccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCcc
Q 045553 158 SSLRLINLSGNQFNGTIPAF---FGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELR 234 (1082)
Q Consensus 158 ~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 234 (1082)
++|++|+|++|++++..|.. +.++++|++|++++|++.+..|. ..+++|++|+|++|++++.+|. ++++++|+
T Consensus 151 ~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~ 226 (768)
T 3rgz_A 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQ 226 (768)
T ss_dssp TTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSCC
T ss_pred CCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCCC
Confidence 99999999999999888876 88999999999999999977665 3689999999999999987777 99999999
Q ss_pred EEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCC-cccccCCCCCCcccccCCCcc
Q 045553 235 SLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGP-LYSREHGDLPIQPVVDGGEDY 313 (1082)
Q Consensus 235 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~-~~~~~~~~l~~~~~~~~~~~~ 313 (1082)
+|+|++|++++.+|..|..+++|++|++++|++++.+|.. .+++|++|++++|.+. ..+...... ...+.......
T Consensus 227 ~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~-~~~L~~L~Ls~ 303 (768)
T 3rgz_A 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA-CDTLTGLDLSG 303 (768)
T ss_dssp EEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTT-CTTCSEEECCS
T ss_pred EEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhh-cCcCCEEECcC
Confidence 9999999999999999999999999999999999887775 8999999999988654 333222221 01223333455
Q ss_pred cccCCCCCccccCCCCCcEEEcCCCcccCCCCcc-cccccCCCeEEcCCccccCCCCccccCCC-CCCEEecCCCcCccc
Q 045553 314 NFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN-WELCSKLEMLNLAHNFFTGQIPASLGNCK-SLYFLDLSSNNLTGL 391 (1082)
Q Consensus 314 n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~-l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~ 391 (1082)
|.+.+.+|..|+.+++|++|++++|.+.+..|.. +..+++|++|+|++|++++.+|..+.+++ +|+.|+|++|++++.
T Consensus 304 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~ 383 (768)
T 3rgz_A 304 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383 (768)
T ss_dssp SEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEE
T ss_pred CcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCC
Confidence 6777777777777777777777777777555544 77777777777777777777777777776 777777777777776
Q ss_pred CCCCcc---cCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEee
Q 045553 392 LPEEVS---VPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHD 468 (1082)
Q Consensus 392 ~p~~~~---l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (1082)
+|..+. +++|+.|++++|.+++.+|..- ..|. +++.++ +..+.+.+..+.....-.-+..++
T Consensus 384 ~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l-~~l~------~L~~L~--------Ls~N~l~~~~p~~l~~l~~L~~L~ 448 (768)
T 3rgz_A 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTL-SNCS------ELVSLH--------LSFNYLSGTIPSSLGSLSKLRDLK 448 (768)
T ss_dssp CCTTTTCSTTCCCCEEECCSSEEEEECCGGG-GGCT------TCCEEE--------CCSSEEESCCCGGGGGCTTCCEEE
T ss_pred cChhhhhcccCCccEEECCCCccccccCHHH-hcCC------CCCEEE--------CcCCcccCcccHHHhcCCCCCEEE
Confidence 666552 5667777777777777666321 1111 112222 222333333222222223355678
Q ss_pred ccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEE
Q 045553 469 FSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFL 548 (1082)
Q Consensus 469 l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L 548 (1082)
+++|.++|.+|..+..+..+ ..+++++|.+++. +|..+..+.+|++|++++|++.+.+|.++.. +++|++|
T Consensus 449 L~~n~l~~~~p~~~~~l~~L-----~~L~L~~N~l~~~---~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L 519 (768)
T 3rgz_A 449 LWLNMLEGEIPQELMYVKTL-----ETLILDFNDLTGE---IPSGLSNCTNLNWISLSNNRLTGEIPKWIGR-LENLAIL 519 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTC-----CEEECCSSCCCSC---CCGGGGGCTTCCEEECCSSCCCSCCCGGGGG-CTTCCEE
T ss_pred CCCCcccCcCCHHHcCCCCc-----eEEEecCCcccCc---CCHHHhcCCCCCEEEccCCccCCcCChHHhc-CCCCCEE
Confidence 89999999999888766554 5677888888764 5777888899999999999999999988764 6789999
Q ss_pred EccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccc-----------------------------------------
Q 045553 549 SMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYI----------------------------------------- 587 (1082)
Q Consensus 549 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~----------------------------------------- 587 (1082)
+|++|++++.+|..|..+++|++|+|++|.++|.+|..+
T Consensus 520 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (768)
T 3rgz_A 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599 (768)
T ss_dssp ECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTC
T ss_pred ECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999987777544
Q ss_pred -----------------------------cCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCC
Q 045553 588 -----------------------------NKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKL 638 (1082)
Q Consensus 588 -----------------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 638 (1082)
..+++|++|+|++|+++|.+|..|++++.|+.|+|++|+++|.+|..|+.+
T Consensus 600 ~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L 679 (768)
T 3rgz_A 600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 679 (768)
T ss_dssp CGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred cchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCC
Confidence 335789999999999999999999999999999999999999999999999
Q ss_pred cccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCCcc---cccccCCCCCCCC
Q 045553 639 EHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSL---IKCENVQGNPNLQ 697 (1082)
Q Consensus 639 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~---~~~~~~~~Np~~c 697 (1082)
++|+.|||++|+++|.+|..|..+++|++||+++|+|+|.+|.... +....+.|||++|
T Consensus 680 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEE
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhc
Confidence 9999999999999999999999999999999999999999998754 4566899999994
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-58 Score=575.61 Aligned_cols=528 Identities=30% Similarity=0.421 Sum_probs=357.3
Q ss_pred CCCCcccccccc---ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccc
Q 045553 94 SSDKLSGNLSRA---IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQF 170 (1082)
Q Consensus 94 ~~~~l~g~l~~~---l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 170 (1082)
+.+.+++..|.. +.++++|++|+|++|.+++..| +..+++|++|+|++|.+++.+|. ++++++|++|+|++|++
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l 235 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCC
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcC
Confidence 344444444444 4555555555555555554433 25566666666666666655555 66666666666666666
Q ss_pred ccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCC-CCccEEEccCCcCCCCcCc
Q 045553 171 NGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNC-TELRSLLLSSNMLQGDIPS 249 (1082)
Q Consensus 171 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~ 249 (1082)
++.+|..|..+++|++|+|++|++.+.+|.. .+++|++|++++|++++.+|..+..+ ++|++|+|++|++++.+|.
T Consensus 236 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~ 312 (768)
T 3rgz_A 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312 (768)
T ss_dssp CSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCG
T ss_pred CCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccch
Confidence 6666666666666666666666666655554 45666666666666666666666554 6677777777776666666
Q ss_pred cccCCCCCCEEeCCCCcCcccCCcc-ccCCCCCcEEEeccccCC-cccccCCCCCCcccccCCCcccccCCCCCccccC-
Q 045553 250 SFGQLVNLEVLDLSRNFLSGIVPSE-LGMCKQLKVLVLRNDYGP-LYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITR- 326 (1082)
Q Consensus 250 ~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~l~~n~~~-~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~- 326 (1082)
.|+.+++|++|++++|++++.+|.. +..+++|++|++++|.+. ..+.....++ ..+.....+.|.+.+.+|..+..
T Consensus 313 ~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~~L~~L~Ls~N~l~~~~~~~~~~~ 391 (768)
T 3rgz_A 313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLS-ASLLTLDLSSNNFSGPILPNLCQN 391 (768)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHT-TTCSEEECCSSEEEEECCTTTTCS
T ss_pred HHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhh-cCCcEEEccCCCcCCCcChhhhhc
Confidence 6666677777777777666556654 666667777776666443 1111111110 01222223445555555555555
Q ss_pred -CCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-ccCcccEE
Q 045553 327 -LPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVF 404 (1082)
Q Consensus 327 -l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~~L 404 (1082)
+++|++|++++|.+.+..|..+..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+ .+++|+.|
T Consensus 392 ~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 471 (768)
T 3rgz_A 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL 471 (768)
T ss_dssp TTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred ccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEE
Confidence 5566666666666666666666666666666666666666666666666666666666666666555554 35566666
Q ss_pred EecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCcccc
Q 045553 405 NVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLID 484 (1082)
Q Consensus 405 ~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~ 484 (1082)
++++|+++|.+|.. ...-.-+..+++++|.++|.+|.++..
T Consensus 472 ~L~~N~l~~~~p~~---------------------------------------l~~l~~L~~L~L~~N~l~~~~p~~~~~ 512 (768)
T 3rgz_A 472 ILDFNDLTGEIPSG---------------------------------------LSNCTNLNWISLSNNRLTGEIPKWIGR 512 (768)
T ss_dssp ECCSSCCCSCCCGG---------------------------------------GGGCTTCCEEECCSSCCCSCCCGGGGG
T ss_pred EecCCcccCcCCHH---------------------------------------HhcCCCCCEEEccCCccCCcCChHHhc
Confidence 66666665554421 001111345678888888888888776
Q ss_pred CCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCC---------------------
Q 045553 485 SDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCK--------------------- 543 (1082)
Q Consensus 485 ~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~--------------------- 543 (1082)
+..| ..+++++|.+++. +|..++.+.+|++|++++|++.|.+|..++....
T Consensus 513 l~~L-----~~L~L~~N~l~~~---~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (768)
T 3rgz_A 513 LENL-----AILKLSNNSFSGN---IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK 584 (768)
T ss_dssp CTTC-----CEEECCSSCCEEE---CCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCC
T ss_pred CCCC-----CEEECCCCcccCc---CCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccc
Confidence 6554 4567778877653 5677788888888888888888888887765321
Q ss_pred ------------------------cccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcC
Q 045553 544 ------------------------CMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS 599 (1082)
Q Consensus 544 ------------------------~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 599 (1082)
.+..++++.|.+.|.+|..|..+++|++|||++|+++|.+|..|+.+++|+.|+|+
T Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls 664 (768)
T 3rgz_A 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664 (768)
T ss_dssp TTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCc
Confidence 12233445577788888889999999999999999999999999999999999999
Q ss_pred CCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccc
Q 045553 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676 (1082)
Q Consensus 600 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 676 (1082)
+|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++|+|++|+++|.+|.. ..+..+....+.+|+--
T Consensus 665 ~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~L 740 (768)
T 3rgz_A 665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGL 740 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEE
T ss_pred CCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchh
Confidence 99999999999999999999999999999999999999999999999999999999975 34555555566777643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-55 Score=545.39 Aligned_cols=547 Identities=20% Similarity=0.231 Sum_probs=392.8
Q ss_pred CCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccccc
Q 045553 95 SDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTI 174 (1082)
Q Consensus 95 ~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 174 (1082)
.+.+.+..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|++|++++..
T Consensus 34 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 113 (680)
T 1ziw_A 34 HNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113 (680)
T ss_dssp SSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccC
Confidence 35555555556666777777777777776666666677777777777777766433345667777777777777776555
Q ss_pred CccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCcccc--CCCCccEEEccCCcCCCCcCcccc
Q 045553 175 PAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG--NCTELRSLLLSSNMLQGDIPSSFG 252 (1082)
Q Consensus 175 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~ 252 (1082)
|..|+++++|++|+|++|.+++..|..+. .+++|++|++++|++++..+..+. .+++|++|++++|++++..|..|.
T Consensus 114 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~ 192 (680)
T 1ziw_A 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQV-QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192 (680)
T ss_dssp SCTTTTCTTCCEEECCSSCCSCCCCCSSS-CCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGG
T ss_pred hhHccccCCCCEEECCCCcccccCchhhc-ccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhh
Confidence 56666777777777777776654444443 466777777777776655554433 346677777777776666666555
Q ss_pred CCC---------------------------CCCEEeCCCCcCcccCCccccCCCC--CcEEEeccccCCcccccCCCCCC
Q 045553 253 QLV---------------------------NLEVLDLSRNFLSGIVPSELGMCKQ--LKVLVLRNDYGPLYSREHGDLPI 303 (1082)
Q Consensus 253 ~l~---------------------------~L~~L~Ls~N~l~~~~p~~l~~l~~--L~~L~l~~n~~~~~~~~~~~l~~ 303 (1082)
.++ +|++|++++|.+++..|..|..++. |+.|++++
T Consensus 193 ~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~--------------- 257 (680)
T 1ziw_A 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY--------------- 257 (680)
T ss_dssp GSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTT---------------
T ss_pred hhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCC---------------
Confidence 544 4555555555555555555555543 66666655
Q ss_pred cccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccC-----CCCc----cccC
Q 045553 304 QPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTG-----QIPA----SLGN 374 (1082)
Q Consensus 304 ~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~-----~~p~----~~~~ 374 (1082)
|.+.+..|..|..+++|++|++++|++.+..+..|..+++|++|++++|...+ .+|. .|..
T Consensus 258 ----------n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~ 327 (680)
T 1ziw_A 258 ----------NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327 (680)
T ss_dssp ----------SCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTT
T ss_pred ----------CCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhccc
Confidence 44455556677777788888888888777777777777888888887765543 2232 5677
Q ss_pred CCCCCEEecCCCcCcccCCCCc-ccCcccEEEecCCcceec-CCCCCCcccccccccccccceeeeeecccccccccccC
Q 045553 375 CKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFNVSQNLLSGE-IPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTS 452 (1082)
Q Consensus 375 l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~~L~l~~N~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (1082)
+++|++|+|++|++++..+..+ .+++|+.|++++|.+.+. ++... +..
T Consensus 328 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~------------------------------f~~ 377 (680)
T 1ziw_A 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET------------------------------FVS 377 (680)
T ss_dssp CTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTT------------------------------TGG
T ss_pred CCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhh------------------------------hcc
Confidence 7788888888888877766655 567788888887775421 11110 000
Q ss_pred cCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccc
Q 045553 453 CAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIG 532 (1082)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~ 532 (1082)
+. ..-+..+++++|.+++..|..+..+..+ ..+++++|.+++.+. +..+....++++|++++|++.
T Consensus 378 ~~------~~~L~~L~L~~n~l~~~~~~~~~~l~~L-----~~L~L~~N~l~~~~~--~~~~~~l~~L~~L~Ls~n~l~- 443 (680)
T 1ziw_A 378 LA------HSPLHILNLTKNKISKIESDAFSWLGHL-----EVLDLGLNEIGQELT--GQEWRGLENIFEIYLSYNKYL- 443 (680)
T ss_dssp GT------TSCCCEEECTTSCCCEECTTTTTTCTTC-----CEEECCSSCCEEECC--SGGGTTCTTCCEEECCSCSEE-
T ss_pred cc------cCcCceEECCCCCCCeEChhhhhCCCCC-----CEEeCCCCcCccccC--cccccCcccccEEecCCCCcc-
Confidence 00 0113456788899988777777665554 467778888765432 145567788999999999988
Q ss_pred cCCccccccCCcccEEEccCCccc--ccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCc--
Q 045553 533 EVPSDMGSHCKCMKFLSMAGNEFV--GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIP-- 608 (1082)
Q Consensus 533 ~ip~~~~~~~~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-- 608 (1082)
.++...+..+++|+.|++++|.++ +..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|++++..+
T Consensus 444 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 523 (680)
T 1ziw_A 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHA 523 (680)
T ss_dssp ECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTT
T ss_pred eeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhh
Confidence 566666778899999999999997 5788999999999999999999998888889999999999999999986522
Q ss_pred ------hhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC
Q 045553 609 ------WELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN 682 (1082)
Q Consensus 609 ------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 682 (1082)
..|.++++|++|+|++|+|+...+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|++++..|..
T Consensus 524 ~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 603 (680)
T 1ziw_A 524 NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603 (680)
T ss_dssp STTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHH
T ss_pred ccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhH
Confidence 23789999999999999999655567999999999999999999887888899999999999999999866642
Q ss_pred -----cccccccCCCCCCCCCCCCCCCCCccccc
Q 045553 683 -----SLIKCENVQGNPNLQLCHTDPSSSEWERQ 711 (1082)
Q Consensus 683 -----~~~~~~~~~~Np~~c~c~~~~~~~~~~~~ 711 (1082)
..+....+.+|||.|+|....|...|...
T Consensus 604 ~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~~~ 637 (680)
T 1ziw_A 604 FGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637 (680)
T ss_dssp HHHHHTTCSEEECTTCCCCBCCCCCSSEECCSSC
T ss_pred hcccccccCEEEccCCCcccCCccHHHHHHHHHh
Confidence 34567789999999999865666677654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-56 Score=545.69 Aligned_cols=497 Identities=19% Similarity=0.266 Sum_probs=374.1
Q ss_pred CHHHHHHHHhcccCCCCCC-------CCCCCCCCCCcee---eeeEeeCCCCCeeeeecCCCccccccccCCCCCCCCCC
Q 045553 1 KNALLQLKSAITEDPLGLT-------SNWNPKDTDSCSW---HGVTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPG 70 (1082)
Q Consensus 1 ~~~l~~~k~~~~~~~~~~~-------~~W~~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~ 70 (1082)
++||++||.++..+.+... ++|+. ++|||.| .||+|+.. |||++|+|++
T Consensus 32 ~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~-~~V~~L~L~~------------------- 90 (636)
T 4eco_A 32 YLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSN-GRVTGLSLEG------------------- 90 (636)
T ss_dssp HHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTT-CCEEEEECTT-------------------
T ss_pred HHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCC-CCEEEEEecC-------------------
Confidence 4799999999875555433 48985 6899999 99999864 8999999986
Q ss_pred CCcccCcCcccccccccCcccCCCCCCccccccccccCCCCCCEEEcccCCC------cc------cCChhhcCCCCCCE
Q 045553 71 GNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGF------SG------ELPLEIGQLSLLEI 138 (1082)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~ 138 (1082)
+++.|.+|++|++|++|++|+|++|.+ .+ .+|... +.+|+
T Consensus 91 -------------------------~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~- 142 (636)
T 4eco_A 91 -------------------------FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR- 142 (636)
T ss_dssp -------------------------SCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-
T ss_pred -------------------------cccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-
Confidence 568899999999999999999999976 23 445444 55667
Q ss_pred EeCcCCCCCCCCCccccC-CCCCCeEEccCcccccccCccccCCCCCcEEEcc--cCcccccCCcccccccccccEEEcc
Q 045553 139 LDLSFNSFHGPIPPTLQN-CSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLS--FNLLSGSVPEEFGDNCVSLEHILLA 215 (1082)
Q Consensus 139 L~Ls~n~l~~~~p~~l~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~--~N~l~~~~p~~~~~~l~~L~~L~L~ 215 (1082)
++++.|.+.+.+|..+.. +..+..+++....+.. .....++.+.+. .|++++ +|..++ .+++|++|+|+
T Consensus 143 l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~-~l~~L~~L~Ls 214 (636)
T 4eco_A 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVM-RLTKLRQFYMG 214 (636)
T ss_dssp THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGG-GCTTCCEEEEE
T ss_pred hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHh-cccCCCEEECc
Confidence 888888888777766652 2233333333222210 011122222222 345554 555443 35555555555
Q ss_pred cCccCCC-----------------CCcccc--CCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCc-Ccc-cCCcc
Q 045553 216 ANSLTGS-----------------IPPSLG--NCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF-LSG-IVPSE 274 (1082)
Q Consensus 216 ~N~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~ 274 (1082)
+|++++. +|..++ ++++|++|+|++|++.+.+|..|+++++|++|++++|+ +++ .+|..
T Consensus 215 ~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~ 294 (636)
T 4eco_A 215 NSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294 (636)
T ss_dssp SCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHH
T ss_pred CCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHH
Confidence 5555543 777777 77788888888887777777777778888888888887 776 67777
Q ss_pred ccCC------CCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCc--cccCCCCCcEEEcCCCcccCCCCc
Q 045553 275 LGMC------KQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPD--SITRLPNLRVFWAPNLNLEGIFPQ 346 (1082)
Q Consensus 275 l~~l------~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~--~l~~l~~L~~L~l~~n~l~~~~~~ 346 (1082)
++.+ ++|++|++++| .+. .+|. .++.+++|++|++++|.+.+.+|
T Consensus 295 ~~~L~~~~~l~~L~~L~L~~n-------------------------~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip- 347 (636)
T 4eco_A 295 WQALADAPVGEKIQIIYIGYN-------------------------NLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP- 347 (636)
T ss_dssp HHHHHHSGGGGTCCEEECCSS-------------------------CCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-
T ss_pred HHhhhccccCCCCCEEECCCC-------------------------cCC-ccCchhhhccCCCCCEEeCcCCcCccchh-
Confidence 7665 77888887763 344 5676 78888888888888888887777
Q ss_pred ccccccCCCeEEcCCccccCCCCccccCCCC-CCEEecCCCcCcccCCCCcc---cCcccEEEecCCcceecCCCCCCcc
Q 045553 347 NWELCSKLEMLNLAHNFFTGQIPASLGNCKS-LYFLDLSSNNLTGLLPEEVS---VPCMAVFNVSQNLLSGEIPRISHSE 422 (1082)
Q Consensus 347 ~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~---l~~L~~L~l~~N~l~~~~~~~~~~~ 422 (1082)
.+..+++|++|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|..+. +++|+.|++++|.+++.+|..-.
T Consensus 348 ~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-- 423 (636)
T 4eco_A 348 AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD-- 423 (636)
T ss_dssp CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSC--
T ss_pred hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhc--
Confidence 8888888888888888888 78888888888 888888888888 5555543 34788888888888765553100
Q ss_pred cccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCC
Q 045553 423 CSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNS 502 (1082)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~ 502 (1082)
+
T Consensus 424 ---------------------------------------------------------~---------------------- 424 (636)
T 4eco_A 424 ---------------------------------------------------------P---------------------- 424 (636)
T ss_dssp ---------------------------------------------------------T----------------------
T ss_pred ---------------------------------------------------------c----------------------
Confidence 0
Q ss_pred CccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCC-------CCCEEEcc
Q 045553 503 LKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFD-------SLRNLNLS 575 (1082)
Q Consensus 503 ~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~-------~L~~L~L~ 575 (1082)
.....+...++++|++++|++. .+|..++..+++|++|+|++|+|+.+.+..|.... +|++|+|+
T Consensus 425 -------~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls 496 (636)
T 4eco_A 425 -------LDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496 (636)
T ss_dssp -------TCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECC
T ss_pred -------cccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECc
Confidence 0001112345689999999998 89999998889999999999999966555555443 89999999
Q ss_pred CCCCCCCCccccc--CCCCCCEEEcCCCcCCccCchhhhcCcccchhhc------cCcccCCCCCccccCCcccceeccc
Q 045553 576 RNHLQGPLPSYIN--KMEDLKFLSLSLNNFTGAIPWELTQLASLEVLEL------SANSLSGEIPSEFSKLEHLNVLRLD 647 (1082)
Q Consensus 576 ~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~L~ 647 (1082)
+|+|+ .+|..+. .+++|+.|+|++|++++ +|..+.++++|++|+| ++|++.+.+|..+..+++|++|+|+
T Consensus 497 ~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls 574 (636)
T 4eco_A 497 FNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574 (636)
T ss_dssp SSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECC
T ss_pred CCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECC
Confidence 99999 6777776 99999999999999997 8999999999999999 5688899999999999999999999
Q ss_pred CcccCCCCCCCCCCCCcccEEeccCCcccc
Q 045553 648 HNNLTGRIPPGFGTRSSLSIFDVSFNNLSG 677 (1082)
Q Consensus 648 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 677 (1082)
+|+|+ .+|..+. ++|+.|++++|++.+
T Consensus 575 ~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 575 SNDIR-KVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp SSCCC-BCCSCCC--TTCCEEECCSCTTCE
T ss_pred CCcCC-ccCHhHh--CcCCEEECcCCCCcc
Confidence 99994 7888766 899999999999875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=540.33 Aligned_cols=514 Identities=20% Similarity=0.160 Sum_probs=388.5
Q ss_pred CCccccccccccCCCCCCEEEcccCCCcccC-ChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccccc
Q 045553 96 DKLSGNLSRAIGDLTQLRVLLLAFNGFSGEL-PLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTI 174 (1082)
Q Consensus 96 ~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 174 (1082)
|.+++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++.+
T Consensus 34 N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 113 (844)
T 3j0a_A 34 NYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113 (844)
T ss_dssp CCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCC
T ss_pred CcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCccc
Confidence 5667777778888888888888888655555 677888888888888888888777888888888888888888888766
Q ss_pred Ccc--ccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCC--CCccEEEccCCcCCCCcCcc
Q 045553 175 PAF--FGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNC--TELRSLLLSSNMLQGDIPSS 250 (1082)
Q Consensus 175 p~~--~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~ 250 (1082)
|.. |..+++|++|+|++|.+++..+...+..+++|++|+|++|.+++..+..+..+ ++|+.|++++|.+.+..|..
T Consensus 114 ~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~ 193 (844)
T 3j0a_A 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193 (844)
T ss_dssp STTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCC
T ss_pred ccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccc
Confidence 554 88888888888888888865554444578888888888888887777777776 78888888888888777777
Q ss_pred ccCCCC------CCEEeCCCCcCcccCCccccCC---CCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCC
Q 045553 251 FGQLVN------LEVLDLSRNFLSGIVPSELGMC---KQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLP 321 (1082)
Q Consensus 251 ~~~l~~------L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p 321 (1082)
++.+++ |++|++++|.+++..+..+... .+++.|.+..+... .+...+.+.+..+
T Consensus 194 ~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~----------------~~~~~~~l~~~~~ 257 (844)
T 3j0a_A 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG----------------AGFGFHNIKDPDQ 257 (844)
T ss_dssp CCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCB----------------CSSSCSSSTTGGG
T ss_pred hhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccc----------------ccccccccCCCCh
Confidence 666655 8888888888877777666543 56677776643211 1112234444445
Q ss_pred ccccCC--CCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-cc
Q 045553 322 DSITRL--PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SV 398 (1082)
Q Consensus 322 ~~l~~l--~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l 398 (1082)
..|.++ ++|+.|++++|.+.+..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+ .+
T Consensus 258 ~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 337 (844)
T 3j0a_A 258 NTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL 337 (844)
T ss_dssp TTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSC
T ss_pred hhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCC
Confidence 556554 689999999999999888899999999999999999998888889999999999999999988877766 68
Q ss_pred CcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCC
Q 045553 399 PCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPV 478 (1082)
Q Consensus 399 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~ 478 (1082)
++|+.|++++|.+.+..+.. ...
T Consensus 338 ~~L~~L~L~~N~i~~~~~~~-~~~-------------------------------------------------------- 360 (844)
T 3j0a_A 338 PKVAYIDLQKNHIAIIQDQT-FKF-------------------------------------------------------- 360 (844)
T ss_dssp TTCCEEECCSCCCCCCCSSC-SCS--------------------------------------------------------
T ss_pred CCCCEEECCCCCCCccChhh-hcC--------------------------------------------------------
Confidence 89999999999886433221 000
Q ss_pred CCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCccccc
Q 045553 479 PPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGL 558 (1082)
Q Consensus 479 p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~ 558 (1082)
+ ..+..+.+++|.+++ ++ ...+++.|++++|++. .+|.. ..+++.|++++|++++.
T Consensus 361 ------l-----~~L~~L~Ls~N~l~~----i~----~~~~L~~L~l~~N~l~-~l~~~----~~~l~~L~ls~N~l~~l 416 (844)
T 3j0a_A 361 ------L-----EKLQTLDLRDNALTT----IH----FIPSIPDIFLSGNKLV-TLPKI----NLTANLIHLSENRLENL 416 (844)
T ss_dssp ------C-----CCCCEEEEETCCSCC----CS----SCCSCSEEEEESCCCC-CCCCC----CTTCCEEECCSCCCCSS
T ss_pred ------C-----CCCCEEECCCCCCCc----cc----CCCCcchhccCCCCcc-ccccc----ccccceeecccCccccC
Confidence 0 012233444444332 11 1445678888999887 66655 34588999999999875
Q ss_pred Cc-cccCCCCCCCEEEccCCCCCCCCcc-cccCCCCCCEEEcCCCcCC-----ccCchhhhcCcccchhhccCcccCCCC
Q 045553 559 IP-QSFTNFDSLRNLNLSRNHLQGPLPS-YINKMEDLKFLSLSLNNFT-----GAIPWELTQLASLEVLELSANSLSGEI 631 (1082)
Q Consensus 559 ~~-~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 631 (1082)
.. ..+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|++.+
T Consensus 417 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 496 (844)
T 3j0a_A 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496 (844)
T ss_dssp TTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCC
T ss_pred chhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccC
Confidence 33 2456889999999999999865543 4567889999999999987 445567888999999999999999888
Q ss_pred CccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC-cccccccCCCCCCCCCCCCCCCCCccc
Q 045553 632 PSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN-SLIKCENVQGNPNLQLCHTDPSSSEWE 709 (1082)
Q Consensus 632 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~Np~~c~c~~~~~~~~~~ 709 (1082)
|..|..+++|+.|+|++|+|++.+|..+. ++|+.|++++|+|++.+|.. ..+....+.+|||.|+|. ..+...|.
T Consensus 497 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~-~~~f~~~~ 572 (844)
T 3j0a_A 497 PGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE-LSTFINWL 572 (844)
T ss_dssp TTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS-CCSHHHHH
T ss_pred hhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc-cHHHHHHH
Confidence 88899999999999999999977777665 88999999999999888754 234566788999999997 33444443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=533.11 Aligned_cols=513 Identities=18% Similarity=0.235 Sum_probs=365.9
Q ss_pred CHHHHHHHHhcccCCCCCCCCCCCCC----CCC--cee------------eeeEeeCCCCCeeeeecCCCccccccccCC
Q 045553 1 KNALLQLKSAITEDPLGLTSNWNPKD----TDS--CSW------------HGVTCDPLSGRVTSLNLSSNLSRTSCSLLS 62 (1082)
Q Consensus 1 ~~~l~~~k~~~~~~~~~~~~~W~~~~----~~~--c~w------------~gv~C~~~~~~v~~l~l~~~~~~~~~~~~~ 62 (1082)
++||++||+++. +| +|+..+ .+| |.| .||+|+. .+||++|+|++
T Consensus 271 ~~ALl~~k~~l~-~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~----------- 332 (876)
T 4ecn_A 271 YKALKAIWEALD-GK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAG----------- 332 (876)
T ss_dssp HHHHHHHHHHTT-GG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTT-----------
T ss_pred HHHHHHHHHHcC-CC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECcc-----------
Confidence 479999999995 66 686543 355 999 9999986 69999999986
Q ss_pred CCCCCCCCCCcccCcCcccccccccCcccCCCCCCccccccccccCCCCCCEEEc-ccCCCcccCChhhcCCC-CCCE--
Q 045553 63 LPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLL-AFNGFSGELPLEIGQLS-LLEI-- 138 (1082)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~g~l~~~l~~l~~L~~L~L-~~n~l~~~~p~~~~~l~-~L~~-- 138 (1082)
++++|.+|++|++|++|++|+| ++|.+.|..|-...... .+..
T Consensus 333 ---------------------------------~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~ 379 (876)
T 4ecn_A 333 ---------------------------------FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379 (876)
T ss_dssp ---------------------------------TCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHH
T ss_pred ---------------------------------CCCCCcCchHHhccccceEeeecccccccccccccccccccccchhH
Confidence 5788999999999999999999 89988877543211110 0000
Q ss_pred ------------EeC-cCCCCC-----------CCCCccccCCCCCCeEEccC--cccccccCccccCCCCCcEEEcccC
Q 045553 139 ------------LDL-SFNSFH-----------GPIPPTLQNCSSLRLINLSG--NQFNGTIPAFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 139 ------------L~L-s~n~l~-----------~~~p~~l~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~L~~N 192 (1082)
++. ....+. ...+........++.+.+.. |++++ +|..|+++++|+.|+|++|
T Consensus 380 l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N 458 (876)
T 4ecn_A 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANS 458 (876)
T ss_dssp HHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESC
T ss_pred HHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCC
Confidence 000 000000 01111123334555555655 88887 8889999999999999999
Q ss_pred cccc-cCCcccccccccccEEEcccCccCCCCCcccc--CCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCc-Cc
Q 045553 193 LLSG-SVPEEFGDNCVSLEHILLAANSLTGSIPPSLG--NCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF-LS 268 (1082)
Q Consensus 193 ~l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~ 268 (1082)
++++ .+|..+.. .+.|.+++.+|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ ++
T Consensus 459 ~Lsg~~i~~~~~~---------~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ls 529 (876)
T 4ecn_A 459 PFTYDNIAVDWED---------ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529 (876)
T ss_dssp CCCGGGBSSSCSC---------TTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSC
T ss_pred cCCCCcccccccc---------cccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcc
Confidence 9987 23322211 122455556666665 67777777777777666667667777777777777776 66
Q ss_pred c-cCCccccCCC-------CCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCc--cccCCCCCcEEEcCCC
Q 045553 269 G-IVPSELGMCK-------QLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPD--SITRLPNLRVFWAPNL 338 (1082)
Q Consensus 269 ~-~~p~~l~~l~-------~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~--~l~~l~~L~~L~l~~n 338 (1082)
+ .+|..++.++ +|++|++++| .+. .+|. .|+++++|+.|++++|
T Consensus 530 g~~iP~~i~~L~~~~~~l~~L~~L~Ls~N-------------------------~L~-~ip~~~~l~~L~~L~~L~Ls~N 583 (876)
T 4ecn_A 530 AAQLKADWTRLADDEDTGPKIQIFYMGYN-------------------------NLE-EFPASASLQKMVKLGLLDCVHN 583 (876)
T ss_dssp HHHHHHHHHHHHHCTTTTTTCCEEECCSS-------------------------CCC-BCCCHHHHTTCTTCCEEECTTS
T ss_pred cccchHHHHhhhhcccccCCccEEEeeCC-------------------------cCC-ccCChhhhhcCCCCCEEECCCC
Confidence 5 5666555544 7777777663 333 4566 6777777777777777
Q ss_pred cccCCCCcccccccCCCeEEcCCccccCCCCccccCCCC-CCEEecCCCcCcccCCCCcc-c--CcccEEEecCCcceec
Q 045553 339 NLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKS-LYFLDLSSNNLTGLLPEEVS-V--PCMAVFNVSQNLLSGE 414 (1082)
Q Consensus 339 ~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~-l--~~L~~L~l~~N~l~~~ 414 (1082)
.+. .+| .|..+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|+|+ .+|..+. + ++|+.|++++|+++|.
T Consensus 584 ~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ 659 (876)
T 4ecn_A 584 KVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSE 659 (876)
T ss_dssp CCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred Ccc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCc
Confidence 777 445 7777788888888888888 77777888887 888888888887 4555543 2 3488888888887765
Q ss_pred CCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccc
Q 045553 415 IPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYY 494 (1082)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~ 494 (1082)
+|.+... +
T Consensus 660 ip~l~~~------------------------------------------------------------l------------ 667 (876)
T 4ecn_A 660 GRNISCS------------------------------------------------------------M------------ 667 (876)
T ss_dssp SSSCSSC------------------------------------------------------------T------------
T ss_pred cccchhh------------------------------------------------------------h------------
Confidence 5543100 0
Q ss_pred eeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCC-------C
Q 045553 495 GFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNF-------D 567 (1082)
Q Consensus 495 ~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l-------~ 567 (1082)
......+|+.|++++|++. .+|..++..+++|+.|+|++|+|+.+.+..|... +
T Consensus 668 ------------------~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~ 728 (876)
T 4ecn_A 668 ------------------DDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728 (876)
T ss_dssp ------------------TTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGG
T ss_pred ------------------ccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccC
Confidence 0011235678899999988 8898888888889999999999985555555433 3
Q ss_pred CCCEEEccCCCCCCCCccccc--CCCCCCEEEcCCCcCCccCchhhhcCcccchhhccC------cccCCCCCccccCCc
Q 045553 568 SLRNLNLSRNHLQGPLPSYIN--KMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSA------NSLSGEIPSEFSKLE 639 (1082)
Q Consensus 568 ~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~ 639 (1082)
+|++|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+|++ |++.+.+|..|..++
T Consensus 729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~ 806 (876)
T 4ecn_A 729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP 806 (876)
T ss_dssp GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCS
T ss_pred CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCC
Confidence 8999999999999 6777776 89999999999999996 788899999999999976 888889999999999
Q ss_pred ccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC----cccccccCCCCCCCC--CCC
Q 045553 640 HLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN----SLIKCENVQGNPNLQ--LCH 700 (1082)
Q Consensus 640 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~----~~~~~~~~~~Np~~c--~c~ 700 (1082)
+|+.|+|++|+| +.+|..+. ++|+.|||++|++...-+.. .......+.+|++.+ .|.
T Consensus 807 ~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~ 870 (876)
T 4ecn_A 807 SLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD 870 (876)
T ss_dssp SCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCG
T ss_pred CCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCC
Confidence 999999999999 58888765 69999999999987533321 112345567777764 554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=515.95 Aligned_cols=485 Identities=19% Similarity=0.153 Sum_probs=343.0
Q ss_pred CCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccc
Q 045553 93 NSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNG 172 (1082)
Q Consensus 93 ~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 172 (1082)
.+.+.+.+..|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++
T Consensus 40 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 119 (606)
T 3t6q_A 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119 (606)
T ss_dssp CTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC
T ss_pred ccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCccc
Confidence 45567777777788888888888888888887778888888888888888888887778888888888888888888887
Q ss_pred ccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCcc--EEEccCCcCCCCcCcc
Q 045553 173 TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELR--SLLLSSNMLQGDIPSS 250 (1082)
Q Consensus 173 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~p~~ 250 (1082)
..+..|+.+++|++|+|++|++.+..+..+. .+++|++|++++|++++..+..++.+++|+ .|++++|.+++..|..
T Consensus 120 l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~ 198 (606)
T 3t6q_A 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGF-PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGA 198 (606)
T ss_dssp GGGSCCTTCTTCCEEECCSSCCCCCCCCTTC-CCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTT
T ss_pred CCcchhccCCcccEEECCCCcccccCccccc-CCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhH
Confidence 6677788888888888888888853323333 378888888888888877777788888888 7888888888766666
Q ss_pred ccCCCCCCEEeCCCCcCc--------------------------ccCCccccCCC--CCcEEEeccccCCcccccCCCCC
Q 045553 251 FGQLVNLEVLDLSRNFLS--------------------------GIVPSELGMCK--QLKVLVLRNDYGPLYSREHGDLP 302 (1082)
Q Consensus 251 ~~~l~~L~~L~Ls~N~l~--------------------------~~~p~~l~~l~--~L~~L~l~~n~~~~~~~~~~~l~ 302 (1082)
|.. .+|++|++++|... ...+..+..+. +|+.|++++
T Consensus 199 ~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~-------------- 263 (606)
T 3t6q_A 199 FDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK-------------- 263 (606)
T ss_dssp TTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTT--------------
T ss_pred hhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeec--------------
Confidence 544 57788888776511 01111222222 455566554
Q ss_pred CcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEe
Q 045553 303 IQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLD 382 (1082)
Q Consensus 303 ~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 382 (1082)
|.+.+..+..|..+++|++|++++|.+.. +|..+..+++|++|++++|++++..|..+..+++|+.|+
T Consensus 264 -----------n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 331 (606)
T 3t6q_A 264 -----------HYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331 (606)
T ss_dssp -----------CCCSSCCTTTTTTCTTCSEEECTTSCCSC-CCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEE
T ss_pred -----------CccCccCHHHhccccCCCEEeccCCccCC-CChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEE
Confidence 55666677789999999999999999984 577889999999999999999988888999999999999
Q ss_pred cCCCcCcccCCCC-c-ccCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCC
Q 045553 383 LSSNNLTGLLPEE-V-SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPS 460 (1082)
Q Consensus 383 Ls~N~l~~~~p~~-~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (1082)
+++|.+.+.+|.. + .+++|+.|++++|.+++....
T Consensus 332 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~------------------------------------------- 368 (606)
T 3t6q_A 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC------------------------------------------- 368 (606)
T ss_dssp CCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEES-------------------------------------------
T ss_pred CCCCCcccccchhhhhccCcCCEEECCCCccccccCc-------------------------------------------
Confidence 9999998776654 3 689999999999988642200
Q ss_pred CCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccc
Q 045553 461 NGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGS 540 (1082)
Q Consensus 461 ~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~ 540 (1082)
|..+....++++|++++|++.+. +...+.
T Consensus 369 --------------------------------------------------~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~ 397 (606)
T 3t6q_A 369 --------------------------------------------------NLQLRNLSHLQSLNLSYNEPLSL-KTEAFK 397 (606)
T ss_dssp --------------------------------------------------TTTTTTCTTCCEEECCSCSCEEE-CTTTTT
T ss_pred --------------------------------------------------chhcccCCCCCEEECCCCcCCcC-CHHHhc
Confidence 00111223345666666666533 333344
Q ss_pred cCCcccEEEccCCcccccCcc-ccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCcc---CchhhhcCcc
Q 045553 541 HCKCMKFLSMAGNEFVGLIPQ-SFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGA---IPWELTQLAS 616 (1082)
Q Consensus 541 ~~~~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~ 616 (1082)
.+++|++|++++|++++..+. .|..+++|++|+|++|.+++..|..|..+++|++|+|++|++++. .+..+..+++
T Consensus 398 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~ 477 (606)
T 3t6q_A 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477 (606)
T ss_dssp TCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTT
T ss_pred CCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCC
Confidence 455666666666666655443 366666666666666666666666666666666666666666642 2245666666
Q ss_pred cchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC----cccccccCCC
Q 045553 617 LEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN----SLIKCENVQG 692 (1082)
Q Consensus 617 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~----~~~~~~~~~~ 692 (1082)
|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++| .|++++|++++..|.. ..+....+.+
T Consensus 478 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 556 (606)
T 3t6q_A 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQ 556 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTT
T ss_pred ccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCC
Confidence 6666666666666666666666666666666666666666666666666 6666666666554432 2335556677
Q ss_pred CCCCCCCC
Q 045553 693 NPNLQLCH 700 (1082)
Q Consensus 693 Np~~c~c~ 700 (1082)
|||.|+|.
T Consensus 557 N~~~c~c~ 564 (606)
T 3t6q_A 557 NPLDCTCS 564 (606)
T ss_dssp CCEECSGG
T ss_pred CCccccCC
Confidence 77778876
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=514.50 Aligned_cols=495 Identities=18% Similarity=0.143 Sum_probs=400.3
Q ss_pred ccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCC
Q 045553 102 LSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQS 181 (1082)
Q Consensus 102 l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 181 (1082)
+|..+. .++++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++
T Consensus 27 iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 104 (606)
T 3t6q_A 27 IPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104 (606)
T ss_dssp CCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSC
T ss_pred CcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhccc
Confidence 444443 278999999999998889999999999999999999998889999999999999999999999899999999
Q ss_pred CCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCC--E
Q 045553 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLE--V 259 (1082)
Q Consensus 182 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~--~ 259 (1082)
++|++|+|++|++++..|..+ ..+++|++|++++|++++...+.+..+++|++|++++|.+++..|..|+.+++|+ +
T Consensus 105 ~~L~~L~L~~n~i~~l~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~ 183 (606)
T 3t6q_A 105 KALKHLFFIQTGISSIDFIPL-HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183 (606)
T ss_dssp TTCCEEECTTSCCSCGGGSCC-TTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEE
T ss_pred ccccEeeccccCcccCCcchh-ccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeE
Confidence 999999999999995445555 4799999999999999975555666699999999999999988889999999999 9
Q ss_pred EeCCCCcCcccCCccccCCCCCcEEEeccccCCc-ccccCCCCCCcccccCCCcccccCCCCCccccCCC--CCcEEEcC
Q 045553 260 LDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPL-YSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP--NLRVFWAP 336 (1082)
Q Consensus 260 L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~--~L~~L~l~ 336 (1082)
|++++|.+++..|..+.. .+|+.|++++|.... ............+..............+..+..+. +|+.|+++
T Consensus 184 L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~ 262 (606)
T 3t6q_A 184 LNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262 (606)
T ss_dssp EECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECT
T ss_pred EecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEee
Confidence 999999999887777654 689999998874110 00000000000010000000111112233344443 78899999
Q ss_pred CCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-ccCcccEEEecCCcceecC
Q 045553 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFNVSQNLLSGEI 415 (1082)
Q Consensus 337 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~~L~l~~N~l~~~~ 415 (1082)
+|.+.++.+..|..+++|++|++++|+++ .+|..+.++++|++|+|++|++++..|..+ .+++|+.|++++|.+.+.+
T Consensus 263 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 341 (606)
T 3t6q_A 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341 (606)
T ss_dssp TCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBC
T ss_pred cCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCccccc
Confidence 99999988888999999999999999998 788888999999999999999998877665 6788999999888876544
Q ss_pred CCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccce
Q 045553 416 PRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYG 495 (1082)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~ 495 (1082)
|..
T Consensus 342 ~~~----------------------------------------------------------------------------- 344 (606)
T 3t6q_A 342 GTG----------------------------------------------------------------------------- 344 (606)
T ss_dssp CSS-----------------------------------------------------------------------------
T ss_pred chh-----------------------------------------------------------------------------
Confidence 421
Q ss_pred eeeccCCCccccCCcccccccCCceeEEEccCCcccccCC-ccccccCCcccEEEccCCcccccCccccCCCCCCCEEEc
Q 045553 496 FWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVP-SDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNL 574 (1082)
Q Consensus 496 ~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip-~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 574 (1082)
.+....++++|++++|++.+..+ ...+..+++|++|++++|++.+..|..|..+++|++|+|
T Consensus 345 -----------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 407 (606)
T 3t6q_A 345 -----------------CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407 (606)
T ss_dssp -----------------TTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred -----------------hhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence 01123456789999999885431 344567788999999999999999999999999999999
Q ss_pred cCCCCCCCCcc-cccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCC---CCccccCCcccceecccCcc
Q 045553 575 SRNHLQGPLPS-YINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGE---IPSEFSKLEHLNVLRLDHNN 650 (1082)
Q Consensus 575 ~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~ 650 (1082)
++|++++..|. .|..+++|+.|++++|++++..|..|..+++|++|+|++|++++. .+..+..+++|++|+|++|+
T Consensus 408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~ 487 (606)
T 3t6q_A 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487 (606)
T ss_dssp TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence 99999977654 489999999999999999999999999999999999999999863 34678999999999999999
Q ss_pred cCCCCCCCCCCCCcccEEeccCCccccCCCCC----cccccccCCCCCCC
Q 045553 651 LTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN----SLIKCENVQGNPNL 696 (1082)
Q Consensus 651 l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~----~~~~~~~~~~Np~~ 696 (1082)
+++..|..|..+++|+.|++++|++++..|.. ..+ ..++.+|...
T Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~ 536 (606)
T 3t6q_A 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCC
T ss_pred cCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCccc
Confidence 99999999999999999999999999877643 223 4556777543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=517.78 Aligned_cols=521 Identities=17% Similarity=0.163 Sum_probs=391.5
Q ss_pred CCCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccc
Q 045553 92 SNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFN 171 (1082)
Q Consensus 92 ~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 171 (1082)
+.+.+.+.+..+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|+++
T Consensus 38 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 117 (606)
T 3vq2_A 38 DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117 (606)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCC
T ss_pred ECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccc
Confidence 34557788877888999999999999999999888888999999999999999999777899999999999999999998
Q ss_pred cccCccccCCCCCcEEEcccCcccc-cCCcccccccccccEEEcccCccCCCCCccccCCCCcc----EEEccCCcCCCC
Q 045553 172 GTIPAFFGQSPGFQVVSLSFNLLSG-SVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELR----SLLLSSNMLQGD 246 (1082)
Q Consensus 172 ~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~ 246 (1082)
+..+..|+++++|++|+|++|++.+ .+|..+. .+++|++|++++|++++..+..++.+++|+ +|++++|.+++.
T Consensus 118 ~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~ 196 (606)
T 3vq2_A 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS-NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFI 196 (606)
T ss_dssp CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGG-TCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEE
T ss_pred cccccccCCCCCCCEEeCCCCcccceechHhHh-hcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCccee
Confidence 7777889999999999999999985 5677776 689999999999999988888887777665 899999999865
Q ss_pred cCccccCCCCCCEEeCCCCcCc-ccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCcccc
Q 045553 247 IPSSFGQLVNLEVLDLSRNFLS-GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSIT 325 (1082)
Q Consensus 247 ~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~ 325 (1082)
.+..+... +|++|++++|.++ +..|..+..+++|+.+.+..+...... ....+....+..+.
T Consensus 197 ~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~----------------~l~~~~~~~~~~l~ 259 (606)
T 3vq2_A 197 QDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER----------------NLEIFEPSIMEGLC 259 (606)
T ss_dssp CTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC----------------CCSCCCGGGGTTGG
T ss_pred CcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCC----------------cccccChHHhhhhh
Confidence 55555544 8999999999886 467888899999998888654322110 00111112222233
Q ss_pred CCCCCcEEEc-CCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEE
Q 045553 326 RLPNLRVFWA-PNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVF 404 (1082)
Q Consensus 326 ~l~~L~~L~l-~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L 404 (1082)
.+ +++.+.+ ..+.+.+..|. +..+++|+.|++++|.+. .+| .+..+++|+.|++++|++ +.+|.. .+++|+.|
T Consensus 260 ~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp~~-~l~~L~~L 333 (606)
T 3vq2_A 260 DV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFPTL-DLPFLKSL 333 (606)
T ss_dssp GS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCCCC-CCSSCCEE
T ss_pred hc-cHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccccC-CCCcccee
Confidence 33 4566666 66777777776 888888888888888887 556 778888888888888888 556644 77888888
Q ss_pred EecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCcccc
Q 045553 405 NVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLID 484 (1082)
Q Consensus 405 ~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~ 484 (1082)
++++|...+.++.. .+. -+..+++++|.+++.
T Consensus 334 ~l~~n~~~~~~~~~---~l~--------------------------------------~L~~L~ls~n~l~~~------- 365 (606)
T 3vq2_A 334 TLTMNKGSISFKKV---ALP--------------------------------------SLSYLDLSRNALSFS------- 365 (606)
T ss_dssp EEESCSSCEECCCC---CCT--------------------------------------TCCEEECCSSCEEEE-------
T ss_pred eccCCcCccchhhc---cCC--------------------------------------CCCEEECcCCccCCC-------
Confidence 88888654332110 000 011233444444321
Q ss_pred CCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCc-ccc
Q 045553 485 SDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIP-QSF 563 (1082)
Q Consensus 485 ~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~-~~~ 563 (1082)
...|..+....++++|++++|++. .+| ..+..+++|++|++++|++.+..| ..|
T Consensus 366 -----------------------~~~~~~~~~~~~L~~L~L~~n~l~-~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 420 (606)
T 3vq2_A 366 -----------------------GCCSYSDLGTNSLRHLDLSFNGAI-IMS-ANFMGLEELQHLDFQHSTLKRVTEFSAF 420 (606)
T ss_dssp -----------------------EECCHHHHCCSCCCEEECCSCSEE-EEC-CCCTTCTTCCEEECTTSEEESTTTTTTT
T ss_pred -----------------------cchhhhhccCCcccEeECCCCccc-cch-hhccCCCCCCeeECCCCccCCccChhhh
Confidence 011334445566778888888877 466 444567778888888888888777 678
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCc-cCchhhhcCcccchhhccCcccCCCCCccccCCcccc
Q 045553 564 TNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG-AIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLN 642 (1082)
Q Consensus 564 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 642 (1082)
..+++|++|++++|.+++..|..|..+++|++|++++|++++ .+|..|..+++|++|+|++|++++..|..|..+++|+
T Consensus 421 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 500 (606)
T 3vq2_A 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500 (606)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCC
Confidence 888888888888888888888888888888888888888887 4788888888888888888888888888888888888
Q ss_pred eecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC-----cccccccCCCCCCCCCCCCCCCCCccccc
Q 045553 643 VLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN-----SLIKCENVQGNPNLQLCHTDPSSSEWERQ 711 (1082)
Q Consensus 643 ~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-----~~~~~~~~~~Np~~c~c~~~~~~~~~~~~ 711 (1082)
+|+|++|++++.+|..|..+++|+.|++++|+++ .+|.. ..+....+.+|||.|+|.. .+...|.+.
T Consensus 501 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~-~~~~~~l~~ 572 (606)
T 3vq2_A 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH-QKFLQWVKE 572 (606)
T ss_dssp EEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT-HHHHTTTTT
T ss_pred EEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc-HHHHHHHHc
Confidence 8888888888888888888888888888888888 45543 1245567889999999973 344455443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=500.41 Aligned_cols=552 Identities=21% Similarity=0.186 Sum_probs=401.3
Q ss_pred CCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccC
Q 045553 96 DKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIP 175 (1082)
Q Consensus 96 ~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 175 (1082)
++++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+
T Consensus 14 ~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~ 90 (680)
T 1ziw_A 14 LKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSD 90 (680)
T ss_dssp SCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCT
T ss_pred CCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccCh
Confidence 4443 3666554 799999999999998777889999999999999999998889999999999999999999997666
Q ss_pred ccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCcccc--C
Q 045553 176 AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFG--Q 253 (1082)
Q Consensus 176 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~ 253 (1082)
..|+++++|++|+|++|++++..|..+ ..+++|++|++++|++++..+..++++++|++|++++|.+++..+..+. .
T Consensus 91 ~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 169 (680)
T 1ziw_A 91 KTFAFCTNLTELHLMSNSIQKIKNNPF-VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169 (680)
T ss_dssp TTTTTCTTCSEEECCSSCCCCCCSCTT-TTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGT
T ss_pred hhhccCCCCCEEECCCCccCccChhHc-cccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccc
Confidence 789999999999999999984444445 4799999999999999999899999999999999999999987777664 5
Q ss_pred CCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCccccc--CCCCCCcccccCCCcccccCCCCCccccCCCC--
Q 045553 254 LVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSRE--HGDLPIQPVVDGGEDYNFFDGGLPDSITRLPN-- 329 (1082)
Q Consensus 254 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~--~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~-- 329 (1082)
+++|++|++++|++++..|..+..+++|+.|++.++.+...... ...+....+.......|.+.+..|.+|..++.
T Consensus 170 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~ 249 (680)
T 1ziw_A 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249 (680)
T ss_dssp TCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSC
T ss_pred cccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCC
Confidence 68999999999999999999999999999999987643210000 00000001111112233444444444444433
Q ss_pred CcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCccc-----CCC----Cc-ccC
Q 045553 330 LRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL-----LPE----EV-SVP 399 (1082)
Q Consensus 330 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~----~~-~l~ 399 (1082)
|+.|++++|.+.++.+..|..+++|++|+|++|++++..|..|.++++|+.|+|++|...+. +|. .+ .++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~ 329 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCC
Confidence 55555555555544444455555555555555555544444455555555555554433321 111 11 244
Q ss_pred cccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCC
Q 045553 400 CMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVP 479 (1082)
Q Consensus 400 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p 479 (1082)
+|+.|++++|.+++..+. ....-.-+..+++++|.+++...
T Consensus 330 ~L~~L~l~~n~l~~~~~~---------------------------------------~~~~l~~L~~L~Ls~n~~~~~~l 370 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSN---------------------------------------MFTGLINLKYLSLSNSFTSLRTL 370 (680)
T ss_dssp TCCEEECCSCCBCCCCTT---------------------------------------TTTTCTTCCEEECTTCBSCCCEE
T ss_pred CCCEEECCCCccCCCChh---------------------------------------HhccccCCcEEECCCCchhhhhc
Confidence 455555555544432221 11111224456778777654322
Q ss_pred CccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccC
Q 045553 480 PFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLI 559 (1082)
Q Consensus 480 ~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~ 559 (1082)
+.. ....+....+..+++++|.+++. .|..+....++++|++++|++.+.+|...+..+++|++|++++|++.+..
T Consensus 371 ~~~-~f~~~~~~~L~~L~L~~n~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 446 (680)
T 1ziw_A 371 TNE-TFVSLAHSPLHILNLTKNKISKI---ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446 (680)
T ss_dssp CTT-TTGGGTTSCCCEEECTTSCCCEE---CTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECC
T ss_pred chh-hhcccccCcCceEECCCCCCCeE---ChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeC
Confidence 110 01112223567788888887753 34566778899999999999999999888899999999999999999999
Q ss_pred ccccCCCCCCCEEEccCCCCC--CCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCC-----
Q 045553 560 PQSFTNFDSLRNLNLSRNHLQ--GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIP----- 632 (1082)
Q Consensus 560 ~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----- 632 (1082)
+..|..+++|+.|++++|.++ +..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+
T Consensus 447 ~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 526 (680)
T 1ziw_A 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPG 526 (680)
T ss_dssp TTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTT
T ss_pred hhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccC
Confidence 999999999999999999987 5788999999999999999999998888889999999999999999986422
Q ss_pred ---ccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC----cccccccCCCCC
Q 045553 633 ---SEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN----SLIKCENVQGNP 694 (1082)
Q Consensus 633 ---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~----~~~~~~~~~~Np 694 (1082)
..|..+++|++|+|++|+++...+..|..+++|+.|++++|++++..+.. ..+....+.+|.
T Consensus 527 ~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~ 595 (680)
T 1ziw_A 527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595 (680)
T ss_dssp SCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCc
Confidence 34789999999999999999665667999999999999999999543321 223444555553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=498.73 Aligned_cols=521 Identities=21% Similarity=0.224 Sum_probs=417.7
Q ss_pred ceeeeeEeeCCCCCeeeeecCCCccccccccCCCCCCCCCCCCcccCcCcccccccccCcccCCCCCCccccc-cccccC
Q 045553 30 CSWHGVTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNL-SRAIGD 108 (1082)
Q Consensus 30 c~w~gv~C~~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~g~l-~~~l~~ 108 (1082)
|.|..|.+ ...+++.|||++|.... +.+.. | ..+......+.+.+...+.+ |.+|.+
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~------i~~~~-----~---------~~l~~L~~LdLs~n~~~~~i~~~~f~~ 71 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRT------VTASS-----F---------PFLEQLQLLELGSQYTPLTIDKEAFRN 71 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCE------ECSSS-----C---------SSCCSCSEEEECTTCCCCEECTTTTSS
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCc------cChhH-----C---------cccccCeEEeCCCCCCccccCHHHhcC
Confidence 56788877 45689999999874432 11111 1 11122223334556667777 678999
Q ss_pred CCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCcc--ccCCCCCCeEEccCcccccccC-ccccCCCCCc
Q 045553 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT--LQNCSSLRLINLSGNQFNGTIP-AFFGQSPGFQ 185 (1082)
Q Consensus 109 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~ 185 (1082)
+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|+
T Consensus 72 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ 151 (844)
T 3j0a_A 72 LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151 (844)
T ss_dssp CTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCC
T ss_pred CCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCC
Confidence 999999999999999889999999999999999999999877765 9999999999999999997765 6899999999
Q ss_pred EEEcccCcccccCCccccccc--ccccEEEcccCccCCCCCccccCCCC------ccEEEccCCcCCCCcCccccCC---
Q 045553 186 VVSLSFNLLSGSVPEEFGDNC--VSLEHILLAANSLTGSIPPSLGNCTE------LRSLLLSSNMLQGDIPSSFGQL--- 254 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~L~~N~l~~~~p~~~~~l--- 254 (1082)
+|+|++|.+++..+..+. .+ ++|+.|++++|.+.+..|..++.+++ |+.|++++|.+++..+..+...
T Consensus 152 ~L~Ls~N~i~~~~~~~l~-~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~ 230 (844)
T 3j0a_A 152 SIDFSSNQIFLVCEHELE-PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISK 230 (844)
T ss_dssp EEEEESSCCCCCCSGGGH-HHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCS
T ss_pred EEECCCCcCCeeCHHHcc-cccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCc
Confidence 999999999987777765 35 79999999999999998888877766 9999999999998888777643
Q ss_pred CCCCEEeCCC---------CcCcccCCccccCC--CCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCcc
Q 045553 255 VNLEVLDLSR---------NFLSGIVPSELGMC--KQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDS 323 (1082)
Q Consensus 255 ~~L~~L~Ls~---------N~l~~~~p~~l~~l--~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~ 323 (1082)
++++.|.++. |.+.+..+..|..+ ++|+.|++++| .+.+..|..
T Consensus 231 ~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n-------------------------~l~~~~~~~ 285 (844)
T 3j0a_A 231 SQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHG-------------------------FVFSLNSRV 285 (844)
T ss_dssp CCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTC-------------------------CCCEECSCC
T ss_pred ccccceecccccccccccccccCCCChhhhhccccCCccEEECCCC-------------------------cccccChhh
Confidence 5778888773 34444444555554 68999999874 445556778
Q ss_pred ccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-ccCccc
Q 045553 324 ITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMA 402 (1082)
Q Consensus 324 l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~ 402 (1082)
|..+++|+.|++++|++.++.+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+ .+++|+
T Consensus 286 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 365 (844)
T 3j0a_A 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365 (844)
T ss_dssp SSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCC
T ss_pred hhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCC
Confidence 8899999999999999999989999999999999999999998888899999999999999999988887766 588999
Q ss_pred EEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCcc
Q 045553 403 VFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFL 482 (1082)
Q Consensus 403 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~ 482 (1082)
.|++++|.+++. +.. . -+...++++|.++ .+|
T Consensus 366 ~L~Ls~N~l~~i-~~~-----~--------------------------------------~L~~L~l~~N~l~-~l~--- 397 (844)
T 3j0a_A 366 TLDLRDNALTTI-HFI-----P--------------------------------------SIPDIFLSGNKLV-TLP--- 397 (844)
T ss_dssp EEEEETCCSCCC-SSC-----C--------------------------------------SCSEEEEESCCCC-CCC---
T ss_pred EEECCCCCCCcc-cCC-----C--------------------------------------CcchhccCCCCcc-ccc---
Confidence 999999988631 110 0 0011233444443 222
Q ss_pred ccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCc-cccccCCcccEEEccCCcccccCcc
Q 045553 483 IDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPS-DMGSHCKCMKFLSMAGNEFVGLIPQ 561 (1082)
Q Consensus 483 ~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~-~~~~~~~~L~~L~L~~N~i~~~~~~ 561 (1082)
.. ...++.|++++|++.+ ++. .....+++|+.|+|++|++++..+.
T Consensus 398 -----------------------------~~---~~~l~~L~ls~N~l~~-l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 444 (844)
T 3j0a_A 398 -----------------------------KI---NLTANLIHLSENRLEN-LDILYFLLRVPHLQILILNQNRFSSCSGD 444 (844)
T ss_dssp -----------------------------CC---CTTCCEEECCSCCCCS-STTHHHHTTCTTCCEEEEESCCCCCCCSS
T ss_pred -----------------------------cc---ccccceeecccCcccc-CchhhhhhcCCccceeeCCCCcccccccc
Confidence 11 2345789999999884 333 2334678899999999999976554
Q ss_pred -ccCCCCCCCEEEccCCCCC-----CCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccc
Q 045553 562 -SFTNFDSLRNLNLSRNHLQ-----GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEF 635 (1082)
Q Consensus 562 -~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 635 (1082)
.+..+++|++|+|++|.++ +..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+
T Consensus 445 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~ 524 (844)
T 3j0a_A 445 QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524 (844)
T ss_dssp SSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCC
T ss_pred cccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhh
Confidence 5677899999999999997 4555778999999999999999999999999999999999999999998777776
Q ss_pred cCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCCcc
Q 045553 636 SKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSL 684 (1082)
Q Consensus 636 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~ 684 (1082)
. ++|+.|+|++|+|++.+|..| .+|+.|++++|++.|.++...+
T Consensus 525 ~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~~f 568 (844)
T 3j0a_A 525 P--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTF 568 (844)
T ss_dssp C--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCCSH
T ss_pred h--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccHHH
Confidence 6 899999999999999998876 4789999999999999886543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=441.71 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=217.9
Q ss_pred cCccccceecccCceEEEEEEEc------CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|++++++++|||||+++++|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45788899999999999999764 478999999987766677889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEE
Q 045553 875 IYNYLPGGNLEKFIQDRP-----------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL 943 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 943 (1082)
||||+++|+|.++++... ...++|.++.+|+.|||+||+|||+. +|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999998642 35799999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHH
Q 045553 944 SDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
+|||+|+........ ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||... ...+.+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--------~~~~~~~ 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--------SNNEVIE 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHH
Confidence 999999876543332 2334569999999999999999999999999999999998 89999632 2333333
Q ss_pred HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1022 MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.+. .+... ..|..++.++.+|+.+||+.||++||||.||++.|+++.
T Consensus 242 ~i~-~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 242 CIT-QGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHH-HTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH-cCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 333 23221 234456678999999999999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=443.99 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=211.8
Q ss_pred cCccccceecccCceEEEEEEEc------CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++++|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35677889999999999999864 478999999987766677889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcE
Q 045553 875 IYNYLPGGNLEKFIQDRP-------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 941 (1082)
||||+++|+|.++++... ...++|.++.+|+.|||+||+|||+. +|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999998643 24699999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHH
Q 045553 942 YLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||... ...+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--------~~~~~ 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--------SNTEA 269 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--------CHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC--------CHHHH
Confidence 9999999987654332 23345679999999999999999999999999999999999 89999632 22333
Q ss_pred HHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1020 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
+..+. .+... ..|..++.++.+|+.+||+.||++||||.||+++|+.+..
T Consensus 270 ~~~i~-~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 270 IDCIT-QGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHH-HTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHH-cCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 33332 22211 2344566789999999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=437.48 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=215.7
Q ss_pred cCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
..+++.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34677899999999999999863 46899999996543 344678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC
Q 045553 874 LIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL 939 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 939 (1082)
+||||+++|+|.++++.+. ...++|..+.+|+.|||+||+|||+. +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999997542 24589999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHH
Q 045553 940 NAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 940 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~ 1017 (1082)
.+||+|||+|+.....+. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||... ...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--------~~~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQ 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--------CHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------CHH
Confidence 999999999987644332 23445679999999999999999999999999999999998 88998632 223
Q ss_pred HHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
+.+..+ ..+... +.|..++.++.+++.+||+.||++||||.||+++|+...
T Consensus 255 ~~~~~i-~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 255 DVVEMI-RNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHH-HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHH-HcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 333333 333221 234566778999999999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=433.61 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=208.5
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
+++++.++||+|+||+||+|++. ..||||+++... ....+.|.+|++++++++|||||++++++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 46788899999999999999865 369999987543 3446789999999999999999999998865 568999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC-C
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE-T 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-~ 957 (1082)
+++|+|.++++.. ...++|.++..|+.|||+||+|||+. +||||||||+|||+++++.+||+|||+|+...... .
T Consensus 113 ~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999865 45799999999999999999999999 99999999999999999999999999998765332 2
Q ss_pred ccccCcccCCCcccchhccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMT---CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.......||+.|||||++.+ ..|+.++|||||||++|||+||+.||.... ....+...+..+...
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~--------~~~~~~~~~~~~~~~---- 256 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN--------NRDQIIFMVGRGYAS---- 256 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--------CHHHHHHHHHTTCCC----
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhcCCCC----
Confidence 33455689999999999964 468999999999999999999999996321 122233333333211
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
+.+ ...+..++.++.+++.+||+.||++||||.||+++|+.++.+
T Consensus 257 p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 257 PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 111 122345567899999999999999999999999999988653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=478.03 Aligned_cols=530 Identities=17% Similarity=0.150 Sum_probs=416.4
Q ss_pred CCCceee----eeEeeC---------CCCCeeeeecCCCccccccccCCCCCCCCCCCCcccCcCcccccccccCcccCC
Q 045553 27 TDSCSWH----GVTCDP---------LSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSN 93 (1082)
Q Consensus 27 ~~~c~w~----gv~C~~---------~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (1082)
.++|.|. .|.|.. ...+++.|+|++|.... ++..+ +..+......+.
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~------~~~~~--------------~~~l~~L~~L~L 63 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKI------LKSYS--------------FSNFSELQWLDL 63 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCE------ECTTT--------------TTTCTTCCEEEC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCE------eChhh--------------ccCCccCcEEeC
Confidence 3567663 588853 12578999999874332 12111 111222333445
Q ss_pred CCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccc-
Q 045553 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNG- 172 (1082)
Q Consensus 94 ~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~- 172 (1082)
+.+.+.+..|.+|.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..++++++|++|+|++|++.+
T Consensus 64 s~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 143 (606)
T 3vq2_A 64 SRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143 (606)
T ss_dssp TTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCC
T ss_pred CCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccce
Confidence 6688998889999999999999999999998889999999999999999999997777889999999999999999986
Q ss_pred ccCccccCCCCCcEEEcccCcccccCCccccccccccc----EEEcccCccCCCCCccccCCCCccEEEccCCcCC-CCc
Q 045553 173 TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLE----HILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ-GDI 247 (1082)
Q Consensus 173 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~ 247 (1082)
.+|..|+++++|++|+|++|++++..|..+. .+.+|+ +|++++|.+++..+..+.. .+|+.|++++|.++ +..
T Consensus 144 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~~l~~L~l~~n~l~~~~~~~~~~-~~L~~L~L~~n~~~~~~~ 221 (606)
T 3vq2_A 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ-FLRENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHELTLRGNFNSSNIM 221 (606)
T ss_dssp CCCGGGGTCTTCCEEECCSSCCCEECTTTTH-HHHHCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSCHHHH
T ss_pred echHhHhhcCCCCEEEccCCcceecChhhhh-hhhccccccceeeccCCCcceeCcccccC-ceeeeeeccCCccchhHH
Confidence 5799999999999999999999966666554 466554 8999999999665555554 49999999999997 467
Q ss_pred CccccCCCCCCEEeCCCCcCcc------cCCccccCCCC--CcEEEeccccCCcccccCCCCCCcccccCCCcccccCCC
Q 045553 248 PSSFGQLVNLEVLDLSRNFLSG------IVPSELGMCKQ--LKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGG 319 (1082)
Q Consensus 248 p~~~~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~~--L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~ 319 (1082)
|..+..+++|+.+++..+.+.+ ..+..+..+.. ++.+.+.. .+.+.+.
T Consensus 222 ~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~------------------------~~~~~~~ 277 (606)
T 3vq2_A 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY------------------------TNDFSDD 277 (606)
T ss_dssp HHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC------------------------CTTCCGG
T ss_pred HHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc------------------------ccccccc
Confidence 8889999999999886555432 12223333333 33333321 2556666
Q ss_pred CCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccC
Q 045553 320 LPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVP 399 (1082)
Q Consensus 320 ~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~ 399 (1082)
+|. +..+++|+.|++++|.+.... .+..+++|++|++++|++ +.+| .+ .+++|+.|++++|+..+.. ....++
T Consensus 278 ~~~-~~~l~~L~~L~l~~~~~~~l~--~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~-~~~~l~ 350 (606)
T 3vq2_A 278 IVK-FHCLANVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF-KKVALP 350 (606)
T ss_dssp GGS-CGGGTTCSEEEEESCCCCCCC--CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC-CCCCCT
T ss_pred ccc-cccCCCCCEEEecCccchhhh--hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch-hhccCC
Confidence 666 888888999999998886654 788888899999999998 4777 44 8889999999999666544 344678
Q ss_pred cccEEEecCCcceecC--CCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCC
Q 045553 400 CMAVFNVSQNLLSGEI--PRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGP 477 (1082)
Q Consensus 400 ~L~~L~l~~N~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~ 477 (1082)
+|+.|++++|.+++.. +.. +..+
T Consensus 351 ~L~~L~ls~n~l~~~~~~~~~-------------------------------~~~~------------------------ 375 (606)
T 3vq2_A 351 SLSYLDLSRNALSFSGCCSYS-------------------------------DLGT------------------------ 375 (606)
T ss_dssp TCCEEECCSSCEEEEEECCHH-------------------------------HHCC------------------------
T ss_pred CCCEEECcCCccCCCcchhhh-------------------------------hccC------------------------
Confidence 8999999999887531 110 0000
Q ss_pred CCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccc
Q 045553 478 VPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG 557 (1082)
Q Consensus 478 ~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~ 557 (1082)
..+..+++++|.++ .+|..+....++++|++++|++.+..|...+..+++|++|++++|++++
T Consensus 376 -------------~~L~~L~L~~n~l~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 438 (606)
T 3vq2_A 376 -------------NSLRHLDLSFNGAI----IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438 (606)
T ss_dssp -------------SCCCEEECCSCSEE----EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEE
T ss_pred -------------CcccEeECCCCccc----cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCc
Confidence 01122333333322 2334455667788999999999977776777888999999999999999
Q ss_pred cCccccCCCCCCCEEEccCCCCCC-CCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCcccc
Q 045553 558 LIPQSFTNFDSLRNLNLSRNHLQG-PLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFS 636 (1082)
Q Consensus 558 ~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 636 (1082)
..|..|..+++|++|+|++|.+++ .+|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++.+|..|.
T Consensus 439 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 518 (606)
T 3vq2_A 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518 (606)
T ss_dssp CCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTT
T ss_pred cchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHcc
Confidence 999999999999999999999997 4788999999999999999999999999999999999999999999998899999
Q ss_pred CCcccceecccCcccCCCCCCCCCCCC-cccEEeccCCccccCCCCC
Q 045553 637 KLEHLNVLRLDHNNLTGRIPPGFGTRS-SLSIFDVSFNNLSGSAPRN 682 (1082)
Q Consensus 637 ~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~ls~N~l~~~~p~~ 682 (1082)
.+++|++|+|++|+|+ .+|..+..++ +|++|++++|++.|.++..
T Consensus 519 ~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 519 QLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp TCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred CCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 9999999999999999 6777798887 6999999999999988864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=466.61 Aligned_cols=494 Identities=20% Similarity=0.194 Sum_probs=375.0
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
+++++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 47889999999998777788999999999999999998777788899999999999999998777788999999999999
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCC-CCCccccCCCCccEEEccCCcCCCCcCccccCCCCC----CEEeCCC
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTG-SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNL----EVLDLSR 264 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~Ls~ 264 (1082)
++|+++ .++......+++|++|++++|.+++ .+|..++++++|++|++++|++++..+..|+.+++| +.|++++
T Consensus 108 ~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp TTSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred cccccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 999988 4554334478899999999999886 468888999999999999999987777888888888 8899999
Q ss_pred CcCcccCCccccCCCCCcEEEeccccCCc--ccccCCCCCCcc---cccC-CCcccccCCCCCccccCCC--CCcEEEcC
Q 045553 265 NFLSGIVPSELGMCKQLKVLVLRNDYGPL--YSREHGDLPIQP---VVDG-GEDYNFFDGGLPDSITRLP--NLRVFWAP 336 (1082)
Q Consensus 265 N~l~~~~p~~l~~l~~L~~L~l~~n~~~~--~~~~~~~l~~~~---~~~~-~~~~n~~~~~~p~~l~~l~--~L~~L~l~ 336 (1082)
|.+++..|..+..+ +|+.|++++|.... .+.....+.... +... ......+.......+..+. .++.+.++
T Consensus 187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 99988877777766 78899888874221 000000000000 0000 0000111111122233333 25667777
Q ss_pred CC-cccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceecC
Q 045553 337 NL-NLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEI 415 (1082)
Q Consensus 337 ~n-~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~~ 415 (1082)
++ .+.+..+..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+.. +|. ..+++|+.|++++|.+.+.+
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~-l~~-~~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQ-FPT-LKLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSS-CCB-CBCSSCCEEEEESCBSCCBC
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccc-cCc-ccccccCEEeCcCCcccccc
Confidence 77 777888888999999999999999998 688888888 99999999999984 443 46788999999999876544
Q ss_pred CCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccce
Q 045553 416 PRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYG 495 (1082)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~ 495 (1082)
+.. .+. -+..+++++|.+++.
T Consensus 342 ~~~---~~~--------------------------------------~L~~L~l~~n~l~~~------------------ 362 (570)
T 2z63_A 342 SEV---DLP--------------------------------------SLEFLDLSRNGLSFK------------------ 362 (570)
T ss_dssp CCC---BCT--------------------------------------TCCEEECCSSCCBEE------------------
T ss_pred ccc---cCC--------------------------------------CCCEEeCcCCccCcc------------------
Confidence 320 000 011233344433311
Q ss_pred eeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCc-cccCCCCCCCEEEc
Q 045553 496 FWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIP-QSFTNFDSLRNLNL 574 (1082)
Q Consensus 496 ~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L 574 (1082)
...|..+....++++|++++|++. .+|.. +..+++|++|++++|++.+..+ ..|..+++|++|+|
T Consensus 363 ------------~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 428 (570)
T 2z63_A 363 ------------GCCSQSDFGTTSLKYLDLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428 (570)
T ss_dssp ------------EEEEHHHHTCSCCCEEECCSCSEE-EEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEEC
T ss_pred ------------ccccccccccCccCEEECCCCccc-ccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeC
Confidence 011334445667789999999988 45555 6677889999999999988766 57889999999999
Q ss_pred cCCCCCCCCcccccCCCCCCEEEcCCCcCC-ccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCC
Q 045553 575 SRNHLQGPLPSYINKMEDLKFLSLSLNNFT-GAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTG 653 (1082)
Q Consensus 575 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 653 (1082)
++|.+.+..|..|..+++|++|+|++|+++ +.+|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++
T Consensus 429 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 508 (570)
T 2z63_A 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS 508 (570)
T ss_dssp TTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred cCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCC
Confidence 999999888888999999999999999997 5788889999999999999999998888899999999999999999998
Q ss_pred CCCCCCCCCCcccEEeccCCccccCCCCC
Q 045553 654 RIPPGFGTRSSLSIFDVSFNNLSGSAPRN 682 (1082)
Q Consensus 654 ~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 682 (1082)
.+|..|..+++|+.|++++|+++|.+|..
T Consensus 509 ~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 509 VPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 88888899999999999998888777754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=432.76 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=209.4
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999965 469999999997653 2345779999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|++||+|.+++...+...+++..++.|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999877667789999999999999999999999 99999999999999999999999999998764321
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.. .+..+.+..+.... ..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~--------~~~~~~~~~i~~~~-~~------- 243 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA--------GSMKNLVLKIISGS-FP------- 243 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTC-CC-------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHHcCC-CC-------
Confidence 123446799999999999999999999999999999999999999963 23444444444332 11
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223445689999999999999999999999863
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=465.16 Aligned_cols=152 Identities=24% Similarity=0.260 Sum_probs=98.3
Q ss_pred CceeEEEccCCcccccCCc--cccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCE
Q 045553 518 LDGLIFDIGNNKLIGEVPS--DMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKF 595 (1082)
Q Consensus 518 ~~l~~l~l~~n~l~~~ip~--~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 595 (1082)
.++++|++++|++. .+|. ..+..+++|++|++++|+|+ .+|..+..+++|++|+|++|+|++ +|..+. ++|++
T Consensus 361 ~~L~~L~Ls~N~l~-~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~ 435 (549)
T 2z81_A 361 PSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEV 435 (549)
T ss_dssp TTCCEEECTTSCCC-CHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSE
T ss_pred ccCcEEEccCCccc-ccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceE
Confidence 34566777777665 3332 34555666777777777777 345666677777777777777763 333332 46777
Q ss_pred EEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCcc
Q 045553 596 LSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675 (1082)
Q Consensus 596 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l 675 (1082)
|+|++|++++.+ ..+++|++|+|++|+|+ .+|. ...+++|++|+|++|+|++.+|..|..+++|+.|++++|++
T Consensus 436 L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 509 (549)
T 2z81_A 436 LDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509 (549)
T ss_dssp EECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCB
T ss_pred EECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCc
Confidence 777777777532 35667777777777776 4554 35667777777777777766666677777777777766666
Q ss_pred ccCCC
Q 045553 676 SGSAP 680 (1082)
Q Consensus 676 ~~~~p 680 (1082)
+|.+|
T Consensus 510 ~~~~~ 514 (549)
T 2z81_A 510 DCSCP 514 (549)
T ss_dssp CCCHH
T ss_pred cCCCc
Confidence 55444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=425.21 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=213.5
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
..|++.++||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46889999999999999999764 69999999998766566677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 999999999863 599999999999999999999999 999999999999999999999999999998754332 3
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||... +..+.+..+.. +.....
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~-~~~~~~------- 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMIRD-NLPPRL------- 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHH-SSCCCC-------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHc-CCCCCC-------
Confidence 45578999999999999999999999999999999999999999632 22333333322 211111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+.++.+|+.+|++.||++|||+.|++++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1223456789999999999999999999999874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=457.34 Aligned_cols=493 Identities=19% Similarity=0.225 Sum_probs=394.0
Q ss_pred CCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEccc
Q 045553 112 LRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSF 191 (1082)
Q Consensus 112 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 191 (1082)
.+.++-++.+++ .+|..+. +++++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 85 (570)
T 2z63_A 9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (570)
T ss_dssp TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence 356777777787 6777553 6899999999999988888999999999999999999988889999999999999999
Q ss_pred CcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCC-CcCccccCCCCCCEEeCCCCcCccc
Q 045553 192 NLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG-DIPSSFGQLVNLEVLDLSRNFLSGI 270 (1082)
Q Consensus 192 N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~ 270 (1082)
|++++..|..+ ..+++|++|++++|++++..+..++++++|++|++++|.+++ .+|..|+.+++|++|++++|++++.
T Consensus 86 n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~ 164 (570)
T 2z63_A 86 NPIQSLALGAF-SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (570)
T ss_dssp CCCCEECTTTT-TTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE
T ss_pred CcCCccCHhhh-cCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcccee
Confidence 99995444555 479999999999999997666689999999999999999986 4699999999999999999999988
Q ss_pred CCccccCCCCC----cEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCc-------
Q 045553 271 VPSELGMCKQL----KVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLN------- 339 (1082)
Q Consensus 271 ~p~~l~~l~~L----~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~------- 339 (1082)
.|..++.+++| +.|++++|.+.. ..|..+..+ +|+.|++++|.
T Consensus 165 ~~~~~~~l~~L~~~~~~L~l~~n~l~~-------------------------~~~~~~~~~-~L~~L~l~~n~~~~~~~~ 218 (570)
T 2z63_A 165 YCTDLRVLHQMPLLNLSLDLSLNPMNF-------------------------IQPGAFKEI-RLHKLTLRNNFDSLNVMK 218 (570)
T ss_dssp CGGGGHHHHTCTTCCCEEECTTCCCCE-------------------------ECTTTTTTC-EEEEEEEESCCSCTTHHH
T ss_pred cHHHccchhccchhhhhcccCCCCcee-------------------------cCHHHhccC-cceeEecccccccccchh
Confidence 88999999999 899998865443 333334333 55666555542
Q ss_pred ------------------------ccCCCCccccccc--CCCeEEcCCc-cccCCCCccccCCCCCCEEecCCCcCcccC
Q 045553 340 ------------------------LEGIFPQNWELCS--KLEMLNLAHN-FFTGQIPASLGNCKSLYFLDLSSNNLTGLL 392 (1082)
Q Consensus 340 ------------------------l~~~~~~~l~~l~--~L~~L~Ls~N-~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 392 (1082)
+.......+..+. .++.+++++| .+.+..|..+..+++|+.|++++|.+++.+
T Consensus 219 ~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~ 298 (570)
T 2z63_A 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298 (570)
T ss_dssp HHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCC
T ss_pred hhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhhh
Confidence 1222223333333 2567777777 788888999999999999999999999654
Q ss_pred CCCcccCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCC
Q 045553 393 PEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNN 472 (1082)
Q Consensus 393 p~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n 472 (1082)
+....+ +|+.|++++|.+. .+|.. .+.. +..+++++|
T Consensus 299 ~~~~~~-~L~~L~l~~n~~~-~l~~~---~l~~--------------------------------------L~~L~l~~n 335 (570)
T 2z63_A 299 DFSYNF-GWQHLELVNCKFG-QFPTL---KLKS--------------------------------------LKRLTFTSN 335 (570)
T ss_dssp BCCSCC-CCSEEEEESCBCS-SCCBC---BCSS--------------------------------------CCEEEEESC
T ss_pred hhhccC-CccEEeeccCccc-ccCcc---cccc--------------------------------------cCEEeCcCC
Confidence 444456 9999999999986 33321 0000 112233444
Q ss_pred cccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCC-ccccccCCcccEEEcc
Q 045553 473 LFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVP-SDMGSHCKCMKFLSMA 551 (1082)
Q Consensus 473 ~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip-~~~~~~~~~L~~L~L~ 551 (1082)
.+.+.+|. ....++++|++++|++.+... ...+..+++|++|+++
T Consensus 336 ~~~~~~~~----------------------------------~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~ 381 (570)
T 2z63_A 336 KGGNAFSE----------------------------------VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381 (570)
T ss_dssp BSCCBCCC----------------------------------CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECC
T ss_pred cccccccc----------------------------------ccCCCCCEEeCcCCccCccccccccccccCccCEEECC
Confidence 43332221 345678899999999875421 2334567889999999
Q ss_pred CCcccccCccccCCCCCCCEEEccCCCCCCCCc-ccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccC-C
Q 045553 552 GNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLP-SYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLS-G 629 (1082)
Q Consensus 552 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~ 629 (1082)
+|++++..+. |..+++|++|++++|.+++..| ..|..+++|++|++++|++++..|..|.++++|++|+|++|+++ +
T Consensus 382 ~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 460 (570)
T 2z63_A 382 FNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460 (570)
T ss_dssp SCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccc
Confidence 9999987666 9999999999999999997766 57899999999999999999999999999999999999999998 5
Q ss_pred CCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC----cccccccCCCCCCCCCCCCCCCC
Q 045553 630 EIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN----SLIKCENVQGNPNLQLCHTDPSS 705 (1082)
Q Consensus 630 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~----~~~~~~~~~~Np~~c~c~~~~~~ 705 (1082)
.+|..|..+++|++|+|++|++++..|..|..+++|++|++++|++++..|.. ..+....+.+||+.|+|....+.
T Consensus 461 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 540 (570)
T 2z63_A 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540 (570)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred cchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHH
Confidence 78999999999999999999999998999999999999999999999876643 33466789999999999854433
Q ss_pred CcccccC
Q 045553 706 SEWERQH 712 (1082)
Q Consensus 706 ~~~~~~~ 712 (1082)
..|....
T Consensus 541 ~~wl~~~ 547 (570)
T 2z63_A 541 SRWLNKN 547 (570)
T ss_dssp HHHHHHT
T ss_pred HHHHHhc
Confidence 3666543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=420.08 Aligned_cols=270 Identities=24% Similarity=0.317 Sum_probs=205.6
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCC----eEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA----EMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 876 (1082)
.+|.+.++||+|+||+||+|++ +|+.||||++..... ....+.+|+..+.+++|||||++++++.+++ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3577889999999999999988 489999999865432 1223345666677899999999999998653 689999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC-----VPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
||+++|+|.++++.. .++|+.+.+++.|+++||+|||+.+ .++|+||||||+|||++.++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999864 5899999999999999999999863 45899999999999999999999999999987
Q ss_pred cCCCCCc---cccCcccCCCcccchhcccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCccC---C---C-CCcc
Q 045553 952 LGTSETH---ATTDVAGTFGYVAPEYAMTC------RVSDKADVYSFGVVLLELISDKKALDPSFCS---F---G-NGFN 1015 (1082)
Q Consensus 952 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGvll~elltg~~p~~~~~~~---~---~-~~~~ 1015 (1082)
....... .....+||+.|+|||++.+. .++.++|||||||++|||+||+.|+...... + . ....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 7544322 22346799999999999764 4678999999999999999998887533211 0 0 1112
Q ss_pred HHHHHHHHHhcCCCccccccccCC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1016 IVAWASMLLLQGRPCEFFTAGLWD-CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
..++... +..+.. ++.+-. ..+.+....+.+++.+||+.||++||||.||++.|+++...
T Consensus 238 ~~~~~~~-~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKV-VCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHH-HTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHH-HhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 2232222 222211 111111 01235667899999999999999999999999999988654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=416.75 Aligned_cols=247 Identities=21% Similarity=0.342 Sum_probs=211.7
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999965 46899999999753 2344678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||++||+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999874 4699999999999999999999999 99999999999999999999999999999875433
Q ss_pred C-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 T-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||... +..+....+.... .
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~~-~------ 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEGLIFAKIIKLE-Y------ 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC-C------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCC-C------
Confidence 2 3455678999999999999999999999999999999999999999632 2334444433322 1
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
..|...+.++.+++.+|++.||++|||+.|+.
T Consensus 252 ----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12334456789999999999999999998863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=420.48 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=207.4
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
...|++.++||+|+||+||+|+.. +|+.||||+++..... .+|++++++++|||||++++++.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999754 6899999999765332 4799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecccceecCCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~~~ 957 (1082)
++||+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999874 4699999999999999999999999 999999999999999988 699999999998754322
Q ss_pred c----cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 958 H----ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 958 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .- +..+..+.....
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~----~~~i~~~~~~~~-- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----PL----CLKIASEPPPIR-- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS----CC----HHHHHHSCCGGG--
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HH----HHHHHcCCCCch--
Confidence 1 223467999999999999999999999999999999999999999753221 11 112222211100
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+.+++.+||+.||++|||+.|++++|...
T Consensus 277 ------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 ------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp ------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12345567899999999999999999999999888653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=426.35 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=218.0
Q ss_pred HHHHHhcCccccceecccCceEEEEEEEcC------CeEEEEEEeecCcc-ccHHHHHHHHHHHhccCC-CceeeEeeee
Q 045553 795 NVVRATAGFNVQNCIGSGGFGATYKAEIIP------GVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQH-PNLVTLIGYH 866 (1082)
Q Consensus 795 ~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l~~~~ 866 (1082)
+.+...++|++.+.||+|+||+||+|++.. ++.||||++..... ...+.|.+|++++++++| ||||+++++|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 333445789999999999999999997642 36899999976543 345679999999999976 8999999998
Q ss_pred ccC-CeEEEEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCC
Q 045553 867 VSE-AEMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931 (1082)
Q Consensus 867 ~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 931 (1082)
.+. ...++|||||++|+|.++++... ...+++.++..++.|||+||+|||+. +||||||||+
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~ 214 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 214 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcc
Confidence 764 56899999999999999998642 24589999999999999999999999 9999999999
Q ss_pred CEEEcCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccC
Q 045553 932 NILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCS 1009 (1082)
Q Consensus 932 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~ 1009 (1082)
|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999977544332 3445679999999999999999999999999999999998 89999743211
Q ss_pred CCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1010 FGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
+.+...+.++... ..|...+.++.+++.+||+.||++||||.||+++|+.+.
T Consensus 295 --------~~~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 295 --------EEFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp --------HHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HHHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 2233333333222 234455678999999999999999999999999998864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=410.32 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=200.5
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc----CCeEEEE
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS----EAEMFLI 875 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV 875 (1082)
|++.+.||+|+||+||+|... ++..||+|++.... ....+.|.+|++++++++|||||++++++.+ +...|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999754 58999999996543 3345679999999999999999999998864 3568999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeccCCCCCEEEc-CCCcEEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR--VLHRDIKPSNILLD-NNLNAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~ 952 (1082)
|||+++|+|.++++.. ..+++..+..++.||+.||+|||++ + |+||||||+|||++ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999999874 4799999999999999999999998 6 99999999999998 4799999999999864
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||... ........ .+..+.....
T Consensus 183 ~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~-------~~~~~~~~-~i~~~~~~~~ 250 (290)
T 3fpq_A 183 RA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYR-RVTSGVKPAS 250 (290)
T ss_dssp CT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHH-HHTTTCCCGG
T ss_pred CC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC-------CcHHHHHH-HHHcCCCCCC
Confidence 32 23345689999999998865 6999999999999999999999999632 12223222 2333322211
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
++ ...+.++.+++.+||+.||++|||+.|++++
T Consensus 251 ~~--------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 FD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC--------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1223578999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=426.69 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=214.0
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
..|++.+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+.+|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999754 69999999998766666677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
+||+|.++++.. .+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 999999999864 599999999999999999999999 999999999999999999999999999998754332 3
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+.+..+.... ....
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~~-~~~~------- 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMIRDNL-PPRL------- 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSC-CCCC-------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCC-CCCC-------
Confidence 45678999999999999999999999999999999999999999632 2333333332221 1111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1123445689999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=404.56 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=195.6
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999964 469999999997542 234567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+ +|+|.+++..+ ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 78999999874 4799999999999999999999999 99999999999999999999999999998764332
Q ss_pred CccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||... +..+......... .
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------~~~~~~~~i~~~~-~------ 229 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------SIPVLFKNISNGV-Y------ 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC-C------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCC-C------
Confidence 3345689999999999998876 57999999999999999999999632 3334444333221 1
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..|...+.++.+++.+|++.||++|||+.|++++
T Consensus 230 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 ----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1223345678999999999999999999999874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=446.85 Aligned_cols=486 Identities=15% Similarity=0.157 Sum_probs=338.9
Q ss_pred cccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccC
Q 045553 101 NLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQ 180 (1082)
Q Consensus 101 ~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 180 (1082)
.+|+.+. ++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|++
T Consensus 19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 96 (549)
T 2z81_A 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96 (549)
T ss_dssp SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTT
T ss_pred cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhcc
Confidence 4565554 78899999999988777888899999999999999998777788889999999999999998777777888
Q ss_pred CCCCcEEEcccCcccc-cCCcccccccccccEEEcccCccCCCCC-ccccCCCCccEEEccCCcCCCCcCccccCCCCCC
Q 045553 181 SPGFQVVSLSFNLLSG-SVPEEFGDNCVSLEHILLAANSLTGSIP-PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLE 258 (1082)
Q Consensus 181 l~~L~~L~L~~N~l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 258 (1082)
+++|++|+|++|++++ ..|..+ ..+++|++|++++|++.+.+| ..+.++++|++|++++|++++..|..++.+++|+
T Consensus 97 l~~L~~L~Ls~n~l~~~~~~~~~-~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 175 (549)
T 2z81_A 97 LSSLKYLNLMGNPYQTLGVTSLF-PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIH 175 (549)
T ss_dssp CTTCCEEECTTCCCSSSCSSCSC-TTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEE
T ss_pred CCCCcEEECCCCcccccchhhhh-hccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCc
Confidence 8999999999998885 234444 367888888888888444444 5788888888888888888877888888888888
Q ss_pred EEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCC
Q 045553 259 VLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNL 338 (1082)
Q Consensus 259 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n 338 (1082)
+|+++.|.+....+..+..+++|++|++++|.+...... .......+++|+.|++++|
T Consensus 176 ~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----------------------~~~~~~~~~~L~~L~l~~n 233 (549)
T 2z81_A 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS----------------------PLPVDEVSSPMKKLAFRGS 233 (549)
T ss_dssp EEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCC----------------------CCSSCCCCCCCCEEEEESC
T ss_pred eEecccCcccccchhhHhhcccccEEEccCCcccccccc----------------------ccchhhhhhcccceecccc
Confidence 888888887643333345677788888877643321100 0011123455555555555
Q ss_pred cccCCCCcc----cccccCCCeEEcCCccccCCC------CccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecC
Q 045553 339 NLEGIFPQN----WELCSKLEMLNLAHNFFTGQI------PASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQ 408 (1082)
Q Consensus 339 ~l~~~~~~~----l~~l~~L~~L~Ls~N~i~~~~------p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~ 408 (1082)
.+.+..+.. +..+++|+.|++++|.+.+.. ...+..+ ++++.|++.+
T Consensus 234 ~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l-----------------------~~L~~L~l~~ 290 (549)
T 2z81_A 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL-----------------------GKVETVTIRR 290 (549)
T ss_dssp EEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCC-----------------------TTCCEEEEES
T ss_pred ccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhh-----------------------cccccccccc
Confidence 554433222 233455555555555554321 1112333 4445555554
Q ss_pred CcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCc
Q 045553 409 NLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSL 488 (1082)
Q Consensus 409 N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l 488 (1082)
+.+....... .++ .. ...
T Consensus 291 ~~i~~~~~~~------~l~-----------~~-----------------------------------------~~~---- 308 (549)
T 2z81_A 291 LHIPQFYLFY------DLS-----------TV-----------------------------------------YSL---- 308 (549)
T ss_dssp CBCSCGGGSC------CCC-----------HH-----------------------------------------HHH----
T ss_pred cccchhhhcc------cch-----------hh-----------------------------------------hhh----
Confidence 4432100000 000 00 000
Q ss_pred cccccceeeeccCCCccccCCcccccc-cCCceeEEEccCCcccccCCcc--ccccCCcccEEEccCCcccccCc--ccc
Q 045553 489 SSRPYYGFWLSGNSLKGNLSTYPFDLC-LSLDGLIFDIGNNKLIGEVPSD--MGSHCKCMKFLSMAGNEFVGLIP--QSF 563 (1082)
Q Consensus 489 ~~~~~~~~~~~~n~~~~~l~~~p~~~~-~~~~l~~l~l~~n~l~~~ip~~--~~~~~~~L~~L~L~~N~i~~~~~--~~~ 563 (1082)
...+..+.+++|.++ .+|..+. ...++++|++++|++.+.+|.. .+..+++|++|+|++|+|++..+ ..|
T Consensus 309 -~~~L~~L~l~~n~l~----~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 383 (549)
T 2z81_A 309 -LEKVKRITVENSKVF----LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383 (549)
T ss_dssp -STTCCEEEEESSCCC----CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHG
T ss_pred -cccceEEEeccCccc----cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhh
Confidence 001122233333322 3344442 4567889999999999877643 34567889999999999997754 568
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccce
Q 045553 564 TNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNV 643 (1082)
Q Consensus 564 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 643 (1082)
..+++|++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+. ++|++|+|++|+|++.+ ..+++|++
T Consensus 384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~ 455 (549)
T 2z81_A 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQE 455 (549)
T ss_dssp GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCE
T ss_pred hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcE
Confidence 99999999999999999 67889999999999999999998 4555443 68999999999999643 57899999
Q ss_pred ecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC----cccccccCCCCCCCCCCCCCCCCCccccc
Q 045553 644 LRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN----SLIKCENVQGNPNLQLCHTDPSSSEWERQ 711 (1082)
Q Consensus 644 L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~----~~~~~~~~~~Np~~c~c~~~~~~~~~~~~ 711 (1082)
|+|++|+|+ .+|. ...+++|++|++++|++++.+|.. ..+....+.+|||.|+|....+...|...
T Consensus 456 L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~l~~~l~~ 525 (549)
T 2z81_A 456 LYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNK 525 (549)
T ss_dssp EECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHHHHHHHHHH
T ss_pred EECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccHHHHHHHHHh
Confidence 999999999 6776 467999999999999999877753 34567789999999999744444455543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=463.62 Aligned_cols=453 Identities=19% Similarity=0.234 Sum_probs=333.6
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCC------C------CCCccccCCCCCCeEEccCcccccccCcc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFH------G------PIPPTLQNCSSLRLINLSGNQFNGTIPAF 177 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~------~------~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 177 (1082)
.+++.|+|++|++.|.+|.+|++|++|++|+|++|.+. + .+|... +..|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 47889999999999999999999999999999999762 2 344433 45666 777788777776665
Q ss_pred ccCC-CCCcEEEcccCcccccCCcccccccccccEEEcc--cCccCCCCCccccCCCCccEEEccCCcCCCC--------
Q 045553 178 FGQS-PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA--ANSLTGSIPPSLGNCTELRSLLLSSNMLQGD-------- 246 (1082)
Q Consensus 178 ~~~l-~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~--~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-------- 246 (1082)
+..+ ..+..+++....+.. .....++.+.+. .|++++ +|..++++++|++|+|++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~-------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 229 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK-------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC-------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred HHHHHHHHhhcCcccccccc-------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence 5422 223333333322220 011223333332 577776 777788888888888888888764
Q ss_pred ---------cCcccc--CCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccc
Q 045553 247 ---------IPSSFG--QLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNF 315 (1082)
Q Consensus 247 ---------~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~ 315 (1082)
+|..++ ++++|++|+|++|++.+.+|..|+++++|++|++++| .
T Consensus 230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n-------------------------~ 284 (636)
T 4eco_A 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN-------------------------R 284 (636)
T ss_dssp TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC-------------------------T
T ss_pred cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC-------------------------C
Confidence 777777 7778888888888777777777777777777777663 3
Q ss_pred -cCC-CCCccccCC------CCCcEEEcCCCcccCCCCc--ccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCC
Q 045553 316 -FDG-GLPDSITRL------PNLRVFWAPNLNLEGIFPQ--NWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSS 385 (1082)
Q Consensus 316 -~~~-~~p~~l~~l------~~L~~L~l~~n~l~~~~~~--~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~ 385 (1082)
+++ .+|..++.+ ++|++|++++|++. .+|. .+..+++|++|+|++|+++|.+| .+..+++|+.|+|++
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 445 566666665 67777777777777 4555 67777777777777777776666 667777777777777
Q ss_pred CcCcccCCCCcccCc-ccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCce
Q 045553 386 NNLTGLLPEEVSVPC-MAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLF 464 (1082)
Q Consensus 386 N~l~~~~p~~~~l~~-L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (1082)
|+++..+.....+++ |+.|++++|.++ .+|
T Consensus 363 N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp------------------------------------------------ 393 (636)
T 4eco_A 363 NQITEIPANFCGFTEQVENLSFAHNKLK-YIP------------------------------------------------ 393 (636)
T ss_dssp SEEEECCTTSEEECTTCCEEECCSSCCS-SCC------------------------------------------------
T ss_pred CccccccHhhhhhcccCcEEEccCCcCc-ccc------------------------------------------------
Confidence 777733333335666 777777766665 222
Q ss_pred eEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccc----
Q 045553 465 ILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGS---- 540 (1082)
Q Consensus 465 ~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~---- 540 (1082)
..+. .....++++|++++|++.+.+|..+..
T Consensus 394 ---------------~~~~------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~ 428 (636)
T 4eco_A 394 ---------------NIFD------------------------------AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428 (636)
T ss_dssp ---------------SCCC------------------------------TTCSSCEEEEECCSSCTTTTTTCSSCTTCSS
T ss_pred ---------------hhhh------------------------------hcccCccCEEECcCCcCCCcchhhhcccccc
Confidence 1110 011235689999999999888877651
Q ss_pred --cCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCC-------CCCEEEcCCCcCCccCchhh
Q 045553 541 --HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKME-------DLKFLSLSLNNFTGAIPWEL 611 (1082)
Q Consensus 541 --~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~ 611 (1082)
.+++|++|+|++|+|+.+.+..|..+++|++|+|++|+++.+.+..+..+. +|++|+|++|+++ .+|..+
T Consensus 429 ~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~ 507 (636)
T 4eco_A 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDF 507 (636)
T ss_dssp CCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGG
T ss_pred cccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhh
Confidence 345799999999999977777788899999999999999944444444333 9999999999999 788888
Q ss_pred h--cCcccchhhccCcccCCCCCccccCCcccceecc------cCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC-
Q 045553 612 T--QLASLEVLELSANSLSGEIPSEFSKLEHLNVLRL------DHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN- 682 (1082)
Q Consensus 612 ~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~- 682 (1082)
. .+++|+.|+|++|+|++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|+.|++++|++ +.+|..
T Consensus 508 ~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~ 585 (636)
T 4eco_A 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI 585 (636)
T ss_dssp STTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC
T ss_pred hhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhH
Confidence 7 99999999999999997 8999999999999999 56889999999999999999999999999 788864
Q ss_pred -cccccccCCCCCCCC
Q 045553 683 -SLIKCENVQGNPNLQ 697 (1082)
Q Consensus 683 -~~~~~~~~~~Np~~c 697 (1082)
..+....+.+||+.|
T Consensus 586 ~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 586 TPNISVLDIKDNPNIS 601 (636)
T ss_dssp CTTCCEEECCSCTTCE
T ss_pred hCcCCEEECcCCCCcc
Confidence 345667889999884
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=410.07 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=201.4
Q ss_pred cCccccceecccCceEEEEEEEc----CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999652 47899999996542 2234468899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||++||+|.++++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999874 4699999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||... +..+.+..+.... .
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~-~----- 243 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--------DRKETMTMILKAK-L----- 243 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C-----
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc--------CHHHHHHHHHcCC-C-----
Confidence 322 334578999999999999999999999999999999999999999732 3334444443321 1
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQ 1072 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 1072 (1082)
..|...+.++.+++.+||+.||++||| ++|+++
T Consensus 244 -----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 123345568999999999999999998 467764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=444.15 Aligned_cols=520 Identities=21% Similarity=0.181 Sum_probs=312.5
Q ss_pred CCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccccc
Q 045553 95 SDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTI 174 (1082)
Q Consensus 95 ~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 174 (1082)
.|+|++..+.+|.++++|++|+|++|+|++..|.+|+++++|++|+|++|+|++..+..|.++++|++|+|++|++++..
T Consensus 61 ~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~ 140 (635)
T 4g8a_A 61 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 140 (635)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCST
T ss_pred CCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCC
Confidence 34444444444555555555555555555444444555555555555555555333344555555555555555555444
Q ss_pred CccccCCCCCcEEEcccCccccc-CCcccccccccccEEEcccCccCCCCCccccCCCCc----cEEEccCCcCCCCcCc
Q 045553 175 PAFFGQSPGFQVVSLSFNLLSGS-VPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTEL----RSLLLSSNMLQGDIPS 249 (1082)
Q Consensus 175 p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~p~ 249 (1082)
+..|+++++|++|+|++|++++. +|..+ ..+++|++|++++|++++..+..+..+.++ ..++++.|.++...+.
T Consensus 141 ~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~ 219 (635)
T 4g8a_A 141 NFPIGHLKTLKELNVAHNLIQSFKLPEYF-SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 219 (635)
T ss_dssp TCCCTTCTTCCEEECCSSCCCCCCCCGGG-GGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTT
T ss_pred hhhhhcCcccCeeccccCccccCCCchhh-ccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcc
Confidence 44455555555555555555422 22222 234555555555555554444444333222 2444555555432222
Q ss_pred cccCCCCCCEEeCCCCcCcc-cCCccccCCCCCcEEEeccccCCcccccCC-CC-CCccccc---CC---CcccccCCCC
Q 045553 250 SFGQLVNLEVLDLSRNFLSG-IVPSELGMCKQLKVLVLRNDYGPLYSREHG-DL-PIQPVVD---GG---EDYNFFDGGL 320 (1082)
Q Consensus 250 ~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~-~l-~~~~~~~---~~---~~~n~~~~~~ 320 (1082)
.+ ....++.|++.+|.... ..+..+..+..++...+..+.......... .. ....... .. ..........
T Consensus 220 ~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 298 (635)
T 4g8a_A 220 AF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGI 298 (635)
T ss_dssp TT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEEC
T ss_pred cc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccch
Confidence 22 22334444554443321 122334445555544443221111000000 00 0000000 00 0011122234
Q ss_pred CccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCc
Q 045553 321 PDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPC 400 (1082)
Q Consensus 321 p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~ 400 (1082)
+..+..+.+++.+.+.++.+.... .+....+|+.|++.+|.+.+..+ ..++.|+.+++++|.+... +....+++
T Consensus 299 ~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~-~~~~~l~~ 372 (635)
T 4g8a_A 299 IDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA-FSEVDLPS 372 (635)
T ss_dssp TTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB-CCCCBCTT
T ss_pred hhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC-cccccccc
Confidence 556677888999999999887754 35667899999999999985443 3467899999999988754 44557899
Q ss_pred ccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCC
Q 045553 401 MAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPP 480 (1082)
Q Consensus 401 L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~ 480 (1082)
|+.|++++|.+....+.. . .. ..+. -....+++.|...
T Consensus 373 L~~L~ls~n~l~~~~~~~------~-~~----------------------~~~~--------~L~~L~~~~~~~~----- 410 (635)
T 4g8a_A 373 LEFLDLSRNGLSFKGCCS------Q-SD----------------------FGTI--------SLKYLDLSFNGVI----- 410 (635)
T ss_dssp CCEEECCSSCCBEEEECC------H-HH----------------------HSCS--------CCCEEECCSCSEE-----
T ss_pred cccchhhccccccccccc------c-ch----------------------hhhh--------hhhhhhccccccc-----
Confidence 999999999886321100 0 00 0000 0011222222221
Q ss_pred ccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCc
Q 045553 481 FLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIP 560 (1082)
Q Consensus 481 ~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~ 560 (1082)
..+.......+++.+++++|+..+..+...+..+++++.++++.|++.+..+
T Consensus 411 ----------------------------~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~ 462 (635)
T 4g8a_A 411 ----------------------------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 462 (635)
T ss_dssp ----------------------------EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCT
T ss_pred ----------------------------cccccccccccccchhhhhccccccccccccccccccccccccccccccccc
Confidence 1223344556677888888888878888888888889999999999988888
Q ss_pred cccCCCCCCCEEEccCCCC-CCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCc
Q 045553 561 QSFTNFDSLRNLNLSRNHL-QGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLE 639 (1082)
Q Consensus 561 ~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 639 (1082)
..+..++.|++|+|++|.+ .+..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..++
T Consensus 463 ~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~ 542 (635)
T 4g8a_A 463 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 542 (635)
T ss_dssp TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCT
T ss_pred cccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCC
Confidence 8888889999999998874 345678888889999999999999988888898999999999999999888888888899
Q ss_pred ccceecccCcccCCCCCCCCCCC-CcccEEeccCCccccCCCCCcccccccCCCCCCCCCCCCCCCCCcccccCC
Q 045553 640 HLNVLRLDHNNLTGRIPPGFGTR-SSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQLCHTDPSSSEWERQHS 713 (1082)
Q Consensus 640 ~L~~L~L~~N~l~~~~p~~~~~l-~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~Np~~c~c~~~~~~~~~~~~~~ 713 (1082)
+|++|+|++|+|++.+|..|..+ ++|++|+|+ +|||.|+|. ..|...|.+...
T Consensus 543 ~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~--------------------~Np~~C~C~-~~~~~~wl~~~~ 596 (635)
T 4g8a_A 543 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT--------------------QNDFACTCE-HQSFLQWIKDQR 596 (635)
T ss_dssp TCCEEECTTSCCCBCCSSCTTCCCTTCCEEECT--------------------TCCBCCSGG-GHHHHHHHHHTT
T ss_pred CCCEEECCCCcCCCCCHHHHHhhhCcCCEEEee--------------------CCCCcccCC-cHHHHHHHHhCC
Confidence 99999999999998888888887 578888875 455668887 455666665443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=443.63 Aligned_cols=159 Identities=26% Similarity=0.264 Sum_probs=119.9
Q ss_pred CceeEEEccCCcccccCCccccccCCcccEEEccCCcccc--cCccccCCCCCCCEEEccCCCCCCCCcc-cccCCCCCC
Q 045553 518 LDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG--LIPQSFTNFDSLRNLNLSRNHLQGPLPS-YINKMEDLK 594 (1082)
Q Consensus 518 ~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~ 594 (1082)
.++++|++++|++.+.+|..+ ..+++|++|++++|+|++ .+|..|..+++|++|+|++|.+++.+|. .|..+++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENC-GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTC-CCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhhhh-ccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 455788888888887677665 456778888888888886 4456788888888888888888874554 477788888
Q ss_pred EEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCc
Q 045553 595 FLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNN 674 (1082)
Q Consensus 595 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~ 674 (1082)
+|+|++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|+
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~ 479 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP 479 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCC
Confidence 888888888877766654 67888888888888 677777788888888888888884333347888888888887777
Q ss_pred cccCCC
Q 045553 675 LSGSAP 680 (1082)
Q Consensus 675 l~~~~p 680 (1082)
++|.++
T Consensus 480 ~~c~c~ 485 (520)
T 2z7x_B 480 WDCSCP 485 (520)
T ss_dssp BCCCHH
T ss_pred CcccCC
Confidence 664433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=442.99 Aligned_cols=462 Identities=20% Similarity=0.230 Sum_probs=327.0
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccC
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (1082)
++|++++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 45677777776 5665554 67777777777777655666777777777777777777666677777777777777777
Q ss_pred cccccCCcccccccccccEEEcccCccCC-CCCccccCCCCccEEEccCCcCCCCcCccccCCCCC--CEEeCCCCcC--
Q 045553 193 LLSGSVPEEFGDNCVSLEHILLAANSLTG-SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNL--EVLDLSRNFL-- 267 (1082)
Q Consensus 193 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l-- 267 (1082)
+++ .+|.. .+++|++|+|++|++++ .+|..++++++|++|++++|++++ ..+..+++| ++|++++|.+
T Consensus 80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~ 152 (520)
T 2z7x_B 80 KLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG 152 (520)
T ss_dssp CCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred cee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence 776 56655 46677777777777765 356677777777777777777764 345556666 7777777777
Q ss_pred cccCCccccCCCC-CcEEEeccccCCcccccCCCCCCcccccCCCcccccCCC-CCccccCCCCCcEEEcCCCc------
Q 045553 268 SGIVPSELGMCKQ-LKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGG-LPDSITRLPNLRVFWAPNLN------ 339 (1082)
Q Consensus 268 ~~~~p~~l~~l~~-L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~-~p~~l~~l~~L~~L~l~~n~------ 339 (1082)
.+..|..+..++. ...+++++ |.+.+. .+..+..+++|+.|++++|.
T Consensus 153 ~~~~~~~l~~l~~~~l~l~l~~-------------------------n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 207 (520)
T 2z7x_B 153 EKEDPEGLQDFNTESLHIVFPT-------------------------NKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207 (520)
T ss_dssp SSCCTTTTTTCCEEEEEEECCS-------------------------SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTH
T ss_pred cccccccccccccceEEEEecc-------------------------Ccchhhhhhhhhhcccceeeccccccccccccc
Confidence 6666666665552 12223333 222222 23455667777777777776
Q ss_pred -ccCCCCcccccccCCCeEEcCCccccCCCCcccc---CCCCCCEEecCCCcCcccCCCCc------ccCcccEEEecCC
Q 045553 340 -LEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLG---NCKSLYFLDLSSNNLTGLLPEEV------SVPCMAVFNVSQN 409 (1082)
Q Consensus 340 -l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p~~~------~l~~L~~L~l~~N 409 (1082)
+.+..+ .+..+++|+.|++++|.+++..+..+. .+++|+.|++++|++++.+|..+ .++.|+.+++++|
T Consensus 208 ~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n 286 (520)
T 2z7x_B 208 YFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD 286 (520)
T ss_dssp HHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEEC
T ss_pred eeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEecccccc
Confidence 555444 667777888888887777653322221 14578888888888877666653 4677777777777
Q ss_pred cceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCcc
Q 045553 410 LLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLS 489 (1082)
Q Consensus 410 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~ 489 (1082)
.+ .+|.- .+
T Consensus 287 ~~--~~p~~--------------------------------------------------------------~~------- 295 (520)
T 2z7x_B 287 VF--GFPQS--------------------------------------------------------------YI------- 295 (520)
T ss_dssp CC--CSCTH--------------------------------------------------------------HH-------
T ss_pred ce--ecchh--------------------------------------------------------------hh-------
Confidence 65 22210 00
Q ss_pred ccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCC
Q 045553 490 SRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSL 569 (1082)
Q Consensus 490 ~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L 569 (1082)
..+....+++.|++++|++.+ ++ .+..+++|++|++++|++++..|..|..+++|
T Consensus 296 ----------------------~~~~~~~~L~~L~l~~n~l~~-~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 350 (520)
T 2z7x_B 296 ----------------------YEIFSNMNIKNFTVSGTRMVH-ML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350 (520)
T ss_dssp ----------------------HHHHHTCCCSEEEEESSCCCC-CC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSC
T ss_pred ----------------------hcccccCceeEEEcCCCcccc-cc--chhhCCcccEEEeECCccChhhhhhhccCCCC
Confidence 000011234678888887652 22 22567889999999999999999999999999
Q ss_pred CEEEccCCCCCC--CCcccccCCCCCCEEEcCCCcCCccCchh-hhcCcccchhhccCcccCCCCCccccCCcccceecc
Q 045553 570 RNLNLSRNHLQG--PLPSYINKMEDLKFLSLSLNNFTGAIPWE-LTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRL 646 (1082)
Q Consensus 570 ~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 646 (1082)
++|+|++|++++ .+|..|..+++|++|+|++|++++.+|.. |..+++|++|+|++|++++.+|..+. ++|+.|+|
T Consensus 351 ~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~L 428 (520)
T 2z7x_B 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDL 428 (520)
T ss_dssp CEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEEC
T ss_pred CEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEEC
Confidence 999999999996 45678999999999999999999856654 88999999999999999988777665 79999999
Q ss_pred cCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC-----cccccccCCCCCCCCCCCCCCCC-Cccccc
Q 045553 647 DHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN-----SLIKCENVQGNPNLQLCHTDPSS-SEWERQ 711 (1082)
Q Consensus 647 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-----~~~~~~~~~~Np~~c~c~~~~~~-~~~~~~ 711 (1082)
++|+|+ .+|..+..+++|+.|++++|+++ .+|.. ..+....+.+||+.|+|.. .+. ..|...
T Consensus 429 s~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~-~~~~~~~~~~ 496 (520)
T 2z7x_B 429 HSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR-IDYLSRWLNK 496 (520)
T ss_dssp CSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH-HHHHHHHHHH
T ss_pred CCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCc-hHHHHHHHHh
Confidence 999999 78888889999999999999999 46654 2345678899999999973 333 556543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=396.04 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=190.3
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCC--------
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA-------- 870 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 870 (1082)
.+|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999754 689999999975543 34567899999999999999999999886543
Q ss_pred ----eEEEEEeecCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEee
Q 045553 871 ----EMFLIYNYLPGGNLEKFIQDRPR-RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSD 945 (1082)
Q Consensus 871 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 945 (1082)
..|+||||+++|+|.++++.... ...++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36999999999999999987532 3456777899999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCc-----------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCc
Q 045553 946 FGLARLLGTSETH-----------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGF 1014 (1082)
Q Consensus 946 fGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~ 1014 (1082)
||+|+.+...... .....+||+.|||||++.+..|+.++||||+||++|||++ ||... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------~ 231 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------M 231 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------c
Confidence 9999877543221 2234679999999999999999999999999999999996 66421 1
Q ss_pred cHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1015 NIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.....+.. ......... .......+..++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~-~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ERVRTLTD-VRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-HHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHH-HhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 222221111 1223345678999999999999999999987
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=443.64 Aligned_cols=451 Identities=20% Similarity=0.223 Sum_probs=349.0
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeC-cCCCCCCCCCccccCC----CCCC--eEE----------ccCccccc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDL-SFNSFHGPIPPTLQNC----SSLR--LIN----------LSGNQFNG 172 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~l~~l----~~L~--~L~----------Ls~N~l~~ 172 (1082)
.+++.|+|++|++.|.+|++|++|++|++|+| ++|.++|..|-..... ..++ .+. .....+.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57888899999998888988999999999999 8888877644321111 0000 000 00001111
Q ss_pred c-----------cCccccCCCCCcEEEccc--CcccccCCcccccccccccEEEcccCccCC-CCCccccCCCCccEEEc
Q 045553 173 T-----------IPAFFGQSPGFQVVSLSF--NLLSGSVPEEFGDNCVSLEHILLAANSLTG-SIPPSLGNCTELRSLLL 238 (1082)
Q Consensus 173 ~-----------~p~~~~~l~~L~~L~L~~--N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L 238 (1082)
. .+........++.+.+.. |++++ +|..++ .+++|++|+|++|++++ .++..+.. .
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~-~L~~L~~L~Ls~N~Lsg~~i~~~~~~--------~ 472 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQ-RLTKLQIIYFANSPFTYDNIAVDWED--------A 472 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGG-GCTTCCEEEEESCCCCGGGBSSSCSC--------T
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHh-cCCCCCEEECcCCcCCCCcccccccc--------c
Confidence 1 111112334555555554 89997 998876 69999999999999997 33333221 2
Q ss_pred cCCcCCCCcCcccc--CCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCccccc
Q 045553 239 SSNMLQGDIPSSFG--QLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFF 316 (1082)
Q Consensus 239 ~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~ 316 (1082)
+.|.+.+.+|..++ ++++|++|+|++|++.+.+|..|+++++|+.|++++|. .+
T Consensus 473 s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~------------------------~l 528 (876)
T 4ecn_A 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR------------------------GI 528 (876)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT------------------------TS
T ss_pred ccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC------------------------Cc
Confidence 33667778999988 99999999999999999999999999999999998852 15
Q ss_pred CC-CCCccccCCC-------CCcEEEcCCCcccCCCCc--ccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCC
Q 045553 317 DG-GLPDSITRLP-------NLRVFWAPNLNLEGIFPQ--NWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSN 386 (1082)
Q Consensus 317 ~~-~~p~~l~~l~-------~L~~L~l~~n~l~~~~~~--~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N 386 (1082)
++ .+|..++.++ +|++|++++|++. .+|. .+..+++|+.|+|++|+++ .+| .|..+++|+.|+|++|
T Consensus 529 sg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N 605 (876)
T 4ecn_A 529 SAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYN 605 (876)
T ss_dssp CHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSS
T ss_pred ccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCC
Confidence 55 5777666554 9999999999999 6677 8999999999999999999 888 8999999999999999
Q ss_pred cCcccCCCC-cccCc-ccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCce
Q 045553 387 NLTGLLPEE-VSVPC-MAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLF 464 (1082)
Q Consensus 387 ~l~~~~p~~-~~l~~-L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (1082)
+++ .+|.. ..+++ |+.|++++|.++ .+|..
T Consensus 606 ~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~---------------------------------------------- 637 (876)
T 4ecn_A 606 QIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNI---------------------------------------------- 637 (876)
T ss_dssp CCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSC----------------------------------------------
T ss_pred ccc-cchHHHhhccccCCEEECcCCCCC-cCchh----------------------------------------------
Confidence 999 55544 47888 999999999986 33321
Q ss_pred eEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccc---c-c
Q 045553 465 ILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDM---G-S 540 (1082)
Q Consensus 465 ~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~---~-~ 540 (1082)
+. .....+|+.|++++|++.+.+|... . -
T Consensus 638 -----------------~~------------------------------~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~ 670 (876)
T 4ecn_A 638 -----------------FN------------------------------AKSVYVMGSVDFSYNKIGSEGRNISCSMDDY 670 (876)
T ss_dssp -----------------CC------------------------------TTCSSCEEEEECCSSCTTTTSSSCSSCTTTC
T ss_pred -----------------hh------------------------------ccccCCCCEEECcCCcCCCccccchhhhccc
Confidence 00 0011235788888888887666432 1 1
Q ss_pred cCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccC-C-------CCCCEEEcCCCcCCccCchhhh
Q 045553 541 HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINK-M-------EDLKFLSLSLNNFTGAIPWELT 612 (1082)
Q Consensus 541 ~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l-------~~L~~L~Ls~N~l~~~~p~~~~ 612 (1082)
...+|+.|+|++|+|+.+.+..+..+++|+.|+|++|+|+ .+|..+.. . ++|+.|+|++|+|+ .+|..+.
T Consensus 671 ~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~ 748 (876)
T 4ecn_A 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFR 748 (876)
T ss_dssp CCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGS
T ss_pred cCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhh
Confidence 2347999999999999766666778999999999999999 55544433 2 39999999999999 7888887
Q ss_pred --cCcccchhhccCcccCCCCCccccCCcccceecccC------cccCCCCCCCCCCCCcccEEeccCCccccCCCCC--
Q 045553 613 --QLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDH------NNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN-- 682 (1082)
Q Consensus 613 --~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-- 682 (1082)
.+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|..+++|+.|+|++|++ +.+|..
T Consensus 749 ~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~ 826 (876)
T 4ecn_A 749 ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT 826 (876)
T ss_dssp TTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC
T ss_pred hccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc
Confidence 99999999999999997 798999999999999976 889999999999999999999999999 788875
Q ss_pred cccccccCCCCCCC
Q 045553 683 SLIKCENVQGNPNL 696 (1082)
Q Consensus 683 ~~~~~~~~~~Np~~ 696 (1082)
..+...++.+||+.
T Consensus 827 ~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 827 PQLYILDIADNPNI 840 (876)
T ss_dssp SSSCEEECCSCTTC
T ss_pred CCCCEEECCCCCCC
Confidence 33456678899875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=393.87 Aligned_cols=291 Identities=35% Similarity=0.651 Sum_probs=257.0
Q ss_pred cccccHHHHHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeee
Q 045553 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYH 866 (1082)
Q Consensus 788 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~ 866 (1082)
...++++++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 356889999999999999999999999999999887899999999875432 2233689999999999999999999999
Q ss_pred ccCCeEEEEEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEe
Q 045553 867 VSEAEMFLIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS 944 (1082)
Q Consensus 867 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 944 (1082)
......++||||+++|+|.++++... ...+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998754 3359999999999999999999999877899999999999999999999999
Q ss_pred ecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 945 DFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 945 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
|||+++..............||+.|+|||++.+..++.++||||+|+++|||++|+.||+..............|+....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999987655555555667999999999999999999999999999999999999999754444445667888888877
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.........+.......+......+.+++.+|++.+|++|||+.||+++|++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 777788888888887888899999999999999999999999999999998643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=386.66 Aligned_cols=283 Identities=35% Similarity=0.579 Sum_probs=247.6
Q ss_pred ccHHHHHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCC
Q 045553 791 LTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 870 (1082)
+.+.++..++++|++.+.||+|+||.||+|...+++.||||++........+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33444556788999999999999999999998889999999988776667788999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997653 23589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 949 ARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 949 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......|.......+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNG 263 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhccccc
Confidence 987643322 2334456899999999999999999999999999999999999999765433 3456777877777777
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.....+++......+.+.+..+.+++.+|++.||++||++.||+++|+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 778888888777778889999999999999999999999999999998764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=422.99 Aligned_cols=457 Identities=19% Similarity=0.177 Sum_probs=288.7
Q ss_pred CCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEccc
Q 045553 112 LRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSF 191 (1082)
Q Consensus 112 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 191 (1082)
.+++++++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 367777777777 4665553 6777777777777766666777777777777777777776677777777777777777
Q ss_pred CcccccCCcccccccccccEEEcccCccCC-CCCccccCCCCccEEEccCCcCCCCcCccccCCCCC--CEEeCCCCcC-
Q 045553 192 NLLSGSVPEEFGDNCVSLEHILLAANSLTG-SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNL--EVLDLSRNFL- 267 (1082)
Q Consensus 192 N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l- 267 (1082)
|+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++. .+..+++| ++|++++|++
T Consensus 110 N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~ 182 (562)
T 3a79_B 110 NRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH 182 (562)
T ss_dssp SCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred CcCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence 7777 66665 46777777777777775 2356777777777777777777653 34444444 7777777777
Q ss_pred -cccCCccccCCCCCcE--EEeccccCCcccccCCCCCCcccccCCCcccccCCCCC-ccccCCCCCcEEEcCCCcc---
Q 045553 268 -SGIVPSELGMCKQLKV--LVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLP-DSITRLPNLRVFWAPNLNL--- 340 (1082)
Q Consensus 268 -~~~~p~~l~~l~~L~~--L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p-~~l~~l~~L~~L~l~~n~l--- 340 (1082)
++..|..+..++. +. +++++| .+.+.++ ..+..+++|+.+++++|..
T Consensus 183 ~~~~~~~~l~~l~~-~~l~l~l~~n-------------------------~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 236 (562)
T 3a79_B 183 IKGGETESLQIPNT-TVLHLVFHPN-------------------------SLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236 (562)
T ss_dssp CCSSSCCEEEECCE-EEEEEEECSS-------------------------SCCCCCCEEEESSEEEEEEEEEECCSTTHH
T ss_pred ccccCcccccccCc-ceEEEEecCc-------------------------cchhhhhhhcccccceEEEecccccccccc
Confidence 6666776666541 22 233332 2222222 3455677777777777641
Q ss_pred --cCCCCcccccccCCCeEEcCCccccCCC----CccccCCCCCCEEecCCCcCcccCCCCc------ccCcccEEEecC
Q 045553 341 --EGIFPQNWELCSKLEMLNLAHNFFTGQI----PASLGNCKSLYFLDLSSNNLTGLLPEEV------SVPCMAVFNVSQ 408 (1082)
Q Consensus 341 --~~~~~~~l~~l~~L~~L~Ls~N~i~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------~l~~L~~L~l~~ 408 (1082)
.+ ....+..+++|+.|+++++.+.+.. +..+ ..++|++|++++|.+++.+|..+ .+..|+.+++..
T Consensus 237 ~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~ 314 (562)
T 3a79_B 237 RLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314 (562)
T ss_dssp HHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEE
T ss_pred hHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccc
Confidence 11 1234566677777777776665321 2211 23477777777777776666543 233444444444
Q ss_pred CcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCc
Q 045553 409 NLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSL 488 (1082)
Q Consensus 409 N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l 488 (1082)
|.+ .+|.. ....+ +
T Consensus 315 ~~~--~~p~~---~~~~~-------------------------------------------------------------~ 328 (562)
T 3a79_B 315 QVF--LFSKE---ALYSV-------------------------------------------------------------F 328 (562)
T ss_dssp CCC--SSCHH---HHHHH-------------------------------------------------------------H
T ss_pred cee--ecChh---hhhhh-------------------------------------------------------------h
Confidence 433 11100 00000 0
Q ss_pred cccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccC--ccccCCC
Q 045553 489 SSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLI--PQSFTNF 566 (1082)
Q Consensus 489 ~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~--~~~~~~l 566 (1082)
+...+..+++++|.+... +. .....++++|++++|++.+.+|..+ ..+++|++|++++|+|+++. |..|..+
T Consensus 329 ~~~~L~~L~l~~n~~~~~----~~-~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~~~l 402 (562)
T 3a79_B 329 AEMNIKMLSISDTPFIHM----VC-PPSPSSFTFLNFTQNVFTDSVFQGC-STLKRLQTLILQRNGLKNFFKVALMTKNM 402 (562)
T ss_dssp HTCCCSEEEEESSCCCCC----CC-CSSCCCCCEEECCSSCCCTTTTTTC-CSCSSCCEEECCSSCCCBTTHHHHTTTTC
T ss_pred ccCcceEEEccCCCcccc----cC-ccCCCCceEEECCCCccccchhhhh-cccCCCCEEECCCCCcCCcccchhhhcCC
Confidence 000111222222222110 00 0233456778888888876666554 45667888888888887643 4567888
Q ss_pred CCCCEEEccCCCCCCCCc-ccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceec
Q 045553 567 DSLRNLNLSRNHLQGPLP-SYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLR 645 (1082)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 645 (1082)
++|++|+|++|++++.+| ..|..+++|++|+|++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++|++|+
T Consensus 403 ~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~ 479 (562)
T 3a79_B 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479 (562)
T ss_dssp TTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEE
T ss_pred CCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEE
Confidence 888888888888886344 4577788888888888888766665543 67888888888887 5666666888888888
Q ss_pred ccCcccCCCCCCC-CCCCCcccEEeccCCccccCCCCC
Q 045553 646 LDHNNLTGRIPPG-FGTRSSLSIFDVSFNNLSGSAPRN 682 (1082)
Q Consensus 646 L~~N~l~~~~p~~-~~~l~~L~~l~ls~N~l~~~~p~~ 682 (1082)
|++|+|++ +|.. |..+++|+.|++++|+++|.+|..
T Consensus 480 L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 516 (562)
T 3a79_B 480 VASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPGI 516 (562)
T ss_dssp CCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred CCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence 88888884 4444 778888888888888877766643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=393.79 Aligned_cols=260 Identities=22% Similarity=0.371 Sum_probs=203.3
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc------CC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS------EA 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 870 (1082)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999965 469999999996543 2345678899999999999999999998753 36
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..|+||||++ |+|.+++.. ...+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999995 789999986 35799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC---CccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-
Q 045553 951 LLGTSE---THATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL- 1025 (1082)
Q Consensus 951 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 1025 (1082)
.+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||... +..+.+..+..
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~--------~~~~~l~~I~~~ 278 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK--------NYVHQLQLIMMV 278 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS--------SHHHHHHHHHHH
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHh
Confidence 764322 2234567899999999998875 5689999999999999999999999742 11222222211
Q ss_pred cCCCccccccc------------cCC--CCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 QGRPCEFFTAG------------LWD--CGP-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~~~~~d~~------------l~~--~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+......... +.. ..+ ...+.++.+|+.+|++.||++|||+.|++++
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11111110000 000 000 1234678899999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=387.11 Aligned_cols=203 Identities=27% Similarity=0.429 Sum_probs=174.3
Q ss_pred HHHHHHHhcCccccceecccCceEEEEEEEc----CCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeec
Q 045553 793 YENVVRATAGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHV 867 (1082)
Q Consensus 793 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 867 (1082)
++.+.+..++|++.++||+|+||+||+|+.+ +++.||||++.... ...++.+|+++++.+ +||||+++++++.
T Consensus 13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 3444456788999999999999999999643 46899999986543 346688999999988 6999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-CcEEEeec
Q 045553 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-LNAYLSDF 946 (1082)
Q Consensus 868 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Df 946 (1082)
+.+..|+||||+++|+|.++++ .+++.++..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 9999999999999999999985 389999999999999999999999 99999999999999877 79999999
Q ss_pred ccceecCCCCC---------------------------ccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHh
Q 045553 947 GLARLLGTSET---------------------------HATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELIS 998 (1082)
Q Consensus 947 Gla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~ellt 998 (1082)
|+|+....... ......+||+.|+|||++.+. .|+.++||||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99986643221 112345799999999999875 58999999999999999999
Q ss_pred CCCCCCC
Q 045553 999 DKKALDP 1005 (1082)
Q Consensus 999 g~~p~~~ 1005 (1082)
|+.||..
T Consensus 243 G~~Pf~~ 249 (361)
T 4f9c_A 243 GRYPFYK 249 (361)
T ss_dssp TCSSSSC
T ss_pred CCCCCCC
Confidence 9999963
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=397.13 Aligned_cols=140 Identities=26% Similarity=0.267 Sum_probs=130.5
Q ss_pred CcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhc
Q 045553 543 KCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLEL 622 (1082)
Q Consensus 543 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 622 (1082)
++|+.|++++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 45899999999999999999999999999999999999888999999999999999999999888999999999999999
Q ss_pred cCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC
Q 045553 623 SANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN 682 (1082)
Q Consensus 623 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 682 (1082)
++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++|+++|.+|..
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 999999888999999999999999999999877778899999999999999999887753
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=411.70 Aligned_cols=462 Identities=20% Similarity=0.209 Sum_probs=348.8
Q ss_pred CCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEE
Q 045553 134 SLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213 (1082)
Q Consensus 134 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~ 213 (1082)
...+++|+++|.++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+. .+++|++|+
T Consensus 31 ~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~ 106 (562)
T 3a79_B 31 ELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFL-FNQDLEYLD 106 (562)
T ss_dssp --CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTT-TCTTCCEEE
T ss_pred CCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhC-CCCCCCEEE
Confidence 34589999999999 5887664 8999999999999988889999999999999999999965566654 689999999
Q ss_pred cccCccCCCCCccccCCCCccEEEccCCcCCC-CcCccccCCCCCCEEeCCCCcCcccCCccccCCCCC--cEEEecccc
Q 045553 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQG-DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQL--KVLVLRNDY 290 (1082)
Q Consensus 214 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L--~~L~l~~n~ 290 (1082)
|++|+++ .+|.. .+++|++|+|++|++++ .+|..|+.+++|++|++++|++++. .+..+++| ++|++++|.
T Consensus 107 Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~ 180 (562)
T 3a79_B 107 VSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVS 180 (562)
T ss_dssp CTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESS
T ss_pred CCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccc
Confidence 9999999 66666 79999999999999986 3468999999999999999999863 45555555 999998753
Q ss_pred CCcccccCCCCCCcccccCCCcccccCCCCCccccCCC--CCcEEEcCCCcccCCCCc-ccccccCCCeEEcCCcc----
Q 045553 291 GPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP--NLRVFWAPNLNLEGIFPQ-NWELCSKLEMLNLAHNF---- 363 (1082)
Q Consensus 291 ~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~--~L~~L~l~~n~l~~~~~~-~l~~l~~L~~L~Ls~N~---- 363 (1082)
+. ..+..|..+..+. .| .++++.|.+.+..+. .+..+++|+.|++++|+
T Consensus 181 l~-----------------------~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 236 (562)
T 3a79_B 181 YH-----------------------IKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236 (562)
T ss_dssp CC-----------------------CCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH
T ss_pred cc-----------------------ccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccc
Confidence 20 0455677776655 33 457788887775544 46678889999999885
Q ss_pred -ccCCCCccccCCCCCCEEecCCCcCcccC----CCCcccCcccEEEecCCcceecCCCCCCcccccccccccccceeee
Q 045553 364 -FTGQIPASLGNCKSLYFLDLSSNNLTGLL----PEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLI 438 (1082)
Q Consensus 364 -i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (1082)
+. ..+..+..+++|+.|+|++|.+.+.. +.....++|+.|++++|.++|.+|.......
T Consensus 237 ~l~-~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~--------------- 300 (562)
T 3a79_B 237 RLM-TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS--------------- 300 (562)
T ss_dssp HHH-HHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCC---------------
T ss_pred hHH-HHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcc---------------
Confidence 22 22345677888888888888776531 2222345788888888888777664210000
Q ss_pred eecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCC
Q 045553 439 GFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSL 518 (1082)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~ 518 (1082)
...-.-+.+.+++.|.+ .+|. .....+....
T Consensus 301 -------------------~~~L~~L~~~~~~~~~~--~~p~----------------------------~~~~~~~~~~ 331 (562)
T 3a79_B 301 -------------------ETALKSLMIEHVKNQVF--LFSK----------------------------EALYSVFAEM 331 (562)
T ss_dssp -------------------SCSCCEEEEEEEEECCC--SSCH----------------------------HHHHHHHHTC
T ss_pred -------------------cccchheehhhccccee--ecCh----------------------------hhhhhhhccC
Confidence 00000011222222222 1111 0011122335
Q ss_pred ceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCC--cccccCCCCCCEE
Q 045553 519 DGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL--PSYINKMEDLKFL 596 (1082)
Q Consensus 519 ~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L 596 (1082)
++++|++++|.+.. + .....+++|++|++++|++++..|..|..+++|++|+|++|++++.. |..|..+++|++|
T Consensus 332 ~L~~L~l~~n~~~~-~--~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L 408 (562)
T 3a79_B 332 NIKMLSISDTPFIH-M--VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL 408 (562)
T ss_dssp CCSEEEEESSCCCC-C--CCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEE
T ss_pred cceEEEccCCCccc-c--cCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEE
Confidence 68899999998752 2 22356788999999999999999999999999999999999999643 4679999999999
Q ss_pred EcCCCcCCccCch-hhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCcc
Q 045553 597 SLSLNNFTGAIPW-ELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675 (1082)
Q Consensus 597 ~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l 675 (1082)
+|++|++++.+|. .|..+++|++|+|++|+|++.+|..+. ++|++|+|++|+|+ .+|..+..+++|+.|++++|++
T Consensus 409 ~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l 485 (562)
T 3a79_B 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485 (562)
T ss_dssp ECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCC
T ss_pred ECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCC
Confidence 9999999984554 588999999999999999987776554 79999999999999 6787777999999999999999
Q ss_pred ccCCCCC-----cccccccCCCCCCCCCCCC
Q 045553 676 SGSAPRN-----SLIKCENVQGNPNLQLCHT 701 (1082)
Q Consensus 676 ~~~~p~~-----~~~~~~~~~~Np~~c~c~~ 701 (1082)
+ .+|.. ..+....+.+|||.|+|..
T Consensus 486 ~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 486 K-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp C-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred C-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 9 56654 2345678999999999973
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=408.41 Aligned_cols=493 Identities=20% Similarity=0.181 Sum_probs=382.1
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
+++++|||++|+|++..|.+|.++++|++|||++|+|++..|.+|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 47899999999999777789999999999999999999777888999999999999999999877789999999999999
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCC-CCCccccCCCCccEEEccCCcCCCCcCccccCCCCC----CEEeCCC
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTG-SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNL----EVLDLSR 264 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~Ls~ 264 (1082)
++|+++ .+|...+..+++|++|+|++|++++ ..|..++.+++|++|+|++|++++..+..|..+.++ ..++++.
T Consensus 132 s~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 132 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp TTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred CCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence 999999 5666555579999999999999986 357888999999999999999998888888766554 4789999
Q ss_pred CcCcccCCccccCCCCCcEEEeccccCCc--ccccCCCCCCccccc----CCCcccccCCCCCccccCCCCCcEEEcCCC
Q 045553 265 NFLSGIVPSELGMCKQLKVLVLRNDYGPL--YSREHGDLPIQPVVD----GGEDYNFFDGGLPDSITRLPNLRVFWAPNL 338 (1082)
Q Consensus 265 N~l~~~~p~~l~~l~~L~~L~l~~n~~~~--~~~~~~~l~~~~~~~----~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n 338 (1082)
|.++...+..+ ....++.+++.+|.... .......+....... .......+....+..+..+..+....+..+
T Consensus 211 n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 211 NPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp CCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred CcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 99986555544 44567788888875431 111111111111100 011223344444556666677777666554
Q ss_pred cccC---CCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceecC
Q 045553 339 NLEG---IFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEI 415 (1082)
Q Consensus 339 ~l~~---~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~~ 415 (1082)
.... .....+..+.+++.+++.+|.+... ..+.....|+.|++++|.+.+..+. .+..|+.+++++|.+.+..
T Consensus 290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~--~l~~L~~l~l~~n~~~~~~ 365 (635)
T 4g8a_A 290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL--KLKSLKRLTFTSNKGGNAF 365 (635)
T ss_dssp CCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC--BCTTCCEEEEESCCSCCBC
T ss_pred hhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc--cchhhhhcccccccCCCCc
Confidence 3322 2344567788999999999998843 3466778999999999999876553 4578889999998876432
Q ss_pred CCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccce
Q 045553 416 PRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYG 495 (1082)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~ 495 (1082)
.... +. -+...++++|.+...
T Consensus 366 ~~~~---l~--------------------------------------~L~~L~ls~n~l~~~------------------ 386 (635)
T 4g8a_A 366 SEVD---LP--------------------------------------SLEFLDLSRNGLSFK------------------ 386 (635)
T ss_dssp CCCB---CT--------------------------------------TCCEEECCSSCCBEE------------------
T ss_pred cccc---cc--------------------------------------ccccchhhccccccc------------------
Confidence 2110 00 011234444444311
Q ss_pred eeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCc-cccCCCCCCCEEEc
Q 045553 496 FWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIP-QSFTNFDSLRNLNL 574 (1082)
Q Consensus 496 ~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L 574 (1082)
...+.......+++++++..|.+.+ ++.. +..+++|+.++++.|++....+ ..|..+++++.+++
T Consensus 387 ------------~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~-~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~l 452 (635)
T 4g8a_A 387 ------------GCCSQSDFGTISLKYLDLSFNGVIT-MSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 452 (635)
T ss_dssp ------------EECCHHHHSCSCCCEEECCSCSEEE-ECSC-CTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEEC
T ss_pred ------------cccccchhhhhhhhhhhcccccccc-cccc-ccccccccchhhhhccccccccccccccccccccccc
Confidence 1123344456678899999999874 4443 4467889999999998876554 57899999999999
Q ss_pred cCCCCCCCCcccccCCCCCCEEEcCCCcC-CccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCC
Q 045553 575 SRNHLQGPLPSYINKMEDLKFLSLSLNNF-TGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTG 653 (1082)
Q Consensus 575 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 653 (1082)
++|.+++..+..+..+++|+.|+|++|++ .+..|..|..+++|++|+|++|+|++.+|..|.++++|++|+|++|+|++
T Consensus 453 s~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~ 532 (635)
T 4g8a_A 453 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 532 (635)
T ss_dssp TTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCB
T ss_pred cccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCC
Confidence 99999999999999999999999999985 44678899999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccEEeccCCccccCCCC
Q 045553 654 RIPPGFGTRSSLSIFDVSFNNLSGSAPR 681 (1082)
Q Consensus 654 ~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 681 (1082)
..|..|..+++|++|+|++|+|++..|.
T Consensus 533 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 560 (635)
T 4g8a_A 533 LDTFPYKCLNSLQVLDYSLNHIMTSKKQ 560 (635)
T ss_dssp CCCGGGTTCTTCCEEECTTSCCCBCCSS
T ss_pred CChhHHhCCCCCCEEECCCCcCCCCCHH
Confidence 9899999999999999999999987774
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=397.66 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=203.0
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHH---HHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQF---AAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
++|++.++||+|+||+||+|+.. +|+.||||++.... ......+ ..++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56999999999999999999654 69999999996432 1222223 34467778889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||++||+|.+++... ..+++..+..++.||+.||+|||+. +||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999874 4699999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... ....+||+.|+|||++.. ..|+.++||||+||++|||++|+.||..... .+............ .
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-----~~~~~i~~~i~~~~-~--- 411 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTMA-V--- 411 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-----CCHHHHHHHHHHCC-C---
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhhcCCC-C---
Confidence 433 345689999999999974 5799999999999999999999999974321 12222222222211 1
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQ 1072 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 1072 (1082)
..|...+.++.+|+.+|++.||++|++ +.||.+
T Consensus 412 -------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 123445678999999999999999998 677764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=403.53 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=213.2
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+++++.++|||||++++++.+....|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 35799999999999999999965 46999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC--CcEEEeecccceecCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN--LNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfGla~~~~~~~ 956 (1082)
++||+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999754 35699999999999999999999999 99999999999999854 899999999999875433
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||... +..+.+..+....... ...
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~--------~~~~~~~~i~~~~~~~---~~~ 378 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCDWNM---DDS 378 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHTTCCCC---CSG
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHhCCCCC---Ccc
Confidence 234468999999999999999999999999999999999999999732 2233333333222110 111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.....+.++.+|+.+|++.||++||++.|++++
T Consensus 379 ----~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 ----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112345678999999999999999999999874
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=385.19 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=152.2
Q ss_pred CCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCC-------------CeEEccCccccccc
Q 045553 108 DLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSL-------------RLINLSGNQFNGTI 174 (1082)
Q Consensus 108 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L-------------~~L~Ls~N~l~~~~ 174 (1082)
..++|++|++++|.+ +.+|++|+++++|++|++++|.+.+.+|..++++++| ++|++++|++++ +
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-l 86 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-L 86 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-C
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-C
Confidence 457888888888888 5888888888888888888888888888888888765 777777777774 3
Q ss_pred CccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCC
Q 045553 175 PAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQL 254 (1082)
Q Consensus 175 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 254 (1082)
|.. .++|++|++++|++++ +|.. +++|++|++++|++++ ++.. .++|++|++++|++++ +| .|+.+
T Consensus 87 p~~---~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l 152 (454)
T 1jl5_A 87 PEL---PPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNS 152 (454)
T ss_dssp CSC---CTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTC
T ss_pred CCC---cCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCC
Confidence 432 3677777777777774 5543 3577777777777773 2221 1577777777777774 56 47777
Q ss_pred CCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEE
Q 045553 255 VNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW 334 (1082)
Q Consensus 255 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~ 334 (1082)
++|++|++++|++++ +|..+ ++|++|++++|. +.+ +| .++++++|++|+
T Consensus 153 ~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~-------------------------l~~-l~-~~~~l~~L~~L~ 201 (454)
T 1jl5_A 153 SFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQ-------------------------LEE-LP-ELQNLPFLTAIY 201 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSC-------------------------CSS-CC-CCTTCTTCCEEE
T ss_pred CCCCEEECCCCcCcc-cCCCc---ccccEEECcCCc-------------------------CCc-Cc-cccCCCCCCEEE
Confidence 777777777777774 45433 477777776643 332 34 467777777777
Q ss_pred cCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcce
Q 045553 335 APNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLS 412 (1082)
Q Consensus 335 l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~ 412 (1082)
+++|.+.++ |.. .++|++|++++|+++ .+|. +..+++|+.|++++|++++. |.. .++|+.|++++|+++
T Consensus 202 l~~N~l~~l-~~~---~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~l-~~~--~~~L~~L~l~~N~l~ 270 (454)
T 1jl5_A 202 ADNNSLKKL-PDL---PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTL-PDL--PPSLEALNVRDNYLT 270 (454)
T ss_dssp CCSSCCSSC-CCC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSC-CSC--CTTCCEEECCSSCCS
T ss_pred CCCCcCCcC-CCC---cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCcc-ccc--ccccCEEECCCCccc
Confidence 777777763 222 247777777777777 5663 77777777777777777753 322 356777777777665
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=373.14 Aligned_cols=287 Identities=31% Similarity=0.499 Sum_probs=214.5
Q ss_pred CHHHHHHHHhcccCCCCCCCCCCCCCCCCce--eeeeEeeCCC--CCeeeeecCCCccccccccCCCCCCCCCCCCcccC
Q 045553 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCS--WHGVTCDPLS--GRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFH 76 (1082)
Q Consensus 1 ~~~l~~~k~~~~~~~~~~~~~W~~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 76 (1082)
++||++||+++. ||. .+++|.. ++|||. |.||+|+..+ ++|+.|+|++
T Consensus 8 ~~aL~~~k~~~~-~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~------------------------- 59 (313)
T 1ogq_A 8 KQALLQIKKDLG-NPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSG------------------------- 59 (313)
T ss_dssp HHHHHHHHHHTT-CCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEEC-------------------------
T ss_pred HHHHHHHHHhcC-Ccc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCC-------------------------
Confidence 479999999995 775 7899975 578998 9999998655 8999999976
Q ss_pred cCcccccccccCcccCCCCCCccc--cccccccCCCCCCEEEccc-CCCcccCChhhcCCCCCCEEeCcCCCCCCCCCcc
Q 045553 77 FPCLQLHQHDRGNINSNSSDKLSG--NLSRAIGDLTQLRVLLLAF-NGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153 (1082)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~l~g--~l~~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~ 153 (1082)
+++.| .+|++|.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+|..
T Consensus 60 -------------------~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 120 (313)
T 1ogq_A 60 -------------------LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120 (313)
T ss_dssp -------------------CCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG
T ss_pred -------------------CCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHH
Confidence 45667 7889999999999999995 9999999999999999999999999999899999
Q ss_pred ccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccc-cccEEEcccCccCCCCCccccCCCC
Q 045553 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCV-SLEHILLAANSLTGSIPPSLGNCTE 232 (1082)
Q Consensus 154 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~ 232 (1082)
|.++++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..++. ++ +|++|++++|++++.+|..+..++
T Consensus 121 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~-l~~~L~~L~L~~N~l~~~~~~~~~~l~- 198 (313)
T 1ogq_A 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS-FSKLFTSMTISRNRLTGKIPPTFANLN- 198 (313)
T ss_dssp GGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGC-CCTTCCEEECCSSEEEEECCGGGGGCC-
T ss_pred HhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhh-hhhcCcEEECcCCeeeccCChHHhCCc-
Confidence 999999999999999999889999999999999999999888778877764 44 677777777777777776666665
Q ss_pred ccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCc
Q 045553 233 LRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGED 312 (1082)
Q Consensus 233 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~ 312 (1082)
|++|++++|++++..|..|..+++|++|+|++|++++.+|.
T Consensus 199 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------------------------------------- 239 (313)
T 1ogq_A 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK--------------------------------------- 239 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG---------------------------------------
T ss_pred ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc---------------------------------------
Confidence 77777777776666666666666666666666666543322
Q ss_pred ccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCc
Q 045553 313 YNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387 (1082)
Q Consensus 313 ~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~ 387 (1082)
+..+++|++|++++|.+.+..|..+..+++|++|+|++|++++.+|.. .++++|+.|++++|+
T Consensus 240 -----------~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 240 -----------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp -----------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred -----------ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 223334444444444444444555555555555555555555555544 455555555555554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=384.68 Aligned_cols=365 Identities=22% Similarity=0.231 Sum_probs=222.4
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCC-CccccCCCCCCeEEccCcccccccCccccCCCCCcEEE
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPI-PPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVS 188 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 188 (1082)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 46677777777776666666777777777777777665443 44566777777777777777666666677777777777
Q ss_pred cccCcccccCCcc-cccccccccEEEcccCccCCCCCcc-ccCCCCccEEEccCCcCCCCcCccccCC--CCCCEEeCCC
Q 045553 189 LSFNLLSGSVPEE-FGDNCVSLEHILLAANSLTGSIPPS-LGNCTELRSLLLSSNMLQGDIPSSFGQL--VNLEVLDLSR 264 (1082)
Q Consensus 189 L~~N~l~~~~p~~-~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~ 264 (1082)
|++|++++.+|.. .+..+++|++|+|++|++++..|.. +.++++|++|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 7777766543332 2335667777777777777655554 5667777777777777766666666555 5667777777
Q ss_pred CcCcccCCccc--------cCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCC---CCCcEE
Q 045553 265 NFLSGIVPSEL--------GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRL---PNLRVF 333 (1082)
Q Consensus 265 N~l~~~~p~~l--------~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l---~~L~~L 333 (1082)
|.+.+..+..+ ..+++|++|++++| .+.+..|..+..+ ++|+.|
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n-------------------------~l~~~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGN-------------------------GFKESMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTS-------------------------CCCHHHHHHHHHHTTTCCEEEE
T ss_pred CcccccchhhccccccccccccceeeeEecCCC-------------------------cccccchhhhhccccccceeeE
Confidence 77665443322 24455555555543 2222233333221 344444
Q ss_pred EcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccC--CCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcc
Q 045553 334 WAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGN--CKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLL 411 (1082)
Q Consensus 334 ~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l 411 (1082)
++++|.+.+.. +..+.+.+..+..+.. .++|+.|+|++|++++.+|..+
T Consensus 245 ~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~--------------- 295 (455)
T 3v47_A 245 ILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVF--------------- 295 (455)
T ss_dssp ECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTT---------------
T ss_pred eeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhc---------------
Confidence 44444332210 1111222112222222 2345555555555443222211
Q ss_pred eecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCcccc
Q 045553 412 SGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSR 491 (1082)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~ 491 (1082)
T Consensus 296 -------------------------------------------------------------------------------- 295 (455)
T 3v47_A 296 -------------------------------------------------------------------------------- 295 (455)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCE
Q 045553 492 PYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRN 571 (1082)
Q Consensus 492 ~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 571 (1082)
..+++|++|+|++|+|++..|..|..+++|++
T Consensus 296 ------------------------------------------------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 327 (455)
T 3v47_A 296 ------------------------------------------------SHFTDLEQLTLAQNEINKIDDNAFWGLTHLLK 327 (455)
T ss_dssp ------------------------------------------------TTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ------------------------------------------------ccCCCCCEEECCCCcccccChhHhcCcccCCE
Confidence 12334666667777776666777777777777
Q ss_pred EEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCccc
Q 045553 572 LNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNL 651 (1082)
Q Consensus 572 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 651 (1082)
|+|++|.+++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++
T Consensus 328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 407 (455)
T 3v47_A 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407 (455)
T ss_dssp EECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred EECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCc
Confidence 77777777766677777777777777777777777777777777888888888887766666677778888888888888
Q ss_pred CCCCC
Q 045553 652 TGRIP 656 (1082)
Q Consensus 652 ~~~~p 656 (1082)
++..|
T Consensus 408 ~~~~~ 412 (455)
T 3v47_A 408 DCSCP 412 (455)
T ss_dssp CCCTT
T ss_pred ccCCC
Confidence 76655
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=368.70 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=214.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.++||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357899999999999999999764 5899999998776666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.++++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999875 45699999999999999999999999 9999999999999999999999999999876543221
Q ss_pred c-------------ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC-CccHHHHHHHHH
Q 045553 959 A-------------TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN-GFNIVAWASMLL 1024 (1082)
Q Consensus 959 ~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~ 1024 (1082)
. .....||+.|+|||++.+..++.++||||||+++|||++|..|+......... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence 1 12467999999999999999999999999999999999999998753322111 1111111110
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+...+..+.+++.+|++.||++||++.|+++.|++++
T Consensus 243 ---------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 ---------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ---------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112233457899999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=358.68 Aligned_cols=284 Identities=31% Similarity=0.516 Sum_probs=233.0
Q ss_pred ccccccHHHHHHHhcCcccc------ceecccCceEEEEEEEcCCeEEEEEEeecCc----cccHHHHHHHHHHHhccCC
Q 045553 787 IGVQLTYENVVRATAGFNVQ------NCIGSGGFGATYKAEIIPGVVVAVKRLSVGR----FQGVQQFAAEIRTLGRVQH 856 (1082)
Q Consensus 787 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h 856 (1082)
....|++.++..++.+|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34578999999999999877 8999999999999976 58899999986532 2346779999999999999
Q ss_pred CceeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 857 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
|||+++++++.+.+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999997532 34689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCc
Q 045553 936 DNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGF 1014 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~ 1014 (1082)
+.++.+||+|||+++........ ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||...... .
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~ 241 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP----Q 241 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS----S
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch----H
Confidence 99999999999999876543322 2334579999999998865 5789999999999999999999999754322 2
Q ss_pred cHHHHHHHHHhcCC-CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1015 NIVAWASMLLLQGR-PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
....+......... ..+.++..+ ...+...+..+.+++.+|++.+|++||++.||+++|+++..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 22333333322222 223344433 235667788999999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=353.89 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=218.6
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.+.||+|+||.||+|+..++..||||++..... ..+++.+|++++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457999999999999999999998888999999976543 4577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++... ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+..........
T Consensus 86 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 999999999875 34689999999999999999999999 99999999999999999999999999998876554444
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....+++.|+|||++.+..++.++||||+|+++|||++ |+.||+.. .............. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~-~-------- 224 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY--------TNSEVVLKVSQGHR-L-------- 224 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHHHHHHTTCC-C--------
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc--------ChHHHHHHHHcCCC-C--------
Confidence 445567788999999999899999999999999999999 99998632 12222222222111 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
..+...+..+.+++.+|++.+|++|||+.|+++.|+.+++..
T Consensus 225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 225 -YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp -CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred -CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 112334567999999999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=358.08 Aligned_cols=251 Identities=23% Similarity=0.403 Sum_probs=213.5
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..+|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999964 56899999999877666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999864 589999999999999999999999 999999999999999999999999999987654433
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... ............+... .
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~~~~~~~~~-~------ 236 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--------NPLRALYLIATNGTPE-L------ 236 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHHCSCC-C------
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCCC-C------
Confidence 334567999999999999999999999999999999999999999632 1222222222222111 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+..+.+++.+|++.||++|||+.|++++
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1234456789999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=371.44 Aligned_cols=258 Identities=24% Similarity=0.423 Sum_probs=214.4
Q ss_pred hcCccccceecccCceEEEEEEEc--------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII--------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE 869 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 869 (1082)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357899999999999999999752 35689999997653 23456789999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
+..|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999998753 24589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCC
Q 045553 936 DNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNG 1013 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 1013 (1082)
+.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-----~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----H
Confidence 9999999999999987654332 22334567889999999999999999999999999999999 999986431 1
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
... ... +..+.. ...+...+.++.+++.+||+.+|++||++.|+++.|+++.
T Consensus 312 ~~~---~~~-~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 EEL---FKL-LKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp GGH---HHH-HHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH---HHH-HhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 111 222211 1223455678999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=355.53 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=217.6
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.+|++.+.||+|+||.||+|...+++.||+|++.... ...+++.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5689999999999999999998889999999997654 345779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.++++.. ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999765 45689999999999999999999999 999999999999999999999999999987654433334
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....+++.|+|||++.+..++.++||||+|+++|||++ |+.||... ...+......... ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~--------~~~~~~~~~~~~~----------~~ 226 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--------SNSEVVEDISTGF----------RL 226 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTTC----------CC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC--------CHHHHHHHHhcCc----------cC
Confidence 44567889999999999999999999999999999999 89998632 2223333322211 11
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
..+...+..+.+++.+|++.+|++||++.|++++|+++.+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 12333456799999999999999999999999999988643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=361.79 Aligned_cols=260 Identities=28% Similarity=0.454 Sum_probs=207.5
Q ss_pred HhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
...+|++.+.||+|+||+||+|+. +|+.||||++..... ...+++.+|++++++++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 456799999999999999999977 589999999875542 34567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 877 NYLPGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPR--VLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999998643 12489999999999999999999999 8 9999999999999999999999999998654
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+............
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~--------~~~~~~~~~~~~~~~~--- 258 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--------NPAQVVAAVGFKCKRL--- 258 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS--------CHHHHHHHHHHSCCCC---
T ss_pred ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcCCCC---
Confidence 322 2233457999999999999999999999999999999999999999732 2223333222222111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
..+...+.++.+++.+||+.+|++||++.||++.|+.+...
T Consensus 259 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 22344556899999999999999999999999999987553
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=362.78 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=212.6
Q ss_pred hcCccccceecccCceEEEEEEEc----CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
..+|++.+.||+|+||.||+|... .+..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356899999999999999999774 35679999997653 3445679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++++|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999765 45699999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 955 SETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 955 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||... ...+.........
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--------~~~~~~~~~~~~~---- 271 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--------TNRDVISSVEEGY---- 271 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--------CHHHHHHHHHTTC----
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHHcCC----
Confidence 3322 2233456778999999999999999999999999999999 99998632 2223333322221
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
....+...+..+.+++.+||+.||++||++.||++.|+.+..
T Consensus 272 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 272 ------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112234456789999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=356.65 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=219.3
Q ss_pred ccccHHHHHHHhcC----------ccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCC
Q 045553 789 VQLTYENVVRATAG----------FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857 (1082)
Q Consensus 789 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ 857 (1082)
..++++++..++.. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 35778888887764 777889999999999999776 6999999999877666778899999999999999
Q ss_pred ceeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC
Q 045553 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN 937 (1082)
Q Consensus 858 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 937 (1082)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 999999999999999999999999999999875 3689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHH
Q 045553 938 NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 938 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 1017 (1082)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~--------~~~ 247 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD--------SPV 247 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHH
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHH
Confidence 99999999999987654332 234567999999999999999999999999999999999999999632 222
Q ss_pred HHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+......... .... ..+...+..+.+++.+|++.||++||++.|++++
T Consensus 248 ~~~~~~~~~~-~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAMKRLRDSP-PPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSS-CCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCC-CCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222222221 1111 1122345678999999999999999999999874
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=373.00 Aligned_cols=400 Identities=23% Similarity=0.292 Sum_probs=270.8
Q ss_pred CCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCC-------------CEEeCcCCCCCCCCCccccCCCC
Q 045553 93 NSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLL-------------EILDLSFNSFHGPIPPTLQNCSS 159 (1082)
Q Consensus 93 ~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~Ls~n~l~~~~p~~l~~l~~ 159 (1082)
.+.+++ |.+|++|+++++|++|++++|.++|.+|..++.+++| ++|++++|.+++ +|.. .++
T Consensus 18 l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~ 92 (454)
T 1jl5_A 18 RHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPH 92 (454)
T ss_dssp -----------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTT
T ss_pred cccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCC
Confidence 455778 8999999999999999999999999999999999875 999999999994 5652 479
Q ss_pred CCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEcc
Q 045553 160 LRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLS 239 (1082)
Q Consensus 160 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 239 (1082)
|++|++++|++++ +|.. +++|++|++++|+++ .+|.. .++|++|++++|++++ +| .++++++|++|+++
T Consensus 93 L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 93 LESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVD 161 (454)
T ss_dssp CSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECC
Confidence 9999999999997 6654 489999999999998 45432 2689999999999996 77 69999999999999
Q ss_pred CCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCC
Q 045553 240 SNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGG 319 (1082)
Q Consensus 240 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~ 319 (1082)
+|++++ +|..+ .+|++|++++|++++ +| .++.+++|++|++++|.+..
T Consensus 162 ~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-------------------------- 209 (454)
T 1jl5_A 162 NNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-------------------------- 209 (454)
T ss_dssp SSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS--------------------------
T ss_pred CCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc--------------------------
Confidence 999995 66543 599999999999996 56 69999999999999865432
Q ss_pred CCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccC
Q 045553 320 LPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVP 399 (1082)
Q Consensus 320 ~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~ 399 (1082)
+|.. .++|++|++++|.+.. +| .+..+++|++|++++|++++ +|.. +++|+.|++++|++++. |.. .+
T Consensus 210 l~~~---~~~L~~L~l~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l-~~~--~~ 277 (454)
T 1jl5_A 210 LPDL---PLSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDL-PEL--PQ 277 (454)
T ss_dssp CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCC-CCC--CT
T ss_pred CCCC---cCcccEEECcCCcCCc-cc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCccccc-Ccc--cC
Confidence 2322 2489999999999995 45 48999999999999999994 5653 48899999999999974 433 37
Q ss_pred cccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCC
Q 045553 400 CMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVP 479 (1082)
Q Consensus 400 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p 479 (1082)
+|+.|++++|.+++. |. +|
T Consensus 278 ~L~~L~ls~N~l~~l-~~------------------------------------------------------------~~ 296 (454)
T 1jl5_A 278 SLTFLDVSENIFSGL-SE------------------------------------------------------------LP 296 (454)
T ss_dssp TCCEEECCSSCCSEE-SC------------------------------------------------------------CC
T ss_pred cCCEEECcCCccCcc-cC------------------------------------------------------------cC
Confidence 899999999988641 10 01
Q ss_pred CccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccC
Q 045553 480 PFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLI 559 (1082)
Q Consensus 480 ~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~ 559 (1082)
.+++.|++++|++.+ ++. ..++|++|++++|+++++
T Consensus 297 --------------------------------------~~L~~L~l~~N~l~~-i~~----~~~~L~~L~Ls~N~l~~l- 332 (454)
T 1jl5_A 297 --------------------------------------PNLYYLNASSNEIRS-LCD----LPPSLEELNVSNNKLIEL- 332 (454)
T ss_dssp --------------------------------------TTCCEEECCSSCCSE-ECC----CCTTCCEEECCSSCCSCC-
T ss_pred --------------------------------------CcCCEEECcCCcCCc-ccC----CcCcCCEEECCCCccccc-
Confidence 123577777777763 332 224689999999999874
Q ss_pred ccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCc--cCchhhhcCcccchhhccCcccCCCCCccccC
Q 045553 560 PQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG--AIPWELTQLASLEVLELSANSLSGEIPSEFSK 637 (1082)
Q Consensus 560 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 637 (1082)
|.. +++|++|+|++|++++ +|. .+++|++|++++|++++ .+|..+.. |+.|.+.+.+|..
T Consensus 333 p~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~--- 394 (454)
T 1jl5_A 333 PAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL--- 394 (454)
T ss_dssp CCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-----------
T ss_pred ccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---
Confidence 443 5789999999999984 565 47899999999999997 67766543 3457777777763
Q ss_pred CcccceecccCcccCC--CCCCCCCCCCcccEEeccCCccccCCCC
Q 045553 638 LEHLNVLRLDHNNLTG--RIPPGFGTRSSLSIFDVSFNNLSGSAPR 681 (1082)
Q Consensus 638 l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 681 (1082)
+++|+.|+|++|++++ .+|. +++.|.+.+|.+.+.+|.
T Consensus 395 ~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 395 PQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYEF 434 (454)
T ss_dssp ----------------------------------------------
T ss_pred cCcCCEEECCCCcCCccccchh------hHhheeCcCcccCCcccc
Confidence 5789999999999997 5554 466777889998877664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=360.99 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=210.8
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999976 579999999997543 344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999999774 4689999999999999999999999 99999999999999999999999999998764332
Q ss_pred CccccCcccCCCcccchhcccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVS-DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
......||+.|+|||++.+..++ .++||||+||++|||++|+.||+.. +..+......... .
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~-~------ 231 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ--------NLKELRERVLRGK-Y------ 231 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C------
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC-C------
Confidence 33456799999999999988765 7999999999999999999999732 3334433333322 1
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..|...+.++.+++.+|++.||++|||+.|++++
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1223345678999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=354.98 Aligned_cols=259 Identities=23% Similarity=0.378 Sum_probs=215.0
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.+.||+|+||.||+|+..++..||||++..... ..+++.+|++++++++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457899999999999999999999899999999976543 3577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++.........
T Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 999999999864 34699999999999999999999999 99999999999999999999999999998765443333
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....+++.|+|||++.+..++.++||||+|+++|||++ |+.||... ............. .
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~--------~~~~~~~~~~~~~----------~ 239 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--------TNSETAEHIAQGL----------R 239 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHHHHHHTTC----------C
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--------ChhHHHHHHhccc----------C
Confidence 444567888999999999999999999999999999998 99998632 2222222222211 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
...+...+..+.+++.+|++.+|++||++.|++++|+++.+..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 1122334568999999999999999999999999999886543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.15 Aligned_cols=268 Identities=28% Similarity=0.409 Sum_probs=212.4
Q ss_pred hcCccccceecccCceEEEEEEE-----cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-----IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 872 (1082)
..+|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35799999999999999999975 35899999999877666678899999999999999999999988653 568
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 9999999999999999875 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccC-------CCCCccHHHHHHHH
Q 045553 953 GTSET--HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS-------FGNGFNIVAWASML 1023 (1082)
Q Consensus 953 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~ 1023 (1082)
..... .......++..|+|||++.+..++.++||||||+++|||++|..|+...... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 54332 1223345778899999999999999999999999999999999998642110 00011111111122
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
...+ .....+...+.++.+++.+||+.+|++|||+.|+++.|+++++.
T Consensus 245 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 245 LKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred Hhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 2221 11123445567899999999999999999999999999988653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=360.30 Aligned_cols=271 Identities=28% Similarity=0.428 Sum_probs=212.7
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCC----eEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA----EMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV 875 (1082)
..+|++.++||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 457999999999999999999876 8999999997543 23445667999999999999999999988643 47999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------CCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC-------VPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
|||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999999864 4999999999999999999999862 34899999999999999999999999999
Q ss_pred ceecCCCCCc-cccCcccCCCcccchhcccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCC--------CCc
Q 045553 949 ARLLGTSETH-ATTDVAGTFGYVAPEYAMTC-----RVSDKADVYSFGVVLLELISDKKALDPSFCSFG--------NGF 1014 (1082)
Q Consensus 949 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~--------~~~ 1014 (1082)
++.+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9877544332 23346799999999999863 456789999999999999999999975432211 111
Q ss_pred cHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1015 NIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
....+........... .+.... .+...+.++.+++.+||+.||++|||+.||++.|++++.
T Consensus 258 ~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRP-VLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CHHHHHHHHTTSCCCC-CCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCC-Cccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2223322222221111 111110 123456779999999999999999999999999998864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.33 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=206.3
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhc--cCCCceeeEeeeecc----CCeEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR--VQHPNLVTLIGYHVS----EAEMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~ 873 (1082)
.++|++.+.||+|+||+||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999987 5999999998643 34555666666665 799999999998654 35689
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeccCCCCCEEEcCCCcEEEee
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH--------DECVPRVLHRDIKPSNILLDNNLNAYLSD 945 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 945 (1082)
+||||+++|+|.++++. ..+++..+.+++.|++.||+||| +. +|+||||||+||+++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999964 46999999999999999999999 77 999999999999999999999999
Q ss_pred cccceecCCCCCcc---ccCcccCCCcccchhcccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC
Q 045553 946 FGLARLLGTSETHA---TTDVAGTFGYVAPEYAMTC------RVSDKADVYSFGVVLLELISD----------KKALDPS 1006 (1082)
Q Consensus 946 fGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGvll~elltg----------~~p~~~~ 1006 (1082)
||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998765433321 2345799999999999876 455799999999999999999 7777643
Q ss_pred ccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1007 FCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
... ....................... ..+...+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus 237 ~~~---~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 237 VPN---DPSFEDMRKVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp SCS---SCCHHHHHHHHTTSCCCCCCCGG----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC---CcchhhhhHHHhccCCCCCCChh----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 322 22222322222222211111100 112356788999999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=382.81 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=219.3
Q ss_pred hcCccccceecccCceEEEEEEEcC-CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..+|++.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|++++++++||||+++++++......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3568889999999999999998765 8999999997653 3467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++|+|.++++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999987667799999999999999999999999 9999999999999999999999999999977544333
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.... .....+ .+..+ .
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~----~~~~~---------~ 436 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYE----LLEKD---------Y 436 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHH----HHHTT---------C
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHH----HHHcC---------C
Confidence 3344557789999999999999999999999999999999 889986432 112221 12221 1
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
+...+...+..+.+++.+||+.+|++||++.||++.|+.+...
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1123445567899999999999999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=355.24 Aligned_cols=262 Identities=24% Similarity=0.418 Sum_probs=211.0
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999754 689999999865432 3356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999874 4689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.........||+.|+|||.+.+..++.++||||+|+++|||++|+.||... .............. ... ..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--------~~~~~~~~~~~~~~-~~~-~~ 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE--------TAVSIAIKHIQDSV-PNV-TT 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS--------CHHHHHHHHHSSCC-CCH-HH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHhhccC-CCc-ch
Confidence 444444567999999999999999999999999999999999999999742 22232233332221 111 11
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhhCCC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRP-SMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~i~~~ 1080 (1082)
. .+...+..+.+++.+|++.||++|| ++.++.+.|+.+...
T Consensus 235 ~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 235 D----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp H----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred h----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1 1223456899999999999999998 999999999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=371.38 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=201.6
Q ss_pred cCccccceecccCceEEEEEEEc----CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.+|++.+.||+|+||.||+|+.. ++..||||+++... ....+.|.+|++++++++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 47999999999999999999764 57789999997653 34456799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999999865 45699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcc--ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 956 ETHA--TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 956 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.... .....++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+..... ..+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--------~~~~~~~~i-~~~----- 266 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--------SNQDVIKAV-DEG----- 266 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--------CHHHHHHHH-HTT-----
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHH-HcC-----
Confidence 3221 222345778999999999999999999999999999998 99998632 122222222 221
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.....+...+..+.+++.+||+.+|++||++.||++.|+++.
T Consensus 267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 111223455678999999999999999999999999998864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=378.68 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=216.4
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.+.||+|+||.||+|...++..||||+++... ...+.|.+|++++++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45788999999999999999999889999999997654 45788999999999999999999999986 56789999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++|+|.++++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999999865444689999999999999999999999 99999999999999999999999999998764332222
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+......... +
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i~~~~----------~ 403 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------SNPEVIRALERGY----------R 403 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHHHHHTC----------C
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCC----------C
Confidence 334456789999999999999999999999999999999 99998632 2223333322221 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...+...+.++.+++.+||+.||++||||.+|++.|+.+..
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 12234556789999999999999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=372.91 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=213.1
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|.+.+.||+|+||.||+|... +++.||||++..... ...+.|.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457889999999999999999876 689999999875432 334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999999864 34689999999999999999999999 999999999999999999999999999987543222
Q ss_pred ccc-cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 958 HAT-TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 958 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+.. ..+..+..
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~--------~~~~~-~~~~~~~~------ 333 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--------NQQTR-EFVEKGGR------ 333 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--------HHHHH-HHHHTTCC------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHcCCC------
Confidence 111 12235778999999999999999999999999999998 999986321 12222 22222211
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...+...+..+.+++.+||+.||++|||+.+|++.|++++.
T Consensus 334 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 334 ---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 12234456689999999999999999999999999998864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.56 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=216.4
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.+|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56889999999999999999988899999999976543 35778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...........
T Consensus 87 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 99999999875 35689999999999999999999999 999999999999999999999999999987643322233
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....++..|+|||++.+..++.++||||+|+++|||++ |+.||... ...+....... +.. .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~i~~-~~~---------~ 224 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--------SNSEVVEDIST-GFR---------L 224 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHT-TCC---------C
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC--------CHHHHHHHHhc-CCc---------C
Confidence 34567889999999999999999999999999999999 89998632 22233332222 211 1
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
..+...+..+.+++.+|++.+|++||++.|++++|+++.++
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 12233456899999999999999999999999999988643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=372.10 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=211.1
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCC-eEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA-EMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~ 878 (1082)
..+|++.+.||+|+||.||+|+.. |+.||||+++... ..+.|.+|++++++++||||+++++++.... ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 457889999999999999999876 8899999997653 4577999999999999999999999987654 79999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++|+|.++++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 9999999999986555689999999999999999999999 99999999999999999999999999998653221
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ... ... +..+.
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~---~~~-i~~~~--------- 403 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDV---VPR-VEKGY--------- 403 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTH---HHH-HHTTC---------
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHH---HHH-HHcCC---------
Confidence 22357889999999999999999999999999999998 9999874321 111 122 22221
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
+...+...+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112344556789999999999999999999999999998754
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=367.17 Aligned_cols=238 Identities=19% Similarity=0.179 Sum_probs=165.9
Q ss_pred CccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCc
Q 045553 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPA 176 (1082)
Q Consensus 97 ~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 176 (1082)
...+..+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|.+++ +| ++++++|++|+|++|++++. +
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~- 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D- 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-
T ss_pred CcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-
Confidence 3455566778889999999999999985 45 68899999999999999985 44 88899999999999998864 3
Q ss_pred cccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCC
Q 045553 177 FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256 (1082)
Q Consensus 177 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 256 (1082)
++.+++|++|++++|++++ +| + ..+++|++|++++|++++. .++++++|++|++++|+..+.+ .+..+++
T Consensus 102 -~~~l~~L~~L~L~~N~l~~-l~--~-~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~ 171 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTK-LD--V-SQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQ 171 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSC-CC--C-TTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTT
T ss_pred -cCCCCcCCEEECCCCcCCe-ec--C-CCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCc
Confidence 7888888899888888884 44 3 3577888888888888863 3777788888888888554444 4677778
Q ss_pred CCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcC
Q 045553 257 LEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAP 336 (1082)
Q Consensus 257 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~ 336 (1082)
|++|++++|++++ +| ++.+++|+.|++++|
T Consensus 172 L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N----------------------------------------------- 201 (457)
T 3bz5_A 172 LTTLDCSFNKITE-LD--VSQNKLLNRLNCDTN----------------------------------------------- 201 (457)
T ss_dssp CCEEECCSSCCCC-CC--CTTCTTCCEEECCSS-----------------------------------------------
T ss_pred CCEEECCCCccce-ec--cccCCCCCEEECcCC-----------------------------------------------
Confidence 8888888887775 33 555666666666553
Q ss_pred CCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcc
Q 045553 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLL 411 (1082)
Q Consensus 337 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l 411 (1082)
++.+. .+..+++|++|++++|++++ +| +..+++|+.|++++|++++.++. .+++|+.|++++|.+
T Consensus 202 --~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~--~l~~L~~L~l~~n~L 266 (457)
T 3bz5_A 202 --NITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS--TLSKLTTLHCIQTDL 266 (457)
T ss_dssp --CCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT--TCTTCCEEECTTCCC
T ss_pred --cCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH--HCCCCCEEeccCCCC
Confidence 33332 14445556666666666664 33 55566666666666666654322 344555555555543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=355.14 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=209.6
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+.. +|+.||+|++... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57999999999999999999765 6899999999754 2344667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999999863 4689999999999999999999999 99999999999999999999999999998643222
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... +............ .
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~~~-~------- 222 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLFELILMEE-I------- 222 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C-------
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC-C-------
Confidence 2334568999999999999999999999999999999999999999632 2233333333221 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
..|...+.++.+++.+|++.||++|| ++.||+++
T Consensus 223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 12334456899999999999999999 89998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=358.60 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=216.0
Q ss_pred HhcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999764 34899999997653 2345678999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP----------------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIK 929 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 929 (1082)
.++||||+++|+|.++++... ...+++.+++.++.|+++||+|||+. +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 999999999999999998743 15689999999999999999999999 99999999
Q ss_pred CCCEEEcCCCcEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCc
Q 045553 930 PSNILLDNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSF 1007 (1082)
Q Consensus 930 ~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~ 1007 (1082)
|+||+++.++.+||+|||+++....... .......|++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~- 280 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 280 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC-
Confidence 9999999999999999999987643322 22334568899999999999999999999999999999999 99998632
Q ss_pred cCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1008 CSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1008 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
...+..... ..+... ..+...+..+.+++.+||+.+|++||++.||++.|+++....
T Consensus 281 -------~~~~~~~~~-~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 281 -------AHEEVIYYV-RDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -------CHHHHHHHH-HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -------ChHHHHHHH-hCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 222333322 222221 123345568999999999999999999999999999987653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=373.36 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=209.9
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 45688899999999999999999888899999997654 345789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++|+|.++++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999864445689999999999999999999999 99999999999999999999999999998765433333
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+...... .+. +
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i~-~~~---------~ 399 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQVE-RGY---------R 399 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHH-TTC---------C
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHH-cCC---------C
Confidence 334557889999999999999999999999999999999 89998632 2223333222 221 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...+...+..+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 12334556789999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=354.43 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=218.9
Q ss_pred HhcCccccceecccCceEEEEEEEcC-CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
...+|++.+.||+|+||.||+|.... +..||+|++.... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45679999999999999999997664 8899999997543 446789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999987677899999999999999999999999 999999999999999999999999999987765544
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.......+++.|+|||++.+..++.++||||+|+++|+|++ |..||..... ..... .. ...
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~---~~-~~~--------- 228 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYE---LL-EKD--------- 228 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHH---HH-HTT---------
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---HH-hcc---------
Confidence 44455567889999999999999999999999999999999 9899864321 11111 11 111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.....+...+..+.+++.+|++.+|++||++.|+++.|+.+.
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 111223445578999999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=361.44 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=215.1
Q ss_pred hcCccccceecccCceEEEEEEEc--------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII--------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE 869 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 869 (1082)
.++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457899999999999999999752 24689999997653 33457789999999999 999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999998754 24599999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCC
Q 045553 936 DNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNG 1013 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 1013 (1082)
+.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~------- 297 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------- 297 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------
Confidence 9999999999999987654332 23334567889999999999999999999999999999999 99998632
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...+...... .+... ..+...+.++.+++.+||+.+|++||++.||++.|+++.
T Consensus 298 -~~~~~~~~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 298 -PVEELFKLLK-EGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp -CHHHHHHHHH-TTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CHHHHHHHHH-cCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2233333322 22111 123344568999999999999999999999999998874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=357.13 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=209.3
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc------cHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ------GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
..+.|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999765 6899999999764321 35789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC----cEEEeecc
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL----NAYLSDFG 947 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG 947 (1082)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999999763 4699999999999999999999999 999999999999998877 79999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
++....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||... ...+....+....
T Consensus 165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~--------~~~~~~~~i~~~~ 234 (361)
T 2yab_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANITAVS 234 (361)
T ss_dssp SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHTTC
T ss_pred CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcC
Confidence 998765432 234567999999999999999999999999999999999999999642 2223333322211
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.. +++... ...+..+.+++.+|++.||++|||+.|+++
T Consensus 235 -~~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 -YD--FDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CC--CCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 011111 123467899999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=364.24 Aligned_cols=269 Identities=23% Similarity=0.346 Sum_probs=217.4
Q ss_pred ccHHHHHHHhcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhcc-CCCceeeE
Q 045553 791 LTYENVVRATAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLVTL 862 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l 862 (1082)
+.........++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 444555556788999999999999999999642 458999999976433 3456799999999999 78999999
Q ss_pred eeeeccCC-eEEEEEeecCCCCHHHHHhhCCC------------------------------------------------
Q 045553 863 IGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPR------------------------------------------------ 893 (1082)
Q Consensus 863 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 893 (1082)
++++.+.+ ..++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99988755 48999999999999999987532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 894 ----------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 894 ----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1289999999999999999999999 999999999999999999999999999987644332
Q ss_pred -ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 958 -HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 958 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.......||+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..+......+...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~----- 315 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGTRM----- 315 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--------HHHHHHHHHTCCC-----
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--------HHHHHHHHcCCCC-----
Confidence 23345678999999999999999999999999999999998 99999643211 1122222222111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+...+.++.+++.+|++.+|++||++.||+++|+++..
T Consensus 316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1233345689999999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=349.58 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=199.2
Q ss_pred hcCccccceecccCceEEEEEEEcC----CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4579999999999999999997642 5679999987543 334567899999999999999999999984 567899
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999875 44689999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
..........+++.|+|||++.+..++.++||||||+++|||++ |..||..... .... ... ..+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~~~---~~i-~~~~~~--- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVI---GRI-ENGERL--- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHH---HHH-HTTCCC---
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HHHH---HHH-HcCCCC---
Confidence 44333344567889999999999999999999999999999996 9999874321 1221 121 111111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+...+..+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 123345578999999999999999999999999998874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=343.52 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=211.6
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357899999999999999999875 8999999997653 34456799999999999999999999999877 788999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR--VLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
|||+++|+|.++++......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999986555799999999999999999999998 7 9999999999999999999999999875432
Q ss_pred CCCCccccCcccCCCcccchhcccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVS---DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
. ....||+.|+|||++.+..++ .++||||||+++|||++|+.||... ............+...
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--------SNMEIGMKVALEGLRP 230 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS--------CHHHHHHHHHHSCCCC
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc--------ChHHHHHHHHhcCCCC
Confidence 2 234689999999999876544 4899999999999999999999632 2223333333332211
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+...+..+.+++.+|++.||++|||+.|+++.|+++++
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 ---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 2233455689999999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=353.63 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=214.9
Q ss_pred hcCccccceecccCceEEEEEEE------cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI------IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
..+|.+.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45799999999999999999975 235899999997543 34457789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCC
Q 045553 873 FLIYNYLPGGNLEKFIQDRPR----------------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKP 930 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 930 (1082)
++||||+++++|.+++..... ..+++..++.++.|+++||+|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999987532 3489999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcc
Q 045553 931 SNILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFC 1008 (1082)
Q Consensus 931 ~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~ 1008 (1082)
+||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999877544332 2334467889999999999999999999999999999999 9999864321
Q ss_pred CCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1009 SFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..... .+..+.. ...+...+..+.+++.+|++.||++||++.|++++|+++..
T Consensus 259 -----~~~~~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 -----ERLFN----LLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp -----GGHHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHH----HhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12211 2222211 11233455689999999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=343.49 Aligned_cols=254 Identities=30% Similarity=0.467 Sum_probs=199.0
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc----ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF----QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..+|++.+.||+|+||.||+|... ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357999999999999999999875 89999999865432 3356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC--------CCcEEEeecc
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN--------NLNAYLSDFG 947 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--------~~~~kl~DfG 947 (1082)
|||+++++|.+++.. ..+++..+..++.|++.|++|||+....+|+||||||+||+++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999964 46899999999999999999999992222999999999999986 6789999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
.++....... ....|++.|+|||++.+..++.++||||+|+++|||++|+.||... .............
T Consensus 162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--------DGLAVAYGVAMNK 230 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS--------CHHHHHHHHHTSC
T ss_pred cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHhhhcCC
Confidence 9986643322 2356899999999999999999999999999999999999999632 1122222222221
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
. ....+...+..+.+++.+|++.+|++||++.|++++|+++
T Consensus 231 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 L---------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C---------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1 1122344556899999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.24 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=206.7
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.+.||+|+||+||+|+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467999999999999999999988899999999965432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 996 5888888765 45689999999999999999999999 999999999999999999999999999987753322
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc-
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA- 1035 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~- 1035 (1082)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+..........++...
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-----DDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST-----TTHHHHHHHHHCCCCTTTSGGGT
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHHCCCChHHhhhhh
Confidence 2334578999999999876 5689999999999999999999999974321 2222222222222211111000
Q ss_pred --------cc--CCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 --------GL--WDC-----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 --------~l--~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ... .......++.+++.+|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 000 011234678999999999999999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=356.54 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=204.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCe----EEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGV----VVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
..+|++.++||+|+||+||+|... +++ +||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 356999999999999999999754 343 46888875432 345678999999999999999999999998754 78
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999999876 45799999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 954 TSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 954 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
..... ......||..|+|||++.+..++.++|||||||++|||++ |+.||+.... .... ..+..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~----~~~~~~~--- 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEIS----SILEKGE--- 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHH----HHHHTTC---
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHH----HHHHcCC---
Confidence 44332 2334457889999999999999999999999999999999 9999974321 1221 1222221
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
....+......+.+++.+||+.+|++||++.||+++|+.+.
T Consensus 237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11223445668999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=344.70 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=213.9
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.+.||+|+||.||+|...++..||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 45789999999999999999998888899999997553 34678999999999999999999999986 45689999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 999999999764334689999999999999999999999 99999999999999999999999999998876544333
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+...... .+..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~~~~~~-~~~~--------- 228 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--------TNPEVIQNLE-RGYR--------- 228 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHH-TTCC---------
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc--------CHHHHHHHHh-cccC---------
Confidence 444567889999999998899999999999999999999 89898632 1222222222 2211
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...+...+.++.+++.+|++.+|++||++.++++.|+++.
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1122344568999999999999999999999999998763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=361.46 Aligned_cols=258 Identities=23% Similarity=0.360 Sum_probs=211.9
Q ss_pred hcCccccceecccCceEEEEEEEc------CCeEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
.++|++.+.||+|+||+||+|.+. ++..||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457899999999999999999743 4678999999654 234456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC---cEEEe
Q 045553 873 FLIYNYLPGGNLEKFIQDRP-----RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL---NAYLS 944 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~ 944 (1082)
++||||+++|+|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999998643 24689999999999999999999999 999999999999999555 59999
Q ss_pred ecccceecCCCC-CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHH
Q 045553 945 DFGLARLLGTSE-THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 945 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||... ...+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~--------~~~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------SNQEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH
Confidence 999998653222 122334568899999999999999999999999999999998 99998632 22333333
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...... . ..+...+..+.+++.+||+.+|++||++.||+++|+.+.
T Consensus 299 i~~~~~-~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 299 VTSGGR-M---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHTTCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCC-C---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 322221 1 123344567999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=360.64 Aligned_cols=252 Identities=20% Similarity=0.323 Sum_probs=203.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 874 (1082)
.++|++.++||+|+||+||+|+.. +++.||||+++.... ...+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457999999999999999999765 588999999975432 2234578899998877 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999874 4699999999999999999999999 999999999999999999999999999986332
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||................+...+..+..
T Consensus 206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 279 (396)
T 4dc2_A 206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 279 (396)
T ss_dssp T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence 2 2234456899999999999999999999999999999999999999964322211111222333333333221
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
..|...+.++.+++.+|++.||++||++
T Consensus 280 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1234455689999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=347.63 Aligned_cols=270 Identities=18% Similarity=0.218 Sum_probs=216.2
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCC--eEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA--EMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV 875 (1082)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357999999999999999999765 48999999997543 344677889999999999999999999987654 78999
Q ss_pred EeecCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE----cCCCcEEEeecccce
Q 045553 876 YNYLPGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLAR 950 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGla~ 950 (1082)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998653 23499999999999999999999999 99999999999999 788889999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhcc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAM--------TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... .....+.+..
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~ 238 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG----PRRNKEVMYK 238 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC----GGGCHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----cchhHHHHHH
Confidence 7754332 23457999999999986 57789999999999999999999999974322 1222333333
Q ss_pred HHhcCCCccc--c------------ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1023 LLLQGRPCEF--F------------TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1023 ~~~~~~~~~~--~------------d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.......... + +.......+......+..++.+|++.||++||++.|++++..+..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 3332211100 0 001111234677888999999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=352.79 Aligned_cols=252 Identities=19% Similarity=0.245 Sum_probs=210.0
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999755 58999999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC--CCcEEEeecccceecCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN--NLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~~~~ 956 (1082)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.+....
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999764 34689999999999999999999999 9999999999999987 7899999999998875433
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+............ +..
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~~---~~~ 225 (321)
T 1tki_A 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNAEYTF---DEE 225 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTCCCC---CHH
T ss_pred c--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC--------CHHHHHHHHHcCCCCC---Chh
Confidence 2 33457899999999999988999999999999999999999999632 2233333333322111 000
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ...+.++.+++.+|++.||++|||+.|++++
T Consensus 226 ~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 1235678999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=356.84 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=211.3
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457999999999999999999764 6899999999876655667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC--CCcEEEeecccceecCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN--NLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~~~~ 956 (1082)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999764 34689999999999999999999999 9999999999999974 5789999999998875433
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+........... ++..
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--------~~~~~~~~i~~~~~~---~~~~ 272 (387)
T 1kob_A 206 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--------DDLETLQNVKRCDWE---FDED 272 (387)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHHCCCC---CCSS
T ss_pred c--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCC---CCcc
Confidence 2 23346999999999999999999999999999999999999999732 222333333322211 1111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.....+.++.+++.+|++.||++||++.|++++
T Consensus 273 ----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 ----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 112345689999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.49 Aligned_cols=261 Identities=16% Similarity=0.237 Sum_probs=211.5
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|++.++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45799999999999999999975 579999999986543 234578899999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc-----EEEeecccceec
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN-----AYLSDFGLARLL 952 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfGla~~~ 952 (1082)
|+ +++|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 99999999875 34699999999999999999999999 9999999999999987776 999999999877
Q ss_pred CCCCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 953 GTSETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 953 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~ 236 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYERIGEK 236 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHHHHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc-----ccHHHHHHHHhh
Confidence 544321 234567999999999999999999999999999999999999999753211 112222211111
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...... +.. ....+.++.+++.+|++.+|++||++.+|++.|+++.
T Consensus 237 ~~~~~~--~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 237 KQSTPL--REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHHSCH--HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCccH--HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 000000 000 1133468999999999999999999999999998864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=367.60 Aligned_cols=264 Identities=21% Similarity=0.283 Sum_probs=214.3
Q ss_pred cHHHHHHHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeec
Q 045553 792 TYENVVRATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867 (1082)
Q Consensus 792 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 867 (1082)
.+.++....++|++.++||+|+||+||+|+.. +++.||||++..... .....+.+|..+++.++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45555566789999999999999999999766 478999999965321 22234889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecc
Q 045553 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFG 947 (1082)
Q Consensus 868 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 947 (1082)
+.+..|+||||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999864 35699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--------~~~~~~~~ 292 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGK 292 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC--------ChhHHHHh
Confidence 99877655554455578999999999997 567899999999999999999999999742 22222222
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS--RPSMRQVAQQ 1073 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 1073 (1082)
+......... + ......+.++.+++.+|+..+|++ ||++.|++++
T Consensus 293 i~~~~~~~~~--p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 IMNHKERFQF--P----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHTHHHHCCC--C----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhhccccccC--C----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 2211100000 0 011224567899999999998888 9999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.51 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=208.2
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc------ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999765 589999999975432 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC----cEEEeeccc
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL----NAYLSDFGL 948 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGl 948 (1082)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999763 5689999999999999999999999 999999999999999887 899999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+..........
T Consensus 165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANVSAVNY 234 (326)
T ss_dssp CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHHTCC
T ss_pred CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC--------CHHHHHHHHHhcCC
Confidence 98775332 233457999999999999999999999999999999999999999632 12222222222111
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. . ... .....+..+.+++.+|++.||++|||+.|++++
T Consensus 235 -~-~-~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 -E-F-EDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -C-C-CHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -C-c-Ccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0 000 011234678999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=351.33 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=211.5
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
..+|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999975 5789999999875432 24588999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc-----EEEeecccceec
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN-----AYLSDFGLARLL 952 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfGla~~~ 952 (1082)
|+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.+
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999875 45799999999999999999999999 9999999999999998887 999999999976
Q ss_pred CCCCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 953 GTSETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 953 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERYQKIGDT 235 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHHHHHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHHHHHHhh
Confidence 543322 1245679999999999999999999999999999999999999997532 12232222222111
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.... .. .... ...+ ++.+++.+|++.+|.+||++.+|.+.|+++.
T Consensus 236 ~~~~-~~-~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 236 KRAT-PI-EVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHS-CH-HHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hccC-CH-HHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 1000 00 0000 1123 8999999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=346.46 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=208.3
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|..+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56999999999999999999765 68999999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999999874 4689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||... +............ .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~-~------- 220 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNAE-L------- 220 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHCC-C-------
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC-C-------
Confidence 23457999999999999999999999999999999999999999632 2233333333221 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
..+.....++.+++.+|++.||++|| ++.||.++
T Consensus 221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 12334456899999999999999999 88888753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=353.79 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=205.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999765 689999999875433 234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999999999976 34699999999999999999999999 999999999999999999999999999987643322
Q ss_pred -ccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 958 -HATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 958 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ......| .......
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~----~~~~~~~----- 228 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDW----KEKKTYL----- 228 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT---SHHHHHH----HTTCTTS-----
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHH----hcccccC-----
Confidence 23345679999999999988765 77999999999999999999999743211 1111111 1111100
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.........+.+++.+|++.||++|||+.|++++
T Consensus 229 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1112345678899999999999999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=366.21 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=212.5
Q ss_pred HHHHHHHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeecc
Q 045553 793 YENVVRATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868 (1082)
Q Consensus 793 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 868 (1082)
..++....++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556788999999999999999999765 58999999986421 1223457899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 869 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
....|+||||+++|+|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999864 589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCR----VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||... +.......+.
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~ 286 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSKIM 286 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC--------ChhhHHHHHH
Confidence 9887655444445678999999999998765 788999999999999999999999732 2223333332
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS--RPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 1073 (1082)
........ ......+.++.+++.+|++.+|++ ||++.||.++
T Consensus 287 ~~~~~~~~-------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 287 NHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp THHHHCCC-------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred hccccccC-------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 21100000 011134568999999999999998 9999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=356.99 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=203.7
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecC---ccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 874 (1082)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999765 5899999999754 223456688899999988 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++|+|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999874 4699999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+.... .
T Consensus 177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~-~----- 241 (353)
T 3txo_A 177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE--------NEDDLFEAILNDE-V----- 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C-----
T ss_pred C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCC-C-----
Confidence 2 22334567999999999999989999999999999999999999999732 2233333333221 1
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSM------RQVAQ 1072 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~ev~~ 1072 (1082)
..+......+.+++.+|++.+|++||++ .|+++
T Consensus 242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1233445678999999999999999998 66654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=353.48 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=212.7
Q ss_pred HhcCccccceecccCceEEEEEEE------cCCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI------IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 870 (1082)
..++|++.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456799999999999999999975 246789999997542 23456789999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPR---------------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIK 929 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 929 (1082)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999987532 2479999999999999999999999 99999999
Q ss_pred CCCEEEcCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCc
Q 045553 930 PSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSF 1007 (1082)
Q Consensus 930 ~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~ 1007 (1082)
|+||+++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876543332 2334567889999999999999999999999999999998 999997432
Q ss_pred cCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1008 CSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1008 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
.. ..+......+.. ...+...+.++.+++.+||+.||++||++.||+++|+.+...
T Consensus 280 ~~--------~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VD--------ANFYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CS--------HHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cH--------HHHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 112222222211 112334456899999999999999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.42 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=214.8
Q ss_pred hcCccccceecccCceEEEEEEE------cCCeEEEEEEeecCcc-ccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI------IPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 871 (1082)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45799999999999999999975 3468999999975533 3457789999999999 99999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPR----------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999987542 2489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCC
Q 045553 936 DNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNG 1013 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 1013 (1082)
+.++.+||+|||+++........ ......|++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence 99999999999999877544332 2334567889999999999999999999999999999999 99998643211
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.........+.. ...+...+..+.+++.+|++.||++||++.|++++|+++.
T Consensus 255 ----~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 ----SKFYKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ----HHHHHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----hHHHHHhccCCC---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111222222211 1122344568999999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=340.79 Aligned_cols=253 Identities=26% Similarity=0.517 Sum_probs=207.1
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcccc-------HHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQG-------VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
.++|++.+.||+|+||.||+|.. .+++.||||++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46799999999999999999976 468999999986543211 267899999999999999999999987665
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeccCCCCCEEEcCCCc-----EEEe
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR--VLHRDIKPSNILLDNNLN-----AYLS 944 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~-----~kl~ 944 (1082)
++||||+++++|.+++... ...+++..+..++.|++.|++|||+. + |+||||||+||+++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 7999999999999998765 45799999999999999999999999 8 999999999999988776 9999
Q ss_pred ecccceecCCCCCccccCcccCCCcccchhc--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH
Q 045553 945 DFGLARLLGTSETHATTDVAGTFGYVAPEYA--MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 945 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
|||+++.... ......|++.|+|||++ ....++.++||||+|+++|||++|+.||.... .........
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~ 241 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS------YGKIKFINM 241 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC------CCHHHHHHH
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc------ccHHHHHHH
Confidence 9999975432 23346799999999998 45567899999999999999999999997432 112222333
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
....+.. ...+...+..+.+++.+||+.||++||++.|+++.|+++
T Consensus 242 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREEGLR---------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSCCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HhccCCC---------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 2222211 122344567899999999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.47 Aligned_cols=264 Identities=23% Similarity=0.357 Sum_probs=212.0
Q ss_pred cCccccceecccCceEEEEEEE-----cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccC--CeE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-----IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE--AEM 872 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 872 (1082)
..|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588999999999999999984 368999999997543 34567899999999999999999999999876 668
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999999999999664 35689999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCC--ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCcc-------CCCCCccHHHHHHHH
Q 045553 953 GTSET--HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFC-------SFGNGFNIVAWASML 1023 (1082)
Q Consensus 953 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~ 1023 (1082)
..... .......||..|+|||++.+..++.++||||+|+++|||++|+.|+..... ........... ...
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 255 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL-VNT 255 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH-HHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH-HHH
Confidence 55433 223445688899999999999999999999999999999999998643210 10111111122 222
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...+. ....+...+..+.+++.+|++.||++|||+.|+++.|+++.
T Consensus 256 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22221 11233455678999999999999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=351.71 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=203.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|..+++++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56999999999999999999765 58999999997543 23355688899999887 899999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999999864 4689999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||................+...+..+..
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 233456899999999999999999999999999999999999999974322111111112222222222211
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
..|...+.++.+++.+|++.||++||++
T Consensus 237 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1233455689999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.71 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=208.5
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999764 589999999976532 3456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC---CcEEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN---LNAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~~~ 952 (1082)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||++...
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999999763 4689999999999999999999999 99999999999999865 45999999999876
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... +............ .. .
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~--------~~~~~~~~i~~~~-~~-~ 249 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--------DQHRLYAQIKAGA-YD-Y 249 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC-CC-C
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCC-CC-C
Confidence 5332 234467999999999999999999999999999999999999999632 1222323222221 11 0
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... .....+.++.+++.+|++.||++||++.|++++
T Consensus 250 -~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -PSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CTT----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -Ccc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 012345678999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=360.73 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=208.3
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..++|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456799999999999999999964 4689999999976542 3456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc---CCCcEEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~~ 952 (1082)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||++...
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999874 4699999999999999999999999 999999999999998 5678999999999876
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
..... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||... +.......... +... .
T Consensus 164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~-~~~~-~ 232 (444)
T 3soa_A 164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE--------DQHRLYQQIKA-GAYD-F 232 (444)
T ss_dssp CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHH-TCCC-C
T ss_pred cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHh-CCCC-C
Confidence 54322 234567999999999999999999999999999999999999999632 22222233222 2111 0
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... .....+.++.+++.+|++.||++|||+.|++++
T Consensus 233 -~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 -PSP----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -Ccc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001 112345689999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=351.68 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=205.6
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999975 568999999986432 22345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+ +|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 78999998764 4699999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+..... .....+.
T Consensus 162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------------------~~~~~i~ 221 (336)
T 3h4j_B 162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP------------------NLFKKVN 221 (336)
T ss_dssp B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST------------------TCBCCCC
T ss_pred c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH------------------HHHHHHH
Confidence 2 2344579999999999988776 78999999999999999999999753221 0001111
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ....+...+..+.+++.+|++.||.+|||+.|++++
T Consensus 222 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 222 SC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 112344456789999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.03 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=202.9
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.+.||+|+||+||+|+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47899999999999999999888899999999965432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 96 5999998865 35689999999999999999999999 999999999999999999999999999987643222
Q ss_pred cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc------
Q 045553 959 ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE------ 1031 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 1031 (1082)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+...........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHHCCCChhhchhhhc
Confidence 2234568999999999976 4589999999999999999999999974211 111111111111111000
Q ss_pred --ccccccCC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 --FFTAGLWD-------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 --~~d~~l~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+++.... ......+.++.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01111110 0112345678999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=349.07 Aligned_cols=258 Identities=24% Similarity=0.427 Sum_probs=213.0
Q ss_pred hcCccccceecccCceEEEEEEEc--------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII--------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE 869 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 869 (1082)
.++|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467999999999999999999763 46789999997553 24456789999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPR--------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999986532 3489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCC
Q 045553 936 DNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNG 1013 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 1013 (1082)
+.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------- 263 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------- 263 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-------
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-------
Confidence 99999999999999877544322 2333457889999999999999999999999999999999 99998632
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...+....... +... ..+...+..+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 264 -~~~~~~~~~~~-~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 264 -PVEELFKLLKE-GHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp -CHHHHHHHHHH-TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CHHHHHHHHhc-CCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22233332222 2111 123344568999999999999999999999999998874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=358.88 Aligned_cols=267 Identities=26% Similarity=0.372 Sum_probs=215.6
Q ss_pred hcCccccceecccCceEEEEEEE-----cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeec--cCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-----IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV--SEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 872 (1082)
..+|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35799999999999999999984 368999999998776666778999999999999999999999876 45678
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999999864 23689999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccC------CCCCccHHHHHHHHH
Q 045553 953 GTSETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS------FGNGFNIVAWASMLL 1024 (1082)
Q Consensus 953 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~ 1024 (1082)
...... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 544332 233456888899999999999999999999999999999999998632110 000001111111111
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+ .....+...+..+.+++.+|++.||++||++.|++++|+.+..
T Consensus 258 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 258 EEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111 1222344556789999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=357.64 Aligned_cols=267 Identities=18% Similarity=0.249 Sum_probs=208.9
Q ss_pred HhcCccccceecccCceEEEEEEEcC------CeEEEEEEeecCccccH-----------HHHHHHHHHHhccCCCceee
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIP------GVVVAVKRLSVGRFQGV-----------QQFAAEIRTLGRVQHPNLVT 861 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~ 861 (1082)
..++|++.+.||+|+||.||+|.... ++.||||++........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34579999999999999999997754 47899999876542111 12345666778889999999
Q ss_pred EeeeeccC----CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc-
Q 045553 862 LIGYHVSE----AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD- 936 (1082)
Q Consensus 862 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~- 936 (1082)
+++++... ...++||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 99998764 4589999999 99999999875 45799999999999999999999999 999999999999999
Q ss_pred -CCCcEEEeecccceecCCCCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccC
Q 045553 937 -NNLNAYLSDFGLARLLGTSETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS 1009 (1082)
Q Consensus 937 -~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~ 1009 (1082)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~- 266 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK- 266 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT-
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-
Confidence 8899999999999877533221 12345599999999999999999999999999999999999999974321
Q ss_pred CCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1010 FGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
......+...... ....+.++..+. +...+.++.+++..||+.+|++||++.+|++.|+++.
T Consensus 267 ---~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 ---DPKYVRDSKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp ---CHHHHHHHHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 2222222222222 122333333221 1233568999999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=355.19 Aligned_cols=260 Identities=22% Similarity=0.371 Sum_probs=197.2
Q ss_pred HHhcCccccceecccCceEEEEEEEcC-C---eEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEIIP-G---VVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
...++|++.+.||+|+||.||+|.... + ..||||++... .....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999996543 2 27999999754 33456789999999999999999999999987665
Q ss_pred E------EEEEeecCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcE
Q 045553 872 M------FLIYNYLPGGNLEKFIQDRP----RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941 (1082)
Q Consensus 872 ~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 941 (1082)
. ++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 4 99999999999999997532 22589999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHH
Q 045553 942 YLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~---~ 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AE---I 248 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GG---H
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----HH---H
Confidence 99999999876443322 2233457889999999999999999999999999999999 8999874321 11 1
Q ss_pred HHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1020 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
......... ...+...+.++.+++.+|++.||++||++.|+++.|+++.
T Consensus 249 ~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 249 YNYLIGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHHHHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 122221111 1123345568999999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.07 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=206.6
Q ss_pred hcCccccceecccCceEEEEEEEcC----CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4679999999999999999997543 3469999987653 3456779999999999999999999999865 45689
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999865 35689999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
..........+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ....... . ..+...
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-----~~~~~~~---~-~~~~~~--- 233 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-----NKDVIGV---L-EKGDRL--- 233 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----GGGHHHH---H-HHTCCC---
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-----hHHHHHH---H-hcCCCC---
Confidence 44333444567889999999999999999999999999999998 999996432 1222221 1 111111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+...+..+.+++.+|++.+|++||++.|++++|+++.
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 122334567999999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.25 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=207.2
Q ss_pred hcCccccceecccCceEEEEEEEcC-C-------eEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP-G-------VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
.++|++.+.||+|+||.||+|.... + ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578999999999999999996442 3 5799999987666777889999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc--------EEE
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN--------AYL 943 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl 943 (1082)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999875 34589999999999999999999999 9999999999999998887 999
Q ss_pred eecccceecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH
Q 045553 944 SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
+|||.+...... ....|++.|+|||++.+ ..++.++||||||+++|||++|+.|+... .........
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~~~~ 230 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA-------LDSQRKLQF 230 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHHHHH
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc-------cchHHHHHH
Confidence 999998654321 22457899999999987 77999999999999999999976555421 111222221
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
...... .+...+.++.+++.+||+.||++|||+.|+++.|+++..|.
T Consensus 231 ~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 231 YEDRHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHTTCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred hhccCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 111111 11122346889999999999999999999999999987653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=376.10 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=215.3
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45688999999999999999999888899999997654 345789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++|+|.++++......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999864445689999999999999999999999 99999999999999999999999999998764322222
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+..... ..+. +
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--------~~~~~~~~i-~~~~---------~ 482 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQV-ERGY---------R 482 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--------CHHHHHHHH-HTTC---------C
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHH-HcCC---------C
Confidence 334457789999999999999999999999999999999 89998632 222333222 2221 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...+...+..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 12234556789999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=349.60 Aligned_cols=245 Identities=20% Similarity=0.303 Sum_probs=208.6
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999765 68999999986542 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999874 4689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+......... .
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~~~-~------- 255 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSGK-V------- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C-------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC--------CHHHHHHHHHcCC-C-------
Confidence 23457999999999999999999999999999999999999999632 2233333333221 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 1073 (1082)
..+...+..+.+++.+|++.||++||+ +.||.++
T Consensus 256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 123344568999999999999999998 8888653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=343.93 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=199.8
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccc--------------------------cHHHHHHHHHHHh
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ--------------------------GVQQFAAEIRTLG 852 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~ 852 (1082)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36799999999999999999975 46899999998654311 1356889999999
Q ss_pred ccCCCceeeEeeeecc--CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCC
Q 045553 853 RVQHPNLVTLIGYHVS--EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKP 930 (1082)
Q Consensus 853 ~l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 930 (1082)
+++||||+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999886 5689999999999999887543 4699999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcccchhcccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 045553 931 SNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR---VSDKADVYSFGVVLLELISDKKALDPSF 1007 (1082)
Q Consensus 931 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGvll~elltg~~p~~~~~ 1007 (1082)
+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~- 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE- 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-
Confidence 999999999999999999987654332 234457999999999998765 478999999999999999999999632
Q ss_pred cCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1008 CSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1008 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+........ .. . ......+..+.+++.+|++.||++||++.|++++
T Consensus 244 -------~~~~~~~~~~~~~-~~-~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 -------RIMCLHSKIKSQA-LE-F-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -------SHHHHHHHHHHCC-CC-C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -------cHHHHHHHHhccc-CC-C-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 2223332222221 11 0 1112344679999999999999999999999753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=352.66 Aligned_cols=261 Identities=26% Similarity=0.372 Sum_probs=209.7
Q ss_pred ccccceecccCceEEEEEEEc-----CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeecc--CCeEEE
Q 045553 803 FNVQNCIGSGGFGATYKAEII-----PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEMFL 874 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 874 (1082)
|++.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988643 68999999997653 2445678999999999999999999999986 467899
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999864 489999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccC------CCCCccHHHHHHHHHhc
Q 045553 955 SETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS------FGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 955 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 1026 (1082)
.... ......|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ..............
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 263 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL--- 263 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH---
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH---
Confidence 4321 233456888999999999999999999999999999999999998642110 00000000111111
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
++.......+...+.++.+++.+||+.||++||++.|+++.|+++.
T Consensus 264 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 ------LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp ------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1112222234455678999999999999999999999999998874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=342.50 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=199.9
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.++||+|+||+||+|+.. ..||||++.... ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999754 469999997553 33457789999999999999999999965 4566899999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC-
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE- 956 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~- 956 (1082)
|+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999765 45799999999999999999999999 99999999999999999999999999998654322
Q ss_pred CccccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 957 THATTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
........||+.|+|||++. +..++.++||||+|+++|||++|+.||.... ..... ......+......
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~-~~~~~~~~~~~~~ 247 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------NRDQI-IEMVGRGSLSPDL 247 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-------CHHHH-HHHHHHTSCCCCT
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-------hHHHH-HHHhcccccCcch
Confidence 22334467999999999986 5678899999999999999999999996421 11222 2222222222111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
. ......+.++.+++.+|++.+|++||++.|+++.|+++..
T Consensus 248 ~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 S-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp T-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred h-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1 1123445689999999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=352.75 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=207.0
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 873 (1082)
..++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999765 58999999997542 23456678899999877 9999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 999999999999999873 4689999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+......... .
T Consensus 170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~~~-~---- 235 (345)
T 1xjd_A 170 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--------DEEELFHSIRMDN-P---- 235 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C----
T ss_pred cCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHhCC-C----
Confidence 222 2334568999999999999999999999999999999999999999632 2223333332221 1
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMR-QVA 1071 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 1071 (1082)
..+...+.++.+++.+|++.||++||++. ||.
T Consensus 236 ------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 12334456899999999999999999997 654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=361.92 Aligned_cols=264 Identities=20% Similarity=0.230 Sum_probs=212.0
Q ss_pred ccHHHHHHHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeee
Q 045553 791 LTYENVVRATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 866 (1082)
+.+++.....++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|.+++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344555556788999999999999999999764 68999999996532 12234578899999999999999999999
Q ss_pred ccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 867 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
.+.+..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999999864 34699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccCcccCCCcccchhcc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHH
Q 045553 947 GLARLLGTSETHATTDVAGTFGYVAPEYAM-------TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 947 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
|+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||... +..+.
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~ 278 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--------STAET 278 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC--------CHHHH
Confidence 999887655444444568999999999997 357899999999999999999999999742 22222
Q ss_pred HHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 045553 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSR---PSMRQVAQQ 1073 (1082)
Q Consensus 1020 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ev~~~ 1073 (1082)
...+......... + ..+...+.++.+++.+|++ +|++| |++.||.++
T Consensus 279 ~~~i~~~~~~~~~--p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 279 YGKIVHYKEHLSL--P----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHTHHHHCCC--C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHhcccCcCC--C----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 2222221100000 0 0112345689999999999 99998 689998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=353.89 Aligned_cols=256 Identities=22% Similarity=0.404 Sum_probs=205.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCe----EEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGV----VVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|++.+.||+|+||+||+|... ++. +||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57899999999999999999754 344 38888875432 233456788999999999999999999886 567899
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999865 34689999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 955 SETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 955 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.... ......|+..|+|||++.+..++.++||||||+++|||++ |+.||..... ... .. .+..+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~---~~-~~~~~~~~-- 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEV---PD-LLEKGERL-- 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THH---HH-HHHTTCBC--
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHH---HH-HHHcCCCC--
Confidence 4332 2344568889999999999999999999999999999999 9999974321 111 11 12222111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+...+..+.+++.+||+.+|++||++.|++++|+++..
T Consensus 237 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 -------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1122334468889999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=342.02 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=210.1
Q ss_pred cCccccc-eecccCceEEEEEEEc---CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQN-CIGSGGFGATYKAEII---PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~-~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|.+.+ .||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 9999999999999653 57889999997643 34567789999999999999999999999 55679999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999754 45699999999999999999999999 9999999999999999999999999999887544
Q ss_pred CCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 956 ETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 956 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... ......|++.|+|||++.+..++.++||||||+++|||++ |+.||.... . .+.... +..+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~---~~~~~~-i~~~~~--- 231 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----G---PEVMAF-IEQGKR--- 231 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----T---HHHHHH-HHTTCC---
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H---HHHHHH-HhcCCc---
Confidence 332 2233456889999999998899999999999999999998 999986421 1 122222 222211
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...+...+..+.+++.+|++.+|++||++.|++++|+++.
T Consensus 232 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 232 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1223445678999999999999999999999999998763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=353.74 Aligned_cols=246 Identities=24% Similarity=0.275 Sum_probs=201.3
Q ss_pred cceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 806 QNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 57899999999999975 46899999999877666678899999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE--cCCCcEEEeecccceecCCCCCccccC
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL--DNNLNAYLSDFGLARLLGTSETHATTD 962 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~DfGla~~~~~~~~~~~~~ 962 (1082)
.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.+..... ...
T Consensus 174 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 174 FDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp HHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 9998764 34689999999999999999999999 99999999999999 5678999999999998754332 234
Q ss_pred cccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCC
Q 045553 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042 (1082)
Q Consensus 963 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 1042 (1082)
..||+.|+|||++.+..++.++|||||||++|||++|+.||... ................. .. ..
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~i~~~~~~~~---~~----~~ 312 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD--------NDAETLNNILACRWDLE---DE----EF 312 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTCCCSC---SG----GG
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhccCCCC---hh----hh
Confidence 56999999999999999999999999999999999999999632 22333333333221110 00 01
Q ss_pred hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1043 HDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1043 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
...+.++.+++.+|++.||++||++.|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 233568999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=348.85 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=211.3
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeec----cCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV----SEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~l 874 (1082)
.++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+++++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35799999999999999999976 568999999997766666788999999999999999999999986 3457899
Q ss_pred EEeecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 875 IYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999763 245799999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCc--------cccCcccCCCcccchhcccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHH
Q 045553 953 GTSETH--------ATTDVAGTFGYVAPEYAMTCR---VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 953 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
...... ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||...... .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~-- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVALA-- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHHH--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhHH--
Confidence 321111 112345799999999987654 688999999999999999999998642211 1111111
Q ss_pred HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1022 MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
.... .....+...+..+.+++.+|++.||++||++.|++++|+.++++.
T Consensus 260 --~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 260 --VQNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp --HHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred --hhcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 1111 111112344568999999999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=352.34 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=207.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56999999999999999999755 58899999986532 244577889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999999863 4699999999999999999999999 9999999999999999999999999999876433
Q ss_pred CccccCcccCCCcccchhccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 957 THATTDVAGTFGYVAPEYAMT---CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ...............
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~------ 236 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-----STSSKEIVHTFETTV------ 236 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT-----TSCHHHHHHHHHHCC------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhhcc------
Confidence 23345689999999999974 458899999999999999999999997432 122223222222111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS-MRQVAQ 1072 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~ 1072 (1082)
...+...+..+.+++.+|++.+|++||+ +.+|.+
T Consensus 237 -----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1233445678999999999999999998 666654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=350.92 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=206.4
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-----cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-----FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356999999999999999999654 68999999986432 124678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc---EEEeeccc
Q 045553 874 LIYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN---AYLSDFGL 948 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfGl 948 (1082)
+||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886532 34589999999999999999999999 9999999999999986654 99999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ......... +.
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~-~~ 248 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIK-GK 248 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHH-TC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHc-CC
Confidence 988754332 2344679999999999999999999999999999999999999997421 122222222 21
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ..+... ...+.++.+++.+|++.||++||++.|++++
T Consensus 249 ~~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 249 YK--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 000000 1234678999999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=349.65 Aligned_cols=265 Identities=20% Similarity=0.334 Sum_probs=216.8
Q ss_pred HHHHHhcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeec
Q 045553 795 NVVRATAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867 (1082)
Q Consensus 795 ~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 867 (1082)
+.....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33345678999999999999999999654 36889999997543 234567899999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC
Q 045553 868 SEAEMFLIYNYLPGGNLEKFIQDRP--------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL 939 (1082)
Q Consensus 868 ~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 939 (1082)
+....++||||+++|+|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 9999999999999999999997532 24579999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHH
Q 045553 940 NAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 940 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~ 1017 (1082)
.+||+|||+++....... .......|++.|+|||++.+..++.++||||+|+++|||++ |+.||... ...
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~ 247 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNE 247 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC--------CHH
Confidence 999999999986643322 12233457889999999999999999999999999999999 88888632 222
Q ss_pred HHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
+....... +... ..+...+..+.+++.+|++.+|++||++.|++++|+++..+
T Consensus 248 ~~~~~~~~-~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 248 QVLRFVME-GGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHHHHHT-TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHHHc-CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 33333322 2211 12334456899999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=340.10 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=204.5
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47999999999999999999765 589999999975432 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9964 666666554 35699999999999999999999999 999999999999999999999999999987653322
Q ss_pred ccccCcccCCCcccchhcccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh---cCCCccc-
Q 045553 958 HATTDVAGTFGYVAPEYAMTCR-VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL---QGRPCEF- 1032 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 1032 (1082)
......||+.|+|||++.+.. ++.++||||+||++|||++|+.||... ............ ......+
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~-------~~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-------NDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC-------SSHHHHHHHHHHHHCCCCTTTCT
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC-------CCHHHHHHHHHHHhCCCChhhhh
Confidence 234457899999999998766 799999999999999999999886432 112222222211 1100000
Q ss_pred --cc------------cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 --FT------------AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 --~d------------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+ ..............+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000001122355788999999999999999999999873
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=346.31 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=198.4
Q ss_pred hcCccccceecccCceEEEEEEE----cCCeEEEEEEeecCc----cccHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI----IPGVVVAVKRLSVGR----FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35799999999999999999976 478999999997542 2334567889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999864 4689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ............. .
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~-~-- 238 (327)
T 3a62_A 171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE--------NRKKTIDKILKCK-L-- 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHTC-C--
T ss_pred cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCC-C--
Confidence 433222 233457999999999999999999999999999999999999999732 2223333332221 1
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
..+...+.++.+++.+|++.+|++|| ++.|++++
T Consensus 239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 12334456899999999999999999 77787653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=348.37 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=208.0
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 873 (1082)
..++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+..|.++++.+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467999999999999999999765 47899999997542 24456788999999988 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999999864 4699999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+.... .
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~-~---- 238 (353)
T 2i0e_A 173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEHN-V---- 238 (353)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C----
T ss_pred cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhCC-C----
Confidence 222 2334567999999999999999999999999999999999999999632 2233333333321 1
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQQ 1073 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 1073 (1082)
..|...+.++.+++.+|++.+|++||+ +.||.++
T Consensus 239 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 123345578999999999999999995 5676643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=341.92 Aligned_cols=260 Identities=21% Similarity=0.304 Sum_probs=203.4
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999765 689999999875432 2346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999874 4689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.........|++.|+|||++.+..++.++||||||+++|||++|+.||... .. ..+............
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~-~~~~~~~~~~~~~~~--- 255 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD--------QL-SVMGAHINQAIPRPS--- 255 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC--------HH-HHHHHHHHSCCCCGG---
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc--------hH-HHHHHHhccCCCCcc---
Confidence 433444567999999999999999999999999999999999999999632 11 122222222211100
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhhCCC
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRP-SMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~i~~~ 1080 (1082)
..+...+.++.+++.+|++.||++|| ++.++++.|+++...
T Consensus 256 ----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 256 ----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 11223445799999999999999999 999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=345.32 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=204.6
Q ss_pred cCccccceecccCceEEEEEEEcC-----CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP-----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|++.+.||+|+||.||+|.... +..||||++.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 468888999999999999996543 2469999997543 2345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999875 45799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 955 SETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 955 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+...... .+..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--------~~~~~~~~~~-~~~~-- 268 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--------SNHEVMKAIN-DGFR-- 268 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHH-TTCC--
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHH-CCCc--
Confidence 3221 2223346788999999999999999999999999999999 99998632 1222222222 2211
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...+...+..+.+++.+||+.+|++||++.|++++|+++.
T Consensus 269 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1123345568999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=343.87 Aligned_cols=269 Identities=23% Similarity=0.344 Sum_probs=206.0
Q ss_pred HHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhcc--CCCceeeEeeeeccC----Ce
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV--QHPNLVTLIGYHVSE----AE 871 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~~ 871 (1082)
...++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34568999999999999999999876 999999998643 234455566665554 899999999998876 68
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC-----VPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
.++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 99999999999999999864 5899999999999999999999762 348999999999999999999999999
Q ss_pred ccceecCCCCCcc---ccCcccCCCcccchhcccCCCCch------hhHHHHHHHHHHHHhC----------CCCCCCCc
Q 045553 947 GLARLLGTSETHA---TTDVAGTFGYVAPEYAMTCRVSDK------ADVYSFGVVLLELISD----------KKALDPSF 1007 (1082)
Q Consensus 947 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slGvll~elltg----------~~p~~~~~ 1007 (1082)
|+++.+....... .....||+.|+|||++.+...+.+ +|||||||++|||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9998765433221 234579999999999987766554 9999999999999999 55554322
Q ss_pred cCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1008 CSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1008 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
.. ......+ ............+.... .+...+.++.+++.+||+.||++||++.||+++|+++.+.
T Consensus 267 ~~---~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 267 PS---DPSYEDM-REIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CS---SCCHHHH-HHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC---CCchhhh-HHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 21 1222222 22222211111111100 1236778899999999999999999999999999988654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=347.18 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=201.3
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCC------
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA------ 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 870 (1082)
..++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999775 789999999975443 35678999999999999999999999875433
Q ss_pred ---------------------------------------------------eEEEEEeecCCCCHHHHHhhCC-CCCCCH
Q 045553 871 ---------------------------------------------------EMFLIYNYLPGGNLEKFIQDRP-RRTVEW 898 (1082)
Q Consensus 871 ---------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~-~~~l~~ 898 (1082)
..++||||+++++|.+++.... ....++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 3799999999999999998753 234567
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC-----------ccccCcccCC
Q 045553 899 SMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET-----------HATTDVAGTF 967 (1082)
Q Consensus 899 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~ 967 (1082)
..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999999 999999999999999999999999999998764422 1233457999
Q ss_pred CcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHH
Q 045553 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLI 1047 (1082)
Q Consensus 968 ~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 1047 (1082)
.|+|||++.+..++.++||||+|+++|||++|..|+.. .... ........... .......
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~-~~~~~~~~~~~---------~~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRI-ITDVRNLKFPL---------LFTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHH-HHHHHTTCCCH---------HHHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHH-HHHhhccCCCc---------ccccCCh
Confidence 99999999999999999999999999999998766421 1111 11112221111 1123345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1048 EMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1048 ~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+.+++.+|++.||++||++.|++++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 67899999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=355.49 Aligned_cols=268 Identities=17% Similarity=0.232 Sum_probs=207.4
Q ss_pred HhcCccccceeccc--CceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 799 ATAGFNVQNCIGSG--GFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G--~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
..++|++.++||+| +||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 99999999765 68999999997553 234567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999887667799999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCC------ccccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 954 TSET------HATTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 954 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
.... .......||..|+|||++.+ ..++.++||||+||++|||++|+.||...... ............
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~ 255 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKLNGTVP 255 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST----THHHHC------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCCCC
Confidence 2111 11223478999999999987 67899999999999999999999999753211 111111000000
Q ss_pred ----------------------cCCCcccccc---------ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 ----------------------QGRPCEFFTA---------GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ----------------------~~~~~~~~d~---------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.....+.+.. ......+...+..+.+++.+|++.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000000 00001123345679999999999999999999999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=342.74 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=200.9
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.+|++.+.||+|+||.||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46889999999999999999875 889999998643 345789999999999999999999998874 4799999999
Q ss_pred CCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc-EEEeecccceecCCCCCc
Q 045553 881 GGNLEKFIQDRPR-RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN-AYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 881 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~DfGla~~~~~~~~~ 958 (1082)
+++|.++++.... ..+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986532 24789999999999999999999932229999999999999998886 799999999765432
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+... .......... ..+...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~-~~~~~~-------- 223 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAV-HNGTRP-------- 223 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC------SSHHHHHHHH-HTTCCC--------
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC------ccHHHHHHHH-hcCCCC--------
Confidence 223468999999999999999999999999999999999999997431 1112222222 222111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+...+..+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 224 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1122345678999999999999999999999999988753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.25 Aligned_cols=267 Identities=24% Similarity=0.330 Sum_probs=212.8
Q ss_pred HHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhc--cCCCceeeEeeeeccCC----
Q 045553 797 VRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR--VQHPNLVTLIGYHVSEA---- 870 (1082)
Q Consensus 797 ~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~---- 870 (1082)
....++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|.++++. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34557899999999999999999987 4999999998643 34667888888887 79999999999998765
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeccCCCCCEEEcCCCcEE
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH--------DECVPRVLHRDIKPSNILLDNNLNAY 942 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nill~~~~~~k 942 (1082)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEE
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEE
Confidence 789999999999999999864 5899999999999999999999 77 999999999999999999999
Q ss_pred EeecccceecCCCCCc---cccCcccCCCcccchhcccC------CCCchhhHHHHHHHHHHHHhC----------CCCC
Q 045553 943 LSDFGLARLLGTSETH---ATTDVAGTFGYVAPEYAMTC------RVSDKADVYSFGVVLLELISD----------KKAL 1003 (1082)
Q Consensus 943 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGvll~elltg----------~~p~ 1003 (1082)
|+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999877544322 23445799999999999875 234789999999999999999 6677
Q ss_pred CCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1004 DPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1004 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
...... ......+............. .... ...+....+.+++.+||+.+|++||++.||+++|+++...
T Consensus 268 ~~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 268 YDLVPS---DPSVEEMRKVVCEQKLRPNI-PNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTSCS---SCCHHHHHHHHTTSCCCCCC-CGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCcC---cccHHHHHHHHHHHHhCCCC-cccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 543221 22333333333222211111 1110 1236678899999999999999999999999999988654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=345.78 Aligned_cols=264 Identities=22% Similarity=0.351 Sum_probs=192.3
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
..+|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999654 589999999975432 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 878 YLPGGNLEKFIQDRP----RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
|++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999987532 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc--
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC-- 1030 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1030 (1082)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......+..........
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-----DEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCChhHh
Confidence 3322 2234578999999999976 468999999999999999999999997431 111111111111110000
Q ss_pred -cc-----cccccC------------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 -EF-----FTAGLW------------DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 -~~-----~d~~l~------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ..+.+. ...+...+.++.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 000000 00111234679999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.48 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=199.7
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCC----e
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA----E 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 871 (1082)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999975 5689999999976532 33457889999999999999999999987654 3
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||+++++|.++++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 49999999999999999874 4689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 952 LGTSET--HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 952 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--------~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--------SPVSVAYQHVREDPI 237 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHhcCCCC
Confidence 654322 2233457999999999999999999999999999999999999999632 223333333333322
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHH-HHHHhh
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQV-AQQLKQ 1076 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev-~~~L~~ 1076 (1082)
.... .....+.++.+++.+|++.||++||+..++ ...+.+
T Consensus 238 ~~~~-------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 238 PPSA-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CHHH-------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred Cccc-------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 1110 011235679999999999999999966554 445544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=347.25 Aligned_cols=267 Identities=28% Similarity=0.414 Sum_probs=214.4
Q ss_pred hcCccccceecccCceEEEEEEE-----cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCC--eE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-----IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA--EM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 872 (1082)
..+|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34689999999999999999974 368999999998766666788999999999999999999999887654 78
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999999875 34689999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccC-------CCCCccHHHHHHHH
Q 045553 953 GTSETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCS-------FGNGFNIVAWASML 1023 (1082)
Q Consensus 953 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~ 1023 (1082)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..........+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 544332 123345778899999999988999999999999999999999987632100 00001111111122
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
+..+. ....+...+.++.+++.+||+.+|++||++.||++.|++++.
T Consensus 276 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 276 LKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22111 112234456789999999999999999999999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=353.08 Aligned_cols=251 Identities=19% Similarity=0.324 Sum_probs=200.5
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCC--CceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQH--PNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV 875 (1082)
..+|++.+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++++++| |||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 456999999999999999999888899999999975532 345778999999999987 9999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
||+ .+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++.+...
T Consensus 88 ~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 588999999874 4689999999999999999999999 999999999999997 578999999999876543
Q ss_pred CCc-cccCcccCCCcccchhccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH
Q 045553 956 ETH-ATTDVAGTFGYVAPEYAMT-----------CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML 1023 (1082)
Q Consensus 956 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1023 (1082)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .........
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~~ 233 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLHAI 233 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHHH
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------hHHHHHHHH
Confidence 332 2345679999999999865 678999999999999999999999996321 112222222
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... ......+.....++.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~---------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 IDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcC---------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 221 11112233344678999999999999999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=348.34 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=192.4
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999776 57899999997543 34668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---CCcEEEeecccceecCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla~~~~~ 954 (1082)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999863 4689999999999999999999999 9999999999999975 88999999999987643
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... ...... ..
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~i-~~~~~~-~~- 271 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER-------GDQFMFRRI-LNCEYY-FI- 271 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT-------CHHHHHHHH-HTTCCC-CC-
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc-------ccHHHHHHH-HhCCCc-cC-
Confidence 22 2334579999999999999999999999999999999999999996321 111122222 222111 00
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......+.++.+++.+|++.||++||++.|++++
T Consensus 272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112345689999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=345.34 Aligned_cols=245 Identities=25% Similarity=0.302 Sum_probs=195.9
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.++||+|+||+||+|... +|+.||||++..... .....+..|+..+.+. +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999776 689999999865432 2333455555555555 8999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 77999998875 45699999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..| ..+..+.....
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~--~~~~~~~~~~~---- 272 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGW--QQLRQGYLPPE---- 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHH--HHHTTTCCCHH----
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHH--HHHhccCCCcc----
Confidence 2334569999999999876 7899999999999999999998776421 111 11222211111
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+...+.++.+++.+|++.||++|||+.|++++
T Consensus 273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 112335689999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=348.96 Aligned_cols=253 Identities=22% Similarity=0.248 Sum_probs=198.8
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999765 689999999976533 236688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc--EEEeecccceecCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN--AYLSDFGLARLLGTSE 956 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfGla~~~~~~~ 956 (1082)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 98 ASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 9999999999763 4699999999999999999999999 9999999999999987765 9999999997543222
Q ss_pred CccccCcccCCCcccchhcccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDK-ADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
......||+.|+|||++.+..++.+ +||||+||++|||++|+.||..... .......+.........
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~------ 240 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----PRDYRKTIQRILSVKYS------ 240 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTCCC------
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhcCCCC------
Confidence 2234579999999999988887665 8999999999999999999974322 22333433333322110
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......+..+.+++.+|++.+|++|||+.|++++
T Consensus 241 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 ---IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 01111334678999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.30 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=202.4
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccC-CeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-AEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||.||+|+.. |+.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 457999999999999999999875 8999999987543 457789999999999999999999987654 578999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++++|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999999999875434488999999999999999999999 99999999999999999999999999998654322
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... .... ... +..+.
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~~~---~~~-~~~~~--------- 231 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDV---VPR-VEKGY--------- 231 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGH---HHH-HTTTC---------
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HHHH---HHH-HhcCC---------
Confidence 22357889999999999999999999999999999998 999986432 1111 111 11111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
....+...+..+.+++.+|++.||++||++.|+++.|++++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 112233455789999999999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=348.14 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=203.3
Q ss_pred hcCccccceecccCceEEEEEEEc-CCe----EEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGV----VVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
..+|++.+.||+|+||.||+|... +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 457999999999999999999754 344 4677777543 3355788999999999999999999999998754 88
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999999876 45689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 954 TSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 954 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ..... .+..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~----~~~~~~--- 236 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISS----ILEKGE--- 236 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHH----HHHTTC---
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHH----HHHcCC---
Confidence 43322 2333457889999999999999999999999999999999 9999974321 12211 122221
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
....+...+.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 237 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 ------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 112233455689999999999999999999999999998753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=352.65 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=168.2
Q ss_pred CCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccC
Q 045553 96 DKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIP 175 (1082)
Q Consensus 96 ~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 175 (1082)
.++.+.++. ..+++|+.|+++++.+. .+| .+..+++|++|+|++|.+++. |. +.++++|++|++++|++.+..+
T Consensus 34 ~~~~~~i~~--~~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~ 107 (466)
T 1o6v_A 34 TNVTDTVSQ--TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP 107 (466)
T ss_dssp SSTTSEECH--HHHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG
T ss_pred cccccccCh--hHhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh
Confidence 344555543 45678999999999988 466 488899999999999999954 44 8999999999999999996555
Q ss_pred ccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCC
Q 045553 176 AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255 (1082)
Q Consensus 176 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 255 (1082)
+..+++|++|++++|++++ ++. ...+++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+.. .+..++
T Consensus 108 --~~~l~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~ 177 (466)
T 1o6v_A 108 --LANLTNLTGLTLFNNQITD-IDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLT 177 (466)
T ss_dssp --GTTCTTCCEEECCSSCCCC-CGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCT
T ss_pred --hcCCCCCCEEECCCCCCCC-ChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCC
Confidence 8899999999999999884 443 3468889999999998885 33 48888888988886 4555333 388888
Q ss_pred CCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEc
Q 045553 256 NLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWA 335 (1082)
Q Consensus 256 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l 335 (1082)
+|++|++++|.+++. ..+..+++|++|++++|.+ .+..| ++.+++|+.|++
T Consensus 178 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l-------------------------~~~~~--~~~l~~L~~L~l 228 (466)
T 1o6v_A 178 TLERLDISSNKVSDI--SVLAKLTNLESLIATNNQI-------------------------SDITP--LGILTNLDELSL 228 (466)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC-------------------------CCCGG--GGGCTTCCEEEC
T ss_pred CCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcc-------------------------ccccc--ccccCCCCEEEC
Confidence 888888888888743 3466677777777765432 22222 444555555555
Q ss_pred CCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCc
Q 045553 336 PNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLT 389 (1082)
Q Consensus 336 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~ 389 (1082)
++|.+.+. ..+..+++|++|++++|++++..+ +..+++|+.|++++|+++
T Consensus 229 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 278 (466)
T 1o6v_A 229 NGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278 (466)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC
T ss_pred CCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccC
Confidence 55555543 234455555555555555553322 445555555555555544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=336.15 Aligned_cols=262 Identities=20% Similarity=0.271 Sum_probs=209.3
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeee-ccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYH-VSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 876 (1082)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +++.+|+++++.++|++++..+.++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 356899999999999999999975 57999999998765432 4688999999999998866666554 5667889999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE---cCCCcEEEeecccceecC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~~ 953 (1082)
||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Eec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999 99999999854 35699999999999999999999999 99999999999999 488899999999998775
Q ss_pred CCCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 954 TSETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 954 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch-hhhhhhhhhcccccCCc
Confidence 44331 234567999999999999999999999999999999999999999754322 11122222222211111
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.. .+ ....+.++.+++.+|++.+|++||++.||++.|+++.
T Consensus 239 -~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 239 -IE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -HH-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -hH-----HH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 00 00 1123467999999999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=348.62 Aligned_cols=267 Identities=19% Similarity=0.250 Sum_probs=205.0
Q ss_pred hcCccccceecccCceEEEEEEEc----CCeEEEEEEeecCccc-----------cHHHHHHHHHHHhccCCCceeeEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQ-----------GVQQFAAEIRTLGRVQHPNLVTLIG 864 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~ 864 (1082)
.++|++.+.||+|+||.||+|... ++..||||++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999775 5788999998765321 1234667889999999999999999
Q ss_pred eecc----CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-
Q 045553 865 YHVS----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL- 939 (1082)
Q Consensus 865 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~- 939 (1082)
++.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 9887 67899999999 999999998753 799999999999999999999999 999999999999999887
Q ss_pred -cEEEeecccceecCCCCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC
Q 045553 940 -NAYLSDFGLARLLGTSETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012 (1082)
Q Consensus 940 -~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 1012 (1082)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---- 265 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK---- 265 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT----
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc----
Confidence 9999999999877432211 12445799999999999999999999999999999999999999963211
Q ss_pred CccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1013 GFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
................ ...+.... .+...+.++.+++.+||+.+|++||++.+|++.|+++..+
T Consensus 266 ~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 266 DPVAVQTAKTNLLDEL-PQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp CHHHHHHHHHHHHHTT-THHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred ccHHHHHHHHhhcccc-cHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 1111222222222211 11111100 0113456899999999999999999999999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=345.26 Aligned_cols=269 Identities=23% Similarity=0.344 Sum_probs=216.6
Q ss_pred ccHHHHHHHhcCccccceecccCceEEEEEEE------cCCeEEEEEEeecCcc-ccHHHHHHHHHHHhcc-CCCceeeE
Q 045553 791 LTYENVVRATAGFNVQNCIGSGGFGATYKAEI------IPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLVTL 862 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l 862 (1082)
+.........++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 33444445567899999999999999999964 3468999999976533 3456789999999999 78999999
Q ss_pred eeeeccCC-eEEEEEeecCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecc
Q 045553 863 IGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPR--------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927 (1082)
Q Consensus 863 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 927 (1082)
++++...+ ..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987654 58999999999999999987542 1289999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCcEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 045553 928 IKPSNILLDNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDP 1005 (1082)
Q Consensus 928 lk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~ 1005 (1082)
|||+||+++.++.+||+|||+++....... .......|++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654333 22334567889999999999999999999999999999998 9999864
Q ss_pred CccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1006 SFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1006 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.... ..+......+... ..+...+.++.+++.+|++.+|++||++.||+++|+.+..
T Consensus 254 ~~~~--------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 254 VKID--------EEFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCCS--------HHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchh--------HHHHHHhccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3211 1112222222111 1223345679999999999999999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.28 Aligned_cols=251 Identities=23% Similarity=0.267 Sum_probs=208.0
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567999999999999999999765 477999999987666677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE---cCCCcEEEeecccceecCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~~~ 954 (1082)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999998874 4689999999999999999999999 99999999999999 7889999999999987654
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.. ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||... ...+..............
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~~~~~~~-- 228 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP--------TDSEVMLKIREGTFTFPE-- 228 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCH--
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCCCCCCc--
Confidence 33 23345799999999998764 899999999999999999999999642 122222222222110000
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.. ....+..+.+++.+|++.||++||++.|+++
T Consensus 229 -~~----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 -KD----WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -HH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -hh----hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0123568999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=337.37 Aligned_cols=262 Identities=20% Similarity=0.276 Sum_probs=205.1
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeee-ccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYH-VSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 876 (1082)
..++|++.+.||+|+||.||+|.. .+++.||||++...... +++.+|+++++.++|++++..+.++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999975 57899999987654322 3578899999999988877666655 5677889999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE---cCCCcEEEeecccceecC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~~ 953 (1082)
||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 99999999864 34699999999999999999999999 99999999999999 788999999999998875
Q ss_pred CCCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 954 TSETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 954 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh-hhhhhhhhhhcccccch
Confidence 44331 233567999999999999999999999999999999999999999754322 11122222222211110
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.. . . ....+.++.+++.+|++.+|++||++.||++.|+++.
T Consensus 239 -~~-~----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 239 -IE-V----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -HH-H----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -hh-h----h----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00 0 0 0122468999999999999999999999999998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=349.96 Aligned_cols=261 Identities=24% Similarity=0.276 Sum_probs=206.3
Q ss_pred HHHHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC-----ccccHHHHHHHHHHHhccCCCceeeEeeeecc
Q 045553 795 NVVRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG-----RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868 (1082)
Q Consensus 795 ~~~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 868 (1082)
++....++|++.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3456678899999999999999999976 46889999998653 23456789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCC--------------------------------------CCCCCHHHHHHHHHHHHH
Q 045553 869 EAEMFLIYNYLPGGNLEKFIQDRP--------------------------------------RRTVEWSMLHKIALDVAR 910 (1082)
Q Consensus 869 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~i~~ 910 (1082)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999985210 112467788899999999
Q ss_pred HHHHHhhCCCCCeEeccCCCCCEEEcCCC--cEEEeecccceecCCCCC---ccccCcccCCCcccchhccc--CCCCch
Q 045553 911 ALAYLHDECVPRVLHRDIKPSNILLDNNL--NAYLSDFGLARLLGTSET---HATTDVAGTFGYVAPEYAMT--CRVSDK 983 (1082)
Q Consensus 911 ~L~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~ 983 (1082)
||+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 899999999987643222 22345679999999999975 678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCC
Q 045553 984 ADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSS 1063 (1082)
Q Consensus 984 ~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~ 1063 (1082)
+||||||+++|||++|+.||... ...+.............. ......+..+.+++.+|++.+|++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGV--------NDADTISQVLNKKLCFEN-------PNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCTTS-------GGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCC--------ChHHHHHHHHhcccccCC-------cccccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999999632 222333333332211110 011224568999999999999999
Q ss_pred CCCHHHHHHH
Q 045553 1064 RPSMRQVAQQ 1073 (1082)
Q Consensus 1064 RPt~~ev~~~ 1073 (1082)
||++.|++++
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=341.57 Aligned_cols=250 Identities=23% Similarity=0.394 Sum_probs=209.5
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeecc---------
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--------- 868 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 868 (1082)
...+|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999775 68999999997654 346789999999999999999998754
Q ss_pred -------CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcE
Q 045553 869 -------EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941 (1082)
Q Consensus 869 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 941 (1082)
....++||||+++++|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 45589999999999999999876556799999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHH
Q 045553 942 YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
||+|||.+........ .....|++.|+|||++.+..++.++||||||+++|||++|..|+... ..+..
T Consensus 162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKFFT 229 (284)
T ss_dssp EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHHHH
T ss_pred EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHHHH
Confidence 9999999987754332 23456899999999999999999999999999999999999886421 11111
Q ss_pred HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1022 MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
....+.. +...+..+.+++.+|++.||++||++.|++++|+.++..
T Consensus 230 -~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 -DLRDGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -HHHTTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -Hhhcccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1122211 122345788999999999999999999999999988764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=353.96 Aligned_cols=256 Identities=28% Similarity=0.457 Sum_probs=196.8
Q ss_pred CccccceecccCceEEEEEEEc--CC--eEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeecc-CCeEEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII--PG--VVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-EAEMFLI 875 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV 875 (1082)
.|++.+.||+|+||.||+|... ++ ..||||.+.... ....++|.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4777899999999999999753 22 468999986533 3456789999999999999999999998654 5678999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999864 45688999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCc---cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 956 ETH---ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 956 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.... ...... . +..+...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-----~~~~~~---~-~~~~~~~- 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITV---Y-LLQGRRL- 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----SSCHHH---H-HHTTCCC-
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-----HHHHHH---H-HHcCCCC-
Confidence 221 2234467889999999999999999999999999999999 566665321 112222 1 1222111
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 316 --------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 316 --------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1233445689999999999999999999999999998743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=358.47 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=208.3
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999765 69999999996542 23356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999763 4699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+... ......... .+..
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~-~~~~----- 233 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTLFKKIC-DGIF----- 233 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHHHHHHHH-TTCC-----
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHh-cCCc-----
Confidence 2 2344579999999999988765 689999999999999999999997431 122222222 2211
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.....++.+++.+|++.||++|||+.|++++
T Consensus 234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1123344678999999999999999999999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=340.81 Aligned_cols=259 Identities=29% Similarity=0.459 Sum_probs=205.0
Q ss_pred hcCccccceecccCceEEEEEEEcC----CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeec-cCCeEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHV-SEAEMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~ 873 (1082)
..+|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568899999999999999997542 3468999987543 344577899999999999999999999854 556889
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999999764 45689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC---ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 954 TSET---HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 954 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
.... .......|++.|+|||.+.+..++.++||||+|+++|||++|+.|+..... ..... .... .+..
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~~~---~~~~-~~~~- 250 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDIT---VYLL-QGRR- 250 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC----TTTHH---HHHH-TTCC-
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC----HHHHH---HHHh-cCCC-
Confidence 4322 123345678899999999999999999999999999999995554332211 11111 1111 1111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...+...+..+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 251 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11123345679999999999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=352.63 Aligned_cols=270 Identities=18% Similarity=0.229 Sum_probs=216.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCC--eEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA--EMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV 875 (1082)
..+|++.++||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357999999999999999999765 48999999997543 344677889999999999999999999987654 78999
Q ss_pred EeecCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE----cCCCcEEEeecccce
Q 045553 876 YNYLPGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL----DNNLNAYLSDFGLAR 950 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGla~ 950 (1082)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998643 23499999999999999999999999 99999999999999 778889999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMT--------CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+.+..
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~----~~~~~~~~~ 238 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMYK 238 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT----TTCHHHHHH
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc----cchHHHHHH
Confidence 765432 2334679999999999865 56788999999999999999999999753322 122333333
Q ss_pred HHhcCCCccccc---------------cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1023 LLLQGRPCEFFT---------------AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1023 ~~~~~~~~~~~d---------------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
..... ...... .......+......+.+++.+|++.||++||++.|+++.++++..
T Consensus 239 ~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 239 IITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHSC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HhcCC-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 33332 211110 001112346778889999999999999999999999999988754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.15 Aligned_cols=254 Identities=27% Similarity=0.370 Sum_probs=206.7
Q ss_pred hcCccccc-eecccCceEEEEEEEc---CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 800 TAGFNVQN-CIGSGGFGATYKAEII---PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 800 ~~~~~~~~-~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
..+|++.+ .||+|+||.||+|... +++.||||++..... ...+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45688887 9999999999999543 368899999975432 2357799999999999999999999999 567789
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999999874 4689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcc--ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 954 TSETHA--TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 954 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
...... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.... +..+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~-~~~~~~~ 239 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAM-LEKGERM 239 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHH-HHTTCCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHH-HHcCCCC
Confidence 443321 223346788999999999889999999999999999999 999986421 1222222 2222111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+.+++.+||+.||++||++.||++.|+++
T Consensus 240 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 240 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12334567899999999999999999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=374.19 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=204.3
Q ss_pred Cccccc-eecccCceEEEEEEEc---CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 802 GFNVQN-CIGSGGFGATYKAEII---PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 802 ~~~~~~-~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++.+.+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999764 46789999997653 3457889999999999999999999999976 5699999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999765 45699999999999999999999999 99999999999999999999999999998765433
Q ss_pred Ccc--ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 957 THA--TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 957 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.... . .+.... +..+..
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~---~~~~~~-i~~~~~---- 557 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----G---PEVMAF-IEQGKR---- 557 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----S---HHHHHH-HHTTCC----
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-----H---HHHHHH-HHcCCC----
Confidence 221 222345689999999999999999999999999999998 999997432 1 122222 222221
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
...+...+.++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 558 -----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 558 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 123445667899999999999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.24 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=208.3
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999754 58999999997543 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc---EEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN---AYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfGla~~~ 952 (1082)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||.+...
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999988774 4689999999999999999999999 9999999999999986655 999999999876
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||... .................
T Consensus 159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--------~~~~~~~~~~~~~~~~~- 227 (284)
T 3kk8_A 159 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--------DQHRLYAQIKAGAYDYP- 227 (284)
T ss_dssp CSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCCC-
T ss_pred ccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC--------chhHHHHHHHhccccCC-
Confidence 5433 233467999999999999999999999999999999999999999632 22222222222211100
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. ......+.++.+++.+|++.+|++||++.|++++
T Consensus 228 -~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 -S-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -T-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -c-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0112334678999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=362.31 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=211.7
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456899999999999999999765 68999999996532 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.+++.......+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999876556699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............. ..
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~----~~~~~~i~~~i~~-~~------- 405 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK----KIKREEVERLVKE-VP------- 405 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS----CCCHHHHHHHHHH-CC-------
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc----chhHHHHHHHhhc-cc-------
Confidence 2 23345799999999999999999999999999999999999999975321 1122222222221 11
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
...+...+.++.+++.+|++.||++|| ++.||+++
T Consensus 406 ---~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 ---EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 112334556899999999999999999 78888754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=346.97 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=204.2
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
..|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999975 5789999999975432 33467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+. |++.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9996 6888888654 35789999999999999999999999 9999999999999999999999999999865432
Q ss_pred CccccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 957 THATTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
....||+.|+|||++. +..++.++|||||||++|||++|+.||... .............. ...
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~--------~~~~~~~~~~~~~~-~~~- 273 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNES-PAL- 273 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCC-CCC-
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHhcCC-CCC-
Confidence 2357999999999985 567899999999999999999999998632 22233333333221 111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL 1074 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 1074 (1082)
.+...+..+.+++.+||+.+|++|||+.|++++-
T Consensus 274 -------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 274 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1123456789999999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=341.90 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=208.7
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc------ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456999999999999999999765 589999999975432 1367899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC----cEEEeeccc
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL----NAYLSDFGL 948 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGl 948 (1082)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999863 4689999999999999999999999 999999999999999888 799999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+.........
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~- 234 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANITSVS- 234 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHTTC-
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhcc-
Confidence 98765432 223457999999999999999999999999999999999999999632 2223333222211
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. .++.. ....+..+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YD--FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC--CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc--cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 01111 01234578999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=348.69 Aligned_cols=260 Identities=23% Similarity=0.385 Sum_probs=212.6
Q ss_pred HhcCccccceecccCceEEEEEEEcC------CeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIP------GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 870 (1082)
..++|++.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999997642 2479999997653 23456789999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN 938 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 938 (1082)
..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 9999999999999999997532 34589999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccH
Q 045553 939 LNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNI 1016 (1082)
Q Consensus 939 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~ 1016 (1082)
+.+||+|||+++........ ......|++.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------- 273 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------- 273 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-------
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-------
Confidence 99999999999876443322 2334567889999999999999999999999999999998 88898643211
Q ss_pred HHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1017 VAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.........+.. ...+...+..+.+++.+|++.+|++||++.||++.|+++.
T Consensus 274 -~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 274 -SKFYKLVKDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp -HHHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 111222222211 1122334568999999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=338.24 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=203.4
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..+|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999975 468999999997532 34456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 876 YNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
|||+++++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999752 245689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||... ............ .......
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~-~~~~~~~- 258 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIE-QCDYPPL- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHH-TTCSCCC-
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc------chhHHHHHHHhh-cccCCCC-
Confidence 3322 223456899999999999999999999999999999999999998642 222333333332 2221111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.+...+.++.+++.+|++.||++||++.||++.|+++.+
T Consensus 259 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 259 -------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 112345689999999999999999999999999998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=342.16 Aligned_cols=271 Identities=24% Similarity=0.371 Sum_probs=202.1
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHH--HhccCCCceeeEeeeec-----cCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRT--LGRVQHPNLVTLIGYHV-----SEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~-----~~~~~ 872 (1082)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46799999999999999999976 58999999997543 3344444444 55689999999997443 33467
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC------VPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
++||||+++|+|.+++... ..++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 9999999999999999864 4589999999999999999999873 238999999999999999999999999
Q ss_pred ccceecCCCCC-------ccccCcccCCCcccchhccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC
Q 045553 947 GLARLLGTSET-------HATTDVAGTFGYVAPEYAMT-------CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012 (1082)
Q Consensus 947 Gla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 1012 (1082)
|+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.......
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987653221 12234579999999999987 45667899999999999999998887543222111
Q ss_pred C----------ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1013 G----------FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1013 ~----------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
. .....+............ +.... ......+..+.+++.+||+.||++|||+.||++.|+++..+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPK-FPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCC-CCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCC-CCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1 111111111111111111 11111 11234677899999999999999999999999999987643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=349.55 Aligned_cols=208 Identities=26% Similarity=0.349 Sum_probs=183.1
Q ss_pred ccccHHHHHHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccC-----CCceeeE
Q 045553 789 VQLTYENVVRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-----HPNLVTL 862 (1082)
Q Consensus 789 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l 862 (1082)
..+++++.....++|++.++||+|+||+||+|+. .+++.||||++... ....+.+..|+++++.++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3455555556678999999999999999999976 46899999998743 234566788999999986 9999999
Q ss_pred eeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-----
Q 045553 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN----- 937 (1082)
Q Consensus 863 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----- 937 (1082)
++++...+..++||||+ +++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 99999999999999999 99999999987666799999999999999999999999 9999999999999975
Q ss_pred --------------------CCcEEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHH
Q 045553 938 --------------------NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997 (1082)
Q Consensus 938 --------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ell 997 (1082)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 789999999999875432 23457899999999999999999999999999999999
Q ss_pred hCCCCCCC
Q 045553 998 SDKKALDP 1005 (1082)
Q Consensus 998 tg~~p~~~ 1005 (1082)
+|+.||..
T Consensus 254 ~g~~pf~~ 261 (360)
T 3llt_A 254 TGSLLFRT 261 (360)
T ss_dssp HSSCSCCC
T ss_pred HCCCCCCC
Confidence 99999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=339.39 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=201.6
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc-----ccHHHHHHHHHHHhccC---CCceeeEeeeeccC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF-----QGVQQFAAEIRTLGRVQ---HPNLVTLIGYHVSE 869 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 869 (1082)
..++|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999974 5689999999864321 12345667777776664 99999999998765
Q ss_pred C-----eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEe
Q 045553 870 A-----EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS 944 (1082)
Q Consensus 870 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 944 (1082)
. ..++||||+. ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999995 6999999987666699999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 945 DFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 945 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~ 235 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-----EADQLGKIFDLI 235 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-----HHHHHHHHHHHH
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHh
Confidence 999998664332 2344678999999999999999999999999999999999999996421 111111111111
Q ss_pred hcCCCccccc------cccCC--C-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 LQGRPCEFFT------AGLWD--C-----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ~~~~~~~~~d------~~l~~--~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......+.. ..... . ...+....+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111000000 00000 0 012345678999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.29 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=204.6
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
+.++|++.+.||+|+||.||+|... ++..||||++.... ......+.+|++++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467999999999999999999655 47799999986532 2335678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999874 4689999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||... .............
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~------- 223 (279)
T 3fdn_A 162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------TYQETYKRISRVE------- 223 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTC-------
T ss_pred c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC--------cHHHHHHHHHhCC-------
Confidence 2 223457899999999999999999999999999999999999999632 2222222222211
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...+...+..+.+++.+|++.+|++||++.|++++
T Consensus 224 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01233345678999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.81 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=206.5
Q ss_pred CccccceecccCceEEEEEEEcC-C---eEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE-EEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIP-G---VVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM-FLI 875 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lV 875 (1082)
.|++.++||+|+||+||+|...+ + ..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667999999999999997532 2 379999987543 24457789999999999999999999999876655 999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999874 45789999999999999999999999 9999999999999999999999999999866432
Q ss_pred CC---ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 956 ET---HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 956 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.. .......+++.|+|||.+.+..++.++||||+|+++|||++|+.|+..... ...... .. ..+..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~----~~~~~~---~~-~~~~~--- 246 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTH---FL-AQGRR--- 246 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----GGGHHH---HH-HTTCC---
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC----HHHHHH---Hh-hcCCC---
Confidence 21 223345678999999999999999999999999999999997766543211 112211 11 12111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
...+...+..+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1123344568999999999999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=362.15 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=199.0
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35799999999999999999965 46899999999753 223446678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999874 468999999999999999999998 7 999999999999999999999999999986432
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+..........
T Consensus 302 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~~~~------ 366 (446)
T 4ejn_A 302 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILMEEI------ 366 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCC------
T ss_pred CC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC--------CHHHHHHHHHhCCC------
Confidence 22 2334568999999999999999999999999999999999999999632 22333333332221
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
..+...+.++.+++.+|++.||++|| ++.|++++
T Consensus 367 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 -----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 12334456899999999999999999 99999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=354.81 Aligned_cols=250 Identities=18% Similarity=0.321 Sum_probs=200.4
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccC--CCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQ--HPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 876 (1082)
..|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999988789999999997543 334577899999999997 599999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
|+ .+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++.+....
T Consensus 136 E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 EC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred ec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 94 588999999874 4789999999999999999999999 999999999999995 5799999999998765433
Q ss_pred Cc-cccCcccCCCcccchhccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 957 TH-ATTDVAGTFGYVAPEYAMT-----------CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 957 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~~~~ 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLHAII 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHHHH
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHHHHh
Confidence 22 2345679999999999865 468999999999999999999999996321 1122222222
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... .....+.....++.+++.+||+.||++||++.||+++
T Consensus 282 ~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Ccc---------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 211 1111222334678999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.53 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=200.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357999999999999999999764 58999999987653 3456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE---cCCCcEEEeecccceec
Q 045553 878 YLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~ 952 (1082)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998653 245799999999999999999999999 99999999999999 45678999999999876
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.... ......|++.|+|||++. ..++.++||||+|+++|||++|+.||... ..................
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~--------~~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT--------SLEEVQQKATYKEPNYAV 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCC
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC--------CHHHHHhhhccCCccccc
Confidence 4332 233457899999999886 56899999999999999999999999632 222222222222111110
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. ....+.++.+++.+|++.||++||++.||+++
T Consensus 247 -~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 -E-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -c-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 01134578899999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=342.51 Aligned_cols=263 Identities=22% Similarity=0.389 Sum_probs=201.9
Q ss_pred HHHHhcCccccceecccCceEEEEEEEc----CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC
Q 045553 796 VVRATAGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE 869 (1082)
Q Consensus 796 ~~~~~~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 869 (1082)
+.....+|.+.+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3335677999999999999999999654 34589999987543 33456789999999999999999999998765
Q ss_pred C-----eEEEEEeecCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc
Q 045553 870 A-----EMFLIYNYLPGGNLEKFIQDR----PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN 940 (1082)
Q Consensus 870 ~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 940 (1082)
. ..++||||+++++|.+++... ....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 4 359999999999999999542 245799999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHH
Q 045553 941 AYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVA 1018 (1082)
Q Consensus 941 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 1018 (1082)
+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ..
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~--- 257 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----HE--- 257 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GG---
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----HH---
Confidence 999999999876443322 2233457889999999999999999999999999999999 8888864321 11
Q ss_pred HHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1019 WASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1019 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...... .+... ..+...+..+.+++.+|++.+|++||++.|++++|+++..
T Consensus 258 ~~~~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 258 MYDYLL-HGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHHHH-TTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH-cCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112222 11111 1223445689999999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=349.36 Aligned_cols=246 Identities=26% Similarity=0.315 Sum_probs=196.5
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHH-HhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRT-LGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56999999999999999999765 578999999976532 233456667766 5778999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999873 4689999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....+.... .
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~-~------ 256 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------NTAEMYDNILNKP-L------ 256 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--------BHHHHHHHHHHSC-C------
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhcc-c------
Confidence 2 2344568999999999999999999999999999999999999999632 2233333333221 1
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
..+...+..+.+++.+|++.||++||++.+.+
T Consensus 257 ----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 ----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 12233456789999999999999999985433
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.06 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=203.0
Q ss_pred hcCccccceecccCceEEEEEEEc--CC--eEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII--PG--VVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
..+|++.+.||+|+||.||+|++. ++ ..||||++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999753 23 36899998654 2344678899999999999999999999998765 8
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 8999999999999999864 34689999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 953 GTSETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 953 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+........+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~~ 243 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEGER 243 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC--------CHHHHHHHHHccCCC
Confidence 544332 2233467889999999999889999999999999999999 99998632 223333333332211
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
. ..+...+..+.+++.+|++.+|++||++.++++.|+++++..
T Consensus 244 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 244 L---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred C---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 1 122345578999999999999999999999999999987653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.61 Aligned_cols=250 Identities=25% Similarity=0.418 Sum_probs=186.9
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45799999999999999999976 468999999986432 22346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999864 35789999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.. ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... . ... .....
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~---~~~---------~~~~~ 227 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-----N---TLN---------KVVLA 227 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCSS
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-----H---HHH---------HHhhc
Confidence 22 223456899999999999989999999999999999999999999743211 0 000 00000
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ..+...+.++.+++.+|++.||++||++.|++++
T Consensus 228 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 DY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00 1233445688999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=348.20 Aligned_cols=262 Identities=16% Similarity=0.248 Sum_probs=208.1
Q ss_pred hcCccccceecccCceEEEEEEEcC---------CeEEEEEEeecCccccHHHHHHHHHHHhccCCCceee---------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP---------GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT--------- 861 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 861 (1082)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3579999999999999999997653 789999998754 35789999999999999987
Q ss_pred ------Eeeeecc-CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEE
Q 045553 862 ------LIGYHVS-EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNIL 934 (1082)
Q Consensus 862 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nil 934 (1082)
+++++.. ....++||||+ +++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 5566654 67889999999 99999999976456799999999999999999999999 9999999999999
Q ss_pred EcCCC--cEEEeecccceecCCCCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 045553 935 LDNNL--NAYLSDFGLARLLGTSETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPS 1006 (1082)
Q Consensus 935 l~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~ 1006 (1082)
++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876533221 223457999999999999999999999999999999999999999753
Q ss_pred ccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1007 FCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
... ............. ......+... .....+.++.+++.+|++.||++||++.||++.|+++.
T Consensus 272 ~~~---~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 272 LPN---TEDIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TTC---HHHHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CcC---HHHHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 211 1222222222211 1122211111 01123468999999999999999999999999998874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=343.96 Aligned_cols=257 Identities=29% Similarity=0.412 Sum_probs=206.7
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeE--EEEEEeecC-ccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVV--VAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 874 (1082)
.++|++.+.||+|+||.||+|+. .++.. ||+|++... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 35799999999999999999964 45664 499988753 233456789999999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc
Q 045553 875 IYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN 940 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 940 (1082)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999998643 24799999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHH
Q 045553 941 AYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 941 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||... ...+.
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--------~~~~~ 250 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAEL 250 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHH
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC--------cHHHH
Confidence 999999999753221 12223457889999999999899999999999999999998 99999632 22222
Q ss_pred HHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1020 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.... ..+. ....+...+..+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 251 ~~~~-~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 251 YEKL-PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HHHG-GGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh-hcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2221 1211 112233455789999999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=344.27 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=205.1
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
..++|++.+.||+|+||.||+|... +++.||||++...... ..+|++++.++ +||||+++++++.+....|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999765 6899999999765433 35678888877 7999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC----CcEEEeecccceec
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN----LNAYLSDFGLARLL 952 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfGla~~~ 952 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++..+ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999864 4699999999999999999999999 99999999999998533 35999999999876
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....+....... +...
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~-~~~~-- 241 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-----DDTPEEILARIGS-GKFS-- 241 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-----TSCHHHHHHHHHH-CCCC--
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-----cCCHHHHHHHHcc-CCcc--
Confidence 54332 2344678999999999998889999999999999999999999997421 2233333333322 2211
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.........+.++.+++.+|++.||++||++.|++++
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111223445689999999999999999999998764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=348.82 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=208.9
Q ss_pred hcCccccceecccCceEEEEEEE----cCCeEEEEEEeecCc----cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI----IPGVVVAVKRLSVGR----FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 870 (1082)
..+|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35799999999999999999977 368999999986432 12345577899999999 6999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999874 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
.+............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...............
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHCC-
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc----cchHHHHHHHHhccC-
Confidence 775444444455679999999999986 4578999999999999999999999974321 223333333332221
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQL 1074 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~L 1074 (1082)
...+...+..+.+++.+|++.||++|| ++.|++++.
T Consensus 283 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 112334556889999999999999999 999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=343.44 Aligned_cols=250 Identities=24% Similarity=0.290 Sum_probs=182.9
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
+.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999765 5899999998643 3467789999999997 99999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC---cEEEeecccceecCCCCCcccc
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL---NAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++....... ...
T Consensus 94 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 94 FERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 9999874 5699999999999999999999999 999999999999997765 899999999987654322 234
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 1041 (1082)
...||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ......+.... +..+... .....
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~-i~~~~~~------~~~~~ 239 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKK-IKKGDFS------FEGEA 239 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHH-HTTTCCC------CCSHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHH-HHcCCCC------CCccc
Confidence 4578999999999999999999999999999999999999997533211 11222222222 2222111 00000
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1042 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+.++.+++.+|++.||++||++.|++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12345689999999999999999999998753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=351.40 Aligned_cols=213 Identities=23% Similarity=0.291 Sum_probs=126.9
Q ss_pred cCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCccccccccccc
Q 045553 131 GQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLE 210 (1082)
Q Consensus 131 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~ 210 (1082)
..+++|+.|++++|.++ .+|. +..+++|++|+|++|++++..+ +..+++|++|++++|++.+. +. + ..+++|+
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~-~~l~~L~ 115 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-TP-L-ANLTNLT 115 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-G-TTCTTCC
T ss_pred hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccC-hh-h-cCCCCCC
Confidence 34678899999999888 4664 7888999999999998886544 78888888888888887733 32 2 3466666
Q ss_pred EEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEecccc
Q 045553 211 HILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDY 290 (1082)
Q Consensus 211 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~ 290 (1082)
+|++++|++++. +. +.++++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+.. .+..+++|++|++
T Consensus 116 ~L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l---- 184 (466)
T 1o6v_A 116 GLTLFNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDI---- 184 (466)
T ss_dssp EEECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEEC----
T ss_pred EEECCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEEC----
Confidence 666666666643 22 5566666666666666653 22 35555666666654 3333221 1444455555554
Q ss_pred CCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCc
Q 045553 291 GPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPA 370 (1082)
Q Consensus 291 ~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~ 370 (1082)
++|.+.+. ..+..+++|++|++++|++++..|
T Consensus 185 ---------------------------------------------~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~- 216 (466)
T 1o6v_A 185 ---------------------------------------------SSNKVSDI--SVLAKLTNLESLIATNNQISDITP- 216 (466)
T ss_dssp ---------------------------------------------CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred ---------------------------------------------cCCcCCCC--hhhccCCCCCEEEecCCccccccc-
Confidence 44444443 234555566666666666654333
Q ss_pred cccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcc
Q 045553 371 SLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLL 411 (1082)
Q Consensus 371 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l 411 (1082)
+..+++|+.|++++|++++. +....+++|+.|++++|.+
T Consensus 217 -~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l 255 (466)
T 1o6v_A 217 -LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQI 255 (466)
T ss_dssp -GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCC
T ss_pred -ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCcc
Confidence 45556666666666665543 2222345555555555544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=345.28 Aligned_cols=243 Identities=23% Similarity=0.331 Sum_probs=204.9
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc--------ccHHHHHHHHHHHhccCCCceeeEeeeeccC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF--------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE 869 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 869 (1082)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456799999999999999999964 5689999999976532 1234577899999999999999999999999
Q ss_pred CeEEEEEeecCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 870 AEMFLIYNYLPGG-NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 870 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
+..++||||+.+| +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 999999874 4699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------ 236 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------ 236 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence 987754332 234579999999999988776 88999999999999999999999642110
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..... ..+...+.++.+++.+|++.||++||++.|++++
T Consensus 237 -----~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 1122345679999999999999999999999885
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=341.71 Aligned_cols=263 Identities=18% Similarity=0.236 Sum_probs=210.4
Q ss_pred ccHHHHHHHhcCcccc-ceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccC-CCceeeEeee
Q 045553 791 LTYENVVRATAGFNVQ-NCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQ-HPNLVTLIGY 865 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~ 865 (1082)
+.+.......++|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444555667788887 89999999999999765 58999999987543 344678899999999995 6999999999
Q ss_pred eccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---CCcEE
Q 045553 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAY 942 (1082)
Q Consensus 866 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~k 942 (1082)
+.+....++||||+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999999776567899999999999999999999999 9999999999999998 78999
Q ss_pred EeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH
Q 045553 943 LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 943 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
|+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... .......
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~ 244 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------NQETYLN 244 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------chHHHHH
Confidence 99999998765332 2234579999999999999999999999999999999999999996421 1222222
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...... . .........+..+.+++.+|++.||++|||+.|++++
T Consensus 245 i~~~~~-~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVNV-D------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTCC-C------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhccc-c------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 221110 0 0111122345678999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=356.98 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=210.4
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56889999999999999999765 68999999996542 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 877 NYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999998653 44699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............... .
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~----~~~~~~~~~~i~~~~-~----- 410 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRVLEQA-V----- 410 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC----CCCHHHHHHHHHHCC-C-----
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc----chhHHHHHHHHhhcc-c-----
Confidence 332 23445899999999999999999999999999999999999999975321 122333333333221 1
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSM-----RQVAQ 1072 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~ 1072 (1082)
..+...+..+.+++.+|++.||++||++ .||.+
T Consensus 411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1234456789999999999999999975 55553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=351.01 Aligned_cols=253 Identities=21% Similarity=0.245 Sum_probs=194.2
Q ss_pred hcCcccc-ceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHH-hccCCCceeeEeeeecc----CCeE
Q 045553 800 TAGFNVQ-NCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTL-GRVQHPNLVTLIGYHVS----EAEM 872 (1082)
Q Consensus 800 ~~~~~~~-~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 872 (1082)
.++|.+. +.||+|+||+||+|... +++.||||++... ..+.+|++++ +..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3467766 78999999999999754 6899999998632 4567788886 45589999999998765 5678
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---CCcEEEeecccc
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLA 949 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla 949 (1082)
|+||||+++|+|.+++.......+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999999876556799999999999999999999999 9999999999999997 789999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... .+..+..
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~----~i~~~~~ 284 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKT----RIRMGQY 284 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-CCSHHH----HHHHTCC
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-cHHHHH----HHHcCcc
Confidence 8764322 23456789999999999999999999999999999999999999975432210 111111 1112211
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. . .. ......+.++.+++.+|++.||++|||+.|++++
T Consensus 285 ~-~-~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 E-F-PN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C-C-CT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-C-CC----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 0 00 0112345689999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=341.20 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=207.1
Q ss_pred hcCccccceecccCceEEEEEEE------cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI------IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
..+|++.+.||+|+||.||+|+. .++..||||++.... .....++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999963 347789999996442 34456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---CCcEEEe
Q 045553 873 FLIYNYLPGGNLEKFIQDRPR-----RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLS 944 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~ 944 (1082)
++||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999987532 4589999999999999999999999 9999999999999984 4569999
Q ss_pred ecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHH
Q 045553 945 DFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 945 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
|||+++....... .......|++.|+|||++.+..++.++||||||+++|||++ |+.||... ........
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------SNQEVLEF 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--------CHHHHHHH
Confidence 9999976533222 22233567899999999999999999999999999999998 88888632 22233332
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..... .. ..+...+..+.+++.+||+.+|++||++.||+++|+.+.
T Consensus 258 ~~~~~-~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 258 VTSGG-RM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHTTC-CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCC-CC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 22221 11 122344568999999999999999999999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=345.46 Aligned_cols=250 Identities=16% Similarity=0.165 Sum_probs=204.9
Q ss_pred HhcCccccceecccCceEEEEE------EEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC---CCceeeEeeeeccC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKA------EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ---HPNLVTLIGYHVSE 869 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a------~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 869 (1082)
...+|.+.+.||+|+||+||+| ...+++.||||++... ...++.+|++++++++ |+|++++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 3467999999999999999999 3556899999998754 3456777888888776 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---------
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDR---PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN--------- 937 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--------- 937 (1082)
+..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999752 245799999999999999999999999 9999999999999998
Q ss_pred --CCcEEEeecccceecCC-CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCc
Q 045553 938 --NLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGF 1014 (1082)
Q Consensus 938 --~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~ 1014 (1082)
++.+||+|||+|+.+.. ..........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----- 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG----- 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence 89999999999986642 2233445567999999999999999999999999999999999999998643211
Q ss_pred cHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHhhh
Q 045553 1015 NIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSR-PSMRQVAQQLKQI 1077 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~ev~~~L~~i 1077 (1082)
...++..+.. . .....+.+++..|++.+|.+| |++.++.+.|+++
T Consensus 292 ---------------~~~~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 292 ---------------ECKPEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------EEEECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------ceeechhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0001111111 1 225578889999999999998 6888888888764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=331.87 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=204.2
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc------ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999765 689999999875432 24678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC----cEEEeecccc
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL----NAYLSDFGLA 949 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGla 949 (1082)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||.+
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999763 4689999999999999999999999 999999999999998877 8999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||... ...+......... .
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~ 228 (283)
T 3bhy_A 160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE--------TKQETLTNISAVN-Y 228 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTTC-C
T ss_pred eeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc--------chHHHHHHhHhcc-c
Confidence 87644322 23456899999999999999999999999999999999999999632 1122222221111 1
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. .+... ....+..+.+++.+|++.||++||++.|++++
T Consensus 229 ~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 D--FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C--CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred C--Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 00000 11234678999999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=337.00 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=200.2
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999765 589999999865433 235668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999988763 4689999999999999999999999 999999999999999999999999999987653322
Q ss_pred ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc----------
Q 045553 958 HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ---------- 1026 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 1026 (1082)
......|+..|+|||++.+ ..++.++||||+|+++|||++|+.||..... ......+......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHHHH
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhcccccccccccc
Confidence 2234578999999999976 6689999999999999999999999964321 1111111111110
Q ss_pred -CCCc---cccccccCCC---CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1027 -GRPC---EFFTAGLWDC---GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1027 -~~~~---~~~d~~l~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... ...++..... .....+..+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0000000000 002345678999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=344.86 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=191.0
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeee--------ccC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYH--------VSE 869 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~--------~~~ 869 (1082)
..+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.+++++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999754 68999999997766666778999999999996 99999999988 344
Q ss_pred CeEEEEEeecCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeccCCCCCEEEcCCCcEEEeec
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDR-PRRTVEWSMLHKIALDVARALAYLHDECVPR--VLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
...++||||+. |+|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 56899999995 7999988752 245699999999999999999999999 8 999999999999999999999999
Q ss_pred ccceecCCCCCc-----------cccCcccCCCcccchhc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC
Q 045553 947 GLARLLGTSETH-----------ATTDVAGTFGYVAPEYA---MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012 (1082)
Q Consensus 947 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 1012 (1082)
|+++........ ......||+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 999876543221 11134689999999998 5677899999999999999999999999632110
Q ss_pred CccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1013 GFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.. +........+......+.+++.+|++.+|++||++.|++++|+.+.
T Consensus 260 -----~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 260 -----RI-------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----Hh-------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0011111111222345889999999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=335.87 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=205.7
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
..++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3457999999999999999999765 689999999986655555678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE---cCCCcEEEeecccceecCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~~~ 954 (1082)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999999764 4689999999999999999999999 99999999999999 7889999999999976432
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. ......|++.|+|||++.+..++.++||||+|+++|||++|+.||... ........... +... ..
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~i~~-~~~~--~~ 227 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE--------TESKLFEKIKE-GYYE--FE 227 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHH-CCCC--CC
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHc-CCCC--CC
Confidence 2 223346899999999999999999999999999999999999999642 12222222222 2111 01
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......+..+.+++.+|++.||++||++.|++++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 ----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11123345689999999999999999999999863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=367.66 Aligned_cols=247 Identities=28% Similarity=0.389 Sum_probs=201.4
Q ss_pred ceecccCceEEEEEEEc---CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEII---PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 468899999976432 346789999999999999999999999864 568999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC--cc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET--HA 959 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~--~~ 959 (1082)
|+|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999874 5689999999999999999999999 999999999999999999999999999987754332 22
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||... ...+.... +..+..
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--------~~~~~~~~-i~~~~~--------- 590 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTAM-LEKGER--------- 590 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHH-HHTTCC---------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH-HHcCCC---------
Confidence 233456789999999999999999999999999999998 99999642 12222222 222221
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
...+...+.++.+++.+||+.||++||++.+|++.|+++
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 123345567899999999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=347.84 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=193.8
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC--ccccHHHHHHHHHHHhccC-CCceeeEeeeeccC--CeE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSE--AEM 872 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~ 872 (1082)
...+|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++++. ||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 467899999999999999999965 46899999998643 2344567889999999997 99999999998754 478
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
|+||||++ ++|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999996 6999999863 689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC--------------------CccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCC
Q 045553 953 GTSE--------------------THATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFG 1011 (1082)
Q Consensus 953 ~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~ 1011 (1082)
.... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---- 235 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS---- 235 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 4311 112344679999999999986 678999999999999999999999997431
Q ss_pred CCccHHHHHHHHHh-cCCCc-cccc----------------------cccCC------------CCChHHHHHHHHHHHH
Q 045553 1012 NGFNIVAWASMLLL-QGRPC-EFFT----------------------AGLWD------------CGPHDDLIEMLNLAIM 1055 (1082)
Q Consensus 1012 ~~~~~~~~~~~~~~-~~~~~-~~~d----------------------~~l~~------------~~~~~~~~~l~~li~~ 1055 (1082)
....+..+.. -+... +.+. ..... ..+.....++.+++.+
T Consensus 236 ----~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 236 ----TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp ----HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred ----HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 1111111111 01000 0000 00000 0011234678999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 045553 1056 CTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1056 cl~~~p~~RPt~~ev~~~ 1073 (1082)
|++.||++|||+.|++++
T Consensus 312 ~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKH 329 (388)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred hhccCcccCCCHHHHhCC
Confidence 999999999999999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=357.00 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=196.6
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccC------C
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------A 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 870 (1082)
.++|++.+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999964 46899999999754 234456788999999999999999999998654 4
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999965 57777653 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...++......-+...
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~-------~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-------YIDQWNKVIEQLGTPC 283 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHHHCSCC
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHhcCCCC
Confidence 76432 23345689999999999999999999999999999999999999997421 1222222211111110
Q ss_pred -ccc--------------------------ccccCCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 -EFF--------------------------TAGLWDCG---PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 -~~~--------------------------d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.+ ...+.... ......++.+++.+|++.||++|||+.|++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000 01125679999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=333.62 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=208.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457999999999999999999765 57899999986542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999998763 4689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.. ......|++.|+|||++.+..++.++||||+|+++|||++|+.||... ...+...... .+..
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~-~~~~------ 232 (294)
T 2rku_A 169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--------CLKETYLRIK-KNEY------ 232 (294)
T ss_dssp TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHH-TTCC------
T ss_pred cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHh-hccC------
Confidence 22 233457899999999999988999999999999999999999999642 1222222222 1111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|++.||++||++.|++++
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1223344678999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.61 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=208.1
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeec--cCCeEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHV--SEAEMFL 874 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l 874 (1082)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457999999999999999999765 68999999997543 234567899999999999999999999874 4678999
Q ss_pred EEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEeccCCCCCEEEcCCCcEEEeecc
Q 045553 875 IYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPR-----VLHRDIKPSNILLDNNLNAYLSDFG 947 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlk~~Nill~~~~~~kl~DfG 947 (1082)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997632 34589999999999999999999998 7 9999999999999999999999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
.++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||... ...+.... +..+
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~-i~~~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELAGK-IREG 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHH-HHHT
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc--------CHHHHHHH-Hhhc
Confidence 9987643322 222346899999999999999999999999999999999999998742 12222222 2222
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
... ..+...+.++.+++.+|++.+|++||++.||++++..-.
T Consensus 232 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 KFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ccc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 221 122344568999999999999999999999998775443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=331.93 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=207.8
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467999999999999999999765 68999999997543 244577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..+....
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999875 34689999999999999999999999 99999999999999999999999999998764332
Q ss_pred C-ccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 957 T-HATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 957 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. .......|+..|+|||++.+..+ +.++||||+|+++|||++|+.||...... ......| .......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~~~---- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDW----KEKKTYL---- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHHHHH----HTTCTTS----
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHh----hhccccc----
Confidence 2 22345678999999999987665 77999999999999999999999743211 1112121 1111000
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+..+.+++.+|++.||++|||+.|++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1112345678999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.83 Aligned_cols=246 Identities=23% Similarity=0.315 Sum_probs=201.8
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 874 (1082)
..++|++.+.||+|+||+||+|... +++.||||++.... .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999765 68999999997642 33456788999999999 99999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC--------------
Q 045553 875 IYNYLPGGNLEKFIQDRP--RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-------------- 938 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-------------- 938 (1082)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999998642 25689999999999999999999999 99999999999999844
Q ss_pred -----CcEEEeecccceecCCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC
Q 045553 939 -----LNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012 (1082)
Q Consensus 939 -----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 1012 (1082)
..+||+|||.+....... ...|++.|+|||++.+. .++.++||||||+++|||++|..++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 479999999998765432 23589999999999875 5678999999999999999998776421
Q ss_pred CccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1013 GFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. + ..+..+... ..+...+..+.+++.+|++.||++||++.|++++
T Consensus 235 -~~---~--~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 -DQ---W--HEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HH---H--HHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -hH---H--HHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11 1 112222221 1223345689999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=340.01 Aligned_cols=249 Identities=20% Similarity=0.287 Sum_probs=208.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457999999999999999999765 47899999987542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999998863 4689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||... ...+......... .
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~~~~~~-~------ 258 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--------CLKETYLRIKKNE-Y------ 258 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTC-C------
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC--------CHHHHHHHHhcCC-C------
Confidence 22 234457999999999999999999999999999999999999999632 1222222222211 1
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|++.||++||++.|++++
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122344578999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=330.83 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=206.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357999999999999999999765 57899999986532 23356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999999874 4689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||... ........... ...
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~~~~-~~~------ 229 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP--------SHTETHRRIVN-VDL------ 229 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHT-TCC------
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC--------CHhHHHHHHhc-ccc------
Confidence 2 23457899999999999999999999999999999999999999632 11222222221 111
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+...+..+.+++.+|++.+|++||++.|+++
T Consensus 230 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 ----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 123344568899999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=343.45 Aligned_cols=263 Identities=22% Similarity=0.256 Sum_probs=201.6
Q ss_pred hcCcccc-ceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQ-NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~-~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.+.|++. +.||+|+||.||+|.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4568884 7899999999999964 46899999999876666678899999999884 7999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc---EEEeecccceecC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN---AYLSDFGLARLLG 953 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfGla~~~~ 953 (1082)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999874 4689999999999999999999999 9999999999999998776 9999999997654
Q ss_pred CCCC------ccccCcccCCCcccchhccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCC---c---cH
Q 045553 954 TSET------HATTDVAGTFGYVAPEYAMT-----CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNG---F---NI 1016 (1082)
Q Consensus 954 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~---~---~~ 1016 (1082)
.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......... . ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 12223569999999999875 557889999999999999999999997543221000 0 00
Q ss_pred HHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1017 VAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......+..+... ..+. . ....+..+.+++.+|++.||++||++.|++++
T Consensus 246 ~~~~~~~i~~~~~~-~~~~-~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKYE-FPDK-D----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCCC-CCHH-H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCcc-cCch-h----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111222222111 0000 0 01234679999999999999999999999874
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=355.59 Aligned_cols=176 Identities=22% Similarity=0.180 Sum_probs=88.7
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCC
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 265 (1082)
.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 15 ~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp EEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 3444444444 4444432 34555555555555444555555555555555555555544555555555555555555
Q ss_pred cCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCC
Q 045553 266 FLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFP 345 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~ 345 (1082)
++++..+..|..+++|++|++++| .+.+..|..|..+++|++|++++|.+.++.+
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n-------------------------~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 145 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISEN-------------------------KIVILLDYMFQDLYNLKSLEVGDNDLVYISH 145 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTS-------------------------CCCEECTTTTTTCTTCCEEEECCTTCCEECT
T ss_pred cCCccCcccccCCCCCCEEECCCC-------------------------ccccCChhHccccccCCEEECCCCccceeCh
Confidence 555444444445555555554442 2222233344444444444444445544444
Q ss_pred cccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcc
Q 045553 346 QNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390 (1082)
Q Consensus 346 ~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~ 390 (1082)
..|..+++|++|+|++|++++..+..|.++++|+.|+|++|.+.+
T Consensus 146 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~ 190 (477)
T 2id5_A 146 RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA 190 (477)
T ss_dssp TSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred hhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence 455555555555555555554444445555555555555555543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=343.36 Aligned_cols=136 Identities=21% Similarity=0.232 Sum_probs=93.3
Q ss_pred CCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEE
Q 045553 108 DLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187 (1082)
Q Consensus 108 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 187 (1082)
.+.+|+.|++++|.++...+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|+.+++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 36788899999988885444457888889999998888887667788888888888888888887777777777777777
Q ss_pred EcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcC
Q 045553 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267 (1082)
Q Consensus 188 ~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 267 (1082)
+|++|+++ .+|..+ |.++++|++|++++|++++..+..|..+++|++|++++|++
T Consensus 123 ~L~~n~l~-~l~~~~------------------------~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 177 (390)
T 3o6n_A 123 VLERNDLS-SLPRGI------------------------FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177 (390)
T ss_dssp ECCSSCCC-CCCTTT------------------------TTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCC
T ss_pred ECCCCccC-cCCHHH------------------------hcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcC
Confidence 77777766 444433 33444455555555555444444455555555555555555
Q ss_pred c
Q 045553 268 S 268 (1082)
Q Consensus 268 ~ 268 (1082)
+
T Consensus 178 ~ 178 (390)
T 3o6n_A 178 T 178 (390)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=338.03 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=208.6
Q ss_pred HHHHHHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--------ccHHHHHHHHHHHhcc-CCCceeeEe
Q 045553 794 ENVVRATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--------QGVQQFAAEIRTLGRV-QHPNLVTLI 863 (1082)
Q Consensus 794 ~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~ 863 (1082)
.......++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999875 699999999875431 1145678999999999 799999999
Q ss_pred eeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEE
Q 045553 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL 943 (1082)
Q Consensus 864 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 943 (1082)
+++......++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999863 4689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCccccCcccCCCcccchhccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHH
Q 045553 944 SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT------CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 1017 (1082)
+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--------~~~ 311 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--------RQI 311 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHH
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC--------CHH
Confidence 9999998775432 2344679999999999863 35788999999999999999999999632 112
Q ss_pred HHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....... .+..... .+ .. ...+..+.+++.+|++.||++||++.|++++
T Consensus 312 ~~~~~i~-~~~~~~~-~~-~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 312 LMLRMIM-EGQYQFS-SP-EW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHH-HTCCCCC-HH-HH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHH-hCCCCCC-Cc-cc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2222222 2211100 00 00 1224578999999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=328.34 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=199.4
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357999999999999999999765 68999999986542 23456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999999874 4689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
. ......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||+.. .......... .+..
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~-~~~~----- 228 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE--------HVPTLFKKIR-GGVF----- 228 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHH-HCCC-----
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHhh-cCcc-----
Confidence 2 2234568999999999988765 68999999999999999999999642 1222222222 2111
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|++.||++||++.|++++
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1123345678999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.55 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=195.3
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+....++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 356799999999999999999964 4689999999975433 2245678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc-----CCCcEEEeecccce
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-----NNLNAYLSDFGLAR 950 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-----~~~~~kl~DfGla~ 950 (1082)
|||++ |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99996 5999999875 3589999999999999999999999 999999999999994 55569999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-cCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-QGR 1028 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1028 (1082)
....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....... .+.
T Consensus 186 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 186 AFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--------EIDQLFKIFEVLGL 256 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCC
T ss_pred ccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--------HHHHHHHHHHHhCC
Confidence 7653322 23345689999999999874 48999999999999999999999996421 1111222111 111
Q ss_pred Cccc-c----c--------cccCCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEF-F----T--------AGLWDC-----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~-~----d--------~~l~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... . . +..... .+.....++.+++.+|++.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 0 0 000000 011134678999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=343.52 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=204.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356999999999999999999765 68999999997653 3445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999999874 46899999999999999999999832 7999999999999999999999999999755322
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCC---------------------------
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSF--------------------------- 1010 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~--------------------------- 1010 (1082)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 2234578999999999999999999999999999999999999997432100
Q ss_pred -------CCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1011 -------GNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1011 -------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
................. . ....+...+.++.+++.+|++.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEP-P--------PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSC-C--------CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccC-C--------CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000111110000 0 000112235679999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.45 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=208.9
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
...|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45699999999999999999965 468999999997653 3456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 9999999999975 4689999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......|++.|+|||++.+..++.++||||||+++|||++|+.||... .......... .+...
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~-~~~~~------- 237 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL--------HPMKVLFLIP-KNNPP------- 237 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHH-HSCCC-------
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc--------CHHHHHHHhh-cCCCC-------
Confidence 234457899999999999999999999999999999999999998632 1122222221 22111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+..+.+++.+|++.+|++||++.|++++
T Consensus 238 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 --TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp --CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred --CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1122334679999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=350.49 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=207.5
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCC-CceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH-PNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.++||+|+||.||+|.. .+++.||||++...... .++.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999975 56899999988755332 357889999999987 556666667777888999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE---cCCCcEEEeecccceecCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~~~ 954 (1082)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 84 ~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 99999999865 45699999999999999999999999 99999999999999 6889999999999998754
Q ss_pred CCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 955 SETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 955 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
.... ......||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+.......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~- 232 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKK- 232 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----SHHHHHHHHHHHH-
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----hHHHHHHHHhhcc-
Confidence 4332 123567999999999999999999999999999999999999999753221 1112111111110
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
....++ .+ ....+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 233 ~~~~~~-~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 233 VATSIE-AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHSCHH-HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccHH-HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000000 00 012346899999999999999999999999999876
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=335.56 Aligned_cols=254 Identities=22% Similarity=0.407 Sum_probs=203.8
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4568999999999999999999775 589999999987766677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999998764 35689999999999999999999999 99999999999999999999999999875432111
Q ss_pred ccccCcccCCCcccchhc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 958 HATTDVAGTFGYVAPEYA-----MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.......|++.|+|||++ .+..++.++||||||+++|||++|+.||... ............. ....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~~~~ 242 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSD-PPTL 242 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSC-CCCC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC--------CHHHHHHHHhccC-Cccc
Confidence 112335689999999998 3667899999999999999999999998732 2222223322222 1111
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+..+.+++.+|++.+|++||++.|++++
T Consensus 243 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 -------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1123445689999999999999999999999763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.59 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=203.8
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc----cccHHHHHHHHHHHhccCCCceeeEeeeec--cCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR----FQGVQQFAAEIRTLGRVQHPNLVTLIGYHV--SEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 872 (1082)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999975 468899999997542 234577899999999999999999999884 45688
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++||||++++ +.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999765 88888876677899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-ccccCcccCCCcccchhcccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 953 GTSET-HATTDVAGTFGYVAPEYAMTCR--VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 953 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
..... .......|++.|+|||++.+.. ++.++||||+|+++|||++|+.||... ...+....... +..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~i~~-~~~ 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD--------NIYKLFENIGK-GSY 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHH-CCC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc--------hHHHHHHHHhc-CCC
Confidence 53222 2233456899999999998654 378999999999999999999999732 22233332222 211
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+......+.+++.+|++.||++||++.|++++
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1123345688999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=339.60 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=197.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcccc-HHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.+.||+|+||+||+|... +++.||||++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47999999999999999999765 68999999986543221 12355799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 96 6999999875 45689999999999999999999999 999999999999999999999999999986543322
Q ss_pred cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......+........ .+......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~-~~~~~~~~ 229 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFRILGTPT-EETWPGIL 229 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCC-TTTSTTGG
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCC-hHhchhhh
Confidence 2334578999999999876 568999999999999999999999997432 1122222222221111 11100000
Q ss_pred -------------CC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1038 -------------WD----CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1038 -------------~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.. ........++.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 001233567899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=354.52 Aligned_cols=194 Identities=24% Similarity=0.426 Sum_probs=155.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeecc-----CCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-----EAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 871 (1082)
.++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999999999999644 6899999998653 23445778999999999999999999999843 357
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.|+||||+ +++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 6799999986 35699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--------------------------ccccCcccCCCcccchhc-ccCCCCchhhHHHHHHHHHHHHhC
Q 045553 952 LGTSET--------------------------HATTDVAGTFGYVAPEYA-MTCRVSDKADVYSFGVVLLELISD 999 (1082)
Q Consensus 952 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGvll~elltg 999 (1082)
...... ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 653221 123456789999999986 456799999999999999999994
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=340.08 Aligned_cols=262 Identities=25% Similarity=0.359 Sum_probs=199.4
Q ss_pred HHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcccc-----HHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQG-----VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
...++|++.+.||+|+||.||+|... +|+.||||++....... .+.+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999764 58999999987543211 2467899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999965 899988765 45688899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-cCCC
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-QGRP 1029 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1029 (1082)
+..... ......||+.|+|||++.+. .++.++||||+||++|||++|..||.... ..+....... .+..
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--------~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--------DLDQLTRIFETLGTP 232 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCCC
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHHcCCC
Confidence 653322 23445789999999999764 58999999999999999999999986321 1222222221 1111
Q ss_pred --cccccc---------ccCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 --CEFFTA---------GLWDCGP-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 --~~~~d~---------~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.+. ......+ ...+.++.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 111000 0000011 2335789999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=329.07 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=201.7
Q ss_pred CccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
+|.....||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345556899999999999975 4688999999987666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-CCcEEEeecccceecCCCCCc
Q 045553 881 GGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 881 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||.+........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 999999998753 34577999999999999999999999 9999999999999987 89999999999987653322
Q ss_pred cccCcccCCCcccchhcccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 959 ATTDVAGTFGYVAPEYAMTCR--VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......|++.|+|||++.+.. ++.++||||||+++|||++|+.||..... ........... ..
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-~~-------- 243 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMF-KV-------- 243 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHH-CC--------
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccc-cc--------
Confidence 223457899999999997643 88999999999999999999999963211 11111111111 11
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+...+.++.+++.+|++.||++||++.|++++
T Consensus 244 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 -HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111233445689999999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=346.60 Aligned_cols=199 Identities=22% Similarity=0.397 Sum_probs=168.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccC-----Ce
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-----AE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 871 (1082)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999654 5899999999753 234457789999999999999999999998766 57
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.|+||||++ ++|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999995 699999986 35699999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCC---------------------ccccCcccCCCcccchhc-ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 045553 952 LGTSET---------------------HATTDVAGTFGYVAPEYA-MTCRVSDKADVYSFGVVLLELISDKKALD 1004 (1082)
Q Consensus 952 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGvll~elltg~~p~~ 1004 (1082)
...... ......+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 754321 123567899999999986 55679999999999999999998766654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=341.66 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=197.5
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC------C
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------A 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 870 (1082)
..+|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999976 468999999986432 23356788999999999999999999998765 3
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..|+||||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 8899999986 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH-hcCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL-LQGR 1028 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1028 (1082)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+.+..+. ..+.
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--------HLDQLKEIMKVTGT 244 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCC
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhcCC
Confidence 76432 334578999999999987 789999999999999999999999997431 111112111 1111
Q ss_pred Ccccccccc-------------------CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAGL-------------------WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~l-------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+...+ ...........+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 111000000 001112345679999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.62 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=200.7
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc----CCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS----EAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 873 (1082)
..|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788899999999999999654 57899999987543 3445678999999999999999999998764 45689
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeccCCCCCEEEc-CCCcEEEeecccce
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR--VLHRDIKPSNILLD-NNLNAYLSDFGLAR 950 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~DfGla~ 950 (1082)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999874 4689999999999999999999999 7 99999999999998 78999999999997
Q ss_pred ecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
..... ......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||... .......... ..+...
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~~~~-~~~~~~ 248 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRV-TSGVKP 248 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHH-TTTCCC
T ss_pred ccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCc-------CcHHHHHHHH-hccCCc
Confidence 54332 2234568999999998864 5899999999999999999999999632 2222332222 222111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+ +...+.++.+++.+|++.+|++||++.|++++
T Consensus 249 ~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ASF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111 11223579999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=344.70 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=197.3
Q ss_pred HHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeecc--------
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-------- 868 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 868 (1082)
....+|++.+.||+|+||+||+|.. .+|+.||||++...... ..+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3567899999999999999999965 57899999998754322 3479999999999999999998843
Q ss_pred ------------------------------CCeEEEEEeecCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 045553 869 ------------------------------EAEMFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYLH 916 (1082)
Q Consensus 869 ------------------------------~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH 916 (1082)
....++||||++ ++|.+.+.. .....+++..+..++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334889999997 688887764 23567999999999999999999999
Q ss_pred hCCCCCeEeccCCCCCEEEc-CCCcEEEeecccceecCCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHH
Q 045553 917 DECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLL 994 (1082)
Q Consensus 917 ~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~ 994 (1082)
+. +|+||||||+||+++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++||||+||++|
T Consensus 159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99 999999999999998 688999999999987654332 3345789999999998875 4899999999999999
Q ss_pred HHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC------------Ccccccccc-----CCCCChHHHHHHHHHHHHcc
Q 045553 995 ELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR------------PCEFFTAGL-----WDCGPHDDLIEMLNLAIMCT 1057 (1082)
Q Consensus 995 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~d~~l-----~~~~~~~~~~~l~~li~~cl 1057 (1082)
||++|+.||.... ...+........+. ..+..-+.. ....+...+..+.+++.+|+
T Consensus 234 ell~g~~pf~~~~-------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 234 ELILGKPLFSGET-------SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHSSCSSCCSS-------HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 9999999997421 11111111111111 000000000 00123345567999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045553 1058 GESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1058 ~~~p~~RPt~~ev~~ 1072 (1082)
+.||++|||+.|+++
T Consensus 307 ~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=338.13 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=189.0
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 356899999999999999999964 468999999986543 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 877 NYLPGGNLEKFIQDR------PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
||+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998741 245689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC----ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 951 LLGTSET----HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 951 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
....... .......|++.|+|||++.+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~ 241 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--------KVLMLTLQ 241 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHHHHHT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--------hHHHHHhc
Confidence 6643221 12234578999999999876 56899999999999999999999999743211 11111111
Q ss_pred cCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 QGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+..................+..+.+++.+|++.||++||++.|++++
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 -NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111111000011122345678999999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=345.67 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=205.9
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccC--------CCceeeEeeeec---
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ--------HPNLVTLIGYHV--- 867 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 867 (1082)
.++|++.++||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46799999999999999999965 46899999999754 234567889999999986 788999999887
Q ss_pred -cCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-------
Q 045553 868 -SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL------- 939 (1082)
Q Consensus 868 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~------- 939 (1082)
.....++||||+ ++++.+++.......+++..++.++.||+.||+|||+.+ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 566899999999 677777777655567999999999999999999999964 899999999999999775
Q ss_pred ------------------------------------------cEEEeecccceecCCCCCccccCcccCCCcccchhccc
Q 045553 940 ------------------------------------------NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977 (1082)
Q Consensus 940 ------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 977 (1082)
.+||+|||.+...... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999876533 234578999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc-----------cccccc-----c----
Q 045553 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC-----------EFFTAG-----L---- 1037 (1082)
Q Consensus 978 ~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~d~~-----l---- 1037 (1082)
..++.++|||||||++|||++|+.||....... ...............+... +.+... +
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEE-YTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS-SCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc-cCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999997543221 0111111111111111110 011000 0
Q ss_pred ----------CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 ----------WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
....+......+.+++.+|++.||++|||+.|++++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 001345667889999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=340.47 Aligned_cols=259 Identities=19% Similarity=0.328 Sum_probs=208.2
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCcccc-----------------HHHHHHHHHHHhccCCCceeeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQG-----------------VQQFAAEIRTLGRVQHPNLVTL 862 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 862 (1082)
.++|++.+.||+|+||.||+|.. +++.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 89999999986542211 2789999999999999999999
Q ss_pred eeeeccCCeEEEEEeecCCCCHHHH------HhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEE
Q 045553 863 IGYHVSEAEMFLIYNYLPGGNLEKF------IQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 863 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill 935 (1082)
++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||+|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999999 665446789999999999999999999999 8 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCCccccCcccCCCcccchhcccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCccCCCCC
Q 045553 936 DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC-RVSD-KADVYSFGVVLLELISDKKALDPSFCSFGNG 1013 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slGvll~elltg~~p~~~~~~~~~~~ 1013 (1082)
+.++.+||+|||.+...... ......|+..|+|||++.+. .++. ++||||||+++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999876433 33446799999999999887 6666 999999999999999999999743211
Q ss_pred ccHHHHHHHHHhcCCCccccccc-----cC----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAG-----LW----DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~-----l~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+.... +..+...-..+.. .. .......+..+.+++.+|++.||++||++.|++++
T Consensus 259 ---~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ---VELFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---HHHHHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 122222 2222111100000 00 00113445789999999999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=339.77 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=200.8
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 457999999999999999999765 489999999865433 23456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 104 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999999888765 34699999999999999999999999 99999999999999999999999999998764332
Q ss_pred CccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC-------
Q 045553 957 THATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR------- 1028 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 1028 (1082)
. ......|++.|+|||++.+. .++.++||||+|+++|||++|+.||.... ............+.
T Consensus 179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS-------DIDQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHHHCSCCHHHHH
T ss_pred c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCChhhhh
Confidence 2 23345689999999999875 78999999999999999999999997432 11111111111110
Q ss_pred -------CccccccccCCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 -------PCEFFTAGLWDCGP-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 -------~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+......+ ...+..+.+++.+|++.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00111111111111 1345789999999999999999999998764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=353.46 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=205.7
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++|++.++||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999765 68999999986432 234678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc---CCCcEEEeecccceecC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~~~ 953 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++.+.
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999998764 4689999999999999999999999 999999999999995 56689999999998664
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... ...+..............
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~~~~- 243 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--------NEYDILKRVETGKYAFDL- 243 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCSCS-
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCCCCC-
Confidence 332 2344579999999999876 5899999999999999999999999632 222333333222211110
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+.++.+++.+|++.+|++|||+.|++++
T Consensus 244 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 ------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0112345689999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=329.71 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=203.3
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
...+|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|++++++++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999765 58999999997643 34678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999999743 45789999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ............ ....
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~~~----- 245 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAIFMIPTNP-PPTF----- 245 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCCC-----
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCC-Cccc-----
Confidence 2334578999999999999999999999999999999999999996321 112122211111 1111
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+...+..+.+++.+|++.||++||++.|+++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112334568999999999999999999999976
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=355.70 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=208.1
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999765 68999999996543 34567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE---cCCCcEEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~ 952 (1082)
|||+.+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.+
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999999864 4689999999999999999999999 99999999999999 56789999999999876
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... ...+..............
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA--------NEYDILKKVEKGKYTFEL 248 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCS
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCCCCCCC
Confidence 5433 2234579999999999876 6899999999999999999999999732 222333333222211110
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+..+.+++.+|++.+|++|||+.|++++
T Consensus 249 -------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 249 -------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0112345689999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=337.76 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=202.0
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeecc--------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-------- 868 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 868 (1082)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999976 5689999999865432 234577899999999999999999998876
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 869 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
.+..++||||++ +++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 446899999996 5888877664 35699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC---ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 949 ARLLGTSET---HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 949 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
++.+..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......+....
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~ 245 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQLC 245 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHH
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHh
Confidence 987653222 23345678999999999876 558999999999999999999999997432 111122222211
Q ss_pred hcCCCcccccc----cc-------CCC-CC-hH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 LQGRPCEFFTA----GL-------WDC-GP-HD------DLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ~~~~~~~~~d~----~l-------~~~-~~-~~------~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. ....+.... .. ... .. .+ ....+.+++.+|++.||++|||+.|++++
T Consensus 246 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 246 G-SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp C-CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1 111111000 00 000 00 00 13458899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=364.12 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=208.0
Q ss_pred HhcCccccceecccCceEEEEEEEcC----CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
..++|++.+.||+|+||.||+|.... +..||||++.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678999999999999999997642 5689999987543 234567899999999999999999999985 45689
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999999875 44689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
...........+++.|+|||++.+..++.++||||||+++|||++ |..||... ...+......... ..
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--------~~~~~~~~i~~~~-~~-- 611 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--------KNNDVIGRIENGE-RL-- 611 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHHTC-CC--
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHcCC-CC--
Confidence 444333344567889999999999999999999999999999997 89998632 2223333222221 11
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+...+..+.+++.+||+.||++||++.||++.|+.+.
T Consensus 612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 123345578999999999999999999999999998874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=338.50 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=203.1
Q ss_pred HHHHHHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeecc--
Q 045553 793 YENVVRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVS-- 868 (1082)
Q Consensus 793 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-- 868 (1082)
+.++....++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334445678899999999999999999976 468999999987543 3356788999999999 79999999999876
Q ss_pred ----CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEe
Q 045553 869 ----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS 944 (1082)
Q Consensus 869 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 944 (1082)
....++||||+++++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 46789999999999999999876556799999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHH
Q 045553 945 DFGLARLLGTSETHATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 945 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
|||++........ ......|++.|+|||++. +..++.++||||||+++|||++|+.||.... ....
T Consensus 172 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~ 242 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--------PMRA 242 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHH
T ss_pred eCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHH
Confidence 9999987643222 223457899999999987 5678999999999999999999999996321 1122
Q ss_pred HHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1020 ASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1020 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
........ .... .+...+..+.+++.+|++.||++||++.|++++
T Consensus 243 ~~~~~~~~-~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 LFLIPRNP-APRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHSC-CCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhcCc-cccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22222221 1111 112334689999999999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=342.17 Aligned_cols=269 Identities=23% Similarity=0.297 Sum_probs=203.2
Q ss_pred cccHHHHHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc-----------ccHHHHHHHHHHHhccCCCc
Q 045553 790 QLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF-----------QGVQQFAAEIRTLGRVQHPN 858 (1082)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~n 858 (1082)
+...+++....++|++.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456778888999999999999999999999888899999999854321 12377899999999999999
Q ss_pred eeeEeeeec-----cCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCE
Q 045553 859 LVTLIGYHV-----SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNI 933 (1082)
Q Consensus 859 iv~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 933 (1082)
|+++++++. .....++||||++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999999884 3446899999996 6898888754 45799999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeecccceecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC
Q 045553 934 LLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012 (1082)
Q Consensus 934 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 1012 (1082)
+++.++.+||+|||+++...... ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----- 238 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST----- 238 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-----
Confidence 99999999999999997543322 2334578999999999887 678999999999999999999999997421
Q ss_pred CccHHHHHHHHHh---cCCCcc-----------ccccccCC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1013 GFNIVAWASMLLL---QGRPCE-----------FFTAGLWD-------CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1013 ~~~~~~~~~~~~~---~~~~~~-----------~~d~~l~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
.......... ...... .+...... .........+.+++.+|++.||++|||+.|++
T Consensus 239 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 239 ---FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp ---HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 1122222111 100000 00000000 01123356789999999999999999999998
Q ss_pred HH
Q 045553 1072 QQ 1073 (1082)
Q Consensus 1072 ~~ 1073 (1082)
++
T Consensus 316 ~h 317 (362)
T 3pg1_A 316 RH 317 (362)
T ss_dssp TS
T ss_pred cC
Confidence 74
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=364.94 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=208.7
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecC---ccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 873 (1082)
...+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999755 5889999999753 223456678899999887 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++|+|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999874 4699999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....+.... .
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~~-~---- 559 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEHN-V---- 559 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHSSC-C----
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhCC-C----
Confidence 322 2345578999999999999999999999999999999999999999732 2233333333221 1
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSM-----RQVAQ 1072 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~ 1072 (1082)
.+|...+.++.+|+.+|++.||++||++ .||.+
T Consensus 560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 2344556789999999999999999987 66654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=352.88 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=201.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999765 68999999997543 234567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---CCcEEEeecccceecC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLG 953 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla~~~~ 953 (1082)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.+.
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999988764 4689999999999999999999999 9999999999999976 4559999999998775
Q ss_pred CCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||... ...+............
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~~--- 256 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ--------TDQEILRKVEKGKYTF--- 256 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCC---
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCCC---
Confidence 432 234467999999999986 46899999999999999999999999732 2233333332222111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+...+ ...+..+.+++.+|++.+|++|||+.|++++
T Consensus 257 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11111 1334678999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=351.46 Aligned_cols=241 Identities=17% Similarity=0.180 Sum_probs=190.8
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC---ccccHHHHHHHH---HHHhccCCCceeeEe-------ee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG---RFQGVQQFAAEI---RTLGRVQHPNLVTLI-------GY 865 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 865 (1082)
..+|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999974 56999999999743 334567889999 556666899999998 44
Q ss_pred eccCC-----------------eEEEEEeecCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 045553 866 HVSEA-----------------EMFLIYNYLPGGNLEKFIQDRP-----RRTVEWSMLHKIALDVARALAYLHDECVPRV 923 (1082)
Q Consensus 866 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 923 (1082)
+.+.+ ..++||||+ +|+|.+++.... ...+++..++.|+.|++.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 44432 379999999 689999998632 12334688889999999999999999 99
Q ss_pred EeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcccchhcccC-----------CCCchhhHHHHHHH
Q 045553 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC-----------RVSDKADVYSFGVV 992 (1082)
Q Consensus 924 vH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slGvl 992 (1082)
+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 993 LLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 993 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
+|||++|+.||...... . ....+.. .....+.++.+++.+||+.||++||++.|+++
T Consensus 303 l~elltg~~Pf~~~~~~-----------------~-~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAAL-----------------G-GSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC-----------------------C-CSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccc-----------------c-chhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999643211 0 0111111 01233467999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=333.24 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=201.9
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeecc--CCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVS--EAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|.. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5799999999999999999965 56899999998743 3567899999999997 9999999999987 66789999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecccceecCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFGLARLLGTS 955 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 955 (1082)
||+++++|.++++. +++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999863 78999999999999999999999 999999999999999777 8999999999876543
Q ss_pred CCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH--------HHhc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM--------LLLQ 1026 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~ 1026 (1082)
.. .....|+..|+|||++.+ ..++.++||||+||++|||++|+.||...... ...+...... ....
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHHHHHCHHHHHHHHHH
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch---HHHHHHHHHhcCCchhhhHHHH
Confidence 32 334578999999999987 67899999999999999999999999532111 0111110000 0000
Q ss_pred CC--------------CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1027 GR--------------PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1027 ~~--------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. .....+.......+...+.++.+++.+|++.||++|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 000001111111222346789999999999999999999999874
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=339.83 Aligned_cols=343 Identities=18% Similarity=0.169 Sum_probs=247.8
Q ss_pred CCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccC
Q 045553 96 DKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIP 175 (1082)
Q Consensus 96 ~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 175 (1082)
+.+.+. | .+..+++|++|+|++|++++ +| ++.+++|++|+|++|.+++ ++ ++++++|++|++++|++++ +|
T Consensus 52 n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~ 122 (457)
T 3bz5_A 52 SSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD 122 (457)
T ss_dssp SCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC
T ss_pred CCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec
Confidence 455553 4 68999999999999999996 45 9999999999999999996 44 8999999999999999996 44
Q ss_pred ccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCC
Q 045553 176 AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255 (1082)
Q Consensus 176 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 255 (1082)
++.+++|++|++++|++++ ++ + ..+++|++|++++|+..+.+ .+..+++|++|++++|++++ +| ++.++
T Consensus 123 --~~~l~~L~~L~l~~N~l~~-l~--l-~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~ 191 (457)
T 3bz5_A 123 --VSQNPLLTYLNCARNTLTE-ID--V-SHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNK 191 (457)
T ss_dssp --CTTCTTCCEEECTTSCCSC-CC--C-TTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCT
T ss_pred --CCCCCcCCEEECCCCccce-ec--c-ccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCC
Confidence 8999999999999999995 44 3 36899999999999766666 58899999999999999996 55 88999
Q ss_pred CCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEc
Q 045553 256 NLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWA 335 (1082)
Q Consensus 256 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l 335 (1082)
+|++|++++|++++. .++.+++|++|++++
T Consensus 192 ~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~----------------------------------------------- 221 (457)
T 3bz5_A 192 LLNRLNCDTNNITKL---DLNQNIQLTFLDCSS----------------------------------------------- 221 (457)
T ss_dssp TCCEEECCSSCCSCC---CCTTCTTCSEEECCS-----------------------------------------------
T ss_pred CCCEEECcCCcCCee---ccccCCCCCEEECcC-----------------------------------------------
Confidence 999999999999864 256666666666655
Q ss_pred CCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceecC
Q 045553 336 PNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEI 415 (1082)
Q Consensus 336 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~~ 415 (1082)
|++.++ | +..+++|++|++++|++++.. +..+++|+.|++++|++ +.|++++|++.|.+
T Consensus 222 --N~l~~i-p--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L-------------~~L~l~~n~~~~~~ 280 (457)
T 3bz5_A 222 --NKLTEI-D--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDL-------------LEIDLTHNTQLIYF 280 (457)
T ss_dssp --SCCSCC-C--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCC-------------SCCCCTTCTTCCEE
T ss_pred --Cccccc-C--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCC-------------CEEECCCCccCCcc
Confidence 444442 2 445566667777777766432 34566677777766643 34556666554333
Q ss_pred CCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccce
Q 045553 416 PRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYG 495 (1082)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~ 495 (1082)
|.
T Consensus 281 ~~------------------------------------------------------------------------------ 282 (457)
T 3bz5_A 281 QA------------------------------------------------------------------------------ 282 (457)
T ss_dssp EC------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 21
Q ss_pred eeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEcc
Q 045553 496 FWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLS 575 (1082)
Q Consensus 496 ~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 575 (1082)
..+.+++.|++++|.+.+.+|.. ..+|+.|++++| ++|++|+|+
T Consensus 283 -------------------~~l~~L~~L~Ls~n~~l~~l~~~----~~~L~~L~l~~~-------------~~L~~L~L~ 326 (457)
T 3bz5_A 283 -------------------EGCRKIKELDVTHNTQLYLLDCQ----AAGITELDLSQN-------------PKLVYLYLN 326 (457)
T ss_dssp -------------------TTCTTCCCCCCTTCTTCCEEECT----TCCCSCCCCTTC-------------TTCCEEECT
T ss_pred -------------------cccccCCEEECCCCcccceeccC----CCcceEechhhc-------------ccCCEEECC
Confidence 00122345556666555555532 123444444443 577888888
Q ss_pred CCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCC
Q 045553 576 RNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRI 655 (1082)
Q Consensus 576 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 655 (1082)
+|+|++. + +..+++|+.|++++|++++ ++.|..|++++|+++|. ..+..|+.++|++|+++|.+
T Consensus 327 ~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~i 390 (457)
T 3bz5_A 327 NTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAV 390 (457)
T ss_dssp TCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEEC
T ss_pred CCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEc
Confidence 8888864 3 7778888888888888874 24567777888887764 34556677777777777777
Q ss_pred CCCC
Q 045553 656 PPGF 659 (1082)
Q Consensus 656 p~~~ 659 (1082)
|..+
T Consensus 391 p~~~ 394 (457)
T 3bz5_A 391 SPDL 394 (457)
T ss_dssp CTTC
T ss_pred ChhH
Confidence 6654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=327.53 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=206.7
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---------ccHHHHHHHHHHHhccC-CCceeeEeeeec
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---------QGVQQFAAEIRTLGRVQ-HPNLVTLIGYHV 867 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 867 (1082)
..++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4568999999999999999999765 689999999975431 22456789999999996 999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecc
Q 045553 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFG 947 (1082)
Q Consensus 868 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 947 (1082)
.....++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999873 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHH
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAM------TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
.+....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||... .......
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~ 239 (298)
T 1phk_A 170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--------KQMLMLR 239 (298)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHH
T ss_pred chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc--------cHHHHHH
Confidence 998765433 233457899999999985 456789999999999999999999998632 1222222
Q ss_pred HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1022 MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
...... ... ........+..+.+++.+|++.||++||++.|+++
T Consensus 240 ~~~~~~-~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGN-YQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTC-CCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCC-ccc------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 222221 110 00111244568999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=349.37 Aligned_cols=253 Identities=20% Similarity=0.337 Sum_probs=194.1
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--------ccHHHHHHHHHHHhccCCCceeeEeeeeccC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE 869 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 869 (1082)
..++|.+.+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4678999999999999999999654 589999999875421 122347899999999999999999999754
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC---CcEEEeec
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN---LNAYLSDF 946 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Df 946 (1082)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeec
Confidence 5589999999999999998763 5699999999999999999999999 99999999999999754 45999999
Q ss_pred ccceecCCCCCccccCcccCCCcccchhccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH
Q 045553 947 GLARLLGTSETHATTDVAGTFGYVAPEYAMT---CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML 1023 (1082)
Q Consensus 947 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1023 (1082)
|+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...... .
T Consensus 287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~----~ 356 (419)
T 3i6u_A 287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKD----Q 356 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS----SCCHHH----H
T ss_pred ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc----hHHHHH----H
Confidence 999876432 23345679999999999863 6788899999999999999999999974321 112222 1
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+..+..... +.. ....+..+.+++.+|++.||++||++.|++++
T Consensus 357 i~~~~~~~~--~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYNFI--PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCCCC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCC--chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 222211100 000 01235679999999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=344.57 Aligned_cols=197 Identities=26% Similarity=0.353 Sum_probs=173.8
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhcc------CCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV------QHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~ 872 (1082)
..+|++.+.||+|+||+||+|... +++.||||++.... ...+++.+|+++++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999654 58999999997542 3345677888888777 577999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc--EEEeecccce
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN--AYLSDFGLAR 950 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfGla~ 950 (1082)
++||||+. ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 7999999987666799999999999999999999999 9999999999999999887 9999999997
Q ss_pred ecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDP 1005 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~ 1005 (1082)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 65432 2345789999999999999999999999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=350.36 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=204.4
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-------------ccHHHHHHHHHHHhccCCCceeeEee
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-------------QGVQQFAAEIRTLGRVQHPNLVTLIG 864 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~ 864 (1082)
..++|++.++||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999765 578999999975431 23567899999999999999999999
Q ss_pred eeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC---cE
Q 045553 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL---NA 941 (1082)
Q Consensus 865 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~ 941 (1082)
++.+....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999999764 4699999999999999999999999 999999999999998775 69
Q ss_pred EEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHH
Q 045553 942 YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
||+|||+++.+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... ...+...
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~ 257 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ--------NDQDIIK 257 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHH
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHH
Confidence 999999998775432 2344579999999999874 6899999999999999999999999732 2233333
Q ss_pred HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1022 MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
........... ... ...+.++.+++.+|++.||.+|||+.|++++
T Consensus 258 ~i~~~~~~~~~---~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKYYFDF---NDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCCCCCH---HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCCCCc---ccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 33322211100 000 1234679999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.87 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=190.1
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999976 4689999999975432 22334455566688899999999999999999999999
Q ss_pred eecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 877 NYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||++ |+|.+++... ....+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9996 5888887642 2467999999999999999999999853 899999999999999999999999999987644
Q ss_pred CCCccccCcccCCCcccchhc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 955 SETHATTDVAGTFGYVAPEYA----MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
... .....|++.|+|||++ .+..++.++||||+|+++|||++|+.||.... ................
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-------TPFQQLKQVVEEPSPQ 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-------CHHHHHHHHHHSCCCC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-------chHHHHHHHhccCCCC
Confidence 322 2334689999999996 56678999999999999999999999996321 1222223333322111
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+...+.++.+++.+|++.+|++|||+.|+++
T Consensus 234 ---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 ---------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111234567999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=342.76 Aligned_cols=252 Identities=11% Similarity=0.043 Sum_probs=182.2
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHH---HHHhccCCCceeeEee-------ee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEI---RTLGRVQHPNLVTLIG-------YH 866 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~-------~~ 866 (1082)
..|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+ +.++. +|||+++++. ++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45889999999999999999765 789999999987543 3345677784 45555 7999888553 22
Q ss_pred ccC-----------------CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCCe
Q 045553 867 VSE-----------------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSML------HKIALDVARALAYLHDECVPRV 923 (1082)
Q Consensus 867 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~i 923 (1082)
... ...++||||++ |+|.+++.... ..+++..+ ..++.|++.||+|||+. +|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 221 34899999998 89999998642 23455566 78889999999999999 99
Q ss_pred EeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCC
Q 045553 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKK 1001 (1082)
Q Consensus 924 vH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~ 1001 (1082)
+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998764322 13456799999999987 789999999999999999999999
Q ss_pred CCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1002 ALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1002 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
||........... .....................+..+.+++.+||+.||++||++.|+++
T Consensus 292 Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGSW----------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTCC----------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccch----------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9986532210000 000000000111111112345678999999999999999999999975
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=346.05 Aligned_cols=171 Identities=22% Similarity=0.225 Sum_probs=95.1
Q ss_pred EEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCc
Q 045553 114 VLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNL 193 (1082)
Q Consensus 114 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 193 (1082)
.++.++++++ .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 4555555555 4454332 456666666666665555556666666666666666665555666666666666666666
Q ss_pred ccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCc
Q 045553 194 LSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPS 273 (1082)
Q Consensus 194 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 273 (1082)
++ .+|...+..+++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+.
T Consensus 92 l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 92 LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred CC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 55 44444333455555555555555555555555555566666665555555555555555555555555555544444
Q ss_pred cccCCCCCcEEEecc
Q 045553 274 ELGMCKQLKVLVLRN 288 (1082)
Q Consensus 274 ~l~~l~~L~~L~l~~ 288 (1082)
.+..+++|+.|++++
T Consensus 171 ~l~~l~~L~~L~l~~ 185 (477)
T 2id5_A 171 ALSHLHGLIVLRLRH 185 (477)
T ss_dssp HHTTCTTCCEEEEES
T ss_pred HhcccCCCcEEeCCC
Confidence 444455555444444
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=332.06 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=204.4
Q ss_pred HHhcCccccceecccCceEEEEEEE--cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhcc---CCCceeeEeeeec---
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEI--IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRV---QHPNLVTLIGYHV--- 867 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~--- 867 (1082)
++.++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3567899999999999999999987 4689999999864322 1223456677776666 8999999999987
Q ss_pred --cCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEee
Q 045553 868 --SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSD 945 (1082)
Q Consensus 868 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 945 (1082)
.....++||||++ |+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5677899999996 6999999987666799999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh
Q 045553 946 FGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025 (1082)
Q Consensus 946 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1082)
||.++...... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ......+.....
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHcC
Confidence 99998764322 23446789999999999999999999999999999999999999974311 111111111111
Q ss_pred cCCCcccc----------cc---ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1026 QGRPCEFF----------TA---GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1026 ~~~~~~~~----------d~---~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+. .. ..........+..+.+++.+|++.||++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11000000 00 00001122345688999999999999999999999854
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=339.30 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=193.2
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCC------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA------ 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 870 (1082)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999654 68999999997542 334567889999999999999999999987654
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..++||||++ ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999996 588888863 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc-CCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ-GRP 1029 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1029 (1082)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....+ ...... +..
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~-~~i~~~~~~~ 245 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-------HIDQW-NKVIEQLGTP 245 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHH-HHHHC-CCCC
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHH-HHHHHHhCCC
Confidence 764322 2334679999999999999999999999999999999999999997431 11111 111111 000
Q ss_pred c-cc--------------------------cccccCCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 C-EF--------------------------FTAGLWDCG---PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~-~~--------------------------~d~~l~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. +. +........ +......+.+++.+|++.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 00 000000000 11236789999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=342.09 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=195.0
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCC------eEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA------EMF 873 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 873 (1082)
..+|++.+.||+|+||+||+|+...+..||+|++...... ..+|+++++.++||||+++++++.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3469999999999999999999887778999998654322 247999999999999999999985433 378
Q ss_pred EEEeecCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc-CCCcEEEeecccce
Q 045553 874 LIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLAR 950 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla~ 950 (1082)
+||||++++ +.+.+.. .....+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999764 4443332 1245799999999999999999999999 999999999999999 79999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-cCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-QGR 1028 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1028 (1082)
....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....... .+.
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--------GIDQLVEIIKVLGT 260 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCC
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCC
Confidence 7644332 2345789999999998765 58999999999999999999999997421 1111111111 000
Q ss_pred Cc---------cccc---cccCC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PC---------EFFT---AGLWD-----CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~---------~~~d---~~l~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ...+ +.... ..+...+.++.+++.+|++.||++|||+.|++++
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 0000 00000 0122345689999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=336.19 Aligned_cols=258 Identities=21% Similarity=0.363 Sum_probs=202.7
Q ss_pred HhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
..++|++.+.||+|+||.||+|.... .||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45689999999999999999998753 59999986543 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++......
T Consensus 109 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999999865 35689999999999999999999999 999999999999998 6799999999987653221
Q ss_pred ----CccccCcccCCCcccchhccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH
Q 045553 957 ----THATTDVAGTFGYVAPEYAMT---------CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML 1023 (1082)
Q Consensus 957 ----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1023 (1082)
........|++.|+|||++.+ ..++.++||||||+++|||++|+.||... .........
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~ 255 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--------PAEAIIWQM 255 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC--------CHHHHHHHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHh
Confidence 122233468999999999874 45789999999999999999999999632 222222222
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
..+...... +...+.++.+++.+|++.+|++||++.|++++|+.+...
T Consensus 256 -~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 256 -GTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -HTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -ccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 222111111 112334688999999999999999999999999988754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=330.47 Aligned_cols=264 Identities=20% Similarity=0.319 Sum_probs=208.2
Q ss_pred hcCccccceecccCceEEEEEEE--cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCC------ceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI--IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP------NLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~ 871 (1082)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999975 368999999987542 3456788899999888765 49999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC--------------
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-------------- 937 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-------------- 937 (1082)
.++||||+ +++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 89999999887666799999999999999999999999 9999999999999987
Q ss_pred -----CCcEEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC
Q 045553 938 -----NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012 (1082)
Q Consensus 938 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 1012 (1082)
++.+||+|||.++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----- 238 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD----- 238 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC-----
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----
Confidence 668999999999875432 234578999999999999999999999999999999999999997431
Q ss_pred CccHHHHHHHHHhcCCCccc---------ccc--------------------c--cCCCCChHHHHHHHHHHHHcccCCC
Q 045553 1013 GFNIVAWASMLLLQGRPCEF---------FTA--------------------G--LWDCGPHDDLIEMLNLAIMCTGESL 1061 (1082)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~---------~d~--------------------~--l~~~~~~~~~~~l~~li~~cl~~~p 1061 (1082)
.......+.... ....... +.. . -....+.....++.+++.+|++.||
T Consensus 239 ~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 239 SKEHLAMMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HHHHHHHHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred hHHHHHHHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 111111111111 1100000 000 0 0001233557789999999999999
Q ss_pred CCCCCHHHHHHH--HhhhC
Q 045553 1062 SSRPSMRQVAQQ--LKQIQ 1078 (1082)
Q Consensus 1062 ~~RPt~~ev~~~--L~~i~ 1078 (1082)
++|||+.|++++ +++++
T Consensus 318 ~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 318 AKRITLREALKHPFFDLLK 336 (339)
T ss_dssp TTSCCHHHHTTSGGGGGGG
T ss_pred ccccCHHHHhcCHHHHHHh
Confidence 999999999865 44443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=342.67 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=195.2
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccC------CeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------AEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 873 (1082)
.+|++.+.||+|+||.||+|+.. +|+.||||++..... .+.+|++++++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999875 589999999865432 234799999999999999999987532 2367
Q ss_pred EEEeecCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-CcEEEeecccce
Q 045553 874 LIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-LNAYLSDFGLAR 950 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~ 950 (1082)
+||||+++ ++.+.+.. .....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999964 77766653 2246799999999999999999999999 99999999999999965 578999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH------
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML------ 1023 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 1023 (1082)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...++..
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHH
Confidence 7644332 2345789999999999765 799999999999999999999999974211 11111211110
Q ss_pred -H--hcCCCccccccccCCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 -L--LQGRPCEFFTAGLWDC-----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 -~--~~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+ ......+...+.+... .+...+.++.+|+.+|++.||++||++.|++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 0011111111111100 122345689999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=326.19 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=196.8
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeecc---------
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--------- 868 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 868 (1082)
..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567999999999999999999764 6899999998643 3445778999999999999999999998754
Q ss_pred ----CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEe
Q 045553 869 ----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS 944 (1082)
Q Consensus 869 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 944 (1082)
....++||||+++++|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 45789999999999999999865 45688899999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCC-------------CccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCC
Q 045553 945 DFGLARLLGTSE-------------THATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSF 1010 (1082)
Q Consensus 945 DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~ 1010 (1082)
|||.+....... ........|++.|+|||++.+. .++.++||||+|+++|||++ ||..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~----- 230 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST----- 230 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS-----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC-----
Confidence 999998764321 1122345689999999999864 68999999999999999998 4432
Q ss_pred CCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1011 GNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
............ ... .......+...+..+.+++.+|++.||++|||+.|++++
T Consensus 231 --~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 231 --GMERVNILKKLR-SVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHHHHHHHH-STT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --chhHHHHHHhcc-ccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111222222221 111 011112334455678999999999999999999999874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=354.37 Aligned_cols=135 Identities=21% Similarity=0.234 Sum_probs=93.8
Q ss_pred CCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEE
Q 045553 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVS 188 (1082)
Q Consensus 109 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 188 (1082)
+.+++.|++++|.++...+..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+.+++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56788888888888855555678888888888888888877777888888888888888888877777777777777777
Q ss_pred cccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCc
Q 045553 189 LSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268 (1082)
Q Consensus 189 L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 268 (1082)
|++|.++ .+|..+ |+++++|++|+|++|.+++..|..|+.+++|++|+|++|.++
T Consensus 130 L~~n~l~-~l~~~~------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 130 LERNDLS-SLPRGI------------------------FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CCSSCCC-CCCTTT------------------------TTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eeCCCCC-CCCHHH------------------------hccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 7777666 333332 344555555555555555555555555555555555555554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=338.97 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=184.3
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC------C
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE------A 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 870 (1082)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999964 568999999986532 23456788999999999999999999998654 5
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 7899999875 4699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-cCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-QGR 1028 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1028 (1082)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+.+..+.. .+.
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~l~~i~~~~g~ 248 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQLKLILRLVGT 248 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHHCS
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCC
Confidence 65432 334578999999999987 678999999999999999999999996421 1121221111 111
Q ss_pred Cc-ccccc-----------ccCC--CCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PC-EFFTA-----------GLWD--CGP-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~-~~~d~-----------~l~~--~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. +.+.. .+.. ..+ ......+.+++.+|++.||++|||+.|++++
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11 00000 0000 000 1224578999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=329.07 Aligned_cols=259 Identities=19% Similarity=0.288 Sum_probs=197.1
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeec-----------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV----------- 867 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 867 (1082)
.++|++.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999766 48999999998776666788999999999999999999998873
Q ss_pred ---cCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc-CCCcEEE
Q 045553 868 ---SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYL 943 (1082)
Q Consensus 868 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl 943 (1082)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999996 699999975 4689999999999999999999999 999999999999997 5679999
Q ss_pred eecccceecCCCCC--ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHH
Q 045553 944 SDFGLARLLGTSET--HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 944 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 1020 (1082)
+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... .....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~~~ 234 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH--------ELEQM 234 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 99999987643221 12234467999999998865 678999999999999999999999997432 11222
Q ss_pred HHHHhcCCCc-------------cccccccCC-C-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1021 SMLLLQGRPC-------------EFFTAGLWD-C-----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1021 ~~~~~~~~~~-------------~~~d~~l~~-~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.......... ..+...... . .....+.++.+++.+|++.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 2222111100 000000000 0 012345689999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=341.08 Aligned_cols=267 Identities=21% Similarity=0.331 Sum_probs=185.1
Q ss_pred cCccc-cceecccCceEEEEEEEc---CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeee--ccCCeEEE
Q 045553 801 AGFNV-QNCIGSGGFGATYKAEII---PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYH--VSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~-~~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~~l 874 (1082)
+.|++ .++||+|+||+||+|+.. +++.||||++..... ...+.+|++++++++||||+++++++ ......++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34666 458999999999999865 478999999975432 35688999999999999999999998 45778999
Q ss_pred EEeecCCCCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE----cCCCcEEE
Q 045553 875 IYNYLPGGNLEKFIQDRP-------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL----DNNLNAYL 943 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl 943 (1082)
||||++ ++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999995 68888876321 23599999999999999999999999 99999999999999 67889999
Q ss_pred eecccceecCCCCC--ccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCC--CCccHHH
Q 045553 944 SDFGLARLLGTSET--HATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFG--NGFNIVA 1018 (1082)
Q Consensus 944 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~--~~~~~~~ 1018 (1082)
+|||+++.+..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ......+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987653322 23345679999999999987 4589999999999999999999999974322110 0011111
Q ss_pred HHHHHHhcCCCcc--ccccc-----------c----CCCC---------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1019 WASMLLLQGRPCE--FFTAG-----------L----WDCG---------PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1019 ~~~~~~~~~~~~~--~~d~~-----------l----~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.......-+.... +-+-. . .... .......+.+|+.+|++.||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111111100 00000 0 0000 0011456889999999999999999999987
Q ss_pred H
Q 045553 1073 Q 1073 (1082)
Q Consensus 1073 ~ 1073 (1082)
+
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=335.13 Aligned_cols=253 Identities=19% Similarity=0.314 Sum_probs=200.2
Q ss_pred HHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCc--cccHHHHHHHHHHHhccC--CCceeeEeeeeccCCeEE
Q 045553 798 RATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQ--HPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 798 ~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~ 873 (1082)
....+|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++......+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3456799999999999999999988889999999997543 334577899999999997 599999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||| +.+++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++ +.+||+|||+++...
T Consensus 105 lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 9999 4588999999874 4789999999999999999999999 9999999999999975 899999999998765
Q ss_pred CCCCc-cccCcccCCCcccchhccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHH
Q 045553 954 TSETH-ATTDVAGTFGYVAPEYAMT-----------CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 954 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
..... ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||.... .......
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~ 250 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLH 250 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-------HHHHHHH
Confidence 43322 2234568999999999875 478899999999999999999999996421 1122222
Q ss_pred HHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1022 MLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...... .....+...+.++.+++.+|++.||++||++.|++++
T Consensus 251 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 AIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 222221 1111222334678999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=335.64 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=203.7
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccC-----Ce
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-----AE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 871 (1082)
...+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4568999999999999999999654 68999999997543 23447789999999999999999999998654 46
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 899999996 6999999864 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 952 LGTSETH--ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 952 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~- 251 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSP- 251 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGHHHHHHHHHCSC-
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHHHhCCC-
Confidence 7543222 2345679999999998754 5589999999999999999999999974321 12222221111111
Q ss_pred Cccccccc-----------c--CCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAG-----------L--WDC-----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~-----------l--~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+.+... . ... .......++.+++.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0 000 012234678999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=331.30 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=197.9
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--------ccHHHHHHHHHHHhccCCCceeeEeeeeccCC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 870 (1082)
.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457999999999999999999764 589999999865321 22345789999999999999999999987655
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc---EEEeecc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN---AYLSDFG 947 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG 947 (1082)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 8999999999999999976 35789999999999999999999999 9999999999999987654 9999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
+++...... ......|++.|+|||++. +..++.++||||||+++|||++|+.||..... ...+...+
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~---- 232 (322)
T 2ycf_A 163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQI---- 232 (322)
T ss_dssp TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC----SSCHHHHH----
T ss_pred cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----HHHHHHHH----
Confidence 998764322 223456899999999974 56788999999999999999999999974322 11222221
Q ss_pred hcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1025 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+.... .+.. ....+..+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCcccc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1121110 0000 0123467899999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.35 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=205.1
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4567999999999999999999765 68999999986543 24567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC---CcEEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN---LNAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~~~ 952 (1082)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999998764 4689999999999999999999999 99999999999999754 47999999999866
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
..... .....|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||... ...+....... +....
T Consensus 175 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~-~~~~~- 241 (287)
T 2wei_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--------NEYDILKRVET-GKYAF- 241 (287)
T ss_dssp CCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-CCCCC-
T ss_pred cCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHc-CCCCC-
Confidence 43322 233468999999999876 4899999999999999999999999642 22233333322 21110
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
+... ....+.++.+++.+|++.+|++||++.|+++
T Consensus 242 -~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 -DLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -Cchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000 1123467999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=332.45 Aligned_cols=200 Identities=25% Similarity=0.338 Sum_probs=172.7
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccC-CC-----ceeeEeeeeccCCe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HP-----NLVTLIGYHVSEAE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~ 871 (1082)
..++|++.+.||+|+||+||+|... +++.||||++.... ....++.+|+++++.++ |+ +++++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999755 68899999997542 33566778888888885 44 49999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc--CCCcEEEeecccc
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD--NNLNAYLSDFGLA 949 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfGla 949 (1082)
.++||||++ ++|.+++.......+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999995 6999999987656799999999999999999999952 12899999999999994 5788999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDP 1005 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~ 1005 (1082)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 876432 2345789999999999999999999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=330.16 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=201.0
Q ss_pred HhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccC-----Ce
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-----AE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 871 (1082)
..++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568999999999999999999765 68999999996443 23456788999999999999999999987654 67
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 899999996 6999999863 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---------cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHH
Q 045553 952 LGTSETH---------ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWAS 1021 (1082)
Q Consensus 952 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 1021 (1082)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~ 236 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RHQLLLIF 236 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHH
Confidence 6532211 1233578999999998764 7789999999999999999999999974311 01111111
Q ss_pred HHHhcCCCcccccc-----------ccC--CC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1022 MLLLQGRPCEFFTA-----------GLW--DC-----GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1022 ~~~~~~~~~~~~d~-----------~l~--~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.............. .+. .. .....+.++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111000000000 000 00 012345678999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=330.56 Aligned_cols=254 Identities=20% Similarity=0.253 Sum_probs=177.0
Q ss_pred HhcCccccc-eecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeecc----CCeE
Q 045553 799 ATAGFNVQN-CIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS----EAEM 872 (1082)
Q Consensus 799 ~~~~~~~~~-~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 872 (1082)
..++|.+.+ .||+|+||+||+|... +++.||||++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356788854 6999999999999765 68999999986532 222233344667799999999998875 4568
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---CCcEEEeecccc
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLA 949 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla 949 (1082)
++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999999987666899999999999999999999999 9999999999999976 456999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............+..
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ-----AISPGMKRRIRLGQY 250 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch-----hhhhhHHHhhhcccc
Confidence 876432 223456899999999999889999999999999999999999999643211 000000010111000
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..........+.++.+++.+|++.||++|||+.|++++
T Consensus 251 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 ------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00001112445689999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=334.68 Aligned_cols=265 Identities=21% Similarity=0.296 Sum_probs=203.7
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccC-----------CCceeeEeeeec
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-----------HPNLVTLIGYHV 867 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 867 (1082)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999975 568999999987542 34567888999998886 899999999987
Q ss_pred cCC----eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc------C
Q 045553 868 SEA----EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD------N 937 (1082)
Q Consensus 868 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~------~ 937 (1082)
..+ ..++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ +|+||||||+||+++ .
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 654 789999999 899999999876667999999999999999999999954 899999999999994 4
Q ss_pred CCcEEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHH
Q 045553 938 NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017 (1082)
Q Consensus 938 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 1017 (1082)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS-YTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----------CHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc-cCChHH
Confidence 458999999999876532 233478999999999999999999999999999999999999997542110 001111
Q ss_pred HHHHHHHhcCCCccc-----------ccc----------c---------cCCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 045553 1018 AWASMLLLQGRPCEF-----------FTA----------G---------LWDCGPHDDLIEMLNLAIMCTGESLSSRPSM 1067 (1082)
Q Consensus 1018 ~~~~~~~~~~~~~~~-----------~d~----------~---------l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 1067 (1082)
........-+..... +.. . -....+.....++.+++.+|++.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 111111111111100 000 0 0012346678899999999999999999999
Q ss_pred HHHHHH
Q 045553 1068 RQVAQQ 1073 (1082)
Q Consensus 1068 ~ev~~~ 1073 (1082)
.||+++
T Consensus 329 ~ell~h 334 (373)
T 1q8y_A 329 GGLVNH 334 (373)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=333.71 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=197.6
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE----
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM---- 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 872 (1082)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467999999999999999999654 689999999975432 3356788999999999999999999999876654
Q ss_pred --EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 873 --FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 873 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 688888743 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-cCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-QGR 1028 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1028 (1082)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ...+....... .+.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~~~ 260 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--------DYLDQLTQILKVTGV 260 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCC
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHHhCC
Confidence 65432 234578999999999987 78899999999999999999999999742 11222222211 111
Q ss_pred Cc-ccccc---------------ccCC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PC-EFFTA---------------GLWD---CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~-~~~d~---------------~l~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. +..+. .... ......+..+.+++.+|++.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 10 00000 0000 0012335689999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=331.49 Aligned_cols=265 Identities=22% Similarity=0.325 Sum_probs=191.9
Q ss_pred HHHHHHhcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCe-
Q 045553 794 ENVVRATAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE- 871 (1082)
Q Consensus 794 ~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 871 (1082)
.......++|++.+.||+|+||.||+|+.. +|+.||||++..... ....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445567789999999999999999999764 689999999865432 23456778888899999999999999865333
Q ss_pred ------EEEEEeecCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEeccCCCCCEEEcC-CCc
Q 045553 872 ------MFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYLH--DECVPRVLHRDIKPSNILLDN-NLN 940 (1082)
Q Consensus 872 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlk~~Nill~~-~~~ 940 (1082)
.++||||+++ ++...+.. .....+++..+..++.|++.|+.||| +. +|+||||||+||+++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999965 65555442 23567899999999999999999999 87 9999999999999997 899
Q ss_pred EEEeecccceecCCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHH
Q 045553 941 AYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAW 1019 (1082)
Q Consensus 941 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~ 1019 (1082)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~~~ 240 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN--------SAGQ 240 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC--------hHHH
Confidence 99999999987654332 2345789999999998765 48999999999999999999999997431 1111
Q ss_pred HHHHHh-cCCC-c-------------ccccc------ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1020 ASMLLL-QGRP-C-------------EFFTA------GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1020 ~~~~~~-~~~~-~-------------~~~d~------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
...... .+.. . ...+. ......+...+.++.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111 0000 0 00000 00011122356789999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=327.72 Aligned_cols=259 Identities=19% Similarity=0.301 Sum_probs=203.3
Q ss_pred hcCccccceecccCceEEEEEEEc-CC-eEEEEEEeecCccccHHHHHHHHHHHhccCCCc------eeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PG-VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN------LVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 871 (1082)
.++|++.+.||+|+||+||+|... ++ ..||+|++... ....+.+.+|++++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999764 34 78999998754 234567888999999997765 8999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE----------------
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL---------------- 935 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---------------- 935 (1082)
.++||||+ ++++.+++.......+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 77888888776556799999999999999999999999 99999999999999
Q ss_pred ---cCCCcEEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCC
Q 045553 936 ---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012 (1082)
Q Consensus 936 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~ 1012 (1082)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----- 243 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE----- 243 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----
Confidence 56789999999999875432 234579999999999999999999999999999999999999997421
Q ss_pred CccHHHHHHHHHhcCCCccccc----------cc-c--------------------CCCCChHHHHHHHHHHHHcccCCC
Q 045553 1013 GFNIVAWASMLLLQGRPCEFFT----------AG-L--------------------WDCGPHDDLIEMLNLAIMCTGESL 1061 (1082)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~d----------~~-l--------------------~~~~~~~~~~~l~~li~~cl~~~p 1061 (1082)
.......+.... ......+.. .. . ...........+.+++.+|++.||
T Consensus 244 ~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 244 NREHLVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp HHHHHHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HHHHHHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 111111111111 110000000 00 0 001123446689999999999999
Q ss_pred CCCCCHHHHHHH
Q 045553 1062 SSRPSMRQVAQQ 1073 (1082)
Q Consensus 1062 ~~RPt~~ev~~~ 1073 (1082)
++|||+.|++++
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999853
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=337.60 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=189.8
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998877778999999998653 345678899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCC-----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-------------CcE
Q 045553 880 PGGNLEKFIQDRPRRT-----VEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-------------LNA 941 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-------------~~~ 941 (1082)
. |+|.+++....... .++..++.++.||+.||+|||+. +|+||||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999998653211 13334678999999999999999 99999999999999754 489
Q ss_pred EEeecccceecCCCCCc---cccCcccCCCcccchhccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCC
Q 045553 942 YLSDFGLARLLGTSETH---ATTDVAGTFGYVAPEYAMT-------CRVSDKADVYSFGVVLLELIS-DKKALDPSFCSF 1010 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~ 1010 (1082)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 99999999987543322 2234579999999999975 678999999999999999999 99998643211
Q ss_pred CCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1011 GNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.. ......... +......+...+.++.+++.+|++.||++||++.||++
T Consensus 247 -----~~----~i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 -----ES----NIIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -----HH----HHHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HH----HHhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 111111100 01111123466788999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=325.23 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=180.4
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHH-HHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIR-TLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++|++.+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367899999999999999999764 689999999976532 33445556665 778889999999999999999999999
Q ss_pred eecCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 877 NYLPGGNLEKFIQD---RPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 877 E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
||++ ++|.+++.. .....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9996 588887763 22467899999999999999999999953 89999999999999999999999999998764
Q ss_pred CCCCccccCcccCCCcccchhc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 954 TSETHATTDVAGTFGYVAPEYA----MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
.... .....|++.|+|||++ .+..++.++||||||+++|||++|+.||...... .+.+. ..
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~------~~ 242 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLT------QV 242 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------C------CC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHH------HH
Confidence 3322 2334689999999998 4667899999999999999999999999742111 00000 00
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.....+.+........+..+.+++.+||+.||++||++.||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000011111112234568999999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=327.62 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=197.4
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCe-----
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE----- 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 871 (1082)
..+|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999754 68999999996543 2335678899999999999999999999887653
Q ss_pred -EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 872 -MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 872 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
.++||||++ ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 599999996 688887753 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-cCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-QGR 1028 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1028 (1082)
..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.... ..+.+..... .+.
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQLTQILKVTGV 242 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC--------HHHHHHHHHHHHCB
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCC
Confidence 65322 234578999999999887 678999999999999999999999997421 1122222111 010
Q ss_pred Ccc-c-------------------cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCE-F-------------------FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~-~-------------------~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... . ....+ .......+..+.+++.+|++.||++||++.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0 00000 01123456789999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=326.68 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=193.6
Q ss_pred HHHhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccc------cHHHHHHHHHHHhcc----CCCceeeEeee
Q 045553 797 VRATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ------GVQQFAAEIRTLGRV----QHPNLVTLIGY 865 (1082)
Q Consensus 797 ~~~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~~~ 865 (1082)
....++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999965 46899999999755322 223456789988888 89999999999
Q ss_pred eccCCeEEEEEee-cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc-CCCcEEE
Q 045553 866 HVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYL 943 (1082)
Q Consensus 866 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl 943 (1082)
+...+..++|||| +.+++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 7899999999874 4689999999999999999999999 999999999999999 8899999
Q ss_pred eecccceecCCCCCccccCcccCCCcccchhcccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHH
Q 045553 944 SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS-DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 944 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
+|||+++...... .....|+..|+|||++.+..+. .++||||+|+++|||++|+.||.... .
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~---- 244 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------E---- 244 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------H----
Confidence 9999998765432 2345689999999999876664 58999999999999999999986310 1
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. .... ..+......+.+++.+|++.+|++||++.|++++
T Consensus 245 ~~-~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 IL-EAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HH-HTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred Hh-hhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1100 1223445678999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=327.47 Aligned_cols=242 Identities=26% Similarity=0.395 Sum_probs=200.5
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccc------cHHHHHHHHHHHhccC--CCceeeEeeeeccC
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ------GVQQFAAEIRTLGRVQ--HPNLVTLIGYHVSE 869 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~ 869 (1082)
...+|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 456799999999999999999965 46899999999754321 2245678999999996 59999999999999
Q ss_pred CeEEEEEeecCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc-CCCcEEEeecc
Q 045553 870 AEMFLIYNYLPG-GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFG 947 (1082)
Q Consensus 870 ~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfG 947 (1082)
+..++||||+.+ ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 999999999976 8999999873 4689999999999999999999999 999999999999999 78999999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ....
T Consensus 196 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------------~~~~- 257 (320)
T 3a99_A 196 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIR- 257 (320)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHH-
T ss_pred cccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------------hhhc-
Confidence 99876533 2234569999999999987665 678999999999999999999986321 0111
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.. ..+...+.++.+++.+||+.||++||++.||+++
T Consensus 258 ~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 0122334678999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=334.63 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=189.5
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
..+|++.++||+|+||+||.....+++.||||++...... .+.+|+++++++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3468889999999999977666677999999999754332 256799999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-----CCcEEEeecccceecC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-----NLNAYLSDFGLARLLG 953 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~DfGla~~~~ 953 (1082)
+. |+|.+++.... ....+..+..++.||+.||+|||+. +|+||||||+||+++. ...+||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 95 69999998753 3344556778999999999999999 9999999999999953 3468899999998775
Q ss_pred CCCC--ccccCcccCCCcccchhcc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 954 TSET--HATTDVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 954 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
.... .......||+.|+|||++. ...++.++||||+||++|||++ |..||..... ..... ....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------~~~~~-~~~~ 244 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQANI-LLGA 244 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------HHHHH-HTTC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------HHHHH-Hhcc
Confidence 4322 2334567999999999997 4667889999999999999999 8888853211 11111 1111
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
...... ..+......+.+++.+|++.||++||++.||++
T Consensus 245 ~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111 112345567889999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=318.80 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=183.8
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccc--cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457899999999999999999765 6899999999765322 2233445556788889999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
||+ ++.+..+.... ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 55666555432 4568999999999999999999998 6 8999999999999999999999999999766433
Q ss_pred CCccccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 956 ETHATTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
. ......|++.|+|||++. ...++.++||||||+++|||++|+.||.... .............. .
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~-~ 248 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-------TDFEVLTKVLQEEP-P 248 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHHHHHSCC-C
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-------ccHHHHHHHhccCC-C
Confidence 2 223456899999999994 5678899999999999999999999997321 22233333333221 1
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ......+.++.+++.+|++.||++||++.|++++
T Consensus 249 ~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 LL-------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CC-------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 0111234679999999999999999999999763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=346.01 Aligned_cols=267 Identities=23% Similarity=0.337 Sum_probs=203.7
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeecc------CCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS------EAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 871 (1082)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999965 46899999998754 33445678999999999999999999998765 677
Q ss_pred EEEEEeecCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCc---EEEeecc
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLN---AYLSDFG 947 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG 947 (1082)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998743 23688999999999999999999999 9999999999999997664 9999999
Q ss_pred cceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 948 LARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 948 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
.+....... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||.... ....|........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-------~~~~~~~~i~~~~ 240 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-------QPVQWHGKVREKS 240 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-------HHHHSSTTCC---
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-------chhhhhhhhhccc
Confidence 998765433 2344679999999999999999999999999999999999999997532 1122211111000
Q ss_pred CCccccccc------------cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHhhhC
Q 045553 1028 RPCEFFTAG------------LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQ-----VAQQLKQIQ 1078 (1082)
Q Consensus 1028 ~~~~~~d~~------------l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-----v~~~L~~i~ 1078 (1082)
......... .........+..+.+++.+|++.||++|||+.| ..+.++.+.
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 000000000 011233457889999999999999999999977 445555443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.80 Aligned_cols=275 Identities=21% Similarity=0.242 Sum_probs=170.1
Q ss_pred CHHHHHHHHhcccCCCCCCCCCC---CCCCCCceeeeeEeeC--------CCCCeeeeecCCCccccccccCCCCCCCCC
Q 045553 1 KNALLQLKSAITEDPLGLTSNWN---PKDTDSCSWHGVTCDP--------LSGRVTSLNLSSNLSRTSCSLLSLPPAAGP 69 (1082)
Q Consensus 1 ~~~l~~~k~~~~~~~~~~~~~W~---~~~~~~c~w~gv~C~~--------~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~ 69 (1082)
++||++||+++..||.+.+++|. ..+.++|.|.||.|+. ...+|+.|+|++|
T Consensus 29 ~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n----------------- 91 (328)
T 4fcg_A 29 HDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSV----------------- 91 (328)
T ss_dssp HHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESS-----------------
T ss_pred HHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCC-----------------
Confidence 47999999999889988889994 3467899999999952 2234444544431
Q ss_pred CCCcccCcCcccccccccCcccCCCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCC
Q 045553 70 GGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGP 149 (1082)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 149 (1082)
++. .+|+.+.++++|++|+|++|.++ .+|..|+.+++|++|+|++|.++ .
T Consensus 92 ---------------------------~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~ 141 (328)
T 4fcg_A 92 ---------------------------PLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-A 141 (328)
T ss_dssp ---------------------------CCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-C
T ss_pred ---------------------------Cch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-c
Confidence 122 33444444555555555555554 44555555555555555555554 4
Q ss_pred CCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccC
Q 045553 150 IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGN 229 (1082)
Q Consensus 150 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 229 (1082)
+|..++++++|++|+|++|.+.+.+|..+... .++.. +..+++|++|+|++|+++ .+|..+++
T Consensus 142 lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~---------------~~~~~-~~~l~~L~~L~L~~n~l~-~lp~~l~~ 204 (328)
T 4fcg_A 142 LPASIASLNRLRELSIRACPELTELPEPLAST---------------DASGE-HQGLVNLQSLRLEWTGIR-SLPASIAN 204 (328)
T ss_dssp CCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE---------------C-CCC-EEESTTCCEEEEEEECCC-CCCGGGGG
T ss_pred CcHHHhcCcCCCEEECCCCCCccccChhHhhc---------------cchhh-hccCCCCCEEECcCCCcC-cchHhhcC
Confidence 45455555555555555544444444433220 00000 113566666666666666 56666666
Q ss_pred CCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccC
Q 045553 230 CTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDG 309 (1082)
Q Consensus 230 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~ 309 (1082)
+++|++|+|++|++++ +|..+..+++|++|+|++|++.+.+|..++.+++|++|++++
T Consensus 205 l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~--------------------- 262 (328)
T 4fcg_A 205 LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD--------------------- 262 (328)
T ss_dssp CTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTT---------------------
T ss_pred CCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCC---------------------
Confidence 6677777777776663 555566666777777777666666666666777777777665
Q ss_pred CCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCcccc
Q 045553 310 GEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFT 365 (1082)
Q Consensus 310 ~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~ 365 (1082)
|.+.+.+|..+.++++|++|++++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 263 ----n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 263 ----CSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ----CTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ----CCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 3344556666777777777777777777777777777788888877776665
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.81 Aligned_cols=230 Identities=13% Similarity=0.078 Sum_probs=184.5
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+..+++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357999999999999999999765 489999999976533 2347789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.++++.. ....++.+++.|++.||+|||+. +|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999642 35567889999999999999999 99999999999999999999998543
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
|++ .++.++|||||||++|||++|+.||.......... . ....+..
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-~-------------~~~~~~~ 220 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-P-------------AERDTAG 220 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-E-------------CCBCTTS
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-H-------------HHHHhcc
Confidence 232 36889999999999999999999997543210000 0 0000000
Q ss_pred ccCC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1036 GLWD--CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1036 ~l~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.... ......+.++.+++.+||+.||++| |+.|+++.|+++..
T Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0000 0112345679999999999999999 99999999998654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=344.96 Aligned_cols=239 Identities=23% Similarity=0.305 Sum_probs=194.5
Q ss_pred hcCccccceecccCceEEEEEEEc--CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCe-----
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII--PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE----- 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 871 (1082)
.++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999775 58999999986543 3445678899999999999999999999987655
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.|+||||+++++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988754 689999999999999999999999 99999999999999986 899999999987
Q ss_pred cCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
.... ....||+.|+|||++.+.. +.++|||||||++|||++|..||....... ..
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~~- 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------LP- 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------CC-
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------cc-
Confidence 6433 3457999999999987754 899999999999999999998876432110 00
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhh
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-SMRQVAQQLKQI 1077 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~i 1077 (1082)
...........+.+++.+|++.||++|| ++.++.+.|.++
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0000112345789999999999999999 566666666543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-31 Score=305.06 Aligned_cols=103 Identities=19% Similarity=0.316 Sum_probs=59.3
Q ss_pred cccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhcc
Q 045553 544 CMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623 (1082)
Q Consensus 544 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 623 (1082)
+|++|++++|++++. ..+..+++|++|++++|.+++. ..+..+++|+.|++++|++++..|..|..+++|++|+|+
T Consensus 244 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 319 (347)
T 4fmz_A 244 QLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319 (347)
T ss_dssp TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECC
T ss_pred CCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEcc
Confidence 355555555555443 3455566666666666666643 245566666666666666666666666666666666666
Q ss_pred CcccCCCCCccccCCcccceecccCcccC
Q 045553 624 ANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652 (1082)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 652 (1082)
+|++++..| +..+++|++|++++|+|+
T Consensus 320 ~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 320 QNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCccccccC--hhhhhccceeehhhhccc
Confidence 666664433 556666666666666654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=304.37 Aligned_cols=228 Identities=21% Similarity=0.264 Sum_probs=181.9
Q ss_pred hcCcccc-ceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHH-hccCCCceeeEeeeecc----CCeE
Q 045553 800 TAGFNVQ-NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTL-GRVQHPNLVTLIGYHVS----EAEM 872 (1082)
Q Consensus 800 ~~~~~~~-~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 872 (1082)
.++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567776 7899999999999975 46899999998642 4567888887 66699999999998876 6788
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---CCcEEEeecccc
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLA 949 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla 949 (1082)
++||||+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999987666899999999999999999999999 9999999999999998 789999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
.... +..++.++||||+||++|||++|+.||....... ......
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-------------~~~~~~ 211 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------------ISPGMK 211 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CCSC
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-------------hhHHHH
Confidence 7542 1346789999999999999999999996432110 000000
Q ss_pred ccccccccCCCCC----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 CEFFTAGLWDCGP----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
........ ..+ ...+.++.+++.+|++.||++||++.|++++
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000 111 2345789999999999999999999999874
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=316.45 Aligned_cols=332 Identities=21% Similarity=0.222 Sum_probs=230.3
Q ss_pred cccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEE
Q 045553 206 CVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLV 285 (1082)
Q Consensus 206 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 285 (1082)
+.+++.|++++|.++...+..+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|+.+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 56777788887777744444467777777778877777766666777777777777777777766666666666666666
Q ss_pred eccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCcccc
Q 045553 286 LRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFT 365 (1082)
Q Consensus 286 l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~ 365 (1082)
+++| .+..+.+..|..+++|++|+|++|+++
T Consensus 124 L~~n-------------------------------------------------~l~~l~~~~~~~l~~L~~L~L~~n~l~ 154 (390)
T 3o6n_A 124 LERN-------------------------------------------------DLSSLPRGIFHNTPKLTTLSMSNNNLE 154 (390)
T ss_dssp CCSS-------------------------------------------------CCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCC-------------------------------------------------ccCcCCHHHhcCCCCCcEEECCCCccC
Confidence 6553 333333333444445555555555554
Q ss_pred CCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeeccccc
Q 045553 366 GQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFF 445 (1082)
Q Consensus 366 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (1082)
+..+..|..+++|+.|+|++|++++.. ...++.|+.|++++|.+++..
T Consensus 155 ~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l~~~~------------------------------ 202 (390)
T 3o6n_A 155 RIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLA------------------------------ 202 (390)
T ss_dssp BCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCCSEEE------------------------------
T ss_pred ccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccccccccC------------------------------
Confidence 444444555555555555555554431 122344555555544443100
Q ss_pred ccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEc
Q 045553 446 YENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDI 525 (1082)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l 525 (1082)
. ...++.|++
T Consensus 203 --------------------------------~--------------------------------------~~~L~~L~l 212 (390)
T 3o6n_A 203 --------------------------------I--------------------------------------PIAVEELDA 212 (390)
T ss_dssp --------------------------------C--------------------------------------CSSCSEEEC
T ss_pred --------------------------------C--------------------------------------CCcceEEEC
Confidence 0 012245666
Q ss_pred cCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCc
Q 045553 526 GNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG 605 (1082)
Q Consensus 526 ~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 605 (1082)
++|++. .+|...+ ++|+.|++++|++++. ..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++
T Consensus 213 ~~n~l~-~~~~~~~---~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 286 (390)
T 3o6n_A 213 SHNSIN-VVRGPVN---VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA 286 (390)
T ss_dssp CSSCCC-EEECCCC---SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE
T ss_pred CCCeee-ecccccc---ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc
Confidence 666655 3444332 5699999999999875 579999999999999999998889999999999999999999994
Q ss_pred cCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC--c
Q 045553 606 AIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN--S 683 (1082)
Q Consensus 606 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~--~ 683 (1082)
+|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++. + +..+++|+.|++++|++++..... .
T Consensus 287 -~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~ 361 (390)
T 3o6n_A 287 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFR 361 (390)
T ss_dssp -EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTT
T ss_pred -cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHHHHHH
Confidence 6777788999999999999999 6777888999999999999999954 3 678899999999999999754432 2
Q ss_pred ccccccCCCCCCCCCC
Q 045553 684 LIKCENVQGNPNLQLC 699 (1082)
Q Consensus 684 ~~~~~~~~~Np~~c~c 699 (1082)
.+....+.+++..|.|
T Consensus 362 ~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 362 NVARPAVDDADQHCKI 377 (390)
T ss_dssp TCCTTTBCCCCSCCCT
T ss_pred HHHhhcccccCceecc
Confidence 2334456677777554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=324.01 Aligned_cols=241 Identities=17% Similarity=0.154 Sum_probs=182.2
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCC-Cceee-------------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQH-PNLVT------------- 861 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~------------- 861 (1082)
...|...++||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+++.++| +|...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577889999999999999974 4689999999874332 235778999999999987 32111
Q ss_pred --------Eeeeecc-----CCeEEEEEeecCCCCHHHHHh-----hCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 045553 862 --------LIGYHVS-----EAEMFLIYNYLPGGNLEKFIQ-----DRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923 (1082)
Q Consensus 862 --------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 923 (1082)
+..++.. ...++++|+++ +++|.++++ ......+++..+..++.|+++||+|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1111111 22467777776 789999985 22244678889999999999999999999 99
Q ss_pred EeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcccchhc----------ccCCCCchhhHHHHHHHH
Q 045553 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA----------MTCRVSDKADVYSFGVVL 993 (1082)
Q Consensus 924 vH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slGvll 993 (1082)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999875432 344567 999999999 556688999999999999
Q ss_pred HHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 994 LELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 994 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
|||++|+.||...... +..+..+.. ....+..+.+++.+||+.||++||++.|+++
T Consensus 308 ~elltg~~Pf~~~~~~---------------------~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAAL---------------------GGSEWIFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGG---------------------SCSGGGGSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchh---------------------hhHHHHHhh--cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999743211 011111110 0123467999999999999999999777644
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-31 Score=301.74 Aligned_cols=218 Identities=23% Similarity=0.321 Sum_probs=143.7
Q ss_pred ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 185 (1082)
+.++++|++|++++|.+. .+| .+..+++|++|+|++|.+++ ++. +.++++|++|++++|+++. + ..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCC
Confidence 556778888888888877 444 37778888888888888873 444 7788888888888887774 3 3577777777
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCC
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 265 (1082)
+|++++|++. .++. ...+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|
T Consensus 114 ~L~l~~n~i~-~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 114 ELYLNEDNIS-DISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp EEECTTSCCC-CCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred EEECcCCccc-Cchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 7777777776 3333 2346666666666665443333 35666666666666666653322 555666666666666
Q ss_pred cCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCC
Q 045553 266 FLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFP 345 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~ 345 (1082)
.+.+..+ +..+++|+.|++++|.+.+..+
T Consensus 188 ~l~~~~~---------------------------------------------------~~~l~~L~~L~l~~n~l~~~~~ 216 (347)
T 4fmz_A 188 QIEDISP---------------------------------------------------LASLTSLHYFTAYVNQITDITP 216 (347)
T ss_dssp CCCCCGG---------------------------------------------------GGGCTTCCEEECCSSCCCCCGG
T ss_pred ccccccc---------------------------------------------------ccCCCccceeecccCCCCCCch
Confidence 5553211 3444555555666666655544
Q ss_pred cccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcc
Q 045553 346 QNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390 (1082)
Q Consensus 346 ~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~ 390 (1082)
+..+++|++|++++|++++. +. +..+++|+.|++++|++++
T Consensus 217 --~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~ 257 (347)
T 4fmz_A 217 --VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD 257 (347)
T ss_dssp --GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC
T ss_pred --hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC
Confidence 67778888888888888843 33 7788888888888887763
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=331.42 Aligned_cols=331 Identities=21% Similarity=0.224 Sum_probs=236.0
Q ss_pred cccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEE
Q 045553 206 CVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLV 285 (1082)
Q Consensus 206 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 285 (1082)
+.+++.|++++|.++...+..+.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56788888888888865555677788888888888888877777888888888888888888877666677777777666
Q ss_pred eccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCcccc
Q 045553 286 LRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFT 365 (1082)
Q Consensus 286 l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~ 365 (1082)
+++| .+.++.+..|..+++|++|+|++|.++
T Consensus 130 L~~n-------------------------------------------------~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 160 (597)
T 3oja_B 130 LERN-------------------------------------------------DLSSLPRGIFHNTPKLTTLSMSNNNLE 160 (597)
T ss_dssp CCSS-------------------------------------------------CCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred eeCC-------------------------------------------------CCCCCCHHHhccCCCCCEEEeeCCcCC
Confidence 6653 333333333444444555555555554
Q ss_pred CCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeeccccc
Q 045553 366 GQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFF 445 (1082)
Q Consensus 366 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (1082)
+..|..|..+++|+.|+|++|.+++.. ...++.|+.|++++|.+++..
T Consensus 161 ~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l~~l~------------------------------ 208 (597)
T 3oja_B 161 RIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLA------------------------------ 208 (597)
T ss_dssp BCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCCSEEE------------------------------
T ss_pred CCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCcccccc------------------------------
Confidence 444444555555555555555554432 112344444554444443100
Q ss_pred ccccccCcCCCCCCCCCceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEc
Q 045553 446 YENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDI 525 (1082)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l 525 (1082)
. ...++.|++
T Consensus 209 --------------------------------~--------------------------------------~~~L~~L~l 218 (597)
T 3oja_B 209 --------------------------------I--------------------------------------PIAVEELDA 218 (597)
T ss_dssp --------------------------------C--------------------------------------CTTCSEEEC
T ss_pred --------------------------------C--------------------------------------Cchhheeec
Confidence 0 001235556
Q ss_pred cCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCc
Q 045553 526 GNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG 605 (1082)
Q Consensus 526 ~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 605 (1082)
++|.+. .+|...+ ++|+.|+|++|.+++. ..+..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++
T Consensus 219 s~n~l~-~~~~~~~---~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 292 (597)
T 3oja_B 219 SHNSIN-VVRGPVN---VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA 292 (597)
T ss_dssp CSSCCC-EEECSCC---SCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE
T ss_pred cCCccc-ccccccC---CCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC
Confidence 666554 3343332 4699999999999874 689999999999999999999999999999999999999999995
Q ss_pred cCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC--c
Q 045553 606 AIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN--S 683 (1082)
Q Consensus 606 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~--~ 683 (1082)
+|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++. | +..+++|+.|++++|+|+|..... .
T Consensus 293 -l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~ 367 (597)
T 3oja_B 293 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFR 367 (597)
T ss_dssp -EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTT
T ss_pred -CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHH
Confidence 6777888999999999999999 6888889999999999999999965 3 677899999999999999865433 2
Q ss_pred ccccccCCCCCCCCC
Q 045553 684 LIKCENVQGNPNLQL 698 (1082)
Q Consensus 684 ~~~~~~~~~Np~~c~ 698 (1082)
.+....+.+++..|.
T Consensus 368 ~~~~~~~~~~~~~C~ 382 (597)
T 3oja_B 368 NVARPAVDDADQHCK 382 (597)
T ss_dssp TCCTTTBCCCCCCCC
T ss_pred HHhhhccccccccCC
Confidence 234445667777744
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-31 Score=300.49 Aligned_cols=131 Identities=18% Similarity=0.220 Sum_probs=102.7
Q ss_pred CcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhc
Q 045553 543 KCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLEL 622 (1082)
Q Consensus 543 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 622 (1082)
++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 34777778888888777778888888888888888888777778888888888888888888 67777888888888888
Q ss_pred cCcccCCCCCccccC------CcccceecccCcccC--CCCCCCCCCCCcccEEeccCCc
Q 045553 623 SANSLSGEIPSEFSK------LEHLNVLRLDHNNLT--GRIPPGFGTRSSLSIFDVSFNN 674 (1082)
Q Consensus 623 s~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~l~ls~N~ 674 (1082)
++|+|++..+..|.. ...|+.|++++|++. +..|..|..+++|+.+++++|+
T Consensus 272 ~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 272 HTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 888888766666654 366888888888887 6777788888888888888874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-33 Score=313.88 Aligned_cols=238 Identities=16% Similarity=0.146 Sum_probs=184.0
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecCc--------cccHHHHHHHHHHHhccC---------CCceeeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR--------FQGVQQFAAEIRTLGRVQ---------HPNLVTL 862 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l 862 (1082)
.++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45689999999999999999987 68999999997653 233477889999998886 6666555
Q ss_pred eee-----------------ecc-------------CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHH
Q 045553 863 IGY-----------------HVS-------------EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912 (1082)
Q Consensus 863 ~~~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L 912 (1082)
.++ +.+ ....++||||+++|++.+.+.. ..+++..+..++.|++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 554 433 6789999999999976666643 4689999999999999999
Q ss_pred HHHh-hCCCCCeEeccCCCCCEEEcCCC--------------------cEEEeecccceecCCCCCccccCcccCCCccc
Q 045553 913 AYLH-DECVPRVLHRDIKPSNILLDNNL--------------------NAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971 (1082)
Q Consensus 913 ~~LH-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 971 (1082)
+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 88 999999999999999887 8999999999876432 2479999999
Q ss_pred chhcccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCccCCCCCccHHHHHHH---HHh-cCCCccccccccCCCCChHHH
Q 045553 972 PEYAMTCRVSDKADVYSFGVV-LLELISDKKALDPSFCSFGNGFNIVAWASM---LLL-QGRPCEFFTAGLWDCGPHDDL 1046 (1082)
Q Consensus 972 PE~~~~~~~~~~~Dv~slGvl-l~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~d~~l~~~~~~~~~ 1046 (1082)
||++.+.. +.++||||+|++ .+++++|..||.. ..|... ... ...... ......+...+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~s 309 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFKT----KCNTPAMKQIK 309 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCSS----CCCSHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccCc----ccchhhhhhcC
Confidence 99998766 899999998776 7788889888742 122111 111 111110 00011123567
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1047 IEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1047 ~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
.++.+++.+|++.| |+.|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 88999999999976 899887
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=302.62 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=197.6
Q ss_pred CCCCEEEcccCCCcc--cCChhhcCCCCCCEEeCcC-CCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcE
Q 045553 110 TQLRVLLLAFNGFSG--ELPLEIGQLSLLEILDLSF-NSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQV 186 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 186 (1082)
.+++.|+|++|++++ .+|..|+++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 578888888888888 7888888888888888884 8888888888888888888888888888888888888888888
Q ss_pred EEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCC-CccEEEccCCcCCCCcCccccCCCCCCEEeCCCC
Q 045553 187 VSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCT-ELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265 (1082)
Q Consensus 187 L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 265 (1082)
|+|++|++++.+|..+. .+++|++|++++|++++.+|..++.++ +|++|++++|++++.+|..|..++ |++|++++|
T Consensus 130 L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGG-GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred EeCCCCccCCcCChHHh-cCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 88888888766666654 466666666666666666666666665 666666666666655666666555 666666666
Q ss_pred cCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCC
Q 045553 266 FLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFP 345 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~ 345 (1082)
++++..|. .|..+++|+.|++++|.+.+..+
T Consensus 208 ~l~~~~~~-------------------------------------------------~~~~l~~L~~L~L~~N~l~~~~~ 238 (313)
T 1ogq_A 208 MLEGDASV-------------------------------------------------LFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp EEEECCGG-------------------------------------------------GCCTTSCCSEEECCSSEECCBGG
T ss_pred cccCcCCH-------------------------------------------------HHhcCCCCCEEECCCCceeeecC
Confidence 66554444 44555566666666666766655
Q ss_pred cccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCc-ceec
Q 045553 346 QNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNL-LSGE 414 (1082)
Q Consensus 346 ~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~-l~~~ 414 (1082)
. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|....+++|+.+++++|+ +.|.
T Consensus 239 ~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp G-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred c-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCC
Confidence 5 788899999999999999999999999999999999999999999998889999999999998 5553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=294.25 Aligned_cols=130 Identities=18% Similarity=0.211 Sum_probs=82.9
Q ss_pred cccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhcc
Q 045553 544 CMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623 (1082)
Q Consensus 544 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 623 (1082)
+|++|++++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|+
T Consensus 193 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~ 271 (330)
T 1xku_A 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271 (330)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECC
Confidence 3566666666666666666666666666666666666655556666666666666666666 556666666666666666
Q ss_pred CcccCCCCCccccC------CcccceecccCcccCC--CCCCCCCCCCcccEEeccCCc
Q 045553 624 ANSLSGEIPSEFSK------LEHLNVLRLDHNNLTG--RIPPGFGTRSSLSIFDVSFNN 674 (1082)
Q Consensus 624 ~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~l~ls~N~ 674 (1082)
+|+|++..+..|.. ...|+.|+|++|++.. ..|..|..+.+++.+++++|+
T Consensus 272 ~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 272 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 66666555555532 3567777777777752 455667777777777777774
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=293.64 Aligned_cols=244 Identities=23% Similarity=0.281 Sum_probs=178.1
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
.+|+.++++++.++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 36899999999998 7787664 78999999999999777888999999999999999999888999999999999999
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCC--CCcCccccCCCCCCEEeCCCCcC
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ--GDIPSSFGQLVNLEVLDLSRNFL 267 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l 267 (1082)
++|+++ .+|..++ ++|++|++++|++++..+..+.++++|++|++++|.++ +..+..|..+ +|++|++++|++
T Consensus 110 ~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 999998 7887765 68999999999998666667888899999999999886 3667778777 888888888888
Q ss_pred cccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcc
Q 045553 268 SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN 347 (1082)
Q Consensus 268 ~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~ 347 (1082)
++ +|..+. ++|++|++++| .+.+..|..+..+++|++|++++|.+.+..+..
T Consensus 185 ~~-l~~~~~--~~L~~L~l~~n-------------------------~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 236 (332)
T 2ft3_A 185 TG-IPKDLP--ETLNELHLDHN-------------------------KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGS 236 (332)
T ss_dssp SS-CCSSSC--SSCSCCBCCSS-------------------------CCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTG
T ss_pred Cc-cCcccc--CCCCEEECCCC-------------------------cCCccCHHHhcCCCCCCEEECCCCcCCcCChhH
Confidence 74 454432 45565555543 233333444555555555555555555555555
Q ss_pred cccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcc
Q 045553 348 WELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390 (1082)
Q Consensus 348 l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~ 390 (1082)
+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++
T Consensus 237 ~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp GGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred hhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCc
Confidence 555555555555555555 445555555555555555555543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-30 Score=290.02 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=176.5
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
.+|+.++++++.++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++|++|+|
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 36889999999988 6776654 68999999999999777778999999999999999999888999999999999999
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCC--CcCccccCCCCCCEEeCCCCcC
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG--DIPSSFGQLVNLEVLDLSRNFL 267 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l 267 (1082)
++|+++ .+|..++ ++|++|++++|++++..+..+.++++|++|++++|.++. ..+..|..+++|++|++++|.+
T Consensus 108 s~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 108 SKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 999998 7777664 578888888888887777778888888888888888853 5667788888888888888888
Q ss_pred cccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcc
Q 045553 268 SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN 347 (1082)
Q Consensus 268 ~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~ 347 (1082)
+. +|..+. ++|++|++++| .+.+..|..|..+++|++|++++|.+.+..+..
T Consensus 184 ~~-l~~~~~--~~L~~L~l~~n-------------------------~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 235 (330)
T 1xku_A 184 TT-IPQGLP--PSLTELHLDGN-------------------------KITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235 (330)
T ss_dssp CS-CCSSCC--TTCSEEECTTS-------------------------CCCEECTGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred cc-CCcccc--ccCCEEECCCC-------------------------cCCccCHHHhcCCCCCCEEECCCCcCceeChhh
Confidence 73 444332 55666666553 233333445555555555555555555555555
Q ss_pred cccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcc
Q 045553 348 WELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390 (1082)
Q Consensus 348 l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~ 390 (1082)
+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++
T Consensus 236 ~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~ 277 (330)
T 1xku_A 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277 (330)
T ss_dssp GGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred ccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCc
Confidence 555555555555555555 455555555555555555555553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-34 Score=337.13 Aligned_cols=86 Identities=21% Similarity=0.194 Sum_probs=51.0
Q ss_pred cccEEEccCCccccc----CccccCCCCCCCEEEccCCCCCCCCcccccC-----CCCCCEEEcCCCcCCc----cCchh
Q 045553 544 CMKFLSMAGNEFVGL----IPQSFTNFDSLRNLNLSRNHLQGPLPSYINK-----MEDLKFLSLSLNNFTG----AIPWE 610 (1082)
Q Consensus 544 ~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~ 610 (1082)
+|++|++++|.+++. ++..+..+++|++|+|++|.+++..+..+.. .++|++|+|++|++++ .+|..
T Consensus 314 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 393 (461)
T 1z7x_W 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 393 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHH
Confidence 466666666666543 3444555666666666666665433333322 4566666666666664 55666
Q ss_pred hhcCcccchhhccCcccCC
Q 045553 611 LTQLASLEVLELSANSLSG 629 (1082)
Q Consensus 611 ~~~l~~L~~L~Ls~N~l~~ 629 (1082)
+..+++|++|+|++|+|++
T Consensus 394 l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 394 LLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHCCCCCEEECCSSSCCH
T ss_pred HHhCCCccEEECCCCCCCH
Confidence 6666666666666666653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-32 Score=324.71 Aligned_cols=159 Identities=18% Similarity=0.158 Sum_probs=83.7
Q ss_pred CCCCEEEcccCCCcccCChh-hcCCCCCCEEeCcCCCCCC----CCCccccCCCCCCeEEccCcccccccCccc-cCCC-
Q 045553 110 TQLRVLLLAFNGFSGELPLE-IGQLSLLEILDLSFNSFHG----PIPPTLQNCSSLRLINLSGNQFNGTIPAFF-GQSP- 182 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~- 182 (1082)
++|++|+|++|+++...... +..+++|++|+|++|.++. .++..+..+++|++|+|++|++.+..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 35666777777666433222 5666677777777776663 235556666667777777766664433322 2233
Q ss_pred ---CCcEEEcccCcccc----cCCcccccccccccEEEcccCccCCCCCcccc-----CCCCccEEEccCCcCCCC----
Q 045553 183 ---GFQVVSLSFNLLSG----SVPEEFGDNCVSLEHILLAANSLTGSIPPSLG-----NCTELRSLLLSSNMLQGD---- 246 (1082)
Q Consensus 183 ---~L~~L~L~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~---- 246 (1082)
+|++|+|++|+++. .++..+. .+++|++|++++|.+++..+..+. ..++|++|++++|++++.
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~-~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLR-TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTT-SCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHc-cCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 46666666666552 2233332 345555555555555433222221 133455555555555532
Q ss_pred cCccccCCCCCCEEeCCCCcCcc
Q 045553 247 IPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 247 ~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
++..+..+++|++|++++|.+++
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~ 184 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINE 184 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcch
Confidence 23344445555555555555543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=286.99 Aligned_cols=182 Identities=17% Similarity=0.133 Sum_probs=154.1
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 48999999999999766668999999999999999999877888999999999999999999666666899999999999
Q ss_pred ccCcccccCCc-ccccccccccEEEcccC-ccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcC
Q 045553 190 SFNLLSGSVPE-EFGDNCVSLEHILLAAN-SLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267 (1082)
Q Consensus 190 ~~N~l~~~~p~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 267 (1082)
++|+++ .+|. ..+..+++|++|++++| .+++..+..+.++++|++|++++|++++..|..|..+++|++|++++|++
T Consensus 132 ~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 132 LGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp TTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred CCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 999998 6666 55557899999999998 47766677888999999999999999988888999999999999999998
Q ss_pred cccCCccccCCCCCcEEEeccccCC
Q 045553 268 SGIVPSELGMCKQLKVLVLRNDYGP 292 (1082)
Q Consensus 268 ~~~~p~~l~~l~~L~~L~l~~n~~~ 292 (1082)
+...+..+..+++|+.|++++|.+.
T Consensus 211 ~~~~~~~~~~~~~L~~L~L~~n~l~ 235 (353)
T 2z80_A 211 ILLLEIFVDVTSSVECLELRDTDLD 235 (353)
T ss_dssp TTHHHHHHHHTTTEEEEEEESCBCT
T ss_pred ccchhhhhhhcccccEEECCCCccc
Confidence 7544444556888888888886543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=273.37 Aligned_cols=232 Identities=20% Similarity=0.187 Sum_probs=165.4
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCC--CCccccCCCCCCeEEccCcccccccCccccCCCCCcEE
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGP--IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 187 (1082)
++|++|+|++|+++...+..|+++++|++|+|++|.++.. .|..+.++++|++|+|++|.+. .+|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 5789999999999844445588999999999999998832 3677788999999999999988 567778888999999
Q ss_pred EcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCC-CcCccccCCCCCCEEeCCCCc
Q 045553 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG-DIPSSFGQLVNLEVLDLSRNF 266 (1082)
Q Consensus 188 ~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~ 266 (1082)
++++|++++..+...+..+++|++|++++|.+++..+..+.++++|++|++++|.+++ ..|..|..+++|++|++++|+
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 9999988843332334457777777777777776666667777777777777777765 466677777777777777777
Q ss_pred CcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCc
Q 045553 267 LSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQ 346 (1082)
Q Consensus 267 l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~ 346 (1082)
+++..|..+..+++|++|+++ +|.+.+..+.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~-------------------------------------------------~N~l~~~~~~ 217 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMS-------------------------------------------------HNNFFSLDTF 217 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECT-------------------------------------------------TSCCSBCCSG
T ss_pred cCCcCHHHhcCCCCCCEEECC-------------------------------------------------CCccCccChh
Confidence 766555555555555555554 4445454445
Q ss_pred ccccccCCCeEEcCCccccCCCCccccCCC-CCCEEecCCCcCccc
Q 045553 347 NWELCSKLEMLNLAHNFFTGQIPASLGNCK-SLYFLDLSSNNLTGL 391 (1082)
Q Consensus 347 ~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~ 391 (1082)
.+..+++|++|+|++|++++..|..+..++ +|++|+|++|++++.
T Consensus 218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 218 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp GGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred hccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 555666666666666666666666666663 666677776666654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-30 Score=315.61 Aligned_cols=433 Identities=12% Similarity=0.061 Sum_probs=240.7
Q ss_pred cccccccCCCCCCEEEcccCCC---cccCChhhc------------CCCCCCEEeCcCCCCCCCCCccccCC--CCCCeE
Q 045553 101 NLSRAIGDLTQLRVLLLAFNGF---SGELPLEIG------------QLSLLEILDLSFNSFHGPIPPTLQNC--SSLRLI 163 (1082)
Q Consensus 101 ~l~~~l~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L~~L~Ls~n~l~~~~p~~l~~l--~~L~~L 163 (1082)
..+..+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..+... ++|++|
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L 143 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence 3445567788888888877532 123333322 45556666666665554444444442 235666
Q ss_pred EccCcc-ccc-ccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCC
Q 045553 164 NLSGNQ-FNG-TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSN 241 (1082)
Q Consensus 164 ~Ls~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 241 (1082)
+|++|. +.. .++.....+++|++|+|++|.+++.-... ++..+..+++|++|++++|
T Consensus 144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~---------------------l~~~~~~~~~L~~L~L~~n 202 (592)
T 3ogk_B 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKW---------------------LHELAQHNTSLEVLNFYMT 202 (592)
T ss_dssp EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHH---------------------HHHHHHHCCCCCEEECTTC
T ss_pred ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhH---------------------HHHHHhcCCCccEEEeecc
Confidence 665554 110 11122234455555555555444221110 1122334455566666666
Q ss_pred cCCC----CcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccC
Q 045553 242 MLQG----DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFD 317 (1082)
Q Consensus 242 ~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~ 317 (1082)
.+++ .++..+..+++|++|++++|.+.+ +|..+..+++|+.|+++..... .-.
T Consensus 203 ~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~----------------------~~~ 259 (592)
T 3ogk_B 203 EFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNED----------------------IGM 259 (592)
T ss_dssp CCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCC----------------------TTC
T ss_pred CCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccc----------------------cch
Confidence 5541 233344455666666666666653 4556666666666666531100 001
Q ss_pred CCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCC-ccccCCCCCCEEecCCCcCccc-CCCC
Q 045553 318 GGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIP-ASLGNCKSLYFLDLSSNNLTGL-LPEE 395 (1082)
Q Consensus 318 ~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~-~p~~ 395 (1082)
+..+..+..+++|+.|.++++. ....|..+..+++|++|+|++|.+++... ..+..+++|+.|+|+ |.+... ++..
T Consensus 260 ~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~ 337 (592)
T 3ogk_B 260 PEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVL 337 (592)
T ss_dssp TTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHH
T ss_pred HHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHH
Confidence 1233455566677777776642 33345566677777777777777654333 335667777777777 444332 2222
Q ss_pred c-ccCcccEEEecC-----------CcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCc
Q 045553 396 V-SVPCMAVFNVSQ-----------NLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGL 463 (1082)
Q Consensus 396 ~-~l~~L~~L~l~~-----------N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (1082)
. .+++|+.|++++ |.+++.
T Consensus 338 ~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~------------------------------------------------- 368 (592)
T 3ogk_B 338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQR------------------------------------------------- 368 (592)
T ss_dssp HHHCTTCCEEEEECCCCSSTTSSTTCCCCHH-------------------------------------------------
T ss_pred HHhCCCCCEEEeecCccccccccccCccCHH-------------------------------------------------
Confidence 1 356677777762 121100
Q ss_pred eeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccCC
Q 045553 464 FILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCK 543 (1082)
Q Consensus 464 ~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~~ 543 (1082)
.++.....+.+|++|+++.|++.+..+..+...++
T Consensus 369 ---------------------------------------------~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~ 403 (592)
T 3ogk_B 369 ---------------------------------------------GLIALAQGCQELEYMAVYVSDITNESLESIGTYLK 403 (592)
T ss_dssp ---------------------------------------------HHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCC
T ss_pred ---------------------------------------------HHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCC
Confidence 00000111344567777777776666666666667
Q ss_pred cccEEEcc----CCccccc-----CccccCCCCCCCEEEccCCC--CCCCCccccc-CCCCCCEEEcCCCcCCc-cCchh
Q 045553 544 CMKFLSMA----GNEFVGL-----IPQSFTNFDSLRNLNLSRNH--LQGPLPSYIN-KMEDLKFLSLSLNNFTG-AIPWE 610 (1082)
Q Consensus 544 ~L~~L~L~----~N~i~~~-----~~~~~~~l~~L~~L~L~~N~--l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~ 610 (1082)
+|+.|+++ .|++++. ++..+.++++|+.|+|++|. +++..+..+. .+++|++|+|++|++++ .++..
T Consensus 404 ~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~ 483 (592)
T 3ogk_B 404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF 483 (592)
T ss_dssp SCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHH
T ss_pred CCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHH
Confidence 78888885 5667653 33346667888888887533 5544444443 37788888888888875 34555
Q ss_pred hhcCcccchhhccCcccCCC-CCccccCCcccceecccCcccCCCCCCCC-CCCCcccEEeccCC
Q 045553 611 LTQLASLEVLELSANSLSGE-IPSEFSKLEHLNVLRLDHNNLTGRIPPGF-GTRSSLSIFDVSFN 673 (1082)
Q Consensus 611 ~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~l~ls~N 673 (1082)
+.++++|++|+|++|.+++. ++..+..+++|++|+|++|++++.-...+ ..++.+....+..+
T Consensus 484 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 67788888888888887643 33344567888888888888875433333 34566666555544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-27 Score=262.36 Aligned_cols=248 Identities=23% Similarity=0.245 Sum_probs=182.7
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccc--cCccccCCCCCcEEEcc
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGT--IPAFFGQSPGFQVVSLS 190 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~ 190 (1082)
+.++.++++++ .+|..+. ++|++|+|++|.++...+..|.++++|++|+|++|+++.. .+..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 46788888887 6676443 6888888888888844444578888888888888888733 35666677888888888
Q ss_pred cCcccccCCcccccccccccEEEcccCccCCCCC-ccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 191 FNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP-PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 191 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
+|.+. .+|..+. .+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..+..|..+++|++|++++|.+++
T Consensus 87 ~n~i~-~l~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 87 FNGVI-TMSSNFL-GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp SCSEE-EEEEEEE-TCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCccc-cChhhcC-CCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 88777 4555543 46666666666666664433 355566666666666666655555555566666666666665543
Q ss_pred cCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccc
Q 045553 270 IVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWE 349 (1082)
Q Consensus 270 ~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~ 349 (1082)
. .+|..+..+++|++|++++|.+.+..|..+.
T Consensus 165 ~------------------------------------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 196 (306)
T 2z66_A 165 N------------------------------------------------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196 (306)
T ss_dssp G------------------------------------------------EECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred c------------------------------------------------cchhHHhhCcCCCEEECCCCCcCCcCHHHhc
Confidence 1 2344556667777777777788888888899
Q ss_pred cccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-cc-CcccEEEecCCccee
Q 045553 350 LCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SV-PCMAVFNVSQNLLSG 413 (1082)
Q Consensus 350 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l-~~L~~L~l~~N~l~~ 413 (1082)
.+++|++|+|++|++++..+..+..+++|+.|+|++|++++.+|..+ .+ ++|+.|++++|++++
T Consensus 197 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp TCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred CCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 99999999999999997777789999999999999999999988877 45 489999999999974
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=274.92 Aligned_cols=281 Identities=17% Similarity=0.169 Sum_probs=237.9
Q ss_pred ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 185 (1082)
-..++.....++++++++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|+
T Consensus 27 ~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (353)
T 2z80_A 27 SLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103 (353)
T ss_dssp CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence 334455567899999999 7887665 5999999999999976666899999999999999999988889999999999
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCccCCCCC-ccccCCCCccEEEccCC-cCCCCcCccccCCCCCCEEeCC
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIP-PSLGNCTELRSLLLSSN-MLQGDIPSSFGQLVNLEVLDLS 263 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls 263 (1082)
+|+|++|+++ .+|...+..+++|++|++++|++++..+ ..+.++++|++|++++| .+++..+..|..+++|++|+++
T Consensus 104 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 182 (353)
T 2z80_A 104 HLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182 (353)
T ss_dssp EEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred EEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence 9999999999 6777655579999999999999995444 47899999999999999 5776667889999999999999
Q ss_pred CCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCc-cccCCCCCcEEEcCCCcccC
Q 045553 264 RNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPD-SITRLPNLRVFWAPNLNLEG 342 (1082)
Q Consensus 264 ~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~-~l~~l~~L~~L~l~~n~l~~ 342 (1082)
+|++++..|..+..+++|++|++++|.+. .+|. .+..+++|+.|++++|.+.+
T Consensus 183 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~--------------------------~~~~~~~~~~~~L~~L~L~~n~l~~ 236 (353)
T 2z80_A 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHI--------------------------LLLEIFVDVTSSVECLELRDTDLDT 236 (353)
T ss_dssp ETTCCEECTTTTTTCSEEEEEEEECSCST--------------------------THHHHHHHHTTTEEEEEEESCBCTT
T ss_pred CCCcCccCHHHHhccccCCeecCCCCccc--------------------------cchhhhhhhcccccEEECCCCcccc
Confidence 99999999999999999999999986432 2333 34568999999999999998
Q ss_pred CCCcccc---cccCCCeEEcCCccccC----CCCccccCCCCCCEEecCCCcCcccCCCCc-ccCcccEEEecCCcceec
Q 045553 343 IFPQNWE---LCSKLEMLNLAHNFFTG----QIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFNVSQNLLSGE 414 (1082)
Q Consensus 343 ~~~~~l~---~l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~~L~l~~N~l~~~ 414 (1082)
..+..+. ....++.++|++|.+++ .+|..+..+++|+.|+|++|+|+..++..+ .+++|+.|++++|++.+.
T Consensus 237 ~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 237 FHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp CCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 7766543 46778899999998875 478889999999999999999997666654 789999999999999864
Q ss_pred CC
Q 045553 415 IP 416 (1082)
Q Consensus 415 ~~ 416 (1082)
.|
T Consensus 317 ~~ 318 (353)
T 2z80_A 317 CP 318 (353)
T ss_dssp HH
T ss_pred CC
Confidence 43
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-27 Score=264.32 Aligned_cols=238 Identities=18% Similarity=0.196 Sum_probs=215.4
Q ss_pred CCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEE
Q 045553 108 DLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187 (1082)
Q Consensus 108 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 187 (1082)
...+++.|+|++|+++ .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..|+.+++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3578999999999999 88989999999999999999999 89999999999999999999999 789999999999999
Q ss_pred EcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcC
Q 045553 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267 (1082)
Q Consensus 188 ~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 267 (1082)
+|++|++.+.+|..+... ..+..+.++++|++|+|++|+++ .+|..++.+++|++|+|++|++
T Consensus 156 ~L~~n~~~~~~p~~~~~~----------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l 218 (328)
T 4fcg_A 156 SIRACPELTELPEPLAST----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218 (328)
T ss_dssp EEEEETTCCCCCSCSEEE----------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCC
T ss_pred ECCCCCCccccChhHhhc----------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCC
Confidence 999998888888776521 23345788999999999999999 7899999999999999999999
Q ss_pred cccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcc
Q 045553 268 SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN 347 (1082)
Q Consensus 268 ~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~ 347 (1082)
++ +|..+..+++|++|++++ |.+.+.+|..+..+++|++|++++|++.+..|..
T Consensus 219 ~~-l~~~l~~l~~L~~L~Ls~-------------------------n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~ 272 (328)
T 4fcg_A 219 SA-LGPAIHHLPKLEELDLRG-------------------------CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272 (328)
T ss_dssp CC-CCGGGGGCTTCCEEECTT-------------------------CTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTT
T ss_pred Cc-CchhhccCCCCCEEECcC-------------------------CcchhhhHHHhcCCCCCCEEECCCCCchhhcchh
Confidence 95 677899999999999987 4566678999999999999999999999999999
Q ss_pred cccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCccc
Q 045553 348 WELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391 (1082)
Q Consensus 348 l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 391 (1082)
+..+++|++|+|++|.+.+.+|..++++++|+.+++..|.+...
T Consensus 273 ~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l 316 (328)
T 4fcg_A 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL 316 (328)
T ss_dssp GGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred hhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHH
Confidence 99999999999999999999999999999999999998877643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-26 Score=273.13 Aligned_cols=133 Identities=23% Similarity=0.275 Sum_probs=108.2
Q ss_pred CCcccEEEccC-CcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchh
Q 045553 542 CKCMKFLSMAG-NEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVL 620 (1082)
Q Consensus 542 ~~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 620 (1082)
+++|++|+|++ |.+..+.+..|.++++|++|+|++|.++ .+| .+..+++|+.|+|++|++++..|..|.++++|+.|
T Consensus 159 l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 236 (440)
T 3zyj_A 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL 236 (440)
T ss_dssp CTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEE
Confidence 34466666665 3444455557778888888888888888 344 47888889999999999998888889999999999
Q ss_pred hccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccc
Q 045553 621 ELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676 (1082)
Q Consensus 621 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 676 (1082)
+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.
T Consensus 237 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 237 WMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp ECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 99999999888888999999999999999999888888899999999998666554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=273.71 Aligned_cols=138 Identities=22% Similarity=0.232 Sum_probs=111.6
Q ss_pred cCCcccEEEccC-CcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccch
Q 045553 541 HCKCMKFLSMAG-NEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEV 619 (1082)
Q Consensus 541 ~~~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 619 (1082)
.+++|++|++++ |.+..+.+..|.++++|++|+|++|++++. | .+..+++|+.|+|++|++++..|..|.++++|++
T Consensus 169 ~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 246 (452)
T 3zyi_A 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246 (452)
T ss_dssp TCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCE
T ss_pred cCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCE
Confidence 344466666666 444555556778888888888888888854 4 4778889999999999999888888999999999
Q ss_pred hhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCC
Q 045553 620 LELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680 (1082)
Q Consensus 620 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 680 (1082)
|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.|.+.
T Consensus 247 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred EEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 9999999998888889999999999999999998888888999999999997776664443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=271.19 Aligned_cols=247 Identities=20% Similarity=0.210 Sum_probs=166.0
Q ss_pred CCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcc
Q 045553 111 QLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLS 190 (1082)
Q Consensus 111 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 190 (1082)
..+.++.++++++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 3456777777777 5665543 678888888888887777788888888888888888887777778888888888888
Q ss_pred cCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCC-cCCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 191 FNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSN-MLQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 191 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
+|+++ .+|...+..+++|++|+|++|+++...+..|.++++|+.|++++| .+....+..|..+++|++|+|++|++++
T Consensus 132 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp SSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 88777 555544445677777777777777555556677777777777763 3433333456667777777777776653
Q ss_pred cCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccc
Q 045553 270 IVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWE 349 (1082)
Q Consensus 270 ~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~ 349 (1082)
. | .+. .+++|+.|++++|.+.++.|..|.
T Consensus 211 ~-~-~~~-------------------------------------------------~l~~L~~L~Ls~N~l~~~~~~~~~ 239 (452)
T 3zyi_A 211 M-P-NLT-------------------------------------------------PLVGLEELEMSGNHFPEIRPGSFH 239 (452)
T ss_dssp C-C-CCT-------------------------------------------------TCTTCCEEECTTSCCSEECGGGGT
T ss_pred c-c-ccc-------------------------------------------------ccccccEEECcCCcCcccCccccc
Confidence 2 2 233 344555555555566666666666
Q ss_pred cccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-ccCcccEEEecCCcce
Q 045553 350 LCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFNVSQNLLS 412 (1082)
Q Consensus 350 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~~L~l~~N~l~ 412 (1082)
.+++|+.|+|++|++++..+..|..+++|+.|+|++|+|++.++..+ .+++|+.|++++|++.
T Consensus 240 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 66666666666666666666666666777777777777766665555 4666777777777664
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=269.88 Aligned_cols=247 Identities=20% Similarity=0.201 Sum_probs=168.0
Q ss_pred CCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcc
Q 045553 111 QLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLS 190 (1082)
Q Consensus 111 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 190 (1082)
..+.++.++++++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3456777777777 6676554 678888888888887677778888888888888888887667777777888888887
Q ss_pred cCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCc-CCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 191 FNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNM-LQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 191 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
+|+++ .+|...+..+++|++|+|++|+++...+..|.++++|++|+|++|+ +....+..|..+++|++|+|++|+++
T Consensus 121 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~- 198 (440)
T 3zyj_A 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198 (440)
T ss_dssp SSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-
T ss_pred CCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-
Confidence 77777 4554444456666666666666665555566666666666666633 33223335666666666666666665
Q ss_pred cCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccc
Q 045553 270 IVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWE 349 (1082)
Q Consensus 270 ~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~ 349 (1082)
.+| . +..+++|+.|++++|++.++.+..|.
T Consensus 199 ~~~-~-------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~ 228 (440)
T 3zyj_A 199 EIP-N-------------------------------------------------LTPLIKLDELDLSGNHLSAIRPGSFQ 228 (440)
T ss_dssp SCC-C-------------------------------------------------CTTCSSCCEEECTTSCCCEECTTTTT
T ss_pred ccc-c-------------------------------------------------cCCCcccCEEECCCCccCccChhhhc
Confidence 222 1 34455566666666666666666677
Q ss_pred cccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-ccCcccEEEecCCcce
Q 045553 350 LCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SVPCMAVFNVSQNLLS 412 (1082)
Q Consensus 350 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l~~L~~L~l~~N~l~ 412 (1082)
.+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++..+ .+++|+.|++++|++.
T Consensus 229 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred cCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 77777777777777776666777777777777777777776666655 4677777777777764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-28 Score=271.05 Aligned_cols=249 Identities=21% Similarity=0.205 Sum_probs=167.1
Q ss_pred cccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCC-CCCCcccc-------CCCCCCeEEccCcccccccCc
Q 045553 105 AIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFH-GPIPPTLQ-------NCSSLRLINLSGNQFNGTIPA 176 (1082)
Q Consensus 105 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~-~~~p~~l~-------~l~~L~~L~Ls~N~l~~~~p~ 176 (1082)
.++..++|++|++++|.+ .+|..+... |+.|+|++|.++ ..+|..+. ++++|++|+|++|++++.+|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 456677888888888888 677766655 888888888884 45666665 788888888888888888887
Q ss_pred cc--cCCCCCcEEEcccCcccccCCccccccc-----ccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCC--c
Q 045553 177 FF--GQSPGFQVVSLSFNLLSGSVPEEFGDNC-----VSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGD--I 247 (1082)
Q Consensus 177 ~~--~~l~~L~~L~L~~N~l~~~~p~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~ 247 (1082)
.+ ..+++|++|+|++|++++. |..+. .+ ++|++|+|++|++++..+..++++++|++|+|++|++.+. .
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~-~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 191 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLA-ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHH-HHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHH-HHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHH
Confidence 65 7888888888888888855 65554 34 7788888888888777667777888888888888877654 2
Q ss_pred Cccc--cCCCCCCEEeCCCCcCccc---CCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCc
Q 045553 248 PSSF--GQLVNLEVLDLSRNFLSGI---VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPD 322 (1082)
Q Consensus 248 p~~~--~~l~~L~~L~Ls~N~l~~~---~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~ 322 (1082)
+..+ ..+++|++|+|++|++++. ....+..+++|++|+++
T Consensus 192 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls----------------------------------- 236 (312)
T 1wwl_A 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS----------------------------------- 236 (312)
T ss_dssp HHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECT-----------------------------------
T ss_pred HHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECC-----------------------------------
Confidence 3334 6777788888888777631 11223344555555554
Q ss_pred cccCCCCCcEEEcCCCcccCCCC-cccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcc
Q 045553 323 SITRLPNLRVFWAPNLNLEGIFP-QNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCM 401 (1082)
Q Consensus 323 ~l~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L 401 (1082)
+|.+.+..| ..+..+++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |....+++|
T Consensus 237 --------------~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L 298 (312)
T 1wwl_A 237 --------------HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQV 298 (312)
T ss_dssp --------------TSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEE
T ss_pred --------------CCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCC
Confidence 444444432 23444556666666666666 5555554 5666666666666655 333355666
Q ss_pred cEEEecCCcce
Q 045553 402 AVFNVSQNLLS 412 (1082)
Q Consensus 402 ~~L~l~~N~l~ 412 (1082)
+.|++++|+++
T Consensus 299 ~~L~L~~N~l~ 309 (312)
T 1wwl_A 299 GNLSLKGNPFL 309 (312)
T ss_dssp EEEECTTCTTT
T ss_pred CEEeccCCCCC
Confidence 66666666655
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=279.56 Aligned_cols=289 Identities=23% Similarity=0.251 Sum_probs=225.9
Q ss_pred CCCCCCCCCCCCCCCceeeeeEee------CCCCCeeeeecCCCccccccccCCCCCCCCCCCCcccCcCcccccccccC
Q 045553 15 PLGLTSNWNPKDTDSCSWHGVTCD------PLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRG 88 (1082)
Q Consensus 15 ~~~~~~~W~~~~~~~c~w~gv~C~------~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (1082)
....+++|.. +.+||.|.|..|. -....++.|+++++
T Consensus 8 ~~~~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n------------------------------------ 50 (622)
T 3g06_A 8 YDAVWSAWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGES------------------------------------ 50 (622)
T ss_dssp --CHHHHHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSS------------------------------------
T ss_pred HHHHHHHHHh-cCCcchhccccccCcccccccCCCCcEEEecCC------------------------------------
Confidence 3445667863 5789999774331 11234777887763
Q ss_pred cccCCCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCc
Q 045553 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168 (1082)
Q Consensus 89 ~~~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N 168 (1082)
++. .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|.|+ .+|. .+++|++|+|++|
T Consensus 51 --------~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N 111 (622)
T 3g06_A 51 --------GLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSN 111 (622)
T ss_dssp --------CCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSC
T ss_pred --------CcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCC
Confidence 233 4555554 79999999999999 6776 6799999999999999 6776 7899999999999
Q ss_pred ccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcC
Q 045553 169 QFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP 248 (1082)
Q Consensus 169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 248 (1082)
++++ +|. .+++|+.|++++|+++ .+|.. +++|++|+|++|++++ +|. .+++|+.|++++|++++ +|
T Consensus 112 ~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~----l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~ 177 (622)
T 3g06_A 112 PLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL----PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP 177 (622)
T ss_dssp CCCC-CCC---CCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred cCCC-CCC---CCCCcCEEECCCCCCC-cCCCC----CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc
Confidence 9995 454 6789999999999998 57764 4799999999999994 454 34689999999999995 66
Q ss_pred ccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCC
Q 045553 249 SSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLP 328 (1082)
Q Consensus 249 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~ 328 (1082)
..+++|+.|++++|++++ +|.. +++|+.|++++|.+.. +|. .++
T Consensus 178 ---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~--------------------------l~~---~~~ 221 (622)
T 3g06_A 178 ---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS--------------------------LPA---LPS 221 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS--------------------------CCC---CCT
T ss_pred ---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc--------------------------cCC---CCC
Confidence 457899999999999985 4543 4789999999875432 232 247
Q ss_pred CCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecC
Q 045553 329 NLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQ 408 (1082)
Q Consensus 329 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~ 408 (1082)
+|+.|++++|++.++. ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+..++....+++|+.|++++
T Consensus 222 ~L~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~ 293 (622)
T 3g06_A 222 GLKELIVSGNRLTSLP----VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEG 293 (622)
T ss_dssp TCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCS
T ss_pred CCCEEEccCCccCcCC----CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecC
Confidence 8999999999999854 45689999999999999 5666 67899999999999995543334789999999999
Q ss_pred CcceecCCC
Q 045553 409 NLLSGEIPR 417 (1082)
Q Consensus 409 N~l~~~~~~ 417 (1082)
|++++.+|.
T Consensus 294 N~l~~~~~~ 302 (622)
T 3g06_A 294 NPLSERTLQ 302 (622)
T ss_dssp CCCCHHHHH
T ss_pred CCCCCcCHH
Confidence 999876553
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-29 Score=303.57 Aligned_cols=398 Identities=15% Similarity=0.116 Sum_probs=240.7
Q ss_pred cCCCCCCEEEcccCCCcccCChhhcCC--CCCCEEeCcCCC-CCC-CCCccccCCCCCCeEEccCcccccc----cCccc
Q 045553 107 GDLTQLRVLLLAFNGFSGELPLEIGQL--SLLEILDLSFNS-FHG-PIPPTLQNCSSLRLINLSGNQFNGT----IPAFF 178 (1082)
Q Consensus 107 ~~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~n~-l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~ 178 (1082)
..+++|++|+|++|.+++..+..++.+ .+|++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+
T Consensus 109 ~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~ 188 (592)
T 3ogk_B 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELA 188 (592)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred hhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHH
Confidence 389999999999999987777777764 459999999987 221 1233345899999999999998766 44456
Q ss_pred cCCCCCcEEEcccCcccc----cCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCC---CCcCccc
Q 045553 179 GQSPGFQVVSLSFNLLSG----SVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ---GDIPSSF 251 (1082)
Q Consensus 179 ~~l~~L~~L~L~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~p~~~ 251 (1082)
..+++|++|+|++|.+++ .++.. ...+++|++|++++|.+.+ ++..+.++++|++|+++++... +..+..+
T Consensus 189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~-~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l 266 (592)
T 3ogk_B 189 QHNTSLEVLNFYMTEFAKISPKDLETI-ARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL 266 (592)
T ss_dssp HHCCCCCEEECTTCCCSSCCHHHHHHH-HHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCC
T ss_pred hcCCCccEEEeeccCCCccCHHHHHHH-HhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHh
Confidence 678999999999998872 22222 2346777777777777774 5566777777777777653322 2334455
Q ss_pred cCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCC-CCccccCCCCC
Q 045553 252 GQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGG-LPDSITRLPNL 330 (1082)
Q Consensus 252 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~-~p~~l~~l~~L 330 (1082)
..+++|+.|+++++... .+|..+..+++|++|++++|.+ ++. ++..+..+++|
T Consensus 267 ~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l-------------------------~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 267 VFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALL-------------------------ETEDHCTLIQKCPNL 320 (592)
T ss_dssp CCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCC-------------------------CHHHHHHHHTTCTTC
T ss_pred hccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcC-------------------------CHHHHHHHHHhCcCC
Confidence 66667777777665433 4566666666666666665421 111 11224555666
Q ss_pred cEEEcCCCcccC-CCCcccccccCCCeEEcC-----------CccccCCCCc-cccCCCCCCEEecCCCcCcccCCCCc-
Q 045553 331 RVFWAPNLNLEG-IFPQNWELCSKLEMLNLA-----------HNFFTGQIPA-SLGNCKSLYFLDLSSNNLTGLLPEEV- 396 (1082)
Q Consensus 331 ~~L~l~~n~l~~-~~~~~l~~l~~L~~L~Ls-----------~N~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~- 396 (1082)
++|+++ +.+.. ..+..+..+++|++|+|+ .|.+++.... .+..+++|++|+++.|.+++..+..+
T Consensus 321 ~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~ 399 (592)
T 3ogk_B 321 EVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIG 399 (592)
T ss_dssp CEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHH
T ss_pred CEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHH
Confidence 666665 22222 222223445556666665 2344422111 12335555555555555554333222
Q ss_pred -ccCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCccc
Q 045553 397 -SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFT 475 (1082)
Q Consensus 397 -~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~ 475 (1082)
.+++|+.|+++++.
T Consensus 400 ~~~~~L~~L~l~~~~----------------------------------------------------------------- 414 (592)
T 3ogk_B 400 TYLKNLCDFRLVLLD----------------------------------------------------------------- 414 (592)
T ss_dssp HHCCSCCEEEEEECS-----------------------------------------------------------------
T ss_pred hhCCCCcEEEEeecC-----------------------------------------------------------------
Confidence 13344444443111
Q ss_pred CCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCccccc-----CCccccccCCcccEEEc
Q 045553 476 GPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGE-----VPSDMGSHCKCMKFLSM 550 (1082)
Q Consensus 476 g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~-----ip~~~~~~~~~L~~L~L 550 (1082)
..|++++. ++ .++..+++|++|++
T Consensus 415 --------------------------------------------------~~n~l~~~p~~~~~~-~~~~~~~~L~~L~L 443 (592)
T 3ogk_B 415 --------------------------------------------------REERITDLPLDNGVR-SLLIGCKKLRRFAF 443 (592)
T ss_dssp --------------------------------------------------CCSCCSSCCCHHHHH-HHHHHCTTCCEEEE
T ss_pred --------------------------------------------------CCccccCchHHHHHH-HHHHhCCCCCEEEE
Confidence 02222210 11 11334566888888
Q ss_pred cCCc--ccccCccccC-CCCCCCEEEccCCCCCC-CCcccccCCCCCCEEEcCCCcCCcc-CchhhhcCcccchhhccCc
Q 045553 551 AGNE--FVGLIPQSFT-NFDSLRNLNLSRNHLQG-PLPSYINKMEDLKFLSLSLNNFTGA-IPWELTQLASLEVLELSAN 625 (1082)
Q Consensus 551 ~~N~--i~~~~~~~~~-~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N 625 (1082)
+.|. +++.....+. .+++|++|+|++|++++ .++..+..+++|++|+|++|.+++. ++..+..+++|++|+|++|
T Consensus 444 ~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n 523 (592)
T 3ogk_B 444 YLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGY 523 (592)
T ss_dssp ECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESC
T ss_pred ecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCC
Confidence 7543 5544444333 37788888888888875 3445567788888888888888754 3444567888999999999
Q ss_pred ccCCCCCccc-cCCcccceecccCc
Q 045553 626 SLSGEIPSEF-SKLEHLNVLRLDHN 649 (1082)
Q Consensus 626 ~l~~~~p~~~-~~l~~L~~L~L~~N 649 (1082)
++++.-...+ ..++.|....+..+
T Consensus 524 ~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 524 RASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp BCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred cCCHHHHHHHHHhCCCcEEEEecCc
Confidence 8876533333 35666666665554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-26 Score=250.49 Aligned_cols=107 Identities=19% Similarity=0.248 Sum_probs=77.7
Q ss_pred cCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchh
Q 045553 541 HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVL 620 (1082)
Q Consensus 541 ~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 620 (1082)
.+++|++|++++|++++..|..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+....+.. .-...|+.+
T Consensus 175 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~ 253 (285)
T 1ozn_A 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKF 253 (285)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHC
T ss_pred CccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhc
Confidence 3455788888888888888888888888999999999988777777888889999999999887543321 223456777
Q ss_pred hccCcccCCCCCccccC--CcccceecccC
Q 045553 621 ELSANSLSGEIPSEFSK--LEHLNVLRLDH 648 (1082)
Q Consensus 621 ~Ls~N~l~~~~p~~~~~--l~~L~~L~L~~ 648 (1082)
..+.|.+....|..+.+ +..++..++++
T Consensus 254 ~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~ 283 (285)
T 1ozn_A 254 RGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283 (285)
T ss_dssp CSEECCCBEEESGGGTTCBGGGSCGGGSCC
T ss_pred ccccCccccCCchHhCCcChhhcCHHHhcc
Confidence 77888888777776653 34444444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=254.08 Aligned_cols=172 Identities=22% Similarity=0.182 Sum_probs=103.4
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccC
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (1082)
++++.++++++ .+|..+ .++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45666666666 455433 356677777777766555556666777777777777666665666666666666666666
Q ss_pred c-ccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccC
Q 045553 193 L-LSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIV 271 (1082)
Q Consensus 193 ~-l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 271 (1082)
+ +. .++...+..+++|++|++++|++++..+..+.++++|++|++++|++++..+..|+.+++|++|++++|++++..
T Consensus 91 ~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 91 AQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp TTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 5 44 332222234566666666666666555556666666666666666666555555666666666666666666444
Q ss_pred CccccCCCCCcEEEecc
Q 045553 272 PSELGMCKQLKVLVLRN 288 (1082)
Q Consensus 272 p~~l~~l~~L~~L~l~~ 288 (1082)
+..+..+++|++|++++
T Consensus 170 ~~~~~~l~~L~~L~l~~ 186 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQ 186 (285)
T ss_dssp TTTTTTCTTCCEEECCS
T ss_pred HHHhcCccccCEEECCC
Confidence 44455555555554444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-25 Score=266.21 Aligned_cols=115 Identities=27% Similarity=0.379 Sum_probs=70.2
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
.+++.|++++|+++ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 35788888888887 6776655 67888888888877 5565 4677777777777776 3444 5566666666
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCC
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ 244 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 244 (1082)
++|+++ .+|. .+++|++|++++|++++ +|.. +++|++|+|++|+++
T Consensus 109 s~N~l~-~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~ 154 (622)
T 3g06_A 109 FSNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA 154 (622)
T ss_dssp CSCCCC-CCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred cCCcCC-CCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCC
Confidence 666666 3333 23445555555555552 3322 244444444444444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-27 Score=266.50 Aligned_cols=232 Identities=21% Similarity=0.172 Sum_probs=178.9
Q ss_pred hhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccc-cccCcccc-------CCCCCcEEEcccCcccccCCc
Q 045553 129 EIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFN-GTIPAFFG-------QSPGFQVVSLSFNLLSGSVPE 200 (1082)
Q Consensus 129 ~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~ 200 (1082)
.++..++|++|++++|.+ .+|..+... |++|+|++|++. ..+|..+. ++++|++|+|++|++++.+|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 356677899999999999 688877655 999999999994 45666665 788999999999999888888
Q ss_pred ccc-cccccccEEEcccCccCCCCCccccCC-----CCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccC--C
Q 045553 201 EFG-DNCVSLEHILLAANSLTGSIPPSLGNC-----TELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIV--P 272 (1082)
Q Consensus 201 ~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p 272 (1082)
.++ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+++|++|++++|++.+.. |
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 763 5688888888888888866 7777666 78888888888888777788888888888888888876542 2
Q ss_pred ccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccC---CCCcccc
Q 045553 273 SELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEG---IFPQNWE 349 (1082)
Q Consensus 273 ~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~---~~~~~l~ 349 (1082)
..+ .+..+++|++|++++|.+.+ .....+.
T Consensus 193 ~~~-----------------------------------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 225 (312)
T 1wwl_A 193 SAL-----------------------------------------------CPLKFPTLQVLALRNAGMETPSGVCSALAA 225 (312)
T ss_dssp HHS-----------------------------------------------CTTSCTTCCEEECTTSCCCCHHHHHHHHHH
T ss_pred HHH-----------------------------------------------HhccCCCCCEEECCCCcCcchHHHHHHHHh
Confidence 222 01344555566666666653 2223456
Q ss_pred cccCCCeEEcCCccccCCCC-ccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcceec
Q 045553 350 LCSKLEMLNLAHNFFTGQIP-ASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGE 414 (1082)
Q Consensus 350 ~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~~ 414 (1082)
.+++|++|+|++|++++..| ..+..+++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|++.
T Consensus 226 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~L~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AKLSVLDLSYNRLDRN 289 (312)
T ss_dssp TTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SEEEEEECCSSCCCSC
T ss_pred cCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CCceEEECCCCCCCCC
Confidence 77999999999999998775 56677899999999999999 5565555 8999999999999876
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-27 Score=264.92 Aligned_cols=258 Identities=20% Similarity=0.211 Sum_probs=139.1
Q ss_pred CCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccc
Q 045553 93 NSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNG 172 (1082)
Q Consensus 93 ~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 172 (1082)
.+.+.+...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..+ +.++++|++|+|++|++++
T Consensus 17 ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~ 94 (317)
T 3o53_A 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE 94 (317)
T ss_dssp CCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE
T ss_pred ccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc
Confidence 33344444444444444555555555555554444555555555555555555553322 5555555555555555542
Q ss_pred ccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCcccc
Q 045553 173 TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFG 252 (1082)
Q Consensus 173 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 252 (1082)
.. ..++|++|++++|++++..+. .+++|++|++++|++++..+..+..+++|++|+|++|.+++..+..+.
T Consensus 95 l~-----~~~~L~~L~l~~n~l~~~~~~----~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 165 (317)
T 3o53_A 95 LL-----VGPSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165 (317)
T ss_dssp EE-----ECTTCCEEECCSSCCSEEEEC----CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGG
T ss_pred cc-----CCCCcCEEECCCCccCCcCcc----ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHh
Confidence 21 124555555555555422211 123444445555544444444444444444444444444443333332
Q ss_pred -CCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCc
Q 045553 253 -QLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLR 331 (1082)
Q Consensus 253 -~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~ 331 (1082)
.+++|++|+|++|++++. + ....+++|+
T Consensus 166 ~~l~~L~~L~L~~N~l~~~-~--------------------------------------------------~~~~l~~L~ 194 (317)
T 3o53_A 166 ASSDTLEHLNLQYNFIYDV-K--------------------------------------------------GQVVFAKLK 194 (317)
T ss_dssp GGTTTCCEEECTTSCCCEE-E--------------------------------------------------CCCCCTTCC
T ss_pred hccCcCCEEECCCCcCccc-c--------------------------------------------------cccccccCC
Confidence 344444444444444422 1 112356677
Q ss_pred EEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCc-ccCCCCc-ccCcccEEEecCC
Q 045553 332 VFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLT-GLLPEEV-SVPCMAVFNVSQN 409 (1082)
Q Consensus 332 ~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~-~l~~L~~L~l~~N 409 (1082)
+|++++|++.++.+. +..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+ .++.|+.+++++|
T Consensus 195 ~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~ 272 (317)
T 3o53_A 195 TLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272 (317)
T ss_dssp EEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred EEECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence 777777777765443 777788888888888887 56777788888888888888887 4444444 4677777777733
Q ss_pred -cceec
Q 045553 410 -LLSGE 414 (1082)
Q Consensus 410 -~l~~~ 414 (1082)
.+.|.
T Consensus 273 ~~l~~~ 278 (317)
T 3o53_A 273 KKLTGQ 278 (317)
T ss_dssp HHHHSS
T ss_pred hhccCC
Confidence 34443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-27 Score=263.85 Aligned_cols=244 Identities=21% Similarity=0.182 Sum_probs=187.9
Q ss_pred cccCCCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCc
Q 045553 89 NINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168 (1082)
Q Consensus 89 ~~~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N 168 (1082)
...+.+.+++.+..|..|.++++|++|+|++|.+++..| +..+++|++|+|++|.+++ ++ ..++|++|++++|
T Consensus 37 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l~~n 109 (317)
T 3o53_A 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHAANN 109 (317)
T ss_dssp SEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEECCSS
T ss_pred CEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-cc----CCCCcCEEECCCC
Confidence 344566788999888999999999999999999996655 9999999999999999984 33 4489999999999
Q ss_pred ccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCcccc-CCCCccEEEccCCcCCCCc
Q 045553 169 QFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG-NCTELRSLLLSSNMLQGDI 247 (1082)
Q Consensus 169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~ 247 (1082)
++++..+.. +++|++|++++|++++..+..+ ..+++|++|++++|++++..+..+. .+++|++|+|++|.+++.
T Consensus 110 ~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~- 184 (317)
T 3o53_A 110 NISRVSCSR---GQGKKNIYLANNKITMLRDLDE-GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV- 184 (317)
T ss_dssp CCSEEEECC---CSSCEEEECCSSCCCSGGGBCT-GGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-
T ss_pred ccCCcCccc---cCCCCEEECCCCCCCCccchhh-hccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-
Confidence 999765543 6889999999999995444454 4689999999999999987777774 789999999999999854
Q ss_pred CccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCC
Q 045553 248 PSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRL 327 (1082)
Q Consensus 248 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l 327 (1082)
+. ...+++|++|+|++|++++. |..+..+++|++|++++|.
T Consensus 185 ~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~------------------------------------- 225 (317)
T 3o53_A 185 KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNK------------------------------------- 225 (317)
T ss_dssp EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSC-------------------------------------
T ss_pred cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCc-------------------------------------
Confidence 33 34589999999999999854 4447777777777776643
Q ss_pred CCCcEEEcCCCcccCCCCcccccccCCCeEEcCCcccc-CCCCccccCCCCCCEEecCCC-cCcccCCCCc
Q 045553 328 PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFT-GQIPASLGNCKSLYFLDLSSN-NLTGLLPEEV 396 (1082)
Q Consensus 328 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~ 396 (1082)
+.. +|..+..+++|+.|+|++|.+. +.+|..+..+++|+.|++++| .+++..|...
T Consensus 226 ------------l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~~ 283 (317)
T 3o53_A 226 ------------LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283 (317)
T ss_dssp ------------CCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCCC
T ss_pred ------------ccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhcc
Confidence 332 2334455566667777777766 556666777777777777733 4555555444
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-27 Score=280.94 Aligned_cols=185 Identities=19% Similarity=0.145 Sum_probs=131.4
Q ss_pred eecccCceEEEEE-EEcCCeEEEEEEeecCc----------cccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEE
Q 045553 808 CIGSGGFGATYKA-EIIPGVVVAVKRLSVGR----------FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 808 ~lg~G~~g~Vy~a-~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 875 (1082)
..+.|+.|.+..+ +...|+.||||.+.... ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777766665 34458999999997542 12346799999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||++|++|.+++... ..++.. +|+.||+.||+|+|++ +||||||||+|||+++++++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999999874 356644 5889999999999999 9999999999999999999999999999876543
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCC
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA 1002 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p 1002 (1082)
.. .....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 2344679999999999876 466789999999998877665443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=238.13 Aligned_cols=216 Identities=23% Similarity=0.254 Sum_probs=182.5
Q ss_pred CCCceeeeeEeeCCCCCeeeeecCCCccccccccCCCCCCCCCCCCcccCcCcccccccccCcccCCCCCCccccccccc
Q 045553 27 TDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAI 106 (1082)
Q Consensus 27 ~~~c~w~gv~C~~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~g~l~~~l 106 (1082)
.|+|.|.|+.|.-. +.++.++++++ ++. .+|..+
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~--------------------------------------------~l~-~ip~~~ 35 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSK--------------------------------------------KLT-AIPSNI 35 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTS--------------------------------------------CCS-SCCSCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCC--------------------------------------------CCC-ccCCCC
Confidence 58999999999642 34567777653 222 234333
Q ss_pred cCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcE
Q 045553 107 GDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQV 186 (1082)
Q Consensus 107 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 186 (1082)
. ++|++|+|++|++++..+..|+.+++|++|+|++|.++...+..|.++++|++|+|++|++++..+..|..+++|++
T Consensus 36 ~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 113 (270)
T 2o6q_A 36 P--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAE 113 (270)
T ss_dssp C--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCE
T ss_pred C--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCE
Confidence 3 57999999999999777778999999999999999999655666789999999999999999877788899999999
Q ss_pred EEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCc
Q 045553 187 VSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNF 266 (1082)
Q Consensus 187 L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 266 (1082)
|+|++|+++ .++...+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus 114 L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (270)
T 2o6q_A 114 LRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192 (270)
T ss_dssp EECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCc
Confidence 999999999 4555544579999999999999997766778999999999999999998777889999999999999999
Q ss_pred CcccCCccccCCCCCcEEEeccccC
Q 045553 267 LSGIVPSELGMCKQLKVLVLRNDYG 291 (1082)
Q Consensus 267 l~~~~p~~l~~l~~L~~L~l~~n~~ 291 (1082)
+++..+..|..+++|+.|++++|.+
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 193 LKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred CCcCCHHHhccccCCCEEEecCCCe
Confidence 9987777899999999999999854
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=266.30 Aligned_cols=247 Identities=20% Similarity=0.208 Sum_probs=171.1
Q ss_pred CccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCc
Q 045553 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPA 176 (1082)
Q Consensus 97 ~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 176 (1082)
.+...+......+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+
T Consensus 21 ~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~- 97 (487)
T 3oja_A 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV- 97 (487)
T ss_dssp THHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-
T ss_pred hhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-
Confidence 3333333333344478888888888887777788888888888888888886554 8888888888888888874332
Q ss_pred cccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCcccc-CCC
Q 045553 177 FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFG-QLV 255 (1082)
Q Consensus 177 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~ 255 (1082)
.++|+.|+|++|.+++..+. .+++|++|+|++|++++..|..++.+++|+.|+|++|.+++..|..+. .++
T Consensus 98 ----~~~L~~L~L~~N~l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~ 169 (487)
T 3oja_A 98 ----GPSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169 (487)
T ss_dssp ----CTTCCEEECCSSCCCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTT
T ss_pred ----CCCcCEEECcCCcCCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCC
Confidence 27788888888887744332 246677777777777776676777777777777777777766666665 577
Q ss_pred CCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEc
Q 045553 256 NLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWA 335 (1082)
Q Consensus 256 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l 335 (1082)
+|++|+|++|.+++. |. + ..+++|+.|++
T Consensus 170 ~L~~L~Ls~N~l~~~-~~-~-------------------------------------------------~~l~~L~~L~L 198 (487)
T 3oja_A 170 TLEHLNLQYNFIYDV-KG-Q-------------------------------------------------VVFAKLKTLDL 198 (487)
T ss_dssp TCCEEECTTSCCCEE-EC-C-------------------------------------------------CCCTTCCEEEC
T ss_pred cccEEecCCCccccc-cc-c-------------------------------------------------ccCCCCCEEEC
Confidence 777777777777643 11 1 12455666666
Q ss_pred CCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCc-ccCCCCc-ccCcccEEEec
Q 045553 336 PNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLT-GLLPEEV-SVPCMAVFNVS 407 (1082)
Q Consensus 336 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~-~l~~L~~L~l~ 407 (1082)
++|.+.++.+. +..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++. +.+|..+ .++.|+.++++
T Consensus 199 s~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 199 SSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCCCCCHh-HcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 66666665443 777788888888888888 46777788888888888888887 4344333 45666666665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=263.81 Aligned_cols=225 Identities=18% Similarity=0.165 Sum_probs=173.6
Q ss_pred CChhhcCCC----CCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcc
Q 045553 126 LPLEIGQLS----LLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEE 201 (1082)
Q Consensus 126 ~p~~~~~l~----~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 201 (1082)
+|..+..+. +|++|+|++|.+++..|..|.++++|++|+|++|.+++..| |..+++|++|+|++|.++ .+|.
T Consensus 22 l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~~- 97 (487)
T 3oja_A 22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV- 97 (487)
T ss_dssp HHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE-EEEE-
T ss_pred hHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC-CCCC-
Confidence 455555444 89999999999998778889999999999999999987665 888999999999999888 3331
Q ss_pred cccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCC
Q 045553 202 FGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQL 281 (1082)
Q Consensus 202 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 281 (1082)
.++|++|++++|.+++..+. .+++|+.|+|++|.+++..|..|+.+++|++|+|++|.+++..|..+.
T Consensus 98 ----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~----- 165 (487)
T 3oja_A 98 ----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA----- 165 (487)
T ss_dssp ----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG-----
T ss_pred ----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh-----
Confidence 36788888888888765443 346777888888888777777777777777777777777766555543
Q ss_pred cEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCC
Q 045553 282 KVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAH 361 (1082)
Q Consensus 282 ~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 361 (1082)
..+++|+.|++++|.+.+..+ +..+++|++|+|++
T Consensus 166 -------------------------------------------~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~ 200 (487)
T 3oja_A 166 -------------------------------------------ASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSS 200 (487)
T ss_dssp -------------------------------------------GGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCS
T ss_pred -------------------------------------------hhCCcccEEecCCCccccccc--cccCCCCCEEECCC
Confidence 134455555555566655532 33589999999999
Q ss_pred ccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCcce
Q 045553 362 NFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLS 412 (1082)
Q Consensus 362 N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~ 412 (1082)
|+|++ +|..+..+++|+.|+|++|+|++.++....+++|+.|++++|++.
T Consensus 201 N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 201 NKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp SCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBC
T ss_pred CCCCC-CCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCc
Confidence 99995 555699999999999999999986655557899999999999997
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=232.92 Aligned_cols=156 Identities=26% Similarity=0.365 Sum_probs=129.8
Q ss_pred EEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCC
Q 045553 522 IFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLN 601 (1082)
Q Consensus 522 ~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 601 (1082)
+|++++|++. .+|..+|..+++|++|++++|+|+++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 65 ~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 143 (270)
T 2o6q_A 65 LLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYN 143 (270)
T ss_dssp EEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCC
Confidence 3444444433 455555566677899999999998888888899999999999999999888888999999999999999
Q ss_pred cCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccC
Q 045553 602 NFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGS 678 (1082)
Q Consensus 602 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 678 (1082)
++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++.+.
T Consensus 144 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 144 ELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred cCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 99977777789999999999999999977777899999999999999999977777789999999999976665533
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-27 Score=292.36 Aligned_cols=411 Identities=16% Similarity=0.081 Sum_probs=214.6
Q ss_pred CCCCCeEEccCcccccccCcccc-CCCCCcEEEcccC-cccccCCcccccccccccEEEcccCccCCCCCccc----cCC
Q 045553 157 CSSLRLINLSGNQFNGTIPAFFG-QSPGFQVVSLSFN-LLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL----GNC 230 (1082)
Q Consensus 157 l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l 230 (1082)
+++|++|+|++|.+++..+..+. .+++|++|+|++| .++......+...+++|++|+|++|.+++..+..+ ..+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 34444444444444433333332 3444444444444 22211111222234444444444444443332222 244
Q ss_pred CCccEEEccCCc--CCC-CcCccccCCCCCCEEeCCCC-cCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCccc
Q 045553 231 TELRSLLLSSNM--LQG-DIPSSFGQLVNLEVLDLSRN-FLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPV 306 (1082)
Q Consensus 231 ~~L~~L~L~~N~--l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~ 306 (1082)
++|++|++++|. +.. .++..+..+++|++|++++| .+. .+|..+..+++|+.|+++.+...
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~-------------- 248 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAE-------------- 248 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCC--------------
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCc--------------
Confidence 566666666665 211 11122234566777777766 333 35666666677777766543110
Q ss_pred ccCCCcccccCCCCCccccCCCCCcEE-EcCCCcccCCCCcccccccCCCeEEcCCccccCCCCc-cccCCCCCCEEecC
Q 045553 307 VDGGEDYNFFDGGLPDSITRLPNLRVF-WAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPA-SLGNCKSLYFLDLS 384 (1082)
Q Consensus 307 ~~~~~~~n~~~~~~p~~l~~l~~L~~L-~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~-~~~~l~~L~~L~Ls 384 (1082)
...+.+.+ ++..+.++++|+.| .+.+... ...+..+..+++|++|+|++|.+++.... .+..+++|+.|+++
T Consensus 249 ----~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~ 322 (594)
T 2p1m_B 249 ----VRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322 (594)
T ss_dssp ----CCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred ----cchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCc
Confidence 01122222 33456667777776 3332221 22344445677888888888886643322 35577888888888
Q ss_pred CCcCcccC-CCCc-ccCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCC
Q 045553 385 SNNLTGLL-PEEV-SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNG 462 (1082)
Q Consensus 385 ~N~l~~~~-p~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (1082)
+| ++... +... .+++|+.|+++++.-.| ...|
T Consensus 323 ~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g------~~~~--------------------------------------- 356 (594)
T 2p1m_B 323 DY-IEDAGLEVLASTCKDLRELRVFPSEPFV------MEPN--------------------------------------- 356 (594)
T ss_dssp GG-GHHHHHHHHHHHCTTCCEEEEECSCTTC------SSCS---------------------------------------
T ss_pred Cc-cCHHHHHHHHHhCCCCCEEEEecCcccc------cccC---------------------------------------
Confidence 77 43221 1111 25677777775532110 0000
Q ss_pred ceeEeeccCCcccCCCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEccCCcccccCCccccccC
Q 045553 463 LFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHC 542 (1082)
Q Consensus 463 ~~~~~~l~~n~~~g~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l~~n~l~~~ip~~~~~~~ 542 (1082)
+.+++. .+......+.+|+.|+++.|++.+..+..+...+
T Consensus 357 ---------~~l~~~-------------------------------~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~ 396 (594)
T 2p1m_B 357 ---------VALTEQ-------------------------------GLVSVSMGCPKLESVLYFCRQMTNAALITIARNR 396 (594)
T ss_dssp ---------SCCCHH-------------------------------HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHC
T ss_pred ---------CCCCHH-------------------------------HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhC
Confidence 000000 0000000123455666666776655555555556
Q ss_pred CcccEEEcc--C----CcccccC-----ccccCCCCCCCEEEccCCCCCCCCcccccC-CCCCCEEEcCCCcCCccCchh
Q 045553 543 KCMKFLSMA--G----NEFVGLI-----PQSFTNFDSLRNLNLSRNHLQGPLPSYINK-MEDLKFLSLSLNNFTGAIPWE 610 (1082)
Q Consensus 543 ~~L~~L~L~--~----N~i~~~~-----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~ 610 (1082)
++|+.|+++ + |.++... +..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..
T Consensus 397 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~ 475 (594)
T 2p1m_B 397 PNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHH 475 (594)
T ss_dssp TTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHH
T ss_pred CCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHH
Confidence 778888888 4 5555221 22356677888888876 565444444544 778888888888887655555
Q ss_pred h-hcCcccchhhccCcccCCCCCc-cccCCcccceecccCcccCCCCCCCC-CCCCcccEEeccCCcc
Q 045553 611 L-TQLASLEVLELSANSLSGEIPS-EFSKLEHLNVLRLDHNNLTGRIPPGF-GTRSSLSIFDVSFNNL 675 (1082)
Q Consensus 611 ~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~l~ls~N~l 675 (1082)
+ ..+++|++|+|++|.+++.... ....+++|+.|+|++|+++......+ ..++.|+...+..+.-
T Consensus 476 l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 476 VLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp HHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred HHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 5 6678888888888888543333 33457888888888888753222223 3456666666655543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=237.07 Aligned_cols=147 Identities=27% Similarity=0.305 Sum_probs=115.3
Q ss_pred CcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhc
Q 045553 543 KCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLEL 622 (1082)
Q Consensus 543 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 622 (1082)
++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 34677777777776 44667778888888888888888777788888888888888888888777777888888899999
Q ss_pred cCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCCcccccccCCCCCCCCCCCCC
Q 045553 623 SANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQLCHTD 702 (1082)
Q Consensus 623 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~Np~~c~c~~~ 702 (1082)
++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|+ +|||.|+|+ .
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~--------------------~Np~~C~c~-~ 213 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH--------------------GNPWLCNCE-I 213 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECC--------------------SCCBCCSGG-G
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeC--------------------CCCccCcCc-c
Confidence 999988666667788999999999999998 677777788888888875 455667775 4
Q ss_pred CCCCcccccC
Q 045553 703 PSSSEWERQH 712 (1082)
Q Consensus 703 ~~~~~~~~~~ 712 (1082)
.+...|..++
T Consensus 214 ~~l~~wl~~~ 223 (290)
T 1p9a_G 214 LYFRRWLQDN 223 (290)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHhC
Confidence 4555665544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.8e-24 Score=232.04 Aligned_cols=139 Identities=25% Similarity=0.307 Sum_probs=118.5
Q ss_pred cCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCC-CcccccCCCCCCEEEcCCCcCCccCchhhhcCcccc-
Q 045553 541 HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGP-LPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLE- 618 (1082)
Q Consensus 541 ~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~- 618 (1082)
.+++|++|++++|++++..+..|..+++|++|+|++|.+++. +|..|..+++|++|+|++|++++..+..|..+++|+
T Consensus 98 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 177 (276)
T 2z62_A 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177 (276)
T ss_dssp TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTT
T ss_pred CCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccc
Confidence 445688888888888888777899999999999999999864 588999999999999999999988888888888888
Q ss_pred ---hhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCC
Q 045553 619 ---VLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680 (1082)
Q Consensus 619 ---~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 680 (1082)
.|++++|++++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|++++|+++|.+|
T Consensus 178 l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 178 LNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 889999999966665554 4589999999999998777778999999999998888775544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=230.97 Aligned_cols=210 Identities=22% Similarity=0.239 Sum_probs=110.7
Q ss_pred CCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEc
Q 045553 135 LLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILL 214 (1082)
Q Consensus 135 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L 214 (1082)
+|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+ ..+++|++|++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF-SGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTT-TTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhh-cCCccccEEEC
Confidence 45555555555554444455555555555555555554444455555555555555555542222222 23455555555
Q ss_pred ccCccCCCCCccccCCCCccEEEccCCcCCCC-cCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCc
Q 045553 215 AANSLTGSIPPSLGNCTELRSLLLSSNMLQGD-IPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPL 293 (1082)
Q Consensus 215 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~ 293 (1082)
++|++++..+..+.++++|++|++++|++++. +|..|+.+++|++|++++|++++..+..+..+++|+.|.+
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l------- 180 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL------- 180 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCE-------
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccce-------
Confidence 55555544444566666777777777776642 4666777777777777777776555444444433331100
Q ss_pred ccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCcccc
Q 045553 294 YSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLG 373 (1082)
Q Consensus 294 ~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~ 373 (1082)
.|++++|.+.++.+..+.. .+|++|+|++|++++..+..|.
T Consensus 181 --------------------------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~ 221 (276)
T 2z62_A 181 --------------------------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFD 221 (276)
T ss_dssp --------------------------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTT
T ss_pred --------------------------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhc
Confidence 2333334444333333322 2566666666666644444455
Q ss_pred CCCCCCEEecCCCcCccc
Q 045553 374 NCKSLYFLDLSSNNLTGL 391 (1082)
Q Consensus 374 ~l~~L~~L~Ls~N~l~~~ 391 (1082)
.+++|+.|+|++|++++.
T Consensus 222 ~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 222 RLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp TCCSCCEEECCSSCBCCC
T ss_pred ccccccEEEccCCccccc
Confidence 666666666666666543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-27 Score=288.07 Aligned_cols=378 Identities=15% Similarity=0.133 Sum_probs=261.4
Q ss_pred ccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccC-ccCCC-CCccccCCCCccEEEccCCcCCCCcCcccc-
Q 045553 176 AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAAN-SLTGS-IPPSLGNCTELRSLLLSSNMLQGDIPSSFG- 252 (1082)
Q Consensus 176 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~- 252 (1082)
..+..+++|++|+|++|.+++..+..+...+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.
T Consensus 99 ~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~ 178 (594)
T 2p1m_B 99 AMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSH 178 (594)
T ss_dssp HHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGG
T ss_pred HHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHH
Confidence 334568899999999999887777777656889999999999 55532 333445789999999999998765554443
Q ss_pred ---CCCCCCEEeCCCCc--Ccc-cCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccC
Q 045553 253 ---QLVNLEVLDLSRNF--LSG-IVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITR 326 (1082)
Q Consensus 253 ---~l~~L~~L~Ls~N~--l~~-~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~ 326 (1082)
.+++|++|++++|. +.. .++..+..+++|++|++++|. .+.+ +|..+..
T Consensus 179 ~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~------------------------~~~~-l~~~~~~ 233 (594)
T 2p1m_B 179 FPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV------------------------PLEK-LATLLQR 233 (594)
T ss_dssp SCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTS------------------------CHHH-HHHHHHH
T ss_pred HhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCC------------------------cHHH-HHHHHhc
Confidence 66799999999987 321 122233456899999997751 1222 6667778
Q ss_pred CCCCcEEEcCCCc-------ccCCCCcccccccCCCeE-EcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCC--c
Q 045553 327 LPNLRVFWAPNLN-------LEGIFPQNWELCSKLEML-NLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEE--V 396 (1082)
Q Consensus 327 l~~L~~L~l~~n~-------l~~~~~~~l~~l~~L~~L-~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~ 396 (1082)
+++|+.|.+..+. +.+ .+..+.++++|+.| .+.+.... .++..+..+++|+.|+|++|.+++..... .
T Consensus 234 ~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~ 311 (594)
T 2p1m_B 234 APQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLC 311 (594)
T ss_dssp CTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHT
T ss_pred CCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccchh-hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHh
Confidence 8888888865543 233 23356778888888 45443332 45555556788888888888876543222 1
Q ss_pred ccCcccEEEecCCcceecCCCCCCcccccccccccccceeeeeecccccccccccCcCCCCCCCCCceeEeeccCCcccC
Q 045553 397 SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTG 476 (1082)
Q Consensus 397 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~n~~~g 476 (1082)
.+++|+.|++++| +....
T Consensus 312 ~~~~L~~L~l~~~-~~~~~------------------------------------------------------------- 329 (594)
T 2p1m_B 312 QCPKLQRLWVLDY-IEDAG------------------------------------------------------------- 329 (594)
T ss_dssp TCTTCCEEEEEGG-GHHHH-------------------------------------------------------------
T ss_pred cCCCcCEEeCcCc-cCHHH-------------------------------------------------------------
Confidence 4677888888776 32100
Q ss_pred CCCCccccCCCccccccceeeeccCCCccccCCcccccccCCceeEEEc---------cCCcccccCCccccccCCcccE
Q 045553 477 PVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDI---------GNNKLIGEVPSDMGSHCKCMKF 547 (1082)
Q Consensus 477 ~~p~~~~~~~~l~~~~~~~~~~~~n~~~~~l~~~p~~~~~~~~l~~l~l---------~~n~l~~~ip~~~~~~~~~L~~ 547 (1082)
++.....+.+|++|++ +.+.+.+.-...+...+++|++
T Consensus 330 ---------------------------------l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~ 376 (594)
T 2p1m_B 330 ---------------------------------LEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLES 376 (594)
T ss_dssp ---------------------------------HHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCE
T ss_pred ---------------------------------HHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHH
Confidence 0000011234456666 3344443333334455788999
Q ss_pred EEccCCcccccCccccC-CCCCCCEEEcc--C----CCCCCCC-----cccccCCCCCCEEEcCCCcCCccCchhhhc-C
Q 045553 548 LSMAGNEFVGLIPQSFT-NFDSLRNLNLS--R----NHLQGPL-----PSYINKMEDLKFLSLSLNNFTGAIPWELTQ-L 614 (1082)
Q Consensus 548 L~L~~N~i~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l 614 (1082)
|.++.|++++.....+. .+++|+.|+|+ + |.+++.. +..+..+++|+.|+|++ .+++..+..+.. +
T Consensus 377 L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~ 455 (594)
T 2p1m_B 377 VLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYA 455 (594)
T ss_dssp EEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHC
T ss_pred HHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhc
Confidence 99999999876666665 58999999999 4 6666322 12367789999999988 777666666665 8
Q ss_pred cccchhhccCcccCCCCCccc-cCCcccceecccCcccCCCCCC-CCCCCCcccEEeccCCccc
Q 045553 615 ASLEVLELSANSLSGEIPSEF-SKLEHLNVLRLDHNNLTGRIPP-GFGTRSSLSIFDVSFNNLS 676 (1082)
Q Consensus 615 ~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~l~ls~N~l~ 676 (1082)
++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++.... .+..+++|+.|++++|+++
T Consensus 456 ~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 456 KKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp TTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred hhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 999999999999986555454 6789999999999999754443 3456899999999999885
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-24 Score=255.70 Aligned_cols=185 Identities=20% Similarity=0.252 Sum_probs=147.1
Q ss_pred cccceecccCceEEEEEEEcCCeEEEEEEeecCccc--------cHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 804 NVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQ--------GVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 804 ~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
...++||+|+||.||+|+. .++.+|+|+....... ..+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 4788999987543221 134589999999999999999666666677778999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++++|.++++. +..++.|+++||+|||+. +|+||||||+||+++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999875 558999999999999999 9999999999999999 9999999999987543
Q ss_pred CCcc------ccCcccCCCcccchhccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 045553 956 ETHA------TTDVAGTFGYVAPEYAMT--CRVSDKADVYSFGVVLLELISDKKALD 1004 (1082)
Q Consensus 956 ~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvll~elltg~~p~~ 1004 (1082)
.... .....||+.|+|||++.. ..|+...|+|+...-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3221 235679999999999987 667888999999998888888877663
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-22 Score=220.95 Aligned_cols=203 Identities=21% Similarity=0.170 Sum_probs=115.4
Q ss_pred hcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccc
Q 045553 130 IGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209 (1082)
Q Consensus 130 ~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L 209 (1082)
++++++|+++++++|.++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+++ .++.. ..+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCC--CCCCcC
Confidence 444555555555555555 4444332 45555566665555555555555555555555555555 22222 234555
Q ss_pred cEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccc
Q 045553 210 EHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRND 289 (1082)
Q Consensus 210 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n 289 (1082)
++|+|++|+++ .+|..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------------ 146 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP------------ 146 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTT------------
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhccc------------
Confidence 55555555555 45555666666666666666666555566666666666666666666443333333
Q ss_pred cCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCC
Q 045553 290 YGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIP 369 (1082)
Q Consensus 290 ~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p 369 (1082)
+++|+.|++++|++..+.+..|..+++|++|+|++|+|+ .+|
T Consensus 147 -------------------------------------l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip 188 (290)
T 1p9a_G 147 -------------------------------------TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (290)
T ss_dssp -------------------------------------CTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred -------------------------------------ccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccC
Confidence 333344444444444444445556666777777777776 566
Q ss_pred ccccCCCCCCEEecCCCcCc
Q 045553 370 ASLGNCKSLYFLDLSSNNLT 389 (1082)
Q Consensus 370 ~~~~~l~~L~~L~Ls~N~l~ 389 (1082)
..+..+++|+.|+|++|++.
T Consensus 189 ~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 189 KGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TTTTTTCCCSEEECCSCCBC
T ss_pred hhhcccccCCeEEeCCCCcc
Confidence 66666667777777777664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=227.63 Aligned_cols=153 Identities=23% Similarity=0.275 Sum_probs=117.3
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 600 (1082)
++|++++|++. .+|...+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++
T Consensus 88 ~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 166 (272)
T 3rfs_A 88 TYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSY 166 (272)
T ss_dssp CEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEECCCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCC
Confidence 34444444444 34444445566688888888888877777788888888888888888877777778888888888888
Q ss_pred CcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCC
Q 045553 601 NNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680 (1082)
Q Consensus 601 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 680 (1082)
|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++.+. +++|+.|+++.|+++|.+|
T Consensus 167 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip 239 (272)
T 3rfs_A 167 NQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVR 239 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBB
T ss_pred CCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCccc
Confidence 888877777778888888888888888877777788888888888888888754 4467888888888888888
Q ss_pred C
Q 045553 681 R 681 (1082)
Q Consensus 681 ~ 681 (1082)
.
T Consensus 240 ~ 240 (272)
T 3rfs_A 240 N 240 (272)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=222.15 Aligned_cols=176 Identities=24% Similarity=0.286 Sum_probs=94.6
Q ss_pred ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 185 (1082)
+.++++|+.|++++|.++ .++ .++.+++|++|+|++|.+++ + ..+.++++|++|+|++|++++..+..|..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 455666666666666665 222 36666666666666666663 2 3566666666666666666655555566666666
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCC
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 265 (1082)
+|+|++|+++ .++...+..+++|++|++++|++++..+..+..+++|++|++++|++++..+..|+.+++|++|++++|
T Consensus 113 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 113 ELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp EEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCcCC-ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 6666666665 333332234455555555555555444444455555555555555555444444455555555555555
Q ss_pred cCcccCCccccCCCCCcEEEe
Q 045553 266 FLSGIVPSELGMCKQLKVLVL 286 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~l 286 (1082)
++++..|..+..+++|++|++
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l 212 (272)
T 3rfs_A 192 QLKSVPDGVFDRLTSLQYIWL 212 (272)
T ss_dssp CCSCCCTTTTTTCTTCCEEEC
T ss_pred cCCccCHHHHhCCcCCCEEEc
Confidence 554443333333333333333
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-22 Score=216.01 Aligned_cols=160 Identities=23% Similarity=0.257 Sum_probs=142.8
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
++|+.|+|++|++++..+..|+.+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 58899999999999888889999999999999999999888888999999999999999999888888999999999999
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
++|+++ .+|...+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++.+
T Consensus 115 ~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 115 GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CCCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 999998 6666655578899999999999997766688899999999999999997777788899999999999999875
Q ss_pred c
Q 045553 270 I 270 (1082)
Q Consensus 270 ~ 270 (1082)
.
T Consensus 194 ~ 194 (251)
T 3m19_A 194 S 194 (251)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-24 Score=242.14 Aligned_cols=184 Identities=20% Similarity=0.193 Sum_probs=137.1
Q ss_pred ccccCC--CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCC-CCccccCCCCCCeEEccCcccccccCccccC
Q 045553 104 RAIGDL--TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGP-IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQ 180 (1082)
Q Consensus 104 ~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 180 (1082)
..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+.++++|++|+|++|++++..+..++.
T Consensus 62 ~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~ 140 (336)
T 2ast_B 62 DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK 140 (336)
T ss_dssp HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTT
T ss_pred HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhc
Confidence 445555 7889999999988866554 56788999999999988765 7778888899999999999888888888888
Q ss_pred CCCCcEEEcccC-ccccc-CCcccccccccccEEEcccC-ccCCC-CCccccCCC-CccEEEccCC--cCC-CCcCcccc
Q 045553 181 SPGFQVVSLSFN-LLSGS-VPEEFGDNCVSLEHILLAAN-SLTGS-IPPSLGNCT-ELRSLLLSSN--MLQ-GDIPSSFG 252 (1082)
Q Consensus 181 l~~L~~L~L~~N-~l~~~-~p~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~L~~N--~l~-~~~p~~~~ 252 (1082)
+++|++|+|++| .+++. ++..+ ..+++|++|++++| .+++. ++..+..++ +|++|++++| .++ +.++..+.
T Consensus 141 ~~~L~~L~L~~~~~l~~~~l~~~~-~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~ 219 (336)
T 2ast_B 141 NSNLVRLNLSGCSGFSEFALQTLL-SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 219 (336)
T ss_dssp CTTCSEEECTTCBSCCHHHHHHHH-HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCHHHHHHHH-hcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHh
Confidence 888999999888 56643 33333 35777888888888 77753 455667777 7888888887 444 34566667
Q ss_pred CCCCCCEEeCCCCc-CcccCCccccCCCCCcEEEeccc
Q 045553 253 QLVNLEVLDLSRNF-LSGIVPSELGMCKQLKVLVLRND 289 (1082)
Q Consensus 253 ~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~l~~n 289 (1082)
.+++|++|++++|. +++..+..+..+++|++|++++|
T Consensus 220 ~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~ 257 (336)
T 2ast_B 220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 257 (336)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred hCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence 77778888887777 66566666677777777777664
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-23 Score=239.61 Aligned_cols=254 Identities=18% Similarity=0.123 Sum_probs=142.3
Q ss_pred CCCCCccccccccccCCCCCCEEEcccCCCcccCC----hhhcCCC-CCCEEeCcCCCCCCCCCccccCC-----CCCCe
Q 045553 93 NSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELP----LEIGQLS-LLEILDLSFNSFHGPIPPTLQNC-----SSLRL 162 (1082)
Q Consensus 93 ~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~p~~l~~l-----~~L~~ 162 (1082)
.+.++++|.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.+++..+..+..+ ++|++
T Consensus 5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~ 84 (362)
T 3goz_A 5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS 84 (362)
T ss_dssp CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence 45567777777777777777777777777775555 5667777 77777777777776666666554 77777
Q ss_pred EEccCcccccccCcccc----CC-CCCcEEEcccCcccccCCcccccc----cccccEEEcccCccCCCCCcc----ccC
Q 045553 163 INLSGNQFNGTIPAFFG----QS-PGFQVVSLSFNLLSGSVPEEFGDN----CVSLEHILLAANSLTGSIPPS----LGN 229 (1082)
Q Consensus 163 L~Ls~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~~p~~~~~~----l~~L~~L~L~~N~l~~~~~~~----~~~ 229 (1082)
|+|++|++++..+..+. .+ ++|++|+|++|++++..+..+... .++|++|+|++|++++..+.. +..
T Consensus 85 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~ 164 (362)
T 3goz_A 85 LNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAA 164 (362)
T ss_dssp EECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHT
T ss_pred EECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhc
Confidence 77777777765555333 33 677777777777764433333211 235556666665555433222 223
Q ss_pred CC-CccEEEccCCcCCCCcCcccc----CC-CCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCC
Q 045553 230 CT-ELRSLLLSSNMLQGDIPSSFG----QL-VNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPI 303 (1082)
Q Consensus 230 l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~ 303 (1082)
++ +|++|+|++|++++..+..++ .+ ++|++|+|++|.+++....
T Consensus 165 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~------------------------------ 214 (362)
T 3goz_A 165 IPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA------------------------------ 214 (362)
T ss_dssp SCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH------------------------------
T ss_pred CCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH------------------------------
Confidence 33 555555555555544333222 22 3555555555555431111
Q ss_pred cccccCCCcccccCCCCCccccCC-CCCcEEEcCCCcccCCCC----cccccccCCCeEEcCCccccCC-------CCcc
Q 045553 304 QPVVDGGEDYNFFDGGLPDSITRL-PNLRVFWAPNLNLEGIFP----QNWELCSKLEMLNLAHNFFTGQ-------IPAS 371 (1082)
Q Consensus 304 ~~~~~~~~~~n~~~~~~p~~l~~l-~~L~~L~l~~n~l~~~~~----~~l~~l~~L~~L~Ls~N~i~~~-------~p~~ 371 (1082)
.++..+..+ ++|++|++++|.+.+..+ ..+..+++|++|+|++|.+.+. ++..
T Consensus 215 ---------------~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~ 279 (362)
T 3goz_A 215 ---------------ELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAA 279 (362)
T ss_dssp ---------------HHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTT
T ss_pred ---------------HHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHH
Confidence 112222221 245555555555544433 2234456677777777764322 2335
Q ss_pred ccCCCCCCEEecCCCcCccc
Q 045553 372 LGNCKSLYFLDLSSNNLTGL 391 (1082)
Q Consensus 372 ~~~l~~L~~L~Ls~N~l~~~ 391 (1082)
+..+++|+.|||++|++.+.
T Consensus 280 ~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 280 FPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp STTCCEEEEECTTSCBCCGG
T ss_pred hccCCceEEEecCCCcCCCc
Confidence 55666677777777776644
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-21 Score=210.59 Aligned_cols=176 Identities=14% Similarity=0.147 Sum_probs=146.3
Q ss_pred CCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCC-CCCCCCccccCCCCCCeEEccC-cccccccCccccCCCCCcEEE
Q 045553 111 QLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNS-FHGPIPPTLQNCSSLRLINLSG-NQFNGTIPAFFGQSPGFQVVS 188 (1082)
Q Consensus 111 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 188 (1082)
+|++|+|++|++++..+..|+.+++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 78899999999987666788999999999999997 8866666888999999999998 899877778888999999999
Q ss_pred cccCcccccCCccccccccccc---EEEcccC-ccCCCCCccccCCCCcc-EEEccCCcCCCCcCc-cccCCCCCCEEeC
Q 045553 189 LSFNLLSGSVPEEFGDNCVSLE---HILLAAN-SLTGSIPPSLGNCTELR-SLLLSSNMLQGDIPS-SFGQLVNLEVLDL 262 (1082)
Q Consensus 189 L~~N~l~~~~p~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~-~~~~l~~L~~L~L 262 (1082)
+++|+++ .+|. + ..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++ .+|. .|.. ++|++|++
T Consensus 112 l~~n~l~-~lp~-~-~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~-~~L~~L~L 186 (239)
T 2xwt_C 112 IFNTGLK-MFPD-L-TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG-TKLDAVYL 186 (239)
T ss_dssp EEEECCC-SCCC-C-TTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT-CEEEEEEC
T ss_pred CCCCCCc-cccc-c-ccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC-CCCCEEEc
Confidence 9999998 4776 3 4677887 9999999 88877677788899999 9999999998 4544 4444 88999999
Q ss_pred CCCc-CcccCCccccCC-CCCcEEEeccccC
Q 045553 263 SRNF-LSGIVPSELGMC-KQLKVLVLRNDYG 291 (1082)
Q Consensus 263 s~N~-l~~~~p~~l~~l-~~L~~L~l~~n~~ 291 (1082)
++|+ +++..+..|..+ ++|+.|++++|.+
T Consensus 187 ~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l 217 (239)
T 2xwt_C 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217 (239)
T ss_dssp TTCTTCCEECTTTTTTCSBCCSEEECTTCCC
T ss_pred CCCCCcccCCHHHhhccccCCcEEECCCCcc
Confidence 9995 887777888888 9999999988644
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.7e-23 Score=235.58 Aligned_cols=202 Identities=20% Similarity=0.164 Sum_probs=158.5
Q ss_pred cccCCCCCCcccccc----ccccCCC-CCCEEEcccCCCcccCChhhcCC-----CCCCEEeCcCCCCCCCCCccc----
Q 045553 89 NINSNSSDKLSGNLS----RAIGDLT-QLRVLLLAFNGFSGELPLEIGQL-----SLLEILDLSFNSFHGPIPPTL---- 154 (1082)
Q Consensus 89 ~~~~~~~~~l~g~l~----~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~Ls~n~l~~~~p~~l---- 154 (1082)
...+.+.+.+.+.-+ +.+..++ +|++|+|++|.+++..+..+..+ ++|++|+|++|.+++..+..+
T Consensus 25 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l 104 (362)
T 3goz_A 25 TSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTL 104 (362)
T ss_dssp CEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHH
T ss_pred eEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHH
Confidence 334466778887766 7889999 99999999999998888888775 999999999999997777654
Q ss_pred cCC-CCCCeEEccCcccccccCccc----cCC-CCCcEEEcccCcccccCCccccc---cc-ccccEEEcccCccCCCCC
Q 045553 155 QNC-SSLRLINLSGNQFNGTIPAFF----GQS-PGFQVVSLSFNLLSGSVPEEFGD---NC-VSLEHILLAANSLTGSIP 224 (1082)
Q Consensus 155 ~~l-~~L~~L~Ls~N~l~~~~p~~~----~~l-~~L~~L~L~~N~l~~~~p~~~~~---~l-~~L~~L~L~~N~l~~~~~ 224 (1082)
..+ ++|++|+|++|++++..+..+ ..+ ++|++|+|++|++++..+..+.. .+ ++|++|+|++|++++..+
T Consensus 105 ~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~ 184 (362)
T 3goz_A 105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC 184 (362)
T ss_dssp HTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred HhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence 444 899999999999997766554 343 69999999999999544433321 23 499999999999998777
Q ss_pred cccc----CC-CCccEEEccCCcCCCC----cCccccC-CCCCCEEeCCCCcCcccCC----ccccCCCCCcEEEecccc
Q 045553 225 PSLG----NC-TELRSLLLSSNMLQGD----IPSSFGQ-LVNLEVLDLSRNFLSGIVP----SELGMCKQLKVLVLRNDY 290 (1082)
Q Consensus 225 ~~~~----~l-~~L~~L~L~~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~l~~n~ 290 (1082)
..+. .+ ++|++|+|++|.+++. ++..+.. .++|++|+|++|++++..+ ..+..+++|++|++++|.
T Consensus 185 ~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~ 264 (362)
T 3goz_A 185 AELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDI 264 (362)
T ss_dssp HHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHH
T ss_pred HHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCC
Confidence 5554 44 6999999999999853 4556665 4599999999999987554 344667778888887753
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-21 Score=209.56 Aligned_cols=175 Identities=23% Similarity=0.250 Sum_probs=107.3
Q ss_pred eeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcC
Q 045553 520 GLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS 599 (1082)
Q Consensus 520 l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 599 (1082)
.++++++++.+. .+|..++ ++++.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 345666666665 5665554 346666666666666666666666666666666666666655566666666666666
Q ss_pred CCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCC
Q 045553 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSA 679 (1082)
Q Consensus 600 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 679 (1082)
+|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 66666555555666666666666666666555555566666666666666666555555666666666666666666443
Q ss_pred CCC----cccccccCCCCCCCCC
Q 045553 680 PRN----SLIKCENVQGNPNLQL 698 (1082)
Q Consensus 680 p~~----~~~~~~~~~~Np~~c~ 698 (1082)
+.. ..+....+.+|||.|+
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHHhCCCCCCEEEeeCCceeCC
Confidence 321 2234455666666666
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-23 Score=243.39 Aligned_cols=248 Identities=20% Similarity=0.247 Sum_probs=152.9
Q ss_pred cccccccCCCCCCEEEcccCCCcccCC----hhhcCCCCCCEEeCcCC---CCCCCCCccc-------cCCCCCCeEEcc
Q 045553 101 NLSRAIGDLTQLRVLLLAFNGFSGELP----LEIGQLSLLEILDLSFN---SFHGPIPPTL-------QNCSSLRLINLS 166 (1082)
Q Consensus 101 ~l~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~Ls~n---~l~~~~p~~l-------~~l~~L~~L~Ls 166 (1082)
.++..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++| ++++.+|..+ .++++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 466777888888888888888886533 34667888888888885 4445556555 678888888888
Q ss_pred Cccccc----ccCccccCCCCCcEEEcccCcccccCCccccccc------------ccccEEEcccCccC-CCCC---cc
Q 045553 167 GNQFNG----TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNC------------VSLEHILLAANSLT-GSIP---PS 226 (1082)
Q Consensus 167 ~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l------------~~L~~L~L~~N~l~-~~~~---~~ 226 (1082)
+|++.+ .+|..+..+++|++|+|++|.+....+..+...+ ++|++|+|++|+++ +.++ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 888886 4667777888888888888887644333333222 45555555555554 2222 23
Q ss_pred ccCCCCccEEEccCCcCCC-----CcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCC
Q 045553 227 LGNCTELRSLLLSSNMLQG-----DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDL 301 (1082)
Q Consensus 227 ~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l 301 (1082)
+..+++|++|+|++|+++. ..+..+..+++|++|+|++|.++...
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g------------------------------ 232 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG------------------------------ 232 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH------------------------------
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH------------------------------
Confidence 3444555555555555541 12224444555555555555543100
Q ss_pred CCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCC----CCccccc--ccCCCeEEcCCccccC----CCCcc
Q 045553 302 PIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGI----FPQNWEL--CSKLEMLNLAHNFFTG----QIPAS 371 (1082)
Q Consensus 302 ~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~----~~~~l~~--l~~L~~L~Ls~N~i~~----~~p~~ 371 (1082)
...+|..+..+++|++|++++|.+.+. ++..+.. +++|++|+|++|.|++ .+|..
T Consensus 233 ---------------~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~ 297 (386)
T 2ca6_A 233 ---------------SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297 (386)
T ss_dssp ---------------HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHH
T ss_pred ---------------HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHH
Confidence 012334445555555555555665554 3344422 6778888888888875 36666
Q ss_pred c-cCCCCCCEEecCCCcCcccCC
Q 045553 372 L-GNCKSLYFLDLSSNNLTGLLP 393 (1082)
Q Consensus 372 ~-~~l~~L~~L~Ls~N~l~~~~p 393 (1082)
+ .++++|+.|+|++|++++..+
T Consensus 298 l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 298 IDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHhcCCCceEEEccCCcCCcchh
Confidence 6 557888888888888876653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.8e-23 Score=239.82 Aligned_cols=250 Identities=20% Similarity=0.189 Sum_probs=184.0
Q ss_pred cccCCCCCCcccc----ccccccCCCCCCEEEcccC---CCcccCChhh-------cCCCCCCEEeCcCCCCCC----CC
Q 045553 89 NINSNSSDKLSGN----LSRAIGDLTQLRVLLLAFN---GFSGELPLEI-------GQLSLLEILDLSFNSFHG----PI 150 (1082)
Q Consensus 89 ~~~~~~~~~l~g~----l~~~l~~l~~L~~L~L~~n---~l~~~~p~~~-------~~l~~L~~L~Ls~n~l~~----~~ 150 (1082)
.....+.+.+.+. ++..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|.+++ .+
T Consensus 35 ~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l 114 (386)
T 2ca6_A 35 KEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL 114 (386)
T ss_dssp CEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHH
T ss_pred cEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHH
Confidence 3444566777776 4455889999999999996 5556677665 789999999999999997 47
Q ss_pred CccccCCCCCCeEEccCcccccccCcccc----CC---------CCCcEEEcccCccc-ccCCc--ccccccccccEEEc
Q 045553 151 PPTLQNCSSLRLINLSGNQFNGTIPAFFG----QS---------PGFQVVSLSFNLLS-GSVPE--EFGDNCVSLEHILL 214 (1082)
Q Consensus 151 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~p~--~~~~~l~~L~~L~L 214 (1082)
|..+.++++|++|+|++|.++...+..+. .+ ++|++|+|++|+++ +.+|. .....+++|++|+|
T Consensus 115 ~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 194 (386)
T 2ca6_A 115 IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 194 (386)
T ss_dssp HHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEEC
T ss_pred HHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEEC
Confidence 88899999999999999999855444443 34 99999999999997 34442 12235789999999
Q ss_pred ccCccCC-----CCCccccCCCCccEEEccCCcCC----CCcCccccCCCCCCEEeCCCCcCccc----CCccccCCCCC
Q 045553 215 AANSLTG-----SIPPSLGNCTELRSLLLSSNMLQ----GDIPSSFGQLVNLEVLDLSRNFLSGI----VPSELGMCKQL 281 (1082)
Q Consensus 215 ~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L 281 (1082)
++|+++. ..+..+..+++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ++..+..
T Consensus 195 ~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~---- 270 (386)
T 2ca6_A 195 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK---- 270 (386)
T ss_dssp CSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHT----
T ss_pred cCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhh----
Confidence 9999983 34447889999999999999996 56788899999999999999999865 3333321
Q ss_pred cEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccC----CCCccc-ccccCCCe
Q 045553 282 KVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEG----IFPQNW-ELCSKLEM 356 (1082)
Q Consensus 282 ~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~----~~~~~l-~~l~~L~~ 356 (1082)
+.+++|++|++++|.+.. .+|..+ ..+++|++
T Consensus 271 -------------------------------------------~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~ 307 (386)
T 2ca6_A 271 -------------------------------------------LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 307 (386)
T ss_dssp -------------------------------------------CSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE
T ss_pred -------------------------------------------ccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceE
Confidence 124455555555555555 345555 55788888
Q ss_pred EEcCCccccCCCC--cccc-CCCCCCEEecCC
Q 045553 357 LNLAHNFFTGQIP--ASLG-NCKSLYFLDLSS 385 (1082)
Q Consensus 357 L~Ls~N~i~~~~p--~~~~-~l~~L~~L~Ls~ 385 (1082)
|+|++|++++..+ ..+. .+++++.+++..
T Consensus 308 L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l~~ 339 (386)
T 2ca6_A 308 LELNGNRFSEEDDVVDEIREVFSTRGRGELDE 339 (386)
T ss_dssp EECTTSBSCTTSHHHHHHHHHHHHHTCCEECC
T ss_pred EEccCCcCCcchhHHHHHHHHhhhcCcchhhh
Confidence 8888888886553 3322 234444444433
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-22 Score=230.11 Aligned_cols=253 Identities=15% Similarity=0.149 Sum_probs=158.5
Q ss_pred CCCEEEcccCCCcccCChhhcCC--CCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccc-cCccccCCCCCcEE
Q 045553 111 QLRVLLLAFNGFSGELPLEIGQL--SLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGT-IPAFFGQSPGFQVV 187 (1082)
Q Consensus 111 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 187 (1082)
.++.|+++++.+. |..+..+ ++++.|++++|.+++..+. +.++++|++|+|++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3678888888776 5667777 8889999999988866554 56788899999998888765 77788888888888
Q ss_pred EcccCcccccCCcccccccccccEEEcccC-ccCCC-CCccccCCCCccEEEccCC-cCCCC-cCccccCCC-CCCEEeC
Q 045553 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAAN-SLTGS-IPPSLGNCTELRSLLLSSN-MLQGD-IPSSFGQLV-NLEVLDL 262 (1082)
Q Consensus 188 ~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~L 262 (1082)
+|++|++++..+..+. .+++|++|++++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|++
T Consensus 124 ~L~~~~l~~~~~~~l~-~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l 202 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLA-KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202 (336)
T ss_dssp ECTTCBCCHHHHHHHT-TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred eCcCcccCHHHHHHHh-cCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence 8888888766666665 3777777777777 56642 4555666777777777777 77643 456666777 7777777
Q ss_pred CCC--cCc-ccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCc
Q 045553 263 SRN--FLS-GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLN 339 (1082)
Q Consensus 263 s~N--~l~-~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~ 339 (1082)
++| .++ +.+|..+..+++|++|++++|. .+++..+..+..+++|++|++++|.
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~------------------------~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV------------------------MLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCT------------------------TCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCC------------------------cCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 777 343 3445555666666666665532 1223334445555555555555553
Q ss_pred -ccCCCCcccccccCCCeEEcCCccccCCCCccccCC-CCCCEEecCCCcCcccCCCCc
Q 045553 340 -LEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNC-KSLYFLDLSSNNLTGLLPEEV 396 (1082)
Q Consensus 340 -l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~ 396 (1082)
+.......+..+++|++|++++| ++.. .+..+ ..|..|++++|++++..|...
T Consensus 259 ~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 259 DIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp TCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred CCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCcc
Confidence 21111123445555555555555 2211 12222 124444455555555444433
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-21 Score=217.38 Aligned_cols=228 Identities=20% Similarity=0.190 Sum_probs=169.2
Q ss_pred CCCCEEEcccCCCcccC-Ch--hhcCCCCCCEEeCcCCCCCCCCCccc--cCCCCCCeEEccCcccccccC----ccccC
Q 045553 110 TQLRVLLLAFNGFSGEL-PL--EIGQLSLLEILDLSFNSFHGPIPPTL--QNCSSLRLINLSGNQFNGTIP----AFFGQ 180 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~-p~--~~~~l~~L~~L~Ls~n~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 180 (1082)
..++.|.+.++.++... .. .+..+++|++|+|++|.+++..|..+ .++++|++|+|++|++++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 45788888888776321 11 12345779999999999998999888 899999999999999997655 44567
Q ss_pred CCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCC--C--CccccCCCCccEEEccCCcCCCCcCc----ccc
Q 045553 181 SPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGS--I--PPSLGNCTELRSLLLSSNMLQGDIPS----SFG 252 (1082)
Q Consensus 181 l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~p~----~~~ 252 (1082)
+++|++|+|++|++.+..|..+ ..+++|++|+|++|++.+. + +..+..+++|++|+|++|+++ .++. .++
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~ 221 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQV-RAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAA 221 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSC-CCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHh-ccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHh
Confidence 8999999999999985544555 4689999999999998752 2 233478899999999999997 3444 357
Q ss_pred CCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcE
Q 045553 253 QLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRV 332 (1082)
Q Consensus 253 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~ 332 (1082)
.+++|++|+|++|++++..|..+..+. .+++|++
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~----------------------------------------------~~~~L~~ 255 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCM----------------------------------------------WSSALNS 255 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCC----------------------------------------------CCTTCCC
T ss_pred cCCCCCEEECCCCCCCccchhhHHhcc----------------------------------------------CcCcCCE
Confidence 889999999999999987777665542 1234444
Q ss_pred EEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcc
Q 045553 333 FWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390 (1082)
Q Consensus 333 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~ 390 (1082)
|++++|++..+ |..+. ++|++|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 256 L~Ls~N~l~~l-p~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 256 LNLSFAGLEQV-PKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp EECCSSCCCSC-CSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred EECCCCCCCch-hhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 44455555532 33332 6788888888888843 43 6778888888888888864
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.9e-21 Score=217.21 Aligned_cols=228 Identities=18% Similarity=0.128 Sum_probs=159.0
Q ss_pred CCCCEEeCcCCCCCCCCCc---cccCCCCCCeEEccCcccccccCccc--cCCCCCcEEEcccCcccccCC----ccccc
Q 045553 134 SLLEILDLSFNSFHGPIPP---TLQNCSSLRLINLSGNQFNGTIPAFF--GQSPGFQVVSLSFNLLSGSVP----EEFGD 204 (1082)
Q Consensus 134 ~~L~~L~Ls~n~l~~~~p~---~l~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 204 (1082)
..++.|.+.++.++...-. .+..+++|++|+|++|++.+..|..+ ..+++|++|+|++|++++..+ ..+.
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~- 142 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW- 142 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT-
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh-
Confidence 4578888888877532111 12345678889999998888888777 788888888888888886544 1222
Q ss_pred ccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCC--c--CccccCCCCCCEEeCCCCcCcccCCccccCCCC
Q 045553 205 NCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGD--I--PSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQ 280 (1082)
Q Consensus 205 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 280 (1082)
.+++|++|+|++|++++..+..++++++|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++..
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~------ 215 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGV------ 215 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHH------
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHH------
Confidence 466777777777777666666667777777777777766532 1 1223566667777777766652 1211
Q ss_pred CcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCc-cccCCCCCcEEEcCCCcccCCCCcccccc---cCCCe
Q 045553 281 LKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPD-SITRLPNLRVFWAPNLNLEGIFPQNWELC---SKLEM 356 (1082)
Q Consensus 281 L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l---~~L~~ 356 (1082)
+. .+..+++|++|++++|.+.+..|..+..+ ++|++
T Consensus 216 ----------------------------------------~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~ 255 (310)
T 4glp_A 216 ----------------------------------------CAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNS 255 (310)
T ss_dssp ----------------------------------------HHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCC
T ss_pred ----------------------------------------HHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCE
Confidence 11 13445666666666677777666666555 69999
Q ss_pred EEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCccee
Q 045553 357 LNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSG 413 (1082)
Q Consensus 357 L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~l~~ 413 (1082)
|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |....+++|+.|++++|+++.
T Consensus 256 L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 256 LNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp EECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTTSC
T ss_pred EECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCCCC
Confidence 999999999 7788775 8999999999999976 444578999999999999863
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.8e-21 Score=206.11 Aligned_cols=140 Identities=14% Similarity=0.111 Sum_probs=88.8
Q ss_pred CcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcc-cccccCccccCCCCCcEEEccc-CcccccCC
Q 045553 122 FSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ-FNGTIPAFFGQSPGFQVVSLSF-NLLSGSVP 199 (1082)
Q Consensus 122 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p 199 (1082)
++ .+|. +. ++|++|+|++|++++..+..|.++++|++|++++|+ ++...+..|.++++|++|+|++ |+++ .+|
T Consensus 23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~ 97 (239)
T 2xwt_C 23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YID 97 (239)
T ss_dssp CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EEC
T ss_pred cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcC
Confidence 44 5665 33 377888888888876555577778888888888876 7655556777777777777776 7776 444
Q ss_pred cccccccccccEEEcccCccCCCCCccccCCCCcc---EEEccCC-cCCCCcCccccCCCCCC-EEeCCCCcCc
Q 045553 200 EEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELR---SLLLSSN-MLQGDIPSSFGQLVNLE-VLDLSRNFLS 268 (1082)
Q Consensus 200 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~ 268 (1082)
...+..+++|++|++++|++++ +|. +..+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++
T Consensus 98 ~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 98 PDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp TTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred HHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 4333356666666666666663 443 55555555 6666666 55544444555555565 6666555555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3e-21 Score=211.38 Aligned_cols=154 Identities=14% Similarity=0.121 Sum_probs=124.3
Q ss_pred cHHHHHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc------------------ccHHHHHHHHHHHhc
Q 045553 792 TYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF------------------QGVQQFAAEIRTLGR 853 (1082)
Q Consensus 792 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~ 853 (1082)
....+......|.+.+.||+|+||.||+|...+|+.||||+++.... .....+.+|++++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34455556667888899999999999999887799999999964322 134568899999999
Q ss_pred cCCCceeeEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCE
Q 045553 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNI 933 (1082)
Q Consensus 854 l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 933 (1082)
++ | +++.+++. .+..++||||+++++|.+ +.. .....++.|++.|++|||+. +|+||||||+||
T Consensus 161 l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 161 LQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp TT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred cc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 99 4 56666543 356699999999999988 422 23457999999999999999 999999999999
Q ss_pred EEcCCCcEEEeecccceecCCCCCccccCcccCCCcccchhcc
Q 045553 934 LLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976 (1082)
Q Consensus 934 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 976 (1082)
+++ ++.+||+|||+|+. +..|.|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999 99999999999963 34578899874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=2.6e-20 Score=207.42 Aligned_cols=208 Identities=21% Similarity=0.285 Sum_probs=128.6
Q ss_pred EEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcc
Q 045553 115 LLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLL 194 (1082)
Q Consensus 115 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 194 (1082)
+.+..+.+++.++ +..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..+ +..+++|++|+|++|++
T Consensus 24 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (308)
T ss_dssp HHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcC
Confidence 3455566654332 456788888889888888 455 58888888888888888885444 77888888888888887
Q ss_pred cccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCcc
Q 045553 195 SGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSE 274 (1082)
Q Consensus 195 ~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 274 (1082)
+ .++ .+ ..+++|++|++++|++++ ++ .+..+++|++|++++|++++..+ +..+++|++|++++|++++..+
T Consensus 98 ~-~~~-~~-~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-- 168 (308)
T 1h6u_A 98 K-NVS-AI-AGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-- 168 (308)
T ss_dssp S-CCG-GG-TTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred C-Cch-hh-cCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--
Confidence 7 333 22 245666666666666653 22 25555666666666666653322 5555555566665555553211
Q ss_pred ccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCC
Q 045553 275 LGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKL 354 (1082)
Q Consensus 275 l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 354 (1082)
+. .+++|+.|++++|.+.+..+ +..+++|
T Consensus 169 l~-------------------------------------------------~l~~L~~L~l~~n~l~~~~~--l~~l~~L 197 (308)
T 1h6u_A 169 LA-------------------------------------------------NLSKLTTLKADDNKISDISP--LASLPNL 197 (308)
T ss_dssp GT-------------------------------------------------TCTTCCEEECCSSCCCCCGG--GGGCTTC
T ss_pred hc-------------------------------------------------CCCCCCEEECCCCccCcChh--hcCCCCC
Confidence 33 34444444445555544433 5566667
Q ss_pred CeEEcCCccccCCCCccccCCCCCCEEecCCCcCcc
Q 045553 355 EMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390 (1082)
Q Consensus 355 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~ 390 (1082)
++|+|++|++++.. .+..+++|+.|+|++|++++
T Consensus 198 ~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 198 IEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred CEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 77777777776433 26667777777777777664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-20 Score=207.04 Aligned_cols=169 Identities=23% Similarity=0.327 Sum_probs=142.5
Q ss_pred ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 185 (1082)
+.++++|++|++++|.++ .+| .+..+++|++|+|++|.+++ ++. +.++++|++|+|++|++++. ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 567899999999999998 466 68999999999999999995 554 99999999999999999953 3689999999
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCC
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 265 (1082)
+|+|++|++++ ++. + ..+++|++|++++|++++..+ +..+++|++|++++|++++..+ +..+++|++|++++|
T Consensus 111 ~L~l~~n~l~~-~~~-l-~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n 183 (308)
T 1h6u_A 111 TLDLTSTQITD-VTP-L-AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN 183 (308)
T ss_dssp EEECTTSCCCC-CGG-G-TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred EEECCCCCCCC-chh-h-cCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCC
Confidence 99999999984 554 3 479999999999999996543 8899999999999999996443 999999999999999
Q ss_pred cCcccCCccccCCCCCcEEEeccc
Q 045553 266 FLSGIVPSELGMCKQLKVLVLRND 289 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~l~~n 289 (1082)
++++..+ +..+++|++|++++|
T Consensus 184 ~l~~~~~--l~~l~~L~~L~L~~N 205 (308)
T 1h6u_A 184 KISDISP--LASLPNLIEVHLKNN 205 (308)
T ss_dssp CCCCCGG--GGGCTTCCEEECTTS
T ss_pred ccCcChh--hcCCCCCCEEEccCC
Confidence 9985433 555555555555543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.9e-20 Score=209.35 Aligned_cols=240 Identities=16% Similarity=0.097 Sum_probs=144.1
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccC-ccccCCCCCcE-EEcc
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIP-AFFGQSPGFQV-VSLS 190 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~L~ 190 (1082)
++++.++++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| .+|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 56777777777 667655 3577888888888874444567778888888888887765554 46677776654 5556
Q ss_pred cCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccC-CcCCCCcCccccCCC-CCCEEeCCCCcCc
Q 045553 191 FNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSS-NMLQGDIPSSFGQLV-NLEVLDLSRNFLS 268 (1082)
Q Consensus 191 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~ 268 (1082)
.|+++ .++...+..+++|++|++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+
T Consensus 89 ~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 67776 44444444567777777777777755555555666666666654 455544444555553 4666777777666
Q ss_pred ccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCC-CcccCCCCcc
Q 045553 269 GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPN-LNLEGIFPQN 347 (1082)
Q Consensus 269 ~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~-n~l~~~~~~~ 347 (1082)
.+ |....... +|+.|++.+ |.+..+.++.
T Consensus 168 ~i-~~~~f~~~-------------------------------------------------~L~~l~l~~~n~l~~i~~~~ 197 (350)
T 4ay9_X 168 EI-HNSAFNGT-------------------------------------------------QLDELNLSDNNNLEELPNDV 197 (350)
T ss_dssp EE-CTTSSTTE-------------------------------------------------EEEEEECTTCTTCCCCCTTT
T ss_pred CC-Chhhcccc-------------------------------------------------chhHHhhccCCcccCCCHHH
Confidence 33 32222333 444555542 4444555556
Q ss_pred cccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCC
Q 045553 348 WELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQN 409 (1082)
Q Consensus 348 l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N 409 (1082)
|..+++|++|||++|+|+ .+|.. .+.+|+.|.+.++.--..+|..-.+++|+.++++++
T Consensus 198 f~~l~~L~~LdLs~N~l~-~lp~~--~~~~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 198 FHGASGPVILDISRTRIH-SLPSY--GLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYP 256 (350)
T ss_dssp TTTEECCSEEECTTSCCC-CCCSS--SCTTCCEEECTTCTTCCCCCCTTTCCSCCEEECSCH
T ss_pred hccCcccchhhcCCCCcC-ccChh--hhccchHhhhccCCCcCcCCCchhCcChhhCcCCCC
Confidence 677777777777777777 33332 233444444444433334555556677777776544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-20 Score=212.44 Aligned_cols=191 Identities=16% Similarity=0.091 Sum_probs=149.9
Q ss_pred CCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCC-ccccCCCCCCe-EEccCcccccc
Q 045553 96 DKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIP-PTLQNCSSLRL-INLSGNQFNGT 173 (1082)
Q Consensus 96 ~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~-L~Ls~N~l~~~ 173 (1082)
++++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.++++|++ +.+++|+++..
T Consensus 19 ~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l 95 (350)
T 4ay9_X 19 SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI 95 (350)
T ss_dssp TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEE
T ss_pred CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCccccc
Confidence 4444 466666 3689999999999995555689999999999999999976665 46899999875 67778999988
Q ss_pred cCccccCCCCCcEEEcccCcccccCCcccccccccccEEEccc-CccCCCCCccccCCC-CccEEEccCCcCCCCcCccc
Q 045553 174 IPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA-NSLTGSIPPSLGNCT-ELRSLLLSSNMLQGDIPSSF 251 (1082)
Q Consensus 174 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~ 251 (1082)
.|..|..+++|++|++++|++. .+|...+....++..|++.+ |++....+..|..+. .++.|+|++|+|+. +|...
T Consensus 96 ~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~ 173 (350)
T 4ay9_X 96 NPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSA 173 (350)
T ss_dssp CTTSBCCCTTCCEEEEEEECCS-SCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTS
T ss_pred Cchhhhhccccccccccccccc-cCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhh
Confidence 8899999999999999999999 55555444567888999976 567755566777765 68999999999994 55555
Q ss_pred cCCCCCCEEeCCC-CcCcccCCccccCCCCCcEEEeccccC
Q 045553 252 GQLVNLEVLDLSR-NFLSGIVPSELGMCKQLKVLVLRNDYG 291 (1082)
Q Consensus 252 ~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~l~~n~~ 291 (1082)
...++|++|++++ |.++.+.+..|..+++|++|++++|.+
T Consensus 174 f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l 214 (350)
T 4ay9_X 174 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 214 (350)
T ss_dssp STTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCC
T ss_pred ccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCc
Confidence 5667899999985 667644445677777777777776543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-20 Score=196.96 Aligned_cols=157 Identities=24% Similarity=0.281 Sum_probs=144.8
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCc-cccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIP-QSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS 599 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 599 (1082)
..+++++|++. .+|..++. .+++|+|++|+|+++.+ ..|..+++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus 14 ~~l~~s~n~l~-~iP~~~~~---~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIPQ---YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TEEECCSSCCS-SCCSCCCT---TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEeEeCCCCcc-cCccCCCC---CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 48999999998 78987764 47899999999998865 568999999999999999998888899999999999999
Q ss_pred CCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCC
Q 045553 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSA 679 (1082)
Q Consensus 600 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 679 (1082)
+|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|++++|+|+|.+
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99999888888999999999999999999998999999999999999999999998999999999999999988888665
Q ss_pred CC
Q 045553 680 PR 681 (1082)
Q Consensus 680 p~ 681 (1082)
+.
T Consensus 170 ~l 171 (220)
T 2v70_A 170 YL 171 (220)
T ss_dssp GG
T ss_pred ch
Confidence 53
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.4e-20 Score=194.07 Aligned_cols=163 Identities=23% Similarity=0.205 Sum_probs=143.1
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 58899999999999777777899999999999999999666667899999999999999999777778899999999999
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
++|+++ .+|...+..+++|++|++++|++++..+..+..+++|++|++++|.+.+ .+++|++|+++.|+++|
T Consensus 108 ~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 108 NTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSG 179 (208)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTT
T ss_pred CCCcCc-ccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCc
Confidence 999999 5565555578999999999999997777778999999999999998874 45689999999999999
Q ss_pred cCCccccCCCC
Q 045553 270 IVPSELGMCKQ 280 (1082)
Q Consensus 270 ~~p~~l~~l~~ 280 (1082)
.+|..++.++.
T Consensus 180 ~ip~~~~~l~~ 190 (208)
T 2o6s_A 180 VVRNSAGSVAP 190 (208)
T ss_dssp TBBCTTSSBCT
T ss_pred eeeccCccccC
Confidence 99998887654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.2e-20 Score=195.72 Aligned_cols=152 Identities=24% Similarity=0.326 Sum_probs=141.6
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 600 (1082)
..+++++|++. .+|..++ ++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 57999999988 8898876 5699999999999999999999999999999999999988899999999999999999
Q ss_pred CcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccc
Q 045553 601 NNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676 (1082)
Q Consensus 601 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 676 (1082)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 9999777777899999999999999999988999999999999999999999888888999999999999777665
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-20 Score=222.45 Aligned_cols=195 Identities=24% Similarity=0.335 Sum_probs=161.8
Q ss_pred CCCCCCCCCCCc-----eeeee-EeeCCCCCeeeeecCCCccccccccCCCCCCCCCCCCcccCcCcccccccccCcccC
Q 045553 19 TSNWNPKDTDSC-----SWHGV-TCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINS 92 (1082)
Q Consensus 19 ~~~W~~~~~~~c-----~w~gv-~C~~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (1082)
+.+|.. +.++| .|.|+ .|. .++++.|+|++|
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~--~~~L~~L~Ls~n---------------------------------------- 69 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECL--INQFSELQLNRL---------------------------------------- 69 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHH--HTTCSEEECCSS----------------------------------------
T ss_pred HHHHhc-cCCccccccchhhhccccc--cCCccEEEeCCC----------------------------------------
Confidence 456864 46778 79999 796 357899999863
Q ss_pred CCCCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccc
Q 045553 93 NSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNG 172 (1082)
Q Consensus 93 ~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 172 (1082)
++.+ +|+.+ +++|++|+|++|+|+ .+| ..+++|++|+|++|.|++ +|. +.+ +|++|+|++|+|++
T Consensus 70 ----~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~ 134 (571)
T 3cvr_A 70 ----NLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM 134 (571)
T ss_dssp ----CCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC
T ss_pred ----CCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC
Confidence 3443 55555 378999999999999 788 568999999999999996 787 766 99999999999996
Q ss_pred ccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCcccc
Q 045553 173 TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFG 252 (1082)
Q Consensus 173 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 252 (1082)
+|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|. |.
T Consensus 135 -lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~ 199 (571)
T 3cvr_A 135 -LPE---LPALLEYINADNNQLTM-LPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VP 199 (571)
T ss_dssp -CCC---CCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC
T ss_pred -CCC---cCccccEEeCCCCccCc-CCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HH
Confidence 666 68999999999999994 776 46899999999999996 776 66 89999999999999 6777 65
Q ss_pred CCCCC-------CEEeCCCCcCcccCCccccCCCCCcEEEeccc
Q 045553 253 QLVNL-------EVLDLSRNFLSGIVPSELGMCKQLKVLVLRND 289 (1082)
Q Consensus 253 ~l~~L-------~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n 289 (1082)
. +| +.|+|++|+|+ .+|..+..+++|+.|++++|
T Consensus 200 ~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N 240 (571)
T 3cvr_A 200 V--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240 (571)
T ss_dssp ----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSS
T ss_pred H--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCC
Confidence 4 77 99999999998 57888888999999999885
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=213.70 Aligned_cols=176 Identities=23% Similarity=0.273 Sum_probs=153.1
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccC-CCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFT-NFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS 599 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 599 (1082)
.++++++|++. .+|..++. .++.|+|++|+|+++.+..|. ++++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~~---~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLPS---YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCCT---TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCCC---CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 58999999998 78988764 489999999999999999898 99999999999999998888899999999999999
Q ss_pred CCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCC---CCCCcccEEeccCCccc
Q 045553 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGF---GTRSSLSIFDVSFNNLS 676 (1082)
Q Consensus 600 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~l~ls~N~l~ 676 (1082)
+|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 999998888889999999999999999998889999999999999999999996555555 57999999999999998
Q ss_pred cCCCCCc--c-----cccccCCCCCCCCCCCC
Q 045553 677 GSAPRNS--L-----IKCENVQGNPNLQLCHT 701 (1082)
Q Consensus 677 ~~~p~~~--~-----~~~~~~~~Np~~c~c~~ 701 (1082)
+ +|... . .....+.+|||.|+|..
T Consensus 177 ~-l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 177 K-LPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp C-CCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred c-cCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 5 44221 1 24568899999999973
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=192.07 Aligned_cols=155 Identities=25% Similarity=0.303 Sum_probs=143.6
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 600 (1082)
..++++++++. .+|..++ ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+.+..|..+++|+.|+|++
T Consensus 22 ~~v~c~~~~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP---TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEeEccCCCcC-ccCCCCC---CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 47999999987 8998776 6699999999999999999999999999999999999977778899999999999999
Q ss_pred CcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCC
Q 045553 601 NNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680 (1082)
Q Consensus 601 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 680 (1082)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|+++|.++
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999888888999999999999999999 788999999999999999999998877889999999999999888887665
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.6e-19 Score=186.26 Aligned_cols=148 Identities=23% Similarity=0.265 Sum_probs=74.4
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccC
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (1082)
+.++.++++++ .+|..+ .++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 34555555555 344332 245555555555555444444555555555555555555443344444455555544444
Q ss_pred cccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCC
Q 045553 193 LLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVP 272 (1082)
Q Consensus 193 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 272 (1082)
+++ +..+..+.++++|++|+|++|++++..+..|..+++|++|++++|++++..+
T Consensus 87 ~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 87 QLQ-------------------------SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp CCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCC-------------------------ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence 444 3333334455555555555555554444445555555555555555554433
Q ss_pred ccccCCCCCcEEEecc
Q 045553 273 SELGMCKQLKVLVLRN 288 (1082)
Q Consensus 273 ~~l~~l~~L~~L~l~~ 288 (1082)
..+..+++|++|++++
T Consensus 142 ~~~~~l~~L~~L~l~~ 157 (208)
T 2o6s_A 142 GVFDRLTSLQYIWLHD 157 (208)
T ss_dssp TTTTTCTTCCEEECCS
T ss_pred HHhccCCCccEEEecC
Confidence 3344444444444433
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=8.9e-19 Score=185.96 Aligned_cols=134 Identities=22% Similarity=0.208 Sum_probs=94.9
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
++|++|+|++|++++..|..|..+++|++|+|++|.|+...+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 67888999999988877888888888888888888887555566788888888888888888666666777777777777
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
++|+++ .+|.. +..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.+
T Consensus 120 s~N~l~-~lp~~-------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 120 CCNKLT-ELPRG-------------------------IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CSSCCC-SCCTT-------------------------GGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccc-ccCcc-------------------------cccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 777766 44444 4445555555555555554444455555555666666665553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.79 E-value=9.6e-19 Score=208.93 Aligned_cols=196 Identities=23% Similarity=0.296 Sum_probs=122.7
Q ss_pred CCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcc
Q 045553 111 QLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLS 190 (1082)
Q Consensus 111 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 190 (1082)
+|+.|+|++|++++ +|..+ +++|++|+|++|.|+ .+| ..+++|++|+|++|+|++ +|. +.. +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 67777777777764 56544 266777777777776 555 345667777777777765 555 443 66666666
Q ss_pred cCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCccc
Q 045553 191 FNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI 270 (1082)
Q Consensus 191 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 270 (1082)
+|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|++|+|++|+|+ .
T Consensus 129 ~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~ 194 (571)
T 3cvr_A 129 NNQLTM-LPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-S 194 (571)
T ss_dssp SSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-S
T ss_pred CCcCCC-CCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-c
Confidence 666663 554 25566666666666664 443 34566666666666664 444 44 56666666666665 3
Q ss_pred CCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCccccc
Q 045553 271 VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWEL 350 (1082)
Q Consensus 271 ~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~ 350 (1082)
+|. +.. +| +...+.|+.|++++|+|.. +|..+..
T Consensus 195 lp~-~~~--~L------------------------------------------~~~~~~L~~L~Ls~N~l~~-lp~~l~~ 228 (571)
T 3cvr_A 195 LPA-VPV--RN------------------------------------------HHSEETEIFFRCRENRITH-IPENILS 228 (571)
T ss_dssp CCC-CC----------------------------------------------------CCEEEECCSSCCCC-CCGGGGG
T ss_pred hhh-HHH--hh------------------------------------------hcccccceEEecCCCccee-cCHHHhc
Confidence 333 321 11 0112335788888888876 4566666
Q ss_pred ccCCCeEEcCCccccCCCCccccCCCC
Q 045553 351 CSKLEMLNLAHNFFTGQIPASLGNCKS 377 (1082)
Q Consensus 351 l~~L~~L~Ls~N~i~~~~p~~~~~l~~ 377 (1082)
+++|+.|+|++|.+++.+|..+..++.
T Consensus 229 l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 229 LDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred CCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 889999999999998888888776543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.1e-20 Score=227.10 Aligned_cols=198 Identities=21% Similarity=0.229 Sum_probs=77.7
Q ss_pred CHHHHHHHHhcccCCCCCCCCCCCCCCCCceeeeeEeeCCCCCeeeeecCCCccccccccCCCCCCCCCCCCcccCcCcc
Q 045553 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSGRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFHFPCL 80 (1082)
Q Consensus 1 ~~~l~~~k~~~~~~~~~~~~~W~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (1082)
|+||.++..+...+.+..-++|....+.++.|.++.++. .+|+.++|.++...
T Consensus 134 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~------------------------- 186 (727)
T 4b8c_D 134 KQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKD------------------------- 186 (727)
T ss_dssp CHHHHHHHHHHHHHHTTC--------------------------------------------------------------
T ss_pred hhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCC-------------------------
Confidence 689999998887666666678866667788999999974 67899988764211
Q ss_pred cccccccCcccCCCCCCccccccccccCCCC-----CCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCcccc
Q 045553 81 QLHQHDRGNINSNSSDKLSGNLSRAIGDLTQ-----LRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQ 155 (1082)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~g~l~~~l~~l~~-----L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~ 155 (1082)
. .+..+..... +..+++..|.+. ..|+.|..+++|+.|+|++|.+. .+|..+.
T Consensus 187 -------------------~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~ 244 (727)
T 4b8c_D 187 -------------------E-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIF 244 (727)
T ss_dssp --------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGG
T ss_pred -------------------c-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhc
Confidence 1 1111111111 222333334443 44556666666666666666666 5665566
Q ss_pred CCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccE
Q 045553 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRS 235 (1082)
Q Consensus 156 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 235 (1082)
++++|++|+|++|+|+ .+|..|+.+++|++|+|++|+|+ .+|..++ .+++|++|+|++|.|+ .+|..|+++++|+.
T Consensus 245 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~-~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~ 320 (727)
T 4b8c_D 245 KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELG-SCFQLKYFYFFDNMVT-TLPWEFGNLCNLQF 320 (727)
T ss_dssp GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGG-GGTTCSEEECCSSCCC-CCCSSTTSCTTCCC
T ss_pred CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhc-CCCCCCEEECCCCCCC-ccChhhhcCCCccE
Confidence 6666666666666666 55666666666666666666555 4444443 3444444444444444 33444444444444
Q ss_pred EEccCCcCCCCcCccc
Q 045553 236 LLLSSNMLQGDIPSSF 251 (1082)
Q Consensus 236 L~L~~N~l~~~~p~~~ 251 (1082)
|+|++|.|++.+|..+
T Consensus 321 L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 321 LGVEGNPLEKQFLKIL 336 (727)
T ss_dssp EECTTSCCCSHHHHHH
T ss_pred EeCCCCccCCCChHHH
Confidence 4444444444444433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=5.1e-18 Score=178.85 Aligned_cols=153 Identities=22% Similarity=0.283 Sum_probs=129.4
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccC
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (1082)
+.+++++++++ .+|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 57888888888 6776554 68999999999998766778899999999999999999888889999999999999999
Q ss_pred cccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 193 LLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 193 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
+|+ .+|..++..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus 91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 998 7777766678888888888888887778888888888888888888887777778888888888888888864
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.1e-19 Score=199.72 Aligned_cols=161 Identities=21% Similarity=0.205 Sum_probs=143.1
Q ss_pred ceeEEEccCCcccccCCccccc-cCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEE
Q 045553 519 DGLIFDIGNNKLIGEVPSDMGS-HCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLS 597 (1082)
Q Consensus 519 ~l~~l~l~~n~l~~~ip~~~~~-~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 597 (1082)
.++.|+|++|++. .++...+. .+++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+
T Consensus 40 ~l~~L~Ls~N~l~-~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 118 (361)
T 2xot_A 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118 (361)
T ss_dssp TCSEEECCSSCCC-EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCCCC-ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence 3578999999998 56666665 889999999999999999999999999999999999999988888899999999999
Q ss_pred cCCCcCCccCchhhhcCcccchhhccCcccCCCCCccc---cCCcccceecccCcccCCCCCCCCCCCCc--ccEEeccC
Q 045553 598 LSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEF---SKLEHLNVLRLDHNNLTGRIPPGFGTRSS--LSIFDVSF 672 (1082)
Q Consensus 598 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~l~ls~ 672 (1082)
|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..|..++. |+.|+|++
T Consensus 119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~ 198 (361)
T 2xot_A 119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCS
T ss_pred CCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecC
Confidence 99999999889999999999999999999996555555 67999999999999999766677888887 48899999
Q ss_pred CccccCCC
Q 045553 673 NNLSGSAP 680 (1082)
Q Consensus 673 N~l~~~~p 680 (1082)
|+|.|.+.
T Consensus 199 N~~~C~C~ 206 (361)
T 2xot_A 199 NPLECDCK 206 (361)
T ss_dssp SCEECCHH
T ss_pred CCccCCcC
Confidence 99998765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.2e-18 Score=178.16 Aligned_cols=136 Identities=19% Similarity=0.240 Sum_probs=128.3
Q ss_pred eeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcC
Q 045553 520 GLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS 599 (1082)
Q Consensus 520 l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 599 (1082)
+++|++++|++.+..|...+..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 36899999999977678888899999999999999999999999999999999999999999888899999999999999
Q ss_pred CCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCC
Q 045553 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRI 655 (1082)
Q Consensus 600 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 655 (1082)
+|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+++...
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99999999999999999999999999999988999999999999999999998543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-17 Score=184.31 Aligned_cols=172 Identities=24% Similarity=0.282 Sum_probs=150.1
Q ss_pred ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 185 (1082)
+.++++|++|++++|.++ .++ .+..+++|++|+|++|.+++. +. +.++++|++|+|++|++++ ++ .+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 567899999999999998 444 489999999999999999954 44 9999999999999999985 33 489999999
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCC
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 265 (1082)
+|+|++|++++ ++ .+ ..+++|++|++++|++++. ..+..+++|++|++++|++++..+ +..+++|++|++++|
T Consensus 116 ~L~L~~n~i~~-~~-~l-~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N 188 (291)
T 1h6t_A 116 SLSLEHNGISD-IN-GL-VHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188 (291)
T ss_dssp EEECTTSCCCC-CG-GG-GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred EEECCCCcCCC-Ch-hh-cCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCC
Confidence 99999999984 43 34 3689999999999999965 679999999999999999996555 999999999999999
Q ss_pred cCcccCCccccCCCCCcEEEeccccCC
Q 045553 266 FLSGIVPSELGMCKQLKVLVLRNDYGP 292 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~l~~n~~~ 292 (1082)
.+++ ++ .+..+++|+.|++++|.+.
T Consensus 189 ~i~~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 189 HISD-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred cCCC-Ch-hhccCCCCCEEECcCCccc
Confidence 9985 44 4899999999999997543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-17 Score=200.85 Aligned_cols=170 Identities=24% Similarity=0.297 Sum_probs=127.5
Q ss_pred ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 185 (1082)
+.+|++|+.|+|++|.+. .+| .+..+++|+.|+|++|.|++..| +.++++|++|+|++|++++ +| .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence 567788888888888887 444 58888888888888888885443 8888888888888888874 33 677888888
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCC
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 265 (1082)
.|+|++|++.+ ++ .+ ..+++|+.|+|++|++++. ..+..+++|+.|+|++|.|++..| +..+++|+.|+|++|
T Consensus 113 ~L~Ls~N~l~~-l~-~l-~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N 185 (605)
T 1m9s_A 113 SLSLEHNGISD-IN-GL-VHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 185 (605)
T ss_dssp EEECTTSCCCC-CG-GG-GGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred EEEecCCCCCC-Cc-cc-cCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCC
Confidence 88888888873 43 23 3577888888888888754 567777888888888888876555 777788888888888
Q ss_pred cCcccCCccccCCCCCcEEEecccc
Q 045553 266 FLSGIVPSELGMCKQLKVLVLRNDY 290 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~l~~n~ 290 (1082)
+|++. ..+..+++|+.|+|++|.
T Consensus 186 ~i~~l--~~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 186 HISDL--RALAGLKNLDVLELFSQE 208 (605)
T ss_dssp CCCBC--GGGTTCTTCSEEECCSEE
T ss_pred CCCCC--hHHccCCCCCEEEccCCc
Confidence 87753 356777777777776654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-17 Score=184.47 Aligned_cols=162 Identities=19% Similarity=0.263 Sum_probs=111.1
Q ss_pred CCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEccc
Q 045553 112 LRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSF 191 (1082)
Q Consensus 112 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 191 (1082)
+..+.+..+.+++..+ +..+++|++|++++|.++ .++ .+..+++|++|+|++|++++..+ +..+++|++|+|++
T Consensus 26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 3444566666664333 457889999999999998 444 48889999999999999986544 88888899999888
Q ss_pred CcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccC
Q 045553 192 NLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIV 271 (1082)
Q Consensus 192 N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 271 (1082)
|+++ .+|. + ..+++|++|++++|++++. ..+..+++|+.|++++|++++. ..+..+++|++|++++|++++..
T Consensus 100 n~l~-~~~~-l-~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~ 172 (291)
T 1h6t_A 100 NKVK-DLSS-L-KDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 172 (291)
T ss_dssp SCCC-CGGG-G-TTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred CcCC-CChh-h-ccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch
Confidence 8887 3443 3 3567777777777777743 3566677777777777777643 45666677777777777666433
Q ss_pred CccccCCCCCcEEEecc
Q 045553 272 PSELGMCKQLKVLVLRN 288 (1082)
Q Consensus 272 p~~l~~l~~L~~L~l~~ 288 (1082)
| +..+++|+.|++++
T Consensus 173 ~--l~~l~~L~~L~L~~ 187 (291)
T 1h6t_A 173 P--LAGLTKLQNLYLSK 187 (291)
T ss_dssp G--GTTCTTCCEEECCS
T ss_pred h--hcCCCccCEEECCC
Confidence 2 55555555555544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=200.73 Aligned_cols=164 Identities=20% Similarity=0.278 Sum_probs=116.0
Q ss_pred CCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcc
Q 045553 111 QLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLS 190 (1082)
Q Consensus 111 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 190 (1082)
.+..+.+..+.+...++ +..|++|+.|+|++|.+. .+| .+..+++|++|+|++|++++..| +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 34555667777764443 567888999999999988 455 58889999999999999886554 7888888888888
Q ss_pred cCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCccc
Q 045553 191 FNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI 270 (1082)
Q Consensus 191 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 270 (1082)
+|++. .+| .+ ..+++|++|+|++|++++ + +.+..+++|+.|+|++|.+++. ..|+.+++|+.|+|++|++++.
T Consensus 96 ~N~l~-~l~-~l-~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 96 ENKIK-DLS-SL-KDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp SSCCC-CCT-TS-TTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred CCCCC-CCh-hh-ccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 88887 344 33 356777777777777774 2 3466777777777777777643 4566777777777777777654
Q ss_pred CCccccCCCCCcEEEeccc
Q 045553 271 VPSELGMCKQLKVLVLRND 289 (1082)
Q Consensus 271 ~p~~l~~l~~L~~L~l~~n 289 (1082)
.| +..+++|+.|+|++|
T Consensus 169 ~~--l~~l~~L~~L~Ls~N 185 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKN 185 (605)
T ss_dssp GG--GTTCTTCCEEECCSS
T ss_pred hh--hccCCCCCEEECcCC
Confidence 44 555666666655553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=4.2e-20 Score=222.03 Aligned_cols=202 Identities=21% Similarity=0.197 Sum_probs=109.5
Q ss_pred CCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcc-------------cccccCccccCCCCCcEEE-cccCcccccC
Q 045553 133 LSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ-------------FNGTIPAFFGQSPGFQVVS-LSFNLLSGSV 198 (1082)
Q Consensus 133 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~~ 198 (1082)
+++|+.|+|++|.++ .+|..++++++|+.|++++|. +.+..|..++.+++|+.|+ ++.|.+.
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~--- 423 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD--- 423 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH---
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc---
Confidence 334444444444443 344444444444444443332 3344555555555565555 4444332
Q ss_pred CcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCC
Q 045553 199 PEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMC 278 (1082)
Q Consensus 199 p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 278 (1082)
.|..+.+.+|.++.. +. ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..++.+
T Consensus 424 ---------~L~~l~l~~n~i~~l-~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 424 ---------DLRSKFLLENSVLKM-EY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp ---------HHHHHHHHHHHHHHH-HH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred ---------hhhhhhhhccccccc-Cc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 333344444444421 11 135555555555553 444 555555555555555555 445555555
Q ss_pred CCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCC-CcccccccCCCeE
Q 045553 279 KQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF-PQNWELCSKLEML 357 (1082)
Q Consensus 279 ~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L 357 (1082)
++|+.|+|++| .+++ +| .|+.+++|++|++++|++.+.. |..+..+++|+.|
T Consensus 486 ~~L~~L~Ls~N-------------------------~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 486 RCLEVLQASDN-------------------------ALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp TTCCEEECCSS-------------------------CCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred CCCCEEECCCC-------------------------CCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 55555555553 2222 34 5666667777777777777776 7777778888888
Q ss_pred EcCCccccCCCCcc---ccCCCCCCEEec
Q 045553 358 NLAHNFFTGQIPAS---LGNCKSLYFLDL 383 (1082)
Q Consensus 358 ~Ls~N~i~~~~p~~---~~~l~~L~~L~L 383 (1082)
+|++|++++..|.. +..+++|+.|++
T Consensus 539 ~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 539 NLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp ECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 88888887544322 233778888764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6.1e-20 Score=220.65 Aligned_cols=119 Identities=23% Similarity=0.258 Sum_probs=60.9
Q ss_pred CCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcC
Q 045553 257 LEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAP 336 (1082)
Q Consensus 257 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~ 336 (1082)
|+.|+|++|+|++ +|. ++.+++|+.|++++| .+. .+|..|+.+++|+.|+++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N-------------------------~l~-~lp~~~~~l~~L~~L~Ls 494 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN-------------------------RLR-ALPPALAALRCLEVLQAS 494 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS-------------------------CCC-CCCGGGGGCTTCCEEECC
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCcc-------------------------ccc-ccchhhhcCCCCCEEECC
Confidence 5555555555553 343 555555555555543 222 344555555555555555
Q ss_pred CCcccCCCCcccccccCCCeEEcCCccccCCC-CccccCCCCCCEEecCCCcCcccCCCCcc----cCcccEEE
Q 045553 337 NLNLEGIFPQNWELCSKLEMLNLAHNFFTGQI-PASLGNCKSLYFLDLSSNNLTGLLPEEVS----VPCMAVFN 405 (1082)
Q Consensus 337 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----l~~L~~L~ 405 (1082)
+|.++++ | .+..+++|+.|+|++|+|++.. |..++.+++|+.|+|++|+|++.+|.... +++|+.|+
T Consensus 495 ~N~l~~l-p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 495 DNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp SSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CCCCCCC-c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 5555552 3 4555555555555555555443 55555555555555555555555443321 44555543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=179.65 Aligned_cols=137 Identities=20% Similarity=0.246 Sum_probs=108.0
Q ss_pred CccccceecccCceEEEEEEE-cCCeE--EEEEEeecCccc------------------------cHHHHHHHHHHHhcc
Q 045553 802 GFNVQNCIGSGGFGATYKAEI-IPGVV--VAVKRLSVGRFQ------------------------GVQQFAAEIRTLGRV 854 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 854 (1082)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++.++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999977 67989 999987543111 113678999999999
Q ss_pred CCCce--eeEeeeeccCCeEEEEEeecCC-C----CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEec
Q 045553 855 QHPNL--VTLIGYHVSEAEMFLIYNYLPG-G----NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH-DECVPRVLHR 926 (1082)
Q Consensus 855 ~h~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~ 926 (1082)
+|+++ +.++++ ...++||||+.+ | +|.++... .++..+..++.|++.|+.||| +. +|+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 88764 334432 357899999942 3 77766543 234567789999999999999 88 99999
Q ss_pred cCCCCCEEEcCCCcEEEeecccceec
Q 045553 927 DIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 927 Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-17 Score=169.54 Aligned_cols=154 Identities=15% Similarity=0.149 Sum_probs=110.8
Q ss_pred ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 185 (1082)
..++++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+.++++|++|++++|++++..+..|+.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 366778888888888888 666 6888888888888888665 334688888888888888888877777888888888
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCc-cCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCC
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANS-LTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSR 264 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 264 (1082)
+|+|++|++++..|..+. .+++|++|++++|+ ++ .++ .+..+++|++|++++|++++ ++ .+..+++|++|++++
T Consensus 116 ~L~Ls~n~i~~~~~~~l~-~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKIN-TLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp EEECCSSBCBGGGHHHHT-TCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred EEEecCCccCcHhHHHHh-hCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence 888888888765555554 46777777777776 44 444 56667777777777777764 33 566667777777777
Q ss_pred CcCc
Q 045553 265 NFLS 268 (1082)
Q Consensus 265 N~l~ 268 (1082)
|++.
T Consensus 191 N~i~ 194 (197)
T 4ezg_A 191 QTIG 194 (197)
T ss_dssp C---
T ss_pred cccC
Confidence 7664
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=9e-18 Score=182.14 Aligned_cols=168 Identities=22% Similarity=0.232 Sum_probs=122.2
Q ss_pred CCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEE
Q 045553 108 DLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187 (1082)
Q Consensus 108 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 187 (1082)
++.++..+++++|.+++ ++ .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..+ +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 45556677777777773 33 5777788888888888887 455 57778888888888888875444 7788888888
Q ss_pred EcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcC
Q 045553 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFL 267 (1082)
Q Consensus 188 ~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 267 (1082)
+|++|+++ .+|.... ++|++|+|++|++++. + .+..+++|+.|+|++|++++. + .+..+++|++|++++|++
T Consensus 91 ~L~~N~l~-~l~~~~~---~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 91 SVNRNRLK-NLNGIPS---ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp ECCSSCCS-CCTTCCC---SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred ECCCCccC-CcCcccc---CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence 88888887 4554322 6788888888888753 3 577788888888888888753 3 577788888888888888
Q ss_pred cccCCccccCCCCCcEEEeccccC
Q 045553 268 SGIVPSELGMCKQLKVLVLRNDYG 291 (1082)
Q Consensus 268 ~~~~p~~l~~l~~L~~L~l~~n~~ 291 (1082)
++. ..+..+++|+.|++++|.+
T Consensus 163 ~~~--~~l~~l~~L~~L~l~~N~~ 184 (263)
T 1xeu_A 163 TNT--GGLTRLKKVNWIDLTGQKC 184 (263)
T ss_dssp CBC--TTSTTCCCCCEEEEEEEEE
T ss_pred cch--HHhccCCCCCEEeCCCCcc
Confidence 755 5677777777777777543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-17 Score=170.75 Aligned_cols=129 Identities=26% Similarity=0.324 Sum_probs=79.2
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCcc-ccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQ-SFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS 599 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 599 (1082)
+++++++|++. .+|..++. +|++|++++|+|+++.+. .|..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~---~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT---TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC---CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 46777777775 67766653 466777777777666553 36666666666666666666656666666666666666
Q ss_pred CCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCC
Q 045553 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTG 653 (1082)
Q Consensus 600 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 653 (1082)
+|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 666665555555555555555555555555555555555555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=5.1e-17 Score=167.23 Aligned_cols=135 Identities=20% Similarity=0.273 Sum_probs=122.3
Q ss_pred ccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcc-cccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhcc
Q 045553 545 MKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPS-YINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623 (1082)
Q Consensus 545 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 623 (1082)
-+.+++++|+++.+ |..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 10 ~~~l~~s~~~l~~i-p~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLKEI-PRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSSC-CSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcCcC-ccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 37899999999855 544433 899999999999977664 58999999999999999999999999999999999999
Q ss_pred CcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCC
Q 045553 624 ANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN 682 (1082)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 682 (1082)
+|+|++..+..|..+++|++|+|++|+|++.+|..|..+++|++|++++|+|+|.++..
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~ 145 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch
Confidence 99999988888999999999999999999999999999999999999999999877643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.9e-17 Score=179.59 Aligned_cols=81 Identities=17% Similarity=0.151 Sum_probs=52.2
Q ss_pred CCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEE
Q 045553 326 RLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFN 405 (1082)
Q Consensus 326 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~ 405 (1082)
.+.++..++++++.+.++. .+..+++|++|++++|+++ .++ .+..+++|+.|+|++|+|++..+ ...+++|+.|+
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~ 91 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEE
Confidence 3555666677777776654 4667777777777777777 444 56777777777777777775544 33445555555
Q ss_pred ecCCcc
Q 045553 406 VSQNLL 411 (1082)
Q Consensus 406 l~~N~l 411 (1082)
+++|++
T Consensus 92 L~~N~l 97 (263)
T 1xeu_A 92 VNRNRL 97 (263)
T ss_dssp CCSSCC
T ss_pred CCCCcc
Confidence 555544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.4e-17 Score=167.93 Aligned_cols=154 Identities=13% Similarity=0.210 Sum_probs=134.0
Q ss_pred ccCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCC
Q 045553 515 CLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLK 594 (1082)
Q Consensus 515 ~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 594 (1082)
....+++.|++++|++. .+| . +..+++|++|++++|.++.. ..+..+++|++|+|++|.+++..+..|..+++|+
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~-l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-G-IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-T-GGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhcCCccEEeccCCCcc-ChH-H-HhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 45567889999999998 777 3 55678899999999987643 4799999999999999999987888999999999
Q ss_pred EEEcCCCcCCccCchhhhcCcccchhhccCcc-cCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCC
Q 045553 595 FLSLSLNNFTGAIPWELTQLASLEVLELSANS-LSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFN 673 (1082)
Q Consensus 595 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N 673 (1082)
+|+|++|++++..|..|..+++|++|+|++|+ ++ .+| .+..+++|+.|+|++|++++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 99999999998889999999999999999998 66 555 68999999999999999996 44 7889999999999999
Q ss_pred cccc
Q 045553 674 NLSG 677 (1082)
Q Consensus 674 ~l~~ 677 (1082)
++.+
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 9864
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-17 Score=188.46 Aligned_cols=58 Identities=14% Similarity=0.282 Sum_probs=26.1
Q ss_pred cccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCC
Q 045553 206 CVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSR 264 (1082)
Q Consensus 206 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 264 (1082)
+++|+.|+|.+ +++...+.+|.++++|+.|++++|.+....+.+|..+.++..+.++.
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence 44444444444 44433333445555555555555555444444454444444444433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=7.5e-17 Score=165.94 Aligned_cols=108 Identities=25% Similarity=0.327 Sum_probs=76.1
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceeccc
Q 045553 568 SLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLD 647 (1082)
Q Consensus 568 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 647 (1082)
+|++|+|++|+|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4566666666665 445566666666666666666666666666667777777777777776666677778888888888
Q ss_pred CcccCCCCCCCCCCCCcccEEeccCCccc
Q 045553 648 HNNLTGRIPPGFGTRSSLSIFDVSFNNLS 676 (1082)
Q Consensus 648 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 676 (1082)
+|+|++..+..|..+++|+.|++++|+|.
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 88888666667888888888888666555
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.66 E-value=6.4e-17 Score=200.63 Aligned_cols=148 Identities=17% Similarity=0.238 Sum_probs=91.4
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 600 (1082)
++|+|++|+|. .+|..+ ..+++|++|+|++|+|+ .+|..|..+++|++|+|++|.|+ .+|..|..+++|+.|+|++
T Consensus 250 ~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~ 325 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEI-KNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEG 325 (727)
T ss_dssp SCCBCTTSCCS-CCCGGG-GGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTT
T ss_pred CEEEeeCCcCc-ccChhh-hCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCC
Confidence 45555555555 566554 45677999999999999 56888999999999999999998 6788899999999999999
Q ss_pred CcCCccCchhhhcCcc-cchhhccCcccCCCCCccccCCcccceecccCc--------ccCCCCCCCCCCCCcccEEecc
Q 045553 601 NNFTGAIPWELTQLAS-LEVLELSANSLSGEIPSEFSKLEHLNVLRLDHN--------NLTGRIPPGFGTRSSLSIFDVS 671 (1082)
Q Consensus 601 N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N--------~l~~~~p~~~~~l~~L~~l~ls 671 (1082)
|+|++.+|..+..+.. +..|+|++|.+++.+|.. |+.|++++| .|.+..+..+..+..+....++
T Consensus 326 N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls 399 (727)
T 4b8c_D 326 NPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLS 399 (727)
T ss_dssp SCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------------------------
T ss_pred CccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeee
Confidence 9999999988876533 345899999999888864 456677777 4554555556666677777777
Q ss_pred CCccccC
Q 045553 672 FNNLSGS 678 (1082)
Q Consensus 672 ~N~l~~~ 678 (1082)
+|-+.+.
T Consensus 400 ~Nil~~~ 406 (727)
T 4b8c_D 400 YNTLCQH 406 (727)
T ss_dssp --CCCGG
T ss_pred ccccccc
Confidence 7766543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.3e-16 Score=155.66 Aligned_cols=114 Identities=30% Similarity=0.290 Sum_probs=69.8
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecc
Q 045553 567 DSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRL 646 (1082)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 646 (1082)
++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 34555555555555444444555555555555555555444445556666666666666666555555666677777777
Q ss_pred cCcccCCCCCCCCCCCCcccEEeccCCccccCCC
Q 045553 647 DHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680 (1082)
Q Consensus 647 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 680 (1082)
++|+|++..+..|..+++|++|++++|+++|.+|
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7777775555556667777777777777776555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.5e-16 Score=156.55 Aligned_cols=132 Identities=26% Similarity=0.207 Sum_probs=103.4
Q ss_pred CcccEEEccCCccc-ccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhh
Q 045553 543 KCMKFLSMAGNEFV-GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLE 621 (1082)
Q Consensus 543 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 621 (1082)
++|++|++++|+++ +.+|..|..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45788888888887 56677778888888888888888855 6778888888888888888876777777788888888
Q ss_pred ccCcccCCCC-CccccCCcccceecccCcccCCCCC---CCCCCCCcccEEeccCCccc
Q 045553 622 LSANSLSGEI-PSEFSKLEHLNVLRLDHNNLTGRIP---PGFGTRSSLSIFDVSFNNLS 676 (1082)
Q Consensus 622 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~l~ls~N~l~ 676 (1082)
|++|+|++.. +..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 8888887542 2677888888888888888885544 36788888888888888776
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.5e-16 Score=157.70 Aligned_cols=128 Identities=27% Similarity=0.379 Sum_probs=118.4
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 600 (1082)
.++++++|++. .+|..++ ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 57999999988 8998876 46999999999999 5568999999999999999999988889999999999999999
Q ss_pred CcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCC
Q 045553 601 NNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTG 653 (1082)
Q Consensus 601 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 653 (1082)
|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 99999888899999999999999999997777789999999999999999983
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.1e-16 Score=177.78 Aligned_cols=102 Identities=17% Similarity=0.107 Sum_probs=57.5
Q ss_pred CCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCc-E
Q 045553 254 LVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLR-V 332 (1082)
Q Consensus 254 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~-~ 332 (1082)
+++|+.|+|++|+++.+.+.+|..+++|+.|++.+| +....+.+|.++++|+ .
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n--------------------------i~~I~~~aF~~~~~L~~~ 278 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN--------------------------LKTIGQRVFSNCGRLAGT 278 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT--------------------------CCEECTTTTTTCTTCCEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc--------------------------cceehHHHhhCChhccEE
Confidence 456666666666666555556666666666666543 1122234455555565 5
Q ss_pred EEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccccCCCCCCEEe
Q 045553 333 FWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLD 382 (1082)
Q Consensus 333 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ 382 (1082)
+.+.+ .+..+.+.+|.++++|+.|++++|+++...+..|.++++|+.++
T Consensus 279 l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 279 LELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 55555 55555555566666666666655555544444555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=154.21 Aligned_cols=132 Identities=23% Similarity=0.301 Sum_probs=119.7
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 600 (1082)
..+++++|++. .+|..++ ++|++|++++|+++++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 58999999988 7887765 5699999999999998888999999999999999999988778899999999999999
Q ss_pred CcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCC
Q 045553 601 NNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIP 656 (1082)
Q Consensus 601 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 656 (1082)
|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99998888889999999999999999997777778899999999999999996543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.6e-16 Score=153.00 Aligned_cols=128 Identities=23% Similarity=0.205 Sum_probs=107.7
Q ss_pred CcccEEEccCCccc-ccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhh
Q 045553 543 KCMKFLSMAGNEFV-GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLE 621 (1082)
Q Consensus 543 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 621 (1082)
++|+.|++++|+++ +.+|..+..+++|++|+|++|.+++. ..|..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 55888899999888 67788888899999999999999865 6788899999999999999877888888889999999
Q ss_pred ccCcccCCC-CCccccCCcccceecccCcccCCCCC---CCCCCCCcccEEeccC
Q 045553 622 LSANSLSGE-IPSEFSKLEHLNVLRLDHNNLTGRIP---PGFGTRSSLSIFDVSF 672 (1082)
Q Consensus 622 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~l~ls~ 672 (1082)
|++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999863 34778889999999999999986655 4688888999988863
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=152.55 Aligned_cols=137 Identities=22% Similarity=0.251 Sum_probs=121.4
Q ss_pred CceeEEEccCCccc-ccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEE
Q 045553 518 LDGLIFDIGNNKLI-GEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFL 596 (1082)
Q Consensus 518 ~~l~~l~l~~n~l~-~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 596 (1082)
.++++|++++|++. +.+|.. +..+++|++|++++|+|++. ..|..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGL-TAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSC-CGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHHH-HHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 56789999999998 788877 56678899999999999977 789999999999999999998788888889999999
Q ss_pred EcCCCcCCccC-chhhhcCcccchhhccCcccCCCCC---ccccCCcccceecccCcccCCCCCCC
Q 045553 597 SLSLNNFTGAI-PWELTQLASLEVLELSANSLSGEIP---SEFSKLEHLNVLRLDHNNLTGRIPPG 658 (1082)
Q Consensus 597 ~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~ 658 (1082)
+|++|++++.. +..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+. .+|+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 99999999643 2789999999999999999996655 48999999999999999998 55544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.7e-15 Score=169.44 Aligned_cols=144 Identities=13% Similarity=0.123 Sum_probs=103.4
Q ss_pred HHHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc--------------ccHHH--------HHHHHHHHh
Q 045553 795 NVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--------------QGVQQ--------FAAEIRTLG 852 (1082)
Q Consensus 795 ~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~ 852 (1082)
.+.....=|.+.++||+|+||.||+|...+|+.||||+++.... ..... ..+|+..+.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33344444999999999999999999888899999998753211 00111 234555666
Q ss_pred ccCCCcee--eEeeeeccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCC
Q 045553 853 RVQHPNLV--TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKP 930 (1082)
Q Consensus 853 ~l~h~niv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 930 (1082)
++.+.++. ..+++ ...++||||++|++|.++... +....++.|++.++.|||+. +||||||||
T Consensus 169 rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp 233 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNE 233 (397)
T ss_dssp HHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred HHHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCH
Confidence 65444332 12221 234799999999888665432 13456889999999999999 999999999
Q ss_pred CCEEEcCCC----------cEEEeecccceecC
Q 045553 931 SNILLDNNL----------NAYLSDFGLARLLG 953 (1082)
Q Consensus 931 ~Nill~~~~----------~~kl~DfGla~~~~ 953 (1082)
.|||+++++ .+.|+||+-+....
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999998776 38999999876543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.55 E-value=4e-15 Score=146.26 Aligned_cols=129 Identities=21% Similarity=0.217 Sum_probs=83.3
Q ss_pred CCCCCEEEcccCCCc-ccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEE
Q 045553 109 LTQLRVLLLAFNGFS-GELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVV 187 (1082)
Q Consensus 109 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 187 (1082)
.++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+.++++|++|+|++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 356777777777777 66777777777777777777777744 567777777777777777776566666666666666
Q ss_pred EcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcC---ccccCCCCCCEEeCC
Q 045553 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP---SSFGQLVNLEVLDLS 263 (1082)
Q Consensus 188 ~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls 263 (1082)
++++|++++ +| .+..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 94 ~ls~N~i~~-~~-----------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKD-LS-----------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCS-HH-----------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCC-hH-----------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666652 11 12344555555566666665554333 345556666666554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2e-13 Score=156.65 Aligned_cols=118 Identities=9% Similarity=0.081 Sum_probs=63.1
Q ss_pred ccccCccccCCCCCCCEEEccCCCCC-----CCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCC
Q 045553 555 FVGLIPQSFTNFDSLRNLNLSRNHLQ-----GPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSG 629 (1082)
Q Consensus 555 i~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 629 (1082)
++.+.+.+|.++++|+.+++.+|.+. .+.+..|.++++|+.++|. +.++.+-...|.+|.+|+.++|.+| ++.
T Consensus 259 i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~ 336 (401)
T 4fdw_A 259 VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQ 336 (401)
T ss_dssp CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCE
T ss_pred ccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccE
Confidence 33344444555555555555444433 2344455555555555555 3355455555666666666666443 443
Q ss_pred CCCccccCCcccceecccCcccCCCCCCCCCCCC-cccEEeccCCcc
Q 045553 630 EIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRS-SLSIFDVSFNNL 675 (1082)
Q Consensus 630 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~ls~N~l 675 (1082)
+....|.++ +|+.+++++|.+....+..|..++ +++.|++..|.+
T Consensus 337 I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 337 INFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp ECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred EcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 445556666 666666666666655555565553 566666655543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.53 E-value=3.3e-13 Score=154.92 Aligned_cols=270 Identities=12% Similarity=0.088 Sum_probs=213.1
Q ss_pred CCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEE
Q 045553 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVS 188 (1082)
Q Consensus 109 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 188 (1082)
...++.+.+.+ .++..-..+|.+. +|+.++|..+ ++..-..+|.+. +|+.+.+.+ .++...+.+|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 46778888865 4554556678774 7999999877 665566678774 799999986 67767778999999999999
Q ss_pred cccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCc
Q 045553 189 LSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268 (1082)
Q Consensus 189 L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 268 (1082)
|..|+++ .++...+. ..+|+.+.|..+ ++.....+|.++++|+.+++..| ++.....+|.+ .+|+.+.+ .+.++
T Consensus 187 l~~n~l~-~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~ 260 (401)
T 4fdw_A 187 LSKTKIT-KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT 260 (401)
T ss_dssp CTTSCCS-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC
T ss_pred cCCCcce-EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc
Confidence 9999998 77777765 689999999854 77677778999999999999875 56566777887 89999999 45677
Q ss_pred ccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCccc
Q 045553 269 GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNW 348 (1082)
Q Consensus 269 ~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l 348 (1082)
.+...+|..+++|+.+.+.+|.... +......+..|.++++|+.+.+. +.+..+...+|
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~--------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF 319 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFND--------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLL 319 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCC--------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTT
T ss_pred EEChhHhhCCCCCCEEEeCCccccC--------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhh
Confidence 6778899999999999998764320 11122345678899999999999 45888888999
Q ss_pred ccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-cc-CcccEEEecCCcce
Q 045553 349 ELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-SV-PCMAVFNVSQNLLS 412 (1082)
Q Consensus 349 ~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~l-~~L~~L~l~~N~l~ 412 (1082)
.++.+|+.++|..| ++......|.++ +|+.+++++|.+....+..+ .+ ..++.|.+-.+.+.
T Consensus 320 ~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 320 GGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 99999999999665 765677889999 99999999999887776666 34 36778887776553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=7.3e-15 Score=148.82 Aligned_cols=130 Identities=18% Similarity=0.160 Sum_probs=98.9
Q ss_pred cCCcccEEEccCCcccccCccccCCC-CCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccch
Q 045553 541 HCKCMKFLSMAGNEFVGLIPQSFTNF-DSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEV 619 (1082)
Q Consensus 541 ~~~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 619 (1082)
.+.+|++|++++|+|+.+ |. +..+ ++|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..|..+++|++
T Consensus 17 ~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp CTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 345678888888888754 44 4444 4888888888888854 57788888888888888888665566688888888
Q ss_pred hhccCcccCCCCCc--cccCCcccceecccCcccCCCCCCC----CCCCCcccEEeccCCccc
Q 045553 620 LELSANSLSGEIPS--EFSKLEHLNVLRLDHNNLTGRIPPG----FGTRSSLSIFDVSFNNLS 676 (1082)
Q Consensus 620 L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~l~ls~N~l~ 676 (1082)
|+|++|+|+ .+|. .+..+++|+.|+|++|+++ .+|.. +..+++|+.||+++|.+.
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888886 4555 6788888888888888888 45654 778888888888888765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.2e-13 Score=154.78 Aligned_cols=153 Identities=19% Similarity=0.201 Sum_probs=82.4
Q ss_pred hhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccc
Q 045553 128 LEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCV 207 (1082)
Q Consensus 128 ~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~ 207 (1082)
.+|.++.+|+.+.|..+ ++..-..+|.++++|+.++|.++ ++.....+|.++++|+.+.+..+ +. .+....+..+.
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~aF~~~~ 140 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVEAFKGCD 140 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTTTTTTCC
T ss_pred HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecceeeeccc
Confidence 34555555555555422 44233344555555555555433 33333445555555555444333 22 22222222332
Q ss_pred cccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEec
Q 045553 208 SLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287 (1082)
Q Consensus 208 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 287 (1082)
.++ .... +.+......+|.++++|+.+.+.++... .....|.++++|+.+++..| ++.+...+|..+..|+.+.+.
T Consensus 141 ~~~-~~~~-~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~ 216 (394)
T 4fs7_A 141 FKE-ITIP-EGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFP 216 (394)
T ss_dssp CSE-EECC-TTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCC
T ss_pred ccc-cccC-ccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecC
Confidence 222 2221 1122233456788888888888765433 55677888888888888776 554666777777777777664
Q ss_pred c
Q 045553 288 N 288 (1082)
Q Consensus 288 ~ 288 (1082)
+
T Consensus 217 ~ 217 (394)
T 4fs7_A 217 N 217 (394)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=5.3e-14 Score=141.41 Aligned_cols=109 Identities=25% Similarity=0.239 Sum_probs=75.4
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccC
Q 045553 569 LRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDH 648 (1082)
Q Consensus 569 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 648 (1082)
.++|++++|.|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 355666666666 3444442 5667777777777766666677777777777777777766666677777777888888
Q ss_pred cccCCCCCCCCCCCCcccEEeccCCccccCCC
Q 045553 649 NNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680 (1082)
Q Consensus 649 N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 680 (1082)
|+|++..+..|..+++|+.|+|++|+|++.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 88776666667778888888887777775554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=3.9e-14 Score=143.43 Aligned_cols=132 Identities=19% Similarity=0.233 Sum_probs=114.8
Q ss_pred cCCceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCE
Q 045553 516 LSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKF 595 (1082)
Q Consensus 516 ~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 595 (1082)
...++++|++++|++. .+|. +....++|++|++++|+|++. ..|..+++|++|+|++|+|++..+..|..+++|++
T Consensus 17 ~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp CTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 4567789999999998 5654 555555899999999999987 68999999999999999999776667799999999
Q ss_pred EEcCCCcCCccCch--hhhcCcccchhhccCcccCCCCCcc----ccCCcccceecccCcccCC
Q 045553 596 LSLSLNNFTGAIPW--ELTQLASLEVLELSANSLSGEIPSE----FSKLEHLNVLRLDHNNLTG 653 (1082)
Q Consensus 596 L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~ 653 (1082)
|+|++|+|+ .+|. .+..+++|+.|+|++|.++ .+|.. +..+++|+.||+++|.+..
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 999999997 5665 8999999999999999998 55654 8999999999999998763
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=138.57 Aligned_cols=105 Identities=26% Similarity=0.257 Sum_probs=59.7
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCc
Q 045553 570 RNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHN 649 (1082)
Q Consensus 570 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 649 (1082)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34555555554 3333332 45555555555555555555555555666666666665444444566666666666666
Q ss_pred ccCCCCCCCCCCCCcccEEeccCCcccc
Q 045553 650 NLTGRIPPGFGTRSSLSIFDVSFNNLSG 677 (1082)
Q Consensus 650 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 677 (1082)
+|++..+..|..+++|+.|+|++|+|.+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 6665544456666666666666665553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=7.1e-16 Score=159.65 Aligned_cols=150 Identities=21% Similarity=0.224 Sum_probs=80.5
Q ss_pred ccCCCCCCEEEcccCCCcccCCh------hhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCcccc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPL------EIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFG 179 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 179 (1082)
+.....++.++++.+.+++.+|. .|..+++|++|+|++|.+++ +| .+.++++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44555666666666666665554 56666666666666666663 44 5566666666666666665 4454444
Q ss_pred CCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcC-ccccCCCCCC
Q 045553 180 QSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP-SSFGQLVNLE 258 (1082)
Q Consensus 180 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~ 258 (1082)
.+++|+.|+|++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|+
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~--------------------------~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~ 143 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS--------------------------GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH--------------------------HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCS
T ss_pred cCCcCCEEECcCCcCCc-CC--------------------------ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCC
Confidence 44555555555555542 33 34444455555555555542111 2445555555
Q ss_pred EEeCCCCcCcccCCc----------cccCCCCCcEEE
Q 045553 259 VLDLSRNFLSGIVPS----------ELGMCKQLKVLV 285 (1082)
Q Consensus 259 ~L~Ls~N~l~~~~p~----------~l~~l~~L~~L~ 285 (1082)
+|++++|.+++..|. .+..+++|+.|+
T Consensus 144 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp EEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred EEEecCCccccccccccchHHHHHHHHHhCCCcEEEC
Confidence 555555555444332 245555555554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-12 Score=149.67 Aligned_cols=67 Identities=13% Similarity=0.207 Sum_probs=43.3
Q ss_pred CCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcc
Q 045553 146 FHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215 (1082)
Q Consensus 146 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~ 215 (1082)
++.+-..+|.++++|+.+.|..+ ++.....+|.++++|+.++|..+ ++ .++...+.++.+|+.+.+.
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p 125 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLP 125 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCC
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ce-Eccchhhcccccchhhccc
Confidence 44344567888888888888644 66555677888888888877654 44 4555555556666655443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-15 Score=157.67 Aligned_cols=111 Identities=21% Similarity=0.216 Sum_probs=81.5
Q ss_pred cccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCC
Q 045553 177 FFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256 (1082)
Q Consensus 177 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 256 (1082)
.|..+++|++|+|++|++++ +| .+ ..+++|++|++++|+++ .+|..+..+++|++|++++|++++ +| .+..+++
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~-~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~ 116 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SL-SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CH-HHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHH
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-cc-ccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCC
Confidence 45555555555555555552 44 22 24566666666666666 566666677899999999999985 55 6889999
Q ss_pred CCEEeCCCCcCcccCC-ccccCCCCCcEEEeccccCCc
Q 045553 257 LEVLDLSRNFLSGIVP-SELGMCKQLKVLVLRNDYGPL 293 (1082)
Q Consensus 257 L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~n~~~~ 293 (1082)
|++|++++|++++..+ ..+..+++|++|++++|.+..
T Consensus 117 L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 9999999999985433 578999999999999997643
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=2.7e-13 Score=136.18 Aligned_cols=104 Identities=24% Similarity=0.300 Sum_probs=67.9
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 600 (1082)
+++++++|++. .+|..++ ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus 12 ~~l~~s~n~l~-~ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 46777777776 5666554 4466677777777666666666666666666666666665555566666666666666
Q ss_pred CcCCccCchhhhcCcccchhhccCcccC
Q 045553 601 NNFTGAIPWELTQLASLEVLELSANSLS 628 (1082)
Q Consensus 601 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 628 (1082)
|+|++..+..|..+++|++|+|++|.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 6666555555666666666666666655
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.2e-13 Score=137.32 Aligned_cols=104 Identities=22% Similarity=0.281 Sum_probs=77.5
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSL 600 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 600 (1082)
..+++++|++. .+|..++ ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC---CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 57888888875 7787665 5577888888888877777777788888888888887766666667777777777777
Q ss_pred CcCCccCchhhhcCcccchhhccCcccC
Q 045553 601 NNFTGAIPWELTQLASLEVLELSANSLS 628 (1082)
Q Consensus 601 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 628 (1082)
|+|++..+..|..+++|++|+|++|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 7777555555777777777777777776
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.28 E-value=2.4e-10 Score=131.57 Aligned_cols=90 Identities=13% Similarity=0.238 Sum_probs=48.4
Q ss_pred cCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhh
Q 045553 533 EVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELT 612 (1082)
Q Consensus 533 ~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 612 (1082)
.|++..|..+.+|+.+++..+ ++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+++.+|.... ..|.
T Consensus 301 ~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~ 375 (394)
T 4gt6_A 301 ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAIS 375 (394)
T ss_dssp EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCB
T ss_pred ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhh
Confidence 455566666666677666643 55555666777777777777544 454555666666777777666654331 3445
Q ss_pred cCcccchhhccCccc
Q 045553 613 QLASLEVLELSANSL 627 (1082)
Q Consensus 613 ~l~~L~~L~Ls~N~l 627 (1082)
.+.+|+.+.+..|.+
T Consensus 376 ~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 376 TDSGLQNLPVAPGSI 390 (394)
T ss_dssp CCCCC----------
T ss_pred ccCCCCEEEeCCCCE
Confidence 555566665555543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=7.5e-12 Score=141.67 Aligned_cols=91 Identities=23% Similarity=0.153 Sum_probs=42.7
Q ss_pred ccCCCCCCEEEcCC-CcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcc
Q 045553 587 INKMEDLKFLSLSL-NNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSL 665 (1082)
Q Consensus 587 ~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 665 (1082)
|..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++..|..+. |
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L 105 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L 105 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence 44444444444443 444444444444444444444444444444444444455555555555555543333333333 5
Q ss_pred cEEeccCCccccC
Q 045553 666 SIFDVSFNNLSGS 678 (1082)
Q Consensus 666 ~~l~ls~N~l~~~ 678 (1082)
+.|+|++|+|.+.
T Consensus 106 ~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 106 QELVLSGNPLHCS 118 (347)
T ss_dssp CEEECCSSCCCCC
T ss_pred eEEEeeCCCccCC
Confidence 5555555555443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.8e-10 Score=131.00 Aligned_cols=113 Identities=13% Similarity=0.191 Sum_probs=60.8
Q ss_pred cCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhh
Q 045553 533 EVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELT 612 (1082)
Q Consensus 533 ~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 612 (1082)
.|....|..+++|+.+.+. +.++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..+ ++.+-..+|.
T Consensus 278 ~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~ 354 (394)
T 4gt6_A 278 SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFS 354 (394)
T ss_dssp EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGT
T ss_pred eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhh
Confidence 3444555555666666664 4455566666777777777777654 44455566666666776666543 5545555666
Q ss_pred cCcccchhhccCcccCCCCCccccCCcccceecccCccc
Q 045553 613 QLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNL 651 (1082)
Q Consensus 613 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 651 (1082)
+|.+|+.+++.+|.... ..|....+|+.+.+..|.+
T Consensus 355 ~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 355 NCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 66666666666655431 3444555566555554443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.6e-13 Score=154.27 Aligned_cols=87 Identities=18% Similarity=0.121 Sum_probs=40.2
Q ss_pred CCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccc-----cCCCCccEEEccCCcCCCC----cCcccc
Q 045553 182 PGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL-----GNCTELRSLLLSSNMLQGD----IPSSFG 252 (1082)
Q Consensus 182 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~p~~~~ 252 (1082)
++|++|+|++|.++......+...+++|++|+|++|+|+......+ ...++|++|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 3455555555544432222333333445555555555543322222 1234556666666655421 233334
Q ss_pred CCCCCCEEeCCCCcCc
Q 045553 253 QLVNLEVLDLSRNFLS 268 (1082)
Q Consensus 253 ~l~~L~~L~Ls~N~l~ 268 (1082)
.+++|++|+|++|.|+
T Consensus 181 ~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLG 196 (372)
T ss_dssp TCSSCCEEECTTSSCH
T ss_pred cCCCcCEEeCCCCCCC
Confidence 5555666666666554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.9e-13 Score=152.76 Aligned_cols=170 Identities=19% Similarity=0.088 Sum_probs=124.1
Q ss_pred CCCCCEEEcccCCCcccCChhhcCC-----CCCCEEeCcCCCCCCCCCccc-cCCCCCCeEEccCcccccccCccc----
Q 045553 109 LTQLRVLLLAFNGFSGELPLEIGQL-----SLLEILDLSFNSFHGPIPPTL-QNCSSLRLINLSGNQFNGTIPAFF---- 178 (1082)
Q Consensus 109 l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~~---- 178 (1082)
+++|++|+|++|.++......+... ++|++|+|++|.++......+ ..+++|++|+|++|+++......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3679999999999985444444333 799999999999875433333 346789999999999986544444
Q ss_pred -cCCCCCcEEEcccCcccccCCcccc---cccccccEEEcccCccCCCC----CccccCCCCccEEEccCCcCCCC----
Q 045553 179 -GQSPGFQVVSLSFNLLSGSVPEEFG---DNCVSLEHILLAANSLTGSI----PPSLGNCTELRSLLLSSNMLQGD---- 246 (1082)
Q Consensus 179 -~~l~~L~~L~L~~N~l~~~~p~~~~---~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~---- 246 (1082)
...++|++|+|++|.|+......+. ..+++|++|+|++|.|++.. +..+...++|++|+|++|.|+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 3568899999999998742222221 24678999999999988533 45567778999999999999853
Q ss_pred cCccccCCCCCCEEeCCCCcCcccCCccccCC
Q 045553 247 IPSSFGQLVNLEVLDLSRNFLSGIVPSELGMC 278 (1082)
Q Consensus 247 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 278 (1082)
++..+...++|++|+|++|.|++.....+..+
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 34455567899999999999986655555443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.17 E-value=3.3e-11 Score=136.39 Aligned_cols=104 Identities=20% Similarity=0.183 Sum_probs=75.8
Q ss_pred eEEEccCC-cccccCCccccccCCcccEEEccC-CcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEc
Q 045553 521 LIFDIGNN-KLIGEVPSDMGSHCKCMKFLSMAG-NEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSL 598 (1082)
Q Consensus 521 ~~l~l~~n-~l~~~ip~~~~~~~~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 598 (1082)
..++++++ ++. .||. +..+++|++|+|++ |+|+++.+..|.++++|++|+|++|+|+++.|..|.++++|++|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 35688887 676 5777 44556677788875 7777777777777777777777777777777777777777777777
Q ss_pred CCCcCCccCchhhhcCcccchhhccCcccC
Q 045553 599 SLNNFTGAIPWELTQLASLEVLELSANSLS 628 (1082)
Q Consensus 599 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 628 (1082)
++|+|++..+..|..++ |+.|+|++|.+.
T Consensus 88 ~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 77777765555565554 777777777776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.2e-10 Score=126.19 Aligned_cols=148 Identities=12% Similarity=0.018 Sum_probs=115.4
Q ss_pred HHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEE
Q 045553 796 VVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 796 ~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 874 (1082)
+.....+|++...++.|+.+.||++... +..+++|+...........+.+|+++++.+. +..+.++++++...+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567988888999999999999754 7899999986532222345888999998884 6678889999988889999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC----------------------------------- 919 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 919 (1082)
||||++|.++.+.+.. ......++.+++++++.||+..
T Consensus 88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999876321 1223468889999999999810
Q ss_pred ---------------------CCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 920 ---------------------VPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 920 ---------------------~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.+.++|||++|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13689999999999998766667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=3.1e-10 Score=122.62 Aligned_cols=140 Identities=17% Similarity=0.153 Sum_probs=104.1
Q ss_pred HhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCc--eeeEeeeeccCCeEEEEE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN--LVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~ 876 (1082)
...++.+....+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34456665444566679999998777888999997643 2245778999988886544 556888888888899999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC------------------------------------- 919 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------- 919 (1082)
||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 95 e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 95 GEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp ECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999998884 211 11 2357788888888888752
Q ss_pred ------------------CCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 920 ------------------VPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 920 ------------------~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.+.++|||++|.||+++++..+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.95 E-value=5.8e-08 Score=111.01 Aligned_cols=81 Identities=17% Similarity=0.168 Sum_probs=52.3
Q ss_pred cCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhh
Q 045553 533 EVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELT 612 (1082)
Q Consensus 533 ~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 612 (1082)
.++...|..+++|+.+.+.++.++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..+ ++.+-..+|.
T Consensus 276 ~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~ 353 (379)
T 4h09_A 276 TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFE 353 (379)
T ss_dssp EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhh
Confidence 455556666667777777777777666777777777777777654 55455566777777777766544 5544555565
Q ss_pred cCc
Q 045553 613 QLA 615 (1082)
Q Consensus 613 ~l~ 615 (1082)
++.
T Consensus 354 ~c~ 356 (379)
T 4h09_A 354 GSS 356 (379)
T ss_dssp TSS
T ss_pred CCC
Confidence 553
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.2e-07 Score=108.20 Aligned_cols=104 Identities=10% Similarity=0.128 Sum_probs=74.6
Q ss_pred cCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhh
Q 045553 533 EVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELT 612 (1082)
Q Consensus 533 ~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 612 (1082)
.|+...|..+.+|+.+.+..+ ++.+...+|.++++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+-..+|.
T Consensus 253 ~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 330 (379)
T 4h09_A 253 SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFK 330 (379)
T ss_dssp EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred EeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhh
Confidence 455566666677777777643 66666778888888888888888887666778888888888888654 6656667788
Q ss_pred cCcccchhhccCcccCCCCCccccCCc
Q 045553 613 QLASLEVLELSANSLSGEIPSEFSKLE 639 (1082)
Q Consensus 613 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 639 (1082)
++.+|+.+.+..+ ++.+-..+|.++.
T Consensus 331 ~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 331 NCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred CCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 8888888877654 5534455666553
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.84 E-value=5.9e-10 Score=125.40 Aligned_cols=184 Identities=12% Similarity=0.134 Sum_probs=126.1
Q ss_pred ccccccCCCCCCEEEcccCCCc---------ccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccc
Q 045553 102 LSRAIGDLTQLRVLLLAFNGFS---------GELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNG 172 (1082)
Q Consensus 102 l~~~l~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 172 (1082)
+.+++..+++|+.|.+...... +.+...+..+++|+.|+|++|.-. .++. +. +++|++|+|..|.+..
T Consensus 131 L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~ 207 (362)
T 2ra8_A 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPD 207 (362)
T ss_dssp HHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCH
T ss_pred HHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCCh
Confidence 4556778889999999765331 235566788899999999988311 2343 43 8899999999998875
Q ss_pred ccCcccc--CCCCCcEEEccc--Cccccc-----CCcccc-cccccccEEEcccCccCCCCCcccc---CCCCccEEEcc
Q 045553 173 TIPAFFG--QSPGFQVVSLSF--NLLSGS-----VPEEFG-DNCVSLEHILLAANSLTGSIPPSLG---NCTELRSLLLS 239 (1082)
Q Consensus 173 ~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~ 239 (1082)
.....+. .+|+|+.|+|+. |...+. +...+. ..+++|++|+|.+|.+.+..+..+. .+++|++|+|+
T Consensus 208 ~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs 287 (362)
T 2ra8_A 208 SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287 (362)
T ss_dssp HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECC
T ss_pred HHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECC
Confidence 5444554 789999999864 222111 111121 2478999999999998754443333 57899999999
Q ss_pred CCcCCCCc----CccccCCCCCCEEeCCCCcCcccCCccccC-CCCCcEEEecccc
Q 045553 240 SNMLQGDI----PSSFGQLVNLEVLDLSRNFLSGIVPSELGM-CKQLKVLVLRNDY 290 (1082)
Q Consensus 240 ~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~l~~n~ 290 (1082)
.|.+++.. +..+..+++|+.|+|++|.|+...-..+.. + ...++++++.
T Consensus 288 ~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp SSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 99998543 334456789999999999987554444443 2 3567777653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.79 E-value=1e-08 Score=116.32 Aligned_cols=141 Identities=15% Similarity=0.207 Sum_probs=106.2
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEee--cCc-cccHHHHHHHHHHHhccCC--CceeeEeeeeccC---CeEEEEEe
Q 045553 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLS--VGR-FQGVQQFAAEIRTLGRVQH--PNLVTLIGYHVSE---AEMFLIYN 877 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lV~E 877 (1082)
.+.++.|.++.||+.+.. +..+++|+.. ... ......+.+|+++++.+.+ ..++++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 467899999999999765 4678888775 332 1234567889999998874 4578888888766 45899999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC-------------------------------------- 919 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 919 (1082)
|++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99988774421 224678888899999999999999731
Q ss_pred -----------------CCCeEeccCCCCCEEEcCCCc--EEEeeccccee
Q 045553 920 -----------------VPRVLHRDIKPSNILLDNNLN--AYLSDFGLARL 951 (1082)
Q Consensus 920 -----------------~~~ivH~Dlk~~Nill~~~~~--~kl~DfGla~~ 951 (1082)
.+.++|||+++.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=5.7e-09 Score=115.40 Aligned_cols=186 Identities=18% Similarity=0.212 Sum_probs=123.0
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCc--eeeEeeeeccCC---eEEEEEeec
Q 045553 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPN--LVTLIGYHVSEA---EMFLIYNYL 879 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~E~~ 879 (1082)
.+.++.|....||++. ..+++|+.... .....+.+|+++++.+. +.. +.+++.+..... ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 56888885432 33567889999998874 322 445555544333 348899999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----------------------------------------
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE----------------------------------------- 918 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------- 918 (1082)
+|.++.+.... .++.+++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888754332 367778888888999988888861
Q ss_pred --------------CCCCeEeccCCCCCEEEcC--CCcEEEeecccceecCCCCCccccC-------------cccCCCc
Q 045553 919 --------------CVPRVLHRDIKPSNILLDN--NLNAYLSDFGLARLLGTSETHATTD-------------VAGTFGY 969 (1082)
Q Consensus 919 --------------~~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~-------------~~gt~~y 969 (1082)
..+.++|||++|.||++++ ...+.|+||+.+..-.....-.... +...+++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1246899999999999998 4568899999987642211100000 0000011
Q ss_pred cc-chhcccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 045553 970 VA-PEYAMTCRVSDKADVYSFGVVLLELISDKKAL 1003 (1082)
Q Consensus 970 ~a-PE~~~~~~~~~~~Dv~slGvll~elltg~~p~ 1003 (1082)
.. |+.... .....+.|++|.++|++.+|..+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 222111 112368999999999999998765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.69 E-value=3.6e-10 Score=120.43 Aligned_cols=68 Identities=22% Similarity=0.255 Sum_probs=35.0
Q ss_pred cCCCCCCEEeCcCCCCCC--CCCccccCCCCCCeEEccCccccccc-CccccCCCCCcEEEcccCcccccCC
Q 045553 131 GQLSLLEILDLSFNSFHG--PIPPTLQNCSSLRLINLSGNQFNGTI-PAFFGQSPGFQVVSLSFNLLSGSVP 199 (1082)
Q Consensus 131 ~~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p 199 (1082)
.++++|+.|+|++|+|++ .+|..+..+++|++|+|++|+|++.- ...+..+ +|++|+|++|.+.+.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccC
Confidence 445566666666666664 23344555666666666666665431 1122222 55555555555554443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.67 E-value=9e-09 Score=115.73 Aligned_cols=179 Identities=19% Similarity=0.244 Sum_probs=123.6
Q ss_pred CCCCEEEcccCCCcc-c-------CChhhcCCCCCCEEeCcCCCCC---------CCCCccccCCCCCCeEEccCccccc
Q 045553 110 TQLRVLLLAFNGFSG-E-------LPLEIGQLSLLEILDLSFNSFH---------GPIPPTLQNCSSLRLINLSGNQFNG 172 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~-~-------~p~~~~~l~~L~~L~Ls~n~l~---------~~~p~~l~~l~~L~~L~Ls~N~l~~ 172 (1082)
..++.|.+......+ . +..++..+++|+.|.+..+... +.+...+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 456788887665542 2 2334667899999999765432 235566688899999999998422
Q ss_pred ccCccccCCCCCcEEEcccCcccccCCcccc-cccccccEEEccc--CccCCC-----CCccc--cCCCCccEEEccCCc
Q 045553 173 TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFG-DNCVSLEHILLAA--NSLTGS-----IPPSL--GNCTELRSLLLSSNM 242 (1082)
Q Consensus 173 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~~l~~L~~L~L~~--N~l~~~-----~~~~~--~~l~~L~~L~L~~N~ 242 (1082)
.++. +. +++|++|+|..|.+.......+. ..+++|++|+|+. |...+. +...+ ..+++|++|+|++|.
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 2333 43 89999999999988744333343 2589999999863 222111 11222 357999999999999
Q ss_pred CCCCcCcccc---CCCCCCEEeCCCCcCccc----CCccccCCCCCcEEEeccccC
Q 045553 243 LQGDIPSSFG---QLVNLEVLDLSRNFLSGI----VPSELGMCKQLKVLVLRNDYG 291 (1082)
Q Consensus 243 l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~n~~ 291 (1082)
+.+..+..+. .+++|++|+|+.|.+.+. ++..+..+++|+.|++++|.+
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 9754443443 578999999999999864 344456679999999988643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.32 E-value=4.7e-08 Score=104.05 Aligned_cols=64 Identities=39% Similarity=0.470 Sum_probs=31.3
Q ss_pred CCCCCCCEEEccCCCCCCC--CcccccCCCCCCEEEcCCCcCCccCchhhhcCc--ccchhhccCcccCC
Q 045553 564 TNFDSLRNLNLSRNHLQGP--LPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA--SLEVLELSANSLSG 629 (1082)
Q Consensus 564 ~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~ 629 (1082)
.++++|+.|+|++|+|+++ +|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence 3455566666666666542 224444555555555555555533 1222222 44444444444443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.30 E-value=9.8e-08 Score=96.77 Aligned_cols=99 Identities=11% Similarity=0.145 Sum_probs=70.7
Q ss_pred CccccccccccCCCCCCEEEcccC-CCccc----CChhhcCCCCCCEEeCcCCCCCCC----CCccccCCCCCCeEEccC
Q 045553 97 KLSGNLSRAIGDLTQLRVLLLAFN-GFSGE----LPLEIGQLSLLEILDLSFNSFHGP----IPPTLQNCSSLRLINLSG 167 (1082)
Q Consensus 97 ~l~g~l~~~l~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~ 167 (1082)
.+...+...+...+.|++|+|++| .++.. +...+...++|++|+|++|.|... +...+...++|++|+|++
T Consensus 23 ~~~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~ 102 (185)
T 1io0_A 23 DVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVES 102 (185)
T ss_dssp CHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCS
T ss_pred HHHHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcC
Confidence 344556677888899999999998 88742 445567778888899988888743 344556667888888888
Q ss_pred cccccc----cCccccCCCCCcEEEc--ccCccc
Q 045553 168 NQFNGT----IPAFFGQSPGFQVVSL--SFNLLS 195 (1082)
Q Consensus 168 N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~ 195 (1082)
|.|... +...+...++|++|+| ++|.+.
T Consensus 103 N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 103 NFISGSGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp SCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred CcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 888753 3455556667777777 667665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.22 E-value=2e-07 Score=94.46 Aligned_cols=122 Identities=16% Similarity=0.165 Sum_probs=71.9
Q ss_pred CChhhcCCCCCCEEeCcCC-CCCCC----CCccccCCCCCCeEEccCccccccc----CccccCCCCCcEEEcccCcccc
Q 045553 126 LPLEIGQLSLLEILDLSFN-SFHGP----IPPTLQNCSSLRLINLSGNQFNGTI----PAFFGQSPGFQVVSLSFNLLSG 196 (1082)
Q Consensus 126 ~p~~~~~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~ 196 (1082)
+...+...++|++|+|++| .|... +...+...++|++|+|++|+|.... ...+...++|++|+|++|.|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4445666777888888877 77632 3445566677777777777776432 2333344555555555555542
Q ss_pred cCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEc--cCCcCCCC----cCccccCCCCCCEEeCCCCcCc
Q 045553 197 SVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLL--SSNMLQGD----IPSSFGQLVNLEVLDLSRNFLS 268 (1082)
Q Consensus 197 ~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 268 (1082)
.... .+...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 108 ~g~~---------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGIL---------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHH---------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHH---------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 1111 12334555567777777 66777633 2344455577788888777764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.1e-05 Score=88.83 Aligned_cols=135 Identities=20% Similarity=0.214 Sum_probs=95.4
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCC---ceeeEeeeec-cCCeEEEEEeecCCC
Q 045553 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP---NLVTLIGYHV-SEAEMFLIYNYLPGG 882 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~~g 882 (1082)
+.++.|....||+. |..+++|+-. .......+.+|+++++.+.+. .+.+++.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56788888999987 5678888842 223456788999999999753 3556666664 455678999999998
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------------------------------------------
Q 045553 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE-------------------------------------------- 918 (1082)
Q Consensus 883 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------- 918 (1082)
++.+.... .++......++.++++.|+.||+.
T Consensus 99 ~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 99 ILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp ECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred ECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88763221 234455555555566555555542
Q ss_pred -------------CCCCeEeccCCCCCEEEcC---CCc-EEEeeccccee
Q 045553 919 -------------CVPRVLHRDIKPSNILLDN---NLN-AYLSDFGLARL 951 (1082)
Q Consensus 919 -------------~~~~ivH~Dlk~~Nill~~---~~~-~kl~DfGla~~ 951 (1082)
..+.++|||+++.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2336799999999999987 455 48999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=3.3e-05 Score=83.32 Aligned_cols=141 Identities=17% Similarity=0.142 Sum_probs=99.7
Q ss_pred cCccccceecccCce-EEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFG-ATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g-~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.+|+.. .+..|..| .||+.... ++..+++|+-... ....+.+|...++.+. +--+.++++++.+.+..++|||
T Consensus 25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 344443 45556555 68987654 4567899986532 3456788999888774 2236778888888899999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC-------------------------------------- 919 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 919 (1082)
+++|.++.+..... ......++.++++.++.||+..
T Consensus 101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 99998887765432 1223356666777777776421
Q ss_pred -----------------CCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 920 -----------------VPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 920 -----------------~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.+.++|||+.+.||+++.++.+-|+||+.+..
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999887778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=1e-05 Score=91.33 Aligned_cols=79 Identities=8% Similarity=0.045 Sum_probs=54.8
Q ss_pred cee-cccCceEEEEEEEc-------CCeEEEEEEeecCc---cccHHHHHHHHHHHhccCC---CceeeEeeeeccC---
Q 045553 807 NCI-GSGGFGATYKAEII-------PGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQH---PNLVTLIGYHVSE--- 869 (1082)
Q Consensus 807 ~~l-g~G~~g~Vy~a~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~--- 869 (1082)
+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88989999998654 26788888865432 1012456778888887742 3467788877655
Q ss_pred CeEEEEEeecCCCCHH
Q 045553 870 AEMFLIYNYLPGGNLE 885 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~ 885 (1082)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4578999999887654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.76 E-value=7.7e-06 Score=80.57 Aligned_cols=84 Identities=8% Similarity=-0.077 Sum_probs=63.0
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCC-CCCCCCccccCC----CCCCeEEccCcc-cccccCccccCCCC
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNS-FHGPIPPTLQNC----SSLRLINLSGNQ-FNGTIPAFFGQSPG 183 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~l~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 183 (1082)
.+|++|||+++.++..--..+..+++|++|+|++|. |+..--..+..+ ++|++|+|++|. |+...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 478889999888876655667888888888888884 775555556664 368888888874 77655566777888
Q ss_pred CcEEEcccCc
Q 045553 184 FQVVSLSFNL 193 (1082)
Q Consensus 184 L~~L~L~~N~ 193 (1082)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888888775
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=1.5e-05 Score=74.98 Aligned_cols=71 Identities=21% Similarity=0.289 Sum_probs=50.3
Q ss_pred hhhccCcccC-CCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCCcccccccCCCCCCCC
Q 045553 619 VLELSANSLS-GEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQ 697 (1082)
Q Consensus 619 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~Np~~c 697 (1082)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+| .+|||.|
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L--------------------~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHL--------------------GANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEEC--------------------CSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEe--------------------cCCCeec
Confidence 5666777765 24454433 46888899999998776777888888888877 5677889
Q ss_pred CCCCCCCCCcccccC
Q 045553 698 LCHTDPSSSEWERQH 712 (1082)
Q Consensus 698 ~c~~~~~~~~~~~~~ 712 (1082)
+|. ..|...|....
T Consensus 70 dC~-l~~l~~wl~~~ 83 (130)
T 3rfe_A 70 DCR-LVPLRAWLAGR 83 (130)
T ss_dssp SGG-GHHHHHHHHTS
T ss_pred cCc-cHHHHHHHHhC
Confidence 998 55566666543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00018 Score=80.33 Aligned_cols=140 Identities=18% Similarity=0.282 Sum_probs=80.0
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCC--CceeeEeee------eccCCeEEEEEee
Q 045553 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH--PNLVTLIGY------HVSEAEMFLIYNY 878 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~------~~~~~~~~lV~E~ 878 (1082)
+.|+.|..+.||+....+| .+++|+.... ...+..|+++++.+.. -.+.+++.. ....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999987654 5889988652 2333445555554431 123344431 1235678999999
Q ss_pred cCCCCHH--------------HHHhhC------CC------CCCCHHHH-------------------------------
Q 045553 879 LPGGNLE--------------KFIQDR------PR------RTVEWSML------------------------------- 901 (1082)
Q Consensus 879 ~~~gsL~--------------~~l~~~------~~------~~l~~~~~------------------------------- 901 (1082)
++|..+. .-+|.. +. ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9886542 112211 00 01123211
Q ss_pred HHHHHHHHHHHHHHhh----------CCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 902 HKIALDVARALAYLHD----------ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 902 ~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
..+...+..++++|+. ...+.++|||+.+.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223445666663 1235899999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00017 Score=82.54 Aligned_cols=75 Identities=12% Similarity=0.024 Sum_probs=48.6
Q ss_pred cceecccCceEEEEEEEc-CCeEEEEEEeecCcc-------ccHHHHHHHHHHHhccCC--C-ceeeEeeeeccCCeEEE
Q 045553 806 QNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-------QGVQQFAAEIRTLGRVQH--P-NLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l 874 (1082)
.+.||.|..+.||++... +++.++||....... .....+..|.++++.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 357899999999999643 468899998643211 123456778888887742 3 344555543 345689
Q ss_pred EEeecCCC
Q 045553 875 IYNYLPGG 882 (1082)
Q Consensus 875 V~E~~~~g 882 (1082)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.56 E-value=2e-05 Score=77.60 Aligned_cols=35 Identities=9% Similarity=-0.002 Sum_probs=20.1
Q ss_pred CCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCc
Q 045553 134 SLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168 (1082)
Q Consensus 134 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N 168 (1082)
.+|+.|||+++.|+..--..+.++++|++|+|++|
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 35666666666655444444555556666666655
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00042 Score=75.80 Aligned_cols=137 Identities=16% Similarity=0.189 Sum_probs=92.4
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC---CCceeeEeeeeccCCeEEEEEeecCCC
Q 045553 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ---HPNLVTLIGYHVSEAEMFLIYNYLPGG 882 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~~g 882 (1082)
.+.|+.|....+|+.+. ++..+++|+.... ....+.+|++.++.+. ...++++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35689999999999875 4678889987532 3567888998888874 356888888888888899999999987
Q ss_pred CHHH-----------HHhhCCC-C-------------------CCCHHHHH---HHHH----------------HHHHH-
Q 045553 883 NLEK-----------FIQDRPR-R-------------------TVEWSMLH---KIAL----------------DVARA- 911 (1082)
Q Consensus 883 sL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~----------------~i~~~- 911 (1082)
.+.. -+|.... . .-+|.... ++.. .+...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 5421 2333211 0 12455432 1111 11111
Q ss_pred HHHHhh-CCCCCeEeccCCCCCEEEcCCCcEEEeecc
Q 045553 912 LAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFG 947 (1082)
Q Consensus 912 L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 947 (1082)
...|.. ...+.++|+|+.+.|++++.++ +.|.|++
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123422 2356899999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00027 Score=76.88 Aligned_cols=78 Identities=17% Similarity=0.130 Sum_probs=57.6
Q ss_pred CccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCC---ceeeEeeeeccCCeEEEEEee
Q 045553 802 GFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP---NLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lV~E~ 878 (1082)
...-.+.+|.|..+.||+.+..+|+.|+||+-..........|.+|++.|+.+.-. -+++++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 34445779999999999999999999999987655444445678899998887422 244555543 34789999
Q ss_pred cCCCC
Q 045553 879 LPGGN 883 (1082)
Q Consensus 879 ~~~gs 883 (1082)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00017 Score=83.10 Aligned_cols=79 Identities=10% Similarity=0.018 Sum_probs=48.1
Q ss_pred CCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccccCcccCCCcccchhcccC---CCCchhhHHHHHHHHHHH
Q 045553 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC---RVSDKADVYSFGVVLLEL 996 (1082)
Q Consensus 920 ~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvll~el 996 (1082)
.+.++|||+++.||+++.++ ++|+||+.+..-.....-...-..-...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34899999999999999876 99999999875321111000000001346666655321 112235566778888877
Q ss_pred HhC
Q 045553 997 ISD 999 (1082)
Q Consensus 997 ltg 999 (1082)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.002 Score=71.15 Aligned_cols=158 Identities=13% Similarity=0.138 Sum_probs=88.7
Q ss_pred ccHHHHHHHhcCccc-----cceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCc--eeeEe
Q 045553 791 LTYENVVRATAGFNV-----QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN--LVTLI 863 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~ 863 (1082)
++.+++......|.+ .+.|+.|....+|+....+| .+++|+..... ....+..|+.+++.+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 455666666666655 23566788899999987655 67889876521 1234556777766664222 33344
Q ss_pred eee------ccCCeEEEEEeecCCCCHHH--------------HHhhC----CCCC------CCHHHHHH----------
Q 045553 864 GYH------VSEAEMFLIYNYLPGGNLEK--------------FIQDR----PRRT------VEWSMLHK---------- 903 (1082)
Q Consensus 864 ~~~------~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~~------l~~~~~~~---------- 903 (1082)
... ...+..++||||++|..+.. -+|.. .... ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 321 12356789999998865321 11211 0000 11222110
Q ss_pred --HHHHHHHHHHHHhhC----CCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 904 --IALDVARALAYLHDE----CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 904 --i~~~i~~~L~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
+...+.+.+++++.. ..++++|+|+.+.||+++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 234789999999999999876668999998753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00028 Score=70.79 Aligned_cols=94 Identities=14% Similarity=0.092 Sum_probs=65.1
Q ss_pred cccccccccCCCCCCEEEcccC-CCcc----cCChhhcCCCCCCEEeCcCCCCCCC----CCccccCCCCCCeEEccCcc
Q 045553 99 SGNLSRAIGDLTQLRVLLLAFN-GFSG----ELPLEIGQLSLLEILDLSFNSFHGP----IPPTLQNCSSLRLINLSGNQ 169 (1082)
Q Consensus 99 ~g~l~~~l~~l~~L~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~N~ 169 (1082)
...+...+.+-+.|++|+|++| +|.. .+-+.+..-+.|+.|+|++|.|... +.+.+..-+.|++|+|++|+
T Consensus 30 ~~~l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~ 109 (197)
T 1pgv_A 30 ESCINRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNF 109 (197)
T ss_dssp HHHHHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSB
T ss_pred HHHHHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCc
Confidence 3345556677788999999885 7763 2455567778899999999988743 34455667888888888888
Q ss_pred cccccC----ccccCCCCCcEEEcccC
Q 045553 170 FNGTIP----AFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 170 l~~~~p----~~~~~l~~L~~L~L~~N 192 (1082)
|..... .++..-+.|++|+|++|
T Consensus 110 Ig~~Ga~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 110 LTPELLARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp CCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred CCHHHHHHHHHHHhhCCceeEEECCCC
Confidence 885432 34444556777777654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00025 Score=71.22 Aligned_cols=119 Identities=11% Similarity=0.103 Sum_probs=66.0
Q ss_pred hhhcCCCCCCEEeCcCC-CCCCC----CCccccCCCCCCeEEccCcccccccC----ccccCCCCCcEEEcccCcccccC
Q 045553 128 LEIGQLSLLEILDLSFN-SFHGP----IPPTLQNCSSLRLINLSGNQFNGTIP----AFFGQSPGFQVVSLSFNLLSGSV 198 (1082)
Q Consensus 128 ~~~~~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~ 198 (1082)
..+..-+.|++|+|++| .|... +.+.+..-+.|++|+|++|+|..... ..+..-+.|++|+|+.|.|....
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 33455567888888775 66532 34455666777777777777764332 23333455555555555554221
Q ss_pred CcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCC---cCCC----CcCccccCCCCCCEEeCCCCcC
Q 045553 199 PEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSN---MLQG----DIPSSFGQLVNLEVLDLSRNFL 267 (1082)
Q Consensus 199 p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N---~l~~----~~p~~~~~l~~L~~L~Ls~N~l 267 (1082)
-.. +...+..-+.|++|+|++| .+.. .+.+.+..-+.|+.|+++.|.+
T Consensus 115 a~a---------------------la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 115 LAR---------------------LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHH---------------------HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHH---------------------HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 111 1223444456777777654 2331 1334455566777777776655
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0055 Score=67.95 Aligned_cols=141 Identities=12% Similarity=0.053 Sum_probs=72.9
Q ss_pred ceecccCceE-EEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCC--CceeeEeeeeccCCeEEEEEeecCCCC
Q 045553 807 NCIGSGGFGA-TYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH--PNLVTLIGYHVSEAEMFLIYNYLPGGN 883 (1082)
Q Consensus 807 ~~lg~G~~g~-Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gs 883 (1082)
+.|+.|+... +|+....+|..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3465555444 6676554466777776543221 223445666555532 23556676654443 78999997766
Q ss_pred HHHHHhhC---------------------CC---CCCCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 045553 884 LEKFIQDR---------------------PR---RTVEWSMLH-------K-------------IALDVARALAYLH--- 916 (1082)
Q Consensus 884 L~~~l~~~---------------------~~---~~l~~~~~~-------~-------------i~~~i~~~L~~LH--- 916 (1082)
+.+++... .. ..++..... . ....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65444321 00 012111110 0 0011112222221
Q ss_pred hCCCCCeEeccCCCCCEEEcCC----CcEEEeecccceec
Q 045553 917 DECVPRVLHRDIKPSNILLDNN----LNAYLSDFGLARLL 952 (1082)
Q Consensus 917 ~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfGla~~~ 952 (1082)
....+.++|||+.+.||+++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123479999999999999875 68999999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0021 Score=73.85 Aligned_cols=72 Identities=15% Similarity=0.126 Sum_probs=49.3
Q ss_pred ceecccCceEEEEEEEcC--------CeEEEEEEeecCccccHHHHHHHHHHHhccCCCce-eeEeeeeccCCeEEEEEe
Q 045553 807 NCIGSGGFGATYKAEIIP--------GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNL-VTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E 877 (1082)
+.|+.|....+|++...+ +..+++|+..... ....+.+|+.+++.+...++ .++++.+.+ .+|||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 568888899999998753 4789999874321 12455678888887753333 566766543 38999
Q ss_pred ecCCCCH
Q 045553 878 YLPGGNL 884 (1082)
Q Consensus 878 ~~~~gsL 884 (1082)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0018 Score=60.74 Aligned_cols=54 Identities=24% Similarity=0.396 Sum_probs=25.9
Q ss_pred EEEccCCccc-ccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCC
Q 045553 522 IFDIGNNKLI-GEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNH 578 (1082)
Q Consensus 522 ~l~l~~n~l~-~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 578 (1082)
++++++++++ ..+|..+. .+|++|+|++|+|+.+.++.|..+++|+.|+|++|.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp---~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP---VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC---TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSC
T ss_pred EEEeCCCCCccccCCCCCC---cCCCEEECCCCcCCccChhhhhhccccCEEEecCCC
Confidence 6677777664 35555433 224444444444444444444444444444444443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.014 Score=64.48 Aligned_cols=157 Identities=15% Similarity=0.162 Sum_probs=88.6
Q ss_pred ccHHHHHHHhcCccc-----cceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCc--eeeEe
Q 045553 791 LTYENVVRATAGFNV-----QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN--LVTLI 863 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~ 863 (1082)
++.+.+......|.+ ...++ |....||+....+|+.+++|...... .....+..|..+++.+.... +++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 344444444443432 23466 88889999877677789999986432 23456677888777774222 34444
Q ss_pred ee-----eccCCeEEEEEeecCCCCHH-----HH---------Hhh----CC---CCCCCHHHH----HHH---------
Q 045553 864 GY-----HVSEAEMFLIYNYLPGGNLE-----KF---------IQD----RP---RRTVEWSML----HKI--------- 904 (1082)
Q Consensus 864 ~~-----~~~~~~~~lV~E~~~~gsL~-----~~---------l~~----~~---~~~l~~~~~----~~i--------- 904 (1082)
.. ....+..++||||++|..+. .+ +|. .. ....++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 43 11245668899999875432 11 111 10 111222211 001
Q ss_pred ------HHHHHHHHHHHhhC----CCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 905 ------ALDVARALAYLHDE----CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 905 ------~~~i~~~L~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
...+...++.+... ..+.++|||+++.||+++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01111222333221 234688999999999999 4 899999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0058 Score=70.56 Aligned_cols=73 Identities=11% Similarity=0.060 Sum_probs=47.2
Q ss_pred ceecccCceEEEEEEEcC-CeEEEEEEeecCccccHHHHHHHHHHHhccCCCce-eeEeeeeccCCeEEEEEeecCCCCH
Q 045553 807 NCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNL-VTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
+.|+.|-...+|+....+ +..+++|+....... .-...+|..+++.+...++ .++++++.. .+||||++|.++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 568888899999998765 478889987433211 1112578888888865554 467776632 259999987544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0033 Score=68.59 Aligned_cols=137 Identities=13% Similarity=0.104 Sum_probs=74.7
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCce-eeEeeeeccCCeEEEEEeec-CCCC
Q 045553 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNL-VTLIGYHVSEAEMFLIYNYL-PGGN 883 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~~gs 883 (1082)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++++. .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 577889999999998 56788887543211 1122457777766643223 4555544 33457899999 6554
Q ss_pred HHHH------------------HhhCCC---CCCC-HHHHHHHHHH--------------HHHHHH----HHhh-CCCCC
Q 045553 884 LEKF------------------IQDRPR---RTVE-WSMLHKIALD--------------VARALA----YLHD-ECVPR 922 (1082)
Q Consensus 884 L~~~------------------l~~~~~---~~l~-~~~~~~i~~~--------------i~~~L~----~LH~-~~~~~ 922 (1082)
+... +|..+. .... +..+..+... +.+.+. .+.. ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4210 111110 0011 1111111110 111111 1111 12346
Q ss_pred eEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 923 VLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 923 ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
++|+|+.+.||+ ..++.+.++||+.+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998865
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0081 Score=67.44 Aligned_cols=140 Identities=16% Similarity=0.197 Sum_probs=83.8
Q ss_pred ceecccCceEEEEEEEc--------CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCc-eeeEeeeeccCCeEEEEEe
Q 045553 807 NCIGSGGFGATYKAEII--------PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN-LVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E 877 (1082)
+.+..|-...+|+.... +++.+++|+.... ......+.+|.++++.+.-.+ ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888899998764 2478899986332 234556678999888774322 3566776654 29999
Q ss_pred ecCCCCHHHH-----------------HhhCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 045553 878 YLPGGNLEKF-----------------IQDRP---RRTVE--WSMLHKIALDVAR-------------------ALAYLH 916 (1082)
Q Consensus 878 ~~~~gsL~~~-----------------l~~~~---~~~l~--~~~~~~i~~~i~~-------------------~L~~LH 916 (1082)
|++|..+..- +|... ..... |.++.++..++.. .+.+|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9987654310 12111 11222 4555555544422 223332
Q ss_pred ----hC-CCCCeEeccCCCCCEEEcCC----CcEEEeeccccee
Q 045553 917 ----DE-CVPRVLHRDIKPSNILLDNN----LNAYLSDFGLARL 951 (1082)
Q Consensus 917 ----~~-~~~~ivH~Dlk~~Nill~~~----~~~kl~DfGla~~ 951 (1082)
.. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23468999999999999876 7899999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.36 E-value=0.018 Score=57.87 Aligned_cols=105 Identities=12% Similarity=0.100 Sum_probs=70.0
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcccc
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 961 (1082)
-||.+.|..+ +.+++++++|.++.|.+.+|.-.-... .-..+=+.|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 3899999887 679999999999999999987762210 101233457889999999988763 1110
Q ss_pred CcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 045553 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004 (1082)
Q Consensus 962 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~ 1004 (1082)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-+
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 1123466888764 355788999999999999987666543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.95 E-value=0.0088 Score=67.36 Aligned_cols=73 Identities=14% Similarity=0.017 Sum_probs=43.1
Q ss_pred ceecccCceEEEEEEEcC---------CeEEEEEEeecCccccHHHHHHHHHHHhccCCCc-eeeEeeeeccCCeEEEEE
Q 045553 807 NCIGSGGFGATYKAEIIP---------GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN-LVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 876 (1082)
+.|+.|..-.+|+....+ +..+++|+...... .......|.++++.+...+ ..++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 457788888999997654 26888888754321 1112356777777764333 345665442 26899
Q ss_pred eecCCCCH
Q 045553 877 NYLPGGNL 884 (1082)
Q Consensus 877 E~~~~gsL 884 (1082)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.80 E-value=0.056 Score=59.86 Aligned_cols=32 Identities=28% Similarity=0.434 Sum_probs=28.3
Q ss_pred CCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 921 ~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47899999999999998888999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.49 E-value=0.21 Score=56.66 Aligned_cols=139 Identities=13% Similarity=0.149 Sum_probs=82.8
Q ss_pred ceecccCceEEEEEEEcC--------CeEEEEEEeecCccccHHHHHHHHHHHhccCCCc-eeeEeeeeccCCeEEEEEe
Q 045553 807 NCIGSGGFGATYKAEIIP--------GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN-LVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E 877 (1082)
+.+..|-...+|+....+ +..+++|+..... ...-...+|.++++.+...+ ..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 457778889999997753 5788999865432 11112356777777774322 345555432 278999
Q ss_pred ecCCCCHHH-------H----------HhhC-------C----CCCCCHHHHHHHHHHH-------------------HH
Q 045553 878 YLPGGNLEK-------F----------IQDR-------P----RRTVEWSMLHKIALDV-------------------AR 910 (1082)
Q Consensus 878 ~~~~gsL~~-------~----------l~~~-------~----~~~l~~~~~~~i~~~i-------------------~~ 910 (1082)
|++|..+.. . +|.. + ....-|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 998865321 0 1110 0 1111244444443322 22
Q ss_pred HHHHHhh---------------------CCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 911 ALAYLHD---------------------ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 911 ~L~~LH~---------------------~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.+.+|.. .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 11236899999999999 8888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.00 E-value=0.91 Score=51.24 Aligned_cols=30 Identities=30% Similarity=0.420 Sum_probs=25.3
Q ss_pred CeEeccCCCCCEEE------cCCCcEEEeeccccee
Q 045553 922 RVLHRDIKPSNILL------DNNLNAYLSDFGLARL 951 (1082)
Q Consensus 922 ~ivH~Dlk~~Nill------~~~~~~kl~DfGla~~ 951 (1082)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=84.06 E-value=1.2 Score=31.01 Aligned_cols=31 Identities=19% Similarity=0.270 Sum_probs=18.1
Q ss_pred CCCCchhhhHHHHHHHHHHHHHHHHHhhhhc
Q 045553 734 GLNPIEIASITSAAVILSVLIALVLLLICMK 764 (1082)
Q Consensus 734 ~~~~~~i~~i~~~~~~~~~l~~l~~~~~~~r 764 (1082)
+.+...++.++.++++.+.+++.+.+++++|
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 3445566666666666666555555555544
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.77 E-value=2 Score=30.83 Aligned_cols=30 Identities=17% Similarity=0.175 Sum_probs=14.2
Q ss_pred chhhhHHHHHHHHHHHHHHHHHhhhhcccC
Q 045553 738 IEIASITSAAVILSVLIALVLLLICMKKFS 767 (1082)
Q Consensus 738 ~~i~~i~~~~~~~~~l~~l~~~~~~~rk~~ 767 (1082)
..|+..+.+.+++++++++++++++++|+.
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 345444444444444445555555554433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1082 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-11 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 9e-65
Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 22/280 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY + ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMT---C 978
++HRD+K +NI L +L + DFGLA + S +H ++G+ ++APE
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 979 RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038
S ++DVY+FG+VL EL++ + N ++ +G +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYS--------NINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
+C M L C + RP Q+ ++ +
Sbjct: 237 NCPK-----AMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-61
Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+ +G+G FG + VAVK L G F AE + ++QH LV L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRL 73
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
V++ +++I Y+ G+L F++ + + L +A +A +A++ +
Sbjct: 74 YAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+HRD++ +NIL+ + L+ ++DFGLARL+ +E A + APE +
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 983 KADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042
K+DV+SFG++L E+++ + P + N+ M+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-----------------P 232
Query: 1043 HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
+ E+ L +C E RP+ + L+
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-59
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 22/276 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
IGSG FG + + VA+K + G + F E + ++ HP LV L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + +A + L++ ++ G L +++ + L + LDV +AYL + CV
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEEACV-- 122
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+HRD+ N L+ N +SDFG+ R + + ++T + +PE R S
Sbjct: 123 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 983 KADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042
K+DV+SFGV++ E+ S+ K + +V + G P
Sbjct: 182 KSDVWSFGVLMWEVFSEGK----IPYENRSNSEVVED----ISTGFRLYK---------P 224
Query: 1043 HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
+ + C E RP+ ++ +QL +I
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-58
Identities = 62/275 (22%), Positives = 114/275 (41%), Gaps = 22/275 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G+G FG + VA+K + G +F E + + + H LV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + +F+I Y+ G L ++++ R + L ++ DV A+ YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQ 120
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
LHRD+ N L+++ +SDFGL+R + E ++ + PE M + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 983 KADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042
K+D+++FGV++ E+ S K + F N + + + QG P
Sbjct: 181 KSDIWAFGVLMWEIYSLGK---MPYERFTN-----SETAEHIAQGLRLYR---------P 223
Query: 1043 HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
H ++ + C E RP+ + + + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-57
Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 26/295 (8%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+Q IG G FG ++ + G VAVK S R + AEI ++H N++ I
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIA 64
Query: 865 YHVSE----AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
+ +++L+ +Y G+L ++ R TV + K+AL A LA+LH E V
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 921 -----PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH---ATTDVAGTFGYVAP 972
P + HRD+K NIL+ N ++D GLA ++ A GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 973 EYAMTC------RVSDKADVYSFGVVLLELISDKK--ALDPSFCSFGNGFNIVAWASMLL 1024
E +AD+Y+ G+V E+ + + + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 1025 LQGRPCEFFTAGLWD-CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
+ + + + + L M + C + ++R + ++ + L Q+
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-57
Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 22/275 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
++ +G G FG + VA+K L G + F E + + +++H LV L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
E ++++ Y+ G+L F++ + + L +A +A +AY+
Sbjct: 78 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MN 133
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
+HRD++ +NIL+ NL ++DFGLARL+ +E A + APE A+ R +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 983 KADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042
K+DV+SFG++L EL + + P + + +G P
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPG--------MVNREVLDQVERGYRMPC---------P 236
Query: 1043 HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
+ + +L C + RP+ + L+
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 7e-57
Identities = 55/206 (26%), Positives = 105/206 (50%), Gaps = 9/206 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV 860
F + +G+G G +K P G+V+A K + + + Q E++ L P +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH- 124
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+++HRD+KPSNIL+++ L DFG++ L S GT Y++PE
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHY 180
Query: 981 SDKADVYSFGVVLLELISDKKALDPS 1006
S ++D++S G+ L+E+ + + P
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPP 206
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-57
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 28/277 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+ IG G FG + G VAVK + Q F AE + +++H NLV L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 863 IGYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+G V E ++++ Y+ G+L +++ R R + L K +LDV A+ YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+HRD+ N+L+ + A +SDFGL + +++ + APE + S
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFS 178
Query: 982 DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041
K+DV+SFG++L E+ S + P + + +G +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPR--------IPLKDVVPRVEKGYKMDA--------- 221
Query: 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
P + + C + RPS Q+ +QL+ I+
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (496), Expect = 1e-56
Identities = 69/281 (24%), Positives = 124/281 (44%), Gaps = 22/281 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+++ +G G +G Y+ + VAVK L + V++F E + ++HPNLV
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 77
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L+G E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---K 134
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+HRD+ N L+ N ++DFGL+RL+ A + APE + S
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 982 DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041
K+DV++FGV+L E+ + + P ++ LL + E
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPG--------IDLSQVYELLEKDYRMER--------- 237
Query: 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPAS 1082
P ++ L C + S RPS ++ Q + + +S
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (491), Expect = 1e-55
Identities = 66/304 (21%), Positives = 122/304 (40%), Gaps = 39/304 (12%)
Query: 792 TYENVVRATAGFN---------VQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGRF 838
T+E+ A F ++ IG+G FG + + VA+K L G
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 839 -QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE 897
+ + F +E +G+ HPN++ L G + +I ++ G+L+ F++ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-T 126
Query: 898 WSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957
L + +A + YL D +HRD+ NIL+++NL +SDFGL+R L +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 958 HATT----DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNG 1013
T + APE + + +DV+S+G+V+ E++S + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---RPYW----D 236
Query: 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073
+ + R P D + L + C + + RP Q+
Sbjct: 237 MTNQDVINAIEQDYRLPP----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 1074 LKQI 1077
L ++
Sbjct: 287 LDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-55
Identities = 69/283 (24%), Positives = 112/283 (39%), Gaps = 30/283 (10%)
Query: 804 NVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPN 858
+ IG G FG Y ++ + AVK L+ G V QF E + HPN
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 859 LVTLIGYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+++L+G + SE ++ Y+ G+L FI++ L L VA+ +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGM---KF 145
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE---THATTDVAGTFGYVAPEY 974
+ +HRD+ N +LD ++DFGLAR + E H T ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034
T + + K+DV+SFGV+L EL++ N LL R +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-------PYPDVNTFDITVYLLQGRRLLQ--- 255
Query: 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
P + + + C RPS ++ ++ I
Sbjct: 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 8e-55
Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 28/275 (10%)
Query: 809 IGSGGFGATYKAEIIP---GVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIG 864
+G G FG+ + + VA+K L G + ++ E + + ++ +P +V LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+ L+ GG L KF+ + R + S + ++ V+ + YL + +
Sbjct: 77 V-CQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFV 131
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH--ATTDVAGTFGYVAPEYAMTCRVSD 982
HRD+ N+LL N A +SDFGL++ LG +++ A + + APE + S
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 983 KADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGP 1042
++DV+S+GV + E +S + + G ++A+ + QG+ E P
Sbjct: 192 RSDVWSYGVTMWEALSYGQ---KPYKKM-KGPEVMAF----IEQGKRMEC---------P 234
Query: 1043 HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
+ E+ L C RP V Q+++
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 4e-54
Identities = 68/279 (24%), Positives = 118/279 (42%), Gaps = 28/279 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL 859
+ V IG+G +G K G ++ K L G Q +E+ L ++HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 860 VTLIGYHVSEAE--MFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYL 915
V + ++++ Y GG+L I + R+ ++ + ++ + AL
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 916 HD--ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
H + VLHRD+KP+N+ LD N L DFGLAR+L + A GT Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPE 184
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
++K+D++S G +L EL + P F F+ A + +G+
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALM----PPF----TAFSQKELAGK-IREGKFRRI- 234
Query: 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072
P+ E+ + RPS+ ++ +
Sbjct: 235 --------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (479), Expect = 5e-54
Identities = 69/305 (22%), Positives = 123/305 (40%), Gaps = 50/305 (16%)
Query: 803 FNVQNCIGSGGFGATYKAE------IIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQ 855
IG G FG ++A P +VAVK L +Q F E +
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTV------------------- 896
+PN+V L+G M L++ Y+ G+L +F++ TV
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 897 ---EWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953
+ IA VA +AYL + + +HRD+ N L+ N+ ++DFGL+R +
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 954 TSE-THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012
+++ A + A ++ PE R + ++DV+++GVVL E+ S + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL---QPYYGMAH 248
Query: 1013 GFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072
+ G P + +E+ NL +C + + RPS + +
Sbjct: 249 -----EEVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 1073 QLKQI 1077
L+++
Sbjct: 295 ILQRM 299
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-53
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 14/215 (6%)
Query: 793 YENVVR---ATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEI 848
YE+V R + + +G G FG YKA+ V+ A K + + ++ + EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
L HPN+V L+ E ++++ + GG ++ + + R + S + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQT 119
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLHD +++HRD+K NIL + + L+DFG++ + + GT
Sbjct: 120 LDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPY 175
Query: 969 YVAPEYAMTCRVSD-----KADVYSFGVVLLELIS 998
++APE M D KADV+S G+ L+E+
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 9e-53
Identities = 66/285 (23%), Positives = 105/285 (36%), Gaps = 30/285 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQ 855
+ +G G FG + E V VAVK L + + F E+ + +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
H NL+ L G V M ++ P G+L ++ L + A+ VA + YL
Sbjct: 70 HRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYL 127
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH--ATTDVAGTFGYVAPE 973
R +HRD+ N+LL + DFGL R L ++ H F + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
T S +D + FGV L E+ + + + G N + +G
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWI----GLNGSQILHKIDKEGERLPR- 236
Query: 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
P D ++ N+ + C RP+ + L + Q
Sbjct: 237 --------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 44/300 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP------GVVVAVKRLSVGRFQG-VQQFAAEIRTLGRV- 854
+ +G+G FG +A + VAVK L + +E++ L +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR----------------PRRTVEW 898
H N+V L+G +I Y G+L F++ + ++
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 899 SMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958
L + VA+ +A+L + +HRD+ NILL + + DFGLAR + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 959 A-TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017
+ ++APE C + ++DV+S+G+ L EL S + P G +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GMPVD 254
Query: 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
+ ++ +G P EM ++ C RP+ +Q+ Q +++
Sbjct: 255 SKFYKMIKEGFRMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-52
Identities = 62/303 (20%), Positives = 112/303 (36%), Gaps = 49/303 (16%)
Query: 803 FNVQNCIGSGGFGATYKA------EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRV- 854
+GSG FG A + + VAVK L + +E++ + ++
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE----------------- 897
H N+V L+G ++LI+ Y G+L +++ + + E
Sbjct: 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 898 ----WSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953
+ L A VA+ + +L +HRD+ N+L+ + + DFGLAR +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 954 TSETHAT-TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGN 1012
+ + + ++APE + K+DV+S+G++L E+ S P
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP------- 268
Query: 1013 GFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072
G + A L+ G + P E+ + C RPS +
Sbjct: 269 GIPVDANFYKLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 1073 QLK 1075
L
Sbjct: 320 FLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-52
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 809 IGSGGFGATYKAEIIP---GVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLVTLI 863
+GSG FG K VAVK L + AE + ++ +P +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
G +E L+ G L K++Q V+ + ++ V+ + YL +
Sbjct: 75 GICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH--ATTDVAGTFGYVAPEYAMTCRVS 981
+HRD+ N+LL A +SDFGL++ L E + A T + APE + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 982 DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041
K+DV+SFGV++ E S + + + + +L +G
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQ---KPYRGMKG-----SEVTAMLEKGERMGC--------- 231
Query: 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
P EM +L +C + +RP V +L+
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-52
Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 27/280 (9%)
Query: 803 FNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHP 857
+ CIG G FG ++ + P + VA+K V ++F E T+ + HP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
++V LIG ++E +++I G L F+Q R ++ + L A ++ ALAYL
Sbjct: 69 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES 126
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
R +HRDI N+L+ +N L DFGL+R + S + + ++APE
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037
R + +DV+ FGV + E++ +++ + G
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGV----KPFQGVKNNDVIGR----IENGERLPM----- 230
Query: 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
P + + +L C S RP ++ QL I
Sbjct: 231 ----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 8e-52
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 31/272 (11%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGY 865
IG G F YK V VA L + Q+F E L +QHPN+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 866 HVSEAE----MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
S + + L+ + G L+ +++ ++ +L + + L +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRT-P 133
Query: 922 RVLHRDIKPSNILL-DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
++HRD+K NI + + + D GLA L V GT ++APE +
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM-YEEKY 189
Query: 981 SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDC 1040
+ DVY+FG+ +LE+ + + + N + +P F
Sbjct: 190 DESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASF-------- 234
Query: 1041 GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072
+ E+ + C ++ R S++ +
Sbjct: 235 -DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-51
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 30/289 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPG-----VVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQH 856
Q IG+G FG YK + V VA+K L G + F E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
N++ L G M +I Y+ G L+KF++++ L + +A + YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL--GTSETHATTDVAGTFGYVAPEY 974
+ +HRD+ NIL+++NL +SDFGL+R+L T+ T+ + APE
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034
+ + +DV+SFG+V+ E+++ + + N + G
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGE---RPYWELSN-----HEVMKAINDGFRLPT-- 234
Query: 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI-QPPAS 1082
P D + L + C + + RP + L ++ + P S
Sbjct: 235 -------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-51
Identities = 75/294 (25%), Positives = 116/294 (39%), Gaps = 41/294 (13%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPG---VVVAVKRLS-VGRFQGVQQFAAEIRTLGRV-QHP 857
Q+ IG G FG KA I + A+KR+ + FA E+ L ++ HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHK 903
N++ L+G ++L Y P GNL F++ T+ L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A DVAR + YL + +HRD+ NIL+ N A ++DFGL+R T
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMG 186
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML 1023
++A E + +DV+S+GV+L E++S +C G L
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---TPYC----GMTCAELYEKL 239
Query: 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
R + P + E+ +L C E RPS Q+ L ++
Sbjct: 240 PQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 9e-51
Identities = 67/289 (23%), Positives = 111/289 (38%), Gaps = 36/289 (12%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPN 858
F+ IG G FGA Y A + VVA+K++S Q Q E+R L +++HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ G ++ E +L+ Y G + ++ ++ + + + LAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
++HRD+K NILL L DFG A ++ GT ++APE +
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAM 186
Query: 979 ---RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035
+ K DV+S G+ +EL K L N ++ + P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLF--------NMNAMSALYHIAQNESPALQ--- 235
Query: 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQPPAS 1082
N C + RP+ + + + + +PP
Sbjct: 236 ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-50
Identities = 63/283 (22%), Positives = 121/283 (42%), Gaps = 26/283 (9%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ IG G G Y A + G VA++++++ + + EI + ++PN+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+ ++ E++++ YL GG+L + + + + + + +AL +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSN--- 135
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
+V+HRDIK NILL + + L+DFG + ++ +T V GT ++APE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 982 DKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCG 1041
K D++S G++ +E+I + N + ++ G P L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYL--------NENPLRALYLIATNGTPELQNPEKLSA-- 244
Query: 1042 PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQPPAS 1082
+ C + R S +++ Q LK +P +S
Sbjct: 245 ------IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-50
Identities = 64/282 (22%), Positives = 122/282 (43%), Gaps = 29/282 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-----GVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQH 856
F +GSG FG YK IP + VA+K L + ++ E + V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P++ L+G + + LI +P G L ++++ + + L + +A+ + YL
Sbjct: 71 PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYA 975
D R++HRD+ N+L+ + ++DFGLA+LLG E + ++A E
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035
+ + ++DV+S+GV + EL++ +G +S+L R +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGS-------KPYDGIPASEISSILEKGERLPQ---- 234
Query: 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
P I++ + + C SRP R++ + ++
Sbjct: 235 ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 6e-50
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 9/206 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLV 860
+++ +G G +G A VAVK + + R + EI + H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G+ +L Y GG L I P + + + + YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIG- 123
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCR 979
+ HRDIKP N+LLD N +SDFGLA + + + GT YVAPE
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 980 VSD-KADVYSFGVVLLELISDKKALD 1004
DV+S G+VL +++ + D
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWD 207
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-49
Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 31/274 (11%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPN 858
F + +G G FG Y A ++A+K L + Q E+ ++HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ L GY ++LI Y P G + + +Q + + ++A AL+Y H +
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK 125
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
RV+HRDIKP N+LL + ++DFG + +S + GT Y+ PE
Sbjct: 126 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGR 179
Query: 979 RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038
+K D++S GV+ E + K F + + ++ +F T G
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-------FEANTYQETYKRISRVEFTFPDFVTEGAR 232
Query: 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072
D L + S RP +R+V +
Sbjct: 233 D------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-47
Identities = 69/300 (23%), Positives = 121/300 (40%), Gaps = 45/300 (15%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP--------GVVVAVKRLSVGRFQ-GVQQFAAEIRTLGR 853
+ +G G FG AE I VAVK L + + +E+ +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 854 V-QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEW 898
+ +H N++ L+G + +++I Y GNL +++Q R P +
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 899 SMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958
L A VAR + YL + +HRD+ N+L+ + ++DFGLAR + + +
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 959 ATTDV-AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIV 1017
T ++APE + ++DV+SFGV+L E+ + + P V
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPV 243
Query: 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
LL +G + P + E+ + C S RP+ +Q+ + L +I
Sbjct: 244 EELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 65/299 (21%), Positives = 110/299 (36%), Gaps = 43/299 (14%)
Query: 803 FNVQNCIGSGGFGATYKA------EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGR-V 854
+ +G G FG +A + VAVK L G + +E++ L
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 855 QHPNLVTLIGYHVSEAE-MFLIYNYLPGGNLEKFIQDR--------------PRRTVEWS 899
H N+V L+G + +I + GNL +++ + + +
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959
L + VA+ + +L + +HRD+ NILL + DFGLAR + +
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 960 -TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVA 1018
D ++APE + ++DV+SFGV+L E+ S + P G I
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDE 244
Query: 1019 WASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
L +G P EM + C S RP+ ++ + L +
Sbjct: 245 EFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (423), Expect = 6e-46
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+++ +G+G FG ++ G A K + + EI+T+ ++HP LV
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L + EM +IY ++ GG L + + D + + + V + L ++H+
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 922 RVLHRDIKPSNILLDNNLNAY--LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
+H D+KP NI+ + L DFGL L ++ T GT + APE A
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKP 201
Query: 980 VSDKADVYSFGVVLLELIS 998
V D++S GV+ L+S
Sbjct: 202 VGYYTDMWSVGVLSYILLS 220
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-45
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPN 858
F +G G F A + A+K L V E + R+ HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I+ + + ++ AL YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 126
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L S+ GT YV+PE
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 185 KSACKSSDLWALGCIIYQLVA 205
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-44
Identities = 54/294 (18%), Positives = 110/294 (37%), Gaps = 36/294 (12%)
Query: 803 FNVQNCIGSGGFGATYKAE------IIPGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQ 855
+ +G G FG Y+ P VA+K ++ + +F E +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE--------WSMLHKIALD 907
++V L+G +I + G+L+ +++ S + ++A +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGT 966
+A +AYL+ + +HRD+ N ++ + + DFG+ R + T
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026
+++PE + +DV+SFGVVL E+ + + + N +++
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---QPYQGLSN-----EQVLRFVME 250
Query: 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080
G + P + + L MC + RPS ++ +K+ P
Sbjct: 251 GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 9e-44
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 9/199 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+++ +GSG FG ++ E G V K ++ EI + ++ HP L+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L + EM LI +L GG L I + + + + L ++H+
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEH--- 146
Query: 922 RVLHRDIKPSNILLDNNLNAY--LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
++H DIKP NI+ + + + DFGLA L E T + APE
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREP 204
Query: 980 VSDKADVYSFGVVLLELIS 998
V D+++ GV+ L+S
Sbjct: 205 VGFYTDMWAIGVLGYVLLS 223
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 3e-43
Identities = 57/285 (20%), Positives = 98/285 (34%), Gaps = 27/285 (9%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ + IGSG FG Y I G VA+K V Q E + +Q +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
I + +E + ++ L G +LE + + R + +A + + Y+H +
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--- 122
Query: 922 RVLHRDIKPSNIL---LDNNLNAYLSDFGLARLLGTSETHA------TTDVAGTFGYVAP 972
+HRD+KP N L Y+ DFGLA+ + TH ++ GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 973 EYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032
+ S + D+ S G VL+ + + A+ R E
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSL-----------PWQGLKAATKRQKYERISEK 231
Query: 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
+ + E C +P + Q + +
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 5e-43
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 6/200 (3%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLV 860
++ ++ +G+G F AE +VA+K ++ +G + EI L +++HPN+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L + S ++LI + GG L I ++ T ++ V A+ YLHD +
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT--ERDASRLIFQVLDAVKYLHDLGI 128
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+ LD + +SDFGL+++ + GT GYVAPE
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLAQKPY 186
Query: 981 SDKADVYSFGVVLLELISDK 1000
S D +S GV+ L+
Sbjct: 187 SKAVDCWSIGVIAYILLCGY 206
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (386), Expect = 6e-42
Identities = 60/287 (20%), Positives = 116/287 (40%), Gaps = 31/287 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPN 858
+ + +G GG + A + VAVK L + +F E + + HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 859 LVTLIGYHVSEAE----MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+V + +E +++ Y+ G L + T ++ D +AL +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT--PKRAIEVIADACQALNF 126
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAP 972
H ++HRD+KP+NI++ + DFG+AR + S T V GT Y++P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 973 EYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032
E A V ++DVYS G VL E+++ + P F G + V+ A + +
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGE----PPF----TGDSPVSVAYQHVREDPI--- 232
Query: 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-SMRQVAQQLKQIQ 1078
+ + ++ + + ++ +R + ++ L ++
Sbjct: 233 PPSARHEGLSA----DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (385), Expect = 7e-42
Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF---------QGVQQFAAEIRTLG 852
+ + +G G + P AVK + V + + E+ L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 853 RVQ-HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARA 911
+V HPN++ L + + FL+++ + G L ++ ++ + KI +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS--EKETRKIMRALLEV 122
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ LH ++HRD+KP NILLD+++N L+DFG + L E +V GT Y+A
Sbjct: 123 ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 972 PEYAMTCRV------SDKADVYSFGVVLLELISDK 1000
PE + D++S GV++ L++
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-41
Identities = 44/199 (22%), Positives = 78/199 (39%), Gaps = 10/199 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ + +G G FG ++ K + V + EI L +H N++
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILH 65
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L S E+ +I+ ++ G ++ + I + + V AL +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS---H 121
Query: 922 RVLHRDIKPSNILLDNNLNAY--LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
+ H DI+P NI+ ++ + +FG AR L + Y APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDV 179
Query: 980 VSDKADVYSFGVVLLELIS 998
VS D++S G ++ L+S
Sbjct: 180 VSTATDMWSLGTLVYVLLS 198
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 9e-41
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 11/203 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF---QGVQQFAAEIRTLGRV-QHP 857
F + +G G FG + AE A+K L V+ E R L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
L + ++ +F + YL GG+L IQ + S A ++ L +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD--LSRATFYAAEIILGLQFLHS 121
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+++RD+K NILLD + + ++DFG+ + + T GT Y+APE +
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177
Query: 978 CRVSDKADVYSFGVVLLELISDK 1000
+ + D +SFGV+L E++ +
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (383), Expect = 1e-40
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQ--- 855
F+V IG GGFG Y G + A+K L R QG E L V
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
P +V + + ++ I + + GG+L + + + + A ++ L ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLEHM 123
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H+ V++RD+KP+NILLD + + +SD GLA + HA+ GT GY+APE
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 177
Query: 976 MTCRVSD-KADVYSFGVVLLELISDK 1000
D AD +S G +L +L+
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (377), Expect = 1e-40
Identities = 45/287 (15%), Positives = 91/287 (31%), Gaps = 29/287 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ V IG G FG ++ + VA+K R Q E RT + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+ Y E ++ L G +LE + R+ ++ A + + +H+
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM-AAKQMLARVQSIHE---K 120
Query: 922 RVLHRDIKPSNILLDNNLN-----AYLSDFGLARLLGTSETHA------TTDVAGTFGYV 970
+++RDIKP N L+ + Y+ DFG+ + T +++GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030
+ + S + D+ + G V + + G + + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGS------LPWQGLKAATNKQKYERIGEKKQS 234
Query: 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
E + + P + ++
Sbjct: 235 TPLRELCAGFPE-----EFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (379), Expect = 2e-40
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F + +G+G FG + G A+K L V R + V+ E L V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ + G ++F+I +Y+ GG L ++ R + A +V AL YLH
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEVCLALEYLHS- 122
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
+++RD+KP NILLD N + ++DFG A+ + + GT Y+APE T
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTK 176
Query: 979 RVSDKADVYSFGVVLLELISDKK 1001
+ D +SFG+++ E+++
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 7/201 (3%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL 859
F IG G +G YKA G VVA+K++ + EI L + HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
V LHRD+KP N+L++ L+DFGLAR G T +V +
Sbjct: 123 V---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 980 VSDKADVYSFGVVLLELISDK 1000
S D++S G + E+++ +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRR 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-39
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV 860
+ + IG G +G A V VA+K++S Q Q+ EI+ L R +H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 861 TLIGYHVSEA----EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + + + +L G +L K ++ + + + + R L Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH 126
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT--TDVAGTFGYVAPEY 974
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 975 AMTCRVSD-KADVYSFGVVLLELISDK 1000
+ + D++S G +L E++S++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 70/295 (23%), Positives = 113/295 (38%), Gaps = 26/295 (8%)
Query: 798 RATAGFNVQNCIGSGGFGATYKAEIIP--GVVVAVKRLSV-----GRFQGVQQFAAEIRT 850
RA + IG G +G +KA + G VA+KR+ V G + A +R
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 851 LGRVQHPNLVTLIGYHVS-----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIA 905
L +HPN+V L E ++ L++ ++ ++ P V + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMM 122
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
+ R L +LH V +HRD+KP NIL+ ++ L+DFGLAR+ S A T V
Sbjct: 123 FQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVV 177
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPS--------FCSFGNGFNIV 1017
T Y APE + + D++S G + E+ K S
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 1018 AWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072
W + L + +A + D +L + C + + R S
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 807 NCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQG-----VQQFAAEIRTLGRVQHPNLV 860
+ +G G F YKA +VA+K++ +G + EI+ L + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L+ ++ + L+++++ I + S + L + L YLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
LHRD+KP+N+LLD N L+DFGLA+ G S A T T Y APE R+
Sbjct: 122 ---LHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 981 SD-KADVYSFGVVLLELIS 998
D+++ G +L EL+
Sbjct: 178 YGVGVDMWAVGCILAELLL 196
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 62/284 (21%), Positives = 103/284 (36%), Gaps = 40/284 (14%)
Query: 805 VQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNLVTL 862
+G G G + A+K L Q + E+ R Q P++V +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRI 70
Query: 863 IGY----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ + + ++ L GG L IQDR + +I + A+ YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 919 CVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
+ HRD+KP N+L N L+DFG A+ + + T T YVAPE
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF-FT 1034
+ D++S GV++ L+ P F + +A + + + R ++ F
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGY----PPF----YSNHGLAISPGMKTRIRMGQYEFP 237
Query: 1035 AGLWDCGPHD--DLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQ 1076
W + LI L L + P+ R +
Sbjct: 238 NPEWSEVSEEVKMLIRNL----------LKTEPTQRMTITEFMN 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (354), Expect = 1e-37
Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 7/198 (3%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLV 860
++ IG G +G YKA+ G A+K++ + + EI L ++H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L ++ + L++ +L + D +E L + +AY HD
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHD--- 118
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
RVLHRD+KP N+L++ ++DFGLAR G T ++ + + +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 981 SDKADVYSFGVVLLELIS 998
S D++S G + E+++
Sbjct: 179 STTIDIWSVGCIFAEMVN 196
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-37
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG------VQQFAAEIRTLGRVQ 855
++ +GSG F K E G+ A K + R + + E+ L +Q
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
HPN++TL + ++ ++ LI + GG L F+ ++ + + + + YL
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYL 129
Query: 916 HDECVPRVLHRDIKPSNILLDNN----LNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
H + H D+KP NI+L + + DFGLA + + ++ GT +VA
Sbjct: 130 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVA 184
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELIS 998
PE + +AD++S GV+ L+S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLS 211
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 51/200 (25%), Positives = 76/200 (38%), Gaps = 10/200 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPN 858
F+ +G G FG G A+K L V E R L +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
L L + + + Y GG L + T E ++ AL YLH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER--ARFYGAEIVSALEYLHS- 123
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
V++RDIK N++LD + + ++DFGL + + GT Y+APE
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDN 180
Query: 979 RVSDKADVYSFGVVLLELIS 998
D + GVV+ E++
Sbjct: 181 DYGRAVDWWGLGVVMYEMMC 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 5e-36
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ IG+G FG Y+A++ G +VA+K++ Q + E++ + ++ H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 862 LIGYHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAY 914
L + S E + L+ +Y+P R ++T+ + + R+LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 915 LHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+H + HRDIKP N+LLD + L DFG A+ L E + + + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPEL 193
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ DV+S G VL EL+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLL 218
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 6e-36
Identities = 62/295 (21%), Positives = 106/295 (35%), Gaps = 23/295 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL 859
+ IG G +G +KA+ +VA+KR+ + EI L ++H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L S+ ++ L++ + D ++ ++ + + L + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
V LHRD+KP N+L++ N L++FGLAR G + +V +
Sbjct: 122 V---LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 980 VSDKADVYSFGVVLLELISDKKALDPS---------FCSFGNGFNIVAWASMLLL---QG 1027
S D++S G + EL + + L P W SM L +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQPP 1080
P T L + P + +L + R S + Q PP
Sbjct: 239 YPMYPATTSLVNVVPKLN-ATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 5e-35
Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 18/209 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQG------VQQFAAEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 856 --HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
++ L+ + LI R ++ + V A+
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVR 124
Query: 914 YLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
+ H+ VLHRDIK NIL+D N L DFG LL + TD GT Y P
Sbjct: 125 HCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 178
Query: 973 EYAMTCRVSDK-ADVYSFGVVLLELISDK 1000
E+ R + A V+S G++L +++
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-34
Identities = 48/213 (22%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNL 859
+ IG G FG +KA G VA+K++ + + EI+ L ++H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 860 VTLIG--------YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARA 911
V LI Y+ + ++L++++ + T+ + ++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNG 129
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET---HATTDVAGTFG 968
L Y+H ++LHRD+K +N+L+ + L+DFGLAR ++ + T+ T
Sbjct: 130 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 969 YVAPEYAMTCR-VSDKADVYSFGVVLLELISDK 1000
Y PE + R D++ G ++ E+ +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 7e-34
Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG + G A+K L V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
LV L + ++++ Y+ GG + ++ R + A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARFYAAQIVLTFEYLHSL 160
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
+++RD+KP N+L+D ++DFG A+ T + GT +APE ++
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSK 213
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
+ D ++ GV++ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-33
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLS----VGRFQGVQQFAAEIRTLGRV 854
F + +G+G +G + I G + A+K L V + + + E + L +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 855 QH-PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
+ P LVTL +E ++ LI +Y+ GG L + R R T ++ V +
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEIVL 140
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
L +++RDIK NILLD+N + L+DFGL++ ET D GT Y+AP+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 974 YAMTCRVSD--KADVYSFGVVLLELISDK 1000
D +S GV++ EL++
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 3e-31
Identities = 49/279 (17%), Positives = 105/279 (37%), Gaps = 25/279 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLV 860
+ + +G G + ++A I V VK L + ++ EI+ L ++ PN++
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNII 93
Query: 861 TLIGYHVSEAE--MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
TL L++ ++ + ++ Q T+ + ++ +AL Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM 148
Query: 919 CVPRVLHRDIKPSNILLDN-NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ HRD+KP N+++D+ + L D+GLA + + + + PE +
Sbjct: 149 GIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVD 203
Query: 978 CRVSD-KADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
++ D D++S G +L +I K+ F N + + G +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPF------FHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
++ ++L E + V+ +
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 7e-31
Identities = 55/247 (22%), Positives = 99/247 (40%), Gaps = 26/247 (10%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL 859
+ IGSG G A + + VA+K+LS ++ E+ + V H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 860 VTLIGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
++L+ + +++L+ + + + + + + +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIK 133
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH + +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 134 HLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPE 188
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
+ + D++S G ++ E++ K F I W ++ G PC F
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK-------ILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 1034 TAGLWDC 1040
L
Sbjct: 242 MKKLQPT 248
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 7e-30
Identities = 49/259 (18%), Positives = 100/259 (38%), Gaps = 26/259 (10%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL 859
+ +GSG +GA A + G VA+K+L ++ E+R L ++H N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 860 VTLIGYHVSE------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
+ L+ + + +L+ ++ G + + + + + + L
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG--EDRIQFLVYQMLKGLR 135
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
Y+H + HRD+KP N+ ++ + + DFGLAR + T V +
Sbjct: 136 YIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEV 189
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
R + D++S G ++ E+I+ K F ++ ++ + G P F
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTL-------FKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 1034 TAGLWDCGPHDDLIEMLNL 1052
L + + + L
Sbjct: 243 VQRLQSDEAKNYMKGLPEL 261
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-28
Identities = 47/206 (22%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNL 859
+ + +GSG +G+ A G+ VAVK+LS ++ E+R L ++H N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 860 VTLIGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+ L+ + E + +L G +L ++ + + + + R L Y
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT---DDHVQFLIYQILRGLKY 136
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
+H + HRD+KPSN+ ++ + + DFGLAR ++ T VA +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 190
Query: 975 AMTCRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 4e-26
Identities = 48/266 (18%), Positives = 90/266 (33%), Gaps = 21/266 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ + +G G F + A+ + VA+K + G + EI+ L RV +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 862 LIG--------------YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
+ ++ + G NL I+ R + + +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTD-VAG 965
+ L Y+H C ++H DIKP N+L++ + L +A L
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL 1025
T Y +PE + AD++S ++ ELI+ L + A ++ L
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 1026 QGRPCEFFTAGLWDCGPHDDLIEMLN 1051
G + + +L
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLR 276
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.1 bits (233), Expect = 1e-22
Identities = 34/203 (16%), Positives = 63/203 (31%), Gaps = 27/203 (13%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVG----------RFQGVQQFAAEIRTLGRV 854
+ +G G A + VK VG R G F+ R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+ L L G V + +Y + L + I + V ++ + +A
Sbjct: 64 EFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG--TSETHATTDVAGTFGYVAP 972
+ ++H D+ N+L+ ++ DF + +G DV Y +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174
Query: 973 EYAMTCRVSDKADVYSFGVVLLE 995
Y + D+ S +L+
Sbjct: 175 TYRT------EKDINSAIDRILQ 191
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 89.8 bits (221), Expect = 7e-20
Identities = 63/297 (21%), Positives = 104/297 (35%), Gaps = 13/297 (4%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSCSWHGVTCDPLSG--RVTSLNLSSN------ 52
K ALLQ+K + +P L+S D + +W GV CD + RV +L+LS
Sbjct: 8 KQALLQIKKDLG-NPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 53 -LSRTSCSLLSLPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQ 111
+ + +L L G N + + + + + +SG + + +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 112 LRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFN 171
L L ++N SG LP I L L + N G IP + + S L N
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR--N 184
Query: 172 GTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCT 231
+ + + + A + +G
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 232 ELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
L L L +N + G +P QL L L++S N L G +P + G ++ V N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 8e-14
Identities = 50/259 (19%), Positives = 85/259 (32%), Gaps = 4/259 (1%)
Query: 160 LRLINLSGNQFNG--TIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAAN 217
+ ++LSG IP+ P + + L ++ +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 218 SLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGM 277
+++G+IP L L +L S N L G +P S L NL + N +SG +P G
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 278 CKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPN 337
+L + + + + G +
Sbjct: 172 FSKLFTS--MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 338 LNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVS 397
N L L L+L +N G +P L K L+ L++S NNL G +P+ +
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 398 VPCMAVFNVSQNLLSGEIP 416
+ V + N P
Sbjct: 290 LQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.0 bits (141), Expect = 1e-09
Identities = 31/171 (18%), Positives = 60/171 (35%), Gaps = 3/171 (1%)
Query: 510 YPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSL 569
P + + + N++ G +P GS K ++++ N G IP +F N +
Sbjct: 141 LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA 200
Query: 570 RNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSG 629
+ + K + L++ + +L N + G
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL--DLRNNRIYG 258
Query: 630 EIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680
+P ++L+ L+ L + NNL G IP G + + N +P
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 5e-09
Identities = 20/66 (30%), Positives = 27/66 (40%), Gaps = 1/66 (1%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
L L L N G LP + QL L L++SFN+ G I P N + + N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNK 302
Query: 170 FNGTIP 175
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 18/60 (30%), Positives = 24/60 (40%), Gaps = 1/60 (1%)
Query: 140 DLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVP 199
DL N +G +P L L +N+S N G IP G F V + + N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 18/84 (21%), Positives = 34/84 (40%), Gaps = 3/84 (3%)
Query: 75 FHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLS 134
F ++ N ++++ G L + + L L L ++FN GE+P + G L
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQ 291
Query: 135 LLEILDLSFNSFHGPIPPTLQNCS 158
++ + N P L C+
Sbjct: 292 RFDVSAYANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 21/77 (27%), Positives = 32/77 (41%), Gaps = 4/77 (5%)
Query: 155 QNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILL 214
+L ++L N+ GT+P Q +++SFN L G +P+ G N +
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAY 298
Query: 215 AANSLTGSIPPSLGNCT 231
A N P L CT
Sbjct: 299 ANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.4 bits (111), Expect = 5e-06
Identities = 51/308 (16%), Positives = 77/308 (25%), Gaps = 51/308 (16%)
Query: 228 GNCTELRSLLLSSNMLQGD--IPSSFGQLVNLEVLDLSRN-FLSGIVPSELGMCKQLKVL 284
+ +L LS L IPSS L L L + L G +P + QL L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF 344
+ + G +PD ++++ L L G
Sbjct: 107 YIT-------------------------HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141
Query: 345 PQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVF 404
P + L + N +G IP S G+ L+ S N
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR---------------L 186
Query: 405 NVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLF 464
+ M + + +
Sbjct: 187 TGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246
Query: 465 ILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFD 524
D NN G +P L L S +S N+L G + D +
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHS-----LNVSFNNLCGEIPQ--GGNLQRFDVSAYA 299
Query: 525 IGNNKLIG 532
N L G
Sbjct: 300 -NNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 46/246 (18%), Positives = 86/246 (34%), Gaps = 15/246 (6%)
Query: 249 SSFGQLVNLEVLDLSRNFLSGI--VPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPV 306
+ Q + LDLS L +PS L L L + + + +
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 307 VDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTG 366
+ G +PD ++++ L L G P + L + N +G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 367 QIPASLGNCKSLYF-LDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSK 425
IP S G+ L+ + +S N LTG +P + +A ++S+N+L G+ + S+ +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 426 MSVNWSMSQVDLIGFYTAFF--------YENALTSCAP--FSSPSNGLFILHDFSNNLFT 475
++ + + + N + P + L L + S N
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF-LHSL-NVSFNNLC 281
Query: 476 GPVPPF 481
G +P
Sbjct: 282 GEIPQG 287
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.5 bits (218), Expect = 4e-19
Identities = 63/371 (16%), Positives = 123/371 (33%), Gaps = 46/371 (12%)
Query: 323 SITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLD 382
S T L + A L ++ I E + L +N ++N T P L N L +
Sbjct: 39 SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94
Query: 383 LSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYT 442
+++N P + N++ L + ++N + I +
Sbjct: 95 MNNNQ------IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDIS 148
Query: 443 AFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNS 502
A +L + + ++ + + + S + N
Sbjct: 149 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQ 208
Query: 503 LKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQS 562
+ P + +LD L + K IG + S + L +A N+ L P
Sbjct: 209 ISDIT---PLGILTNLDELSLNGNQLKDIGTLAS-----LTNLTDLDLANNQISNLAP-- 258
Query: 563 FTNFDSLRNLNLSRNHLQGPLP--------------------SYINKMEDLKFLSLSLNN 602
+ L L L N + P S I+ +++L +L+L NN
Sbjct: 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318
Query: 603 FTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTR 662
+ P ++ L L+ L + N +S S + L ++N L HN ++ P
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANL 372
Query: 663 SSLSIFDVSFN 673
+ ++ ++
Sbjct: 373 TRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 86.2 bits (212), Expect = 2e-18
Identities = 39/179 (21%), Positives = 67/179 (37%), Gaps = 15/179 (8%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
T L L L N + L+ L LDL+ N P L + L + L NQ
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 170 FNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGN 229
+ P G ++ + N +L ++ L N+++ P + +
Sbjct: 275 ISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSS 327
Query: 230 CTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
T+L+ L ++N + SS L N+ L N +S + P L ++ L L +
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.7 bits (190), Expect = 2e-15
Identities = 60/412 (14%), Positives = 124/412 (30%), Gaps = 57/412 (13%)
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPS 273
L ++T ++ + + ++ +L ++ I L NL ++ S N L+ I P
Sbjct: 29 LGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP- 83
Query: 274 ELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVF 333
L +L +++ N+ + + G D + L NL
Sbjct: 84 -LKNLTKLVDILMNNNQIADITPLANLTNLT-----GLTLFNNQITDIDPLKNLTNLNRL 137
Query: 334 WAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLP 393
+ + I + + L N + S+N +
Sbjct: 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLK-----PLANLTT-LERLDISSNKVSDIS 191
Query: 394 EEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSC 453
+ + + N +S P + ++S+N N L
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILTNLDELSLNG-----------------NQLKDI 234
Query: 454 APFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFD 513
+S +N + D +NN + P L L+ +S S L+
Sbjct: 235 GTLASLTNLTDL--DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL 290
Query: 514 LCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLN 573
S+ K + +L++ N + P ++ L+ L
Sbjct: 291 EL-------------NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 335
Query: 574 LSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSAN 625
+ N + S + + ++ +LS N + P L L + L L+
Sbjct: 336 FANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.0 bits (183), Expect = 1e-14
Identities = 45/189 (23%), Positives = 72/189 (38%), Gaps = 15/189 (7%)
Query: 205 NCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSR 264
+LE ++ N ++ P T L L L+ N L+ + L NL LDL+
Sbjct: 195 KLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 265 NFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSI 324
N +S + P L +L L L + S G + + N I
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALT-----NLELNENQLEDISPI 303
Query: 325 TRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLS 384
+ L NL N+ I P +KL+ L A+N + +SL N ++ +L
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 385 SNNLTGLLP 393
N ++ L P
Sbjct: 360 HNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.9 bits (154), Expect = 4e-11
Identities = 48/326 (14%), Positives = 96/326 (29%), Gaps = 26/326 (7%)
Query: 352 SKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLL 411
++ L + +L ++ S+N LT + P + N+++ +
Sbjct: 44 DQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP---------LKNLTKLVD 92
Query: 412 SGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSN 471
++ T LT+ SN + + S
Sbjct: 93 ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSG 152
Query: 472 NLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLI 531
+ +D N + L + NN++
Sbjct: 153 LTSLQQLSFGNQVTDLKPLANLTTLERLDI--SSNKVSDISVLAKLTNLESLIATNNQIS 210
Query: 532 GEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKME 591
P + + LS+ GN+ + + +L +L+L+ N + P ++ +
Sbjct: 211 DITPLGI---LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLT 263
Query: 592 DLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNL 651
L L L N + P + N E S S L++L L L NN+
Sbjct: 264 KLTELKLGANQISNISPLAGLTALTNL----ELNENQLEDISPISNLKNLTYLTLYFNNI 319
Query: 652 TGRIPPGFGTRSSLSIFDVSFNNLSG 677
+ P + + L + N +S
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 2e-08
Identities = 18/84 (21%), Positives = 31/84 (36%), Gaps = 6/84 (7%)
Query: 109 LTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGN 168
L L L L FN S P + L+ L+ L + N +L N +++ ++ N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHN 361
Query: 169 QFNGTIPAFFGQSPGFQVVSLSFN 192
Q + P + L+
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.1 bits (108), Expect = 1e-05
Identities = 56/398 (14%), Positives = 110/398 (27%), Gaps = 52/398 (13%)
Query: 108 DLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSG 167
L + +L + + L + L ++ ++L IN S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 168 NQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL 227
NQ P + ++ N ++ P N L +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTL-------------FNN 120
Query: 228 GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287
L++ ++ + L L + G ++L L L
Sbjct: 121 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 180
Query: 288 NDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQN 347
+ S + + N P I NL L+ I
Sbjct: 181 DISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--GT 236
Query: 348 WELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVS 407
+ L L+LA+N + P L L L L +N ++ + P
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA------------ 282
Query: 408 QNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILH 467
+ +++ E ++ + +L Y N ++ +P SS + L L
Sbjct: 283 ------GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTK-LQRL- 334
Query: 468 DFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKG 505
F+NN + L + +++ N +
Sbjct: 335 FFANNKVSD--VSSLANLTNINW-----LSAGHNQISD 365
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.5 bits (205), Expect = 6e-18
Identities = 56/284 (19%), Positives = 97/284 (34%), Gaps = 16/284 (5%)
Query: 197 SVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256
VP++ + + L N +T N L +L+L +N + P +F LV
Sbjct: 24 KVPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 257 LEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFF 316
LE L LS+N L + ++L+ V N+ + L VV+ G +
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELR--VHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 317 DGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCK 376
G + + L + N+ I L L L+L N T ASL
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLN 195
Query: 377 SLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVD 436
+L L LS N+++ + ++ N ++P V + +
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS 255
Query: 437 LIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPP 480
IG N + ++ + FSN + + P
Sbjct: 256 AIG-------SNDFCPPGYNTKKAS-YSGVSLFSNPVQYWEIQP 291
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.2 bits (199), Expect = 4e-17
Identities = 44/287 (15%), Positives = 80/287 (27%), Gaps = 39/287 (13%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
+L L N + + L L L L N P L + LS NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 170 FNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGD-NCVSLEHILLAANSLTGSIPPSLG 228
Q + + N ++ F N + + + +G +
Sbjct: 91 LKELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 229 NCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
+L + ++ + IP +L L L N ++ + + L L L
Sbjct: 148 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL---- 200
Query: 289 DYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNW 348
G +N S+ P+LR N L +
Sbjct: 201 ---------------------GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLA 239
Query: 349 ELCSKLEMLNLAHNFFTG------QIPASLGNCKSLYFLDLSSNNLT 389
+ ++++ L +N + P S + L SN +
Sbjct: 240 DHKY-IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.1 bits (139), Expect = 1e-09
Identities = 33/210 (15%), Positives = 65/210 (30%), Gaps = 5/210 (2%)
Query: 527 NNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSY 586
++ + +VP D+ L + N+ + F N +L L L N + P
Sbjct: 18 SDLGLEKVPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 587 INKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRL 646
+ L+ L LS N L L V E + + + +++ + L
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGT 133
Query: 647 DHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQLCHTDPSSS 706
+ +G F LS ++ N++ + P+ + + N S
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLK 192
Query: 707 EWERQHSGNVSQQEAYSPSESIQGNSSGLN 736
+S + N+ L
Sbjct: 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLR 222
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.9 bits (128), Expect = 4e-08
Identities = 29/138 (21%), Positives = 43/138 (31%), Gaps = 3/138 (2%)
Query: 568 SLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSL 627
LR + S L+ +P + D L L N T + L +L L L N +
Sbjct: 11 HLRVVQCSDLGLEK-VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 628 SGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKC 687
S P F+ L L L L N L T L + + + S
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 688 ENVQGNPNLQLCHTDPSS 705
G L+ + +
Sbjct: 128 VVELGTNPLKSSGIENGA 145
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.5 bits (114), Expect = 2e-06
Identities = 44/210 (20%), Positives = 75/210 (35%), Gaps = 17/210 (8%)
Query: 468 DFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGN 527
D NN T + +L + +S +S F + L+ L
Sbjct: 37 DLQNNKITEIKDGDFKNLKNLHTLILINNKISK------ISPGAFAPLVKLERLYLS--K 88
Query: 528 NKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQ--GPLPS 585
N+L E+P M K ++ L + NE + F + + + L N L+ G
Sbjct: 89 NQL-KELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 144
Query: 586 YINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLR 645
M+ L ++ ++ N T IP L SL L L N ++ + L +L L
Sbjct: 145 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 646 LDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
L N+++ L ++ N L
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKL 231
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (177), Expect = 2e-14
Identities = 50/267 (18%), Positives = 84/267 (31%), Gaps = 9/267 (3%)
Query: 125 ELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGF 184
+P+ I + + + L N + + C +L ++ L N A F
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ 244
+ + LS N SV L + L L P L+ L L N LQ
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 245 GDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR-NDYGPLYSREHGDLPI 303
+F L NL L L N +S + L L+L N ++ DL
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 304 QPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNF 363
+ N +++ L L+ + L + L+ + +
Sbjct: 203 LMTLY--LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWLQKFRGSSSE 259
Query: 364 FTGQIPASLGNCKSLYFLDLSSNNLTG 390
+P L L++N+L G
Sbjct: 260 VPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (153), Expect = 2e-11
Identities = 29/147 (19%), Positives = 53/147 (36%), Gaps = 4/147 (2%)
Query: 531 IGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKM 590
+ +P D + L + GN + ++F SL L L +N + P +
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 591 EDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNN 650
L L L NN + L L +L+ L L+ N + + L R +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSE 259
Query: 651 LTGRIPPGFGTRSSLSIFDVSFNNLSG 677
+ +P + + ++ N+L G
Sbjct: 260 VPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (136), Expect = 3e-09
Identities = 26/203 (12%), Positives = 58/203 (28%), Gaps = 3/203 (1%)
Query: 247 IPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPV 306
+P + + L N +S + + C+ L +L L ++
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 307 VDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTG 366
D P + L L L+ + P + + L+ L L N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 367 QIPASLGNCKSLYFLDLSSNNLTGLLPEE-VSVPCMAVFNVSQNLLSGEIPRISHSECSK 425
+ + +L L L N ++ + + + + QN ++ P
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 426 MSVNWSMSQVDLIGFYTAFFYEN 448
M++ + + +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRA 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (133), Expect = 7e-09
Identities = 41/226 (18%), Positives = 69/226 (30%), Gaps = 4/226 (1%)
Query: 457 SSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCL 516
P+ + + V + + LS N+ ++ F
Sbjct: 46 HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG 105
Query: 517 SLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSR 576
L L D + + + +++L + N L +F + +L +L L
Sbjct: 106 RLHTLHLDRCGLQEL---GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 577 NHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFS 636
N + + L L L N P L L L L AN+LS +
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222
Query: 637 KLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRN 682
L L LRL+ N + L F S + + S P+
Sbjct: 223 PLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR 267
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 0.002
Identities = 31/125 (24%), Positives = 45/125 (36%), Gaps = 5/125 (4%)
Query: 97 KLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQN 156
++S RA L L LLL N + P L L L L N+ L
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 157 CSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAA 216
+L+ + L+ N + A Q S + + S+P+ L+ LAA
Sbjct: 224 LRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG--RDLKR--LAA 278
Query: 217 NSLTG 221
N L G
Sbjct: 279 NDLQG 283
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.6 bits (155), Expect = 3e-11
Identities = 53/458 (11%), Positives = 101/458 (22%), Gaps = 28/458 (6%)
Query: 207 VSLEHILLAANSLTGSIPPSL-GNCTELRSLLLSSNMLQGD----IPSSFGQLVNLEVLD 261
+ ++ + + L+ + L + + + L L I S+ L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 262 LSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLP 321
L N L + + Q ++ +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 121
Query: 322 DSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFL 381
+ + + + E CS P S +
Sbjct: 122 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 181
Query: 382 DLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFY 441
+ + + ++ A+ S + V S +L
Sbjct: 182 NEAGVRVLCQGLKDSPCQLEALKLESCG------VTSDNCRDLCGIVASKASLRELALGS 235
Query: 442 TAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGN 501
C PS+ L L + + + S +
Sbjct: 236 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 295
Query: 502 SLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGS--------HCKCMKFLSMAGN 553
+G L + + S S + +
Sbjct: 296 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 355
Query: 554 EFVGLIPQSFTNFDSLRNLNLSRNHLQG----PLPSYINKMEDLKFLSLSLNNFTGAIPW 609
L LR L L+ + L + + L+ L LS N A
Sbjct: 356 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415
Query: 610 ELTQ-----LASLEVLELSANSLSGEIPSEFSKLEHLN 642
+L + LE L L S E+ LE
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 21/95 (22%), Positives = 34/95 (35%), Gaps = 9/95 (9%)
Query: 197 SVPEEFGDNCVSLEHILLAANSLTG----SIPPSLGNCTELRSLLLSSNMLQGDIPSSFG 252
+ + G L + LA ++ S+ +L LR L LS+N L
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 253 QLV-----NLEVLDLSRNFLSGIVPSELGMCKQLK 282
+ V LE L L + S + L ++ K
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 12/91 (13%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 568 SLRNLNLSRNHLQ-GPLPSYINKMEDLKFLSLSLNNFTG----AIPWELTQLASLEVLEL 622
+++L++ L + ++ + + L T I L +L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 623 SANSLSGEIPSEFSKLEHLNVLRLDHNNLTG 653
+N L + ++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 15/71 (21%), Positives = 26/71 (36%), Gaps = 5/71 (7%)
Query: 616 SLEVLELSANSLSGEIPSE-FSKLEHLNVLRLDHNNLTGR----IPPGFGTRSSLSIFDV 670
++ L++ LS +E L+ V+RLD LT I +L+ ++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 671 SFNNLSGSAPR 681
N L
Sbjct: 63 RSNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 13/90 (14%), Positives = 25/90 (27%), Gaps = 5/90 (5%)
Query: 112 LRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHG----PIPPTLQNCSSLRLINLS 166
++ L + S E+ L +++ L I L+ +L +NL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 167 GNQFNGTIPAFFGQSPGFQVVSLSFNLLSG 196
N+ Q + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 15/80 (18%), Positives = 26/80 (32%), Gaps = 9/80 (11%)
Query: 134 SLLEILDLSFNSFHG----PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQS-----PGF 184
S+L +L L+ + TL SLR ++LS N +S
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 185 QVVSLSFNLLSGSVPEEFGD 204
+ + L S + +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.004
Identities = 12/88 (13%), Positives = 27/88 (30%), Gaps = 10/88 (11%)
Query: 94 SSDKLSGN-LSRAIGDLTQLRVLLLAFNGFSGE----LPLEIGQLSLLEILDLSFNSFHG 148
++LS + + L Q +V+ L G + + + L L+L N
Sbjct: 10 QCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD 69
Query: 149 PIPPTL-----QNCSSLRLINLSGNQFN 171
+ ++ ++L
Sbjct: 70 VGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 62.9 bits (151), Expect = 6e-11
Identities = 51/329 (15%), Positives = 94/329 (28%), Gaps = 24/329 (7%)
Query: 350 LCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQN 409
L + L L + + +P + +SL S N+LT L S+ + V N +
Sbjct: 36 LDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLTELPELPQSLKSLLVDNNNLK 91
Query: 410 LLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDF 469
LS P + + S + + N+L + ++
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 470 S------NNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIF 523
NL +S L +
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 524 DIGNNKLIGEVPSDMGSHCKCMK-----FLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNH 578
D K + ++P + + F+ + F+ L N
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 579 LQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKL 638
+ S + L+ L++S N +P LE L S N L+ E+P L
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNL 326
Query: 639 EHLNVLRLDHNNLTGRIPPGFGTRSSLSI 667
+ L+ +++N L P + L +
Sbjct: 327 KQLH---VEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 4e-09
Identities = 49/307 (15%), Positives = 100/307 (32%), Gaps = 22/307 (7%)
Query: 349 ELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLP------------EEV 396
EL LE L + N T ++P + KSL + + L+ L P E++
Sbjct: 55 ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKL 113
Query: 397 SVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPF 456
+ F ++ + + ++ S + +Q++ + + A+ +
Sbjct: 114 PELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNS 173
Query: 457 SSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCL 516
L + + + + + Y L S ++
Sbjct: 174 LKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRD 233
Query: 517 SLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSR 576
+ + ++ + +V ++ S + N I SL LN+S
Sbjct: 234 NYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSN 293
Query: 577 NHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFS 636
N L LP+ + L+ L S N+ +P +L+ L + N L E P
Sbjct: 294 NKLIE-LPALPPR---LERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPE 344
Query: 637 KLEHLNV 643
+E L +
Sbjct: 345 SVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 19/79 (24%), Positives = 31/79 (39%), Gaps = 9/79 (11%)
Query: 205 NCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSR 264
SLE + ++ N L +P L L+ S N L ++P NL+ L +
Sbjct: 282 LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQ---NLKQLHVEY 333
Query: 265 NFLSGIVPSELGMCKQLKV 283
N L P + L++
Sbjct: 334 NPLREF-PDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 6e-05
Identities = 56/366 (15%), Positives = 98/366 (26%), Gaps = 51/366 (13%)
Query: 230 CTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRND 289
+ L L++ L +P +LE L S N L+ + P K L V
Sbjct: 37 DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLTEL-PELPQSLKSLLVDNNNL- 90
Query: 290 YGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWE 349
+++ LP L + + N P+
Sbjct: 91 --------------------------------KALSDLPPLLEYLGVSNNQLEKLPELQN 118
Query: 350 LCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQN 409
+ ++ + L LP ++
Sbjct: 119 SSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLP 178
Query: 410 LLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDF 469
L + I + + L Y L P N
Sbjct: 179 DLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTD 238
Query: 470 SNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNK 529
L + ++ N+ N DL SL+ L ++ NNK
Sbjct: 239 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS-SNEIRSLCDLPPSLEEL--NVSNNK 295
Query: 530 LIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINK 589
LI E+P+ ++ L + N +P+ N L+ L++ N L+ P
Sbjct: 296 LI-ELPALPPR----LERLIASFNHLAE-VPELPQN---LKQLHVEYNPLRE-FPDIPES 345
Query: 590 MEDLKF 595
+EDL+
Sbjct: 346 VEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 8e-05
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 10/94 (10%)
Query: 141 LSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPE 200
N+ I SL +N+S N+ +PA + + + SFN L+ VPE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPE 321
Query: 201 EFGDNCVSLEHILLAANSLTGSIPPSLGNCTELR 234
+L+ + + N L P + +LR
Sbjct: 322 LPQ----NLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 3e-04
Identities = 61/321 (19%), Positives = 94/321 (29%), Gaps = 22/321 (6%)
Query: 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQ 169
Q L L G S LP L E L S NS +P Q+ SL + N +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 170 FNGTIP--AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSL 227
+ P + G S S + +N + L + + L
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 228 GNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLR 287
EL++L + + + + L + + EL L +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 288 NDYGPLYSREHGDLPIQPVVD-------GGEDYNFFDGGLPDSITRLPNLRVFWAPNLNL 340
N+ L V D F + + L L
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 341 EGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPC 400
+L LE LN+++N ++PA L L S N+L +PE
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPE--LPQN 325
Query: 401 MAVFNVSQNLLSGEIPRISHS 421
+ +V N L E P I S
Sbjct: 326 LKQLHVEYNPLR-EFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 20/109 (18%), Positives = 30/109 (27%), Gaps = 9/109 (8%)
Query: 72 NFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIG 131
N + S + L L ++ N ELP
Sbjct: 246 LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP 304
Query: 132 QLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQ 180
+L E L SFN +P QN L+ +++ N P
Sbjct: 305 RL---ERLIASFNHLAE-VPELPQN---LKQLHVEYNPLR-EFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 26/100 (26%), Positives = 34/100 (34%), Gaps = 8/100 (8%)
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
LEL+ LS +P LE L N+LT +P SL V NNL
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQ---SLKSLLVDNNNL 90
Query: 676 SGSAPRNSLIKCENVQGNPNLQLCHTDPSSSEWERQHSGN 715
+ L++ V N +L SS N
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNN 130
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 40/207 (19%), Positives = 64/207 (30%), Gaps = 9/207 (4%)
Query: 204 DNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
S + +LT ++PP L + L LS N+L ++ L L+L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 264 RNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDS 323
R ++L + L VL + P + + LP
Sbjct: 64 RAE-----LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 324 ITRLPNLRVFWAPNLNLEG-IFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLD 382
R N + P KLE L+LA+N T L ++L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 383 LSSNNLTGLLPEEVSVPCMAVFNVSQN 409
L N+L + + + N
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 1e-06
Identities = 36/203 (17%), Positives = 54/203 (26%), Gaps = 24/203 (11%)
Query: 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINL 165
+ + + + LP ++ IL LS N + TL + L +NL
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 166 SGNQFNGTIPAFFGQS--------------------PGFQVVSLSFNLLSGSVPEEFGDN 205
+ V S+P
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 206 CVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265
L+ + L N L P L +L L L++N L L NL+ L L N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 266 FLSGIVPSELGMCKQLKVLVLRN 288
L +P L L
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHG 204
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 44/255 (17%), Positives = 74/255 (29%), Gaps = 70/255 (27%)
Query: 527 NNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRN--------- 577
+ + + +P D+ L ++ N + + L LNL R
Sbjct: 18 DKRNLTALPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74
Query: 578 ------------------------------------HLQGPLPSYINKMEDLKFLSLSLN 601
L + + +L+ L L N
Sbjct: 75 TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134
Query: 602 NFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGT 661
P LT LE L L+ N+L+ + LE+L+ L L N+L IP GF
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193
Query: 662 RSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQLCHTDPSSSEWERQHSGNVSQQEA 721
L + GNP L C W + ++ NV +
Sbjct: 194 SHLLPFAFLH--------------------GNPWLCNCEILY-FRRWLQDNAENVYVWKQ 232
Query: 722 YSPSESIQGNSSGLN 736
+++ N + +
Sbjct: 233 GVDVKAMTSNVASVQ 247
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.002
Identities = 13/53 (24%), Positives = 18/53 (33%), Gaps = 1/53 (1%)
Query: 119 FNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFN 171
N + + L L+ L L NS + IP L L GN +
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 4e-10
Identities = 38/242 (15%), Positives = 83/242 (34%), Gaps = 13/242 (5%)
Query: 163 INLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTG- 221
++L+G + + S G + + + E F + ++H+ L+ + +
Sbjct: 5 LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIEVS 61
Query: 222 SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS--RNFLSGIVPSELGMCK 279
++ L C++L++L L L I ++ + NL L+LS F + + L C
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 280 QLKVLVLRNDYGPLYSREHGDLPIQP------VVDGGEDYNFFDGGLPDSITRLPNLRVF 333
+L L L + + + G + +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 334 WAPNLNLEGIFPQNWELCSKLEMLNLAH-NFFTGQIPASLGNCKSLYFLDLSSNNLTGLL 392
+ ++ L+ Q + + L+ L+L+ + LG +L L + G L
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 393 PE 394
Sbjct: 242 QL 243
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 5e-07
Identities = 38/289 (13%), Positives = 85/289 (29%), Gaps = 19/289 (6%)
Query: 381 LDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGF 440
LDL+ NL + + + F ++ + + S ++ S S +++
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTL 63
Query: 441 YTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSG 500
+ + L + + P+ L + +L G
Sbjct: 64 HGILSQCSKLQNL--------------SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109
Query: 501 NSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIP 560
L + L FD + V + + + L
Sbjct: 110 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 169
Query: 561 QSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS-LNNFTGAIPWELTQLASLEV 619
+ + L+ ++ L+ LSLS + EL ++ +L+
Sbjct: 170 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229
Query: 620 LELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIF 668
L++ G + L H L+++ ++ T P G + + I+
Sbjct: 230 LQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEIW 275
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 5e-06
Identities = 42/279 (15%), Positives = 81/279 (29%), Gaps = 42/279 (15%)
Query: 135 LLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLL 194
L + LDL+ + H + L + + + + + F Q + LS +++
Sbjct: 1 LWQTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVI 58
Query: 195 SGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSL--LLSSNMLQGDIPSSFG 252
S C L+++ L L+ I +L + L L S + + +
Sbjct: 59 EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118
Query: 253 QLVNLEVLDLSRNFLSG--------------IVPSELGMCKQLKVLVLRNDYGPLYSREH 298
L+ L+LS F I L ++ +
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178
Query: 299 GDLPIQPVVDGGEDY-----------------NFFDGGLPDSITRLPNLRVFWAPNLNLE 341
V+ + + + +P L+ L +
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT-----LQVF 233
Query: 342 GIFPQN--WELCSKLEMLNLAHNFFTGQIPASLGNCKSL 378
GI P L L L + + FT ++GN K+
Sbjct: 234 GIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.2 bits (123), Expect = 2e-07
Identities = 38/329 (11%), Positives = 74/329 (22%), Gaps = 20/329 (6%)
Query: 337 NLNLEGI--FPQNWELCSKLEMLNLAHNFFTGQ----IPASLGNCKSLYFLDLSSNNLTG 390
+ E ++ + L+ N + + ++ + K L + S
Sbjct: 14 AITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGR 73
Query: 391 LLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLIGFYTAFFYENAL 450
+ E + + + + + ++ + + N L
Sbjct: 74 VKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133
Query: 451 TSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTY 510
A + + P +I + W L T
Sbjct: 134 GPQAG--AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191
Query: 511 PFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLR 570
I + L + + + L L
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251
Query: 571 NLNLSRN-HLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWEL-----TQLASLEVLELSA 624
+ LS + L+ L L N L ++ L LEL+
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 625 NSLSGE------IPSEFSKLEHLNVLRLD 647
N S E I FS + LD
Sbjct: 312 NRFSEEDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 8e-05
Identities = 31/297 (10%), Positives = 71/297 (23%), Gaps = 14/297 (4%)
Query: 367 QIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKM 426
+ A L S+ + LS N + +S + ++ S E +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 427 SVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSD 486
+ + +T +NA A L + P
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 487 SLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMK 546
+ + + + N+ + + + M + +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 547 FLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGA 606
+ + + N + L + +L+ L L+ +
Sbjct: 202 GIEH---LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258
Query: 607 IPWELTQ------LASLEVLELSANSLSGEIPSE-----FSKLEHLNVLRLDHNNLT 652
+ L+ L L N + + K+ L L L+ N +
Sbjct: 259 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 30/309 (9%), Positives = 70/309 (22%), Gaps = 30/309 (9%)
Query: 112 LRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGP----IPPTLQNCSSLRLINLSG 167
L++ + + + + ++ + LS N+ + + + L + S
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 168 NQFNGTIPAFFGQSPGFQVVSLSFNLLS--GSVPEEFGDNCVSLEHILLAANSLTGSIPP 225
L L FG L+ ++ +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 226 SLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL-GMCKQLKVL 284
++ + + + L + RN L E + ++L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGED-------------YNFFDGGLPDSITRLPNLR 331
E + + + ++ +
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248
Query: 332 VFWAPNLNLEGIFPQNWELC----SKLEMLNLAHNFFTGQIPASL-----GNCKSLYFLD 382
L+ G L+ L L +N +L L FL+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 383 LSSNNLTGL 391
L+ N +
Sbjct: 309 LNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 14/82 (17%), Positives = 32/82 (39%), Gaps = 8/82 (9%)
Query: 208 SLEHILLAANSLTG----SIPPSLGNCTELRSLLLSSNMLQGD----IPSSFGQLVNLEV 259
S+E L +++T S+ L ++ ++LS N + + + + +LE+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 260 LDLSRNFLSGIVPSELGMCKQL 281
+ S F + + L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLL 85
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 22/121 (18%), Positives = 41/121 (33%), Gaps = 8/121 (6%)
Query: 138 ILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGS 197
+L L+ + L+ + ++LS N+ PA + + + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALA----ALRCLEVLQASDNAL 55
Query: 198 VPEEFGDNCVSLEHILLAANSLTG-SIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVN 256
+ N L+ +LL N L + L +C L L L N L +L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 257 L 257
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 24/129 (18%), Positives = 41/129 (31%), Gaps = 10/129 (7%)
Query: 161 RLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLT 220
R+++L+ T+ Q + LS N L P C+ + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQA----SDNA 54
Query: 221 GSIPPSLGNCTELRSLLLSSNMLQG-DIPSSFGQLVNLEVLDLSRNFLSGI---VPSELG 276
+ N L+ LLL +N LQ L +L+L N L
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 277 MCKQLKVLV 285
M + ++
Sbjct: 115 MLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 20/109 (18%), Positives = 34/109 (31%), Gaps = 6/109 (5%)
Query: 546 KFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTG 605
+ L +A + L + +L+LS N L+ P+ ++
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVL---QASDNAL 55
Query: 606 AIPWELTQLASLEVLELSANSL-SGEIPSEFSKLEHLNVLRLDHNNLTG 653
+ L L+ L L N L L +L L N+L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 25/134 (18%), Positives = 39/134 (29%), Gaps = 31/134 (23%)
Query: 259 VLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDG 318
VL L+ L+ + L + L L + N
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSH-------------------------NRLRA 34
Query: 319 GLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTG-QIPASLGNCKS 377
P ++ L L V A + LE + + L L +N L +C
Sbjct: 35 LPP-ALAALRCLEVLQASDNALENVDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPR 91
Query: 378 LYFLDLSSNNLTGL 391
L L+L N+L
Sbjct: 92 LVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.002
Identities = 19/125 (15%), Positives = 38/125 (30%), Gaps = 5/125 (4%)
Query: 234 RSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPL 293
R L L+ L + QL+ + LDLS N L + P+ + + N +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 294 YSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSK 353
+ + ++ + + P L + +L L
Sbjct: 59 DGVANLPRLQELLLC---NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 354 LEMLN 358
L ++
Sbjct: 116 LPSVS 120
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (108), Expect = 3e-06
Identities = 20/137 (14%), Positives = 42/137 (30%), Gaps = 6/137 (4%)
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
N R L L + I + L + +D S N + + + ++LK L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 68
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFW---APNLNLE 341
++ N+ + + + G D + L +L P N +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 342 GIFPQNWELCSKLEMLN 358
++ +L+
Sbjct: 129 HYRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 20/146 (13%), Positives = 43/146 (29%), Gaps = 9/146 (6%)
Query: 97 KLSGNL---SRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
KL+ L + + + R L L + L + +D S N
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDG 58
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
L+ + ++ N+ P + L+ N L + + SL ++
Sbjct: 59 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118
Query: 214 L---AANSLTGSIPPSLGNCTELRSL 236
+ + + ++R L
Sbjct: 119 ILRNPVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 11/126 (8%), Positives = 32/126 (25%), Gaps = 7/126 (5%)
Query: 351 CSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNL 410
+ L+L I +D S N + L + + V+ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LDGFPLLRRLKTLLVNNNR 74
Query: 411 LSGEIPRISHSECSKMSVNWSMSQVDLIGFYTA-----FFYENALTSCAPFSSPSNGLFI 465
+ + + + + + + +G + + L++
Sbjct: 75 ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134
Query: 466 LHDFSN 471
++
Sbjct: 135 IYKVPQ 140
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 24/137 (17%), Positives = 43/137 (31%), Gaps = 8/137 (5%)
Query: 152 PTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEH 211
N R ++L G + I F + S N + + L+
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI---RKLDGFPLLRRLKT 67
Query: 212 ILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG----DIPSSFGQLVNLEVLDLSRNFL 267
+L+ N + +L L+L++N L D +S L L +L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 268 SGIVPSELGMCKQLKVL 284
+ Q++VL
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 40/227 (17%), Positives = 75/227 (33%), Gaps = 28/227 (12%)
Query: 77 FPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLL 136
FP L + ++ ++ +++A DL + L G + + + L+ L
Sbjct: 13 FPDPALANAIKIAAGKSN---VTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNL 65
Query: 137 EILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSG 196
L+L N L+N + + + LSGN QS ++ +
Sbjct: 66 IGLELKDNQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 197 SVPEEFGDNCVSLEHILLA---------------ANSLTGSIPPSLGNCTELRSLLLSSN 241
+ + L+ + + S L N ++L +L N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 242 MLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
+ P L NL + L N +S + P L L ++ L N
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 24/203 (11%), Positives = 53/203 (26%), Gaps = 19/203 (9%)
Query: 204 DNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
+ I +++T ++ + + + +L + I L NL L+L
Sbjct: 16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELK 71
Query: 264 RNFL------SGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFD 317
N + + + + G + Q
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 318 GGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCS-------KLEMLNLAHNFFTGQIPA 370
L + ++ N+ KL L N + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 371 SLGNCKSLYFLDLSSNNLTGLLP 393
L + +L + L +N ++ + P
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 6e-04
Identities = 25/210 (11%), Positives = 54/210 (25%), Gaps = 22/210 (10%)
Query: 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDI 247
+ + ++ +V + + + + +T +I + L L L N +
Sbjct: 25 AAGKSNVTDTVTQA---DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLA 79
Query: 248 PSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHG-------- 299
P + L + + + D PL +
Sbjct: 80 PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
Query: 300 -----DLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKL 354
+ L L A + + I P L
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNL 197
Query: 355 EMLNLAHNFFTGQIPASLGNCKSLYFLDLS 384
++L +N + P L N +L+ + L+
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 19/64 (29%), Positives = 28/64 (43%), Gaps = 5/64 (7%)
Query: 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINL 165
+ +L++L L N S PL L L + L N P L N S+L ++ L
Sbjct: 169 LANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 166 SGNQ 169
+ NQ
Sbjct: 225 T-NQ 227
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 28/180 (15%), Positives = 50/180 (27%), Gaps = 24/180 (13%)
Query: 222 SIPPSLGNCTE---LRSLLLSSNMLQGDIP------SSFGQLVNLEVLDLSRNFLSGIVP 272
+I ++ E + + L G IP ++ L + L LS N + I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-- 63
Query: 273 SELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRV 332
S L + L++L L + + + + +
Sbjct: 64 SSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL---SGIEKLVNLRVL 120
Query: 333 FWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPAS----------LGNCKSLYFLD 382
+ + N KLE L LA N + + +L LD
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 30/197 (15%), Positives = 58/197 (29%), Gaps = 23/197 (11%)
Query: 204 DNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
D L S+T ++ + + ++ +++ ++ L N+ L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 264 RNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPI---------------QPVVD 308
N L+ I P L ++ L
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 309 GGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQI 368
++RL L + + I P +KL+ L L+ N +
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-- 192
Query: 369 PASLGNCKSLYFLDLSS 385
+L K+L L+L S
Sbjct: 193 LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 34/196 (17%), Positives = 69/196 (35%), Gaps = 23/196 (11%)
Query: 108 DLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSG 167
+ L + + +L+ ++ + + + +Q ++ + L+G
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 168 NQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEH---------------I 212
N+ P ++ G+ + + S+ + +SLEH
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 213 LLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVP 272
L + + L T+L +L L N + +P L L+ L LS+N +S +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-- 193
Query: 273 SELGMCKQLKVLVLRN 288
L K L VL L +
Sbjct: 194 RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 26/200 (13%), Positives = 53/200 (26%), Gaps = 22/200 (11%)
Query: 77 FPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLL 136
F + + N+ S +L + ++ + ++ L +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT-----QNELNSIDQIIANNSDIKSVQGIQ--YLPNV 70
Query: 137 EILDLSFNSFHGPI-----PPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSF 191
L L+ N + + +
Sbjct: 71 TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130
Query: 192 NLLSGSVPEEFGDNCVSLEHI--------LLAANSLTGSIPPSLGNCTELRSLLLSSNML 243
L G+N ++ + L+ S L T+L++L LS N +
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190
Query: 244 QGDIPSSFGQLVNLEVLDLS 263
+ L NL+VL+L
Sbjct: 191 SD--LRALAGLKNLDVLELF 208
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 30/224 (13%), Positives = 61/224 (27%), Gaps = 10/224 (4%)
Query: 367 QIPASLGNCKSLYFLDLSSNNLTGLLPEEVS-VPCMAVFNVSQNLLSGEIPRISHSECSK 425
+IP+ L ++ L L + S + +SQN + I S K
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 426 MSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDS 485
+ +L+ F S+ ++L + +
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 486 DSLSSRPYYGFWLSG----NSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSH 541
R + K + ++ +N + E+P+D+
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 542 CKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPS 585
L ++ L N LR + +L+ LP+
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 17/122 (13%), Positives = 33/122 (27%), Gaps = 3/122 (2%)
Query: 536 SDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKF 595
+ S K + + N L L++N +Q N + +
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181
Query: 596 LSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRI 655
NN + +L++S + L+ L NL ++
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK-KL 238
Query: 656 PP 657
P
Sbjct: 239 PT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 9/42 (21%), Positives = 15/42 (35%)
Query: 247 IPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288
F +LD+SR + + L K+L+ N
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 20/213 (9%), Positives = 53/213 (24%), Gaps = 7/213 (3%)
Query: 185 QVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ 244
+V + ++ +P + N + L + +L + +S N +
Sbjct: 11 RVFLCQESKVT-EIPSDLPRN---AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66
Query: 245 GDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQ 304
I + + + + + + L +
Sbjct: 67 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126
Query: 305 PVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLA--HN 362
+ + + + + + LN GI + + ++ L N
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186
Query: 363 FFTGQIPA-SLGNCKSLYFLDLSSNNLTGLLPE 394
++P LD+S + L
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSY 219
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 30/188 (15%), Positives = 59/188 (31%), Gaps = 15/188 (7%)
Query: 204 DNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLS 263
+L ++T ++ S + ++ +L ++ I L NL ++ S
Sbjct: 15 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 70
Query: 264 RNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDS 323
N L+ I P + ++ +L D
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLT-------LFNNQITDIDP 123
Query: 324 ITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDL 383
+ L NL + + I + + + N T P L N +L LD+
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFS--SNQVTDLKP--LANLTTLERLDI 179
Query: 384 SSNNLTGL 391
SSN ++ +
Sbjct: 180 SSNKVSDI 187
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 3e-04
Identities = 24/132 (18%), Positives = 40/132 (30%), Gaps = 7/132 (5%)
Query: 568 SLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSL 627
S + L+L + L+ ++ + + L L LS N L
Sbjct: 23 SQQALDLKGLRS----DPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRL 77
Query: 628 SG--EIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLI 685
++ S K +L +L L N L L + N+LS + S
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
Query: 686 KCENVQGNPNLQ 697
+ P L
Sbjct: 138 ISAIRERFPKLL 149
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.004
Identities = 24/132 (18%), Positives = 44/132 (33%), Gaps = 12/132 (9%)
Query: 583 LPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLN 642
L ++K D +L L + P +L VL ++ + + + L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR-SDP-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 643 VLRLDHNNLTGR--IPPGFGTRSSLSIFDVSFNNLS----GSAPRNSLIKCENVQGNPNL 696
L L +N L + +L I ++S N L + ++ + GN
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS-- 126
Query: 697 QLCHTDPSSSEW 708
L T S +
Sbjct: 127 -LSDTFRDQSTY 137
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.2 bits (87), Expect = 0.002
Identities = 27/156 (17%), Positives = 50/156 (32%), Gaps = 7/156 (4%)
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFV 556
L+ N L S F L+ + + + ++ L + N+
Sbjct: 35 LLNDNELGRISSDGLFGRL---PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 557 GLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLAS 616
+ + F L+ LNL N + +P + L L+L+ N F
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEW 150
Query: 617 LEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLT 652
L L+ + P SK+ + + L H+
Sbjct: 151 LRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.9 bits (86), Expect = 0.003
Identities = 23/196 (11%), Positives = 50/196 (25%), Gaps = 30/196 (15%)
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVL 284
P++ +C E ++ + L+ +IP + L L+ N L I L V
Sbjct: 3 PAMCHC-EGTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 285 VLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIF 344
+ + + + N L L+ + + +
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 345 PQNWELCSKLEM-----------------------LNLAHNFFTGQIPASLGNCKSLYFL 381
P ++E + L +L P+ + + +
Sbjct: 119 PGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIK 175
Query: 382 DLSSNNLTGLLPEEVS 397
DL +
Sbjct: 176 DLPHSEFKCSSENSEG 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1082 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.71 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.69 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.62 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.46 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.32 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.41 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.39 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.83 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.65 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.47 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=415.06 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=206.9
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
.+|++.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688899999999999999999889999999997543 445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+|+|.+++... ...+++..+..++.|+|+||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99999998865 45789999999999999999999999 999999999999999999999999999988765544444
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDC 1040 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 1040 (1082)
....||+.|+|||++.+..++.++|||||||++|||+|++.|+.. .....+.......... ..
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~-------~~~~~~~~~~i~~~~~----------~~ 222 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFR----------LY 222 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC-------SCCHHHHHHHHHHTCC----------CC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC-------CCCHHHHHHHHHhcCC----------CC
Confidence 556799999999999999999999999999999999996655542 2222333333322211 12
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1041 GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1041 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.|...+.++.+++.+||+.||++||||+||+++|++|.+
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 233445689999999999999999999999999998854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=413.77 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=215.5
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
++|++.+.||+|+||+||+|.+++++.||||++.... ...++|.+|++++++++|||||++++++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5688999999999999999999888999999997543 446789999999999999999999998755 56799999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+|+|.+++.......+++..+.+|+.||++||+|||+. +|+||||||+|||+++++.+||+|||+|+..........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999988765455699999999999999999999999 999999999999999999999999999998866555555
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDC 1040 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 1040 (1082)
....||+.|+|||++.++.++.++|||||||++|||+||+.|+... ....+..... ..+. +..
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-------~~~~~~~~~i-~~~~---------~~~ 230 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNL-ERGY---------RMV 230 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHH-HTTC---------CCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC-------CCHHHHHHHH-HhcC---------CCC
Confidence 5678999999999999999999999999999999999977766422 1222332222 2221 112
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1041 GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1041 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
.|...+.++.+++.+||+.+|++||||.||++.|+.+
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 2344556899999999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-47 Score=417.27 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=222.7
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||+||+|... +++.||||+++... ...++|.+|++++++++|||||++++++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356888999999999999999775 58999999987543 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+++|+|.+++.......+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+|+........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999887677899999999999999999999999 9999999999999999999999999999987655555
Q ss_pred cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+... .+..+... .+..+. +
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-------~~~~~~~~-~i~~~~---------~ 234 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-------IDLSQVYE-LLEKDY---------R 234 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHHHHHH-HHHTTC---------C
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-------chHHHHHH-HHhcCC---------C
Confidence 555567899999999999999999999999999999999988776532 22222222 222221 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
...+...+.++.+|+.+||+.||++||||.||++.|+.+....
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 2234455678999999999999999999999999999886543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=412.55 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=207.7
Q ss_pred hcCccccceecccCceEEEEEEEcCCeEEEEEEeecC--ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVG--RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.+.||+|+||+||+|++. ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 357899999999999999999764 46999998654 34456789999999999999999999998754 56899999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+++|+|.++++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999865 45699999999999999999999999 999999999999999999999999999987654332
Q ss_pred -ccccCcccCCCcccchhccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 958 -HATTDVAGTFGYVAPEYAMT---CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 958 -~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... . ...+...+..+......
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-------~-~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------N-RDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------C-HHHHHHHHHHTSCCCCG
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-------h-HHHHHHHHhcCCCCCcc
Confidence 33455689999999999864 358999999999999999999999996321 1 12222333333211111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
. ..+...+.++.+++.+||+.+|++||||.||+++|+.++.
T Consensus 232 ~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 S-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp G-----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred h-----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 1233455689999999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-47 Score=416.67 Aligned_cols=256 Identities=24% Similarity=0.415 Sum_probs=202.2
Q ss_pred cCccccceecccCceEEEEEEEcC-C---eEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP-G---VVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
.+|++.++||+|+||+||+|+... + ..||||++.... ....+.|.+|++++++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 346778899999999999997642 2 368999886543 34457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.+++... ...+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999998865 44689999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCc----cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 956 ETH----ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 956 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||... ...+.+..... +.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--------~~~~~~~~i~~-~~-- 250 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------TNQDVINAIEQ-DY-- 250 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHT-TC--
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC--------CHHHHHHHHHc-CC--
Confidence 322 1223467899999999999999999999999999999998 89998632 22333333322 21
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
+...+.+.+.++.+++.+||+.||++||||.||++.|+++.
T Consensus 251 -------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 251 -------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11234456678999999999999999999999999998864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=402.92 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=219.0
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
++|++.++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 47899999999999999999998899999999986543 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+|+|.+++... ...+++..+++++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 99999997765 45689999999999999999999999 999999999999999999999999999987766555555
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||... ...+..... ..+.. .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--------~~~~~~~~i-~~~~~---------~ 220 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--------TNSETAEHI-AQGLR---------L 220 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--------CHHHHHHHH-HTTCC---------C
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC--------CHHHHHHHH-HhCCC---------C
Confidence 56779999999999999999999999999999999998 78888632 223333332 33211 1
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..|...+.++.+++.+||+.||++||||.||+++|.+|
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 23344557899999999999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=405.71 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=213.7
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.+|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999964 569999999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++|+|.+++... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+|+.+..... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 999999998764 589999999999999999999999 999999999999999999999999999998754332 3
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 1039 (1082)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+.+......+... .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~~~~~~~~~-~------- 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--------NPLRALYLIATNGTPE-L------- 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHHCSCC-C-------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC--------CHHHHHHHHHhCCCCC-C-------
Confidence 34567999999999999999999999999999999999999999632 2223333333333211 1
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1040 CGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1040 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123445678999999999999999999999976
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=406.54 Aligned_cols=252 Identities=25% Similarity=0.304 Sum_probs=205.8
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999976 4689999999976533 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC-
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET- 957 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 957 (1082)
+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999976 45799999999999999999999999 999999999999999999999999999997754332
Q ss_pred ccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... . .............
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~---~----~~~~~~~~~~~~~------ 226 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---C----QEYSDWKEKKTYL------ 226 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT---S----HHHHHHHTTCTTS------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH---H----HHHHHHhcCCCCC------
Confidence 33455789999999999988776 57899999999999999999999743211 1 1111111111110
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+.++.+++.+|++.||++|||+.|++++
T Consensus 227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112345678899999999999999999999763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=400.25 Aligned_cols=245 Identities=26% Similarity=0.398 Sum_probs=209.2
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999764 6899999998643 2344677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 999999999999874 4699999999999999999999999 9999999999999999999999999999865433
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+...... .+..
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~-~~~~------- 221 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------TYQETYKRIS-RVEF------- 221 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHH-TTCC-------
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC--------CHHHHHHHHH-cCCC-------
Confidence 233467999999999999999999999999999999999999999632 2233333322 2211
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..|...+.++.+++.+|++.||++|||+.|+++
T Consensus 222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 123345568999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=401.01 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=210.2
Q ss_pred cCccccce-ecccCceEEEEEEEc---CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNC-IGSGGFGATYKAEII---PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~-lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|.+.+. ||+|+||+||+|.+. ++..||||+++... ....++|.+|++++++++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 35666674 999999999999653 45689999997543 3446789999999999999999999999865 468999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.+++... ...+++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999998754 45799999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 956 ETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 956 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+.... +..+...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--------~~~~~~~-i~~~~~~-- 231 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--------GPEVMAF-IEQGKRM-- 231 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------THHHHHH-HHTTCCC--
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--------HHHHHHH-HHcCCCC--
Confidence 332 2334568999999999999999999999999999999998 899997421 1222222 2333222
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..|...+.++.+|+.+||+.+|++||||.+|.+.|+.+
T Consensus 232 -------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 -------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 23445567899999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=400.14 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=206.6
Q ss_pred cCccccceecccCceEEEEEEEcCC-----eEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPG-----VVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|+..++||+|+||+||+|.+... ..||||++..... ....+|.+|++++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999976542 4799999965433 345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
||||+.++++.+++... ...+++.++.+++.|++.|++|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999988765 45799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 955 SET--HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 955 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....+..... ..+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-------~~~~~~~~~i-~~~----- 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-------LSNHEVMKAI-NDG----- 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHH-HTT-----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc-------CCHHHHHHHH-hcc-----
Confidence 322 2333456899999999999999999999999999999999987776522 2223333332 222
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.+...+...+.++.+|+.+||+.+|++||+|.||++.|+++.
T Consensus 230 ----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 230 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 122334456678999999999999999999999999998864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=401.62 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=197.2
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeecc--CCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV 875 (1082)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+ ....|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4699999999999999999975 4689999999976532 345678999999999999999999998865 4568999
Q ss_pred EeecCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 876 YNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDEC--VPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998753 2457999999999999999999999861 11499999999999999999999999999987
Q ss_pred cCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE 1031 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1082)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+..... ..+...
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--------~~~~~~~~i-~~~~~~- 232 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELAGKI-REGKFR- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHH-HHTCCC-
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC--------CHHHHHHHH-HcCCCC-
Confidence 754332 334568999999999999999999999999999999999999999632 222333332 233222
Q ss_pred ccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1032 FFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1032 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 233 --------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 123345568999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=402.05 Aligned_cols=256 Identities=24% Similarity=0.386 Sum_probs=209.2
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLP 880 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 880 (1082)
++|++.+.||+|+||+||+|...++..||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4699999999999999999999888899999997553 446789999999999999999999999854 56899999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCccc
Q 045553 881 GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960 (1082)
Q Consensus 881 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 960 (1082)
+|+|..++.......++|.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999998875556799999999999999999999999 999999999999999999999999999987765554455
Q ss_pred cCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccCCC
Q 045553 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDC 1040 (1082)
Q Consensus 961 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 1040 (1082)
....||+.|+|||++.++.++.++|||||||++|||++|+.|+... ....+....+.... +.+
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-------~~~~~~~~~i~~~~----------~~~ 234 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------MVNREVLDQVERGY----------RMP 234 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC----------CCC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-------CCHHHHHHHHHhcC----------CCC
Confidence 5567999999999999999999999999999999999987776532 22333333332221 112
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1041 GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1041 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.+...+.++.+++.+||+.||++||+|.+|+++|+..-
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 33455678999999999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=403.92 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=210.5
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
+.|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999764 68999999998776666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999999998764 35699999999999999999999999 99999999999999999999999999997653221 22
Q ss_pred ccCcccCCCcccchhcc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 960 TTDVAGTFGYVAPEYAM-----TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.....||+.|+|||++. +..|+.++||||+||++|||++|+.||..... .+.+....... ....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~~~~i~~~~-~~~~-- 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSE-PPTL-- 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHHHHHHHSC-CCCC--
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCC-CCCC--
Confidence 34567999999999984 45688999999999999999999999974321 12222222222 1111
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+...+.++.+++.+||+.||++|||+.|++++
T Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234456789999999999999999999999763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=396.19 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=202.3
Q ss_pred ceecccCceEEEEEEEcC---CeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeecCC
Q 045553 807 NCIGSGGFGATYKAEIIP---GVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG 881 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 881 (1082)
++||+|+||+||+|.+.. ++.||||+++... ....++|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999997643 4789999996542 2345679999999999999999999999865 467899999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc--c
Q 045553 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH--A 959 (1082)
Q Consensus 882 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~ 959 (1082)
|+|.++++.. ..+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999999874 5699999999999999999999999 9999999999999999999999999999977544332 2
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
.....||+.|+|||++.+..++.++|||||||++|||++ |+.||... ...+... .+..+...
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--------~~~~~~~-~i~~~~~~-------- 229 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTA-MLEKGERM-------- 229 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHH-HHHTTCCC--------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--------CHHHHHH-HHHcCCCC--------
Confidence 334578999999999999999999999999999999998 89998632 2223222 22333211
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..|...+.++.+|+.+||+.||++||||+||.+.|+..
T Consensus 230 -~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 23445567899999999999999999999999988753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=398.55 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=206.3
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR---FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4699999999999999999976 468999999986432 244577999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999998874 4799999999999999999999999 99999999999999999999999999999875433
Q ss_pred C-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 957 T-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 957 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+. .+..
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~-~~~~------ 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEYLIFQKII-KLEY------ 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHH-TTCC------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc--------CHHHHHHHHH-cCCC------
Confidence 2 2344568999999999999999999999999999999999999999732 2223333332 2211
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVA 1071 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 1071 (1082)
..|...+.++.+++.+|++.||++|||+.|+.
T Consensus 228 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 12334456889999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=391.68 Aligned_cols=246 Identities=24% Similarity=0.377 Sum_probs=199.6
Q ss_pred ccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc----CCeEEEE
Q 045553 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS----EAEMFLI 875 (1082)
Q Consensus 803 ~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV 875 (1082)
|++.+.||+|+||+||+|... +++.||+|++.... ....+.|.+|++++++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 367778999999999999764 68899999987543 3345678999999999999999999998864 3568999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeccCCCCCEEEc-CCCcEEEeecccceec
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR--VLHRDIKPSNILLD-NNLNAYLSDFGLARLL 952 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~ 952 (1082)
|||+++|+|.++++.. ..+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999999874 4689999999999999999999998 6 99999999999996 5789999999999864
Q ss_pred CCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||... ....+... .+..+.....
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-------~~~~~~~~-~i~~~~~~~~ 233 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYR-RVTSGVKPAS 233 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHH-HHTTTCCCGG
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-------ccHHHHHH-HHHcCCCCcc
Confidence 322 2345689999999999875 5999999999999999999999999632 12222222 2333322211
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
++ ...+.++.+++.+||+.||++|||+.|++++
T Consensus 234 ~~--------~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 FD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cC--------ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 1234568999999999999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=404.14 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=209.2
Q ss_pred cCccccceecccCceEEEEEEEcC------CeEEEEEEeecC-ccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP------GVVVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 872 (1082)
++|++.++||+|+||+||+|+... ...||||++... .......+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999997643 247999998654 233456789999999998 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCC
Q 045553 873 FLIYNYLPGGNLEKFIQDRPR---------------------RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 931 (1082)
++||||+++|+|.++++.... ..+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999986532 3589999999999999999999999 9999999999
Q ss_pred CEEEcCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccC
Q 045553 932 NILLDNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCS 1009 (1082)
Q Consensus 932 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~ 1009 (1082)
||+++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999876544332 3345678999999999999999999999999999999998 8999864321
Q ss_pred CCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 045553 1010 FGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075 (1082)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 1075 (1082)
. +.+...+..+. +...|...+.++.+|+.+||+.||++||||+||+++|.
T Consensus 273 ---~----~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 ---D----ANFYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ---S----HHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---H----HHHHHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 12222333322 11234455678999999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=393.98 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=201.9
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeecc-CCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-EAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 879 (1082)
++|++.+.||+|+||.||+|++. |+.||||+++.. ...++|.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45788899999999999999885 889999999654 345789999999999999999999998865 46689999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
++|+|.++++......+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999999999875445689999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccccC
Q 045553 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 1038 (1082)
....++..|+|||++.++.++.++|||||||++|||+| |+.||.... ...+..+ +..+. +
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----~~~~~~~----i~~~~---------~ 218 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPR----VEKGY---------K 218 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHH----HTTTC---------C
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----HHHHHHH----HHcCC---------C
Confidence 23467899999999999999999999999999999998 566665321 2222222 22221 1
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1039 DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1039 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
.+.+...+.++.+++.+||+.||++||||.||+++|++++
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 2234455578999999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-44 Score=403.30 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=213.5
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999975 46999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc--CCCcEEEeecccceecCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD--NNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfGla~~~~~~~ 956 (1082)
+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999654 34699999999999999999999999 999999999999996 46789999999999875433
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+........ .
T Consensus 181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~~~~---~- 246 (350)
T d1koaa2 181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCDWNMD---D- 246 (350)
T ss_dssp C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCSC---C-
T ss_pred c--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCCCC---c-
Confidence 2 34467999999999999999999999999999999999999999632 23344444333221110 0
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
......+.++.+++.+|++.||++|||+.|++++
T Consensus 247 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 ---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112345688999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=406.36 Aligned_cols=260 Identities=23% Similarity=0.385 Sum_probs=205.4
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.++||+|+||+||+|+. .+|+.||+|+++... ....+++.+|++++++++|||||++++++.++++.|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46799999999999999999975 468999999997653 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 99999999999874 469999999999999999999997 5 8999999999999999999999999999866422
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcc-----
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCE----- 1031 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1031 (1082)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...... . .+........+....
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK-----E-LELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT-----H-HHHHC---------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----H-HHHHHHHHhcCCcccCCccc
Confidence 234568999999999999999999999999999999999999999753211 0 000000000000000
Q ss_pred ----------------------ccccccCC---CCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1032 ----------------------FFTAGLWD---CGP-HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1032 ----------------------~~d~~l~~---~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..+..... ..+ ...+.++.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000 000 1234678999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-44 Score=397.84 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=194.2
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
.+.|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456999999999999999999764 689999999975532 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc---CCCcEEEeecccceecCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~~~~ 954 (1082)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999986 35799999999999999999999999 999999999999994 578999999999987643
Q ss_pred CCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 955 SETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 955 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+......... ..
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~~~-~~---- 227 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE--------NDAKLFEQILKAE-YE---- 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHTTC-CC----
T ss_pred CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHhccC-CC----
Confidence 32 234567999999999999999999999999999999999999999732 2223223332222 11
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.....+...+.++.+++.+|++.||++|||+.|++++
T Consensus 228 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 --FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111223445689999999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.5e-44 Score=400.90 Aligned_cols=252 Identities=20% Similarity=0.252 Sum_probs=212.9
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999975 569999999998776666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc--CCCcEEEeecccceecCCCCC
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD--NNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfGla~~~~~~~~ 957 (1082)
++|+|.+++... ...+++.+++.|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 999999887654 45699999999999999999999999 999999999999998 67899999999999875443
Q ss_pred ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 1037 (1082)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+...... .
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~~~~-------~ 247 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--------DDLETLQNVKRCDWE-------F 247 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHHCCCC-------C
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCC-------C
Confidence 234457999999999999999999999999999999999999999632 223333333322211 0
Q ss_pred CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1038 WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1038 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
........+.++.+++.+|++.||++|||+.|++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223445688999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-44 Score=396.08 Aligned_cols=245 Identities=26% Similarity=0.363 Sum_probs=204.4
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
..|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3589999999999999999965 5689999999976543 33467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|++..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 99999999877765 35799999999999999999999999 999999999999999999999999999986543
Q ss_pred CccccCcccCCCcccchhccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccc
Q 045553 957 THATTDVAGTFGYVAPEYAMT---CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1082)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||... ...+.+........ ...
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~--------~~~~~~~~i~~~~~-~~~- 234 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNES-PAL- 234 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCC-CCC-
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCCC-CCC-
Confidence 234579999999999864 46899999999999999999999999632 22233333333221 111
Q ss_pred ccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1034 d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
.+...+..+.+++.+||+.||++|||+.|+++
T Consensus 235 -------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11234568999999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-44 Score=395.34 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=214.9
Q ss_pred HhcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhccCCCceeeEeeeeccCCe
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 871 (1082)
..++|++.+.||+|+||+||+|++. +++.||||++..... ...++|.+|++++++++||||+++++++.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4567999999999999999999764 357899999975543 345679999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP----------------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIK 929 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 929 (1082)
.++||||+++|+|.++++... ...+++..+.+|+.|++.||+|||+. +|+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 999999999999999997532 23589999999999999999999999 99999999
Q ss_pred CCCEEEcCCCcEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCc
Q 045553 930 PSNILLDNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKK-ALDPSF 1007 (1082)
Q Consensus 930 ~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~-p~~~~~ 1007 (1082)
|+|||++.++.+||+|||+|+.+..... .......|++.|+|||++.+..++.++|||||||++|||++|.. ||..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-- 245 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-- 245 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC--
Confidence 9999999999999999999987644332 23345678999999999999999999999999999999999964 5542
Q ss_pred cCCCCCccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1008 CSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1008 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.+..+.... +..+... ..+...+.++.+|+.+||+.+|++||||.||+++|++|.+
T Consensus 246 ------~~~~e~~~~-v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 246 ------MAHEEVIYY-VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ------SCHHHHHHH-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ------CCHHHHHHH-HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 223333333 3333222 1233455689999999999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=391.68 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=199.7
Q ss_pred cCccccceecccCceEEEEEEEcC----CeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|++.+.||+|+||+||+|.... +..||||+++... ....+.|.+|++++++++||||+++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 468999999999999999997642 4578999886543 334567999999999999999999999986 4678999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|++.+++... ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 86 ~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999988765 45789999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1034 (1082)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+ ... +..+...
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~---~~~-i~~~~~~---- 228 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDV---IGR-IENGERL---- 228 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGH---HHH-HHTTCCC----
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHH---HHH-HHcCCCC----
Confidence 5545556678999999999999999999999999999999998 7888864321 122 222 2222211
Q ss_pred cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1035 ~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+...+.++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 229 -----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 229 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 223455678999999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=389.19 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=209.5
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc------ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF------QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999976 4689999999865322 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC----cEEEeeccc
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL----NAYLSDFGL 948 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGl 948 (1082)
|+||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999999874 4699999999999999999999999 999999999999998776 499999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+..........
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANVSAVNY 233 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHTTCC
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC--------CHHHHHHHHHhcCC
Confidence 98875432 234467999999999999999999999999999999999999999732 22333333322211
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
... . ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~---~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EFE---D----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCC---H----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC---c----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 0112335678999999999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=387.47 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=203.3
Q ss_pred cCccccceecccCceEEEEEEEcC----CeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIP----GVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
.+|++.+.||+|+||+||+|+... ...||||++... .....++|.+|++++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 468999999999999999997542 247899998654 22345789999999999999999999999976 4678
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++|++.+++... ...+++..+..++.|+|.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999999988765 34699999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCc--cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 954 TSETH--ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 954 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
..... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.. .+..+.+..+...+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~--------~~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--------LNGSQILHKIDKEGERL 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTSCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC--------cCHHHHHHHHHhCCCCC
Confidence 44332 2334568889999999999999999999999999999998 8999863 23344444444443222
Q ss_pred cccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1031 EFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1031 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
+.+...+.++.+++.+||+.||++||||.||.+.|++.+
T Consensus 235 ---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 235 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 123344568999999999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=395.09 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=205.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCe----EEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGV----VVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 874 (1082)
.+|++.++||+|+||+||+|.+. +|+ +||+|++... .....++|.+|++++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35999999999999999999764 343 6899988643 335577899999999999999999999999865 5678
Q ss_pred EEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCC
Q 045553 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 954 (1082)
+|||+.+|+|.+++... ...+++..+.+++.|||.||+|||+. +|+||||||+||+++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 88999999999998875 56799999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 955 SETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 955 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||+... ...+. ..+..+.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~----~~i~~~~---- 230 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEIS----SILEKGE---- 230 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHH----HHHHHTC----
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHH----HHHHcCC----
Confidence 4333 2334568999999999999999999999999999999998 778876432 11222 2222221
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
+...|...+.++.+++.+||+.||++||||.||+++|+.+
T Consensus 231 -----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1123445667899999999999999999999999998875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-43 Score=384.38 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=208.0
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhccCCCceeeEeeeeccCC----e
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF---QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA----E 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 871 (1082)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999965 5799999999975432 33567899999999999999999999887643 4
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.|+||||+++++|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999999998774 4699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC--ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 952 LGTSET--HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 952 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+........+..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--------SPVSVAYQHVREDPI 232 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCCCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc--------CHHHHHHHHHhcCCC
Confidence 643322 2344567999999999999999999999999999999999999999632 333444444444332
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhhC
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-SMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~i~ 1078 (1082)
... ......+.++.+++.+|++.||++|| +++|+.+.|.+++
T Consensus 233 ~~~-------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CGG-------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCc-------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 211 01123456899999999999999999 8999999998875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=391.25 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=210.9
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4699999999999999999975 57999999999754 2345677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999874 4689999999999999999999999 99999999999999999999999999998754332
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||... +..+......... .
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~--------~~~~~~~~i~~~~-~------- 222 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLFELILMEE-I------- 222 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C-------
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc--------CHHHHHHHHhcCC-C-------
Confidence 2344578999999999999999999999999999999999999999742 2233333333221 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 1073 (1082)
..|...+.++.+++.+|++.||++||+ +.|++++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 123445568899999999999999995 7888763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=388.09 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=207.8
Q ss_pred cceecccCceEEEEEEEcC----CeEEEEEEeecC-ccccHHHHHHHHHHHhccCCCceeeEeeeecc-CCeEEEEEeec
Q 045553 806 QNCIGSGGFGATYKAEIIP----GVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-EAEMFLIYNYL 879 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 879 (1082)
.++||+|+||+||+|.+.+ ...||||+++.. .....++|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999997653 246899998643 44556789999999999999999999999865 56899999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc-
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH- 958 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 958 (1082)
++|+|.++++.. ....++..+.+++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999998865 45678899999999999999999999 9999999999999999999999999999877543322
Q ss_pred --cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 959 --ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 959 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.... +..++..... .+...
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-------~~~~~~~~i~-~g~~~------ 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDITVYLL-QGRRL------ 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHH-TTCCC------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-------CHHHHHHHHH-cCCCC------
Confidence 2334578999999999999999999999999999999999988876432 1222333322 22211
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
..|...+.++.+++.+||+.||++||+|.||+++|+++..+
T Consensus 254 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12334456899999999999999999999999999988643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=392.44 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=203.3
Q ss_pred hcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhcc-CCCceeeEeeeeccC-C
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE-A 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 870 (1082)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357999999999999999999753 24789999987543 34456678888888777 688999999987654 5
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD 936 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 936 (1082)
..++||||+++|+|.++++... ...+++..+..++.||++||+|||+. +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 6899999999999999997642 23589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCccCCCCCc
Q 045553 937 NNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKK-ALDPSFCSFGNGF 1014 (1082)
Q Consensus 937 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~-p~~~~~~~~~~~~ 1014 (1082)
+++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|.. ||.....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------ 242 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------ 242 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH------
Confidence 9999999999999876544332 3445679999999999999999999999999999999999754 5643211
Q ss_pred cHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCCC
Q 045553 1015 NIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~~ 1081 (1082)
.+.+...+..+... ..+...+.++.+++.+||+.||++|||+.||+++|+++.+++
T Consensus 243 --~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 243 --DEEFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp --SHHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 12233333333222 223345568999999999999999999999999999886543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.9e-43 Score=385.71 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=209.3
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
.+|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4699999999999999999976 46899999999643 2344678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+++|++..++... ..+++..+..++.||+.|++|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999999874 5688999999999999999999999 9999999999999999999999999999886533
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+.... .
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~-~------- 218 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNAE-L------- 218 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHCC-C-------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc--------CHHHHHHHHHcCC-C-------
Confidence 23468999999999999999999999999999999999999999732 2333333333321 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 1073 (1082)
..|...+.++.+++.+|++.||++|| ++.|++++
T Consensus 219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 12334456799999999999999996 89998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=386.87 Aligned_cols=255 Identities=29% Similarity=0.418 Sum_probs=206.7
Q ss_pred cCccccceecccCceEEEEEEEc-CCe--EEEEEEeecC-ccccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGV--VVAVKRLSVG-RFQGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|++.++||+|+||+||+|.+. +|. .||||++... .....+.|.+|+++++++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56889999999999999999765 444 5788887543 334556799999999998 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcE
Q 045553 876 YNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 941 (1082)
|||+++|+|.++++.. ....+++..+.+++.|||+|+.|+|+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 246799999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCccCCCCCccHHHHH
Q 045553 942 YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA-LDPSFCSFGNGFNIVAWA 1020 (1082)
Q Consensus 942 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p-~~~~~~~~~~~~~~~~~~ 1020 (1082)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|..| |.. .+..+..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~--------~~~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAELY 236 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC--------CCHHHHH
Confidence 999999998654322 22345689999999999999999999999999999999998764 532 2233333
Q ss_pred HHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhC
Q 045553 1021 SMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078 (1082)
Q Consensus 1021 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~ 1078 (1082)
..+ ..+. +...+...+.++.+++.+||+.||++||||.||+++|+++.
T Consensus 237 ~~i-~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 237 EKL-PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHG-GGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH-HhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 322 2221 11234455678999999999999999999999999998865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=390.06 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=213.8
Q ss_pred hcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhcc-CCCceeeEeeeeccCCe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSEAE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 871 (1082)
.++|++.++||+|+||.||+|++. +++.||||+++.... ....+|.+|+.+++++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 357889999999999999999752 467899999976443 4456789999999999 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 872 MFLIYNYLPGGNLEKFIQDRP----------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
.++||||+++|+|.++++... ...+++..+..++.||++|++|||++ +|+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999998643 23689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCC-ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCc
Q 045553 936 DNNLNAYLSDFGLARLLGTSET-HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGF 1014 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~ 1014 (1082)
+.++.+|++|||.++....... .......||+.|+|||++.++.++.++|||||||++|||+|++.|+...... .
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---~- 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---D- 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---S-
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH---H-
Confidence 9999999999999998765433 3344568999999999999999999999999999999999965554422111 1
Q ss_pred cHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1015 NIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
..+...+..+. +...+...+.++.+|+.+||+.||++||||.||+++|+++
T Consensus 255 ---~~~~~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 ---SKFYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ---HHHHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11222222221 1223344567899999999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=382.16 Aligned_cols=270 Identities=24% Similarity=0.293 Sum_probs=203.2
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCC----eEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA----EMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 876 (1082)
..|.+.+.||+|+||+||+|++ +|+.||||++..... ....+..|+..+++++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3577889999999999999986 589999999864422 1122334555666789999999999997643 689999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC-----VPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
||+++|+|.++++.. .++|..+.+++.|+|.||+|+|+.. .++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999864 5899999999999999999999731 24999999999999999999999999999987
Q ss_pred cCCCCCc---cccCcccCCCcccchhcccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCccCC------CCCccH
Q 045553 952 LGTSETH---ATTDVAGTFGYVAPEYAMTCR------VSDKADVYSFGVVLLELISDKKALDPSFCSF------GNGFNI 1016 (1082)
Q Consensus 952 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGvll~elltg~~p~~~~~~~~------~~~~~~ 1016 (1082)
....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+....... ......
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 7543322 234567999999999987643 5779999999999999999998875322110 001112
Q ss_pred HHHHHHHHhcCCCccccccccCCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1017 VAWASMLLLQGRPCEFFTAGLWDC-GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
.+........+.. ++.+... .+.+....+.+++.+||+.||++||||.||+++|+++..
T Consensus 238 ~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 2222333222221 1111111 123456779999999999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-42 Score=375.84 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=207.9
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccc---------cHHHHHHHHHHHhccC-CCceeeEeeeeccC
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---------GVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSE 869 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 869 (1082)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999975 46899999999754321 2346889999999997 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccc
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 949 (1082)
+..|+||||+++|+|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999874 4699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMT------CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML 1023 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1023 (1082)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||... +.......+
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~--------~~~~~~~~i 227 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--------KQMLMLRMI 227 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHH
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC--------CHHHHHHHH
Confidence 9875432 2345679999999999863 34688999999999999999999999742 222222333
Q ss_pred HhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1024 LLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1024 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... .. .........+.++.+++.+|++.+|++||++.||+++
T Consensus 228 ~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCC-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3222 11 0111123456789999999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=383.78 Aligned_cols=260 Identities=20% Similarity=0.350 Sum_probs=216.2
Q ss_pred hcCccccceecccCceEEEEEEEc------CCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeE
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII------PGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 872 (1082)
.++|++.+.||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++||||+++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 357889999999999999999653 35789999997543 34455789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEe
Q 045553 873 FLIYNYLPGGNLEKFIQDRP--------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS 944 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 944 (1082)
++||||+++|+|.++++... ...+++..+.+++.|+|+||+|||+. +|+||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999987531 24579999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCccCCCCCccHHHHHHH
Q 045553 945 DFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDK-KALDPSFCSFGNGFNIVAWASM 1022 (1082)
Q Consensus 945 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 1022 (1082)
|||+|+........ ......||+.|+|||.+.+..++.++||||||+++|||+||+ .||. +....++...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~--------~~~~~~~~~~ 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--------GLSNEQVLRF 247 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT--------TSCHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC--------CCCHHHHHHH
Confidence 99999876543332 334457899999999999999999999999999999999996 4553 2344455544
Q ss_pred HHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCCC
Q 045553 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPP 1080 (1082)
Q Consensus 1023 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~~ 1080 (1082)
+.. +... ..+...+..+.+++.+||+.+|++||||.||+++|++...+
T Consensus 248 i~~-~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 248 VME-GGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHT-TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHh-CCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 433 2221 12334456899999999999999999999999999987665
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=382.58 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=209.5
Q ss_pred hcCccccceecccCceEEEEEEEcC--------CeEEEEEEeecCcc-ccHHHHHHHHHHHhcc-CCCceeeEeeeeccC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEIIP--------GVVVAVKRLSVGRF-QGVQQFAAEIRTLGRV-QHPNLVTLIGYHVSE 869 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 869 (1082)
.++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578899999999999999996432 35799999976543 3457788899999888 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEE
Q 045553 870 AEMFLIYNYLPGGNLEKFIQDRP--------------RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935 (1082)
Q Consensus 870 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 935 (1082)
+..++||||+++|+|.+++..+. ...+++.++++++.|++.||+|||+. +|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 99999999999999999998653 24689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccceecCCCCCc-cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCccCCCCC
Q 045553 936 DNNLNAYLSDFGLARLLGTSETH-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS-DKKALDPSFCSFGNG 1013 (1082)
Q Consensus 936 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~ellt-g~~p~~~~~~~~~~~ 1013 (1082)
+.++.+||+|||+++........ ......|++.|+|||++.++.++.++|||||||++|||++ |..||...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~------- 241 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------- 241 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-------
Confidence 99999999999999877544332 3345678999999999999999999999999999999998 57776522
Q ss_pred ccHHHHHHHHHhcCCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhCC
Q 045553 1014 FNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQP 1079 (1082)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i~~ 1079 (1082)
...+ +...+..+... ..|...+.++.+++.+||+.||++|||+.||++.|++|.+
T Consensus 242 -~~~~-~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 242 -PVEE-LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -CHHH-HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CHHH-HHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2222 22333333222 2233455689999999999999999999999999998854
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=383.50 Aligned_cols=252 Identities=19% Similarity=0.230 Sum_probs=209.0
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
.++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+|++++++++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999764 689999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC--CcEEEeecccceecCCCC
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN--LNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfGla~~~~~~~ 956 (1082)
+++|+|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999999865 34689999999999999999999999 99999999999999854 589999999998764432
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......|++.|+|||...+..++.++||||+||++|||++|+.||... ...+....+....... +..
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~--------~~~~~~~~i~~~~~~~---~~~ 225 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNAEYTF---DEE 225 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTCCCC---CHH
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCCC---Chh
Confidence 233457899999999999999999999999999999999999999732 2233333333322111 000
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
. ....+.++.+++.+|++.||++|||+.|++++
T Consensus 226 ~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 A----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01234578999999999999999999999873
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-42 Score=386.22 Aligned_cols=244 Identities=20% Similarity=0.301 Sum_probs=208.6
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecC---ccccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVG---RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 876 (1082)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4699999999999999999976 46999999998643 2244577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 956 (1082)
||+.+|+|.+++... ..+++..++.++.||+.||.|||+. +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999999874 4699999999999999999999999 9999999999999999999999999999987532
Q ss_pred CccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 957 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||... +.......+.... .
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~-~------- 255 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSGK-V------- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C-------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--------CHHHHHHHHhcCC-C-------
Confidence 23467999999999999999999999999999999999999999632 2333333333221 1
Q ss_pred cCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045553 1037 LWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQ 1072 (1082)
Q Consensus 1037 l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 1072 (1082)
..+...+.++.+++.+|++.||++|+ ++.|+++
T Consensus 256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12334456899999999999999994 8999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=382.33 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=205.5
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc---cccHHHHHHHHHHHh-ccCCCceeeEeeeeccCCeEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR---FQGVQQFAAEIRTLG-RVQHPNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV 875 (1082)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47999999999999999999654 69999999997432 234556677777665 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCC
Q 045553 876 YNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955 (1082)
Q Consensus 876 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 955 (1082)
|||+++|+|.++++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999874 4689999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCcccccc
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1035 (1082)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+...... .+.+
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~-~~~~------ 220 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--------DEEELFHSIR-MDNP------ 220 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHH-HCCC------
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHH-cCCC------
Confidence 3 2334567999999999999999999999999999999999999999732 2233333332 2211
Q ss_pred ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 045553 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMR-QVAQ 1072 (1082)
Q Consensus 1036 ~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~~ 1072 (1082)
..|...+.++.+++.+|++.||++||++. |+.+
T Consensus 221 ----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12334456799999999999999999985 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9e-42 Score=385.04 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=201.1
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCcc---ccHHHHH---HHHHHHhccCCCceeeEeeeeccCCeEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRF---QGVQQFA---AEIRTLGRVQHPNLVTLIGYHVSEAEMF 873 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~ 873 (1082)
++|++.++||+|+||.||+|+.. +|+.||||++..... .....+. +|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999764 689999999864321 2223333 4577788889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecC
Q 045553 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG 953 (1082)
Q Consensus 874 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 953 (1082)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999874 4689999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccc
Q 045553 954 TSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEF 1032 (1082)
Q Consensus 954 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1082)
... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||..... ......... .....
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~-~~~~~---- 225 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRM-TLTMA---- 225 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHH-SSSCC----
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-cccCC----
Confidence 432 334579999999999975 5689999999999999999999999975321 122221111 11110
Q ss_pred cccccCCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 045553 1033 FTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPS-----MRQVAQ 1072 (1082)
Q Consensus 1033 ~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 1072 (1082)
...+...+.++.+++.+|++.||++||| +.|+++
T Consensus 226 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1123344568999999999999999999 578765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=383.23 Aligned_cols=253 Identities=22% Similarity=0.249 Sum_probs=200.6
Q ss_pred hcCccccc-eecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhc-cCCCceeeEeeeecc----CCeE
Q 045553 800 TAGFNVQN-CIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR-VQHPNLVTLIGYHVS----EAEM 872 (1082)
Q Consensus 800 ~~~~~~~~-~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~ 872 (1082)
.++|++.+ .||+|+||+||+|.. .+++.||||+++.. ..+.+|++++.+ .+|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788764 699999999999965 56899999998642 457789988655 489999999998865 4678
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC---CCcEEEeecccc
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLA 949 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla 949 (1082)
|+||||++||+|.+++..+....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876567899999999999999999999999 9999999999999985 567999999999
Q ss_pred eecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 950 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
+...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...... .....+...+..+..
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-----~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKTRIRMGQY 234 (335)
T ss_dssp EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSCSS
T ss_pred eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH-----HHHHHHHHHHhcCCC
Confidence 8775433 234567999999999999999999999999999999999999999643211 111111110000000
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
..........+.++.+++.+|++.||++|||+.|++++
T Consensus 235 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000112345789999999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=375.27 Aligned_cols=268 Identities=26% Similarity=0.420 Sum_probs=208.4
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|++++++++|||||++++++.+....|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4799999999999999999975 5689999999965432 235678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
|+. +++.+++.......+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 995 5666666655567799999999999999999999999 999999999999999999999999999987654332
Q ss_pred ccccCcccCCCcccchhcccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc
Q 045553 958 HATTDVAGTFGYVAPEYAMTCR-VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1036 (1082)
......||+.|+|||+..... ++.++||||+||++|||++|+.||.... ....+.......+...+..-+.
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-------EIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHHHCCCCTTTSTT
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC-------HHHHHHHHHHhcCCCchhhccc
Confidence 344467999999999887655 5789999999999999999999997431 1111111111111111111100
Q ss_pred ------cCCCC-----------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhCCC
Q 045553 1037 ------LWDCG-----------PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQPP 1080 (1082)
Q Consensus 1037 ------l~~~~-----------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~~~ 1080 (1082)
..... ....+.++.+++.+|++.||++|||+.|++++ ++++.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 00000 01234678999999999999999999999986 7666554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=372.00 Aligned_cols=257 Identities=24% Similarity=0.307 Sum_probs=195.6
Q ss_pred cceecccCceEEEEEEE-cCCeEEEEEEeecCcccc-----HHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEeec
Q 045553 806 QNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQG-----VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879 (1082)
Q Consensus 806 ~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 879 (1082)
.++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 47899999999999975 468999999986543221 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCcc
Q 045553 880 PGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA 959 (1082)
Q Consensus 880 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 959 (1082)
.++++..+... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 83 ~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A 156 (299)
T ss_dssp SEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred cchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence 88777666543 45688999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred ccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCccccccc--
Q 045553 960 TTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG-- 1036 (1082)
Q Consensus 960 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-- 1036 (1082)
....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....+.............+..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-----~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-----HHHHHHHHHHhcCCCChhhccchhcc
Confidence 3346799999999998754 57999999999999999999999986421 111111111111111100000000
Q ss_pred ----cC---CCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1037 ----LW---DCGP-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1037 ----l~---~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ...+ .....++.+++.+|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 0011 1235679999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.2e-41 Score=366.85 Aligned_cols=259 Identities=22% Similarity=0.274 Sum_probs=202.0
Q ss_pred cCccccceecccCceEEEEEEEcCCeEEEEEEeecCcc--ccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEee
Q 045553 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY 878 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 878 (1082)
++|++.++||+|+||+||+|+..+|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57999999999999999999988999999999966532 3357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCCc
Q 045553 879 LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958 (1082)
Q Consensus 879 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 958 (1082)
+.++.+..+.+. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 977666666554 46799999999999999999999999 999999999999999999999999999987654332
Q ss_pred cccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH---hcCCCcccc-
Q 045553 959 ATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL---LQGRPCEFF- 1033 (1082)
Q Consensus 959 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~- 1033 (1082)
......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.... ..+...... .........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--------EADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--------HHHHHHHHHHhhCCCChhhccc
Confidence 2334568999999999876 456899999999999999999999997431 111111111 110000000
Q ss_pred -------ccccC-------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1034 -------TAGLW-------DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1034 -------d~~l~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.... .......+..+.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 01112345678999999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=371.29 Aligned_cols=241 Identities=26% Similarity=0.398 Sum_probs=198.9
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCcc------ccHHHHHHHHHHHhccC--CCceeeEeeeeccCC
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRF------QGVQQFAAEIRTLGRVQ--HPNLVTLIGYHVSEA 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 870 (1082)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999975 4689999999865321 11234678999999987 899999999999999
Q ss_pred eEEEEEeecCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCC-CcEEEeeccc
Q 045553 871 EMFLIYNYLPG-GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN-LNAYLSDFGL 948 (1082)
Q Consensus 871 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGl 948 (1082)
..++||||+.+ +++.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 6888888763 4799999999999999999999999 99999999999999854 7999999999
Q ss_pred ceecCCCCCccccCcccCCCcccchhcccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcC
Q 045553 949 ARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027 (1082)
Q Consensus 949 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1082)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ... .+
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~-~~ 219 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EII-RG 219 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHH-HC
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHh-hc
Confidence 9875432 3345679999999999987765 567999999999999999999996321 111 11
Q ss_pred CCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1028 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.. ..+...+.++.+++.+|++.||++|||+.|++++
T Consensus 220 ~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 1122345688999999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=368.41 Aligned_cols=268 Identities=26% Similarity=0.344 Sum_probs=202.2
Q ss_pred HhcCccccceecccCceEEEEEEEc-C-CeEEEEEEeecCcc--ccHHHHHHHHHHHhcc---CCCceeeEeeeecc---
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEII-P-GVVVAVKRLSVGRF--QGVQQFAAEIRTLGRV---QHPNLVTLIGYHVS--- 868 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~--- 868 (1082)
..++|++.+.||+|+||+||+|+.. + ++.||||+++.... .....+.+|+++++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 4578999999999999999999763 4 67899999864322 2223456677766655 89999999998853
Q ss_pred --CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeec
Q 045553 869 --EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946 (1082)
Q Consensus 869 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 946 (1082)
....+++|||+.++++..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred ccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 357899999997766654443 3466799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-
Q 045553 947 GLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL- 1025 (1082)
Q Consensus 947 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 1025 (1082)
|.++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.......
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~~~~~i~~~ 230 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--------DVDQLGKILDV 230 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHH
T ss_pred hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHh
Confidence 999865332 23455689999999999999999999999999999999999999997421 1122222111
Q ss_pred cCCC-cccccc-------ccC-------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhCCC
Q 045553 1026 QGRP-CEFFTA-------GLW-------DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQPP 1080 (1082)
Q Consensus 1026 ~~~~-~~~~d~-------~l~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~~~ 1080 (1082)
.+.. .+.... ... .......+..+.+|+.+|++.||++|||+.|++++ +++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 0000 000000 000 00122345678899999999999999999999876 6666543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-39 Score=354.39 Aligned_cols=260 Identities=17% Similarity=0.234 Sum_probs=207.2
Q ss_pred hcCccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCC-CceeeEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH-PNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999754 689999999865432 2456788899999876 899999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcC-----CCcEEEeecccceec
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN-----NLNAYLSDFGLARLL 952 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~DfGla~~~ 952 (1082)
|+ +++|.++++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+|+.+
T Consensus 82 ~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 78999998765 45799999999999999999999999 9999999999999974 578999999999987
Q ss_pred CCCCC------ccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhc
Q 045553 953 GTSET------HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQ 1026 (1082)
Q Consensus 953 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1082)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-----~~~~~~~~i~~~ 231 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYERIGEK 231 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch-----hHHHHHHHHHhc
Confidence 54322 1234567999999999999999999999999999999999999999743221 112211111111
Q ss_pred CCCccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1027 GRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1027 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
...... +.+. ...+.++.+++..|++.+|++||+++.+.+.|+++
T Consensus 232 ~~~~~~--~~l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 232 KQSTPL--RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHSCH--HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cCCCCh--HHhc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 000000 0011 12345789999999999999999999998888765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-39 Score=357.46 Aligned_cols=260 Identities=20% Similarity=0.262 Sum_probs=201.2
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCcee-eEeeeeccCCeEEEEEe
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLV-TLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E 877 (1082)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... .+++..|++++++++|++++ .+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46799999999999999999975 5689999999876433 24578899999999877655 45556677788999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEc---CCCcEEEeecccceecCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGT 954 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~~~~ 954 (1082)
|+ ++++...+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++ .+..+|++|||+|+.+..
T Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred Ec-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99 66777776654 45799999999999999999999999 999999999999986 355799999999998754
Q ss_pred CCCc------cccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCC
Q 045553 955 SETH------ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028 (1082)
Q Consensus 955 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1082)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~-~~~~~~~~~~~~~~~-~~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMS-TP 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-SC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH-HHHHHHHHhhcccCC-CC
Confidence 3322 234567999999999999999999999999999999999999999753221 011111111111111 10
Q ss_pred CccccccccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 045553 1029 PCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077 (1082)
Q Consensus 1029 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~i 1077 (1082)
.. .+ ....+.++.+++.+|++.+|++||++.++.+.|+.+
T Consensus 237 ~~-----~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 IE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HH-----HH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hh-----Hh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00 01 112346799999999999999999999998888764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.1e-39 Score=363.42 Aligned_cols=222 Identities=32% Similarity=0.543 Sum_probs=180.2
Q ss_pred CHHHHHHHHhcccCCCCCCCCCCCCCCCCc--eeeeeEeeCCC--CCeeeeecCCCccccccccCCCCCCCCCCCCcccC
Q 045553 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSC--SWHGVTCDPLS--GRVTSLNLSSNLSRTSCSLLSLPPAAGPGGNFSFH 76 (1082)
Q Consensus 1 ~~~l~~~k~~~~~~~~~~~~~W~~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 76 (1082)
|+||++||+++. || +.+++|.. ++||| .|.||+|++.+ +||++|||+++
T Consensus 8 ~~aLl~~k~~~~-~~-~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~------------------------ 60 (313)
T d1ogqa_ 8 KQALLQIKKDLG-NP-TTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL------------------------ 60 (313)
T ss_dssp HHHHHHHHHHTT-CC-GGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECC------------------------
T ss_pred HHHHHHHHHHCC-CC-CcCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCC------------------------
Confidence 689999999997 55 46899984 68999 59999998754 48999999873
Q ss_pred cCcccccccccCcccCCCCCCccc--cccccccCCCCCCEEEccc-CCCcccCChhhcCCCCCCEEeCcCCCCCCCCCcc
Q 045553 77 FPCLQLHQHDRGNINSNSSDKLSG--NLSRAIGDLTQLRVLLLAF-NGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153 (1082)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~l~g--~l~~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~ 153 (1082)
+++| .+|++|++|++|++|+|++ |+++|.+|.+|++|++|++|+|++|++.+..+..
T Consensus 61 --------------------~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~ 120 (313)
T d1ogqa_ 61 --------------------NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120 (313)
T ss_dssp --------------------CCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG
T ss_pred --------------------CCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccccccccc
Confidence 3334 5789999999999999986 8899999999999999999999999999888888
Q ss_pred ccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCc
Q 045553 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTEL 233 (1082)
Q Consensus 154 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 233 (1082)
+..+.+|+++++++|++.+.+|..+.++++|+.+++++|.+.+.+|..++.....++.+++++|++++..|..+..+..+
T Consensus 121 ~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~ 200 (313)
T d1ogqa_ 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA 200 (313)
T ss_dssp GGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS
T ss_pred ccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999999999999999888888776433334777777777777777666665433
Q ss_pred cEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCccc
Q 045553 234 RSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGI 270 (1082)
Q Consensus 234 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 270 (1082)
.+++++|.+.+.+|..+..+++|+.|++++|.+.+.
T Consensus 201 -~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~ 236 (313)
T d1ogqa_ 201 -FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp -EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred -cccccccccccccccccccccccccccccccccccc
Confidence 577777777666666666677777777777666543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=362.68 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=196.4
Q ss_pred CccccceecccCceEEEEEEEc-CCeEEEEEEeecCccccHHHHHHHHHHHhccCCCceeeEeeeecc------CCeEEE
Q 045553 802 GFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS------EAEMFL 874 (1082)
Q Consensus 802 ~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~l 874 (1082)
.|+..++||+|+||+||+|+.. +|+.||||++...... +.+|++++++++||||+++++++.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999764 6899999999765422 3479999999999999999998853 234789
Q ss_pred EEeecCCCCHHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecccceec
Q 045553 875 IYNYLPGGNLEKFIQD-RPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFGLARLL 952 (1082)
Q Consensus 875 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~ 952 (1082)
||||++++.+..+.+. .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976544433321 2355799999999999999999999999 999999999999999775 8999999999877
Q ss_pred CCCCCccccCcccCCCcccchhccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHH-------H
Q 045553 953 GTSETHATTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML-------L 1024 (1082)
Q Consensus 953 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~ 1024 (1082)
..... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+....+.. .
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~----~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHHHHHCCCCHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH----HHHHHHHHHHhCCChHHhh
Confidence 54332 334579999999998875 5789999999999999999999999964311 01111111000 0
Q ss_pred --hcCCCcccccccc-----CCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhCC
Q 045553 1025 --LQGRPCEFFTAGL-----WDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQP 1079 (1082)
Q Consensus 1025 --~~~~~~~~~d~~l-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~~ 1079 (1082)
......+..-+.. ........+.++.+|+.+|++.||++|||+.|++++ ++++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000000000000 001122345678999999999999999999999874 555543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=355.58 Aligned_cols=263 Identities=20% Similarity=0.247 Sum_probs=197.2
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc--------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS-------- 868 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 868 (1082)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|++++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999976 579999999986542 2345678899999999999999999998754
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccc
Q 045553 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGL 948 (1082)
Q Consensus 869 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 948 (1082)
....++||||++++.+..+... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 3468999999987766655443 45789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC---ccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH
Q 045553 949 ARLLGTSET---HATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024 (1082)
Q Consensus 949 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1024 (1082)
++.+..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-----~~~~~~~i~~~~ 238 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQLC 238 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHH
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-----HHHHHHHHHHhc
Confidence 987754322 223345799999999998765 68999999999999999999999997421 111111111111
Q ss_pred hcCCCccccccc-----------cCC-CCCh-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 LQGRPCEFFTAG-----------LWD-CGPH-------DDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ~~~~~~~~~d~~-----------l~~-~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.....+..... ... ..+. .....+.+|+.+|++.||++|||+.|++++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 -GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp -CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11111110000 000 0000 113457789999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=349.14 Aligned_cols=266 Identities=22% Similarity=0.298 Sum_probs=209.7
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCCeEEEEEe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 877 (1082)
++|++.+.||+|+||+||+|+. .+++.||||+++... ....+++.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4799999999999999999975 468999999996543 2346788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceecCCCCC
Q 045553 878 YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957 (1082)
Q Consensus 878 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 957 (1082)
++.++++..+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999999888776 45789999999999999999999999 999999999999999999999999999998754433
Q ss_pred ccccCcccCCCcccchhcccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHh-cCCC-cccc-
Q 045553 958 HATTDVAGTFGYVAPEYAMTCR-VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLL-QGRP-CEFF- 1033 (1082)
Q Consensus 958 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~- 1033 (1082)
......++..|+|||++.+.. ++.++||||+||++|||++|+.||.. +.+..+....... .+.. ....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-------GNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC-------CSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC-------CCCHHHHHHHHHhhcCCCChhhhh
Confidence 233346788999999987765 68999999999999999999999753 2222233222211 1100 0000
Q ss_pred ------cc---------ccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhCC
Q 045553 1034 ------TA---------GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQP 1079 (1082)
Q Consensus 1034 ------d~---------~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~~ 1079 (1082)
+. .-...........+.+++.+|++.||.+|||++||+++ ++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 00 00001123345678999999999999999999999874 444433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-39 Score=359.50 Aligned_cols=263 Identities=24% Similarity=0.307 Sum_probs=198.2
Q ss_pred HhcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc-cccHHHHHHHHHHHhccCCCceeeEeeeeccCC----eE
Q 045553 799 ATAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA----EM 872 (1082)
Q Consensus 799 ~~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 872 (1082)
.+.+|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++|||++++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999999964 579999999997543 334567899999999999999999999987543 34
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccceec
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 952 (1082)
++++||+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 5556667799999999864 589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--ccccCcccCCCcccchhcc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 953 GTSET--HATTDVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 953 ~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
..... .......||+.|+|||++. +..++.++||||+||++|||++|+.||...... +. .+..........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-----~~-~~~~~~~~~~~~ 233 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQ-LNHILGILGSPS 233 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HH-HHHHHHHHCSCC
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH-----HH-HHHHhhhccCCC
Confidence 44322 2334567999999999985 456789999999999999999999999743210 11 111111111100
Q ss_pred ccccccc-----------c--CCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1030 CEFFTAG-----------L--WDCGP-----HDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1030 ~~~~d~~-----------l--~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.+..... . ....+ .....++.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0 00001 1223578899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-39 Score=357.44 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=206.8
Q ss_pred cCccccceecccCceEEEEEEEc----CCeEEEEEEeecCc----cccHHHHHHHHHHHhccCC-CceeeEeeeeccCCe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGR----FQGVQQFAAEIRTLGRVQH-PNLVTLIGYHVSEAE 871 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 871 (1082)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 46999999999999999999642 47899999986432 2334668899999999977 899999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||+.+|+|.++++.. ..+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999874 4578899999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCccccCcccCCCcccchhcccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMTC--RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
+............|++.|+|||.+.+. .++.++||||+||++|||++|+.||..... ................
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~----~~~~~~i~~~~~~~~~- 253 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSEP- 253 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHCCC-
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcccCCC-
Confidence 765555555567899999999999764 468899999999999999999999975422 2222332222222111
Q ss_pred ccccccccCCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 045553 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRP-----SMRQVAQ 1072 (1082)
Q Consensus 1030 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 1072 (1082)
..+...+.++.+++.+|+++||++|| |++|+++
T Consensus 254 ----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 12345567899999999999999999 4788876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=358.26 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=197.6
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccCC------
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEA------ 870 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 870 (1082)
.++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999975 469999999997542 234567889999999999999999999987654
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeecccce
Q 045553 871 EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR 950 (1082)
Q Consensus 871 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 950 (1082)
+.|+||||+ +.+|..+.+. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 579999999 6788888765 3699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCC
Q 045553 951 LLGTSETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029 (1082)
Q Consensus 951 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1082)
..... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ............+..
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~-------~~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-------HLDQLKEIMKVTGTP 238 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHHHCCC
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC-------hHHHHHHHHhccCCC
Confidence 76432 3446799999999998764 56899999999999999999999997431 111111111001100
Q ss_pred c-cccc--------------cccC----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhhC
Q 045553 1030 C-EFFT--------------AGLW----DCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ--LKQIQ 1078 (1082)
Q Consensus 1030 ~-~~~d--------------~~l~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~i~ 1078 (1082)
. +... +... ..........+.+|+.+|++.||++|||+.|++++ ++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 0000 0000 00112334678899999999999999999999986 55543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.8e-38 Score=349.77 Aligned_cols=253 Identities=19% Similarity=0.245 Sum_probs=197.8
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeecc--CCeEEEEE
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVS--EAEMFLIY 876 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 876 (1082)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|++++++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999975 56899999998743 3567889999999995 9999999999874 45689999
Q ss_pred eecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCC-cEEEeecccceecCCC
Q 045553 877 NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNL-NAYLSDFGLARLLGTS 955 (1082)
Q Consensus 877 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 955 (1082)
||+.+++|..+. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997764 3589999999999999999999999 999999999999998655 6999999999876543
Q ss_pred CCccccCcccCCCcccchhcccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH----------
Q 045553 956 ETHATTDVAGTFGYVAPEYAMTC-RVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL---------- 1024 (1082)
Q Consensus 956 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 1024 (1082)
. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||..... ...++.....
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~------~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD------NYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS------HHHHHHHHHHHHCHHHHHHH
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch------hHHHHHHHHHHHCCchhhhh
Confidence 3 23445789999999998775 479999999999999999999999964321 1111111100
Q ss_pred -hcCCCc--cccc------------cccCCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 045553 1025 -LQGRPC--EFFT------------AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQ 1072 (1082)
Q Consensus 1025 -~~~~~~--~~~d------------~~l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 1072 (1082)
...... .... ...........+.++.+|+.+|++.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000 00111111234567899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-37 Score=348.61 Aligned_cols=255 Identities=22% Similarity=0.276 Sum_probs=189.6
Q ss_pred cCccccceecccCceEEEEEEEc-CCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeecc------CCe
Q 045553 801 AGFNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS------EAE 871 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 871 (1082)
++|++.++||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999754 69999999997543 3345678899999999999999999999863 367
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.|+||||+.++ +.+.+. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 89999999654 445443 3589999999999999999999999 999999999999999999999999999886
Q ss_pred cCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHH-------
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL------- 1024 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 1024 (1082)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .........
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~--------~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--------YIDQWNKVIEQLGTPC 238 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCCCC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC--------HHHHHHHHHHhccCCC
Confidence 5433 23344579999999999999999999999999999999999999996321 111111111
Q ss_pred ---------------hcCC-C-----ccccccccCCC---CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1025 ---------------LQGR-P-----CEFFTAGLWDC---GPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1025 ---------------~~~~-~-----~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
.... . ...+....... .....+.++.+|+.+|++.||++|||++||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0 00000001110 112346778999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=349.59 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=195.6
Q ss_pred hcCccccceecccCceEEEEEEE-cCCeEEEEEEeecCc--cccHHHHHHHHHHHhccCCCceeeEeeeeccC-----Ce
Q 045553 800 TAGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGR--FQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSE-----AE 871 (1082)
Q Consensus 800 ~~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 871 (1082)
.++|++.++||+|+||+||+|.. .+|+.||||++.... ....+++.+|++++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999965 579999999997543 23456788999999999999999999988633 34
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 872 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.++||||+.+|+|.++++. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|++|||.+..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 5677788889999999975 3699999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccCcccCCCcccchhcccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHHHHHHHHhcCCCc
Q 045553 952 LGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPC 1030 (1082)
Q Consensus 952 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1082)
... ......|++.|+|||+..+.. ++.++||||+||++|+|++|+.||.... .......+.... .....
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-----~~~~~~~i~~~~-~~~~~ 240 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLV-GTPGA 240 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHH-CCCCH
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhc-CCCCh
Confidence 432 334467999999999877654 6889999999999999999999996421 111111111110 10000
Q ss_pred ccccc-----------ccCC--CC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 045553 1031 EFFTA-----------GLWD--CG-----PHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073 (1082)
Q Consensus 1031 ~~~d~-----------~l~~--~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 1073 (1082)
+.... .... .. ......++.+|+.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000 0000 00 01234678899999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-33 Score=318.57 Aligned_cols=264 Identities=20% Similarity=0.242 Sum_probs=192.6
Q ss_pred cCccccceecccCceEEEEEEE-cCCeEEEEEEeecCccccHHHHHHHHHHHhccC-----------CCceeeEeeeecc
Q 045553 801 AGFNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-----------HPNLVTLIGYHVS 868 (1082)
Q Consensus 801 ~~~~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 868 (1082)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4599999999999999999975 579999999997553 23456788998888775 5789999988764
Q ss_pred C--CeEEEEEeecCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcCCC-----
Q 045553 869 E--AEMFLIYNYLPGG-NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDNNL----- 939 (1082)
Q Consensus 869 ~--~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~----- 939 (1082)
. ...+++|++...+ +............+++..+..++.|++.|++|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 3 4556666665444 44444455556789999999999999999999998 6 899999999999998654
Q ss_pred -cEEEeecccceecCCCCCccccCcccCCCcccchhcccCCCCchhhHHHHHHHHHHHHhCCCCCCCCccCCCCCccHHH
Q 045553 940 -NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVA 1018 (1082)
Q Consensus 940 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvll~elltg~~p~~~~~~~~~~~~~~~~ 1018 (1082)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||.+...... ......
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~-~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY-TKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----------CHHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc-cchhHH
Confidence 4999999999865432 2345799999999999999999999999999999999999999975432211 111111
Q ss_pred HHHHHHhcCCC-----------cccccc-----c--------------cCCCCChHHHHHHHHHHHHcccCCCCCCCCHH
Q 045553 1019 WASMLLLQGRP-----------CEFFTA-----G--------------LWDCGPHDDLIEMLNLAIMCTGESLSSRPSMR 1068 (1082)
Q Consensus 1019 ~~~~~~~~~~~-----------~~~~d~-----~--------------l~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 1068 (1082)
.......-+.. ....+. . .....+.....++.+|+.+|++.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 11111111110 000000 0 01112356678899999999999999999999
Q ss_pred HHHHH
Q 045553 1069 QVAQQ 1073 (1082)
Q Consensus 1069 ev~~~ 1073 (1082)
|++++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=3.8e-29 Score=277.67 Aligned_cols=252 Identities=29% Similarity=0.447 Sum_probs=176.3
Q ss_pred CCCCEEEcccCCCcc--cCChhhcCCCCCCEEeCcC-CCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcE
Q 045553 110 TQLRVLLLAFNGFSG--ELPLEIGQLSLLEILDLSF-NSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQV 186 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 186 (1082)
.+++.|+|++|+++| .+|+++++|++|++|+|++ |.++|.+|.+|+++++|++|+|++|++.+..+..+..+++|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 468889999988887 4788888889999999886 7888888888888888888888888888888888888888888
Q ss_pred EEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCc-cEEEccCCcCCCCcCccccCCCCCCEEeCCCC
Q 045553 187 VSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTEL-RSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265 (1082)
Q Consensus 187 L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 265 (1082)
+++++|.+.+.+|..+. .++.|+.+++++|.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|
T Consensus 130 l~l~~N~~~~~~p~~l~-~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~ 207 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGG-GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSS
T ss_pred cccccccccccCchhhc-cCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 88888877766666655 46666666666666666666666666554 566666666666666655555433 4666666
Q ss_pred cCcccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCC
Q 045553 266 FLSGIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFP 345 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~ 345 (1082)
.+.+.+|..+..+++|+.+++ ++|.+.+.++
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~-------------------------------------------------~~~~l~~~~~ 238 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHL-------------------------------------------------AKNSLAFDLG 238 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEEC-------------------------------------------------CSSEECCBGG
T ss_pred ccccccccccccccccccccc-------------------------------------------------cccccccccc
Confidence 666555555555555555554 4444444332
Q ss_pred cccccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCcccCcccEEEecCCc-cee
Q 045553 346 QNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNL-LSG 413 (1082)
Q Consensus 346 ~~l~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~l~~N~-l~~ 413 (1082)
.+..+++|++|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|+...+.+|+.+++++|+ +.|
T Consensus 239 -~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 239 -KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp -GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred -ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC
Confidence 3555566777777777777677777777777777777777777766665566677777777776 344
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=6.8e-27 Score=267.32 Aligned_cols=114 Identities=21% Similarity=0.259 Sum_probs=78.0
Q ss_pred CCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccC
Q 045553 96 DKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIP 175 (1082)
Q Consensus 96 ~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 175 (1082)
.++.+.++. .++.+|++|++++++|+. + +.+..+++|++|+|++|+|++ +| .++++++|++|++++|++.+..
T Consensus 32 ~~~~~~~~~--~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~- 104 (384)
T d2omza2 32 TNVTDTVSQ--TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADIT- 104 (384)
T ss_dssp SSTTSEECH--HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG-
T ss_pred CCCCCccCH--HHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccccc-
Confidence 445555543 466788888888888873 4 457788888888888888884 44 3888888888888888887543
Q ss_pred ccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccC
Q 045553 176 AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLT 220 (1082)
Q Consensus 176 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~ 220 (1082)
.++.+++|+.|++++|.+++..+ .. ....+..+....|.+.
T Consensus 105 -~l~~l~~L~~L~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~l~ 145 (384)
T d2omza2 105 -PLANLTNLTGLTLFNNQITDIDP-LK--NLTNLNRLELSSNTIS 145 (384)
T ss_dssp -GGTTCTTCCEEECCSSCCCCCGG-GT--TCTTCSEEEEEEEEEC
T ss_pred -ccccccccccccccccccccccc-cc--cccccccccccccccc
Confidence 36777888888888777763322 21 2345555555555555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=1.2e-26 Score=265.21 Aligned_cols=96 Identities=17% Similarity=0.208 Sum_probs=63.4
Q ss_pred EcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCccc
Q 045553 116 LLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195 (1082)
Q Consensus 116 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 195 (1082)
.+..+.+++.+. ...+.+|++|++++|.|+. + +.+..+++|++|+|++|+|++.. .++++++|++|++++|++.
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence 455666665554 3466788888888888873 3 45788888888888888888543 2777777777777777776
Q ss_pred ccCCcccccccccccEEEcccCccC
Q 045553 196 GSVPEEFGDNCVSLEHILLAANSLT 220 (1082)
Q Consensus 196 ~~~p~~~~~~l~~L~~L~L~~N~l~ 220 (1082)
+ ++. + ..+++|+.|++++|.++
T Consensus 102 ~-i~~-l-~~l~~L~~L~~~~~~~~ 123 (384)
T d2omza2 102 D-ITP-L-ANLTNLTGLTLFNNQIT 123 (384)
T ss_dssp C-CGG-G-TTCTTCCEEECCSSCCC
T ss_pred c-ccc-c-ccccccccccccccccc
Confidence 2 221 1 23455555555555544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=4.3e-24 Score=235.59 Aligned_cols=266 Identities=19% Similarity=0.243 Sum_probs=206.4
Q ss_pred CCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcc
Q 045553 111 QLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLS 190 (1082)
Q Consensus 111 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 190 (1082)
.++.++=++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|..+++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4566676777777 6676553 578888888888874444567888888888888888887667778888888888888
Q ss_pred cCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCC--CCcCccccCCCCCCEEeCCCCcCc
Q 045553 191 FNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQ--GDIPSSFGQLVNLEVLDLSRNFLS 268 (1082)
Q Consensus 191 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~ 268 (1082)
+|+++ .+|..+. ..+..|.+.+|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|.++
T Consensus 88 ~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 88 KNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp SSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCccC-cCccchh---hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 88887 6666543 46788888888888666666777777888888877654 334566788888888888888887
Q ss_pred ccCCccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCccc
Q 045553 269 GIVPSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNW 348 (1082)
Q Consensus 269 ~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l 348 (1082)
.+|..+ +++|+.|++++| ......+..|.+++.++.|++++|.+.++.+..+
T Consensus 164 -~l~~~~--~~~L~~L~l~~n-------------------------~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~ 215 (305)
T d1xkua_ 164 -TIPQGL--PPSLTELHLDGN-------------------------KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 215 (305)
T ss_dssp -SCCSSC--CTTCSEEECTTS-------------------------CCCEECTGGGTTCTTCCEEECCSSCCCEECTTTG
T ss_pred -ccCccc--CCccCEEECCCC-------------------------cCCCCChhHhhccccccccccccccccccccccc
Confidence 345443 578888888764 3444567788888899999999999999989999
Q ss_pred ccccCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCcccCCCCc-------ccCcccEEEecCCcce
Q 045553 349 ELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGLLPEEV-------SVPCMAVFNVSQNLLS 412 (1082)
Q Consensus 349 ~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-------~l~~L~~L~l~~N~l~ 412 (1082)
..+++|++|+|++|+|+ .+|.+|.++++|++|+|++|+|+......+ .+++|+.|++++|++.
T Consensus 216 ~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 216 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp GGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 99999999999999998 678899999999999999999997655443 3578999999999985
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=6.4e-24 Score=234.17 Aligned_cols=84 Identities=23% Similarity=0.319 Sum_probs=46.1
Q ss_pred cccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhcc
Q 045553 544 CMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623 (1082)
Q Consensus 544 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 623 (1082)
+|+.|++++|.+++..+..|.+++.+++|++++|.+++..+..|.++++|++|+|++|+|+ .+|..|.++++|++|+|+
T Consensus 172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls 250 (305)
T d1xkua_ 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 250 (305)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred ccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECC
Confidence 3555555555555555555555555555555555555555555555555555555555555 344455555555555555
Q ss_pred CcccC
Q 045553 624 ANSLS 628 (1082)
Q Consensus 624 ~N~l~ 628 (1082)
+|+|+
T Consensus 251 ~N~i~ 255 (305)
T d1xkua_ 251 NNNIS 255 (305)
T ss_dssp SSCCC
T ss_pred CCccC
Confidence 55555
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=8.8e-24 Score=230.33 Aligned_cols=114 Identities=19% Similarity=0.258 Sum_probs=82.8
Q ss_pred ccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCc
Q 045553 536 SDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615 (1082)
Q Consensus 536 ~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 615 (1082)
...|..+++|+++++++|+++++.|..|.++++|++|++++|.+.+..+..|..+++|++|+|++|.+...-+ .-.-..
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~ 248 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWA 248 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHH
T ss_pred hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHH
Confidence 3344455668888888888888888888888888999999999888888888888889999998888875432 112224
Q ss_pred ccchhhccCcccCCCCCccccCCcccceecccCcccCC
Q 045553 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTG 653 (1082)
Q Consensus 616 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 653 (1082)
.++++....+++....|..+. .+..++++.+.|+|
T Consensus 249 ~l~~~~~~~~~~~C~~p~~l~---g~~l~~l~~~~l~g 283 (284)
T d1ozna_ 249 WLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283 (284)
T ss_dssp HHHHCCSEECCCBEEESGGGT---TCBGGGSCGGGSCC
T ss_pred HHHhCcCCCCceEeCCchHHc---CCccccCCHHHCCC
Confidence 567777777777766666654 34556666666665
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.4e-23 Score=226.15 Aligned_cols=147 Identities=27% Similarity=0.307 Sum_probs=120.4
Q ss_pred CCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhh
Q 045553 542 CKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLE 621 (1082)
Q Consensus 542 ~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 621 (1082)
+++|++|+|++|+++.. +..+..+++|++|++++|.+.+..+..+..+.++++|++++|.++...+..+..++.|+.|+
T Consensus 76 l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~ 154 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (266)
T ss_dssp CTTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccccc-ccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcc
Confidence 34577777777777744 55788888899999999988887888888888999999999999877778888889999999
Q ss_pred ccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCCCCCcccccccCCCCCCCCCCCC
Q 045553 622 LSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQGNPNLQLCHT 701 (1082)
Q Consensus 622 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~Np~~c~c~~ 701 (1082)
+++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|+ ||||.|+|.
T Consensus 155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~--------------------~Np~~CdC~- 212 (266)
T d1p9ag_ 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH--------------------GNPWLCNCE- 212 (266)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECC--------------------SCCBCCSGG-
T ss_pred cccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEec--------------------CCCCCCCcc-
Confidence 9999999887888899999999999999999 788888888999998884 567778887
Q ss_pred CCCCCccccc
Q 045553 702 DPSSSEWERQ 711 (1082)
Q Consensus 702 ~~~~~~~~~~ 711 (1082)
..+...|.+.
T Consensus 213 ~~~l~~wl~~ 222 (266)
T d1p9ag_ 213 ILYFRRWLQD 222 (266)
T ss_dssp GHHHHHHHHH
T ss_pred hHHHHHHHHh
Confidence 4455566554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.8e-23 Score=227.87 Aligned_cols=226 Identities=20% Similarity=0.183 Sum_probs=142.5
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcc-c
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLS-F 191 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~ 191 (1082)
..++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++....+..+..++.++.+... .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 34566777777 6665543 567788888888875555567777788888888887776666677777777776654 3
Q ss_pred CcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccC
Q 045553 192 NLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIV 271 (1082)
Q Consensus 192 N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 271 (1082)
|.+. .++...+.++++|++|++++|.+....+..+...++|+.+++++|++++..+..|+.+++|++|++++|++++..
T Consensus 91 ~~~~-~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 91 AQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp TTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cccc-cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 3443 443333334555555555555555444445555555555555555555444455555555555555555555444
Q ss_pred CccccCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccc
Q 045553 272 PSELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELC 351 (1082)
Q Consensus 272 p~~l~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l 351 (1082)
+. +|.++++|+++++++|++.++.|..|..+
T Consensus 170 ~~-------------------------------------------------~f~~l~~L~~l~l~~N~l~~i~~~~f~~l 200 (284)
T d1ozna_ 170 ER-------------------------------------------------AFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200 (284)
T ss_dssp TT-------------------------------------------------TTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred hh-------------------------------------------------hhccccccchhhhhhccccccChhHhhhh
Confidence 44 44455555555556666666666677777
Q ss_pred cCCCeEEcCCccccCCCCccccCCCCCCEEecCCCcCccc
Q 045553 352 SKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTGL 391 (1082)
Q Consensus 352 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 391 (1082)
++|++|++++|++.+..+..|..+++|++|+|++|++...
T Consensus 201 ~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 7777777777777766667777777777777777777654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=3.4e-21 Score=207.18 Aligned_cols=200 Identities=22% Similarity=0.171 Sum_probs=110.1
Q ss_pred CCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEE
Q 045553 133 LSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHI 212 (1082)
Q Consensus 133 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L 212 (1082)
...+.+.|.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|.. ..+++|++|
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~--~~l~~L~~L 82 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD--GTLPVLGTL 82 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC--SCCTTCCEE
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccccc--ccccccccc
Confidence 344444555555555 4454432 34556666666665444455555555666666555555 33321 134455555
Q ss_pred EcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEeccccCC
Q 045553 213 LLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGP 292 (1082)
Q Consensus 213 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n~~~ 292 (1082)
+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~------------------ 143 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL------------------ 143 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT------------------
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceecccc------------------
Confidence 55555554 33445555566666666666665555555555566666666666555333322
Q ss_pred cccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCCeEEcCCccccCCCCccc
Q 045553 293 LYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASL 372 (1082)
Q Consensus 293 ~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~p~~~ 372 (1082)
+..+++|+.+++++|++.++.+..|..+++|++|+|++|+|+ .+|+.+
T Consensus 144 -------------------------------~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~ 191 (266)
T d1p9ag_ 144 -------------------------------LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191 (266)
T ss_dssp -------------------------------TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTT
T ss_pred -------------------------------ccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhH
Confidence 233344444444455555555555666666777777777776 666666
Q ss_pred cCCCCCCEEecCCCcCc
Q 045553 373 GNCKSLYFLDLSSNNLT 389 (1082)
Q Consensus 373 ~~l~~L~~L~Ls~N~l~ 389 (1082)
..+++|+.|+|++|++.
T Consensus 192 ~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 192 FGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTCCCSEEECCSCCBC
T ss_pred CCCCCCCEEEecCCCCC
Confidence 66667777777666654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=6.3e-21 Score=193.90 Aligned_cols=163 Identities=15% Similarity=0.182 Sum_probs=121.4
Q ss_pred cccceecccCceEEEEEEEcCCeEEEEEEeecCcc------------------ccHHHHHHHHHHHhccCCCceeeEeee
Q 045553 804 NVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF------------------QGVQQFAAEIRTLGRVQHPNLVTLIGY 865 (1082)
Q Consensus 804 ~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 865 (1082)
.+.++||+|+||+||+|...+|+.||||+++.... .....+.+|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999888899999998753211 012335578899999999999988766
Q ss_pred eccCCeEEEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCEEEcCCCcEEEee
Q 045553 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSD 945 (1082)
Q Consensus 866 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 945 (1082)
.. .++||||+++..+.+ +++.....++.|++++++|||+. +|+||||||+|||++++ .++++|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 42 379999998765433 33345668999999999999999 99999999999999965 589999
Q ss_pred cccceecCCCCCccccCcccCCCccc------chhcccCCCCchhhHHHHHHHH
Q 045553 946 FGLARLLGTSETHATTDVAGTFGYVA------PEYAMTCRVSDKADVYSFGVVL 993 (1082)
Q Consensus 946 fGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Dv~slGvll 993 (1082)
||.|.....+.... |.. .|. ..+.|..++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99998764332211 111 111 235677888999976443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=2.9e-18 Score=192.20 Aligned_cols=134 Identities=21% Similarity=0.251 Sum_probs=79.4
Q ss_pred CCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEE
Q 045553 134 SLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213 (1082)
Q Consensus 134 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~ 213 (1082)
.+|++|||++|.++ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.. .+.|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l----p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh----cccccccc
Confidence 36888888888888 67753 467888888888888 56654 346777778877776 44421 13466666
Q ss_pred cccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccccCCCCCcEEEecc
Q 045553 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288 (1082)
Q Consensus 214 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 288 (1082)
+++|.++ .+|. ++.+++|+.|++++|.+.. .+. ....+..+.+..+... .+..+..++.++.|.+++
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~ 171 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADN 171 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCS
T ss_pred ccccccc-cccc-hhhhccceeeccccccccc-ccc---ccccccchhhcccccc--ccccccccccceeccccc
Confidence 6666666 3342 4556666666666666552 222 2234555555544443 223344444455554444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=4.3e-18 Score=190.75 Aligned_cols=139 Identities=27% Similarity=0.279 Sum_probs=109.7
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEc
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSL 189 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 189 (1082)
.+|++|+|++++++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 47899999999998 67853 578999999999999 788654 57899999999988 34432 246999999
Q ss_pred ccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcc
Q 045553 190 SFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSG 269 (1082)
Q Consensus 190 ~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 269 (1082)
++|++. .+|.. ..+++|++|++++|.+.. .+.. ...+..+.+..+... ....+..++.++.|++++|.+..
T Consensus 106 ~~n~l~-~lp~~--~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 106 SNNQLE-KLPEL--QNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp CSSCCS-SCCCC--TTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS
T ss_pred cccccc-cccch--hhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceecccccccccc
Confidence 999998 77753 368999999999999883 3333 356778888777665 44567888999999999998873
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=3.2e-19 Score=181.27 Aligned_cols=175 Identities=21% Similarity=0.186 Sum_probs=138.9
Q ss_pred eEEEccCCcccccCCccccccCCcccEEEccCCcccc-cCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcC
Q 045553 521 LIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVG-LIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLS 599 (1082)
Q Consensus 521 ~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 599 (1082)
.++++++|+++ .||+.++ +++++|+|++|+|++ ..+..|.++++|++|+|++|.+.+..+..|..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 47899999988 8898876 458899999999976 456678899999999999999998888899999999999999
Q ss_pred CCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCccccCC
Q 045553 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSA 679 (1082)
Q Consensus 600 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 679 (1082)
+|+|+++.|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++....+ ...-...++.+.+..|.+++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCC
Confidence 999998888889999999999999999998888888899999999999998874332 2112234666778888888777
Q ss_pred CCC-cccccccCCCCCCCCCCC
Q 045553 680 PRN-SLIKCENVQGNPNLQLCH 700 (1082)
Q Consensus 680 p~~-~~~~~~~~~~Np~~c~c~ 700 (1082)
|.. ......++..|...|.+.
T Consensus 166 p~~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 166 PSKVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp STTTTTSBGGGSCTTTCCCCCC
T ss_pred ChhhcCCEeeecCHhhCcCCCC
Confidence 754 223445667777776543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=2.9e-18 Score=174.08 Aligned_cols=159 Identities=19% Similarity=0.225 Sum_probs=139.5
Q ss_pred CceeEEEccCCcccccCCccccccCCcccEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEE
Q 045553 518 LDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLS 597 (1082)
Q Consensus 518 ~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 597 (1082)
.++++|+|++|+|++.++...|..+++|++|+|++|++..+.++.|..+++|++|+|++|+|+.+.|..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 45679999999998889999999999999999999999999999999999999999999999988899999999999999
Q ss_pred cCCCcCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCCCCCCCcccEEeccCCcccc
Q 045553 598 LSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSG 677 (1082)
Q Consensus 598 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 677 (1082)
|++|+|++..|+.|..+++|++|+|++|.+..... ...-...++.+.+..|.++...|..+ ..++.++|+.|.|+|
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCC
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcC
Confidence 99999999999999999999999999999985432 22223457888899999987777654 566778999999997
Q ss_pred CCC
Q 045553 678 SAP 680 (1082)
Q Consensus 678 ~~p 680 (1082)
..+
T Consensus 185 ~~~ 187 (192)
T d1w8aa_ 185 SSE 187 (192)
T ss_dssp CCC
T ss_pred CCC
Confidence 655
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.4e-17 Score=174.19 Aligned_cols=152 Identities=16% Similarity=0.148 Sum_probs=77.6
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccC-ccccCCCCCcEEEccc
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIP-AFFGQSPGFQVVSLSF 191 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~ 191 (1082)
+.++.++.+++ .+|+.+. +++++|||++|.|+...+..|.++++|++|+|++|.+...++ ..|..++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45666666666 5665442 466677777777663333456666677777777666654433 4566666666666543
Q ss_pred -CcccccCCcccccccccccEEEcccCccCCCCCc-cccCCCCccEEEccCCcCCCCcCccccCCC-CCCEEeCCCCcCc
Q 045553 192 -NLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPP-SLGNCTELRSLLLSSNMLQGDIPSSFGQLV-NLEVLDLSRNFLS 268 (1082)
Q Consensus 192 -N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~ 268 (1082)
|.+. .++...+..+++|++|++++|+++...+. .+..+..+..+..+++.+....+..|..++ .++.|++++|+++
T Consensus 88 ~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 88 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CTTCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccc-ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 4444 33333333455555555555555432221 122333444444444444433333443332 4444455544444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=3.8e-20 Score=215.70 Aligned_cols=85 Identities=18% Similarity=0.135 Sum_probs=47.0
Q ss_pred CCCEEEcccCCCccc-CChhhcCCCCCCEEeCcCCCCCC----CCCccccCCCCCCeEEccCccccccc----Ccccc-C
Q 045553 111 QLRVLLLAFNGFSGE-LPLEIGQLSLLEILDLSFNSFHG----PIPPTLQNCSSLRLINLSGNQFNGTI----PAFFG-Q 180 (1082)
Q Consensus 111 ~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~-~ 180 (1082)
+|++|||+.|++++. +...+..+++|+.|+|++|.++. .++..+..+++|++|||++|+|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 466777777777642 23335556677777777776652 23444566667777777777665221 11121 1
Q ss_pred CCCCcEEEcccCccc
Q 045553 181 SPGFQVVSLSFNLLS 195 (1082)
Q Consensus 181 l~~L~~L~L~~N~l~ 195 (1082)
.++|++|+|++|+++
T Consensus 83 ~~~L~~L~L~~n~it 97 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLT 97 (460)
T ss_dssp TCCCCEEECTTSCCB
T ss_pred CCCCCEEECCCCCcc
Confidence 234555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1e-16 Score=167.38 Aligned_cols=201 Identities=19% Similarity=0.250 Sum_probs=95.2
Q ss_pred EcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCccc
Q 045553 116 LLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195 (1082)
Q Consensus 116 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 195 (1082)
+++.+++++.+ .++.+.+|+.|++++|.|+ .++ .+.++++|++|++++|++.+..| +..+++|+.+++++|.++
T Consensus 25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (227)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc
Confidence 34444444322 2344555555555555555 232 35555556666665555553322 445555555555555444
Q ss_pred ccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCCccc
Q 045553 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL 275 (1082)
Q Consensus 196 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 275 (1082)
.++. +. .+++|+.+.++++...+. ..+...+.++.+.++++.+... ..+..+++|++|++++|.+.+.
T Consensus 99 -~i~~-l~-~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~----- 166 (227)
T d1h6ua2 99 -NVSA-IA-GLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL----- 166 (227)
T ss_dssp -CCGG-GT-TCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC-----
T ss_pred -cccc-cc-cccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc-----
Confidence 2221 11 233344444433333321 1233344455555555554421 1234444555555555544321
Q ss_pred cCCCCCcEEEeccccCCcccccCCCCCCcccccCCCcccccCCCCCccccCCCCCcEEEcCCCcccCCCCcccccccCCC
Q 045553 276 GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLE 355 (1082)
Q Consensus 276 ~~l~~L~~L~l~~n~~~~~~~~~~~l~~~~~~~~~~~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 355 (1082)
..++++++|+.|++++|++.++. .++.+++|+
T Consensus 167 ----------------------------------------------~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~ 198 (227)
T d1h6ua2 167 ----------------------------------------------TPLANLSKLTTLKADDNKISDIS--PLASLPNLI 198 (227)
T ss_dssp ----------------------------------------------GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCC
T ss_pred ----------------------------------------------hhhcccccceecccCCCccCCCh--hhcCCCCCC
Confidence 11334444555555555554432 255666666
Q ss_pred eEEcCCccccCCCCccccCCCCCCEEecC
Q 045553 356 MLNLAHNFFTGQIPASLGNCKSLYFLDLS 384 (1082)
Q Consensus 356 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls 384 (1082)
+|+|++|++++ ++ .+.++++|+.|+|+
T Consensus 199 ~L~Ls~N~lt~-i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 199 EVHLKNNQISD-VS-PLANTSNLFIVTLT 225 (227)
T ss_dssp EEECTTSCCCB-CG-GGTTCTTCCEEEEE
T ss_pred EEECcCCcCCC-Cc-ccccCCCCCEEEee
Confidence 66666666663 33 25666666666664
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=1.4e-16 Score=163.91 Aligned_cols=176 Identities=23% Similarity=0.298 Sum_probs=147.1
Q ss_pred CCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccC
Q 045553 96 DKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIP 175 (1082)
Q Consensus 96 ~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 175 (1082)
+.+.+.++. .++..|++|++++|.+++ ++ .+..+++|++|+|++|+|++ ++ .++++++|++|++++|++++ +|
T Consensus 34 ~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~ 106 (210)
T d1h6ta2 34 KSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS 106 (210)
T ss_dssp SCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG
T ss_pred CccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc
Confidence 455555543 357799999999999984 44 48899999999999999995 44 37899999999999999984 44
Q ss_pred ccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCC
Q 045553 176 AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255 (1082)
Q Consensus 176 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 255 (1082)
.+..+++|+.|++++|.+. .++. + ..++.++.+++++|.+++. ..+..+++|+.+++++|++++ ++ .+++++
T Consensus 107 -~l~~l~~L~~L~l~~~~~~-~~~~-l-~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~ 178 (210)
T d1h6ta2 107 -SLKDLKKLKSLSLEHNGIS-DING-L-VHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IV-PLAGLT 178 (210)
T ss_dssp -GGTTCTTCCEEECTTSCCC-CCGG-G-GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CG-GGTTCT
T ss_pred -ccccccccccccccccccc-cccc-c-ccccccccccccccccccc--ccccccccccccccccccccc-cc-cccCCC
Confidence 5889999999999999987 4443 3 3689999999999999843 357789999999999999985 33 389999
Q ss_pred CCCEEeCCCCcCcccCCccccCCCCCcEEEecc
Q 045553 256 NLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRN 288 (1082)
Q Consensus 256 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 288 (1082)
+|++|+|++|+|+. +| .+..+++|++|++++
T Consensus 179 ~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 179 KLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp TCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred CCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 99999999999984 55 599999999999964
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=9.7e-17 Score=169.47 Aligned_cols=179 Identities=15% Similarity=0.046 Sum_probs=137.8
Q ss_pred CCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCC-CccccCCCCCCeEEccC-cccccccCccccCCCCCcEE
Q 045553 110 TQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPI-PPTLQNCSSLRLINLSG-NQFNGTIPAFFGQSPGFQVV 187 (1082)
Q Consensus 110 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 187 (1082)
+++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++.. |.+....+..|.++++|++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 47899999999998555567999999999999999987654 45788999999999864 77887888899999999999
Q ss_pred EcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCC-CccEEEccCCcCCCCcCccccCCCCCCEE-eCCCC
Q 045553 188 SLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCT-ELRSLLLSSNMLQGDIPSSFGQLVNLEVL-DLSRN 265 (1082)
Q Consensus 188 ~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-~Ls~N 265 (1082)
++++|++....+......+..+..+...++++....+..+.+++ .++.|++++|+++...+..| ..+++.++ ++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhcccccccc
Confidence 99999998443444445567777778888888866667777765 78999999999985444444 45555544 56778
Q ss_pred cCcccCCccccCCCCCcEEEeccc
Q 045553 266 FLSGIVPSELGMCKQLKVLVLRND 289 (1082)
Q Consensus 266 ~l~~~~p~~l~~l~~L~~L~l~~n 289 (1082)
+++...+..|.++++|++|++++|
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N 211 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRT 211 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTS
T ss_pred ccccccHHHhcCCCCCCEEECCCC
Confidence 888554555677777777777664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=2.5e-16 Score=164.40 Aligned_cols=178 Identities=20% Similarity=0.290 Sum_probs=142.7
Q ss_pred CCCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCccccccc
Q 045553 95 SDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTI 174 (1082)
Q Consensus 95 ~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 174 (1082)
.+++++.+ .+.++.+|+.|++.+|+|+ .++ .+.++++|++|++++|.+++..| +.++++|++|++++|.++. +
T Consensus 28 ~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i 100 (227)
T d1h6ua2 28 KSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V 100 (227)
T ss_dssp CSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C
T ss_pred CCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c
Confidence 35555543 4677899999999999999 454 59999999999999999995433 8999999999999999983 3
Q ss_pred CccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCC
Q 045553 175 PAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQL 254 (1082)
Q Consensus 175 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 254 (1082)
..+.++++|+.+++++|+..+..+ + ...+.++.+.++.+.+.... .+.++++|+.|++++|.+... ..+.++
T Consensus 101 -~~l~~l~~L~~l~l~~~~~~~~~~--~-~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l 172 (227)
T d1h6ua2 101 -SAIAGLQSIKTLDLTSTQITDVTP--L-AGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANL 172 (227)
T ss_dssp -GGGTTCTTCCEEECTTSCCCCCGG--G-TTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred -ccccccccccccccccccccccch--h-ccccchhhhhchhhhhchhh--hhccccccccccccccccccc--hhhccc
Confidence 357899999999999999874332 2 24688999999999988543 477889999999999999843 348899
Q ss_pred CCCCEEeCCCCcCcccCCccccCCCCCcEEEeccc
Q 045553 255 VNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRND 289 (1082)
Q Consensus 255 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~n 289 (1082)
++|++|+|++|++++. + .++.+++|++|++++|
T Consensus 173 ~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N 205 (227)
T d1h6ua2 173 SKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNN 205 (227)
T ss_dssp TTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTS
T ss_pred ccceecccCCCccCCC-h-hhcCCCCCCEEECcCC
Confidence 9999999999999853 3 3666666666666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.1e-19 Score=211.64 Aligned_cols=89 Identities=24% Similarity=0.144 Sum_probs=53.3
Q ss_pred CCcccEEEccCCccccc----Ccccc-CCCCCCCEEEccCCCCCCC----CcccccCCCCCCEEEcCCCcCCccCchhh-
Q 045553 542 CKCMKFLSMAGNEFVGL----IPQSF-TNFDSLRNLNLSRNHLQGP----LPSYINKMEDLKFLSLSLNNFTGAIPWEL- 611 (1082)
Q Consensus 542 ~~~L~~L~L~~N~i~~~----~~~~~-~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~- 611 (1082)
..+|++|+|++|+|+.. ++..+ ...+.|++|+|++|.|+.. +...+..+++|++|+|++|+|+......|
T Consensus 339 ~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~ 418 (460)
T d1z7xw1 339 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418 (460)
T ss_dssp CSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHH
T ss_pred ccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHH
Confidence 34577777777776532 22223 2355677777777777632 33445566777777777777764333222
Q ss_pred ---h-cCcccchhhccCcccCCC
Q 045553 612 ---T-QLASLEVLELSANSLSGE 630 (1082)
Q Consensus 612 ---~-~l~~L~~L~Ls~N~l~~~ 630 (1082)
. +...|+.|++++|.+...
T Consensus 419 ~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 419 ESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHHTSTTCCCCEEECTTCCCCHH
T ss_pred HHHHhCCCccCEEECCCCCCCHH
Confidence 1 233677788877777643
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=3.7e-16 Score=159.28 Aligned_cols=172 Identities=25% Similarity=0.332 Sum_probs=142.4
Q ss_pred CCccccccccccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccC
Q 045553 96 DKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIP 175 (1082)
Q Consensus 96 ~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 175 (1082)
+.+++.++ ..++.+|++|++++|+++ .++ .+..+++|++|+|++|++++. +. ++++++|++|++++|.+.. ++
T Consensus 28 ~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~-~~ 100 (199)
T d2omxa2 28 TNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIAD-IT 100 (199)
T ss_dssp SSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG
T ss_pred CCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCc-cc-ccCCccccccccccccccc-cc
Confidence 45555443 356889999999999998 443 588999999999999999954 43 9999999999999999884 33
Q ss_pred ccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCC
Q 045553 176 AFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLV 255 (1082)
Q Consensus 176 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 255 (1082)
.+.++++|+.|++++|.+.. ++ .+ ..+++|+.|++++|++. .++ .+..+++|+.|++++|++++. + .+++++
T Consensus 101 -~l~~l~~L~~L~l~~~~~~~-~~-~~-~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~ 172 (199)
T d2omxa2 101 -PLANLTNLTGLTLFNNQITD-ID-PL-KNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLT 172 (199)
T ss_dssp -GGTTCTTCSEEECCSSCCCC-CG-GG-TTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCT
T ss_pred -cccccccccccccccccccc-cc-cc-chhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC-c-cccCCC
Confidence 48899999999999999874 33 23 36899999999999998 443 588999999999999999853 3 489999
Q ss_pred CCCEEeCCCCcCcccCCccccCCCCCcEE
Q 045553 256 NLEVLDLSRNFLSGIVPSELGMCKQLKVL 284 (1082)
Q Consensus 256 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 284 (1082)
+|++|++++|++++ ++ .++.+++|++|
T Consensus 173 ~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 173 TLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp TCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred CCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 99999999999985 43 58899999876
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=4.8e-16 Score=159.79 Aligned_cols=118 Identities=19% Similarity=0.233 Sum_probs=64.0
Q ss_pred EcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCccc
Q 045553 116 LLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLS 195 (1082)
Q Consensus 116 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 195 (1082)
.+..+.+++.++. ..+.+|++|++++|.++. ++ .+..+++|++|+|++|+|++.. .++.+++|+.|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc
Confidence 4555555544442 245567777777777763 32 3666677777777777666422 2445555555555555554
Q ss_pred ccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCc
Q 045553 196 GSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLS 268 (1082)
Q Consensus 196 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 268 (1082)
.+| .+.++++|+.|++++|.+.. + ..+..+++++.+++++|.++
T Consensus 104 -~l~--------------------------~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~ 147 (210)
T d1h6ta2 104 -DLS--------------------------SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT 147 (210)
T ss_dssp -CGG--------------------------GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCC
T ss_pred -ccc--------------------------cccccccccccccccccccc-c-cccccccccccccccccccc
Confidence 222 24445555555555555542 1 23455555555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.62 E-value=2.7e-15 Score=152.70 Aligned_cols=164 Identities=22% Similarity=0.272 Sum_probs=136.5
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccC
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (1082)
..+.++.+.+++.++ ...+.+|++|++++|.++ .+. .++.+++|++|++++|++++..| ++++++|++|++++|
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence 345667788776544 356789999999999998 443 58999999999999999996543 899999999999999
Q ss_pred cccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCC
Q 045553 193 LLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVP 272 (1082)
Q Consensus 193 ~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 272 (1082)
.+. .++. + ..++.|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|++|++++|++++. +
T Consensus 95 ~~~-~~~~-l-~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~ 166 (199)
T d2omxa2 95 QIA-DITP-L-ANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K 166 (199)
T ss_dssp CCC-CCGG-G-TTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G
T ss_pred ccc-cccc-c-ccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c
Confidence 988 5553 3 4689999999999998853 358889999999999999973 4 3588999999999999999864 3
Q ss_pred ccccCCCCCcEEEeccccC
Q 045553 273 SELGMCKQLKVLVLRNDYG 291 (1082)
Q Consensus 273 ~~l~~l~~L~~L~l~~n~~ 291 (1082)
.++++++|++|++++|.+
T Consensus 167 -~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 167 -PLANLTTLERLDISSNKV 184 (199)
T ss_dssp -GGTTCTTCCEEECCSSCC
T ss_pred -cccCCCCCCEEECCCCCC
Confidence 489999999999998643
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3e-14 Score=139.01 Aligned_cols=128 Identities=16% Similarity=0.109 Sum_probs=73.6
Q ss_pred ccCCCCCCEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCc
Q 045553 106 IGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQ 185 (1082)
Q Consensus 106 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 185 (1082)
+.+...|++|+|++|+|+ .++..+..+++|+.|+|++|.|+ .++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 455566666666666666 44555556666666666666666 332 356666666666666666644444444555555
Q ss_pred EEEcccCcccccCCcccccccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcC----ccccCCCCCCEEe
Q 045553 186 VVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP----SSFGQLVNLEVLD 261 (1082)
Q Consensus 186 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~ 261 (1082)
.|++++|+++ .++. ...+..+++|++|++++|.++. .| ..++.+++|++||
T Consensus 91 ~L~L~~N~i~-~~~~-----------------------l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLV-ELGD-----------------------LDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCC-CGGG-----------------------GGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred cceecccccc-cccc-----------------------ccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 5555555554 2221 0235556666666666666652 23 2456677777766
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3.2e-14 Score=138.79 Aligned_cols=127 Identities=19% Similarity=0.139 Sum_probs=82.6
Q ss_pred hcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccc
Q 045553 130 IGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSL 209 (1082)
Q Consensus 130 ~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L 209 (1082)
|.+..+|++|||++|+|+ .++..+..+++|++|+|++|+|+. ++ .|.. +++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~-------------------------l~~L 65 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPL-------------------------LRRL 65 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCC-------------------------CSSC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-Cccc-------------------------Ccch
Confidence 444555556666666655 344444555555555555555552 21 2333 4555
Q ss_pred cEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcC--ccccCCCCCCEEeCCCCcCcccCC----ccccCCCCCcE
Q 045553 210 EHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP--SSFGQLVNLEVLDLSRNFLSGIVP----SELGMCKQLKV 283 (1082)
Q Consensus 210 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~ 283 (1082)
++|++++|+++...+..+..+++|++|++++|+|+. ++ ..+..+++|++|++++|+++. .| ..+..+++|++
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~ 143 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRV 143 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSE
T ss_pred hhhhcccccccCCCccccccccccccceeccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCe
Confidence 555555555553333345567888888888888874 33 468899999999999999974 44 35888999999
Q ss_pred EEe
Q 045553 284 LVL 286 (1082)
Q Consensus 284 L~l 286 (1082)
|+-
T Consensus 144 LD~ 146 (162)
T d1a9na_ 144 LDF 146 (162)
T ss_dssp ETT
T ss_pred eCC
Confidence 975
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=4e-14 Score=131.25 Aligned_cols=102 Identities=25% Similarity=0.335 Sum_probs=59.9
Q ss_pred cEEEccCCcccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccCc
Q 045553 546 KFLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSAN 625 (1082)
Q Consensus 546 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 625 (1082)
|.|+|++|+|+.. + .+..+++|++|++++|+|+ .+|..|..+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 3456666666533 2 2566666666666666666 345556666666666666666663 33 3566666666666666
Q ss_pred ccCCCC-CccccCCcccceecccCcccC
Q 045553 626 SLSGEI-PSEFSKLEHLNVLRLDHNNLT 652 (1082)
Q Consensus 626 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 652 (1082)
+|+... ...+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 665332 234556666666666666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=9e-15 Score=157.71 Aligned_cols=60 Identities=20% Similarity=0.255 Sum_probs=31.9
Q ss_pred CCCCCEEeCcCCCCCCC-CCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccC
Q 045553 133 LSLLEILDLSFNSFHGP-IPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 133 l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (1082)
..+|++|||++|.++.. +...+.++++|++|+|++|.+.+..+..++.+++|++|+|++|
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccc
Confidence 34555555555555422 2233455555566666555555555555555555555555553
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.7e-14 Score=155.54 Aligned_cols=126 Identities=15% Similarity=0.133 Sum_probs=64.9
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccc-cCccccCCCCCcEEEccc
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGT-IPAFFGQSPGFQVVSLSF 191 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~ 191 (1082)
+.|||+++.+.......+.. ..+..+.++...+.... .......+|++|||++|.+... ++..+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 46777776665322222211 23456666665555222 2233455777777777776633 334556666777777776
Q ss_pred CcccccCCcccccccccccEEEcccC-ccCCCCC-ccccCCCCccEEEccCC
Q 045553 192 NLLSGSVPEEFGDNCVSLEHILLAAN-SLTGSIP-PSLGNCTELRSLLLSSN 241 (1082)
Q Consensus 192 N~l~~~~p~~~~~~l~~L~~L~L~~N-~l~~~~~-~~~~~l~~L~~L~L~~N 241 (1082)
|.+.+..+..++ .+++|++|+++++ .+++..- .-..++++|++|+++++
T Consensus 81 ~~l~~~~~~~l~-~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 81 LRLSDPIVNTLA-KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp CBCCHHHHHHHT-TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred cCCCcHHHHHHh-cCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 666544444443 3455666666553 3332111 11233455555555553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.44 E-value=4.6e-15 Score=165.25 Aligned_cols=95 Identities=22% Similarity=0.242 Sum_probs=67.2
Q ss_pred cccccccCCCCCCEEEcccCCCccc----CChhhcCCCCCCEEeCcCCCCCCC----------CCccccCCCCCCeEEcc
Q 045553 101 NLSRAIGDLTQLRVLLLAFNGFSGE----LPLEIGQLSLLEILDLSFNSFHGP----------IPPTLQNCSSLRLINLS 166 (1082)
Q Consensus 101 ~l~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----------~p~~l~~l~~L~~L~Ls 166 (1082)
.+..++.+...|+.|+|++|.++.. +...+...++|+.|+++++..... +...+...++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3455677788899999999988643 334466778999999988765421 12335667888888888
Q ss_pred Ccccccc----cCccccCCCCCcEEEcccCccc
Q 045553 167 GNQFNGT----IPAFFGQSPGFQVVSLSFNLLS 195 (1082)
Q Consensus 167 ~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 195 (1082)
+|.+... +...+...++|++|++++|.+.
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred ccccccccccchhhhhcccccchheeccccccc
Confidence 8888754 3344556778888888888765
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.9e-13 Score=126.55 Aligned_cols=102 Identities=30% Similarity=0.382 Sum_probs=61.7
Q ss_pred CEEEcccCCCcccCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccC
Q 045553 113 RVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFN 192 (1082)
Q Consensus 113 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 192 (1082)
|+|+|++|+++ .++ .++.+++|++|++++|.|+ .+|..++.+++|++|++++|+|++ +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 46777777776 444 3677777777777777776 566667777777777777777763 33 3666666666666666
Q ss_pred cccccCCc-ccccccccccEEEcccCccC
Q 045553 193 LLSGSVPE-EFGDNCVSLEHILLAANSLT 220 (1082)
Q Consensus 193 ~l~~~~p~-~~~~~l~~L~~L~L~~N~l~ 220 (1082)
+++ .+|. .....+++|++|++++|.++
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 665 2321 11223444444444444443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=9.5e-13 Score=127.28 Aligned_cols=107 Identities=21% Similarity=0.126 Sum_probs=81.6
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCCEEEcCCC-cCCccCchhhhcCcccchhhccCcccCCCCCccccCCcccceec
Q 045553 567 DSLRNLNLSRNHLQGPLPSYINKMEDLKFLSLSLN-NFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLR 645 (1082)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 645 (1082)
...+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.|..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34556788888877 45677888888888888765 48877777888888888888888888877788888899999999
Q ss_pred ccCcccCCCCCCCCCCCCcccEEeccCCcc
Q 045553 646 LDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675 (1082)
Q Consensus 646 L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l 675 (1082)
|++|+|+...+..|. ..+|+.|+|++|+|
T Consensus 87 Ls~N~l~~l~~~~~~-~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 87 LSFNALESLSWKTVQ-GLSLQELVLSGNPL 115 (156)
T ss_dssp CCSSCCSCCCSTTTC-SCCCCEEECCSSCC
T ss_pred ccCCCCcccChhhhc-cccccccccCCCcc
Confidence 999999854444454 44688888755543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.34 E-value=3.9e-14 Score=157.61 Aligned_cols=165 Identities=20% Similarity=0.239 Sum_probs=98.7
Q ss_pred cCChhhcCCCCCCEEeCcCCCCCCC----CCccccCCCCCCeEEccCcccccc----------cCccccCCCCCcEEEcc
Q 045553 125 ELPLEIGQLSLLEILDLSFNSFHGP----IPPTLQNCSSLRLINLSGNQFNGT----------IPAFFGQSPGFQVVSLS 190 (1082)
Q Consensus 125 ~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~L~ 190 (1082)
.+...+.....|+.|+|++|.+... +...+...++|+.|+++++.+... +...+...++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 4556677889999999999988643 334567788999999988765421 22345567888888888
Q ss_pred cCcccccCCcccc---cccccccEEEcccCccCCCCCccc-------------cCCCCccEEEccCCcCCCC----cCcc
Q 045553 191 FNLLSGSVPEEFG---DNCVSLEHILLAANSLTGSIPPSL-------------GNCTELRSLLLSSNMLQGD----IPSS 250 (1082)
Q Consensus 191 ~N~l~~~~p~~~~---~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~L~~N~l~~~----~p~~ 250 (1082)
+|.+...-...+. ...++|++|++++|.++......+ ...+.|+.|++++|.++.. +...
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~ 181 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccch
Confidence 8887643222221 235677777777777642111111 2345666777777766522 2233
Q ss_pred ccCCCCCCEEeCCCCcCccc-----CCccccCCCCCcEEEeccc
Q 045553 251 FGQLVNLEVLDLSRNFLSGI-----VPSELGMCKQLKVLVLRND 289 (1082)
Q Consensus 251 ~~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~l~~n 289 (1082)
+...+.|++|+|++|+++.. +...+..+++|+.|++++|
T Consensus 182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N 225 (344)
T d2ca6a1 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN 225 (344)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSS
T ss_pred hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccc
Confidence 44556677777777766531 2223444455555555443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=6e-14 Score=141.91 Aligned_cols=131 Identities=23% Similarity=0.264 Sum_probs=68.3
Q ss_pred cCChhhcCCCCCCEEeCcCCCCCCCCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCccccc
Q 045553 125 ELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGD 204 (1082)
Q Consensus 125 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 204 (1082)
.+|.++..+++|++|+|++|.|+ .++ .+.++++|++|+|++|+|+ .+|..+..+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~----------------------- 92 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVA----------------------- 92 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHH-----------------------
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccc-----------------------
Confidence 34445555555555555555555 232 3555555555555555554 233333333
Q ss_pred ccccccEEEcccCccCCCCCccccCCCCccEEEccCCcCCCCcC-ccccCCCCCCEEeCCCCcCcccCCc----------
Q 045553 205 NCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP-SSFGQLVNLEVLDLSRNFLSGIVPS---------- 273 (1082)
Q Consensus 205 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~---------- 273 (1082)
++|++|++++|+++. + +.+..+++|+.|++++|+|+.... ..+..+++|++|+|++|++....+.
T Consensus 93 --~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~ 168 (198)
T d1m9la_ 93 --DTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp --HHCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHH
T ss_pred --ccccccccccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHH
Confidence 345555555555542 2 234555666666666666653211 3456666666666666666533222
Q ss_pred cccCCCCCcEEE
Q 045553 274 ELGMCKQLKVLV 285 (1082)
Q Consensus 274 ~l~~l~~L~~L~ 285 (1082)
.+..+++|+.||
T Consensus 169 vi~~lp~L~~LD 180 (198)
T d1m9la_ 169 VVKRLPNLKKLD 180 (198)
T ss_dssp HHHHCSSCCEES
T ss_pred HHHHCCCcCEeC
Confidence 145667777765
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=9.5e-14 Score=140.39 Aligned_cols=115 Identities=23% Similarity=0.245 Sum_probs=80.5
Q ss_pred CCCccccCCCCCCeEEccCcccccccCccccCCCCCcEEEcccCcccccCCcccccccccccEEEcccCccCCCCCcccc
Q 045553 149 PIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLG 228 (1082)
Q Consensus 149 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 228 (1082)
.++..+..+++|++|+|++|+|+. ++ .+.. +++|++|+|++|+|+ .++..+.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~-------------------------l~~L~~L~Ls~N~i~-~i~~~~~ 90 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSG-------------------------MENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHH-------------------------HTTCCEEECCEEEEC-SCSSHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccC-------------------------CccccChhhcccccc-ccccccc
Confidence 345556666666666666666652 22 2444 445555555555555 4444445
Q ss_pred CCCCccEEEccCCcCCCCcCccccCCCCCCEEeCCCCcCcccCC-ccccCCCCCcEEEeccccCCc
Q 045553 229 NCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVP-SELGMCKQLKVLVLRNDYGPL 293 (1082)
Q Consensus 229 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~n~~~~ 293 (1082)
.+++|++|++++|+++. + ..+..+++|++|++++|+|+.... ..+..+++|+.|++++|++..
T Consensus 91 ~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 91 VADTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 56789999999999984 4 358889999999999999985422 578999999999999997643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=5.8e-12 Score=121.64 Aligned_cols=111 Identities=19% Similarity=0.201 Sum_probs=73.0
Q ss_pred ccCCceeEEEccCCcccccCCccccccCCcccEEEccCC-cccccCccccCCCCCCCEEEccCCCCCCCCcccccCCCCC
Q 045553 515 CLSLDGLIFDIGNNKLIGEVPSDMGSHCKCMKFLSMAGN-EFVGLIPQSFTNFDSLRNLNLSRNHLQGPLPSYINKMEDL 593 (1082)
Q Consensus 515 ~~~~~l~~l~l~~n~l~~~ip~~~~~~~~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 593 (1082)
|.+.....++++++++. .+|..+. .+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.|.+|..+++|
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~-~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLP-GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSC-SCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCcCCCCeEEecCCCCc-cCccccc-CccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 44444456777777776 5565543 3456777777655 4776666777777777777777777776666777777777
Q ss_pred CEEEcCCCcCCccCchhhhcCcccchhhccCcccC
Q 045553 594 KFLSLSLNNFTGAIPWELTQLASLEVLELSANSLS 628 (1082)
Q Consensus 594 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 628 (1082)
++|+|++|+|+...+..|.. ..|+.|+|++|.+.
T Consensus 83 ~~L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 SRLNLSFNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred cceeccCCCCcccChhhhcc-ccccccccCCCccc
Confidence 77777777777444444443 35777777777664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=3.2e-09 Score=102.69 Aligned_cols=86 Identities=24% Similarity=0.177 Sum_probs=44.7
Q ss_pred cccccCCCCCCEEEcCCCcCCccC--chhhhcCcccchhhccCcccCCCCCccccCCcccceecccCcccCCCCCCC---
Q 045553 584 PSYINKMEDLKFLSLSLNNFTGAI--PWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPG--- 658 (1082)
Q Consensus 584 p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--- 658 (1082)
+..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+.|+|++|+++......
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 333344555666666666655332 233555666666666666666332222333345666666666665443321
Q ss_pred ----CCCCCcccEEe
Q 045553 659 ----FGTRSSLSIFD 669 (1082)
Q Consensus 659 ----~~~l~~L~~l~ 669 (1082)
+..+++|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 44566666654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=2e-08 Score=96.96 Aligned_cols=103 Identities=27% Similarity=0.221 Sum_probs=77.3
Q ss_pred EEEccCCcccccCccccCCCCCCCEEEccCCCCCCCC--cccccCCCCCCEEEcCCCcCCccCchhhhcCcccchhhccC
Q 045553 547 FLSMAGNEFVGLIPQSFTNFDSLRNLNLSRNHLQGPL--PSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSA 624 (1082)
Q Consensus 547 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 624 (1082)
.++..++.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+.....|+.|+|++
T Consensus 46 ~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~ 124 (162)
T d1koha1 46 VLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDG 124 (162)
T ss_dssp CTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTT
T ss_pred hcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCC
Confidence 3444444333 44556678899999999999999653 35577899999999999999965554555667899999999
Q ss_pred cccCCCCCc-------cccCCcccceecccCcccC
Q 045553 625 NSLSGEIPS-------EFSKLEHLNVLRLDHNNLT 652 (1082)
Q Consensus 625 N~l~~~~p~-------~~~~l~~L~~L~L~~N~l~ 652 (1082)
|.+...... .+..+|+|+.|| ++.+.
T Consensus 125 Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v~ 157 (162)
T d1koha1 125 NSLSDTFRDQSTYISAIRERFPKLLRLD--GHELP 157 (162)
T ss_dssp STTSSSSSSHHHHHHHHHTTSTTCCEET--TEECC
T ss_pred CCcCcCcccchhHHHHHHHHCCCCCEEC--cCCCc
Confidence 999865543 367889999887 55553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.24 E-value=1.8e-06 Score=90.27 Aligned_cols=150 Identities=12% Similarity=0.030 Sum_probs=103.4
Q ss_pred HHHHHHhcCccccceecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccC-CCceeeEeeeeccCCeE
Q 045553 794 ENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYHVSEAEM 872 (1082)
Q Consensus 794 ~~~~~~~~~~~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 872 (1082)
.++.+..+.|+..+..+.++.+.||+... ++..+++|+...........+.+|...++.+. +--+.+++++...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 34556667787777655555678999864 46667888876554444445678888877664 33356788888888889
Q ss_pred EEEEeecCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------
Q 045553 873 FLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC--------------------------------- 919 (1082)
Q Consensus 873 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------- 919 (1082)
++|||+++|.++.+..... . ....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886554321 1 12334555666666666421
Q ss_pred -----------------------CCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 920 -----------------------VPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 920 -----------------------~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877677999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=3.1e-05 Score=80.01 Aligned_cols=131 Identities=18% Similarity=0.147 Sum_probs=84.7
Q ss_pred eecccC-ceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCC--CceeeEeeeeccCCeEEEEEeecCCCCH
Q 045553 808 CIGSGG-FGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH--PNLVTLIGYHVSEAEMFLIYNYLPGGNL 884 (1082)
Q Consensus 808 ~lg~G~-~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL 884 (1082)
.+..|. -+.||+....++..+++|....... ..+..|...++.+.. -.+.+++++..+.+..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344555 3689999887788889998654433 235667777766643 3366788888888899999999988655
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 045553 885 EKFIQDRPRRTVEWSMLHKIALDVARALAYLH------------------------------------------------ 916 (1082)
Q Consensus 885 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH------------------------------------------------ 916 (1082)
.+.. ... ...+.++++.++-||
T Consensus 94 ~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 3210 000 011122222233333
Q ss_pred ---hCC----CCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 917 ---DEC----VPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 917 ---~~~----~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
... .+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 13479999999999999887778999998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.41 E-value=2.5e-05 Score=74.91 Aligned_cols=39 Identities=5% Similarity=-0.151 Sum_probs=18.4
Q ss_pred cCCCCccEEEccCCcCCCC-------cCccccCCCCCCEEeCCCCc
Q 045553 228 GNCTELRSLLLSSNMLQGD-------IPSSFGQLVNLEVLDLSRNF 266 (1082)
Q Consensus 228 ~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~ 266 (1082)
...++|++|+|++|.+... +...+...+.|+.|+++.+.
T Consensus 97 ~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 97 LVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp TTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3344555555555543311 22333444556666665543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.39 E-value=2.9e-05 Score=74.45 Aligned_cols=89 Identities=16% Similarity=0.091 Sum_probs=59.0
Q ss_pred cCCCCCCEEEcccC-CCccc----CChhhcCCCCCCEEeCcCCCCCCC----CCccccCCCCCCeEEccCccccccc---
Q 045553 107 GDLTQLRVLLLAFN-GFSGE----LPLEIGQLSLLEILDLSFNSFHGP----IPPTLQNCSSLRLINLSGNQFNGTI--- 174 (1082)
Q Consensus 107 ~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~--- 174 (1082)
.+.++|++|+|+++ .++.. +-..+...++|++|+|++|.++.. +...+...+.|++|+|++|.|+...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45578888888864 46532 334566777888888888887632 3344556678888888888877432
Q ss_pred -CccccCCCCCcEEEcccCccc
Q 045553 175 -PAFFGQSPGFQVVSLSFNLLS 195 (1082)
Q Consensus 175 -p~~~~~l~~L~~L~L~~N~l~ 195 (1082)
-..+..-+.|++|+|++|++.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 234555566777777776554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.83 E-value=0.0014 Score=71.71 Aligned_cols=75 Identities=12% Similarity=0.020 Sum_probs=47.0
Q ss_pred ceecccCceEEEEEEEcC-CeEEEEEEeecC-------ccccHHHHHHHHHHHhccC-C--CceeeEeeeeccCCeEEEE
Q 045553 807 NCIGSGGFGATYKAEIIP-GVVVAVKRLSVG-------RFQGVQQFAAEIRTLGRVQ-H--PNLVTLIGYHVSEAEMFLI 875 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lV 875 (1082)
+.||.|....||++...+ ++.|+||.-... ......+...|++.++.+. + ..+++++.+. .+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 458999999999996544 678899864321 1112334556787777663 2 3455566553 4456899
Q ss_pred EeecCCCC
Q 045553 876 YNYLPGGN 883 (1082)
Q Consensus 876 ~E~~~~gs 883 (1082)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.65 E-value=0.00015 Score=69.14 Aligned_cols=95 Identities=12% Similarity=0.148 Sum_probs=60.2
Q ss_pred cccccccCCCCCCEEEccc-CCCccc----CChhhcCCCCCCEEeCcCCCCCCC----CCccccCCCCCCeEEccCcccc
Q 045553 101 NLSRAIGDLTQLRVLLLAF-NGFSGE----LPLEIGQLSLLEILDLSFNSFHGP----IPPTLQNCSSLRLINLSGNQFN 171 (1082)
Q Consensus 101 ~l~~~l~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 171 (1082)
.+.....+.+.|++|+|++ +.++.. +-..+...++|++|+|++|.++.. +...+...++|+.|++++|.+.
T Consensus 8 ~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 8 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 3444456678888888887 456532 334456778888888888887643 2334566778888888888776
Q ss_pred cc----cCccccCCCCCcEEEcc--cCccc
Q 045553 172 GT----IPAFFGQSPGFQVVSLS--FNLLS 195 (1082)
Q Consensus 172 ~~----~p~~~~~l~~L~~L~L~--~N~l~ 195 (1082)
.. +...+...++|+.++|+ +|.+.
T Consensus 88 ~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 88 GSGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred chhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 43 22455556667665543 44443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.49 E-value=0.00012 Score=70.02 Aligned_cols=116 Identities=16% Similarity=0.186 Sum_probs=56.4
Q ss_pred cCCCCCCEEeCcC-CCCCCC----CCccccCCCCCCeEEccCcccccccC----ccccCCCCCcEEEcccCcccccCCcc
Q 045553 131 GQLSLLEILDLSF-NSFHGP----IPPTLQNCSSLRLINLSGNQFNGTIP----AFFGQSPGFQVVSLSFNLLSGSVPEE 201 (1082)
Q Consensus 131 ~~l~~L~~L~Ls~-n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~ 201 (1082)
.+.++|++|+|++ +.++.. +-..+...++|++|+|++|.+..... ..+...++++.|++++|.+....-.
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~- 92 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL- 92 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH-
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH-
Confidence 4456666666665 345422 22334455666666666666553221 2233344455555554444311111
Q ss_pred cccccccccEEEcccCccCCCCCccccCCCCccEEEc--cCCcCCC----CcCccccCCCCCCEEeCCCCcC
Q 045553 202 FGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLL--SSNMLQG----DIPSSFGQLVNLEVLDLSRNFL 267 (1082)
Q Consensus 202 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l 267 (1082)
.+...+...++|+.++| ++|.+.. .+.+.+...++|+.|+++.+..
T Consensus 93 --------------------~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 --------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp --------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred --------------------HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 12234445566665444 3455542 2334445566777777766543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.37 E-value=0.0033 Score=66.78 Aligned_cols=135 Identities=16% Similarity=0.151 Sum_probs=78.5
Q ss_pred ceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCcee--eEee-----eeccCCeEEEEEeecCCCCHH-
Q 045553 814 FGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLV--TLIG-----YHVSEAEMFLIYNYLPGGNLE- 885 (1082)
Q Consensus 814 ~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~~-----~~~~~~~~~lV~E~~~~gsL~- 885 (1082)
.-.||+++..+|..|++|+..... ...+++.+|.+.+..+....+. ..+. .+...+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 348999998899999999986543 3457788898888877533221 1111 223356688999999764221
Q ss_pred ----HH-------------HhhCC---CCCCCHH----------------------HHHHHHHHHHHHHHHH-hhCCCCC
Q 045553 886 ----KF-------------IQDRP---RRTVEWS----------------------MLHKIALDVARALAYL-HDECVPR 922 (1082)
Q Consensus 886 ----~~-------------l~~~~---~~~l~~~----------------------~~~~i~~~i~~~L~~L-H~~~~~~ 922 (1082)
.+ .+... ....++. .....+.++...+.-. .+....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 11 11110 0111111 1122222232222221 1223457
Q ss_pred eEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 923 VLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 923 ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.75 E-value=0.014 Score=63.65 Aligned_cols=72 Identities=14% Similarity=0.087 Sum_probs=48.9
Q ss_pred ceecccCceEEEEEEEcCC--------eEEEEEEeecCccccHHHHHHHHHHHhccCCCc-eeeEeeeeccCCeEEEEEe
Q 045553 807 NCIGSGGFGATYKAEIIPG--------VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN-LVTLIGYHVSEAEMFLIYN 877 (1082)
Q Consensus 807 ~~lg~G~~g~Vy~a~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E 877 (1082)
+.|+.|-.=.+|+++..++ +.|.+++.. . ........+|..+++.+.-.+ ..++++++.. .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5688888899999976543 567777664 2 223345668888888775334 3467777754 68999
Q ss_pred ecCCCCH
Q 045553 878 YLPGGNL 884 (1082)
Q Consensus 878 ~~~~gsL 884 (1082)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.47 E-value=0.04 Score=57.66 Aligned_cols=158 Identities=13% Similarity=0.041 Sum_probs=84.3
Q ss_pred ccHHHHHHHhcCccccce-----ecccCceEEEEEEEcCCeEEEEEEeecCccccHHHHHHHHHHHhccCCCce--eeEe
Q 045553 791 LTYENVVRATAGFNVQNC-----IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNL--VTLI 863 (1082)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~ 863 (1082)
++-+++.....+|.+.+. |..|.--+.|+.+..+|+ +++|++..... .+++..|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 466778888888887554 345666788999877664 78998754322 2334456666666543221 1111
Q ss_pred e------eeccCCeEEEEEeecCCCCHHH--------------HHhh----CC---CCC------------------CCH
Q 045553 864 G------YHVSEAEMFLIYNYLPGGNLEK--------------FIQD----RP---RRT------------------VEW 898 (1082)
Q Consensus 864 ~------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~----~~---~~~------------------l~~ 898 (1082)
. +.........++.++.+..... .++. .. ... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1112345666777765542211 0110 00 000 000
Q ss_pred HHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCEEEcCCCcEEEeeccccee
Q 045553 899 SMLHKIALDVARALAYLHD-ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL 951 (1082)
Q Consensus 899 ~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 951 (1082)
......+......+...+. ..+.++||+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1111222222222333222 2345899999999999999988778999998853
|